PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Neuendorf, E; Weber, A; Saalmueller, A; Schatzl, H; Reifenberg, K; Pfaff, E; Groschup, MH				Neuendorf, E; Weber, A; Saalmueller, A; Schatzl, H; Reifenberg, K; Pfaff, E; Groschup, MH			Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE NEUROBLASTOMA-CELLS; CULTURED-CELLS; STRAIN VARIATION; RESISTANT PRP; LINKED GLYCOSYLATION; MOLECULAR ANALYSIS; MASS-SPECTROMETRY; N-GLYCOSYLATION; TRANSGENIC MICE; CONVERSION	The conversion into abnormally folded prion protein (PrP) plays a key role in prion diseases. PrPC carries two N-linked glycan chains at amino acid residues 180 and 196 ( mouse). Previous in vitro data indicated that the conversion process may not require glycosylation of PrP. However, it is conceivable that these glycans function as intermolecular binding sites during the de novo infection of cells on susceptible organisms and/or play a role for the interaction of both PrP isoforms. Such receptor-like properties could contribute to the formation of specific prion strains. However, in earlier studies, mutations at the glycosylation sites of PrP led to intracellular trafficking abnormalities, which made it impossible to generate PrP glycosylation-deficient mice that were susceptible to bovine spongiform encephalopathy (BSE) or scrapie. We have now tested more than 25 different mutations at both consensus sites and found one nonglycosylated (T182N/T198A) and two monoglycosylated (T182N and T198A) mutants that rather retained authentic cellular trafficking properties. In vitro all three mutants were converted into PrPres. PrP mutant T182N/T198A also provoked a strong dominant-negative inhibition on the endogenous wild type PrP conversion reaction. By using the two monoglycosylated mutants, we generated transgenic mice overexpressing PrPC in their brains at levels of 2 - 4 times that of nontransgenic mice. Most interestingly, such mice proved readily susceptible to a challenge with either scrapie ( Chandler and Me7) or with BSE. Incubation times were comparable or in some instances even significantly shorter than those of nontransgenic mice. These data indicate that diglycosylation of PrPC is not mandatory for prion infection in vivo.	Fed Res Ctr Virus Dis Anim, Inst Novel & Emerging Infect Dis, Boddenblick 5A, D-17943 Greifswald, Isle Of Riems, Germany; Fed Res Ctr Virus Dis Anim, Inst Immunol, D-72076 Tubingen, Germany; Tech Univ Munich, Inst Virol, D-80802 Munich, Germany; Johannes Gutenberg Univ Mainz, Centralized Anim Facil, D-55101 Mainz, Germany	Technical University of Munich; Johannes Gutenberg University of Mainz	Groschup, MH (corresponding author), Fed Res Ctr Virus Dis Anim, Inst Novel & Emerging Infect Dis, Boddenblick 5A, D-17943 Greifswald, Isle Of Riems, Germany.	martin.groschup@rie.bfav.de	Schatzl, Hermann/G-4958-2011; Saalmüller, Armin/AAN-9058-2020	Saalmuller, Armin/0000-0002-7703-3252; Schatzl, Hermann/0000-0003-4972-8740				Ali BRS, 2000, GLYCOBIOLOGY, V10, P383, DOI 10.1093/glycob/10.4.383; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FUKUSHIMA Y, 1995, BIOCHEM J, V310, P553, DOI 10.1042/bj3100553; GROSCHUP MH, 1993, J GEN VIROL, V74, P1451, DOI 10.1099/0022-1317-74-7-1451; HARAGUCHI T, 1989, ARCH BIOCHEM BIOPHYS, V274, P1, DOI 10.1016/0003-9861(89)90409-8; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Herrmann LM, 1998, NEUROREPORT, V9, P2457, DOI 10.1097/00001756-199808030-00006; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; Holscher C, 1998, J VIROL, V72, P1153; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KASCSAK RJ, 1985, J GEN VIROL, V66, P1715, DOI 10.1099/0022-1317-66-8-1715; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; KOZAK SL, 1990, J VIROL, V64, P3500, DOI 10.1128/JVI.64.7.3500-3508.1990; Kuczius T, 1998, J INFECT DIS, V178, P693, DOI 10.1086/515337; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; LOCHT C, 1986, P NATL ACAD SCI USA, V83, P6372, DOI 10.1073/pnas.83.17.6372; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; LYNCH CM, 1991, J VIROL, V65, P3887, DOI 10.1128/JVI.65.7.3887-3890.1991; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McFarlane I, 2000, NEUROREPORT, V11, P1543, DOI 10.1097/00001756-200005150-00035; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; NEARY K, 1991, J VIROL, V65, P1031, DOI 10.1128/JVI.65.2.1031-1034.1991; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OLIVARES L, 1995, J BIOL CHEM, V270, P9437, DOI 10.1074/jbc.270.16.9437; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Petersen RB, 1996, J BIOL CHEM, V271, P12661, DOI 10.1074/jbc.271.21.12661; Priola SA, 1999, BIOMED PHARMACOTHER, V53, P27, DOI 10.1016/S0753-3322(99)80057-2; PRIOLA SA, 1995, J VIROL, V69, P7754, DOI 10.1128/JVI.69.12.7754-7758.1995; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; Priola SA, 2001, EMBO J, V20, P6692, DOI 10.1093/emboj/20.23.6692; Roberts SJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P227, DOI 10.1006/abbi.1997.0551; ROBERTSON MN, 1992, J VIROL, V66, P3271, DOI 10.1128/JVI.66.6.3271-3277.1992; RODRIGUEZ CG, 1995, J BIOL CHEM, V270, P25178, DOI 10.1074/jbc.270.42.25178; ROGERS M, 1990, Glycobiology, V1, P101, DOI 10.1093/glycob/1.1.101; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	68	56	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53306	53316		10.1074/jbc.M410796200	http://dx.doi.org/10.1074/jbc.M410796200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15448157	hybrid			2022-12-27	WOS:000225680600062
J	Thomas, LR; Johnson, RL; Reed, JC; Thorburn, A				Thomas, LR; Johnson, RL; Reed, JC; Thorburn, A			The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT APOPTOSIS; EFFECTOR DOMAIN; CASPASE-8; INITIATION; BINDING; FAMILY; DR4	Members of the tumor necrosis factor (TNF) superfamily of receptors such as Fas/CD95 and the TNF-related apoptosis-inducing ligand (TRAIL) receptors DR4 and DR5 induce apoptosis by recruiting adaptor molecules and caspases. The central adaptor molecule for these receptors is a death domain-containing protein, FADD, which binds to the activated receptor via death domain-death domain interactions. Here, we show that in addition to the death domain, the C-terminal tails of DR4 and DR5 positively regulate FADD binding, caspase activation and apoptosis. In contrast, the corresponding region in the Fas receptor has the opposite effect and inhibits binding to the receptor death domain. Replacement of wild-type or mutant DR5 molecules into DR5-deficient BJAB cells indicates that some agonistic antibodies display an absolute requirement for the C-terminal tail for FADD binding and signaling while other antibodies can function in the absence of this mechanism. These data demonstrate that regions outside the death domains of DR4 and DR5 have opposite effects to that of Fas in regulating FADD recruitment and show that different death receptor agonists can use distinct molecular mechanisms to activate signaling from the same receptor.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, UCHSC Fitzsimmons, Aurora, CO 80045 USA; Burnham Inst, La Jolla, CA 92037 USA; Human Genome Sci Inc, Rockville, MD 20850 USA; Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Sanford Burnham Prebys Medical Discovery Institute; GlaxoSmithKline; Human Genome Sciences Inc; Wake Forest University; Wake Forest University	Thorburn, A (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, UCHSC Fitzsimmons, POB 6508,Mail Stop 8303, Aurora, CO 80045 USA.	Andrew.Thorburn@uchsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061694] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61694] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; ITOH N, 1993, J BIOL CHEM, V268, P10932; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; Mori E, 2004, CELL DEATH DIFFER, V11, P203, DOI 10.1038/sj.cdd.4401331; Muhlenbeck F, 2000, J BIOL CHEM, V275, P32208, DOI 10.1074/jbc.M000482200; Peter ME, 2000, CELL DEATH DIFFER, V7, P759, DOI 10.1038/sj.cdd.4400735; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Thomas LR, 2004, J BIOL CHEM, V279, P32780, DOI 10.1074/jbc.M401680200; Thomas LR, 2002, J BIOL CHEM, V277, P34343, DOI 10.1074/jbc.M204169200; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517	27	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52479	52486		10.1074/jbc.M409578200	http://dx.doi.org/10.1074/jbc.M409578200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452120	hybrid			2022-12-27	WOS:000225493400093
J	Blanco, J; Bosch, B; Fernandez-Figueras, MT; Barretina, J; Clotet, B; Este, JA				Blanco, J; Bosch, B; Fernandez-Figueras, MT; Barretina, J; Clotet, B; Este, JA			High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1; ENTRY; INFECTION; LYMPHOCYTES; PROTEIN; CYTOSKELETON; ENDOCYTOSIS; RECEPTOR; BINDING	Cell-to-cell virus transmission is one of the most efficient mechanisms of human immunodeficiency virus (HIV) spread, requires CD4 and coreceptor expression in target cells, and may also lead to syncytium formation and cell death. Here, we show that in addition to this classical coreceptor-mediated transmission, the contact between HIV-producing cells and primary CD4 T cells lacking the appropriate coreceptor induced the uptake of HIV particles by target cells in the absence of membrane fusion or productive HIV replication. HIV uptake by CD4 T cells required cellular contacts mediated by the binding of gp120 to CD4 and intact actin cytoskeleton. HIV antigens taken up by CD4 T cells were rapidly endocytosed to trypsin-resistant compartments inducing a partial disappearance of CD4 molecules from the cell surface. Once the cellular contact was stopped, captured HIV were released as infectious particles. Electron microscopy revealed that HIV particles attached to the surface of target cells and accumulated in large (0.5 - 1.0 mum) intracellular vesicles containing 1 - 14 virions, without any evidence for massive clathrin-mediated HIV endocytosis. The capture of HIV particles into trypsin-resistant compartments required the availability of the gp120 binding site of CD4 but was independent of the intracytoplasmic tail of CD4. In conclusion, we describe a novel mechanism of HIV transmission, activated by the contact of infected and uninfected primary CD4 T cells, by which HIV could exploit CD4 T cells lacking the appropriate coreceptor as an itinerant virus reservoir.	Hosp Univ Germans Trias & Pujol, Fdn IrsiCaixa, Lab Retrovirol, Barcelona 08916, Spain; Hosp Univ Germans Trias & Pujol, Dept Pathol, Barcelona 08916, Spain	Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol	Blanco, J (corresponding author), Hosp Univ Germans Trias & Pujol, Fdn IrsiCaixa, Lab Retrovirol, Ctra Canyet S-N, Barcelona 08916, Spain.	jblanco@ns.hugtip.scs.es	Este, Jose/B-5509-2008; Blanco, Julià/A-5347-2008; Barretina, Jordi/A-7192-2013	Este, Jose/0000-0002-1436-5823; Blanco, Julià/0000-0002-2225-0217; Barretina, Jordi/0000-0002-3478-4080				Barretina J, 2003, ANTIVIR THER, V8, P155; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Blanco J, 2002, AIDS RES HUM RETROV, V18, P27, DOI 10.1089/088922202753394691; Blanco J, 2001, VIROLOGY, V285, P356, DOI 10.1006/viro.2001.0969; Blanco J, 1999, AIDS, V13, P909, DOI 10.1097/00002030-199905280-00006; Blanco J, 2003, VIROLOGY, V305, P318, DOI 10.1006/viro.2002.1764; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215; Deschambeault J, 1999, J VIROL, V73, P5010, DOI 10.1128/JVI.73.6.5010-5017.1999; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; EWING EP, 1983, NEW ENGL J MED, V308, P819, DOI 10.1056/NEJM198304073081407; Fackler OT, 2000, CURR BIOL, V10, P1005, DOI 10.1016/S0960-9822(00)00654-0; FAIS S, 1995, AIDS, V9, P329, DOI 10.1097/00002030-199509040-00003; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GENDELMAN HE, 1987, VIROLOGY, V160, P323, DOI 10.1016/0042-6822(87)90002-X; Goto T, 1998, MICRON, V29, P123, DOI 10.1016/S0968-4328(98)00002-X; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; KELLER GA, 1992, EMBO J, V11, P863, DOI 10.1002/j.1460-2075.1992.tb05124.x; KIELIAN M, 1990, MOL BIOL MED, V7, P17; Lagaye S, 2001, J VIROL, V75, P4780, DOI 10.1128/JVI.75.10.4780-4791.2001; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Llano A, 2003, J VIROL, V77, P4389, DOI 10.1128/JVI.77.7.4389-4395.2003; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; Marechal V, 1998, J VIROL, V72, P2208; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; PEARCEPRATT R, 1994, J VIROL, V68, P2898, DOI 10.1128/JVI.68.5.2898-2905.1994; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Schaeffer E, 2004, J VIROL, V78, P1375, DOI 10.1128/JVI.78.3.1375-1383.2004; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Valenzuela A, 1997, J VIROL, V71, P8289, DOI 10.1128/JVI.71.11.8289-8298.1997; Vidricaire G, 2003, J BIOL CHEM, V278, P15832, DOI 10.1074/jbc.M210470200	45	85	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51305	51314		10.1074/jbc.M408547200	http://dx.doi.org/10.1074/jbc.M408547200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371410	hybrid			2022-12-27	WOS:000225355800080
J	Pruett, ND; Tkatchenko, TV; Jave-Suarez, L; Jacobs, DF; Potter, CS; Tkatchenko, AV; Schweizer, J; Awgulewitsch, A				Pruett, ND; Tkatchenko, TV; Jave-Suarez, L; Jacobs, DF; Potter, CS; Tkatchenko, AV; Schweizer, J; Awgulewitsch, A			Krtap16, characterization of a new hair keratin-associated protein (KAP) gene complex on mouse chromosome 16 and evidence for regulation by Hoxc13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE-TYROSINE; MAMMARY-GLAND; EXPRESSION; FOLLICLE; MICE; DOMAIN; CATALOG; CLUSTER; MEMBERS; GROWTH	Intermediate filament (IF) keratins and keratin- associated proteins (KAPs) are principal structural components of hair and encoded by members of multiple gene families. The severe hair growth defects observed upon aberrant expression of certain keratin and KAP genes in both mouse and man suggest that proper hair growth requires their spatio-temporally coordinated activation. An essential prerequisite for studying these cis-regulatory mechanisms is to define corresponding gene families, their genomic organization, and expression patterns. This work characterizes eight recently identified high glycine/tyrosine (HGT)-type KAP genes collectively designated Krtap16-n. These genes are shown to be integrated into a larger KAP gene domain on mouse chromosome 16 (MMU16) that is orthologous to a recently described HGT- and high sulfur (HS)-type KAP gene complex on human chromosome 21q22.11. All Krtap16 genes exhibit strong expression in a narrowly defined pattern restricted to the lower and middle cortical region of the hair shaft in both developing and cycling hair. During hair follicle regression (catagen), expression levels decrease until expression is no longer detectable in follicles at resting stage (telogen). Since isolation of the Krtap16 genes was based on their differential expression in transgenic mice overexpressing the Hoxc13 transcriptional regulator in hair, we examined whether bona fide Hoxc13 binding sites associated with these genes might be functionally relevant by performing electrophoretic mobility shift assays (EMSAs). The data provide evidence for sequence-specific interaction between Hoxc13 and Krtap16 genes, thus supporting the concept of a regulatory relationship between Hoxc13 and these KAP genes.	Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; German Canc Res Inst, Sect Normal & Neoplast Epidermal Differentiat, D-69120 Heidelberg, Germany; Med Univ S Carolina, Dept Dermatol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Awgulewitsch, A (corresponding author), Med Univ S Carolina, Dept Med, 96 Jonathan Lucas St,Suite CSB 912, Charleston, SC 29425 USA.	awgulewa@musc.edu	Jave-Suarez, Luis Felipe/T-7036-2018	Jave-Suarez, Luis Felipe/0000-0001-6209-5031	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047204] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR47204] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abzhanov A, 2003, DEVELOPMENT, V130, P4567, DOI 10.1242/dev.00673; Aoki N, 1997, J BIOL CHEM, V272, P30512, DOI 10.1074/jbc.272.48.30512; Aoki N, 1998, J INVEST DERMATOL, V111, P804, DOI 10.1046/j.1523-1747.1998.00387.x; Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; AWGULEWITSCH A, 1991, METHODS NUCLEIC ACID, P359; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Duboule D, 1991, CURR OPIN GENET DEV, V1, P211, DOI 10.1016/S0959-437X(05)80072-3; FRATINI A, 1993, J BIOL CHEM, V268, P4511; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; HUH N, 1994, J INVEST DERMATOL, V102, P716, DOI 10.1111/1523-1747.ep12375385; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; KEOUGH R, 1995, J CELL SCI, V108, P957; Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004; KOZAK M, 1983, CELL, V34, P971, DOI 10.1016/0092-8674(83)90554-8; Kuhn F, 1997, FEBS LETT, V413, P65, DOI 10.1016/S0014-5793(97)00836-3; Kuhn F, 1999, MECH DEVELOP, V86, P193, DOI 10.1016/S0925-4773(99)00115-X; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; PAUS R, 1990, BRIT J DERMATOL, V122, P777, DOI 10.1111/j.1365-2133.1990.tb06266.x; PINKUS H., 1958, BIOL HAIR GROWTH, P1; Powell B C, 1997, EXS, V78, P59; POWELL BC, 1991, ANN NY ACAD SCI, V642, P1; POWELL BC, 1990, EMBO J, V9, P1485, DOI 10.1002/j.1460-2075.1990.tb08266.x; ROGERS GE, 1993, J INVEST DERMATOL, V101, pS50, DOI 10.1111/1523-1747.ep12362626; Rogers MA, 2004, J INVEST DERMATOL, V122, P147, DOI 10.1046/j.0022-202X.2003.22128.x; Rogers MA, 2002, J BIOL CHEM, V277, P48993, DOI 10.1074/jbc.M206422200; Rogers MA, 2001, J BIOL CHEM, V276, P19440, DOI 10.1074/jbc.M100657200; Rogers MA, 2000, J INVEST DERMATOL, V114, P464, DOI 10.1046/j.1523-1747.2000.00910.x; Shang L, 2002, MECH DEVELOP, V113, P207, DOI 10.1016/S0925-4773(02)00022-9; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Tkatchenko AV, 2000, BBA-MOL BASIS DIS, V1500, P17, DOI 10.1016/S0925-4439(99)00084-8; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Winter H, 1997, NAT GENET, V16, P372, DOI 10.1038/ng0897-372; Wojcik SM, 1999, DIFFERENTIATION, V65, P97, DOI 10.1046/j.1432-0436.1999.6520097.x	42	40	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51524	51533		10.1074/jbc.M404331200	http://dx.doi.org/10.1074/jbc.M404331200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385554	hybrid			2022-12-27	WOS:000225355800106
J	Barros, MH; Bandy, B; Tahara, EB; Kowaltowski, AJ				Barros, MH; Bandy, B; Tahara, EB; Kowaltowski, AJ			Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIE RESTRICTION; OXIDATIVE STRESS; SPECIES PRODUCTION; STATIONARY-PHASE; DNA-DAMAGE; SHORT-TERM; YEAST; LONGEVITY; SUPEROXIDE; GENERATION	Increased replicative longevity in Saccharomyces cerevisiae because of calorie restriction has been linked to enhanced mitochondrial respiratory activity. Here we have further investigated how mitochondrial respiration affects yeast life span. We found that calorie restriction by growth in low glucose increased respiration but decreased mitochondrial reactive oxygen species production relative to oxygen consumption. Calorie restriction also enhanced chronological life span. The beneficial effects of calorie restriction on mitochondrial respiration, reactive oxygen species release, and replicative and chronological life span could be mimicked by uncoupling agents such as dinitrophenol. Conversely, chronological life span decreased in cells treated with antimycin (which strongly increases mitochondrial reactive oxygen species generation) or in yeast mutants null for mitochondrial superoxide dismutase (which removes superoxide radicals) and for RTG2 (which participates in retrograde feedback signaling between mitochondria and the nucleus). These results suggest that yeast aging is linked to changes in mitochondrial metabolism and oxidative stress and that mild mitochondrial uncoupling can increase both chronological and replicative life span.	Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Genet, BR-18618000 Sao Paulo, Brazil; Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil	Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; University of Saskatchewan; Universidade de Sao Paulo	Kowaltowski, AJ (corresponding author), Av Prof Lineu Prestes 748,Cidade Univ, BR-05508900 Sao Paulo, Brazil.	alicia@iq.usp.br	Barros, Mario H/B-8118-2012; Kowaltowski, Alicia J/H-8698-2012; Barros, Mario/Q-6358-2019	Barros, Mario/0000-0003-2977-9815				Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213; Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9; Barros MH, 2003, FREE RADICAL BIO MED, V35, P179, DOI 10.1016/S0891-5849(03)00307-1; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Borghouts C, 2004, GENETICS, V166, P765, DOI 10.1534/genetics.166.2.765; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Ferranti R, 2003, FEBS LETT, V536, P51, DOI 10.1016/S0014-5793(03)00007-3; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190; Harris N, 2003, FREE RADICAL BIO MED, V34, P1599, DOI 10.1016/S0891-5849(03)00210-7; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769; Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641	40	241	257	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49883	49888		10.1074/jbc.M408918200	http://dx.doi.org/10.1074/jbc.M408918200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383542	hybrid			2022-12-27	WOS:000225229500042
J	Collis, SJ; Schwaninger, JM; Ntambi, AJ; Keller, TW; Nelson, WG; Dillehay, LE; DeWeese, TL				Collis, SJ; Schwaninger, JM; Ntambi, AJ; Keller, TW; Nelson, WG; Dillehay, LE; DeWeese, TL			Evasion of early cellular response mechanisms following low level radiation-induced DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DOSE HYPER-RADIOSENSITIVITY; IONIZING-RADIATION; GENOMIC INSTABILITY; ATM ACTIVATION; CELLS; REPAIR; SENSITIVITY; EXPOSURE	DNA damage that is not repaired with high fidelity can lead to chromosomal aberrations or mitotic cell death. To date, it is unclear what factors control the ultimate fate of a cell receiving low levels of DNA damage (i.e. survival at the risk of increased mutation or cell death). We investigated whether DNA damage could be introduced into human cells at a level and frequency that could evade detection by cellular sensors of DNA damage. To achieve this, we exposed cells to equivalent doses of ionizing radiation delivered at either a high dose rate (HDR) or a continuous low dose rate (LDR). We observed reduced activation of the DNA damage sensor ataxia-telangiectasia mutated (ATM) and its downstream target histone H2A variant (H2AX) following LDR compared with HDR exposures in both cancerous and normal human cells. This lack of DNA damage signaling was associated with increased amounts of cell killing following LDR exposures. Increased killing by LDR radiation has been previously termed the "inverse dose rate effect," an effect for which no clear molecular processes have been described. These LDR effects could be abrogated by the preactivation of ATM or simulated in HDR-treated cells by inhibiting ATM function. These data are the first to demonstrate that DNA damage introduced at a reduced rate does not activate the DNA damage sensor ATM and that failure to activate ATM-associated repair pathways contributes to the increased lethality of continuous LDR radiation exposures. This inactivation may reflect one strategy by which cells avoid accumulating mutations as a result of error-prone DNA repair and may have a broad range of implications for carcinogenesis and, potentially, the clinical treatment of solid tumors.	Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Dept Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Dept Urol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	DeWeese, TL (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Dept Radiat Oncol & Mol Radiat Sci, Canc Res Bldg,Rm 144,1650 Orleans St, Baltimore, MD 21231 USA.	deweete@jhmi.edu		Collis, Spencer/0000-0002-7874-1891				Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banath JP, 2003, CANCER RES, V63, P4347; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Collis SJ, 2003, CANCER RES, V63, P1550; DEALMODOVAR JMR, 1994, RADIAT RES, V138, pS93, DOI 10.2307/3578771; DeWeese TL, 1997, INT J RADIAT ONCOL, V37, P145, DOI 10.1016/S0360-3016(96)00448-8; Deweese TL, 1998, J UROLOGY, V159, P591, DOI 10.1016/S0022-5347(01)63990-9; Downs JA, 2003, NATURE, V424, P732, DOI 10.1038/424732a; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; HALL EJ, 1994, RADIOBIOLOGY RADIOLO, P45; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Horejsi Z, 2004, ONCOGENE, V23, P3122, DOI 10.1038/sj.onc.1207447; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Joiner MC, 2001, INT J RADIAT ONCOL, V49, P379, DOI 10.1016/S0360-3016(00)01471-1; KNOX SJ, 1993, RADIAT RES, V135, P24, DOI 10.2307/3578392; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; MARIN LA, 1991, INT J RADIAT ONCOL, V21, P397, DOI 10.1016/0360-3016(91)90788-6; Marples B, 2003, RADIAT RES, V160, P38, DOI 10.1667/RR3013; Marples B, 2004, RADIAT RES, V161, P247, DOI 10.1667/RR3130; Mitchell CR, 2002, RADIAT RES, V158, P311, DOI 10.1667/0033-7587(2002)158[0311:EOETLD]2.0.CO;2; MITCHELL JB, 1979, RADIAT RES, V79, P520, DOI 10.2307/3575178; NAGASAWA H, 1992, RADIAT RES, V132, P375, DOI 10.2307/3578247; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vilenchik MM, 2000, P NATL ACAD SCI USA, V97, P5381, DOI 10.1073/pnas.090099497; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002	40	112	129	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49624	49632		10.1074/jbc.M409600200	http://dx.doi.org/10.1074/jbc.M409600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377658	hybrid			2022-12-27	WOS:000225229500012
J	Gomes, AV; Venkatraman, G; Davis, JP; Tikunova, SB; Engel, P; Solaro, RJ; Potter, JD				Gomes, AV; Venkatraman, G; Davis, JP; Tikunova, SB; Engel, P; Solaro, RJ; Potter, JD			Cardiac troponin T isoforms affect the Ca2+ sensitivity of force development in the presence of slow skeletal troponin I - Insights into the role of troponin T isoforms in the fetal heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBRILLAR ADENOSINE-TRIPHOSPHATASE; MAGNESIUM BINDING-SITES; MUSCLE CONTRACTION; CALCIUM-BINDING; TRANSGENIC MICE; REGULATORY SITES; FAILING HEART; RABBIT HEART; MOUSE HEART; EXPRESSION	In this study we investigated the physiological role of the cardiac troponin T (cTnT) isoforms in the presence of human slow skeletal troponin I (ssTnI). ssTnI is the main troponin I isoform in the fetal human heart. In reconstituted fibers containing the cTnT isoforms in the presence of ssTnI, cTnT1-containing fibers showed increased Ca2+ sensitivity of force development compared with cTnT3- and cTnT4-containing fibers. The maximal force in reconstituted skinned fibers was significantly greater for the cTnT1 (predominant fetal cTnT isoform) when compared with cTnT3 (adult TnT isoform) in the presence of ssTnI. Troponin (Tn) complexes containing ssTnI and reconstituted with cTnT isoforms all yielded different maximal actomyosin ATPase activities. Tn complexes containing cTnT1 and cTnT4 (both fetal isoforms) had a reduced ability to inhibit actomyosin ATPase activity when compared with cTnT3 (adult isoform) in the presence of ssTnI. The rate at which Ca2+ was released from site II of cTnC in the cTnI.cTnC complex (122/s) was 12.5-fold faster than for the ssTnI.cTnC complex (9.8/s). Addition of cTnT3 to the cTnI.cTnC complex resulted in a 3.6-fold decrease in the Ca2+ dissociation rate from site II of cTnC. Addition of cTnT3 to the ssTnI.cTnC complex resulted in a 1.9-fold increase in the Ca2+ dissociation rate from site II of cTnC. The rate at which Ca2+ dissociated from site II of cTnC in Tn complexes also depended on the cTnT isoform present. However, the TnI isoforms had greater effects on the Ca2+ dissociation rate of site II than the cTnT isoforms. These results suggest that the different N-terminal TnT isoforms would produce distinct functional properties in the presence of ssTnI when compared with cTnI and that each isoform would have a specific physiological role in cardiac muscle.	Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Miami; University of Miami; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Potter, JD (corresponding author), Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	Gomes, Aldrin V/I-6529-2018	Gomes, Aldrin V/0000-0002-9819-3036	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL042325, R01HL067415, P01HL062426, T32HL007692, R01HL042325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR020792] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL07692, HL62426, HL 42325, HL67415, HL073600] Funding Source: Medline; NIAMS NIH HHS [AR20792] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; Barton PJR, 2004, MOL CELL BIOCHEM, V263, P91, DOI 10.1023/B:MCBI.0000041851.53074.72; Davis JP, 2004, J BIOL CHEM, V279, P17348, DOI 10.1074/jbc.M314095200; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; Fiske CH, 1925, J BIOL CHEM, V66, P375; GAO LH, 1995, J MOL CELL CARDIOL, V27, P541, DOI 10.1016/S0022-2828(08)80049-1; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; GUTH K, 1987, J BIOL CHEM, V262, P13627; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; HILL LE, 1992, J BIOL CHEM, V267, P16106; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Huang XP, 1999, CIRC RES, V84, P1; Javadpour MM, 2003, J CLIN INVEST, V112, P768, DOI 10.1172/JC1200315967; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; JOHNSON JD, 1979, J BIOL CHEM, V254, P3497; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; JOHNSON JD, 1978, J BIOL CHEM, V253, P3775; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; MCAULIFFE JJ, 1990, CIRC RES, V66, P1204, DOI 10.1161/01.RES.66.5.1204; Metzger JM, 2003, J BIOL CHEM, V278, P13118, DOI 10.1074/jbc.M212601200; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Moore DD, 1995, GLOB MOB SURV; Morimoto S, 2000, BIOCHEM BIOPH RES CO, V267, P912, DOI 10.1006/bbrc.1999.2068; NASSAR R, 1991, CIRC RES, V69, P1470, DOI 10.1161/01.RES.69.6.1470; Ogut O, 1999, AM J PHYSIOL-CELL PH, V276, pC1162, DOI 10.1152/ajpcell.1999.276.5.C1162; Ogut O, 2000, J BIOL CHEM, V275, P26089, DOI 10.1074/jbc.M910360199; Parsons B, 1997, J MUSCLE RES CELL M, V18, P599, DOI 10.1023/A:1018623604365; POTTER JD, 1975, J BIOL CHEM, V250, P4628; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; REISER PJ, 1992, J PHYSIOL-LONDON, V449, P573, DOI 10.1113/jphysiol.1992.sp019102; Ricchiuti V, 1999, CLIN CHEM, V45, P2129; SASSE S, 1993, CIRC RES, V72, P932, DOI 10.1161/01.RES.72.5.932; SCHACHAT FH, 1987, J MOL BIOL, V198, P551, DOI 10.1016/0022-2836(87)90300-7; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P9538, DOI 10.1073/pnas.87.24.9538; Szczesna D, 1999, J BIOL CHEM, V274, P29536, DOI 10.1074/jbc.274.41.29536; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; TOBACMAN LS, 1988, J BIOL CHEM, V263, P2668; TOBACMAN LS, 1987, J BIOL CHEM, V262, P4059; TOWNSEND PJ, 1995, J MOL CELL CARDIOL, V27, P2223, DOI 10.1016/S0022-2828(95)91587-7; Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444; Wolska BM, 2001, J PHYSIOL-LONDON, V536, P863, DOI 10.1111/j.1469-7793.2001.00863.x; ZHU L, 1995, DEV BIOL, V169, P487, DOI 10.1006/dbio.1995.1163; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	49	66	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49579	49587		10.1074/jbc.M407340200	http://dx.doi.org/10.1074/jbc.M407340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15358779	hybrid			2022-12-27	WOS:000225229500007
J	Loschi, L; Brokx, SJ; Hills, TL; Zhang, G; Bertero, MG; Lovering, AL; Weiner, JH; Strynadka, NCJ				Loschi, L; Brokx, SJ; Hills, TL; Zhang, G; Bertero, MG; Lovering, AL; Weiner, JH; Strynadka, NCJ			Structural and biochemical identification of a novel bacterial oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; HUMAN SULFITE OXIDASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ALDEHYDE OXIDOREDUCTASE; XANTHINE DEHYDROGENASE; RHODOBACTER-CAPSULATUS; ANGSTROM RESOLUTION; NITRATE REDUCTASE; ELECTRON-TRANSFER	By using a bioinformatics screen of the Escherichia coli genome for potential molybdenum-containing enzymes, we have identified a novel oxidoreductase conserved in the majority of Gram-negative bacteria. The identified operon encodes for a proposed heterodimer, YedYZ in Escherichia coli, consisting of a soluble catalytic subunit termed YedY, which is likely anchored to the membrane by a heme-containing trans-membrane subunit termed YedZ. YedY is uniquely characterized by the presence of one molybdenum molybdopterin not conjugated by an additional nucleotide, and it represents the only molybdoenzyme isolated from E. coli characterized by the presence of this cofactor form. We have further characterized the catalytic subunit YedY in both the molybdenum- and tungsten-substituted forms by using crystallographic analysis. YedY is very distinct in overall architecture from all known bacterial reductases but does show some similarity with the catalytic domain of the eukaryotic chicken liver sulfite oxidase. However, the strictly conserved residues involved in the metal coordination sphere and in the substrate binding pocket of YedY are strikingly different from that of chicken liver sulfite oxidase, suggesting a catalytic activity more in keeping with a reductase than that of a sulfite oxidase. Preliminary kinetic analysis of YedY with a variety of substrates supports our proposal that YedY and its many orthologues may represent a new type of membrane-associated bacterial reductase.	Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; Univ Alberta, Dept Biochem, Canadian Inst Hlth Res Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada	University of British Columbia; University of Alberta	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Lovering, Andrew/0000-0002-1856-7975; Bertero, Michela/0000-0002-2012-6706				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENZ R, 1978, J BACTERIOL, V135, P1080, DOI 10.1128/JB.135.3.1080-1090.1978; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; BILOUS PT, 1985, J BACTERIOL, V162, P1151, DOI 10.1128/JB.162.3.1151-1155.1985; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buc J, 1999, MOL MICROBIOL, V32, P159, DOI 10.1046/j.1365-2958.1999.01340.x; COHEN HJ, 1971, J BIOL CHEM, V246, P359; Czjzek M, 1998, J MOL BIOL, V284, P435, DOI 10.1006/jmbi.1998.2156; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELANO WL, 2002, PYMOL MOL GRPAHICS S; Dias JM, 1999, STRUCTURE, V7, P65, DOI 10.1016/S0969-2126(99)80010-0; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Ellis PJ, 2001, STRUCTURE, V9, P125, DOI 10.1016/S0969-2126(01)00566-4; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Feng CJ, 2003, BIOCHEMISTRY-US, V42, P12235, DOI 10.1021/bi0350194; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; GREENWOOD N, 1984, CHEM ELEMENTS, P170; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Johnson Jean L, 2002, Hum Mutat, V20, P74, DOI 10.1002/humu.9038; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; KRAULIS PJ, 1991, SCIENCE, V254, P581, DOI 10.1126/science.1658931; Lam CW, 2002, MOL GENET METAB, V75, P91, DOI 10.1006/mgme.2001.3267; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NEU HC, 1965, J BIOL CHEM, V240, P3685; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rebelo JM, 2001, J BIOL INORG CHEM, V6, P791, DOI 10.1007/s007750100255; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Sambrook J., 2001, MOL CLONING LAB MANU; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; SimalaGrant JL, 1996, MICROBIOL-SGM, V142, P3231, DOI 10.1099/13500872-142-11-3231; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Stewart LJ, 2000, J MOL BIOL, V299, P593, DOI 10.1006/jmbi.2000.3702; STIEFEL EI, 1993, ACS S SERIES, V535; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wilson HL, 2004, J BIOL CHEM, V279, P15105, DOI 10.1074/jbc.M314288200	51	89	93	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50391	50400		10.1074/jbc.M408876200	http://dx.doi.org/10.1074/jbc.M408876200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355966	hybrid			2022-12-27	WOS:000225229500104
J	Malygin, EG; Sclavi, B; Zinoviev, VV; Evdokimov, AA; Hattman, S; Buckle, M				Malygin, EG; Sclavi, B; Zinoviev, VV; Evdokimov, AA; Hattman, S; Buckle, M			Bacteriophage T4Dam DNA-(adenine-N-6)-methyltransferase - Comparison of pre-steady state and single turnover methylation of 40-mer duplexes containing two (un)modified target sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA N-6-ADENINE METHYLTRANSFERASE; ESCHERICHIA-COLI; GENE-EXPRESSION; PHAGE-T4 DNA; DAM; RESTRICTION; PURIFICATION; RECOGNITION; ENDONUCLEASE; MUTANTS	We analyzed pre-steady state and single turnover kinetics of bacteriophage T4Dam DNA-(adenine-N-6)methyltransferase- mediated methyl group transfer from S-adenosyl-L-methionine ( AdoMet) to 40-mer duplexes containing native recognition sites (5'-GATC/5'- GATC) or some modified variant(s). The results extend a model from studies with single-site 20-mer duplexes. Under pre-steady state conditions, monomeric T4Dam methyltransferase- AdoMet complexes were capable of rapid methylation of adenine residues in 40-mer duplexes containing two sites. During processive movement of T4Dam to the next site, the rate-limiting step was the exchange of the product S-adenosyl-L-homocysteine ( AdoHcy) for AdoMet without T4Dam dissociating from the duplex. Consequently, instead of a single exponential rate dependence, complex methylation curves were obtained with at least two pre-steady state steps. With 40-mer duplexes containing a single target site, the kinetics were simpler, fitting a single exponential followed by a linear steady state phase. Single turnover methylation of 40-mer duplexes also proceeded in two stages. First, two dimeric T4Dam-AdoMet molecules bound, and each catalyzed a two-step methylation. Instead of processive movement of T4Dam, a conformational adaptation occurred. We propose that following methyl transfer to one strand, dimeric ( T4Dam-AdoMet)-(T4Dam-AdoHcy) was capable of rapidly reorienting itself and catalyzing methyl transfer to the target adenine on the complementary, unmethylated strand. This second stage methyl transfer occurred at a rate about 25-fold slower than in the first step; it was rate-limited by Dam-AdoHcy dissociation or its clearance from the methylated complementary strand. Under single turnover conditions, there was complete methylation of all target adenine residues with each of the two-site 40-mer duplexes.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; State Res Ctr Virol & Biotechnol Vector, Inst Mol Biol, Novosibirsk 630559, Russia; Ecole Normale Super, CNRS, UMR 8113, Lab Biotechnol & Pharmacol Genet Appl, F-94235 Cachan, France	University of Rochester; State Research Center of Virology & Biotechnology VECTOR; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Hattman, S (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	modDNA@mail.rochester.edu	Evdokimov, Alexey/A-6485-2014; Sclavi, Bianca/AAT-4554-2021; sclavi, bianca/F-8536-2010; Ernst, Malygin/A-6741-2014	Sclavi, Bianca/0000-0002-3883-8592; 	FIC NIH HHS [R03 TW05755] Funding Source: Medline; NIGMS NIH HHS [GM29227] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW005755] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Bae SH, 2003, J BIOL CHEM, V278, P45987, DOI 10.1074/jbc.M306038200; Bheemanaik S, 2003, J BIOL CHEM, V278, P7863, DOI 10.1074/jbc.M211458200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DELACAMPA AG, 1987, J MOL BIOL, V196, P457, DOI 10.1016/0022-2836(87)90024-6; Dong AP, 2004, BIOL CHEM, V385, P373, DOI 10.1515/bchm.385.13.373.57208; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P1579, DOI 10.1093/nar/20.7.1579; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P31657; Evdokimov AA, 2002, J BIOL CHEM, V277, P279, DOI 10.1074/jbc.M108864200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Hattman S, 2004, PROG NUCLEIC ACID RE, V77, P67, DOI 10.1016/S0079-6603(04)77003-8; HATTMAN S, 1970, VIROLOGY, V42, P359, DOI 10.1016/0042-6822(70)90279-5; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; KASZUBSKA W, 1992, GENE, V118, P5, DOI 10.1016/0378-1119(92)90242-H; KOSSYKH VG, 1995, J BIOL CHEM, V270, P14389, DOI 10.1074/jbc.270.24.14389; KURGANOV BI, 1982, ALLOSTERIC ENZYMES K, P151; LEHMAN IR, 1960, J BIOL CHEM, V235, P3254; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; Malygin EG, 2000, NUCLEIC ACIDS RES, V28, P4207, DOI 10.1093/nar/28.21.4207; Malygin EG, 2003, J BIOL CHEM, V278, P41749, DOI 10.1074/jbc.M306397200; Malygin EG, 2001, NUCLEIC ACIDS RES, V29, P2361, DOI 10.1093/nar/29.11.2361; MINER Z, 1988, J BACTERIOL, V170, P5177, DOI 10.1128/jb.170.11.5177-5184.1988; Minko I, 2001, NUCLEIC ACIDS RES, V29, P1484, DOI 10.1093/nar/29.7.1484; MODRICH P, 1989, J BIOL CHEM, V264, P6597; MODRICH P, 1982, CRC CR REV BIOCH MOL, V13, P287, DOI 10.3109/10409238209114231; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; REVEL HR, 1971, VIROLOGY, V45, P484, DOI 10.1016/0042-6822(71)90348-5; SANTOS ME, 1994, GENETICS, V138, P553; SCHLAGMAN SL, 1989, NUCLEIC ACIDS RES, V17, P9101, DOI 10.1093/nar/17.22.9101; Shier VK, 2001, J BIOL CHEM, V276, P14744, DOI 10.1074/jbc.M010688200; Thielking V, 1997, BIOL CHEM, V378, P407, DOI 10.1515/bchm.1997.378.5.407; WYATT GR, 1952, NATURE, V170, P1072, DOI 10.1038/1701072a0; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; YOO H, 1987, J BIOL CHEM, V262, P8066; Zinoviev VV, 1998, BIOL CHEM, V379, P481, DOI 10.1515/bchm.1998.379.4-5.481; Zinoviev VV, 2003, J BIOL CHEM, V278, P7829, DOI 10.1074/jbc.M210769200	37	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50012	50018		10.1074/jbc.M409786200	http://dx.doi.org/10.1074/jbc.M409786200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375160	hybrid			2022-12-27	WOS:000225229500058
J	Robichaud, GA; Nardini, M; Laflamme, M; Cuperlovic-Culf, M; Ouellette, RJ				Robichaud, GA; Nardini, M; Laflamme, M; Cuperlovic-Culf, M; Ouellette, RJ			Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; DNA-BINDING; BSAP PAX-5; PAIRED DOMAIN; TRANSCRIPTION ACTIVATION; GENE-EXPRESSION; AMINO-ACIDS; SEQUENCE; PROTEINS; MOUSE	The transcription factor Pax-5 occupies a central role in B cell differentiation and has been implicated in the development of B cell lymphoma. The transcriptional activation function of Pax-5 requires an intact N-terminal DNA-binding domain and is strongly influenced by the C-terminal transactivation domain. We report the identification and characterization of five human Pax-5 isoforms, which occur through the alternative splicing of exons that encode for the C-terminal transactivation domain. These isoforms arise from the inclusion or exclusion of exon 7, exon 8, and/or exon 9. Three of the Pax-5 isoforms generate novel protein sequences rich in proline, serine, and threonine amino acids that are the hallmarks of transactivation domains. The Pax-5 isoforms are expressed in peripheral blood mononuclear cells, cancerous and non-cancerous B cell lines, as well as in primary B cell lymphoma tissue. Electrophoretic mobility shift assays demonstrate that the isoforms possess specific DNA binding activity and recognize the PAX-5 consensus binding sites. In reporter assays using the CD19 promoter, the transactivation properties of the various isoforms were significantly influenced by the changes in the C-terminal protein sequence. Finally, we demonstrate, for the first time, that human Pax-5 isoform expression is modulated by specific signaling pathways in B lymphocytes.	Inst Rech Med Beausejour, Moncton, NB E1C 8X3, Canada; Univ Moncton, Dept Chim & Biochim, Moncton, NB E1C 8X3, Canada	University of Moncton	Ouellette, RJ (corresponding author), Inst Rech Med Beausejour, 35 Providence St, Moncton, NB E1C 8X3, Canada.	rodneyo@health.nb.ca	Cuperlovic-Culf, Miroslava/C-7876-2016	Cuperlovic-Culf, Miroslava/0000-0002-9483-8159; Laflamme, Mark/0000-0001-5955-7098				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Baranova A, 2003, GENE, V321, P103, DOI 10.1016/j.gene.2003.08.007; BARBERIS A, 1990, GENE DEV, V4, P849, DOI 10.1101/gad.4.5.849; Barr FG, 1997, INT J BIOCHEM CELL B, V29, P1449, DOI 10.1016/S1357-2725(97)00095-2; Borson ND, 2002, BLOOD, V100, P4629, DOI 10.1182/blood.V100.13.4629; Busslinger M, 1996, P NATL ACAD SCI USA, V93, P6129, DOI 10.1073/pnas.93.12.6129; CHALEPAKIS G, 1994, P NATL ACAD SCI USA, V91, P12745, DOI 10.1073/pnas.91.26.12745; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FICKENSCHER HR, 1993, DNA CELL BIOL, V12, P381, DOI 10.1089/dna.1993.12.381; Fitzsimmons D, 2001, NUCLEIC ACIDS RES, V29, P4154, DOI 10.1093/nar/29.20.4154; Hagman J, 2000, CURR TOP MICROBIOL, V245, P169; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; Jaworski C, 1997, BIOCHEM BIOPH RES CO, V240, P196, DOI 10.1006/bbrc.1997.7623; Johnson K, 2003, CURR OPIN GENET DEV, V13, P522, DOI 10.1016/j.gde.2003.08.004; Kovac CR, 2000, J BIOL CHEM, V275, P16752, DOI 10.1074/jbc.M001551200; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; KOZMIK Z, 1995, P NATL ACAD SCI USA, V92, P5709, DOI 10.1073/pnas.92.12.5709; Kumar MB, 2001, J BIOL CHEM, V276, P42302, DOI 10.1074/jbc.M104798200; Lai EC, 2003, CURR BIOL, V13, pR285, DOI 10.1016/S0960-9822(03)00203-3; Lechner MS, 1996, J BIOL CHEM, V271, P21088, DOI 10.1074/jbc.271.35.21088; Lowen M, 2001, J BIOL CHEM, V276, P42565, DOI 10.1074/jbc.M106536200; Lynch KW, 2000, MOL CELL BIOL, V20, P70, DOI 10.1128/MCB.20.1.70-80.2000; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; MULLER MM, 1989, NUCLEIC ACIDS RES, V17, P6420, DOI 10.1093/nar/17.15.6420; Nurtdinov RN, 2003, HUM MOL GENET, V12, P1313, DOI 10.1093/hmg/ddg137; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Reen RK, 2002, ARCH BIOCHEM BIOPHYS, V408, P93, DOI 10.1016/S0003-9861(02)00518-0; Ruscher K, 2000, J BIOTECHNOL, V78, P163, DOI 10.1016/S0168-1656(00)00207-8; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Sgambato V, 2003, J NEUROCHEM, V86, P153, DOI 10.1046/j.1471-4159.2003.01816.x; Starczynowski DT, 2003, ONCOGENE, V22, P6928, DOI 10.1038/sj.onc.1206801; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; Szostak JW, 2002, NATURE, V419, P890, DOI 10.1038/419890a; TREMBLAY P, 1994, PHARMACOL THERAPEUT, V61, P205, DOI 10.1016/0163-7258(94)90063-9; Underhill DA, 2000, BIOCHEM CELL BIOL, V78, P629, DOI 10.1139/bcb-78-5-629; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Zwollo P, 1997, J BIOL CHEM, V272, P10160, DOI 10.1074/jbc.272.15.10160	49	44	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49956	49963		10.1074/jbc.M407171200	http://dx.doi.org/10.1074/jbc.M407171200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385562	hybrid			2022-12-27	WOS:000225229500051
J	Woods, YL; Xirodimas, DP; Prescott, AR; Sparks, A; Lane, DP; Saville, MK				Woods, YL; Xirodimas, DP; Prescott, AR; Sparks, A; Lane, DP; Saville, MK			p14 arf promotes small ubiquitin-like modifier conjugation of Werners helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO E3 LIGASE; TUMOR-SUPPRESSOR; SYNDROME PROTEIN; IN-VIVO; NUCLEAR-LOCALIZATION; STABILIZES P53; YEAST SEPTINS/; GENE-PRODUCT; DNA-DAMAGE; MDM2	Here we demonstrate a novel p53-independent interaction between the nucleolar tumor suppressors, p14 Arf and Werners helicase (WRN). Binding of p14 Arf to WRN is multivalent and resembles the binding of p14 Arf to Mdm2. Residues 2 - 14 and 82 - 101 of p14 Arf and residues in the central region and C terminus of WRN have particular importance for binding. p14 Arf promotes small ubiquitin-like modifier ( SUMO) modification of WRN in a synergistic manner with the SUMO-conjugating enzyme, UBCH9. p14 Arf causes redistribution of WRN within the nucleus, and this effect is reversed by expression of a SUMO-specific protease, thus implicating the SUMO conjugation pathway in WRN re-localization. We establish that the ability to promote SUMO conjugation is a general property of the p14 Arf tumor suppressor.	Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee	Woods, YL (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp, Ninewells Ave, Dundee DD1 9SY, Scotland.	y.l.woods@dundee.ac.uk	Lane, David P/C-4920-2008; Prescott, Alan/Y-5956-2018	Prescott, Alan/0000-0002-0747-7317; Xirodimas, Dimitris/0000-0001-9275-1140; Lane, David/0000-0003-0551-3545				Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Baynton K, 2003, J BIOL CHEM, V278, P36476, DOI 10.1074/jbc.M303885200; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; Bottger A, 1997, CURR BIOL, V7, P860, DOI 10.1016/S0960-9822(06)00374-5; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 2003, ONCOGENE, V22, P5348, DOI 10.1038/sj.onc.1206851; Chen Lishan, 2002, Journal of Biomedicine & Biotechnology, V2, P46, DOI 10.1155/S1110724302201011; Cheng WH, 2003, MOL CELL BIOL, V23, P6385, DOI 10.1128/MCB.23.18.6385-6395.2003; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Duprez E, 1999, J CELL SCI, V112, P381; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kuo ML, 2003, CANCER RES, V63, P1046; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lohrum MAE, 2000, CURR BIOL, V10, P539, DOI 10.1016/S0960-9822(00)00472-3; Matsumoto T, 1998, INT J MOL MED, V1, P71; Menendez S, 2003, J BIOL CHEM, V278, P18720, DOI 10.1074/jbc.M211007200; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; O'Leary KA, 2004, MOL CELL BIOL, V24, P186, DOI 10.1128/MCB.24.1.186-191.2004; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; POOT M, 1992, EXP CELL RES, V202, P267, DOI 10.1016/0014-4827(92)90074-I; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sakamoto S, 2001, GENES CELLS, V6, P421, DOI 10.1046/j.1365-2443.2001.00433.x; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; von Kobbe C, 2002, J CELL SCI, V115, P3901, DOI 10.1242/jcs.00076; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2002, FEBS LETT, V528, P207, DOI 10.1016/S0014-5793(02)03310-0; Yarbrough WG, 2002, CANCER RES, V62, P1171; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	54	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50157	50166		10.1074/jbc.M405414200	http://dx.doi.org/10.1074/jbc.M405414200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355988	hybrid			2022-12-27	WOS:000225229500075
J	Bhat, GJ; Samikkannu, T; Thomas, JJ; Thekkumkara, TJ				Bhat, GJ; Samikkannu, T; Thomas, JJ; Thekkumkara, TJ			alpha-Thrombin rapidly induces tyrosine phosphorylation of a novel, 74-78-kDa stress response protein(s) in lung fibroblast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; JAK-STAT PATHWAY; RECEPTOR ACTIVATION; MITOCHONDRIAL HSP70; COUPLED RECEPTORS; HUMAN PLATELETS; ANGIOTENSIN-II; CLONING; FAMILY; KINASE	We demonstrated previously that exposure of CCL39 lung fibroblasts to alpha-thrombin rapidly inhibits interleukin 6-induced tyrosine phosphorylation of signal transducers and activators of transcription 3 (Stat3). While studying the cross-talk between alpha-thrombin and interleukin 6, we observed that the phospho-specific (tyrosine) anti-Stat3 antibody specifically cross-reacted with a 74-78-kDa protein(s) in alpha-thrombin-treated cells. In this study, we demonstrate that in alpha-thrombin-treated CCL39 cells, the 74-78-kDa protein(s) rapidly undergoes tyrosine phosphorylation. The phosphorylation by alpha-thrombin was detected as early as 5 min and reached a maximum at 15 min; however, low levels were present at 2 h. alpha-Thrombin receptor agonist peptide (SFLLRN) induced its tyrosine phosphorylation, suggesting that alpha-thrombin mediates the effects via protease-activated receptor type 1. Anti-Stat3 antibodies specific to different regions of Stat3 failed to recognize the 74-78-kDa protein(s), suggesting that it is unrelated to Stat3. Cell fractionation experiments showed that it is localized to the cytoplasm. Mass spectrometric analysis of the immunoprecipitated protein showed that the 74-78-kDa protein(s) is related to glucose-regulated protein 75 (GRP75), a member of the heat shock/stress-response protein family. Consistent with these data, we observed tyrosine phosphorylation of GRP-75 in alpha-thrombin-treated cells. Exposure of cells to pervanadate, a stress-inducing agent, stimulated its tyrosine phosphorylation; however, cytokines and growth factors were ineffective. This is the first report of tyrosine phosphorylation of GRP-75-related stress protein(s) by alpha-thrombin and suggests that this pathway may contribute to the ability of alpha-thrombin to prevent apoptosis in cells exposed to stress or in the injured tissue.	Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Bhat, GJ (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, 1300 Coulter Dr, Amarillo, TX 79106 USA.	Jayarama.gunaje@ttuhsc.edu		Thekkumkara, Thomas/0000-0001-8865-1446	NHLBI NIH HHS [HL061356, R01 HL66000] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061356, R01HL066000] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adinolfi E, 2003, J BIOL CHEM, V278, P37344, DOI 10.1074/jbc.M301508200; BERNDT MC, 1981, PLATELETS BIOL PATHO, P43; Bhat GJ, 1998, ARCH BIOCHEM BIOPHYS, V350, P307, DOI 10.1006/abbi.1997.0520; Bhat GJ, 1996, J BIOL CHEM, V271, P22447, DOI 10.1074/jbc.271.37.22447; BHAT GJ, 1995, J BIOL CHEM, V270, P19059, DOI 10.1074/jbc.270.32.19059; BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Chalmers CJ, 2003, BIOCHEM J, V375, P99, DOI 10.1042/BJ20030346; CHEN LB, 1975, P NATL ACAD SCI USA, V72, P131, DOI 10.1073/pnas.72.1.131; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Cottrell CS, 2002, ESSAYS BIOCHEM, V38, P169, DOI 10.1042/bse0380169; COUGHLIN SR, 1994, TRENDS CARDIOVAS MED, V4, P77, DOI 10.1016/1050-1738(94)90013-2; DOMANICO SZ, 1993, MOL CELL BIOL, V13, P3598, DOI 10.1128/MCB.13.6.3598; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; Hadari YR, 1997, J BIOL CHEM, V272, P657; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Kaul SC, 1998, ONCOGENE, V17, P907, DOI 10.1038/sj.onc.1202017; Kaul SC, 2000, FEBS LETT, V474, P159, DOI 10.1016/S0014-5793(00)01594-5; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; LI RY, 1995, EMBO J, V14, P2519, DOI 10.1002/j.1460-2075.1995.tb07249.x; Madamanchi NR, 2001, J BIOL CHEM, V276, P18915, DOI 10.1074/jbc.M008802200; MASSA SM, 1995, J NEUROSCI RES, V40, P807, DOI 10.1002/jnr.490400612; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; MICHIKAWA Y, 1993, FEBS LETT, V336, P27, DOI 10.1016/0014-5793(93)81602-V; MIMNAUGH EG, 1995, J BIOL CHEM, V270, P28654, DOI 10.1074/jbc.270.48.28654; MIZZEN LA, 1991, CELL REGUL, V2, P165, DOI 10.1091/mbc.2.2.165; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Polanowska-Grabowska R, 2000, PLATELETS, V11, P6; RAO GN, 1995, J BIOL CHEM, V270, P27871, DOI 10.1074/jbc.270.46.27871; RIVARD N, 1995, J BIOL CHEM, V270, P11017, DOI 10.1074/jbc.270.18.11017; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; SHUMAN MA, 1986, ANN NY ACAD SCI, V485, P228, DOI 10.1111/j.1749-6632.1986.tb34585.x; SILVER IA, 1994, J NEUROSCI, V14, P5068; Singh B, 1997, EXP CELL RES, V234, P205, DOI 10.1006/excr.1997.3609; TANAKO S, 2001, BIOCHEM J, V357, P393; Tibbles HE, 2001, J BIOL CHEM, V276, P17815, DOI 10.1074/jbc.M011405200; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; ZHU Y, 1994, BLOOD, V84, P3715, DOI 10.1182/blood.V84.11.3715.bloodjournal84113715	46	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48915	48922		10.1074/jbc.M409043200	http://dx.doi.org/10.1074/jbc.M409043200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364938	hybrid			2022-12-27	WOS:000225098100053
J	Inoue, M; Digman, MA; Cheng, M; Breusegem, SY; Halaihel, N; Sorribas, V; Mantulin, WW; Gratton, E; Barry, NP; Levi, M				Inoue, M; Digman, MA; Cheng, M; Breusegem, SY; Halaihel, N; Sorribas, V; Mantulin, WW; Gratton, E; Barry, NP; Levi, M			Partitioning of NaPi cotransporter in cholesterol-, sphingomyelin-, and glycosphingolipid-enriched membrane domains modulates NaPi protein diffusion, clustering, and activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; 2-PHOTON FLUORESCENCE MICROSCOPY; LIPID RAFTS; BRUSH-BORDER; MODEL MEMBRANES; CELL-SURFACE; CORRELATION SPECTROSCOPY; TARGETED DISRUPTION; PLASMA-MEMBRANE; MICRODOMAINS	In dietary potassium deficiency there is a decrease in the transport activity of the type IIa sodium/phosphate cotransporter protein (NaPi) despite an increase in its apical membrane abundance. This novel posttranslational regulation of NaPi activity is mediated by the increased glycosphingolipid content of the potassium-deficient apical membrane. However, the mechanisms by which these lipids modulate NaPi activity have not been determined. We determined if in potassium deficiency NaPi is increasingly partitioned in cholesterol-, sphingomyelin-, and glycosphingolipid-enriched microdomains of the apical membrane and if the increased presence of NaPi in these microdomains modulates its activity. By using a detergent-free density gradient flotation technique, we found that 80% of the apical membrane NaPi partitions into the low density cholesterol-, sphingomyelin-, and GM1-enriched fractions characterized as "lipid raft" fractions. In potassium deficiency, a higher proportion of NaPi was localized in the lipid raft fractions. By combining fluorescence correlation spectroscopy and photon counting histogram methods for control and potassium-deficient apical membranes reconstituted into giant unilamellar vesicles, we showed a 2-fold decrease in lateral diffusion of NaPi protein and a greater than 2-fold increase in size of protein aggregates/clusters in potassium deficiency. Our results indicate that NaPi protein is localized in membrane microdomains, that in potassium deficiency a larger proportion of NaPi protein is present in these microdomains, and that NaPi lateral diffusion is slowed down and NaPi aggregation/clustering is increased in potassium deficiency, both of which could be associated with the decreased Na/P-i cotransport activity in potassium deficiency.	Univ Colorado, Hlth Sci Ctr, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Physiol, Div Renal Dis & Hypertens, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biophys, Div Renal Dis & Hypertens, Denver, CO 80262 USA; Denver Vet Affairs Med Ctr, Denver, CO 80262 USA; Univ Illinois, Dept Phys, Fluorescence Dynam Lab, Urbana, IL 61801 USA; Univ Zaragoza, Dept Toxicol, E-50013 Zaragoza, Spain	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Illinois System; University of Illinois Urbana-Champaign; University of Zaragoza	Levi, M (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, Div Renal Dis & Hypertens, 4200 E 9th Ave, Denver, CO 80262 USA.	Moshe.Levi@UCHSC.edu	Halaihel, Nabil/J-2973-2016	Sorribas, Victor/0000-0003-3457-323X; Levi, Moshe/0000-0002-6225-946X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062209] Funding Source: NIH RePORTER; NCRR NIH HHS [5 P41-RRO3155] Funding Source: Medline; NIDDK NIH HHS [5R01 DK062209-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Bagatolli LA, 1999, BIOPHYS J, V77, P2090, DOI 10.1016/S0006-3495(99)77050-5; BERLAND KM, 1995, BIOPHYS J, V68, P694, DOI 10.1016/S0006-3495(95)80230-4; Blasco T, 2003, AM J PHYSIOL-RENAL, V285, pF799, DOI 10.1152/ajprenal.00149.2003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown DA, 2001, TRAFFIC, V2, P668, DOI 10.1034/j.1600-0854.2001.20909.x; Chen Y, 1999, METHODS, V19, P234, DOI 10.1006/meth.1999.0854; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Draeger A, 2003, DEV BIOL, V262, P324, DOI 10.1016/S0012-1606(03)00398-1; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Elkjaer ML, 2002, AM J PHYSIOL-RENAL, V283, pF1376, DOI 10.1152/ajprenal.00186.2002; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; He XX, 2002, ANAL BIOCHEM, V306, P115, DOI 10.1006/abio.2002.5686; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kahya N, 2002, J BIOL CHEM, V277, P39304, DOI 10.1074/jbc.M202635200; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Khan TK, 2003, BIOCHEMISTRY-US, V42, P4780, DOI 10.1021/bi0265877; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ledoux S, 2003, CIRC RES, V92, P848, DOI 10.1161/01.RES.0000069022.95401.FE; LEVI M, 1990, J CLIN INVEST, V85, P231, DOI 10.1172/JCI114417; LEVI M, 1995, J CLIN INVEST, V96, P207, DOI 10.1172/JCI118022; LEVI M, 1993, PHOTOCHEM PHOTOBIOL, V57, P420, DOI 10.1111/j.1751-1097.1993.tb02312.x; LEVI M, 1989, AM J PHYSIOL, V256, pF85, DOI 10.1152/ajprenal.1989.256.1.F85; Li X, 2004, GASTROENTEROLOGY, V126, P122, DOI 10.1053/j.gastro.2003.10.061; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lipardi C, 2000, MOL BIOL CELL, V11, P531, DOI 10.1091/mbc.11.2.531; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; MOLITORIS BA, 1985, AM J PHYSIOL, V249, pF12, DOI 10.1152/ajprenal.1985.249.1.F12; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Pribanic S, 2003, AM J PHYSIOL-RENAL, V285, pF784, DOI 10.1152/ajprenal.00109.2003; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Ruan QQ, 2004, BIOPHYS J, V87, P1260, DOI 10.1529/biophysj.103.036483; Ruan QQ, 2002, BIOPHYS J, V83, P3177, DOI 10.1016/S0006-3495(02)75320-4; Runembert I, 2002, J CELL SCI, V115, P713; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Sorribas V, 2001, KIDNEY INT, V59, P1024, DOI 10.1046/j.1523-1755.2001.0590031024.x; Tenenhouse HS, 2003, J AM SOC NEPHROL, V14, P240, DOI 10.1097/01.ASN.0000045045.47494.71; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Zajicek HK, 2001, KIDNEY INT, V60, P694, DOI 10.1046/j.1523-1755.2001.060002694.x	70	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49160	49171		10.1074/jbc.M408942200	http://dx.doi.org/10.1074/jbc.M408942200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355967	hybrid, Green Submitted			2022-12-27	WOS:000225098100081
J	Mutka, AL; Lusa, S; Linder, MD; Jokitalo, E; Kopra, O; Jauhiainen, M; Ikonen, E				Mutka, AL; Lusa, S; Linder, MD; Jokitalo, E; Kopra, O; Jauhiainen, M; Ikonen, E			Secretion of sterols and the NPC2 protein from primary astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICK C1-DEFICIENT NEURONS; C DISEASE; CHOLESTEROL-METABOLISM; RAT-BRAIN; SYNTHESIZED CHOLESTEROL; DOCOSAHEXAENOIC ACID; HUMAN EPIDIDYMIS; BINDING-PROTEIN; DISTAL AXONS; MOUSE-BRAIN	Astrocytes secrete cholesterol in lipoprotein particles. Here we show that primary murine embryonic astrocytes secrete endogenously synthesized cholesterol but also the cholesterol precursors desmosterol and lathosterol. In astrocyte membranes, desmosterol and cholesterol were the predominant sterols. Astrocytes derived from Niemann-Pick type C lipidosis (NPC1(-/-)) mice displayed late endosomal cholesterol deposits, but the secretion of biosynthetic sterols from the cells was not inhibited. Both wild-type and NPC1(-/-) astrocytes secreted the NPC2 protein. Size-exclusion chromatography combined with electron microscopy showed that the majority of sterols were secreted separately from NPC2 in heterogeneous spherical particles with an average diameter of 20 nm. These data suggest that NPC2 and the majority of sterols secreted from astrocytes are not released together and that the secretion of neither sterols nor NPC2 requires NPC1 function. In addition, the findings reveal a complexity of sterol species in astrocytes and bring up the possibility that some of the effects assigned to astrocyte cholesterol may be attributed to its penultimate precursors.	Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Biomedicum Helsinki, Natl Publ Hlth Inst, Helsinki 00251, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki	Ikonen, E (corresponding author), Univ Helsinki, Inst Biotechnol, Viikinkaari 9, FIN-00014 Helsinki, Finland.	elina.ikonen@helsinki.fi	Jokitalo, Eija/C-8375-2009	Jokitalo, Eija/0000-0002-4159-6934; Ikonen, Elina/0000-0001-8382-1135				Aula N, 2004, NEUROBIOL DIS, V15, P251, DOI 10.1016/j.nbd.2003.11.017; Blom TS, 2003, HUM MOL GENET, V12, P257, DOI 10.1093/hmg/ddg025; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Connor WE, 1998, J LIPID RES, V39, P1404; Danik M, 1999, CRIT REV NEUROBIOL, V13, P357, DOI 10.1615/CritRevNeurobiol.v13.i4.20; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Heino S, 2000, P NATL ACAD SCI USA, V97, P8375, DOI 10.1073/pnas.140218797; Henderson LP, 2000, J BIOL CHEM, V275, P20179, DOI 10.1074/jbc.M001793200; HINSE CH, 1971, J NEUROCHEM, V18, P1989, DOI 10.1111/j.1471-4159.1971.tb09604.x; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; Ikonen E, 2004, SEMIN CELL DEV BIOL, V15, P445, DOI 10.1016/j.semcdb.2004.03.001; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Karten B, 2003, J BIOL CHEM, V278, P4168, DOI 10.1074/jbc.M205406200; Kirchhoff C, 1996, BIOL REPROD, V54, P847, DOI 10.1095/biolreprod54.4.847; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; KRITCHEVSKY D, 1962, BIOCHEM BIOPH RES CO, V7, P128, DOI 10.1016/0006-291X(62)90160-2; Laitinen S, 2002, J LIPID RES, V43, P245; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; LIN DS, 1993, J LIPID RES, V34, P491; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lusa S, 2003, J BIOL CHEM, V278, P19844, DOI 10.1074/jbc.M212503200; Lutjohann D, 2002, J LIPID RES, V43, P1078, DOI 10.1194/jlr.M200071-JLR200; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; OLKKONEN VM, 1993, J NEUROSCI RES, V35, P445, DOI 10.1002/jnr.490350412; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Patterson MC, 2003, NEUROLOGIST, V9, P301, DOI 10.1097/01.nrl.0000094627.78754.5b; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Reid PC, 2004, J LIPID RES, V45, P582, DOI 10.1194/jlr.D300032-JLR200; Reid PC, 2003, J LIPID RES, V44, P1010, DOI 10.1194/jlr.M300009-JLR200; SHAH SN, 1986, NEUROCHEM RES, V11, P813, DOI 10.1007/BF00965206; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Snipes G J, 1997, Subcell Biochem, V28, P173; Suresh S, 1998, J NEUROCHEM, V70, P242; VOLPE JJ, 1977, BIOCHIM BIOPHYS ACTA, V486, P408, DOI 10.1016/0005-2760(77)90090-X; Waterham HR, 2000, BBA-MOL CELL BIOL L, V1529, P340, DOI 10.1016/S1388-1981(00)00159-1; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776	45	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48654	48662		10.1074/jbc.M405345200	http://dx.doi.org/10.1074/jbc.M405345200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355983	hybrid			2022-12-27	WOS:000225098100022
J	Veljkovic, E; Bacconi, A; Stetak, A; Hajnal, A; Stasiuk, S; Skelly, PJ; Forster, I; Shoemaker, CB; Verrey, F				Veljkovic, E; Bacconi, A; Stetak, A; Hajnal, A; Stasiuk, S; Skelly, PJ; Forster, I; Shoemaker, CB; Verrey, F			Aromatic amino acid transporter AAT-9 of Caenorhabditis elegans localizes to neurons and muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/P-I COTRANSPORTER; CHANNEL; RESIDUES; GENETICS; BIOLOGY; CLONING	The Caenorhabditis elegans genome encodes nine homologues of mammalian glycoprotein-associated amino acid transporters. Two of these C. elegans proteins (AAT-1 and AAT-3) have been shown to function as catalytic subunits (light chains) of heteromeric amino acid transporters. These proteins need to associate with a glycoprotein heavy chain subunit (ATG-2) to reach the cell surface in a manner similar to that of their mammalian homologues. AAT-1 and AAT-3 contain a cysteine residue in the second putative extracellular loop through which a disulfide bridge can form with a heavy chain. In contrast, six C. elegans members of this family (AAT-4 to AAT-9) lack such a cysteine residue. We show here that one of these transporter proteins, AAT-9, reaches the cell surface in Xenopus oocytes without an exogenous heavy chain and that it functions as an exchanger of aromatic amino acids. Two-electrode voltage clamp experiments demonstrate that AAT-9 displays a substrate-activated conductance. Immunofluorescence shows that it is expressed close to the pharyngeal bulbs within C. elegans neurons. The selective expression of an aat-9 promoter-green fluorescent protein construct in several neurons of this region and in wall muscle cells around the mouth supports and extends these localization data. Taken together, the results show that AAT-9 is expressed in excitable cells of the nematode head and pharynx in which it may provide a pathway for aromatic amino acid transport.	Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; AgRes Anim Hlth, Wallaceville Anim Res Ctr, Upper Hutt, New Zealand; Tufts Univ, Sch Vet Med, Dept Biomed Sci, Grafton, MA 01536 USA	University of Zurich; University of Zurich; AgResearch - New Zealand; Tufts University	Verrey, F (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	verrey@access.unizh.ch		Forster, Ian/0000-0003-3087-9952; Hajnal, Alex/0000-0002-4098-3721; Verrey, Francois/0000-0003-3250-9824				BRENNER S, 1974, GENETICS, V77, P71; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Forster I, 1998, J GEN PHYSIOL, V112, P1, DOI 10.1085/jgp.112.1.1; Harlow E., 1988, ANTIBODIES LAB MANUA; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanai Y, 2001, CURR DRUG METAB, V2, P339, DOI 10.2174/1389200013338324; Kim DK, 2002, GENOMICS, V79, P95, DOI 10.1006/geno.2001.6678; Kim DK, 2001, J BIOL CHEM, V276, P17221, DOI 10.1074/jbc.M009462200; Kohler K, 2002, J GEN PHYSIOL, V120, P693, DOI 10.1085/jgp.20028645; MADURO M, 1995, GENETICS, V141, P977; Mastroberardino L, 1998, NATURE, V395, P288, DOI 10.1038/26246; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Pfeiffer R, 1999, MOL BIOL CELL, V10, P4135, DOI 10.1091/mbc.10.12.4135; Pfeiffer R, 1998, FEBS LETT, V439, P157, DOI 10.1016/S0014-5793(98)01359-3; Puoti A, 1997, P NATL ACAD SCI USA, V94, P5949, DOI 10.1073/pnas.94.11.5949; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Strange K, 2003, PHYSIOL REV, V83, P377, DOI 10.1152/physrev.00025.2002; Veljkovic E, 2004, J BIOL CHEM, V279, P7655, DOI 10.1074/jbc.M309528200; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Verrey F, 1999, J MEMBRANE BIOL, V172, P181, DOI 10.1007/s002329900595; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991	25	5	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49268	49273		10.1074/jbc.M404470200	http://dx.doi.org/10.1074/jbc.M404470200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364921	Green Accepted, hybrid			2022-12-27	WOS:000225098100094
J	Walerych, D; Kudla, G; Gutkowska, M; Wawrzynow, B; Muller, L; King, FW; Helwak, A; Boros, J; Zylicz, A; Zylicz, M				Walerych, D; Kudla, G; Gutkowska, M; Wawrzynow, B; Muller, L; King, FW; Helwak, A; Boros, J; Zylicz, A; Zylicz, M			Hsp90 chaperones wild-type p53 tumor suppressor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCED PHOSPHORYLATION; C-TERMINAL DOMAIN; MUTANT P53; DNA-BINDING; MOLECULAR CHAPERONE; ATP HYDROLYSIS; RNA-POLYMERASE; CORE DOMAIN; MUTATED P53; IN-VIVO	Immortalized human fibroblasts were used to investigate the putative interactions of the Hsp90 molecular chaperone with the wild-type p53 tumor suppressor protein. We show that geldanamycin or radicicol, specific inhibitors of Hsp90, diminish specific wild-type p53 binding to the p21 promoter sequence. Consequently, these inhibitors decrease p21 mRNA levels, which lead to a reduction in cellular p21/Waf1 protein, known to induce cell cycle arrest. In control experiments, we show that neither geldanamycin nor radicicol affect p53 mRNA levels. A minor decrease in p53 protein level following the treatment of human fibroblasts with the inhibitors suggests the potential involvement of Hsp90 in the stabilization of wild-type p53. To support our in vivo findings, we used a reconstituted system with highly purified recombinant proteins to examine the effects of Hsp90 on wildtype p53 binding to the p21 promoter sequence. The human recombinant Hsp90 alpha-isoform as well as bovine brain Hsp90 were purified to homogeneity. Both of these molecular chaperones displayed ATPase activity and the ability to refold heat-inactivated luciferase in a geldanamycin- and radicicol-sensitive manner, suggesting that post-translational modifications are not involved in the modulation of Hsp90alpha activity. We show that the incubation of recombinant p53 at 37degreesC decreases the level of its wildtype conformation and strongly inhibits the in vitro binding of p53 to the p21 promoter sequence. Interestingly, Hsp90 in an ATP-dependent manner can positively modulate p53 DNA binding after incubation at physiological temperature of 37degreesC. Other recombinant human chaperones from Hsp70 and Hsp40 families were not able to efficiently substitute Hsp90 in this reaction. Consistent with our in vivo results, geldanamycin can suppress Hsp90 ability to regulate in vitro p53 DNA binding to the promoter sequence. In summary, the results presented in this article state that chaperone activity of Hsp90 is important for the transcriptional activity of genotypically wild-type p53.	Int Inst Mol & Cell Biol Warsaw, PL-02109 Warsaw, Poland; Polish Acad Sci, M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland; Tech Univ Munich, Dept Chem, D-85747 Garching, Germany; Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Technical University of Munich; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zylicz, M (corresponding author), Int Inst Mol & Cell Biol Warsaw, Trojdena 4 St, PL-02109 Warsaw, Poland.	zylicz@iimcb.gov.pl	Walerych, Dawid/I-2517-2016	Gutkowska, Malgorzata/0000-0001-6584-7964; Zylicz, Alicja/0000-0003-4174-3073; Kudla, Grzegorz/0000-0002-7924-2744; Walerych, Dawid/0000-0002-8440-1375				Akakura S, 2001, J BIOL CHEM, V276, P14649, DOI 10.1074/jbc.M100200200; Anderson ME, 1997, MOL CELL BIOL, V17, P6255, DOI 10.1128/MCB.17.11.6255; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; HAINAUT P, 1995, ONCOGENE, V10, P27; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; MILNER J, 1990, ONCOGENE, V5, P1683; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Peng YH, 2001, J BIOL CHEM, V276, P6874, DOI 10.1074/jbc.C000781200; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Sepehrnia B, 1996, J BIOL CHEM, V271, P15084, DOI 10.1074/jbc.271.25.15084; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Wawrzynow A, 1996, MOL MICROBIOL, V21, P895, DOI 10.1046/j.1365-2958.1996.421404.x; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19300, DOI 10.1074/jbc.270.33.19300; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 1997, ONCOGENE, V14, P2809, DOI 10.1038/sj.onc.1201120; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Yakovleva T, 2001, J BIOL CHEM, V276, P15650, DOI 10.1074/jbc.M100482200; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; ZIEMIENOWICZ A, 1995, J BIOL CHEM, V270, P15479, DOI 10.1074/jbc.270.26.15479; ZIEMIENOWICZ A, 1993, J BIOL CHEM, V268, P25425; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	65	119	122	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48836	48845		10.1074/jbc.M407601200	http://dx.doi.org/10.1074/jbc.M407601200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358769	hybrid			2022-12-27	WOS:000225098100045
J	Begenisich, T; Nakamoto, T; Ovitt, CE; Nehrke, K; Brugnara, C; Alper, SL; Melvin, JE				Begenisich, T; Nakamoto, T; Ovitt, CE; Nehrke, K; Brugnara, C; Alper, SL; Melvin, JE			Physiological roles of the intermediate conductance, Ca2+-activated potassium channel Kcnn4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANDIBULAR SECRETORY-CELLS; PAROTID ACINAR-CELLS; K+ CHANNEL; ERYTHROCYTE DEHYDRATION; GARDOS CHANNEL; FUNCTIONAL-CHARACTERIZATION; CATION CHANNELS; T-LYMPHOCYTES; SAD MICE; CALCIUM	Three broad classes of Ca2+-activated potassium channels are defined by their respective single channel conductances, i.e. the small, intermediate, and large conductance channels, often termed the SK, IK, and BK channels, respectively. SK channels are likely encoded by three genes, Kcnn1- 3, whereas IK and most BK channels are most likely products of the Kcnn4 and Slo (Kcnma1) genes, respectively. IK channels are prominently expressed in cells of the hematopoietic system and in organs involved in salt and fluid transport, including the colon, lung, and salivary glands. IK channels likely underlie the K+ permeability in red blood cells that is associated with water loss, which is a contributing factor in the pathophysiology of sickle cell disease. IK channels are also involved in the activation of T lymphocytes. The fluid-secreting acinar cells of the parotid gland express both IK and BK channels, raising questions about their particular respective roles. To test the physiological roles of channels encoded by the Kcnn4 gene, we constructed a mouse deficient in its expression. Kcnn4 null mice were of normal appearance and fertility, their parotid acinar cells expressed no IK channels, and their red blood cells lost K+ permeability. The volume regulation of T lymphocytes and erythrocytes was severely impaired in Kcnn4 null mice but was normal in parotid acinar cells. Despite the loss of IK channels, activated fluid secretion from parotid glands was normal. These results confirm that IK channels in red blood cells, T lymphocytes, and parotid acinar cells are indeed encoded by the Kcnn4 gene. The role of these channels in water movement and the subsequent volume changes in red blood cells and T lymphocytes is also confirmed. Surprisingly, Kcnn4 channels appear to play no required role in fluid secretion and regulatory volume decrease in the parotid gland.	Univ Rochester, Med Ctr, Aab Inst Biomed Sci, Ctr Oral Biol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Mol & Vasc Med Unit, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA	University of Rochester; University of Rochester; University of Rochester; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Melvin, JE (corresponding author), Univ Rochester, Med Ctr, Aab Inst Biomed Sci, Ctr Oral Biol, Box 611,601 Elmwood Ave, Rochester, NY 14642 USA.	james_melvin@urmc.rochester.edu	Brugnara, Carlo/A-8041-2010	Brugnara, Carlo/0000-0001-8192-8713; Nehrke, Keith/0000-0001-9697-726X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE008921, R01DE009692, P01DE013539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R21DK061051, R01DK050422, R01DK057662] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL73112] Funding Source: Medline; NIDCR NIH HHS [DE013539, DE08921, DE09692] Funding Source: Medline; NIDDK NIH HHS [DK61051, DK34854, DK50422, DK57662] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERS DM, 1994, METHOD CELL BIOL, V40, P3; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Brugnara C, 2001, DRUG NEWS PERSPECT, V14, P208, DOI 10.1358/dnp.2001.14.4.858404; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Elliott JL, 2003, EMBO REP, V4, P189, DOI 10.1038/sj.embor.embor722; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; HALPERIN JA, 1989, J CLIN INVEST, V83, P1466, DOI 10.1172/JCI114039; Hayashi T, 1996, J MEMBRANE BIOL, V151, P19, DOI 10.1007/s002329900054; Hayashi T, 1996, J MEMBRANE BIOL, V152, P253, DOI 10.1007/s002329900103; Hoffman JF, 2003, P NATL ACAD SCI USA, V100, P7366, DOI 10.1073/pnas.1232342100; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; ISHIKAWA T, 1994, PFLUG ARCH EUR J PHY, V428, P516, DOI 10.1007/BF00374573; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MARUYAMA Y, 1986, JPN J PHYSIOL, V36, P219, DOI 10.2170/jjphysiol.36.219; MEREDITH AL, J BIOL CHEM, V279, P36746; Nehrke K, 2003, AM J PHYSIOL-CELL PH, V284, pC535, DOI 10.1152/ajpcell.00044.2002; Park K, 2001, ARCH ORAL BIOL, V46, P801, DOI 10.1016/S0003-9969(01)00047-4; Rivera A, 1999, AM J PHYSIOL-CELL PH, V277, pC746, DOI 10.1152/ajpcell.1999.277.4.C746; SCHMUKLER BE, 2001, BIOCHIM BIOPHYS ACTA, V1518, P36; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Takahata T, 2003, AM J PHYSIOL-CELL PH, V284, pC127, DOI 10.1152/ajpcell.00250.2002; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WEGMAN EA, 1992, AM J PHYSIOL, V263, pG786, DOI 10.1152/ajpgi.1992.263.5.G786; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Zhang BM, 2001, BIOCHEMISTRY-US, V40, P3189, DOI 10.1021/bi001675h	30	155	163	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47681	47687		10.1074/jbc.M409627200	http://dx.doi.org/10.1074/jbc.M409627200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347667	Green Published, hybrid			2022-12-27	WOS:000224957000033
J	Kosta, A; Roisin-Bouffay, C; Luciani, MF; Otto, GP; Kessin, RH; Golstein, P				Kosta, A; Roisin-Bouffay, C; Luciani, MF; Otto, GP; Kessin, RH; Golstein, P			Autophagy gene disruption reveals a non-vacuolar cell death pathway in Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; SACCHAROMYCES-CEREVISIAE; SLIME-MOLD; DISCOIDEUM; MUTANTS; DIFFERENTIATION; MECHANISMS; APOPTOSIS; MACROAUTOPHAGY; MITOCHONDRIA	Types of cell death include apoptosis, necrosis, and autophagic cell death. The latter can be defined as death of cells containing autophagosomes, autophagic bodies, and/or vacuoles. Are autophagy and vacuolization causes, consequences, or side effects in cell death with autophagy? Would control of autophagy suffice to control this type of cell death? We disrupted the atg1 autophagy gene in Dictyostelium discoideum, a genetically tractable model for developmental autophagic vacuolar cell death. The procedure that induced autophagy, vacuolization, and death in wild-type cells led in atg1 mutant cells to impaired autophagy and to no vacuolization, demonstrating that atg1 is required for vacuolization. Unexpectedly, however, cell death still took place, with a non-vacuolar and centrally condensed morphology. Thus, a cell death mechanism that does not require vacuolization can operate in this cell death model showing conspicuous vacuolization. The revelation of non-vacuolar cell death in this protist by autophagy gene disruption is reminiscent of caspase inhibition revealing necrotic cell death in animal cells. Thus, hidden alternative cell death pathways may be found across kingdoms and for diverse types of cell death.	Univ Mediterranee Marseille Luminy, Ctr Immunol, INSERM, CNRS, F-13288 Marseille 9, France; Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Columbia University	Golstein, P (corresponding author), Univ Mediterranee Marseille Luminy, Ctr Immunol, INSERM, CNRS, Case 906,Campus Luminy,Ave Luminy, F-13288 Marseille 9, France.	golstein@ciml.univ-mrs.fr	Golstein, Pierre/A-4954-2014	Golstein, Pierre/0000-0003-1750-3483; Otto, Grant/0000-0001-8709-3366; Kosta, Artemis/0000-0001-7115-4566				Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Al-Saffar NMS, 2002, BRIT J CANCER, V86, P963, DOI 10.1038/sj/bjc/6600188; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; BEAULATION J, 1977, J MORPHOL, V154, P39, DOI 10.1002/jmor.1051540104; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; CORNILLON S, 1994, J CELL SCI, V107, P2691; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; Dementhon K, 2003, EUKARYOT CELL, V2, P238, DOI 10.1128/EC.2.2.238-246.2003; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; GEORGE RP, 1972, J GEN MICROBIOL, V70, P477, DOI 10.1099/00221287-70-3-477; Golstein P, 2003, NAT REV MOL CELL BIO, V4, P798, DOI 10.1038/nrm1224; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hall DH, 1997, J NEUROSCI, V17, P1033; Harris E, 2002, MOL BIOL CELL, V13, P656, DOI 10.1091/mbc.01-09-0454; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; KAY RR, 1987, METHOD CELL BIOL, V28, P433; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levraud JP, 2003, J CELL BIOL, V160, P1105, DOI 10.1083/jcb.200212104; LOCKSHIN RICHARD A., 1965, J INSECT PHYSIOL, V11, P123, DOI 10.1016/0022-1910(65)90099-5; MAEDA Y, 1969, DEV GROWTH DIFFER, V11, P232; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Olie RA, 1998, CURR BIOL, V8, P955, DOI 10.1016/S0960-9822(98)70395-1; Otto GP, 2004, J BIOL CHEM, V279, P15621, DOI 10.1074/jbc.M311139200; Otto GP, 2004, MOL MICROBIOL, V51, P63, DOI 10.1046/j.1365-2958.2003.03826.x; Otto GP, 2003, J BIOL CHEM, V278, P17636, DOI 10.1074/jbc.M212467200; PADH H, 1989, J CELL BIOL, V108, P865, DOI 10.1083/jcb.108.3.865; Pinan-Lucarre R, 2003, MOL MICROBIOL, V47, P321, DOI 10.1046/j.1365-2958.2003.03208.x; QUIVIGER B, 1980, BIOL CELLULAIRE, V37, P241; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roisin-Bouffay C, 2004, J BIOL CHEM, V279, P11489, DOI 10.1074/jbc.M312741200; RYTER A, 1977, J CELL BIOL, V75, P200, DOI 10.1083/jcb.75.1.200; SCHAAP P, 1981, BIOL CELL, V41, P133; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Weeks JC, 2003, PROG NEUROBIOL, V70, P421, DOI 10.1016/S0301-0082(03)00102-3; WHITTINGHAM WF, 1960, P NATL ACAD SCI USA, V46, P642, DOI 10.1073/pnas.46.5.642; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; ZAKERI Z, 1995, CELL DEATH DIFFER, V2, P87	56	81	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48404	48409		10.1074/jbc.M408924200	http://dx.doi.org/10.1074/jbc.M408924200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15358773	hybrid			2022-12-27	WOS:000224957000116
J	Tucker, WC; Schwarz, A; Levine, T; Du, ZY; Gromet-Elhanan, Z; Richter, ML; Haran, G				Tucker, WC; Schwarz, A; Levine, T; Du, ZY; Gromet-Elhanan, Z; Richter, ML; Haran, G			Observation of calcium-dependent unidirectional rotational motion in recombinant photosynthetic F-1-ATPase molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SUBUNIT OLIGOMER; BINDING CHANGE MECHANISM; F0F1 ATP SYNTHASE; GAMMA-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; COUPLING FACTOR; WILD-TYPE; HYDROLYSIS; BETA; DICYCLOHEXYLCARBODIIMIDE	ATP hydrolysis and synthesis by the F0F1-ATP synthase are coupled to proton translocation across the membrane in the presence of magnesium. Calcium is known, however, to disrupt this coupling in the photosynthetic enzyme in a unique way: it does not support ATP synthesis, and CaATP hydrolysis is decoupled from any proton translocation, but the membrane does not become leaky to protons. Understanding the molecular basis of these calcium-dependent effects can shed light on the as yet unclear mechanism of coupling between proton transport and rotational catalysis. We show here, using an actin filament gamma-rotation assay, that CaATP is capable of sustaining rotational motion in a highly active hybrid photosynthetic F-1-ATPase consisting of alpha and beta subunits from Rhodospirillum rubrum and gamma subunit from spinach chloroplasts (alpha(3)(R)beta(3)(R)gamma(C)). The rotation was found to be similar to that induced by MgATP in Escherichia coli F-1-ATPase molecules. Our results suggest a possible long range pathway that enables the bound CaATP to induce full rotational motion of gamma but might block transmission of this rotational motion into proton translocation by the F-0 part of the ATP synthase.	Weizmann Inst Sci, Dept Chem Phys, IL-71600 Rehovot, Israel; Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Weizmann Inst Sci, Dept Biol Chem, IL-71600 Rehovot, Israel	Weizmann Institute of Science; University of Kansas; Weizmann Institute of Science	Haran, G (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-71600 Rehovot, Israel.	gilad.haran@weizmann.ac.il	HARAN, GILAD/K-1489-2012		NIGMS NIH HHS [GM08545] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; Du ZY, 1999, EUR J BIOCHEM, V263, P430, DOI 10.1046/j.1432-1327.1999.00512.x; Du ZY, 2001, J BIOL CHEM, V276, P11517, DOI 10.1074/jbc.M007568200; Gromet-Elhanan Z., 1995, ANOXYGENIC PHOTOSYNT, P807; GROMETELHANAN Z, 1989, BIOCHEMISTRY-US, V28, P3645, DOI 10.1021/bi00435a004; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; HOCHMAN Y, 1976, FEBS LETT, V61, P255, DOI 10.1016/0014-5793(76)81051-4; Hochman Y, 2000, INDIAN J BIOCHEM BIO, V37, P459; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUNOYAGI A, 1993, J BIOL CHEM, V268, P1539; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; Muller M, 2002, J BIOL CHEM, V277, P23308, DOI 10.1074/jbc.M201998200; Nathanson L, 2000, J BIOL CHEM, V275, P901, DOI 10.1074/jbc.275.2.901; Nathanson L, 1998, J BIOL CHEM, V273, P10933, DOI 10.1074/jbc.273.18.10933; NELSON N, 1972, J BIOL CHEM, V247, P6506; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589; PICK U, 1988, EUR J BIOCHEM, V173, P623, DOI 10.1111/j.1432-1033.1988.tb14044.x; Richter ML, 2000, BBA-BIOENERGETICS, V1458, P326, DOI 10.1016/S0005-2728(00)00084-0; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Sokolov M, 1999, J BIOL CHEM, V274, P13824, DOI 10.1074/jbc.274.20.13824; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P898, DOI 10.1073/pnas.031564198; Tucker WC, 2001, EUR J BIOCHEM, V268, P2179, DOI 10.1046/j.1432-1327.2001.02110.x; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P10583, DOI 10.1073/pnas.94.20.10583	42	24	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47415	47418		10.1074/jbc.C400269200	http://dx.doi.org/10.1074/jbc.C400269200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15377671	hybrid			2022-12-27	WOS:000224957000002
J	Zang, MW; Zuccollo, A; Hou, XY; Nagata, D; Walsh, K; Herscovitz, H; Brecher, P; Ruderman, NB; Cohen, RA				Zang, MW; Zuccollo, A; Hou, XY; Nagata, D; Walsh, K; Herscovitz, H; Brecher, P; Ruderman, NB; Cohen, RA			AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; MALONYL-COA DECARBOXYLASE; CELLULAR-ENERGY; SKELETAL-MUSCLE; GENE-EXPRESSION; GLUCOSE; PHOSPHORYLATION; CASCADE; SECRETION; LKB1	The antidiabetic drug metformin stimulates AMP-activated protein kinase (AMPK) activity in the liver and in skeletal muscle. To better understand the role of AMPK in the regulation of hepatic lipids, we studied the effect of metformin on AMPK and its downstream effector, acetyl-CoA carboxylase (ACC), as well as on lipid content in cultured human hepatoma HepG2 cells. Metformin increased Thr-172 phosphorylation of the alpha subunit of AMPK in a dose- and time-dependent manner. In parallel, phosphorylation of ACC at Ser-79 was increased, which was consistent with decreasing ACC activity. Intracellular triacylglycerol and cholesterol contents were also decreased. These effects of metformin were mimicked or completely abrogated by adenoviral-mediated expression of a constitutively active AMPKalpha or a kinase-inactive AMPKalpha, respectively. An insulin-resistant state was induced by exposing cells to 30 mM glucose as indicated by decreased phosphorylation of Akt and its downstream effector, glycogen synthase kinase 3alpha/beta. Under these conditions, the phosphorylation of AMPK and ACC was also decreased, and the level of hepatocellular triacylglycerols increased. The inhibition of AMPK and the accumulation of lipids caused by high glucose concentrations were prevented either by metformin or by expressing the constitutively active AMPKalpha. The kinase-inactive AMPKalpha increased lipid content and blocked the ability of metformin to decrease lipid accumulation caused by high glucose concentrations. Taken together, these results indicate that AMPKalpha negatively regulates ACC activity and hepatic lipid content. Inhibition of AMPK may contribute to lipid accumulation induced by high concentrations of glucose associated with insulin resistance. Metformin lowers hepatic lipid content by activating AMPK, thereby mediating beneficial effects in hyperglycemia and insulin resistance.	Boston Univ, Sch Med, Vasc Biol Unit, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Boston Univ, Sch Med, Diabet & Metab Unit, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Cohen, RA (corresponding author), Boston Univ, Sch Med, Vasc Biol Unit, X708,650 Albany St, Boston, MA 02118 USA.	racohen@bu.edu		/0000-0002-1070-6408; Ruderman, Neil/0000-0002-6589-6587; Herscovitz, Haya/0000-0001-8067-6091; Zang, Mengwei/0000-0002-2502-2586; Brecher, Peter/0000-0002-9347-6643	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040197] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL68758] Funding Source: Medline; NIAMS NIH HHS [AR40197] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Anurag P, 2002, DIABETES OBES METAB, V4, P36, DOI 10.1046/j.1463-1326.2002.00178.x; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Davidson MB, 1997, AM J MED, V102, P99, DOI 10.1016/S0002-9343(96)00353-1; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; FEDELE D, 1976, DIABETES METAB, V2, P127; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; HERMANN LS, 1979, DIABETES METAB, V5, P233; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MIKOKOSHI Y, 2004, NATURE, V428, P569; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Payne KL, 1997, EUR J ENDOCRINOL, V137, P415, DOI 10.1530/eje.0.1370415; Riebeling C, 2002, BRIT J CANCER, V87, P366, DOI 10.1038/sj.bjc.6600476; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Ruderman N, 2001, SCIENCE, V291, P2558, DOI 10.1126/science.1060277; Saha AK, 2000, J BIOL CHEM, V275, P24279, DOI 10.1074/jbc.C000291200; Sambandam N, 2004, EUR J BIOCHEM, V271, P2831, DOI 10.1111/j.1432-1033.2004.04218.x; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; WITTERS LA, 1988, P NATL ACAD SCI USA, V85, P5473, DOI 10.1073/pnas.85.15.5473; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xavier GD, 2003, BIOCHEM J, V371, P761; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yu-Poth S, 2004, J NUTR, V134, P68, DOI 10.1093/jn/134.1.68; Yuan L, 2003, ACTA PHARMACOL SIN, V24, P55; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200; Zang MW, 2001, J BIOL CHEM, V276, P25157, DOI 10.1074/jbc.M100152200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	49	369	386	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47898	47905		10.1074/jbc.M408149200	http://dx.doi.org/10.1074/jbc.M408149200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15371448	hybrid			2022-12-27	WOS:000224957000060
J	Kuhn, FJP; Luckhoff, A				Kuhn, FJP; Luckhoff, A			Sites of the NUDT9-H domain critical for ADP-ribose activation of the cation channel TRPM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUDIX HYDROLASES; FAMILY; PYROPHOSPHATASE; LTRPC2; PROTEINS; REVEALS; GENE	TRPM2 is a cation channel unique within the transient receptor potential family because of its gating by ADP-ribose (ADPR). ADPR gating is enabled by a cytosolic C-terminal Nudix box sequence motif embedded into a region homologous to the NUDT9 ADPR pyrophosphatase. A recently discovered splice variant of TRPM2 (TRPM2-DeltaC) lacks 34 amino acid residues in the NUDT9 domain and is insensitive to ADPR. To analyze in detail which parts of the deleted sequence (DeltaC-stretch) are critical for ADPR gating, we tested mutants that lacked 19, 25, and 29 amino acid residues in the N-terminal part or had amino acid residues substituted in the remaining C-terminal part of the DeltaC-stretch. All of these mutants displayed typical ADPR-induced currents. However, the deletion or substitution of the amino acid residue Asn-1326 immediately downstream of the DeltaC-stretch abrogated ADPR gating. We furthermore analyzed the mutation I1405E/L1406F in the Nudix box of TRPM2, because a considerably decreased ADPRase activity of the TRPM2 NUDT9-H protein in comparison to the NUDT9 pyrophosphatase has been attributed to the reverse exchange EF --> IL. The I1405E/L1406F variant of TRPM2 failed to respond to ADPR even at concentrations up to 10 mM. We concluded that the DeltaC-stretch contains no individual amino acid residues essential for ADPR gating but may act as a spacer segment stabilizing a conformation necessary for the essential residue Asn-1326 to interact with other channel regions. Enhancing the enzymatic activity of the Nudix box abolishes the ADPR gating of TRPM2, pointing to the requirement of prolonged binding rather than degradation.	Rhein Westfal TH Aachen, Inst Physiol, Fak Med, D-52057 Aachen, Germany	RWTH Aachen University	Luckhoff, A (corresponding author), Rhein Westfal TH Aachen, Inst Physiol, Fak Med, Pauwelsstr 30, D-52057 Aachen, Germany.	luckhoff@physiology.rwth-aachen.de	Kuehn, Frank JP/H-5889-2018					Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Birnbaumer L, 2003, CELL CALCIUM, V33, P419, DOI 10.1016/S0143-4160(03)00068-X; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; GUSE AH, 2002, CURR MOL MED, V2, P272; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Heiner I, 2003, BIOCHEM J, V371, P1045, DOI 10.1042/BJ20021975; Inamura K, 2003, J MEMBRANE BIOL, V191, P201, DOI 10.1007/s00232-002-1057-x; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Shen BW, 2003, J MOL BIOL, V332, P385, DOI 10.1016/S0022-2836(03)00954-9; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Zitt C, 2002, PROG NEUROBIOL, V66, P243, DOI 10.1016/S0301-0082(02)00002-3	21	102	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46431	46437		10.1074/jbc.M407263200	http://dx.doi.org/10.1074/jbc.M407263200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347676	hybrid			2022-12-27	WOS:000224832400013
J	Azriel-Tamir, H; Sharir, H; Schwartz, B; Hershfinkel, M				Azriel-Tamir, H; Sharir, H; Schwartz, B; Hershfinkel, M			Extracellular zinc triggers ERK-dependent activation of Na+/H+ exchange in colonocytes mediated by the zinc-sensing receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; GLOMERULAR MESANGIAL CELLS; SIGNAL-REGULATED KINASE; PH REGULATION; INTRACELLULAR CA2+; COLONIC CRYPTS; T-84 CELLS; CROSS-TALK; CALCIUM	Extracellular zinc promotes cell proliferation and its deficiency leads to impairment of this process, which is particularly important in epithelial cells. We have recently characterized a zinc-sensing receptor (ZnR) linking extracellular zinc to intracellular release of calcium. In the present study, we addressed the role of extracellular zinc, acting via the ZnR, in regulating the MAP kinase pathway and Na+/H+ exchange in colonocytes. We demonstrate that Ca2+ release, mediated by the ZnR, induces phosphorylation of ERK1/2, which is highly metal-specific, mediated by physiological concentrations of extracellular Zn2+ but not by Cd2+, Fe2+, Ni2+, or Mn2+. Desensitization of the ZnR by Zn2+, is followed by similar to90% inhibition of the Zn2+-dependent ERK1/2 phosphorylation, indicating that the ZnR is a principal link between extracellular Zn2+ and ERK1/2 activation. Application of both the IP3 pathway and PI 3-kinase antagonists largely inhibited Zn2+-dependent ERK1/2 phosphorylation. The physiological significance of the Zn2+-dependent activation of ERK1/2 was addressed by monitoring Na+/H+ exchanger activity in HT29 cells and in native colon epithelium. Preincubation of the cells with zinc was followed by robust activation of Na+/H+ exchange, which was eliminated by cariporide (0.5 muM); indicating that zinc enhances the activity of NHE1. Activation of NHE1 by zinc was totally blocked by the ERK1/2 inhibitor, U0126. Prolonged acidification, in contrast, stimulates NHE1 by a distinct pathway that is not affected by extracellular Zn2+ or inhibitors of the MAP kinase pathway. Desensitization of ZnR activity eliminates the Zn2+-dependent, but not the prolonged acidification-dependent activation of NHE1, indicating that Zn2+-dependent activation of H+ extrusion is specifically mediated by the ZnR. Our results support a role for extracellular zinc, acting through the ZnR, in regulating multiple signaling pathways that affect pH homeostasis in colonocytes. Furthermore activation of both, ERK and NHE1, by extracellular zinc may provide the mechanism linking zinc to enhanced cell proliferation.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Morphol, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Canc Res Ctr, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Fac Agr, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem	Hershfinkel, M (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Morphol, Zlotowski Ctr Neurosci, Box 653, IL-84105 Beer Sheva, Israel.	hmichal@bgu.ac.il	Hershfinkel, Michal/F-1548-2012	Hershfinkel, Michal/0000-0003-1652-1989				Aliaga JC, 1999, AM J PHYSIOL-GASTR L, V277, pG631, DOI 10.1152/ajpgi.1999.277.3.G631; ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; Bachmann O, 2004, AM J PHYSIOL-GASTR L, V287, pG125, DOI 10.1152/ajpgi.00332.2003; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Busche R, 1997, COMP BIOCHEM PHYS A, V118, P395, DOI 10.1016/S0300-9629(96)00327-1; Cammarota M, 2002, CELL MOL NEUROBIOL, V22, P259, DOI 10.1023/A:1020763716886; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHEN SM, 2004, NEPHRON PHYSIOL, V96, P113; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Chu JS, 2002, AM J PHYSIOL-CELL PH, V283, pC358, DOI 10.1152/ajpcell.01380.2000; CHU SY, 1995, P NATL ACAD SCI USA, V92, P3303, DOI 10.1073/pnas.92.8.3303; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dudeja PK, 1996, AM J PHYSIOL-GASTR L, V271, pG483, DOI 10.1152/ajpgi.1996.271.3.G483; Duvillard C, 2004, ANTI-CANCER DRUG, V15, P295, DOI 10.1097/00001813-200403000-00015; Egea J, 2000, MOL CELL BIOL, V20, P1931, DOI 10.1128/MCB.20.6.1931-1946.2000; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Ginnan R, 2002, AM J PHYSIOL-CELL PH, V282, pC754, DOI 10.1152/ajpcell.00335.2001; Gonda T, 1999, AM J PHYSIOL-GASTR L, V276, pG259, DOI 10.1152/ajpgi.1999.276.1.G259; Hasselblatt P, 2000, PFLUG ARCH EUR J PHY, V441, P118, DOI 10.1007/s004240000377; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Hazan-Halevy I, 2000, J BIOL CHEM, V275, P12416, DOI 10.1074/jbc.275.17.12416; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Kaiser GC, 1999, EXP CELL RES, V249, P349, DOI 10.1006/excr.1999.4488; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Keely SJ, 1999, J BIOL CHEM, V274, P33449, DOI 10.1074/jbc.274.47.33449; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; Kiss Z, 1997, FEBS LETT, V415, P71, DOI 10.1016/S0014-5793(97)01095-8; KNUDSEN E, 1995, J NUTR, V125, P1274; Koh SD, 1999, J PHYSIOL-LONDON, V517, P75, DOI 10.1111/j.1469-7793.1999.0075z.x; Krishnan S, 2003, AM J PHYSIOL-CELL PH, V285, pC1246, DOI 10.1152/ajpcell.00598.2002; LAWSON MJ, 1988, BIOL TRACE ELEM RES, V18, P115, DOI 10.1007/BF02917495; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Maouyo D, 2000, AM J PHYSIOL-CELL PH, V278, pC973, DOI 10.1152/ajpcell.2000.278.5.C973; Maret W, 2001, P NATL ACAD SCI USA, V98, P12325, DOI 10.1073/pnas.231481398; Maret W, 2001, BIOMETALS, V14, P187, DOI 10.1023/A:1012945110820; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; MCKEARN TJ, 1993, CANCER, V71, P4302, DOI 10.1002/1097-0142(19930615)71:12+<4302::AID-CNCR2820711820>3.0.CO;2-M; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Montrose MH, 1997, COMP BIOCHEM PHYS A, V118, P389, DOI 10.1016/S0300-9629(96)00326-X; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Park KS, 2003, AM J PHYSIOL-GASTR L, V19, P19; Phillips WA, 1998, CANCER, V83, P41, DOI 10.1002/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H; Philp AJ, 2001, CANCER RES, V61, P7426; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Praskova M, 2002, ARCH DERMATOL RES, V294, P198, DOI 10.1007/s00403-002-0312-4; Praskova M, 2002, EXP DERMATOL, V11, P344, DOI 10.1034/j.1600-0625.2002.110408.x; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; ROBINSON NC, 2004, J PHYSL, V30, P30; Samet JM, 1998, AM J PHYSIOL-LUNG C, V275, pL551, DOI 10.1152/ajplung.1998.275.3.L551; SANDSTROM B, 1995, ANALYST, V120, P913, DOI 10.1039/an9952000913; SANDSTROM B, 1986, AM J CLIN NUTR, V44, P501, DOI 10.1093/ajcn/44.4.501; Schultheiss Gerhard, 2002, Biological Procedures Online, V3, P70, DOI 10.1251/bpo25; SEKLER I, 1995, J BIOL CHEM, V270, P21028, DOI 10.1074/jbc.270.36.21028; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; TAKEWAKI S, 1995, J MOL CELL CARDIOL, V27, P729, DOI 10.1016/S0022-2828(08)80063-6; Thamilselvan V, 2003, J SURG RES, V110, P255, DOI 10.1016/S0022-4804(03)00028-3; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Velazquez OC, 1997, ADV EXP MED BIOL, V427, P123; Wang QD, 2000, ANTICANCER RES, V20, P75; Wang YG, 2003, CIRC RES, V93, P776, DOI 10.1161/01.RES.0000094746.24774.DC; Wapnir RA, 2000, J NUTR, V130, p1388S, DOI 10.1093/jn/130.5.1388S; Winter DC, 2000, BRIT J SURG, V87, P1684, DOI 10.1046/j.1365-2168.2000.01584.x; Wolf I, 2001, J BIOL CHEM, V276, P24490, DOI 10.1074/jbc.M103352200; WORRELL RT, 1991, AM J PHYSIOL, V260, pC877, DOI 10.1152/ajpcell.1991.260.4.C877; WU FYH, 1987, ANNU REV NUTR, V7, P251, DOI 10.1146/annurev.nu.07.070187.001343; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Xie WW, 1998, J PHYSIOL-LONDON, V510, P661, DOI 10.1111/j.1469-7793.1998.661bj.x; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0	78	86	88	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51804	51816		10.1074/jbc.M406581200	http://dx.doi.org/10.1074/jbc.M406581200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15355987	hybrid			2022-12-27	WOS:000225493400013
J	Bailey, MJ; Beremand, PD; Hammer, R; Reidel, E; Thomas, TK; Cassone, VM				Bailey, MJ; Beremand, PD; Hammer, R; Reidel, E; Thomas, TK; Cassone, VM			Transcriptional profiling of circadian patterns of mRNA expression in the chick retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN N-ACETYLTRANSFERASE; PINEAL-GLAND; SUPRACHIASMATIC NUCLEUS; MELATONIN SYNTHESIS; PIGMENT-EPITHELIUM; MICROARRAY ANALYSIS; MAMMALIAN RETINA; BIOLOGICAL CLOCK; BINDING-PROTEIN; COLUMBA-LIVIA	Previous transcriptome analyses have identified candidate molecular components of the avian pineal clock, and herein we employ high density cDNA microarrays of pineal gland transcripts to determine oscillating transcripts in the chick retina under daily and constant darkness conditions. Subsequent comparative transcriptome analysis of the pineal and retinal oscillators distinguished several transcriptional similarities between the two as well as significant differences. Rhythmic retinal transcripts were classified according to functional categories including phototransductive elements, transcription/translation factors, carrier proteins, cell signaling molecules, and stress response genes. Candidate retinal clock transcripts were also organized relative to time of day mRNA abundance, revealing groups accumulating peak mRNA levels across the circadian day but primarily reaching peak values at subjective dawn or subjective dusk. Comparison of the chick retina transcriptome to the pineal transcriptome under constant conditions yields an interesting group of conserved genes. This group includes putative clock elements cry1 and per3 in addition to several previously unidentified and uninvestigated genes exhibiting profiles of mRNA abundance that varied markedly under daily and constant conditions. In contrast, many transcripts were differentially regulated, including those believed to be involved in both melatonin biosynthesis and circadian clock mechanisms. Our results indicate an intimate transcriptional relationship between the avian pineal and retina in addition to providing previously uncharacterized molecular elements that we hypothesize to be involved in circadian rhythm generation.	Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX 77843 USA; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Texas A&M Univ, Lab Funct Genom, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cassone, VM (corresponding author), Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX 77843 USA.	vmc@mail.bio.tamu.edu	Cassone, Vincent/AAD-5191-2022		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS39546] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adachi A, 2002, GLIA, V39, P268, DOI 10.1002/glia.10109; Akhmedov NB, 1998, INVEST OPHTH VIS SCI, V39, P1775; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Allen G, 2001, J NEUROSCI, V21, P7937, DOI 10.1523/JNEUROSCI.21-20-07937.2001; Bailey MJ, 2003, MOL ENDOCRINOL, V17, P2084, DOI 10.1210/me.2003-0121; Bailey MJ, 2002, FEBS LETT, V513, P169, DOI 10.1016/S0014-5793(02)02276-7; Beaule C, 2003, NEUROSCIENCE, V121, P253, DOI 10.1016/S0306-4522(03)00420-2; BERMAN P, 1987, CELL, V51, P135, DOI 10.1016/0092-8674(87)90018-3; Bernard M, 1997, J NEUROCHEM, V68, P213; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; BINKLEY S, 1971, SCIENCE, V174, P311, DOI 10.1126/science.174.4006.311; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; Cassone VM, 1988, J BIOL RHYTHM, V3, P71, DOI 10.1177/074873048800300106; CASSONE VM, 1984, J EXP ZOOL, V232, P539, DOI 10.1002/jez.1402320321; Cassone VM, 1998, CHRONOBIOL INT, V15, P457, DOI 10.3109/07420529808998702; Chong NW, 2000, J BIOL CHEM, V275, P32991, DOI 10.1074/jbc.M005671200; Chong NW, 2003, J NEUROCHEM, V85, P851, DOI 10.1046/j.1471-4159.2003.01723.x; Chong NW, 1998, MOL BRAIN RES, V61, P243, DOI 10.1016/S0169-328X(98)00219-8; Coon SL, 1999, AM J PHYSIOL-ENDOC M, V277, pE792, DOI 10.1152/ajpendo.1999.277.5.E792; CRABB JW, 1991, J BIOL CHEM, V266, P16674; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Doyle SE, 2002, VISUAL NEUROSCI, V19, P593, DOI 10.1017/S0952523802195058; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EBIHARA S, 1984, J COMP PHYSIOL, V154, P59, DOI 10.1007/BF00605391; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; GASTON S, 1968, SCIENCE, V160, P1125, DOI 10.1126/science.160.3832.1125; Glossop NRJ, 2002, J CELL SCI, V115, P3369; Haeseleer F, 2000, METHOD ENZYMOL, V316, P372; Haque R, 2003, MOL VIS, V9, P52; Haque R, 2002, NEUROREPORT, V13, P2247, DOI 10.1097/00001756-200212030-00016; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hinterhuber G, 2004, J INVEST DERMATOL, V122, P406, DOI 10.1046/j.0022-202X.2004.22216.x; Iuvone PM, 1997, BIOL SIGNAL, V6, P217; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; Ko GYP, 2003, J NEUROSCI, V23, P3145; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; LU J, 1995, J COMP PHYSIOL A, V177, P299, DOI 10.1007/BF00192419; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; McGoogan JM, 1999, AM J PHYSIOL-REG I, V277, pR1418, DOI 10.1152/ajpregu.1999.277.5.R1418; MENAKER M, 1972, SCI AM, V226, P22, DOI 10.1038/scientificamerican0372-22; Morin F, 2001, J NEUROCHEM, V78, P88, DOI 10.1046/j.1471-4159.2001.00407.x; Morre DJ, 2002, BIOCHEMISTRY-US, V41, P11941, DOI 10.1021/bi020392h; Natesan A, 2002, CELL TISSUE RES, V309, P35, DOI 10.1007/s00441-002-0571-6; Niki T, 1998, BIOCHEM BIOPH RES CO, V248, P115, DOI 10.1006/bbrc.1998.8916; NYCE J, 1977, PHOTOCHEM PHOTOBIOL, V25, P529, DOI 10.1111/j.1751-1097.1977.tb09123.x; Okano T, 2001, GENES CELLS, V6, P825, DOI 10.1046/j.1365-2443.2001.00462.x; PETERS JL, 2003, 33 ANN M SOC NEUR NO; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosbash Michael, 2003, Novartis Found Symp, V253, P223; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Tan Y, 2004, CURR BIOL, V14, P433, DOI 10.1016/j.cub.2004.02.035; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; UNDERWOOD H, 1984, J EXP ZOOL, V232, P557, DOI 10.1002/jez.1402320323; UNDERWOOD H, 1988, J BIOL RHYTHM, V3, P323, DOI 10.1177/074873048800300402; Wu WQ, 2000, J BIOL RHYTHM, V15, P317, DOI 10.1177/074873000129001422; Yamazaki S, 2002, J BIOL RHYTHM, V17, P315, DOI 10.1177/074873040201700405; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; ZAWILSKA JB, 1992, NEUROSCI LETT, V135, P71, DOI 10.1016/0304-3940(92)90138-W; Zhuang MH, 2000, MOL BRAIN RES, V82, P52, DOI 10.1016/S0169-328X(00)00177-7	69	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52247	52254		10.1074/jbc.M405679200	http://dx.doi.org/10.1074/jbc.M405679200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448147	hybrid			2022-12-27	WOS:000225493400065
J	Dobransky, T; Doherty-Kirby, A; Kim, AR; Brewer, D; Lajoie, G; Rylett, RJ				Dobransky, T; Doherty-Kirby, A; Kim, AR; Brewer, D; Lajoie, G; Rylett, RJ			Protein kinase C isoforms differentially phosphorylate human choline acetyltransferase regulating its catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; NERVE GROWTH-FACTOR; BASAL FOREBRAIN; HIERARCHICAL PHOSPHORYLATION; TYROSINE-HYDROXYLASE; MYASTHENIC SYNDROME; NEURONS; ACETYLCHOLINE; ACTIVATION; MUTATIONS	Choline acetyltransferase ( ChAT) synthesizes acetylcholine in cholinergic neurons; regulation of its activity or response to physiological stimuli is poorly understood. We show that ChAT is differentially phosphorylated by protein kinase C (PKC) isoforms on four serines (Ser-440, Ser-346, Ser-347, and Ser-476) and one threonine (Thr-255). This phosphorylation is hierarchical, with phosphorylation at Ser-476 required for phosphorylation at other serines. Phosphorylation at some, but not all, sites regulates basal catalysis and activation. Ser-476 with Ser-440 and Ser-346/347 maintains basal ChAT activity. Ser-440 is targeted by Arg-442 for phosphorylation by PKC. Arg-442 is mutated spontaneously (R442H) in congenital myasthenic syndrome, rendering ChAT inactive and causing neuromuscular failure. This mutation eliminates phosphorylation of Ser-440, and Arg-442, not phosphorylation of Ser-440, appears primarily responsible for ChAT activity, with Ser-440 phosphorylation modulating catalysis. Finally, basal ChAT phosphorylation in neurons is mediated predominantly by PKC at Ser-476, with PKC activation increasing phosphorylation at Ser-440 and enhancing ChAT activity.	Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; Cell Biol Res Grp, London, ON N6A 5C1, Canada; Robarts Res Inst, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Rylett, RJ (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	jane.rylett@fmd.uwo.ca	Rylett, Rebecca Jane/K-3597-2013	Rylett, Rebecca Jane/0000-0002-9158-9599				Battaini F, 2001, PHARMACOL RES, V44, P353, DOI 10.1006/phrs.2001.0893; BELL RM, 1991, J BIOL CHEM, V266, P4661; BENOREPARSONS M, 1989, ARCH BIOCHEM BIOPHYS, V272, P274, DOI 10.1016/0003-9861(89)90220-8; Blusztajn JK, 2000, METAB BRAIN DIS, V15, P45, DOI 10.1007/BF02680013; Boissiere F, 1997, NEUROSCI LETT, V225, P169, DOI 10.1016/S0304-3940(97)00210-3; BRUCE G, 1989, NEUROCHEM RES, V14, P613, DOI 10.1007/BF00964869; Cai YY, 2004, EMBO J, V23, P2047, DOI 10.1038/sj.emboj.7600221; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Cronin CN, 1998, J BIOL CHEM, V273, P24465, DOI 10.1074/jbc.273.38.24465; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dettwiler S, 1999, J VIROL, V73, P7410, DOI 10.1128/JVI.73.9.7410-7420.1999; Dobransky T, 2003, J BIOL CHEM, V278, P5883, DOI 10.1074/jbc.M212080200; Dobransky T, 2001, J BIOL CHEM, V276, P22244, DOI 10.1074/jbc.M011702200; Dobransky T, 2000, BIOCHEM J, V349, P141, DOI 10.1042/0264-6021:3490141; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; FONNUM F, 1969, BIOCHEM J, V115, P465, DOI 10.1042/bj1150465; Gingras AC, 2001, GENE DEV, V15, P2852; HABERT E, 1992, J NEUROCHEM, V58, P1447, DOI 10.1111/j.1471-4159.1992.tb11362.x; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; Jicha GA, 1999, J NEUROCHEM, V72, P214, DOI 10.1046/j.1471-4159.1999.0720214.x; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOLIATSOS VE, 1990, J NEUROSCI, V10, P3801, DOI 10.1523/JNEUROSCI.10-12-03801.1990; Kumer SC, 1996, J NEUROCHEM, V67, P443; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le Merrer J, 2000, PHARMACOL RES, V41, P503; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; Maselli RA, 2003, MUSCLE NERVE, V27, P180, DOI 10.1002/mus.10300; McMillan PJ, 1996, J NEUROSCI, V16, P1860; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; OHNO S, 1987, NATURE, V325, P161, DOI 10.1038/325161a0; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pongrac JL, 1996, J NEUROCHEM, V66, P804; RYLETT RJ, 1993, J NEUROCHEM, V61, P1388, DOI 10.1111/j.1471-4159.1993.tb13632.x; SCHMIDT BM, 1993, J NEUROCHEM, V61, P1774, DOI 10.1111/j.1471-4159.1993.tb09815.x; Schreiber KL, 2001, AM J PHYSIOL-HEART C, V281, pH2062, DOI 10.1152/ajpheart.2001.281.5.H2062; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi BT, 1998, J NEUROSCI, V18, P9326; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Tandon A, 1996, J NEUROCHEM, V66, P1033; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	46	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52059	52068		10.1074/jbc.M407085200	http://dx.doi.org/10.1074/jbc.M407085200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15381704	hybrid			2022-12-27	WOS:000225493400043
J	Hanisch, UK; van Rossum, D; Xie, YH; Gast, K; Misselwitz, R; Auriola, S; Goldsteins, G; Koistinaho, J; Kettenmann, H; Moller, T				Hanisch, UK; van Rossum, D; Xie, YH; Gast, K; Misselwitz, R; Auriola, S; Goldsteins, G; Koistinaho, J; Kettenmann, H; Moller, T			The microglia-activating potential of thrombin - The protease is not involved in the induction of proinflammatory cytokines and chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIGRAL DOPAMINERGIC-NEURONS; CENTRAL-NERVOUS-SYSTEM; SERINE PROTEASES; TYROSINE KINASE; EDEMA FORMATION; ALPHA-THROMBIN; RAT ASTROCYTES; IN-VIVO; RECEPTORS; BRAIN	The serine protease thrombin is known as a blood coagulation factor. Through limited cleavage of proteinase-activated receptors it can also control growth and functions in various cell types, including neurons, astrocytes, and microglia ( brain macrophages). A number of previous studies indicated that thrombin induces the release of proinflammatory cytokines and chemokines from microglial cells, suggesting another important role for the protease beyond hemostasis. In the present report, we provide evidence that this effect is not mediated by any proteolytic or non-proteolytic mechanism involving thrombin proper. Inhibition of the enzymatic thrombin activity did not affect the microglial release response. Instead the cyto-/chemokine-inducing activity solely resided in a high molecular weight protein fraction that could be isolated in trace amounts even from apparently homogenous alpha- and gamma-thrombin preparations. High molecular weight material contained thrombin-derived peptides as revealed by mass spectrometry but was devoid of thrombin-like enzymatic activity. Separated from the high molecular weight fraction by fast protein liquid chromatography, enzymatically intact alpha- and gamma-thrombin failed to trigger any release. Our findings may force a revision of the notion that thrombin itself is a direct proinflammatory release signal for microglia. In addition, they could be relevant for the study of other cellular activities and their assignment to this protease.	Univ Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany; Max Delbruck Ctr Mol Med, Dept Cellular Neurosci, D-13092 Berlin, Germany; Max Delbruck Ctr Mol Med, Dept Biopolymer Spect, D-13092 Berlin, Germany; Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; Univ Potsdam, Dept Phys Biochem, D-14476 Potsdam, Germany; Univ Kuopio, Dept Pharmaceut Chem, FIN-70211 Kuopio, Finland; Univ Kuopio, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland	University of Gottingen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Washington; University of Washington Seattle; University of Potsdam; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital	Hanisch, UK (corresponding author), Univ Gottingen, Inst Neuropathol, Robert Koch Str 40, D-37075 Gottingen, Germany.	ukhanisch@med.uni-goettingen.de	Goldsteins, Gundars/X-1240-2019; Kettenmann, Helmut/AAJ-5142-2021	Kettenmann, Helmut/0000-0001-8208-0291	NINDS NIH HHS [R01 NS044337-02, NS44337] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044337] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; Balcaitis S, 2003, NEUROREPORT, V14, P2373, DOI 10.1097/00001756-200312190-00017; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; BISCHOFF R, 1989, J CHROMATOGR, V476, P245, DOI 10.1016/S0021-9673(01)93873-7; BODE W, 1992, PROTEIN SCI, V1, P426; Carreno-Muller E, 2003, J NEUROCHEM, V84, P1201, DOI 10.1046/j.1471-4159.2003.01634.x; Choi SH, 2003, J NEUROSCI, V23, P5877; Cocks TM, 2000, TRENDS PHARMACOL SCI, V21, P103, DOI 10.1016/S0165-6147(99)01440-6; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; CROMACK DT, 1992, J SURG RES, V53, P117, DOI 10.1016/0022-4804(92)90022-R; DECRISTOFARO R, 1995, J MOL BIOL, V245, P447; DODT J, 1988, FEBS LETT, V229, P87, DOI 10.1016/0014-5793(88)80803-2; Dong JF, 1997, BLOOD, V89, P4355, DOI 10.1182/blood.V89.12.4355; Donovan FM, 1997, J NEUROSCI, V17, P5316; Friedmann I, 2001, J NEUROIMMUNOL, V121, P12, DOI 10.1016/S0165-5728(01)00397-6; Furman MI, 1998, P NATL ACAD SCI USA, V95, P3082, DOI 10.1073/pnas.95.6.3082; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Gingrich MB, 2000, TRENDS NEUROSCI, V23, P399, DOI 10.1016/S0166-2236(00)01617-9; Grand RJA, 1996, BIOCHEM J, V313, P353, DOI 10.1042/bj3130353; Grandaliano G, 1999, EXP NEPHROL, V7, P20; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2001, EUR J IMMUNOL, V31, P2104, DOI 10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3; Hausler KG, 2002, EUR J NEUROSCI, V16, P2113, DOI 10.1046/j.1460-9568.2002.02287.x; Kim KY, 2002, NEUROREPORT, V13, P849, DOI 10.1097/00001756-200205070-00022; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Nakamura Y, 2000, J NEUROCHEM, V75, P2309, DOI 10.1046/j.1471-4159.2000.0752309.x; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; O'Brien PJ, 2001, ONCOGENE, V20, P1570, DOI 10.1038/sj.onc.1204194; Ohyama H, 2001, BRAIN RES, V902, P264, DOI 10.1016/S0006-8993(01)02354-X; Prinz M, 1999, J NEUROPATH EXP NEUR, V58, P1078, DOI 10.1097/00005072-199910000-00006; Ryu J, 2002, J IMMUNOL, V168, P5805, DOI 10.4049/jimmunol.168.11.5805; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; Shikamoto Y, 1999, FEBS LETT, V463, P387, DOI 10.1016/S0014-5793(99)01657-9; Si QS, 2000, EXP NEUROL, V162, P89, DOI 10.1006/exnr.2000.7334; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Suidan HS, 1996, SEMIN THROMB HEMOST, V22, P125, DOI 10.1055/s-2007-998999; Suo Z., 2004, Current Drug Targets - Inflammation and Allergy, V3, P105, DOI 10.2174/1568010043483953; Suo ZM, 2003, J BIOL CHEM, V278, P31177, DOI 10.1074/jbc.M302137200; Tomimatsu Y, 2002, LIFE SCI, V72, P355, DOI 10.1016/S0024-3205(02)02285-3; Turgeon VL, 1997, BRAIN RES REV, V25, P85, DOI 10.1016/S0165-0173(97)00015-5; Ubl JJ, 2000, J PHYSIOL-LONDON, V525, P319, DOI 10.1111/j.1469-7793.2000.00319.x; VANROSSUM D, 2004, BRAIN DAMAGE REPAIR, P181; Vivien D, 2000, J CEREBR BLOOD F MET, V20, P755, DOI 10.1097/00004647-200005000-00001; Wagner KR, 2002, DEV NEUROSCI-BASEL, V24, P154, DOI 10.1159/000065703; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang H, 2002, GLIA, V37, P53, DOI 10.1002/glia.10012; Weinstein JR, 1998, J NEUROCHEM, V71, P1034; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; Yamazaki Y, 1999, J BIOCHEM-TOKYO, V126, P655, DOI 10.1093/oxfordjournals.jbchem.a022499; Zoubine MN, 1996, DEV BIOL, V179, P447, DOI 10.1006/dbio.1996.0274	53	48	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51880	51887		10.1074/jbc.M408318200	http://dx.doi.org/10.1074/jbc.M408318200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452111	hybrid			2022-12-27	WOS:000225493400021
J	Davidson, MK; Shandilya, HK; Hirota, K; Ohta, K; Wahls, WP				Davidson, MK; Shandilya, HK; Hirota, K; Ohta, K; Wahls, WP			Atf1-Pcr1-M26 complex links stress-activated MAPK and cAMP-dependent protein kinase pathways via chromatin remodeling of cgs2(+)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; MEIOTIC RECOMBINATION HOTSPOT; ATF1 TRANSCRIPTION FACTOR; FISSION YEAST; SEXUAL DEVELOPMENT; OXIDATIVE STRESS; HOT-SPOT; BINDING PROTEIN; GENE-EXPRESSION; OSMOTIC-STRESS	Although co-ordinate interaction between different signal transduction pathways is essential for developmental decisions, interpathway connections are often obscured and difficult to identify due to cross-talk. Here signals from the fission yeast stress-activated MAPK Spc1 are shown to regulate Cgs2, a negative regulator of the cAMP-dependent protein kinase ( protein kinase A) pathway. Pathway integration is achieved via Spc1-dependent binding of Atf1-Pcr1 heterodimer to an M26 DNA site in the cgs2(+) promoter, which remodels chromatin to regulate expression of cgs2(+) and targets downstream of protein kinase A. This direct interpathway connection co-ordinates signals of nitrogen and carbon source depletion to affect a G(0) cell-cycle checkpoint and sexual differentiation. The Atf1-Pcr1-M26 complex-dependent chromatin remodeling provides a molecular mechanism whereby Atf1-Pcr1 heterodimer can function differentially as either a transcriptional activator, or as a transcriptional repressor, or as an inducer of meiotic recombination. We also show that the Atf1-Pcr1-M26 complex functions as both an inducer and repressor of chromatin remodeling, which provides a way for various chromatin remodeling-dependent effector functions to be regulated.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; Inst Phys & Chem Res, Genet Dynam Res Unit Lab, Wako, Saitama 3510198, Japan	University of Arkansas System; University of Arkansas Medical Sciences; RIKEN	Wahls, WP (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, 4301 W Markham St,Slot 516, Little Rock, AR 72205 USA.	wahlswaynep@uams.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062801, R01GM062244] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062801-03, GM62801, R01 GM062244-05, R01 GM062244-03, R01 GM062801, R01 GM062244, GM62244] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; DalSanto P, 1996, J CELL SCI, V109, P1919; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; DEVOTI J, 1991, EMBO J, V10, P3759, DOI 10.1002/j.1460-2075.1991.tb04945.x; Fox ME, 2000, GENETICS, V156, P59; Gaits F, 1997, J BIOL CHEM, V272, P17873, DOI 10.1074/jbc.272.28.17873; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hirota K, 2004, NUCLEIC ACIDS RES, V32, P855, DOI 10.1093/nar/gkh251; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; KIM J, 1995, NUCLEIC ACIDS RES, V23, P2531, DOI 10.1093/nar/23.13.2531; Kitamura K, 2001, DEV CELL, V1, P389, DOI 10.1016/S1534-5807(01)00037-5; Kon N, 1998, MOL CELL BIOL, V18, P7575, DOI 10.1128/MCB.18.12.7575; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Krawchuk MD, 1999, GENETICS, V153, P57; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; MAEDA T, 1994, J BIOL CHEM, V269, P9632; MATVIW H, 1993, BIOCHEM BIOPH RES CO, V194, P79, DOI 10.1006/bbrc.1993.1787; MCLEOD M, 1986, EMBO J, V5, P3665, DOI 10.1002/j.1460-2075.1986.tb04697.x; Mizuno K, 2001, GENETICS, V159, P1467; Mizuno K, 1997, GENE DEV, V11, P876, DOI 10.1101/gad.11.7.876; MOCHIZUKI N, 1992, MOL GEN GENET, V233, P17, DOI 10.1007/BF00587556; Nakagawa CW, 1998, J BIOCHEM-TOKYO, V123, P1048; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Peng Z, 2003, CURR GENET, V43, P178, DOI 10.1007/s00294-003-0384-5; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Sato M, 2002, CURR BIOL, V12, P141, DOI 10.1016/S0960-9822(01)00654-6; Sharif Wallace D, 2002, Cell Chromosome, V1, P1, DOI 10.1186/1475-9268-1-1; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Stettler S, 1996, J CELL SCI, V109, P1927; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; WAHLS WP, 1991, NUCLEIC ACIDS RES, V19, P3269, DOI 10.1093/nar/19.12.3269; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; WATANABE Y, 1988, EMBO J, V7, P761, DOI 10.1002/j.1460-2075.1988.tb02873.x; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; WU SY, 1995, MOL CELL BIOL, V15, P1479; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431, DOI 10.1247/csf.21.431; YU G, 1994, GENE, V151, P215, DOI 10.1016/0378-1119(94)90659-9	50	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50857	50863		10.1074/jbc.M409079200	http://dx.doi.org/10.1074/jbc.M409079200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448137	Green Accepted, hybrid			2022-12-27	WOS:000225355800028
J	Kessi, J; Hanselmann, KW				Kessi, J; Hanselmann, KW			Similarities between the abiotic reduction of selenite with glutathione and the dissimilatory reaction mediated by Rhodospirillum rubrum and Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENTAL SELENIUM; SUPEROXIDE; SELENODIGLUTATHIONE; THIOREDOXIN; DISULFIDES; MECHANISMS; TOXICITY; SELENATE	Various mechanisms have been proposed to explain the biological dissimilatory reduction of selenite (SeO32-) to elemental selenium (Se-o), although none is without controversy. Glutathione, the most abundant thiol in the eukaryotic cells, the cyanobacteria, and the alpha, beta, and gamma groups of the proteobacteria, has long been suspected to be involved in selenium metabolism. Experiments with the phototrophic alpha proteobacterium Rhodospirillum rubrum showed that the rate of selenite reduction was decreased when bacteria synthesized lower than normal levels of glutathione, and in Rhodobacter sphaeroides and Escherichia coli the reaction was reported to induce glutathione reductase. In the latter organism superoxide dismutase was also induced in cells grown in the presence of selenite, indicating that superoxide anions (O-2(-)) were produced. These observations led us to investigate the abiotic ( chemical) reduction of selenite by glutathione and to compare the features of this reaction with those of the reaction mediated by R. rubrum and E. coli. Our findings imply that selenite was first reduced to selenodiglutathione, which reached its maximum concentration within the 1st min of the reaction. Formation of selenodiglutathione was paralleled by a rapid reduction of cytochrome c, a known oxidant for superoxide anions. Cytochrome c reduction was inhibited by superoxide dismutase, indicating that O-2(-) was the source of electrons for the reduction. These results demonstrated that superoxide was produced in the abiotic reduction of selenite with glutathione, thus lending support to the hypothesis that glutathione may be involved in the reaction mediated by R. rubrum and E. coli. The second phase of the reaction, which led to the formation of elemental selenium (Se-o), developed more slowly. Se-o precipitation reached a maximum within 2 h after the beginning of the reaction. Secondary reactions leading to the degradation of the superoxide significantly decreased the yield of Se-o in the abiotic reaction compared with that of the bacterially mediated selenite reduction. Abiotically formed selenium particles showed the same characteristic orange-red color, spherical structure, and size as particles produced by R. rubrum, again providing support for the hypothesis that glutathione is involved in the reduction of selenite to elemental selenium in this organism.	Univ Zurich, Inst Plant Biol, Microbial Ecol Grp, CH-8008 Zurich, Switzerland	University of Zurich	Kessi, J (corresponding author), Univ Zurich, Inst Plant Biol, Microbial Ecol Grp, Zollikerstr 107, CH-8008 Zurich, Switzerland.	Janine.kessi@access.unizh.ch		Kessi, Janine/0000-0002-9414-4050				APONTOWEIL P, 1975, BIOCHIM BIOPHYS ACTA, V399, P1, DOI 10.1016/0304-4165(75)90205-6; Bebien M, 2001, APPL ENVIRON MICROB, V67, P4440, DOI 10.1128/AEM.67.10.4440-4447.2001; Bebien M, 2002, J BACTERIOL, V184, P1556, DOI 10.1128/JB.184.6.1556-1564.2002; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BJORNSTEDT M, 1992, J BIOL CHEM, V267, P8030; BJORNSTEDT M, 1995, METHOD ENZYMOL, V252, P209; Dungan RS, 2003, ENVIRON MICROBIOL, V5, P287, DOI 10.1046/j.1462-2920.2003.00410.x; FREW JE, 1983, ANAL CHIM ACTA, V155, P139, DOI 10.1016/S0003-2670(00)85587-7; GANTHER HE, 1971, BIOCHEMISTRY-US, V10, P4089, DOI 10.1021/bi00798a013; Garbisu C, 1995, BIOFACTORS, V5, P29; Garbisu C, 1999, BIOFACTORS, V10, P311, DOI 10.1002/biof.5520100401; Gates B, 2002, ADV FUNCT MATER, V12, P219, DOI 10.1002/1616-3028(200203)12:3<219::AID-ADFM219>3.0.CO;2-U; HESS WM, 1966, STAIN TECHNOL, V41, P27, DOI 10.3109/10520296609116276; KESSI J, 1994, BIOCHEMISTRY-US, V33, P10825, DOI 10.1021/bi00201a033; Kessi J, 1999, APPL ENVIRON MICROB, V65, P4734; KRAMER GF, 1988, MUTAT RES, V201, P169, DOI 10.1016/0027-5107(88)90123-6; LAPAGE SP, 1968, J APPL BACTERIOL, V31, P568, DOI 10.1111/j.1365-2672.1968.tb00407.x; LAUCHLI A, 1993, BOT ACTA, V106, P455; LORTIE L, 1992, APPL ENVIRON MICROB, V58, P4042, DOI 10.1128/AEM.58.12.4042-4044.1992; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; NEWTON GL, 1989, GLUTATHIONE METABOLI, P69; O'Toole D, 1998, BOOK SOIL P, V64, P355; OHLENDORF H M, 1989, SSSA Special Publication, P133; Oremland RS, 2004, APPL ENVIRON MICROB, V70, P52, DOI 10.1128/AEM.70.1.52-60.2004; Painter EP, 1941, CHEM REV, V28, P179, DOI 10.1021/cr60090a001; Roux M, 2001, APPL ENVIRON MICROB, V67, P769, DOI 10.1128/AEM.67.2.769-773.2001; SINGH R, 1991, J ORG CHEM, V56, P6931, DOI 10.1021/jo00024a041; SWERDLOW RD, 1983, J BACTERIOL, V153, P475, DOI 10.1128/JB.153.1.475-484.1983; WATKINSON JH, 1966, ANAL CHEM, V38, P92; WINTERBOURN CC, 1995, METHOD ENZYMOL, V251, P81, DOI 10.1016/0076-6879(95)51112-1	30	150	165	6	70	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50662	50669		10.1074/jbc.M405887200	http://dx.doi.org/10.1074/jbc.M405887200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371444	hybrid			2022-12-27	WOS:000225355800006
J	Kukkonen, A; Perakyla, M; Akerman, KEO; Nasman, J				Kukkonen, A; Perakyla, M; Akerman, KEO; Nasman, J			Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMBA DENDROASPIS-ANGUSTICEPS; GREEN MAMBA; ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; NONCOMPETITIVE ANTAGONISM; ADENOSINE RECEPTOR; SNAKE-VENOM; BINDING; M-1; PROTEINS	Muscarinic toxin 7 (MT7) is a mamba venom protein antagonist with extremely high selectivity for the M1 muscarinic acetylcholine receptor. To map the sites for the interaction of MT7 with muscarinic receptors we have used chimeric M1: M3 receptors and site-directed mutagenesis of the M3 and M4 receptor subtypes. Two Glu residues in M1, one in extracellular loop 2 and one in extracellular loop 3, were found to be important for the high affinity binding of MT7. Substitution of the corresponding Lys residues in the M3 receptor with Glu converted the M3 mutant to an MT7 binding receptor, albeit with lower affinity compared with M1. A Phe --> Tyr substitution in extracellular loop 2 of M3 together with the 2 Glu mutations generated a receptor with an increased MT7 affinity (apparent K-i = 0.26 nM in a functional assay) compared with the M1 receptor (apparent K-i = 1.31 nM). The importance of the identified amino acid residues was confirmed with a mutated M4 receptor constructs. The results indicate that the high selectivity of MT7 for the M1 receptor depends on very few residues, thus providing good prospects for future design and synthesis of muscarinic receptor-selective ligands.	AI Virtanen Inst Mol Sci, Dept Neurobiol, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Chem, FIN-70211 Kuopio, Finland	University of Eastern Finland	Nasman, J (corresponding author), AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FIN-70211 Kuopio, Finland.	Johnny.Nasman@uku.fi						ADEM A, 1988, BIOCHIM BIOPHYS ACTA, V968, P340, DOI 10.1016/0167-4889(88)90025-0; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bradley KN, 2000, PHARMACOL THERAPEUT, V85, P87, DOI 10.1016/S0163-7258(99)00064-9; Carsi JM, 2000, TOXICON, V38, P187, DOI 10.1016/S0041-0101(99)00141-5; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; Christopoulos A, 1999, EUR J PHARMACOL, V382, P217, DOI 10.1016/S0014-2999(99)00550-6; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; HARVEY AL, 1980, N-S ARCH PHARMACOL, V312, P1, DOI 10.1007/BF00502565; HARVEY AL, 1984, J PHYSIOL-PARIS, V79, P222; Hulme EC, 2003, BIOCHEM SOC T, V31, P29, DOI 10.1042/bst0310029; JANSSON CC, 1995, EUR J PHARM-MOLEC PH, V290, P75, DOI 10.1016/0922-4106(95)90019-5; Jerusalinsky D, 2000, TOXICON, V38, P747, DOI 10.1016/S0041-0101(99)00196-8; JOLKKONEN M, 1995, EUR J BIOCHEM, V234, P579, DOI 10.1111/j.1432-1033.1995.579_b.x; JOLKKONEN M, 1994, FEBS LETT, V352, P91, DOI 10.1016/0014-5793(94)00933-3; JOLKKONEN M, 1996, THESIS UPPSALA U UPP; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Karlsson E, 2000, BIOCHIMIE, V82, P793, DOI 10.1016/S0300-9084(00)01176-7; Kim JH, 1996, MOL PHARMACOL, V49, P683; Krajewski JL, 2001, MOL PHARMACOL, V60, P725; KUKKONEN J, 1992, BIOCHEM BIOPH RES CO, V189, P919, DOI 10.1016/0006-291X(92)92291-5; Kukkonen JP, 1998, BIOCHEM BIOPH RES CO, V243, P41, DOI 10.1006/bbrc.1997.8054; Kukkonen JP, 1996, J PHARMACOL EXP THER, V279, P593; Liang JS, 1996, TOXICON, V34, P1257, DOI 10.1016/S0041-0101(96)00109-2; Marchot P, 1998, TOXICON, V36, P1613, DOI 10.1016/S0041-0101(98)00154-8; Marchot P, 1997, J BIOL CHEM, V272, P3502, DOI 10.1074/jbc.272.6.3502; MAX SI, 1993, J NEUROSCI, V13, P4293; MAX SI, 1993, MOL PHARMACOL, V44, P1171; MAX SI, 1993, J PHARMACOL EXP THER, V267, P480; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; Milligan G, 1999, TRENDS PHARMACOL SCI, V20, P118, DOI 10.1016/S0165-6147(99)01320-6; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; NAKAMURA F, 1995, J BIOL CHEM, V270, P6246, DOI 10.1074/jbc.270.11.6246; Nasman J, 2000, BIOCHEM BIOPH RES CO, V271, P435, DOI 10.1006/bbrc.2000.2657; OLAH ME, 1994, J BIOL CHEM, V269, P18016; Olianas MC, 2000, BRIT J PHARMACOL, V131, P447, DOI 10.1038/sj.bjp.0703606; Olianas MC, 2004, EUR J PHARMACOL, V487, P65, DOI 10.1016/j.ejphar.2004.01.029; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SEGALAS I, 1995, BIOCHEMISTRY-US, V34, P1248, DOI 10.1021/bi00004a019; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; SHUTTLEWORTH TJ, 1991, J BIOL CHEM, V266, P1410; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; TUCEK S, 1995, TRENDS PHARMACOL SCI, V16, P205, DOI 10.1016/S0165-6147(00)89023-9; VANDERMEERS A, 1995, TOXICON, V33, P1171, DOI 10.1016/0041-0101(95)00057-S; Wurch T, 2000, J NEUROCHEM, V75, P1180, DOI 10.1046/j.1471-4159.2000.0751180.x; Zeng FY, 1999, J NEUROCHEM, V72, P2404, DOI 10.1046/j.1471-4159.1999.0722404.x; Zhao MM, 1996, MOL PHARMACOL, V50, P1118	51	28	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50923	50929		10.1074/jbc.M406424200	http://dx.doi.org/10.1074/jbc.M406424200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452105	hybrid			2022-12-27	WOS:000225355800035
J	Walsh, EJ; O'Brien, LM; Liang, XW; Hook, M; Foster, TJ				Walsh, EJ; O'Brien, LM; Liang, XW; Hook, M; Foster, TJ			Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASAL CARRIAGE; PROTEIN-A; CLEAVAGE; DOMAIN; KERATIN-10; MUTATION; MODEL; CLFB	The primary habitat of Staphylococcus aureus in humans is the moist squamous epithelium of the anterior nares. We showed previously that S. aureus adheres to desquamated epithelial cells and that clumping factor B (ClfB), a surface-located MSCRAMM ( microbial surface components recognizing adhesive matrix molecules) known for its ability to bind to the alpha-chain of fibrinogen, is partly responsible (O'Brien, L. M., Walsh, E. J., Massey, R. C., Peacock, S. J., and Foster, T. J. ( 2002) Cell. Microbiol. 4, 759 - 770). We identified cytokeratin 10 (K10) as the ligand recognized by ClfB. Here we have shown that purified recombinant human and murine K10 immobilized on a plastic surface supports adherence of S. aureus in a ClfB-dependent manner. Furthermore, the recombinant A domain of ClfB (rClfB 45 - 542) bound to immobilized K10 dose-dependently and saturably. Subdomains of human and murine K10 were expressed and purified. The N-terminal head domain ( residues 1 - 145) did not support the binding of rClfB or adherence of S. aureus ClfB(+). In contrast, the C-terminal tail domains ( human rHK10 452 - 593, mouse rMK10 454 - 570) promoted avid binding and adherence. Isothermal titration microcalorimetry and intrinsic tryptophan fluorescence experiments gave dissociation constants for rClfB 45 - 542 binding to rMK10 454 - 570 of 1.4 and 1.7 muM, respectively. The tail region of K10 is composed largely of quasi-repeats of Tyr-(Gly/Ser)(n). A synthetic peptide corresponding to a typical glycine loop (YGGGSSGGGSSGGY; Y-Y loop peptide) inhibited the adherence of S. aureus ClfB(+) to immobilized MK10 to a level of 80%, whereas control peptides had no effect. The K-D of rClfB 45-542 for the Y-Y loop peptide was 5.3 muM by intrinsic tryptophan fluorescence. Thus ClfB binds to the glycine loop region of the tail domain of keratin 10 where there are probably multiple binding sites. Binding is discussed in the context of the dock-lock-latch model for MSCRAMM-ligand interactions. We provide an explanation for the molecular basis for S. aureus adherence to the squamous epithelium and suggest that nasal colonization might be prevented by reagents that inhibit this interaction.	Univ Dublin Trinity Coll, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland; Texas A&M Univ, Hlth Sci Syst, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; Texas A&M Univ, Hlth Sci Syst, Dept Biochem & Biophys, Inst Biosci & Technol, Houston, TX 77030 USA	Trinity College Dublin; Texas A&M University System; Texas A&M University System	Foster, TJ (corresponding author), Univ Dublin Trinity Coll, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland.	tfoster@tcd.ie		Liang, Xiaowen/0000-0002-6174-2951	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020624] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20624] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carlson SA, 2002, LIFE SCI, V70, P1415, DOI 10.1016/S0024-3205(01)01512-0; Cole AM, 2001, CLIN DIAGN LAB IMMUN, V8, P1064, DOI 10.1128/CDLI.8.6.1064-1069.2001; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Hartleib J, 2000, BLOOD, V96, P2149; KARTASOVA T, 1993, J CELL BIOL, V120, P1251, DOI 10.1083/jcb.120.5.1251; Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004; Kluytmans J, 1998, J HOSP INFECT, V40, pS25, DOI 10.1016/S0195-6701(98)90201-8; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; NI ED, 1998, MOL MICROBIOL, V30, P245; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; PARRY DAD, 1995, INTERMEDIATE FILAMEN, P20; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Perkins S, 2001, J BIOL CHEM, V276, P44721, DOI 10.1074/jbc.M106741200; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Sajjan U, 2002, CELL MICROBIOL, V4, P73, DOI 10.1046/j.1462-5822.2002.00171.x; Sojar HT, 2002, INFECT IMMUN, V70, P96, DOI 10.1128/IAI.70.1.96-101.2002; Sprecher E, 2001, J INVEST DERMATOL, V116, P511, DOI 10.1046/j.1523-1747.2001.01292.x; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Whittock NV, 2002, J INVEST DERMATOL, V118, P838, DOI 10.1046/j.1523-1747.2002.01750.x; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; ZHOU XM, 1988, J BIOL CHEM, V263, P15584	31	96	103	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50691	50699		10.1074/jbc.M408713200	http://dx.doi.org/10.1074/jbc.M408713200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385531	hybrid			2022-12-27	WOS:000225355800010
J	Ahn, HJ; Kim, KH; Lee, J; Ha, JY; Lee, HH; Kim, D; Yoon, HJ; Kwon, AR; Suh, SW				Ahn, HJ; Kim, KH; Lee, J; Ha, JY; Lee, HH; Kim, D; Yoon, HJ; Kwon, AR; Suh, SW			Crystal structure of agmatinase reveals structural conservation and inhibition mechanism of the ureohydrolase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINUCLEAR MANGANESE CLUSTER; ELECTRON-DENSITY MAPS; ESCHERICHIA-COLI AGMATINASE; TRANSITION-STATE ANALOG; CATALYTIC-ACTIVITY; PHYSIOLOGICAL-ROLE; ERECTILE FUNCTION; LIVER ARGINASE; NITRIC-OXIDE; RAT-BRAIN	Agmatine is the product of arginine decarboxylation and can be hydrolyzed by agmatinase to putrescine, the precursor for biosynthesis of higher polyamines, spermidine, and spermine. Besides being an intermediate in polyamine metabolism, recent findings indicate that agmatine may play important regulatory roles in mammals. Agmatinase is a binuclear manganese metalloenzyme and belongs to the ureohydrolase superfamily that includes arginase, formiminoglutamase, and proclavaminate amidinohydrolase. Compared with a wealth of structural information available for arginases, no three-dimensional structure of agmatinase has been reported. Agmatinase from Deinococcus radiodurans, a 304-residue protein, shows similar to 33% of sequence identity to human mitochondrial agmatinase. Here we report the crystal structure of D. radiodurans agmatinase in Mn2+-free, Mn2+-bound, and Mn2+-inhibitor-bound forms, representing the first structure of agmatinase. It reveals the conservation as well as variation in folding, oligomerization, and the active site of the ureohydrolase superfamily. D. radiodurans agmatinase exists as a compact homohexamer of 32 symmetry. Its binuclear manganese cluster is highly similar but not identical to the clusters of arginase and proclavaminate amidinohydrolase. The structure of the inhibited complex reveals that inhibition by 1,6-diaminohexane arises from the displacement of the metal-bridging water.	Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea	Seoul National University (SNU)	Suh, SW (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea.	sewonsuh@snu.ac.kr	Suh, Won/H-8306-2013; Kim, Do Jin/I-7675-2014	Suh, Won/0000-0002-1768-4635; 				Baggio R, 1997, J AM CHEM SOC, V119, P8107, DOI 10.1021/ja971312d; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bewley MC, 1999, STRUCT FOLD DES, V7, P435, DOI 10.1016/S0969-2126(99)80056-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cama E, 2004, BIOCHEMISTRY-US, V43, P8987, DOI 10.1021/bi0491705; Cama E, 2003, BIOCHEMISTRY-US, V42, P7748, DOI 10.1021/bi030074y; Cama E, 2003, BIOCHEMISTRY-US, V42, P8445, DOI 10.1021/bi034340j; Carvajal N, 1999, BIOCHEM BIOPH RES CO, V264, P196, DOI 10.1006/bbrc.1999.1505; Carvajal N, 1999, BIOCHEM BIOPH RES CO, V258, P808, DOI 10.1006/bbrc.1999.0709; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Cox JD, 2001, BIOCHEMISTRY-US, V40, P2689, DOI 10.1021/bi002318+; Cox JD, 1999, NAT STRUCT BIOL, V6, P1043; Elkins JM, 2002, BIOCHEM J, V366, P423, DOI 10.1042/BJ20020125; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gilad GM, 1996, NEUROREPORT, V7, P1730, DOI 10.1097/00001756-199607290-00007; Iyer RK, 2002, MOL GENET METAB, V75, P209, DOI 10.1006/mgme.2001.3277; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANYO Z, 1996, THESIS U PENNSYLVANI; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; KHANGULOV SV, 1995, BIOCHEMISTRY-US, V34, P2015, DOI 10.1021/bi00006a023; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P8539, DOI 10.1021/bi972874c; KHRAMOV V A, 1976, Biokhimiya, V41, P553; Kim NN, 2001, BIOCHEMISTRY-US, V40, P2678, DOI 10.1021/bi002317h; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JA, 2004, ACTA CRYSTALLOGR D, V60, P1890, DOI 10.1107/S0907444904018761; Levitt DG, 2001, ACTA CRYSTALLOGR D, V57, P1013, DOI 10.1107/S0907444901006394; LOTRIE MJ, 1996, J CLIN INVEST, V97, P413; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mistry SK, 2002, AM J PHYSIOL-GASTR L, V282, pG375, DOI 10.1152/ajpgi.00386.2001; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OUZOUNIS CA, 1994, J MOL EVOL, V39, P101; RAASCH W, 1995, LIFE SCI, V56, P2319, DOI 10.1016/0024-3205(95)00226-V; REGUNATHAN S, 1995, NEUROREPORT, V6, P1897, DOI 10.1097/00001756-199510020-00018; Reis DJ, 2000, TRENDS PHARMACOL SCI, V21, P187, DOI 10.1016/S0165-6147(00)01460-7; Reis DJ, 1999, ANN NY ACAD SCI, V881, P65, DOI 10.1111/j.1749-6632.1999.tb09343.x; Sastre M, 1996, J NEUROCHEM, V67, P1761; Sastre M, 1998, BIOCHEM J, V330, P1405, DOI 10.1042/bj3301405; SATISHCHANDRAN C, 1986, J BACTERIOL, V165, P843, DOI 10.1128/jb.165.3.843-848.1986; Sekowska A, 2000, MICROBIOL-SGM, V146, P1815, DOI 10.1099/00221287-146-8-1815; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001	44	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50505	50513		10.1074/jbc.M409246200	http://dx.doi.org/10.1074/jbc.M409246200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355972	hybrid			2022-12-27	WOS:000225229500116
J	Fanara, P; Turner, S; Busch, R; Killion, S; Awada, M; Turner, H; Mahsut, A; LaPrade, KL; Stark, JM; Hellerstein, MK				Fanara, P; Turner, S; Busch, R; Killion, S; Awada, M; Turner, H; Mahsut, A; LaPrade, KL; Stark, JM; Hellerstein, MK			In vivo measurement of microtubule dynamics using stable isotope Labeling with heavy water - Effect of taxanes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYCLE-DEPENDENT CHANGES; CELL-CYCLE; MITOTIC SPINDLE; INDIVIDUAL MICROTUBULES; TUBULIN SYNTHESIS; MORPHOLOGICAL EVIDENCE; SUPPRESSES DYNAMICS; DEUTERIUM-OXIDE; DNA-SYNTHESIS; BETA-TUBULIN	Microtubules are dynamic polymers with central roles in the mitotic checkpoint, mitotic spindle assembly, and chromosome segregation. Agents that block mitotic progression and cell proliferation by interfering with microtubule dynamics (microtubule-targeted tubulin-polymerizing agents (MTPAs)) are powerful antitumor agents. Effects of MTPAs (e.g. paclitaxel) on microtubule dynamics have not yet been directly demonstrated in intact animals, however. Here we describe a method that measures microtubule dynamics as an exchange of tubulin dimers into microtubules in vivo. The incorporation of deuterium (H-2) from heavy water ((H2O)-H-2) into tubulin dimers and polymers is measured by gas chromatography/mass spectrometry. In cultured human lung and breast cancer cell lines, or in tumors implanted into nude mice, tubulin dimers and polymerized microtubules exhibited nearly identical label incorporation rates, reflecting their rapid exchange. Administration of paclitaxel during 24 h of (H2O)-H-2 labeling in vivo reduced H-2 labeling in polymers while increasing H-2 in dimers, indicating diminished flux of dimers into polymers (i.e. inhibition of microtubule dynamic equilibrium). In vivo inhibition of microtubule dynamics was dose-dependent and correlated with inhibition of DNA replication, a stable isotopic measure of tumor cell growth. In contrast, microtubule polymers from sciatic nerve of untreated mice were not in dynamic equilibrium with tubulin dimers, and paclitaxel increased label incorporation into polymers. Our results directly demonstrate altered microtubule dynamics as an important action of MTPAs in vivo. This sensitive and quantitative in vivo assay of microtubule dynamics may prove useful for pre-clinical and clinical development of the next generation of MTPAs as anticancer drugs.	KineMed Inc, Emeryville, CA 94608 USA; Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA	University of California System; University of California Berkeley; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Fanara, P (corresponding author), KineMed Inc, 5980 Horton St,Ste 470, Emeryville, CA 94608 USA.	pfanara@kinemed.com		Busch, Robert/0000-0002-4132-0751				AMINHANJANI S, 1991, CELL MOTIL CYTOSKEL, V20, P136, DOI 10.1002/cm.970200206; Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Barlow SB, 2002, J CELL SCI, V115, P3469; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; BENZEEV A, 1979, CELL, V17, P319, DOI 10.1016/0092-8674(79)90157-0; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; BLACK MM, 1987, J NEUROSCI, V7, P3695; BRANDT R, 1993, J BIOL CHEM, V268, P3414; BRANDT R, 1996, FRONT BIOSCI, V1, P118; Brooks TA, 2004, ANTICANCER RES, V24, P409; Busch R, 2004, J IMMUNOL METHODS, V286, P97, DOI 10.1016/j.jim.2003.12.012; CABRAL F, 1989, FASEB J, V3, P1593, DOI 10.1096/fasebj.3.5.2646163; CABRAL F, 1981, P NATL ACAD SCI-BIOL, V78, P4388, DOI 10.1073/pnas.78.7.4388; Cabral F, 2001, DRUG RESIST UPDATE, V4, P3, DOI 10.1054/drup.2000.0172; CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763; Cavaletti G, 1997, NEUROTOXICOLOGY, V18, P137; Chakrabarti G, 1999, BIOCHEMISTRY-US, V38, P3067, DOI 10.1021/bi982461r; Checchi PM, 2003, TRENDS PHARMACOL SCI, V24, P361, DOI 10.1016/S0165-6147(03)00161-5; Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P10, DOI 10.1016/S0955-0674(89)80030-4; CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6; Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Dabydeen DA, 2004, CANCER CHEMOTH PHARM, V53, P397, DOI 10.1007/s00280-003-0755-0; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; Derry WB, 1998, CANCER RES, V58, P1177; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; Fanara P, 1999, EMBO J, V18, P565, DOI 10.1093/emboj/18.3.565; FANARA P, 1997, BRAIN MICROTUBULE AS, P259; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Gluck S, 1998, EUR J CANCER, V34, P1008, DOI 10.1016/S0959-8049(97)10168-X; Goncalves A, 2001, P NATL ACAD SCI USA, V98, P11737, DOI 10.1073/pnas.191388598; Grego S, 2001, BIOPHYS J, V81, P66, DOI 10.1016/S0006-3495(01)75680-9; Gupta Y. K., 2001, Indian Journal of Physiology and Pharmacology, V45, P253; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Hellerstein MK, 2004, CURR OPIN MOL THER, V6, P249; Hellerstein MK, 2004, METAB ENG, V6, P85, DOI 10.1016/j.ymben.2003.10.005; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Hellerstein MK, 2002, FASEB J, V16, pA256; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; HUMPHREY TJ, 1976, BIOCHEM J, V156, P561, DOI 10.1042/bj1560561; Ilschner S, 1996, GLIA, V18, P129, DOI 10.1002/(SICI)1098-1136(199610)18:2<129::AID-GLIA5>3.3.CO;2-G; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; KATZ JJ, 1957, JNCI-J NATL CANCER I, V18, P641; Kim SJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1464, DOI 10.1152/ajpcell.00139.2003; LAMPRECHT J, 1991, J CELL SCI, V98, P463; Lauria G, 2003, NEUROLOGY, V61, P631, DOI 10.1212/01.WNL.0000070781.92512.A4; LOPES NM, 1993, CANCER CHEMOTH PHARM, V32, P235, DOI 10.1007/BF00685842; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; Michalides R, 2002, BREAST CANCER RES TR, V74, P55, DOI 10.1023/A:1016074309582; MILAS L, 1995, CANCER CHEMOTH PHARM, V35, P297, DOI 10.1007/BF00689448; Mimura Y, 2000, NEUROTOXICOLOGY, V21, P513; MISELL LM, 2004, IN PRESS BREAST CANC; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Nakata T, 1999, NEUROSCI RES, V35, P113, DOI 10.1016/S0168-0102(99)00074-7; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; Neese RA, 2001, ANAL BIOCHEM, V298, P189, DOI 10.1006/abio.2001.5375; Newton CN, 2002, J BIOL CHEM, V277, P42456, DOI 10.1074/jbc.M207134200; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; PENG SK, 1972, ARCH PATHOL, V94, P81; PEPPERKOK R, 1990, J CELL BIOL, V111, P3003, DOI 10.1083/jcb.111.6.3003; Pignata S, 2000, ANN ONCOL, V11, P455, DOI 10.1023/A:1008379922120; Previs SF, 1996, J MASS SPECTROM, V31, P639, DOI 10.1002/(SICI)1096-9888(199606)31:6<639::AID-JMS336>3.0.CO;2-S; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; ROBERTS JR, 1990, CANCER RES, V50, P710; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; ROMIJN JC, 1988, PROSTATE, V12, P99, DOI 10.1002/pros.2990120112; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Rutten T, 1997, P NATL ACAD SCI USA, V94, P4469, DOI 10.1073/pnas.94.9.4469; SAHENK Z, 1987, CELL MOTIL CYTOSKEL, V8, P155, DOI 10.1002/cm.970080207; SALMON ED, 1984, J CELL BIOL, V99, P1066, DOI 10.1083/jcb.99.3.1066; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sorger PK, 1997, CURR OPIN CELL BIOL, V9, P807, DOI 10.1016/S0955-0674(97)80081-6; STARGELL LA, 1992, MOL CELL BIOL, V12, P1443, DOI 10.1128/MCB.12.4.1443; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; Tanner KD, 1998, J COMP NEUROL, V395, P481; TAY KY, 1999, BIOCHEM BIOPH RES CO, V263, P398; Theiss C, 2000, CELL TISSUE RES, V299, P213, DOI 10.1007/s004419900120; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Van Bree C, 2000, INT J ONCOL, V16, P739; Vredenburg MR, 2001, JNCI-J NATL CANCER I, V93, P1234, DOI 10.1093/jnci/93.16.1234; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WatermanStorer CM, 1997, CURR BIOL, V7, pR369, DOI 10.1016/S0960-9822(06)00177-1; WILSON L, 1985, BIOCHEMISTRY-US, V24, P5254, DOI 10.1021/bi00340a045; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhou BB, 1999, CELL MOTIL CYTOSKEL, V43, P43; Zhou J, 2002, J CELL SCI, V115, P3547, DOI 10.1242/jcs.00029	105	25	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49940	49947		10.1074/jbc.M409660200	http://dx.doi.org/10.1074/jbc.M409660200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385549	hybrid			2022-12-27	WOS:000225229500049
J	Lee, HH; Kim, DJ; Ahn, HJ; Ha, JY; Suh, SW				Lee, HH; Kim, DJ; Ahn, HJ; Ha, JY; Suh, SW			Crystal structure of T-protein of the glycine cleavage system - Cofactor binding, insights into H-protein recognition, and molecular basis for understanding nonketotic hyperglycinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEA LEAF MITOCHONDRIA; ESCHERICHIA-COLI; DECARBOXYLASE COMPLEX; TETRAHYDROFOLATE POLYGLUTAMATES; SERINE HYDROXYMETHYLTRANSFERASE; TERMINAL REGION; GENE; CRYSTALLIZATION; PURIFICATION; ASSOCIATION	The glycine cleavage system catalyzes the oxidative decarboxylation of glycine in bacteria and in mitochondria of animals and plants. Its deficiency in human causes nonketotic hyperglycinemia, an inborn error of glycine metabolism. T-protein, one of the four components of the glycine cleavage system, is a tetrahydrofolate-dependent aminomethyltransferase. It catalyzes the transfer of the methylene carbon unit to tetrahydrofolate from the methylamine group covalently attached to the lipoamide arm of H-protein. To gain insight into the T-protein function at the molecular level, we have determined the first crystal structure of T-protein from Thermotoga maritima by the multiwavelength anomalous diffraction method of x-ray crystallography and refined four structures: the apoform; the tetrahydrofolate complex; the folinic acid complex; and the lipoic acid complex. The overall fold of T-protein is similar to that of the C-terminal tetrahydrofolate-binding region ( residues 421 - 830) of Arthrobacter globiformis dimethylglycine oxidase. Tetrahydrofolate ( or folinic acid) is bound near the center of the tripartite T-protein. Lipoic acid is bound adjacent to the tetrahydrofolate binding pocket, thus defining the interaction surface for H-protein binding. A homology model of the human T-protein provides the structural framework for understanding the molecular mechanisms underlying the development of nonketotic hyperglycinemia due to missense mutations of the human T-protein.	Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea	Seoul National University (SNU)	Suh, SW (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea.	sewonsuh@snu.ac.kr	Suh, Won/H-8306-2013; Kim, Do Jin/I-7675-2014	Suh, Won/0000-0002-1768-4635; 				BESSON V, 1993, BIOCHEM J, V292, P425, DOI 10.1042/bj2920425; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen-Addad C, 1997, BIOCHIMIE, V79, P637, DOI 10.1016/S0300-9084(97)83496-7; COHENADDAD C, 1995, NAT STRUCT BIOL, V2, P63, DOI 10.1038/nsb0195-63; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Faure M, 2000, EUR J BIOCHEM, V267, P2890, DOI 10.1046/j.1432-1033.2000.01330.x; Guilhaudis L, 2000, BIOCHEMISTRY-US, V39, P4259, DOI 10.1021/bi992674w; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kure S, 1998, J HUM GENET, V43, P135, DOI 10.1007/s100380050055; Kure S, 1998, HUM GENET, V102, P430, DOI 10.1007/s004390050716; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leys D, 2003, EMBO J, V22, P4038, DOI 10.1093/emboj/cdg395; Lokanath NK, 2004, ACTA CRYSTALLOGR D, V60, P1450, DOI 10.1107/S0907444904012910; Macherel D, 1996, EUR J BIOCHEM, V236, P27, DOI 10.1111/j.1432-1033.1996.00027.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOTOKAWA Y, 1995, BIOTHIOLS HLTH DIS, P389; Nakai T, 2003, ACTA CRYSTALLOGR D, V59, P1610, DOI 10.1107/S0907444903014975; Nakai T, 2003, ACTA CRYSTALLOGR D, V59, P554, DOI 10.1107/S090744490300043X; NANAO K, 1994, HUM GENET, V93, P655; Nicholas KB, 1997, EMBNEW NEWS, V4, P14; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Okamura-Ikeda K, 1999, EUR J BIOCHEM, V264, P446, DOI 10.1046/j.1432-1327.1999.00637.x; Okamura-Ikeda K, 2003, J BIOL CHEM, V278, P10067, DOI 10.1074/jbc.M210853200; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARES S, 1994, P NATL ACAD SCI USA, V91, P4850, DOI 10.1073/pnas.91.11.4850; REBEILLE F, 1994, BIOCHEM J, V302, P223, DOI 10.1042/bj3020223; Sakata Y, 2001, MOL BRAIN RES, V94, P119, DOI 10.1016/S0169-328X(01)00225-X; TADA K, 1993, J INHERIT METAB DIS, V16, P691, DOI 10.1007/BF00711901; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toone JR, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<76::AID-HUMU17>3.0.CO;2-0; Toone JR, 2000, MOL GENET METAB, V70, P116, DOI 10.1006/mgme.2000.3000; Toone JR, 2003, MOL GENET METAB, V79, P272, DOI 10.1016/S1096-7192(03)00115-X; Toone JR, 2001, MOL GENET METAB, V72, P322, DOI 10.1006/mgme.2001.3158	40	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50514	50523		10.1074/jbc.M409672200	http://dx.doi.org/10.1074/jbc.M409672200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355973	hybrid			2022-12-27	WOS:000225229500117
J	Fu, DC; Wen, Y; Ma, J				Fu, DC; Wen, Y; Ma, J			The co-activator CREB-binding protein participates in enhancer-dependent activities of bicoid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL TRANSCRIPTION FACTORS; DROSOPHILA EMBRYO; DNA-BINDING; ACETYLTRANSFERASE ACTIVITY; ACTIVATION; CBP; RECRUITMENT; REPRESSION; EXPRESSION; PROMOTER	Bicoid (Bcd) is a transcriptional activator required for early embryonic patterning in Drosophila. Despite extensive studies, it currently remains unclear how Bcd activates transcription and what proteins participate in its activation process. In this report, we describe experiments to analyze the role of the Drosophila co-activator dCBP in Bcd-mediated activation. In Drosophila S2 cells, the Bcd activity is increased by the co-transfection of plasmids expressing dCBP and reduced by double-stranded RNA-mediated interference against dCBP. We further show that Bcd and dCBP can interact with each other and that Bcd-interacting domains of dCBP can cause dominant negative effects on Bcd activity in S2 cells. Our comparison of two Bcd-responsive enhancers, hunchback (hb) and knirps (kni), reveals a differential role of dCBP in facilitating Bcd activation. A dCBP mutant defective in its histone acetyltransferase activity exhibits a reduced, but not abolished, co-activator function for Bcd. Our chromatin immunoprecipitation experiments show that dCBP can increase not only the occupancy of Bcd itself at the enhancers but also the recruitment of general transcription factors to the promoter. Together, these experiments suggest that dCBP is an enhancer-dependent co-activator of Bcd, facilitating its activation through multiple mechanisms.	Univ Cincinnati, Coll Med, Grad Program Mol & Dev Biol, Cincinnati Childrens Hosp Res Fdn,Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Ma, J (corresponding author), Univ Cincinnati, Coll Med, Grad Program Mol & Dev Biol, Cincinnati Childrens Hosp Res Fdn,Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jun.ma@cchmc.org	Ma, Jun/GLT-4809-2022	Ma, Jun/0000-0002-1609-3294				Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Chan HM, 2001, J CELL SCI, V114, P2363; CHATTERJEE S, 1995, NATURE, V374, P820, DOI 10.1038/374820a0; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V342, P149, DOI 10.1038/342149a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Driever W., 1992, TRANSCRIPTIONAL REGU, P1221; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Florence B, 1998, GENETICS, V150, P1497; Fu DC, 2003, MOL CELL BIOL, V23, P4439, DOI 10.1128/MCB.23.13.4439-4448.2003; Gao Q, 1996, MECH DEVELOP, V56, P3, DOI 10.1016/0925-4773(96)00504-7; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Johnson RA, 2001, J BIOL CHEM, V276, P27716, DOI 10.1074/jbc.C100121200; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; KLEIN C, 1994, SCIENCE, V266, P280, DOI 10.1126/science.7939664; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Ludlam WH, 2002, MOL CELL BIOL, V22, P3832, DOI 10.1128/MCB.22.11.3832-3841.2002; Ma XG, 1996, DEVELOPMENT, V122, P1195; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; SAUER F, 1995, SCIENCE, V270, P1825, DOI 10.1126/science.270.5243.1825; Schaeffer V, 1999, P NATL ACAD SCI USA, V96, P4461, DOI 10.1073/pnas.96.8.4461; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Yuan D, 1999, J BIOCHEM-TOKYO, V125, P809, DOI 10.1093/oxfordjournals.jbchem.a022353; Zeng XY, 2001, J BIOL CHEM, V276, P48, DOI 10.1074/jbc.C000722200; Zhao C, 2000, MOL CELL BIOL, V20, P8112, DOI 10.1128/MCB.20.21.8112-8123.2000; Zhao C, 2003, J BIOL CHEM, V278, P43901, DOI 10.1074/jbc.M302714200; Zhao C, 2002, DEVELOPMENT, V129, P1669; ZHAO C, 2003, RRD MOLEC CELL BIOL, V4, P115	52	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48725	48733		10.1074/jbc.M407066200	http://dx.doi.org/10.1074/jbc.M407066200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358774	hybrid			2022-12-27	WOS:000225098100030
J	Wei, HJ; Ahn, S; Barnes, WG; Lefkowitz, RJ				Wei, HJ; Ahn, S; Barnes, WG; Lefkowitz, RJ			Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; PROTEIN-KINASE; II RECEPTOR; DEPENDENT DEGRADATION; INTRACELLULAR DOMAINS; GENE-EXPRESSION; ERK ACTIVATION; PHOSPHORYLATION; LOOP; DESENSITIZATION	receptors (7MSRs) not only leads to receptor desensitization and endocytosis but also elicits additional signaling processes. We recently proposed that stimulation of the angiotensin type 1A (AT(1A)) receptor results in independent beta-arrestin 2- and G protein-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation. Here we utilize two AT(1A) mutant receptors to study these independent pathways, one truncated at residue 324, thus removing all potential carboxyl-terminal phosphorylation sites, and the other bearing four mutations in the serine/threonine-rich clusters in the carboxyl terminus. As assessed by confocal microscopy, the two mutant receptors interacted with beta-arrestin 2- green fluorescent protein with much lower affinity than did the wild-type receptor. In addition, the mutant receptors more robustly stimulated G protein-mediated inositol phosphate production. Approximately one-half of the wild-type AT(1A) receptor-stimulated ERK1/2 activation was via a beta-arrestin 2-dependent pathway ( suppressed by beta-arrestin 2 small interfering RNA), whereas the rest was mediated by a G protein-dependent pathway ( suppressed by protein kinase C inhibitor). ERK1/2 activation by the mutant receptors was insensitive to beta-arrestin 2 small interfering RNA but was reduced more than 80% by a protein kinase C inhibitor. The biochemical consequences of ERK activation by the G protein and beta-arrestin 2-dependent pathways were also distinct. G-protein-mediated ERK activation enhanced the transcription of early growth response 1, whereas beta-arrestin 2- dependent ERK activation did not. In addition, stimulation of the truncated AT(1A) mutant receptor caused significantly greater early growth response 1 transcription than did the wild-type receptor. These findings demonstrate how the ability of receptors to interact with beta-arrestins determines both the mechanism of ERK activation as well as the physiological consequences of this activation.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Box 3821, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL70631, R01 HL16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Angulo E, 2003, BRAIN PATHOL, V13, P440; Bhaskaran RS, 2003, BIOCHEMISTRY-US, V42, P13950, DOI 10.1021/bi034907w; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Cen B, 2001, J NEUROCHEM, V76, P1887, DOI 10.1046/j.1471-4159.2001.00204.x; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Day FL, 1999, J BIOL CHEM, V274, P23726, DOI 10.1074/jbc.274.34.23726; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Guillemot L, 2001, J BIOL CHEM, V276, P39394, DOI 10.1074/jbc.M103862200; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; Min L, 2002, J BIOL CHEM, V277, P702, DOI 10.1074/jbc.M106082200; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Qian HW, 1999, BIOCHEM J, V343, P637, DOI 10.1042/0264-6021:3430637; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; Thomas WG, 1999, REGUL PEPTIDES, V79, P9, DOI 10.1016/S0167-0115(98)00140-2; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	29	67	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48255	48261		10.1074/jbc.M406205200	http://dx.doi.org/10.1074/jbc.M406205200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355986	hybrid			2022-12-27	WOS:000224957000101
J	Cipollo, JF; Awad, AM; Costello, CE; Hirschberg, CB				Cipollo, JF; Awad, AM; Costello, CE; Hirschberg, CB			srf-3, a mutant of Caenorhabditis elegans, resistant to bacterial infection and to biofilm binding, is deficient in glycoconjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCANS; LINKED GLYCANS; HOST; PATHOGEN; ADHESIN; MODEL; GLYCOSYLATION; EXPRESSION; TOXIN; GENES	srf-3 is a mutant of C. elegans that is resistant to infection by Microbacterium nematophilum and to binding of the biofilm produced by Yersinia pseudotuberculosis and Yersinia pestis. Recently, SRF-3 was characterized as a nucleotide sugar transporter of the Golgi apparatus occurring exclusively in hypodermal seam cells, pharyngeal cells, and spermatheca. Based on the above observations, we hypothesized that srf-3 may have altered glyconjugates that may enable the mutant nematode to grow unaffected in the presence of the above pathogenic bacteria. Following analyses of N- and O-linked glycoconjugates of srf-3 and wild type nematodes using a combination of enzymatic degradation, permethylation, and mass spectrometry, we found in srf-3 a 65% reduction of acidic O-linked glycoconjugates containing glucuronic acid and galactose as well as a reduction of N- linked glycoconjugates containing galactose and fucose. These results are consistent with the specificity of SRF-3 for UDP-galactose and strongly suggest that the above glycoconjugates play an important role in allowing adhesion of M. nematophilum or Y. pseudotuberculosis biofilm to wild type C. elegans. Furthermore, because seam cells as well as pharyngeal cells secrete their glycoconjugates to the cuticle and surrounding surfaces, the results also demonstrate the critical role of these cells and their secreted glycoproteins in nematode-bacteria interactions and offer a mechanistic basis for strategies to block such recognition processes.	Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Mass Spectrometry Resource, Boston, MA 02118 USA	Boston University; Boston University	Hirschberg, CB (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, 715 Albany St,Evans 437, Boston, MA 02118 USA.	chirschb@bu.edu		Hirschberg, Carlos/0000-0003-2299-7721; Costello, Catherine/0000-0003-1594-5122	NCRR NIH HHS [P41 RR10888, S10 RR15942] Funding Source: Medline; NIGMS NIH HHS [F32 GM66486, R01 GM30365] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888, S10RR015942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066486, R01GM030365] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; Chen SH, 2002, BBA-GEN SUBJECTS, V1573, P271, DOI 10.1016/S0304-4165(02)00393-8; Cipollo JF, 2002, J BIOL CHEM, V277, P49143, DOI 10.1074/jbc.M208020200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gemmill TR, 1998, GLYCOBIOLOGY, V8, P1087, DOI 10.1093/glycob/8.11.1087; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Harvey DJ, 1999, MASS SPECTROM REV, V18, P349, DOI 10.1002/(SICI)1098-2787(1999)18:6<349::AID-MAS1>3.3.CO;2-8; Haslam SM, 2003, BIOCHIMIE, V85, P25, DOI 10.1016/S0300-9084(03)00041-5; Haslam SM, 2002, BIOCHEM SOC SYMP, V69, P117; HEMMER RM, 1991, J CELL BIOL, V115, P1237, DOI 10.1083/jcb.115.5.1237; Hirabayashi J, 2001, PROTEOMICS, V1, P295, DOI 10.1002/1615-9861(200102)1:2<295::AID-PROT295>3.0.CO;2-C; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Hoeflich J, 2004, J BIOL CHEM; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Karlsson KA, 2001, ADV EXP MED BIOL, V491, P431; KRAMER JM, 1997, C ELEGANS, V2, P471; Kurz CL, 2000, TRENDS MICROBIOL, V8, P142, DOI 10.1016/S0966-842X(99)01691-1; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Marroquin LD, 2000, GENETICS, V155, P1693; Natsuka S, 2002, J BIOCHEM, V131, P807, DOI 10.1093/oxfordjournals.jbchem.a003169; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Peterson C, 2000, J HISTOCHEM CYTOCHEM, V48, P877, DOI 10.1177/002215540004800616; Rad R, 2002, J IMMUNOL, V168, P3033, DOI 10.4049/jimmunol.168.6.3033; Rajamohan F, 1998, PROG NUCLEIC ACID RE, V60, P1, DOI 10.1016/S0079-6603(08)60887-9; Schachter H, 2002, BIOCHEM SOC SYMP, V69, P1; Schurks N, 2002, INT J BIOL MACROMOL, V30, P105, DOI 10.1016/S0141-8130(02)00002-8; Silverman MA, 1997, J NEMATOL, V29, P296; Verostek MF, 2000, ANAL BIOCHEM, V278, P111, DOI 10.1006/abio.1999.4433; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931	39	51	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					52893	52903		10.1074/jbc.M409557200	http://dx.doi.org/10.1074/jbc.M409557200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15452127	hybrid			2022-12-27	WOS:000225680600013
J	Adams, CM; Reitz, J; De Brabander, JK; Feramisco, JD; Li, L; Brown, MS; Goldstein, JL				Adams, CM; Reitz, J; De Brabander, JK; Feramisco, JD; Li, L; Brown, MS; Goldstein, JL			Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and insigs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYSTEROL-BINDING-PROTEIN; LOW-DENSITY-LIPOPROTEIN; A REDUCTASE-ACTIVITY; HUMAN FIBROBLASTS; MEMBRANE-PROTEIN; CDNA CLONING; STEROL; CLEAVAGE; RECEPTOR; CELLS	The current paper demonstrates that cholesterol and its hydroxylated derivative, 25-hydroxycholesterol (25-HC), inhibit cholesterol synthesis by two different mechanisms, both involving the proteins that control sterol regulatory element-binding proteins (SREBPs), membrane-bound transcription factors that activate genes encoding enzymes of lipid synthesis. Using methyl-beta-cyclodextrin as a delivery vehicle, we show that cholesterol enters cultured Chinese hamster ovary cells and elicits a conformational change in SREBP cleavage-activating protein (SCAP), as revealed by the appearance of a new fragment in tryptic digests. This change causes SCAP to bind to Insigs, which are endoplasmic reticulum retention proteins that abrogate movement of the SCAP.SREBP complex to the Golgi apparatus where SREBPs are normally processed to their active forms. Direct binding of cholesterol to SCAP in intact cells was demonstrated by showing that a photoactivated derivative of cholesterol cross-links to the membrane domain of SCAP. The inhibitory actions of cholesterol do not require the isooctyl side chain or the Delta5-double bond of cholesterol, but they do require the 3beta-hydroxyl group. 25-HC is more potent than cholesterol in eliciting SCAP binding to Insigs, but 25-HC does not cause a detectable conformational change in SCAP. Moreover, a photoactivated derivative of 25-HC does not cross-link to SCAP. These data imply that cholesterol interacts with SCAP directly by inducing it to bind to Insigs, whereas 25-HC works indirectly through a putative 25-HC sensor protein that elicits SCAP-Insig binding.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu		Adams, Christopher/0000-0002-5795-7212	NHLBI NIH HHS [HL20948] Funding Source: Medline; NIGMS NIH HHS [GM-08014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1974, J BIOL CHEM, V249, P7306; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; GOLDSTEIN JL, 1975, LIPIDS LIPOPROTEINS, P77; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; KANDUTSCH AA, 1978, SCIENCE, V201, P498, DOI 10.1126/science.663671; KANDUTSCH AA, 1974, J BIOL CHEM, V249, P6057; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; KRIEGER M, 1978, P NATL ACAD SCI USA, V75, P5052, DOI 10.1073/pnas.75.10.5052; LEVANON D, 1990, GENOMICS, V7, P65, DOI 10.1016/0888-7543(90)90519-Z; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; Mintzer EA, 2002, FEBS LETT, V510, P181, DOI 10.1016/S0014-5793(01)03271-9; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; TAVARES R, 1993, TETRAHEDRON, V49, P5079, DOI 10.1016/S0040-4020(01)81873-1; TAYLOR FR, 1985, CHEM PHYS LIPIDS, V38, P187, DOI 10.1016/0009-3084(85)90066-0; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	41	311	330	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52772	52780		10.1074/jbc.M410302200	http://dx.doi.org/10.1074/jbc.M410302200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452130	hybrid			2022-12-27	WOS:000225493400124
J	Park, KM; Kim, JI; Ahn, Y; Bonventre, AJ; Bonventre, JV				Park, KM; Kim, JI; Ahn, Y; Bonventre, AJ; Bonventre, JV			Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR ENDOTHELIAL-CELLS; INDUCED FUNCTIONAL INJURY; MAPK KINASE ACTIVATION; REPERFUSION INJURY; SEX-HORMONES; L-ARGININE; IN-VITRO; MYOCARDIAL-ISCHEMIA; MONOCYTE ADHESION	Female mice are much more resistant to ischemia/reperfusion (I/R)-induced kidney injury when compared with males. Although estrogen administration can partially reduce kidney injury associated with I/R, we demonstrated that the presence of testosterone, more than the absence of estrogen, plays a critical role in gender differences in susceptibility of the kidney to ischemic injury. Testosterone administration to females increases kidney susceptibility to ischemia. Dihydrotestosterone, which can not be aromatized to estrogen, has effects equal to those of testosterone. Castration reduces the I/R-induced kidney injury. In contrast, ovariectomy does not affect kidney injury induced by ischemia in females. Testosterone reduces ischemia-induced activation of nitric oxide synthases (NOSs) and Akt and the ratio of extracellular signal related kinase (ERK) to c-jun N-terminal kinase (JNK) phosphorylation. Pharmacological (N-omega-nitro-L-arginine) or genetic ( endothelial NOS or inducible NOS) inhibition of NOSs in females enhances kidney susceptibility to ischemia. Nitric oxide increases Akt phosphorylation and protects Madin-Darby canine kidney epithelial cells from oxidant stress. Antagonists of androgen or estrogen receptors do not affect the gender differences. In conclusion, testosterone inhibits the post-ischemic activation of NOSs and Akt and the ratio of ERK to JNK phosphorylation through non-androgen receptor-medicated mechanisms, leading to increased inflammation and increased functional injury to the kidney. These findings provide a new paradigm for the design of therapies for ischemia/reperfusion injury and may be important to our understanding of the pathophysiology of acute renal failure in pregnancy where plasma androgen levels are elevated.	Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu 700422, South Korea; Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Renal Div, Boston, MA 02115 USA	Harvard University; Harvard University; Massachusetts General Hospital; Kyungpook National University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bonventre, JV (corresponding author), Harvard Inst Med, 4 Blackfan Circle, Boston, MA 02115 USA.	joseph_bonventre@hms.harvard.edu			NIDDK NIH HHS [DK 39773, DK 38452, DK46267] Funding Source: Medline; NINDS NIH HHS [NS 10828] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039773, R37DK039773, P01DK038452, R01DK046267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS010828, P50NS010828] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexander BT, 2002, HYPERTENSION, V39, P586, DOI 10.1161/hy0202.103288; Alvarez A, 2002, CIRC RES, V91, P1142, DOI 10.1161/01.RES.0000046018.23605.3E; Andreucci M, 2003, KIDNEY INT, V64, P1189, DOI 10.1046/j.1523-1755.2003.00204.x; BAKER PJ, 1978, AM J PHYSIOL, V235, pH242, DOI 10.1152/ajpheart.1978.235.2.H242; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Chao W, 2003, J GENE MED, V5, P277, DOI 10.1002/jgm.347; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DIMARI J, 1999, AM J PHYSIOL, pF195; Fernandez M, 2001, J AM SOC NEPHROL, V12, P1900, DOI 10.1681/ASN.V1291900; Friedl R, 2000, LIFE SCI, V68, P417, DOI 10.1016/S0024-3205(00)00953-X; Fukuda K, 2000, STROKE, V31, P155, DOI 10.1161/01.STR.31.1.155; Goligorsky MS, 2002, KIDNEY INT, V61, P855, DOI 10.1046/j.1523-1755.2002.00233.x; Guo ZY, 2002, J BIOL CHEM, V277, P7044, DOI 10.1074/jbc.M109808200; Ha KS, 2003, FASEB J, V17, P1036, DOI 10.1096/fj.02-0738com; Hickey MJ, 2001, CLIN SCI, V100, P1, DOI 10.1042/CS20000135; Hirschberg R, 1998, MINER ELECTROL METAB, V24, P211, DOI 10.1159/000057373; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Ivanov VN, 2002, J BIOL CHEM, V277, P4932, DOI 10.1074/jbc.M108233200; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Ling H, 1999, AM J PHYSIOL-RENAL, V277, pF383; Ling SH, 2002, ENDOCRINOLOGY, V143, P1119, DOI 10.1210/en.143.3.1119; Maestri M, 1997, TRANSPLANTATION, V64, P185, DOI 10.1097/00007890-199707270-00001; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; McCrohon JA, 1999, CIRCULATION, V99, P2317, DOI 10.1161/01.CIR.99.17.2317; McNeill AM, 1999, STROKE, V30, P2186, DOI 10.1161/01.STR.30.10.2186; Medina A, 2002, PEDIATR NEPHROL, V17, P1005, DOI 10.1007/s00467-002-0979-y; MILEWICH L, 1982, J STEROID BIOCHEM, V17, P61, DOI 10.1016/0022-4731(82)90592-1; Mori M, 2004, LIFE SCI, V75, P599, DOI 10.1016/j.lfs.2003.12.023; Muller V, 2002, KIDNEY INT, V62, P1364, DOI 10.1111/j.1523-1755.2002.kid590.x; Neugarten J, 1997, J AM SOC NEPHROL, V8, P1240; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; Park KM, 2002, J BIOL CHEM, V277, P2040, DOI 10.1074/jbc.M107525200; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; PARK KM, 2000, J AM SOC NEPHROL, V11, P594; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; RABB H, 1995, BIOCHEM BIOPH RES CO, V211, P67, DOI 10.1006/bbrc.1995.1779; Rodriguez E, 2002, LIFE SCI, V71, P2181, DOI 10.1016/S0024-3205(02)01999-9; Schramm L, 2002, KIDNEY INT, V61, P1423, DOI 10.1046/j.1523-1755.2002.00268.x; Serin IS, 2001, ACTA OBSTET GYN SCAN, V80, P1009, DOI 10.1034/j.1600-0412.2001.801107.x; Sheridan AM, 2000, CURR OPIN NEPHROL HY, V9, P427, DOI 10.1097/00041552-200007000-00015; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Squadrito F, 1997, EUR J PHARMACOL, V335, P185, DOI 10.1016/S0014-2999(97)01201-6; Sugden PH, 2001, CIRC RES, V88, P975, DOI 10.1161/hh1001.091864; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Vos IHC, 2001, J AM SOC NEPHROL, V12, P361, DOI 10.1681/ASN.V122361; WAKASUGI M, 1989, PROSTAG OTH LIPID M, V37, P401, DOI 10.1016/0090-6980(89)90090-7; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; WEYRICH AS, 1992, CIRCULATION, V86, P279, DOI 10.1161/01.CIR.86.1.279; Wunderlich F, 2002, STEROIDS, V67, P535, DOI 10.1016/S0039-128X(01)00175-1; Yang SH, 2002, J APPL PHYSIOL, V92, P195, DOI 10.1152/jappl.2002.92.1.195	50	232	247	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52282	52292		10.1074/jbc.M407629200	http://dx.doi.org/10.1074/jbc.M407629200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15358759	hybrid			2022-12-27	WOS:000225493400069
J	Eichacker, LA; Granvogl, B; Mirus, O; Muller, BC; Miess, C; Schleiff, E				Eichacker, LA; Granvogl, B; Mirus, O; Muller, BC; Miess, C; Schleiff, E			Hiding behind hydrophobicity - Transmembrane segments in mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN COMPLEXES; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; IDENTIFICATION; ELECTROPHORESIS; IMPORT; PHOSPHORYLATION; CHLOROPLASTS; CHALLENGES; DISCOVERY	Proteomics of membrane proteins is essential for the understanding of cellular function. However, mass spectrometric analysis of membrane proteomes has been less successful than the proteomic determination of soluble proteins. To elucidate the mystery of transmembrane proteins in mass spectrometry, we present a detailed statistical analysis of experimental data derived from chloroplast membranes. This approach was further accomplished by the analysis of the Arabidopsis thaliana proteome after in silico digestion. We demonstrate that both the length and the hydrophobicity of the proteolytic fragments containing transmembrane segments are major determinants for detection by mass spectrometry. Based on a comparative analysis, we discuss possibilities to overcome the problem and provide possible protocols to shift the hydrophobicity of transmembrane segment-containing peptides to facilitate their detection.	Univ Munich, Dept Biol 1, D-80368 Munich, Germany; Hoffmann La Roche AG, Roche Ctr Med Genom, CH-4070 Basel, Switzerland	University of Munich; Roche Holding	Eichacker, LA (corresponding author), Univ Munich, Dept Biol 1, Menzinger Str 67, D-80368 Munich, Germany.	eichacker@lrz.uni-muenchen.de; schleiff@lrz.uni-muenchen.de	Schleiff, Enrico/C-5105-2017	Schleiff, Enrico/0000-0002-0518-3489				Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Anderson NL, 2000, CURR OPIN BIOTECH, V11, P408, DOI 10.1016/S0958-1669(00)00118-X; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Blonder J, 2004, PROTEOMICS, V4, P31, DOI 10.1002/pmic.200300543; Canovas FM, 2004, PROTEOMICS, V4, P285, DOI 10.1002/pmic.200300602; Cash P, 2003, ADV BIOCHEM ENG BIOT, V83, P93; Cooper R. A., 2004, Current Drug Targets - Infectious Disorders, V4, P41, DOI 10.2174/1568005043480989; Devreese B, 2002, ELECTROPHORESIS, V23, P2525, DOI 10.1002/1522-2683(200208)23:15<2525::AID-ELPS2525>3.0.CO;2-I; Eckart K, 2002, EMBO REP, V3, P557, DOI 10.1093/embo-reports/kvf110; EICHACKER L, 2001, Patent No. 100119597; Eichacker LA, 1996, J BIOL CHEM, V271, P32174, DOI 10.1074/jbc.271.50.32174; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fukao Y, 2002, PLANT CELL PHYSIOL, V43, P689, DOI 10.1093/pcp/pcf101; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Hixson KK, 2002, ELECTROPHORESIS, V23, P3224, DOI 10.1002/1522-2683(200209)23:18<3224::AID-ELPS3224>3.0.CO;2-#; Kashino Y, 2003, J CHROMATOGR B, V797, P191, DOI 10.1016/S1570-0232(03)00428-8; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuchler M, 2002, EMBO J, V21, P6136, DOI 10.1093/emboj/cdf621; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lister R, 2004, PLANT PHYSIOL, V134, P777, DOI 10.1104/pp.103.033910; Onyango P, 2004, CURR CANCER DRUG TAR, V4, P111, DOI 10.2174/1568009043481588; Peltier JB, 2000, PLANT CELL, V12, P319, DOI 10.1105/tpc.12.3.319; Rachakonda S, 2004, CURR MED CHEM, V11, P775, DOI 10.2174/0929867043455774; Rowley A, 2000, METHODS, V20, P383, DOI 10.1006/meth.2000.0951; Santoni V, 1999, ELECTROPHORESIS, V20, P705, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<705::AID-ELPS705>3.3.CO;2-H; Santoni V, 2000, ELECTROPHORESIS, V21, P3329, DOI 10.1002/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F; Schafer H, 2001, ELECTROPHORESIS, V22, P2955, DOI 10.1002/1522-2683(200108)22:14<2955::AID-ELPS2955>3.0.CO;2-U; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schleiff E, 2003, PROTEIN SCI, V12, P748, DOI 10.1110/ps.0237503; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Thidholm E, 2002, FEBS LETT, V513, P217, DOI 10.1016/S0014-5793(02)02314-1; Turck N, 2004, PROTEOMICS, V4, P93, DOI 10.1002/pmic.200300480; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; van Wijk KJ, 2001, PLANT PHYSIOL, V126, P501, DOI 10.1104/pp.126.2.501; Veenstra TD, 2003, ADV PROTEIN CHEM, V65, P161; Venter H, 2002, BIOCHEM J, V363, P243, DOI 10.1042/0264-6021:3630243; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Zhu H, 2003, ANNU REV BIOCHEM, V72, P783, DOI 10.1146/annurev.biochem.72.121801.161511; Zolg JW, 2004, MOL CELL PROTEOMICS, V3, P345, DOI 10.1074/mcp.M400007-MCP200	44	83	87	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50915	50922		10.1074/jbc.M405875200	http://dx.doi.org/10.1074/jbc.M405875200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452135	hybrid			2022-12-27	WOS:000225355800034
J	Fewell, SW; Smith, CM; Lyon, MA; Dumitrescu, TP; Wipf, P; Day, BW; Brodsky, JL				Fewell, SW; Smith, CM; Lyon, MA; Dumitrescu, TP; Wipf, P; Day, BW; Brodsky, JL			Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMIAN-VIRUS-40 LARGE-T; HEAT-SHOCK-PROTEIN; YEAST ENDOPLASMIC-RETICULUM; PEPTIDE-BINDING DOMAIN; ANTIGEN J-DOMAIN; SACCHAROMYCES-CEREVISIAE; CYSTIC-FIBROSIS; IN-VITRO; IMMUNOSUPPRESSANT 15-DEOXYSPERGUALIN; DIFFERENTIAL EXPRESSION	The molecular chaperone and cytoprotective activities of the Hsp70 and Hsp40 chaperones represent therapeutic targets for human diseases such as cancer and those that arise from defects in protein folding; however, very few Hsp70 and no Hsp40 modulators have been described. Using an assay for ATP hydrolysis, we identified and screened small molecules with structural similarity to 15-deoxyspergualin and NSC 630668-R/1 for their effects on endogenous and Hsp40-stimulated Hsp70 ATPase activity. Several of these compounds modulated Hsp70 ATPase activity, consistent with the action of NSC 630668-R/1 observed previously (Fewell, S. W., Day, B. W., and Brodsky, J. L. ( 2001) J. Biol. Chem. 276, 910 - 914). In contrast, three compounds inhibited the ability of Hsp40 to stimulate Hsp70 ATPase activity but did not affect the endogenous activity of Hsp70. Two of these agents also compromised the Hsp70/Hsp40-mediated post-translational translocation of a secreted pre-protein in vitro. Together, these data indicate the potential for continued screening of small molecule Hsp70 effectors and that specific modulators of Hsp70-Hsp40 interaction can be obtained, potentially for future therapeutic use.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, 274 Crawford Hall, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Wipf, Peter/AAG-1771-2021	Wipf, Peter/0000-0001-7693-5863; Day, Billy/0000-0001-6208-9950	NCI NIH HHS [CA78039, CA099024] Funding Source: Medline; NIGMS NIH HHS [GM067082] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA078039, R21CA099024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbanti-Brodano G, 1998, ADV VIRUS RES, V50, P69, DOI 10.1016/S0065-3527(08)60806-4; Beck J, 2003, J BIOL CHEM, V278, P36128, DOI 10.1074/jbc.M301069200; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Brodsky JL, 1998, J VIROL, V72, P5329, DOI 10.1128/JVI.72.7.5329-5334.1998; Brodsky JL, 2001, AM J PHYSIOL-LUNG C, V281, pL39, DOI 10.1152/ajplung.2001.281.1.L39; Brodsky JL, 1999, BIOCHEM PHARMACOL, V57, P877, DOI 10.1016/S0006-2952(98)00376-1; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Cantalupo P, 1999, METHOD ENZYMOL, V306, P297; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Castellino AM, 1997, J VIROL, V71, P7549, DOI 10.1128/JVI.71.10.7549-7559.1997; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CIOCCA DR, 1993, J NATL CANCER I, V85, P570, DOI 10.1093/jnci/85.7.570; CYR DM, 1992, J BIOL CHEM, V267, P20927; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; Domling A, 2000, ANGEW CHEM INT EDIT, V39, P3168, DOI 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U; Ferber D, 2002, SCIENCE, V296, P1012, DOI 10.1126/science.296.5570.1012; Fewell SW, 2002, P NATL ACAD SCI USA, V99, P2002, DOI 10.1073/pnas.042670999; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Gelman MS, 2002, J CLIN INVEST, V110, P1591, DOI 10.1172/JCI200216786; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; JIANG C, 2000, AM J PHYSIOL, V278, pC259; Jiang CW, 1998, AM J PHYSIOL-CELL PH, V275, pC171, DOI 10.1152/ajpcell.1998.275.1.C171; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Kaur J, 1995, INT J CANCER, V63, P774, DOI 10.1002/ijc.2910630604; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Le Gac NT, 2002, J BIOL CHEM, V277, P5660, DOI 10.1074/jbc.M108316200; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lin BY, 2002, MOL CELL BIOL, V22, P6592, DOI 10.1128/MCB.22.18.6592-6604.2002; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Mamelak D, 2001, J BIOL CHEM, V276, P449, DOI 10.1074/jbc.M006732200; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McClellan AJ, 2000, GENETICS, V156, P501; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; NADLER SG, 1995, THER DRUG MONIT, V17, P700, DOI 10.1097/00007691-199512000-00026; Nadler SG, 1998, BIOCHEM BIOPH RES CO, V253, P176, DOI 10.1006/bbrc.1998.9775; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; PIPAS JM, 1992, J VIROL, V66, P3979, DOI 10.1128/JVI.66.7.3979-3985.1992; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Ralhan R, 1995, CLIN CANCER RES, V1, P1217; Rice RL, 1997, BIOCHEMISTRY-US, V36, P15965, DOI 10.1021/bi971338h; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; Santarosa M, 1997, EUR J CANCER, V33, P873, DOI 10.1016/S0959-8049(97)00002-6; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Seo JS, 1996, BIOCHEM BIOPH RES CO, V218, P582, DOI 10.1006/bbrc.1996.0103; Sock E, 1999, MOL CELL BIOL, V19, P2455; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; Studer A, 1997, J ORG CHEM, V62, P2917, DOI 10.1021/jo970095w; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; Sullivan CS, 2001, VIROLOGY, V287, P1, DOI 10.1006/viro.2001.1038; Sullivan CS, 2000, MOL CELL BIOL, V20, P5749, DOI 10.1128/MCB.20.15.5749-5757.2000; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Tanabe K, 2000, TRANSPLANT P, V32, P1745, DOI 10.1016/S0041-1345(00)01427-5; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; WANG TF, 1993, J BIOL CHEM, V268, P26049; Whetstone H, 2003, BIOCHEMISTRY-US, V42, P1611, DOI 10.1021/bi026735t; WICKNER S, 1991, NATURE, V350, P165, DOI 10.1038/350165a0; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; Wipf P, 1997, BIOORGAN MED CHEM, V5, P165, DOI 10.1016/S0968-0896(96)00199-X; WIPF P, 1995, TETRAHEDRON LETT, V36, P7819, DOI 10.1016/0040-4039(95)01660-A; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; ZIEGELHOFFER T, 1995, J BIOL CHEM, V270, P10412, DOI 10.1074/jbc.270.18.10412	85	163	172	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51131	51140		10.1074/jbc.M404857200	http://dx.doi.org/10.1074/jbc.M404857200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448148	Green Accepted, hybrid			2022-12-27	WOS:000225355800059
J	Kawai, Y; Morinaga, H; Kondo, H; Miyoshi, N; Nakamura, Y; Uchida, K; Osawa, T				Kawai, Y; Morinaga, H; Kondo, H; Miyoshi, N; Nakamura, Y; Uchida, K; Osawa, T			Endogenous formation of novel halogenated 2 '-deoxycytidine - Hypohalous acid-mediated DNA modification at the site of inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXIDE-CHLORIDE SYSTEM; LUNG-CANCER RISK; HYPOCHLORITE-INDUCED DAMAGE; HUMAN NEUTROPHILS EMPLOY; CALF THYMUS DNA; HUMAN PHAGOCYTES; EOSINOPHIL PEROXIDASE; BROMINATING OXIDANTS; GENERATED OXIDANTS; REACTIVE OXYGEN	A potential role of DNA damage by leukocyte-derived reactive species in carcinogenesis has been suggested. Leukocyte-derived peroxidases, such as myeloperoxidase and eosinophil peroxidase, use hydrogen peroxide and halides (Cl- and Br-) to generate hypohalous acids (HOCl and HOBr), halogenating intermediates. It has been suggested that these oxidants lead to the formation of halogenated products upon reaction with nucleobases. To verify the consequences of phagocyte-mediated DNA damage at the site of inflammation, we developed a novel monoclonal antibody (mAb2D3) that recognizes the hypohalous acid-modified DNA and found that the antibody most significantly recognized HOCl/HOBr-modified 2'-deoxycytidine residues. The immunoreactivity of HOCl-treated oligonucleotide was attenuated by excess methionine, suggesting that chloramine-like species may be the plausible epitopes of the antibody. On the basis of further characterization combined with mass spectrometric analysis, the epitopes of mAb2D3 were determined to be novel N-4,5-dihalogenated 2'-deoxycytidine residues. The formation of the dihalogenated 2'-deoxycytidine in vivo was immunohistochemically demonstrated in the lung and liver nuclei of mice treated with lipopolysaccharides, an experimental inflammatory model. These results strongly suggest that phagocyte-derived oxidants, hypohalous acids, endogenously generate the halogenated DNA bases such as a novel dihalogenated 2'-deoxycytidine in vivo. Halogenation ( chlorination and/or bromination) of DNA therefore may constitute one mechanism for oxidative DNA damage at the site of inflammation.	Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan	Nagoya University	Kawai, Y (corresponding author), Univ Tokushima, Grad Sch Nutr & Biosci, Dept Food Sci, Tokushima 7708503, Japan.	y-kawai@nutr.med.tokushima-u.ac.jp	Miyoshi, Noriyuki/F-4554-2010; Kawai, Yoshichika/G-3231-2011	Uchida, Koji/0000-0003-3894-5299; Miyoshi, Noriyuki/0000-0002-4233-4282				Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; Byun J, 1999, BIOCHEMISTRY-US, V38, P2590, DOI 10.1021/bi9822980; Carr AC, 1997, BIOCHEM J, V327, P275, DOI 10.1042/bj3270275; Cascorbi I, 2000, CANCER RES, V60, P644; Chen HJC, 2002, CHEM RES TOXICOL, V15, P262, DOI 10.1021/tx015578g; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; GOULD JP, 1984, WATER RES, V18, P205, DOI 10.1016/0043-1354(84)90070-8; GOULD JP, 1984, WATER RES, V18, P991, DOI 10.1016/0043-1354(84)90250-1; Hawkins CL, 2002, CHEM RES TOXICOL, V15, P83, DOI 10.1021/tx015548d; Hawkins CL, 2001, ARCH BIOCHEM BIOPHYS, V395, P137, DOI 10.1006/abbi.2001.2581; Hawkins CL, 2001, CHEM RES TOXICOL, V14, P1071, DOI 10.1021/tx010071r; HAYATSU H, 1971, CHEM PHARM BULL, V19, P2189; Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HEINECKE JW, 1994, BIOCHEMISTRY-US, V33, P10127, DOI 10.1021/bi00199a041; Henderson JP, 1999, J BIOL CHEM, V274, P33440, DOI 10.1074/jbc.274.47.33440; Henderson JP, 2003, J BIOL CHEM, V278, P23522, DOI 10.1074/jbc.M303928200; Henderson JP, 2001, J BIOL CHEM, V276, P7867, DOI 10.1074/jbc.M005379200; Henderson JP, 2001, P NATL ACAD SCI USA, V98, P1631, DOI 10.1073/pnas.041146998; HEWETT JA, 1993, PHARMACOL REV, V45, P381; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HOLZBECHER J, 1980, CLIN BIOCHEM, V13, P277, DOI 10.1016/S0009-9120(80)80009-9; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; ISHII A, 1994, MUTAT RES, V305, P273, DOI 10.1016/0027-5107(94)90247-X; Jiang Q, 2003, J BIOL CHEM, V278, P32834, DOI 10.1074/jbc.M304021200; Kato Y, 1997, J AGR FOOD CHEM, V45, P3004, DOI 10.1021/jf960865p; Kawai Y, 2002, CARCINOGENESIS, V23, P485, DOI 10.1093/carcin/23.3.485; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Le Marchand L, 2000, CANCER EPIDEM BIOMAR, V9, P181; London SJ, 1997, CANCER RES, V57, P5001; MARQUEZ LA, 1994, J BIOL CHEM, V269, P7950; Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200; Nakamura Y, 1998, CANCER RES, V58, P4832; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; PATTON W, 1972, BIOCHEM BIOPH RES CO, V48, P880, DOI 10.1016/0006-291X(72)90690-0; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Schabath MB, 2000, CARCINOGENESIS, V21, P1163, DOI 10.1093/carcin/21.6.1163; SHACTER E, 1988, CARCINOGENESIS, V9, P2297, DOI 10.1093/carcin/9.12.2297; Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y; Shen ZZ, 2001, BIOCHEMISTRY-US, V40, P2041, DOI 10.1021/bi001961t; SUEOKA NOBORU, 1962, JOUR MOLECULAR BIOL, V4, P161; TEST ST, 1984, J CLIN INVEST, V74, P1341, DOI 10.1172/JCI111544; Thomas E L, 1986, Methods Enzymol, V132, P569; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WEITZMAN SA, 1990, BLOOD, V76, P655; Whiteman M, 1997, CHEM RES TOXICOL, V10, P1240, DOI 10.1021/tx970086i; Whiteman M, 1999, BIOCHEM BIOPH RES CO, V257, P572, DOI 10.1006/bbrc.1999.0448; Whiteman M, 1999, BIOMARKERS, V4, P303, DOI 10.1080/135475099230831; WINTERBOURN CC, 1992, ARCH BIOCHEM BIOPHYS, V296, P547, DOI 10.1016/0003-9861(92)90609-Z; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702	53	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51241	51249		10.1074/jbc.M408210200	http://dx.doi.org/10.1074/jbc.M408210200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15364942	hybrid			2022-12-27	WOS:000225355800072
J	Kempna, P; Reiter, E; Arock, M; Azzi, A; Zingg, JM				Kempna, P; Reiter, E; Arock, M; Azzi, A; Zingg, JM			Inhibition of HMC-1 mast cell proliferation by vitamin E - Involvement of the protein kinase B pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; MAMMARY EPITHELIAL-CELLS; ALPHA-TOCOPHEROL; C-KIT; PHOSPHATIDYLINOSITOL 3-KINASE; SCAVENGER RECEPTOR; SIGNALING PATHWAY; GAMMA-TOCOPHEROL; GENE-EXPRESSION; DOWN-REGULATION	The effects of four natural tocopherols on the proliferation and signaling pathways were examined in the human mastocytoma cell line (HMC-1). The four tocopherols inhibited HMC-1 cell proliferation with different potency (delta > alpha = gamma > beta). Growth inhibition correlated with the reduction of PKB ( protein kinase B) phosphorylation by the different tocopherols. The reduction of PKB phosphorylation led to a decrease of its activity, as judged from a parallel reduction of GSKalpha/beta phosphorylation. The translocation of PKB to the membrane, as a response to receptor stimulation by NGFbeta, is also prevented by treatment with tocopherols. In the presence of PKC or PP2A inhibitors, the reduction of PKB phosphorylation by tocopherols was still observed, thus excluding the direct involvement of these enzymes. Other pathways, such as the Ras-stimulated ERK1/2 ( extracellular signal responsive kinase) pathway, were not affected by tocopherol treatment. The tocopherols did not significantly change oxidative stress in HMC-1 cells, suggesting that the observed effects are not the result of a general reduction of oxidative stress. Thus, the tocopherols interfere with PKB phosphorylation and reduce proliferation of HMC-1 cells, possibly by modulating either phosphatidylinositol 3-kinase, a kinase phosphorylating PKB (PDK1/2), or a phosphatase that dephosphorylates it. Inhibition of proliferation and PKB signaling in HMC-1 cells by vitamin E suggests a role in preventing diseases with mast cell involvement, such as allergies, atherosclerosis, and tumorigenesis.	Univ Bern, Inst Biochem & Mol Biol, CH-3012 Bern, Switzerland; Fac Pharm, CNRS, Unit FRE 2444, F-75006 Paris, France	University of Bern; Centre National de la Recherche Scientifique (CNRS)	Zingg, JM (corresponding author), Univ Bern, Inst Biochem & Mol Biol, Buhlstr 28, CH-3012 Bern, Switzerland.	zingg@mci.unibe.ch	Zingg, Jean-Marc/H-6960-2019					Akazawa A, 2002, JPN J PHARMACOL, V89, P417, DOI 10.1254/jjp.89.417; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; ARITA M, 1995, BIOCHEM J, V306, P437, DOI 10.1042/bj3060437; Azzi A, 1998, BIOFACTORS, V7, P3, DOI 10.1002/biof.5520070102; Barella L, 2004, BBA-MOL BASIS DIS, V1689, P66, DOI 10.1016/j.bbadis.2004.02.002; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Boscoboinik D, 1992, EXS, V62, P164; BOSCOBOINIK D, 1991, J BIOL CHEM, V266, P6188; Cachia O, 1998, J BIOL CHEM, V273, P32801, DOI 10.1074/jbc.273.49.32801; Chandra V, 2002, J MOL BIOL, V320, P215, DOI 10.1016/S0022-2836(02)00473-4; Chun KH, 2003, JNCI-J NATL CANCER I, V95, P291, DOI 10.1093/jnci/95.4.291; Clement S, 1997, EUR J BIOCHEM, V246, P745, DOI 10.1111/j.1432-1033.1997.t01-2-00745.x; Cook D, 1996, EMBO J, V15, P4526, DOI 10.1002/j.1460-2075.1996.tb00830.x; DOUGLAS CE, 1986, BIOCHIM BIOPHYS ACTA, V876, P639, DOI 10.1016/0005-2760(86)90053-6; Egger T, 2001, J NEUROCHEM, V79, P1169, DOI 10.1046/j.1471-4159.2001.00641.x; Fabbro D, 2000, ANTI-CANCER DRUG DES, V15, P17; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Galli S J, 1994, Curr Opin Hematol, V1, P33; GOODE N, 1992, J BIOL CHEM, V267, P16878; Gueck T, 2002, VET DERMATOL, V13, P301, DOI 10.1046/j.1365-3164.2002.00307.x; Gysin R, 2002, FASEB J, V16, P1952, DOI 10.1096/fj.02-0362fje; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; JacobsHelber SM, 1997, J BIOL CHEM, V272, P6850, DOI 10.1074/jbc.272.11.6850; Jiang Q, 2000, P NATL ACAD SCI USA, V97, P11494, DOI 10.1073/pnas.200357097; KAARTINEN M, 1994, CIRCULATION, V90, P1669, DOI 10.1161/01.CIR.90.4.1669; KANAKURA Y, 1994, LEUKEMIA, V8, pS18; Karlsson R, 2003, J LEUKOCYTE BIOL, V74, P923, DOI 10.1189/jlb.0403142; Kempna P, 2003, FREE RADICAL BIO MED, V34, P1458, DOI 10.1016/S0891-5849(03)00173-4; Kovanen PT, 1996, CURR OPIN LIPIDOL, V7, P281, DOI 10.1097/00041433-199610000-00004; Landes N, 2003, BIOCHEM PHARMACOL, V65, P269, DOI 10.1016/S0006-2952(02)01520-4; Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847; Ludowyke RI, 2000, J BIOL CHEM, V275, P6144, DOI 10.1074/jbc.275.9.6144; McIntyre BS, 2000, P SOC EXP BIOL MED, V224, P292, DOI 10.1046/j.1525-1373.2000.22434.x; McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Neuzil J, 2002, BIOCHEM J, V362, P709, DOI 10.1042/0264-6021:3620709; Nilsson G, 1997, EUR J IMMUNOL, V27, P2295, DOI 10.1002/eji.1830270925; Pal S, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-3; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Qin SF, 2003, BIOCHEMISTRY-US, V42, P2995, DOI 10.1021/bi0205911; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Rossi G, 2003, MODERN PATHOL, V16, P1041, DOI 10.1097/01.MP.0000089780.30006.DE; Sattler M, 2004, LEUKEMIA RES, V28, pS11, DOI 10.1016/j.leukres.2003.10.004; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Shi DY, 2003, FEBS LETT, V542, P60, DOI 10.1016/S0014-5793(03)00338-7; Shivakrupa R, 2003, CANCER RES, V63, P4412; Spencer JPE, 2003, J BIOL CHEM, V278, P34783, DOI 10.1074/jbc.M305063200; Sylvester PW, 2002, ASIA PAC J CLIN NUTR, V11, pS452, DOI 10.1046/j.1440-6047.11.s.7.9.x; Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Venugopal SK, 2004, ATHEROSCLEROSIS, V175, P213, DOI 10.1016/j.atherosclerosis.2004.03.012; Wen HC, 2003, CELL SIGNAL, V15, P37, DOI 10.1016/S0898-6568(02)00047-5; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zhang Y, 2002, P NATL ACAD SCI USA, V99, P7408, DOI 10.1073/pnas.102014399; Zingg JM, 2004, CURR MED CHEM, V11, P1113, DOI 10.2174/0929867043365332	66	79	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50700	50709		10.1074/jbc.M410800200	http://dx.doi.org/10.1074/jbc.M410800200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385541	hybrid			2022-12-27	WOS:000225355800011
J	Kim, YJ; Lee, MH; Wozney, JM; Cho, JY; Ryoo, HM				Kim, YJ; Lee, MH; Wozney, JM; Cho, JY; Ryoo, HM			Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCALCIN GENE-EXPRESSION; GROWTH-FACTOR BETA-1; OSTEOBLAST DIFFERENTIATION; HOMEODOMAIN PROTEINS; MOLECULAR-BASIS; HOMEOBOX GENES; UP-REGULATION; DNA-BINDING; CELL-LINE; RUNX2	Alkaline phosphatase ( ALP) is a widely accepted bone marker. Its expression is stimulated by bone morphogenetic protein (BMP)-2 treatment, the activation of BMP receptors and R-Smads, and the expression of Dlx5 and Runx2. However, how BMP-2 induces ALP expression is not clearly understood. We dissected the murine ALP promoter and found within it a Dlx5-binding cis-acting element by electrophoretic mobility shift assays and site-directed mutagenesis of the element. Dlx5 and the product of its target gene, Runx2, stimulated ALP promoter activity in an additive manner. However, because Dlx5 continued to stimulate ALP expression in Runx2(-/-) cells, the ALP stimulatory activity of Dlx5 is independent of Runx2. We also found that overexpression of Msx2 suppressed the mRNA level and enzyme activity of ALP that were induced by BMP-2 stimulation, and suppressed the Dlx5-stimulated ALP promoter activity by competing with Dlx5 for the cis-acting element in the ALP promoter. Moreover, Msx2 levels are constitutively high in C2C12 myogenic cells but decrease over time after BMP-2 treatment. This may explain why BMP-2 treatment of these cells results in immediate Dlx5 expression yet ALP expression commences only 1 - 2 days later. In other words, Msx2 in high levels counteracts initially the transcriptional activity of Dlx5 in low levels until a threshold Dlx5: Msx2 ratio is reached to the levels that allow the ALP stimulatory activity of Dlx5 to prevail. Thus, Dlx5 transactivates ALP expression, directly by binding to its cognate response element and/or indirectly by stimulating Runx2 expression, and Msx2 counteracts the direct transactivation of Dlx5.	Kyungpook Natl Univ, Sch Dent, Dept Biochem, Taegu 700422, South Korea; Kyungpook Natl Univ, Skeletal Dis Genome Res Ctr, Taegu 700422, South Korea; Wyeth Inc, Cambridge, MA 02140 USA	Kyungpook National University; Kyungpook National University; Pfizer	Ryoo, HM (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Biochem, 101 Dong In Dong, Taegu 700422, South Korea.	hmryoo@knu.ac.kr	Ryoo, Hyun-Mo/D-5839-2012	Ryoo, Hyun-Mo/0000-0001-6769-8341; Lee, Mi-Hye/0000-0002-5484-3383				Barnes GL, 2003, CANCER RES, V63, P2631; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; Bidder M, 1998, J BONE MINER RES, V13, P609, DOI 10.1359/jbmr.1998.13.4.609; BILEZIKIAN JP, 1996, PRINCIPLES BONE BIOL; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; Dodig M, 1996, J BIOL CHEM, V271, P16422, DOI 10.1074/jbc.271.27.16422; Ferrari D, 2002, DEV BIOL, V252, P257, DOI 10.1006/dbio.2002.0862; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; HOFFMANN HM, 1994, P NATL ACAD SCI USA, V91, P12887, DOI 10.1073/pnas.91.26.12887; Hu GZ, 2001, DEVELOPMENT, V128, P2373; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; SAKANO S, 1993, CLIN ORTHOP RELAT R, P337; Semba I, 2000, DEV DYNAM, V217, P401, DOI 10.1002/(SICI)1097-0177(200004)217:4<401::AID-DVDY7>3.0.CO;2-D; SEMENZA GL, 1995, BIOCHEM BIOPH RES CO, V209, P257, DOI 10.1006/bbrc.1995.1497; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Takahashi K, 2001, DEV DYNAM, V222, P252, DOI 10.1002/dvdy.1185; TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	38	159	169	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50773	50780		10.1074/jbc.M404145200	http://dx.doi.org/10.1074/jbc.M404145200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383550	hybrid			2022-12-27	WOS:000225355800019
J	Revollo, JR; Grimm, AA; Imai, S				Revollo, JR; Grimm, AA; Imai, S			The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-ENHANCING FACTOR; DEPENDENT HISTONE DEACETYLASE; LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; PROTEIN DEACETYLASES; NMN ADENYLYLTRANSFERASE; TRANSCRIPTION FACTORS; ADENINE-DINUCLEOTIDE; HAEMOPHILUS-DUCREYI	Recent studies have revealed new roles for NAD and its derivatives in transcriptional regulation. The evolutionarily conserved Sir2 protein family requires NAD for its deacetylase activity and regulates a variety of biological processes, such as stress response, differentiation, metabolism, and aging. Despite its absolute requirement for NAD, the regulation of Sir2 function by NAD biosynthesis pathways is poorly understood in mammals. In this study, we determined the kinetics of the NAD biosynthesis mediated by nicotinamide phosphoribosyltransferase (Nampt) and nicotinamide/nicotinic acid mononucleotide adenylyltransferase (Nmnat), and we examined its effects on the transcriptional regulatory function of the mouse Sir2 ortholog, Sir2alpha, in mouse fibroblasts. We found that Nampt was the rate-limiting component in this mammalian NAD biosynthesis pathway. Increased dosage of Nampt, but not Nmnat, increased the total cellular NAD level and enhanced the transcriptional regulatory activity of the catalytic domain of Sir2alpha recruited onto a reporter gene in mouse fibroblasts. Gene expression profiling with oligonucleotide microarrays also demonstrated a significant correlation between the expression profiles of Nampt- and Sir2alpha-overexpressing cells. These findings suggest that NAD biosynthesis mediated by Nampt regulates the function of Sir2alpha and thereby plays an important role in controlling various biological events in mammals.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Imai, S (corresponding author), Campus Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	imaishin@molecool.wustl.edu		Revollo, Javier/0000-0003-0518-2096				Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BERNOFSKY C, 1980, MOL CELL BIOCHEM, V33, P135; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Emanuelli M, 1996, J CHROMATOGR B, V676, P13, DOI 10.1016/0378-4347(95)00408-4; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GREENGARD P, 1964, J BIOL CHEM, V239, P1887; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; JACOBSON EL, 1995, BIOCHIMIE, V77, P394, DOI 10.1016/0300-9084(96)88152-1; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KAPLAN NO, 1956, J BIOL CHEM, V219, P287; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Marcotte PA, 2004, ANAL BIOCHEM, V332, P90, DOI 10.1016/j.ab.2004.05.039; Martin PR, 2001, J BACTERIOL, V183, P1168, DOI 10.1128/JB.183.4.1168-1174.2001; Micheli V, 1997, METHOD ENZYMOL, V280, P211; Miller ES, 2003, J BACTERIOL, V185, P5220, DOI 10.1128/JB.185.17.5220-5233.2003; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Munson RS, 2004, INFECT IMMUN, V72, P1143, DOI 10.1128/IAI.72.2.1143-1146.2004; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; NEUBERT D, 1964, BIOCHIM BIOPHYS ACTA, V92, P610, DOI 10.1016/0926-6569(64)90023-9; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sandmeier JJ, 2002, GENETICS, V160, P877; Scearce LM, 2002, DIABETES, V51, P1997, DOI 10.2337/diabetes.51.7.1997; Schmidt MT, 2004, J BIOL CHEM, V279, P40122, DOI 10.1074/jbc.M407484200; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	60	716	760	1	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50754	50763		10.1074/jbc.M408388200	http://dx.doi.org/10.1074/jbc.M408388200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15381699	hybrid			2022-12-27	WOS:000225355800017
J	Belikov, S; Holmqvist, PH; Astrand, C; Wrange, O				Belikov, S; Holmqvist, PH; Astrand, C; Wrange, O			Nuclear factor 1 and octamer transcription factor 1 binding preset the chromatin structure of the mouse mammary tumor virus promoter for hormone induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME POSITIONING SEQUENCES; GLUCOCORTICOID RESPONSE ELEMENT; MMTV PROMOTER; IN-VIVO; RECEPTOR-BINDING; GENE-EXPRESSION; FACTOR ACCESS; POU PROTEINS; DNA; ACCESSIBILITY	When the mouse mammary tumor virus ( MMTV) is integrated into the genome of a mammalian cell, its long terminal repeat (LTR) harbors six specifically positioned nucleosomes. Transcription from the MMTV promoter is regulated by the glucocorticoid hormone via the glucocorticoid receptor (GR). The mechanism of the apparently constitutive nucleosome arrangement has remained unclear. Previous in vitro reconstitution of nucleosome(s) on small segments of the MMTV LTR suggested that the DNA sequence was decisive for the nucleosome arrangement. However, microinjection of MMTV LTR DNA in Xenopus oocytes rendered randomly distributed nucleosomes. This indicated that oocytes lack factor( s) that induces nucleosome positioning at the MMTV LTR in other cells. Here we demonstrate that specific and concomitant binding of nuclear factor 1 (NF1) and octamer factor 1 (Oct1) to their cognate sites within the MMTV promoter induce a partial nucleosome positioning that is an intermediary state between the randomly organized inactive promoter and the hormone and GR-activated promoter containing distinctly positioned nucleosomes. Oct1 and NF1 reciprocally facilitate each other's binding to the MMTV LTR in vivo. The NF1 and Oct1 binding also facilitate hormone-dependent GR-DNA interaction and result in a faster and stronger hormone response. Since NF1 and Oct1 generate an intermediary state of nucleosome positioning and enhance the hormone-induced response, we refer to this as a preset chromatin structure. We propose that this state of NF1 and Oct1-induced chromatin presetting mimics the early step(s) of chromatin remodeling involved in tissue-specific gene expression.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Wrange, O (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, POB 285, SE-17177 Stockholm, Sweden.	orjan.wrange@cmb.ki.se	Holmqvist, Per-Henrik/A-2804-2016	Holmqvist, Per-Henrik/0000-0001-8074-2749				ALMOUZNI G, 1993, GENE DEV, V7, P2033, DOI 10.1101/gad.7.10.2033; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Beato M, 1996, J MOL MED, V74, P711, DOI 10.1007/s001090050076; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Belikov S, 2004, MOL CELL BIOL, V24, P3036, DOI 10.1128/MCB.24.7.3036-3047.2004; Belikov S, 2001, EMBO J, V20, P2802, DOI 10.1093/emboj/20.11.2802; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; BRUGGEMEIER U, 1991, CELL, V64, P565, DOI 10.1016/0092-8674(91)90240-Y; BUETTI E, 1994, MOL CELL BIOL, V14, P1191, DOI 10.1128/MCB.14.2.1191; BUETTI E, 1986, J MOL BIOL, V190, P379, DOI 10.1016/0022-2836(86)90009-4; CARTWRIGHT IL, 1983, P NATL ACAD SCI-BIOL, V80, P3213, DOI 10.1073/pnas.80.11.3213; CATO ACB, 1988, EMBO J, V7, P1403, DOI 10.1002/j.1460-2075.1988.tb02957.x; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Fu XH, 2002, EXP CELL RES, V278, P1, DOI 10.1006/excr.2002.5555; Gelius B, 2001, EXP CELL RES, V265, P319, DOI 10.1006/excr.2001.5184; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; GUNZBURG WH, 1992, BIOCHEM J, V283, P625; Hager GL, 2001, PROG NUCLEIC ACID RE, V66, P279; HENRARD D, 1988, J VIROL, V62, P3046, DOI 10.1128/JVI.62.8.3046-3049.1988; HINKLEY CS, 1992, MOL CELL BIOL, V12, P638, DOI 10.1128/MCB.12.2.638; Huber MC, 1996, NUCLEIC ACIDS RES, V24, P1443, DOI 10.1093/nar/24.8.1443; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Lefevre P, 2003, MOL CELL BIOL, V23, P4386, DOI 10.1128/MCB.23.12.4386-4400.2003; LI Q, 1995, MOL CELL BIOL, V15, P4375; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; LU Q, 1995, EMBO J, V14, P4738, DOI 10.1002/j.1460-2075.1995.tb00155.x; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MINK S, 1992, MOL CELL BIOL, V12, P4906, DOI 10.1128/MCB.12.11.4906; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; Prado F, 2002, J BIOL CHEM, V277, P4911, DOI 10.1074/jbc.M110094200; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; SHRADER TE, 1989, P NATL ACAD SCI USA, V86, P7418, DOI 10.1073/pnas.86.19.7418; SIMPSON RT, 1991, PROG NUCLEIC ACID RE, V40, P143; Spangenberg C, 1998, J MOL BIOL, V278, P725, DOI 10.1006/jmbi.1998.1718; TANAKA S, 1992, EMBO J, V11, P1187, DOI 10.1002/j.1460-2075.1992.tb05159.x; TOOHEY MG, 1990, J VIROL, V64, P4477, DOI 10.1128/JVI.64.9.4477-4488.1990; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; Ura K, 1996, EMBO J, V15, P4959, DOI 10.1002/j.1460-2075.1996.tb00876.x; Venditti P, 1998, NUCLEIC ACIDS RES, V26, P3657, DOI 10.1093/nar/26.16.3657; WALLRATH LL, 1994, BIOESSAYS, V16, P165, DOI 10.1002/bies.950160306; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; WHITFIELD T, 1993, DEV BIOL, V155, P361, DOI 10.1006/dbio.1993.1035; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3; ZernickaGoetz M, 1996, DEVELOPMENT, V122, P3719; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	58	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49857	49867		10.1074/jbc.M409713200	http://dx.doi.org/10.1074/jbc.M409713200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381691	hybrid			2022-12-27	WOS:000225229500039
J	Vieira, KF; Levings, PP; Hill, MA; Crusselle, VJ; Kang, SHL; Engel, JD; Bungert, JR				Vieira, KF; Levings, PP; Hill, MA; Crusselle, VJ; Kang, SHL; Engel, JD; Bungert, JR			Recruitment of transcription complexes to the beta-globin gene locus in vivo and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; CONTROL REGION; HYPERSENSITIVE SITES; TARGETED DELETION; TRANSGENIC MICE; CHROMATIN; ACTIVATION; PROMOTER; ELEMENTS	Erythroid-specific, high level expression of the beta-globin genes is regulated by the locus control region (LCR), composed of multiple DNase I-hypersensitive sites and located far upstream of the genes. Recent studies have shown that LCR core elements recruit RNA polymerase II (pol II). In the present study we demonstrate the following: 1) pol II and other basal transcription factors are recruited to LCR core hypersensitive elements; 2) pol II dissociates from and re-associates with the globin gene locus during replication; 3) pol II interacts with the LCR but not with the beta-globin gene prior to erythroid differentiation in embryonic stem cells; and 4) the erythroid transcription factor NF-E2 facilitates the transfer of pol II from immobilized LCR constructs to a beta-globin gene in vitro. The data are consistent with the hypothesis that the LCR serves as the primary attachment site for the recruitment of macromolecular complexes involved in chromatin structure alterations and transcription of the globin genes.	Univ Florida, Coll Med, Dept Biochem & Mol Biol, Ctr Gene Therapy, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Biochem & Mol Biol, Ctr Mammalian Genet, Gainesville, FL 32610 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Michigan System; University of Michigan	Bungert, JR (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Ctr Gene Therapy, POB 100245,1600 SW Archer Rd, Gainesville, FL 32610 USA.	jbungert@college.med.ufl.edu			NIDDK NIH HHS [R01 DK052356, R01 DK052356-15A1, DK0522356, R01 DK058209, R01 DK052356-10, DK058209] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058209, R01DK052356] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; DUBREZ L, 1995, LEUKEMIA, V9, P1013; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; FIERING S, 1995, GENE DEV, V9, P2203, DOI 10.1101/gad.9.18.2203; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; GREENBERG ME, 1997, CURRENT PROTOCOLS MO; Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hug BA, 1996, MOL CELL BIOL, V16, P2906; Johnson KD, 2003, MOL CELL BIOL, V23, P6484, DOI 10.1128/MCB.23.18.6484-6493.2003; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kang SHL, 2003, MOL CELL BIOL, V23, P4150, DOI 10.1128/MCB.23.12.4150-4161.2003; Kim A, 2004, P NATL ACAD SCI USA, V101, P7028, DOI 10.1073/pnas.0307985101; Kitajima K, 2003, METHOD ENZYMOL, V365, P72; Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Long QM, 1998, GENOMICS, V54, P542, DOI 10.1006/geno.1998.5608; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; McDowell JC, 1999, MOL CELL BIOL, V19, P7600; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Molete JM, 2001, MOL CELL BIOL, V21, P2969, DOI 10.1128/MCB.21.9.2969-2980.2001; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; MULLER HP, 1990, TRENDS GENET, V6, P300, DOI 10.1016/0168-9525(90)90236-Y; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; Onishi Y, 2003, J BIOL CHEM, V278, P8163, DOI 10.1074/jbc.M209612200; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Scherer CA, 1996, CELL GROWTH DIFFER, V7, P1393; Schreiber R, 2001, BRAZ J MED BIOL RES, V34, P489, DOI 10.1590/S0100-879X2001000400008; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Spicuglia S, 2002, MOL CELL, V10, P1479, DOI 10.1016/S1097-2765(02)00791-8; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Yoshida C, 1999, GENES CELLS, V4, P643, DOI 10.1046/j.1365-2443.1999.00291.x	45	57	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50350	50357		10.1074/jbc.M408883200	http://dx.doi.org/10.1074/jbc.M408883200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385559	hybrid, Green Accepted			2022-12-27	WOS:000225229500099
J	Fritz, DT; Liu, DL; Xu, JW; Jiang, S; Rogers, MB				Fritz, DT; Liu, DL; Xu, JW; Jiang, S; Rogers, MB			Conservation of Bmp2 post-transcriptional regulatory mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; EMBRYONAL CARCINOMA-CELLS; 3' UNTRANSLATED REGION; ACID RECEPTOR-ALPHA; MESSENGER-RNA DECAY; RETINOIC ACID; PROCESSING EFFICIENCY; DECAPENTAPLEGIC GENE; SITE SELECTION; MOUSE	Bone morphogenetic protein (BMP) orthologs from diverse species like flies and humans are functionally interchangeable and play key roles in fundamental processes such as dorso-ventral axis formation in metazoans. Because both transcriptional and post-transcriptional mechanisms play central roles in modulating developmental protein levels, we have analyzed the 3'-untranslated region (3'UTR) of the Bmp 2 gene. This 3' UTR is unusually long and is alternatively polyadenylated. Mouse, human, and dog mRNAs are 83 - 87% identical within this region. A 265-nucleotide sequence, conserved between mammals, birds, frogs, and fish, is present in Bmp2 but not Bmp4. The ability of AmphiBMP2/4, a chordate ortholog to Bmp2 and Bmp4, to align with this sequence suggests that its function may have been lost in Bmp4. Activation of reporter genes by the conserved region acts by a post-transcriptional mechanism. Mouse, human, chick, and zebrafish Bmp2 synthetic RNAs decay rapidly in extracts from cells not expressing Bmp2. In contrast, these RNAs are relatively stable in extracts from Bmp2-expressing cells. Thus, Bmp2 RNA half-lives in vitro correlate with natural Bmp2 mRNA levels. The fact that non-murine RNAs interact appropriately with the mouse decay machinery suggests that the function of these cis-regulatory regions has been conserved for 450 million years since the fish and tetrapod lineages diverged. Overall, our results suggest that the Bmp2 3' UTR contains essential regulatory elements that act post-transcriptionally.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rogers, MB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, MSB E627,185 S Orange Ave,POB 1709, Newark, NJ 07101 USA.	rogersmb@umdnj.edu	Jiang, Shan/F-9770-2010		NICHD NIH HHS [HD31117] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD031117, R01HD031117] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abrams KL, 2004, J BIOL CHEM, V279, P15916, DOI 10.1074/jbc.M313531200; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; BAGGA PS, 1995, NUCLEIC ACIDS RES, V23, P1625, DOI 10.1093/nar/23.9.1625; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Baur ST, 2000, DEVELOPMENT, V127, P605; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Canestro C, 2003, EVOL DEV, V5, P157, DOI 10.1046/j.1525-142X.2003.03022.x; Chang H, 1999, DEVELOPMENT, V126, P1631; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; Chen F, 1998, NUCLEIC ACIDS RES, V26, P2891, DOI 10.1093/nar/26.12.2891; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Davidson E. H., 1986, GENE ACTIVITY EARLY; DENOME RM, 1988, MOL CELL BIOL, V8, P4829, DOI 10.1128/MCB.8.11.4829; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; EDWALDSGILBERT G, 1993, MOL CELL BIOL, V13, P3472, DOI 10.1128/MCB.13.6.3472; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Fritz DT, 2004, CELL BIOCHEM BIOPHYS, V41, P265, DOI 10.1385/CBB:41:2:265; Fritz DT, 2000, SCI STKE, V2000, P11; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; GIL A, 1984, NATURE, V312, P473, DOI 10.1038/312473a0; GIL A, 1987, CELL, V49, P399, DOI 10.1016/0092-8674(87)90292-3; Glozak MA, 1996, DEV BIOL, V179, P458, DOI 10.1006/dbio.1996.0275; Graff JM, 1997, CELL, V89, P171, DOI 10.1016/S0092-8674(00)80196-8; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Heller LC, 1999, J BIOL CHEM, V274, P1394, DOI 10.1074/jbc.274.3.1394; Helvering LM, 2000, GENE, V256, P123, DOI 10.1016/S0378-1119(00)00364-4; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; HOGAN BLM, 1995, NATURE, V376, P210, DOI 10.1038/376210a0; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; JONES CM, 1991, DEVELOPMENT, V111, P531; Kakoki M, 2004, DEV CELL, V6, P597, DOI 10.1016/S1534-5807(04)00094-2; Keene JD, 2003, MOL CELL, V12, P1347, DOI 10.1016/S1097-2765(03)00496-9; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lelong C, 2001, BIOCHIMIE, V83, P423, DOI 10.1016/S0300-9084(01)01260-3; LYONS KM, 1990, DEVELOPMENT, V109, P833; LYONS KM, 1989, GENE DEV, V3, P1657, DOI 10.1101/gad.3.11.1657; MacDonald CC, 2002, MOL CELL ENDOCRINOL, V190, P1, DOI 10.1016/S0303-7207(02)00044-8; MANLEY JL, 1995, CURR OPIN GENET DEV, V5, P222, DOI 10.1016/0959-437X(95)80012-3; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Mukherjee Devi, 2004, Methods Mol Biol, V257, P193, DOI 10.1385/1-59259-750-5:193; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; Newfeld SJ, 1997, GENETICS, V145, P297; Nohara M, 2004, ZOOL SCI, V21, P203, DOI 10.2108/zsj.21.203; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; Panopoulou GD, 1998, DEV DYNAM, V213, P130, DOI 10.1002/(SICI)1097-0177(199809)213:1<130::AID-AJA13>3.0.CO;2-6; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rajagopalan LE, 1997, PROG NUCLEIC ACID RE, V56, P257, DOI 10.1016/S0079-6603(08)61007-7; Reddi AH, 2001, J BONE JOINT SURG AM, V83A, pS1, DOI 10.2106/00004623-200100001-00001; Richter B, 1997, GENETICS, V145, P311; ROGERS MB, 1992, MOL BIOL CELL, V3, P189, DOI 10.1091/mbc.3.2.189; Rogers MB, 1996, CELL GROWTH DIFFER, V7, P115; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; SAMPATH TK, 1993, P NATL ACAD SCI USA, V90, P6004, DOI 10.1073/pnas.90.13.6004; SanchezSalazar J, 1996, DEV GENES EVOL, V206, P237, DOI 10.1007/s004270050049; Shabalina SA, 2004, NUCLEIC ACIDS RES, V32, P1774, DOI 10.1093/nar/gkh313; Shabalina SA, 2003, NUCLEIC ACIDS RES, V31, P5433, DOI 10.1093/nar/gkg751; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Spicher A, 1998, MOL CELL BIOL, V18, P7371, DOI 10.1128/MCB.18.12.7371; STJOHNSTON RD, 1990, GENE DEV, V4, P1114, DOI 10.1101/gad.4.7.1114; STRIJKER R, 1989, EMBO J, V8, P2669, DOI 10.1002/j.1460-2075.1989.tb08407.x; Sugiura T, 1999, BIOCHEM J, V338, P433, DOI 10.1042/0264-6021:3380433; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yang X, 1999, DEVELOPMENT, V126, P1571; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yi SE, 2000, DEVELOPMENT, V127, P621; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhou SH, 2003, MOL ENDOCRINOL, V17, P56, DOI 10.1210/me.2002-0210; Zile MH, 1998, J NUTR, V128, p455S, DOI 10.1093/jn/128.2.455S; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	95	20	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48950	48958		10.1074/jbc.M409620200	http://dx.doi.org/10.1074/jbc.M409620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358784	hybrid			2022-12-27	WOS:000225098100057
J	Linder, T; Gustafsson, CM				Linder, T; Gustafsson, CM			The Soh1/MED31 protein is an ancient component of Schizosaccharomyces pombe and Saccharomyces cerevisiae mediator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; SEQUENCE ALIGNMENT; COFACTOR COMPLEX; TERMINAL DOMAIN; REPEAT DOMAIN; SUBUNITS; YEAST; PURIFICATION; MUTATIONS	We here demonstrated that the Soh1/MED31 protein is a stable component of Mediator complex isolated from Schizosaccharomyces pombe and Saccharomyces cerevisiae. Bioinformatic analysis traces the Soh1/MED31 family of Mediator subunits to the point of major eukaryotic divergence, before the appearance of the canonical heptapeptide repeat structure of the RNA polymerase II C-terminal domain.	Karolinska Inst, Novum, Karolinska Univ Hosp, Dept Med Nutr, SE-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Gustafsson, CM (corresponding author), Karolinska Inst, Novum, Karolinska Univ Hosp, Dept Med Nutr, SE-14186 Stockholm, Sweden.	claes.gustafsson@mednut.ki.se	Linder, Tomas/AAN-3433-2020; Linder, Tomas/B-2492-2009	Linder, Tomas/0000-0001-5365-0494; Linder, Tomas/0000-0001-5365-0494; Gustafsson, Claes/0000-0003-3531-8468				BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Borggrefe T, 2001, J BIOL CHEM, V276, P47150, DOI 10.1074/jbc.M109581200; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fan HY, 1996, GENETICS, V142, P749; FAN HY, 1994, GENETICS, V137, P945; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grallert A, 1999, YEAST, V15, P669, DOI 10.1002/(SICI)1097-0061(19990615)15:8<669::AID-YEA411>3.0.CO;2-K; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gustafsson CM, 1998, J BIOL CHEM, V273, P30851, DOI 10.1074/jbc.273.47.30851; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malagon F, 2004, GENETICS, V166, P1215, DOI 10.1534/genetics.166.3.1215; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; NONET ML, 1989, GENETICS, V123, P715; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ryu SJ, 1999, P NATL ACAD SCI USA, V96, P7137, DOI 10.1073/pnas.96.13.7137; Samuelsen CO, 2003, P NATL ACAD SCI USA, V100, P6422, DOI 10.1073/pnas.1030497100; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Spahr H, 2001, P NATL ACAD SCI USA, V98, P11985, DOI 10.1073/pnas.211253898; Stiller JW, 2002, P NATL ACAD SCI USA, V99, P6091, DOI 10.1073/pnas.082646199; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; Szilagyi Z, 2002, MOL GENET GENOMICS, V268, P553, DOI 10.1007/s00438-002-0773-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	35	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49455	49459		10.1074/jbc.M409046200	http://dx.doi.org/10.1074/jbc.M409046200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15356001	hybrid			2022-12-27	WOS:000225098100115
J	Hernandez, JM; Heine, GF; Irani, NG; Feller, A; Kim, MG; Matulnik, T; Chandler, VL; Grotewold, E				Hernandez, JM; Heine, GF; Irani, NG; Feller, A; Kim, MG; Matulnik, T; Chandler, VL; Grotewold, E			Different mechanisms participate in the R-dependent activity of the R2R3 MYB transcription factor C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; REGULATORY GENE; MYB DOMAIN; MAIZE C1; PROTEIN; ANTHOCYANIN; ARABIDOPSIS; PROMOTER; ACTIVATION; FAMILY	The R2R3 MYB transcription factor C1 requires the basic helix-loop-helix factor R as an essential co-activator for the transcription of maize anthocyanin genes. In contrast, the R2R3 MYB protein P1 activates a subset of the C1-regulated genes independently of R. Substitution of six amino acids in P1 with the C1 amino acids results in P1*, whose activity on C1-regulated and P1-regulated genes is R-dependent or R-enhanced, respectively. We have used P1* in combination with various promoters to uncover two mechanisms for R function. On synthetic promoters that contain only C1/P1 binding sites, R is an essential co-activator of C1. This function of R is unlikely to simply be the result of an increase in the C1 DNA-binding affinity, since transcriptional activity of a C1 mutant that binds DNA at a higher affinity, comparable with P1, remains R-dependent. The differential transcriptional activity of C1 fusions with the yeast Gal4 DNA-binding domain in yeast and maize cells suggests that part of the function of R is to relieve C1 from a plant-specific inhibitor. A second function of R requires cis-regulatory elements in addition to the C1/P1 DNA-binding sites for R-enhanced transcription of a1. We hypothesize that R functions in this mode by binding or recruiting additional factors to the anthocyanin regulatory element conserved in the promoters of several anthocyanin genes. Together, these findings suggest a model in which combinatorial interactions with co-activators enable R2R3 MYB factors with very similar DNA binding preferences to discriminate between target genes in vivo.	Ohio State Univ, Dept Plant Cellular & Mol Biol, Columbus, OH 43210 USA; Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Plant Biotechnol, Columbus, OH 43210 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Arizona	Grotewold, E (corresponding author), Ohio State Univ, Dept Plant Cellular & Mol Biol, 206 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	grotewold.1@osu.edu	Feller, Antje C/B-8188-2011	Irani, Niloufer/0000-0003-3252-4493; Grotewold, Erich/0000-0002-4720-7290				Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; BODEAU JP, 1992, MOL GEN GENET, V233, P379, DOI 10.1007/BF00265434; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; Burr FA, 1996, PLANT CELL, V8, P1249, DOI 10.1105/tpc.8.8.1249; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; DOSEFF AI, 1995, GENETICS, V141, P857; Elomaa P, 2003, PLANT PHYSIOL, V133, P1831, DOI 10.1104/pp.103.026039; FLICK JS, 1990, MOL CELL BIOL, V10, P4757, DOI 10.1128/MCB.10.9.4757; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOFF SA, 1991, GENE DEV, V5, P298, DOI 10.1101/gad.5.2.298; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Irani NG, 2003, RECENT ADV PHYTOCHEM, V37, P59; James P, 1996, GENETICS, V144, P1425; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kroon A., 2004, THESIS VRIJE U AMSTE; Lesnick M.L., 1997, THESIS U OREGON EUGE, P32; Lesnick ML, 1998, PLANT PHYSIOL, V117, P437, DOI 10.1104/pp.117.2.437; LUDWIG SR, 1990, CELL, V62, P849, DOI 10.1016/0092-8674(90)90259-H; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Payne CT, 2000, GENETICS, V156, P1349; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Pooma W, 2002, GENETICS, V161, P793; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rabinowicz PD, 1999, GENETICS, V153, P427; Romero I, 1998, PLANT J, V14, P273, DOI 10.1046/j.1365-313X.1998.00113.x; SABLOWSKI RWM, 1994, EMBO J, V13, P128, DOI 10.1002/j.1460-2075.1994.tb06242.x; Sainz MB, 1997, MOL CELL BIOL, V17, P115, DOI 10.1128/MCB.17.1.115; Sainz MB, 1997, PLANT CELL, V9, P611, DOI 10.1105/tpc.9.4.611; SAINZ MB, 1997, THESIS U OREGON EUGE, P144; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Selinger DA, 1999, PLANT CELL, V11, P5, DOI 10.1105/tpc.11.1.5; SHIEH MW, 1993, PLANT PHYSIOL, V101, P353, DOI 10.1104/pp.101.2.353; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Suzuki A, 1998, PLANT CELL PHYSIOL, V39, P555, DOI 10.1093/oxfordjournals.pcp.a029404; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; TUERCK JA, 1994, PLANT CELL, V6, P1655, DOI 10.1105/tpc.6.11.1655; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Williams CE, 1997, J BIOL CHEM, V272, P563, DOI 10.1074/jbc.272.1.563; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681	49	102	129	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48205	48213		10.1074/jbc.M407845200	http://dx.doi.org/10.1074/jbc.M407845200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347654	hybrid			2022-12-27	WOS:000224957000095
J	Lam, AKM; Ko, BCB; Tam, S; Morris, R; Yang, JY; Chung, SK; Chung, SSM				Lam, AKM; Ko, BCB; Tam, S; Morris, R; Yang, JY; Chung, SK; Chung, SSM			Osmotic response element-binding protein (OREBP) is an essential regulator of the urine concentrating mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UREA TRANSPORTER; VASOPRESSIN ANTAGONIST; TRANSCRIPTION FACTOR; WATER PERMEABILITY; EXPRESSION; GENE; AQUAPORIN-2; KIDNEY; MOUSE; NFAT5	OREBP (osmotic response element-binding protein), also called TonEBP or NFAT5, is thought to induce the expression of genes that increase the accumulation of organic osmolytes to protect cells against a hypertonic environment. To investigate the consequences of lacking OREBP activity, transgenic (Tg) mice that overexpress OREBPdn (dominant negative form of OREBP) specifically in the epithelial cells of the renal collecting tubules were generated. These mice showed impairment in their urine concentrating mechanism, most likely due to reduced expression of the aquaporin AQP2 and the urea transporter UT-A1 and UT-A2 mRNAs. When deprived of water or after the administration of a vasopressin analogue, urine osmolality of the Tg mice was significantly increased but not to the same extent as that of the wild type mice. The expression of AQP2 and UT-A1, but not UT-A2 mRNAs, was increased to the same level as that of the wild type mice in the water deprivation state, indicating that the vasopressin regulatory mechanism was not affected by OREBPdn. These data indicate that in addition to vasopressin, OREBP is another essential regulator of the urine concentrating mechanism. Furthermore, the OREBPdn Tg mice developed progressive hydronephrosis soon after weaning, confirming the osmoprotective function of OREBP implicated by the in vitro experiments.	Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Inst Mol Biol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Div Clin Biochem, Hong Kong, Hong Kong, Peoples R China; NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bethesda, MD 20892 USA	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ko, BCB (corresponding author), Univ Hong Kong, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China.	cbko@hkucc.hku.hk; smchung@hkucc.hku.hk	Ko, Chi-bun/ACH-7514-2022; Lam, Alfred/C-1652-2008	Lam, Alfred/0000-0003-2771-564X; Ko, Ben Chi Bun/0000-0003-2027-5899				Bagnasco SM, 2001, AM J PHYSIOL-RENAL, V281, pF400, DOI 10.1152/ajprenal.2001.281.3.F400; Burdmann EA, 2003, SEMIN NEPHROL, V23, P465, DOI 10.1016/S0270-9295(03)00090-1; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Cha JH, 2001, J AM SOC NEPHROL, V12, P2221, DOI 10.1681/ASN.V12112221; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; DIGIOVANNI SR, 1994, P NATL ACAD SCI USA, V91, P8984, DOI 10.1073/pnas.91.19.8984; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2002, AM J PHYSIOL-RENAL, V282, pF630, DOI 10.1152/ajprenal.00264.2001; Ferraris JD, 1996, J BIOL CHEM, V271, P18318, DOI 10.1074/jbc.271.31.18318; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; HOLTHOFER H, 1987, CELL TISSUE RES, V249, P481; Igarashi P, 1999, AM J PHYSIOL-RENAL, V277, pF599, DOI 10.1152/ajprenal.1999.277.4.F599; Kihara M, 1998, KIDNEY INT, V53, P548, DOI 10.1046/j.1523-1755.1998.00801.x; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; LANKFORD SP, 1991, AM J PHYSIOL, V261, pF554, DOI 10.1152/ajprenal.1991.261.3.F554; Leroy C, 2000, BIOCHEM BIOPH RES CO, V271, P368, DOI 10.1006/bbrc.2000.2640; Lim SW, 2004, AM J PHYSIOL-RENAL, V287, pF139, DOI 10.1152/ajprenal.00240.2003; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Marples D, 1998, AM J PHYSIOL-RENAL, V275, pF400, DOI 10.1152/ajprenal.1998.275.3.F400; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nakayama Y, 2001, BBA-GENE STRUCT EXPR, V1518, P19, DOI 10.1016/S0167-4781(00)00311-0; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Nielsen S, 1996, P NATL ACAD SCI USA, V93, P5495, DOI 10.1073/pnas.93.11.5495; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Promeneur D, 1998, J AM SOC NEPHROL, V9, P1359; SANDS JM, 1987, J CLIN INVEST, V79, P138, DOI 10.1172/JCI112774; SCHULTE BA, 1983, AM J ANAT, V168, P345, DOI 10.1002/aja.1001680308; Sheikh-Hamad D, 2001, J AM SOC NEPHROL, V12, P2732, DOI 10.1681/ASN.V12122732; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; TSUBOI Y, 1994, J ENDOCRINOL, V143, P227, DOI 10.1677/joe.0.1430227; YAMAMURA Y, 1992, BRIT J PHARMACOL, V105, P787, DOI 10.1111/j.1476-5381.1992.tb09058.x; Yang BX, 2001, J BIOL CHEM, V276, P624, DOI 10.1074/jbc.M008664200; Yang BX, 2001, J BIOL CHEM, V276, P2775, DOI 10.1074/jbc.M008216200; Zhang Z, 2002, AM J PHYSIOL-RENAL, V283, pF302, DOI 10.1152/ajprenal.00038.2002	38	73	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48048	48054		10.1074/jbc.M407224200	http://dx.doi.org/10.1074/jbc.M407224200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347663	hybrid			2022-12-27	WOS:000224957000076
J	Sathish, JG; Walters, J; Luo, JC; Johnson, KG; LeRoy, FG; Brennan, P; Kim, KP; Gygi, SP; Neel, BG; Matthews, RJ				Sathish, JG; Walters, J; Luo, JC; Johnson, KG; LeRoy, FG; Brennan, P; Kim, KP; Gygi, SP; Neel, BG; Matthews, RJ			CD22 is a functional ligand for SH2 domain-containing protein-tyrosine phosphatase-1 in primary T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SIGNAL-TRANSDUCTION; IG-LIKE RECEPTOR-1; ANTIGEN RECEPTOR; PROLIFERATIVE RESPONSE; CD22-DEFICIENT MICE; NEGATIVE REGULATION; B-CELLS; SHP-1; ACTIVATION; SELECTION	The intracellular Src homology 2 (SH2) domain-containing protein-tyrosine phosphatase (SHP-1) has been characterized as a negative regulator of T cell function, contributing to the definition of T cell receptor signaling thresholds in developing and peripheral mouse T lymphocytes. The activation of SHP-1 is achieved through the engagement of its tandem SH2 domains by tyrosine-phosphorylated proteins; however, the identity of the activating ligand(s) for SHP-1, within mouse primary T cells, is presently unresolved. The identification of SHP-1 ligand( s) in primary T cells would provide crucial insight into the molecular mechanisms by which SHP-1 contributes to in vivo thresholds for T cell activation. Here we present a combination of biochemical and yeast genetic analyses indicating CD22 to be a T cell ligand for the SHP-1 SH2 domains. Based on these observations we have confirmed that CD22 is indeed expressed on mouse primary T cells and capable of associating with SHP-1. Significantly, CD22-deficient T cells demonstrate enhanced proliferation in response to anti-CD3 or allogeneic stimulation. Furthermore, the co-engagement of CD3 and CD22 results in a raising of TCR signaling thresholds hence demonstrating a previously unsuspected functional role for CD22 in primary T cells.	Cardiff Univ, Sect Infect & Immun, Cardiff CF14 4XX, S Glam, Wales; Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Canc Biol Program, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Cardiff University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Matthews, RJ (corresponding author), Cardiff Univ, Sect Infect & Immun, Henry Wellcome Bldg Biomed Res Wales, Cardiff CF14 4XX, S Glam, Wales.	matthewsrj@cardiff.ac.uk	Brennan, Paul/ABB-9196-2021; Jin Cai, Luo/A-7900-2011; Brennan, Paul/B-9210-2009	Brennan, Paul/0000-0001-8792-0499; Brennan, Paul/0000-0001-8792-0499; Kim, Kwang Pyo/0000-0003-0095-3787; Sathish, Jean/0000-0002-5605-6957	NIDDK NIH HHS [R01 DK66600] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066600] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blery M, 1999, CLIN CHEM LAB MED, V37, P187, DOI 10.1515/CCLM.1999.035; Carter JD, 1999, INT IMMUNOL, V11, P1999, DOI 10.1093/intimm/11.12.1999; CASTELLS MC, 1994, J BIOL CHEM, V269, P8393; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Guler ML, 1999, MICROBES INFECT, V1, P79, DOI 10.1016/S1286-4579(99)80018-5; Havelkova H, 1999, IMMUNOGENETICS, V49, P235, DOI 10.1007/s002510050485; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; Johnson KG, 1999, J IMMUNOL, V162, P3802; Krulova M, 1997, GENOMICS, V42, P11, DOI 10.1006/geno.1997.4694; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; LORENZ U, 1994, MOL CELL BIOL, V14, P1824, DOI 10.1128/MCB.14.3.1824; Lorenz U, 1996, P NATL ACAD SCI USA, V93, P9624, DOI 10.1073/pnas.93.18.9624; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; NAKAYAMA E, 1989, P NATL ACAD SCI USA, V86, P1352, DOI 10.1073/pnas.86.4.1352; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Plas DR, 1999, J IMMUNOL, V162, P5680; Plas DR, 1996, SCIENCE, V272, P1173, DOI 10.1126/science.272.5265.1173; Robinson WH, 1997, IMMUNOGENETICS, V45, P195, DOI 10.1007/s002510050189; Sathish JG, 2001, J IMMUNOL, V166, P1763, DOI 10.4049/jimmunol.166.3.1763; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; SCOTT D, 1991, IMMUNOGENETICS, V33, P54, DOI 10.1007/BF00211696; SECRIST JP, 1993, J BIOL CHEM, V268, P5886; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; TORRES RM, 1992, J IMMUNOL, V149, P2641; Williams O, 1996, EUR J IMMUNOL, V26, P532, DOI 10.1002/eji.1830260305; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	36	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47783	47791		10.1074/jbc.M402354200	http://dx.doi.org/10.1074/jbc.M402354200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364920	hybrid			2022-12-27	WOS:000224957000046
J	Freie, BW; Ciccone, SLM; Li, XX; Plett, PA; Orschell, CM; Srour, EF; Hanenberg, H; Schindler, D; Lee, SH; Clapp, DW				Freie, BW; Ciccone, SLM; Li, XX; Plett, PA; Orschell, CM; Srour, EF; Hanenberg, H; Schindler, D; Lee, SH; Clapp, DW			A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G(2) checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CELL-CYCLE; ATAXIA-TELANGIECTASIA; HOMOLOGOUS RECOMBINATION; NUCLEAR-COMPLEX; IONIZING-RADIATION; VERTEBRATE CELLS; KINASE-ACTIVITY; HISTONE H3; G2 ARREST	Fanconi anemia ( FA) is a complex, heterogeneous genetic disorder composed of at least 11 complementation groups. The FA proteins have recently been found to functionally interact with the cell cycle regulatory proteins ATM and BRCA1; however, the function of the FA proteins in cell cycle control remains incompletely understood. Here we show that the Fanconi anemia complementation group C protein (Fancc) is necessary for proper function of the DNA damage-induced G(2)/M checkpoint in vitro and in vivo. Despite apparently normal induction of the G(2)/M checkpoint after ionizing radiation, murine and human cells lacking functional FANCC did not maintain the G(2) checkpoint as compared with wild-type cells. The increased rate of mitotic entry seen in Fancc -/- mouse embryo fibroblasts correlated with decreased inhibitory phosphorylation of cdc2 kinase on tyrosine 15. An increased inability to maintain the DNA damage-induced G(2) checkpoint was observed in Fancc -/-; Trp53 -/- cells compared with Fancc -/- cells, indicating that Fancc and p53 cooperated to maintain the G(2) checkpoint. In contrast, genetic disruption of both Fancc and Atm did not cooperate in the G(2) checkpoint. These data indicate that Fancc and p53 in separate pathways converge to regulate the G(2) checkpoint. Finally, fibroblasts lacking FANCD2 were found to have a G(2) checkpoint phenotype similar to FANCC-deficient cells, indicating that FANCD2, which is activated by the FA complex, was also required to maintain the G(2) checkpoint. Because a proper checkpoint function is critical for the maintenance of genomic stability and is intricately related to the function and integrity of the DNA repair process, these data have implications in understanding both the function of FA proteins and the mechanism of genomic instability in FA.	Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Biochem, Indianapolis, IN 46202 USA; Univ Dusseldorf, Dept Pediat, D-40225 Dusseldorf, Germany; Univ Wurzburg, Biozentrum, Inst Humangenet, D-97074 Wurzburg, Germany	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Heinrich Heine University Dusseldorf; University of Wurzburg	Clapp, DW (corresponding author), Canc Res Inst, 1044 W Walnut St,Rm 408, Indianapolis, IN 46202 USA.	dclapp@iupui.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055716, R01HL063219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049218] Funding Source: NIH RePORTER; NCI NIH HHS [CA92111] Funding Source: Medline; NHLBI NIH HHS [R01 HL063219-04, R01 HL55716] Funding Source: Medline; NIDDK NIH HHS [P50 DK49218] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ando T, 2001, J BIOL CHEM, V276, P42971, DOI 10.1074/jbc.M106460200; Asaad NA, 2000, ONCOGENE, V19, P5788, DOI 10.1038/sj.onc.1203953; AUERBACH AD, 1991, CANCER GENET CYTOGEN, V51, P1, DOI 10.1016/0165-4608(91)90002-C; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Beamish H, 1996, J BIOL CHEM, V271, P20486, DOI 10.1074/jbc.271.34.20486; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Centurion SA, 2000, EXP CELL RES, V260, P216, DOI 10.1006/excr.2000.4995; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001; Christianson TA, 2000, BLOOD, V95, P725, DOI 10.1182/blood.V95.2.725; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Digweed M, 2002, CARCINOGENESIS, V23, P1121, DOI 10.1093/carcin/23.7.1121; Donahue SL, 2003, J BIOL CHEM, V278, P29487, DOI 10.1074/jbc.M213251200; DUCKWORTHRYSIECKI G, 1985, CANCER RES, V45, P416; Flatt PM, 2000, MOL CELL BIOL, V20, P4210, DOI 10.1128/MCB.20.12.4210-4223.2000; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Haneline LS, 1998, BLOOD, V91, P4092; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Heinrich MC, 2000, BLOOD, V95, P3970; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; ISHIDA R, 1982, CANCER RES, V42, P4000; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jin SQ, 2002, ONCOGENE, V21, P8696, DOI 10.1038/sj.onc.1206034; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Kupfer GM, 1997, BLOOD, V90, P1047, DOI 10.1182/blood.V90.3.1047.1047_1047_1054; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; LOCK RB, 1990, CANCER RES, V50, P3761; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; Morrison C, 2000, EMBO J, V19, P463, DOI 10.1093/emboj/19.3.463; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; PAULES RS, 1995, CANCER RES, V55, P1763; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sala-Trepat M, 2000, EXP CELL RES, V260, P208, DOI 10.1006/excr.2000.4994; Smith J, 1998, J MOL BIOL, V281, P815, DOI 10.1006/jmbi.1998.1971; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2002, INT J HEMATOL, V75, P123, DOI 10.1007/BF02982016; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TUCKER JD, 1991, MUTAT RES, V254, P143, DOI 10.1016/0921-8777(91)90005-A; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wang X, 2003, RADIAT RES, V159, P426, DOI 10.1667/0033-7587(2003)159[0426:CIRIIO]2.0.CO;2; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Winters ZE, 1998, ONCOGENE, V17, P673, DOI 10.1038/sj.onc.1201991; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435	69	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50986	50993		10.1074/jbc.M407160200	http://dx.doi.org/10.1074/jbc.M407160200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15377654	hybrid			2022-12-27	WOS:000225355800043
J	Zhang, M; Hu, PR; Napoli, JL				Zhang, M; Hu, PR; Napoli, JL			Elements in the N-terminal signaling sequence that determine cytosolic topology of short-chain dehydrogenases/reductases Studies with retinol dehydrogenase type 1 and cis-retinol/androgen dehydrogenase type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGENIC 17-BETA-HYDROXYSTEROID DEHYDROGENASE; ENDOPLASMIC-RETICULUM MEMBRANE; DELAYED DARK-ADAPTATION; ALL-TRANS-RETINOL; BINDING-PROTEIN; ALCOHOL-DEHYDROGENASE; VITAMIN-A; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; FUNDUS-ALBIPUNCTATUS; PIGMENT EPITHELIUM	High affinity, retinoid-specific binding proteins chaperone retinoids to manage their transport and metabolism. Proposing mechanisms of retinoid transfer between these binding proteins and membrane-associated retinoid-metabolizing enzymes requires insight into enzyme topology. We therefore determined the topology of mouse retinol dehydrogenase type 1 (Rdh1) and cis-retinoid androgen dehydrogenase type 1 (Crad1) in the endoplasmic reticulum of intact mammalian cells. The properties of Rdh1 were compared with a chimera with a luminal signaling sequence (11beta-hydroxysteroid dehydrogenase ( 11beta-HSD1)( 1 - 41)/Rdh1( 23 - 317); the green fluorescent protein (GFP) fusion proteins Rdh1( 1 - 22)/ GFP, Crad1( 1 - 22)/ GFP, and 11beta-HSD1( 1 - 41)/ GFP; and signaling sequence charge difference mutants using confocal immunofluorescence, antibody access, proteinase K sensitivity, and deglycosylation assays. An N-terminal signaling sequence of 22 residues, consisting of a hydrophobic helix ending in a net positive charge, anchors Rdh1 and Crad1 in the endoplasmic reticulum facing the cytoplasm. Mutating arginine to glutamine in the signaling sequence did not affect topology. Inserting one or two arginine residues near the N terminus of the signaling sequence caused 28-95% inversion from cytoplasmic to luminal, depending on the net positive charge remaining at the C terminus of the signaling sequence; e. g. the mutant L3R, L5R, R16Q, R19Q, R21Q faced the lumen. Experiments with N- and C-terminal epitope-tagged Rdh1 and molecular modeling indicated that a hydrophobic helix-turn-helix near the C terminus of Rdh1 ( residues 289 - 311) projects into the cytoplasm. These data provide insight into the features necessary to orient type III ( reverse signal-anchor) proteins and demonstrate that Rdh1, Crad1, and other short-chain dehydrogenases/reductases, which share similar N- terminal signaling sequences such as human Rdh5 and mouse Rdh4, orient with their catalytic domains facing the cytoplasm.	Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 119 Morgan Hall,MC 3104, Berkeley, CA 94720 USA.	jna@nature.berkeley.edu			NIDDK NIH HHS [DK047839, DK36870] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870, R01DK047839] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BOERMAN MHEM, 1995, BIOCHEMISTRY-US, V34, P7027, DOI 10.1021/bi00021a014; Boerman MHEM, 1996, J BIOL CHEM, V271, P5610, DOI 10.1074/jbc.271.10.5610; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; CHAI XY, 1995, J BIOL CHEM, V270, P28408, DOI 10.1074/jbc.270.47.28408; DELUCA LM, 1993, BASIC LIFE SCI, V61, P17; E XP, 2002, J BIOL CHEM, V277, P36617, DOI 10.1074/jbc.M205519200; Eusebio A, 1998, EXP CELL RES, V241, P181, DOI 10.1006/excr.1998.4042; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; Frick C, 2004, J BIOL CHEM, V279, P31131, DOI 10.1074/jbc.M313666200; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P11824, DOI 10.1021/bi035227w; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Jurukovski V, 1999, MOL GENET METAB, V67, P62, DOI 10.1006/mgme.1999.2840; Kedishvili NY, 1998, BIOCHEM BIOPH RES CO, V249, P191, DOI 10.1006/bbrc.1998.9105; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lapshina EA, 2003, BIOCHEMISTRY-US, V42, P776, DOI 10.1021/bi026836r; Liden M, 2003, MOL ASPECTS MED, V24, P403, DOI 10.1016/S0098-2997(03)00036-0; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Molotkov A, 2002, J BIOL CHEM, V277, P13804, DOI 10.1074/jbc.M112039200; Molotkov A, 2002, P NATL ACAD SCI USA, V99, P5337, DOI 10.1073/pnas.082093299; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Odermatt A, 1999, J BIOL CHEM, V274, P28762, DOI 10.1074/jbc.274.40.28762; OZOLS J, 1995, J BIOL CHEM, V270, P2305, DOI 10.1074/jbc.270.5.2305; Palmer M, 1998, BIOCHEMISTRY-US, V37, P2378, DOI 10.1021/bi9720890; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Romert A, 2000, EXP CELL RES, V256, P338, DOI 10.1006/excr.2000.4817; Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Simon A, 1999, J CELL SCI, V112, P549; Song MS, 2003, J BIOL CHEM, V278, P40079, DOI 10.1074/jbc.M304910200; Tryggvason K, 2001, J BIOL CHEM, V276, P19253, DOI 10.1074/jbc.M100215200; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wang J, 2001, BIOCHEMISTRY-US, V40, P12533, DOI 10.1021/bi011396+; WOLF G, 1984, PHYSIOL REV, V64, P873, DOI 10.1152/physrev.1984.64.3.873; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	59	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51482	51489		10.1074/jbc.M409051200	http://dx.doi.org/10.1074/jbc.M409051200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15355969	hybrid			2022-12-27	WOS:000225355800101
J	Shi, HF; Ullu, E; Tschudi, C				Shi, HF; Ullu, E; Tschudi, C			Function of the trypanosome argonaute 1 protein in RNA interference requires the N-terminal RGG domain and arginine 735 in the Piwi domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PAZ DOMAIN; BINDING; BRUCEI; GENE	Argonaute proteins are central components of RNA interference (RNAi) and related phenomena in a wide variety of eukaryotes, including the early diverging protozoan Trypanosoma brucei. The single T. brucei Argonaute protein (TbAGO1) is in a complex with small interfering RNAs (siRNAs), and a fraction of this ribonucleoprotein particle is associated with polyribosomes. In this study, we generated a panel of insertion, deletion, and single point mutants of TbAGO1 and assayed them in vivo for their function in RNAi. In addition to the signature domains of Argonaute proteins, PAZ and Piwi, TbAGO1 has an N-terminal domain with a high abundance of RGG repeats. Deletion of the N-terminal domain blocked association of AGO1 with polyribosomes and severely affected mRNA cleavage. Nevertheless, the mutant protein was in a complex with siRNAs. In contrast, deletion of the Piwi domain led to a loss of siRNAs but did not abolish polyribosome association. Site-directed mutagenesis of conserved amino acids in the Piwi domain identified arginine 735 as essential for RNAi. Although the R735A mutant bound siRNAs and associated with polyribosomes, it displayed a severe defect in the cleavage of target mRNA.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University; Yale University	Tschudi, C (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 295 Congress Ave, New Haven, CT 06536 USA.	christian.tschudi@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI028798, R01AI028798] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28798] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Djikeng A, 2003, RNA, V9, P802, DOI 10.1261/rna.5270203; Djikeng A, 2001, RNA, V7, P1522; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Ullu E, 2002, PHILOS T ROY SOC B, V357, P65, DOI 10.1098/rstb.2001.0952; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129	22	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49889	49893		10.1074/jbc.M409280200	http://dx.doi.org/10.1074/jbc.M409280200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383544	hybrid			2022-12-27	WOS:000225229500043
J	Liao, YF; Wang, BJ; Cheng, HT; Kuo, LH; Wolfe, MS				Liao, YF; Wang, BJ; Cheng, HT; Kuo, LH; Wolfe, MS			Tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; ALZHEIMERS-DISEASE; SIGNAL-TRANSDUCTION; DIFFERENTIAL ACTIVATION; BETA-APP; PRESENILIN; COMPLEX; NICASTRIN; RECEPTOR; DOMAIN	The deposition of the amyloid beta (Abeta) peptide in neuritic plaques plays a critical role in the pathogenesis of Alzheimer's disease (AD). Abeta is generated through the proteolysis of amyloid precursor protein (APP) by the sequential actions of beta- and gamma-secretases. Although recent evidence has unveiled much about the biochemical identity and characteristics of gamma-secretase, the mechanism regulating endogenous gamma-secretase activity remains elusive. To identify possible extracellular signals and associated signaling cascades that could regulate APP proteolysis by gamma-secretase activity, we have developed a cell-based reporter gene assay by stably cotransfecting HEK293 cells with the Gal4-driven luciferase reporter gene and the Gal4/VP16-tagged C-terminal fragment of APP (C99-GV), the immediate substrate of gamma-secretase. The cleavage of C99-GV by gamma-secretase releases the transcription factor that activates luciferase expression, providing a quantitative measurement of gamma-secretase activity. Using this reporter assay, we have demonstrated that interferon-gamma, interleukin-1beta, and tumor necrosis factor-alpha can specifically stimulate gamma-secretase activity, concomitant with increased production of Abeta and the intracellular domain of APP (AICD). The gamma-secretase-dependent cleavage of Notch is also enhanced upon the stimulation of these cytokines. The cytokine-enhanced gamma-secretase activity can be suppressed by a potent inhibitor of c-Jun N-terminal kinase (JNK). Furthermore, cells transfected with dominant-positive MEKK1, one of the most potent activators of the JNK cascade, exhibit increased gamma-secretase activity, suggesting that the JNK-dependent mitogen-activated protein kinase pathway could mediate the cytokine-elicited regulation of gamma-secretase. Our studies provide direct evidence that cytokine-elicited signaling cascades control Abeta production by modulating gamma-secretase activity.	Acad Sinica, Inst Zool, Mol Neurobiol Lab, Taipei 115, Taiwan; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Academia Sinica - Taiwan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liao, YF (corresponding author), Acad Sinica, Inst Zool, Mol Neurobiol Lab, 129 Sec 2 Acad Rd,Rm 328, Taipei 115, Taiwan.	yliao@sinica.edu.tw	Liao, Yung-Feng/A-9761-2011					Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Auron PE, 1998, CYTOKINE GROWTH F R, V9, P221, DOI 10.1016/S1359-6101(98)00018-5; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blasko I, 1999, FASEB J, V13, P63, DOI 10.1096/fasebj.13.1.63; Blasko I, 2000, NEUROBIOL DIS, V7, P682, DOI 10.1006/nbdi.2000.0321; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Combs CK, 2001, J NEUROSCI, V21, P1179; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Griffin WST, 2002, J LEUKOCYTE BIOL, V72, P233; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kim JW, 2001, J CELL BIOL, V153, P457, DOI 10.1083/jcb.153.3.457; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; PETRY RP, 2001, NEUROBIOL AGING, V22, P873; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rogers J., 1998, NEUROINFLAMMATION ME, P177; Sakatsume M, 1998, J BIOL CHEM, V273, P3021, DOI 10.1074/jbc.273.5.3021; Savage MJ, 2002, J NEUROSCI, V22, P3376; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Shoji M, 2000, MOL BRAIN RES, V85, P221, DOI 10.1016/S0169-328X(00)00245-X; Siow YL, 1997, J BIOL CHEM, V272, P7586, DOI 10.1074/jbc.272.12.7586; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tang J, 2003, J MOL NEUROSCI, V20, P299, DOI 10.1385/JMN:20:3:299; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Wolozin B, 1998, NEUROBIOL AGING, V19, pS23, DOI 10.1016/S0197-4580(98)00041-4; Xia WM, 2003, J CELL SCI, V116, P2839, DOI 10.1242/jcs.00651; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhao WQ, 2002, NEUROBIOL DIS, V11, P166, DOI 10.1006/nbdi.2002.0520; Zhu XW, 2003, J NEUROCHEM, V86, P136, DOI 10.1046/j.1471-4159.2003.01820.x; Zhu XW, 2003, J NEUROCHEM, V85, P87, DOI 10.1046/j.1471-4159.2003.01645.x; Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6	53	268	276	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49523	49532		10.1074/jbc.M402034200	http://dx.doi.org/10.1074/jbc.M402034200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347683	hybrid			2022-12-27	WOS:000225098100123
J	Meurer, S; Pioch, S; Wagner, K; Muller-Esterl, W; Gross, S				Meurer, S; Pioch, S; Wagner, K; Muller-Esterl, W; Gross, S			AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; FULL-LENGTH HUMAN; ACTIVITY REQUIRES; KINASE-C; EXPRESSION; PHOSPHORYLATION; PURIFICATION; CYTOHESINS; CENTAURINS; INHIBITOR	Nitric oxide (NO)-sensitive soluble guanylyl cyclase (sGC) is the major cytosolic receptor for NO, catalyzing the conversion of GTP to cGMP. In a search for proteins specifically interacting with human sGC, we have identified the multidomain protein AGAP1, the prototype of an ArfGAP protein with a GTPase-like domain, Ankyrin repeats, and a pleckstrin homology domain. AGAP1 binds through its carboxyl terminal portion to both the alpha(1) and beta(1) subunits of sGC. We demonstrate that AGAP1 mRNA and protein are co-expressed with sGC in human, murine, and rat cells and tissues and that the two proteins interact in vitro and in vivo. We also show that AGAP1 is prone to tyrosine phosphorylation by Src-like kinases and that tyrosine phosphorylation potently increases the interaction between AGAP1 and sGC, indicating that complex formation is modulated by reversible phosphorylation. Our findings may hint to a potential role of AGAP1 in integrating signals from Arf, NO/cGMP, and tyrosine kinase signaling pathways.	Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Muller-Esterl, W (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7,Bldg 75, D-60590 Frankfurt, Germany.	office@biochem2.de						Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barnstable CJ, 2004, NEUROCHEM INT, V45, P875, DOI 10.1016/j.neuint.2004.03.018; Bauersachs J, 1998, CARDIOVASC RES, V37, P772, DOI 10.1016/S0008-6363(97)00250-2; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; BUECHLER WA, 1991, BIOCHEM BIOPH RES CO, V174, P351, DOI 10.1016/0006-291X(91)90527-E; Chen LH, 2000, CIRC RES, V86, P520, DOI 10.1161/01.RES.86.5.520; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Gibb BJ, 2003, BRIT J PHARMACOL, V139, P1032, DOI 10.1038/sj.bjp.0705318; Gupta G, 1997, J CLIN INVEST, V100, P1488, DOI 10.1172/JCI119670; Hanafy KA, 2004, J BIOL CHEM, V279, P46946, DOI 10.1074/jbc.M404134200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HARTENECK C, 1990, FEBS LETT, V272, P221, DOI 10.1016/0014-5793(90)80489-6; Hawadle MA, 2002, BIOL RES, V35, P247, DOI 10.4067/S0716-97602002000200017; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; KIM TD, 1994, J BIOL CHEM, V269, P15540; Koglin M, 2004, BIOCHEM PHARMACOL, V67, P1579, DOI 10.1016/j.bcp.2004.01.007; LOUIS JC, 1993, BIOCHIM BIOPHYS ACTA, V1177, P299, DOI 10.1016/0167-4889(93)90126-A; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Nedvetsky PI, 2002, P NATL ACAD SCI USA, V99, P16510, DOI 10.1073/pnas.262701999; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Xia CZ, 2003, MOL CELL BIOL, V23, P2476, DOI 10.1128/MCB.23.7.2476-2488.2003; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200; ZWILLER J, 1985, J BIOL CHEM, V260, P1350; ZWILLER J, 1981, BIOCHEM BIOPH RES CO, V101, P1381, DOI 10.1016/0006-291X(81)91600-4	44	29	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49346	49354		10.1074/jbc.M410565200	http://dx.doi.org/10.1074/jbc.M410565200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15381706	hybrid			2022-12-27	WOS:000225098100104
J	Swindle, EJ; Metcalfe, DD; Coleman, JW				Swindle, EJ; Metcalfe, DD; Coleman, JW			Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; HISTAMINE-RELEASE; IFN-GAMMA; GENERATION; DIPHENYLENEIODONIUM; DEGRANULATION; SUPEROXIDE; PHOSPHORYLATION; INHIBITION; INFECTION	In immunity, reactive oxygen species (ROS) and nitric oxide (NO) are important antimicrobial agents and regulators of cell signaling and activation pathways. However, the cellular sources of ROS and NO are much debated. Particularly, there is contention over whether mast cells, key secretory cells in allergy and immunity, can generate these chemical species, and if so, whether they are of functional significance. We therefore examined directly by flow cytometry the capacity of mast cells to generate intracellular ROS and NO using the respective cell-permeable fluorescent probes dichlorodihydrofluorescein and diaminofluorescein and evaluated the effects of inhibitors of ROS and NO synthesis on cell degranulation. For each of three mast cell types ( rat peritoneal mast cells, mouse bone marrow-derived mast cells, and human blood-derived mast cells), degranulation stimulated by IgE/antigen was accompanied by production of intracellular ROS but not NO. Inhibition of ROS production led to reduced degranulation, indicating a facilitatory role for ROS, whereas NO synthase inhibitors were without effect. Likewise, bacterial lipopolysaccharide and interferon-gamma over a wide range of conditions failed to generate intracellular NO in mast cells, whereas these agents readily induced intracellular NO in macrophages. NO synthase protein, as assessed by Western blotting, was readily induced in macrophages but not mast cells. We conclude that rodent and human mast cells generate intracellular ROS but not NO and that intracellular ROS but not intracellular NO are functionally linked to mast cell degranulation.	NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; Univ Liverpool, Dept Pharmacol, Liverpool L69 3GE, Merseyside, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Liverpool	Swindle, EJ (corresponding author), NIAID, Lab Allerg Dis, NIH, Bldg 10,Rm 11C 209, Bethesda, MD 20892 USA.	ejswindle@niaid.nih.gov		Swindle, Emily/0000-0003-3644-7747	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000607] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bidri M, 1997, EUR J IMMUNOL, V27, P2907, DOI 10.1002/eji.1830271124; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Brooks AC, 1999, BRIT J PHARMACOL, V128, P585, DOI 10.1038/sj.bjp.0702838; Brooks B, 2000, J IMMUNOL, V164, P573, DOI 10.4049/jimmunol.164.2.573; Chen SS, 2000, IMMUNOLOGY, V100, P471, DOI 10.1046/j.1365-2567.2000.00045.x; Deschoolmeester ML, 1999, IMMUNOLOGY, V96, P138; Eastmond NC, 1997, J IMMUNOL, V159, P1444; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; FORMAN HJ, 1986, ANNU REV PHYSIOL, V48, P669; Fukuishi N, 1997, BIOCHEM MOL MED, V61, P107, DOI 10.1006/bmme.1997.2594; Gilchrist M, 2003, J BIOL CHEM, V278, P50607, DOI 10.1074/jbc.M307777200; Gilchrist M, 2002, J LEUKOCYTE BIOL, V71, P618; Gilchrist M, 2004, BLOOD, V104, P462, DOI 10.1182/blood-2003-08-2990; Guerin-Marchand C, 2001, INFLAMM RES, V50, P341, DOI 10.1007/PL00000254; GUSHCHIN IS, 1990, AGENTS ACTIONS, V30, P85, DOI 10.1007/BF01969005; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HENDERSON WR, 1978, J CLIN INVEST, V61, P187, DOI 10.1172/JCI108917; HOLLAND PC, 1973, J BIOL CHEM, V248, P6050; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; KUROSAWA M, 1990, ARZNEIMITTEL-FORSCH, V40-2, P767; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Matsui T, 2000, BIOCHEM BIOPH RES CO, V276, P742, DOI 10.1006/bbrc.2000.3545; McDermott JR, 2003, P NATL ACAD SCI USA, V100, P7761, DOI 10.1073/pnas.1231488100; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; PEDERSEN UB, 1994, EUR J PHARM-MOLEC PH, V267, P85, DOI 10.1016/0922-4106(94)90228-3; RAGAN CI, 1977, BIOCHEM J, V163, P605, DOI 10.1042/bj1630605; SALVEMINI D, 1990, BIOCHEM BIOPH RES CO, V169, P596, DOI 10.1016/0006-291X(90)90372-T; Suzuki Y, 2003, J IMMUNOL, V171, P6119, DOI 10.4049/jimmunol.171.11.6119; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Tkaczyk C, 2002, J IMMUNOL METHODS, V268, P239, DOI 10.1016/S0022-1759(02)00210-7; TSINKALOVSKY OR, 1994, APMIS, V102, P474, DOI 10.1111/j.1699-0463.1994.tb04901.x; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Williams CMM, 2000, J ALLERGY CLIN IMMUN, V105, P847, DOI 10.1067/mai.2000.106485; Wolfreys K, 1997, EUR J IMMUNOL, V27, P297, DOI 10.1002/eji.1830270143; Yoshimaru T, 2002, CLIN EXP ALLERGY, V32, P612, DOI 10.1046/j.0954-7894.2002.01263.x	40	81	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48751	48759		10.1074/jbc.M409738200	http://dx.doi.org/10.1074/jbc.M409738200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15361524	hybrid			2022-12-27	WOS:000225098100033
J	Zanetti, L; Ristoratore, F; Bertoni, A; Cariello, L				Zanetti, L; Ristoratore, F; Bertoni, A; Cariello, L			Characterization of sea urchin transglutaminase, a protein regulated by guanine/adenine nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; CROSS-LINKING; LIVER TRANSGLUTAMINASE; EMBRYONIC-DEVELOPMENT; EGG FERTILIZATION; SEQUENCE-ANALYSIS; STRUCTURAL BASIS; BINDING-PROTEIN; GTP HYDROLYSIS; CDNA CLONING	Transglutaminases (TGs) are calcium-dependent enzymes that catalyze the transamidation of glutamine residues to form intermolecular isopeptide bonds. Nine distinct TGs have been identified in mammals, and three of them (types 2, 3, and 5) are regulated by GTP/ATP and are able to hydrolyze GTP, working as bifunctional enzymes. We have isolated a cDNA clone encoding a TG from a cDNA library prepared from the blastula stage of sea urchin Paracentrotus lividus (PlTG). The cDNA sequence has an open reading frame coding for a protein of 738 amino acids, including a Cys active site and two other residues critical for catalytic activity, His and Asp. We have studied its expression pattern by in situ hybridization and have also demonstrated that the in vitro expressed PlTG had GTP- and ATP-hydrolyzing activity; moreover, GTP inhibited the transamidating activity of this enzyme as it does that of human TG2, TG3, and TG5.	Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Cariello, L (corresponding author), Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, I-80121 Naples, Italy.	lcariel@szn.it						Ahvazi B, 2004, J BIOL CHEM, V279, P7180, DOI 10.1074/jbc.M312310200; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Aniello F, 1996, GENE, V178, P57, DOI 10.1016/0378-1119(96)00334-4; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; BATTAGLIA DE, 1988, J CELL BIOL, V107, P2447, DOI 10.1083/jcb.107.6.2447; Candi E, 2004, BIOCHEM J, V381, P313, DOI 10.1042/BJ20031474; CARIELLO L, 1994, BIOCHEM BIOPH RES CO, V205, P565, DOI 10.1006/bbrc.1994.2702; Cariello L, 1997, FEBS LETT, V408, P171, DOI 10.1016/S0014-5793(97)00342-6; CARIELLO L, 1990, BIOCHEMISTRY-US, V29, P5103, DOI 10.1021/bi00473a015; CARIELLO L, 1984, BIOCHEMISTRY-US, V23, P6843, DOI 10.1021/bi00321a087; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Fraij BM, 1996, BIOCHEM BIOPH RES CO, V218, P45, DOI 10.1006/bbrc.1996.0009; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; Huang CC, 2004, DEV COMP IMMUNOL, V28, P279, DOI 10.1016/j.dci.2003.08.005; Iismaa SE, 2000, J BIOL CHEM, V275, P18259, DOI 10.1074/jbc.M000583200; Iismaa SE, 2003, P NATL ACAD SCI USA, V100, P12636, DOI 10.1073/pnas.1635052100; Iismaa SE, 1997, BIOCHEMISTRY-US, V36, P11655, DOI 10.1021/bi970545e; Lai TS, 1996, J BIOL CHEM, V271, P31191, DOI 10.1074/jbc.271.49.31191; LEE KN, 1989, BIOCHEM BIOPH RES CO, V162, P1370, DOI 10.1016/0006-291X(89)90825-5; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; MISRA S, 2002, GENOME BIOL; Murthy SNP, 1999, P NATL ACAD SCI USA, V96, P11815, DOI 10.1073/pnas.96.21.11815; Murthy SNP, 2000, P NATL ACAD SCI USA, V97, P7744, DOI 10.1073/pnas.140210197; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; Sano K, 1996, BIOSCI BIOTECH BIOCH, V60, P1790, DOI 10.1271/bbb.60.1790; SINGER MA, 1992, DEV BIOL, V154, P143, DOI 10.1016/0012-1606(92)90055-L; Sugino H, 2002, EUR J BIOCHEM, V269, P1957, DOI 10.1046/j.1432-1033.2002.02847.x; TAKEUCHI K, 1982, FED PROC, V41, P1453; TOKUNAGA F, 1993, J BIOL CHEM, V268, P262; Wada F, 2002, EUR J BIOCHEM, V269, P3451, DOI 10.1046/j.1432-1033.2002.03026.x; Wang R, 2001, FISH SHELLFISH IMMUN, V11, P623, DOI 10.1006/fsim.2001.0341; YASUEDA H, 1995, EUR J BIOCHEM, V232, P411, DOI 10.1111/j.1432-1033.1995.tb20826.x; ZWERSCHKE W, 1994, J BIOL CHEM, V269, P23351	40	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49289	49297		10.1074/jbc.M405926200	http://dx.doi.org/10.1074/jbc.M405926200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15381689	hybrid			2022-12-27	WOS:000225098100097
J	Chen, SU; Cho, M; Karlsberg, K; Zhou, DJ; Yuan, YC				Chen, SU; Cho, M; Karlsberg, K; Zhou, DJ; Yuan, YC			Biochemical and biological characterization of a novel anti-aromatase coumarin derivative	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; RECONSTITUTED BASEMENT-MEMBRANE; BREAST-CANCER; ISOFLAVONE PHYTOESTROGENS; ACCEPTOR OXIDOREDUCTASE; ESTROGEN BIOSYNTHESIS; STEROID SULFATASE; EPITHELIAL-CELLS; MOLECULAR-BASIS; TUMOR-CELLS	Estrogen stimulates the proliferation of estrogen receptor (ER)-positive breast cancer cells. Aromatase is the enzyme responsible for the conversion of androgens into estrogens, and synthetic aromatase inhibitors such as letrozole, anastrozole, and exemestane have proven to be effective endocrine regimens for ER-positive breast cancer. In a recent study, we have found that 4-benzyl-3(4'-chlorophenyl)-7-methoxycoumarin is a potent competitive inhibitor of aromatase with respect to the androgen substrate. Its K-i value was determined to be 84 nM, significantly more potent than several known aromatase inhibitors. The specific interaction of this compound with aromatase was further demonstrated by the reduction of its binding by several mutations at the active site region of aromatase and evaluated by computer modeling analysis. The structure-activity studies have revealed that three functional groups (i.e. 3-(4'-chlorophenyl), 4-benzyl, and 7-methoxyl) of this coumarin are important in its inhibition of aromatase. In addition, through a matrigel thread three-dimensional cell culture, this compound was shown to behave like known aromatase inhibitors that suppress the proliferation of aromatase and estrogen receptor positive MCF-7aro breast cancer cells. This coumarin has been shown not to be cytotoxic at up to 40 muM. It was found not to be an inhibitor of steroid 5alpha-reductase that also utilizes androgen as the substrate and not to be a ligand of ERalpha, ERbeta, estrogen-related receptors, or androgen receptor. These results demonstrate that coumarins (a common type of phytochemical) or their derivatives can be potent inhibitors of aromatase and may be useful in suppressing aromatase- and ER-positive breast tumors.	City Hope Natl Med Ctr, Beckman Res Inst, Dept Surg Res, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Informat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, SU (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Surg Res, Duarte, CA 91010 USA.	schen@coh.org			NATIONAL CANCER INSTITUTE [R01CA044735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008258] Funding Source: NIH RePORTER; NCI NIH HHS [CA44735] Funding Source: Medline; NIEHS NIH HHS [ES08258] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adam L, 2001, CANCER RES, V61, P81; ALBINI A, 1987, CANCER RES, V47, P3239; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; CASCIARI JJ, 1995, IN VITRO CELL DEV-AN, V31, P582, DOI 10.1007/BF02634310; Chen S, 2001, J BIOL CHEM, V276, P28465, DOI 10.1074/jbc.M102638200; CHEN S, 1993, ARCH BIOCHEM BIOPHYS, V302, P72, DOI 10.1006/abbi.1993.1182; DALY PF, 1988, FASEB J, V2, P2596, DOI 10.1096/fasebj.2.10.3384239; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Eng ET, 2003, CANCER RES, V63, P8516; ESTEBAN JM, 1992, AM J PATHOL, V140, P337; Fang MZ, 2003, CANCER RES, V63, P7563; Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4; Johnston SRD, 2001, AROMATASE INHIBITION AND BREAST CANCER, P29; Kao YC, 2001, EUR J BIOCHEM, V268, P243, DOI 10.1046/j.1432-1327.2001.01886.x; Kao YC, 1996, CANCER RES, V56, P3451; Kao YC, 1998, ENVIRON HEALTH PERSP, V106, P85, DOI 10.1289/ehp.9810685; Kinoshita Y, 2003, CANCER RES, V63, P3546; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Lemmen C, 1998, J MED CHEM, V41, P4502, DOI 10.1021/jm981037l; LIU XF, 1990, MOL PHARMACOL, V37, P911; Lu Q, 1996, ENDOCRINOLOGY, V137, P3061, DOI 10.1210/en.137.7.3061; MARTIN PM, 1978, ENDOCRINOLOGY, V103, P1860, DOI 10.1210/endo-103-5-1860; MCGUIRE PG, 1989, J CELL BIOCHEM, V40, P215, DOI 10.1002/jcb.240400210; PEARLMAN RS, 1998, CONCORD VERSION 4 0; Purohit A, 2003, J STEROID BIOCHEM, V86, P423, DOI 10.1016/S0960-0760(03)00353-4; SANTEN RJ, 1994, J CLIN ENDOCR METAB, V79, P627, DOI 10.1210/jc.79.2.627; Shields-Botella J, 2003, J STEROID BIOCHEM, V84, P327, DOI 10.1016/S0960-0760(03)00046-3; Suetsugi M, 2003, MOL CANCER RES, V1, P981; Sun XZ, 1997, J STEROID BIOCHEM, V63, P29, DOI 10.1016/S0960-0760(97)00068-X; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; *SYB, 2002, VERS 6 9; TANIGUCHI S, 1989, CANCER RES, V49, P6738; TERRANOVA VP, 1986, P NATL ACAD SCI USA, V83, P465, DOI 10.1073/pnas.83.2.465; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; *TRIP INC, 2003, FORC FIELD MAN; Winer EP, 2002, J CLIN ONCOL, V20, P3317, DOI 10.1200/JCO.2002.06.020; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; Yang C, 1998, CANCER RES, V58, P5695; ZHOU D, 1990, CANCER RES, V50, P6949; ZHOU DJ, 1994, J BIOL CHEM, V269, P19501; Zhou DJ, 2001, NUCLEIC ACIDS RES, V29, P3939, DOI 10.1093/nar/29.19.3939	42	64	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48071	48078		10.1074/jbc.M406847200	http://dx.doi.org/10.1074/jbc.M406847200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15358790	hybrid			2022-12-27	WOS:000224957000079
J	Simard, CF; Daigle, ND; Bergeron, MJ; Brunet, GM; Caron, L; Noel, M; Montminy, V; Isenring, P				Simard, CF; Daigle, ND; Bergeron, MJ; Brunet, GM; Caron, L; Noel, M; Montminy, V; Isenring, P			Characterization of a novel interaction between the secretory Na+-K+-Cl(-)cotransporter and the chaperone hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; SHARK RECTAL GLAND; HEAT-SHOCK PROTEINS; NA+-K+-2CL(-) COTRANSPORTER; FUNCTIONAL EXPRESSION; MOLECULAR CHARACTERIZATION; CHLORIDE COTRANSPORTER; BUMETANIDE BINDING; ION-TRANSPORT; CELL-VOLUME	The first isoform of the Na+-K+-Cl- cotransporter (NKCC1) is of central importance for the control of cellular ion concentration and epithelium-mediated salt secretion. Several studies have established that a change in intracellular [Cl-] (Cl-i(-)) represents a key signaling mechanism by which NKCC1-induced Cl- movement is autoregulated and by which Cl- entry and exit on opposite sides of polarized cells are coordinated. Although this signaling mechanism is coupled to a pathway that leads to post-translational modification of the carrier, no unifying model currently accounts for the ion dependence of NKCC1 regulation. In this paper, evidence is presented for the first time that hsp90 associates with the cytosolic C terminus of NKCC1, probably when the carrier is predominantly in its unfolded form during early biogenesis. Evidence is also presented that the Cl-i(-)-dependent regulatory pathway can be activated by a thermal stress but that it is no longer operational if NKCC1-expressing cells are pretreated with geldanamycin, an antibiotic that inhibits hsp90, albeit nonspecifically. Taken together, our data indicate that binding of hsp90 to NKCC1 may be required for Na+-K+-Cl- cotransport to occur at the cell surface and that it could play an important role in ion-dependent signaling mechanisms, insofar as the maneuvers that were used to alter the expression or activity of the chaperone do not exert their main effect by inducing other cellular events such as the unfolded protein response. Further studies will be required to elucidate the functional relevance of this novel interaction.	Univ Laval, Dept Med, Nephrol Res Grp, Fac Med, Quebec City, PQ G1R 2J6, Canada	Laval University	Isenring, P (corresponding author), Hotel Dieu Quebec Res Ctr, 10 Rue McMahon,Rm 3852, Quebec City, PQ G1R 2J6, Canada.	paul.isenring@crhdq.ulaval.ca						Bachmann O, 2003, J PHYSIOL-LONDON, V549, P525, DOI 10.1113/jphysiol.2002.030205; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Caplan Avrom J., 2003, EMBO Reports, V4, P126, DOI 10.1038/sj.embor.embor742; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Evans RL, 2000, J BIOL CHEM, V275, P26720; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; FORBUSH B, 1994, RENAL PHYSIOL BIOCH, V17, P201; Fuller W, 2000, J BIOL CHEM, V275, P37462, DOI 10.1074/jbc.M006278200; Gagnon E, 2002, AM J PHYSIOL-RENAL, V283, pF1046, DOI 10.1152/ajprenal.00107.2002; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Garon L, 2000, J BIOL CHEM, V275, P32027, DOI 10.1074/jbc.M000108200; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; HAAS M, 1990, AM J PHYSIOL, V259, pC557, DOI 10.1152/ajpcell.1990.259.4.C557; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Isenring P, 1998, P NATL ACAD SCI USA, V95, P7179, DOI 10.1073/pnas.95.12.7179; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Isenring P, 2001, COMP BIOCHEM PHYS A, V130, P487, DOI 10.1016/S1095-6433(01)00420-2; ISENRING P, 1997, INT SOC NEPHR; Jacoby SC, 1999, AM J PHYSIOL-CELL PH, V277, pC684, DOI 10.1152/ajpcell.1999.277.4.C684; Kinard TA, 2001, DIABETES, V50, P992, DOI 10.2337/diabetes.50.5.992; Klein JD, 1999, AM J PHYSIOL-CELL PH, V277, pC425, DOI 10.1152/ajpcell.1999.277.3.C425; Kurihara K, 1999, AM J PHYSIOL-CELL PH, V277, pC1184, DOI 10.1152/ajpcell.1999.277.6.C1184; Lawson B, 1998, J CELL PHYSIOL, V174, P170, DOI 10.1002/(SICI)1097-4652(199802)174:2<170::AID-JCP4>3.3.CO;2-A; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; LUDT J, 1993, J MEMBRANE BIOL, V134, P143; LYTLE C, 1992, J BIOL CHEM, V267, P25428; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Malhotra V, 2001, AM J RESP CELL MOL, V25, P92, DOI 10.1165/ajrcmb.25.1.4384; MANABE KI, 2004, IN PRESS PFLUGERS AR; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Oehler R, 1998, FASEB J, V12, P553, DOI 10.1096/fasebj.12.7.553; PAYNE JA, 1995, CURR OPIN CELL BIOL, V7, P493, DOI 10.1016/0955-0674(95)80005-0; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; PRATT WB, 1992, BIOESSAYS, V14, P841, DOI 10.1002/bies.950141209; PRATT WB, 1993, J BIOL CHEM, V268, P21455; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Shillingford JM, 2002, MOL ENDOCRINOL, V16, P1309, DOI 10.1210/me.16.6.1309; Shin JH, 2004, J BIOL CHEM, V279, P18567, DOI 10.1074/jbc.M400639200; Shumaker H, 1999, AM J PHYSIOL-CELL PH, V277, pC1100, DOI 10.1152/ajpcell.1999.277.6.C1100; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Solit DB, 2003, CANCER RES, V63, P2139; Suffia I, 1997, INT J PARASITOL, V27, P1547, DOI 10.1016/S0020-7519(97)00142-2; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	55	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48449	48456		10.1074/jbc.M407012200	http://dx.doi.org/10.1074/jbc.M407012200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347682	hybrid			2022-12-27	WOS:000224957000122
J	Heydorn, A; Sondergaard, BP; Ersboll, B; Holst, B; Nielsen, FC; Haft, CR; Whistler, J; Schwartz, TW				Heydorn, A; Sondergaard, BP; Ersboll, B; Holst, B; Nielsen, FC; Haft, CR; Whistler, J; Schwartz, TW			A library of 7TM receptor C-terminal tails - Interactions with the proposed post-endocytic sorting proteins ERM-binding phosphoprotein 50 (EBP50), N-ethylmaleimide-sensitive factor (NSF), sorting nexin 1 (SNX1), and G protein-coupled receptor-associated sorting protein (GASP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EXCHANGER REGULATORY FACTOR; METABOTROPIC GLUTAMATE RECEPTORS; 3RD INTRACELLULAR LOOP; GROWTH-FACTOR RECEPTOR; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; BETA(1)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; SYNAPTIC-TRANSMISSION; OPIOID RECEPTORS	Adaptor and scaffolding proteins determine the cellular targeting, the spatial, and thereby the functional association of G protein-coupled seven-transmembrane receptors with co-receptors, transducers, and downstream effectors and the adaptors determine post-signaling events such as receptor sequestration through interactions, mainly with the C-terminal intracellular tails of the receptors. A library of tails from 59 representative members of the super family of seven-transmembrane receptors was probed as glutathione S-transferase fusion proteins for interactions with four different adaptor proteins previously proposed to be involved in post-endocytotic sorting of receptors. Of the two proteins suggested to target receptors for recycling to the cell membrane, which is the route believed to be taken by a majority of receptors, ERM (ezrin-radixin-moesin)binding phosphoprotein 50 (EBP50) bound only a single receptor tail, i.e. the beta(2)-adrenergic receptor, whereas N-ethylmaleimide-sensitive factor bound 11 of the tail-fusion proteins. Of the two proteins proposed to target receptors for lysosomal degradation, sorting nexin 1 (SNX1) bound 10 and the C-terminal domain of G protein-coupled receptor-associated sorting protein bound 23 of the 59 tail proteins. Surface plasmon resonance analysis of the binding kinetics of selected hits from the glutathione S-transferase pull-down experiments, i.e. the tails of the virally encoded receptor US28 and the delta-opioid receptor, confirmed the expected nanomolar affinities for interaction with SNX1. Truncations of the NK1 receptor revealed that an extended binding epitope is responsible for the interaction with both SNX1 and G protein-coupled receptor-associated sorting protein as well as with N-ethylmaleimide-sensitive factor. It is concluded that the tail library provides useful information on the general importance of certain adaptor proteins, for example, in this case, ruling out EBP50 as being a broad spectrum-recycling adaptor.	Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; Tech Univ Denmark, DK-2800 Lyngby, Denmark; Rigshosp, Dept Clin Biochem, DK-2200 Copenhagen, Denmark; NIDDK, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Ernest Gallo Res Ctr, San Francisco, CA 94608 USA; 7TM Pharma AS, DK-2970 Horsholm, Denmark	University of Copenhagen; Technical University of Denmark; Rigshospitalet; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Schwartz, TW (corresponding author), Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark.	schwartz@molpharm.dk	Nielsen, Finn Cilius/AAA-4926-2020	Ersboll, Bjarne Kjaer/0000-0003-1262-7890; Holst, Birgitte/0000-0001-7432-097X; Schwartz, Thue W./0000-0002-0261-6904; Nielsen, Finn Cilius/0000-0002-9829-1031				Alexander S., 1999, TRENDS PHARMACOL SCI, V19, P1; Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Bachner D, 2002, FEBS LETT, V526, P124, DOI 10.1016/S0014-5793(02)03115-0; Becamel C, 2001, J BIOL CHEM, V276, P12974, DOI 10.1074/jbc.M008089200; Bennett VJ, 2002, J PHARMACOL EXP THER, V303, P1155, DOI 10.1124/jpet.102.040378; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Brady AE, 2003, J BIOL CHEM, V278, P32405, DOI 10.1074/jbc.M304195200; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Brdickova N, 2001, FEBS LETT, V507, P133, DOI 10.1016/S0014-5793(01)02955-6; Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; Brunger AT, 2001, ANNU REV BIOPH BIOM, V30, P157, DOI 10.1146/annurev.biophys.30.1.157; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Csaba Z, 2001, NEUROPEPTIDES, V35, P1, DOI 10.1054/npep.2001.0848; DeGraff JL, 2002, J BIOL CHEM, V277, P43247, DOI 10.1074/jbc.M207495200; Dev KK, 2000, J NEUROSCI, V20, P7252; FAGNI L, 2002, SCI STKE; Feng GJ, 2003, J BIOL CHEM, V278, P33400, DOI 10.1074/jbc.M305866200; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Garland AM, 1996, MOL PHARMACOL, V49, P438; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gray JA, 2002, SCIENCE, V297, P529, DOI 10.1126/science.1075453; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Han SY, 2000, BIOCHEM J, V352, P165, DOI 10.1042/0264-6021:3520165; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Hegedus T, 2003, BIOCHEM BIOPH RES CO, V302, P454, DOI 10.1016/S0006-291X(03)00196-7; Hein L, 1997, MOL ENDOCRINOL, V11, P1266, DOI 10.1210/me.11.9.1266; Heydorn A, 2004, FEBS LETT, V556, P276, DOI 10.1016/S0014-5793(03)01431-5; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Jenkinson KM, 2000, NEUROSCIENCE, V100, P191, DOI 10.1016/S0306-4522(00)00259-1; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kneussel M, 2002, BRAIN RES REV, V39, P74, DOI 10.1016/S0165-0173(02)00159-5; Krudewig R, 2000, J NEUROCHEM, V74, P1721, DOI 10.1046/j.1471-4159.2000.0741721.x; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Kurten RC, 2001, J CELL SCI, V114, P1743; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LUIS J, 1988, BIOCHIMIE, V70, P1311, DOI 10.1016/0300-9084(88)90002-8; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 2003, J MOL ENDOCRINOL, V30, P117, DOI 10.1677/jme.0.0300117; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Muller JMM, 2002, J CELL BIOL, V157, P1161, DOI 10.1083/jcb.200202082; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Ouali R, 1997, ENDOCRINOLOGY, V138, P725, DOI 10.1210/en.138.2.725; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Phillips SA, 2001, J BIOL CHEM, V276, P5074, DOI 10.1074/jbc.M004671200; Pushkin A, 2003, AM J PHYSIOL-CELL PH, V284, pC667, DOI 10.1152/ajpcell.00225.2002; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; RAIL RA, 1998, NATURE, V392, P626; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Schmidlin F, 2002, P NATL ACAD SCI USA, V99, P3324, DOI 10.1073/pnas.052161299; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; SCHWARTZ TW, 2003, TXB RECEPTOR PHARM, P81; Schwarz DG, 2002, MOL BIOL CELL, V13, P3588, DOI 10.1091/mbc.E02-03-0145; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; TAXT T, 1991, PATTERN RECOGN LETT, V12, P731, DOI 10.1016/0167-8655(91)90070-3; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 2003, J PHARMACOL EXP THER, V307, P437, DOI 10.1124/jpet.103.052100; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; van Koppen CJ, 2001, BIOCHEM SOC T, V29, P505, DOI 10.1042/BST0290505; Wang YJ, 2002, MOL BIOL CELL, V13, P1965, DOI 10.1091/mbc.E01-11-0131; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	112	136	141	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2004	279	52					54291	54303		10.1074/jbc.M406169200	http://dx.doi.org/10.1074/jbc.M406169200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	880MJ	15452121	hybrid			2022-12-27	WOS:000225793600050
J	Anderson, SP; Howroyd, P; Liu, J; Qian, X; Bahnemann, R; Swanson, C; Kwak, MK; Kensler, TW; Corton, JC				Anderson, SP; Howroyd, P; Liu, J; Qian, X; Bahnemann, R; Swanson, C; Kwak, MK; Kensler, TW; Corton, JC			The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-ALPHA; NULL MICE; DIFFERENTIAL EXPRESSION; PROTEASOME ACTIVITY; 20S PROTEASOME; PROTECTION; PROTEINS; DITHIOLETHIONES; CLOFIBRATE; APOPTOSIS	The nuclear receptor peroxisome proliferator-activated receptor alpha(PPARalpha), in addition to regulating lipid homeostasis, controls the level of tissue damage after chemical or physical stress. To determine the role of PPARalpha in oxidative stress responses, we examined damage after exposure to chemicals that increase oxidative stress in wild-type or PPARalpha-null mice. Primary hepatocytes from wild-type but not PPARalpha-null mice pretreated with the PPAR pan-agonist WY-14,643 (WY) were protected from damage to cadmium and paraquat. The livers from intact wild-type but not PPARalpha-null mice were more resistant to damage after carbon tetrachloride treatment. To determine the molecular basis of the protection by PPARalpha, we identified by transcript profiling genes whose expression was altered by a 7-day exposure to WY in wild-type and PPARalpha-null mice. Of the 815 genes regulated by WY in wild-type mice ( p less than or equal to 0.001; greater than or equal to 1.5-fold or less than or equal to - 1.5-fold), only two genes were regulated similarly by WY in PPARalpha-null mice. WY increased expression of stress modifier genes that maintain the health of the proteome, including those that prevent protein aggregation (heat stress-inducible chaperones) and eliminate damaged proteins ( proteasome components). Although the induction of proteasomal genes significantly overlapped with those regulated by 1,2-dithiole-3-thione, an activator of oxidant-inducible Nrf2, WY increased expression of proteasomal genes independently of Nrf2. Thus, PPARalpha controls the vast majority of gene expression changes after exposure to WY in the mouse liver and protects the liver from oxidant-induced damage, possibly through regulation of a distinct set of proteome maintenance genes.	ToxicoGenom, Chapel Hill, NC 27514 USA; Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; BASF AG, D-67056 Ludwigshafen, Germany; NCI, NIEHS, NIH, Res Triangle Pk, NC 27709 USA; Chem Ind Inst Toxicol, Ctr Hlth Res, Res Triangle Pk, NC 27709 USA; Expt Pathol Labs Inc, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline Res & Dev Ltd, Invest Toxicol & Pathol Grp, Safety Assessment, Res Triangle Pk, NC 27709 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; BASF; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Environmental Health Sciences (NIEHS); GlaxoSmithKline	Corton, JC (corresponding author), ToxicoGenom, 209 Silver Creek Tr, Chapel Hill, NC 27514 USA.	ccorton@msn.com	Kensler, Thomas W/D-8686-2014	Kensler, Thomas W/0000-0002-6676-261X	NIEHS NIH HHS [ES09775-01] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES009775] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANDERSON SA, 2004, IN PRESS MOL PHARM; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Blanquart C, 2002, J BIOL CHEM, V277, P37254, DOI 10.1074/jbc.M110598200; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Chen C, 2000, TOXICOL SCI, V57, P338, DOI 10.1093/toxsci/57.2.338; Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Cumming DVE, 1996, J MOL CELL CARDIOL, V28, P2343, DOI 10.1006/jmcc.1996.0227; DeLuca JG, 2000, MOL PHARMACOL, V58, P470, DOI 10.1124/mol.58.3.470; Demasi M, 2003, J BIOL CHEM, V278, P679, DOI 10.1074/jbc.M209282200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hatayama T, 2001, BIOCHEM BIOPH RES CO, V288, P528, DOI 10.1006/bbrc.2001.5802; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Hill CP, 2002, CURR TOP MICROBIOL, V268, P73; Howroyd P, 2004, TOXICOL PATHOL, V32, P591, DOI 10.1080/01926230490515283; Kedderis GL, 1996, TOXICOL APPL PHARM, V140, P124, DOI 10.1006/taap.1996.0205; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Lee MW, 2001, BIOCHEM BIOPH RES CO, V284, P261, DOI 10.1006/bbrc.2001.4938; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Mehendale HM, 2000, TOXICOL SCI, V57, P187, DOI 10.1093/toxsci/57.2.187; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; O'Brien ML, 2002, TOXICOL SCI, V69, P139, DOI 10.1093/toxsci/69.1.139; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Peters JM, 2003, BBA-MOL CELL BIOL L, V1632, P80, DOI 10.1016/S1388-1981(03)00065-9; Plaa GL, 2000, ANNU REV PHARMACOL, V40, P43, DOI 10.1146/annurev.pharmtox.40.1.43; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Shankar K, 2003, FASEB J, V17, P1748, DOI 10.1096/fj.02-1186fje; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299	38	67	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52390	52398		10.1074/jbc.M409347200	http://dx.doi.org/10.1074/jbc.M409347200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15375163	hybrid			2022-12-27	WOS:000225493400083
J	Hayashi, F; Itoh, N; Uzumaki, T; Iwase, R; Tsuchiya, Y; Yamakawa, H; Moirishita, M; Onai, K; Itoh, S; Ishiura, M				Hayashi, F; Itoh, N; Uzumaki, T; Iwase, R; Tsuchiya, Y; Yamakawa, H; Moirishita, M; Onai, K; Itoh, S; Ishiura, M			Roles of two ATPase-motif-containing domains in cyanobacterial circadian clock protein KaiC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENE	Cyanobacterial clock protein KaiC has a hexagonal, pot-shaped structure composed of six identical dumb-bell-shaped subunits. Each subunit has duplicated domains, and each domain has a set of ATPase motifs. The two spherical regions of the dumbbell are likely to correspond to two domains. We examined the role of the two sets of ATPase motifs by analyzing the in vitro activity of ATPgammaS binding, AMPPNP-induced hexamerization, thermostability, and phosphorylation of KaiC and by in vivo rhythm assays both in wild type KaiC (KaiC(WT)) and KaiCs carrying mutations in either Walker motif A or deduced catalytic Glu residues. We demonstrated that 1) the KaiC subunit had two types of ATP-binding sites, a high affinity site in N-terminal ATPase motifs and a low affinity site in C-terminal ATPase motifs, 2) the N-terminal motifs were responsible for hexamerization, and 3) the C-terminal motifs were responsible for both stabilization and phosphorylation of the KaiC hexamer. We proposed the following reaction mechanism. ATP preferentially binds to the N-terminal high affinity site, inducing the hexamerization of KaiC. Additional ATP then binds to the C-terminal low affinity site, stabilizing and phosphorylating the hexamer. We discussed the effect of these KaiC mutations on circadian bioluminescence rhythm in cells of cyanobacteria.	Nagoya Univ, Ctr Gene Res, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Biooriented Technol Res Adv Inst, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Div Mat Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Ishiura, M (corresponding author), Nagoya Univ, Ctr Gene Res, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	ishiura@gene.nagoya-u.ac.jp		Onai, Kiyoshi/0000-0001-9062-2548				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Hayashi F, 2004, BIOCHEM BIOPH RES CO, V316, P195, DOI 10.1016/j.bbrc.2004.02.034; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Kutsuna S, 1998, J BACTERIOL, V180, P2167, DOI 10.1128/JB.180.8.2167-2174.1998; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Onai M, 2004, J BACTERIOL, V186, P4972, DOI 10.1128/JB.186.15.4972-4977.2004; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Uzumaki T, 2004, NAT STRUCT MOL BIOL, V11, P623, DOI 10.1038/nsmb781; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168	16	36	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52331	52337		10.1074/jbc.M406604200	http://dx.doi.org/10.1074/jbc.M406604200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15377674	hybrid			2022-12-27	WOS:000225493400075
J	Balasubramanyam, K; Varier, RA; Altaf, M; Swaminathan, V; Siddappa, NB; Ranga, U; Kundu, TK				Balasubramanyam, K; Varier, RA; Altaf, M; Swaminathan, V; Siddappa, NB; Ranga, U; Kundu, TK			Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUBINSTEIN-TAYBI-SYNDROME; VIRUS TYPE-1 PROMOTER; LONG TERMINAL REPEAT; THERAPEUTIC STRATEGIES; GENE-EXPRESSION; P300; HIV-1; TAT; CELLS; CBP	Acetylation of histones and non-histone proteins is an important post-translational modification involved in the regulation of gene expression in eukaryotes and all viral DNA that integrates into the human genome ( e. g. the human immunodeficiency virus). Dysfunction of histone acetyltransferases (HATs) is often associated with the manifestation of several diseases. In this respect, HATs are the new potential targets for the design of therapeutics. In this study, we report that curcumin (diferuloylmethane), a major curcumanoid in the spice turmeric, is a specific inhibitor of the p300/CREB-binding protein (CBP) HAT activity but not of p300/CBP-associated factor, in vitro and in vivo. Furthermore, curcumin could also inhibit the p300-mediated acetylation of p53 in vivo. It specifically represses the p300/CBP HAT activity-dependent transcriptional activation from chromatin but not a DNA template. It is significant that curcumin could inhibit the acetylation of HIV-Tat protein in vitro by p300 as well as proliferation of the virus, as revealed by the repression in syncytia formation upon curcumin treatment in SupT1 cells. Thus, nontoxic curcumin, which targets p300/CBP, may serve as a lead compound in combinatorial HIV therapeutics.	Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Bangalore 560064, Karnataka, India; Jawaharlal Nehru Ctr Adv Sci Res, Mol Virol Lab, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in		Byrareddy, Siddappa/0000-0002-7423-1763; Varier, Radhika/0000-0003-1302-3159; Venkatesh, Swaminathan/0000-0001-9837-1501; Kundu, Tapas/0000-0001-7790-214X				Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Barnes PJ, 2004, LANCET, V363, P731, DOI 10.1016/S0140-6736(04)15650-X; Barthelemy S, 1998, RES VIROLOGY, V149, P43, DOI 10.1016/S0923-2516(97)86899-9; BONNER WM, 1980, EUR J BIOCHEM, V109, P17, DOI 10.1111/j.1432-1033.1980.tb04762.x; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cebrat M, 2003, BIOORGAN MED CHEM, V11, P3307, DOI 10.1016/S0968-0896(03)00265-7; Chambers AE, 2003, EUR J CANCER, V39, P1165, DOI 10.1016/S0959-8049(03)00072-8; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; Coull JJ, 2002, J VIROL, V76, P12349, DOI 10.1128/JVI.76.23.12349-12354.2002; Demonte D, 2004, BIOCHEM PHARMACOL, V68, P1231, DOI 10.1016/j.bcp.2004.05.040; GERA A, 1986, METHOD ENZYMOL, V119, P729; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Gusterson RJ, 2003, J BIOL CHEM, V278, P6838, DOI 10.1074/jbc.M211762200; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; JAPOUR AJ, 1994, J CLIN MICROBIOL, V32, P2291, DOI 10.1128/JCM.32.9.2291-2294.1994; Kalkhoven E, 2003, HUM MOL GENET, V12, P441, DOI 10.1093/hmg/ddg039; Kanamoto T, 2001, ANTIMICROB AGENTS CH, V45, P1225, DOI 10.1128/AAC.45.4.1225-1230.2001; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kramer OH, 2001, TRENDS ENDOCRIN MET, V12, P294, DOI 10.1016/S1043-2760(01)00438-6; Kundu TK, 1999, MOL CELL BIOL, V19, P1605; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lin Jen-Kun, 2001, Proceedings of the National Science Council Republic of China Part B Life Sciences, V25, P59; MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A; MCKEATING JA, 1989, J GEN VIROL, V70, P3327, DOI 10.1099/0022-1317-70-12-3327; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; Muraoka M, 1996, ONCOGENE, V12, P1565; Murata T, 2001, HUM MOL GENET, V10, P1071, DOI 10.1093/hmg/10.10.1071; Neely KE, 2002, MOL GENET METAB, V76, P1, DOI 10.1016/S1096-7192(02)00014-8; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Pan MH, 2001, J AGR FOOD CHEM, V49, P1464, DOI 10.1021/jf001129v; Phillips AC, 2000, BREAST CANCER RES, V2, P244, DOI 10.1186/bcr63; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Quivy V, 2002, BIOCHEM PHARMACOL, V64, P925, DOI 10.1016/S0006-2952(02)01152-8; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; RYAN CA, 2001, CURRENT PROTOCOLS MO; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Taher MM, 2003, MOL CELL BIOCHEM, V254, P289, DOI 10.1023/A:1027393719610; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Wang T, 2001, EMBO J, V20, P6404, DOI 10.1093/emboj/20.22.6404; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252	49	614	634	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51163	51171		10.1074/jbc.M409024200	http://dx.doi.org/10.1074/jbc.M409024200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383533	hybrid			2022-12-27	WOS:000225355800063
J	Jeimy, SB; Woram, RA; Fuller, N; Quinn-Allen, MA; Nicolaes, GAF; Dahlback, B; Kane, WH; Hayward, CPM				Jeimy, SB; Woram, RA; Fuller, N; Quinn-Allen, MA; Nicolaes, GAF; Dahlback, B; Kane, WH; Hayward, CPM			Identification of the MMRN1 binding region within the C2 domain of human factor V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-V; FACTOR-VIII; PROTHROMBINASE COMPLEX; B-DOMAIN; PHOSPHOLIPID-VESICLES; PARTIAL GLYCOSYLATION; ALPHA-GRANULES; CDNA SEQUENCE; FACTOR XA; PROTEIN	In platelets, coagulation cofactor V is stored in complex with multimerin 1 in alpha-granules for activation- induced release during clot formation. The molecular nature of multimerin 1 factor V binding has not been determined, although multimerin 1 is known to interact with the factor V light chain. We investigated the region in factor V important for multimerin 1 binding using modified enzyme-linked immunoassays and recombinant factor V constructs. Factor V constructs lacking the C2 region or entire light chain had impaired and absent multimerin 1 binding, respectively, whereas the B domain deleted construct had modestly reduced binding. Analyses of point mutated constructs indicated that the multimerin 1 binding site in the C2 domain of factor V partially overlaps the phosphatidylserine binding site and that the factor V B domain enhances multimerin 1 binding. Multimerin 1 did not inhibit factor V phosphatidylserine binding, and it bound to phosphatidylserine independently of factor V. There was a reduction in factor V in complex with multimerin 1 after activation, and thrombin cleavage significantly reduced factor V binding to multimerin 1. In molar excess, multimerin 1 minimally reduced factor V procoagulant activity in prothrombinase assays and only if it was added before factor V activation. The dissociation of factor V-multimerin 1 complexes following factor V activation suggests a role for multimerin 1 in delivering and localizing factor V onto platelets prior to prothrombinase assembly.	McMaster Univ, Med Ctr, Hlth Sci Ctr 2N31, Hamilton, ON L8N 3Z5, Canada; Duke Univ, Med Ctr, Durham, NC 27710 USA; Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; Lund Univ, S-20502 Malmo, Sweden	McMaster University; Duke University; Maastricht University; Lund University	Hayward, CPM (corresponding author), McMaster Univ, Med Ctr, Hlth Sci Ctr 2N31, Room 2N31,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	haywrdc@mcmaster.ca	Nicolaes, Gerry A.F./A-8421-2016; Jeimy, Samira/S-1135-2019	Nicolaes, Gerry A.F./0000-0002-2482-0412; Hayward, Catherine/0000-0002-2843-0817; Dahlback, Bjorn/0000-0003-1546-0328; Jeimy, Samira/0000-0002-3425-1874	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043106] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43106, HL54939] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON LO, 1981, BIOCHEM J, V200, P161, DOI 10.1042/bj2000161; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; DAHLBACK B, 1984, SEMIN THROMB HEMOST, V10, P139, DOI 10.1055/s-2007-1004416; Guasch JF, 1998, BRIT J HAEMATOL, V101, P32, DOI 10.1046/j.1365-2141.1998.00664.x; GUINTO ER, 1992, J BIOL CHEM, V267, P2971; Hayward CPM, 2004, THROMB HAEMOSTASIS, V92, P1349, DOI 10.1160/TH03-02-0123; HAYWARD CPM, 1991, J BIOL CHEM, V266, P7114; HAYWARD CPM, 1995, J BIOL CHEM, V270, P19217, DOI 10.1074/jbc.270.33.19217; Hayward CPM, 2001, BRIT J HAEMATOL, V113, P871, DOI 10.1046/j.1365-2141.2001.02833.x; HAYWARD CPM, 1993, J CLIN INVEST, V91, P2630, DOI 10.1172/JCI116502; HAYWARD CPM, 1995, J BIOL CHEM, V270, P18246, DOI 10.1074/jbc.270.31.18246; KALAFATIS M, 2003, J BIOL CHEM, V279, P2383; KANE WH, 1988, BLOOD, V71, P539; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; Kim SW, 1999, BIOCHEMISTRY-US, V38, P11448, DOI 10.1021/bi991275y; Kim SW, 2000, BIOCHEMISTRY-US, V39, P1951, DOI 10.1021/bi992256r; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P5714; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; MILETICH JP, 1978, J CLIN INVEST, V62, P824, DOI 10.1172/JCI109194; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Nicolaes GAF, 2000, BLOOD COAGUL FIBRIN, V11, P89, DOI 10.1097/00001721-200011010-00010; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; ORTEL TL, 1994, J BIOL CHEM, V269, P15898; ORTEL TL, 1992, J BIOL CHEM, V267, P4189; Peng WM, 2004, BIOCHEMISTRY-US, V43, P4385, DOI 10.1021/bi035763o; PITTMAN DD, 1994, BLOOD, V84, P4214, DOI 10.1182/blood.V84.12.4214.bloodjournal84124214; PITTMAN DD, 1994, BIOCHEMISTRY-US, V33, P6952, DOI 10.1021/bi00188a026; ROSING J, 1980, J BIOL CHEM, V255, P274; Salzman, 2001, HEMOSTASIS THROMBOSI, P157; Steen M, 2002, SCAND J CLIN LAB INV, V62, P5, DOI 10.1080/003655102762377439; Thompson AR, 2003, SEMIN THROMB HEMOST, V29, P11, DOI 10.1055/s-2003-37935; Thorelli E, 1998, J BIOL CHEM, V273, P16140, DOI 10.1074/jbc.273.26.16140; Thorelli E, 1997, EUR J BIOCHEM, V247, P12, DOI 10.1111/j.1432-1033.1997.00012.x; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Yang TL, 1998, BLOOD, V91, P4593, DOI 10.1182/blood.V91.12.4593.412a02_4593_4599	37	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51466	51471		10.1074/jbc.M409866200	http://dx.doi.org/10.1074/jbc.M409866200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452129	hybrid			2022-12-27	WOS:000225355800099
J	Okuda, M; Tanaka, A; Arai, Y; Satoh, M; Okamura, H; Nagadoi, A; Hanaoka, F; Ohkuma, Y; Nishimura, Y				Okuda, M; Tanaka, A; Arai, Y; Satoh, M; Okamura, H; Nagadoi, A; Hanaoka, F; Ohkuma, Y; Nishimura, Y			A novel zinc finger structure in the large subunit of human general transcription factor TFIIE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR TFIIS; 2-DIMENSIONAL NMR EXPERIMENTS; INITIATION COMPLEX-FORMATION; TERMINAL DOMAIN; EUCARYAL TRANSCRIPTION; C-13-LABELED PROTEINS; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; SCALAR COUPLINGS	The zinc finger domain in the large subunit of TFIIE (TFIIEalpha) is phylogenetically conserved and is essential for transcription. Here, we determined the solution structure of this domain by using NMR. It consisted of one alpha-helix and five beta-strands, showing novel features distinct from previously determined zinc-binding structures. We created point mutants of TFIIEalpha in this domain and examined their binding abilities to other general transcription factors as well as their transcription activities. Four Zn2+-ligand mutants, in which each of cysteine residues at positions 129, 132, 154, and 157 was replaced by alanine, possessed no transcription activities on a linearized template, whereas, on a supercoiled template, interesting functional asymmetry was observed: although the C-terminal two mutants abolished transcription activity (< 5%), the N-terminal two mutants retained about 20% activities. The N-terminal two mutants bound stronger to the small subunit of TFIIF than the wild type and the C-terminal two mutants were impaired in their binding abilities to the XPB subunits of TFIIH. These suggest that the structural integrity of the zinc finger domain is essential for the TFIIE function, particularly in the transition from the transcription initiation to elongation and the conformational tuning of this domain for appropriate positioning of TFIIF, TFIIH, and polymerase II would be needed depending on the situation and timing.	Yokohama City Univ, Grad Sch Integrated Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Kihara Mem Yokohama Fdn Advancement Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan; RIKEN, Cellular Physiol Lab, Wako, Saitama 3510198, Japan	Yokohama City University; Osaka University; Osaka University; RIKEN	Nishimura, Y (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	nisimura@tsurumi.yokohama-cu.ac.jp		Nishimura, Yoshifumi/0000-0002-5148-3458; Okuda, Masahiko/0000-0001-5834-0559				Bell SD, 2001, EMBO REP, V2, P133, DOI 10.1093/embo-reports/kve021; Brunger A.T., 1993, X PLOR VERSION 3 1 S; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chen HT, 2000, PROTEIN SCI, V9, P1743, DOI 10.1110/ps.9.9.1743; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Douziech M, 2000, MOL CELL BIOL, V20, P8168, DOI 10.1128/MCB.20.21.8168-8177.2000; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hanzelka BL, 2001, J BACTERIOL, V183, P1813, DOI 10.1128/JB.183.5.1813-1818.2001; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krichna N.R., 1998, BIOL MAGNETIC RESONA, V16; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leuther KK, 1996, CELL, V85, P773, DOI 10.1016/S0092-8674(00)81242-8; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; LUI A, 2000, J BIOMOL NMR, V17, P79; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; MAXON ME, 1994, P NATL ACAD SCI USA, V91, P9529, DOI 10.1073/pnas.91.20.9529; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; OHKUMA Y, 1991, NATURE, V354, P398, DOI 10.1038/354398a0; Okamoto T, 1998, J BIOL CHEM, V273, P19866, DOI 10.1074/jbc.273.31.19866; Okuda M, 2000, EMBO J, V19, P1346, DOI 10.1093/emboj/19.6.1346; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PARVIN JD, 1994, J BIOL CHEM, V269, P18414; PETERSON MG, 1991, NATURE, V354, P369; Prompers JJ, 1998, J MAGN RESON, V130, P68, DOI 10.1006/jmre.1997.1277; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; SUMIMOTO H, 1991, NATURE, V354, P401, DOI 10.1038/354401a0; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; TONG X, 1995, MOL CELL BIOL, V15, P4735; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; Wang B, 1998, STRUCTURE, V6, P555, DOI 10.1016/S0969-2126(98)00058-6; Watanabe T, 2003, MOL CELL BIOL, V23, P2914, DOI 10.1128/MCB.23.8.2914-2926.2003; Yamamoto S, 2001, MOL CELL BIOL, V21, P1, DOI 10.1128/MCB.21.1.1-15.2001; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	53	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51395	51403		10.1074/jbc.M404722200	http://dx.doi.org/10.1074/jbc.M404722200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385556	hybrid			2022-12-27	WOS:000225355800091
J	Liu, SJ; Zhang, JY; Li, HL; Fang, ZY; Wang, Q; Deng, HM; Gong, CX; Grundke-Iqbal, I; Iqbal, K; Wang, JZ				Liu, SJ; Zhang, JY; Li, HL; Fang, ZY; Wang, Q; Deng, HM; Gong, CX; Grundke-Iqbal, I; Iqbal, K; Wang, JZ			Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; GLYCOGEN-SYNTHASE KINASE-3; DEPENDENT PROTEIN-KINASE; ALZHEIMER-LIKE PHOSPHORYLATION; ABNORMAL PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; FETAL TAU; DISEASE; SITES; BINDING	Microtubule-associated protein tau is abnormally hyperphosphorylated in Alzheimer's disease ( AD) and other tauopathies and is believed to lead to neurodegeneration in this family of diseases. Here we show that infusion of forskolin, a specific cAMP-dependent protein kinase A (PKA) activator, into the lateral ventricle of brain in adult rats induced activation of PKA by several-fold and concurrently enhanced the phosphorylation of tau at Ser-214, Ser-198, Ser-199, and or Ser-202 (Tau-1 site) and Ser-396 and or Ser-404 (PHF-1 site), which are among the major abnormally hyperphosphorylated sites seen in AD. PKA activation positively correlated to the extent of tau phosphorylation at these sites. Infusion of forskolin together with PKA inhibitor or glycogen synthase kinase-3 (GSK-3) inhibitor revealed that the phosphorylation of tau at Ser-214 was catalyzed by PKA and that the phosphorylation at both the Tau-1 and the PHF-1 sites is induced by basal level of GSK-3, because forskolin activated PKA and not GSK-3 and inhibition of the latter inhibited the phosphorylation at Tau-1 and PHF-1 sites. Inhibition of cdc2, cdk5, or MAPK had no significant effect on the forskolin-induced hyperphosphorylation of tau. Forskolin inhibited spatial memory in a dose-dependent manner in the absence but not in the presence of Rp-adenosine 3', 5'-cyclic monophosphorothioate triethyl ammonium salt, a PKA inhibitor. These results demonstrate for the first time that phosphorylation of tau by PKA primes it for phosphorylation by GSK-3 at the Tau-1 and the PHF-1 sites and that an associated loss in spatial memory is inhibited by inhibition of the hyperphosphorylation of tau. These data provide a novel mechanism of the hyperphosphorylation of tau and identify both PKA and GSK-3 as promising therapeutic targets for AD and other tauopathies.	Hua Zhong Univ Sci & Technol, Tongji Med Coll, Inst Neurosci, Dept Pathophysiol, Wuhan 430030, Peoples R China; New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Huazhong University of Science & Technology; Institute for Basic Research in Developmental Disabilities	Wang, JZ (corresponding author), Hua Zhong Univ Sci & Technol, Tongji Med Coll, Inst Neurosci, Dept Pathophysiol, Wuhan 430030, Peoples R China.	wangjz@mails.tjmu.edu.cn		Zhang, jiayu/0000-0003-0137-746X	NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER; NIA NIH HHS [AG19158] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADASHI EY, 1986, J CELL BIOCHEM, V31, P217, DOI 10.1002/jcb.240310304; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Avila J, 2002, MOL NEUROBIOL, V25, P213, DOI 10.1385/MN:25:3:213; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bennecib M, 2000, ALZHEIMERS REP, V3, P295; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Clare PM, 2001, J BIOL CHEM, V276, P48292, DOI 10.1074/jbc.M102034200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; IQBAL K, 1986, LANCET, V2, P421; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; IQBAL K, 1995, NEUROBIOL AGING, V16, P375, DOI 10.1016/0197-4580(95)00033-B; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Jicha GA, 1999, J NEUROCHEM, V72, P214, DOI 10.1046/j.1471-4159.1999.0720214.x; Johnson G V, 1999, J Alzheimers Dis, V1, P329; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Kultz D, 1998, J BIOL CHEM, V273, P13645, DOI 10.1074/jbc.273.22.13645; Lau Lit-Fui, 2002, Current Topics in Medicinal Chemistry, V2, P395, DOI 10.2174/1568026024607526; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEW J, 1992, J BIOL CHEM, V267, P13383; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; LoGrasso PV, 1997, BIOCHEMISTRY-US, V36, P10422, DOI 10.1021/bi9706778; Lovestone S, 1997, NEUROSCIENCE, V78, P309; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; ROBERTSON J, 1993, DEMENTIA, V4, P256, DOI 10.1159/000107331; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Singh TJ, 1996, MOL CELL BIOCHEM, V154, P143, DOI 10.1007/BF00226782; SINGH TJ, 1995, FEBS LETT, V358, P267, DOI 10.1016/0014-5793(94)01445-7; SONG JS, 1995, J PROTEIN CHEM, V14, P95, DOI 10.1007/BF01888367; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Tolnay M, 1999, NEUROPATH APPL NEURO, V25, P171; Tsujio I, 2000, FEBS LETT, V469, P111, DOI 10.1016/S0014-5793(00)01234-5; Wang JZ, 1996, NAT MED, V2, P871, DOI 10.1038/nm0896-871; Wang JZ, 1998, FEBS LETT, V436, P28, DOI 10.1016/S0014-5793(98)01090-4; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; YANG SD, 1994, J NEUROCHEM, V63, P1416; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	64	141	163	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50078	50088		10.1074/jbc.M406109200	http://dx.doi.org/10.1074/jbc.M406109200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375165	hybrid			2022-12-27	WOS:000225229500066
J	Olmo-Mira, MF; Gavira, M; Richardson, DJ; Castillo, F; Moreno-Vivian, C; Roldan, MD				Olmo-Mira, MF; Gavira, M; Richardson, DJ; Castillo, F; Moreno-Vivian, C; Roldan, MD			NapF is a cytoplasmic iron-sulfur protein required for Fe-S cluster assembly in the periplasmic nitrate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; SPHAEROIDES DSM 158; RHODOBACTER-SPHAEROIDES; GENE-EXPRESSION; RHODOPSEUDOMONAS-CAPSULATA; POLYACRYLAMIDE GELS; EXPORT PATHWAY; MEMBRANE; SYSTEM; SITES	The periplasmic nitrate reductase (Nap) is widespread in proteobacteria. NapA, the nitrate reductase catalytic subunit, contains a Mo-bisMGD cofactor and one [4Fe-4S] cluster. The nap gene clusters in many bacteria, including Rhodobacter sphaeroides DSM158, contain an napF gene, disruption of which drastically decreases both in vitro and in vivo nitrate reductase activities. In spite its importance in the Nap system, NapF has never been characterized biochemically, and its role remains unknown. The NapF protein has four polycysteine clusters that suggest that it is an iron-sulfur-containing protein. In the present study, a His(6)-tagged NapF protein was overproduced in Escherichia coli and purified anaerobically. The purified NapF protein was used to obtain polyclonal antibodies raised in rabbit, and cellular fractionation of R. sphaeroides followed by immunoprobing with anti-NapF antibodies revealed that the native NapF protein is located in the cytoplasm. This contrasts with the periplasmic location of the mature NapA. However, NapA could not be detected in an isogenic napF(-) strain of R. sphaeroides. The His(6)-tagged NapF protein displayed spectral properties indicative of Fe-S clusters, but these features were rapidly lost, suggesting cluster lability. However, reconstitution of the Fe-S centers into the apo-NapF protein was achieved in the presence of Azotobacter vinelandii cysteine desulfurase (NifS), and this allowed the recovery of nitrate reductase activity in NapA protein that had previously been treated with 2,2'-dipyridyl to remove the [4Fe-4S] cluster. This activity was not recovered in the absence of NapF. Taking into account the cytoplasmic localization of NapF, the presence of labile Fe-S clusters in the protein, the napF(-) strain phenotype, and the NapF-dependent reactivation of the 2,2'-dipyridyltreated NapA, we propose a role for NapF in assembling the [4Fe-4S] center of the catalytic subunit NapA.	Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa, E-14071 Cordoba, Spain; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Universidad de Cordoba; University of East Anglia	Roldan, MD (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Edificio Severo Ochoa, Campus Rabanales,1a Planta, E-14071 Cordoba, Spain.	bb2rorum@uco.es	Richardson, David J/E-2275-2011; Moreno, Conrado/K-3976-2014; Roldán Ruiz, María Dolores/K-4370-2014	Roldán Ruiz, María Dolores/0000-0001-7173-8641				ARNOLD W, 1988, GENE, V70, P171, DOI 10.1016/0378-1119(88)90115-1; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Brondijk THC, 2002, MOL MICROBIOL, V44, P245, DOI 10.1046/j.1365-2958.2002.02875.x; Buc J, 1995, EUR J BIOCHEM, V234, P766, DOI 10.1111/j.1432-1033.1995.766_a.x; CARITHERS RP, 1977, J BIOL CHEM, V252, P7461; Delgado MJ, 2003, MICROBIOL-SGM, V149, P3395, DOI 10.1099/mic.0.26620-0; DIEZ J, 1989, ARCH BIOCHEM BIOPHYS, V268, P707, DOI 10.1016/0003-9861(89)90339-1; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; FRANCIS RT, 1984, ANAL BIOCHEM, V136, P509, DOI 10.1016/0003-2697(84)90253-7; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Gavira M, 2002, J BACTERIOL, V184, P1693, DOI 10.1128/JB.184.6.1693-1702.2002; Grove J, 1996, MOL MICROBIOL, V19, P467, DOI 10.1046/j.1365-2958.1996.383914.x; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; JONES RW, 1977, BIOCHEM J, V164, P199, DOI 10.1042/bj1640199; Kamps A, 2004, MOL MICROBIOL, V52, P713, DOI 10.1111/j.1365-2958.2004.04024.x; KERBER NL, 1982, J BACTERIOL, V150, P1091, DOI 10.1128/JB.150.3.1091-1097.1982; KHOROSHILOVA N, 1995, P NATL ACAD SCI USA, V92, P2499, DOI 10.1073/pnas.92.7.2499; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCEWAN AG, 1984, ARCH MICROBIOL, V137, P344, DOI 10.1007/BF00410732; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; MORENOVIVIAN C, 1986, FEMS MICROBIOL LETT, V34, P105, DOI 10.1111/j.1574-6968.1986.tb01358.x; Nilsson UA, 2002, FREE RADICAL RES, V36, P677, DOI 10.1080/10715760290029128; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Potter LC, 1999, BIOCHEM J, V344, P69, DOI 10.1042/0264-6021:3440069; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Reyes F, 1996, MOL MICROBIOL, V19, P1307, DOI 10.1111/j.1365-2958.1996.tb02475.x; Reyes F, 1998, BIOCHEM J, V331, P897, DOI 10.1042/bj3310897; ROLDAN MD, 1994, CURR MICROBIOL, V29, P241, DOI 10.1007/BF01570161; Sambongi Y, 1996, MOL MICROBIOL, V19, P1193, DOI 10.1111/j.1365-2958.1996.tb02465.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sears HJ, 2000, MICROBIOL-UK, V146, P2977, DOI 10.1099/00221287-146-11-2977; SMITH AF, 1983, METHOD ENZYMAT AN, V3, P166; Stoll R, 1996, MICROBIOL-UK, V142, P2577, DOI 10.1099/00221287-142-9-2577; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	44	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49727	49735		10.1074/jbc.M406502200	http://dx.doi.org/10.1074/jbc.M406502200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371424	hybrid			2022-12-27	WOS:000225229500023
J	Riquelme, G; Llanos, P; Tischner, E; Neil, J; Campos, BA				Riquelme, G; Llanos, P; Tischner, E; Neil, J; Campos, BA			Annexin 6 modulates the maxi-chloride channel of the apical membrane of syncytiotrophoblast isolated from human placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; PROTEIN-KINASE-C; LARGE-CONDUCTANCE; MICROVILLOUS MEMBRANE; PLASMA-MEMBRANE; GIANT LIPOSOMES; SPINAL-CORD; CELLS; VI; LOCALIZATION	The syncytiotrophoblast separates the maternal and fetal blood and constitutes the primary barrier for maternal-fetal transport. The Maxi-chloride channel from the apical membrane of the syncytiotrophoblast plays a role in the chloride conductance. Annexins can play an important role in the regulation of membrane events. In this study we evaluate the role of annexin 6 in the Maxichloride channel properties. The results showed that annexin 6 is bound in the apical placenta membranes in a calcium-dependent phospholipid-binding manner but also in a calcium-independent fashion. The neutralization of annexin 6 decreased the total current by 39 +/- 1.9% in the range of +/- 80 mV, and the currents decrease with the time. The single-channel slope conductance was decreased from 253 +/- 7.4 pS ( control) to 105 +/- 13 pS, and the amplitude decreased by 50%. The open probability was also affected when higher voltage steps were used, changes in either the positive or negative direction induced the channel to close, and the open probability (P-o) did not decrease. In channels with neutralized annexin 6, it was maintained at 1 at +/- 40 mV and at +/- 80 mV. These results suggest that endogenous annexin 6 could regulate the Maxi-chloride channel. The results obtained with normal placentae, in which annexin 6 was neutralized, are similar to those described for the Maxichloride channel isolated from pre-eclamptic placenta. Together these data suggest that annexin 6 could play an important role in ion transport of the placenta.	Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 7, Chile	University System of Ohio; University of Cincinnati; Universidad de Chile	Campos, BA (corresponding author), Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	Begona.Campos@uc.edu		Llanos, Paola/0000-0003-1383-7961; Neil, Jessica/0000-0003-0770-5321				Babiychuk EB, 1999, J BIOL CHEM, V274, P35191, DOI 10.1074/jbc.274.49.35191; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Babiychuk EB, 2004, J MEMBRANE BIOL, V198, P95, DOI 10.1007/s00232-004-0663-1; Babiychuk EB, 2002, BBA-PROTEINS PROTEOM, V1600, P154, DOI 10.1016/S1570-9639(02)00456-9; Bahamonde MI, 2003, J BIOL CHEM, V278, P33284, DOI 10.1074/jbc.M302814200; Bathori G, 1999, J BIOL CHEM, V274, P29607, DOI 10.1074/jbc.274.42.29607; Bernucci L, 2003, PLACENTA, V24, P895, DOI 10.1016/S0143-4004(03)00144-9; Birdsey TJ, 1999, AM J PHYSIOL-REG I, V276, pR1479, DOI 10.1152/ajpregu.1999.276.5.R1479; BISSONNETTE JM, 1994, PLACENTA, V15, P445, DOI 10.1016/0143-4004(94)90011-6; BLATZ AL, 1983, BIOPHYS J, V43, P237, DOI 10.1016/S0006-3495(83)84344-6; BROWN PD, 1993, PLACENTA, V14, P103, DOI 10.1016/S0143-4004(05)80253-X; BUDAVARI S, 1996, MERCK INDEX, P1438; Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297; CHAN HC, 1994, J BIOL CHEM, V269, P32464; Clarson LH, 2001, PLACENTA, V22, P328, DOI 10.1053/plac.2000.0622; Colombini M, 1996, Ion Channels, V4, P169; CRUMPTON MJ, 1990, NATURE, V345, P212, DOI 10.1038/345212a0; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; DUBOIS T, 1995, BIOCHEM BIOPH RES CO, V212, P270, DOI 10.1006/bbrc.1995.1966; Dubois T, 1998, BIOCHEM J, V330, P1277, DOI 10.1042/bj3301277; Dubois T, 1996, BBA-MOL CELL RES, V1313, P290, DOI 10.1016/0167-4889(96)00102-4; GASNIER F, 1993, ANAL BIOCHEM, V212, P173, DOI 10.1006/abio.1993.1309; Golczak M, 2001, BIOCHEM BIOPH RES CO, V284, P785, DOI 10.1006/bbrc.2001.5051; Golczak M, 2001, FEBS LETT, V496, P49, DOI 10.1016/S0014-5793(01)02402-4; Golczak Marcin, 2001, FASEB Journal, V15, P1083; Gray H H, 1984, J Hypertens Suppl, V2, pS467; HALM DR, 1992, J GEN PHYSIOL, V99, P339, DOI 10.1085/jgp.99.3.339; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Henriquez M, 2003, J MEMBRANE BIOL, V191, P59, DOI 10.1007/s00232-002-1038-0; ILLSLEY NP, 1990, BIOCHIM BIOPHYS ACTA, V1029, P218, DOI 10.1016/0005-2736(90)90157-J; Jimenez V, 2004, PLACENTA, V25, P422, DOI 10.1016/j.placenta.2003.10.013; KAETZEL MA, 1994, BBA-MOL CELL RES, V1223, P368, DOI 10.1016/0167-4889(94)90097-3; Mira JP, 1997, J BIOL CHEM, V272, P10474; Naciff JM, 1996, AM J PHYSIOL-CELL PH, V271, pC2004; Naciff JM, 1996, J COMP NEUROL, V368, P356; NELSON DJ, 1984, J MEMBRANE BIOL, V80, P81, DOI 10.1007/BF01868692; Nilius B, 1996, J BIOL CHEM, V271, P30631, DOI 10.1074/jbc.271.48.30631; NOBILE M, 1988, BIOCHEM BIOPH RES CO, V154, P719, DOI 10.1016/0006-291X(88)90199-4; RAMBOTTI MG, 1993, CELL MOL BIOL RES, V39, P579; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Riquelme G, 1999, AM J OBSTET GYNECOL, V180, P469, DOI 10.1016/S0002-9378(99)70234-6; RIQUELME G, 1995, AM J OBSTET GYNECOL, V173, P733, DOI 10.1016/0002-9378(95)90332-1; RIQUELME G, 1990, FEBS LETT, V276, P54, DOI 10.1016/0014-5793(90)80505-D; Russo-Marie F, 1999, CLIN CHEM LAB MED, V37, P287, DOI 10.1515/CCLM.1999.050; Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251; Seaton BA, 1998, BIOMETALS, V11, P399, DOI 10.1023/A:1009205925714; Sun JX, 2002, P NATL ACAD SCI USA, V99, P13108, DOI 10.1073/pnas.202260999; Suzuki M, 2004, J BIOL CHEM, V279, P22461, DOI 10.1074/jbc.M313813200; SWAIRJO MA, 1994, ANNU REV BIOPH BIOM, V23, P193, DOI 10.1146/annurev.bb.23.060194.001205; THINNES FP, 1992, J BIOENERG BIOMEMBR, V24, P71, DOI 10.1007/BF00769533; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Yu WH, 1996, J BIOENERG BIOMEMBR, V28, P93, DOI 10.1007/BF02110638	54	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50601	50608		10.1074/jbc.M407859200	http://dx.doi.org/10.1074/jbc.M407859200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355961	hybrid			2022-12-27	WOS:000225229500124
J	Thai, R; Moine, G; Desmadril, M; Servent, D; Tarride, JL; Menez, A; Leonetti, M				Thai, R; Moine, G; Desmadril, M; Servent, D; Tarride, JL; Menez, A; Leonetti, M			Antigen stability controls antigen presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MOLECULES; T-CELL DETERMINANT; NAJA-NIGRICOLLIS; INTACT PROTEINS; DISULFIDE BONDS; EPITOPE IMMUNODOMINANCE; ACETYLCHOLINE-RECEPTOR; QUATERNARY STRUCTURE; CURAREMIMETIC TOXIN; MONOCLONAL-ANTIBODY	We investigated whether protein stability controls antigen presentation using a four disulfide-containing snake toxin and three derivatives carrying one or two mutations (L1A, L1A/H4Y, and H4Y). These mutations were anticipated to increase (H4Y) or decrease (L1A) the antigen non-covalent stabilizing interactions, H4Y being naturally and frequently observed in neurotoxins. The chemically synthesized derivatives shared similar three-dimensional structure, biological activity, and T epitope pattern. However, they displayed differential thermal unfolding capacities, ranging from 65 to 98degreesC. Using these differentially stable derivatives, we demonstrated that antigen stability controls antigen proteolysis, antigen processing in antigen-presenting cells, T cell stimulation, and kinetics of expression of T cell determinants. Therefore, non-covalent interactions that control the unfolding capacity of an antigen are key parameters in the efficacy of antigen presentation. By affecting the stabilizing interaction network of proteins, some natural mutations may modulate the subsequent T-cell stimulation and might help microorganisms to escape the immune response.	Ctr Etud Saclay, Commissariat Energie Atom, DIEP, F-91191 Gif Sur Yvette, France; EP1088 Univ Paris Sud, Lab Modelisat & Ingn Prot, F-91405 Orsay, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay	Leonetti, M (corresponding author), Ctr Etud Saclay, Commissariat Energie Atom, DIEP, Batiment 152, F-91191 Gif Sur Yvette, France.	michel.leonetti@cea.fr	Desmadril, Michel/AAC-8174-2020	Thai, Robert/0000-0001-9438-4225; Servent, Denis/0000-0002-0774-1691				Akasako A, 1997, J BIOL CHEM, V272, P18686, DOI 10.1074/jbc.272.30.18686; ALEXANDER P, 1992, BIOCHEMISTRY-US, V31, P3597, DOI 10.1021/bi00129a007; ALLEN PM, 1984, AM J ANAT, V170, P483, DOI 10.1002/aja.1001700319; Ametani A, 2003, BIOSCI BIOTECH BIOCH, V67, P1507, DOI 10.1271/bbb.67.1507; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; BONIFACINO JS, 2001, CURRENT PROTOCOLS IM, V2; BOULAIN JC, 1982, BIOCHEMISTRY-US, V21, P2910, DOI 10.1021/bi00541a016; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Buckle AM, 1996, BIOCHEMISTRY-US, V35, P4298, DOI 10.1021/bi9524676; Carmicle S, 2002, J BIOL CHEM, V277, P155, DOI 10.1074/jbc.M107624200; Castellino F, 1998, J IMMUNOL, V161, P4048; CHESNUT RW, 1982, J IMMUNOL, V128, P1764; Chianese-Bullock KA, 1998, J IMMUNOL, V161, P1599; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Dai GX, 2002, J BIOL CHEM, V277, P161, DOI 10.1074/jbc.M102259200; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DONERMEYER DL, 1989, J IMMUNOL, V142, P1063; EISENLOHR LC, 1988, J IMMUNOL, V141, P1870; Endo T., 1991, P165; FAGAIN C, 1995, BBA-PROTEIN STRUCT M, V1252, P1, DOI 10.1016/0167-4838(95)00133-F; GLIMCHER LH, 1983, J IMMUNOL, V131, P2868; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; ISHIKAWA Y, 1977, TOXICON, V15, P477, DOI 10.1016/0041-0101(77)90098-8; Janssen R, 1996, INT IMMUNOL, V8, P829, DOI 10.1093/intimm/8.6.829; JENSEN PE, 1991, J EXP MED, V174, P1121, DOI 10.1084/jem.174.5.1121; JENSEN PE, 1993, J IMMUNOL, V150, P3347; KANAYA S, 1993, J BIOTECHNOL, V28, P117, DOI 10.1016/0168-1656(93)90129-B; Larsen SL, 1996, J EXP MED, V184, P183, DOI 10.1084/jem.184.1.183; LEE P, 1988, J IMMUNOL, V140, P1063; LEONETTI M, 1990, J IMMUNOL, V145, P4214; MAILLERE B, 1993, J IMMUNOL, V150, P5270; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MATSUMURA M, 1986, NATURE, V323, P356, DOI 10.1038/323356a0; MCCOY KL, 1989, J IMMUNOL, V143, P29; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MENEZ A, 1971, FEBS LETT, V17, P333, DOI 10.1016/0014-5793(71)80180-1; Moudgil KD, 1998, IMMUNOL TODAY, V19, P217, DOI 10.1016/S0167-5699(97)01233-4; Mourier G, 2000, PROTEIN ENG, V13, P217, DOI 10.1093/protein/13.3.217; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; PERKINS DL, 1991, J IMMUNOL, V146, P2137; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; ROUAS N, 1993, J IMMUNOL, V150, P782; Ruegg U T, 1977, Methods Enzymol, V47, P111; Runnels HA, 1997, MOL IMMUNOL, V34, P471, DOI 10.1016/S0161-5890(97)00043-6; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; SETTE A, 1989, J IMMUNOL, V143, P1265; So T, 1997, J BIOL CHEM, V272, P32136, DOI 10.1074/jbc.272.51.32136; So T, 2001, IMMUNOLOGY, V104, P259, DOI 10.1046/j.1365-2567.2001.01314.x; STEARMAN RS, 1988, BIOCHEMISTRY-US, V27, P7571, DOI 10.1021/bi00419a059; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STREICHER HZ, 1984, P NATL ACAD SCI-BIOL, V81, P6831, DOI 10.1073/pnas.81.21.6831; TREMEAU O, 1986, FEBS LETT, V208, P236, DOI 10.1016/0014-5793(86)81024-9; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; WANG Y, 1992, J IMMUNOL, V148, P3034; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; ZINNJUSTIN S, 1993, BIOCHEMISTRY-US, V32, P6884, DOI 10.1021/bi00078a011; ZINNJUSTIN S, 1992, BIOCHEMISTRY-US, V31, P11335, DOI 10.1021/bi00161a011	61	61	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50257	50266		10.1074/jbc.M405738200	http://dx.doi.org/10.1074/jbc.M405738200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364925	hybrid			2022-12-27	WOS:000225229500087
J	Vedhachalam, C; Liu, LJ; Nickel, M; Dhanasekaran, P; Anantharamaiah, GM; Lund-Katz, S; Rothblat, GH; Phillips, MC				Vedhachalam, C; Liu, LJ; Nickel, M; Dhanasekaran, P; Anantharamaiah, GM; Lund-Katz, S; Rothblat, GH; Phillips, MC			Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; C-TERMINAL DOMAIN; PLASMA-MEMBRANE MICROSOLUBILIZATION; AMPHIPATHIC HELICAL PEPTIDES; BINDING; ABCA1; AFFINITY; HDL	The influence of apolipoprotein (apo) A-I structure on ABCA1-mediated efflux of cellular unesterified (free) cholesterol (FC) and phospholipid (PL) is not well understood. To address this issue, we used a series of apoA-I mutants to examine the contributions of various domains in the molecule to ABCA1-mediated FC and PL efflux from mouse J774 macrophages and human skin fibroblasts. Irrespective of the cell type, deletion or disruption of the C-terminal lipid-binding domain of apoA-I drastically reduced the FC and PL efflux (similar to90%), indicating that the C-terminal amphipathic alpha-helix is required for high affinity microsolubilization of FC and PL. Deletion in the N-terminal region of apoA-I also reduced the lipid efflux (similar to30%) and increased the K-m about 2-fold compared with wild type apoA-I, whereas deletion of the central domain (Delta123-166) had no effect on either K-m or V-max. These results indicate that ABCA1-mediated lipid efflux is relatively insensitive to the organization of the apoA-I N-terminal helix-bundle domain. Alterations in apoA-I structure caused parallel changes in its ability to bind to a PL bilayer and to induce efflux of FC and PL. Overall, these results are consistent with a two-step model for ABCA1-mediated lipid efflux. In the first step, apoA-I binds to ABCA1 and hydrophobic alpha-helices in the C-terminal domain of apoA-I insert into the region of the perturbed PL bilayer created by the PL transport activity of ABCA1, thereby allowing the second step of lipidation of apoA-I and formation of nascent high density lipoprotein particles to occur.	Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div GI Nutr,Abramson Res Ctr, Philadelphia, PA 19104 USA; Univ Alabama, Dept Med Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Arteriosclerosis Res Unit, Birmingham, AL 35294 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Phillips, MC (corresponding author), Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div GI Nutr,Abramson Res Ctr, Suite 1102,3615 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	Phillipsmi@email.chop.edu		Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANANTHARAMAIAH GM, 1986, METHOD ENZYMOL, V128, P627; Barter PJ, 1996, ATHEROSCLEROSIS, V121, P1, DOI 10.1016/0021-9150(95)05675-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Brewer HB, 2003, AM J CARDIOL, V91, p3E, DOI 10.1016/S0002-9149(02)03382-9; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Burgess JW, 1999, BIOCHEMISTRY-US, V38, P14524, DOI 10.1021/bi990930z; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Favari E, 2002, BIOCHEM BIOPH RES CO, V299, P801, DOI 10.1016/S0006-291X(02)02745-6; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; Gillotte-Taylor K, 2002, J BIOL CHEM, V277, P11811, DOI 10.1074/jbc.M108268200; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McManus DC, 2000, J BIOL CHEM, V275, P5043, DOI 10.1074/jbc.275.7.5043; MENDEZ AJ, 1994, J CLIN INVEST, V94, P1698, DOI 10.1172/JCI117515; Natarajan P, 2004, J BIOL CHEM, V279, P24044, DOI 10.1074/jbc.M400561200; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Oram JF, 1996, J LIPID RES, V37, P2473; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; Schulman BA, 1996, NAT STRUCT BIOL, V3, P682, DOI 10.1038/nsb0896-682; Schultz Joshua R., 1994, Current Opinion in Lipidology, V5, P126, DOI 10.1097/00041433-199404000-00009; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Sviridov D, 2002, ATHEROSCLEROSIS, V161, P245, DOI 10.1016/S0021-9150(01)00677-3; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD	41	71	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49931	49939		10.1074/jbc.M406924200	http://dx.doi.org/10.1074/jbc.M406924200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383537	hybrid			2022-12-27	WOS:000225229500048
J	Lee, JH; Lau, KF; Perkinton, MS; Standen, CL; Rogelj, B; Falinska, A; McLoughlin, DM; Miller, CCJ				Lee, JH; Lau, KF; Perkinton, MS; Standen, CL; Rogelj, B; Falinska, A; McLoughlin, DM; Miller, CCJ			The neuronal adaptor protein X11 beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; MUTANT PRESENILIN-1; CYTOPLASMIC DOMAIN; DISTINCT SITES; X11; PHOSPHORYLATION; METABOLISM; DEPOSITION; EXPRESSION	Accumulation of cerebral amyloid beta-protein (Abeta) is believed to be part of the pathogenic process in Alzheimer's disease. Abeta is derived by proteolytic cleavage from a precursor protein, the amyloid precursor protein (APP). APP is a type-1 membrane-spanning protein, and its carboxyl-terminal intracellular domain binds to X11beta, a neuronal adaptor protein. X11beta has been shown to inhibit the production of Abeta in transfected non-neuronal cells in culture. However, whether this is also the case in vivo in the brain and whether X11beta can also inhibit the deposition of Abeta as amyloid plaques is not known. Here we show that transgenic overexpression of X11beta in neurons leads to a decrease in cerebral Abeta levels in transgenic APPswe Tg2576 mice that are a model of the amyloid pathology of Alzheimer's disease. Moreover, overexpression of X11beta retards amyloid plaque formation in these APPswe mice. Our findings suggest that modulation of X11beta function may represent a novel therapeutic approach for preventing the amyloid pathology of Alzheimer's disease.	Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England; Kings Coll London, Inst Psychiat, Old Age Psychiat Sect, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Miller, CCJ (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci, POB P037,De Crespigny Pk,Denmark Hill, London SE5 8AF, England.	chris.miller@iop.kcl.ac.uk	Rogelj, Boris/G-9252-2011; Miller, Christopher/H-5733-2012	Rogelj, Boris/0000-0003-3898-1943; McLoughlin, Declan/0000-0003-4574-2799; Miller, Christopher/0000-0002-5130-1845; Lau, Kwok-Fai/0000-0002-0193-1152	Medical Research Council [G0000749] Funding Source: Medline; MRC [G0000749] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Biederer T, 2002, J NEUROSCI, V22, P7340; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1999, J NEUROSCI, V19, P1307; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dineley KT, 2002, J BIOL CHEM, V277, P22768, DOI 10.1074/jbc.M200164200; Duff K, 2001, CURR OPIN NEUROL, V14, P441, DOI 10.1097/00019052-200108000-00003; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; Kurt MA, 2001, EXP NEUROL, V171, P59, DOI 10.1006/exnr.2001.7717; Lau KF, 2002, MOL CELL NEUROSCI, V20, P13, DOI 10.1006/mcne.2002.1108; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee DS, 2000, J BIOL CHEM, V275, P23134, DOI 10.1074/jbc.C000302200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesuisse C, 2001, HUM MOL GENET, V10, P2525, DOI 10.1093/hmg/10.22.2525; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; McLoughlin DM, 1996, FEBS LETT, V397, P197; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Nakajima Y, 2001, MOL BRAIN RES, V92, P27, DOI 10.1016/S0169-328X(01)00126-7; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Sumioka A, 2003, BIOCHEM J, V374, P261, DOI 10.1042/BJ20030489; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Taru H, 2004, J BIOL CHEM, V279, P21628, DOI 10.1074/jbc.M312007200; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Tomita S, 2000, J BIOL CHEM, V275, P13056, DOI 10.1074/jbc.C000019200; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Wong PC, 2002, NAT NEUROSCI, V5, P633, DOI 10.1038/nn0702-633; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	54	59	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49099	49104		10.1074/jbc.M405602200	http://dx.doi.org/10.1074/jbc.M405602200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347685	hybrid, Green Published			2022-12-27	WOS:000225098100074
J	Liao, BS; Patel, M; Hu, Y; Charles, S; Herrick, DJ; Brewer, G				Liao, BS; Patel, M; Hu, Y; Charles, S; Herrick, DJ; Brewer, G			Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; BECKWITH-WIEDEMANN-SYNDROME; CULTURED-MAMMALIAN-CELLS; C-MYC EXPRESSION; IN-VITRO; INTERFERING RNA; IGF-II; ANTISENSE OLIGONUCLEOTIDES; CAENORHABDITIS-ELEGANS; BIOLOGICAL ACTIONS	The c-myc mRNA coding region determinant-binding protein (CRD-BP) was first identified as a masking protein that stabilizes c-myc mRNA in a cell-free mRNA degradation system. Thus, CRD-BP is thought to promote cell proliferation by maintaining c-Myc at critical levels. CRD-BP also appears to be an oncofetal protein, based upon its expression during mammalian development and in some tumors. By using K562 leukemia cells as a model, we show that CRD-BP gene silencing by RNA interference significantly promoted proliferation, indicating an inhibitory effect of CRD-BP on proliferation. Unexpectedly, CRD-BP knockdown had no discernible effect on c-myc mRNA levels. CRD-BP is also known as insulin-like growth factor II (IGF-II) mRNA-binding protein-1. It has been reported to repress translation of a luciferase reporter mRNA containing an IGF-II 5'-untranslated region known as leader 3 but not one containing IGF-II leader 4. CRD-BP knockdown markedly increased IGF-II mRNA and protein levels but did not alter translation of luciferase reporter mRNAs containing 5'-untranslated regions consisting of either IGF-II leader 3 or leader 4. Addition of antibody against IGF-II to cell cultures inhibited the proliferative effect of CRD-BP knockdown, suggesting that regulation of IGF-II gene expression, rather than c-myc mRNA levels, mediates the proliferative effect of CRD-BP knockdown. Thus, we have identified a dominant function for CRD-BP in cell proliferation of human K562 cells, involving a possible IGF-II-dependent mechanism that appears independent of its ability to serve as a c-myc mRNA masking protein.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA; Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Jefferson University	Brewer, G (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	brewerga@umdnj.edu			NCI NIH HHS [CA094243] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA094243] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aro ALA, 2002, LEUKEMIA RES, V26, P831, DOI 10.1016/S0145-2126(02)00006-1; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Brewer G, 2000, J BIOL CHEM, V275, P33336, DOI 10.1074/jbc.M006145200; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; Chiu YL, 2002, MOL CELL, V10, P549, DOI 10.1016/S1097-2765(02)00652-4; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Doyle GA, 2000, CANCER RES, V60, P2756; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; HAMMARBERG B, 1991, J BIOL CHEM, V266, P11058; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Harborth J, 2001, J CELL SCI, V114, P4557; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Ioannidis P, 2001, INT J CANCER, V94, P480, DOI 10.1002/ijc.1512; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Khandwala HM, 2000, ENDOCR REV, V21, P215, DOI 10.1210/er.21.3.215; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; Lee CH, 1998, J BIOL CHEM, V273, P25261, DOI 10.1074/jbc.273.39.25261; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; PEPE MG, 1987, J CELL PHYSIOL, V133, P219, DOI 10.1002/jcp.1041330204; Prendergast GC, 1999, ONCOGENE, V18, P2967, DOI 10.1038/sj.onc.1202727; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; SANDBERG AC, 1988, NEUROSCI LETT, V93, P114, DOI 10.1016/0304-3940(88)90022-5; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Sharp PA, 2000, SCIENCE, V287, P2431, DOI 10.1126/science.287.5462.2431; SINGH P, 1994, AM J PHYSIOL, V267, P608; Stewart DA, 2002, NUCLEIC ACIDS RES, V30, P2565, DOI 10.1093/nar/30.11.2565; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; TALLY M, 1987, BIOCHEM BIOPH RES CO, V148, P811, DOI 10.1016/0006-291X(87)90948-X; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Thorgeirsson SS, 1996, BRIT J CLIN PHARMACO, V42, P43, DOI 10.1046/j.1365-2125.1996.03748.x; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; van Dijk EL, 2001, NUCLEIC ACIDS RES, V29, P3477, DOI 10.1093/nar/29.17.3477; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WORBY CA, 2001, SCI STKE; Yi HK, 2001, EUR J CANCER, V37, P2257, DOI 10.1016/S0959-8049(01)00269-6; ZAPF J, 1986, HORM RES, V24, P121, DOI 10.1159/000180551; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; Zhang QM, 1997, J BIOL CHEM, V272, P23703, DOI 10.1074/jbc.272.38.23703; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	61	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48716	48724		10.1074/jbc.M405853200	http://dx.doi.org/10.1074/jbc.M405853200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355996	hybrid			2022-12-27	WOS:000225098100029
J	Namkung, Y; Sibley, DR				Namkung, Y; Sibley, DR			Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D-2 dopamine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; HAMSTER OVARY CELLS; COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; D2 RECEPTORS; HETEROLOGOUS-DESENSITIZATION; DEPENDENT PHOSPHORYLATION; DIFFERENTIAL REGULATION; CROSS-TALK; BETA	Previously, D-2 dopamine receptors (D-2 DARs) have been shown to undergo G-protein-coupled receptor kinase phosphorylation in an agonist-specific fashion. We have now investigated the ability of the second messenger-activated protein kinases, protein kinase A (PKA) and protein kinase C (PKC), to mediate phosphorylation and desensitization of the D-2 DAR. HEK293T cells were transiently transfected with the D-2 DAR and then treated with intracellular activators and inhibitors of PKA or PKC. Treatment with agents that increase cAMP, and activate PKA, had no effect on the phosphorylation state of the D-2 DAR, suggesting that PKA does not phosphorylate the D-2 DAR in HEK293T cells. In contrast, cellular treatment with phorbol 12-myristate 13-acetate (PMA), a PKC activator, resulted in an similar to3-fold increase in D-2 DAR phosphorylation. The phosphorylation was specific for PKC as the PMA effect was mimicked by phorbol 12,13-dibutyrate, but not by 4alpha-phorbol 12,13-didecanoate, active and inactive, phorbol diesters, respectively. The PMA-mediated D-2 DAR phosphorylation was completely blocked by co-treatment with the PKC inhibitor, bisindolylmaleimide II, and augmented by co-transfection with PKCbetaI. In contrast, PKC inhibition had no effect on agonist-promoted phosphorylation, suggesting that PKC is not involved in this response. PKC phosphorylation of the D-2 DAR was found to promote receptor desensitization as reflected by a decrease in agonist potency for inhibiting cAMP accumulation. Most interestingly, PKC phosphorylation also promoted internalization of the D-2 DAR through a beta-arrestin- and dynamin-dependent pathway, a response not usually associated with PKC phosphorylation of G-protein-coupled receptors. Site-directed mutagenesis experiments resulted in the identification of two domains of PKC phosphorylation sites within the third intracellular loop of the receptor. Both of these domains are involved in regulating sequestration of the D-2 DAR, whereas only one domain is involved in receptor desensitization. These results indicate that PKC can mediate phosphorylation of the D-2 DAR, resulting in both functional desensitization and receptor internalization.	NINDS, NIH, Mol Neuropharmacol Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Sibley, DR (corresponding author), NINDS, NIH, Mol Neuropharmacol Sect, Bldg 10,Rm 5C108,10 Ctr Dr,MSC 1406, Bethesda, MD 20892 USA.	sibley@helix.nih.gov	Sibley, David/AAC-3591-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002263, Z01NS002263] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akam E, 2004, BIOCHEM PHARMACOL, V67, P2039, DOI 10.1016/j.bcp.2004.02.017; CUBEDDU LX, 1989, J PHARMACOL EXP THER, V251, P687; DIMARZO V, 1993, J NEUROSCI, V13, P4846; ELAZAR Z, 1991, J NEUROCHEM, V56, P75, DOI 10.1111/j.1471-4159.1991.tb02564.x; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GUAN XM, 1992, J BIOL CHEM, V267, P21995; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HEINZEL SS, 1988, J VIROL, V62, P3738, DOI 10.1128/JVI.62.10.3738-3746.1988; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hosey MM, 1999, AM J PHYSIOL-CELL PH, V277, pC856, DOI 10.1152/ajpcell.1999.277.5.C856; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Itokawa M, 1996, MOL PHARMACOL, V49, P560; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Jackson A, 2002, J NEUROCHEM, V82, P683, DOI 10.1046/j.1471-4159.2002.01001.x; Jirousek MR, 1996, J MED CHEM, V39, P2664, DOI 10.1021/jm950588y; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Koks S, 2003, NEUROPEPTIDES, V37, P25, DOI 10.1016/S0143-4179(02)00137-3; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lachowicz JE, 1997, BIOCHEM BIOPH RES CO, V237, P394, DOI 10.1006/bbrc.1997.7146; Lamey M, 2002, J BIOL CHEM, V277, P9415, DOI 10.1074/jbc.M111811200; Legault M, 2002, NEUROSCIENCE, V111, P177, DOI 10.1016/S0306-4522(01)00614-5; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; LIU YF, 1992, J NEUROCHEM, V59, P2311; Mason JN, 2002, MOL PHARMACOL, V61, P806, DOI 10.1124/mol.61.4.806; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Murthy KS, 2000, AM J PHYSIOL-CELL PH, V279, pC925, DOI 10.1152/ajpcell.2000.279.4.C925; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Neve K. A., 1997, DOPAMINE RECEPTORS, P27; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; ROGUE P, 1990, BIOCHEM INT, V22, P575; Scarselli M, 2001, J BIOL CHEM, V276, P30308, DOI 10.1074/jbc.M102297200; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SIBLEY DR, 1997, DOPAMINE RECEPTORS, P383; Tiberi M, 1996, J BIOL CHEM, V271, P3771; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; VALLAR L, 1990, J BIOL CHEM, V265, P10320; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vazquez-Prado J, 2003, CELL SIGNAL, V15, P549, DOI 10.1016/S0898-6568(02)00151-1; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wagey R, 2001, J NEUROCHEM, V78, P715, DOI 10.1046/j.1471-4159.2001.00459.x; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Wise A, 2004, ANNU REV PHARMACOL, V44, P43, DOI 10.1146/annurev.pharmtox.44.101802.121419; YOSHIMURA M, 1993, J BIOL CHEM, V268, P4604; Yu SG, 2003, J NEUROCHEM, V86, P1006, DOI 10.1046/j.1471-4159.2003.01912.x; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; ZHANG LJ, 1994, MOL PHARMACOL, V45, P878	58	115	116	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49533	49541		10.1074/jbc.M408319200	http://dx.doi.org/10.1074/jbc.M408319200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347675	hybrid			2022-12-27	WOS:000225098100124
J	Ize, B; Porcelli, I; Lucchini, S; Hinton, JC; Berks, BC; Palmer, T				Ize, B; Porcelli, I; Lucchini, S; Hinton, JC; Berks, BC; Palmer, T			Novel phenotypes of Escherichia coli tat mutants revealed by global gene expression and phenotypic analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; SEC-INDEPENDENT PROTEIN; PHAGE SHOCK PROTEIN; SIGNAL-TRANSDUCTION PATHWAY; TRANSPORT-SYSTEM; OUTER-MEMBRANE; EXPORT PATHWAY; CYTOPLASMIC MEMBRANE; BIOFILM FORMATION; ANAEROBIC GROWTH	The Tat protein export system serves to export folded proteins harboring an N-terminal twin arginine signal peptide across the cytoplasmic membrane. In this study, we have used gene expression profiling of Escherichia coli supported by phenotypic analysis to investigate how cells respond to a defect in the Tat pathway. Previous work has demonstrated that strains mutated in genes encoding essential Tat pathway components are defective in the integrity of their cell envelope because of the mislocalization of two amidases involved in cell wall metabolism (Ize, B., Stanley, N.R., Buchanan, G., and Palmer, T. (2003) Mol. Microbiol. 48, 1183-1193). To distinguish between genes that are differentially expressed specifically because of the cell envelope defect and those that result from other effects of the tatC deletion, we also analyzed two different transposon mutants of the DeltatatC strain that have their outer membrane integrity restored. Approximately 50% of the genes that were differentially expressed in the tatC mutant are linked to the envelope defect, with the products of many of these genes involved in self-defense or protection mechanisms, including the production of exopolysaccharide. Among the changes that were not explicitly linked to envelope integrity, we characterized a role for the Tat system in iron acquisition and copper homeostasis. Finally, we have demonstrated that overproduction of the Tat substrate SufI saturates the Tat translocon and produces effects on global gene expression that are similar to those resulting from the DeltatatC mutation.	John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Inst Food Res, Inst Food Res, Mol Microbiol Grp, Norwich NR4 7UA, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Palmer, T (corresponding author), John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	tracy.palmer@bbsrc.ac.uk	IZE, Bérengère/GLQ-7207-2022; Hinton, Jay C. D./B-2142-2008	IZE, Bérengère/0000-0001-9106-9254; Hinton, Jay C. D./0000-0003-2671-6026; Berks, Ben/0000-0001-9685-4067; Palmer, Tracy/0000-0001-9043-2592				Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Anjum MF, 2003, INFECT IMMUN, V71, P4674, DOI 10.1128/IAI.71.8.4674-4683.2003; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; COHEN N, 1956, ANN I PASTEUR PARIS, V91, P693; CROOKE H, 2001, ABSTR MICR PATH HOST; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; DeLisa MP, 2004, J BACTERIOL, V186, P366, DOI 10.1128/JB.186.2.366-373.2004; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Ding ZY, 2003, J BACTERIOL, V185, P760, DOI 10.1128/JB.185.3.760-771.2003; Earhart C.F., 1996, ESCHERICHIA COLI SAL, V2nd ed., P1075; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; GUTIERREZ C, 1987, J MOL BIOL, V195, P289, DOI 10.1016/0022-2836(87)90650-4; Hagenmaier S, 1997, J BACTERIOL, V179, P2073, DOI 10.1128/jb.179.6.2073-2076.1997; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Hoshino N, 1999, FREE RADICAL BIO MED, V27, P1245, DOI 10.1016/S0891-5849(99)00157-4; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kaldalu M, 2004, ANTIMICROB AGENTS CH, V48, P890, DOI 10.1128/AAC.48.3.890-896.2004; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; KOSTER W, 1991, BIOL MET, V4, P23, DOI 10.1007/BF01135553; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; MECSAS J, 1993, GENE DEV, V7, P2618, DOI 10.1101/gad.7.12b.2618; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nienaber A, 2001, MOL MICROBIOL, V41, P787, DOI 10.1046/j.1365-2958.2001.02555.x; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; RAETZ CRH, 1996, ESCHERICHIA COLI SAL, P1035; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; ROHRBACH MR, 1995, MOL GEN GENET, V248, P33, DOI 10.1007/BF02456611; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schembri MA, 2001, J INFECT DIS, V183, pS28, DOI 10.1086/318847; SILVESTRO A, 1988, BIOCHIM BIOPHYS ACTA, V954, P1, DOI 10.1016/0167-4838(88)90049-0; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; STYRVOLD OB, 1991, J BACTERIOL, V173, P1187, DOI 10.1128/jb.173.3.1187-1192.1991; TSUI HCT, 1994, MOL MICROBIOL, V11, P189, DOI 10.1111/j.1365-2958.1994.tb00300.x; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WEINER L, 1994, P NATL ACAD SCI USA, V91, P2191, DOI 10.1073/pnas.91.6.2191; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	78	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47543	47554		10.1074/jbc.M406910200	http://dx.doi.org/10.1074/jbc.M406910200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347649	hybrid			2022-12-27	WOS:000224957000018
J	Leal, NA; Olteanu, H; Banerjee, R; Bobik, TA				Leal, NA; Olteanu, H; Banerjee, R; Bobik, TA			Human ATP : Cob(I)alamin adenosyltransferase and its interaction with methionine synthase reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; ATP-CORRINOID ADENOSYLTRANSFERASE; SEROVAR TYPHIMURIUM LT2; COMPLEMENTATION GROUP; SALMONELLA-TYPHIMURIUM; ENZYMATIC CONVERSION; COBALAMIN METABOLISM; FLAVOPROTEIN SYSTEM; INBORN ERROR; VITAMIN B12S	The final step in the conversion of vitamin B-12 into coenzyme B-12 (adenosylcobalamin, AdoCbl) is catalyzed by ATP: cob(I) alamin adenosyltransferase (ATR). Prior studies identified the human ATR and showed that defects in its encoding gene underlie cblB methylmalonic aciduria. Here two common polymorphic variants of the ATR that are found in normal individuals are expressed in Escherichia coli, purified, and partially characterized. The specific activities of ATR variants 239K and 239M were 220 and 190 nmol min(-1) mg(-1), and their K-m values were 6.3 and 6.9 muM for ATP and 1.2 and 1.6 muM for cob(I) alamin, respectively. These values are similar to those obtained for previously studied bacterial ATRs indicating that both human variants have sufficient activity to mediate AdoCbl synthesis in vivo. Investigations also showed that purified recombinant human methionine synthase reductase (MSR) in combination with purified ATR can convert cob(II) alamin to AdoCbl in vitro. In this system, MSR reduced cob( II) alamin to co-b(I) alamin that was adenosylated to AdoCbl by ATR. The optimal stoichiometry for this reaction was similar to4 MSR/ATR and results indicated that MSR and ATR physically interacted in such a way that the highly reactive reaction intermediate [cob(I) alamin] was sequestered. The finding that MSR reduced cob(II) alamin to cob(I) alamin for AdoCbl synthesis (in conjunction with the prior finding that MSR reduced cob(II) alamin for the activation of methionine synthase) indicates a dual physiological role for MSR.	Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Iowa State University; State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Lincoln	Bobik, TA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	bobik@iastate.edu	Olteanu, Horatiu/AAH-1051-2021	Olteanu, Horatiu/0000-0001-5783-4485; Leal, Nicole/0000-0001-6953-4519	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK064959, R01DK045776, R01DK064771] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK064771, DK45776, DK64959] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banerjee R., 1999, Chemistry and biochemistry of B12., P707; Banerjee R., 1999, CHEM BIOCH B 12; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P1129, DOI 10.1021/bi00457a005; Bauer CB, 2001, BIOCHEMISTRY-US, V40, P361, DOI 10.1021/bi002145o; BOBIK TA, 1989, J BACTERIOL, V171, P1423, DOI 10.1128/jb.171.3.1423-1427.1989; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; DEBUSSCHE L, 1991, J BACTERIOL, V173, P6300, DOI 10.1128/jb.173.19.6300-6302.1991; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Fonseca MV, 2001, J BIOL CHEM, V276, P32101, DOI 10.1074/jbc.M102510200; Fonseca MV, 2000, J BACTERIOL, V182, P4304, DOI 10.1128/JB.182.15.4304-4309.2000; Fonseca MV, 2002, J BIOL CHEM, V277, P33127, DOI 10.1074/jbc.M203893200; FRIEDMANN HC, 1975, COBALAMIN BIOCH PATH, P75; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; FUJII K, 1974, J BIOL CHEM, V249, P6745; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; HUENNEKENS FM, 1982, B12, V1, P145; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; KOLHOUSE JF, 1977, P NATL ACAD SCI USA, V74, P921, DOI 10.1073/pnas.74.3.921; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Leal NA, 2003, J BIOL CHEM, V278, P9227, DOI 10.1074/jbc.M212739200; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Leclerc D, 1999, GENE, V240, P75, DOI 10.1016/S0378-1119(99)00431-X; Maniatis T., 1982, MOL CLONING; MATTHEWS RG, 1999, CHEM BIOCH B12, P707; MELLMAN I, 1979, J BIOL CHEM, V254, P1847; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; NHAM SU, 1990, GENOMICS, V8, P710, DOI 10.1016/0888-7543(90)90259-W; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; PEZACKA E, 1990, BIOCHEM BIOPH RES CO, V169, P443, DOI 10.1016/0006-291X(90)90351-M; PEZACKA EH, 1993, BIOCHIM BIOPHYS ACTA, V1157, P167, DOI 10.1016/0304-4165(93)90061-C; Rosenblatt D. S., 1999, Chemistry and biochemistry of B12., P367; Saridakis V, 2004, J BIOL CHEM, V279, P23646, DOI 10.1074/jbc.M401395200; Schneider Z., 1987, COMPREHENSIVE B12, P157, DOI [10.1515/9783110844795.157, DOI 10.1515/9783110844795.157]; Schneider Z., 1987, COMPREHENSIVE B12; SCHRAUZER GN, 1968, J AM CHEM SOC, V90, P2441, DOI 10.1021/ja01011a054; Segel I.H., 1976, BIOCH CALCULATIONS S; SUH SJ, 1995, J BACTERIOL, V177, P921, DOI 10.1128/jb.177.4.921-925.1995; VASSILIADIS A, 1991, EXP CELL RES, V195, P295, DOI 10.1016/0014-4827(91)90376-6; VITOLS E, 1966, J BIOL CHEM, V241, P1455; Watkins D, 2001, ENDOCRINOLOGIST, V11, P98, DOI 10.1097/00019616-200103000-00005; Watkins D, 2000, J MED GENET, V37, P510, DOI 10.1136/jmg.37.7.510; WEISSBACH H, 1963, J BIOL CHEM, V238, P3318; WEISSBACH H, 1961, J BIOL CHEM, V236, pPC40; Wilson A, 1999, HUM MOL GENET, V8, P2009, DOI 10.1093/hmg/8.11.2009	47	45	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47536	47542		10.1074/jbc.M405449200	http://dx.doi.org/10.1074/jbc.M405449200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347655	hybrid			2022-12-27	WOS:000224957000017
J	Pappan, K; Zheng, L; Krishnamoorthi, R; Wang, XM				Pappan, K; Zheng, L; Krishnamoorthi, R; Wang, XM			Evidence for and characterization of Ca2+ binding to the catalytic region of Arabidopsis thaliana phospholipase D beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; D-ALPHA; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; D-DELTA; CALCIUM; ACTIVATION; DOMAINS; MECHANISM; ACID	Most types of plant phospholipase D (PLD) require Ca2+ for activity, but how Ca2+ affects PLD activity is not well understood. We reported previously that Ca2+ binds to the regulatory C2 domain that occurs in the N terminus of the Ca2+-requiring PLDs. Using Arabidopsis thaliana PLDbeta and C2-deleted PLDbeta (PLDbetacat), we now show that Ca2+ also interacts with the catalytic regions of PLD. PLDbetacat exhibited Ca2+-dependent activity, was much less active, and required a higher level of Ca2+ than the full-length PLDbeta. Ca2+ binding of the proteins was stimulated by phospholipids; phosphatidylserine was the most effective among those tested. Scatchard plot analysis of Ca2+ binding data yielded an estimate of 3.6 high affinity (K-d = 29 muM) binding sites on PLDbeta. The Ca2+-PLDbetacat interaction increased the affinity of the protein for the activator, phosphatidylinositol 4,5-bisphosphate, but not for the substrate, phosphatidylcholine. This is in contrast to the effect of Ca2+ binding to the C2 domain, which stimulates phosphatidylcholine binding but inhibits phosphatidylinositol 4,5-bisphosphate binding of the domain. These results demonstrate the contrasting and complementary effects of the Ca2+- and lipid-binding properties of the C2 and catalytic domains of plant PLD and provide insight into the mechanism by which Ca2+ regulates PLD activity.	Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Kansas State University	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Wang, Xuemin/M-2853-2013; Pappan, Kirk/AAV-5946-2021	Pappan, Kirk/0000-0002-2341-8798; wang, xuemin/0000-0002-6251-6745				BAZZI MD, 1990, BIOCHEMISTRY-US, V29, P7624, DOI 10.1021/bi00485a012; BAZZI MD, 1991, BIOCHEMISTRY-US, V30, P971, DOI 10.1021/bi00218a013; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; deVrije T, 1997, J EXP BOT, V48, P1631, DOI 10.1093/jexbot/48.314.1631; DROBAK BK, 1993, PLANT PHYSIOL, V102, P705, DOI 10.1104/pp.102.3.705; EVANS TC, 1994, BIOCHEMISTRY-US, V33, P13231, DOI 10.1021/bi00249a009; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Heller M, 1978, Adv Lipid Res, V16, P267; Keranen LM, 1997, J BIOL CHEM, V272, P25959, DOI 10.1074/jbc.272.41.25959; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; LUO JH, 1993, J BIOL CHEM, V268, P3715; LUO JH, 1993, J BIOL CHEM, V268, P23580; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; NORBY JG, 1980, ANAL BIOCHEM, V102, P318, DOI 10.1016/0003-2697(80)90160-8; Nozawa Y, 2002, BBA-MOL CELL BIOL L, V1585, P77, DOI 10.1016/S1388-1981(02)00327-X; Pappan K, 1999, ARCH BIOCHEM BIOPHYS, V368, P347, DOI 10.1006/abbi.1999.1325; Pappan K, 1997, J BIOL CHEM, V272, P7055, DOI 10.1074/jbc.272.11.7055; Pappan K, 1998, ARCH BIOCHEM BIOPHYS, V353, P131, DOI 10.1006/abbi.1998.0640; Pappan K, 1997, J BIOL CHEM, V272, P7048, DOI 10.1074/jbc.272.11.7048; POINTING CP, 1996, PROTEIN SCI, V5, P914; Ponting CP, 1996, PROTEIN SCI, V5, P162; Qin CB, 2002, J BIOL CHEM, V277, P49685, DOI 10.1074/jbc.M209598200; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Qin WS, 1997, J BIOL CHEM, V272, P28267, DOI 10.1074/jbc.272.45.28267; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Ryu SB, 1996, BBA-LIPID LIPID MET, V1303, P243, DOI 10.1016/0005-2760(96)00096-3; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Shank KJ, 2001, PLANT PHYSIOL, V126, P267, DOI 10.1104/pp.126.1.267; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Wang CX, 2001, PLANT PHYSIOL, V127, P1102, DOI 10.1104/pp.010444; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961; Zheng L, 2000, J BIOL CHEM, V275, P19700, DOI 10.1074/jbc.M001945200; Zheng L, 2002, BIOCHEMISTRY-US, V41, P4546, DOI 10.1021/bi0158775	40	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47833	47839		10.1074/jbc.M402789200	http://dx.doi.org/10.1074/jbc.M402789200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15356005	hybrid, Green Published			2022-12-27	WOS:000224957000052
J	Riganti, C; Gazzano, E; Polimeni, M; Costamagna, C; Bosia, A; Ghigo, D				Riganti, C; Gazzano, E; Polimeni, M; Costamagna, C; Bosia, A; Ghigo, D			Diphenyleneiodonium inhibits the cell redox metabolism and induces oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE-GENERATING-SYSTEM; NEUTROPHIL NADPH OXIDASE; PENTOSE CYCLE ACTIVITY; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; DIAPHORASE ACTIVITY; IODONIUM COMPOUNDS; DIPHENYLIODONIUM; GLUTATHIONE; MECHANISM; REDUCTASE	Diphenyleneiodonium (DPI) and the structurally related compound diphenyliodonium ( DIP) are widely used as inhibitors of flavoenzymes, particularly NADPH oxidase. Here we report further evidence that DPI and DIP are not specific flavin binders. A 3-h incubation of N11 glial cells with DPI significantly inhibited in a dose-dependent way both the pentose phosphate pathway and the tricarboxylic acid cycle. In parallel, we observed a dose-dependent increase of reactive oxygen species generation and lipoperoxidation and increased leakage of lactate dehydrogenase activity in the extracellular medium. The glutathione/glutathione disulfide ratio decreased, whereas the efflux of glutathione out of the cells increased. This suggests that DPI causes an augmented oxidative stress and exerts a cytotoxic effect in N11 cells. Indeed, the cells were protected from these events when loaded with glutathione. Similar results were observed using DIP instead of DPI and also in other cell types. We suggest that the DPI-elicited inhibition of the pentose phosphate pathway and tricarboxylic acid cycle may be mediated by the blockade of several NAD(P)-dependent enzymes, such as glucose 6-phosphate dehydrogenase, glyceraldehyde 3-phosphate dehydrogenase, and lactate dehydrogenase. In light of these results, we think that some effects of DPI or DIP in in vitro and in vivo experimental models should be interpreted with caution.	Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy	University of Turin	Ghigo, D (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Via Santena 5 Bis, I-10126 Turin, Italy.	dario.ghigo@unito.it		Ghigo, Dario/0000-0001-6050-1577; Riganti, Chiara/0000-0001-9787-4836				Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Beutler E, 1982, GLUTATHIONE RED CELL, V3 rd; Brandes RP, 1997, J PHYSIOL-LONDON, V500, P331, DOI 10.1113/jphysiol.1997.sp022024; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; CROSS AR, 1987, BIOCHEM PHARMACOL, V36, P489, DOI 10.1016/0006-2952(87)90356-X; DOUSSIERE J, 1992, EUR J BIOCHEM, V208, P61, DOI 10.1111/j.1432-1033.1992.tb17159.x; Doussiere J, 1999, BIOCHEMISTRY-US, V38, P3694, DOI 10.1021/bi9823481; EGGLESTON LV, 1974, BIOCHEM J, V138, P425, DOI 10.1042/bj1380425; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; GATLEY SJ, 1976, BIOCHEM J, V158, P307, DOI 10.1042/bj1580307; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; GORDON G, 1995, ARCH BIOCHEM BIOPHYS, V318, P25, DOI 10.1006/abbi.1995.1199; HOLLAND PC, 1973, J BIOL CHEM, V248, P6050; Li NY, 2003, FREE RADICAL BIO MED, V34, P465, DOI 10.1016/S0891-5849(02)01325-4; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; LUZZATTO L, 1967, BIOCHIM BIOPHYS ACTA, V146, P18, DOI 10.1016/0005-2744(67)90069-1; MARKS PA, 1960, P NATL ACAD SCI USA, V46, P447, DOI 10.1073/pnas.46.4.447; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; NAFTALIN RJ, 1993, BIOCHIM BIOPHYS ACTA, V1148, P39, DOI 10.1016/0005-2736(93)90158-V; Nakamura Y, 1997, NEUROSCIENCE, V76, P459, DOI 10.1016/S0306-4522(96)00375-2; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; PESCARMONA GP, 1982, INT J BIOCHEM, V14, P243, DOI 10.1016/0020-711X(82)90146-X; Pullar JM, 2002, J BIOL CHEM, V277, P19402, DOI 10.1074/jbc.M111053200; RAGAN CI, 1977, BIOCHEM J, V163, P605, DOI 10.1042/bj1630605; RIEGER D, 1992, REPROD FERT DEVELOP, V4, P547, DOI 10.1071/RD9920547; Riganti C, 2002, FREE RADICAL BIO MED, V32, P938, DOI 10.1016/S0891-5849(02)00800-6; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P587, DOI 10.1089/15230860260220085; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Shuto M, 1997, NEUROCHEM INT, V31, P73, DOI 10.1016/S0197-0186(96)00140-4; SPOLARICS Z, 1993, HEPATOLOGY, V17, P615, DOI 10.1002/hep.1840170415; SPOLARICS Z, 1993, BIOCHIM BIOPHYS ACTA, V1179, P134, DOI 10.1016/0167-4889(93)90134-B; Spolarics Z, 1998, J LEUKOCYTE BIOL, V63, P534, DOI 10.1002/jlb.63.5.534; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; TEW DG, 1993, BIOCHEMISTRY-US, V32, P10209, DOI 10.1021/bi00089a042; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; WEFERS H, 1983, ARCH BIOCHEM BIOPHYS, V224, P568, DOI 10.1016/0003-9861(83)90244-8; WEIR EK, 1994, J APPL PHYSIOL, V76, P2611, DOI 10.1152/jappl.1994.76.6.2611; WYATT CN, 1994, NEUROSCI LETT, V172, P63, DOI 10.1016/0304-3940(94)90663-7	39	156	161	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47726	47731		10.1074/jbc.M406314200	http://dx.doi.org/10.1074/jbc.M406314200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15358777	hybrid			2022-12-27	WOS:000224957000039
J	Sarmiento, JM; Anazco, CC; Campos, DM; Prado, GN; Navarro, J; Gonzalez, CB				Sarmiento, JM; Anazco, CC; Campos, DM; Prado, GN; Navarro, J; Gonzalez, CB			Novel down-regulatory mechanism of the surface expression of the vasopressin V-2 receptor by an alternative splice receptor variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NEURODEGENERATIVE DISEASE; PROTEIN; RESCUE; CELL; OLIGOMERIZATION; CHAPERONES; OXYTOCIN; PATHWAYS; KIDNEY	In rat kidney, two alternatively spliced transcripts are generated from the V-2 vasopressin receptor gene. The large transcript (1.2 kb) encodes the canonical V-2 receptor, whereas the small transcript encodes a splice variant displaying a distinct sequence corresponding to the putative seventh transmembrane domain and the intracellular C terminus of the V-2 receptor. This work showed that the small spliced transcript is translated in the rat kidney collecting tubules. However, the protein encoded by the small transcript (here called the V-2b splice variant) is retained inside the cell, in contrast to the preferential surface distribution of the V-2 receptor (here called the V-2a receptor). Cells expressing the V-2b splice variant do not exhibit binding to H-3-labeled vasopressin. Interestingly, we found that expression of the splice variant V-2b down-regulates the surface expression of the V(2)a receptor, most likely via the formation of V-2a.V-2b heterodimers as demonstrated by co-immunoprecipitation and fluorescence resonance energy transfer experiments between the V-2a receptor and the V-2b splice variant. The V-2b splice variant would then be acting as a dominant negative. The effect of the V-2b splice variant is specific, as it does not affect the surface expression of the G protein-coupled interleukin-8 receptor (CXCR1). Furthermore, the sequence encompassing residues 242-339, corresponding to the C-terminal domain of the V-2b splice variant, also down-regulates the surface expression of the V-2a receptor. We suggest that some forms of nephrogenic diabetes insipidus are due to overexpression of the splice variant V-2b, which could retain the wild-type V-2a receptor inside the cell via the formation of V-2a.V-2b heterodimers.	Univ Austral Chile, Dept Physiol, Valdivia 2 5119300, Chile; Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	Universidad Austral de Chile; University of Texas System; University of Texas Medical Branch Galveston	Gonzalez, CB (corresponding author), Univ Austral Chile, Dept Physiol, Valdivia 2 5119300, Chile.	cbgonzal@uach.cl		Navarro, Javier/0000-0001-7098-4373; Anazco, Carolina/0000-0003-1311-9492	NATIONAL EYE INSTITUTE [R01EY014218] Funding Source: NIH RePORTER; NEI NIH HHS [EY014218] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; BIRBAUMER M, 1999, ARCH MED RES, V30, P465; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bouley R, 2003, AM J PHYSIOL-CELL PH, V285, pC750, DOI 10.1152/ajpcell.00477.2002; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Buxbaum JN, 2003, TRENDS BIOCHEM SCI, V28, P585, DOI 10.1016/j.tibs.2003.09.009; Chelli M, 2001, J BIOL CHEM, V276, P46975, DOI 10.1074/jbc.M106432200; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; FIRSOV D, 1994, PFLUG ARCH EUR J PHY, V429, P79, DOI 10.1007/BF02584033; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gonzalez CB, 1999, BIOL RES, V32, P63; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; PIND S, 1994, J BIOL CHEM, V269, P12784; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; SEIBOLD A, 1992, AM J HUM GENET, V51, P1078; SzczepanskaSadowska E, 1996, REGUL PEPTIDES, V66, P65, DOI 10.1016/0167-0115(96)00053-5; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Thibonnier M, 1998, PROG BRAIN RES, V119, P147; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	29	28	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					47017	47023		10.1074/jbc.M410011200	http://dx.doi.org/10.1074/jbc.M410011200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15355989	hybrid			2022-12-27	WOS:000224832400086
J	Wang, F; Zhang, RX; Beischlag, TV; Muchardt, C; Yaniv, M; Hankinson, O				Wang, F; Zhang, RX; Beischlag, TV; Muchardt, C; Yaniv, M; Hankinson, O			Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR-I; REMODELING COMPLEX; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVATION; HISTONE ACETYLTRANSFERASE; ENHANCER ELEMENT; BINDING-PROTEIN; HIF-ALPHA; EXPRESSION; RECEPTOR	Upon hypoxia, the human erythropoietin (EPO) gene is transactivated by the heterodimeric hypoxia-inducible factor 1 (HIF-1). Mammalian SWI/SNF is a chromatin-remodeling complex involved in the modulation of gene expression. We demonstrate that Brahma (Brm) and Brahma/SWI2-related gene 1 (Brg-1), alternative ATPase subunits of SWI/SNF, potentiate reporter gene activation mediated by HIF-1 in an ATPase-dependent manner. Brm was more potent than Brg-1 in the reporter gene assays. Simultaneous depletion of both Brm and Brg-1 by small interfering RNAs significantly compromised the transcription of the endogenous EPO gene triggered by hypoxia. Whereas knocking down Brm alone resulted in a moderate reduction in transcription of the EPO gene, depletion of Brg-1 resulted in an augmentation of transcription of both the EPO gene and the Brm gene, indicating that Brm can compensate for loss of Brg-1. Chromatin immunoprecipitation (ChIP) and sequential ChIP (re-ChIP) analysis showed that both Brm and Brg-1 associate with the enhancer region of the EPO gene in vivo in a hypoxia-dependent fashion and that each is present in a complex with HIF-1. Brm and Brg-1 were also recruited to the promoter of the vascular endothelial growth factor (VEGF) gene in a hypoxia-dependent fashion, although hypoxic induction of VEGF transcription was not affected by depletions of either or both Brm and Brg-1. Together these studies reveal a novel role for SWI/SNF in the activation of transcription of the EPO gene, indicate an important communication and compensation between Brm and Brg-1, and suggest that the requirement for SWI/SNF during hypoxic induction is gene-specific.	Univ Calif Los Angeles, Inst Mol Biol, Jonsson Comprehens Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Penn State Univ, Dept Vet Sci, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; Inst Pasteur, Dept Dev Biol, CNRS, URA 1644,Unite Express Genet & Malad, F-75724 Paris, France	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hankinson, O (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med, Ctr Hlth Sci, Box 951732, Los Angeles, CA 90095 USA.	ohank@mednet.ucla.edu			NATIONAL CANCER INSTITUTE [R01CA028868] Funding Source: NIH RePORTER; NCI NIH HHS [CA28868, R01 CA028868] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; BECK I, 1991, J BIOL CHEM, V266, P15563; BLANCHARD KL, 1992, MOL CELL BIOL, V12, P5373, DOI 10.1128/MCB.12.12.5373; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; GLEADLE JM, 1995, AM J PHYSIOL-CELL PH, V268, pC1362, DOI 10.1152/ajpcell.1995.268.6.C1362; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; MAHER PA, 1993, J BIOL CHEM, V268, P4244; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; PROBST MR, 1993, MOL PHARMACOL, V44, P511; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Sanchez-Elsner T, 2004, J MOL BIOL, V336, P9, DOI 10.1016/j.jmb.2003.12.023; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P8725, DOI 10.1073/pnas.88.19.8725; Strobeck MW, 2002, J BIOL CHEM, V277, P4782, DOI 10.1074/jbc.M109532200; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang S, 2002, J BIOL CHEM, V277, P11821, DOI 10.1074/jbc.M110122200	40	55	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46733	46741		10.1074/jbc.M409002200	http://dx.doi.org/10.1074/jbc.M409002200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347669	hybrid			2022-12-27	WOS:000224832400051
J	Yoo, YG; Yeo, MG; Kim, DK; Park, H; Lee, MO				Yoo, YG; Yeo, MG; Kim, DK; Park, H; Lee, MO			Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SERUM GROWTH-FACTORS; FACTOR-L-ALPHA; FACTOR 1-ALPHA; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; NGFI-B; MEDIATED INDUCTION; STEROID-RECEPTOR; ACTIVATION	Hypoxia-inducible factor-1alpha (HIF-1alpha) plays a central role in oxygen homeostasis by inducing the expression of a broad range of genes in a hypoxia-dependent manner. Here, we show that the orphan nuclear receptor Nur77 is an important regulator of HIF-1alpha. Under hypoxic conditions, Nur77 protein and transcripts were induced in a time-dependent manner. When Nur77 was exogenously introduced, it enhanced the transcriptional activity of HIF-1, whereas the dominant negative Nur77 mutant abolished the function of HIF-1. The HIF-1alpha protein was greatly increased and completely localized in the nucleus when coexpressed with Nur77. The N-terminal transactivation domain of Nur77 was required and sufficient for the activation of HIF-1alpha. The association of HIF-1alpha with von Hippel-Lindau protein was not affected, whereas that with mouse double minute 2 (MDM2) was greatly reduced in the presence of Nur77. Further we found that the expression of MDM2 was repressed at transcription level in the presence of Nur77 as well as under hypoxic conditions. Finally, PD98059 decreased Nur77-induced HIF-1alpha stability and recovered MDM2 expression, indicating that the extracellular signal-regulated kinase pathway is critical in the Nur77-induced activation of HIF-1alpha. Together, our results demonstrate a novel function for Nur77 in the stabilization of HIF-1alpha and suggest a potential role for Nur77 in tumor progression and metastasis.	Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea; Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; Univ Seoul, Dept Life Sci, Seoul 130743, South Korea	Sejong University; Chung Ang University; University of Seoul	Lee, MO (corresponding author), Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea.	molee@sejong.ac.kr						Alarcon R, 1999, CANCER RES, V59, P6046; Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Bardos JI, 2004, MOL CELL BIOL, V24, P2905, DOI 10.1128/MCB.24.7.2905-2914.2004; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bras A, 2000, CELL DEATH DIFFER, V7, P262, DOI 10.1038/sj.cdd.4400653; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Choi JW, 2004, CANCER RES, V64, P35, DOI 10.1158/0008-5472.CAN-03-0145; Chun YS, 2003, CANCER RES, V63, P8700; Cioffi CL, 2003, BIOCHEM BIOPH RES CO, V303, P947, DOI 10.1016/S0006-291X(03)00453-4; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Erez N, 2003, CANCER RES, V63, P8777; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hur E, 2001, MOL PHARMACOL, V59, P1216, DOI 10.1124/mol.59.5.1216; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee MO, 2001, BIOCHEM BIOPH RES CO, V288, P1162, DOI 10.1006/bbrc.2001.5910; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Ravi R, 2000, GENE DEV, V14, P34; Richard DE, 2000, J BIOL CHEM, V275, P26765; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845, DOI 10.1128/MCB.18.5.2845; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Slagsvold HH, 2002, BIOCHEM BIOPH RES CO, V291, P1146, DOI 10.1006/bbrc.2002.6579; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Suzuki S, 2003, P NATL ACAD SCI USA, V100, P8276, DOI 10.1073/pnas.0932598100; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; WILLIAMS GT, 1993, MOL CELL BIOL, V13, P6124, DOI 10.1128/MCB.13.10.6124; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Winoto A, 1997, Semin Immunol, V9, P51, DOI 10.1006/smim.1996.0053; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Yoo YG, 2003, J BIOL CHEM, V278, P39076, DOI 10.1074/jbc.M305101200; YOON JK, 1994, MOL CELL BIOL, V14, P7731, DOI 10.1128/MCB.14.12.7731; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhu YH, 2002, J BIOL CHEM, V277, P22909, DOI 10.1074/jbc.M200042200	56	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53365	53373		10.1074/jbc.M408554200	http://dx.doi.org/10.1074/jbc.M408554200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385570	hybrid			2022-12-27	WOS:000225680600069
J	Bernhard, OK; Lai, J; Wilkinson, J; Sheil, MM; Cunningham, AL				Bernhard, OK; Lai, J; Wilkinson, J; Sheil, MM; Cunningham, AL			Proteomic analysis of DC-SIGN on dendritic cells detects tetramers required for ligand binding but no association with CD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE RECOGNITION; VIRUS; ENTRY; HIV; INFECTION; RECEPTORS; MECHANISM; SUBUNIT; PROTEIN; CIS	DC-SIGN ( dendritic cell specific intracellular adhesion molecule 3 grabbing non-integrin) or CD209 is a type II transmembrane protein and one of several C-type lectin receptors expressed by dendritic cell subsets, which bind to high mannose glycoproteins promoting their endocytosis and potential degradation. DC-SIGN also mediates attachment of HIV to dendritic cells and binding to this receptor can subsequently lead to endocytosis or enhancement of CD4/CCR5-dependent infection. The latter was proposed to be facilitated by an interaction between DC-SIGN and CD4. Endocytosis of HIV virions does not necessarily lead to their complete degradation. A proportion of the virions remain infective and can be later presented to T cells mediating their infection in trans. Previously, the extracellular domain of recombinant DC-SIGN has been shown to assemble as tetramers and in the current study we use a short range covalent cross-linker and show that DC-SIGN exists as tetramers on the surface of immature monocyte-derived dendritic cells. There was no evidence of direct binding between DC-SIGN and CD4 either by cross-linking or by fluorescence resonance energy transfer measurements suggesting that there is no constitutive association of the majority of these proteins in the membrane. Importantly we also show that the tetrameric complexes, in contrast to DC-SIGN monomers, bind with high affinity to high mannose glycoproteins such as mannan or HIV gp120 suggesting that such an assembly is required for high affinity binding of glycoproteins to DC-SIGN, providing the first direct evidence that DC-SIGN tetramers are essential for high affinity interactions with pathogens like HIV.	Westmead Hosp, Ctr Virus Res, Westmead Millennium Inst, Sydney, NSW 2145, Australia; Univ Wollongong, Dept Chem, Wollongong, NSW 2522, Australia; Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; University of Wollongong; University of Sydney	Cunningham, AL (corresponding author), Westmead Millennium Inst, Ctr Virus Res, Darcy Rd, Sydney, NSW 2145, Australia.	tony_cunningham@wmi.usyd.edu.au	Sheil, Margaret/F-2949-2015	Cunningham, Anthony/0000-0002-6744-5667; wilkinson, john/0000-0001-8728-4146				Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bernhard OK, 2004, BIOCHEMISTRY-US, V43, P256, DOI 10.1021/bi034847u; Bernhard OK, 2003, PROTEOMICS, V3, P139, DOI 10.1002/pmic.200390022; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Nobile C, 2003, J VIROL, V77, P5313, DOI 10.1128/JVI.77.9.5313-5323.2003; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Szollosi Janos, 2002, J Biotechnol, V82, P251, DOI 10.1016/S1389-0352(01)00041-1; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0	24	47	48	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51828	51835		10.1074/jbc.M402741200	http://dx.doi.org/10.1074/jbc.M402741200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15385553	hybrid			2022-12-27	WOS:000225493400015
J	Inou, Y; Taguchi, H; Kishimoto, A; Yoshida, M				Inou, Y; Taguchi, H; Kishimoto, A; Yoshida, M			Hsp104 binds to yeast Sup35 prion fiber but needs other factor(s) to sever it	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PSI+ PRION; PROTEIN; ELIMINATION	The interaction of Hsp104 with yeast prion fibers made of Sup35NM, a prion-inducing domain of Sup35, was tested. When fluorescently labeled Hsp104 was added to the preformed fibers, individual fibers were fluorescently decorated uniformly along the fiber length. However, the density of fluorescence differed from one fiber to another, indicating the presence of subspecies of Sup35NM fibers. The time course of fiber formation from monomer Sup35NM was delayed by Hsp104. Hsp104-mediated fragmentation of fibers was tested using bead-tethered fibers. In contrast with the recent report (Shorter, J., and Lindquist, S. (2004) Science 304, 1793-1797), Hsp104 alone was unable to sever the fibers. Yeast cell lysate or the Hsp104-deficient cell lysate plus Hsp104 caused ATP-dependent, guanidine hydrochloride-sensitive fragmentation of the fibers. Thus, in our experimental setup, Hsp104 plus other factor(s) in the yeast cytosol are required for severing yeast prion fiber. The reason of discrepancy from the above report is unknown but is possibly caused by different conformational subspecies of prion fibers.	Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba 2778562, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Tokyo Institute of Technology; University of Tokyo; Osaka University	Yoshida, M (corresponding author), Tokyo Inst Technol, Chem Resources Lab, R1-7,4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	myoshida@res.titech.ac.jp	Taguchi, Hideki/B-6946-2009; taguchi, hideki/AAM-2663-2021	Taguchi, Hideki/0000-0002-6612-9339; taguchi, hideki/0000-0002-6612-9339				CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Inoue Y, 2001, J BIOL CHEM, V276, P35227, DOI 10.1074/jbc.C100304200; INOUE Y, 2004, COLD SPRING HARB LAB; Kawai R, 1999, CELL STRESS CHAPERON, V4, P46, DOI 10.1054/csac.1999.0076; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Kushnirov VV, 1998, CELL, V94, P13, DOI 10.1016/S0092-8674(00)81216-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Schirmer EC, 1997, P NATL ACAD SCI USA, V94, P13932, DOI 10.1073/pnas.94.25.13932; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TUITE MF, 1981, GENETICS, V98, P691; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; YOSHIDA M, 2003, EURESCO C FEBS ADV C	25	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52319	52323		10.1074/jbc.M408159200	http://dx.doi.org/10.1074/jbc.M408159200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448141	hybrid			2022-12-27	WOS:000225493400073
J	Martins, RP; Ostermeier, GC; Krawetz, SA				Martins, RP; Ostermeier, GC; Krawetz, SA			Nuclear matrix interactions at the human protamine domain - A working model of potentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE CHROMATIN HUB; I SENSITIVE DOMAIN; BETA-GLOBIN LOCUS; GENE-EXPRESSION; ATTACHMENT REGIONS; REGULATORY REGIONS; MOUSE; DNA; SITES; TRANSCRIPTION	The compact eukaryotic genome must be selectively opened to grant trans-factor access to cis-regulatory elements to overcome the primary barrier to gene transcription. The mechanism that governs the selective opening of chromatin domains (i.e. potentiation) remains poorly understood. In the absence of a well defined locus control region, the nuclear matrix is considered the primary candidate regulating the opening of the multigenic PRM1 --> PRM2 --> TNP2 human protamine domain. To directly examine its role, four lines of transgenic mice with different configurations of flanking nuclear matrix attachment regions (MARs) encompassing the protamine domain were created. We show that upon removal of the MARs, the locus becomes subject to position effects. The 3' MAR alone may be sufficient to protect against silencing. In concert, the MARs bounding this domain likely synergize to regulate the expression of the various members of this gene cluster. Interestingly, the MARs may convey a selective reproductive advantage, such that constructs bearing both 5' and 3' MARs are passed to their offspring with greater frequency. Thus, the MARs bounding the PRM1 --> PRM2 --> TNP2 protamine domain have many and varied functions.	Wayne State Univ, Sch Med, Inst Comp Sci, Dept Obstet & Gynecol Mol Med & Genet, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University	Krawetz, SA (corresponding author), Wayne State Univ, Sch Med, Inst Comp Sci, Dept Obstet & Gynecol Mol Med & Genet, Detroit, MI 48201 USA.	steve@compbio.med.wayne.edu	Ostermeier, G. Charles/Y-1172-2019; krawetz, stephen/GQQ-3308-2022	Ostermeier, G. Charles/0000-0002-3951-512X; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036512] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36512] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALEVY MC, 1984, BIOCHEMISTRY-US, V23, P2309, DOI 10.1021/bi00305a034; Alvarez JD, 2000, GENE DEV, V14, P521; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; BALHORN R, 1992, ARCH BIOCHEM BIOPHYS, V296, P384, DOI 10.1016/0003-9861(92)90588-N; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Cai ST, 1999, METHODS, V19, P394, DOI 10.1006/meth.1999.0875; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; CHOUDHARY SK, 1995, J BIOL CHEM, V270, P8755, DOI 10.1074/jbc.270.15.8755; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; CONOVER WJ, 1980, PRACTICAL NONPARAMET, P213; CONOVER WJ, 1980, PRACTICAL NONPARAMET, P143; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; FREEMAN L A, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P165; Georgel PT, 2003, GENE DEV, V17, P1617, DOI 10.1101/gad.1097603; GROSS DS, 1987, TRENDS BIOCHEM SCI, V12, P293, DOI 10.1016/0968-0004(87)90144-7; Hendzel MJ, 1998, MOL BIOL CELL, V9, P2491, DOI 10.1091/mbc.9.9.2491; Heng HHQ, 2001, CYTOGENET CELL GENET, V93, P155, DOI 10.1159/000056977; Ishiguro K, 2004, EUR J BIOCHEM, V271, P2379, DOI 10.1111/j.1432-1033.2004.04157.x; Jackson DA, 2000, J CELL BIOCHEM, P69; JANTZEN K, 1986, NUCLEIC ACIDS RES, V14, P6085, DOI 10.1093/nar/14.15.6085; KEENE MA, 1980, EUR J CELL BIOL, V22, P95; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kieffer LJ, 2002, J IMMUNOL, V168, P3915, DOI 10.4049/jimmunol.168.8.3915; Kramer JA, 1998, DEVELOPMENT, V125, P4749; Kramer JA, 1997, GENET TEST, V1, P125, DOI 10.1089/gte.1997.1.125; Kramer JA, 2000, MOL REPROD DEV, V56, P254, DOI 10.1002/(SICI)1098-2795(200006)56:2+<254::AID-MRD9>3.0.CO;2-#; Kramer JA, 1996, J BIOL CHEM, V271, P11619, DOI 10.1074/jbc.271.20.11619; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LAWSON GM, 1982, J BIOL CHEM, V257, P1501; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Ma H, 1999, J CELL BIOL, V146, P531, DOI 10.1083/jcb.146.3.531; Martins RP, 2004, ANAL BIOCHEM, V329, P337, DOI 10.1016/j.ab.2004.02.041; MCPHERSON S, 1993, EUR J HISTOCHEM, V37, P109; NELSON JE, 1994, J BIOL CHEM, V269, P31067; NELSON JE, 1995, DNA SEQUENCE, V5, P163, DOI 10.3109/10425179509029356; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Ostermeier GC, 2003, NUCLEIC ACIDS RES, V31, P3257, DOI 10.1093/nar/gkg424; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; ROSE SM, 1984, J BIOL CHEM, V259, P8534; Samuel SK, 1997, CANCER RES, V57, P147; Samuel SK, 1997, J CELL BIOCHEM, V66, P9; SCHOLER HR, 1985, EMBO J, V4, P3005, DOI 10.1002/j.1460-2075.1985.tb04036.x; SCOTT WA, 1978, CELL, V15, P1511, DOI 10.1016/0092-8674(78)90073-9; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Spencer VA, 2001, J BIOL CHEM, V276, P34810, DOI 10.1074/jbc.M104886200; Sun JM, 2001, J BIOL CHEM, V276, P49435, DOI 10.1074/jbc.M108364200; VARSHAVSKY AJ, 1979, CELL, V16, P453, DOI 10.1016/0092-8674(79)90021-7; Vassetzky Y, 2000, GENE DEV, V14, P1541; VICKERS MA, 1993, P NATL ACAD SCI USA, V90, P3437, DOI 10.1073/pnas.90.8.3437; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; WARD WS, 1989, CHROMOSOMA, V98, P153, DOI 10.1007/BF00329678; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3; Wolffe AP, 2000, BIOCHEM SOC T, V28, P379, DOI 10.1042/0300-5127:0280379; WU C, 1979, CELL, V16, P797, DOI 10.1016/0092-8674(79)90095-3; Wykes SM, 2003, MOL BIOTECHNOL, V25, P131, DOI 10.1385/MB:25:2:131; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; WYKES SM, 2004, IN PRESS RES TRENDS; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; ZAMBROWICZ BP, 1994, BIOL REPROD, V50, P65, DOI 10.1095/biolreprod50.1.65; ZAMBROWICZ BP, 1993, P NATL ACAD SCI USA, V90, P5071, DOI 10.1073/pnas.90.11.5071	73	63	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51862	51868		10.1074/jbc.M409415200	http://dx.doi.org/10.1074/jbc.M409415200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452126	hybrid			2022-12-27	WOS:000225493400019
J	Kuramochi, Y; Cote, GM; Guo, XX; Lebrasseur, NK; Cui, L; Liao, R; Sawyer, DB				Kuramochi, Y; Cote, GM; Guo, XX; Lebrasseur, NK; Cui, L; Liao, R; Sawyer, DB			Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1 beta/erbB4 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT VENTRICULAR MYOCYTES; EPIDERMAL GROWTH-FACTOR; HYDROGEN-PEROXIDE; DILATED CARDIOMYOPATHY; DEPENDENT ACTIVATION; CONTRACTILE ACTIVITY; NEUREGULIN RECEPTOR; KINASE ACTIVATION; AORTIC-STENOSIS; HEART-FAILURE	Neuregulin (NRG)-1beta has a prosurvival effect on cardiac myocytes via the phosphatidylinositol-3-kinase/Akt pathway, but the physiological regulators of this system in the intact heart are unknown. In this study, we tested the hypothesis that reactive oxygen species regulate NRG/erbB signaling. We used isolated adult rat ventricular myocytes (ARVMs) or cardiac microvascular endothelial cells (CMECs) in monoculture, or together in coculture. H2O2 induced NRG-1beta release from CMECs in a concentration-dependent manner, and conditioned medium from H2O2-treated CMEC activated ARVM erbB4. NRG-1beta release occurred via proteolytic cleavage of 115-kDa transmembrane NRG-1beta and was inhibited by the metalloproteinase inhibitor 1,10-phenanthroline. In myocyte monoculture, H2O2 induced erbB4-dependent, but NRG-independent, activation of Akt. To elucidate the bioactivity of CMEC-derived NRG-1beta on ARVMs, we examined H2O2-induced myocyte apoptosis in co-culture using an antibody to NRG-1beta. The percentages of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells were significantly higher in the anti-NRG-1beta group than in the control group. The change in apoptosis induced by anti-NRG-1beta in co-culture was similar in magnitude to the protection of myocytes by addition of recombinant NRG-1beta to ARVM monocultures. Activation of NRG/erbB paracrine signaling was also seen in the intact heart subjected to oxidative stress by ischemia-reperfusion injury. Isolated perfused mouse hearts subjected to 15 min of ischemia, followed by 30 min of reperfusion, showed complete proteolytic cleavage of 115-kDa NRG-1beta, with concomitant erbB4 phosphorylation. These results demonstrate that reactive oxygen species activate NRG-1beta/erbB4 paracrine signaling in the heart and suggest that this system is involved in cardiac adaptation to oxidative stress.	Boston Univ, Med Ctr, Dept Med, Whitaker Cardiovasc Inst,Ctr Mol Stress Response, Boston, MA 02118 USA	Boston University	Sawyer, DB (corresponding author), Boston Univ, Med Ctr, Dept Med, Whitaker Cardiovasc Inst,Ctr Mol Stress Response, EBRC Rm 329,650 Albany St, Boston, MA 02118 USA.	Douglas.Sawyer@bmc.org		Cote, Gregory/0000-0003-0181-886X; LeBrasseur, Nathan/0000-0002-2002-0418	NHLBI NIH HHS [HL68144, R01 HL068144] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068144] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Canto C, 2004, J BIOL CHEM, V279, P12260, DOI 10.1074/jbc.M308554200; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Cote GM, 2001, FASEB J, V15, pA762; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; DEBONO DP, 1995, ATHEROSCLEROSIS, V114, P235, DOI 10.1016/0021-9150(94)05488-5; Erickson SL, 1996, MOL BIOL CELL, V7, P669; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fujino T, 1998, CARDIOVASC RES, V38, P365, DOI 10.1016/S0008-6363(98)00010-8; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Fukazawa R, 2000, CIRCULATION, V102, P138; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Jain M, 2004, CIRCULATION, V109, P898, DOI 10.1161/01.CIR.0000112605.43318.CA; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Kuramochi Y, 2004, AM J PHYSIOL-CELL PH, V286, pC222, DOI 10.1152/ajpcell.00312.2003; Kwon SH, 2003, J MOL CELL CARDIOL, V35, P615, DOI 10.1016/S0022-2828(03)00084-1; Lebrasseur NK, 2003, AM J PHYSIOL-CELL PH, V284, pC1149, DOI 10.1152/ajpcell.00487.2002; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lemmens K, 2004, CIRCULATION, V109, P324, DOI 10.1161/01.CIR.0000114521.88547.5E; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Rohrbach S, 1999, CIRCULATION, V100, P407, DOI 10.1161/01.CIR.100.4.407; Sawyer DB, 2002, CIRCULATION, V105, P1551, DOI 10.1161/01.CIR.0000013839.41224.1C; Shirakabe K, 2001, J BIOL CHEM, V276, P9352, DOI 10.1074/jbc.M007913200; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Snabaitis AK, 2002, CARDIOVASC RES, V53, P470, DOI 10.1016/S0008-6363(01)00464-3; Wei S, 2001, AM J PHYSIOL-CELL PH, V281, pC1542, DOI 10.1152/ajpcell.2001.281.5.C1542; Yan XH, 2003, CIRCULATION, V108, P260; Yan XH, 2000, CIRCULATION, V102, P71; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261; Zhou SY, 2001, TOXICOL LETT, V121, P151, DOI 10.1016/S0378-4274(01)00329-0; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	39	152	169	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51141	51147		10.1074/jbc.M408662200	http://dx.doi.org/10.1074/jbc.M408662200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385548	hybrid			2022-12-27	WOS:000225355800060
J	Liu, D; O'Connor, MS; Qin, J; Songyang, Z				Liu, D; O'Connor, MS; Qin, J; Songyang, Z			Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN RAP1; LENGTH; TIN2; TRF2; POT1; END; ELONGATION; REGULATOR; TANKYRASE	In mammalian cells, telomere-binding proteins TRF1 and TRF2 play crucial roles in telomere biology. They interact with several other telomere regulators including TIN2, PTOP, POT1, and RAP1 to ensure proper maintenance of telomeres. TRF1 and TRF2 are believed to exert distinct functions. TRF1 forms a complex with TIN2, PTOP, and POT1 and regulates telomere length, whereas TRF2 mediates t-loop formation and end protection. However, whether cross-talk occurs between the TRF1 and TRF2 complexes and how the signals from these complexes are integrated for telomere maintenance remain to be elucidated. Through gel filtration and co-immunoprecipitation experiments, we found that TRF1 and TRF2 are in fact subunits of a telomere-associated high molecular weight complex (telosome) that also contains POT1, PTOP, RAP1, and TIN2. We demonstrated that the TRF1-interacting protein TIN2 binds TRF2 directly and in vivo, thereby bridging TRF2 to TRF1. Consistent with this multi-protein telosome model, stripping TRF1 off the telomeres by expressing tankyrase reduced telomere recruitment of not only TIN2 but also TRF2. These results help to unify previous observations and suggest that telomere maintenance depends on the multi-subunit telosome.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA	Baylor College of Medicine	Songyang, Z (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	songyang@bcm.tmc.edu						Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; Colgin LM, 2003, CURR BIOL, V13, P942, DOI 10.1016/S0960-9822(03)00339-7; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Dubrana K, 2001, CURR OPIN CELL BIOL, V13, P281, DOI 10.1016/S0955-0674(00)00210-6; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim S, 2002, ONCOGENE, V21, P503, DOI 10.1038/sj.onc.1205077; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wei C, 2003, CELL MOL LIFE SCI, V60, P2283, DOI 10.1007/s00018-003-3244-z; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	30	316	339	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51338	51342		10.1074/jbc.M409293200	http://dx.doi.org/10.1074/jbc.M409293200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383534	hybrid			2022-12-27	WOS:000225355800084
J	Nadauld, LD; Sandoval, IT; Chidester, S; Yost, HJ; Jones, DA				Nadauld, LD; Sandoval, IT; Chidester, S; Yost, HJ; Jones, DA			Adenomatous polyposis coli control of retinoic acid biosynthesis is critical for zebrafish intestinal development and differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A-DEFICIENCY; NULL MUTANT MICE; BETA-CATENIN; COLORECTAL-CANCER; GENE-EXPRESSION; CARCINOMA-CELLS; POSTERIOR AXIS; EMBRYONIC AXIS; DEHYDROGENASE; APC	Mutations in the APC ( adenomatous polyposis coli) tumor suppressor gene cause uncontrolled proliferation and impaired differentiation of intestinal epithelial cells. Recent studies indicate that human colon adenomas and carcinomas lack retinol dehydrogenases (RDHs) and that APC regulates the expression of human RDHL. These data suggest a model wherein APC controls enterocyte differentiation by controlling retinoic acid production. However, the importance of APC and retinoic acid in mediating control of normal enterocyte development and differentiation remains unclear. To examine the relationship between APC and retinoic acid biosynthesis in normal enterocytes, we have identified two novel zebrafish retinol dehydrogenases, termed zRDHA and zRDHB, that show strong expression within the gut of developing zebrafish embryos. Morpholino knockdown of either APC or zRDHB in zebrafish embryos resulted in defects in structures known to require retinoic acid. These defects included cardiac abnormalities, pericardial edema, failed jaw and pectoral fin development, and the absence of differentiated endocrine and exocrine pancreas. In addition, APC or zRDHB morphant fish developed intestines that lacked columnar epithelial cells and failed to express the differentiation marker intestinal fatty acid-binding protein. Treatment of either APC or zRDHB morphant embryos with retinoic acid rescued the defective phenotypes. Downstream of retinoic acid production, we identified hoxc8 as a retinoic acid-induced gene that, when ectopically expressed, rescued phenotypes of APC- and zRDHB-deficient zebrafish. Our data establish a genetic link supporting a critical role for retinoic acid downstream of APC and confirm the importance of retinoic acid in enterocyte differentiation.	Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Dept Med Chem, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Jones, DA (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, 2000 Circle Hope,Rm 5262, Salt Lake City, UT 84112 USA.	david.jones@hci.utah.edu		Chidester, Stephanie/0000-0003-4163-3480	NCI NIH HHS [CA073992-06A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA073992] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andre M, 2000, INT J DEV BIOL, V44, P249; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; BLANER WS, 1999, RETINOIDS BIOCH MOL, P117; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Deltour L, 1999, DEV GENET, V25, P1, DOI 10.1002/(SICI)1520-6408(1999)25:1<1::AID-DVG1>3.0.CO;2-W; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; Grandel H, 2002, DEVELOPMENT, V129, P2851; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoier EF, 2000, GENE DEV, V14, P874; Houle VM, 2003, AM J PHYSIOL-GASTR L, V284, pG722, DOI 10.1152/ajpgi.00458.2002; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; MAVILIO F, 1988, DIFFERENTIATION, V37, P73, DOI 10.1111/j.1432-0436.1988.tb00798.x; Mic FA, 2002, DEVELOPMENT, V129, P2271; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NARISAWA T, 1976, CANCER RES, V36, P1379; NZEGWU H, 1991, GUT, V32, P1324, DOI 10.1136/gut.32.11.1324; NZEGWU HC, 1992, GUT, V33, P794, DOI 10.1136/gut.33.6.794; Pack M, 1996, DEVELOPMENT, V123, P321; Perz-Edwards A, 2001, DEV BIOL, V229, P89, DOI 10.1006/dbio.2000.9979; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Samowitz WS, 1999, CANCER RES, V59, P1442; Shah S, 2002, J BIOL CHEM, V277, P25313, DOI 10.1074/jbc.M203158200; Sparks AB, 1998, CANCER RES, V58, P1130; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Traber PG, 1999, ADV EXP MED BIOL, V470, P1; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; ZILE M, 1977, J NUTR, V107, P552, DOI 10.1093/jn/107.4.552	46	51	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51581	51589		10.1074/jbc.M408830200	http://dx.doi.org/10.1074/jbc.M408830200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15358764	hybrid			2022-12-27	WOS:000225355800114
J	Sala, A; Campagnoli, M; Perani, E; Romano, A; Labo, S; Monzani, E; Minchiotti, L; Galliano, M				Sala, A; Campagnoli, M; Perani, E; Romano, A; Labo, S; Monzani, E; Minchiotti, L; Galliano, M			Human alpha-1-microglobulin is covalently bound to kynurenine-derived chromophores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN MODIFICATION; ALPHA(1)-MICROGLOBULIN; 3-HYDROXYKYNURENINE; NEUROTOXIN; PRODUCTS; RELEVANCE; OXIDATION; TARGETS; FILTER	alpha-1-Microglobulin carries a set of covalently linked chromophores that give it a peculiar yellow-brown color, fluorescence properties, and both charge and size heterogeneity. In this report it is shown that these features are due to the adducts with the tryptophan metabolite, 3-hydroxykynurenine, and its autoxidation products and that the modification is more pronounced in the protein isolated from urine of hemodialyzed patients. The light yellow amniotic fluid alpha-1-microglobulin acquires the optical properties and charge heterogeneity of the urinary counterpart following incubation with kynurenines. The colored amino acid adducts of urinary and amniotic fluid alpha-1-microglobulins were separated by chromatography after acid hydrolysis and analyzed by mass spectrometry. Human serum albumin samples, native and treated with 3-hydroxykynurenine in the presence of oxygen, were used as a control. The retention times and mass fragmentation products were compared, and a lysyl adduct with hydroxantommathin was identified in the urinary alpha-1-microglobulin and in the modified albumin samples. The more extensive modification of the urinary protein appears to be correlated with uremia, a condition in which the catabolism of tryptophan via the kynurenine pathway is increased, and the consequent rise in the concentration of its derivatives is accompanied by the oxidative processes due to the hemodialysis treatment. The oxidative derivatives of 3-hydroxykynurenine, which are known to act as protein cross-linking agents, are the likely cause of the propensity of urinary alpha-1-microglobulin to form dimers and oligomers. This process, as well as the redox properties of these metabolites, may contribute to the toxic effects of the kynurenine species.	Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; Univ Pavia, Ctr Grandi Strumenti, I-27100 Pavia, Italy; Univ Pavia, Dept Gen Chem, I-27100 Pavia, Italy	University of Pavia; University of Pavia; University of Pavia	Galliano, M (corresponding author), Univ Pavia, Dept Biochem, Viale Taramelli 3B, I-27100 Pavia, Italy.	galliano@unipv.it		MONZANI, ENRICO/0000-0002-8791-6446				Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P172, DOI 10.1016/S0167-4838(00)00157-6; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; Amoresano A, 2000, EUR J BIOCHEM, V267, P2105, DOI 10.1046/j.1432-1327.2000.01217.x; Aquilina JA, 1999, BIOCHEMISTRY-US, V38, P11455, DOI 10.1021/bi990458h; Aquilina JA, 1997, EXP EYE RES, V64, P727, DOI 10.1006/exer.1996.0258; Aquilina JA, 2000, BIOCHEMISTRY-US, V39, P16176, DOI 10.1021/bi001230t; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Berggard T, 1998, J HISTOCHEM CYTOCHEM, V46, P887, DOI 10.1177/002215549804600803; Berggard T, 1999, PROTEIN SCI, V8, P2611; CHURCHICH JE, 1972, BIOCHIM BIOPHYS ACTA, V285, P91, DOI 10.1016/0005-2795(72)90183-3; ESCRIBANO J, 1991, J BIOL CHEM, V266, P15758; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; GALLIANO M, 1990, P NATL ACAD SCI USA, V87, P8721, DOI 10.1073/pnas.87.22.8721; Garner B, 2000, BBA-PROTEIN STRUCT M, V1476, P265, DOI 10.1016/S0167-4838(99)00234-4; GIANAZZA E, 1985, ELECTROPHORESIS, V6, P332, DOI 10.1002/elps.1150060706; GRUBB A, 1992, CLIN NEPHROL, V38, pS20; Hood BD, 1999, J BIOL CHEM, V274, P32547, DOI 10.1074/jbc.274.46.32547; ISHII T, 1992, ARCH BIOCHEM BIOPHYS, V294, P616, DOI 10.1016/0003-9861(92)90733-D; Iwahashi H, 1997, J CHROMATOGR A, V773, P23, DOI 10.1016/S0021-9673(97)00271-9; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; KAUMEYER JF, 1986, NUCLEIC ACIDS RES, V14, P7839, DOI 10.1093/nar/14.20.7839; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindqvist A, 1999, GENE, V234, P329, DOI 10.1016/S0378-1119(99)00191-2; Liu ZF, 2003, CHEM RES TOXICOL, V16, P901, DOI 10.1021/tx0300030; MENDEZ E, 1986, P NATL ACAD SCI USA, V83, P1472, DOI 10.1073/pnas.83.5.1472; OGAWA T, 1992, NEUROLOGY, V42, P1702, DOI 10.1212/WNL.42.9.1702; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; Pawlak D., 2001, International Urology and Nephrology, V33, P399, DOI 10.1023/A:1015238418500; PEARSON SJ, 1992, NEUROSCI LETT, V144, P199, DOI 10.1016/0304-3940(92)90749-W; Salier JP, 2000, BBA-PROTEIN STRUCT M, V1482, P25, DOI 10.1016/S0167-4838(00)00144-8; SARDAR AM, 1995, J NEUROCHEM, V64, P932; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; TRUSCOTT RJW, 1994, FEBS LETT, V348, P173, DOI 10.1016/0014-5793(94)00601-6; Tyagi S, 2004, J BIOL CHEM, V279, P29308, DOI 10.1074/jbc.M402017200; Vazquez S, 2000, FREE RADICAL RES, V32, P11, DOI 10.1080/10715760000300021; Vazquez S, 2002, J BIOL CHEM, V277, P4867, DOI 10.1074/jbc.M107529200; Vazquez S, 2001, J AM SOC MASS SPECTR, V12, P786, DOI 10.1016/S1044-0305(01)00255-0	40	30	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51033	51041		10.1074/jbc.M408242200	http://dx.doi.org/10.1074/jbc.M408242200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452109	hybrid			2022-12-27	WOS:000225355800048
J	Meinild, AK; Sitte, HH; Gether, U				Meinild, AK; Sitte, HH; Gether, U			Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEROTONIN TRANSPORTER; CARRIER-MEDIATED RELEASE; ACID GABA TRANSPORTER-1; MONOAMINE TRANSPORTERS; CHARGE-TRANSFER; AMPHETAMINE; ZN2+; COCAINE; MECHANISM; BINDING	Binding of Zn2+ to an endogenous binding site in the dopamine transporter (DAT) leads to inhibition of dopamine (DA) uptake and enhancement of carrier-mediated substrate efflux. To elucidate the molecular mechanism for this dual effect, we expressed the DAT and selected mutants in Xenopus laevis oocytes and applied the two-electrode voltage clamp technique together with substrate flux studies employing radiolabeled tracers. Under voltage clamp conditions we found that Zn2+ (10 muM) enhanced the current induced by both DA and amphetamine. This was not accompanied by a change in the uptake rate but by a marked increase in the charge/DA flux coupling ratio as assessed from concomitant measurements of [H-3] DA uptake and currents in voltage-clamped oocytes. These data suggest that Zn2+ facilitates an uncoupled ion conductance mediated by DAT. Whereas this required substrate in the wild type (WT), we observed that Zn2+ by itself activated such a conductance in a previously described mutant (Y335A). This signifies that the conductance is not strictly dependent on an active transport process. Ion substitution experiments in Y335A, as well as in WT, indicated that the uncoupled conductance activated by Zn2+ was mainly carried by Cl-. Experiments in oocytes under non-voltage-clamped conditions revealed furthermore that Zn2+ could enhance the depolarizing effect of substrates in oocytes expressing WT. The data suggest that by potentiating an uncoupled Cl- conductance, Zn2+ is capable of modulating the membrane potential of cells expressing DAT and as a result cause simultaneous inhibition of uptake and enhancement of efflux.	Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen N, Denmark; Med Univ Vienna, Inst Pharmacol, A-1090 Vienna, Austria	University of Copenhagen; Medical University of Vienna	Gether, U (corresponding author), Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Neuropharmacol Grp, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	gether@neuropharm.ku.dk	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Gether, Ulrik/0000-0002-0020-3807	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA 12408] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; DeFelice LJ, 2004, TRENDS NEUROSCI, V27, P352, DOI 10.1016/j.tins.2004.04.007; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Goldberg NR, 2003, EUR J PHARMACOL, V479, P3, DOI 10.1016/j.ejphar.2003.08.052; GU H, 1994, J BIOL CHEM, V269, P7124; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jones SR, 1998, J NEUROSCI, V18, P1979; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; LEVI G, 1993, TRENDS NEUROSCI, V16, P415, DOI 10.1016/0166-2236(93)90010-J; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Li Y, 2001, J NEUROSCI, V21, P8015, DOI 10.1523/JNEUROSCI.21-20-08015.2001; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; MacAulay N, 2002, J PHYSIOL-LONDON, V544, P447, DOI 10.1113/jphysiol.2002.022897; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Mayfield RD, 2001, J NEUROCHEM, V79, P1070, DOI 10.1046/j.1471-4159.2001.00656.x; MCELVAIN JS, 1992, BIOCHEM PHARMACOL, V43, P2189, DOI 10.1016/0006-2952(92)90178-L; Meinild AK, 2001, BIOCHEMISTRY-US, V40, P11897, DOI 10.1021/bi011026l; Norregaard L, 2001, Curr Opin Drug Discov Devel, V4, P591; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Norregaard L, 2000, BIOCHEMISTRY-US, V39, P15836, DOI 10.1021/bi0018335; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; Pifl C, 2004, NEUROPHARMACOLOGY, V46, P223, DOI 10.1016/j.neuropharm.2003.09.007; PIFL C, 1995, MOL PHARMACOL, V47, P368; Prasad BM, 2001, J NEUROSCI, V21, P7561, DOI 10.1523/JNEUROSCI.21-19-07561.2001; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; RICHFIELD EK, 1993, MOL PHARMACOL, V43, P100; Rudnick G, 1997, NEUROTRANSMITTER TRA, P73; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; SCHWIEBERT EM, 1999, PHYSL REV S, V79, P145; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sonders MS, 1997, J NEUROSCI, V17, P960; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; WALL SC, 1995, MOL PHARMACOL, V47, P544	50	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49671	49679		10.1074/jbc.M407660200	http://dx.doi.org/10.1074/jbc.M407660200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15358780	hybrid			2022-12-27	WOS:000225229500017
J	Minami, T; Horiuchi, K; Miura, M; Abid, MR; Takabe, W; Noguchi, N; Kohro, T; Ge, XJ; Aburatani, H; Hamakubo, T; Kodama, T; Aird, WC				Minami, T; Horiuchi, K; Miura, M; Abid, MR; Takabe, W; Noguchi, N; Kohro, T; Ge, XJ; Aburatani, H; Hamakubo, T; Kodama, T; Aird, WC			Vascular endothelial growth factor-and thrombin-induced termination factor, down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED T-CELLS; DEPENDENT TRANSCRIPTIONAL PATHWAY; GLYCOGEN-SYNTHASE KINASE-3; NUCLEAR-FACTOR; ADHESION MOLECULE-1; STRIATED-MUSCLES; TYROSINE KINASE; CYCLOSPORINE-A; POTENTIAL ROLE	Activation and dysfunction of the endothelium underlie many vascular disorders including atherosclerosis, tumor growth, and inflammation. Endothelial cell activation is mediated by many different extra-cellular signals, which result in overlapping yet distinct patterns of gene expression. Here we show, in DNA microarray analyses, that vascular endothelial growth factor ( VEGF) and thrombin result in dramatic and rapid upregulation of Down syndrome critical region (DSCR)-1 gene encoding exons 4 - 7, a negative feedback regulator of calcium-calcineurin-NF-AT signaling. VEGF- and thrombin-mediated induction of DSCR-1 involves the cooperative binding of NF-ATc and GATA-2/3 to neighboring consensus motifs in the upstream promoter. Constitutive expression of DSCR-1 in endothelial cells markedly impaired NF-ATc nuclear localization, proliferation, and tube formation. Under in vivo conditions, overexpression of DSCR-1 reduced vascular density in matrigel plugs and melanoma tumor growth in mice. Taken together, these findings support a model in which VEGF- and thrombin-mediated induction of endothelial cell proliferation triggers a negative feedback loop consisting of DSCR-1 gene induction and secondary inhibition of NF-AT signaling. As a natural brake in the angiogenic process, this negative pathway may lend itself to therapeutic manipulation in pathological states.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Mol & Vasc Med, Boston, MA 02215 USA	University of Tokyo; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Minami, T (corresponding author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	minami@med.rcast.u-tokyo.ac.jp; kodama@lsbm.org	Ge, Xijin/AAP-6237-2021; Ge, Steven/ABF-1186-2021; 興梠, 貴英/F-9724-2012	Ge, Steven/0000-0001-7406-3782; HORIUCHI, KEIKO/0000-0003-4811-5133				Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Boss V, 1998, MOL PHARMACOL, V54, P264, DOI 10.1124/mol.54.2.264; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; COCKERILL GW, 1995, BLOOD, V86, P2689; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Ho IC, 1998, P NATL ACAD SCI USA, V95, P15537, DOI 10.1073/pnas.95.26.15537; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Isner JM, 1999, NAT MED, V5, P491, DOI 10.1038/8374; Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minami T, 2004, J BIOL CHEM, V279, P20626, DOI 10.1074/jbc.M308730200; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Wang YL, 2002, AM J PHYSIOL-HEART C, V283, pH533, DOI 10.1152/ajpheart.00002.2002; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347	45	189	195	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50537	50554		10.1074/jbc.M406454200	http://dx.doi.org/10.1074/jbc.M406454200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448146	hybrid			2022-12-27	WOS:000225229500119
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, IV; Olshevskaya, EV; Dizhoor, AM			Ca2+-dependent conformational changes in guanylyl cyclase-activating protein 2 (GCAP-2) revealed by site-specific phosphorylation and partial proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-BINDING PROTEINS; CALCIUM-CONCENTRATION; 3-DIMENSIONAL STRUCTURE; PHOTORECEPTORS; BINDING; KINASE; RECOVERIN; PHOSDUCIN; RODS; PHOTOTRANSDUCTION	Guanylyl cyclase-activating proteins (GCAPs) are calcium sensor proteins of the EF-hand superfamily that inhibit retinal photoreceptor membrane guanylyl cyclase (retGC) in the dark when they bind Ca2+ but activate retGC when Ca2+ dissociates from GCAPs in response to light stimulus. We addressed the difference in exposure of GCAP-2 structure to protein kinase and a protease as indicators of conformational change caused by binding and release of Ca2+. We have found that unlike its homolog, GCAP-1, the C terminus of GCAP-2 undergoes phosphorylation by cyclic nucleotide-dependent protein kinases (CNDPK) present in the retinal extract and rapid dephosphorylation by the protein phosphatase PP2C present in the retina. Inactivation of the CNDPK phosphorylation site in GCAP-2 by substitutions S201G or S201D, as well as phosphorylation or thiophosphorylation of Ser(201), had little effect on the ability of GCAP-2 to regulate retGC in reconstituted membranes in vitro. At the same time, Ca2+ strongly inhibited phosphorylation of the wild-type GCAP-2 by retinal CNDPK but did not affect phosphorylation of a constitutively active Ca2+-insensitive GCAP-2 mutant. Partial digestion of purified GCAP-2 with Glu-C protease revealed at least two sites that become exposed or constrained in a Ca2+-sensitive manner. The Ca2+-dependent conformational changes in GCAP-2 affect the areas around Glu(62) residue in the entering helix of EF-hand 2, the areas proximal to the exiting helix of EF-hand 3, and Glu(136)-Glu(138) between EF-hand 3 and EF-hand 4. These changes also cause the release of the C-terminal Ser(201) from the constraint caused by the Ca2+-bound conformation.	Penn Coll Optometry, Hafter Res Labs, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Penn Coll Optometry, Hafter Res Labs, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@pco.edu		Dizhoor, Alexander/0000-0001-6770-9186	NATIONAL EYE INSTITUTE [R01EY011522] Funding Source: NIH RePORTER; NEI NIH HHS [EY11522] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ames JB, 2002, ADV EXP MED BIOL, V514, P333; Ames JB, 2002, BIOCHEMISTRY-US, V41, P5776, DOI 10.1021/bi012153k; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Aparicio JG, 1996, J BIOL CHEM, V271, P27083, DOI 10.1074/jbc.271.43.27083; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Burgoyne RD, 2001, BIOCHEM J, V353, P1; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Dizhoor AM, 2000, CELL SIGNAL, V12, P711, DOI 10.1016/S0898-6568(00)00134-0; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gamm DM, 2000, INVEST OPHTH VIS SCI, V41, P2766; GERGELY P, 1976, BIOCHIM BIOPHYS ACTA, V429, P809, DOI 10.1016/0005-2744(76)90327-2; GORCZYCA WA, 1994, BIOCHEMISTRY-US, V33, P3217, DOI 10.1021/bi00177a011; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Haeseleer F, 2002, BIOCHEM BIOPH RES CO, V290, P615, DOI 10.1006/bbrc.2001.6228; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hurley JB, 2000, METHOD ENZYMOL, V315, P708; Klumpp S, 1998, J NEUROSCI RES, V51, P328, DOI 10.1002/(SICI)1097-4547(19980201)51:3<328::AID-JNR6>3.0.CO;2-I; Krylov DM, 1999, J BIOL CHEM, V274, P10833, DOI 10.1074/jbc.274.16.10833; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; LEE RH, 1990, J BIOL CHEM, V265, P15860; Li N, 2001, BIOL CHEM, V382, P1179, DOI 10.1515/BC.2001.148; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PAGHROEHL K, 1995, J NEUROSCI, V15, P6475; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sampath AP, 1999, J GEN PHYSIOL, V113, P267, DOI 10.1085/jgp.113.2.267; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Sokal I, 1999, J BIOL CHEM, V274, P19829, DOI 10.1074/jbc.274.28.19829; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1997, BIOCHEMISTRY-US, V36, P11995, DOI 10.1021/bi971212k; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Willardson BM, 1996, P NATL ACAD SCI USA, V93, P1475, DOI 10.1073/pnas.93.4.1475; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; Yamazaki A, 2003, J BIOL CHEM, V278, P33150, DOI 10.1074/jbc.M303678200	49	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50342	50349		10.1074/jbc.M408683200	http://dx.doi.org/10.1074/jbc.M408683200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448139	hybrid			2022-12-27	WOS:000225229500098
J	Saini, AK; Maithal, K; Chand, P; Chowdhury, S; Vohra, R; Goyal, A; Dubey, GP; Chopra, P; Chandra, R; Tyagi, AK; Singh, Y; Tandon, V				Saini, AK; Maithal, K; Chand, P; Chowdhury, S; Vohra, R; Goyal, A; Dubey, GP; Chopra, P; Chandra, R; Tyagi, AK; Singh, Y; Tandon, V			RETRACTED: Nuclear localization and in situ DNA damage by Mycobacterium tuberculosis nucleoside-diphosphate kinase (Retracted article. See vol. 294, pg. 18949, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							X-RAY STRUCTURE; TRIPHOSPHATE SYNTHESIS; CLEAVAGE; GENE; AUTOPHOSPHORYLATION; SUPEROXIDE; RESONANCE; ALIGNMENT; DISTINCT; FORM	Nucleoside-diphosphate kinase of Mycobacterium tuberculosis (mNdK) is a secretory protein, but the rationale behind secreting an enzyme involved in the maintenance of cellular pool of nucleoside triphosphates is not clearly understood. To elucidate the biological significance of mNdK secretion, we expressed mNdK fused to green fluorescent protein in HeLa and COS-1 cells. Interestingly, mNdK was detected in the nuclei of HeLa and COS-1 cells. Incubation of mNdK with nuclei isolated from HeLa and COS-1 cells led to in situ damage of chromosomal DNA. Surface plasmon resonance studies demonstrated that mNdK binds supercoiled plasmid DNA lacking apurinic/apyrimidinic sites with a dissociation constant of 30 +/- 3.2 muM. Plasmid cleavage by mNdK was found to be dependent on the specific divalent metal ion and inhibited by a metal ion chelator. Moreover, the metal ion-dependent DNA cleavage by mNdK was mediated by superoxide radicals as detected by electron paramagnetic resonance. The cleavage reaction was inhibited under nitrogen atmosphere confirming the necessity of molecular oxygen for DNA cleavage. In view of the findings that mNdK is secreted by intracellular mycobacteria and damages the nuclear DNA, it can be postulated that mNdK may cause cell death that could help in the dissemination of the pathogen.	Inst Genom & Integrat Biol, Delhi 110007, India; Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; Indian Inst Technol, Dept Phys, Kanpur 208076, Uttar Pradesh, India; Univ Delhi, Dept Biochem, New Delhi 110021, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; University of Delhi	Singh, Y (corresponding author), Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.	ysingh@igib.res.in; vtandon@acbrdu.edu	TYAGI, AKHILESH KUMAR/D-2649-2009; Saini, Reena V/ABA-6052-2020	Saini, Adesh/0000-0002-5445-5786; Saini, Reena Vohra/0000-0002-8163-5790				AGARWAL RP, 1971, J BIOL CHEM, V246, P2258; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Bennett SE, 2004, P NATL ACAD SCI USA, V101, P6391, DOI 10.1073/pnas.0401031101; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; CRUMBLISS AL, 1970, J AM CHEM SOC, V92, P55, DOI 10.1021/ja00704a009; DUMAS C, 1992, EMBO J, V11, P3203, DOI 10.1002/j.1460-2075.1992.tb05397.x; Fan Z, 2003, CELL, V115; FINKELSTEIN E, 1980, ARCH BIOCHEM BIOPHYS, V200, P1, DOI 10.1016/0003-9861(80)90323-9; FREIFELDER D, 1969, BIOPOLYMERS, V7, P681, DOI 10.1002/bip.1969.360070506; GILLES AM, 1991, J BIOL CHEM, V266, P8784; Gounaris K, 2001, INFECT IMMUN, V69, P3658, DOI 10.1128/IAI.69.6.3658-3662.2001; HERTZBERG RP, 1982, J AM CHEM SOC, V104, P313, DOI 10.1021/ja00365a069; HOFFMAN BM, 1970, J AM CHEM SOC, V92, P61, DOI 10.1021/ja00704a010; HUGHES MN, 1985, INORGANIC CHEM BIOL, P273; Imanishi M, 2002, BIOCHEMISTRY-US, V41, P1328, DOI 10.1021/bi011761x; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Kaim W., 1994, BIOINORGANIC CHEM IN; KORYTOWSKI W, 1986, BIOCHIM BIOPHYS ACTA, V882, P145, DOI 10.1016/0304-4165(86)90149-2; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; MCHUGH PJ, 1995, NUCLEIC ACIDS RES, V23, P1664, DOI 10.1093/nar/23.10.1664; MUNOZDORADO J, 1993, J BACTERIOL, V175, P1176; MUNOZDORADO J, 1990, J BIOL CHEM, V265, P2702; Panayotou G, 1998, J BIOL CHEM, V273, P45, DOI 10.1074/jbc.273.1.45; Postel EH, 2003, P NATL ACAD SCI USA, V100, P13247, DOI 10.1073/pnas.2333230100; Postel EH, 1999, J BIOL CHEM, V274, P22821, DOI 10.1074/jbc.274.32.22821; Postel EH, 2000, P NATL ACAD SCI USA, V97, P14194, DOI 10.1073/pnas.97.26.14194; Punj V, 2000, INFECT IMMUN, V68, P4930, DOI 10.1128/IAI.68.9.4930-4937.2000; Shankar S, 1996, J BACTERIOL, V178, P1777, DOI 10.1128/jb.178.7.1777-1781.1996; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Zaborina O, 1999, MOL MICROBIOL, V31, P1333, DOI 10.1046/j.1365-2958.1999.01240.x	40	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50142	50149		10.1074/jbc.M409944200	http://dx.doi.org/10.1074/jbc.M409944200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377659	hybrid			2022-12-27	WOS:000225229500073
J	Schonfeld, C; Wobbe, L; Borgstadt, R; Kienast, A; Nixon, PJ; Kruse, O				Schonfeld, C; Wobbe, L; Borgstadt, R; Kienast, A; Nixon, PJ; Kruse, O			The nucleus-encoded protein MOC1 is essential for mitochondrial light acclimation in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION TERMINATION FACTOR; DOMINANT SELECTABLE MARKER; STATE TRANSITIONS; ALTERNATIVE OXIDASE; PLANT-MITOCHONDRIA; ELECTRON-TRANSFER; GENE-EXPRESSION; PHOTOSYSTEM-I; COMPLEX-I; DNA	Mitochondrial respiration plays an important role in optimizing photosynthetic efficiency in plants. As yet, the mechanisms by which plant mitochondria sense and respond to changes in the environment are unclear, particularly when exposed to light. Here we describe the characterization of the Chlamydomonas reinhardtii mutant stm6, which was identified on the basis of impaired state transitions, a mechanism that regulates light harvesting in the chloroplast. The gene disrupted in stm6, termed Moc1, encodes a homologue of the human mitochondrial transcription termination factor (mTERF). MOC1 is targeted to the mitochondrion, and its expression is up-regulated in response to light. Loss of MOC1 causes a high light-sensitive phenotype and disrupts the transcription and expression profiles of the mitochondrial respiratory complexes causing, as compared with wild type, light-mediated changes in the expression levels of nuclear and mitochondrial encoded cytochrome c oxidase subunits and ubiquinone-NAD subunits. The absence of MOC1 leads to a reduction in the levels of cytochrome c oxidase and of rotenone-insensitive external NADPH dehydrogenase activities of the mitochondrial respiratory electron transfer chain. Overall, we have identified a novel mitochondrial factor that regulates the composition of the mitochondrial respiratory chain in the light so that it can act as an effective sink for reductant produced by the chloroplast.	Univ Bielefeld, Mol Cell Physiol Grp, Dept Biol, D-33501 Bielefeld, Germany; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England	University of Bielefeld; Imperial College London	Kruse, O (corresponding author), Univ Bielefeld, Mol Cell Physiol Grp, Dept Biol, D-33501 Bielefeld, Germany.	olaf.kruse@uni-bielefeld.de	Kruse, Olaf/O-1127-2015	Nixon, Peter/0000-0003-1952-6937; Kruse, Olaf/0000-0001-9874-382X				ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Baurain D, 2003, PLANT PHYSIOL, V131, P1418, DOI 10.1104/pp.013409; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; BULTE L, 1990, BIOCHIM BIOPHYS ACTA, V1020, P72, DOI 10.1016/0005-2728(90)90095-L; Cardol P, 2003, PLANT PHYSIOL, V133, P2010, DOI 10.1104/pp.103.028076; DAGA A, 1993, J BIOL CHEM, V268, P8123; DAY A, 1988, EMBO J, V7, P1917, DOI 10.1002/j.1460-2075.1988.tb03029.x; de Vitry C, 1999, PLANT CELL, V11, P2031, DOI 10.1105/tpc.11.10.2031; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Duby F, 1999, PLANT CELL, V11, P115; Dutilleul C, 2003, PLANT PHYSIOL, V131, P264, DOI 10.1104/pp.011155; Dyer T. A., 1981, The biochemistry of plants. A comprehensive treatise. Volume 6. Proteins and nucleic acids., P111; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Finazzi G, 1999, BBA-BIOENERGETICS, V1413, P117, DOI 10.1016/S0005-2728(99)00089-4; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Flugge UI, 1998, CURR OPIN PLANT BIOL, V1, P201, DOI 10.1016/S1369-5266(98)80105-2; GANS P, 1995, BBA-BIOENERGETICS, V1228, P51, DOI 10.1016/0005-2728(94)00159-3; GRAY MW, 1988, PHILOS T R SOC B, V319, P135, DOI 10.1098/rstb.1988.0038; GU JY, 1993, PLANT CELL, V5, P963, DOI 10.1105/tpc.5.8.963; Gumpel Nicola J., 1994, Trends in Cell Biology, V4, P299, DOI 10.1016/0962-8924(94)90222-4; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; HORTON P, 1981, FEBS LETT, V125, P193, DOI 10.1016/0014-5793(81)80716-8; Huertas IE, 2002, PLANT PHYSIOL, V130, P284, DOI 10.1104/pp.004598; HUSIC DW, 1987, P NATL ACAD SCI USA, V84, P1555, DOI 10.1073/pnas.84.6.1555; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; KROMER S, 1991, PLANT PHYSIOL, V95, P1270, DOI 10.1104/pp.95.4.1270; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Kruse O, 1999, PHOTOSYNTH RES, V61, P43, DOI 10.1023/A:1006229308606; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Lown FJ, 2001, BIOCHEM SOC T, V29, P452, DOI 10.1042/BST0290452; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Michalecka AM, 2003, PLANT PHYSIOL, V133, P642, DOI 10.1104/pp.103.024208; Michel KP, 1999, MICROBIOL-SGM, V145, P1473, DOI 10.1099/13500872-145-6-1473; Millar AH, 1996, FEBS LETT, V398, P155, DOI 10.1016/S0014-5793(96)01230-6; Millenaar FF, 2003, PLANT BIOLOGY, V5, P2, DOI 10.1055/s-2003-37974; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Nurani G, 1997, PLANT MOL BIOL, V35, P973, DOI 10.1023/A:1005878614878; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Polosa PL, 1999, NUCLEIC ACIDS RES, V27, P1890, DOI 10.1093/nar/27.8.1890; PURTON S, 1995, EUR J PHYCOL, V30, P141, DOI 10.1080/09670269500650901; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; RASMUSSON AG, 1991, PHYSIOL PLANTARUM, V83, P357, DOI 10.1111/j.1399-3054.1991.tb00106.x; REBEILLE F, 1988, PLANT PHYSIOL, V88, P973, DOI 10.1104/pp.88.4.973; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; Roberti M, 2003, NUCLEIC ACIDS RES, V31, P1597, DOI 10.1093/nar/gkg272; Selwood SP, 2000, BIOCHEM SOC T, V28, P154, DOI 10.1042/bst0280154; SINGH DP, 1995, PHOTOCHEM PHOTOBIOL, V62, P314, DOI 10.1111/j.1751-1097.1995.tb05274.x; Snyders S, 2001, J BIOL CHEM, V276, P32169, DOI 10.1074/jbc.M102539200; Stevens DR, 1996, MOL GEN GENET, V251, P23; Strauss C, 2001, PHOTOSYNTH RES, V70, P311, DOI 10.1023/A:1014713612509; Svensson AS, 2001, PLANT J, V28, P73, DOI 10.1046/j.1365-313X.2001.01128.x; TAM LW, 1993, GENETICS, V135, P375; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Vener AV, 1999, BIOCHEMISTRY-US, V38, P14955, DOI 10.1021/bi990971v; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Zerges W, 1998, J CELL BIOL, V140, P101, DOI 10.1083/jcb.140.1.101; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961; Zottini M, 2002, FEBS LETT, V515, P75, DOI 10.1016/S0014-5793(02)02438-9	66	78	78	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50366	50374		10.1074/jbc.M408477200	http://dx.doi.org/10.1074/jbc.M408477200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448140	hybrid			2022-12-27	WOS:000225229500101
J	Wicher, D; Messutat, S; Lavialle, C; Lapied, B				Wicher, D; Messutat, S; Lavialle, C; Lapied, B			A new regulation of non-capacitative calcium entry in insect pacemaker neurosecretory neurons - Involvement of arachidonic acid, NO-guanylyl cyclase/cGMP, and cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE-A; CA2+ ENTRY; NITRIC-OXIDE; CYCLIC-GMP; PEPTIDERGIC MODULATION; MEDIAN NEURONS; CURRENTS; PATHWAYS; VASOPRESSIN	Efferent dorsal unpaired median neurons are pacemaker neurosecretory cells. A Ca2+ background current contributing to the pacemaker activity of cockroach dorsal unpaired median neurons is up-regulated by neurohormone D (NHD), an octapeptide belonging to the adipokinetic hormone family. This modulation accelerates spiking and increases [Ca2+](i). Using patch clamp, calcium imaging, and immunocytochemistry, we investigated the signaling pathway of NHD-induced current modulation. The membrane depolarization produced by NHD was related to the increase in membrane conductance for Ca-+(2), Ba2+, or Sr2+. This increase was abolished by LOE 908, an inhibitor of noncapacitive Ca2+ entry (NCCE), and it was strongly attenuated by the phospholipase C inhibitor U37122 and the diacylglycerol lipase inhibitor RHC80267. Arachidonic acid and ETYA mimicked the NHD effect on background current. This was abolished by L-NAME and ODQ, inhibitors of NO synthase and NO-sensitive guanylyl cyclase, respectively, but mimicked by the NO donor sodium nitroprusside and 8-bromo-cGMP. Immunocytochemistry using cGMP antibodies indicated that NHD and ETYA increase cGMP. Inhibition of protein kinase G with KT5823 and R-p-8-pCPT-cGMPS had no effect, whereas zaprinast, a cGMP-specific phosphodiesterase 5,6,9 inhibitor, mimicked the NHD effect. Furthermore, inhibition of the cGMP-activated phosphodiesterase 2 by EHNA and trequinsin abolished the effect of NHD. We conclude that the final step of the NHD signal transduction is the phosphodiesterase 2-induced down-regulation of the cAMP level. This removes a depression of NCCE directly attributed to cAMP because inhibition of protein kinase A with KT5720, R-p-cAMPS, and PKI14-22 amide did not mimic the NHD effect. We also demonstrate that any mechanism increasing the cGMP level can induce NCCE.	Saxon Acad Sci, Dept Neurohormones, D-07743 Jena, Germany; Univ Angers, Lab Recepteurs & Canaus Ioniques Membranaires, RCIM, UPRES EA 2647, F-49045 Angers, France	Universite d'Angers	Wicher, D (corresponding author), Saxon Acad Sci, Dept Neurohormones, Erbertstr 1, D-07743 Jena, Germany.	b6widi@pan.zoo.uni-jena.de	; Defaix, Celine/G-9339-2018	Lapied, Bruno/0000-0002-0354-4375; Defaix, Celine/0000-0002-2354-855X				Achenbach H, 1997, NEUROREPORT, V8, P3737, DOI 10.1097/00001756-199712010-00016; Amat C, 1998, J NEUROPHYSIOL, V80, P2718, DOI 10.1152/jn.1998.80.5.2718; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Burrows M., 1996, NEUROBIOLOGY INSECT; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; FRENCH AS, 1993, J NEUROBIOL, V24, P939, DOI 10.1002/neu.480240707; Grolleau F, 1996, J NEUROPHYSIOL, V76, P963, DOI 10.1152/jn.1996.76.2.963; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heine M, 1998, NEUROREPORT, V9, P3309, DOI 10.1097/00001756-199810050-00029; IGNARRO LJ, 1987, BIOCHIM BIOPHYS ACTA, V928, P160, DOI 10.1016/0167-4889(87)90117-0; LAPIED B, 1989, J EXP BIOL, V144, P535; Lucas KA, 2000, PHARMACOL REV, V52, P375; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; Messutat S, 2001, CELL CALCIUM, V30, P199, DOI 10.1054/ceca.2001.0227; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Moneer Z, 2003, BIOCHEM J, V370, P439, DOI 10.1042/BJ20021104; Moneer Z, 2002, BIOCHEM J, V362, P13, DOI 10.1042/0264-6021:3620013; MORTON DB, 1992, J NEUROCHEM, V59, P1522, DOI 10.1111/j.1471-4159.1992.tb08469.x; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Shuttleworth TJ, 1996, BIOCHEM J, V316, P819, DOI 10.1042/bj3160819; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; WICHER D, 1994, J COMP PHYSIOL A, V174, P507; Wicher D, 1997, J NEUROPHYSIOL, V77, P186, DOI 10.1152/jn.1997.77.1.186; Wicher D, 2001, PROG NEUROBIOL, V64, P431, DOI 10.1016/S0301-0082(00)00066-6; Wicher D, 2001, J NEUROPHYSIOL, V85, P374, DOI 10.1152/jn.2001.85.1.374; Wicher D, 2001, J NEUROPHYSIOL, V86, P2353, DOI 10.1152/jn.2001.86.5.2353	29	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50410	50419		10.1074/jbc.M405800200	http://dx.doi.org/10.1074/jbc.M405800200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364947	hybrid			2022-12-27	WOS:000225229500106
J	Kibler, KV; Miyazato, A; Yedavalli, VSRK; Dayton, AI; Jacobs, BL; Dapolito, G; Kim, SJ; Jeang, KT				Kibler, KV; Miyazato, A; Yedavalli, VSRK; Dayton, AI; Jacobs, BL; Dapolito, G; Kim, SJ; Jeang, KT			Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN; HIV-1; ACTIVATION; PRECURSOR; CLEAVAGE; PROTEIN; MATURATION; PEPTIDES; CONVERTASES; PROTEASES	Correct endoproteolytic maturation of gp160 is essential for the infectivity of human immunodeficiency virus type 1. This processing of human immunodeficiency virus-1 envelope protein, gp160, into gp120 and gp41 has been attributed to the activity of the cellular subtilisin-like proprotein convertase furin. The prototypic furin recognition cleavage site is Arg-X-Arg/Lys-Arg. Arg-Arg-Arg-Arg- Arg-Arg or longer iterations of polyarginine have been shown to be competitive inhibitors of substrate cleavage by furin. Here, we tested polyarginine for inhibition of productive human immunodeficiency virus-1-infection in T-cell lines, primary peripheral blood mononuclear cells, and macrophages. We found that polyarginine inhibited significantly human immunodeficiency virus-1 replication at concentrations that were benign to cell cultures ex vivo and mice in vivo. Using a fluorogenic assay, we demonstrated that polyarginine potently inhibited substrate-specific proteolytic cleavage by furin. Moreover, we verified that authentic processing of human immunodeficiency virus-1 gp160 synthesized in human cells from an infectious human immunodeficiency virus-1 (HIV-1) molecular clone was effectively blocked by polyarginine. Taken together, our data support that inhibitors of proteolytic processing of gp160 may be useful for combating human immunodeficiency virus-1 and that polyarginine represents a lead example of such inhibitors.	NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA); Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jeang, KT (corresponding author), NIAID, Mol Microbiol Lab, NIH, Bldg 4,Rm 306,9000 Rockville Pike, Bethesda, MD 20892 USA.	kj7e@nih.gov	Jeang, Kuan-Teh/A-2424-2008		NATIONAL CANCER INSTITUTE [Z01BC005617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000547, ZIAAI000547] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Bahbouhi B, 2002, BIOCHEM J, V366, P863, DOI 10.1042/BJ20020052; Bahbouhi B, 2001, BIOCHEM J, V360, P127, DOI 10.1042/0264-6021:3600127; Bultmann A, 2001, J VIROL, V75, P5263, DOI 10.1128/JVI.75.11.5263-5276.2001; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chesney M, 2003, AIDS PATIENT CARE ST, V17, P169, DOI 10.1089/108729103321619773; Cushman DW, 1999, NAT MED, V5, P1110, DOI 10.1038/13423; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GU ML, 1995, FEBS LETT, V365, P95, DOI 10.1016/0014-5793(95)00447-H; Hallenberger S, 1997, J VIROL, V71, P1036, DOI 10.1128/JVI.71.2.1036-1045.1997; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hook VYH, 2003, J NEUROSCI RES, V74, P393, DOI 10.1002/jnr.10784; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Kasai T, 2002, J BIOL CHEM, V277, P5187, DOI 10.1074/jbc.M110295200; Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997; Kimura T, 1996, FEBS LETT, V390, P15, DOI 10.1016/0014-5793(96)00614-X; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; Menard J, 2001, ADV PROTEIN CHEM, V56, P13; Miller WR, 2003, J STEROID BIOCHEM, V86, P413, DOI 10.1016/S0960-0760(03)00352-2; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Natsume H, 1999, INT J PHARM, V185, P1, DOI 10.1016/S0378-5173(99)00100-3; Park J, 2002, J GEN VIROL, V83, P1173, DOI 10.1099/0022-1317-83-5-1173; Rich EA, 2002, J BIOMED SCI, V9, P721, DOI 10.1159/000067293; RYSER HJP, 1965, SCIENCE, V150, P501, DOI 10.1126/science.150.3695.501; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Sarac MS, 2002, INFECT IMMUN, V70, P7136, DOI 10.1128/IAI.70.12.7136-7139.2002; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; SEIDAH NG, 1998, MOL B INT U, V2, P49; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Theodore TS, 1996, AIDS RES HUM RETROV, V12, P191, DOI 10.1089/aid.1996.12.191; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; WILLEY RL, 1988, P NATL ACAD SCI USA, V85, P9580, DOI 10.1073/pnas.85.24.9580; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	47	34	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49055	49063		10.1074/jbc.M403394200	http://dx.doi.org/10.1074/jbc.M403394200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371436	hybrid			2022-12-27	WOS:000225098100069
J	Moussatche, P; Klee, HJ				Moussatche, P; Klee, HJ			Autophosphorylation activity of the Arabidopsis ethylene receptor multigene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE KINASE; RAF-LIKE KINASE; HISTIDINE KINASE; PROTEIN-KINASE; GENE FAMILY; ETR1; PHYTOCHROME; DOMAIN; BINDING; CTR1	Receptors for the gaseous phytohormone ethylene show sequence similarity to bacterial two-component histidine kinases. These receptors are encoded by a multigene family that can be divided into subfamilies 1 and 2. It has been previously shown that a subfamily 1 Arabidopsis thaliana ethylene receptor, ETR1, autophosphorylates in vitro on a conserved histidine residue (1). However, sequence comparisons between the five ethylene receptor family members suggest that subfamily 2 members do not have all the motifs necessary for histidine kinase activity. Further, a tobacco subfamily 2 receptor, NTHK1, autophosphorylates on serines and threonines in vitro (2). Here we show that all five Arabidopsis ethylene receptor proteins autophosphorylate in vitro. We analyzed the nature of the phosphorylated amino acids by acid/base stability and bi-dimensional thin layer electrophoresis and demonstrated that unlike ETR1 all other ethylene receptors autophosphorylate predominantly on serine residues. ERS1, the only other subfamily 1 receptor, is able to phosphorylate on both histidine and serine residues in the presence of Mn2+. However, histidine autophosphorylation is lost when ERS1 is assayed in the presence of both Mg2+ and Mn2+, suggesting that this activity may not occur in vivo. Furthermore, mutation of the histidine residue conserved in two-component systems does not abolish serine autophosphorylation, eliminating the possibility of a histidine to serine phosphotransfer. Our biochemical observations complement the recently published genetic data that histidine kinase activity is not necessary for ethylene receptor function in plants and suggest that ethylene signal transduction does not occur through a phosphorelay mechanism.	Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Klee, HJ (corresponding author), Univ Florida, Dept Hort Sci, POB 110690, Gainesville, FL 32611 USA.	hjklee@ifas.ufl.edu	Klee, Harry/A-7912-2008	Moussatche, Patricia/0000-0003-4540-0609				Abeles F, 1992, ETHYLENE PLANT BIOL; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; CHANG C, 1995, P NATL ACAD SCI USA, V92, P4129, DOI 10.1073/pnas.92.10.4129; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; DAVIE JR, 1995, J BIOL CHEM, V270, P19861, DOI 10.1074/jbc.270.34.19861; DUCLOS B, 1991, METHOD ENZYMOL, V201, P10; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; Lapko VN, 1999, PROTEIN SCI, V8, P1032, DOI 10.1110/ps.8.5.1032; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; MUKHOPADHYAY MJ, 1991, BOT REV, V57, P117, DOI 10.1007/BF02858767; Nollen EAA, 2002, J CELL SCI, V115, P2809; O'Sullivan W J, 1979, Methods Enzymol, V63, P294; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PERRIN DD, 1967, TALANTA, V14, P833, DOI 10.1016/0039-9140(67)80105-X; POPOV KM, 1992, J BIOL CHEM, V267, P13127; POPOV KM, 1993, J BIOL CHEM, V268, P26602; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; PUTNAMEVANS CL, 1990, BIOCHEMISTRY-US, V29, P2488, DOI 10.1021/bi00462a008; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; SCHNEIDERPOETSCH HAW, 1991, FEBS LETT, V281, P245, DOI 10.1016/0014-5793(91)80403-P; SHERMAN MY, 1991, J BACTERIOL, V173, P7249, DOI 10.1128/jb.173.22.7249-7256.1991; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thelen JJ, 2000, BIOCHEM J, V349, P195, DOI 10.1042/0264-6021:3490195; Tuazon PT, 1998, BIOCHEMISTRY-US, V37, P17024, DOI 10.1021/bi982103o; Tuganova A, 2001, J BIOL CHEM, V276, P17994, DOI 10.1074/jbc.M009327200; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Xie C, 2003, PLANT J, V33, P385, DOI 10.1046/j.1365-313X.2003.01631.x; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	48	146	159	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48734	48741		10.1074/jbc.M403100200	http://dx.doi.org/10.1074/jbc.M403100200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358768	hybrid			2022-12-27	WOS:000225098100031
J	Rosner, M; Hengstschlager, M				Rosner, M; Hengstschlager, M			Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SCLEROSIS COMPLEX; TSC2 GENE; INHIBITOR P27; DEGRADATION; PRODUCT; HAMARTIN; PATHWAY	TSC1 ((t) under bar uberous (s) under bar clerosis (c) under bar omplex (1) under bar) encoding hamartin and TSC2 encoding tuberin are tumor suppressor genes responsible for the autosomal dominantly inherited disease tuberous sclerosis. These genes have been demonstrated to negatively regulate cell cycle progression, the activity of cdk2, and the degradation of the cyclin-dependent kinase inhibitor p27. To date, the underlying molecular mechanism remains elusive. Here, we show that tuberin binds to p27. Whereas tuberin also binds p27 in TSC1-negative cells, hamartin does not bind p27 without tuberin. p27 protein levels are regulated through ubiquitin-dependent degradation. Skp2 is the F-box protein, which, together with other proteins, forms an SCF ((S) under bar kp1/(c) under bar ullin/(F) under bar -box protein)-type E3 ubiquitin ligase complex whose task is to target p27 for degradation by the proteasome. We found that neither tuberin nor hamartin are in a complex with Skp2. Tuberin does not affect Skp2 protein levels, and the SCFSkp2 ubiquitin ligase does not regulate tuberin stability. But binding of tuberin to p27 sequesters p27 from Skp2 accompanied by an up-regulation of the p27 interaction with cdk2. Skp2-induced p27 degradation and cell cycle progression is abolished by tuberin's protective binding to p27. This work, the first description of the direct interaction of a tumor suppressor protein with p27, provides a molecular explanation for the effects of tuberous sclerosis complex genes on the cell cycle and demonstrates a new aspect of the SCFSkp2-mediated regulation of p27 stability.	Med Univ Vienna, A-1090 Vienna, Austria	Medical University of Vienna	Hengstschlager, M (corresponding author), Med Univ Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	markus.hengstschlaeger@akh-wien.ac.at						Amati B, 1999, NAT CELL BIOL, V1, pE91, DOI 10.1038/12087; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Honda S, 2003, MOL CARCINOGEN, V37, P122, DOI 10.1002/mc.10123; Knowles MA, 2003, BIOCHEM SOC T, V31, P597, DOI 10.1042/BST0310597; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Miloloza A, 2002, J NEUROPATH EXP NEUR, V61, P154, DOI 10.1093/jnen/61.2.154; Miloloza A, 2000, HUM MOL GENET, V9, P1721, DOI 10.1093/hmg/9.12.1721; NELLIST M, 1993, CELL, V75, P1305; Nho Richard Seonghun, 2003, Prog Cell Cycle Res, V5, P249; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pan DJ, 2004, TRENDS CELL BIOL, V14, P78, DOI 10.1016/j.tcb.2003.12.006; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Plank TL, 1998, CANCER RES, V58, P4766; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Soucek T, 2001, ONCOGENE, V20, P4904, DOI 10.1038/sj.onc.1204627; Soucek T, 1997, J BIOL CHEM, V272, P29301, DOI 10.1074/jbc.272.46.29301; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Uhlmann EJ, 2002, ONCOGENE, V21, P4050, DOI 10.1038/sj.onc.1205435; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381	34	55	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48707	48715		10.1074/jbc.M405528200	http://dx.doi.org/10.1074/jbc.M405528200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355997	hybrid			2022-12-27	WOS:000225098100028
J	Beer, SM; Taylor, ER; Brown, SE; Dahm, CC; Costa, NJ; Runswick, MJ; Murphy, MP				Beer, SM; Taylor, ER; Brown, SE; Dahm, CC; Costa, NJ; Runswick, MJ; Murphy, MP			Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins - Implications for mitochondrial redox regulation and antioxidant defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; ELECTRON-TRANSPORT CHAIN; CARBONIC-ANHYDRASE III; COMPLEX-I; DISULFIDE-ISOMERASE; MIXED DISULFIDE; THIOREDOXIN; SUPEROXIDE; APOPTOSIS; STRESS	The redox poise of the mitochondrial glutathione pool is central in the response of mitochondria to oxidative damage and redox signaling, but the mechanisms are uncertain. One possibility is that the oxidation of glutathione (GSH) to glutathione disulfide (GSSG) and the consequent change in the GSH/GSSG ratio causes protein thiols to change their redox state, enabling protein function to respond reversibly to redox signals and oxidative damage. However, little is known about the interplay between the mitochondrial glutathione pool and protein thiols. Therefore we investigated how physiological GSH/GSSG ratios affected the redox state of mitochondrial membrane protein thiols. Exposure to oxidized GSH/GSSG ratios led to the reversible oxidation of reactive protein thiols by thiol-disulfide exchange, the extent of which was dependent on the GSH/GSSG ratio. There was an initial rapid phase of protein thiol oxidation, followed by gradual oxidation over 30 min. A large number of mitochondrial proteins contain reactive thiols and most of these formed intraprotein disulfides upon oxidation by GSSG; however, a small number formed persistent mixed disulfides with glutathione. Both protein disulfide formation and glutathionylation were catalyzed by the mitochondrial thiol transferase glutaredoxin 2 (Grx2), as were protein deglutathionylation and the reduction of protein disulfides by GSH. Complex I was the most prominent protein that was persistently glutathionylated by GSSG in the presence of Grx2. Maintenance of complex I with an oxidized GSH/GSSG ratio led to a dramatic loss of activity, suggesting that oxidation of the mitochondrial glutathione pool may contribute to the selective complex I inactivation seen in Parkinson's disease. Most significantly, Grx2 catalyzed reversible protein glutathionylation/deglutathionylation over a wide range of GSH/GSSG ratios, from the reduced levels accessible under redox signaling to oxidized ratios only found under severe oxidative stress. Our findings indicate that Grx2 plays a central role in the response of mitochondria to both redox signals and oxidative stress by facilitating the interplay between the mitochondrial glutathione pool and protein thiols.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Murphy, MP (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	mpm@mrc-dunn.cam.ac.uk	Dahm, Christina C/G-9787-2014; Murphy, Michael P/C-2120-2009	Dahm, Christina C/0000-0003-0481-2893; Murphy, Michael P/0000-0003-1115-9618				Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Bustamante J, 1997, ARCH BIOCHEM BIOPHYS, V337, P121, DOI 10.1006/abbi.1996.9754; Cabiscol E, 1996, P NATL ACAD SCI USA, V93, P4170, DOI 10.1073/pnas.93.9.4170; Costa NJ, 2003, ANTIOXID REDOX SIGN, V5, P291, DOI 10.1089/152308603322110878; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Di Simplicio P, 1998, ARCH BIOCHEM BIOPHYS, V355, P145, DOI 10.1006/abbi.1998.0694; DIMONTE DA, 1992, ANN NEUROL, V32, pS111, DOI 10.1002/ana.410320719; ELLMAN G, 1979, ANAL BIOCHEM, V93, P98, DOI 10.1016/S0003-2697(79)80122-0; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; GILBERT HF, 1984, METHOD ENZYMOL, V107, P330; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; JENNER P, 1993, ACTA NEUROL SCAND, V87, P6; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Mallis RJ, 2000, FEBS LETT, V482, P237, DOI 10.1016/S0014-5793(00)02022-6; MEREDITH MJ, 1982, J BIOL CHEM, V257, P3747; REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ruoppolo M, 1997, BIOCHEMISTRY-US, V36, P12259, DOI 10.1021/bi970851s; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Scarlett JL, 1996, BIOCHEM PHARMACOL, V52, P1047, DOI 10.1016/0006-2952(96)99426-5; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; VANDENDOBBELSTE.AF, 1996, BIOCHIM BIOPHYS ACTA, V271, P15420; Venkatraman A, 2004, AM J PHYSIOL-GASTR L, V286, pG521, DOI 10.1152/ajpgi.00399.2003; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; WINTERBOURN CC, 1993, FREE RADICAL BIO MED, V14, P85, DOI 10.1016/0891-5849(93)90512-S; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; ZIEGLER DM, 1985, ANNU REV BIOCHEM, V54, P305, DOI 10.1146/annurev.bi.54.070185.001513	50	321	325	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47939	47951		10.1074/jbc.M408011200	http://dx.doi.org/10.1074/jbc.M408011200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347644	hybrid			2022-12-27	WOS:000224957000064
J	Bikker, FJ; Lightenberg, AJM; End, C; Renner, M; Blaich, S; Lyer, S; Wittig, R; van't Hof, W; Veerman, ECI; Nazmi, K; de Blieck-Hogervorst, JMA; Kioschis, P; Amerongen, AVN; Poustka, A; Mollenhauer, J				Bikker, FJ; Lightenberg, AJM; End, C; Renner, M; Blaich, S; Lyer, S; Wittig, R; van't Hof, W; Veerman, ECI; Nazmi, K; de Blieck-Hogervorst, JMA; Kioschis, P; Amerongen, AVN; Poustka, A; Mollenhauer, J			Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPONGE GEODIA-CYDONIUM; SURFACTANT PROTEIN-D; SALIVARY AGGLUTININ; SRCR DOMAIN; MOLECULAR-CLONING; MEMBER; FAMILY; DMBT1; SUPERFAMILY; GENE	The scavenger receptor cysteine-rich (SRCR) proteins form an archaic group of metazoan proteins characterized by the presence of SRCR domains. These proteins are classified in group A and B based on the number of conserved cysteine residues in their SRCR domains, i.e. six for group A and eight for group B. The protein DMBT1 (deleted in malignant brain tumors 1), which is identical to salivary agglutinin and lung gp-340, belongs to the group B SRCR proteins and is considered to be involved in tumor suppression and host defense by pathogen binding. In a previous study we used non-overlapping synthetic peptides covering the SRCR consensus sequence to identify a 16-amino acid bacteria-binding protein loop (peptide SRCRP2; QGRVEVLYRGSWGTVC) within the SRCR domains. In this study, using overlapping peptides, we pinpointed the minimal bacteria-binding site on SRCRP2, and thus DMBT1, to an 11-amino acid motif (DMBT1 pathogen-binding site 1 or DMBT1pbs1; GRVEVLYRGSW). An alanine substitution scan revealed that VEVL and Trp are critical residues in this motif. Bacteria binding by DMBT1pbs1 was different from the bacteria binding by the macrophage receptor MARCO in which an RXR motif was critical. In addition, the homologous consensus sequences of a number of SRCR proteins were synthesized and tested for bacteria binding. Only consensus sequences of DMBT1 orthologues bound bacteria by this motif.	Free Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, NL-1081 BT Amsterdam, Netherlands; Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; German Canc Res Ctr, Dept Mol Genome Anal, D-69120 Heidelberg, Germany; Univ Appl Sci Mannheim, Inst Mol Biol & Cell Culture Technol, D-68163 Mannheim, Germany	Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ); University of Mannheim	Lightenberg, AJM (corresponding author), Free Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Biochem, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	ajm.ligtenberg@vumc.nl	Mollenhauer, Jan/G-4452-2012; Wittig, Rainer/AAT-5361-2021; Bikker, Floris/B-1187-2012; Bikker, Floris/R-1941-2019; Abrams, William R/A-5782-2008	Wittig, Rainer/0000-0002-3735-9370; Bikker, Floris/0000-0002-9453-4630; 				ARUFFO A, 1991, J EXP MED, V174, P949, DOI 10.1084/jem.174.4.949; Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bikker FJ, 2002, J DENT RES, V81, P134, DOI 10.1177/154405910208100210; Bosch JA, 2003, J MICROBIOL METH, V53, P51, DOI 10.1016/S0167-7012(02)00220-8; Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378; Carlen A, 1998, J DENT RES, V77, P81, DOI 10.1177/00220345980770011301; Cheng H, 1996, ANAT REC, V244, P327; DOI T, 1993, J BIOL CHEM, V268, P2126; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gronlund J, 2000, J IMMUNOL, V165, P6406, DOI 10.4049/jimmunol.165.11.6406; Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; JONES NH, 1986, NATURE, V323, P346, DOI 10.1038/323346a0; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; Ligtenberg TJM, 2001, BIOCHEM J, V359, P243, DOI 10.1042/0264-6021:3590243; MAYER WE, 1995, GENE, V164, P267, DOI 10.1016/0378-1119(95)94092-Z; Mollenhauer J, 1997, NAT GENET, V17, P32, DOI 10.1038/ng0997-32; Mollenhauer J, 1999, ONCOGENE, V18, P6233, DOI 10.1038/sj.onc.1203071; Muller WEG, 1997, CELL TISSUE RES, V289, P383, DOI 10.1007/s004410050885; Nagle GT, 2001, EUR J BIOCHEM, V268, P1213, DOI 10.1046/j.1432-1327.2001.01972.x; NUNES DP, 1995, BIOCHEM J, V310, P41, DOI 10.1042/bj3100041; Pahler S, 1998, J EXP ZOOL, V282, P332, DOI 10.1002/(SICI)1097-010X(19981015)282:3<332::AID-JEZ6>3.3.CO;2-6; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Takito J, 1999, AM J PHYSIOL-RENAL, V277, pF277, DOI 10.1152/ajprenal.1999.277.2.F277; Tino MJ, 1999, AM J RESP CELL MOL, V20, P759, DOI 10.1165/ajrcmb.20.4.3439	37	99	102	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47699	47703		10.1074/jbc.M406095200	http://dx.doi.org/10.1074/jbc.M406095200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355985	hybrid			2022-12-27	WOS:000224957000035
J	Karamysheva, ZN; Surovtseva, YV; Vespa, L; Shakirov, EV; Shippen, DE				Karamysheva, ZN; Surovtseva, YV; Vespa, L; Shakirov, EV; Shippen, DE			A C-terminal Myb extension domain defines a novel family of double-strand telomeric DNA-binding proteins in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEATS IN-VITRO; GENE-EXPRESSION; THALIANA; LENGTH; TRF1; SEQUENCE; CELLS; YEAST; COMPLEX; MAINTENANCE	Little is known about the protein composition of plant telomeres. We queried the Arabidopsis thaliana genome data base in search of genes with similarity to the human telomere proteins hTRF1 and hTRF2. hTRF1/hTRF2 are distinguished by the presence of a single Myb-like domain in their C terminus that is required for telomeric DNA binding in vitro. Twelve Arabidopsis genes fitting this criterion, dubbed TRF-like (TRFL), fell into two distinct gene families. Notably, TRFL family 1 possessed a highly conserved region C-terminal to the Myb domain called Myb-extension (Myb-ext) that is absent in TRFL family 2 and hTRF1/hTRF2. Immunoprecipitation experiments revealed that recombinant proteins from TRFL family 1, but not those from family 2, formed homodimers and heterodimers in vitro. DNA binding studies with isolated C-terminal fragments from TRFL family 1 proteins, but not family 2, showed specific binding to double-stranded plant telomeric DNA in vitro. Removal of the Myb-ext domain from TRFL1, a family 1 member, abolished DNA binding. However, when the Myb-ext domain was introduced into the corresponding region in TRFL3, a family 2 member, telomeric DNA binding was observed. Thus, Myb-ext is required for binding plant telomeric DNA and defines a novel class of proteins in Arabidopsis.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Shippen, DE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, TAMU 2128, College Stn, TX 77643 USA.	dshippen@tamu.edu	Shakirov, Eugene V/A-1363-2012	Shakirov, Eugene V/0000-0003-2689-7410	NIGMS NIH HHS [GM65383] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065383] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Bryan TM, 2000, J BIOL CHEM, V275, P24199, DOI 10.1074/jbc.M003246200; Chen CM, 2001, J BIOL CHEM, V276, P16511, DOI 10.1074/jbc.M009659200; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; De Rycker M, 2003, BIOCHEM J, V372, P87, DOI 10.1042/BJ20021450; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gallego ME, 2003, PLANT CELL, V15, P782, DOI 10.1105/tpc.008623; Hall AR, 1997, ONCOGENE, V14, P1371, DOI 10.1038/sj.onc.1200962; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hwang MG, 2001, FEBS LETT, V503, P35, DOI 10.1016/S0014-5793(01)02685-0; ISHIKAWA T, 2001, NUCL ACIDS RES S, V1, P273; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1998, NUCLEIC ACIDS RES, V26, P1731, DOI 10.1093/nar/26.7.1731; Kranz HD, 1998, PLANT J, V16, P263, DOI 10.1046/j.1365-313x.1998.00278.x; Krutilina RI, 2001, BIOCHEM BIOPH RES CO, V280, P471, DOI 10.1006/bbrc.2000.4143; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; LUGERT T, 1994, PLANT MOL BIOL, V25, P493, DOI 10.1007/BF00043877; Marian CO, 2003, PLANT PHYSIOL, V133, P1336, DOI 10.1104/pp.103.026856; McKnight TD, 2004, PLANT CELL, V16, P794, DOI 10.1105/tpc.160470; McKnight TD, 2002, PLANT MOL BIOL, V48, P331, DOI 10.1023/A:1014091032750; Nishikawa T, 1998, STRUCT FOLD DES, V6, P1057, DOI 10.1016/S0969-2126(98)00106-3; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; REGAD F, 1994, J MOL BIOL, V239, P163, DOI 10.1006/jmbi.1994.1360; Rhodes D, 2002, EMBO REP, V3, P1139, DOI 10.1093/embo-reports/kvf246; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; Riha K, 2003, P NATL ACAD SCI USA, V100, P611, DOI 10.1073/pnas.0236128100; Riha K, 2002, EMBO J, V21, P2819, DOI 10.1093/emboj/21.11.2819; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schrumpfova P, 2004, GENOME, V47, P316, DOI [10.1139/G03-136, 10.1139/g03-136]; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SILVA ODE, 1993, PLANT J, V4, P125, DOI 10.1046/j.1365-313X.1993.04010125.x; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Tremousaygue D, 1999, PLANT J, V20, P553, DOI 10.1046/j.1365-313X.1999.00627.x; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Yang SW, 2003, J BIOL CHEM, V278, P21395, DOI 10.1074/jbc.M209973200; Yu EY, 2000, J BIOL CHEM, V275, P24208, DOI 10.1074/jbc.M003250200; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141; ZENTGRAF U, 1995, PLANT MOL BIOL, V27, P467, DOI 10.1007/BF00019314; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	53	66	79	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47799	47807		10.1074/jbc.M407938200	http://dx.doi.org/10.1074/jbc.M407938200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364931	hybrid			2022-12-27	WOS:000224957000048
J	Enkvetchakul, D; Bhattacharyya, J; Jeliazkova, I; Groesbeck, DK; Cukras, CA; Nichols, CG				Enkvetchakul, D; Bhattacharyya, J; Jeliazkova, I; Groesbeck, DK; Cukras, CA; Nichols, CG			Functional characterization of a prokaryotic Kir channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNELS; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; PH; RECTIFICATION; MECHANISM	The Kir gene family encodes inward rectifying K+ ( Kir) channels that are widespread and critical regulators of excitability in eukaryotic cells. A related gene family (KirBac) has recently been identified in prokaryotes. While a crystal structure of one member, KirBac1.1, has been solved, there has been no functional characterization of any KirBac gene products. Here we present functional characterization of KirBac1.1 reconstituted in liposomes. Utilizing a Rb-86(+) uptake assay, we demonstrate that KirBac1.1 generates a K+-selective permeation path that is inhibited by extraliposomal Ba2+ and Ca2+ ions. In contrast to KcsA ( an acid-activated bacterial potassium channel), KirBac1.1 is inhibited by extraliposomal acid (pK(a) similar to 6). This characterization of KirBac1.1 activity now paves the way for further correlation of structure and function in this model Kir channel.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Renal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@cellbio.wustl.edu	Nichols, Colin/D-6336-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060086] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54171, R01 HL054171] Funding Source: Medline; NIDDK NIH HHS [K08 DK060086, DK60086] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; Bhattacharyya J, 2003, BIOPHYS J, V84, p78A; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Casamassima M, 2003, J BIOL CHEM, V278, P43533, DOI 10.1074/jbc.M306596200; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-14; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Heginbotham L, 1997, BIOCHEMISTRY-US, V36, P10335, DOI 10.1021/bi970988i; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; HILLE B, 1992, ION CHANNELS EXCITAB, P352; Jiang C, 2002, TRENDS CARDIOVAS MED, V12, P5, DOI 10.1016/S1050-1738(01)00132-3; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sackin H, 2003, BIOPHYS J, V84, P910, DOI 10.1016/S0006-3495(03)74908-X; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Thompson GA, 2000, J PHYSIOL-LONDON, V526, P231, DOI 10.1111/j.1469-7793.2000.00231.x; Wu JP, 2002, J PHYSIOL-LONDON, V543, P495, DOI 10.1113/jphysiol.2002.025247	26	46	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					47076	47080		10.1074/jbc.C400417200	http://dx.doi.org/10.1074/jbc.C400417200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15448150	hybrid, Green Accepted			2022-12-27	WOS:000224832400093
J	Rui, LY; Cao, L; Chen, W; Reardon, KF; Wood, TK				Rui, LY; Cao, L; Chen, W; Reardon, KF; Wood, TK			Active site engineering of the epoxide hydrolase from Agrobacterium radiobacter AD1 to enhance aerobic mineralization of cis-1,2-dichloroethylene in cells expressing an evolved toluene ortho-monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; BURKHOLDERIA-CEPACIA G4; CHLORINATED ETHENES; CATALYTIC MECHANISM; TRICHLOROETHYLENE OXIDATION; HALOALKANE DEHALOGENASE; 1-NAPHTHOL SYNTHESIS; CORYNEBACTERIUM SP; O-MONOOXYGENASE; ENCODING GENE	Chlorinated ethenes are the most prevalent groundwater pollutants, and the toxic epoxides generated during their aerobic biodegradation limit the extent of transformation. Hydrolysis of the toxic epoxide by epoxide hydrolases represents the major biological detoxification strategy; however, chlorinated epoxyethanes are not accepted by known bacterial epoxide hydrolases. Here, the epoxide hydrolase from Agrobacterium radiobacter AD1 (EchA), which enables growth on epichlorohydrin, was tuned to accept cis-1,2-dichloroepoxyethane as a substrate by accumulating beneficial mutations from three rounds of saturation mutagenesis at three selected active site residues, Phe-108, Ile-219, and Cys-248 (no beneficial mutations were found at position Ile-111). The EchA F108L/I219L/C248I variant coexpressed with a DNA-shuffled toluene ortho-monooxygenase, which initiates attack on the chlorinated ethene, enhanced the degradation of cis-dichloroethylene (cis-DCE) an infinite extent compared with wildtype EchA at low concentrations (6.8 muM) and up to 10-fold at high concentrations (540 muM). EchA variants with single mutations (F108L, I219F, or C248I) enhanced cis-DCE mineralization 2.5-fold (540 muM), and EchA variants with double mutations, I219L/C248I and F108L/C248I, increased cis-DCE mineralization 4- and 7-fold, respectively (540 muM). For complete degradation of cis-DCE to chloride ions, the apparent V-max/K-m for the recombinant Escherichia coli strain expressing the EchA F108L/I219L/C248I variant was increased over 5-fold as a result of the evolution of EchA. The EchA F108L/I219L/C248I variant also had enhanced activity for 1,2-epoxyhexane (2-fold) and the natural substrate epichlorohydrin (6-fold).	Univ Connecticut, Dept Chem Engn, Storrs, CT 06269 USA; Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; Univ Calif Riverside, Dept Environm Chem & Engn, Riverside, CA 92521 USA; Colorado State Univ, Dept Chem Engn, Ft Collins, CO 80523 USA	University of Connecticut; University of Connecticut; University of California System; University of California Riverside; Colorado State University	Wood, TK (corresponding author), Univ Connecticut, Dept Chem Engn, Storrs, CT 06269 USA.	twood@engr.uconn.edu	Wood, Thomas/GWZ-2481-2022; Reardon, Kenneth/A-1952-2016; Chen, Wilfred/H-4335-2013; Reardon, Kenneth/X-8472-2019	Wood, Thomas/0000-0001-8962-8571; Reardon, Kenneth/0000-0002-7753-4049; Reardon, Kenneth/0000-0002-7753-4049; Wood, Thomas/0000-0002-6258-529X				Archelas A, 1998, TRENDS BIOTECHNOL, V16, P108, DOI 10.1016/S0167-7799(97)01161-X; Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637; Baskaran N, 1996, GENOME RES, V6, P633, DOI 10.1101/gr.6.7.633; BOLT HM, 1982, BIOCHEM PHARMACOL, V31, P1, DOI 10.1016/0006-2952(82)90227-1; Bradley PM, 1998, ENVIRON SCI TECHNOL, V32, P553, DOI 10.1021/es970498d; Brannigan JA, 2002, NAT REV MOL CELL BIO, V3, P964, DOI 10.1038/nrm975; Canada KA, 2002, J BACTERIOL, V184, P344, DOI 10.1128/JB.184.2.344-349.2002; CARTER SR, 1993, WATER RES, V27, P607, DOI 10.1016/0043-1354(93)90170-M; Dolfing Jan, 1993, Biodegradation, V4, P261, DOI 10.1007/BF00695974; Faber K, 1996, ACTA CHEM SCAND, V50, P249, DOI 10.3891/acta.chem.scand.50-0249; FRANKEN SM, 1991, EMBO J, V10, P1297, DOI 10.1002/j.1460-2075.1991.tb07647.x; Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6; Gibson T. J., 1984, THESIS CAMBRIDGE U C; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENSCHLER D, 1994, ANGEW CHEM INT EDIT, V33, P1920, DOI 10.1002/anie.199419201; HERNANDEZ O, 1982, METABOLIC BASIS DETO, P207; JACOBS MHJ, 1991, EUR J BIOCHEM, V202, P1217, DOI 10.1111/j.1432-1033.1991.tb16493.x; Luu PP, 1995, APPL MICROBIOL BIOT, V44, P259, DOI 10.1007/BF00164512; Magnuson JK, 1998, APPL ENVIRON MICROB, V64, P1270; McCarty PL, 1997, SCIENCE, V276, P1521, DOI 10.1126/science.276.5318.1521; Misawa E, 1998, EUR J BIOCHEM, V253, P173, DOI 10.1046/j.1432-1327.1998.2530173.x; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; NAKAMURA T, 1994, APPL ENVIRON MICROB, V60, P4630, DOI 10.1128/AEM.60.12.4630-4633.1994; Nardini M, 1999, J BIOL CHEM, V274, P14579, DOI 10.1074/jbc.274.21.14579; Nardini M, 2001, J MOL CATAL B-ENZYM, V11, P1035, DOI 10.1016/S1381-1177(00)00049-7; NELSON MJK, 1986, APPL ENVIRON MICROB, V52, P383, DOI 10.1128/AEM.52.2.383-384.1986; Newman LM, 1997, J BACTERIOL, V179, P90, DOI 10.1128/jb.179.1.90-96.1997; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perry R. H, 1973, CHEM ENG HDB; Rink R, 1997, J BIOL CHEM, V272, P14650, DOI 10.1074/jbc.272.23.14650; Rink R, 2000, BIOCHEMISTRY-US, V39, P5600, DOI 10.1021/bi9922392; Rui LY, 2004, APPL ENVIRON MICROB, V70, P3246, DOI 10.1128/AEM.70.6.3246-3252.2004; Rui LY, 2004, ENVIRON MICROBIOL, V6, P491, DOI 10.1111/j.1462-2920.2004.00586.x; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3882, DOI 10.1128/AEM.67.9.3882-3887.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHIELDS MS, 1994, BIOREMEDIATION OF CHLORINATED AND POLYCYCLIC AROMATIC HYDROCARBON COMPOUNDS, P50; SHIELDS MS, 1989, APPL ENVIRON MICROB, V55, P1624, DOI 10.1128/AEM.55.6.1624-1629.1989; SHIELDS MS, 1996, Patent No. 5543317; Shim HJ, 2000, BIOTECHNOL BIOENG, V70, P693, DOI 10.1002/1097-0290(20001220)70:6<693::AID-BIT12>3.0.CO;2-W; Spelberg JHL, 1998, TETRAHEDRON-ASYMMETR, V9, P459, DOI 10.1016/S0957-4166(98)00003-2; Steinreiber A, 2001, CURR OPIN BIOTECH, V12, P552, DOI 10.1016/S0958-1669(01)00262-2; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; Visser H, 2000, APPL MICROBIOL BIOT, V53, P415, DOI 10.1007/s002530051635; Visser H, 1999, APPL ENVIRON MICROB, V65, P5459; Vlieg JETV, 1997, APPL ENVIRON MICROB, V63, P4961, DOI 10.1128/AEM.63.12.4961-4964.1997; Vlieg JETV, 1996, APPL ENVIRON MICROB, V62, P3304, DOI 10.1128/AEM.62.9.3304-3312.1996; Vlieg JETV, 2001, J BIOTECHNOL, V85, P81, DOI 10.1016/S0168-1656(00)00364-3; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Weijers CAGM, 1999, J MOL CATAL B-ENZYM, V6, P199, DOI 10.1016/S1381-1177(98)00123-4; Yeager CM, 2001, APPL ENVIRON MICROB, V67, P2107, DOI 10.1128/AEM.67.5.2107-2115.2001; Zou JY, 2000, STRUCTURE, V8, P111, DOI 10.1016/S0969-2126(00)00087-3	54	44	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46810	46817		10.1074/jbc.M407466200	http://dx.doi.org/10.1074/jbc.M407466200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347647	hybrid			2022-12-27	WOS:000224832400061
J	Falasca, C; Perrier, NL; Massoulie, J; Bon, S				Falasca, C; Perrier, NL; Massoulie, J; Bon, S			Determinants of the t peptide involved in folding, degradation, and secretion of acetylcholinesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAINS; QUATERNARY ASSOCIATIONS; ATTACHMENT DOMAIN; CAUDATE-NUCLEUS; DISULFIDE BONDS; MOLECULAR-FORMS; COLLAGEN TAIL; CHOLINESTERASES; SUBUNITS; TORPEDO	The C-terminal 40-residue t peptide of acetylcholinesterase (AChE) forms an amphiphilic alpha helix with a cluster of seven aromatic residues. It allows oligomerization and induces a partial degradation of AChE subunits through the endoplasmic reticulum-associated degradation pathway. We show that the t peptide induces the misfolding of a fraction of AChE subunits, even when mutations disorganized the cluster of aromatic residues or when these residues were replaced by leucines, indicating that this effect is due to hydrophobic residues. Mutations in the aromatic-rich region affected the cellular fate of AChE in a similar manner, with or without mutations that prevented dimerization. Degradation was decreased and secretion was increased when aromatic residues were replaced by leucines, and the opposite occurred when the amphiphilic alpha helix was disorganized. The last two residues (Asp-Leu) somewhat resembled an endoplasmic reticulum retention signal and caused a partial retention but only in mutants possessing aromatic residues in their t peptide. Our results suggested that several "signals" in the catalytic domain and in the t peptide act cooperatively for AChE quality control.	Ecole Normale Super, Neurobiol Cellulaire & Mol Lab, CNRS, UMR 8544, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Bon, S (corresponding author), Ecole Normale Super, Neurobiol Cellulaire & Mol Lab, CNRS, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.	jean.massoulie@biologie.ens.fr						Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Bon S, 2004, EUR J BIOCHEM, V271, P33, DOI 10.1046/j.1432-1033.2003.03892.x; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BON S, 1988, J NEUROCHEM, V51, P786, DOI 10.1111/j.1471-4159.1988.tb01813.x; Coussen F, 2001, J BIOL CHEM, V276, P27881, DOI 10.1074/jbc.M010817200; DUVAL N, 1992, J CELL BIOL, V118, P641, DOI 10.1083/jcb.118.3.641; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE SL, 1982, J BIOL CHEM, V257, P12282; MARSH D, 1984, J NEUROCHEM, V43, P204, DOI 10.1111/j.1471-4159.1984.tb06698.x; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; ROSENBERRY TL, 1977, BIOCHEMISTRY-US, V16, P3550, DOI 10.1021/bi00635a008; Rost B, 1996, METHOD ENZYMOL, V266, P525; Simon S, 1998, EMBO J, V17, P6178, DOI 10.1093/emboj/17.21.6178; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; VELAN B, 1991, J BIOL CHEM, V266, P23977; VELAN B, 1994, J BIOL CHEM, V269, P22719	29	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2005	280	2					878	886		10.1074/jbc.M409201200	http://dx.doi.org/10.1074/jbc.M409201200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	885ZF	15452125	hybrid			2022-12-27	WOS:000226195200006
J	Corcoran, JA; Syvitski, R; Top, D; Epand, RM; Epand, RF; Jakeman, D; Duncan, R				Corcoran, JA; Syvitski, R; Top, D; Epand, RM; Epand, RF; Jakeman, D; Duncan, R			Myristoylation, a protruding loop, and structural plasticity are essential features of a nonenveloped virus fusion peptide motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; FATTY ACYLATION SITES; SEMLIKI-FOREST-VIRUS; CELL-CELL FUSION; MEMBRANE-FUSION; INFLUENZA HEMAGGLUTININ; CIRCULAR-DICHROISM; NMR-SPECTROSCOPY; CONFORMATIONAL-CHANGE; DISTANCE GEOMETRY	Members of the fusion-associated small transmembrane ( FAST) protein family are a distinct class of membrane fusion proteins encoded by nonenveloped fusogenic reoviruses. The 125-residue p14 FAST protein of reptilian reovirus has an similar to38-residue myristoylated N-terminal ectodomain containing a moderately apolar N-proximal region, termed the hydrophobic patch. Mutagenic analysis indicated sequence-specific elements in the N-proximal portion of the p14 hydrophobic patch affected cell-cell fusion activity, independent of overall effects on the relative hydrophobicity of the motif. Circular dichroism ( CD) of a myristoylated peptide representing the majority of the p14 ectodomain suggested this region is mostly disordered in solution but assumes increased structure in an apolar environment. From NMR spectroscopic data and simulated annealing, the soluble nonmyristoylated p14 ectodomain peptide consists of an N-proximal extended loop flanked by two proline hinges. The remaining two-thirds of the ectodomain peptide structure is disordered, consistent with predictions based on CD spectra of the myristoylated peptide. The myristoylated p14 ectodomain peptide, but not a nonmyristoylated version of the same peptide nor a myristoylated scrambled peptide, mediated extensive lipid mixing in a liposome fusion assay. Based on the lipid mixing activity, structural plasticity, environmentally induced conformational changes, and kinked structures predicted for the p14 ectodomain and hydrophobic patch ( all features associated with fusion peptides), we propose that the majority of the p14 ectodomain is composed of a fusion peptide motif, the first such motif dependent on myristoylation for membrane fusion activity.	Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; Dalhousie Univ, Coll Pharm, Halifax, NS B3H 4H7, Canada; McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada	Dalhousie University; Dalhousie University; McMaster University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Tupper Med Bldg,Rm 7S, Halifax, NS B3H 1X5, Canada.	roy.duncan@dal.ca	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558; Jakeman, David/0000-0003-3002-3388; Duncan, Roy/0000-0002-5162-5081; Top, Deniz/0000-0002-1042-8460				AHNE W, 1987, ARCH VIROL, V94, P135, DOI 10.1007/BF01313731; Blumenthal R, 2003, CHEM REV, V103, P53, DOI 10.1021/cr000036+; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Chicharro C, 2001, ANTIMICROB AGENTS CH, V45, P2441, DOI 10.1128/AAC.45.9.2441-2449.2001; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Cross KJ, 2001, EMBO J, V20, P4432, DOI 10.1093/emboj/20.16.4432; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; Davies SMA, 1998, FEBS LETT, V425, P415, DOI 10.1016/S0014-5793(98)00274-9; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; Epand RM, 2001, BIOCHEMISTRY-US, V40, P8800, DOI 10.1021/bi0107187; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Han X, 2000, J MOL BIOL, V304, P953, DOI 10.1006/jmbi.2000.4251; Hsu CH, 2002, J BIOL CHEM, V277, P22725, DOI 10.1074/jbc.M200089200; IUPAC-IUB, 1970, BIOCHEMISTRY-US, V9, P3471; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOSEPH M, 1995, J BIOL CHEM, V270, P19439, DOI 10.1074/jbc.270.33.19439; JOSEPH M, 1995, J BIOL CHEM, V270, P16749, DOI 10.1074/jbc.270.28.16749; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LUNEBERG J, 1995, J BIOL CHEM, V270, P27606; MARTIN I, 1993, BIOCHIM BIOPHYS ACTA, V1145, P124, DOI 10.1016/0005-2736(93)90389-H; Martin I, 1996, J VIROL, V70, P298, DOI 10.1128/JVI.70.1.298-304.1996; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; NILGES M, 1991, NATO ADV SCI I A-LIF, V225, P451; Pecheur EI, 2000, J BIOL CHEM, V275, P3936, DOI 10.1074/jbc.275.6.3936; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Sham S, 2002, BIOCHEMISTRY-US, V41, P12498, DOI 10.1021/bi020347+; Shmulevitz M, 2004, J VIROL, V78, P2808, DOI 10.1128/JVI.78.6.2808-2818.2004; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Shome SG, 2001, VIROLOGY, V279, P146, DOI 10.1006/viro.2000.0688; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Sowadski JM, 1996, J BIOENERG BIOMEMBR, V28, P7; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tamm LK, 2003, BBA-BIOMEMBRANES, V1614, P14, DOI 10.1016/S0005-2736(03)00159-7; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Wang PL, 1996, BIOCHEMISTRY-US, V35, P11319, DOI 10.1021/bi960783u; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; WHITT MA, 1990, J VIROL, V64, P4907, DOI 10.1128/JVI.64.10.4907-4913.1990; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WISHART DS, 1991, FEBS LETT, V293, P72, DOI 10.1016/0014-5793(91)81155-2; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yang J, 2001, BIOCHEMISTRY-US, V40, P8126, DOI 10.1021/bi0100283; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	61	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51386	51394		10.1074/jbc.M406990200	http://dx.doi.org/10.1074/jbc.M406990200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448165	hybrid			2022-12-27	WOS:000225355800090
J	Martin, SS; Boucard, AA; Clement, M; Escher, E; Leduc, R; Guillemette, G				Martin, SS; Boucard, AA; Clement, M; Escher, E; Leduc, R; Guillemette, G			Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; BINDING-SITE CREVICE; CONSTITUTIVE ACTIVATION; AT(1) RECEPTOR; CONFORMATIONAL-CHANGES; ACCESSIBILITY METHOD; LIGAND-BINDING; CONTACT POINTS; RHODOPSIN	Activation of G protein-coupled receptors by agonists involves significant movement of transmembrane domains (TMD) following agonist binding. The underlying structural mechanism by which receptor activation takes place is largely unknown but can be inferred by detecting variability within the environment of the ligand-binding pocket, which is a water-accessible crevice surrounded by the seven TMD helices. Using the substituted-cysteine accessibility method, we identified the residues within the third TMD of the wild-type angiotensin II (AT(1)) receptor that contribute to the formation of the binding site pocket. Each residue within the Ile(103) - Tyr(127) region was mutated one at a time to a cysteine. Treating the A104C, N111C, and L112C mutant receptors with the charged sulfhydryl-specific alkylating agent methanethiosulfonate-ethylammonium ( MTSEA) strongly inhibited ligand binding, which suggests that these residues orient themselves within the water-accessible binding pocket of the AT(1) receptor. Interestingly, this pattern of acquired MTSEA sensitivity was altered for TMD3 reporter cysteines engineered in a constitutively active AT(1) receptor. Indeed, two additional mutants (S109C and V116C) were found to be sensitive to MTSEA treatment. Our results suggest that constitutive activation of the AT(1) receptor causes a minor counterclockwise rotation of TMD3, thereby exposing residues, which are not present in the inactive state, to the binding pocket. This pattern of accessibility of residues in the TMD3 of the AT1 receptor parallels that of homologous residues in rhodopsin. This study identified key elements of TMD3 that contribute to the activation of class A G protein-coupled receptors through structural rearrangements.	Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Guillemette, G (corresponding author), Univ Sherbrooke, Fac Med, Dept Pharmacol, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Gaetan.Guillemette@USherbrooke.ca	Boucard, Antony/CAJ-3093-2022; Boucard, Antony/ABA-9769-2020	BOUCARD, Antony Jr/0000-0002-5538-0464; Escher, Emanuel/0000-0001-6601-987X				AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15483, DOI 10.1021/bi011546g; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; KOJIMA I, 1984, J BIOL CHEM, V259, P4448; Lagerstrom MC, 2003, J BIOL CHEM, V278, P51521, DOI 10.1074/jbc.M307683200; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0	37	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51415	51423		10.1074/jbc.M407965200	http://dx.doi.org/10.1074/jbc.M407965200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452107	hybrid			2022-12-27	WOS:000225355800093
J	Nandini, CD; Mikami, T; Ohta, M; Itoh, N; Akiyama-Nambu, F; Sugahara, K				Nandini, CD; Mikami, T; Ohta, M; Itoh, N; Akiyama-Nambu, F; Sugahara, K			Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish - Neuritogenic and binding activities for growth factors and neurotrophic factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; DERMATAN SULFATE; NEURITE OUTGROWTH; HEPARAN-SULFATE; FACTOR VEGF; IDURONIC ACID; PROTEOGLYCANS; GLYCOSAMINOGLYCANS; BRAIN; OLIGOSACCHARIDES	Oversulfated chondroitin sulfate (CS)/dermatan sulfate (DS) hybrid chains were purified from the notochord of hagfish. The chains ( previously named CS-H for hagfish) have an average molecular mass of 18 kDa. Composition analysis using various chondroitinases demonstrated a variety of D-glucuronic acid ( GlcUA)and L-iduronic acid (IdoUA)-containing disaccharides variably sulfated with a higher proportion of GlcUA/ IdoUA-GalNAc 4,6-O-disulfate, revealing complex CS/DS hybrid features. The hybrid chains showed neurite outgrowth-promoting activity of an axonic nature, which resembled the activity of squid cartilage CS-E and which was abolished fully by chondroitinase ABC digestion and partially by chondroitinase AC-I or B digestion, suggesting the involvement of both GlcUA and IdoUA in neuritogenic activity. Purified CS-H exhibited interactions in a BIAcore system with various heparin-binding proteins and neurotrophic factors ( viz. fibroblast growth factor-2, - 10, - 16, and - 18; midkine; pleiotrophin; heparin-binding epidermal growth factor-like growth factor; vascular endothelial growth factor; brain-derived neurotrophic factor; and glial cell line-derived neurotrophic factor), most of which are expressed in the brain, although fibroblast growth factor-1 and ciliary neurotrophic factor showed no binding. Kinetic analysis revealed high affinity binding of these growth factors and, for the first time, of the neurotrophic factors. Competitive inhibition revealed the involvement of both IdoUA and GlcUA in the binding of these growth factors, suggesting the importance of the hybrid nature of CS-H for the efficient binding of these growth factors. These findings, together with those from the recent analysis of brain CS/DS chains from neonatal mouse and embryonic pig (Bao, X., Nishimura, S., Mikami, T., Yamada, S., Itoh, N., and Sugahara, K. ( 2004) J. Biol. Chem. 279, 9765 9776), suggest physiological roles of the hybrid chains in the development of the brain.	Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Kobe Pharmaceut Univ, Dept Clin Chem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Kyoto 6068501, Japan; Ochanomizu Univ, Fac Sci, Dept Chem, Tokyo 1128610, Japan	Kobe Pharmaceutical University; Kobe Pharmaceutical University; Kyoto University; Ochanomizu University	Sugahara, K (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	k-sugar@kobepharma-u.ac.jp						ANNO K, 1971, BIOCHIM BIOPHYS ACTA, V237, P173, DOI 10.1016/0304-4165(71)90046-8; ASAHARA T, 1995, CIRCULATION, V92, P365, DOI 10.1161/01.CIR.92.9.365; Bao XF, 2004, J BIOL CHEM, V279, P9765, DOI 10.1074/jbc.M310877200; Barnett MW, 2002, J CELL SCI, V115, P4495, DOI 10.1242/jcs.00114; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BRUCKNER J, 1955, BIOCHEM J, V60, P200; CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Danilenko DM, 1999, ARCH BIOCHEM BIOPHYS, V361, P34, DOI 10.1006/abbi.1998.0967; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fuller M, 2004, GLYCOBIOLOGY, V14, P443, DOI 10.1093/glycob/cwh049; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; GREGOIRE PE, 1972, BIOCHIM BIOPHYS ACTA, V279, P102, DOI 10.1016/0304-4165(72)90245-0; Hikino M, 2003, J BIOL CHEM, V278, P43744, DOI 10.1074/jbc.M308169200; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; HIYAMA K, 1976, J BIOCHEM-TOKYO, V80, P1201, DOI 10.1093/oxfordjournals.jbchem.a131390; ICHIJO H, 2003, CONNECT TISSUE, V35, P11; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Maeda N, 2003, J BIOL CHEM, V278, P35805, DOI 10.1074/jbc.M305530200; MARK M P, 1990, International Journal of Developmental Biology, V34, P191; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Ogunshola OO, 2002, J BIOL CHEM, V277, P11410, DOI 10.1074/jbc.M111085200; OHTA K, 1995, BIOCHEM MOL BIOL INT, V35, P283; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sakai S, 2003, CARBOHYD RES, V338, P263, DOI 10.1016/S0008-6215(02)00442-1; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Ueoka C, 1999, GLYCOCONJUGATE J, V16, P291, DOI 10.1023/A:1007022229813; Vacherot F, 1999, J BIOL CHEM, V274, P7741, DOI 10.1074/jbc.274.12.7741; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Yamada Shuhei, 2003, Methods Mol Biol, V213, P71; YOSHIDA K, 1989, ANAL BIOCHEM, V177, P327, DOI 10.1016/0003-2697(89)90061-4; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x	58	111	116	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50799	50809		10.1074/jbc.M404746200	http://dx.doi.org/10.1074/jbc.M404746200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385557	hybrid			2022-12-27	WOS:000225355800022
J	Jiang, TY; Guo, ZY; Dai, BJ; Kang, MY; Ann, DK; Kung, HJ; Qiu, Y				Jiang, TY; Guo, ZY; Dai, BJ; Kang, MY; Ann, DK; Kung, HJ; Qiu, Y			Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; PROSTATE-CANCER CELLS; WILD-TYPE P53; C-ABL; APOPTOTIC RESPONSE; FAMILY KINASES; BREAST-CANCER; PH-DOMAIN; BAX GENE; ACTIVATION	Etk/Bmx, a member of the Tec family of nonreceptor tyrosine kinases, has been implicated in the regulation of various cellular processes including proliferation, differentiation, motility, and apoptosis. Here, we report the identification of Tec family kinases as the potential interacting proteins of the tumor suppressor p53 by an Src homology 3 domain array screening. Etk is physically associated with p53 through its Src homology 3 domain and the proline-rich domain of p53. Induction of p53 expression by DNA damage inhibits Etk activity in several cell types. Down-regulation of Etk expression by a specific small interfering RNA sensitizes prostate cancer cells to doxorubicin-induced apoptosis, suggesting that inhibition of Etk activity is required for apoptosis in response to DNA damage. We also show that Etk primarily interacts with p53 in the cytoplasm and that such interaction leads to bidirectional inhibition of the activities of both proteins. Overexpression of Etk in prostate cancer cells results in inhibition of p53 transcriptional activity and its interaction with the mitochondrial protein BAK and confers the resistance to doxorubicin. Therefore, we propose that the stoichiometry between p53 and the Tec family kinases in a given cell type may determine its sensitivity to chemotherapeutic drugs.	Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; Univ So Calif, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA; Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University System of Maryland; University of Maryland Baltimore; University of Southern California; University of California System; University of California Davis	Qiu, Y (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.	yqiu@som.umaryland.edu	Kung, Hsing-Jien/C-7651-2013		NATIONAL CANCER INSTITUTE [R01CA085380] Funding Source: NIH RePORTER; NCI NIH HHS [CA85380] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agami R, 1999, NATURE, V399, P809; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Chau CH, 2002, ONCOGENE, V21, P8817, DOI 10.1038/sj.onc.1206032; CHEADLE C, 1994, J BIOL CHEM, V269, P24034; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Drabek D, 1997, P NATL ACAD SCI USA, V94, P610, DOI 10.1073/pnas.94.2.610; Gong JG, 1999, NATURE, V399, P806; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Paavonen K, 2004, MOL BIOL CELL, V15, P4226, DOI 10.1091/mbc.E04-03-0241; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; TSUKADA S, 1994, ADV EXP MED BIOL, V365, P233; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533	43	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50181	50189		10.1074/jbc.M409108200	http://dx.doi.org/10.1074/jbc.M409108200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355990	hybrid			2022-12-27	WOS:000225229500078
J	Pitts, KR; McNiven, MA; Yoon, Y				Pitts, KR; McNiven, MA; Yoon, Y			Mitochondria-specific function of the dynamin family protein DLP1 is mediated by its C-terminal domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLE FORMATION; GTPASE EFFECTOR DOMAIN; TRANS-GOLGI NETWORK; MAMMALIAN-CELLS; SH3 DOMAINS; ENDOPLASMIC-RETICULUM; NEUROENDOCRINE CELLS; BINDING PROTEIN; PH DOMAIN; ENDOCYTOSIS	The dynamin superfamily of large GTPases has been implicated in a variety of distinct intracellular membrane remodeling events. One of these family members, DLP1/Drp1, is similar to conventional dynamins as it contains an N-terminal GTPase domain followed by a middle region (MID), an unconserved region (UC), and a coiled-coil (CC) domain. DLP1 has been shown to function in membrane-based processes distinct from conventional dynamin, most notably mitochondrial fission. In this study, we tested whether the functional specificities of DLP1 and dynamin stems from differences in the individual domains of these proteins by generating dynamin/DLP1 chimeras in which correlate domains had been interchanged. Here we report that three consecutive C-terminal domains of DLP1 (MID-UC-CC) contain information necessary for DLP1-specific function and removing any one of these domains results in a loss of DLP1 function. Importantly, the coiled-coil (CC) domain of DLP1 alone targets specifically and exclusively to mitochondria, implicating its involvement in localizing DLP1 to this organelle in vivo. The mitochondrial targeting information within the DLP1 CC domain is not sufficient to retarget dynamin to mitochondria but is still able to adequately function as an assembly domain in a dynamin background. These data suggest that whereas the GTPase domain of DLP1 provides an enzymatic function, other domains contain information for intermolecular assembly and mitochondrial targeting.	Univ Rochester, Med Ctr, Sch Med & Dent, Dept Anesthesiol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Sch Med & Dent, Dept Pharmacol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol, Rochester, NY 14642 USA; Mayo Clin & Mayo Fdn, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	University of Rochester; University of Rochester; University of Rochester; Mayo Clinic	Yoon, Y (corresponding author), 601 Elmwood Ave,Box 604, Rochester, NY 14642 USA.	yisang_yoon@urmc.rochester.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	NIDDK NIH HHS [DK44650, R01 DK061991, DK61991] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061991, R01DK044650, R29DK044650, R37DK044650] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artalejo CR, 1997, EMBO J, V16, P1565, DOI 10.1093/emboj/16.7.1565; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Henley JR, 1996, J CELL BIOL, V133, P761, DOI 10.1083/jcb.133.4.761; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kamimoto T, 1998, J BIOL CHEM, V273, P1044, DOI 10.1074/jbc.273.2.1044; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Krenz M, 2003, J BIOL CHEM, V278, P17466, DOI 10.1074/jbc.M210804200; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Liu JP, 1997, MOL CELL ENDOCRINOL, V132, P61, DOI 10.1016/S0303-7207(97)00120-2; Liu X, 2000, P NATL ACAD SCI USA, V97, P12553, DOI 10.1073/pnas.230441497; Llorente A, 1998, J CELL BIOL, V140, P553, DOI 10.1083/jcb.140.3.553; Maier O, 1996, BIOCHEM BIOPH RES CO, V223, P229, DOI 10.1006/bbrc.1996.0876; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Nicoziani P, 2000, MOL BIOL CELL, V11, P481, DOI 10.1091/mbc.11.2.481; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; SEEDORF K, 1994, J BIOL CHEM, V269, P16009; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shin HW, 1999, J BIOL CHEM, V274, P2780, DOI 10.1074/jbc.274.5.2780; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Shu S, 2002, J CELL SCI, V115, P4237, DOI 10.1242/jcs.00112; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; TUMA PL, 1994, J BIOL CHEM, V269, P30842; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; UYEDA TQP, 1994, NATURE, V368, P567, DOI 10.1038/368567a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Yang ZY, 2001, J BIOL CHEM, V276, P4251, DOI 10.1074/jbc.M006371200; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhang ZM, 2000, J BIOL CHEM, V275, P8779, DOI 10.1074/jbc.275.12.8779; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	53	47	49	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50286	50294		10.1074/jbc.M405531200	http://dx.doi.org/10.1074/jbc.M405531200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364948	hybrid			2022-12-27	WOS:000225229500091
J	Faria, TQ; Lima, JC; Bastos, M; Macanita, AL; Santos, H				Faria, TQ; Lima, JC; Bastos, M; Macanita, AL; Santos, H			Protein stabilization by osmolytes from hyperthermophiles - Effect of mannosylglycerate on the thermal unfolding of recombinant nuclease a from Staphylococcus aureus studied by picosecond time-resolved fluorescence and calorimetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPATIBLE SOLUTES; DIGLYCEROL PHOSPHATE; ESCHERICHIA-COLI; RIBONUCLEASE-A; SALT-SOLUTIONS; ANION-BINDING; STABILITY; TRYPTOPHAN; DECAY; WATER	2-O-alpha-Mannosylglycerate, a negatively charged osmolyte widely distributed among (hyper) thermophilic microorganisms, is known to provide notable protection to proteins against thermal denaturation. To study the mechanism responsible for protein stabilization, picosecond time-resolved fluorescence spectroscopy was used to characterize the thermal unfolding of a model protein, Staphylococcus aureus recombinant nuclease A ( SNase), in the presence or absence of mannosylglycerate. The fluorescence decay times are signatures of the protein state, and the pre-exponential coefficients are used to evaluate the molar fractions of the folded and unfolded states. Hence, direct determination of equilibrium constants of unfolding from molar fractions was carried out. Van't Hoff plots of the equilibrium constants provided reliable thermodynamic data for SNase unfolding. Differential scanning calorimetry was used to validate this thermodynamic analysis. The presence of 0.5 M potassium mannosylglycerate caused an increase of 7 degreesC in the SNase melting temperature and a 2-fold increase in the unfolding heat capacity. Despite the considerable degree of stabilization rendered by this solute, the nature and population of protein states along unfolding were not altered in the presence of mannosylglycerate, denoting that the unfolding pathway of SNase was unaffected. The stabilization of SNase by mannosylglycerate arises from decreased unfolding entropy up to 65 degreesC and from an enthalpy increase above this temperature. In molecular terms, stabilization is interpreted as resulting from destabilization of the denatured state caused by preferential exclusion of the solute from the protein hydration shell upon unfolding, and stabilization of the native state by specific interactions. The physiological significance of charged solutes in hyperthermophiles is discussed.	Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; Univ Porto, Fac Ciencias, Ctr Invest Quim, P-4169007 Oporto, Portugal; Univ Tecn Lisboa, Inst Super Tecn, P-1049001 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade do Porto; Universidade de Lisboa; Instituto Superior Tecnico	Santos, H (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Rua Quinta Grande 6,Apartado 127, P-2780156 Oeiras, Portugal.	santos@itqb.unl.pt	Santos, Helena/B-9141-2011; Bastos, Margarida/A-4791-2009; Faria, Tiago/A-4223-2015; Lima, João/F-3658-2010; Macanita, Antonio L./H-9284-2012	Santos, Helena/0000-0002-8050-9485; Bastos, Margarida/0000-0001-7464-3568; Faria, Tiago/0000-0003-0564-8415; Lima, João/0000-0003-0528-1967; Macanita, Antonio L./0000-0003-0976-6654				Ababou A, 2001, PROTEIN SCI, V10, P2102, DOI 10.1110/ps.05501; Anjum F, 2000, BBA-PROTEIN STRUCT M, V1476, P75, DOI 10.1016/S0167-4838(99)00215-0; BAILEY JE, 1968, EUR J BIOCHEM, V7, P5, DOI 10.1111/j.1432-1033.1968.tb19566.x; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Borges ML, 1998, PHOTOCHEM PHOTOBIOL, V67, P184, DOI 10.1562/0031-8655(1998)067<0184:PPAPAO>2.3.CO;2; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bostrom M, 2003, BIOPHYS J, V85, P686, DOI 10.1016/S0006-3495(03)74512-3; BROCHON JC, 1974, EUR J BIOCHEM, V41, P577, DOI 10.1111/j.1432-1033.1974.tb03299.x; BUSBY TF, 1984, BIOCHIM BIOPHYS ACTA, V799, P80, DOI 10.1016/0304-4165(84)90329-5; Chen HM, 1999, EUR J BIOCHEM, V261, P599, DOI 10.1046/j.1432-1327.1999.00317.x; CHEN RF, 1991, BIOCHEMISTRY-US, V30, P5184, DOI 10.1021/bi00235a011; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; COWGILL RW, 1976, BIOCH FLUORESCENCE C, V2, P411; da Costa M. S., 1998, V61, P117; Davis-Searles PR, 2001, ANNU REV BIOPH BIOM, V30, P271, DOI 10.1146/annurev.biophys.30.1.271; DELPINO IMP, 1995, BIOCHEMISTRY-US, V34, P8621, DOI 10.1021/bi00027a011; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; EFTINK MR, 1991, BIOCHEMISTRY-US, V30, P8945, DOI 10.1021/bi00101a005; Faria TQ, 2003, CHEMBIOCHEM, V4, P734, DOI 10.1002/cbic.200300574; Giestas L, 2003, J PHYS CHEM A, V107, P3263, DOI 10.1021/jp0265900; GRIKO YV, 1988, P NATL ACAD SCI USA, V85, P3343, DOI 10.1073/pnas.85.10.3343; GRINVALD A, 1976, BIOCHIM BIOPHYS ACTA, V427, P663, DOI 10.1016/0005-2795(76)90210-5; Guzman-Casado M, 2003, J MOL BIOL, V329, P731, DOI 10.1016/S0022-2836(03)00513-8; Hinz HJ, 2001, PURE APPL CHEM, V73, P745, DOI 10.1351/pac200173040745; Kaushik JK, 1999, PROTEIN SCI, V8, P222; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; KIRCHHOFF WH, 1993, 1401 NIST; Lakowicz JR, 2000, PHOTOCHEM PHOTOBIOL, V72, P421, DOI 10.1562/0031-8655(2000)072<0421:OSRIP>2.0.CO;2; Lamosa P, 2003, EUR J BIOCHEM, V270, P4606, DOI 10.1046/j.1432-1033.2003.03861.x; Lamosa P, 2000, APPL ENVIRON MICROB, V66, P1974, DOI 10.1128/AEM.66.5.1974-1979.2000; LEE JC, 1981, J BIOL CHEM, V256, P7193; MACANITA AL, 1989, J PHYS CHEM-US, V93, P336, DOI 10.1021/j100338a066; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; MARTINS LO, 1995, APPL ENVIRON MICROB, V61, P3299, DOI 10.1128/AEM.61.9.3299-3303.1995; MELO ECC, 1991, J COLLOID INTERF SCI, V141, P439, DOI 10.1016/0021-9797(91)90341-5; MELO TSE, 1988, PHOTOCHEM PHOTOBIOL, V48, P429, DOI 10.1111/j.1751-1097.1988.tb02841.x; Murov S.L., 1993, HDB PHOTOCHEMISTRY, P1; NEU HC, 1965, J BIOL CHEM, V240, P3685; Nishimura C, 2001, BIOCHEMISTRY-US, V40, P2113, DOI 10.1021/bi000861k; PETRICH JW, 1983, J AM CHEM SOC, V105, P3824, DOI 10.1021/ja00350a014; Ramos A, 1997, APPL ENVIRON MICROB, V63, P4020, DOI 10.1128/AEM.63.10.4020-4025.1997; Ramos CHI, 2002, PROTEIN SCI, V11, P1771, DOI 10.1110/ps.0205902; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Robic S, 2003, P NATL ACAD SCI USA, V100, P11345, DOI 10.1073/pnas.1635051100; Russo AT, 2003, J MOL BIOL, V330, P851, DOI 10.1016/S0022-2836(03)00626-0; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P5278, DOI 10.1021/bi00138a006; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Schellman JA, 2003, BIOPHYS J, V85, P108, DOI 10.1016/S0006-3495(03)74459-2; SHORTLE D, 1988, BIOCHEMISTRY-US, V27, P4761, DOI 10.1021/bi00413a027; Striker G, 1999, J PHYS CHEM B, V103, P8612, DOI 10.1021/jp991425e; SZABO AG, 1980, J AM CHEM SOC, V102, P554, DOI 10.1021/ja00522a020; TAKAHARA M, 1985, J BIOL CHEM, V260, P2670; Timasheff S. N., 1992, WATER LIFE, P70; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Uversky VN, 1998, J MOL BIOL, V278, P879, DOI 10.1006/jmbi.1998.1741; VARELA AP, 1995, J PHYS CHEM-US, V99, P16093, DOI 10.1021/j100043a059; Zhou HX, 2002, BIOPHYS J, V83, P3126, DOI 10.1016/S0006-3495(02)75316-2	57	54	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48680	48691		10.1074/jbc.M408806200	http://dx.doi.org/10.1074/jbc.M408806200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347691	hybrid			2022-12-27	WOS:000225098100025
J	Koren, R; Rainis, L; Kleinberger, T				Koren, R; Rainis, L; Kleinberger, T			The scaffolding A/Tpd3 subunit and high phosphatase activity are dispensable for Cdc55 function in the Saccharomyces cerevisiae spindle checkpoint and in cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS E4ORF4 PROTEIN; TERMINAL LEUCINE RESIDUE; PP2A CATALYTIC SUBUNIT; B-ALPHA SUBUNIT; EARLY REGION 4; REGULATORY SUBUNIT; BUDDING YEAST; CELL-CYCLE; P53-INDEPENDENT APOPTOSIS; CARBOXYL METHYLATION	Protein serine/threonine phosphatase 2A (PP2A) is a multifunctional enzyme whose trimeric form consists of a scaffolding A subunit, a catalytic C subunit, and one of several regulatory B subunits (B, B', and B"). The adenovirus E4orf4 protein associates with PP2A by directly binding the B or B' subunits. An interaction with an active PP2A containing the B subunit, or its homologue in yeast, Cdc55, is required for E4orf4-induced apoptosis in mammalian cells and for induction of growth arrest in Saccharomyces cerevisiae. In this work, Cdc55 was randomly mutagenized by low-fidelity PCR amplification, and Cdc55 mutants that lost the ability to transduce the E4orf4 toxic signal in yeast were selected. The mutations obtained by this protocol inhibited the association of Cdc55 with E4orf4, or with the PP2A-AC subunits, or both. Functional analysis revealed that a mutant that does not bind Tpd3, the yeast A subunit, as well as wild type Cdc55 in a tpd3Delta background, can form a heterodimer with the catalytic subunit. This association requires C subunit carboxyl methylation. The residual phosphatase activity associated with Cdc55 in the absence of Tpd3 is sufficient to maintain a partially active spindle checkpoint and to prevent cytokinesis defects.	Technion Israel Inst Technol, Fac Med, Gonda Ctr Mol Microbiol, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res Med Sci, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Kleinberger, T (corresponding author), Technion Israel Inst Technol, Fac Med, Gonda Ctr Mol Microbiol, IL-31096 Haifa, Israel.	tamark@tx.technion.ac.il						Afifi R, 2001, J VIROL, V75, P4444, DOI 10.1128/JVI.75.9.4444-4447.2001; Aronheim A, 2001, METHOD ENZYMOL, V332, P260; Bondesson M, 1996, J VIROL, V70, P3844, DOI 10.1128/JVI.70.6.3844-3851.1996; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; DEANA AD, 1988, BIOCHIM BIOPHYS ACTA, V968, P179, DOI 10.1016/0167-4889(88)90006-7; Evans DRH, 2000, MOL GEN GENET, V264, P425; Evans DRH, 1999, J BIOL CHEM, V274, P24038, DOI 10.1074/jbc.274.34.24038; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; KAMIBAYASHI C, 1992, J BIOL CHEM, V267, P21864; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Marcellus RC, 1998, J VIROL, V72, P7144, DOI 10.1128/JVI.72.9.7144-7153.1998; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; MULLER U, 1992, J VIROL, V66, P5867; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Roopchand DE, 2001, ONCOGENE, V20, P5279, DOI 10.1038/sj.onc.1204693; Sherman F., 1982, METHODS YEAST GENETI; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; Shu YM, 1997, MOL CELL BIOL, V17, P3242, DOI 10.1128/MCB.17.6.3242; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SNEDDON AA, 1990, EMBO J, V9, P4339, DOI 10.1002/j.1460-2075.1990.tb07883.x; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Toyn JH, 2000, YEAST, V16, P553, DOI 10.1002/(SICI)1097-0061(200004)16:6<553::AID-YEA554>3.0.CO;2-7; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; VANZYL W, 1992, MOL CELL BIOL, V12, P4946, DOI 10.1128/MCB.12.11.4946; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wang YC, 1997, MOL CELL BIOL, V17, P620, DOI 10.1128/MCB.17.2.620; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Whalen SG, 1997, J VIROL, V71, P3545, DOI 10.1128/JVI.71.5.3545-3553.1997; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhu T, 1997, ARCH BIOCHEM BIOPHYS, V339, P210, DOI 10.1006/abbi.1996.9835	49	26	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48598	48606		10.1074/jbc.M409359200	http://dx.doi.org/10.1074/jbc.M409359200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347656	hybrid			2022-12-27	WOS:000225098100015
J	Yang, GD; Cao, K; Wu, LY; Wang, R				Yang, GD; Cao, K; Wu, LY; Wang, R			Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21(Cip/WAK-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE TRANSCRIPTION-PCR; PROTEIN-KINASE PATHWAY; HYDROGEN-SULFIDE; BETA-SYNTHASE; CYCLE ARREST; MYELOID-LEUKEMIA; GROWTH-FACTOR; RAT; EXPRESSION; ACTIVATION	Cystathionine gamma-lyase (CSE) is a key enzyme in the trans-sulfuration pathway. CSE uses L-cysteine as a substrate to produce hydrogen sulfide (H2S). The CSE/H2S system has been shown to play an important role in regulating cellular functions in different systems. In the present study, we used CSE stably overexpressed HEK293 cells to explore the effect of the CSE/H2S system on cell growth and proliferation. The overexpression of CSE resulted in increases in CSE mRNA levels, CSE proteins, and intracellular H2S production rates, as well as the inhibition of cell proliferation and DNA synthesis. These effects were accompanied by a sustained ERK activation and up-regulation of the cyclin-dependent kinase inhibitor p21(Cip/WAK-1). Blocking the action of ERK with U0126 inhibited the induction of p21(Cip/WAK-1), suggesting that ERK activation functions upstream of p21(Cip/WAK-1) activation to initiate the CSE overexpression-induced cell growth inhibition. The antiproliferative effect of CSE is likely mediated by endogenously produced H2S because the H2S scavenger methemoglobin (10 muM) significantly decreased the H2S production rate and reversed the antiproliferative effect afforded by CSE. Exogenous H2S (100 muM) also inhibited cell proliferation. However, the other CSE-catalyzed products, ammonium and pyruvate, failed to inhibit cell proliferation. Methemoglobin also abolished the inhibitory effect of exogenous H2S on cell proliferation. Moreover, exogenous H2S induced a sustained ERK and p21(Cip/WAK-1) activation. These findings support the hypothesis that endogenously produced H2S may play a fundamental role in cell proliferation and survival.	Univ Saskatchewan, Coll Med, Dept Physiol, Cardiovasc Res Grp, Saskatoon, SK S7N 5E5, Canada; Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan; University of Saskatchewan	Wang, R (corresponding author), Univ Saskatchewan, Coll Med, Dept Physiol, Cardiovasc Res Grp, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	wangrui@duke.usask.ca	Yang, Guangdong/G-4129-2011; Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620				Barber T, 1999, J NUTR, V129, P928, DOI 10.1093/jn/129.5.928; Baumbach GL, 2002, CIRC RES, V91, P931, DOI 10.1161/01.RES.0000041408.64867.1D; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Brenneman KA, 2002, TOXICOL PATHOL, V30, P200, DOI 10.1080/019262302753559533; Cao K, 2002, BIOCHEM BIOPH RES CO, V296, P463, DOI 10.1016/S0006-291X(02)00892-6; CHANG MW, 1995, J CLIN INVEST, V96, P2260, DOI 10.1172/JCI118281; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Dombkowski RA, 2004, AM J PHYSIOL-REG I, V286, pR678, DOI 10.1152/ajpregu.00419.2003; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; EPLANCKE B, 2003, FASEB J, V17, P1310; ERICKSON PF, 1990, BIOCHEM J, V269, P335, DOI 10.1042/bj2690335; Eto K, 2002, J NEUROCHEM, V83, P80, DOI 10.1046/j.1471-4159.2002.01097.x; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; HRISTL SU, 1996, DIGEST DIS SCI, V41, P2477; Hu PPC, 1999, J BIOL CHEM, V274, P35381, DOI 10.1074/jbc.274.50.35381; KERY V, 1994, J BIOL CHEM, V269, P25283; Kobayashi T, 2004, BIOL PHARM BULL, V27, P587, DOI 10.1248/bpb.27.587; Leung DW, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-15; Mariggio MA, 1998, IMMUNOPHARM IMMUNOT, V20, P399, DOI 10.3109/08923979809034822; Martin S, 2003, BIOCHEM PHARMACOL, V65, P669, DOI 10.1016/S0006-2952(02)01568-X; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Saussoy P, 2004, CLIN CHEM, V50, P1165, DOI 10.1373/clinchem.2003.030114; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Sun XF, 2004, BIOCHEM PHARMACOL, V67, P147, DOI 10.1016/j.bcp.2003.08.041; Taniguchi F, 2003, J CLIN ENDOCR METAB, V88, P773, DOI 10.1210/jc.2002-021062; Ullmannova V, 2003, LEUKEMIA RES, V27, P1115, DOI 10.1016/S0145-2126(03)00103-6; VALITUTTI S, 1990, ANN ALLERGY, V65, P463; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu HB, 2004, ONCOGENE, V23, P4984, DOI 10.1038/sj.onc.1207645	38	138	152	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49199	49205		10.1074/jbc.M408997200	http://dx.doi.org/10.1074/jbc.M408997200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347670	hybrid			2022-12-27	WOS:000225098100085
J	Bertos, NR; Gilquin, B; Chan, GKT; Yen, TJ; Khochbin, S; Yang, XJ				Bertos, NR; Gilquin, B; Chan, GKT; Yen, TJ; Khochbin, S; Yang, XJ			Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; IMPORTIN-BETA; TUBULIN; RAN; IDENTIFICATION; MICROTUBULES; LEUKEMIA; PROTEIN; HDAC6; RNA	Histone deacetylase 6 (HDAC6) contains tandem catalytic domains and a ubiquitin-binding zinc finger and displays deacetylase activity toward acetylated microtubules. Here we show that unlike its orthologs from Caenorhabditis elegans, Drosophila, and mouse, human HDAC6 possesses a tetradecapeptide repeat domain located between the second deacetylase domain and the C-terminal ubiquitin-binding motif. Related to this structural difference, the cytoplasmic localization of human, but not murine, HDAC6 is resistant to treatment with leptomycin B (LMB). Although it is dispensable for the deacetylase and ubiquitin binding activities of human HDAC6, the tetradecapeptide repeat domain displays acetyl-microtubule targeting ability. Moreover, it forms a unique structure and is required for the LMB-resistant cytoplasmic localization of human HDAC6. Besides the tetradecapeptide repeat domain, human HDAC6 possesses two LMB-sensitive nuclear export signals and a nuclear localization signal. These results thus indicate that the cytoplasmic localization for murine and human HDAC6 proteins is differentially regulated and suggest that the tetradecapeptide repeat domain serves as an important sequence element to stably retain human HDAC6 in the cytoplasm.	McGill Univ, Ctr Hlth, Dept Med, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; Fac Med, Inst Albert Bonniot, INSERM U309, Equipe Chromat & Express Genes, F-38706 La Tronche, France; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Fox Chase Cancer Center	Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Mol Oncol Grp, Rm H5-41,687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	xiang-jiao.yang@mcgill.ca	Khochbin, Saadi/M-8090-2013; GILQUIN, Benoit/A-6234-2014; Chan, Gordon/AAN-7784-2020	Khochbin, Saadi/0000-0002-0455-0857; Chan, Gordon/0000-0003-0497-9407; GILQUIN, benoit/0000-0001-8138-7021; Yen, Tim/0000-0003-2159-0997				Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Barlow AL, 2001, EXP CELL RES, V265, P90, DOI 10.1006/excr.2001.5162; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kovacs Jeffery J, 2004, Novartis Found Symp, V259, P170; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; PERKINS A, 1989, J ACQ IMMUN DEF SYND, V2, P256; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Scott M, 2001, NUCLEIC ACIDS RES, V29, P2052, DOI 10.1093/nar/29.10.2052; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yamaguchi R, 2003, CELL, V113, P115, DOI 10.1016/S0092-8674(03)00200-9; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	48	114	118	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48246	48254		10.1074/jbc.M408583200	http://dx.doi.org/10.1074/jbc.M408583200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347674	hybrid			2022-12-27	WOS:000224957000100
J	Miki, T; Yoneda, Y				Miki, T; Yoneda, Y			Alternative splicing of Staufen2 creates the nuclear export signal for CRM1 (exportin 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA LOCALIZATION; PROTEIN; IDENTIFICATION; TRANSPORT; DOMAIN; MECHANISMS; PARTICLES; GRANULES; HOMOLOG	Mammalian Staufen2 (Stau2), a brain-specific double-stranded RNA-binding protein, is involved in the localization of mRNA in neurons. To gain insights into the function of Stau2, the subcellular localization of Stau2 isoforms fused to the green fluorescence protein was examined. Fluorescence microscopic analysis showed that Stau2 functions as a nucleocytoplasmic shuttle protein. The nuclear export of the 62-kDa isoform of Stau2 (Stau2(62)) is mediated by the double-stranded RNA-binding domain 3 (RBD3) because a mutation to RBD3 led to nuclear accumulation. On the other hand, the shorter isoform of Stau2, Stau2(59), is exported from the nucleus by two distinct pathways, one of which is RBD3-mediated and the other of which is CRM1 (exportin1)-dependent. The nuclear export signal recognized by CRM1 was found to be located in the N-terminal region of Stau2(59). These results suggest that Stau2 may carry a variety of RNAs out of the nucleus, using the two export pathways. The present study addresses the issue of why plural Stau2 isoforms are expressed in neurons.	Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Yoneda, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yyoneda@anat3.med.osaka-u.ac.jp	Miki, Takashi/S-7569-2018; Miki, Takashi/AGV-9237-2022	Miki, Takashi/0000-0003-3715-7039; Miki, Takashi/0000-0003-3715-7039				Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Buchner G, 1999, GENOMICS, V62, P113, DOI 10.1006/geno.1999.6015; Duchaine TF, 2002, J CELL SCI, V115, P3285; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; Gwizdek C, 2003, J BIOL CHEM, V278, P5505, DOI 10.1074/jbc.C200668200; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kress TL, 2004, J CELL BIOL, V165, P203, DOI 10.1083/jcb.200309145; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Macchi P, 2004, J BIOL CHEM, V279, P31440, DOI 10.1074/jbc.C400226200; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Saxton WM, 2001, CELL, V107, P707, DOI 10.1016/S0092-8674(01)00602-X; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2	24	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47473	47479		10.1074/jbc.M407883200	http://dx.doi.org/10.1074/jbc.M407883200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364930	hybrid			2022-12-27	WOS:000224957000009
J	Paillart, JC; Dettenhofer, M; Yu, XF; Ehresmann, C; Ehresmann, B; Marquet, R				Paillart, JC; Dettenhofer, M; Yu, XF; Ehresmann, C; Ehresmann, B; Marquet, R			First snapshots of the HIV-1 RNA structure in infected cells and in virions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PRIMER ACTIVATION SIGNAL; DIMERIZATION INITIATION SITE; MAJOR SPLICE DONOR; IN-VITRO EVIDENCE; REVERSE TRANSCRIPTION; GENOMIC-RNA; PACKAGING SIGNAL; NUCLEOCAPSID PROTEIN; SECONDARY STRUCTURE	With the increasing interest of RNAs in regulating a range of cell biological processes, very little is known about the structure of RNAs in tissue culture cells. We focused on the 5'-untranslated region of the human immunodeficiency virus type 1 RNA genome, a highly conserved RNA region, which contains structural domains that regulate key steps in the viral replication cycle. Up until now, structural information only came from in vitro studies. Here, we developed chemical modification assays to test nucleotide accessibility directly in infected cells and viral particles, thus circumventing possible biases and artifacts linked to in vitro assays. The secondary structure of the 5'-untranslated region in infected cells points to the existence of the various stem-loop motifs associated to distinct functions, proposed from in vitro probing, mutagenesis, and phylogeny. However, compared with in vitro data, subtle differences were observed in the dimerization initiation site hairpin, and none of the proposed long range interactions were observed between the functional domains. Moreover, no global RNA rearrangement was observed; structural differences between infected cells and viral particles were limited to the primer binding site, which became protected against chemical modification upon tRNA(3)(Lys) annealing in virions and to the main packaging signal. In addition, our data suggested that the genomic RNA could already dimerize in the cytoplasm of infected cells. Taken together, our results provided the first analysis of the dynamic of RNA structure of the human immunodeficiency virus type 1 RNA genome during virus assembly ex vivo.	Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, UPR 9002, F-67084 Strasbourg, France; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University	Paillart, JC (corresponding author), Univ Strasbourg 1, Inst Biol Mol & Cellulaire, CNRS, UPR 9002, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	jc.paillart@ibmc.u-strasbg.fr	Dettenhofer, Markus/ABB-9840-2021; Paillart, Jean-Christophe/A-4171-2010	Dettenhofer, Markus/0000-0003-1972-7026; Paillart, Jean-Christophe/0000-0003-1647-8917; Marquet, Roland/0000-0002-4209-3976				Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; ALFORD RL, 1991, VIROLOGY, V183, P611, DOI 10.1016/0042-6822(91)90990-S; Andersen ES, 2004, J BIOL CHEM, V279, P22243, DOI 10.1074/jbc.M314326200; Ashe MP, 2000, RNA, V6, P170, DOI 10.1017/S1355838200991957; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; Beerens N, 2000, J BIOL CHEM, V275, P15474, DOI 10.1074/jbc.275.20.15474; Beerens N, 2000, NUCLEIC ACIDS RES, V28, P4130, DOI 10.1093/nar/28.21.4130; Beerens N, 2002, J VIROL, V76, P2329, DOI 10.1128/JVI.76.5.2329-2339.2002; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Berkhout B, 2002, J BIOL CHEM, V277, P19967, DOI 10.1074/jbc.M200950200; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Brunel C, 2000, METHOD ENZYMOL, V318, P3; Clever JL, 1999, J VIROL, V73, P101, DOI 10.1128/JVI.73.1.101-109.1999; Clever JL, 2002, J VIROL, V76, P12381, DOI 10.1128/JVI.76.23.12381-12387.2002; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Clever JL, 1996, J VIROL, V70, P5902, DOI 10.1128/JVI.70.9.5902-5908.1996; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Dettenhofer M, 1999, J VIROL, V73, P1460, DOI 10.1128/JVI.73.2.1460-1467.1999; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; Fabris D, 1996, J AM CHEM SOC, V118, P12242, DOI 10.1021/ja962863r; Fabris D, 1999, INORG CHEM, V38, P1322, DOI 10.1021/ic9809963; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; Goldschmidt V, 2004, J BIOL CHEM, V279, P35923, DOI 10.1074/jbc.M404473200; Goldschmidt V, 2003, NUCLEIC ACIDS RES, V31, P850, DOI 10.1093/nar/gkg187; Greatorex J, 2002, J MOL BIOL, V322, P543, DOI 10.1016/S0022-2836(02)00776-3; HARRISON GP, 1992, J VIROL, V66, P4144, DOI 10.1128/JVI.66.7.4144-4153.1992; Harrison GP, 1998, J VIROL, V72, P5886, DOI 10.1128/JVI.72.7.5886-5896.1998; Helga-Maria C, 1999, J VIROL, V73, P4127, DOI 10.1128/JVI.73.5.4127-4135.1999; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; Huang Y, 1997, J VIROL, V71, P726, DOI 10.1128/JVI.71.1.726-728.1997; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Huthoff H, 2002, BIOCHEMISTRY-US, V41, P10439, DOI 10.1021/bi025993n; Huthoff H, 2004, RNA, V10, P412, DOI 10.1261/rna.5161304; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Iwatani Y, 2003, J BIOL CHEM, V278, P14185, DOI 10.1074/jbc.M211618200; Kao S, 2003, J VIROL, V77, P1131, DOI 10.1128/JVI.77.2.1131-1140.2003; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; Kleiman L, 2004, CURR HIV RES, V2, P163, DOI 10.2174/1570162043484988; KUIKEN CI, 2002, 033564 LAUR LOS AL N; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Le Grice SFJ, 2003, BIOCHEMISTRY-US, V42, P14349, DOI 10.1021/bi030201q; LEVER A, 1989, J VIROL, V63, P4085, DOI 10.1128/JVI.63.9.4085-4087.1989; MOOG C, 1994, ANTIVIR RES, V24, P275, DOI 10.1016/0166-3542(94)90075-2; MURIAUX D, 1995, J BIOL CHEM, V270, P8209, DOI 10.1074/jbc.270.14.8209; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Paillart JC, 2002, J BIOL CHEM, V277, P5995, DOI 10.1074/jbc.M108972200; Paillart JC, 1997, J MOL BIOL, V270, P36, DOI 10.1006/jmbi.1997.1096; Paillart JC, 1996, J VIROL, V70, P8348, DOI 10.1128/JVI.70.12.8348-8354.1996; Poon DTK, 2002, VIROLOGY, V293, P368, DOI 10.1006/viro.2001.1283; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Richter S, 2002, P NATL ACAD SCI USA, V99, P7928, DOI 10.1073/pnas.122119999; Russell RS, 2003, J VIROL, V77, P84, DOI 10.1128/JVI.77.1.84-96.2003; Shehu-Xhilaga M, 2001, J VIROL, V75, P9156, DOI 10.1128/JVI.75.19.9156-9164.2001; Shen N, 2000, J VIROL, V74, P5729, DOI 10.1128/JVI.74.12.5729-5735.2000; Shen N, 2001, J VIROL, V75, P10543, DOI 10.1128/JVI.75.21.10543-10549.2001; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Takahashi KI, 2000, RNA, V6, P96, DOI 10.1017/S1355838200991635; Yu E, 2003, J MOL BIOL, V330, P211, DOI 10.1016/S0022-2836(03)00589-8; Zeffman A, 2000, J MOL BIOL, V297, P877, DOI 10.1006/jmbi.2000.3611; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	116	119	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48397	48403		10.1074/jbc.M408294200	http://dx.doi.org/10.1074/jbc.M408294200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355993	hybrid			2022-12-27	WOS:000224957000115
J	Manguikian, AD; Barbour, SE				Manguikian, AD; Barbour, SE			Cell cycle dependence of group VIA calcium-independent phospholipase A(2) activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ARACHIDONIC-ACID RELEASE; PHOSPHATIDYLCHOLINE SYNTHESIS; PROTEIN PHOSPHATASE-1; SR PROTEINS; FATTY-ACIDS; METABOLISM; CERAMIDE; GENE; DEPHOSPHORYLATION	Homeostasis of phosphatidylcholine (PC) is regulated by the opposing actions between CTP: phosphocholine cytidylyltransferase (CT) and the group VIA Ca2+-independent phospholipase A(2) (iPLA(2)). We investigated this process during the cell cycle. PC mass doubles during late G(1) and early S phase when its rate of catabolism is lowest. We show that iPLA(2) activity is cell cycle-dependent with peak activity during G(2)/M and late S phase. iPLA(2) activity declines during G(1) and is lowest at the G(1)/S transition and early S phase. The accumulation of PC correlates with decreased iPLA(2) activity, suggesting that regulation of this enzyme contributes to phospholipid accumulation. The levels of 80 kDa iPLA(2) protein do not change and thus cannot account for changes in enzyme activity. Reverse transcriptase and real-time PCR experiments show that splice variant iPLA(2) mRNAs are preferentially expressed during G(2)/M. Immunoblot analyses with an antibody directed against the N terminus of iPLA(2) revealed a similar to50 kDa protein that is of appropriate size to be the truncated protein encoded by the ankyrin-iPLA(2)-1 splice variant mRNA. The levels of truncated iPLA(2) protein were high in cells in late G(1) and S phase cells that had low iPLA(2) activity and low in G(2)/M cells that had high iPLA(2) activity. The truncated protein co- immunoprecipitated with full-length iPLA(2), indicating a physical interaction between the two proteins. Together, these data suggest that truncated iPLA(2) proteins associate with active iPLA(2) and down-regulate its activity during G(1). This down-regulation may contribute to phospholipid accumulation during the cell cycle.	Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA	Virginia Commonwealth University	Barbour, SE (corresponding author), Virginia Commonwealth Univ, Dept Biochem, Box 980614, Richmond, VA 23298 USA.	sbarbour@hsc.vcu.edu						ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; BERGERON JJ, 1970, BIOCHEM J, V119, P489, DOI 10.1042/bj1190489; Blencowe BJ, 2003, CURR BIOL, V13, pR149, DOI 10.1016/S0960-9822(03)00079-4; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chiu CH, 2001, BIOCHEM BIOPH RES CO, V287, P600, DOI 10.1006/bbrc.2001.5632; CORNELL R, 1977, EXP CELL RES, V109, P299, DOI 10.1016/0014-4827(77)90009-X; Cremona O, 2001, J CELL SCI, V114, P1041; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Forsell PKAL, 1998, FEBS LETT, V434, P295, DOI 10.1016/S0014-5793(98)00999-5; Forsell PKAL, 1999, EUR J BIOCHEM, V262, P575, DOI 10.1046/j.1432-1327.1999.00418.x; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Golfman LS, 2001, J BIOL CHEM, V276, P43688, DOI 10.1074/jbc.M108170200; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jackowski S, 2000, BBA-MOL CELL BIOL L, V1483, P301, DOI 10.1016/S1388-1981(99)00203-6; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Kates M., 1986, TECHNIQUES LIPIDOLOG, P114; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Steed P. M., 2001, Current Pharmaceutical Biotechnology, V2, P241, DOI 10.2174/1389201013378644; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; TERCE F, 1994, J LIPID RES, V35, P2130; TONES MA, 1988, BIOCHEM J, V249, P51, DOI 10.1042/bj2490051; Tseu I, 2002, AM J RESP CELL MOL, V26, P506, DOI 10.1165/ajrcmb.26.4.4702; Venable ME, 1999, BBA-MOL CELL BIOL L, V1439, P291, DOI 10.1016/S1388-1981(99)00101-8; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; Worgall TS, 2002, J BIOL CHEM, V277, P3878, DOI 10.1074/jbc.M102393200; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	46	48	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					52881	52892		10.1074/jbc.M410659200	http://dx.doi.org/10.1074/jbc.M410659200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385540	hybrid			2022-12-27	WOS:000225680600012
J	Madsen, M; Moller, HJ; Nielsen, MJ; Jacobsen, C; Graversen, JH; van den Berg, T; Moestrup, SK				Madsen, M; Moller, HJ; Nielsen, MJ; Jacobsen, C; Graversen, JH; van den Berg, T; Moestrup, SK			Molecular characterization of the haptoglobin center dot hemoglobin receptor CD163 - Ligand binding properties of the scavenger receptor cysteine-rich domain region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE CD163; HUMAN MACROPHAGES; IN-VITRO; PROTEIN; PLASMA; IDENTIFICATION; SUPERFAMILY; OXYGENASE-1; ANCIENT; RELEASE	CD163 is the macrophage receptor for endocytosis of haptoglobin . hemoglobin complexes. The extracellular region consisting of nine scavenger receptor cysteine-rich ( SRCR) domains also circulates in plasma as a soluble protein. By ligand binding analysis of a broad spectrum of soluble CD163 truncation variants, the amino-terminal third of the SRCR region was shown to be crucial for the binding of haptoglobin . hemoglobin complexes. By Western blotting of the CD163 variants, a panel of ten monoclonal antibodies was mapped to SRCR domains 1, 3, 4, 6, 7, and 9, respectively. Only the two antibodies binding to SRCR domain 3 exhibited effective inhibition of ligand binding. Furthermore, analysis of purified native CD163 revealed that proteolytic cleavage in SRCR domain 3 inactivates ligand binding. Calcium protects against cleavage in this domain. Analysis of the calcium sensitivity of ligand binding to CD163 demonstrated that optimal ligand binding requires physiological plasma calcium concentrations, and an immediate ligand release occurs at the low calcium concentrations measured in acidifying endosomes. In conclusion, SRCR domain 3 of CD163 is an exposed domain and a critical determinant for the calcium-sensitive coupling of haptoglobin . hemoglobin complexes.	Univ Aarhus, Dept Med Biochem, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark; VU Med Ctr, Dept Mol Cell Biol, NL-1007 MB Amsterdam, Netherlands	Aarhus University; Aarhus University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Moestrup, SK (corresponding author), Univ Aarhus, Dept Med Biochem, DK-8000 Aarhus C, Denmark.	skm@biokemi.au.dk	van den Berg, Timo K/AAC-2479-2022; Moestrup, Søren Kragh/AAD-1735-2019; Moestrup, Søren Kragh/A-1403-2014	Moestrup, Søren Kragh/0000-0003-3862-2107; Graversen, Jonas Heilskov/0000-0001-7119-2108; Graversen, Jonas Heilskov/0000-0002-2411-9933; Madsen, Mette/0000-0001-7241-6505; Moller, Holger Jon/0000-0001-7687-5995				Ahn JS, 2002, J LEUKOCYTE BIOL, V72, P382; Bowen MA, 2000, PROTEINS, V40, P420; BUNN HF, 2001, HARRISONS PRINCIPLES, P681; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; Frings W, 2002, FEBS LETT, V526, P93, DOI 10.1016/S0014-5793(02)03142-3; Gburek J, 2002, J AM SOC NEPHROL, V13, P423, DOI 10.1681/ASN.V132423; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; Gronlund J, 2000, J IMMUNOL, V165, P6406, DOI 10.4049/jimmunol.165.11.6406; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; Moestrup SK, 1998, J BIOL CHEM, V273, P5235, DOI 10.1074/jbc.273.9.5235; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moller HJ, 2004, EUR J HAEMATOL, V72, P135, DOI 10.1046/j.0902-4441.2003.00193.x; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Ritter M, 2001, EUR J IMMUNOL, V31, P999, DOI 10.1002/1521-4141(200104)31:4<999::AID-IMMU999>3.0.CO;2-R; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; SCHAER DJ, 2004, IN PRESS EUR J HAEMA; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Sulahian TH, 2001, J IMMUNOL METHODS, V252, P25, DOI 10.1016/S0022-1759(01)00328-3; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858	28	113	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51561	51567		10.1074/jbc.M409629200	http://dx.doi.org/10.1074/jbc.M409629200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448162	hybrid			2022-12-27	WOS:000225355800111
J	Russo, S; Baumann, U				Russo, S; Baumann, U			Crystal structure of a dodecameric tetrahedral-shaped aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROMONAS-PROTEOLYTICA AMINOPEPTIDASE; TRICORN PROTEASE; DIFFRACTION DATA; 20S PROTEASOME; RESOLUTION; ZINC; REFINEMENT; MECHANISM; DATABASE; REVEALS	Protein turnover is an essential process in living cells. The degradation of cytosolic polypeptides is mainly carried out by the proteasome, resulting in 7 - 9-amino acid long peptides. Further degradation is usually carried out by energy-independent proteases like the tricorn protease from Thermoplasma acidophilum. Recently, a novel tetrahedral-shaped dodecameric 480-kDa aminopeptidase complex (TET) has been described in Haloarcula marismortui that differs from the known ring- or barrel-shaped self-compartmentalizing proteases. This complex is capable of degrading most peptides down to amino acids. We present here the crystal structure of the tetrahedral aminopeptidase homolog FrvX from Pyrococcus horikoshii. The monomer has a typical clan MH fold, as found for example in Aeromonas proteolytica aminopeptidase, containing a dinuclear zinc active center. The quaternary structure is built by dimers with a length of 100 Angstrom that form the edges of the tetrahedron. All 12 active sites are located on the inside of the tetrahedron. Substrate access is granted by pores with a maximal diameter of 10 Angstrom, allowing only small peptides and unfolded proteins access to the active site.	Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Baumann, U (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	ulrich.baumann@ibc.unibe.ch	Baumann, Ulrich/B-1220-2013					Bennett B, 1997, BIOCHEMISTRY-US, V36, P9837, DOI 10.1021/bi970735p; Bennett B, 1997, J AM CHEM SOC, V119, P1923, DOI 10.1021/ja963021v; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1990, P NATL ACAD SCI USA, V87, P6878, DOI 10.1073/pnas.87.17.6878; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Chevrier B, 1996, EUR J BIOCHEM, V237, P393, DOI 10.1111/j.1432-1033.1996.0393k.x; De Paola CC, 1999, BIOCHEMISTRY-US, V38, P9048, DOI 10.1021/bi9900572; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRESCOTT JM, 1983, BIOCHEM BIOPH RES CO, V114, P646, DOI 10.1016/0006-291X(83)90829-X; Rawlings ND, 1999, NUCLEIC ACIDS RES, V27, P325, DOI 10.1093/nar/27.1.325; Remaut H, 2001, NAT STRUCT BIOL, V8, P674, DOI 10.1038/90380; RODERICK SL, 1993, BIOCHEMISTRY-US, V32, P3907, DOI 10.1021/bi00066a009; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Stamper C, 2001, BIOCHEMISTRY-US, V40, P7035, DOI 10.1021/bi0100891; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2	38	50	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51275	51281		10.1074/jbc.M409455200	http://dx.doi.org/10.1074/jbc.M409455200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15375159	hybrid, Green Published			2022-12-27	WOS:000225355800076
J	Tsukatani, Y; Miyamoto, R; Itoh, S; Oh-oka, H				Tsukatani, Y; Miyamoto, R; Itoh, S; Oh-oka, H			Function of a PscD subunit in a homodimeric reaction center complex of the photosynthetic green sulfur bacterium Chlorobium tepidum studied by Insertional gene inactivation - Regulation of energy transfer and ferredoxin-mediated NADP(+) reduction on the cytoplasmic side	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-I; CYTOCHROME-C; PROSTHECOCHLORIS-AESTUARII; BACTERIOCHLOROPHYLL-C; ANGSTROM RESOLUTION; ELECTRON-ACCEPTORS; CRYSTAL-STRUCTURE; P840; PROTEIN; VIBRIOFORME	The PscD subunit in the homodimeric "type I" photosynthetic reaction center (RC) complex of the green sulfur bacterium Chlorobium tepidum was disrupted by insertional mutagenesis of its relevant pscD gene. This is the first report on the use of the direct mutagenic approach into the RC-related genes in green sulfur bacteria. The RC complex of C. tepidum is supposed to form a homodimer of two identical PscA subunits together with three other subunits: PscB (F-A/F-B-containing protein), PscC ( cytochrome c(z)), and PscD. PscD shows a relatively low but significant similarity in its amino acid sequence to PsaD in the photosystem I of plants and cyanobacteria. We studied the biochemical and spectroscopic properties of a mutant lacking PscD in order to elucidate its unknown function. 1) The RC complex isolated from the mutant cells showed no band corresponding to PscD on SDS-PAGE analysis. 2) The growth rate of the PscD-less mutant was slower than that of the wildtype cells at low light intensities. 3) Time-resolved fluorescence spectra at 77 K revealed prolonged decay times of the fluorescence from bacteriochlorophyll c on the antenna chlorosome and from bacteriochlorophyll a on the Fenna-Matthews-Olson antenna protein in the mutant cells. The loss of PscD led to a much slower energy transfer from the antenna pigments to the special pair bacteriochlorophyll a (P840). 4) The mutant strain exhibited slightly less activity of ferredoxin-mediated NADP(+) photoreduction compared with that in the wild-type strain. The extent of suppression, however, was less significant than that reported in the PsaD-less mutants of cyanobacterial photosystem I. The evolutionary relationship between PscD and PsaD was also discussed based on a structural homology modeling of the former.	Osaka Univ, Grad Sch Sci, Dept Biol, Osaka 5600043, Japan; Nagoya Univ, Grad Sch Sci, Sch Mat Sci Phys, Nagoya, Aichi 4648602, Japan	Osaka University; Nagoya University	Tsukatani, Y (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol, Machikaneyama 1-1, Osaka 5600043, Japan.	tsuka@bio.sci.osaka-u.ac.jp	Tsukatani, Yusuke/A-6448-2014	Tsukatani, Yusuke/0000-0003-2831-8996				Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, V2, P399, DOI DOI 10.1007/0-306-47954-0; BUTTNER M, 1992, P NATL ACAD SCI USA, V89, P8135, DOI 10.1073/pnas.89.17.8135; CUI JY, 1989, J BIOCHEM-TOKYO, V105, P390, DOI 10.1093/oxfordjournals.jbchem.a122674; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Frigaard NU, 2002, J BACTERIOL, V184, P3368, DOI 10.1128/JB.184.12.3368-3376.2002; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Griesbeck C, 1998, BBA-BIOENERGETICS, V1365, P285, DOI 10.1016/S0005-2728(98)00081-4; HAGERBRAUN C, 1995, BIOCHEMISTRY-US, V34, P9617, DOI 10.1021/bi00029a039; HagerBraun C, 1997, PHOTOSYNTH RES, V51, P127, DOI 10.1023/A:1005787209977; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Heathcote P, 2003, PHILOS T ROY SOC B, V358, P231, DOI 10.1098/rstb.2002.1178; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KJAER B, 1994, PHOTOSYNTH RES, V41, P105, DOI 10.1007/BF02184150; KJAER B, 1996, PHOTOSYNTH RES, V17, P33; KUSUMOTO N, 1994, PLANT CELL PHYSIOL, V35, P17; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee C, 2001, IBM SYST J, V40, P592, DOI 10.1147/sj.402.0592; Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189; Maresca JA, 2004, J BACTERIOL, V186, P2558, DOI 10.1128/JB.186.9.2558-2566.2004; MATTHEWS BW, 1979, J MOL BIOL, V131, P259, DOI 10.1016/0022-2836(79)90076-7; NITSCHKE W, 1990, BIOCHEMISTRY-US, V29, P3834, DOI 10.1021/bi00468a005; Oh-Oka H, 1998, BIOCHEMISTRY-US, V37, P12293, DOI 10.1021/bi9800799; OhOka H, 1997, BIOCHEMISTRY-US, V36, P9267, DOI 10.1021/bi9701787; OHOKA H, 1995, FEBS LETT, V365, P30, DOI 10.1016/0014-5793(95)00433-A; OKKELS JS, 1992, J BIOL CHEM, V267, P21139; Olson JM, 1998, PHOTOCHEM PHOTOBIOL, V67, P61, DOI 10.1111/j.1751-1097.1998.tb05166.x; Permentier HP, 2000, PHOTOSYNTH RES, V64, P27, DOI 10.1023/A:1026515027824; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Remigy HW, 2002, PHOTOSYNTH RES, V71, P91, DOI 10.1023/A:1014963816574; Remigy HW, 1999, J MOL BIOL, V290, P851, DOI 10.1006/jmbi.1999.2925; Sakurai H, 1996, PHOTOCHEM PHOTOBIOL, V64, P5, DOI 10.1111/j.1751-1097.1996.tb02414.x; Sambrook J., 2002, MOL CLONING LAB MANU; Seo D, 2001, BBA-BIOENERGETICS, V1503, P377, DOI 10.1016/S0005-2728(00)00245-0; Tsukatani Y, 2004, PHOTOSYNTH RES, V79, P83, DOI 10.1023/B:PRES.0000011922.56394.92; Vassiliev IR, 2000, BIOPHYS J, V78, P3160, DOI 10.1016/S0006-3495(00)76852-4; Vassiliev IR, 2001, BBA-BIOENERGETICS, V1507, P139, DOI 10.1016/S0005-2728(01)00197-9; WAHLUND TM, 1995, J BACTERIOL, V177, P2583, DOI 10.1128/jb.177.9.2583-2588.1995; WANG J, 1990, BIOCHIM BIOPHYS ACTA, V1015, P457, DOI 10.1016/0005-2728(90)90079-J; XU Q, 1994, J BIOL CHEM, V269, P21512; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	41	30	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51122	51130		10.1074/jbc.M410432200	http://dx.doi.org/10.1074/jbc.M410432200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371432	hybrid			2022-12-27	WOS:000225355800058
J	Wadhwa, R; Yaguchi, T; Kaur, K; Suyama, E; Kawasaki, H; Taira, K; Kaul, SC				Wadhwa, R; Yaguchi, T; Kaur, K; Suyama, E; Kawasaki, H; Taira, K; Kaul, SC			Use of a randomized hybrid ribozyme library for identification of genes involved in muscle differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE WITHDRAWAL; SEX-DETERMINING GENE; IN-VIVO; CAENORHABDITIS-ELEGANS; HAMMERHEAD RIBOZYME; MAMMALIAN-CELLS; MESSENGER-RNA; APOPTOTIC PATHWAY; CLEAVAGE ACTIVITY; SKELETAL-MUSCLE	We have employed the hybrid hammerhead ribozyme-based gene discovery system for identification of genes functionally involved in muscle differentiation using in vitro myoblast differentiation assay. The major muscle regulatory genes (MyoD1, Mylk, myosin, myogenin, and Myf5) were identified endorsing the validity of this method. Other gene targets included tumor suppressors and cell cycle regulators (p19(ARF) and p21(WAF1)), FGFR-4, fibronectin, Prkg2, Pdk4, fem, and six novel proteins. Functional involvement of three of the identified targets in myoblast differentiation was confirmed by their specific knockdown using ribozymes and siRNA. Besides demonstrating a simple and an effective method of isolation of gene functions involved in muscle differentiation, we report for the first time that overexpression of Fem, a member of the sex-determining family of proteins, caused accelerated myotube formation, and its targeting deferred myoblast differentiation. This functional gene screening is not only helpful in understanding the molecular pathways of muscle differentiation but also to design molecular strategies for myopathologic therapies.	Natl Inst Adv Ind Sci & Technol, Gene Funct Res Ctr, Tsukuba, Ibaraki 3058562, Japan; Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Tokyo 1138656, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Gene Funct Res Ctr, 1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916				Adams GR, 1999, J APPL PHYSIOL, V87, P1705, DOI 10.1152/jappl.1999.87.5.1705; Akashi H, 2002, J BIOCHEM, V131, P687, DOI 10.1093/oxfordjournals.jbchem.a003152; Amack JD, 2004, DEV BIOL, V265, P294, DOI 10.1016/j.ydbio.2003.07.021; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Bouzeghrane F, 2004, J MOL CELL CARDIOL, V36, P343, DOI 10.1016/j.yjmcc.2003.11.007; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Cech TR, 2002, BIOCHEM SOC T, V30, P1162, DOI 10.1042/BST0301162; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; DONIACH T, 1984, DEV BIOL, V106, P223, DOI 10.1016/0012-1606(84)90077-0; Endesfelder S, 2003, J MOL MED-JMM, V81, P355, DOI 10.1007/s00109-003-0439-6; Franchini Massimo, 2003, Recenti Progressi in Medicina, V94, P478; Franklin DS, 1996, MOL BIOL CELL, V7, P1587, DOI 10.1091/mbc.7.10.1587; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Goodchild John, 2002, Expert Opin Ther Targets, V6, P235, DOI 10.1517/14728222.6.2.235; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HAWKE TJ, 2003, AM J PHYSIOL-CELL PH, V285, P25; Iyo Mayu, 2004, Methods Mol Biol, V252, P257; Kato Y, 2000, Nucleic Acids Symp Ser, P283; Kato Y, 2001, J BIOL CHEM, V276, P15378, DOI 10.1074/jbc.M010570200; Kawasaki H, 2002, NAT BIOTECHNOL, V20, P376, DOI 10.1038/nbt0402-376; Kawasaki H, 2002, EMBO REP, V3, P443, DOI 10.1093/embo-reports/kvf098; KAWASAKI H, 2002, NUCL ACIDS RES S, V2, P275; KAWASAKI H, 2001, NUCL ACIDS RES S, V1, P133; Kawasaki Hiroaki, 2004, Methods Mol Biol, V252, P237; Kawasaki K, 2002, NUCLEIC ACIDS RES, V30, P3682, DOI 10.1093/nar/gkf487; KIMBLE J, 1984, DEV BIOL, V105, P234, DOI 10.1016/0012-1606(84)90279-3; Koseki S, 1999, J VIROL, V73, P1868, DOI 10.1128/JVI.73.3.1868-1877.1999; Kruger M, 2000, P NATL ACAD SCI USA, V97, P8566, DOI 10.1073/pnas.97.15.8566; Kuwabara T, 2000, TRENDS BIOTECHNOL, V18, P462, DOI 10.1016/S0167-7799(00)01498-0; Kuwabara T, 2002, J BIOCHEM, V132, P149, DOI 10.1093/oxfordjournals.jbchem.a003193; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; MARCELLE C, 1995, DEV BIOL, V172, P100, DOI 10.1006/dbio.1995.0008; Marics I, 2002, DEVELOPMENT, V129, P4559; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Mehra A, 1999, GENE DEV, V13, P1453, DOI 10.1101/gad.13.11.1453; Michienzi A, 2003, ANN NY ACAD SCI, V1002, P63, DOI 10.1196/annals.1281.008; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Miyagishi M, 2001, CANCER CHEMOTH PHARM, V48, pS96, DOI 10.1007/s002800100314; Morla AO, 2000, BIOCHEM BIOPH RES CO, V272, P298, DOI 10.1006/bbrc.2000.2769; Onuki R, 2004, EMBO J, V23, P959, DOI 10.1038/sj.emboj.7600049; Onuki R, 2003, ANTISENSE NUCLEIC A, V13, P75, DOI 10.1089/108729003321629629; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Rossi JJ, 1999, CURR OPIN MOL THER, V1, P316; Sano M, 2002, ANTISENSE NUCLEIC A, V12, P341, DOI 10.1089/108729002761381311; SANO M, 2000, NUCL ACIDS S SER, V44, P203; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Sioud Mouldy, 2001, Current Molecular Medicine (Hilversum), V1, P575, DOI 10.2174/1566524013363366; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Stage-Zimmermann TK, 1998, RNA, V4, P875, DOI 10.1017/S1355838298980876; Suyama E, 2003, P NATL ACAD SCI USA, V100, P5616, DOI 10.1073/pnas.1035850100; Suyama E, 2003, CANCER RES, V63, P119; Takagi Y, 2002, BIOCHEM SOC T, V30, P1145; Taylor MV, 2003, CURR BIOL, V13, pR964, DOI 10.1016/j.cub.2003.11.044; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; Ventura-Holman T, 2003, GENE, V314, P133, DOI 10.1016/S0378-1119(03)00712-1; Ventura-Holman T, 2000, BIOCHEM BIOPH RES CO, V267, P317, DOI 10.1006/bbrc.1999.1942; Verma S, 1997, CURR OPIN CHEM BIOL, V1, P532, DOI 10.1016/S1367-5931(97)80049-X; Wadhwa R, 2003, EMBO REP, V4, P595, DOI 10.1038/sj.embor.embor855; Warashina M, 2001, P NATL ACAD SCI USA, V98, P5572, DOI 10.1073/pnas.091411398; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; Welch PJ, 2000, GENOMICS, V66, P274, DOI 10.1006/geno.2000.6230; Zhao JJ, 1998, MOL CELL NEUROSCI, V11, P92, DOI 10.1006/mcne.1998.0669	65	15	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51622	51629		10.1074/jbc.M407428200	http://dx.doi.org/10.1074/jbc.M407428200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448151	hybrid			2022-12-27	WOS:000225355800118
J	Wilkinson, JC; Wilkinson, AS; Scott, FL; Csomos, RA; Salvesen, GS; Duckett, CS				Wilkinson, JC; Wilkinson, AS; Scott, FL; Csomos, RA; Salvesen, GS; Duckett, CS			Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs) - A caspase-independent mechanism for apoptotic inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; BACULOVIRUS INHIBITOR; OP-IAP; MAMMALIAN-CELLS; PROTEINS; XIAP; ACTIVATION; BINDING; GENES; P35	Numerous members of the IAP family can suppress apoptotic cell death in physiological settings. Whereas certain IAPs directly inhibit caspases, the chief proteolytic effectors of apoptosis, the protective effects of other IAPs do not correlate well with their caspase inhibitory activities, suggesting the involvement of alternative cytoprotective abilities. To examine this issue, we have characterized the protective effects of an ancestral, baculoviral IAP (Op-IAP) in mammalian cells. We show that although Op-IAP potently inhibited Bax-mediated apoptosis in human cells, Op-IAP failed to directly inhibit mammalian caspases. However, Op-IAP efficiently bound the IAP antagonist Smac/Diablo, thereby preventing Smac/Diablo-mediated inhibition of cellular IAPs. Whereas reduction of Smac/Diablo protein levels in the absence of Op-IAP prevented Bax-mediated apoptosis, overexpression of Smac/Diablo neutralized Op-IAP-mediated protection, and an Op-IAP variant unable to bind Smac/Diablo failed to prevent apoptosis. Finally, Op-IAP catalyzed the ubiquitination of Smac/Diablo, an activity that contributed to Op-IAP-mediated inhibition of apoptosis. These data show that cytoprotective IAPs can inhibit apoptosis through the neutralization of IAP antagonists, rather than by directly inhibiting caspases.	Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Burnham Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute	Duckett, CS (corresponding author), Med Sci 1,Rm 5315,1301 Catherine, Ann Arbor, MI 48109 USA.	colind@umich.edu			NCI NIH HHS [T32 CA09676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Clem RJ, 1996, CELL DEATH DIFFER, V3, P9; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Hawkins CJ, 1998, CELL DEATH DIFFER, V5, P569, DOI 10.1038/sj.cdd.4400389; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; Huang QH, 2000, P NATL ACAD SCI USA, V97, P1427, DOI 10.1073/pnas.97.4.1427; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; LaCount DJ, 2000, J BIOL CHEM, V275, P15657, DOI 10.1074/jbc.M000791200; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Manji GA, 1997, J VIROL, V71, P4509, DOI 10.1128/JVI.71.6.4509-4516.1997; Manji GA, 2001, J BIOL CHEM, V276, P16704, DOI 10.1074/jbc.M010179200; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Seshagiri S, 1997, P NATL ACAD SCI USA, V94, P13606, DOI 10.1073/pnas.94.25.13606; SHEN YQ, 1995, CURR OPIN GENET DEV, V5, P105, DOI 10.1016/S0959-437X(95)90061-6; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vaux DL, 2003, BIOCHEM BIOPH RES CO, V304, P499, DOI 10.1016/S0006-291X(03)00622-3; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Vucic D, 1998, J BIOL CHEM, V273, P33915, DOI 10.1074/jbc.273.51.33915; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wright CW, 2002, J BIOL CHEM, V277, P2454, DOI 10.1074/jbc.M110500200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	43	88	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51082	51090		10.1074/jbc.M408655200	http://dx.doi.org/10.1074/jbc.M408655200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371416	hybrid			2022-12-27	WOS:000225355800054
J	Yasuoka, C; Ihara, Y; Ikeda, S; Miyahara, Y; Kondo, T; Kohno, S				Yasuoka, C; Ihara, Y; Ikeda, S; Miyahara, Y; Kondo, T; Kohno, S			Antiapoptotic activity of Akt is down-regulated by Ca2+ in myocardiac H9c2 cells - Evidence of Ca2+-dependent regulation of protein phosphatase 2Ac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KINASE-B; ENDOPLASMIC-RETICULUM; CATALYTIC SUBUNIT; GRANULOCYTIC DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; MOLECULAR-CLONING; TUMOR PROMOTER; RETINOIC ACID; OKADAIC ACID	Cell survival signaling of the Akt/protein kinase B pathway was influenced by a change in the cytoplasmic free calcium concentration ([Ca2+](i)) for over 2 h via the regulation of a Ser/Thr phosphatase, protein phosphatase 2Ac (PP2Ac), in rat myocardiac H9c2 cells. Akt was down-regulated when [Ca2+](i) was elevated by thapsigargin, an inhibitor of the endoplasmic reticulum Ca2+-ATPase, but was up-regulated when it was suppressed by 1,2-bis(o-aminophenoxy) ethane-N,N,N', N'-tetraacetic acid tetra( acetoxymethyl) ester (BAPTA-AM), a cell permeable Ca2+ chelator. The inactivation of Akt was well correlated with the susceptibility to oxidant-induced apoptosis in H9c2 cells. To investigate the mechanism of the Ca2+-dependent regulation of Akt via the regulation of PP2A, we examined the transcriptional regulation of PP2Acalpha in H9c2 cells with Ca2+ modulators. Transcription of the PP2Acalpha gene was increased by thapsigargin but decreased by BAPTA-AM. The promoter activity was examined and the cAMP response element (CRE) was found responsible for the Ca2+-dependent regulation of PP2Acalpha. Furthermore, phosphorylation of CRE-binding protein increased with thapsigargin but decreased with BAPTA-AM. A long term change of [Ca2+](i) regulates PP2Acalpha gene transcription via CRE, resulting in a change in the activation status of Akt leading to an altered susceptibility to apoptosis.	Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Biochem & Mol Biol Dis, Nagasaki 8528523, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med 2, Nagasaki 8528523, Japan	Nagasaki University; Nagasaki University	Ihara, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Biochem & Mol Biol Dis, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	y-ihara@net.nagasaki-u.ac.jp						Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Campos SV, 2000, J CELL PHYSIOL, V182, P88; Chen D, 1999, MOL CELL BIOL, V19, P4684; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Conus NM, 1998, J BIOL CHEM, V273, P4776, DOI 10.1074/jbc.273.8.4776; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gehringer MM, 2004, FEBS LETT, V557, P1, DOI 10.1016/S0014-5793(03)01447-9; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Huber M, 2000, J IMMUNOL, V165, P124, DOI 10.4049/jimmunol.165.1.124; Ihara Y, 1997, J BIOL CHEM, V272, P9629; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Kane CD, 2000, EMBO J, V19, P691, DOI 10.1093/emboj/19.4.691; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KHEWGOODALL Y, 1991, BIOCHEMISTRY-US, V30, P89, DOI 10.1021/bi00215a014; KITAGAWA Y, 1991, BIOCHIM BIOPHYS ACTA, V1089, P339, DOI 10.1016/0167-4781(91)90174-K; KITAGAWA Y, 1988, BIOCHIM BIOPHYS ACTA, V951, P123, DOI 10.1016/0167-4781(88)90032-2; KITAMURA K, 1991, J BIOCHEM-TOKYO, V109, P307; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mora A, 2002, CELL SIGNAL, V14, P557, DOI 10.1016/S0898-6568(01)00282-0; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Muroya T, 2003, BIOCHEM BIOPH RES CO, V309, P900, DOI 10.1016/j.bbrc.2003.08.090; Murriel CL, 2003, ARCH BIOCHEM BIOPHYS, V420, P246, DOI 10.1016/j.abb.2003.08.038; NISHIKAWA M, 1994, CANCER RES, V54, P4879; ORRENIUS S, 2003, NAT REV, V5, P552; Ozes ON, 1999, NATURE, V401, P82; Pan Z, 2001, J BIOL CHEM, V276, P32257, DOI 10.1074/jbc.M100178200; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; TAWARA I, 1993, FEBS LETT, V321, P224, DOI 10.1016/0014-5793(93)80113-9; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Wilson NJ, 1999, BIOCHEM J, V339, P517, DOI 10.1042/0264-6021:3390517; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	69	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51182	51192		10.1074/jbc.M407225200	http://dx.doi.org/10.1074/jbc.M407225200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15375154	hybrid			2022-12-27	WOS:000225355800065
J	Liu, JH; Chang, TW; Huang, CY; Chen, SU; Wu, HN; Chang, MC; Hsiao, CD				Liu, JH; Chang, TW; Huang, CY; Chen, SU; Wu, HN; Chang, MC; Hsiao, CD			Crystal structure of PriB, a primosomal DNA replication protein of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHI X174-TYPE PRIMOSOME; STRAND BINDING-PROTEIN; X-RAY-DIFFRACTION; COPY NUMBER; IN-VITRO; IDENTIFICATION; BACTERIAL; DOMAIN; SSB; PURIFICATION	PriB is one of the Escherichia coli phiX-type primosome proteins that are required for assembly of the primosome, a mobile multi-enzyme complex responsible for the initiation of DNA replication. Here we report the crystal structure of the E. coli PriB at 2.1 Angstrom resolution by multi-wavelength anomalous diffraction using a mercury derivative. The polypeptide chain of PriB is structurally similar to that of single-stranded DNA-binding protein (SSB). However, the biological unit of PriB is a dimer, not a homotetramer like SSB. Electrophoretic mobility shift assays demonstrated that PriB binds single-stranded DNA and single-stranded RNA with comparable affinity. We also show that PriB binds single-stranded DNA with certain base preferences. Based on the PriB structural information and biochemical studies, we propose that the potential tetramer formation surface and several other regions of PriB may participate in protein-protein interaction during DNA replication. These findings may illuminate the role of PriB in phiX-type primosome assembly.	Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan; Natl Cheng Kung Univ, Coll Med, Dept Surg, Tainan 701, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan	National Cheng Kung University; National Cheng Kung University; National Defense Medical Center; Academia Sinica - Taiwan	Chang, MC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem, Tainan 701, Taiwan.	mcchang@mail.ncku.edu.tw; mbhsiao@ccvax.sinica.edu.tw	Wu, Huey Nan/ABA-4484-2021; Hsiao, Chwan-Deng/AAZ-8869-2021; Liu, Jyung-Hurng/C-1340-2010; Hsiao, Chwan-Deng/D-7327-2013	Wu, Huey Nan/0000-0002-1538-7776; Hsiao, Chwan-Deng/0000-0002-7012-1532; Liu, Jyung-Hurng/0000-0002-7173-0372; 				ALLEN GC, 1993, J BIOL CHEM, V268, P19204; ALLEN GC, 1991, J BIOL CHEM, V266, P11610; ARAI K, 1981, J BIOL CHEM, V256, P5281; BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; Berges H, 1997, J BACTERIOL, V179, P956, DOI 10.1128/jb.179.3.956-958.1997; BOBST EV, 1991, BIOCHIM BIOPHYS ACTA, V1078, P199, DOI 10.1016/0167-4838(91)99010-P; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; DEVRIES J, 1994, EUR J BIOCHEM, V224, P613; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; Fairall L, 2000, PRACT APPROACH SER, P65; Flores MJ, 2002, MOL MICROBIOL, V44, P783, DOI 10.1046/j.1365-2958.2002.02913.x; Greipel J., 1989, PROTEIN NUCL ACID IN, P61, DOI [10.1007/978-1-349-09871-2_4, DOI 10.1007/978-1-349-09871-2_4]; Harinarayanan R, 2004, GENETICS, V166, P1165, DOI 10.1534/genetics.166.3.1165; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; KORNBERG A, 1992, DNA REPLICATION, P275; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Liu JI, 1999, P NATL ACAD SCI USA, V96, P3552, DOI 10.1073/pnas.96.7.3552; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOW RL, 1982, J BIOL CHEM, V257, P6242; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Marians KJ, 2000, PROG NUCLEIC ACID RE, V63, P39; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Matsumoto T, 2000, J BIOCHEM, V127, P329, DOI 10.1093/oxfordjournals.jbchem.a022611; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; MINDEN JS, 1985, J BIOL CHEM, V260, P9316; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Ng JY, 1996, J BIOL CHEM, V271, P15649, DOI 10.1074/jbc.271.26.15649; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Ponomarev VA, 2003, J MOL MICROB BIOTECH, V5, P225, DOI 10.1159/000071074; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; SCHEKMAN R, 1974, SCIENCE, V186, P987, DOI 10.1126/science.186.4168.987; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; TOUGU K, 1994, J BIOL CHEM, V269, P4675; Webster G, 1997, FEBS LETT, V411, P313, DOI 10.1016/S0014-5793(97)00747-3; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P4120, DOI 10.1073/pnas.71.10.4120; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; ZAVITZ KH, 1993, J BIOL CHEM, V268, P4337; ZAVITZ KH, 1991, J BIOL CHEM, V266, P13988	59	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50465	50471		10.1074/jbc.M406773200	http://dx.doi.org/10.1074/jbc.M406773200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383524	hybrid			2022-12-27	WOS:000225229500112
J	Staruschenko, A; Nichols, A; Medina, JL; Camacho, P; Zheleznova, NN; Stockand, JD				Staruschenko, A; Nichols, A; Medina, JL; Camacho, P; Zheleznova, NN; Stockand, JD			Rho small GTPases activate the epithelial Na+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; TRANSLOCATION; KINASE; ALDOSTERONE; AQUAPORIN-2; ACTIN; RAC1	Small G proteins in the Rho family are known to regulate diverse cellular processes, including cytoskeletal organization and cell cycling, and more recently, ion channel activity and activity of phosphatidylinositol 4-phosphate 5-kinase (PI(4)P 5-K). The present study investigates regulation of the epithelial Na+ channel ( ENaC) by Rho GTPases. We demonstrate here that RhoA and Rac1 markedly increase ENaC activity. Activation by RhoA was suppressed by the C3 exoenzyme. Inhibition of the downstream RhoA effector Rho kinase, which is necessary for RhoA activation of PI(4)P 5-K, abolished ENaC activation. Similar to RhoA, overexpression of PI(4)P 5-K increased ENaC activity suggesting that production of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in response to RhoA-Rho kinase signaling stimulates ENaC. Supporting this idea, inhibition of phosphatidylinositol 4-kinase, but not the RhoA effector phosphatidylinositol 3-kinase and MAPK cascades, markedly attenuated RhoA-dependent activation of ENaC. RhoA increased ENaC activity by increasing the plasma membrane levels of this channel. We conclude that RhoA activates ENaC via Rho kinase and subsequently activates PI(4)P 5-K with concomitant increases in PI(4,5)P-2 levels promoting channel insertion into the plasma membrane.	Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Staruschenko, A (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	staruschenko@uthscsa.edu		Staruschenko, Alexander/0000-0002-5190-8356; Stockand, James/0000-0002-3817-4319	NIDDK NIH HHS [R01-DK-59594] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059594] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Booth RE, 2003, J BIOL CHEM, V278, P41367, DOI 10.1074/jbc.M305400200; Cachero TG, 1998, CELL, V93, P1077, DOI 10.1016/S0092-8674(00)81212-X; Copeland SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC231, DOI 10.1152/ajpcell.2001.281.1.C231; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Klussmann E, 2001, J BIOL CHEM, V276, P20451, DOI 10.1074/jbc.M010270200; Li LB, 2002, MOL PHARMACOL, V62, P602, DOI 10.1124/mol.62.3.602; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; Tong QS, 2004, J BIOL CHEM, V279, P22654, DOI 10.1074/jbc.M401004200; Tong QS, 2004, AM J PHYSIOL-RENAL, V286, pF1232, DOI 10.1152/ajprenal.00345.2003; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Weernink PAO, 2000, J BIOL CHEM, V275, P10168, DOI 10.1074/jbc.275.14.10168; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; WilkBlaszczak MA, 1997, J NEUROSCI, V17, P4094; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	32	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49989	49994		10.1074/jbc.M409812200	http://dx.doi.org/10.1074/jbc.M409812200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448132	hybrid			2022-12-27	WOS:000225229500055
J	Xu, L; Li, CL; Olson, AJ; Wilson, IA				Xu, L; Li, CL; Olson, AJ; Wilson, IA			Crystal structure of avian aminoimidazole-4-carboxamide ribonucleotide transformylase in complex with a novel non-folate inhibitor identified by virtual ligand screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISUBSTRATE ADDUCT INHIBITOR; HUMAN GAR TFASE; FUNCTIONALIZED ANALOGS; AICAR TRANSFORMYLASE; POTENT INHIBITOR; ACTIVE-SITE; HIGH PH; DESIGN; CYCLOHYDROLASE; INSIGHTS	Aminoimidazole-4-carboxamide ribonucleotide transformylase (AICAR Tfase), one of the two folate-dependent enzymes in the de novo purine biosynthesis pathway, is a promising target for anti-neoplastic chemotherapy. Although classic antifolates, such as methotrexate, have been developed as anticancer agents, their general toxicity and drug resistance are major issues associated with their clinical use and future development. Identification of inhibitors with novel scaffolds could be an attractive alternative. We present here the crystal structure of avian AICAR Tfase complexed with the first non-folate based inhibitor identified through virtual ligand screening of the National Cancer Institute Diversity Set. The inhibitor 326203-A (2-[5-hydroxy-3-methyl-1-(2-methyl-4-sulfophenyl)-1H- pyrazol-4-ylazo]-4-sulfo-benzoic acid) displayed competitive inhibition against the natural cofactor, 10-formyl-tetrahydrofolate, with a K-i of 7.1 muM. The crystal structure of AICAR Tfase with 326203-A at 1.8 Angstrom resolution revealed a unique binding mode compared with antifolate inhibitors. The inhibitor also accessed an additional binding pocket that is not occupied by antifolates. The sulfonate group of 326203-A appears to form the dominant interaction of the inhibitor with the proposed oxyanion hole through interaction with a helix dipole and Lys(267). An aromatic interaction with Phe(316) also likely contributes to favorable binding. Based on these structural insights, several inhibitors with improved potency were subsequently identified in the National Cancer Institute Compound Library and the Available Chemical Directory by similarity search and molecular modeling methods. These results provide further support for our combined virtual ligand screening rational design approach for the discovery of novel, non-folate-based inhibitors of AICAR Tfase.	Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719	NCI NIH HHS [R24 CA95830, P01 CA63536] Funding Source: Medline; NCRR NIH HHS [P41 RR08606] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R24CA095830, P01CA063536] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beardsley GP, 1998, ADV EXP MED BIOL, V431, P221; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLACK SL, 1978, ANAL BIOCHEM, V90, P397, DOI 10.1016/0003-2697(78)90042-8; Boger DL, 1997, BIOORGAN MED CHEM, V5, P1839, DOI 10.1016/S0968-0896(97)00122-3; Boger DL, 1997, BIOORGAN MED CHEM, V5, P1817, DOI 10.1016/S0968-0896(97)00120-X; Boger DL, 1997, BIOORGAN MED CHEM, V5, P1831, DOI 10.1016/S0968-0896(97)00121-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvert H, 1999, SEMIN ONCOL, V26, P3; Chen JM, 1998, BIOCHEMISTRY-US, V37, P17735, DOI 10.1021/bi981848r; Cheong CG, 2004, J BIOL CHEM, V279, P18034, DOI 10.1074/jbc.M313691200; Christopherson RI, 2002, ACCOUNTS CHEM RES, V35, P961, DOI 10.1021/ar0000509; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Davis AM, 1999, ANGEW CHEM INT EDIT, V38, P737, DOI 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R; DeLano W.L, PYMOL MOL GRAPHICS S; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Greasley SE, 1999, BIOCHEMISTRY-US, V38, P16783, DOI 10.1021/bi991888a; Greasley SE, 2001, NAT STRUCT BIOL, V8, P402, DOI 10.1038/87555; Greasley SE, 2001, BIOCHEMISTRY-US, V40, P13538, DOI 10.1021/bi011482+; Hanauske AR, 2001, ONCOLOGIST, V6, P363, DOI 10.1634/theoncologist.6-4-363; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamen B, 1997, SEMIN ONCOL, V24, P30; KLEIN C, 1995, J MOL BIOL, V249, P153, DOI 10.1006/jmbi.1995.0286; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI C, 2004, IN PRESS J MED CHEM; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Roberts JD, 2000, CANCER CHEMOTH PHARM, V45, P103, DOI 10.1007/s002800050017; Rowe P.B, 1971, METHODS ENZYMOL B, V18, P733; Segel I. H., 1993, ENZYME KINETICS BEHA, P100; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; SHOICHET BK, 1993, SCIENCE, V259, P1445, DOI 10.1126/science.8451640; Stout TJ, 1996, STRUCTURE, V4, P67, DOI 10.1016/S0969-2126(96)00010-X; Su Y, 1998, J MOL BIOL, V281, P485, DOI 10.1006/jmbi.1998.1931; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Wolan DW, 2004, BIOCHEMISTRY-US, V43, P1171, DOI 10.1021/bi030162i; Wolan DW, 2003, BIOCHEMISTRY-US, V42, P10904, DOI 10.1021/bi030106h; Wolan DW, 2002, BIOCHEMISTRY-US, V41, P15505, DOI 10.1021/bi020505x; Zhang Y, 2002, BIOCHEMISTRY-US, V41, P14206, DOI 10.1021/bi020522m; Zhang Y, 2003, BIOCHEMISTRY-US, V42, P6043, DOI 10.1021/bi034219c	46	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50555	50565		10.1074/jbc.M406801200	http://dx.doi.org/10.1074/jbc.M406801200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355974	hybrid			2022-12-27	WOS:000225229500120
J	Chen, JH; Stoeber, K; Kingsbury, S; Ozanne, SE; Williams, GH; Hales, CN				Chen, JH; Stoeber, K; Kingsbury, S; Ozanne, SE; Williams, GH; Hales, CN			Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; DNA-REPLICATION; PREMATURE SENESCENCE; CELLULAR SENESCENCE; HYDROGEN-PEROXIDE; GROWTH ARREST; ONCOGENIC RAS; S-PHASE; P53; PROTEIN	Cellular senescence can result from short, dysfunctional telomeres, oxidative stress, or oncogene expression, and may contribute to aging. To investigate the role of cellular senescence in aging it is necessary to define the time-dependent molecular events by which it is characterized. Here we investigated changes in levels of key proteins involved in cell cycle regulation, DNA replication, and stress resistance in senescing human fibroblasts following oxidative stress. An immediate response in stressed cells was dephosphorylation of retinoblastoma (Rb) and cessation of DNA synthesis. This was followed by sequential induction of p53, p21, and p16. Increase in hypophosphorylated Rb and induction of p53 and p21 by a single stress treatment was transient, whereas sustained induction or dephosphorylation were achieved by a second stress. Down-regulation of the critical DNA replication initiation factor Cdc6 occurred early after stress concurring with p53 induction, and was followed by a decrease in Mcm2 levels. A late event in the stress-induced molecular sequence was the induction of SOD1, catalase, and HSP27 coinciding with development of the fully senescent phenotype. Our data suggest that loss of proliferative capacity in oxidatively stressed cells is a multistep process regulated by time-dependent molecular events that may play differential roles in induction and maintenance of cellular senescence.	Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Histopathol, London WC1E 6JJ, England	University of Cambridge; University of London; University College London; University of London; University College London	Chen, JH (corresponding author), Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England.	jhc36@cam.ac.uk		Ozanne, Susan/0000-0001-8753-5144				Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chen QM, 2000, BIOGERONTOLOGY, V1, P335, DOI 10.1023/A:1026590501344; Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208; Chiu CP, 1997, P SOC EXP BIOL MED, V214, P99; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ferbeyre G, 2000, GENE DEV, V14, P2015; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; Krude T, 1997, CELL, V88, P109, DOI 10.1016/S0092-8674(00)81863-2; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Martin-Ruiz C, 2004, J BIOL CHEM, V279, P17826, DOI 10.1074/jbc.M311980200; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Oren M, 2002, ANN NY ACAD SCI, V973, P374, DOI 10.1111/j.1749-6632.2002.tb04669.x; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Stoeber K, 1998, EMBO J, V17, P7219, DOI 10.1093/emboj/17.24.7219; Stoeber K, 1999, LANCET, V354, P1524, DOI 10.1016/S0140-6736(99)04265-8; Stoeber K, 2001, J CELL SCI, V114, P2027; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Toussaint Olivier, 2002, TheScientificWorldJOURNAL, V2, P230; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	49	118	122	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49439	49446		10.1074/jbc.M409153200	http://dx.doi.org/10.1074/jbc.M409153200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15377661	hybrid			2022-12-27	WOS:000225098100113
J	Pucci, B; De Felice, M; Rossi, M; Onesti, S; Pisani, FM				Pucci, B; De Felice, M; Rossi, M; Onesti, S; Pisani, FM			Amino acids of the Sulfolobus solfataricus mini-chromosome maintenance-like DNA helicase involved in DNA binding/remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MCM PROTEINS; REPLICATION INITIATION; BIOCHEMICAL-ANALYSIS; COMPLEX; THERMOAUTOTROPHICUM; BINDING; DUPLEX; FORK; MECHANISM; SUBSTRATE	Herein we report the identification of amino acids of the Sulfolobus solfataricus mini-chromosome maintenance (MCM)-like DNA helicase (SsoMCM), which are critical for DNA binding/remodeling. The crystallographic structure of the N-terminal portion (residues 2-286) of the Methanothermobacter thermoautotrophicum MCM protein revealed a dodecameric assembly with two hexameric rings in a head-to-head configuration and a positively charged central channel proposed to encircle DNA molecules. A structure-guided alignment of the M. thermoautotrophicum and S. solfataricus MCM sequences identified positively charged amino acids in SsoMCM that could point to the center of the channel. These residues (Lys-129, Lys-134, His-146, and Lys-194) were changed to alanine. The purified mutant proteins were all found to form homo-hexamers in solution and to retain full ATPase activity. K129A, H146A, and K194A SsoMCMs are unable to bind DNA either in single- or double-stranded form in band shift assays and do not display helicase activity. In contrast, the substitution of lysine 134 to alanine affects only binding to duplex DNA molecules, whereas it has no effect on binding to single- stranded DNA and on the DNA unwinding activity. These results have important implications for the understanding of the molecular mechanism of the MCM DNA helicase action.	CNR, Ist Biochim Prot, I-80131 Naples, Italy; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Imperial College London	Pisani, FM (corresponding author), CNR, Ist Biochim Prot, Via P Castellino 111, I-80131 Naples, Italy.	fm.pisani@ibp.cnr.it	Pucci, Biagio/AAS-7502-2021; Pisani, Francesca M./AAX-4025-2020; pucci, biagio/AAA-9268-2020	pucci, biagio/0000-0003-4502-1748; Onesti, Silvia/0000-0002-0612-7948				Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Carpentieri F, 2002, J BIOL CHEM, V277, P12118, DOI 10.1074/jbc.M200091200; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; De Felice M, 2004, J BIOL CHEM, V279, P43008, DOI 10.1074/jbc.M406693200; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Grainge I, 2003, NUCLEIC ACIDS RES, V31, P4888, DOI 10.1093/nar/gkg662; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Neuwald AF, 1999, GENOME RES, V9, P27; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Poplawski A, 2001, J BIOL CHEM, V276, P49371, DOI 10.1074/jbc.M108519200; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; THOMPSON JD, 1997, NUCLEIC ACIDS RES, V25, P4867; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Yabuta N, 2003, GENES CELLS, V8, P413, DOI 10.1046/j.1365-2443.2003.00645.x; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576; You ZY, 1999, MOL CELL BIOL, V19, P8003; Yu X, 2002, EMBO REP, V3, P792, DOI 10.1093/embo-reports/kvf160	39	28	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49222	49228		10.1074/jbc.M408967200	http://dx.doi.org/10.1074/jbc.M408967200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371413	hybrid			2022-12-27	WOS:000225098100088
J	Alric, J; Cuni, A; Maki, H; Nagashima, KVP; Vermeglio, A; Rappaport, F				Alric, J; Cuni, A; Maki, H; Nagashima, KVP; Vermeglio, A; Rappaport, F			Electrostatic interaction between redox cofactors in photosynthetic reaction centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRIDIS REACTION-CENTER; REACTION-CENTER COMPLEX; CYTOCHROME-C SUBUNIT; RHODOPSEUDOMONAS-VIRIDIS; TETRAHEME CYTOCHROME; RUBRIVIVAX-GELATINOSUS; OXIDATION-REDUCTION; FUMARATE REDUCTASE; PURPLE BACTERIUM; DONOR SIDE	Intramolecular electron transfer within proteins is an essential process in bioenergetics. Redox cofactors are embedded in proteins, and this matrix strongly influences their redox potential. Several cofactors are usually found in these complexes, and they are structurally organized in a chain with distances between the electron donor and acceptor short enough to allow rapid electron tunneling. Among the different interactions that contribute to the determination of the redox potential of these cofactors, electrostatic interactions are important but restive to direct experimental characterization. The influence of interaction between cofactors is evidenced here experimentally by means of redox titrations and time-resolved spectroscopy in a chimeric bacterial reaction center (Maki, H., Matsuura, K., Shimada, K., and Nagashima, K. V. P. (2003) J. Biol. Chem. 278, 3921-3928) composed of the core subunits of Rubrivivax gelatinosus and the tetraheme cytochrome of Blastochloris viridis. The absorption spectra and orientations of the various cofactors of this chimeric reaction center are similar to those found in their respective native protein, indicating that their local environment is conserved. However, the redox potentials of both the primary electron donor and its closest heme are changed. The redox potential of the primary electron donor is downshifted in the chimeric reaction center when compared with the wild type, whereas, conversely, that of its closet heme is upshifted. We propose a model in which these reciprocal shifts in the midpoint potentials of two electron transfer partners are explained by an electrostatic interaction between them.	CNRS, UPR 1261, Inst Biol Physicochim, F-75005 Paris, France; CEA Aix Marseille II, CNRS, UMR 6191, Lab Genet & Biophys Plantes, F-13288 Marseille, France; Tokyo Metropolitan Univ, Dept Biol, Tokyo 1920397, Japan; CEA Aix Marseille II, CNRS,UMR 6191, CEA Cadarache, DSV DEVM Lab Bioenerget Cellulaire, F-13108 St Paul Les Durance, France	Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Tokyo Metropolitan University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Rappaport, F (corresponding author), CNRS, UPR 1261, Inst Biol Physicochim, 13 Rue P&M Curie, F-75005 Paris, France.	Fabrice.Rappaport@ibpc.fr	Alric, Jean/E-3538-2013; Nagashima, Kenji V. P./M-2208-2017	Alric, Jean/0000-0003-3574-2234; Nagashima, Kenji V. P./0000-0002-4526-6625; Rappaport, Fabrice/0000-0001-9377-4934				ALEGRIA G, 1991, BIOCHIM BIOPHYS ACTA, V1057, P258, DOI 10.1016/S0005-2728(05)80108-2; Armstrong FA, 2000, FARADAY DISCUSS, V116, P191, DOI 10.1039/b002290j; BAYMANN F, 1991, ANAL BIOCHEM, V199, P269, DOI 10.1016/0003-2697(91)90100-8; Baymann F, 1998, BIOCHEMISTRY-US, V37, P15320, DOI 10.1021/bi980963z; Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; BEAL D, 1995, REV SCI INSTRUM, V1232, P180; Chen IP, 2000, BIOCHEMISTRY-US, V39, P3592, DOI 10.1021/bi992443p; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DRACHEVA SM, 1986, FEBS LETT, V205, P41, DOI 10.1016/0014-5793(86)80862-6; DUTTON PL, 1971, BIOCHIM BIOPHYS ACTA, V226, P63, DOI 10.1016/0005-2728(71)90178-2; GAO JL, 1990, BIOCHIM BIOPHYS ACTA, V1015, P96, DOI 10.1016/0005-2728(90)90220-X; Gunner MR, 1997, J BIOL INORG CHEM, V2, P126, DOI 10.1007/s007750050116; GUNNER MR, 1991, P NATL ACAD SCI USA, V88, P9151, DOI 10.1073/pnas.88.20.9151; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Johnson ET, 2002, BIOCHEMISTRY-US, V41, P6483, DOI 10.1021/bi012131y; JOLIOT P, 1980, J CHIM PHYS PCB, V77, P209, DOI 10.1051/jcp/1980770209; Maki H, 2003, J BIOL CHEM, V278, P3921, DOI 10.1074/jbc.M209069200; Nagashima KVP, 1996, FEBS LETT, V385, P209, DOI 10.1016/0014-5793(96)00382-1; Nagashima KVP, 2002, BIOCHEMISTRY-US, V41, P14028, DOI 10.1021/bi026511a; NAGASHIMA KVP, 2004, 13 INT C PHOT; NITSCHKE W, 1994, BIOCHEM SOC T, V22, P694, DOI 10.1042/bst0220694; NITSCHKE W, 1989, BIOCHEMISTRY-US, V28, P3161, DOI 10.1021/bi00434a008; Nitschke W., 1995, ANOXYGENIC PHOTOSYNT, P775; ORTEGA JM, 1992, PHOTOSYNTH RES, V34, P127; ORTEGA JM, 1993, BIOCHEMISTRY-US, V32, P1141, DOI 10.1021/bi00055a020; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PARSON WW, 1990, BIOCHIM BIOPHYS ACTA, V1017, P251, DOI 10.1016/0005-2728(90)90192-7; Rappaport F, 1998, PHOTOSYNTH RES, V55, P317, DOI 10.1023/A:1005930018775; RUTHERFORD AW, 1990, BIOCHIM BIOPHYS ACTA, V1019, P128, DOI 10.1016/0005-2728(90)90133-O; SALERNO JC, 1991, BIOCHEM SOC T, V19, P599, DOI 10.1042/bst0190599; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; SEBBAN P, 1989, BIOCHIM BIOPHYS ACTA, V974, P54, DOI 10.1016/S0005-2728(89)80165-3; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; UNDEN G, 1980, BIOCHIM BIOPHYS ACTA, V591, P275, DOI 10.1016/0005-2728(80)90159-0; VERMEGLIO A, 1989, FEBS LETT, V243, P259, DOI 10.1016/0014-5793(89)80140-1; Warshel A, 1998, CURR OPIN STRUC BIOL, V8, P211, DOI 10.1016/S0959-440X(98)80041-9; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; WOODBURY NW, 1986, BIOCHIM BIOPHYS ACTA, V851, P6, DOI 10.1016/0005-2728(86)90243-4	38	14	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47849	47855		10.1074/jbc.M408888200	http://dx.doi.org/10.1074/jbc.M408888200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347641	hybrid, Green Published			2022-12-27	WOS:000224957000054
J	Aouacheria, A; Cluzel, C; Lethias, C; Gouy, M; Garrone, R; Exposito, JY				Aouacheria, A; Cluzel, C; Lethias, C; Gouy, M; Garrone, R; Exposito, JY			Invertebrate data predict an early emergence of vertebrate fibrillar collagen clades and an anti-incest model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V COLLAGEN; SEQUENCE ALIGNMENT; EXON STRUCTURE; GENE; EVOLUTION; PROCOLLAGEN; EXPRESSION; FIBRILLOGENESIS; IDENTIFICATION; HETEROTRIMERS	Fibrillar collagens are involved in the formation of striated fibrils and are present from the first multicellular animals, sponges, to humans. Recently, a new evolutionary model for fibrillar collagens has been suggested (Boot-Handford, R. P., Tuckwell, D. S., Plumb, D. A., Farrington Rock, C., and Poulsom, R. (2003) J. Biol. Chem. 278, 31067-31077). In this model, a rare genomic event leads to the formation of the founder vertebrate fibrillar collagen gene prior to the early vertebrate genome duplications and the radiation of the vertebrate fibrillar collagen clades (A, B, and C). Here, we present the modular structure of the fibrillar collagen chains present in different invertebrates from the protostome Anopheles gambiae to the chordate Ciona intestinalis. From their modular structure and the use of a triple helix instead of C-propeptide sequences in phylogenetic analyses, we were able to show that the divergence of A and B clades arose early during evolution because alpha chains related to these clades are present in protostomes. Moreover, the event leading to the divergence of B and C clades from a founder gene arose before the appearance of vertebrates; altogether these data contradict the Boot-Handford model. Moreover, they indicate that all the key steps required for the formation of fibrils of variable structure and functionality arose step by step during invertebrate evolution.	Univ Lyon 1, Inst Federat Rech Biosci Lyon Gerland 128, Inst Biol & Chim Prot, CNRS,UMR 5086, F-69367 Lyon 07, France; Univ Lyon 1, Lab Biometrie & Biol Evolut, CNRS, UMR 5558, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Exposito, JY (corresponding author), Univ Lyon 1, Inst Federat Rech Biosci Lyon Gerland 128, Inst Biol & Chim Prot, CNRS,UMR 5086, 7 Passage Vercors, F-69367 Lyon 07, France.	jy.exposito@ibcp.fr		Exposito, Jean-Yves/0000-0002-4926-4942; Cluzel, Caroline/0000-0001-8946-3439				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bailey WJ, 1997, MOL BIOL EVOL, V14, P843, DOI 10.1093/oxfordjournals.molbev.a025825; BIRK DE, 1990, J CELL SCI, V95, P649; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Cluzel C, 2004, J BIOL CHEM, V279, P9811, DOI 10.1074/jbc.M311803200; Cluzel C, 2001, J BIOL CHEM, V276, P18108, DOI 10.1074/jbc.M009597200; Exposito JY, 2000, MATRIX BIOL, V19, P275, DOI 10.1016/S0945-053X(00)00067-6; EXPOSITO JY, 1990, P NATL ACAD SCI USA, V87, P6669, DOI 10.1073/pnas.87.17.6669; EXPOSITO JY, 1993, J MOL EVOL, V37, P254, DOI 10.1007/BF00175502; EXPOSITO JY, 1992, J BIOL CHEM, V267, P17404; EXPOSITO JY, 1992, J BIOL CHEM, V267, P15559; Exposito JY, 2002, ANAT RECORD, V268, P302, DOI 10.1002/ar.10162; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Garrone R, 1985, BIOL INVERTEBRATE LO, P157; HOLLAND PWH, 1994, DEVELOPMENT, P125; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; Lees JF, 1997, EMBO J, V16, P908, DOI 10.1093/emboj/16.5.908; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; MIURA S, 1985, J BIOL CHEM, V260, P5352; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Ohno S., 1970, EVOLUTION GENE DUPLI; Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6; PERALA M, 1994, J BIOL CHEM, V269, P5064; Popovici C, 2001, BIOCHEM BIOPH RES CO, V288, P362, DOI 10.1006/bbrc.2001.5794; Saito M, 2001, EUR J BIOCHEM, V268, P2817, DOI 10.1046/j.1432-1327.2001.02160.x; Sicot FX, 1997, EUR J BIOCHEM, V246, P50, DOI 10.1111/j.1432-1033.1997.00050.x; Smith NGC, 1999, BIOESSAYS, V21, P697, DOI 10.1002/(SICI)1521-1878(199908)21:8<697::AID-BIES9>3.0.CO;2-X; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillet E, 1996, COMP BIOCHEM PHYS B, V113, P239, DOI 10.1016/0305-0491(95)02014-4	33	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47711	47719		10.1074/jbc.M408950200	http://dx.doi.org/10.1074/jbc.M408950200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15358765	Green Published, hybrid			2022-12-27	WOS:000224957000037
J	Chaban, YL; Coskun, U; Keegstra, W; Oostergetel, GT; Boekema, EJ; Gruber, G				Chaban, YL; Coskun, U; Keegstra, W; Oostergetel, GT; Boekema, EJ; Gruber, G			Structural characterization of an ATPase active F-1-/V-1-ATPase (alpha(3)beta(3)EG) hybrid complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; THERMOPHILIC BACTERIUM PS3; ELECTRON-MICROSCOPY; SUBUNIT-G; V-ATPASE; BIOLOGICAL MACROMOLECULES; 3-DIMENSIONAL STRUCTURE; ANGSTROM RESOLUTION; NEUROSPORA-CRASSA; MANDUCA-SEXTA	Co-reconstitution of subunits E and G of the yeast V-ATPase and the alpha and beta subunits of the F-1-ATPase from the thermophilic Bacillus PS3 (TF1) resulted in an alpha(3)beta(3)EG hybrid complex showing 53% of the ATPase activity of TF1. The alpha(3)beta(3)EG oligomer was characterized by electron microscopy. By processing 40,000 single particle projections, averaged two-dimensional projections at 1.2-2.4-nm resolution were obtained showing the hybrid complex in various positions. Difference mapping of top and side views of this complex with projections of the atomic model of the alpha(3)beta(3) subcomplex from TF1 (Shirakihara, Y., Leslie, A.G., Abrahams, J.P., Walker, J.E., Ueda, T., Sekimoto, Y., Kambara, M., Saika, K., Kagawa, Y., and Yoshida, M. (1997) Structure 5, 825-836) demonstrates that a seventh mass is located inside the shaft of the alpha(3)beta(3) barrel and extends out from the hexamer. Furthermore, difference mapping of the alpha(3)beta(3)EG oligomer with projections of the A(3)B(3)E and A(3)B(3)EC subcomplexes of the V-1 from Caloramator fervidus (Chaban, Y., Ubbink-Kok, T., Keegstra, W., Lolkema, J.S., and Boekema, E. J. (2002) EMBO Rep. 3, 982-987) shows that the mass inside the shaft is made up of subunit E, whereby subunit G was assigned to belong at least in part to the density of the protruding stalk. The formation of an active alpha(3)beta(3)EG hybrid complex indicates that the coupling subunit gamma inside the alpha(3)beta(3) oligomer of F-1 can be effectively replaced by subunit E of the V-ATPase. Our results have also demonstrated that the E and gamma subunits are structurally similar, despite the fact that their genes do not show significant homology.	Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; Univ Saarland, Fachrichtung Biophys 2 5, D-66421 Homburg, Germany	University of Groningen; Saarland University	Boekema, EJ (corresponding author), Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	boekema@chem.rug.nl; ggrueber@uniklinik-saarland.de	Coskun, Ünal/F-4683-2011	Coskun, Ünal/0000-0003-4375-3144				Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Armbruster A, 2003, FEBS LETT, V546, P395, DOI 10.1016/S0014-5793(03)00643-4; ARNOLD A, 1976, ANAL BIOCHEM, V71, P209, DOI 10.1016/0003-2697(76)90029-4; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; BOWMAN EJ, 1995, BBA-BIOMEMBRANES, V1237, P95, DOI 10.1016/0005-2736(95)00108-F; Chaban Y, 2002, EMBO REP, V3, P982, DOI 10.1093/embo-reports/kvf196; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Crider BP, 1997, J BIOL CHEM, V272, P10721; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; DSCHIDA WJ, 1992, J BIOL CHEM, V267, P18783; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; FRANK J, 1995, OPTIK, V98, P125; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GOGARTEN JP, 1992, PHOTOSYNTH RES, V33, P137, DOI 10.1007/BF00039176; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Gruber G, 2001, J EXP BIOL, V204, P2597; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Hilario E, 1998, J MOL EVOL, V46, P703, DOI 10.1007/PL00006351; Inoue T, 2003, J BIOENERG BIOMEMBR, V35, P291, DOI 10.1023/A:1025720713747; ISHII N, 1993, J BIOCHEM-TOKYO, V113, P245, DOI 10.1093/oxfordjournals.jbchem.a124034; Jones RPO, 2001, MOL MEMBR BIOL, V18, P283; Kagawa Y, 1979, Methods Enzymol, V55, P781; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; KASHO VN, 1989, P NATL ACAD SCI USA, V86, P8708, DOI 10.1073/pnas.86.22.8708; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI Z, 2004, IN PRESS PLANTA; Lolkema JS, 2003, J BIOENERG BIOMEMBR, V35, P323, DOI 10.1023/A:1025776831494; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; NELSON H, 1995, P NATL ACAD SCI USA, V92, P497, DOI 10.1073/pnas.92.2.497; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; OHTA S, 1988, BIOCHIM BIOPHYS ACTA, V933, P141, DOI 10.1016/0005-2728(88)90064-3; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; Pedersen PL, 2000, J BIOENERG BIOMEMBR, V32, P325, DOI 10.1023/A:1005594800983; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; Rizzo VF, 2003, J BIOL CHEM, V278, P270, DOI 10.1074/jbc.M208623200; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Sun-Wada GH, 2003, J BIOENERG BIOMEMBR, V35, P347, DOI 10.1023/A:1025780932403; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 1998, BBA-BIOENERGETICS, V1365, P93, DOI 10.1016/S0005-2728(98)00048-6	51	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47866	47870		10.1074/jbc.M408460200	http://dx.doi.org/10.1074/jbc.M408460200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355991	Green Published, hybrid			2022-12-27	WOS:000224957000056
J	Lesnefsky, EJ; Chen, Q; Moghaddas, S; Hassan, MO; Tandler, B; Hoppel, CL				Lesnefsky, EJ; Chen, Q; Moghaddas, S; Hassan, MO; Tandler, B; Hoppel, CL			Blockade of electron transport during ischemia protects cardiac mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MYOCARDIAL-ISCHEMIA; COMPLEX-III; OXIDATIVE-PHOSPHORYLATION; SUPEROXIDE-PRODUCTION; HEART-MITOCHONDRIA; ADENINE-NUCLEOTIDE; CARDIOLIPIN; PHOSPHOLIPIDS; RADICALS	Subsarcolemmal mitochondria sustain progressive damage during myocardial ischemia. Ischemia decreases the content of the mitochondrial phospholipid cardiolipin accompanied by a decrease in cytochrome c content and a diminished rate of oxidation through cytochrome oxidase. We propose that during ischemia mitochondria produce reactive oxygen species at sites in the electron transport chain proximal to cytochrome oxidase that contribute to the ischemic damage. Isolated, perfused rabbit hearts were treated with rotenone, an irreversible inhibitor of complex I in the proximal electron transport chain, immediately before ischemia. Rotenone pretreatment preserved the contents of cardiolipin and cytochrome c measured after 45 min of ischemia. The rate of oxidation through cytochrome oxidase also was improved in rotenone-treated hearts. Inhibition of the electron transport chain during ischemia lessens damage to mitochondria. Rotenone treatment of isolated subsarcolemmal mitochondria decreased the production of reactive oxygen species during the oxidation of complex I substrates. Thus, the limitation of electron flow during ischemia preserves cardiolipin content, cytochrome c content, and the rate of oxidation through cytochrome oxidase. The mitochondrial electron transport chain contributes to ischemic mitochondrial damage that in turn augments myocyte injury during subsequent reperfusion.	Louis Stokes Vet Adm Med Ctr, Med Serv, Cleveland, OH 44106 USA; Louis Stokes Vet Adm Med Ctr, Pathol Serv, Cleveland, OH 44106 USA; Louis Stokes Vet Adm Med Ctr, Lab Med Serv, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Dent, Dept Med, Div Cardiol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Dent, Dept Med, Div Clin Pharmacol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Dent, Dept Med, Div Pharmacol, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Lesnefsky, EJ (corresponding author), Louis Stokes VA Med Ctr, Cardiol Sect, Med Serv 111W, 10701 E Blvd, Cleveland, OH 44106 USA.	EXL9@po.cwru.edu			NIA NIH HHS [1K04AG00676] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K04AG000676] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; ANTHONY G, 1993, P NATL ACAD SCI USA, V90, P1652, DOI 10.1073/pnas.90.5.1652; ASIMAKIS GK, 1984, J MOL CELL CARDIOL, V16, P439, DOI 10.1016/S0022-2828(84)80615-X; BABCOCK GT, 1993, J BIOENERG BIOMEMBR, V25, P71, DOI 10.1007/BF00762849; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Borutaite V, 2003, FEBS LETT, V541, P1, DOI 10.1016/S0014-5793(03)00278-3; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; COOPER CE, 1990, BIOCHEMISTRY-US, V29, P3865, DOI 10.1021/bi00468a010; DAS DK, 1989, BIOCHEM BIOPH RES CO, V165, P1004, DOI 10.1016/0006-291X(89)92702-2; DUAN JM, 1989, CAN J PHYSIOL PHARM, V67, P704, DOI 10.1139/y89-114; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; FLAMENG W, 1991, J MOL CELL CARDIOL, V23, P1, DOI 10.1016/0022-2828(91)90034-J; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Gille L, 2001, ARCH BIOCHEM BIOPHYS, V388, P34, DOI 10.1006/abbi.2000.2257; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Grigorieff N, 1999, CURR OPIN STRUC BIOL, V9, P476, DOI 10.1016/S0959-440X(99)80067-0; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; INGALLS ST, 1993, J CHROMATOGR-BIOMED, V619, P9, DOI 10.1016/0378-4347(93)80441-6; KAJIYAMA K, 1987, CIRC RES, V61, P301, DOI 10.1161/01.RES.61.2.301; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lesnefsky EJ, 2000, ANAL BIOCHEM, V285, P246, DOI 10.1006/abio.2000.4783; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; Lesnefsky EJ, 2001, AM J PHYSIOL-HEART C, V280, pH2770; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Moghaddas S, 2003, ARCH BIOCHEM BIOPHYS, V414, P59, DOI 10.1016/S0003-9861(03)00166-8; OBRIEN PJ, 1969, CAN J BIOCHEM CELL B, V47, P485, DOI 10.1139/o69-076; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6; Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6; PARADIES G, 1993, ARCH BIOCHEM BIOPHYS, V307, P91, DOI 10.1006/abbi.1993.1565; PARINANDI NL, 1991, ARCH BIOCHEM BIOPHYS, V289, P118, DOI 10.1016/0003-9861(91)90450-W; PIPER HM, 1985, J MOL CELL CARDIOL, V17, P885, DOI 10.1016/S0022-2828(85)80102-4; POWELL GL, 1985, BIOCHIM BIOPHYS ACTA, V816, P191, DOI 10.1016/0005-2736(85)90409-2; Raha S, 2000, FREE RADICAL BIO MED, V29, P170, DOI 10.1016/S0891-5849(00)00338-5; ROBINSON NC, 1980, BIOCHEMISTRY-US, V19, P3656, DOI 10.1021/bi00557a003; ROUSLIN W, 1983, AM J PHYSIOL, V244, pH743, DOI 10.1152/ajpheart.1983.244.6.H743; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Salamon Z, 1997, J BIOENERG BIOMEMBR, V29, P211, DOI 10.1023/A:1022401825287; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; SHLAFER M, 1990, BASIC RES CARDIOL, V85, P318, DOI 10.1007/BF01907125; SPOONER PJR, 1992, BIOCHEMISTRY-US, V31, P10129, DOI 10.1021/bi00156a037; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; UETA H, 1990, J MOL CELL CARDIOL, V22, P893, DOI 10.1016/0022-2828(90)90120-Q; VandenHoek TL, 1997, J MOL CELL CARDIOL, V29, P2571, DOI 10.1006/jmcc.1997.0497; VEITCH K, 1992, BIOCHEM J, V281, P709, DOI 10.1042/bj2810709; VIK SB, 1977, BIOCHEMISTRY-US, V16, P5755, DOI 10.1021/bi00645a016	55	179	181	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47961	47967		10.1074/jbc.M409720200	http://dx.doi.org/10.1074/jbc.M409720200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347666	hybrid			2022-12-27	WOS:000224957000066
J	Osterloh, A; Meier-Stiegen, F; Veit, A; Fleischer, B; von Bonin, A; Breloer, M				Osterloh, A; Meier-Stiegen, F; Veit, A; Fleischer, B; von Bonin, A; Breloer, M			Lipopolysaccharide-free heat shock protein 60 activates T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; INNATE IMMUNE-SYSTEM; MURINE MACROPHAGES; EXPRESSION VECTOR; DENDRITIC CELLS; DANGER SIGNALS; RECEPTOR; INDUCTION; ENDOTOXIN	A possible function of eukaryotic heat shock protein 60 (Hsp60) as endogenous danger signal has been controversially discussed in the past. Hsp60 was shown to induce the secretion of proinflammatory cytokines in professional antigen-presenting cells and to enhance the activation of T cells in primary stimulation. However, in vitro activation of macrophages by Hsp60 was attributed to contaminating endotoxin in the recombinant Hsp60 protein preparations. Here, we employ low endotoxin recombinant human Hsp60 and murine Hsp60 expressed by eukaryotic cell lines to dissect the Hsp60 protein-mediated effects from biologic effects that are mediated by prokaryotic contaminants in the Hsp60 protein preparation. The induction of tumor necrosis factor-alpha secretion in mouse macrophages is lost after endotoxin removal and is not mediated by Hsp60 expressed in eukaryotic systems. In contrast, the Hsp60-mediated enhancement of antigen-specific T cell activation does not correlate with endotoxin contamination. Moreover, Hsp60 that is expressed on the surface of different eukaryotic cell lines increases the activation of T cells in primary stimulation. Taken together, we provide evidence that endogenous Hsp60, which is thought to be released from dying infected cells in vivo, has a biological function that is not due to contaminating pathogen-associated molecules.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin	Breloer, M (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	MBreloer@aol.com	Breloer, Minka/F-3999-2018; Osterloh, Anke/ABA-8626-2021	Breloer, Minka/0000-0001-6199-4908; 				Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bethke K, 2002, J IMMUNOL, V169, P6141, DOI 10.4049/jimmunol.169.11.6141; Birk OS, 1999, P NATL ACAD SCI USA, V96, P5159, DOI 10.1073/pnas.96.9.5159; Breloer M, 2001, EUR J IMMUNOL, V31, P2051, DOI 10.1002/1521-4141(200107)31:7<2051::AID-IMMU2051>3.0.CO;2-H; Chen W, 1999, J IMMUNOL, V162, P3212; Flohe SB, 2003, J IMMUNOL, V170, P2340, DOI 10.4049/jimmunol.170.5.2340; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gao BC, 2004, BIOCHEM BIOPH RES CO, V317, P1149, DOI 10.1016/j.bbrc.2004.03.160; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Heyrovska N, 1998, BIOL CHEM, V379, P301, DOI 10.1515/bchm.1998.379.3.301; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Matzinger P, 2002, ANN NY ACAD SCI, V961, P341, DOI 10.1111/j.1749-6632.2002.tb03118.x; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; More SH, 2001, INT IMMUNOL, V13, P1121, DOI 10.1093/intimm/13.9.1121; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Singh-Jasuja H, 2001, BIOL CHEM, V382, P629, DOI 10.1515/BC.2001.074; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang MH, 2004, BRIT J CANCER, V90, P926, DOI 10.1038/sj.bjc.6601583; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanin-Zhorov A, 2003, FASEB J, V17, P1567, DOI 10.1096/fj.02-1139fje	33	65	69	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47906	47911		10.1074/jbc.M408440200	http://dx.doi.org/10.1074/jbc.M408440200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15371451	hybrid			2022-12-27	WOS:000224957000061
J	Woo, JR; Kim, SJ; Jeong, WJ; Cho, YH; Lee, SC; Chung, YJ; Rhee, SG; Ryu, SE				Woo, JR; Kim, SJ; Jeong, WJ; Cho, YH; Lee, SC; Chung, YJ; Rhee, SG; Ryu, SE			Structural basis of cellular redox regulation by human TRP14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN-RELATED PROTEIN; DNA-BINDING ACTIVITY; CRYSTAL-STRUCTURES; IDENTIFICATION; ASSOCIATION; REDUCTION; OXIDATION; INSIGHTS; PEPTIDE; TARGET	Thioredoxin-related protein 14 (TRP14) is involved in regulating tumor necrosis factor-alpha-induced signaling pathways in a different manner from human thioredoxin 1 (Trx1). Here, we report the crystal structure of human TRP14 determined at 1.8-Angstrom resolutions. The structure reveals a typical thioredoxin fold with characteristic structural features that account for the substrate specificity of the protein. The surface of TRP14 in the vicinity of the active site includes an extended loop and an additional alpha-helix, and the distribution of charged residues in the surface is different from Trx1. The distinctive dipeptide between the redox-active cysteines contributes to stabilizing the thiolate anion of the active site cysteine 43, increasing reactivity of the cysteine toward substrates. These structural differences in the active site suggest that TRP14 has evolved to regulate cellular redox signaling by recognizing a distinctive group of substrates that would complement the group of proteins regulated by Trx1.	Korea Res Inst Biosci & Biotechnol, Ctr Cellular Switch Prot Struct, Taejon 305806, South Korea; Korea Res Inst Biosci & Biotechnol, Systemic Proteom Res Ctr, Taejon 305806, South Korea; Chungbuk Natl Univ, Dept Biochem, Chonju 360763, South Korea; NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ewha Womans University	Ryu, SE (corresponding author), Korea Res Inst Biosci & Biotechnol, Ctr Cellular Switch Prot Struct, 52 Euh Eun Dong, Taejon 305806, South Korea.	ryuse@kribb.re.kr						Akamatsu Y, 1997, J BIOL CHEM, V272, P14497, DOI 10.1074/jbc.272.23.14497; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; HALLIWELL B, 1999, FREE RADICAL BIO MED, P430; Hirota K, 2002, ANN NY ACAD SCI, V957, P189, DOI 10.1111/j.1749-6632.2002.tb02916.x; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Jeong W, 2004, J BIOL CHEM, V279, P3151, DOI 10.1074/jbc.M307959200; Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SJ, 2003, J BIOL CHEM, V278, P10790, DOI 10.1074/jbc.M209553200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laughner BJ, 1998, PLANT PHYSIOL, V118, P987, DOI 10.1104/pp.118.3.987; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Matsuo Y, 2002, DRUG NEWS PERSPECT, V15, P575, DOI 10.1358/dnp.2002.15.9.840062; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Weeks CM, 1999, ACTA CRYSTALLOGR D, V55, P492, DOI 10.1107/S0907444998012633; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2	35	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48120	48125		10.1074/jbc.M407079200	http://dx.doi.org/10.1074/jbc.M407079200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355959	hybrid			2022-12-27	WOS:000224957000085
J	Lou, ZK; Chen, BPC; Asaithamby, A; Minter-Dykhouse, K; Chen, DJ; Chen, JJ				Lou, ZK; Chen, BPC; Asaithamby, A; Minter-Dykhouse, K; Chen, DJ; Chen, JJ			MDC1 regulates DNA-PK autophosphorylation in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; ATM ACTIVATION; PHOSPHORYLATION; REPAIR; REQUIREMENT; MEDIATOR; COMPLEX; 53BP1; CHK2	DNA damage initiates signaling events through kinase cascades that result in cell cycle checkpoint control and DNA repair. However, it is not yet clear how the signaling pathways relay to DNA damage repair. Using the repeat region of checkpoint protein MDC1 (mediator of DNA damage checkpoint protein 1), we identified DNA-PKcs/Ku as MDC1-associated proteins. Here, we show that MDC1 directly interacts with the Ku/DNA-PKcs complex. Down-regulation of MDC1 resulted in defective phospho-DNA-PKcs foci formation and DNA-PKcs autophosphorylation, suggesting that MDC1 regulates autophosphorylation of DNA-PKcs following DNA damage. Furthermore, DNA-PK-dependent DNA damage repair is defective in cells depleted of MDC1. Taken together, these results suggest that the MDC1 repeat region is involved in protein-protein interaction with DNA-PKcs/Ku, and MDC1 regulates DNA damage repair by influencing DNA-PK autophosphorylation. Therefore, MDC1 acts not only as a mediator of DNA damage checkpoint but also as a mediator of DNA damage repair.	Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Chen, JJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Oncol, 200 1st St SW, Rochester, MN 55905 USA.	Chen.Junjie@mayo.edu	Minter Dykhouse, Katherine/L-4573-2013	Minter Dykhouse, Katherine/0000-0003-4363-5826	NATIONAL CANCER INSTITUTE [R37CA050519, R01CA050519, R01CA092312, R01CA089239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018949] Funding Source: NIH RePORTER; NCI NIH HHS [CA92312, CA50519, R01 CA89239] Funding Source: Medline; NIA NIH HHS [AG18949] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Jackson SP, 1997, INT J BIOCHEM CELL B, V29, P935, DOI 10.1016/S1357-2725(97)00006-X; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mochan TA, 2003, CANCER RES, V63, P8586; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; SMITHRAVIN J, 1989, INT J RADIAT BIOL, V56, P951, DOI 10.1080/09553008914552411; Soubeyrand S, 2003, CANCER RES, V63, P1198; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200	22	64	70	6	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46359	46362		10.1074/jbc.C400375200	http://dx.doi.org/10.1074/jbc.C400375200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15377652	hybrid			2022-12-27	WOS:000224832400003
J	Yang, XL; Karsenty, G				Yang, XL; Karsenty, G			ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; TRANSCRIPTION FACTOR; TARGETED DISRUPTION; CLEIDOCRANIAL DYSPLASIA; OSTEOGENESIS IMPERFECTA; SELECTIVE INHIBITORS; DEGRADATION; ELEMENT; DIFFERENTIATION; OSF2/CBFA1	Based on the analysis of a loss-of-function model, we recently showed that ATF4 regulates osteoblast terminal differentiation and function and is implicated in the pathophysiology of Coffin-Lowry syndrome. That study, however, did not address whether forced expression of Atf4 in non-osteoblastic cells would lead to osteoblast-specific gene expression, one of the most important features of a cell differentiation factor. To address this question we searched for cell lines that would not express Atf4. Contrasting with the restricted pattern of its protein accumulation, Atf4 mRNA was found in all cell lines and mouse tissues tested. Treatment of non-osteoblastic cells with MG115, a proteasome inhibitor, induced ATF4 accumulation and resulted in activation of an Osteocalcin promoter luciferase construct as well as expression of endogenous Osteocalcin, a molecular marker of differentiated osteoblasts and a target gene of ATF4. Eliminating the expression of beta-TrCP1, an ubiquitin-protein isopeptide ligase interacting with ATF4 by RNA interference, led to ATF4 accumulation and to endogenous Osteocalcin expression in fibroblasts. These results indicate that the absence of ATF4 in most cell types is determined, at least in part, by an ubiquitination-dependent process. To our knowledge ATF4 is the first cell-specific transcription factor in which cell-specific distribution is achieved post-translationally. This study also establishes that ATF4, like other osteoblast differentiation factors, such as Runx2 and Osterix, has the ability to induce osteoblast-specific gene expression in non-osteoblastic cells.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Bone Dis Program Texas, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	karsenty@bcm.tmc.edu			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011290] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 11290] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BYERS PH, 1984, AM J MED GENET, V17, P429, DOI 10.1002/ajmg.1320170206; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fischer C, 2004, BIOL REPROD, V70, P371, DOI 10.1095/biolreprod.103.021600; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KLEEREKOPER M, 1998, METABOLIC BONE DIS, P387; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MIELNICKI LM, 1991, NUCLEIC ACIDS RES, V19, P6332, DOI 10.1093/nar/19.22.6332; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PROCKOP DJ, 1984, AM J HUM GENET, V36, P499; Raisz L.G., 2002, PRINCIPLES BONE BIOL, P59; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rowe NM, 1998, PLAST RECONSTR SURG, V102, P2022, DOI 10.1097/00006534-199811000-00033; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; TSUJIMOTO A, 1991, J VIROL, V65, P1420, DOI 10.1128/JVI.65.3.1420-1426.1991; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	28	140	148	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					47109	47114		10.1074/jbc.M410010200	http://dx.doi.org/10.1074/jbc.M410010200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15377660	hybrid			2022-12-27	WOS:000224832400097
J	Kitazume, S; Nakagawa, K; Oka, R; Tachida, Y; Ogawa, K; Luo, Y; Citron, M; Shitara, H; Taya, C; Yonekawa, H; Paulson, JC; Miyoshi, E; Taniguchi, N; Hashimoto, Y				Kitazume, S; Nakagawa, K; Oka, R; Tachida, Y; Ogawa, K; Luo, Y; Citron, M; Shitara, H; Taya, C; Yonekawa, H; Paulson, JC; Miyoshi, E; Taniguchi, N; Hashimoto, Y			In vivo cleavage of alpha 2,6-sialyltransferase by Alzheimer beta-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GALACTOSIDE ALPHA-2,6 SIALYLTRANSFERASE; HEREDITARY HEPATITIS; DIFFERENTIAL EXPRESSION; SERUM SIALYLTRANSFERASE; ASPARTYL PROTEASE; CLEAVING ENZYME; GOLGI-APPARATUS; SIGNAL ANCHOR; LEC RATS	beta-Site amyloid precursor protein-cleaving enzyme 1 (BACE1) is a membrane-bound aspartic protease that cleaves amyloid precursor protein to produce a neurotoxic peptide, Abeta, and is implicated in triggering the pathogenesis of Alzheimer disease. We previously reported that BACE1 cleaved rat beta-galactoside alpha2,6-sialyl-transferase (ST6Gal I) that was overexpressed in COS cells and that the NH2 terminus of ST6Gal I secreted from the cells (E41 form) was Glu(41). Here we report that BACE1 gene knock-out mice have one third as much plasma ST6Gal I as control mice, indicating that BACE1 is a major protease which is responsible for cleaving ST6Gal I in vivo. We also found that BACE1-transgenic mice have increased level of ST6Gal I in plasma. Secretion of ST6Gal I from the liver into the plasma is known to be up-regulated during the acute-phase response. To investigate the role of BACE1 in ST6Gal I secretion in vivo, we analyzed the levels of BACE1 mRNA in the liver, as well as the plasma levels of ST6Gal I, in a hepatopathological model, i.e. Long-Evans Cinnamon (LEC) rats. This rat is a mutant that spontaneously accumulates copper in the liver and incurs hepatic damage. LEC rats exhibited simultaneous increases in BACE1 mRNA in the liver and in the E41 form of the ST6Gal I protein, the BACE1 product, in plasma as early as 6 weeks of age, again suggesting that BACE1 cleaves ST6Gal I in vivo and controls the secretion of the E41 form.	RIKEN, Glyco Chain Funct Lab, Supra Biomol Syst Grp, Frontier Res Syst, Wako, Saitama 3510198, Japan; CREST, Sci & Technol Agcy, Kawaguchi, Saitama 5600082, Japan; Amgen Inc, Dept Biol Sci, Thousand Oaks, CA 91320 USA; Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Tokyo 1138613, Japan; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 565871, Japan	RIKEN; Japan Science & Technology Agency (JST); Amgen; Tokyo Metropolitan Institute of Medical Science; Scripps Research Institute; Osaka University	Hashimoto, Y (corresponding author), RIKEN, Glyco Chain Funct Lab, Supra Biomol Syst Grp, Frontier Res Syst, 2-1 Hirosaw, Wako, Saitama 3510198, Japan.	yasua@postman.riken.go.jp	Taniguchi, Naoyuki/I-4182-2014; Paulson, James/AAG-3565-2019; Taniguchi, Naoyuki/A-7086-2016	Taniguchi, Naoyuki/0000-0001-5889-5968; 				Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; BERNACKI RJ, 1977, SCIENCE, V195, P577, DOI 10.1126/science.835014; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cao Y, 2002, LAB INVEST, V82, P1515, DOI 10.1097/01.LAB.0000038503.34655.98; COLLEY KJ, 1989, J BIOL CHEM, V264, P17619; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; DE SB, 1999, NATURE, V398, P518; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P646, DOI 10.1016/S1044-7431(03)00227-6; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; IP C, 1977, CANCER RES, V37, P3442; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; KESSEL D, 1975, CANCER RES, V35, P670; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kitazume-Kawaguchi S, 1999, GLYCOBIOLOGY, V9, P1397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; MIYOSHI E, 1993, CANCER RES, V53, P3899; Mori M., 1991, LEC RAT NEW MODEL HE; Motonaga K, 2002, NEUROSCI LETT, V326, P64, DOI 10.1016/S0304-3940(02)00287-2; Opat AS, 2000, J BIOL CHEM, V275, P11836, DOI 10.1074/jbc.275.16.11836; PAULSON JC, 1977, J BIOL CHEM, V252, P2356; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; SUGIYAMA T, 1989, CARCINOGENESIS, V10, P2155, DOI 10.1093/carcin/10.11.2155; SUGIYAMA T, 1988, CARCINOGENESIS, V9, P1569, DOI 10.1093/carcin/9.9.1569; SUZUKI K, 1993, CARCINOGENESIS, V14, P1881, DOI 10.1093/carcin/14.9.1881; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; YOSHIDA MC, 1987, J HERED, V78, P361, DOI 10.1093/oxfordjournals.jhered.a110416	48	75	86	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2005	280	9					8589	8595		10.1074/jbc.M409417200	http://dx.doi.org/10.1074/jbc.M409417200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902ZR	15364953	hybrid			2022-12-27	WOS:000227395700135
J	Chen, JF; Takagi, J; Xie, C; Xiao, T; Luo, BH; Springer, TA				Chen, JF; Takagi, J; Xie, C; Xiao, T; Luo, BH; Springer, TA			The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha(4)beta(7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR SEGMENT; CRYSTAL-STRUCTURE; INTEGRIN; ACTIVATION; AFFINITY; COMPLEX; CONFORMATION; SUBUNIT; TRANSDUCTION; ASSOCIATION	We examined the effect of conformational change at the beta(7) I-like/hybrid domain interface on regulating the transition between rolling and firm adhesion by integrin alpha(4)beta(7). An N-glycosylation site was introduced into the I-like/hybrid domain interface to act as a wedge and to stabilize the open conformation of this interface and hence the open conformation of the alpha(4)beta(7) headpiece. Wild-type alpha(4)beta(7) mediates rolling adhesion in Ca2+ and Ca2+/Mg2+ but firm adhesion in Mg2+ and Mn2+. Stabilizing the open headpiece resulted in firm adhesion in all divalent cations. The interaction between metal binding sites in the I-like domain and the interface with the hybrid domain was examined in double mutants. Changes at these two sites can either counterbalance one another or be additive, emphasizing mutuality and the importance of multiple interfaces in integrin regulation. A double mutant with counterbalancing deactivating ligand-induced metal ion binding site ( LIMBS) and activating wedge mutations could still be activated by Mn2+, confirming the importance of the adjacent to metal ion-dependent adhesion site (ADMIDAS) in integrin activation by Mn2+. Overall, the results demonstrate the importance of headpiece allostery in the conversion of rolling to firm adhesion.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Osaka University	Springer, TA (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu	Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013	Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X; Xie, Can/0000-0002-7412-3236	NHLBI NIH HHS [HL 48675, P01 HL048675] Funding Source: Medline; NIAID NIH HHS [R01 AI072765] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072765] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEDNARCZYK JL, 1992, J BIOL CHEM, V267, P25274; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; HEMLER ME, 1990, IMMUNOL REV, V114, P45, DOI 10.1111/j.1600-065X.1990.tb00561.x; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Lu CF, 1998, J BIOL CHEM, V273, P15138, DOI 10.1074/jbc.273.24.15138; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MCINTYRE BW, 1989, J BIOL CHEM, V264, P13745; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; PARKER CM, 1993, J BIOL CHEM, V268, P7028; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; SANCHEZMADRID F, 1986, EUR J IMMUNOL, V16, P1343, DOI 10.1002/eji.1830161106; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Tidswell M, 1997, J IMMUNOL, V159, P1497; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101	36	36	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2004	279	53					55556	55561		10.1074/jbc.M407773200	http://dx.doi.org/10.1074/jbc.M407773200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	882TI	15448154	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000225960800072
J	Adkins, MW; Tyler, JK				Adkins, MW; Tyler, JK			The histone chaperone Asf1p mediates global chromatin disassembly in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; CELL-CYCLE; YEAST; NUCLEOSOME; TRANSCRIPTION; IDENTIFICATION; SENSITIVITY; PROTEIN; REPAIR	The packaging of the eukaryotic genome into chromatin is likely to be mediated by chromatin assembly factors, including histone chaperones. We investigated the function of the histone H3/H4 chaperones anti-silencing function 1 (Asf1p) and chromatin assembly factor 1 (CAF-1) in vivo. Analysis of chromatin structure by accessibility to micrococcal nuclease and DNase I digestion demonstrated that the chromatin from CAF-1 mutant yeast has increased accessibility to these enzymes. In agreement, the supercoiling of the endogenous 2mu plasmid is reduced in yeast lacking CAF-1. These results indicate that CAF-1 mutant yeast globally under-assemble their genome into chromatin, consistent with a role for CAF-1 in chromatin assembly in vivo. By contrast, asf1 mutants globally over-assemble their genome into chromatin, as suggested by decreased accessibility of their chromatin to micrococcal nuclease and DNase I digestion and increased supercoiling of the endogenous 2mu plasmid. Deletion of ASF1 causes a striking loss of acetylation on histone H3 lysine 9, but this is not responsible for the altered chromatin structure in asf1 mutants. These data indicate that Asf1p may have a global role in chromatin disassembly and an unexpected role in histone acetylation in vivo.	Univ Colorado, Hlth Sci Ctr Fitzsimons, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Tyler, JK (corresponding author), Univ Colorado, Hlth Sci Ctr Fitzsimons, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	Jessica.tyler@uchsc.edu		Tyler, Jessica/0000-0001-9765-1659	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064475] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064475, GM64475] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams A, 1997, METHODS YEAST GENETI; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Chimura T, 2002, P NATL ACAD SCI USA, V99, P9334, DOI 10.1073/pnas.142627899; Gregory PD, 1999, METHOD ENZYMOL, V304, P365; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUTTER LC, 1992, MOL CELL BIOL, V12, P5004, DOI 10.1128/MCB.12.11.5004; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Moshkin YM, 2002, GENE DEV, V16, P2621, DOI 10.1101/gad.231202; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; PRUSS GJ, 1985, J MOL BIOL, V185, P51, DOI 10.1016/0022-2836(85)90182-2; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Singer MS, 1998, GENETICS, V150, P613; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Sutton A, 2001, GENETICS, V158, P587; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; WANG JC, 1993, CURR OPIN GENET DEV, V3, P764, DOI 10.1016/S0959-437X(05)80096-6; WANG JC, 1982, CELL, V29, P724, DOI 10.1016/0092-8674(82)90433-0	26	84	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52069	52074		10.1074/jbc.M406113200	http://dx.doi.org/10.1074/jbc.M406113200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452122	hybrid			2022-12-27	WOS:000225493400044
J	Bonini, MG; Miyamoto, S; Di Mascio, P; Augusto, O				Bonini, MG; Miyamoto, S; Di Mascio, P; Augusto, O			Production of the carbonate radical anion during xanthine oxidase turnover in the presence of bicarbonate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC SUPEROXIDE-DISMUTASE; SINGLET MOLECULAR-OXYGEN; NITRIC-OXIDE; PEROXIDASE-ACTIVITY; CU,ZN-SUPEROXIDE DISMUTASE; HYDROXYL RADICALS; IN-VITRO; PEROXYNITRITE; OXIDATION; MECHANISM	Xanthine oxidase is generally recognized as a key enzyme in purine catabolism, but its structural complexity, low substrate specificity, and specialized tissue distribution suggest other functions that remain to be fully identified. The potential of xanthine oxidase to generate superoxide radical anion, hydrogen peroxide, and peroxynitrite has been extensively explored in pathophysiological contexts. Here we demonstrate that xanthine oxidase turnover at physiological pH produces a strong one-electron oxidant, the carbonate radical anion. The radical was shown to be produced from acetaldehyde oxidation by xanthine oxidase in the presence of catalase and bicarbonate on the basis of several lines of evidence such as oxidation of both dihydrorhodamine 123 and 5,5-dimethyl-1-pyrroline-N-oxide and chemiluminescence and isotope labeling/mass spectrometry studies. In the case of xanthine oxidase acting upon xanthine and hypoxanthine as substrates, carbonate radical anion production was also evidenced by the oxidation of 5,5-dimethyl-1-pyrroline-N-oxide and of dihydrorhodamine 123 in the presence of uricase. The results indicated that Fenton chemistry occurring in the bulk solution is not necessary for carbonate radical anion production. Under the conditions employed, the radical was likely to be produced at the enzyme active site by reduction of a peroxymonocarbonate intermediate whose formation and reduction is facilitated by the many xanthine oxidase redox centers. In addition to indicating that the carbonate radical anion may be an important mediator of the pathophysiological effects of xanthine oxidase, the results emphasize the potential of the bicarbonate-carbon dioxide pair as a source of biological oxidants.	Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05513970 Sao Paulo, Brazil	Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Caixa Postal 26077, BR-05513970 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Miyamoto, Sayuri/A-2144-2008; Di Mascio, Paolo/D-1264-2014; Augusto, Ohara/D-3839-2012	Miyamoto, Sayuri/0000-0002-5714-8984; Di Mascio, Paolo/0000-0003-4125-8350; Augusto, Ohara/0000-0002-7220-4286				ALVAREZ MN, 2004, FREE RADIC BIOL M S1, V36, P57; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; AVIS PG, 1956, J CHEM SOC, P1219, DOI 10.1039/jr9560001219; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; Bonini MG, 2001, J BIOL CHEM, V276, P9749, DOI 10.1074/jbc.M008456200; Bonini MG, 1999, J BIOL CHEM, V274, P10802, DOI 10.1074/jbc.274.16.10802; BOUNDS PL, 1991, FREE RADICAL BIO MED, V11, P447, DOI 10.1016/0891-5849(91)90060-G; BRITIGAN BE, 1990, J BIOL CHEM, V265, P17533; BUXTON GV, 1986, RADIAT PHYS CHEM, V27, P241; CADENAS E, 1984, METHOD ENZYMOL, V105, P221; CHEN SN, 1973, RADIAT RES, V56, P40, DOI 10.2307/3573789; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; ERIKSEN TE, 1985, RADIAT PHYS CHEM, V26, P197, DOI 10.1016/0146-5724(85)90185-2; FINKELSTEIN E, 1980, J AM CHEM SOC, V102, P4994, DOI 10.1021/ja00535a029; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; GILBERT DL, 1999, REACTIVE OXYGEN SPEC, P680; Giulivi Cecilia, 1999, P77; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Guo Q, 2003, J AM SOC MASS SPECTR, V14, P862, DOI 10.1016/S1044-0305(03)00336-2; HALLIWELL B, 1998, FREE RADICAL BIO MED, P36; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hodges GR, 2000, FREE RADICAL BIO MED, V29, P434, DOI 10.1016/S0891-5849(00)00298-7; HODGSON EK, 1976, ARCH BIOCHEM BIOPHYS, V172, P202, DOI 10.1016/0003-9861(76)90067-9; Koide T, 2000, ANAL SCI, V16, P1029, DOI 10.2116/analsci.16.1029; KUROSE I, 1994, ANN NY ACAD SCI, V723, P158, DOI 10.1111/j.1749-6632.1994.tb36724.x; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Liochev SI, 2002, J BIOL CHEM, V277, P34674, DOI 10.1074/jbc.M204726200; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Liochev SI, 1999, IUBMB LIFE, V48, P157, DOI 10.1080/152165499307161; LLOYD RV, 1990, J BIOL CHEM, V265, P16733; Massey V, 1997, BIOCHEM SOC T, V25, P750, DOI 10.1042/bst0250750; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Millar TM, 2002, REDOX REP, V7, P65, DOI 10.1179/135100002125000280; Miyamoto S, 2003, J AM CHEM SOC, V125, P6172, DOI 10.1021/ja029115o; MORPETH FF, 1983, BIOCHIM BIOPHYS ACTA, V744, P328, DOI 10.1016/0167-4838(83)90207-8; Nakao LS, 1999, CHEM RES TOXICOL, V12, P1010, DOI 10.1021/tx990055i; Nakao LS, 2000, FREE RADICAL BIO MED, V29, P721, DOI 10.1016/S0891-5849(00)00374-9; NETA P, 1980, J PHYS CHEM-US, V84, P532, DOI 10.1021/j100442a017; Oettl K, 1997, BIOCHEM BIOPH RES CO, V234, P774, DOI 10.1006/bbrc.1997.6712; Parks Dale A., 1999, P397; Radi R., 2000, BIOL CHEM PEROXYNITR, P57; REUVERS AP, 1973, INT J RADIAT BIOL, V24, P533, DOI 10.1080/09553007314551431; Richardson DE, 2000, J AM CHEM SOC, V122, P1729, DOI 10.1021/ja9927467; ROSS D, 1985, BIOCHIM BIOPHYS ACTA, V841, P278, DOI 10.1016/0304-4165(85)90069-8; Shafirovich V, 2001, J BIOL CHEM, V276, P24621, DOI 10.1074/jbc.M101131200; Stoyanovsky DA, 1996, ARCH BIOCHEM BIOPHYS, V330, P3, DOI 10.1006/abbi.1996.0219; TAN S, 1993, PEDIATR RES, V34, P303, DOI 10.1203/00006450-199309000-00013; Wadhawan JD, 2001, J PHYS CHEM B, V105, P10659, DOI 10.1021/jp012160i; Xia Y, 1997, P NATL ACAD SCI USA, V94, P11399, DOI 10.1073/pnas.94.21.11399; Yao HR, 2003, J AM CHEM SOC, V125, P6211, DOI 10.1021/ja0274756; Zhang H, 2000, J BIOL CHEM, V275, P14038, DOI 10.1074/jbc.275.19.14038; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200; Zhang HB, 2002, J BIOL CHEM, V277, P49767, DOI 10.1074/jbc.M204005200; Zhang Z, 1998, BIOCHEM BIOPH RES CO, V249, P767, DOI 10.1006/bbrc.1998.9226	60	65	67	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51836	51843		10.1074/jbc.M406929200	http://dx.doi.org/10.1074/jbc.M406929200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448145	hybrid			2022-12-27	WOS:000225493400016
J	Kenis, H; van Genderen, H; Bennaghmouch, A; Rinia, HA; Frederik, P; Narula, J; Hofstra, L; Reutelingsperger, CPM				Kenis, H; van Genderen, H; Bennaghmouch, A; Rinia, HA; Frederik, P; Narula, J; Hofstra, L; Reutelingsperger, CPM			Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ASYMMETRY; ANTICOAGULANT PROTEIN; IN-VIVO; APOPTOSIS; DEATH; CLEARANCE; BINDING; INHIBITION; BILAYERS; RECEPTOR	Expression of phosphatidylserine (PtdSer) at the cell surface is part of the membrane dynamics of apoptosis. Expressed phosphatidylserine functions as an "eat me" flag toward phagocytes. Here, we report that the expressed phosphatidylserine forms part of a hitherto undescribed pinocytic pathway. Annexin A5, a phosphatidylserine-binding protein, binds to and polymerizes through protein-protein interactions on membrane patches expressing phosphatidylserine. The two-dimensional protein network of annexin A5 at the surface prevents apoptotic body formation without interfering with the progression of apoptosis as demonstrated by activation of caspase-3, PtdSer exposure, and DNA fragmentation. The annexin A5 protein network bends the membrane patch nanomechanically into the cell and elicits budding, endocytic vesicle formation, and cytoskeleton-dependent trafficking of the endocytic vesicle. Annexin A1, which binds to PtdSer without forming a two-dimensional protein network, does not induce the formation of endocytic vesicles. This novel pinocytic pathway differs from macropinocytosis, which is preceded by membrane ruffling and actin polymerization. We clearly showed that actin polymerization is not involved in budding and endocytic vesicle formation but is required for intracellular trafficking. The phosphatidylserine-annexin A5-mediated pinocytic pathway is not restricted to cells in apoptosis. We demonstrated that living tumor cells can take up substances through this novel portal of cell entry. This opens new avenues for targeted drug delivery and cell entry.	Univ Limburg, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; Univ Limburg, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6200 MD Maastricht, Netherlands; Univ Limburg, Cardiovasc Res Inst Maastricht, Dept Electron Microscopy, NL-6200 MD Maastricht, Netherlands; Leiden Inst Phys, NL-2333 CA Leiden, Netherlands; Univ Calif Irvine, Dept Med Cardiol, Irvine, CA 92612 USA	Hasselt University; Maastricht University; Hasselt University; Maastricht University; Hasselt University; Maastricht University; Leiden University; University of California System; University of California Irvine	Reutelingsperger, CPM (corresponding author), Univ Limburg, Cardiovasc Res Inst Maastricht, Dept Biochem, POB 616, NL-6200 MD Maastricht, Netherlands.	c.reutelingsperger@bioch.unimaas.nl						ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Blankenberg FG, 1999, J NUCL MED, V40, P184; Boersma HH, 2004, ANAL BIOCHEM, V327, P126, DOI 10.1016/j.ab.2004.01.004; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dumont EA, 2001, NAT MED, V7, P1352, DOI 10.1038/nm1201-1352; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; FREDERICK PM, 2005, IN PRESS METHODS ENZ; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gidon-Jeangirard C, 1999, J IMMUNOL, V162, P5712; GOVORUKHINA N, 2002, ANNEXINS BIOL IMPORT, P40; Hammill AK, 1999, EXP CELL RES, V251, P16, DOI 10.1006/excr.1999.4581; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Hofstra L, 2000, LANCET, V356, P209, DOI 10.1016/S0140-6736(00)02482-X; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q; Kuijpers TW, 2004, BLOOD, V103, P3915, DOI 10.1182/blood-2003-11-3940; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mira JP, 1997, J BIOL CHEM, V272, P10474; MOSSER G, 1991, J MOL BIOL, V217, P241, DOI 10.1016/0022-2836(91)90538-H; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Narula J, 2001, NAT MED, V7, P1347, DOI 10.1038/nm1201-1347; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; Ran S, 2002, INT J RADIAT ONCOL, V54, P1479, DOI 10.1016/S0360-3016(02)03928-7; Reviakine I, 1998, J STRUCT BIOL, V121, P356, DOI 10.1006/jsbi.1998.4003; Rinia HA, 2001, FEBS LETT, V501, P92, DOI 10.1016/S0014-5793(01)02636-9; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; TAIT JF, 1989, J BIOL CHEM, V264, P7944; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; vandenEijnde SM, 1997, CYTOMETRY, V29, P313, DOI 10.1002/(SICI)1097-0320(19971201)29:4<313::AID-CYTO8>3.0.CO;2-A; VandenEijnde SM, 1997, CELL DEATH DIFFER, V4, P311, DOI 10.1038/sj.cdd.4400241; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M	36	125	134	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52623	52629		10.1074/jbc.M409009200	http://dx.doi.org/10.1074/jbc.M409009200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15381697	hybrid			2022-12-27	WOS:000225493400109
J	Yu, DH; Khan, E; Khaleque, MA; Lee, J; Laco, G; Kohlhagen, G; Kharbanda, S; Cheng, YC; Pommier, Y; Bharti, A				Yu, DH; Khan, E; Khaleque, MA; Lee, J; Laco, G; Kohlhagen, G; Kharbanda, S; Cheng, YC; Pommier, Y; Bharti, A			Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE TYROSINE; N-TERMINAL DOMAIN; CATALYTIC-ACTIVITY; APOPTOTIC RESPONSE; CLEAVAGE COMPLEXES; STRESS-RESPONSE; CYTO-TOXICITY; STRAND BREAKS; SH3 DOMAINS; WILD-TYPE	DNA topoisomerase I ( topo I) is involved in the regulation of DNA supercoiling, gene transcription, recombination, and DNA repair. The anticancer agent camptothecin specifically targets topo I. The mechanisms responsible for the regulation of topo I in cells, however, are not known. This study demonstrates that c-Abl-dependent phosphorylation up-regulates topo I activity. The c-Abl SH3 domain bound directly to the N-terminal region of topo I. The results demonstrate that c-Abl phosphorylated topo I at Tyr(268) in core subdomain II. c-Abl-mediated phosphorylation of topo I Tyr(268) in vitro and in cells conferred activation of the topo I isomerase function. Moreover, activation of c-Abl by treatment of cells with ionizing radiation was associated with c-Abl-dependent phosphorylation of topo I and induction of topo I activity. The functional significance of the c-Abl/topo I interaction is supported by the findings that (i) mutant topo I(Y268F) exhibited loss of c-Abl-induced topo I activity, and (ii) c-Abl(-/-) cells were deficient in the accumulation of protein-linked DNA breaks. In addition, loss of topo I phosphorylation in c-Abl-deficient cells conferred resistance to camptothecin-induced apoptosis. These findings collectively support a model in which c-Abl-mediated phosphorylation of topo I is functionally important to topo I activity and sensitivity to topo I poisons.	Boston Univ, Sch Med, Dept Med, Ctr Mol Stress Response, Boston, MA 02118 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Mol Biol Core Facil, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA	Boston University; Yale University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Bharti, A (corresponding author), Boston Univ, Sch Med, Dept Med, Ctr Mol Stress Response, 650 Albany St,EBRC-311, Boston, MA 02118 USA.	Bharti@bu.edu		Khaleque, Md Abdul/0000-0002-6873-9165; Bharti, Ajit/0000-0001-7972-6688	NATIONAL CANCER INSTITUTE [ZIABC006161, Z01BC006150, ZIABC006150, Z01BC006161] Funding Source: NIH RePORTER; NCI NIH HHS [CA55241] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agami R, 1999, NATURE, V399, P809; Albor A, 1998, CANCER RES, V58, P2091; ALSNER J, 1992, J BIOL CHEM, V267, P12408; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; Champoux JJ, 2000, METH MOL B, V95, P81; CHANG JY, 1992, BIOCHEM PHARMACOL, V43, P2443, DOI 10.1016/0006-2952(92)90325-D; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; COVEY JM, 1989, CANCER RES, V49, P5016; DARPA P, 1988, P NATL ACAD SCI USA, V85, P2543, DOI 10.1073/pnas.85.8.2543; David-Cordonnier MH, 1999, NUCLEIC ACIDS RES, V27, P2265, DOI 10.1093/nar/27.11.2265; David-Cordonnier MH, 1998, BIOCHEMISTRY-US, V37, P6065, DOI 10.1021/bi973030w; DEFFIE AM, 1989, CANCER RES, V49, P58; Edwards TK, 2000, J BIOL CHEM, V275, P36181, DOI 10.1074/jbc.M006628200; ENG WK, 1988, MOL PHARMACOL, V34, P755; ENG WK, 1989, J BIOL CHEM, V264, P13373; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GANGLOFF S, 1994, EXPERIENTIA, V50, P261, DOI 10.1007/BF01924009; Gobert C, 1999, P NATL ACAD SCI USA, V96, P10355, DOI 10.1073/pnas.96.18.10355; Gobert C, 1996, BIOCHEMISTRY-US, V35, P5778, DOI 10.1021/bi952327w; GOGA A, 1995, ONCOGENE, V11, P791; Gong JG, 1999, NATURE, V399, P806; GUPTA M, 1995, BBA-GENE STRUCT EXPR, V1262, P1, DOI 10.1016/0167-4781(95)00029-G; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JAXEL C, 1991, J BIOL CHEM, V266, P20418; Jin SF, 1997, J BIOL CHEM, V272, P24763, DOI 10.1074/jbc.272.40.24763; KANZAWA F, 1990, CANCER RES, V50, P5919; Kharbanda S, 1996, P NATL ACAD SCI USA, V93, P6898, DOI 10.1073/pnas.93.14.6898; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 1995, J BIOL CHEM, V270, P30278, DOI 10.1074/jbc.270.51.30278; Kharbanda S, 2000, CURR BIOL, V10, P568, DOI 10.1016/S0960-9822(00)00483-8; KRETZSCHMAR M, 1993, P NATL ACAD SCI USA, V90, P11508, DOI 10.1073/pnas.90.24.11508; Kumar S, 2001, J BIOL CHEM, V276, P17281, DOI 10.1074/jbc.M101414200; Labourier E, 1998, NUCLEIC ACIDS RES, V26, P2955, DOI 10.1093/nar/26.12.2955; Lanza A, 1996, J BIOL CHEM, V271, P6978, DOI 10.1074/jbc.271.12.6978; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P3487, DOI 10.1073/pnas.78.6.3487; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; LYNN RM, 1989, P NATL ACAD SCI USA, V86, P3559, DOI 10.1073/pnas.86.10.3559; MADDEN KR, 1992, CANCER RES, V52, P525; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; Nie Y, 2000, MOL CELL BIOL, V20, P741, DOI 10.1128/MCB.20.3.741-748.2000; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; POMMIER Y, 1995, P NATL ACAD SCI USA, V92, P8861, DOI 10.1073/pnas.92.19.8861; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pourquier P, 2000, P NATL ACAD SCI USA, V97, P1885, DOI 10.1073/pnas.97.4.1885; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rossi F, 1998, NUCLEIC ACIDS RES, V26, P2963, DOI 10.1093/nar/26.12.2963; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; RUBIN E, 1994, J BIOL CHEM, V269, P2433; Schneider E, 1990, Adv Pharmacol, V21, P149, DOI 10.1016/S1054-3589(08)60342-7; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shykind BM, 1997, GENE DEV, V11, P397, DOI 10.1101/gad.11.3.397; Simmons DT, 1998, J BIOL CHEM, V273, P20390, DOI 10.1074/jbc.273.32.20390; Sionov RV, 1999, J BIOL CHEM, V274, P8371, DOI 10.1074/jbc.274.13.8371; SOLARY E, 1993, BLOOD, V81, P1359; STEVNSNER T, 1993, CARCINOGENESIS, V14, P1841, DOI 10.1093/carcin/14.9.1841; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Stewart L, 1996, J BIOL CHEM, V271, P7593, DOI 10.1074/jbc.271.13.7593; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Subramanian D, 1998, CANCER RES, V58, P976; SUGIMOTO Y, 1990, CANCER RES, V50, P6925; SVEJSTRUP JQ, 1991, J MOL BIOL, V222, P669, DOI 10.1016/0022-2836(91)90503-X; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Urasaki Y, 2001, CANCER RES, V61, P1964; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WEISBROD ST, 1982, NUCLEIC ACIDS RES, V10, P2017, DOI 10.1093/nar/10.6.2017; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; YEH YC, 1994, J BIOL CHEM, V269, P15498; Yuan ZM, 1996, J BIOL CHEM, V271, P26457, DOI 10.1074/jbc.271.43.26457; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; ZAKIAN VA, 1995, CELL, V82, P685, DOI 10.1016/0092-8674(95)90463-8; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23	91	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51851	51861		10.1074/jbc.M404396200	http://dx.doi.org/10.1074/jbc.M404396200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448168	hybrid			2022-12-27	WOS:000225493400018
J	Akgoz, M; Kalyanaraman, V; Gautam, N				Akgoz, M; Kalyanaraman, V; Gautam, N			Receptor-mediated reversible translocation of the G protein beta gamma complex from the plasma membrane to the Golgi complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; PHOSPHOLIPASE-C; SUBUNIT; CELLS; RAS	Heterotrimeric G proteins have been thought to function on the plasma membrane after activation by transmembrane receptors. Here we show that, after activation by receptors, the G protein betagamma complex selectively translocates to the Golgi. Receptor inactivation results in Gbetagamma translocating back to the plasma membrane. Both translocation processes occur rapidly within seconds. The efficiency of translocation is influenced by the type of gamma subunit present in the G protein. Distinctly different receptor types are capable of inducing the translocation. Receptor-mediated translocation of Gbetagamma can spatially segregate G protein signaling activity.	Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Gautam, N (corresponding author), Washington Univ, Sch Med, Dept Genet, Box 8054, St Louis, MO 63110 USA.	gautam@morpheus.wustl.edu	Akgoz, Muslum/A-6234-2015; Akgoz, Muslum/AAG-4598-2019	Akgoz, Muslum/0000-0001-5065-8087; Akgoz, Muslum/0000-0001-5065-8087	NIGMS NIH HHS [GM69027, R01 GM046963, GM46963, R01 GM069027] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069027] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Azpiazu I, 2001, J BIOL CHEM, V276, P41742, DOI 10.1074/jbc.M104034200; Azpiazu I, 1999, J BIOL CHEM, V274, P35305, DOI 10.1074/jbc.274.50.35305; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Carroll RC, 1998, EMBO J, V17, P3036, DOI 10.1093/emboj/17.11.3036; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; KISSELEV O, 1995, P NATL ACAD SCI USA, V92, P9102, DOI 10.1073/pnas.92.20.9102; Liang W, 2000, J ANIM SCI, V78, P2329; Morishita R, 1998, FEBS LETT, V428, P85, DOI 10.1016/S0014-5793(98)00498-0; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	22	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51541	51544		10.1074/jbc.M410639200	http://dx.doi.org/10.1074/jbc.M410639200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448129	hybrid			2022-12-27	WOS:000225355800108
J	Wilkinson, JC; Richter, BWM; Wilkinson, AS; Burstein, E; Rumble, JM; Balliu, B; Duckett, CS				Wilkinson, JC; Richter, BWM; Wilkinson, AS; Burstein, E; Rumble, JM; Balliu, B; Duckett, CS			VIAF, a conserved inhibitor of apoptosis (IAP)-interacting factor that modulates caspase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN-PROTEIN LIGASE; X-LINKED INHIBITOR; CELL-DEATH; STRUCTURAL BASIS; BACULOVIRUS INHIBITOR; MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; BINDING-PROTEINS; MAMMALIAN-CELLS	Inhibitor of apoptosis (IAP) proteins are involved in the suppression of apoptosis, signal transduction, cell cycle control and gene regulation. Here we describe the cloning and characterization of viral IAP-associated factor (VIAF), a highly conserved, ubiquitously expressed phosphoprotein with limited homology to members of the phosducin family that associates with baculovirus Op-IAP. VIAF bound Op-IAP both in vitro and in intact cells, with each protein displaying a predominantly cytoplasmic localization. VIAF lacks a consensus IAP binding motif, and overexpression of VIAF failed to prevent Op-IAP from protecting human cells from a variety of apoptotic stimuli, suggesting that VIAF does not function as an IAP antagonist. VIAF was unable to directly inhibit caspase activation in vitro and a reduction of VIAF protein levels by RNA interference led to a decrease in Bax-mediated caspase activation, suggesting that VIAF functions to co-regulate the apoptotic cascade. Finally, VIAF is a substrate for ubiquitination mediated by Op-IAP. Thus, VIAF is a novel IAP-interacting factor that functions in caspase activation during apoptosis.	Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; NCI, Metab Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Duckett, CS (corresponding author), Med Sci 1,Room 5315,1301 Catherine St, Ann Arbor, MI 48109 USA.	colind@umich.edu	Burstein, Ezra/B-7247-2016	Burstein, Ezra/0000-0003-4341-6367; Duckett, Colin/0000-0001-9413-2263; Rumble, Julie/0000-0001-7220-7631	NCI NIH HHS [T32 CA09676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Beltrami E, 2004, J BIOL CHEM, V279, P2077, DOI 10.1074/jbc.M309479200; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Clem RJ, 1996, CELL DEATH DIFFER, V3, P9; Craft CM, 1998, BIOCHEMISTRY-US, V37, P15758, DOI 10.1021/bi980921a; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; Hawkins CJ, 1998, CELL DEATH DIFFER, V5, P569, DOI 10.1038/sj.cdd.4400389; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hegde R, 2003, J BIOL CHEM, V278, P38699, DOI 10.1074/jbc.M303179200; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang QH, 2000, P NATL ACAD SCI USA, V97, P1427, DOI 10.1073/pnas.97.4.1427; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Jacob J, 2004, J BIOMOL NMR, V28, P197, DOI 10.1023/B:JNMR.0000013820.43366.99; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson BW, 2000, J BIOL CHEM, V275, P31546, DOI 10.1074/jbc.M001363200; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; LaCount DJ, 2000, J BIOL CHEM, V275, P15657, DOI 10.1074/jbc.M000791200; LEE RH, 1988, EXP EYE RES, V46, P829, DOI 10.1016/S0014-4835(88)80035-6; Levkau B, 2001, CIRC RES, V88, P282, DOI 10.1161/01.RES.88.3.282; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lohse MJ, 1996, BIOCHEM SOC T, V24, P975, DOI 10.1042/bst0240975; Lopez P, 2003, J BIOL CHEM, V278, P1751, DOI 10.1074/jbc.M207434200; Manji GA, 1997, J VIROL, V71, P4509, DOI 10.1128/JVI.71.6.4509-4516.1997; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3; Reffey SB, 2001, J BIOL CHEM, V276, P26542, DOI 10.1074/jbc.M100331200; Richter BWM, 2001, MOL CELL BIOL, V21, P4292, DOI 10.1128/MCB.21.13.4292-4301.2001; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002; Sanna MG, 2002, J BIOL CHEM, V277, P30454, DOI 10.1074/jbc.M203312200; Sanna MG, 1998, P NATL ACAD SCI USA, V95, P6015, DOI 10.1073/pnas.95.11.6015; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Silke J, 2001, J CELL SCI, V114, P1821; Silke J, 2000, CELL DEATH DIFFER, V7, P1275, DOI 10.1038/sj.cdd.4400790; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Vaux DL, 2003, BIOCHEM BIOPH RES CO, V304, P499, DOI 10.1016/S0006-291X(03)00622-3; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Wilkinson JC, 2004, J BIOL CHEM, V279, P51082, DOI 10.1074/jbc.M408655200; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; Wright CW, 2002, J BIOL CHEM, V277, P2454, DOI 10.1074/jbc.M110500200; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852	77	22	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51091	51099		10.1074/jbc.M409623200	http://dx.doi.org/10.1074/jbc.M409623200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371430	hybrid			2022-12-27	WOS:000225355800055
J	Argraves, KM; Wilkerson, BA; Argraves, WS; Fleming, PA; Obeid, LM; Drake, CJ				Argraves, KM; Wilkerson, BA; Argraves, WS; Fleming, PA; Obeid, LM; Drake, CJ			Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE RECEPTOR; VEIN ENDOTHELIAL-CELLS; EMBRYONIC BLOOD-VESSELS; LYSOPHOSPHATIDIC ACID; MURINE ALLANTOIS; EDG-1; LIGAND; MOTILITY; ANGIOGENESIS	Here we have investigated the role of sphingosine-1-phosphate (S1P) signaling in the process of vasculogenesis in the mouse embryo. At stages preceding the formation of blood vessels (7.5 - 8 dpc) in the embryo proper, yolk sac, and allantois, the S1P receptor S1P(2) is expressed in conjunction with S1P(1) and/or S1P(3). Additionally, sphingosine kinase-2 (SK2), an enzyme that catalyzes the formation of S1P, is expressed in these tissues throughout periods of vasculogenesis. Using the cultured mouse allantois explant model of blood vessel formation, we found that vasculogenesis was dependent on S1P signaling. We showed that S1P could replace the ability of serum to promote vasculogenesis in cultured allantois explants. Instead of small poorly reticulated clusters of rounded endothelial cells that formed under serum-free conditions, S1P promoted the formation of elongated endothelial cells that arranged into expansive branched networks of capillary-like vessels. These effects could not be reproduced by vascular endothelial growth factor or basic fibroblast growth factor administration. The ability of S1P to promote blood vessel formation was not due to effects on cell survival or on changes in numbers of endothelial cells (Flk1(+)/PECAM(+)), angioblasts (Flk1(+)/PECAM(+)), or undifferentiated mesodermal cells (Flk1(+)/PECAM(-)). The S1P effect on blood vessel formation was attributed to it promoting migratory activities of angioblasts and early endothelial cells required for the expansion of vascular networks. Together, our findings suggest that migratory events critical to the de novo formation of blood vessels are under the influence of S1P, possibly synthesized via the action of SK2, with signaling mediated by S1P receptors that include S1P(1), S1P(2), and S1P(3).	Med Univ S Carolina, Dept Anat & Cell Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; Ralph H Johnson Vet Affairs Med Ctr, Dept Vet Affairs, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Argraves, KM (corresponding author), Med Univ S Carolina, Dept Anat & Cell Biol, Charleston, SC 29425 USA.	argravek@musc.edu		Wilkerson, Brent/0000-0002-3532-3075; obeid, lina/0000-0002-0734-0847	NCI NIH HHS [CA097132] Funding Source: Medline; NCRR NIH HHS [RR17677] Funding Source: Medline; NHLBI NIH HHS [HL52813, HL57375, HL61873] Funding Source: Medline; NIDCR NIH HHS [DE014347] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061873, P01HL052813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014347] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Argraves WS, 2002, DEV DYNAM, V225, P298, DOI 10.1002/dvdy.10162; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Downs KM, 1998, DEVELOPMENT, V125, P4507; Downs KM, 2001, DEV BIOL, V233, P347, DOI 10.1006/dbio.2001.0227; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Endo A, 2002, J BIOL CHEM, V277, P23747, DOI 10.1074/jbc.M111794200; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Graler MH, 2003, J CELL BIOCHEM, V89, P507, DOI 10.1002/jcb.10537; HLA T, 1990, J BIOL CHEM, V265, P9308; Igarashi Y, 1998, AM J HEMATOL, V57, P261; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; LaRue AC, 2003, DEV DYNAM, V228, P21, DOI 10.1002/dvdy.10339; Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612, DOI 10.1152/ajpcell.2000.278.3.C612; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Malek RL, 2001, J BIOL CHEM, V276, P5692, DOI 10.1074/jbc.M003964200; Niedernberg A, 2003, CELL SIGNAL, V15, P435, DOI 10.1016/S0898-6568(02)00119-5; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Rosen H, 2003, CURR OPIN CHEM BIOL, V7, P461, DOI 10.1016/S1367-5931(03)00085-1; Sato K, 1999, MOL BRAIN RES, V74, P182, DOI 10.1016/S0169-328X(99)00279-X; Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9; Uhlenbrock K, 2003, CELL PHYSIOL BIOCHEM, V13, P75, DOI 10.1159/000070251; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Xu CB, 2002, ATHEROSCLEROSIS, V164, P237, DOI 10.1016/S0021-9150(02)00100-4; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zeng X, 1998, DEV DYNAM, V211, P215, DOI 10.1002/(SICI)1097-0177(199803)211:3<215::AID-AJA3>3.0.CO;2-K; Zhang GF, 1999, GENE, V227, P89, DOI 10.1016/S0378-1119(98)00589-7	46	50	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50580	50590		10.1074/jbc.M404432200	http://dx.doi.org/10.1074/jbc.M404432200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377653	hybrid			2022-12-27	WOS:000225229500122
J	Schubert, SW; Kardash, E; Khan, MA; Cheusova, T; Kilian, K; Wegner, M; Hashemolhosseini, S				Schubert, SW; Kardash, E; Khan, MA; Cheusova, T; Kilian, K; Wegner, M; Hashemolhosseini, S			Interaction, cooperative promoter modulation, and renal colocalization of GCMa and Pitx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; TRANSCRIPTION FACTOR; RIEGER-SYNDROME; GENE; DROSOPHILA; PROTEIN; EXPRESSION; HOMOLOG; FAMILY; SWITCH	The transcription factor GCMa is a member of a new small family of transcription factors with a conserved zinc-containing DNA-binding domain. All members of this transcription factor family play crucial roles as master regulators during development. GCMa is restricted to placenta during development and to kidney and thymus at postnatal stages. It is essential for the formation of the placental labyrinth and as a consequence for survival of the embryo from mid-embryogenesis onwards. Here, we identify Pitx transcription factors as GCMa-interacting proteins. We show that Pitx proteins interact via their conserved homeodomain with the DNA-binding domain of GCMa. As a consequence, Pitx proteins and GCMa exhibit cooperative DNA binding. Furthermore, Pitx proteins influence GCMa-dependent promoter activation in a cell-specific manner. One of the three Pitx paralogues in mice, Pitx2, is the predominant Pitx member present in the placenta and colocalizes on the cellular level with GCMa in the kidney. This is the first description of a regulatory cross-talk between a transcription factor of the GCM family and a homeodomain protein.	Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Hashemolhosseini, S (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	sh@biochem.uni-erlangen.de	Hashemolhosseini, Said/N-2464-2013	Hashemolhosseini, Said/0000-0002-6564-5649; Wegner, Michael/0000-0002-4586-3294; Kardash, Elena/0000-0002-7425-9862				Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Amendt BA, 2000, CELL MOL LIFE SCI, V57, P1652, DOI 10.1007/PL00000647; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Arakawa H, 1998, P NATL ACAD SCI USA, V95, P4573, DOI 10.1073/pnas.95.8.4573; Bernardoni R, 1997, DEV BIOL, V191, P118; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; Cohen SX, 2002, FEBS LETT, V528, P95, DOI 10.1016/S0014-5793(02)03257-X; Correa P, 2002, CLIN ENDOCRINOL, V57, P501, DOI 10.1046/j.1365-2265.2002.01627.x; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; FEINGOLD M, 1969, PEDIATRICS, V44, P564; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gage PJ, 1997, HUM MOL GENET, V6, P457, DOI 10.1093/hmg/6.3.457; Graham A, 1999, CURR BIOL, V9, pR368, DOI 10.1016/S0960-9822(99)80229-2; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Harvey RP, 1998, CELL, V94, P273, DOI 10.1016/S0092-8674(00)81468-3; Hashemolhosseini S, 2004, J MOL BIOL, V336, P441, DOI 10.1016/j.jmb.2003.12.029; Hashemolhosseini S, 2003, FEBS LETT, V553, P315, DOI 10.1016/S0014-5793(03)01037-8; Hashemolhosseini S, 2002, MECH DEVELOP, V118, P175, DOI 10.1016/S0925-4773(02)00239-3; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Kanemura Y, 1999, FEBS LETT, V442, P151, DOI 10.1016/S0014-5793(98)01650-0; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Ransick A, 2002, DEV BIOL, V246, P132, DOI 10.1006/dbio.2002.0607; Reifegerste R, 1999, MECH DEVELOP, V82, P141, DOI 10.1016/S0925-4773(99)00027-1; Rieger H, 1935, Z AUGENHEILKD, V86, P333; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Tuerk EE, 2000, J BIOL CHEM, V275, P4774, DOI 10.1074/jbc.275.7.4774; Vincent S, 1996, DEVELOPMENT, V122, P131; Weatherbee SD, 1999, CELL, V97, P283, DOI 10.1016/S0092-8674(00)80737-0; Yamada K, 1999, J BIOL CHEM, V274, P32279, DOI 10.1074/jbc.274.45.32279; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zakaria MM, 2002, MOL ENDOCRINOL, V16, P1840, DOI 10.1210/me.2002-0088	50	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50358	50365		10.1074/jbc.M404587200	http://dx.doi.org/10.1074/jbc.M404587200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385555	hybrid			2022-12-27	WOS:000225229500100
J	Fukatsu, K; Bannai, H; Zhang, SB; Nakamura, H; Inoue, T; Mikoshiba, K				Fukatsu, K; Bannai, H; Zhang, SB; Nakamura, H; Inoue, T; Mikoshiba, K			Lateral diffusion of inositol 1,4,5-trisphosphate receptor type 1 is regulated by actin filaments and 4.1N in neuronal Dendrites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CALCIUM-RELEASE; FLUORESCENT PROTEIN; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; PLASMA-MEMBRANE; GROWTH CONES; CELLS; EXPRESSION; DEPRESSION	Inositol 1,4,5-trisphosphate receptor type1 (IP(3)R1) plays an important role in neuronal functions; however, the lateral diffusion of IP(3)R1 on the endoplasmic reticulum membrane and its regulation in the living neurons remain unknown. We expressed green fluorescent protein-tagged IP(3)R1 in cultured rat hippocampal neurons and observed the lateral diffusion by the fluorescence recovery after photobleaching technique. IP(3)R1 showed lateral diffusion with an effective diffusion constant of similar to 0.3 mum(2)/s. Depletion of actin filaments increased the diffusion constant of IP(3)R1, suggesting that the diffusion of IP(3)R1 is regulated negatively through actin filaments. We also found that protein 4.1N, which binds to IP(3)R1 and contains an actin-spectrin-binding region, was responsible for this actin regulation of the IP(3)R1 diffusion constant. Overexpression of dominant-negative 4.1N and blockade of 4.1N binding to IP3R1 increased the IP(3)R1 diffusion constant. The diffusion of IP3R type 3 (IP(3)R3), one of the isoforms of IP(3)Rs lacking the binding ability to 4.1N, was not dependent on actin filaments but became dependent on actin filaments after the addition of a 4.1N-binding sequence. These data suggest that 4.1N serves as a linker protein between IP(3)R1 and actin filaments. This actin filament-dependent regulation of IP(3)R1 diffusion may be important for the spatiotemporal regulation of intracellular Ca2+ signaling.	Univ Tokyo, Inst Med Sci, Nippon Telegraph & Tel Co, Div Mol Neurobiol,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Nippon Telegraph & Tel Co, Div Neural Signal Informat,Minato Ku, Tokyo 1088639, Japan; RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, ICORP, Calcium Oscillat Project, Minato Ku, Tokyo 1080071, Japan; Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo; Nippon Telegraph & Telephone Corporation; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); University of Tokyo	Inoue, T (corresponding author), Univ Tokyo, Inst Med Sci, Nippon Telegraph & Tel Co, Div Mol Neurobiol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tinoue@ims.u-tokyo.ac.jp	Mikoshiba, Katsuhiko/N-7943-2015; Bannai, Hiroko/I-7130-2014; Inoue, Takafumi/AAM-9533-2020	Bannai, Hiroko/0000-0002-0951-488X; Inoue, Takafumi/0000-0002-2728-0060; Zhang, Songbai/0000-0002-2033-8389; Nakamura, Hideki/0000-0003-2749-8323				Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; DABORA SL, 1988, CELL, V54, P27, DOI 10.1016/0092-8674(88)90176-6; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fujii S, 2000, LEARN MEMORY, V7, P312, DOI 10.1101/lm.34100; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; FURUICHI T, 1995, J NEUROCHEM, V64, P953, DOI 10.1046/j.1471-4159.1995.64030953.x; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Kaech S, 2001, P NATL ACAD SCI USA, V98, P7086, DOI 10.1073/pnas.111146798; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Shen L, 2000, J NEUROSCI, V20, P7932; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; Street VA, 1997, J NEUROSCI, V17, P635; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Walensky LD, 1999, J NEUROSCI, V19, P6457; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; YAMADA KM, 1971, J CELL BIOL, V49, P614, DOI 10.1083/jcb.49.3.614; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200	39	76	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48976	48982		10.1074/jbc.M408364200	http://dx.doi.org/10.1074/jbc.M408364200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364918	hybrid			2022-12-27	WOS:000225098100060
J	Wang, XZ; Grammatikakis, N; Siganou, A; Stevenson, MA; Calderwood, SK				Wang, XZ; Grammatikakis, N; Siganou, A; Stevenson, MA; Calderwood, SK			Interactions between extracellular signal-regulated protein kinase 1, 14-3-3 epsilon, and heat shock factor 1 during stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DNA-BINDING ABILITY; TRANSCRIPTIONAL ACTIVATION; FACTOR-I; GENE-TRANSCRIPTION; C-FOS; PHOSPHORYLATION; CELLS; HSF1; THERMOTOLERANCE	Cytoprotection during the heat shock response is a complex phenomenon involving multiple inducible mechanisms. We have examined the interaction of two key molecular components in the response, heat shock transcription factor 1 (HSF1) and extracellular signal regulated protein kinase (ERK). Whereas both HSF1 and ERK are required to protect cells against apoptosis, ERK activation is paradoxically antagonistic to transactivation of hsp promoters by HSF1 and HSP accumulation during heat shock. We have found that the two pathways interact directly and that heat shock causes the physical association of ERK1 with HSF1, an interaction that promotes the kinase activity of ERK in heat-shocked cells. ERK activation results in the recruitment of the phosphoserine binding protein 14-3-3epsilon in a manner dependent on previous HSF1 phosphorylation by ERK. The effects of 14-3-3epsilon binding on HSF1 were complex, however, depending on extracellular conditions, in that HSF1-14-3-3 binding at 37degreesC led to the cytoplasmic sequestration and repression of HSF1, whereas heat shock overrode these effects and caused quantitative nuclear localization of HSF1. Although the effects of 14-3-3epsilon binding to HSF1 were overridden acutely by stress, during recovery from heat shock, 14-3-3epsilon association again led to enhanced cytoplasmic localization of HSF1, implicating a role for ERK/14-3-3epsilon in HSF1 deactivation in recovering cells. Association of HSF1 with ERK and 14-3-3epsilon during heat shock may thus modulate the amplitude of the response and lead to efficient termination of HSP expression on resumption of growth conditions.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Mol & Cellular Radiat Oncol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University	Calderwood, SK (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Mol & Cellular Radiat Oncol, 21-27 Burlington Ave,Room 553B, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu			NCI NIH HHS [CA31303, CA47407, CA50642] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047407, P01CA031303, R01CA050642] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Chen CM, 1997, J BIOL CHEM, V272, P26803, DOI 10.1074/jbc.272.43.26803; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; GREEN M, 1995, MOL CELL BIOL, V15, P3354; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Kyriakis JM, 1999, BIOCHEM SOC SYMP, P29; KYRIAKIS JM, 1994, PROTEIN KINASES, P81; LANDRY J, 1982, CANCER RES, V42, P2457; LEWIS MJ, 1985, EMBO J, V4, P3137, DOI 10.1002/j.1460-2075.1985.tb04056.x; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Mercier PA, 1999, J CELL SCI, V112, P2765; MIVECHI NF, 1995, CANCER RES, V55, P5512; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Newton EM, 1996, MOL CELL BIOL, V16, P839; PRICE BD, 1991, MOL CELL BIOL, V11, P3365, DOI 10.1128/MCB.11.6.3365; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Rosenquist M, 2003, BRAZ J MED BIOL RES, V36, P403, DOI 10.1590/S0100-879X2003000400001; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SHELDON LA, 1993, GENE DEV, V7, P1549, DOI 10.1101/gad.7.8.1549; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; SUBJECK JR, 1982, BRIT J RADIOL, V55, P579, DOI 10.1259/0007-1285-55-656-579; Tsuchiya S, 1999, J BIOCHEM-TOKYO, V125, P1151, DOI 10.1093/oxfordjournals.jbchem.a022398; Vinciguerra M, 2004, J BIOL CHEM, V279, P9634, DOI 10.1074/jbc.M308721200; Voellmy Richard, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P357; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Wang XZ, 2000, CELL STRESS CHAPERON, V5, P432, DOI 10.1379/1466-1268(2000)005<0432:RRHADH>2.0.CO;2; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; Woessmann W, 1999, J CELL BIOCHEM, V74, P648, DOI 10.1002/(SICI)1097-4644(19990915)74:4<648::AID-JCB14>3.0.CO;2-6; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xie Y, 2003, J BIOL CHEM, V278, P4687, DOI 10.1074/jbc.M210189200; Xie Y, 2002, BIOCHEM BIOPH RES CO, V291, P1071, DOI 10.1006/bbrc.2002.6562; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yaglom J, 2003, MOL CELL BIOL, V23, P3813, DOI 10.1128/MCB.23.11.3813-3824.2003; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; ZUO JR, 1994, MOL CELL BIOL, V14, P7557, DOI 10.1128/MCB.14.11.7557; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	62	51	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49460	49469		10.1074/jbc.M406059200	http://dx.doi.org/10.1074/jbc.M406059200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364926	hybrid			2022-12-27	WOS:000225098100116
J	Zhao, M; Wimmer, A; Trieu, K; DiScipio, RG; Schraufstatter, IU				Zhao, M; Wimmer, A; Trieu, K; DiScipio, RG; Schraufstatter, IU			Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; PROTEIN-KINASE; INTERLEUKIN-8 RECEPTORS; MEDIATED ENDOCYTOSIS; BINDING; RAC; PATHWAY; STRESS; ERK; RHO	Activation of CXCR2 IL-8 receptor leads to activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and rapid receptor endocytosis. Co-immunoprecipitation and co-localization experiments showed that arrestin and CXCR2 form complexes with components of the ERK1/2 cascade following ligand stimulation. However, in contrast to the activation of the beta(2)-adrenergic receptor, arrestin was not necessary for ERK1/2 phosphorylation or receptor endocytosis. In contrast, beta-arrestin 1/2 double knockout cells showed greatly enhanced phosphorylation of ERK1/2, as well as phosphorylation of the stress kinases p38 and c-Jun N-terminal protein kinase. The stimulation of stress kinases in arrestin double knockout cells could be attenuated in the presence of diphenylene iodonium (DPI), an inhibitor of the NADPH oxidase, suggesting that reactive oxidant species (ROS) participated in mitogen-activated protein kinase (MAPK) activation. ROS could indeed be detected in IL-8-stimulated beta-arrestin 1/2 knockout cells, and cytoplasmic Rac was translocated to the membrane fraction, which is a prerequisite for oxidant formation. The oxidative burst induced cell death within 6 h of IL-8 stimulation of these cells, which could be prevented in the presence of DPI. These results indicate a novel function for arrestin, which is protection from an excessive oxidative burst, resulting from the sustained stimulation of G-protein-coupled receptors that cause Rac translocation.	La Jolla Inst Mol Med, Div Canc Biol, San Diego, CA 92121 USA		Zhao, M (corresponding author), La Jolla Inst Mol Med, Div Canc Biol, 4570 Execut Dr,100, San Diego, CA 92121 USA.	mzhao@ljimm.org	Sawant, Kirti V/H-3778-2013		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055657] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL55657] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Avdi NJ, 2002, J BIOL CHEM, V277, P40687, DOI 10.1074/jbc.M204455200; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Budd DC, 1999, J BIOL CHEM, V274, P12355, DOI 10.1074/jbc.274.18.12355; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Dalle S, 2002, MOL CELL BIOL, V22, P6272, DOI 10.1128/MCB.22.17.6272-6285.2002; De Zutter GS, 2001, P NATL ACAD SCI USA, V98, P6168, DOI 10.1073/pnas.111027698; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Fan GH, 2002, J BIOL CHEM, V277, P6590, DOI 10.1074/jbc.M110588200; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; GE L, 2003, J BIOL CHEM, P73200; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; LEE J, 1995, J IMMUNOL, V155, P2158; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li WG, 2001, J BIOL CHEM, V276, P29251, DOI 10.1074/jbc.M102124200; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Pagano PJ, 1997, P NATL ACAD SCI USA, V94, P14483, DOI 10.1073/pnas.94.26.14483; PAYNE DM, 1909, EMBRO J, V10, P885; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Pullar CE, 2003, J BIOL CHEM, V278, P22555, DOI 10.1074/jbc.M300205200; REVANKAR CM, 2004, J BIOL CHEM, P21200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; Schraufstatter IU, 1998, BIOCHEM BIOPH RES CO, V244, P243, DOI 10.1006/bbrc.1998.8246; SCHUMACHER C, 1992, P NATL ACAD SCI USA, V89, P10542, DOI 10.1073/pnas.89.21.10542; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Venkatakrishnan G, 2000, J BIOL CHEM, V275, P6868, DOI 10.1074/jbc.275.10.6868; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WOODMAN RC, 1995, BLOOD, V85, P231, DOI 10.1182/blood.V85.1.231.bloodjournal851231; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328	63	61	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49259	49267		10.1074/jbc.M405118200	http://dx.doi.org/10.1074/jbc.M405118200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364949	hybrid			2022-12-27	WOS:000225098100093
J	Ahn, B; Harrigan, JA; Indig, FE; Wilson, DM; Bohr, VA				Ahn, B; Harrigan, JA; Indig, FE; Wilson, DM; Bohr, VA			Regulation of WRN helicase activity in human base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; DNA-POLYMERASE-BETA; HUMAN APURINIC ENDONUCLEASE; AAA-ATPASE P97/VCP; FLAP ENDONUCLEASE-1; MAJOR HUMAN; BIOCHEMICAL-CHARACTERIZATION; FUNCTIONAL INTERACTION; SUBSTRATE-SPECIFICITY; AP ENDONUCLEASE-1	Werner syndrome patients are deficient in the Werner protein (WRN), which is a multifunctional nuclear protein possessing 3'- 5' exonuclease and ATP-dependent helicase activities. Studies of Werner syndrome cells and biochemical studies of WRN suggest that WRN plays a role in several DNA metabolic pathways. WRN interacts with DNA polymerase beta(pol beta) and stimulates pol beta strand displacement synthesis on a base excision repair (BER) intermediate in a helicase-dependent manner. In this report, we examined the effect of the major human apurinic/apyrimidinic endonuclease (APE1) and of pol beta on WRN helicase activity. The results show that WRN alone is able to unwind several single strand break BER intermediates. However, APE1 inhibits WRN helicase activity on these intermediates. This inhibition is likely due to the binding of APE1 to nicked apurinic/apyrimidinic sites, suggesting that APE1 prevents the promiscuous unwinding of BER intermediates. This inhibitory effect was relieved by the presence of pol beta. A model involving the pol beta-mediated hand-off of WRN protein is proposed based on these results.	NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; Univ Ulsan, Dept Life Sci, Ulsan 680749, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Ulsan	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	vbohr@nih.gov	Wilson, David M/AAK-5409-2021; Bohr, Vilhelm/AAP-5931-2020	Wilson, David M/0000-0002-8945-0395; 	NATIONAL INSTITUTE ON AGING [ZIAAG000727, ZIAAG000726, Z01AG000726, Z01AG000727] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bhakat KK, 2003, METHOD ENZYMOL, V371, P292; Bohr VA, 2001, ENVIRON MOL MUTAGEN, V38, P227, DOI 10.1002/em.1076; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Brosh RM, 2001, EMBO J, V20, P5791; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Harrigan JA, 2003, J BIOL CHEM, V278, P22686, DOI 10.1074/jbc.M213103200; Indig FE, 2004, J STRUCT BIOL, V146, P251, DOI 10.1016/j.jsb.2003.11.009; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Opresko PL, 2003, CARCINOGENESIS, V24, P791, DOI 10.1093/carcin/bgg034; Partridge JJ, 2003, MOL BIOL CELL, V14, P4221, DOI 10.1091/mbc.E03-02-0111; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; Poot M, 2002, FASEB J, V16, P757, DOI 10.1096/fj.01-0906fje; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Ranalli TA, 2002, J BIOL CHEM, V277, P41715, DOI 10.1074/jbc.M207207200; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; von Kobbe C, 2003, MOL CELL BIOL, V23, P8601, DOI 10.1128/MCB.23.23.8601-8613.2003; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Yannone SM, 2001, J BIOL CHEM, V276, P38242	45	70	77	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53465	53474		10.1074/jbc.M409624200	http://dx.doi.org/10.1074/jbc.M409624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385537	hybrid			2022-12-27	WOS:000225680600081
J	Heppel, LA				Heppel, LA			Reminiscences of Leon A. Heppel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ESCHERICHIA-COLI; SPLEEN PHOSPHODIESTERASE; ACTIVE-TRANSPORT; RIBONUCLEASE; NUCLEOTIDE; ATP; GLUTAMINE; SUBUNITS; ENZYMES; MUSCLE		Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Heppel, LA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	lah9@cornell.edu						BERGER EA, 1973, P NATL ACAD SCI USA, V70, P1514, DOI 10.1073/pnas.70.5.1514; BROWN DM, 1954, J CHEM SOC, P40, DOI 10.1039/jr9540000040; DUNN SD, 1980, J BIOL CHEM, V255, P113; HEPPEL LA, 1955, BIOCHEM J, V60, P19, DOI 10.1042/bj0600019; Heppel LA, 1940, AM J PHYSIOL, V128, P0440, DOI 10.1152/ajplegacy.1940.128.3.440; HEPPEL LA, 1955, BIOCHEM J, V60, P1; HEPPEL LA, 1955, BIOCHEM J, V60, P8, DOI 10.1042/bj0600008; Heppel LA, 1939, AM J PHYSIOL, V127, P385, DOI 10.1152/ajplegacy.1939.127.2.385; HEPPEL LA, 1953, NATURE, V171, P1152, DOI 10.1038/1711152a0; HEPPEL LA, 1985, J MEMBRANE BIOL, V86, P189, DOI 10.1007/BF01870597; Heppel LA, 1940, AM J PHYSIOL, V128, P0449, DOI 10.1152/ajplegacy.1940.128.3.449; HUANG NN, 1989, P NATL ACAD SCI USA, V86, P7904, DOI 10.1073/pnas.86.20.7904; NEU HC, 1964, BIOCHEM BIOPH RES CO, V17, P215, DOI 10.1016/0006-291X(64)90386-9; NEU HC, 1964, P NATL ACAD SCI USA, V51, P1267, DOI 10.1073/pnas.51.6.1267; NEU HC, 1965, J BIOL CHEM, V240, P3685; SINGER MF, 1957, BIOCHIM BIOPHYS ACTA, V26, P447, DOI 10.1016/0006-3002(57)90039-2; SMITH JB, 1977, BIOCHEMISTRY-US, V16, P306, DOI 10.1021/bi00621a023; WEINER JH, 1971, J BIOL CHEM, V246, P6933	18	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					52807	52811		10.1074/jbc.X400007200	http://dx.doi.org/10.1074/jbc.X400007200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15371456	hybrid			2022-12-27	WOS:000225680600002
J	Steiner-Mosonyi, M; Creuzenet, C; Keates, RAB; Strub, BR; Mangroo, D				Steiner-Mosonyi, M; Creuzenet, C; Keates, RAB; Strub, BR; Mangroo, D			The Pseudomonas aeruginosa initiation factor IF-2 is responsible for formylation-independent protein initiation in P-aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RIBONUCLEIC-ACID; TRANSFER-RNA TRANSFORMYLASE; STREPTOCOCCUS-FAECALIS-R; ESCHERICHIA-COLI; FACTOR IF2; MITOCHONDRIAL INITIATION-FACTOR-2; SACCHAROMYCES-CEREVISIAE; BINDING-SITE; FACTOR-II; FORMYLTRANSFERASE	Formylation of the initiator methionyl-tRNA (Met-tRNA(fMet)) was generally thought to be essential for initiation of protein synthesis in all eubacteria based on studies conducted primarily in Escherichia coli. However, this view of eubacterial protein initiation has changed because some bacteria have been demonstrated to have the capacity to initiate protein synthesis with the unformylated Met-tRNA(fMet). Here we show that the Pseudomonas aeruginosa initiation factor IF-2 is required for formylation-independent protein initiation in P. aeruginosa, the first bacterium shown to have the ability to initiate protein synthesis with both the initiator formyl-methionyl-tRNA (fMet-tRNA(fMet)) and Met-tRNA(fMet). The E. coli IF-2, which participates exclusively in formylation- dependent protein initiation in E. coli, was unable to facilitate utilization of Met-tRNA(fMet) in initiation in P. aeruginosa. However, the E. coli IF-2 was made to function in formylation-independent protein initiation in P. aeruginosa by decreasing the positive charge potential of the cleft that binds the amino end of the amino acid attached to the tRNA. Furthermore increasing the positive charge potential of this cleft in the P. aeruginosa IF-2 prevented the protein from participating in formylation- independent protein initiation. Thus, this is the first demonstration of a eubacterial IF-2 with an inherent capacity to facilitate utilization of Met-tRNA(fMet) in protein initiation, discounting the dogma that eubacterial IF-2 can only allow the use of fMet-tRNA(fMet) in protein initiation. Furthermore these findings give important clues to the basis for discriminating the initiator Met-tRNA by IF-2 and for the evolution of alternative mechanisms for discrimination.	Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	University of Guelph; Western University (University of Western Ontario)	Mangroo, D (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	dmangroo@uoguelph.ca						Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; DELK AS, 1974, NATURE, V252, P106, DOI 10.1038/252106a0; DICKERMA.HW, 1967, J BIOL CHEM, V242, P1522; DICKERMAN HW, 1971, J MOL BIOL, V59, P425, DOI 10.1016/0022-2836(71)90308-1; EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274; Garofalo C, 2003, ARCH BIOCHEM BIOPHYS, V413, P243, DOI 10.1016/S0003-9861(03)00119-X; Guenneugues M, 2000, EMBO J, V19, P5233, DOI 10.1093/emboj/19.19.5233; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUILLON JM, 1993, J BACTERIOL, V175, P4507, DOI 10.1128/JB.175.14.4507-4514.1993; GUILLON JM, 1992, J BACTERIOL, V174, P4294, DOI 10.1128/JB.174.13.4294-4301.1992; GUILLON JM, 1992, J MOL BIOL, V224, P359, DOI 10.1016/0022-2836(92)91000-F; Guillon JM, 1996, J BIOL CHEM, V271, P22321, DOI 10.1074/jbc.271.37.22321; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; LAALAMI S, 1991, J MOL BIOL, V220, P335, DOI 10.1016/0022-2836(91)90017-Z; LEE CP, 1991, J BIOL CHEM, V266, P18012; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIAO HX, 1991, J BIOL CHEM, V266, P20714; MANGROO D, 1995, J BIOL CHEM, V270, P12203, DOI 10.1074/jbc.270.20.12203; Margolis P, 2001, ANTIMICROB AGENTS CH, V45, P2432, DOI 10.1128/AAC.45.9.2432-2435.2001; Margolis PS, 2000, ANTIMICROB AGENTS CH, V44, P1825, DOI 10.1128/AAC.44.7.1825-1831.2000; Mayer C, 2003, BIOCHEMISTRY-US, V42, P4787, DOI 10.1021/bi034011r; Meunier S, 2000, EMBO J, V19, P1918, DOI 10.1093/emboj/19.8.1918; Newton DT, 1999, J BIOL CHEM, V274, P22143, DOI 10.1074/jbc.274.32.22143; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; SACERDOT C, 1992, J MOL BIOL, V225, P67, DOI 10.1016/0022-2836(92)91026-L; SAMUEL CE, 1970, J BIOL CHEM, V245, P5115; SAMUEL CE, 1974, J BIOL CHEM, V249, P1198; Spurio R, 2000, J BIOL CHEM, V275, P2447, DOI 10.1074/jbc.275.4.2447; SUNDARI RM, 1976, J BIOL CHEM, V251, P3338; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tibbetts AS, 2003, J BIOL CHEM, V278, P31774, DOI 10.1074/jbc.M304962200; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; VARSHNEY U, 1991, J BIOL CHEM, V266, P18018; Vial L, 2003, BIOCHEMISTRY-US, V42, P932, DOI 10.1021/bi026901x	36	19	19	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52262	52269		10.1074/jbc.M408086200	http://dx.doi.org/10.1074/jbc.M408086200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15385567	hybrid			2022-12-27	WOS:000225493400067
J	Bakin, RE; Jung, MO				Bakin, RE; Jung, MO			Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; PROCESSING PEPTIDASE; MEMBRANE; PROTEINS; INTERACTS; FRATAXIN; TUBULIN; CELLS; FORM	Control of global histone acetylation status is largely governed by the opposing enzymatic activities of histone acetyltransferases and deacetylases (HDACs). HDACs were originally identified as modulators of nuclear histone acetylation status and have been linked to chromosomal condensation and subsequent gene repression. Accumulating evidence highlights HDAC modification of non-histone targets. Mitochondria were first characterized as intracellular organelles responsible for energy production through the coupling of oxidative phosphorylation to respiration. More recently, mitochondria have been implicated in programmed cell death whereby release of pro-apoptotic inner membrane space factors facilitates apoptotic progression. Here we describe the novel discovery that the nuclear encoded Class II human histone deacetylase HDAC7 localizes to the mitochondrial inner membrane space of prostate epithelial cells and exhibits cytoplasmic relocalization in response to initiation of the apoptotic cascade. These results highlight a previously unrecognized link between HDACs, mitochondria, and programmed cell death.	Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Radiat Med,Div Radiat Res, Washington, DC 20007 USA	Georgetown University	Jung, MO (corresponding author), Georgetown Univ, Sch Med, Dept Radiat Med, Res Bldg,Rm E-211,Box 571482,3970 Reservoir Rd NW, Washington, DC 20057 USA.	jungm@georgetown.edu			NCI NIH HHS [2P30-CA-51008] Funding Source: Medline; PHS HHS [1S10R15768-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Greenawalt J W, 1974, Methods Enzymol, V31, P310; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Hu W, 2003, LANCET ONCOL, V4, P721, DOI 10.1016/S1470-2045(03)01277-4; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; Jordan J, 2003, J PHYSIOL BIOCHEM, V59, P129, DOI 10.1007/BF03179878; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Liu F, 2004, J BIOL CHEM, V279, P34537, DOI 10.1074/jbc.M402475200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624; Patel PI, 2001, AM J HUM GENET, V69, P15, DOI 10.1086/321283; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Verdin E, 2004, NOVART FDN SYMP, V259, P163; Verdin Eric, 2004, Novartis Found Symp, V259, P115; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2004, RADIAT RES, V161, P667, DOI 10.1667/RR3192	29	59	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51218	51225		10.1074/jbc.M409271200	http://dx.doi.org/10.1074/jbc.M409271200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15364908	hybrid			2022-12-27	WOS:000225355800069
J	Hull, JJ; Ohnishi, A; Moto, K; Kawasaki, Y; Kurata, R; Suzuki, MG; Matsumoto, S				Hull, JJ; Ohnishi, A; Moto, K; Kawasaki, Y; Kurata, R; Suzuki, MG; Matsumoto, S			Cloning and characterization of the pheromone biosynthesis activating neuropeptide receptor from the silkmoth, Bombyx mori - Significance of the carboxyl terminus in receptor internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; FORMYL PEPTIDE RECEPTOR; SIGNAL-TRANSDUCTION; BETA(2)-ADRENERGIC RECEPTOR; GENOME SEQUENCE; HELICOVERPA-ZEA; HORMONE; IDENTIFICATION; TAIL; ENDOCYTOSIS	In most Lepidoptera, pheromone biosynthesis is regulated by a neuropeptide termed pheromone biosynthesis activating neuropeptide ( PBAN). Although much is known about the cellular targets of PBAN, identification and functional characterization of the PBAN receptor (PBANR) has proven to be elusive. Given the sequence similarity between the active C-terminal regions of PBAN and neuromedin U, it was hypothesized that their respective receptors might also be similar in structure ( Park, Y., Kim, Y. J., and Adams, M. E. ( 2002) Proc. Natl. Acad. Sci. U. S. A. 99, 11423 - 11428). Consequently, utilizing primers constructed from the conserved regions of insect neuromedin U receptor homologues, a full-length 2780-nucleotide clone encoding a 46-kDa G protein-coupled receptor was amplified from a Bombyx mori pheromone gland cDNA library. Tissue distribution analyses revealed that the receptor transcript is specific to the pheromone gland where it undergoes significant up-regulation in the day preceding eclosion. When transiently expressed in Sf9 cells, the B. mori PBANR responds to PBAN by mobilizing extracellular calcium in a dose-dependent manner. Confocal microscopic studies demonstrated the specificity of enhanced green fluorescent protein-tagged B. mori PBANR for PBAN and showed that PBAN induces internalization of the PBANR . PBAN complex. The rapid onset of internalization is mediated by a 67-amino acid C-terminal extension absent in the cloned Helicoverpa zea PBANR, which suggests that receptor internalization in that species likely utilizes a different mechanism. From these results, we have concluded that the cloned receptor gene encodes the B. mori PBANR and that it is both structurally and functionally distinct from the H. zea PBANR.	RIKEN, Inst Phys & Chem Res, Mol Entomol Lab, Wako, Saitama 3510198, Japan; Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	RIKEN; Saitama University	Matsumoto, S (corresponding author), RIKEN, Inst Phys & Chem Res, Mol Entomol Lab, Hirosawa 2-1, Wako, Saitama 3510198, Japan.	smatsu@riken.jp		Ohnishi, Atsushi/0000-0003-1213-4439				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BARAK LS, 1995, BIOCHEMISTRY-US, V34, P15407, DOI 10.1021/bi00047a003; Becamel Carine, 2002, Biological Procedures Online, V4, P94, DOI 10.1251/bpo39; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; Cornea A, 1999, ENDOCRINOLOGY, V140, P4272, DOI 10.1210/en.140.9.4272; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FONAGY A, 1992, J PESTIC SCI, V17, P47; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Gripentrog JM, 2000, BIOCHEM J, V352, P399, DOI 10.1042/0264-6021:3520399; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HUNYADY L, 1995, J BIOL CHEM, V270, P16602, DOI 10.1074/jbc.270.28.16602; JURENKA RA, 1991, ARCH INSECT BIOCHEM, V17, P81, DOI 10.1002/arch.940170203; JURENKA RA, 1991, P NATL ACAD SCI USA, V88, P8621, DOI 10.1073/pnas.88.19.8621; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; LeGouill C, 1997, J BIOL CHEM, V272, P21289, DOI 10.1074/jbc.272.34.21289; Lyu RM, 2000, J BIOL CHEM, V275, P36134, DOI 10.1074/jbc.M004612200; Matsumoto S., 1997, Recent Research Developments in Agricultural & Biological Chemistry, V1, P33; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Oh DY, 2003, MOL CELL ENDOCRINOL, V205, P89, DOI 10.1016/S0303-7207(03)00204-1; OZAWA RA, 1993, BIOSCI BIOTECH BIOCH, V57, P2144, DOI 10.1271/bbb.57.2144; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pawson AJ, 1998, J ENDOCRINOL, V156, pR9, DOI 10.1677/joe.0.156R009; Rafaeli A, 2002, INT REV CYTOL, V213, P49; RAINA AK, 1990, INSECT BIOCHEM, V20, P849, DOI 10.1016/0020-1790(90)90103-2; RAINA AK, 1993, ARCH INSECT BIOCHEM, V22, P141, DOI 10.1002/arch.940220112; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; ROELOFS W, 1984, BIOORG CHEM, V12, P279, DOI 10.1016/0045-2068(84)90011-7; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Seifert R, 2003, LIFE SCI, V73, P2263, DOI 10.1016/S0024-3205(03)00654-4; Shapiro DA, 2002, J BIOL CHEM, V277, P11441, DOI 10.1074/jbc.M111675200; SLICE LW, 1994, J BIOL CHEM, V269, P21755; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; VanLeeuwen D, 2003, J BIOL CHEM, V278, P15935, DOI 10.1074/jbc.M211546200; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Yoshiga T, 2000, GENE, V246, P339, DOI 10.1016/S0378-1119(00)00047-0	48	84	93	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51500	51507		10.1074/jbc.M408142200	http://dx.doi.org/10.1074/jbc.M408142200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15358772	hybrid			2022-12-27	WOS:000225355800103
J	Jasuja, R; Allen, BL; Pappano, WN; Rapraeger, AC; Greenspan, DS				Jasuja, R; Allen, BL; Pappano, WN; Rapraeger, AC; Greenspan, DS			Cell-surface heparan sulfate proteoglycans potentiate chordin antagonism of bone morphogenetic protein signaling and are necessary for cellular uptake of chordin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; TWISTED GASTRULATION; EXPRESSION PATTERNS; DROSOPHILA EMBRYO; XENOPUS CHORDIN; BINDING; RECEPTOR; METALLOPROTEASES; REQUIREMENT; GLYPICAN-1	Signaling by bone morphogenetic proteins (BMPs) plays a central role in early embryonic patterning, organogenesis, and homeostasis in a broad range of species. Chordin, an extracellular antagonist of BMP signaling, is thought to readily diffuse in tissues, thus forming gradients of BMP inhibition that result in reciprocal gradients of BMP signaling. The latter determine cell fates along the embryonic dorsoventral axis. The secreted protein Twisted Gastrulation (TSG) is thought to help shape BMP signaling gradients by acting as a cofactor that enhances Chordin inhibition of BMP signaling. Here, we demonstrate that mammalian Chordin binds heparin with an affinity similar to that of factors known to functionally interact with heparan sulfate proteoglycans (HSPGs) in tissues. We further demonstrate that Chordin binding in mouse embryonic tissues was dependent upon its interaction with cell-surface HSPGs and that Chordin bound to cell-surface HSPGs (e.g. syndecans), but not to basement membranes containing the HSPG perlecan. Surprisingly, mammalian TSG did not bind heparin unless prebound to Chordin and/or BMP-4, although Drosophila TSG has been reported to bind heparin on its own. Results are also presented that indicate that Chordin-HSPG interactions strongly potentiate the antagonism of BMP signaling by Chordin and are necessary for the retention and uptake of Chordin by cells. These data and others regarding Chordin diffusion have implications for the paradigm of how Chordin is thought to regulate BMP signaling in the extracellular space and how gradients of BMP signaling are formed.	Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 1300 Univ Ave, Madison, WI 53706 USA.	acraprae@wisc.edu; dsgreens@wisc.edu		Pappano, William/0000-0003-2848-2219; Greenspan, Daniel/0000-0001-8096-7446	NIAMS NIH HHS [AR47746] Funding Source: Medline; NIGMS NIH HHS [GM63471, GM48850, R01 GM048850] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR047746, R01AR047746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048850, R01GM063471] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; ANDRES JL, 1989, J CELL BIOL, V109, P3137, DOI 10.1083/jcb.109.6.3137; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Blader P, 1997, SCIENCE, V278, P1937, DOI 10.1126/science.278.5345.1937; Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Burbach BJ, 2003, MATRIX BIOL, V22, P163, DOI 10.1016/S0945-053X(03)00009-X; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Chang CB, 2001, NATURE, V410, P483, DOI 10.1038/35068583; Cho KWY, 1998, CURR OPIN GENET DEV, V8, P443, DOI 10.1016/S0959-437X(98)80116-0; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Filmus J, 2001, GLYCOBIOLOGY, V11, p19R, DOI 10.1093/glycob/11.3.19R; FRANCOIS V, 1995, CELL, V80, P19, DOI 10.1016/0092-8674(95)90446-8; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Friedl A, 1997, AM J PATHOL, V150, P1443; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Hashimoto O, 1997, J BIOL CHEM, V272, P13835, DOI 10.1074/jbc.272.21.13835; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Larrain J, 2003, EMBO REP, V4, P813, DOI 10.1038/sj.embor.embor902; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Massague J, 2000, GENE DEV, V14, P627; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Pappano WN, 1998, GENOMICS, V52, P236, DOI 10.1006/geno.1998.5474; Paria BC, 1999, DEVELOPMENT, V126, P1997; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; RAPRAEGER AC, 1994, METHOD ENZYMOL, V245, P219; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sakata H, 1997, J BIOL CHEM, V272, P9457; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 2000, DEV DYNAM, V217, P449, DOI 10.1002/(SICI)1097-0177(200004)217:4<449::AID-DVDY12>3.0.CO;2-8; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Sergeant N, 2000, J BIOL CHEM, V275, P17094, DOI 10.1074/jbc.M000237200; Srinivasan S, 2002, DEV CELL, V2, P91, DOI 10.1016/S1534-5807(01)00097-1; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wardle FC, 1999, MECH DEVELOP, V86, P75, DOI 10.1016/S0925-4773(99)00114-8; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zimmermann P, 1999, FASEB J, V13, pS91	62	60	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51289	51297		10.1074/jbc.M408129200	http://dx.doi.org/10.1074/jbc.M408129200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15381701	hybrid			2022-12-27	WOS:000225355800078
J	Shats, I; Milyavsky, M; Tang, XH; Stambolsky, P; Erez, N; Brosh, R; Kogan, I; Braunstein, I; Tzukerman, M; Ginsberg, D; Rotter, V				Shats, I; Milyavsky, M; Tang, XH; Stambolsky, P; Erez, N; Brosh, R; Kogan, I; Braunstein, I; Tzukerman, M; Ginsberg, D; Rotter, V			p53-dependent down-regulation of telomerase is mediated by p21(waf1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 TUMOR-SUPPRESSOR; WILD-TYPE P53; Y TRANSCRIPTION FACTOR; NORMAL HUMAN-CELLS; GENE-EXPRESSION; CANCER-CELLS; HISTONE ACETYLATION; NEGATIVE REGULATION; EPITHELIAL-CELLS; CYCLE ARREST	Inactivation of p53 and activation of telomerase occur in the majority of human cancers, raising the possibility of a link between these two pathways. Overexpression of wild-type p53 down-regulates the enzymatic activity of telomerase in various cancer cell lines through transcriptional repression of its catalytic subunit, human telomerase reverse transcriptase ( hTERT). In this study, we re-evaluated the role of p53 in telomerase regulation using isogenic cell lines expressing physiological levels of p53. We demonstrate that endogenous wild-type p53 was able to down-regulate telomerase activity, hTERT mRNA levels, and promoter activity; however, the ability to repress hTERT expression was found to be cell type-specific. The integrity of the DNA-binding core domain, the N-terminal transactivation domain, and the C-terminal oligomerization domains of p53 was essential for hTERT promoter repression, whereas the proline-rich domain and the extreme C terminus were not required. Southwestern and chromatin immunoprecipitation experiments demonstrated lack of p53 binding to the hTERT promoter, raising the possibility of an indirect repressive mechanism. The down-regulation of hTERT promoter activity was abolished by a dominant-negative E2F1 mutant. Mutational analysis identified a specific E2F site responsible for p53-mediated repression. Knockdown of the key p53 transcriptional target, p21, was sufficient to eliminate the p53-dependent repression of hTERT. Inactivation of the Rb family using either viral oncoproteins or RNA interference attenuated the repression. Inhibition of histone deacetylases also interfered with the repression of hTERT by p53. Therefore, our results suggest that repression of hTERT by endogenous p53 is mediated by p21 and E2F.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Rotter, V (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Herzl 1, IL-76100 Rehovot, Israel.	varda.rotter@weizmann.ac.il	Milyavsky, Michael/E-8306-2011; Brosh, Ran/H-7309-2019; Tang, Xiaohu/AAX-4577-2021; Shats, Igor/AAD-8775-2019; Brosh, Ran/HDL-9562-2022	Brosh, Ran/0000-0001-9714-8623; Shats, Igor/0000-0001-6449-5979; ginsberg, doron/0000-0002-1257-4920; Erez, Neta/0000-0001-6506-9074				Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Braunstein I, 2001, CANCER RES, V61, P5529; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Drissi R, 2001, J BIOL CHEM, V276, P29994, DOI 10.1074/jbc.M101899200; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Ferreira R, 1998, P NATL ACAD SCI USA, V95, P10493, DOI 10.1073/pnas.95.18.10493; Gollahon LS, 1996, ONCOGENE, V12, P715; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035; Harris CC, 1996, BRIT J CANCER, V73, P261, DOI 10.1038/bjc.1996.47; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Holt SE, 1997, P NATL ACAD SCI USA, V94, P10687, DOI 10.1073/pnas.94.20.10687; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kiyooka K, 1999, Ann Thorac Cardiovasc Surg, V5, P293; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; Kusumoto M, 1999, CLIN CANCER RES, V5, P2140; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Mittelman JM, 1999, SOMAT CELL MOLEC GEN, V25, P115, DOI 10.1023/A:1018822121890; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Murphy M, 1996, GENE DEV, V10, P2971, DOI 10.1101/gad.10.23.2971; Nair P, 2000, ACTA ONCOL, V39, P65, DOI 10.1080/028418600430996; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Park M, 2000, CANCER RES, V60, P542; Roos G, 1998, INT J CANCER, V79, P343, DOI 10.1002/(SICI)1097-0215(19980821)79:4<343::AID-IJC6>3.0.CO;2-V; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Stampfer MR, 2003, ONCOGENE, V22, P5238, DOI 10.1038/sj.onc.1206667; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Takakura M, 1999, CANCER RES, V59, P551; Tang XH, 2004, ONCOGENE, V23, P5759, DOI 10.1038/sj.onc.1207706; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; Tzukerman M, 2000, MOL BIOL CELL, V11, P4381, DOI 10.1091/mbc.11.12.4381; Ulaner GA, 1998, CANCER RES, V58, P4168; Wang QJ, 1997, MOL CELL BIOL, V17, P389, DOI 10.1128/MCB.17.1.389; Wege H, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng003; Wisman GBA, 2003, INT J ONCOL, V23, P1451; Won J, 2004, P NATL ACAD SCI USA, V101, P11328, DOI 10.1073/pnas.0401801101; Won JJ, 2002, FASEB J, V16, P1943, DOI 10.1096/fj.02-0311fje; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Yamabe Y, 1998, MOL CELL BIOL, V18, P6191, DOI 10.1128/MCB.18.11.6191; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhao RB, 2000, GENE DEV, V14, P981; Zhou XL, 1999, CANCER RES, V59, P843; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	65	118	128	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50976	50985		10.1074/jbc.M402502200	http://dx.doi.org/10.1074/jbc.M402502200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371422	hybrid			2022-12-27	WOS:000225355800042
J	Bruderer, RM; Brasseur, C; Meyer, HH				Bruderer, RM; Brasseur, C; Meyer, HH			The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; UBIQUITIN INTERACTIONS; TRANSCRIPTION FACTOR; UBX DOMAIN; P97; PROTEIN; ER; COMPLEX; ADAPTER; CDC48	The AAA ATPase p97/VCP forms complexes with different adapters to fulfill distinct cellular functions. We analyzed the structural organization of the Ufd1-Npl4 adapter complex and its interaction with p97 and compared it with another adapter, p47. We found that the binary Ufd1-Npl4 complex forms a heterodimer that cooperatively interacts with p97 via a bipartite binding mechanism. Binding site 1 (BS1) is a short hydrophobic stretch in the C-terminal domain of Ufd1. The second binding site is located at the N terminus of Npl4 and is activated upon binding of Ufd1 to Npl4. It consists of about 80 amino acids that are predicted to form a ubiquitin fold domain (UBD). Despite the lack of overall homology between Ufd1-Npl4 and p47, both adapters use identical binding mechanisms. Like the ubiquitin fold ubiquitin regulatory X (UBX) domain in p47, the Npl4-UBD interacts with p97 via the loop between its strands 3 and 4 and a conserved arginine in strand 1. Furthermore, we identified a region in p47 homologous to Ufd1-BS1. The UBD/UBX and the BS1 of both adapters interact with p97 independently, whereas homologous binding sites in both adapters compete for binding to p97. In contrast to p47, however, Ufd1-Npl4 does not regulate the ATPase activity of p97; nor does a variant of p47 that contains both binding sites but lacks the N-terminal domains. Therefore, the binding sites alone do not regulate p97 directly but rather serve as anchor points to position adapter-specific domains at critical locations to modulate p97-mediated reactions.	ETH Honggerberg HPM, Inst Biochem, Swiss Fed Sch Technol ETH, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Meyer, HH (corresponding author), ETH Honggerberg HPM, Inst Biochem, Swiss Fed Sch Technol ETH, CH-8093 Zurich, Switzerland.	hemmo.meyer@bc.biol.ethz.ch	Meyer, Hemmo/GNH-5784-2022	Meyer, Hemmo/0000-0003-1883-1796; Bruderer, Roland/0000-0002-1049-5524; Stober Brasseur, Catherine/0000-0002-9481-013X				Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Coles M, 1999, CURR BIOL, V9, P1158, DOI 10.1016/S0960-9822(00)80017-2; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuan XM, 2004, EMBO J, V23, P1463, DOI 10.1038/sj.emboj.7600152; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	38	114	119	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49609	49616		10.1074/jbc.M408695200	http://dx.doi.org/10.1074/jbc.M408695200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371428	hybrid			2022-12-27	WOS:000225229500010
J	Chandrashekaran, S; Saravanan, M; Radha, DR; Nagaraja, V				Chandrashekaran, S; Saravanan, M; Radha, DR; Nagaraja, V			Ca2+-mediated site-specific DNA cleavage and suppression of promiscuous activity of KpnI restriction endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ECORI ENDONUCLEASE; CALCIUM-IONS; RECOGNITION SEQUENCE; BINDING SPECIFICITY; CRYSTAL-STRUCTURE; BAMHI; ISOSCHIZOMER; SUBSTRATE; ENZYMES; RSRI	The characteristic feature of type II restriction endonucleases (REases) is their exquisite sequence specificity and obligate Mg2+ requirement for catalysis. Efficient cleavage of DNA only in the presence of Ca2+ ions, comparable with that of Mg2+, is previously not described. Most intriguingly, KpnI REase exhibits Ca2+-dependent specific DNA cleavage. Moreover, the enzyme is highly promiscuous in its cleavage pattern on plasmid DNAs in the presence of Mn2+ or Mg2+, with the complete suppression of promiscuous activity in the presence of Ca2+. KpnI methyltransferase does not exhibit promiscuous activity unlike its cognate REase. The REase binds to oligonucleotides containing canonical and mapped noncanonical sites with comparable affinities. However, the extent of cleavage is varied depending on the metal ion and the sequence. The ability of the enzyme to be promiscuous or specific may reflect an evolutionary design. Based on the results, we suggest that the enzyme KpnI represents an REase evolving to attain higher sequence specificity from an ancient nonspecific nuclease.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in	Matheshwaran, Saravanan/CAG-9469-2022; Matheshwaran, Saravanan/E-9461-2010	MATHESHWARAN, SARAVANAN/0000-0001-6762-9928				AIKEN C, 1988, NUCLEIC ACIDS RES, V16, P7901, DOI 10.1093/nar/16.16.7901; AIKEN CR, 1991, J BIOL CHEM, V266, P19063; BALKE V, 1992, NUCLEIC ACIDS RES, V20, P2777, DOI 10.1093/nar/20.11.2777; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bujnicki JM, 2001, VIRUS GENES, V22, P219, DOI 10.1023/A:1008131810233; Chandrashekaran S, 1999, J BIOSCIENCE, V24, P269, DOI 10.1007/BF02941240; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Cowan JA, 1998, CHEM REV, V98, P1067, DOI 10.1021/cr960436q; Dorner LF, 1999, J MOL BIOL, V285, P1515, DOI 10.1006/jmbi.1998.2408; Gormley NA, 2000, J BIOL CHEM, V275, P6928, DOI 10.1074/jbc.275.10.6928; HALFORD SE, 1986, GENE, V41, P173, DOI 10.1016/0378-1119(86)90096-X; Horton JR, 2000, J MOL BIOL, V300, P1049, DOI 10.1006/jmbi.2000.3938; Lagunavicius A, 1997, BIOCHEMISTRY-US, V36, P11093, DOI 10.1021/bi963126a; LESSER DR, 1993, P NATL ACAD SCI USA, V90, P7548, DOI 10.1073/pnas.90.16.7548; Lukacs CM, 2000, NAT STRUCT BIOL, V7, P134; MAKULA RA, 1980, NUCLEIC ACIDS RES, V8, P3125, DOI 10.1093/nar/8.14.3125; Martin AM, 1999, NAT STRUCT BIOL, V6, P269; Martin AM, 1999, BIOCHEMISTRY-US, V38, P8430, DOI 10.1021/bi9905359; NASRI M, 1987, NUCLEIC ACIDS RES, V15, P7677, DOI 10.1093/nar/15.19.7677; Newman M, 1998, EMBO J, V17, P5466, DOI 10.1093/emboj/17.18.5466; Perona JJ, 1997, J MOL BIOL, V273, P207, DOI 10.1006/jmbi.1997.1315; POLISKY B, 1975, P NATL ACAD SCI USA, V72, P3310, DOI 10.1073/pnas.72.9.3310; Roberts R, 1993, NUCLEASES, P35; ROBINSON CR, 1995, P NATL ACAD SCI USA, V92, P3444, DOI 10.1073/pnas.92.8.3444; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P2186, DOI 10.1073/pnas.95.5.2186; SAMBROOK J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Skirgaila R, 1998, BIOL CHEM, V379, P595; TAYLOR JD, 1991, BIOCHEMISTRY-US, V30, P8743, DOI 10.1021/bi00100a005; TOMASSINI J, 1978, NUCLEIC ACIDS RES, V5, P4055, DOI 10.1093/nar/5.11.4055; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P1113, DOI 10.1021/bi00004a002; XU SY, 1991, J BIOL CHEM, V266, P4425; ZEBALA JA, 1992, J BIOL CHEM, V267, P8097	34	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49736	49740		10.1074/jbc.M409483200	http://dx.doi.org/10.1074/jbc.M409483200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375161	hybrid			2022-12-27	WOS:000225229500024
J	Liu, M; Barth, A				Liu, M; Barth, A			Phosphorylation of the sarcoplasmic reticulum Ca2+-ATPase from ATP and ATP analogs studied by infrared spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; MEMBRANE-PROTEIN STRUCTURE; CHAIN PLEATED SHEET; AMIDE-ONE VIBRATION; CALCIUM-PUMP; RESONANCE INTERACTION; DIFFERENCE SPECTRA; REACTION-MECHANISM; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE	Phosphorylation of the sarcoplasmic reticulum Ca2+-ATPase (SERCA1a) was studied with time-resolved Fourier transform infrared spectroscopy. ATP and ATP analogs (ITP, 2'- and 3'-dATP) were used to study the effect of the adenine ring and the ribose hydroxyl groups on ATPase phosphorylation. All modifications of ATP altered conformational changes and phosphorylation kinetics. The differences compared with ATP increased in the following order: 3'-dATP>ITP>2'-dATP. Enzyme phosphorylation with ITP results in larger absorbance changes in the amide I region, indicating larger conformational changes of the Ca2+-ATPase. The respective absorbance changes obtained with 3'-dATP are significantly different from the others with different band positions and amplitudes in the amide I region, indicating different conformational changes of the protein backbone. ATPase phosphorylation with 3'-dATP is also much (similar to30 times) slower than with ATP. Our results indicate that modifications to functional groups of ATP (the ribose 2'- and 3'-OH and the amino group in the adenine ring) affect gamma-phosphate transfer to the phosphorylation site of the Ca2+-ATPase by changing the extent of conformational change and the phosphorylation rate. ADP binding to the ADP-sensitive phosphoenzyme (Ca(2)E1P) stabilizes the closed conformation of Ca(2)E1P.	Goethe Univ Frankfurt, Inst Biophys, D-60596 Frankfurt, Germany; Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Goethe University Frankfurt; Stockholm University	Liu, M (corresponding author), Goethe Univ Frankfurt, Inst Biophys, D-60596 Frankfurt, Germany.	liu@dbb.su.se	Liu, Man/GXH-3184-2022; Barth, Andreas/N-8872-2013	Liu, Man/0000-0002-1390-7862; Barth, Andreas/0000-0001-5784-7673				ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Barth A, 1998, BIOPHYS J, V75, P538, DOI 10.1016/S0006-3495(98)77543-5; Barth A, 1996, J BIOL CHEM, V271, P30637, DOI 10.1074/jbc.271.48.30637; BARTH A, 1991, BIOCHIM BIOPHYS ACTA, V1057, P115, DOI 10.1016/S0005-2728(05)80091-X; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; BRAIMAN MS, 1988, ANNU REV BIOPHYS BIO, V17, P541; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P466; Cepus V, 1998, BIOCHEMISTRY-US, V37, P10263, DOI 10.1021/bi973183j; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P627, DOI 10.1002/bip.1976.360150403; CHIRGADZE YN, 1976, BIOPOLYMERS, V15, P607, DOI 10.1002/bip.1976.360150402; COAN C, 1993, J BIOL CHEM, V268, P6917; Colthup N.B., 1990, INTRO INFRARED RAMAN; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; de Meis L, 1973, J Biol Chem, V248, P3691; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; Granjon T, 2001, BIOCHEMISTRY-US, V40, P2988, DOI 10.1021/bi002553s; Griffiths P., 1986, FOURIER TRANSFORM IN; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HASSELBACH W, 1974, ENZYMES, P431; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Hua SM, 2002, BIOCHEMISTRY-US, V41, P11405, DOI 10.1021/bi026181u; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; KENDREW J, 1994, ENCY MOL BIOL, P624; Kubelka J, 2001, J AM CHEM SOC, V123, P12048, DOI 10.1021/ja0116627; KUBO K, 1990, BIOCHIM BIOPHYS ACTA, V1040, P251, DOI 10.1016/0167-4838(90)90084-S; LACAPERE JJ, 1990, J BIOL CHEM, V265, P8583; LADNER WE, 1985, J ORG CHEM, V50, P1076, DOI 10.1021/jo00207a032; Liu M, 2003, BIOPHYS J, V85, P3262, DOI 10.1016/S0006-3495(03)74744-4; Liu M, 2003, J BIOL CHEM, V278, P10112, DOI 10.1074/jbc.M212403200; Liu M, 2002, BIOPOLYMERS, V67, P267, DOI 10.1002/bip.10113; MAKINOSE M, 1965, BIOCHEM Z, V343, P383; McIntosh DB, 2000, NAT STRUCT BIOL, V7, P532, DOI 10.1038/76735; MEIS LD, 1971, J BIOL CHEM, V246, P4759; PETRETSKI JH, 1989, J BIOL CHEM, V264, P20339; Resnick SM, 2000, APPL ENVIRON MICROB, V66, P2045, DOI 10.1128/AEM.66.5.2045-2051.2000; Reuter N, 2003, BIOPHYS J, V85, P2186, DOI 10.1016/S0006-3495(03)74644-X; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SIEBERT F, 1995, METHOD ENZYMOL, V246, P501; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; SOUZA DOG, 1976, J BIOL CHEM, V251, P6355; SUZUKI H, 1994, BIOCHEMISTRY-US, V33, P8240, DOI 10.1021/bi00193a010; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Wharton CW, 2000, NAT PROD REP, V17, P447, DOI 10.1039/b002066o	50	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49902	49909		10.1074/jbc.M408062200	http://dx.doi.org/10.1074/jbc.M408062200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381702	hybrid			2022-12-27	WOS:000225229500045
J	Rozanov, DV; Sikora, S; Godzik, A; Postnova, TI; Golubkov, V; Savinov, A; Tomlinson, S; Strongin, AY				Rozanov, DV; Sikora, S; Godzik, A; Postnova, TI; Golubkov, V; Savinov, A; Tomlinson, S; Strongin, AY			Non-proteolytic, receptor/ligand interactions associate cellular membrane type-1 matrix metalloproteinase with the complement component C1q	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; INTEGRIN ALPHA(V) SUBUNIT; CRYSTAL-STRUCTURE; ALPHA-1-PROTEINASE INHIBITOR; PEPTIDE SEQUENCE; MALIGNANT-CELLS; IV COLLAGENASE; GLOBULAR HEAD; MT1-MMP; PROTEIN	Membrane type-1 matrix metalloproteinase (MT1-MMP), a prototypic member of the membrane-tethered MMP family, is an essential component of a cellular proteolysis apparatus. Recognition of protein cleavage targets followed by proteolysis is a main function of MT1-MMP. For the first time, however, we present evidence that MT1-MMP and other structurally related membrane MMPs bind C1q, the recognition unit of the first component of complement C1 that initiates activation of the classical pathway of complement. These interactions involve the catalytic domain of MT1-MMP and the C1q globular domain. In silico modeling followed by mutagenesis and the in vitro and cell-based binding studies showed that the His(171)-Glu-Lys-Gln-Ala-Asp(176) and Val(223)-Arg-Asn(224) peptide sequences of MT1-MMP are directly involved in the binding with C1q. These sequence regions are spatially distant from the active site of the protease. As a result, the catalytically active and the catalytically latent forms of cellular MT1-MMP are both efficient in binding with C1q. In agreement, despite the MT1-MMP/C1q interactions, C1q is totally resistant to MT1-MMP proteolysis. The discovery of the unconventional, receptor/ligand-like interactions of MT1-MMP with C1q, an essential component of immunity, is a significant step toward a more complete understanding of the role of this membrane-tethered protease in cancer.	Burnham Inst, La Jolla, CA 92037 USA; Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Sanford Burnham Prebys Medical Discovery Institute; Medical University of South Carolina	Strongin, AY (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017; Godzik, Adam/AAW-1467-2020; Godzik, Adam/A-7279-2009	Strongin, Alex/0000-0003-3765-3016; Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X	NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NCI NIH HHS [CA83017, CA77470] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alonso-Escolano D, 2004, BRIT J PHARMACOL, V141, P241, DOI 10.1038/sj.bjp.0705606; Arlaud GJ, 2002, MOL IMMUNOL, V39, P383, DOI 10.1016/S0161-5890(02)00143-8; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Deryugina EI, 2003, INT J CANCER, V104, P533, DOI 10.1002/ijc.10977; Deryugina EI, 2002, CANCER RES, V62, P580; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Itoh Y, 2004, TRENDS BIOCHEM SCI, V29, P285, DOI 10.1016/j.tibs.2004.04.001; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2002, IMMUNOBIOLOGY, V205, P355, DOI 10.1078/0171-2985-00138; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; MAST AE, 1991, J BIOL CHEM, V266, P15810; Matsuda A, 2003, J BIOL CHEM, V278, P36350, DOI 10.1074/jbc.M301509200; McGreal E, 2002, BIOCHEM SOC T, V30, P1010, DOI 10.1042/BST0301010; Morgan B P, 2000, Methods Mol Biol, V150, P1; Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nakamura H, 2004, CANCER RES, V64, P876, DOI 10.1158/0008-5472.CAN-03-3502; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Rozanov DV, 2004, J BIOL CHEM, V279, P46551, DOI 10.1074/jbc.M405284200; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozanov DV, 2003, J BIOL CHEM, V278, P8257, DOI 10.1074/jbc.M213246200; Rozanov DV, 2002, J BIOL CHEM, V277, P9318, DOI 10.1074/jbc.M110711200; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Rus HG, 2001, IMMUNOL REV, V180, P49, DOI 10.1034/j.1600-065X.2001.1800104.x; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Sikora S, 2004, PROTEIN SCI, V13, P786, DOI 10.1110/ps.03454904; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Vakser IA, 1997, PROTEINS, P226; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	49	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50321	50328		10.1074/jbc.M409174200	http://dx.doi.org/10.1074/jbc.M409174200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375167	hybrid			2022-12-27	WOS:000225229500095
J	Suzuki, H; Kadowaki, T; Maeda, M; Sasaki, H; Nabekura, J; Sakaguchi, M; Mihara, K				Suzuki, H; Kadowaki, T; Maeda, M; Sasaki, H; Nabekura, J; Sakaguchi, M; Mihara, K			Membrane-embedded C-terminal segment of rat mitochondrial TOM40 constitutes protein-conducting pore with enriched beta-structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; IMPORT RECEPTORS; PREPROTEIN TRANSLOCASE; CORE COMPLEX; CHANNEL; PRESEQUENCE; COMPONENT; DOMAINS; BINDING; PLAYS	TOM40 is the central component of the preprotein translocase of the mitochondrial outer membrane ( TOM complex). We purified recombinant rat TOM40 (rTOM40), which was refolded in Brij35 after solubilization from inclusion bodies by guanidine HCl. rTOM40 ( i) consisted of a 63% beta-sheet structure and (ii) bound a matrix-targeted preprotein with high affinity and partially translocated it into the rTOM40 pore. This partial translocation was inhibited by stabilization of the mature domain of the precursor. (iii) rTOM40 bound preprotein initially through ionic interactions, followed by salt-resistant non-ionic interactions, and (iv) exhibited presequence-sensitive, cation-specific channel activity in reconstituted liposomes. Based on the domain structure of rTOM40 deduced by protease treatment, we purified the elastase-resistant and membrane-embedded C-terminal segment ( rTOM40(DeltaN165)) as a recombinant protein with 62% beta-structure that exhibited properties comparable with those of full-size rTOM40. We concluded that the membrane-embedded C-terminal half of rTOM40 constitutes the preprotein recognition domain with an enriched beta-structure, which forms the preprotein conducting pore containing a salt-sensitive cis-binding site and a salt-resistant trans-binding site.	Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan; Kyushu Univ, Grad Sch Dent Sci, Dept Pharmacol, Tokyo 1058451, Japan; Jikei Univ, Sch Med, Dept Mol Cell Biol, Tokyo 1058451, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Cellular & Syst Physiol, Fukuoka 8128582, Japan; Univ Hyogo, Grad Sch Life Sci, Ako, Hyogo 6781297, Japan	Kyushu University; Kyushu University; Jikei University; Kyushu University; University of Hyogo	Mihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan.	mihara@cell.med.kyushu-u.ac.jp		Sasaki, Hiroyuki/0000-0002-5358-5853				Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; ALLISON DS, 1986, P NATL ACAD SCI USA, V83, P9011, DOI 10.1073/pnas.83.23.9011; COURT DA, 1995, CAN J BOT, V73, P193; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Esaki M, 2003, NAT STRUCT BIOL, V10, P988, DOI 10.1038/nsb1008; Gabriel K, 2003, EMBO J, V22, P2380, DOI 10.1093/emboj/cdg229; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; IWAHASHI J, 1992, J BIOCHEM-TOKYO, V111, P451, DOI 10.1093/oxfordjournals.jbchem.a123778; Iwata K, 1998, BIOCHEM BIOPH RES CO, V253, P648, DOI 10.1006/bbrc.1998.9769; JACKSON ML, 1985, BIOCHIM BIOPHYS ACTA, V812, P369, DOI 10.1016/0005-2736(85)90311-6; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Mannella CA, 1996, J BIOENERG BIOMEMBR, V28, P163, DOI 10.1007/BF02110647; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; MIHARA K, 1982, P NATL ACAD SCI-BIOL, V79, P7102, DOI 10.1073/pnas.79.23.7102; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Nabekura J, 1996, J NEUROPHYSIOL, V76, P2447, DOI 10.1152/jn.1996.76.4.2447; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rapaport D, 1999, J CELL BIOL, V146, P321, DOI 10.1083/jcb.146.2.321; Rapaport D, 1998, J BIOL CHEM, V273, P8806, DOI 10.1074/jbc.273.15.8806; Rapaport D, 2001, MOL BIOL CELL, V12, P1189, DOI 10.1091/mbc.12.5.1189; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Stan T, 2000, EMBO J, V19, P4895, DOI 10.1093/emboj/19.18.4895; Suzuki H, 2000, J BIOL CHEM, V275, P37930, DOI 10.1074/jbc.M006558200; Taylor RD, 2003, J BIOL CHEM, V278, P765, DOI 10.1074/jbc.M208083200; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; ZALMAN LS, 1980, J BIOL CHEM, V255, P1771	36	47	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50619	50629		10.1074/jbc.M408604200	http://dx.doi.org/10.1074/jbc.M408604200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15347672	hybrid			2022-12-27	WOS:000225229500126
J	Tamamori-Adachi, M; Hayashida, K; Nobori, K; Omizu, C; Yamada, K; Sakamoto, N; Kamura, T; Fukuda, K; Ogawa, S; Nakayama, KI; Kitajima, S				Tamamori-Adachi, M; Hayashida, K; Nobori, K; Omizu, C; Yamada, K; Sakamoto, N; Kamura, T; Fukuda, K; Ogawa, S; Nakayama, KI; Kitajima, S			Down-regulation of p27(Kip1) promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear expression of cyclin d1 and CDK4-Evidence for impaired Skp2-dependent degradation of p27 in terminal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK INHIBITORS P27(KIP1); MYOCARDIAL REGENERATION; UBIQUITIN LIGASE; STEM-CELLS; S-PHASE; P57(KIP2); GROWTH; SKP2; SCFSKP2; COMPLEX	Mammalian cardiomyocytes lose their capacity to proliferate during terminal differentiation. We have previously reported that the expression of nuclear localization signal-tagged cyclin D1 (D1NLS) and its partner cyclin-dependent kinase 4 (CDK4) induces proliferation of rat neonatal cardiomyocytes. Here we show that the D1NLS/CDK4 cells, after their entry into the cell cycle, accumulated cyclin-dependent kinase inhibitor p27 in the nuclei and decreased the cyclin-dependent kinase 2 (CDK2) activity, leading to early cell cycle arrest. Biochemical analysis demonstrated that Skp2-dependent p27 ubiquitylation was remarkably suppressed in cardiomyocytes, whereas Skp2, a component of Skp1-CullinF- box protein ubiquitin ligase, was more actively ubiquitylated compared with proliferating rat fibroblasts. Specific degradation of p27 by co-expressing Skp2 or p27 small interfering RNA caused an increase of CDK2 activity and overrode the limited cell cycle. These data altogether indicate that the impaired Skp2-dependent p27 degradation is causally related to the loss of proliferation in cardiomyocytes. This provides a novel insight in understanding the molecular mechanism by which mammalian cardiomyocytes cease to proliferate during terminal differentiation.	Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Bunkyo Ku, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Lab Genome Struct & Regulat, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138510, Japan; Keio Univ, Sch Med, Cardiopulm Div, Dept Internal Med, Tokyo 1608582, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Keio University; Kyushu University	Kitajima, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kita.bgen@mri.tmd.ac.jp	Fukuda, Keiichi/L-3777-2013; Sakamoto, Naoya/G-2734-2012; Hayashida, Kentaro/J-5071-2014	Sakamoto, Naoya/0000-0003-0061-059X; Hayashida, Kentaro/0000-0002-1750-1982				Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Flink IL, 1998, J MOL CELL CARDIOL, V30, P563, DOI 10.1006/jmcc.1997.0620; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nagahama H, 2001, ANAT EMBRYOL, V203, P77, DOI 10.1007/s004290000146; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; TAMALE-SALI E G, 1992, Journal of Obstetrics and Gynaecology (Abingdon), V12, P19, DOI 10.3109/01443619209029911; Tamamori-Adachi M, 2002, BIOCHEM BIOPH RES CO, V296, P274, DOI 10.1016/S0006-291X(02)00854-9; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yeh KH, 2001, BIOCHEM BIOPH RES CO, V281, P884, DOI 10.1006/bbrc.2001.4442; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162	32	32	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50429	50436		10.1074/jbc.M403084200	http://dx.doi.org/10.1074/jbc.M403084200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371458	hybrid			2022-12-27	WOS:000225229500108
J	Ye, X; Nalepa, G; Welcker, M; Kessler, BM; Spooner, E; Qin, J; Ellege, SJ; Clurman, BE; Harper, JW				Ye, X; Nalepa, G; Welcker, M; Kessler, BM; Spooner, E; Qin, J; Ellege, SJ; Clurman, BE; Harper, JW			Recognition of phosphodegron motifs in human cyclin E by the SCFFbw7 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; MULTISITE PHOSPHORYLATION; DEPENDENT DEGRADATION; C-MYC; PROTEIN; SCF; COMPLEX; BETA; CDK; PROTEOLYSIS	Turnover of cyclin E is controlled by SCFFbw7. Three isoforms of Fbw7 are produced by alternative splicing. Whereas Fbw7alpha and -gamma are nuclear and the beta-isoform is cytoplasmic in 293T cells, all three isoforms induce cyclin E destruction in an in vivo degradation assay. Cyclin E is phosphorylated on Thr(62), Ser(88), Ser(372), Thr(380), and Ser(384) in vivo. To examine the roles of phosphorylation in cyclin E turnover, a series of alanine point mutations in each of these sites were analyzed for Fbw7-driven degradation. As expected, mutation of the previously characterized residue Thr(380) to alanine led to profound defects of cyclin E turnover, and largely abolished association with Fbw7. Mutation of Thr(62) to alanine led to a dramatic reduction in the extent of Thr(380) phosphorylation, suggesting an indirect effect of this mutation on cyclin E turnover. Nevertheless, phosphopeptides centered at Thr(62) associated with Fbw7, and residual binding of cyclin E-T380A to Fbw7 was abolished upon mutation of Thr(62), suggesting a minor role for this residue in direct association with Fbw7. Mutation of Ser(384) to alanine also rendered cyclin E resistant to degradation by Fbw7, with the largest effects being observed with Fbw7beta. Cyclin E-S384A associated more weakly with Fbw7alpha and -beta isoforms but was not defective in Thr(380) phosphorylation. Analysis of the localization of cyclin E mutant proteins indicated selective accumulation of cyclin ES384A in the nucleus, which may contribute to the inability of cytoplasmic Fbw7beta to promote turnover of this cyclin E mutant protein.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem, Houston, TX 77030 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Fred Hutchinson Cancer Center	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Clurman, Bruce/AAV-3854-2021; Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Nalepa, Grzegorz/0000-0002-5779-9103; Lab, Nalepa/0000-0002-7560-1906; Harper, Jeffrey/0000-0002-6944-7236; Welcker, Markus/0000-0001-6723-4790	NCI NIH HHS [CA102742] Funding Source: Medline; NIA NIH HHS [R01 AG011085, AG11095] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jackman M, 2002, MOL BIOL CELL, V13, P1030, DOI 10.1091/mbc.01-07-0361; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	40	114	118	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50110	50119		10.1074/jbc.M409226200	http://dx.doi.org/10.1074/jbc.M409226200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364936	hybrid, Green Published			2022-12-27	WOS:000225229500070
J	Yu, JQ; Bian, DF; Mahanivong, C; Cheng, RK; Zhou, WY; Huang, S				Yu, JQ; Bian, DF; Mahanivong, C; Cheng, RK; Zhou, WY; Huang, S			p38 mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; SIGNAL-TRANSDUCTION PATHWAY; MESSENGER-RNA STABILITY; MURINE MESANGIAL CELLS; FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; MAP KINASE; SPHINGOSINE 1-PHOSPHATE; EPITHELIAL-CELLS	The migration of endothelial cells in response to various stimulating factors plays an essential role in angiogenesis. The p38 MAPK pathway has been implicated to play an important role in endothelial cell migration because inhibiting p38 MAPK activity down-regulates vascular endothelial growth factor ( VEGF)-stimulated migration. Currently, the signaling components in the p38 MAPK activation pathway and especially the mechanisms responsible for p38 MAPK-regulated endothelial cell migration are not well understood. In the present study, we found that p38 MAPK activity is required for endothelial cell migration stimulated by both VEGF and nongrowth factor stimulants, sphingosine 1-phosphate and soluble vascular cell adhesion molecule. By using dominant negative forms of signaling components in the p38 MAPK pathway, we identified that a regulatory pathway consisting of MKK3-p38alpha/gamma-MAPK-activated protein kinase 2 participated in VEGF-stimulated migration. In further studies, we showed that a minimum of a 10-h treatment with SB203580 ( specific p38 MAPK inhibitor) was needed to block VEGF-stimulated migration, suggesting an indirect role of p38 MAPK in this cellular event. Most interestingly, the occurrence of SB203580-induced migratory inhibition coincided with a reduction of urokinase plasminogen activator (uPA) expression. Furthermore, agents disrupting uPA and uPA receptor interaction abrogated VEGF-stimulated cell migration. These results suggest a possible association between cell migration and uPA expression. Indeed, VEGF-stimulated migration was not compromised by SB203580 in endothelial cells expressing the uPA transgene; however, VEGF-stimulated migration was inhibited by agents disrupting uPA-uPA receptor interaction. These results thus suggest that the p38 MAPK pathway participates in endothelial cell migration by regulating uPA expression.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Huang, S (corresponding author), Scripps Res Inst, Dept Immunol, IMM-19,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shuang@scripps.edu			NCI NIH HHS [R01 CA93926] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093926] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; Chandrasekar N, 2003, ONCOGENE, V22, P392, DOI 10.1038/sj.onc.1206164; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; Denes L, 2002, BRIT J PHARMACOL, V136, P597, DOI 10.1038/sj.bjp.0704738; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Hannigan MO, 2001, J IMMUNOL, V167, P3953, DOI 10.4049/jimmunol.167.7.3953; Heuertz RM, 1999, J BIOL CHEM, V274, P17968, DOI 10.1074/jbc.274.25.17968; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Huang S, 2000, J BIOL CHEM, V275, P12266, DOI 10.1074/jbc.275.16.12266; Huang XJ, 2002, CANCER RES, V62, P5727; Kaneko T, 2003, CANCER SCI, V94, P43, DOI 10.1111/j.1349-7006.2003.tb01350.x; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kim MS, 2003, CANCER RES, V63, P5454; Koolwijk P, 2001, J CLIN ENDOCR METAB, V86, P3359, DOI 10.1210/jc.86.7.3359; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Kusch A, 2000, J BIOL CHEM, V275, P39466, DOI 10.1074/jbc.M003626200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Liu F, 2001, AM J RESP CELL MOL, V24, P711, DOI 10.1165/ajrcmb.24.6.4323; Martin-Blanco E, 2000, BIOESSAYS, V22, P637, DOI 10.1002/1521-1878(200007)22:7<637::AID-BIES6>3.0.CO;2-E; Mazar A P, 1999, Angiogenesis, V3, P15, DOI 10.1023/A:1009095825561; Meier R, 1996, EUR J BIOCHEM, V236, P796, DOI 10.1111/j.1432-1033.1996.00796.x; Montero L, 1999, CANCER RES, V59, P5286; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Nakao S, 2003, J IMMUNOL, V170, P5704, DOI 10.4049/jimmunol.170.11.5704; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Panetti TS, 2002, BBA-MOL CELL BIOL L, V1582, P190, DOI 10.1016/S1388-1981(02)00155-5; Pavco PA, 2000, CLIN CANCER RES, V6, P2094; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Prager GW, 2004, BLOOD, V103, P955, DOI 10.1182/blood-2003-07-2214; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Ray AK, 2003, J PERIODONTOL, V74, P1320, DOI 10.1902/jop.2003.74.9.1320; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sandberg T, 2001, J CLIN ENDOCR METAB, V86, P1724, DOI 10.1210/jc.86.4.1724; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Sliva D, 2002, BIOCHEM BIOPH RES CO, V290, P552, DOI 10.1006/bbrc.2001.6225; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wilson AJ, 2000, GUT, V47, P105, DOI 10.1136/gut.47.1.105; Xiong SB, 2001, CANCER RES, V61, P1727; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	61	48	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50446	50454		10.1074/jbc.M409221200	http://dx.doi.org/10.1074/jbc.M409221200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371454	hybrid			2022-12-27	WOS:000225229500110
J	Zhu, YX; Li, XM; Kyazike, J; Zhou, Q; Thurberg, BL; Raben, N; Mattaliano, RJ; Cheng, SH				Zhu, YX; Li, XM; Kyazike, J; Zhou, Q; Thurberg, BL; Raben, N; Mattaliano, RJ; Cheng, SH			Conjugation of mannose 6-phosphate-containing oligosaccharides to acid alpha-glucosidase improves the clearance of glycogen in Pompe mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TYPE-II; ENZYME REPLACEMENT THERAPY; GROWTH-FACTOR-II; MALTASE DEFICIENCY; RABBIT MILK; STORAGE; ADULT; INFANTILE; EXPRESSION; RECEPTOR	Clinical studies of enzyme replacement therapy for Pompe disease have indicated that relatively high doses of recombinant human acid alpha-glucosidase (rhGAA) may be required to reduce the abnormal glycogen storage in cardiac and skeletal muscles. This may be because of inefficient cation-independent mannose 6-phosphate receptor (CI-MPR)-mediated endocytosis of the enzyme by the affected target cells. To address this possibility, we examined whether the addition of a high affinity ligand to rhGAA would improve its delivery to these cells. Chemical conjugation of high mannose oligosaccharides harboring mono- and bisphosphorylated mannose 6-phosphates onto rhGAA (neo-rhGAA) significantly improved its uptake characteristics by muscle cells in vitro. Infusion of neo-rhGAA into Pompe mice also resulted in greater delivery of the enzyme to muscle tissues when compared with the unmodified enzyme. Importantly, this increase in enzyme levels was associated with significantly improved clearance of glycogen (similar to5-fold) from the affected tissues. These results suggest that CI-MPR-mediated endocytosis of rhGAA is an important pathway by which the enzyme is delivered to the affected lysosomes of Pompe muscle cells. Hence, the generation of rhGAA containing high affinity ligands for the CI-MPR represents a strategy by which the potency of rhGAA and therefore the clinical efficacy of enzyme replacement therapy for Pompe disease may be improved.	Genzyme Corp, Framingham, MA 01701 USA; NIH, Bethesda, MD 20892 USA	Sanofi-Aventis; Genzyme Corporation; National Institutes of Health (NIH) - USA	Cheng, SH (corresponding author), Genzyme Corp, 31 New York Ave, Framingham, MA 01701 USA.	seng.cheng@genzyme.com	zhou, qun/AAU-7592-2020; Cheng, Seng H/AAC-6564-2022	zhou, qun/0000-0001-6271-3143; 				Amalfitano A, 1999, P NATL ACAD SCI USA, V96, P8861, DOI 10.1073/pnas.96.16.8861; Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; ANDERSON RF, 1960, ARCH BIOCHEM BIOPHYS, V89, P289, DOI 10.1016/0003-9861(60)90056-4; Ausems MGEM, 1999, EUR J HUM GENET, V7, P713, DOI 10.1038/sj.ejhg.5200367; Ausems MGEM, 2001, NEUROLOGY, V57, P1938, DOI 10.1212/WNL.57.10.1938; Bijvoet AGA, 1996, BBA-GENE STRUCT EXPR, V1308, P93, DOI 10.1016/0167-4781(96)00093-0; Bijvoet AGA, 1999, HUM MOL GENET, V8, P2145, DOI 10.1093/hmg/8.12.2145; Bijvoet AGA, 1998, HUM MOL GENET, V7, P1815, DOI 10.1093/hmg/7.11.1815; Brady RO, 2001, J INHERIT METAB DIS, V24, P18, DOI 10.1023/A:1012451320105; BRETTHAU.RK, 1973, BIOCHEMISTRY-US, V12, P1251, DOI 10.1021/bi00731a002; DISTLER JJ, 1991, J BIOL CHEM, V266, P21687; FELICE KJ, 1995, MEDICINE, V74, P131, DOI 10.1097/00005792-199505000-00002; FUNK B, 1992, J CLIN ENDOCR METAB, V75, P424, DOI 10.1210/jc.75.2.424; FURBISH FS, 1981, BIOCHIM BIOPHYS ACTA, V673, P425, DOI 10.1016/0304-4165(81)90474-8; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Haley SM, 2003, DEV MED CHILD NEUROL, V45, P618, DOI 10.1017/S0012162203001129; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; Kikuchi T, 1998, J CLIN INVEST, V101, P827, DOI 10.1172/JCI1722; Laforet P, 2000, NEUROLOGY, V55, P1122, DOI 10.1212/WNL.55.8.1122; LeBowitz JH, 2004, P NATL ACAD SCI USA, V101, P3083, DOI 10.1073/pnas.0308728100; LI M, 1991, Glycobiology, V1, P511, DOI 10.1093/glycob/1.5.511; LIGHTMAN NI, 1977, CHEST, V72, P250, DOI 10.1378/chest.72.2.250; Martiniuk F, 2000, BIOCHEM BIOPH RES CO, V276, P917, DOI 10.1006/bbrc.2000.3555; Martiniuk F, 1998, AM J MED GENET, V79, P69, DOI 10.1002/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2002, MOL THER, V6, P601, DOI 10.1006/mthe.2002.0716; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben Nina, 2002, Current Molecular Medicine (Hilversum), V2, P145, DOI 10.2174/1566524024605789; Reuser AJJ, 2002, EUR J PEDIATR, V161, pS106, DOI 10.1007/s00431-002-1015-8; Sands MS, 2001, J BIOL CHEM, V276, P43160, DOI 10.1074/jbc.M107778200; Slonim AE, 2000, J PEDIATR-US, V137, P283, DOI 10.1067/mpd.2000.107112; SRIVASTAVA OP, 1987, CARBOHYD RES, V161, P195, DOI 10.1016/S0008-6215(00)90077-6; TOLVANEN M, 1986, J BIOL CHEM, V261, P9546; TONG PY, 1989, J BIOL CHEM, V264, P7962; TOWNSEND R R, 1991, Glycobiology, V1, P139, DOI 10.1093/glycob/1.2.139; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; Van den Hout H, 2000, LANCET, V356, P397, DOI 10.1016/S0140-6736(00)02533-2; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; Van den Hout JMP, 2004, PEDIATRICS, V113, pE448, DOI 10.1542/peds.113.5.e448; VANDERPLOEG AT, 1991, J CLIN INVEST, V87, P513, DOI 10.1172/JCI115025; VanHove JLK, 1996, P NATL ACAD SCI USA, V93, P65, DOI 10.1073/pnas.93.1.65; VARKI A, 1980, J BIOL CHEM, V255, P847; Vorgerd M, 1998, NEUROGENETICS, V1, P205, DOI 10.1007/s100480050030; WENK J, 1991, BIOCHEM INT, V23, P723; Winkel LPF, 2004, ANN NEUROL, V55, P495, DOI 10.1002/ana.20019; Yang HW, 1998, PEDIATR RES, V43, P374, DOI 10.1203/00006450-199803000-00011; Zhou Q, 2002, ANAL BIOCHEM, V306, P163, DOI 10.1006/abio.2002.5703	47	61	82	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50336	50341		10.1074/jbc.M409676200	http://dx.doi.org/10.1074/jbc.M409676200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383547	hybrid			2022-12-27	WOS:000225229500097
J	Kumamoto, Y; Higashi, N; Denda-Nagai, K; Tsuiji, M; Sato, K; Crocker, PR; Irimura, T				Kumamoto, Y; Higashi, N; Denda-Nagai, K; Tsuiji, M; Sato, K; Crocker, PR; Irimura, T			Identification of sialoadhesin as a dominant lymph node counter-receptor for mouse macrophage galactose-type C-type lectin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING-RECEPTOR; CYSTEINE-RICH DOMAIN; SENSITIZATION PHASE; MOLECULAR-CLONING; CELLS; PURIFICATION; TRAFFICKING; SPECIFICITY; SIGLECS	In the sensitization phase of contact hypersensitivity in mice, dermal macrophages (MOs) expressing MO galactose-type C-type lectin1 (MGL1) are known to migrate from the dermis to lymph nodes (LNs) where they accumulate in the subcapsular sinus, interfollicular regions, and areas surrounding high endothelial venules. We hypothesize that the interactions between MGL1 and its ligands determine the localizations of MGL1-positive cells within the LNs. In the present study, our major aim was to isolate MGL1 counter-receptor(s) from lysates of LNs using affinity chromatography with immobilized recombinant MGL1. Fractions bound and eluted with EDTA were analyzed by SDS-PAGE and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. One of the predominant components was sialoadhesin (Sn, Siglec-1). Sn from lysates of LNs was immobilized on microtiter plates precoated with anti-Sn monoclonal antibody, and binding of recombinant MGL1 and adhesion of cells expressing MGL1 were tested. The binding of recombinant MGL1 to Sn was shown to be dependent on Ca2+ and N-glycans on Sn. MGL1-transfected Chinese hamster ovary cells adhered to the Sn-coated plates, whereas mock transfectants did not. Immunohistochemical localization of anti-Sn monoclonal antibody in LN coincided with the subcapsular sinus area to which recombinant MGL1 was bound. Furthermore, the distribution of MGL1+ cells after sensitization with FITC was demonstrated to overlap with that of Sn within the subcapsular sinus of draining LNs. These results suggest that Sn acts as an endogenous counter-receptor for MGL1.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Tokyo; University of Dundee	Irimura, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	irimura@mol.f.u-tokyo.ac.jp	Tsuiji, Makoto/G-1411-2010	Tsuiji, Makoto/0000-0002-5607-4880; Denda-Nagai, Kaori/0000-0001-8325-3289; Kumamoto, Yosuke/0000-0001-9369-4934; Crocker, Paul/0000-0001-6230-0293				Angata T, 2002, BBA-GEN SUBJECTS, V1572, P294, DOI 10.1016/S0304-4165(02)00316-1; Chun KH, 2000, INT IMMUNOL, V12, P1695, DOI 10.1093/intimm/12.12.1695; Chun KH, 2000, J LEUKOCYTE BIOL, V68, P471; CROCKER PR, 1989, J EXP MED, V169, P1333, DOI 10.1084/jem.169.4.1333; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; Feizi T, 2000, IMMUNOL REV, V173, P79, DOI 10.1034/j.1600-065X.2000.917310.x; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Higashi N, 2002, J BIOL CHEM, V277, P20686, DOI 10.1074/jbc.M202104200; Kimura T, 2000, MOL IMMUNOL, V37, P151, DOI 10.1016/S0161-5890(00)00027-4; KIMURA T, 1995, J BIOL CHEM, V270, P16056, DOI 10.1074/jbc.270.27.16056; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; ODA S, 1988, J BIOCHEM-TOKYO, V104, P600, DOI 10.1093/oxfordjournals.jbchem.a122518; Sato K, 1998, J IMMUNOL, V161, P6835; Schadee-Eestermans IL, 2000, IMMUNOBIOLOGY, V202, P309, DOI 10.1016/S0171-2985(00)80036-4; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Suzuki N, 1996, J IMMUNOL, V156, P128; Tsuiji M, 2002, J BIOL CHEM, V277, P28892, DOI 10.1074/jbc.M203774200; YAMAMOTO K, 1994, BIOCHEMISTRY-US, V33, P8159, DOI 10.1021/bi00192a021	24	42	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49274	49280		10.1074/jbc.M409300200	http://dx.doi.org/10.1074/jbc.M409300200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364954	hybrid			2022-12-27	WOS:000225098100095
J	Li, AL; Li, HY; Jin, BF; Ye, QN; Zhou, T; Yu, XD; Pan, X; Man, JH; He, K; Yu, M; Hu, MR; Wang, J; Yang, SC; Shen, BF; Zhang, XM				Li, AL; Li, HY; Jin, BF; Ye, QN; Zhou, T; Yu, XD; Pan, X; Man, JH; He, K; Yu, M; Hu, MR; Wang, J; Yang, SC; Shen, BF; Zhang, XM			A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 5A; HYPUSINE FORMATION; PROTEOMIC ANALYSIS; PROTEIN-SYNTHESIS; NITRIC-OXIDE; EIF-5A; PHOSPHORYLATION; RAS; UBIQUITINATION; ACTIVATION	Although eukaryotic translation initiation factor 5A (eIF5A) was originally designated as an "initiation factor," recent data have shown it to be also involved in apoptosis. However, the actual function of eIF5A in apoptosis is still unknown. In this study, we performed yeast two-hybrid screens to identify eIF5A-interacting proteins to help us understand the mechanisms of eIF5A. Our results demonstrated that eIF5A and syntenin could engage in a specific interaction both in vitro and in vivo and functioned collaboratively to regulate p53 activity. Our findings, for the first time, revealed a new biological activity for eIF5A as the regulator of p53. Overexpression of eIF5A or its EFP domain resulted in up-regulation of p53, and silencing eIF5A by small interfering RNA reduced the p53 protein level. Further analysis by reverse transcription PCR showed eIF5A-activated p53 transcription. The effect of eIF5A on p53 transcriptional activity was further demonstrated by the increasing expressions of p21 and Bax, well known target genes of p53. In contrast, a point mutant of eIF5A, hypusination being abolished, was revealed to be functionally defective in p53 up-regulation. Overexpression of eIF5A led to a p53-dependent apoptosis or sensitized cells to induction of apoptosis by chemotherapeutic agents. However, when eIF5A interacted with its novel partner, syntenin, the eIF5A-induced increase in p53 protein level was significantly inhibited. Therefore, eIF5A seems to be a previously unrecognized regulator of p53 that may define a new pathway for p53-dependent apoptosis, and syntenin might regulate p53 by balancing the regulation of eIF5A signaling to p53 for apoptosis.	Natl Ctr Biomed Anal, Inst Basic Med Sci, Beijing 100850, Peoples R China; Beijing Inst Biotechnol, Beijing 100850, Peoples R China		Zhang, XM (corresponding author), Natl Ctr Biomed Anal, Inst Basic Med Sci, 27 Tai Ping Rd, Beijing 100850, Peoples R China.	xmzhang@nic.bmi.ac.cn		Pan, Xin/0000-0002-1982-2261				Appella E, 2000, PATHOL BIOL, V48, P227; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; BENNE R, 1978, J BIOL CHEM, V253, P3078; BEVEC D, 1994, P NATL ACAD SCI USA, V91, P10829, DOI 10.1073/pnas.91.23.10829; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Chen G, 2003, PROTEOMICS, V3, P496, DOI 10.1002/pmic.200390063; Chen KY, 1999, J CHIN CHEM SOC-TAIP, V46, P727, DOI 10.1002/jccs.199900100; Chen KY, 1997, BIOL SIGNAL, V6, P105; Chen ZP, 1997, CANCER LETT, V115, P235, DOI 10.1016/S0304-3835(97)04741-1; Chung HJ, 2000, J NEUROSCI, V20, P7258; Dev KK, 2000, J NEUROSCI, V20, P7252; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Jin BF, 2003, ONCOGENE, V22, P4819, DOI 10.1038/sj.onc.1206738; KANG HA, 1994, J BIOL CHEM, V269, P3934; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; PARK MH, 1993, TRENDS BIOCHEM SCI, V18, P475, DOI 10.1016/0968-0004(93)90010-K; PARK MH, 1993, BIOFACTORS, V4, P95; Park MH, 1997, BIOL SIGNAL, V6, P115; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Rohan TE, 1998, JNCI-J NATL CANCER I, V90, P1262, DOI 10.1093/jnci/90.17.1262; Rosorius O, 1999, J CELL SCI, V112, P2369; Salomoni P, 2002, NAT CELL BIOL, V4, pE152, DOI 10.1038/ncb0602-e152; Seewaldt VL, 2001, J CELL BIOL, V155, P471, DOI 10.1083/jcb.200011001; Tome ME, 1997, BIOCHEM J, V328, P847; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	35	101	119	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49251	49258		10.1074/jbc.M407165200	http://dx.doi.org/10.1074/jbc.M407165200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371445	hybrid			2022-12-27	WOS:000225098100092
J	van der Goot, FG; van Nhieu, GT; Allaoui, A; Sansonetti, P; Lafont, F				van der Goot, FG; van Nhieu, GT; Allaoui, A; Sansonetti, P; Lafont, F			Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLEXNERI IPA INVASINS; III PROTEIN SECRETION; SHIGELLA-FLEXNERI; EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; SERINE PALMITOYLTRANSFERASE; YERSINIA-ENTEROCOLITICA; TRANSLOCATION PORE; PLASMA-MEMBRANE	Infection by the Gram-negative bacterial pathogen Shigella flexneri depends on its ability to invade host cells. Bacterial engulfment requires a functional type III secretion system (TTSS) allowing the translocation into host cells of bacterial effectors that activate cell-signaling cascades. We demonstrated previously that specialized lipid membrane domains enriched in cholesterol and sphingolipids (rafts) are involved during early steps of invasion, namely in binding and host cell entry. In this study, we addressed the issue of contact-mediated secretion by the TTSS. We show that contact-mediated and TTSS-induced hemolysis depend on the presence of cholesterol on the host cell surface. We found that purified detergent resistant membranes were able to activate TTSS. Finally, we found that artificial liposomes, devoid of proteins, were able to activate the TTSS but only when their composition mimicked that of lipid rafts. Altogether, these data indicate that specific lipid packing can trigger contact-mediated secretion by S. flexneri.	Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland; Inst Pasteur, INSERM, U389, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; Free Univ Brussels, Fac Med, Lab Bacteriol Mol, B-1070 Brussels, Belgium	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Lafont, F (corresponding author), Univ Geneva, Fac Med, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	Frank.Lafont@medecine.unige.ch	van der Goot, Gisou G/B-2279-2012; Van Nhieu, Guy Tran/Y-6359-2018	van der Goot, Gisou G/0000-0002-8522-274X; Van Nhieu, Guy Tran/0000-0002-3901-2186; Lafont, frank/0000-0001-8668-2580				Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2001, J BIOL CHEM, V276, P30729, DOI 10.1074/jbc.M102039200; ADAM T, 1995, J CELL BIOL, V129, P367, DOI 10.1083/jcb.129.2.367; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; ALLAOUI A, 1993, MOL MICROBIOL, V7, P59, DOI 10.1111/j.1365-2958.1993.tb01097.x; ALLAOUI A, 1993, INFECT IMMUN, V61, P1707, DOI 10.1128/IAI.61.5.1707-1714.1993; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Barzu S, 1997, INFECT IMMUN, V65, P1599; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Daefler S, 1999, MOL MICROBIOL, V31, P45, DOI 10.1046/j.1365-2958.1999.01141.x; De Geyter C, 2000, EUR J BIOCHEM, V267, P5769, DOI 10.1046/j.1432-1327.2000.01649.x; DeGeyter C, 1997, FEBS LETT, V400, P149, DOI 10.1016/S0014-5793(96)01379-8; Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Giocondi MC, 2004, BIOPHYS J, V86, P861, DOI 10.1016/S0006-3495(04)74161-2; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; HANADA K, 1990, J BIOL CHEM, V265, P22137; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; Jin QL, 2003, MICROBES INFECT, V5, P301, DOI 10.1016/S1286-4579(03)00032-7; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kenny B, 2002, INT J MED MICROBIOL, V291, P469; Knodler LA, 2003, MOL MICROBIOL, V49, P685, DOI 10.1046/j.1365-2958.2003.03598.x; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; Mounier J, 1997, INFECT IMMUN, V65, P774, DOI 10.1128/IAI.65.2.774-782.1997; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1111/j.1574-6976.2001.tb00569.x; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Wachter C, 1999, MOL MICROBIOL, V31, P1695, DOI 10.1046/j.1365-2958.1999.01303.x; Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x; Zaharik ML, 2002, INT J MED MICROBIOL, V291, P593, DOI 10.1078/1438-4221-00179; ZIERLER MK, 1995, INFECT IMMUN, V63, P4024, DOI 10.1128/IAI.63.10.4024-4028.1995; Zobiack N, 2002, J CELL SCI, V115, P91	65	67	68	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47792	47798		10.1074/jbc.M406824200	http://dx.doi.org/10.1074/jbc.M406824200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364928	hybrid			2022-12-27	WOS:000224957000047
J	Takahashi, YH; Inaba, K; Ito, K				Takahashi, YH; Inaba, K; Ito, K			Characterization of the menaquinone-dependent disulfide bond formation pathway of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN DSBB; ELECTRON-TRANSPORT; RESPIRATORY-CHAIN; REDOX PROPERTIES; CYSTEINES; IDENTIFICATION; CATALYST; ROLES; DEMETHYLMENAQUINONE; UBIQUINONE	In the protein disulfide-introducing system of Escherichia coli, plasma membrane-integrated DsbB oxidizes periplasmic DsbA, the primary disulfide donor. Whereas the DsbA-DsbB system utilizes the oxidizing power of ubiquinone (UQ) under aerobic conditions, menaquinone (MK) is believed to function as an immediate electron acceptor under anaerobic conditions. Here, we characterized MK reactivities with DsbB. In the absence of UQ, DsbB was complexed with MK8 in the cell. In vitro studies showed that, by binding to DsbB in a manner competitive with UQ, MK specifically oxidized Cys(41) and Cys(44) of DsbB and activated its catalytic function to oxidize reduced DsbA. In contrast, menadione used in earlier studies proved to be a more nonspecific oxidant of DsbB. During catalysis, MK8 underwent a spectroscopic transition to develop a visible violet color (lambda(max) = 550 nm), which required a reduced state of Cys(44) as shown previously for UQ color development (lambda(max) = 500 nm) on DsbB. In an in vitro reaction system of MK8-dependent oxidation of DsbA at 30 degreesC, two reaction components were observed, one completing within minutes and the other taking > 1 h. Both of these reaction modes were accompanied by the transition state of MK, for which the slower reaction proceeded through the disulfide-linked DsbA-DsbB( MK) intermediate. The MK-dependent pathway provides opportunities to further dissect the quinone-dependent DsbA-DsbB redox reactions.	Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Japan Sci & Technol Corp, Precursory Res Embry Sci & Technol, Kyoto 6068507, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Ito, K (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.	kito@virus.kyoto-u.ac.jp		Inaba, Kenji/0000-0001-8229-0467				AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; COLLET JF, 2002, MOL MICROBIOL, V179, P2465; Dunphy P.J., 1971, METHODS ENZYMOLOGY, VVolume 18, P407, DOI [10.1016/S0076-6879(71)18035-4, DOI 10.1016/S0076-6879(71)18035-4]; Gennis R. B., 1996, ESCHERICHIA COLI SAL, P217; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Kishigami S, 1996, GENES CELLS, V1, P201, DOI 10.1046/j.1365-2443.1996.d01-233.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kobayashi T, 2001, MOL MICROBIOL, V39, P158, DOI 10.1046/j.1365-2958.2001.02229.x; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Regeimbal J, 2003, P NATL ACAD SCI USA, V100, P13779, DOI 10.1073/pnas.1935988100; Regeimbal J, 2002, J BIOL CHEM, V277, P32706, DOI 10.1074/jbc.M205433200; UNDEN G, 1988, ARCH MICROBIOL, V150, P499, DOI 10.1007/BF00422294; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; WISSENBACH U, 1990, ARCH MICROBIOL, V154, P60; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Xie T, 2002, J BIOL CHEM, V277, P1649, DOI 10.1074/jbc.M108697200; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	31	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					47057	47065		10.1074/jbc.M407153200	http://dx.doi.org/10.1074/jbc.M407153200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347648	hybrid			2022-12-27	WOS:000224832400091
J	Kato, S; Ueno, T; Fukuzumi, S; Watanabe, Y				Kato, S; Ueno, T; Fukuzumi, S; Watanabe, Y			Catalase reaction by myoglobin mutants and native catalase - Mechanistic investigation by kinetic isotope effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SPERM-WHALE MYOGLOBIN; COMPOUND-I FORMATION; HYDROGEN-PEROXIDE; HORSERADISH-PEROXIDASE; ELECTRON-TRANSFER; DISTAL HISTIDINE; BOND-CLEAVAGE; HEME ENZYMES; CHLOROPEROXIDASE	The catalase reaction has been studied in detail by using myoglobin (Mb) mutants. Compound I of Mb mutants (Mb-I), a ferryl species ( Fe(IV) = O) paired with a porphyrin radical cation, is readily prepared by the reaction with a nearly stoichiometric amount of m-chloroperbenzoic acid. Upon the addition of H2O2 to an Mb-I solution, Mb-I is reduced back to the ferric state without forming any intermediates. This indicates that Mb-I is capable of performing two-electron oxidation of H2O2 ( catalatic reaction). Gas chromatography-mass spectroscopy analysis of the evolved O-2 from a 50: 50 mixture of (H2O2)-O-18/(H2O2)-O-16 solution containing H64D or F43H/H64L Mb showed the formation of O-18(2) (m/e = 36) and O-16(2) (m/e = 32) but not (OO)-O-16-O-18 (m/e = 34). This implies that O-2 is formed by two-electron oxidation of H2O2 without breaking the O T O bond. Deuterium isotope effects on the catalatic reactions of Mb mutants and catalase suggest that the catalatic reactions of Micrococcus lysodeikticus catalase and F43H/H64L Mb proceed via an ionic mechanism with a small isotope effect of less than 4.0, since the distal histidine residue is located at a proper position to act as a general acid-base catalyst for the ionic reaction. In contrast, other Mb mutants such as H64X (X is Ala, Ser, and Asp) and L29H/H64L Mb oxidize H2O2 via a radical mechanism in which a hydrogen atom is abstracted by Mb-I with a large isotope effect in a range of 10 - 29, due to a lack of the general acid-base catalyst.	Nagoya Univ, Dept Chem, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; Grad Univ Adv Studies, Dept Struct Mol Sci, Okazaki, Aichi 4448585, Japan; Nagoya Univ, Res Ctr Mat Sci, Nagoya, Aichi 4648602, Japan; Osaka Univ, JST, CREST, Grad Sch Engn,Dept Mat & Life Sci, Suita, Osaka 5650871, Japan	Nagoya University; Graduate University for Advanced Studies - Japan; Nagoya University; Japan Science & Technology Agency (JST); Osaka University	Watanabe, Y (corresponding author), Nagoya Univ, Dept Chem, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.	yoshi@nucc.cc.nagoya-u.ac.jp	Fukuzumi, Shunichi/E-4728-2010					ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; ARAISO T, 1981, CAN J BIOCHEM CELL B, V59, P233, DOI 10.1139/o81-031; BISHOP GR, 1995, BIOCHEMISTRY-US, V34, P12082, DOI 10.1021/bi00037a052; BONNICHSEN RK, 1947, ACTA CHEM SCAND, V1, P685, DOI 10.3891/acta.chem.scand.01-0685; BRILL AS, 1961, BIOCHEM J, V78, P253, DOI 10.1042/bj0780253; CHANCE B, 1950, BIOCHEM J, V46, P387, DOI 10.1042/bj0460387; CHANCE B, 1952, ARCH BIOCHEM BIOPHYS, V37, P301, DOI 10.1016/0003-9861(52)90194-X; CHANCE B, 1950, BIOCHEM J, V46, P402, DOI 10.1042/bj0460402; COTTON ML, 1973, CAN J CHEM, V51, P582, DOI 10.1139/v73-088; DEMONTELLANO PRO, 1985, J BIOL CHEM, V260, P9265; DUNFORD HB, 1978, CAN J CHEM, V56, P2844, DOI 10.1139/v78-468; DUNFORD HB, 1999, HEME PEROXIDASES, P435; EGEBERG KD, 1990, BIOCHEMISTRY-US, V29, P9783, DOI 10.1021/bi00494a004; FITA I, 1985, J MOL BIOL, V185, P21, DOI 10.1016/0022-2836(85)90180-9; GEORGE P, 1949, BIOCHEM J, V44, P197, DOI 10.1042/bj0440197; Goto Y, 1999, J AM CHEM SOC, V121, P9497, DOI 10.1021/ja9901359; GROVES JT, 1986, J AM CHEM SOC, V108, P7834, DOI 10.1021/ja00284a058; HAGER LP, 1972, J AM CHEM SOC, V94, P4364, DOI 10.1021/ja00767a068; Hara I, 2001, J BIOL CHEM, V276, P36067, DOI 10.1074/jbc.C100371200; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; JARNAGIN RC, 1958, J AM CHEM SOC, V80, P786, DOI 10.1021/ja01537a008; KREMER ML, 1970, BIOCHIM BIOPHYS ACTA, V198, P199, DOI 10.1016/0005-2744(70)90052-5; KWART H, 1982, ACCOUNTS CHEM RES, V15, P401, DOI 10.1021/ar00084a004; Lardinois OM, 1996, BBA-PROTEIN STRUCT M, V1295, P222, DOI 10.1016/0167-4838(96)00043-X; Matsui T, 1999, J BIOL CHEM, V274, P2838, DOI 10.1074/jbc.274.5.2838; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; Matsui T, 1997, J BIOL CHEM, V272, P32735, DOI 10.1074/jbc.272.52.32735; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; Nesheim JC, 1996, BIOCHEMISTRY-US, V35, P10240, DOI 10.1021/bi960596w; Ozaki SI, 2001, ACCOUNTS CHEM RES, V34, P818, DOI 10.1021/ar9502590; POULOS TL, 1980, J BIOL CHEM, V255, P575; RAO SI, 1993, J BIOL CHEM, V268, P803; Regelsberger G, 2000, J BIOL CHEM, V275, P22854, DOI 10.1074/jbc.M002371200; SAWAKI Y, 1979, J AM CHEM SOC, V101, P6292, DOI 10.1021/ja00515a023; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; SOROKIN A, 1993, J AM CHEM SOC, V115, P7293, DOI 10.1021/ja00069a031; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; THOMAS JA, 1970, J BIOL CHEM, V245, P3129; TschirretGuth RA, 1996, ARCH BIOCHEM BIOPHYS, V335, P93, DOI 10.1006/abbi.1996.0485; Yang HJ, 2003, BIOCHEMISTRY-US, V42, P10174, DOI 10.1021/bi034605u	41	44	45	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52376	52381		10.1074/jbc.M403532200	http://dx.doi.org/10.1074/jbc.M403532200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15347658	hybrid			2022-12-27	WOS:000225493400081
J	O'Brien, KM; Dirmeier, R; Engle, M; Poyton, RO				O'Brien, KM; Dirmeier, R; Engle, M; Poyton, RO			Mitochondrial protein oxidation in yeast mutants lacking manganese- (MnSOD) or copper- and zinc-containing superoxide dismutase (CuZnSOD) - Evidence that MnSOD and CuZnSOD have both unique and overlapping functions in protecting mitochondrial proteins from oxidative damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ELECTRON-TRANSPORT CHAIN; SACCHAROMYCES-CEREVISIAE; CU,ZN-SUPEROXIDE DISMUTASE; STATIONARY-PHASE; RAT-LIVER; HEART-MITOCHONDRIA; HYDROGEN-PEROXIDE; IN-VIVO; CELLS	Saccharomyces cerevisiae expresses two forms of superoxide dismutase (SOD): MnSOD, encoded by SOD2, which is located within the mitochondrial matrix, and CuZnSOD, encoded by SOD1, which is located in both the cytosol and the mitochondrial intermembrane space. Because two different SOD enzymes are located in the mitochondrion, we examined the relative roles of each in protecting mitochondria against oxidative stress. Using protein carbonylation as a measure of oxidative stress, we have found no correlation between overall levels of respiration and the level of oxidative mitochondrial protein damage in either wild type or sod mutant strains. Moreover, mitochondrial protein carbonylation levels in sod1, sod2, and sod1sod2 mutants are not elevated in cells harvested from mid-logarithmic and early stationary phases, suggesting that neither MnSOD nor CuZnSOD is required for protecting the majority of mitochondrial proteins from oxidative damage during these early phases of growth. During late stationary phase, mitochondrial protein carbonylation increases in all strains, particularly in sod1 and sod1sod2 mutants. By using matrix-assisted laser desorption ionization time-of-flight mass spectrometry, we have found that specific proteins become carbonylated in sod1 and sod2 mutants. We identified six mitochondrial protein spots representing five unique proteins that become carbonylated in a sod1 mutant and 19 mitochondrial protein spots representing 11 unique proteins that become carbonylated in a sod2 mutant. Although some of the same proteins are carbonylated in both mutants, other proteins are not. These findings indicate that MnSOD and CuZnSOD have both unique and overlapping functions in the mitochondrion.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Poyton, RO (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	Poyton@spot.colorado.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030228] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30228] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 1995, MECH AGEING DEV, V85, P55, DOI 10.1016/0047-6374(95)01655-4; Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; CASTRO L, 1994, J BIOL CHEM, V269, P29409; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Costa Vitor, 2001, Molecular Aspects of Medicine, V22, P217, DOI 10.1016/S0098-2997(01)00012-7; Costa WMV, 2002, FREE RADICAL BIO MED, V33, P1507, DOI 10.1016/S0891-5849(02)01086-9; Dirmeier R, 2004, METHOD ENZYMOL, V381, P589; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Fortuniak A, 1996, BIOCHEM MOL BIOL INT, V38, P1271; GELLER BL, 1982, J BIOL CHEM, V257, P8945; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; GRALLA EB, 1992, ADV GENET, V30, P251, DOI 10.1016/S0065-2660(08)60322-3; GRALLA EB, 1997, OXIDATIVE STRESS MOL, P495; GUIDOT DM, 1993, J BIOL CHEM, V268, P26699; Hawkins CL, 2001, BBA-BIOENERGETICS, V1504, P196, DOI 10.1016/S0005-2728(00)00252-8; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Jung CW, 2002, J NEUROCHEM, V83, P535, DOI 10.1046/j.1471-4159.2002.01112.x; KELLER GA, 1991, P NATL ACAD SCI USA, V88, P7381, DOI 10.1073/pnas.88.16.7381; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacMillan-Crow LA, 2001, FREE RADICAL RES, V34, P325, DOI 10.1080/10715760100300281; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Norbeck J, 1997, YEAST, V13, P1519, DOI 10.1002/(SICI)1097-0061(199712)13:16<1519::AID-YEA211>3.0.CO;2-U; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Poyton RO, 1998, NAT GENET, V20, P316, DOI 10.1038/3778; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V376, P59, DOI 10.1006/abbi.1999.1680; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; SHERMAN F, 1983, METHODS YEAST GENETI, P62; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	52	100	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51817	51827		10.1074/jbc.M405958200	http://dx.doi.org/10.1074/jbc.M405958200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15385544	hybrid			2022-12-27	WOS:000225493400014
J	Yokokura, T; Dresnek, D; Huseinovic, N; Lisi, S; Abdelwahid, E; Bangs, P; White, K				Yokokura, T; Dresnek, D; Huseinovic, N; Lisi, S; Abdelwahid, E; Bangs, P; White, K			Dissection of DIAP1 functional domains via a mutant replacement strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE OMI/HTRA2; DROSOPHILA CASPASE DRONC; PROGRAMMED CELL-DEATH; APOPTOSIS PROTEINS; IAP PROTEINS; GRIM-REAPER; REGULATING APOPTOSIS; STRUCTURAL BASIS; LIGASE ACTIVITY; HID	Inhibitor of apoptosis proteins (IAPs) act as endogenous inhibitors of active caspases. Drosophila IAP1 (DIAP1) activity is required to keep cells from undergoing apoptosis. The central cell death regulators Reaper and Hid induce apoptosis very rapidly by inhibiting DIAP1 function. We have developed a system for replacing endogenous DIAP1 with mutant forms of the protein, allowing us to examine the roles of various domains of the protein in living and dying cells. We found that DIAP1 is cleaved by a caspase early after the initiation of apoptosis. This cleavage is required for DIAP1 degradation, but Rpr and Hid can still initiate apoptosis in the absence of cleavage. The cleavage of DIAP1 promotes DIAP1 degradation in a manner dependent on the function of the ubiquitin ligase function of the DIAP1 ring domain. This ring domain function is required for Hid-induced apoptosis. We propose a model that synthesizes our data with those of other laboratories and provide a consistent model for DIAP1 function in living and dying cells.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	White, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	kristin.white@CBRC2.MGH.Harvard.edu	White, Kristin/D-7936-2013		NIGMS NIH HHS [R01 GM055568, GM55568] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergmann A, 2003, CURR OPIN CELL BIOL, V15, P717, DOI 10.1016/j.ceb.2003.10.002; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chai JJ, 2003, NAT STRUCT BIOL, V10, P892, DOI 10.1038/nsb989; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Lisi S, 2000, GENETICS, V154, P669; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Olson MR, 2003, J BIOL CHEM, V278, P4028, DOI 10.1074/jbc.M209734200; Palaga T, 2002, NAT CELL BIOL, V4, pE149, DOI 10.1038/ncb0602-e149; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Song ZW, 2000, MOL CELL BIOL, V20, P2907, DOI 10.1128/MCB.20.8.2907-2914.2000; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wing JP, 2002, CURR BIOL, V12, P131, DOI 10.1016/S0960-9822(01)00664-9; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zachariou A, 2003, EMBO J, V22, P6642, DOI 10.1093/emboj/cdg617; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068	52	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52603	52612		10.1074/jbc.M409691200	http://dx.doi.org/10.1074/jbc.M409691200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15371434	hybrid			2022-12-27	WOS:000225493400107
J	Arai, H; Furuya, T; Yasuda, T; Miura, M; Mizuno, Y; Mochizuki, H				Arai, H; Furuya, T; Yasuda, T; Miura, M; Mizuno, Y; Mochizuki, H			Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1 beta, and expression of caspase-11 in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE INTRANIGRAL INJECTION; GROWTH-FACTOR-ALPHA; PARKINSONS-DISEASE; INNATE IMMUNITY; MOUSE MODEL; CELL-DEATH; RAT-BRAIN; SYSTEM; NEURODEGENERATION; DEGENERATION	The endotoxin lipopolysaccharide (LPS), a component of the Gram-negative bacterial cell wall, selectively induces degeneration of substantia nigral (SN) dopaminergic neurons via activation of microglial cells in rats and mice. Caspase-11 plays a crucial role in LPS-induced septic shock in mice. We examined the mechanism of LPS neurotoxicity on SN dopaminergic neurons in C57BL/6 mice and caspase-11 knockout mice. Mice were stereotaxically injected with LPS into the SN on one side and vehicle into the SN of the other side. Immunohistochemistry, Western blotting analysis, enzyme-linked immunosorbent assay, and reverse transcriptase-PCR were performed to evaluate damage of SN dopaminergic neurons and activation of microglial cells. Intranigral injection of LPS at 1 or 3 mug/mul/site decreased tyrosine hydroxylase-positive neurons and increased microglial cells in the SN compared with the contralateral side injected with vehicle at days 7 and 14 post-injection in C57BL/6 mice. Intranigral injection of LPS at 3 mug/mul/ site induced the expression of caspase-11 mRNA in the ventral midbrain at 6, 8, and 12 h postinjection, and the expression of caspase-11-positive cells in the SN at 8 and 12 h post-injection. Moreover, LPS at 3 mug/mul/ site increased interleukin-1beta content in the ventral midbrain at 12 and 24 h post-injection. LPS failed to elicit these responses in caspase-11 knockout mice. Our results indicate that the neurotoxic effects of LPS on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and caspase-11 expression in mice.	Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138421, Japan; Juntendo Univ, Sch Med, Res Inst Dis Old Ages, Bunkyo Ku, Tokyo 1138421, Japan; Univ Tokyo, Dept Genet, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Juntendo University; Juntendo University; University of Tokyo	Mochizuki, H (corresponding author), Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hideki@med.juntendo.ac.jp						Castano A, 1998, J NEUROCHEM, V70, P1584; Castano A, 2002, J NEUROCHEM, V81, P150, DOI 10.1046/j.1471-4159.2002.00799.x; Duan YL, 2003, J NEUROBIOL, V57, P183, DOI 10.1002/neu.10262; Fischer HG, 2001, J IMMUNOL, V166, P2717, DOI 10.4049/jimmunol.166.4.2717; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x; Herrera AJ, 2000, NEUROBIOL DIS, V7, P429, DOI 10.1006/nbdi.2000.0289; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kim NG, 2003, MOL BRAIN RES, V114, P107, DOI 10.1016/S0169-328X(03)00135-9; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Klevenyi P, 1999, NEUROREPORT, V10, P635, DOI 10.1097/00001756-199902250-00035; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Liu B, 2000, J PHARMACOL EXP THER, V295, P125; MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mochizuki H, 2001, P NATL ACAD SCI USA, V98, P10918, DOI 10.1073/pnas.191107398; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5	33	95	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51647	51653		10.1074/jbc.M407328200	http://dx.doi.org/10.1074/jbc.M407328200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383538	hybrid			2022-12-27	WOS:000225355800120
J	Bransteitter, R; Pham, P; Calabrese, P; Goodman, MF				Bransteitter, R; Pham, P; Calabrese, P; Goodman, MF			Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; POLYMERASE-ETA; B-CELLS; AID; MUTATION; REGION; MECHANISM	The synthesis of high affinity antibodies requires activation-induced cytidine deaminase ( AID) to initiate somatic hypermutation and class-switch recombination. Here we investigate AID-catalyzed deamination of C --> U on single-stranded DNA and on actively transcribed closed circular double-stranded DNA. Mutations are initially favored at canonical WRC ( W = A or T, R = A or G) somatic hypermutation hot spot motifs, but over time mutations at neighboring non-hot spot sites increase creating random clusters of mutated regions in a seemingly processive manner. N-terminal AID mutants R35E and R35E/R36D appear less processive and have altered mutational specificity compared with wild type AID. In contrast, a C-terminal deletion mutant defective in CSR in vivo closely resembles wild type AID. A mutational spectrum generated during transcription of closed circular double-stranded DNA indicates that wild type AID retains its specificity for WRC hot spot motifs within the confines of a moving transcription bubble while introducing clusters of multiple deaminations predominantly on the nontranscribed strand.	Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Univ So Calif, Dept Chem, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, SHS Rm 172,Univ Pk, Los Angeles, CA 90089 USA.	mgoodman@usc.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422, R01GM021422] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES012259] Funding Source: Medline; NIGMS NIH HHS [GM21422] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Bhagwat AS, 2004, DNA REPAIR, V3, P85, DOI 10.1016/j.dnarep.2003.09.008; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; LEBECQUE SG, 1990, J EXP MED, V172, P1717, DOI 10.1084/jem.172.6.1717; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Liu YJ, 1996, IMMUNITY, V4, P603, DOI 10.1016/S1074-7613(00)80486-0; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; RADA C, 1994, EUR J IMMUNOL, V24, P1453, DOI 10.1002/eji.1830240632; Rada C, 2001, EMBO J, V20, P4570, DOI 10.1093/emboj/20.16.4570; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Shapiro GS, 2002, J IMMUNOL, V168, P2302, DOI 10.4049/jimmunol.168.5.2302; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	41	120	123	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51612	51621		10.1074/jbc.M408135200	http://dx.doi.org/10.1074/jbc.M408135200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371439	hybrid			2022-12-27	WOS:000225355800117
J	Corre, S; Primot, A; Sviderskaya, E; Bennett, DC; Vaulont, S; Goding, CR; Galibert, MD				Corre, S; Primot, A; Sviderskaya, E; Bennett, DC; Vaulont, S; Goding, CR; Galibert, MD			UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR USF; LOOP-HELIX PROTEINS; PROOPIOMELANOCORTIN GENE; HUMAN MELANOCYTES; TYROSINASE GENE; RECEPTOR MC1R; DNA-BINDING; CYCLIC-AMP; P38 KINASE; ALPHA-MSH	Protection against UV-mediated DNA damage and the onset of oncogenesis is afforded by the tanning response in which UV irradiation triggers melanocytes to increase production of melanin that is then transferred to keratinocytes. A key component of the tanning process is the UV-mediated induction of the pro-opiomelanocortin (POMC) and MC1R genes encoding the alpha-melanocyte-stimulating hormone and its receptor, respectively, which play a crucial role in pigmentation by regulating the intracellular levels of cAMP. How these genes are regulated in response to UV irradiation is not known. Here we have shown that UV-induced activation of the POMC and MC1R promoters is mediated by p38 stress-activated kinase signaling to the transcription factor, upstream stimulating factor-1 (USF-1). Importantly, melanocytes derived from USF-1 -/- mice exhibit a defective UV response and fail to activate POMC and MC1R expression in response to UV irradiation. The results define USF-1 as a critical UV-responsive activator of genes implicated in protection from solar radiation.	Univ Rennes 1, Fac Med, CNRS,UMR 6061, Lab Genet & Dev, F-35043 Rennes, France; Univ London St Georges Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England; Fac Med Cochin, Inst Cochin, Dept Genet Dev & Pathol Mol, F-75014 Paris, France; Marie Curie Res Inst, Eukaryot Transcript Lab, Surrey RH8 OTL, England	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; St Georges University London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Galibert, MD (corresponding author), Univ Rennes 1, Fac Med, CNRS,UMR 6061, Lab Genet & Dev, 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	mgaliber@univ-rennes1.fr	Sviderskaya, Elena V/D-2419-2009; Vaulont, Sophie/O-6732-2017; Bennett, Dorothy C/C-2418-2008; CORRE, Sebastien/B-7069-2018	Bennett, Dorothy C/0000-0002-3639-7527; CORRE, Sebastien/0000-0003-1532-5660; Goding, Colin/0000-0002-1614-3909				ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; ABDELMALEK Z, 2004, PIGM CELL RES, V17, P436; Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Alpert D, 1999, J BIOL CHEM, V274, P22176, DOI 10.1074/jbc.274.32.22176; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3; ARLETT CF, 1993, CANCER RES, V53, P609; Bastiaens M, 2001, HUM MOL GENET, V10, P1701, DOI 10.1093/hmg/10.16.1701; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; GALIBERT MD, 1993, J IMMUNOL, V151, P6099; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; Hadley ME, 1999, ANN NY ACAD SCI, V885, P1; HALAZONETIS TD, 1991, P NATL ACAD SCI USA, V88, P6162, DOI 10.1073/pnas.88.14.6162; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Imokawa G, 1997, PIGM CELL RES, V10, P218, DOI 10.1111/j.1600-0749.1997.tb00488.x; IMOKAWA G, 1995, J INVEST DERMATOL, V105, P32, DOI 10.1111/1523-1747.ep12312500; Kadekaro AL, 2003, PIGM CELL RES, V16, P434, DOI 10.1034/j.1600-0749.2003.00088.x; Kozawa O, 1999, J CELL BIOCHEM, V74, P479, DOI 10.1002/(SICI)1097-4644(19990901)74:3<479::AID-JCB15>3.3.CO;2-0; Kvam E, 1997, CARCINOGENESIS, V18, P2379, DOI 10.1093/carcin/18.12.2379; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Moro O, 1999, BIOCHEM BIOPH RES CO, V262, P452, DOI 10.1006/bbrc.1999.1228; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; North S, 1999, ONCOGENE, V18, P1945, DOI 10.1038/sj.onc.1202506; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Rana BK, 1999, GENETICS, V151, P1547; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; Scott MC, 2002, PIGM CELL RES, V15, P433, DOI 10.1034/j.1600-0749.2002.02051.x; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Sturm RA, 2003, PIGM CELL RES, V16, P266, DOI 10.1034/j.1600-0749.2003.00041.x; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; Thody AJ, 1999, ANN NY ACAD SCI, V885, P217, DOI 10.1111/j.1749-6632.1999.tb08679.x; Tsatmalia M, 1999, ANN NY ACAD SCI, V885, P466; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	53	99	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51226	51233		10.1074/jbc.M409768200	http://dx.doi.org/10.1074/jbc.M409768200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15358786	hybrid			2022-12-27	WOS:000225355800070
J	Deroo, T; Denayer, T; Van Roy, F; Vleminckx, K				Deroo, T; Denayer, T; Van Roy, F; Vleminckx, K			Global inhibition of Lef1/Tcf-dependent Wnt signaling at its nuclear end point abrogates development in transgenic Xenopus embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MEDIATED TRANSCRIPTION; GENE-EXPRESSION; MAMMARY-GLAND; STEM-CELLS; PATHWAY; PROTEIN; COMPLEX; APOPTOSIS; LAEVIS	Analysis of canonical Wnt signaling during vertebrate development by means of knock-out or transgenic approaches is often hampered by functional redundancy as well as pathway bifurcations downstream of the manipulated components. We report the design of an optimized chimera capable of blocking transcriptional activation of Lef1/Tcf-beta-catenin target genes, thus enabling intervention with the canonical Wnt pathway at its nuclear end point. This construct was made hormone-inducible, both functionally and transcriptionally, and was transgenically integrated in Xenopus embryos. Down-regulation of target genes was clearly observed upon treatment of these embryos with dexamethasone. In addition, exposure of variously aged transgenic embryos to dexamethasone caused complex phenotypes with many new but also several recognizable features stemming from inhibition of canonical Wnt signaling. At least in some tissues, a significant reduction in cell proliferation and an increase in programmed cell death appeared to underlie these phenotypes. Our inducible transgenic system can serve a broad range of experimental settings designed to unveil new functional aspects of Lef1/ Tcf-beta-catenin signaling during vertebrate embryogenesis.	Univ Ghent, Flainders Interuniv Biotechnol, Dev Biol Unit, B-9052 Ghent, Belgium; Univ Ghent, Flainders Interuniv Biotechnol, Dept Mol Biomed Res, Mol Cell Biol Unit, B-9052 Ghent, Belgium	Ghent University; Ghent University	Vleminckx, K (corresponding author), Univ Ghent, Flainders Interuniv Biotechnol, Dev Biol Unit, B-9052 Ghent, Belgium.	Kris.Vleminckx@dmbr.ugent.be	van Roy, Frans M/C-6123-2009; Vleminckx, Kris/J-5699-2013	van Roy, Frans M/0000-0003-4358-1039; 				Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Baker RK, 2001, MECH DEVELOP, V104, P129, DOI 10.1016/S0925-4773(01)00363-X; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beck CW, 1999, DEVELOPMENT, V126, P1611; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Das B, 2004, P NATL ACAD SCI USA, V101, P4839, DOI 10.1073/pnas.0401011101; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Ishizuya-Oka A, 1997, DEV BIOL, V192, P149, DOI 10.1006/dbio.1997.8749; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kessler DS, 1997, P NATL ACAD SCI USA, V94, P13017, DOI 10.1073/pnas.94.24.13017; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; ONATE SA, 1995, SCIENCE, V270, P1354; Picard D, 2000, METHOD ENZYMOL, V327, P385, DOI 10.1016/S0076-6879(00)27291-1; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Schwartz DR, 2003, CANCER RES, V63, P2913; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tepera SB, 2003, J CELL SCI, V116, P1137, DOI 10.1242/jcs.00334; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong MH, 2002, J BIOL CHEM, V277, P15843, DOI 10.1074/jbc.M200184200; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	50	18	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50670	50675		10.1074/jbc.M408969200	http://dx.doi.org/10.1074/jbc.M408969200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371453	hybrid			2022-12-27	WOS:000225355800007
J	Giessl, A; Pulvermuller, A; Trojan, P; Park, JH; Choe, HW; Ernst, OP; Hofmann, KP; Wolfrum, U				Giessl, A; Pulvermuller, A; Trojan, P; Park, JH; Choe, HW; Ernst, OP; Hofmann, KP; Wolfrum, U			Differential expression and interaction with the visual G-protein transducin of centrin isoforms in mammalian photoreceptor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC SPINDLE POLES; ROD OUTER SEGMENTS; LIGHT-SCATTERING; CA2+-BINDING PROTEINS; RAT RETINA; RHODOPSIN; TRANSLOCATION; ACTIVATION; MECHANISM; BINDING	Photoisomerization of rhodopsin activates a heterotrimeric G-protein cascade leading to closure of cGMP-gated channels and hyperpolarization of photoreceptor cells. Massive translocation of the visual G-protein transducin, G(t), between subcellular compartments contributes to long term adaptation of photoreceptor cells. Ca2+-triggered assembly of a centrin-transducin complex in the connecting cilium of photoreceptor cells may regulate these transducin translocations. Here we demonstrate expression of all four known, closely related centrin isoforms in the mammalian retina. Interaction assays revealed binding potential of the four centrin isoforms to G(t)betagamma heterodimers. High affinity binding to G(t)betagamma and subcellular localization of the centrin isoforms Cen1 and Cen2 in the connecting cilium indicated that these isoforms contribute to the centrin-transducin complex and potentially participate in the regulation of transducin translocation through the photoreceptor cilium. Binding of Cen2 and Cen4 to Gbetagamma of non-visual G-proteins may additionally regulate G-proteins involved in centrosome and basal body functions.	Univ Mainz, Inst Zool, Abt 1, D-55099 Mainz, Germany; Charite Univ Med Berlin, Inst Med Phys, D-10098 Berlin, Germany; Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea	Johannes Gutenberg University of Mainz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University	Pulvermuller, A (corresponding author), Univ Mainz, Inst Zool, Abt 1, Mullerweg 6, D-55099 Mainz, Germany.	alexander.pulvermueller@charite.de; wolfrum@mail.uni-mainz.de		Giessl, Andreas/0000-0002-9768-2049				BARON AT, 1992, BIOL CELL, V76, P383, DOI 10.1016/0248-4900(92)90442-4; BARON AT, 1991, CELL MOTIL CYTOSKEL, V18, P1, DOI 10.1002/cm.970180102; Besharse JC., 1990, CILIARY FLAGELLAR ME, P389; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Cismowski MJ, 2001, LIFE SCI, V68, P2301, DOI 10.1016/S0024-3205(01)01019-0; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; ERRABOLU R, 1994, J CELL SCI, V107, P9; Gavet O, 2003, MOL BIOL CELL, V14, P1818, DOI 10.1091/mbc.E02-11-0709; GIESSL A, 2004, CELL BIOL RELATED DI, P195; Goldstein B, 2003, CURR BIOL, V13, pR879, DOI 10.1016/j.cub.2003.10.050; Hardie R, 2002, NEURON, V34, P3, DOI 10.1016/S0896-6273(02)00650-5; Hart PE, 2001, GENE, V264, P205, DOI 10.1016/S0378-1119(01)00342-0; Heck M, 2000, METHOD ENZYMOL, V315, P329; HECK M, 1993, BIOCHEMISTRY-US, V32, P8220, DOI 10.1021/bi00083a024; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Knust E, 2001, CELL, V107, P125, DOI 10.1016/S0092-8674(01)00534-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laoukili J, 2000, J CELL SCI, V113, P1355; LEE VD, 1993, P NATL ACAD SCI USA, V90, P11039, DOI 10.1073/pnas.90.23.11039; Levy YY, 1996, CELL MOTIL CYTOSKEL, V33, P298; Madeddu L, 1996, EUR J BIOCHEM, V238, P121, DOI 10.1111/j.1432-1033.1996.0121q.x; Matthews HR, 2001, J PHYSIOL-LONDON, V532, P305, DOI 10.1111/j.1469-7793.2001.0305f.x; Meng TC, 1996, MOL BIOCHEM PARASIT, V79, P103, DOI 10.1016/0166-6851(96)02636-9; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; MOLDAY RS, 2000, MOL MECH VISUAL TRAN, V3, P143; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Popescu A, 2003, J BIOL CHEM, V278, P40252, DOI 10.1074/jbc.M302546200; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; PULVERMULLER A, 1993, BIOCHEMISTRY-US, V32, P14082, DOI 10.1021/bi00214a002; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SALISBURY JL, 1989, J PHYCOL, V25, P201; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; SALISBURY JL, 1988, J CELL BIOL, V107, P635, DOI 10.1083/jcb.107.2.635; SCHIEBEL E, 1995, TRENDS CELL BIOL, V5, P197, DOI 10.1016/S0962-8924(00)88999-0; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schroder K, 2002, J BIOL CHEM, V277, P43987, DOI 10.1074/jbc.M206211200; SMITH HG, 1975, EXP EYE RES, V20, P211, DOI 10.1016/0014-4835(75)90134-7; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SPANG A, 1995, J CELL BIOL, V128, P863, DOI 10.1083/jcb.128.5.863; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Wiech H, 1996, J BIOL CHEM, V271, P22453, DOI 10.1074/jbc.271.37.22453; WOLFRUM U, 1995, CELL MOTIL CYTOSKEL, V32, P55, DOI 10.1002/cm.970320107; Wolfrum U, 2000, CELL MOTIL CYTOSKEL, V46, P95, DOI 10.1002/1097-0169(200006)46:2<95::AID-CM2>3.0.CO;2-Q; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; Wolfrum U, 2002, ADV EXP MED BIOL, V514, P155; WOLFRUM U, 1991, CELL TISSUE RES, V266, P231, DOI 10.1007/BF00318178; WOTTRICH R, 1998, THESIS U KARLSRUHE K	56	66	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51472	51481		10.1074/jbc.M406770200	http://dx.doi.org/10.1074/jbc.M406770200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15347651	hybrid			2022-12-27	WOS:000225355800100
J	Jana, A; Pahan, K				Jana, A; Pahan, K			Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase - Implications for Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR-PROTEIN; TRANSGENIC MICE; CELL-DEATH; CERAMIDE PRODUCTION; ADOPTIVE TRANSFER; APOPTOSIS; CHOLESTEROL; INVOLVEMENT; ASTROCYTES; PATHWAY	Alzheimer's disease is a major illness of dementia characterized by the presence of amyloid plaques, neurofibrillary tangles, and extensive neuronal apoptosis. However, the mechanism behind neuronal apoptosis in the Alzheimer's-diseased brain is poorly understood. This study underlines the importance of neutral sphingomyelinase in fibrillar Abeta peptide-induced apoptosis and cell death in human primary neurons. Abeta1-42 peptides induced the activation of sphingomyelinases and the production of ceramide in neurons. Interestingly, neutral (N-SMase), but not acidic (A-SMase), sphingomyelinase was involved in Abeta1-42-mediated neuronal apoptosis and cell death. Abeta1-42-induced production of ceramide was redox-sensitive, as reactive oxygen species were involved in the activation of N-SMase but not A-SMase. Abeta1-42 peptides induced the NADPH oxidase-mediated production of superoxide radicals in neurons that was involved in the activation of N-SMase, but not A-SMase, via hydrogen peroxide. Consistently, superoxide radicals generated by hypoxanthine and xanthine oxidase also induced the activation of N-SMase, but not A-SMase, through a catalase-sensitive pathway. Furthermore, antisense knockdown of p22phox, a subunit of NADPH oxidase, inhibited Abeta1-42-induced neuronal apoptosis and cell death. These studies suggest that fibrillar Abeta1-42 peptides induce neuronal apoptosis through the NADPH oxidase-superoxide-hydrogen peroxide-NS-Mase-ceramide pathway.	Univ Nebraska, Med Ctr, Dept Oral Biol, Sect Neurosci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska Medical Center	Pahan, K (corresponding author), Univ Nebraska, Med Ctr, Dept Oral Biol, Sect Neurosci, 40th & Holdrege, Lincoln, NE 68583 USA.	kpahan@unmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG019487] Funding Source: NIH RePORTER; NIA NIH HHS [AG19487, R03 AG019487-01] Funding Source: Medline; NINDS NIH HHS [R01 NS039940, NS39940, R01 NS039940-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Bastianetto S, 2000, EUR J NEUROSCI, V12, P1882, DOI 10.1046/j.1460-9568.2000.00069.x; BLOOMFIELD M, 1992, Biochemical Society Transactions, V20, p293S; Brugg B, 1996, J NEUROCHEM, V66, P733; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dasgupta S, 2003, J IMMUNOL, V170, P3874, DOI 10.4049/jimmunol.170.7.3874; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Masliah E, 1996, J NEUROSCI, V16, P5795; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pahan K, 1998, J BIOL CHEM, V273, P2591, DOI 10.1074/jbc.273.5.2591; Pahan K, 2000, J NEUROCHEM, V75, P576, DOI 10.1046/j.1471-4159.2000.0750576.x; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Singh I, 1998, J BIOL CHEM, V273, P20354, DOI 10.1074/jbc.273.32.20354; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; Wiesner DA, 1996, J NEUROCHEM, V66, P1418; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	28	154	167	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51451	51459		10.1074/jbc.M404635200	http://dx.doi.org/10.1074/jbc.M404635200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452132	Green Accepted, hybrid			2022-12-27	WOS:000225355800097
J	Mackey, AT; Sproul, LR; Sontag, CA; Satterwhite, LL; Correia, JJ; Gilbert, SP				Mackey, AT; Sproul, LR; Sontag, CA; Satterwhite, LL; Correia, JJ; Gilbert, SP			Mechanistic analysis of the Saccharomyces cerevisiae kinesin Kar3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-DIRECTED MOTOR; MITOTIC SPINDLE; SEDIMENTATION-VELOCITY; KINETIC MECHANISM; PROTEIN CIK1P; BUDDING YEAST; MEIOSIS-I; MICROTUBULE; NCD; ATPASE	Kar3 is a minus-end-directed microtubule motor that is implicated in meiotic and mitotic spindle function in Saccharomyces cerevisiae. To date, the only truncated protein of Kar3 that has been reported to promote unidirectional movement in vitro is GSTKar3. This motor contains an NH2-terminal glutathione S-transferase (GST) tag followed by the Kar3 sequence that is predicted to form an extended alpha-helical coiled-coil. The alpha-helical domain leads into the neck linker and COOH-terminal motor domain. Kar3 does not homodimerize with itself but forms a heterodimer with either Cik1 or Vik1, both of which are non-motor polypeptides. We evaluated the microtubule-GSTKar3 complex in comparison to the microtubule-Kar3 motor domain complex to determine the distinctive mechanistic features required for GSTKar3 motility. Our results indicate that ATP binding was significantly faster for GSTKar3 than that observed previously for the Kar3 motor domain. In addition, microtubule-activated ADP release resulted in an intermediate that bound ADP weakly in contrast to the Kar3 motor domain, suggesting that after ADP release, the microtubule-GSTKar3 motor binds ATP in preference to ADP. The kinetics also showed that GSTKar3 readily detached from the microtubule rather than remaining bound for multiple ATP turnovers. These results indicate that the extended alpha-helical domain NH2-terminal to the catalytic core provides the structural transitions in response to the ATPase cycle that are critical for motility and that dimerization is not specifically required. This study provides the foundation to define the mechanistic contributions of Cik1 and Vik1 for Kar3 force generation and function in vivo.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; Duke Univ, Med Ctr, Dept Med Cardiol, Durham, NC 27710 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Mississippi; University of Mississippi Medical Center; Duke University	Gilbert, SP (corresponding author), Univ Pittsburgh, Dept Biol Sci, 518 Langley Hall, Pittsburgh, PA 15260 USA.	spg1@pitt.edu		Hoverman, Lisa/0000-0002-3396-6982	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141] Funding Source: NIH RePORTER; NIAMS NIH HHS [K02 AR047841, K02-AR47841] Funding Source: Medline; NIGMS NIH HHS [R37 GM054141, R01 GM054141, GM54141] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; BascomSlack CA, 1997, J CELL BIOL, V139, P459, DOI 10.1083/jcb.139.2.459; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; CORREIA JJ, 1995, BIOCHEMISTRY-US, V34, P4898, DOI 10.1021/bi00014a047; Correia JJ, 1992, ANAL ULTRACENTRIFUGA, P231; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; ENDOW SA, 1994, EMBO J, V13, P2708, DOI 10.1002/j.1460-2075.1994.tb06561.x; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOYT MA, 1993, GENETICS, V135, P35; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Huyett A, 1998, J CELL SCI, V111, P295; Jiang W, 1997, J BIOL CHEM, V272, P5616, DOI 10.1074/jbc.272.9.5616; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Maddox PS, 2000, NAT CELL BIOL, V2, P36, DOI 10.1038/71357; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MIDDLETON K, 1994, P NATL ACAD SCI USA, V91, P7212, DOI 10.1073/pnas.91.15.7212; Moyer ML, 1996, BIOCHEMISTRY-US, V35, P6321, DOI 10.1021/bi960017n; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Pechatnikova E, 1997, J BIOL CHEM, V272, P30735, DOI 10.1074/jbc.272.49.30735; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; Saunders W, 1997, J CELL BIOL, V137, P417, DOI 10.1083/jcb.137.2.417; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shanks RMQ, 2004, CELL CYCLE, V3, P363; Shanks RMQ, 2001, GENETICS, V159, P939; Song H, 1996, BIOCHEMISTRY-US, V35, P11203, DOI 10.1021/bi960997b; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028	46	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51354	51361		10.1074/jbc.M406268200	http://dx.doi.org/10.1074/jbc.M406268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385545	hybrid, Green Accepted			2022-12-27	WOS:000225355800086
J	Piotrowski, M; Schemenewitz, A; Lopukhina, A; Muller, A; Janowitz, T; Weiler, EW; Oecking, C				Piotrowski, M; Schemenewitz, A; Lopukhina, A; Muller, A; Janowitz, T; Weiler, EW; Oecking, C			Desulfoglucosinolate sulfotransferases from Arabidopsis thaliana catalyze the final step in the biosynthesis of the glucosinolate core structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE STEROID SULFOTRANSFERASE; MOLECULAR-CLONING; OILSEED RAPE; SUSPENSION-CULTURES; BRASSICA-NAPUS; AUXIN; GENE; INVOLVEMENT; CONVERSION; CYP83B1	The phytotoxin coronatine is a structural analog of octadecanoid signaling molecules, which are well known mediators of plant defense reactions. To isolate novel coronatine-regulated genes from Arabidopsis thaliana, differential mRNA display was performed. Transcript levels of CORI-7 ( coronatine induced-7) were rapidly and transiently increased in coronatine-treated plants, and the corresponding cDNA was found to encode the sulfotransferase AtST5a. Likewise, upon wounding, an immediate and transient increase in AtST5a mRNA levels could be observed in both locally wounded and unwounded ( systemic) leaves. Furthermore, application of octadecanoids and ethylene as compounds involved in plant wound defense reactions resulted in AtST5a gene activation, whereas pathogen defense-related signals ( yeast elicitor and salicylic acid) were inactive. AtST5a and its close homologs AtST5b and AtST5c were purified as His(6)-tagged proteins from Escherichia coli. The three enzymes were shown to catalyze the final step in the biosynthesis of the glucosinolate (GS) core structure, the sulfation of desulfoglucosinolates (dsGSs). They accept a broad range of dsGSs as substrates. However, in a competitive situation, AtST5a clearly prefers tryptophan- and phenylalanine-derived dsGSs, whereas long chain dsGSs derived from methionine are the preferred substrates of AtST5b and AtST5c. Treatment of Arabidopsis plants with low concentrations of coronatine resulted in an increase in the amounts of specific GSs, primarily glucobrassicin and neoglucobrassicin. Hence, it is suggested that AtST5a is the sulfotransferase responsible for the biosynthesis of tryptophan- derived GSs in vivo.	Ruhr Univ Bochum, Dept Plant Physiol, D-44801 Bochum, Germany; Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany	Ruhr University Bochum; Eberhard Karls University of Tubingen	Weiler, EW (corresponding author), Ruhr Univ Bochum, Dept Plant Physiol, Univ Str 150, D-44801 Bochum, Germany.	Elmar.Weiler@ruhr-uni-bochum.de	Piotrowski, Markus/F-5419-2010	Piotrowski, Markus/0000-0002-6347-3337				ANANVORANICH S, 1994, PLANT PHYSIOL, V106, P485, DOI 10.1104/pp.106.2.485; ANANVORANICH S, 1995, PLANT PHYSIOL, V107, P1019, DOI 10.1104/pp.107.3.1019; [Anonymous], 2004, CURRENT PROTOCOLS MO; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; BARKAN A, 1989, PLANT CELL, V1, P437, DOI 10.1105/tpc.1.4.437; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; BARRON D, 1988, PHYTOCHEMISTRY, V27, P2375, DOI 10.1016/0031-9422(88)87003-1; Bennett RN, 1997, PLANT PHYSIOL, V114, P1283, DOI 10.1104/pp.114.4.1283; BODNARYK RP, 1994, PHYTOCHEMISTRY, V35, P301, DOI 10.1016/S0031-9422(00)94752-6; BODNARYK RP, 1992, PHYTOCHEMISTRY, V31, P2671, DOI 10.1016/0031-9422(92)83609-3; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; DOUGHTY KJ, 1995, PHYTOCHEMISTRY, V38, P347, DOI 10.1016/0031-9422(94)00653-B; ETTLINGER MG, 1961, P NATL ACAD SCI USA, V47, P1875, DOI 10.1073/pnas.47.12.1875; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gidda SK, 2003, J BIOL CHEM, V278, P17895, DOI 10.1074/jbc.M211943200; GLENDENING TM, 1990, PLANT PHYSIOL, V94, P811, DOI 10.1104/pp.94.2.811; Halkier BA, 1997, TRENDS PLANT SCI, V2, P425, DOI 10.1016/S1360-1385(97)01128-X; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; JAIN JC, 1990, PHYTOCHEMISTRY, V29, P1425, DOI 10.1016/0031-9422(90)80094-W; Jones PR, 2003, J BIOL CHEM, V278, P10291, DOI 10.1074/jbc.M212207200; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; Lacomme C, 1996, PLANT MOL BIOL, V30, P995, DOI 10.1007/BF00020810; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lopukhina A, 2001, PLANT PHYSIOL, V126, P1678, DOI 10.1104/pp.126.4.1678; Marillia EF, 2001, PHYSIOL PLANTARUM, V113, P176, DOI 10.1034/j.1399-3054.2001.1130204.x; Marsolais F, 2004, PLANT SCI, V166, P1359, DOI 10.1016/j.plantsci.2004.01.019; Marsolais F, 2000, RECENT ADV PHYTOCHEM, V34, P433, DOI 10.1016/S0079-9920(00)80015-5; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Muller A, 2000, PLANTA, V211, P855, DOI 10.1007/s004250000353; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Rouleau M, 1999, J BIOL CHEM, V274, P20925, DOI 10.1074/jbc.274.30.20925; Sakakibara Y, 1998, J BIOL CHEM, V273, P33929, DOI 10.1074/jbc.273.51.33929; Sambrook J., 2001, MOL CLONING LAB MANU; Varin L, 1997, FASEB J, V11, P517, DOI 10.1096/fasebj.11.7.9212075; VARIN L, 1992, P NATL ACAD SCI USA, V89, P1286, DOI 10.1073/pnas.89.4.1286; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Wittstock U, 2000, J BIOL CHEM, V275, P14659, DOI 10.1074/jbc.275.19.14659; XIA ZQ, 1993, PLANTA MED, V59, P575, DOI 10.1055/s-2006-959770; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	49	149	166	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50717	50725		10.1074/jbc.M407681200	http://dx.doi.org/10.1074/jbc.M407681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15358770	hybrid			2022-12-27	WOS:000225355800013
J	Hsu, GW; Kiefer, JR; Burnouf, D; Becherel, OJ; Fuchs, RPP; Beese, LS				Hsu, GW; Kiefer, JR; Burnouf, D; Becherel, OJ; Fuchs, RPP; Beese, LS			Observing translesion synthesis of an aromatic amine DNA adduct by a high-fidelity DNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATTACHED AMINOFLUORENE RING; C-8-MODIFIED SYN GUANINE; ESCHERICHIA-COLI; DAMAGED DNA; OPPOSITE DC; STRUCTURAL-CHARACTERIZATION; SOLUTION CONFORMATION; NUCLEOTIDE INSERTION; BASE DISPLACEMENT; COVALENT BINDING	Aromatic amines have been studied for more than a half-century as model carcinogens representing a class of chemicals that form bulky adducts to the C8 position of guanine in DNA. Among these guanine adducts, the N-(2'-deoxyguanosin-8-yl)-aminofluorene (G-AF) and N-2-(2'-deoxyguanosin-8-yl)-acetylaminofluorene (G-AAF) derivatives are the best studied. Although G-AF and G-AAF differ by only an acetyl group, they exert different effects on DNA replication by replicative and high-fidelity DNA polymerases. Translesion synthesis of G-AF is achieved with high-fidelity polymerases, whereas replication of G-AAF requires specialized bypass polymerases. Here we have presented structures of G-AF as it undergoes one round of accurate replication by a high-fidelity DNA polymerase. Nucleotide incorporation opposite G-AF is achieved in solution and in the crystal, revealing how the polymerase accommodates and replicates past G-AF, but not G-AAF. Like an unmodified guanine, G-AF adopts a conformation that allows it to form Watson-Crick hydrogen bonds with an opposing cytosine that results in protrusion of the bulky fluorene moiety into the major groove. Although incorporation opposite G-AF is observed, the C: G-AF base pair induces distortions to the polymerase active site that slow translesion synthesis.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; CNRS, Unite Propre Rech 9003, F-67400 Strasbourg, France	Duke University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	lsb@biochem.duke.edu	Classen, Scott/AAY-8176-2020; beese, lorena/G-4993-2010	Kiefer, James/0000-0001-6317-0902	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA92584] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BECKMAN RA, 1993, Q REV BIOPHYS, V26, P225, DOI 10.1017/S0033583500002869; BELGUISEVALLADIER P, 1994, J MOL BIOL, V236, P151, DOI 10.1006/jmbi.1994.1125; BELGUISEVALLADIER P, 1995, J MOL BIOL, V249, P903, DOI 10.1006/jmbi.1995.0347; BICHARA M, 1985, J MOL BIOL, V183, P341, DOI 10.1016/0022-2836(85)90005-1; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRIEBA LG, 2004, EMBO J; BROYDE S, 1983, BIOPOLYMERS, V22, P2423, DOI 10.1002/bip.360221109; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHO BP, 1994, BIOCHEMISTRY-US, V33, P1373, DOI 10.1021/bi00172a013; Cordonnier AM, 1999, MUTAT RES-DNA REPAIR, V435, P111, DOI 10.1016/S0921-8777(99)00047-6; DAUNE MP, 1981, NATL CANCER I MONOGR, V58, P201; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; ECKEL LM, 1994, NAT STRUCT BIOL, V1, P89, DOI 10.1038/nsb0294-89; ECKEL LM, 1994, BIOCHEMISTRY-US, V33, P13611, DOI 10.1021/bi00250a012; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; FUCHS R, 1973, FEBS LETT, V34, P295, DOI 10.1016/0014-5793(73)80815-4; FUCHS R, 1972, BIOCHEMISTRY-US, V11, P2659, DOI 10.1021/bi00764a017; FUCHS RPP, 1976, BIOCHEMISTRY-US, V15, P3347, DOI 10.1021/bi00660a027; FUCHS RPP, 1974, BIOCHEMISTRY-US, V13, P4435, DOI 10.1021/bi00718a028; FUCHS RPP, 1975, NATURE, V257, P151, DOI 10.1038/257151a0; FUCHS RPP, 1984, EMBO J, V3, P757, DOI 10.1002/j.1460-2075.1984.tb01880.x; Fujii S, 2004, J MOL BIOL, V341, P405, DOI 10.1016/j.jmb.2004.06.017; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Gu ZT, 1999, BIOCHEMISTRY-US, V38, P10855, DOI 10.1021/bi991266p; HEFLICH RH, 1994, MUTAT RES-REV GENET, V318, P73, DOI 10.1016/0165-1110(94)90025-6; Hoffmann GR, 1997, CHEM RES TOXICOL, V10, P347, DOI 10.1021/tx960128n; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1992, J BIOL CHEM, V267, P24485; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P208, DOI 10.1016/S0076-6879(97)77013-7; KOEHL P, 1989, J MOL BIOL, V207, P355, DOI 10.1016/0022-2836(89)90259-3; KoffelSchwartz N, 1996, P NATL ACAD SCI USA, V93, P7805, DOI 10.1073/pnas.93.15.7805; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; LANG MCE, 1979, CHEM-BIOL INTERACT, V28, P171, DOI 10.1016/0009-2797(79)90159-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEFEVRE JF, 1978, BIOCHEMISTRY-US, V17, P2561, DOI 10.1021/bi00606a016; Lehmann AR, 2002, MUTAT RES-FUND MOL M, V509, P23, DOI 10.1016/S0027-5107(02)00227-0; Lenne-Samuel N, 2000, MOL MICROBIOL, V38, P299, DOI 10.1046/j.1365-2958.2000.02116.x; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; LINDSLEY JE, 1994, BIOCHEMISTRY-US, V33, P764, DOI 10.1021/bi00169a018; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Mao B, 1995, BIOCHEMISTRY-US, V34, P16641, DOI 10.1021/bi00051a012; MAO B, 1995, BIOCHEMISTRY-US, V34, P6226, DOI 10.1021/bi00018a027; Mao B, 1998, BIOCHEMISTRY-US, V37, P81, DOI 10.1021/bi972257o; Mao B, 1998, BIOCHEMISTRY-US, V37, P95, DOI 10.1021/bi972258g; MICHAELS ML, 1987, J BIOL CHEM, V262, P14648; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; MOORE PD, 1982, P NATL ACAD SCI-BIOL, V79, P7166, DOI 10.1073/pnas.79.23.7166; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; NORMAN D, 1989, BIOCHEMISTRY-US, V28, P7462, DOI 10.1021/bi00444a046; OHANDLEY SF, 1993, BIOCHEMISTRY-US, V32, P2481, DOI 10.1021/bi00061a005; Ohashi E, 2000, GENE DEV, V14, P1589; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; SAGE E, 1979, FEBS LETT, V108, P66, DOI 10.1016/0014-5793(79)81180-1; SAGE E, 1979, BIOCHEMISTRY-US, V18, P1328, DOI 10.1021/bi00574a032; SALLES B, 1983, NUCLEIC ACIDS RES, V11, P5235, DOI 10.1093/nar/11.15.5235; SHIBUTANI S, 1990, J AM CHEM SOC, V112, P5667, DOI 10.1021/ja00170a056; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STRAUSS BS, 1991, BIOESSAYS, V13, P79, DOI 10.1002/bies.950130206; STRAUSS BS, 1990, CARCINOGENESIS, V11, P2103, DOI 10.1093/carcin/11.12.2103; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhang YB, 2001, NUCLEIC ACIDS RES, V29, P928, DOI 10.1093/nar/29.4.928	82	65	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50280	50285		10.1074/jbc.M409224200	http://dx.doi.org/10.1074/jbc.M409224200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385534	hybrid			2022-12-27	WOS:000225229500090
J	Jung, J; Kim, M; Kim, MJ; Kim, J; Moon, J; Lim, JS; Kim, M; Lee, K				Jung, J; Kim, M; Kim, MJ; Kim, J; Moon, J; Lim, JS; Kim, M; Lee, K			Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATPASE; STIMULATION; MECHANISMS; OUABAIN; ANKYRIN; IDENTIFICATION; NA+,K+-ATPASE; POLYPEPTIDE; SEQUENCE; FORTILIN	Translationally controlled tumor protein (TCTP) is a growth-related protein under transcriptional as well as translational control. We screened a rat skeletal muscle cDNA library using yeast two-hybrid system and found that TCTP interacts with the third large cytoplasmic domain of alpha1 as well as alpha2 isoforms of Na,K-ATPase, believed involved in the regulation of Na,K-ATPase activity. Interaction between TCTP and Na,K-ATPase was confirmed by coimmunoprecipitation in yeast and mammalian cells. We also showed, using Rb-86(+) uptake assay, that overexpression of TCTP inhibited Na,K-ATPase activity in HeLa cells. Northern and Western blotting studies of HeLa cells transiently transfected with GFP-tagged TCTP showed that overexpression of TCTP did not change mRNA and protein levels of Na,K-ATPase. Recombinant TCTP protein purified from an Escherichia coli expression system inhibited purified HeLa cell plasma membrane Na,K-ATPase in a dose-dependent manner. Using deletion analysis, we also found that the C-terminal 102-172-amino-acid region of rat TCTP that contains the TCTP homology region 2 is essential for its association with, and inhibition of, Na,K-ATPase.	Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling Res, Seoul 120750, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University	Lee, K (corresponding author), Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling Res, Seoul 120750, South Korea.	klyoon@ewha.ac.kr						BERTORELLO AM, 1993, AM J PHYSIOL, V265, pF743, DOI 10.1152/ajprenal.1993.265.6.F743; BOMMER UA, 1994, CELL MOL BIOL RES, V40, P633; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; Coppi MV, 1997, ARCH BIOCHEM BIOPHYS, V346, P312, DOI 10.1006/abbi.1997.0332; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; FEHLMANN M, 1981, J BIOL CHEM, V256, P7449; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Fiske CH, 1925, J BIOL CHEM, V66, P375; FORBUSH B, 1978, BIOCHEMISTRY-US, V17, P3667, DOI 10.1021/bi00610a037; Gachet Y, 1999, J CELL SCI, V112, P1257; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; JORDAN C, 1995, J BIOL CHEM, V270, P29971; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Jung JH, 2002, J BIOL CHEM, V277, P48931, DOI 10.1074/jbc.M208806200; KAPLOWITZ PB, 1976, CELL DIFFER DEV, V5, P109, DOI 10.1016/0045-6039(76)90004-X; KOOB R, 1990, EUR J CELL BIOL, V53, P93; KORT JJ, 1990, J CELL PHYSIOL, V145, P253, DOI 10.1002/jcp.1041450209; Lee K, 2001, BIOCHEM J, V353, P377, DOI 10.1042/0264-6021:3530377; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; LINGHAM RB, 1982, BIOCHIM BIOPHYS ACTA, V688, P475, DOI 10.1016/0005-2736(82)90359-5; MCGILL DL, 1991, J BIOL CHEM, V266, P15824; Murata Y, 1996, JPN J PHARMACOL, V72, P347, DOI 10.1254/jjp.72.347; Nestor NB, 1997, ANN NY ACAD SCI, V834, P579, DOI 10.1111/j.1749-6632.1997.tb52324.x; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; ULLRICH KJ, 1979, ANNU REV PHYSIOL, V41, P181, DOI 10.1146/annurev.ph.41.030179.001145; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yoon T, 2000, ARCH BIOCHEM BIOPHYS, V384, P379, DOI 10.1006/abbi.2000.2108; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	34	70	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49868	49875		10.1074/jbc.M400895200	http://dx.doi.org/10.1074/jbc.M400895200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383549	hybrid			2022-12-27	WOS:000225229500040
J	Barlic, J; McDermott, DH; Merrell, MN; Gonzales, J; Via, LE; Murphy, PM				Barlic, J; McDermott, DH; Merrell, MN; Gonzales, J; Via, LE; Murphy, PM			Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATED T-CELLS; PERIPHERAL-BLOOD LYMPHOCYTES; INTERFERON-GAMMA; IMMUNOSUPPRESSIVE AGENTS; TARGETED DELETION; NUCLEAR FACTOR; B-CELLS; FRACTALKINE; GENE	We have recently reported that interleukin (IL)-15 and IL-2, which signal through IL-2Rbetagamma, oppositely regulate expression of the proinflammatory chemokine receptor CX3CR1. Here we delineate molecular mechanisms responsible for this paradox. By using a luciferase reporter plasmid, we identified a 433-bp region spanning the major transcriptional start point of human CX3CR1 that, when expressed in human peripheral blood mononuclear cells (PBMCs), possessed strong constitutive promoter activity. IL-2 and IL-15 treatment increased and abolished this activity, respectively, mimicking their effects on endogenous CX3CR1. IL-2 and IL-15 have been reported to also have opposite effects on the immunoregulatory transcription factor NFAT ( nuclear factor of activated T cells), and the 433-bp region contains a kappaB-like NFAT site. The effects of IL-15 and IL-2 on both CX3CR1 reporter activity and endogenous CX3CR1 transcription in PBMCs were abolished by the NFAT inhibitors cyclosporin A and VIVIT. Moreover, mutation of the kappaB-like NFAT sequence markedly attenuated IL-2 and IL-15 modulation of CX3CR1 promoter-reporter activity in PBMCs. Furthermore, chromatin immunoprecipitation revealed that IL-15 promoted specific recruitment of NFAT1 but not NFAT2 to the CX3CR1 promoter, whereas IL-2 had the converse effect. This appears to be relevant in vivo because mouse CX3CR1 mRNA was expressed in both PBMCs and splenocytes from NFAT1(-/-) mice injected with recombinant IL-15 but was undetectable in cells from IL-15-injected NFAT1(+/+) BALB/c mice; as predicted, IL-2 up-regulated cx3cr1 in both mouse strains to a similar extent. Thus, by pharmacologic, genetic, and biochemical criteria in vitro and in vivo, our results suggest that IL-15 and IL-2 oppositely regulate CX3CR1 gene expression by differentially recruiting NFAT1 and NFAT2 to a kappaB-like NFAT site within the CX3CR1 promoter. We propose that expression of CX3CR1 and possibly other immunoregulatory genes may be determined in part by the balance of NFAT1 and NFAT2 activity in leukocytes.	NIAID, Mol Signaling Sect, Host Def Lab, NIH, Bethesda, MD 20892 USA; NIAID, TB Res Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Murphy, PM (corresponding author), NIAID, Mol Signaling Sect, Host Def Lab, NIH, Bldg 10,Rm 11N113, Bethesda, MD 20892 USA.	pmm@nih.gov	Via, Laura/AAD-3917-2021; McDermott, David/AAP-2459-2021	Via, Laura/0000-0001-6074-9521; McDermott, David/0000-0001-6978-0867	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000615, ZIAAI000615] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHUJA SS, 1995, TRANSPLANTATION, V60, P718, DOI 10.1097/00007890-199510150-00018; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Barlic J, 2003, BLOOD, V102, P3494, DOI 10.1182/blood-2003-03-0946; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bulanova E, 2001, J IMMUNOL, V167, P6292, DOI 10.4049/jimmunol.167.11.6292; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Cao CM, 2003, J PHARMACOL EXP THER, V306, P572, DOI 10.1124/jpet.102.048264; Chen SZ, 2002, J NEUROIMMUNOL, V133, P46, DOI 10.1016/S0165-5728(02)00354-5; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 1998, BIOCHEM BIOPH RES CO, V253, P728, DOI 10.1006/bbrc.1998.9849; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cristillo AD, 2003, BLOOD, V101, P216, DOI 10.1182/blood-2002-03-0697; Cristillo AD, 2002, J BIOL CHEM, V277, P4465, DOI 10.1074/jbc.M108598200; DeVries ME, 2003, J BIOL CHEM, V278, P11985, DOI 10.1074/jbc.M211422200; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Eicher DM, 2003, CELL IMMUNOL, V223, P133, DOI 10.1016/S0008-8749(03)00168-0; Fehniger T A, 2001, Int Rev Immunol, V20, P503, DOI 10.3109/08830180109054417; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Forcina G, 2004, CYTOKINE, V25, P283, DOI 10.1016/j.cyto.2003.12.004; Garin A, 2002, BIOCHEM J, V368, P753, DOI 10.1042/BJ20020951; Garton KJ, 2001, J BIOL CHEM, V276, P37993; GEARING AJH, 1985, IMMUNOL LETT, V10, P297, DOI 10.1016/0165-2478(85)90105-1; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GOLDFELD AE, 1993, J EXP MED, V178, P1365, DOI 10.1084/jem.178.4.1365; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Haskell Christopher A, 2002, Curr Opin Investig Drugs, V3, P399; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Imaizumi T, 2000, TOHOKU J EXP MED, V192, P127, DOI 10.1620/tjem.192.127; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Kraan TCTMV, 1996, J IMMUNOL, V156, P1818; Lavergne E, 2003, CANCER RES, V63, P7468; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Mastroianni CM, 2004, TRENDS IMMUNOL, V25, P121, DOI 10.1016/j.it.2004.01.002; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; Ohteki Toshiaki, 2002, Current Molecular Medicine (Hilversum), V2, P371, DOI 10.2174/1566524023362519; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RAPORT CJ, 1995, GENE, V163, P295, DOI 10.1016/0378-1119(95)00336-5; Robinson LA, 2003, CELL IMMUNOL, V225, P122, DOI 10.1016/j.cellimm.2003.09.010; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Seidel MG, 1998, N-S ARCH PHARMACOL, V358, P382, DOI 10.1007/PL00005268; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Tsytsykova AV, 2000, J EXP MED, V192, P581, DOI 10.1084/jem.192.4.581; UTSUNOMIYA N, 1986, BIOCHEMISTRY-US, V25, P2582, DOI 10.1021/bi00357a045; Waldmann TA, 2002, J CLIN IMMUNOL, V22, P51, DOI 10.1023/A:1014416616687; Waldmann T, 2002, ARTHRITIS RES THER, V4, pS161, DOI 10.1186/ar584; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Yoshida H, 2001, NEUROSCI LETT, V303, P132, DOI 10.1016/S0304-3940(01)01699-8	70	29	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48520	48534		10.1074/jbc.M406978200	http://dx.doi.org/10.1074/jbc.M406978200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347678	hybrid			2022-12-27	WOS:000225098100007
J	Hoang, T; Fenne, IS; Cook, C; Borud, B; Bakke, M; Lien, EA; Mellgren, G				Hoang, T; Fenne, IS; Cook, C; Borud, B; Bakke, M; Lien, EA; Mellgren, G			cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-HORMONE RECEPTORS; HUMAN ESTROGEN-RECEPTOR; AMP SIGNALING PATHWAY; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTIONAL COACTIVATOR; ANDROGEN RECEPTOR; BINDING DOMAINS; GENE-EXPRESSION; 26S PROTEASOME; ACTIVATION	Nuclear receptors and their coactivators are key regulators of numerous physiological functions. GRIP1 ( glucocorticoid receptor-interacting protein) is a member of the steroid receptor coactivator family. Here, we show that GRIP1 is regulated by cAMP-dependent protein kinase (PKA) that induces its degradation through the ubiquitin-proteasome pathway. GRIP1 was downregulated in transiently transfected COS-1 cells after treatment with 8-para-chlorophenylthio-cAMP or forskolin and 3-isobutyl-1-methylxanthine and in adrenocortical Y1 cells after incubation with adrenocorticotropic hormone. Pulse-chase experiments with transiently transfected COS-1 cells demonstrated that the half-life of GRIP1 was markedly reduced in cells overexpressing the PKA catalytic subunit, suggesting that activation of PKA increases the turnover of GRIP1 protein. The proteasome inhibitors MG132 and lactacystin abolished the PKA-mediated degradation of GRIP1. Using ts20 cells, a temperature-sensitive cell line that contains a thermolabile ubiquitin-activating E1 enzyme, it was confirmed that PKA-mediated degradation of GRIP1 is dependent upon the ubiquitin-proteasome pathway. Coimmunoprecipitation studies of COS-1 cells transfected with expression vectors encoding GRIP1 and ubiquitin using anti-GRIP1 and anti-ubiquitin antibodies showed that the ubiquitination of GRIP1 was increased by overexpression of PKA. Finally, we show that PKA regulates the intracellular distribution pattern of green fluorescent protein-GRIP1 and stimulates recruitment of GRIP1 to subnuclear foci that are colocalized with the proteasome. Taken together, these data demonstrate that GRIP1 is ubiquitinated and degraded through activation of the PKA pathway. This may represent a novel regulatory mechanism whereby hormones down-regulate a nuclear receptor coactivator.	Univ Bergen, Haukeland Univ Hosp, Inst Med,Sect Endocrinol, Hormone Lab, N-5021 Bergen, Norway; Univ Bergen, Hormone Lab, Endocrinol Sect, Inst Med, N-5020 Bergen, Norway; Univ Bergen, Dept Biomed, Div Anat & Cell Biol, N-5020 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Mellgren, G (corresponding author), Univ Bergen, Haukeland Univ Hosp, Inst Med,Sect Endocrinol, Hormone Lab, N-5021 Bergen, Norway.	gunnar.mellgren@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Borud, Bente/0000-0002-5460-1800				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BAKKE M, 1995, MOL ENDOCRINOL, V9, P327, DOI 10.1210/me.9.3.327; Baumann CT, 2001, MOL ENDOCRINOL, V15, P485, DOI 10.1210/me.15.4.485; Black BE, 2004, MOL ENDOCRINOL, V18, P834, DOI 10.1210/me.2003-0145; Borud B, 2002, MOL ENDOCRINOL, V16, P757, DOI 10.1210/me.16.4.757; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Glass CK, 2000, GENE DEV, V14, P121; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; Henttu PMA, 1997, MOL CELL BIOL, V17, P1832, DOI 10.1128/MCB.17.4.1832; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hong H, 1999, J BIOL CHEM, V274, P3496, DOI 10.1074/jbc.274.6.3496; Karvonen U, 2002, FEBS LETT, V523, P43, DOI 10.1016/S0014-5793(02)02929-0; Kinyamu HK, 2003, MOL CELL BIOL, V23, P5867, DOI 10.1128/MCB.23.16.5867-5881.2003; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Le T, 2001, ENDOCRINOLOGY, V142, P4282, DOI 10.1210/en.142.10.4282; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; LIU JL, 1994, BIOCHEM J, V301, P863, DOI 10.1042/bj3010863; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lopez GN, 2001, J BIOL CHEM, V276, P22177, DOI 10.1074/jbc.M010718200; Ma H, 1999, MOL CELL BIOL, V19, P6164; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; MCGUINNESS MP, 1994, BIOL REPROD, V51, P116, DOI 10.1095/biolreprod51.1.116; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKenna NJ, 2000, J STEROID BIOCHEM, V74, P351, DOI 10.1016/S0960-0760(00)00112-6; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MOYER ML, 1993, J BIOL CHEM, V268, P22933; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nazareth LV, 1999, MOL ENDOCRINOL, V13, P2065, DOI 10.1210/me.13.12.2065; Ogawa H, 2004, BIOCHEM BIOPH RES CO, V320, P218, DOI 10.1016/j.bbrc.2004.05.161; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; PENNIE WD, 1995, MOL CELL BIOL, V15, P2125; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Saitoh M, 2002, MOL ENDOCRINOL, V16, P694, DOI 10.1210/me.16.4.694; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Westin S, 2000, ADV PHARMACOL, V47, P89; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Yan F, 2003, MOL ENDOCRINOL, V17, P1315, DOI 10.1210/me.2002-0209; Zhang ZG, 1998, J BIOL CHEM, V273, P30660, DOI 10.1074/jbc.273.46.30660	66	59	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49120	49130		10.1074/jbc.M409746200	http://dx.doi.org/10.1074/jbc.M409746200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347661	hybrid			2022-12-27	WOS:000225098100077
J	Whitaker, SL; Knox, BE				Whitaker, SL; Knox, BE			Conserved transcriptional activators of the Xenopus rhodopsin gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD HOMEOBOX; LEUCINE-ZIPPER; EYE SPECIFICATION; BRAIN-DEVELOPMENT; NUCLEAR PROTEINS; TRANSGENIC MICE; FACTOR NRL; CRX GENES; OTX GENES; EXPRESSION	Vertebrate rhodopsin promoters exhibit striking sequence identities proximal to the initiation site, suggesting that conserved transcription factors regulate rhodopsin expression in these animals. We identify and characterize two transcriptional activators of the Xenopus rhodopsin gene: homologs of the mammalian Crx and Nrl transcription factors, XOtx5 and XL-Nrl ( originally named XL-maf), respectively. XOtx5 stimulated transcription similar to 10-fold in human 293 cells co-transfected with a plasmid containing the rhodopsin promoter ( - 508 to + 41) upstream of luciferase, similar to the similar to 6-fold stimulation with human Crx. XL-Nrl stimulated transcription similar to 27-fold in mammalian 293 cells co-transfected with the rhodopsin luciferase reporter, slightly more than the similar to 17-fold stimulation with Nrl. Together, the Xenopus transcription factors synergistically activated the rhodopsin promoter (similar to 140-fold), as well as in combination with mammalian homologs. Deletion of the Nrl-response element, TGCTGA, eliminated the synergistic activation by both mammalian and Xenopus transcription factors. Deletion of the conserved ATTA sequences (Ret-1 or BAT-1), binding sites for Crx, did not significantly decrease activation by Crx/XOtx5. However, there was increased activation by Nrl/XL-Nrl and an increased synergy when the Ret-1 site was disrupted. These results illustrate conservation of mechanisms of retinal gene expression among vertebrates. In transgenic tadpoles, XOtx5 and XL-Nrl directed premature and ectopic expression from the Xenopus rhodopsin promoter-GFP transgene. Furthermore, activation of the endogenous rhodopsin gene was also observed in some animals, showing that XOtx5 and XL-Nrl can activate the promoter in native chromatin environment.	SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Knox, BE (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	knoxb@upstate.edu			NEI NIH HHS [EY-12975, EY-11256] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011256, R01EY012975] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acampora D, 2003, GENE EXPR PATTERNS, V3, P497, DOI 10.1016/S1567-133X(03)00056-5; Acampora D, 1998, DEVELOPMENT, V125, P1691; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; Batni S, 2000, METHOD ENZYMOL, V316, P50; Bibb LC, 2001, HUM MOL GENET, V10, P1571, DOI 10.1093/hmg/10.15.1571; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Boatright JH, 2001, FEBS LETT, V504, P27, DOI 10.1016/S0014-5793(01)02662-X; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cook T, 2003, BIOESSAYS, V25, P921, DOI 10.1002/bies.10356; DESJARDIN LE, 1993, J BIOL CHEM, V268, P6953; Dowling J. E., 1987, RETINA APPROACHABLE; Fei YJ, 2000, INVEST OPHTH VIS SCI, V41, P2849; Felsenstein J, 1993, PHYLIP PHYLOGENY INT; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; Germot A, 2001, MOL BIOL EVOL, V18, P1668, DOI 10.1093/oxfordjournals.molbev.a003955; GOURAS P, 1994, VISUAL NEUROSCI, V11, P1227, DOI 10.1017/S0952523800007021; GRAF JD, 1991, METHOD CELL BIOL, V36, P19; Hanson IM, 2001, SEMIN CELL DEV BIOL, V12, P475, DOI 10.1006/scdb.2001.0271; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Ishibashi S, 2001, MECH DEVELOP, V101, P155, DOI 10.1016/S0925-4773(00)00585-2; *JOINT GEN I, 2004, XEN TROP DAT ASS VER; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kumar JP, 2001, SEMIN CELL DEV BIOL, V12, P469, DOI 10.1006/scdb.2001.0270; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Kuroda H, 2000, DEV GROWTH DIFFER, V42, P87; Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Leuzinger S, 1998, DEVELOPMENT, V125, P1703; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Ma GC, 2001, FEBS LETT, V508, P265, DOI 10.1016/S0014-5793(01)03058-7; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; Martinez JA, 1998, BIOCHEM BIOPH RES CO, V250, P175, DOI 10.1006/bbrc.1998.9261; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Oliver G, 1997, TRENDS NEUROSCI, V20, P415, DOI 10.1016/S0166-2236(97)01082-5; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Perkins BD, 2002, VISUAL NEUROSCI, V19, P257, DOI 10.1017/S0952523802192030; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; Plouhinec JL, 2003, MOL BIOL EVOL, V20, P513, DOI 10.1093/molbev/msg085; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sauka-Spengler T, 2001, DEV GENES EVOL, V211, P533, DOI 10.1007/s00427-001-0191-2; Sharon D, 2002, P NATL ACAD SCI USA, V99, P315, DOI 10.1073/pnas.012582799; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Sparrow D B, 2000, Nucleic Acids Res, V28, pE12, DOI 10.1093/nar/28.4.e12; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; SWOFFORD DL, 1996, PAUP 4B10 PHYLOGENET; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; TREISMAN JE, 1988, MOL CELL BIOL, V8, P1570, DOI 10.1128/MCB.8.4.1570; Tzekov R T, 2000, Ophthalmic Genet, V21, P89; Tzekov RT, 2001, INVEST OPHTH VIS SCI, V42, P1319; Viczian AS, 2003, DEVELOPMENT, V130, P1281, DOI 10.1242/dev.00343; Vignali R, 2000, MECH DEVELOP, V96, P3, DOI 10.1016/S0925-4773(00)00367-1; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Wang XJ, 2002, J BIOL CHEM, V277, P43288, DOI 10.1074/jbc.M207952200; Yanagi Y, 2000, BIOCHEM BIOPH RES CO, V269, P410, DOI 10.1006/bbrc.2000.2304; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4; Zhang T, 2003, GENE, V313, P189, DOI 10.1016/S0378-1119(03)00680-2	69	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49010	49018		10.1074/jbc.M406080200	http://dx.doi.org/10.1074/jbc.M406080200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347652	hybrid			2022-12-27	WOS:000225098100064
J	Hodara, R; Norris, EH; Giasson, BI; Mishizen-Eberz, AJ; Lynch, DR; Lee, VMY; Ischiropoulos, H				Hodara, R; Norris, EH; Giasson, BI; Mishizen-Eberz, AJ; Lynch, DR; Lee, VMY; Ischiropoulos, H			Functional consequences of alpha-synuclein tyrosine nitration - Diminished binding to lipid vesicles and increased fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; PARKINSONS-DISEASE; IN-VITRO; LEWY BODIES; INHIBITS FIBRILLATION; PROTEASOMAL FUNCTION; HUMAN BRAIN; PROTEIN; PATHOGENESIS; AGGREGATION	Previous studies have shown the presence of nitrated alpha-synuclein (alpha-syn) in human Lewy bodies and other alpha-syn inclusions. Herein, the effects of tyrosine nitration on alpha-syn fibril formation, lipid binding, chaperone-like function, and proteolytic degradation were systematically examined by employing chromatographically isolated nitrated monomeric, dimeric, and oligomeric alpha-syn. Nitrated alpha-syn monomers and dimers but not oligomers accelerated the rate of fibril formation of unmodified alpha-syn when present at low concentrations. Immunoelectron microscopy revealed that nitrated monomers and dimers are incorporated into the fibrils. However, the purified nitrated alpha-syn monomer by itself was unable to form fibrils. Nitration of the tyrosine residue at position 39 was largely responsible for decreased binding of nitrated monomeric alpha-syn to synthetic vesicles, which correlated with an impairment of the nitrated protein to adopt alpha-helical conformation in the presence of liposomes. The chaperone-like activity of alpha-syn was not inhibited by nitration or oxidation. Furthermore, the 20 S proteasome and calpain I degraded nitrated monomeric alpha-syn, although at a slower rate compared with control alpha-syn. Collectively, these data suggest that post-translational modification of alpha-syn by nitration can promote the formation of intracytoplasmic inclusions that constitute the hallmark of Parkinson disease and other synucleinopathies.	Childrens Hosp Philadelphia, Stokes Res Inst, Abramson Res Ctr 416D, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Neurol & Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Ischiropoulos, H (corresponding author), Childrens Hosp Philadelphia, Stokes Res Inst, Abramson Res Ctr 416D, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu		Norris, Erin/0000-0002-4522-3537				Baba M, 1998, AM J PATHOL, V152, P879; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Cassina AM, 2000, J BIOL CHEM, V275, P21409, DOI 10.1074/jbc.M909978199; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Hokenson MJ, 2004, BIOCHEMISTRY-US, V43, P4621, DOI 10.1021/bi049979h; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kim SJ, 2003, J BIOL CHEM, V278, P41890, DOI 10.1074/jbc.M306017200; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; MORRISON WR, 1964, ANAL BIOCHEM, V7, P218, DOI 10.1016/0003-2697(64)90231-3; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Norris EH, 2003, J BIOL CHEM, V278, P27230, DOI 10.1074/jbc.M212436200; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uversky VN, 2002, FEBS LETT, V517, P239, DOI 10.1016/S0014-5793(02)02638-8; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	55	202	211	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47746	47753		10.1074/jbc.M408906200	http://dx.doi.org/10.1074/jbc.M408906200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364911	hybrid			2022-12-27	WOS:000224957000042
J	Jeon, SH; Kayhan, B; Ben-Yedidia, T; Arnon, R				Jeon, SH; Kayhan, B; Ben-Yedidia, T; Arnon, R			A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SELECTION; VIRUS HEMAGGLUTININ; MEMBRANE-FUSION; IMMUNIZATION; INHIBITION; ANTIBODIES; LIGANDS; MICE	Influenza A virus infection is a major source of morbidity and mortality worldwide. Current means of control for influenza are based on prophylaxis by vaccines and on treatment by the available specific influenza neuraminidase inhibitor drugs. The approach taken in the present study is to prevent and/or ameliorate influenza infection by site-specific blocking of the viral binding to host cell receptors. We describe a novel oligonucleotide, known also as an aptamer, which has been designed to complement the receptor-binding region of the influenza hemagglutinin molecule. It was constructed by screening a DNA library and processing by the selective evolution of ligands by exponential enrichment (SELEX) procedure. We show that this DNA aptamer is indeed capable of inhibiting the hemagglutinin capacity of the virus, as well as in the prevention of viral infectivity in vitro, in tissue culture. Furthermore, it inhibits viral infection by different influenza strains in an animal model, as manifested by 90-99% reduction of virus burden in the lungs of treated mice. The mode of action of this aptamer is by blocking the binding of influenza virus to target cell receptors and consequently prevention of the virus invasion into the host cells.	Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Arnon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ruth.arnon@weizmann.ac.il	KAYHAN, BASAK/ABH-9314-2020					ARNON R, 1992, CURR OPIN IMMUNOL, V4, P449, DOI 10.1016/S0952-7915(06)80037-3; BARRETT T, 1985, GROWTH PURIFICATION, P119; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; BROWN LE, 1990, ARCH VIROL, V114, P1, DOI 10.1007/BF01311008; Bruno JG, 1999, BIOSENS BIOELECTRON, V14, P457, DOI 10.1016/S0956-5663(99)00028-7; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Couch RB, 2000, NEW ENGL J MED, V343, P1778, DOI 10.1056/NEJM200012143432407; Demicheli V, 2000, VACCINE, V18, P957, DOI 10.1016/S0264-410X(99)00332-1; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gravenstein S, 2002, CLIN INFECT DIS, V35, P729, DOI 10.1086/341246; Guo CT, 2002, GLYCOBIOLOGY, V12, P183, DOI 10.1093/glycob/12.3.183; Hesselberth J, 2000, J Biotechnol, V74, P15, DOI 10.1016/S1389-0352(99)00005-7; Jeon SH, 2002, VIRAL IMMUNOL, V15, P165, DOI 10.1089/088282402317340314; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; LEVI R, 1995, J VIROL METHODS, V52, P55, DOI 10.1016/0166-0934(94)00137-6; Lipatov AS, 2004, J VIROL, V78, P8951, DOI 10.1128/JVI.78.17.8951-8959.2004; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Morris KN, 1998, P NATL ACAD SCI USA, V95, P2902, DOI 10.1073/pnas.95.6.2902; Mozdzanowska K, 1997, J VIROL, V71, P4347, DOI 10.1128/JVI.71.6.4347-4355.1997; MULLER GM, 1982, P NATL ACAD SCI-BIOL, V79, P569, DOI 10.1073/pnas.79.2.569; PAN WH, 1995, P NATL ACAD SCI USA, V92, P11509, DOI 10.1073/pnas.92.25.11509; Schofield DJ, 1997, J GEN VIROL, V78, P2431, DOI 10.1099/0022-1317-78-10-2431; Sekiya S, 2003, J BIOCHEM, V133, P351, DOI 10.1093/jb/mvg047; Sekkal D, 2002, ANTISENSE NUCLEIC A, V12, P265, DOI 10.1089/108729002320351584; Sidwell RW, 1998, ANTIVIR RES, V37, P107, DOI 10.1016/S0166-3542(97)00065-X; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ulrich H, 2002, J BIOL CHEM, V277, P20756, DOI 10.1074/jbc.M111859200; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	137	154	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48410	48419		10.1074/jbc.M409059200	http://dx.doi.org/10.1074/jbc.M409059200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15358767	hybrid			2022-12-27	WOS:000224957000117
J	Rozanov, DV; Savinov, AY; Golubkov, VS; Postnova, TI; Remacle, A; Tomlinson, S; Strongin, AY				Rozanov, DV; Savinov, AY; Golubkov, VS; Postnova, TI; Remacle, A; Tomlinson, S; Strongin, AY			Cellular membrane type-1 matrix metalloproteinase (MT1-MMP) cleaves C3b, an essential component of the complement system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; HUMAN-MELANOMA CELLS; INTEGRIN ALPHA(V) SUBUNIT; DECAY-ACCELERATING FACTOR; 3RD COMPONENT; TUMOR-GROWTH; CYSTEINE PROTEINASE; REGULATORY PROTEINS; BONE SIALOPROTEIN; TISSUE INHIBITOR	Neoplasms have developed numerous strategies to protect themselves against the host immune system. Membrane type-1 matrix metalloproteinase (MT1-MMP) is strongly associated with many cancer types and is up-regulated in the aggressive, metastatic neoplasms. During the past few years, there has been an increasing appreciation of the important, albeit incompletely understood, role of MT1-MMP in cancer. We have discovered, using cell-free and cell-based assays in vitro, that MT1-MMP proteolysis specifically targets C3b, an essential component of the complement propagation pathway. MT1-MMP proteolysis liberates the deposited C3 activation fragments from the cell surface. The shedding of these cell-deposited opsonins by MT1-MMP inhibits the complement cascade and protects breast carcinoma MCF7 cells from direct complement-mediated injury in the in vitro tests. The functional link associating MT1-MMP with the host immune system, heretofore unrecognized, may empower tumors with an escape mechanism that contributes to the protection against the host antitumor immunity as well as to the survival of invading and metastatic malignant cells in the bloodstream.	Burnham Inst, La Jolla, CA 92037 USA; Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Sanford Burnham Prebys Medical Discovery Institute; Medical University of South Carolina	Strongin, AY (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; 	NCI NIH HHS [CA83017, CA77470] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARA S, 1987, J IMMUNOL, V138, P1303; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Caragine TA, 2002, CANCER RES, V62, P1110; Carroll MC, 1997, CURR OPIN IMMUNOL, V9, P64, DOI 10.1016/S0952-7915(97)80160-4; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; Dachs GU, 1997, ONCOL RES, V9, P313; DECLERCK YA, 1991, J BIOL CHEM, V266, P3893; DELIBRIAS C, 1997, COMPLEMENT SYSTEM, P211; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Fedarko NS, 2000, J BIOL CHEM, V275, P16666, DOI 10.1074/jbc.M001123200; Frade R, 1998, CANCER RES, V58, P2733; Gorter A, 1999, IMMUNOL TODAY, V20, P576, DOI 10.1016/S0167-5699(99)01537-6; Hernandez-Barrantes S, 2002, SEMIN CANCER BIOL, V12, P131, DOI 10.1006/scbi.2001.0421; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Jean D, 1996, CANCER RES, V56, P254; Jean D, 1995, BIOCHEM J, V312, P961, DOI 10.1042/bj3120961; Jurianz K, 1999, MOL IMMUNOL, V36, P316; Jurianz K, 1999, IMMUNOPHARMACOLOGY, V42, P209, DOI 10.1016/S0162-3109(99)00006-5; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; KIM SH, 1987, J IMMUNOL, V138, P1530; KINOSHITA T, 1985, J EXP MED, V162, P75, DOI 10.1084/jem.162.1.75; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Lhotak S, 2001, CLIN EXP METASTAS, V18, P463, DOI 10.1023/A:1011800919981; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Maenpaa A, 1996, AM J PATHOL, V148, P1139; Morgan B P, 2000, Methods Mol Biol, V150, P1; Morgan BP, 1999, CRIT REV IMMUNOL, V19, P173; Morgan BP., 1999, COMPLEMENT REGULATOR; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nielsen CH, 2002, J LEUKOCYTE BIOL, V72, P249; Nuttall RK, 2003, MOL CANCER RES, V1, P333; OLLERT MW, 1993, CANCER RES, V53, P592; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Rozanov DV, 2002, J BIOL CHEM, V277, P9318, DOI 10.1074/jbc.M110711200; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Rus HG, 2001, IMMUNOL REV, V180, P49, DOI 10.1034/j.1600-065X.2001.1800104.x; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Ueno H, 1997, CANCER RES, V57, P2055; Yu J, 1999, CLIN EXP IMMUNOL, V115, P13; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	55	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46551	46557		10.1074/jbc.M405284200	http://dx.doi.org/10.1074/jbc.M405284200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15381670	hybrid			2022-12-27	WOS:000224832400027
J	Spinella, F; Rosano, L; Di Castro, V; Natali, PG; Bagnato, A				Spinella, F; Rosano, L; Di Castro, V; Natali, PG; Bagnato, A			Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR; CANCER CELLS; EMERGING ROLE; EXPRESSION; CYCLOOXYGENASE-2; E-2; ACTIVATION; TRANSACTIVATION; AUTOCRINE; NEOVASCULARIZATION	Cyclooxygenase (COX)-1- and COX-2-derived prostaglandins are implicated in the development and progression of several malignancies. We have recently demonstrated that treatment of ovarian carcinoma cells with endothelin-1 (ET-1) induces expression of both COX-1 and COX-2, which contributes to vascular endothelial growth factor ( VEGF) production. In this study, we show that in HEY and OVCA 433 ovarian carcinoma cells, ET-1, through the binding with ETA receptor (ETAR), induces prostaglandin E2 (PGE(2)) production, as the more represented PG types, and increases the expression of PGE2 receptor type 2 (EP2) and type 4 (EP4). The use of pharmacological EP agonists and antagonists indicates that ET-1 and PGE(2) stimulate VEGF production principally through EP2 and EP4 receptors. At the mechanistic level, we prove that the induction of PGE(2) and VEGF by ET-1 involves Src-mediated epidermal growth factor receptor transactivation. Finally, we demonstrate that ETAR-mediated activation of PGE(2)-dependent signaling participates in the regulation of the invasive behavior of ovarian carcinoma cells by activating tumor-associated matrix metalloproteinase. These results implicate EP2 and EP4 receptors in the induction of VEGF expression and cell invasiveness by ET-1 and provide a mechanism by which ETAR/ET-1 can promote and interact with PGE(2)-dependent machinery to amplify its proangiogenic and invasive phenotype in ovarian carcinoma cells. Pharmacological blockade of ETAR can therefore represent an additional strategy to control PGE(2) signaling, which has been associated with ovarian carcinoma progression.	Regina Elena Inst Canc Res, Lab Mol Pathol & Ultrastruct, I-00158 Rome, Italy; Regina Elena Inst Canc Res, Immunol Lab, I-00158 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Bagnato, A (corresponding author), Regina Elena Inst Canc Res, Lab Mol Pathol & Ultrastruct, Via Messi dOro 156, I-00158 Rome, Italy.	bagnato@ifo.it	Rosanò, Laura/B-2863-2018; Di Castro, Valeriana/H-8873-2017; Rosanò, Laura/AAB-7821-2019; Bagnato, Anna/G-9747-2016; ROSANO', Laura/AAK-1424-2020; Rosanò, Laura/I-9266-2012; spinella, francesca/AAZ-8982-2020	Rosanò, Laura/0000-0002-9962-6411; Di Castro, Valeriana/0000-0002-1899-3683; Rosanò, Laura/0000-0002-3981-8593; Bagnato, Anna/0000-0002-7269-9522; ROSANO', Laura/0000-0002-9962-6411; 				ALBINI A, 1987, CANCER RES, V47, P3239; Ashby B, 1998, BIOCHEM PHARMACOL, V55, P239, DOI 10.1016/S0006-2952(97)00241-4; Azuma Y, 2004, J PHARMACOL SCI, V94, P261, DOI 10.1254/jphs.94.261; Bagnato A, 1999, CANCER RES, V59, P720; Bagnato A, 1995, CLIN CANCER RES, V1, P1059; Bagnato A, 1997, CANCER RES, V57, P1306; Bagnato A, 2003, TRENDS ENDOCRIN MET, V14, P44, DOI 10.1016/S1043-2760(02)00010-3; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Del Bufalo D, 2002, MOL PHARMACOL, V61, P524, DOI 10.1124/mol.61.3.524; Denkert C, 2002, AM J PATHOL, V160, P893, DOI 10.1016/S0002-9440(10)64912-7; Denkert C, 2003, ONCOGENE, V22, P8653, DOI 10.1038/sj.onc.1206920; Dohadwala M, 2002, J BIOL CHEM, V277, P50828, DOI 10.1074/jbc.M210707200; Eibl G, 2003, BIOCHEM BIOPH RES CO, V306, P887, DOI 10.1016/S0006-291X(03)01079-9; Erkinheimo TL, 2004, CLIN CANCER RES, V10, P538, DOI 10.1158/1078-0432.CCR-0132-03; Ferrandina G, 2002, GYNECOL ONCOL, V85, P305, DOI 10.1006/gyno.2002.6620; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Fukuda R, 2003, CANCER RES, V63, P2330; Gschwind A, 2002, CANCER RES, V62, P6329; Gupta RA, 2003, CANCER RES, V63, P906; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Narko K, 2001, J CLIN ENDOCR METAB, V86, P1765, DOI 10.1210/jc.86.4.1765; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Rosano L, 2003, CANCER RES, V63, P2447; Rosano L, 2001, CANCER RES, V61, P8340; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Salani D, 2000, AM J PATHOL, V157, P1537, DOI 10.1016/S0002-9440(10)64791-8; Sales KJ, 2002, CANCER RES, V62, P424; Sales KJ, 2004, MOL ENDOCRINOL, V18, P1533, DOI 10.1210/me.2004-0022; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Seno H, 2002, CANCER RES, V62, P506; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Spinella F, 2004, CLIN CANCER RES, V10, P4670, DOI 10.1158/1078-0432.CCR-04-0315; Spinella F, 2003, J BIOL CHEM, V278, P41294, DOI 10.1074/jbc.M304785200; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Vacca F, 2000, CANCER RES, V60, P5310; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286	42	81	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46700	46705		10.1074/jbc.M408584200	http://dx.doi.org/10.1074/jbc.M408584200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347673	hybrid			2022-12-27	WOS:000224832400047
J	Ahuja, A; Purcarea, C; Ebert, R; Sadecki, S; Guy, HI; Evans, DR				Ahuja, A; Purcarea, C; Ebert, R; Sadecki, S; Guy, HI; Evans, DR			Aquifex aeolicus Dihydroorotase - Association with aspartate transcarbamoylase switches on catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIFUNCTIONAL PROTEIN CAD; EHRLICH ASCITES-CARCINOMA; ESCHERICHIA-COLI; HAMSTER DIHYDROOROTASE; SUBUNIT STRUCTURE; MAMMALIAN DIHYDROOROTASE; PYRIMIDINE BIOSYNTHESIS; CARBAMOYL-PHOSPHATE; DOMAIN; PURIFICATION	Dihydroorotase (DHOase) catalyzes the reversible condensation of carbamoyl aspartate to form dihydroorotate in de novo pyrimidine biosynthesis. The enzyme from Aquifex aeolicus, a hyperthermophilic organism of ancient lineage, was cloned and expressed in Escherichia coli. The purified protein was found to be a 45-kDa monomer containing a single zinc ion. Although there is no other DHOase gene in the A. aeolicus genome, the recombinant protein completely lacked catalytic activity at any temperature tested. However, DHOase formed an active complex with aspartate transcarbamoylase ( ATCase) from the same organism. Whereas the k(cat) of 13.8 +/- 0.03 s(-1) was close to the value observed for the mammalian enzyme, the Km for dihydroorotate, 3.03 +/- 0.05 mM was 433-fold higher. Gel filtration and chemical cross-linking showed that the complex exists as a 240-kDa hexamer (DHO3-ATC(3)) and a 480-kDa duo-decamer (DHO6-ATC(6)) probably in rapid equilibrium. Complex formation protects both DHOase and ATCase against thermal degradation at temperatures near 100 degreesC where the organism grows optimally. These results lead to the reclassification of both enzymes: ATCase, previously considered a Class C homotrimer, now falls into Class A, whereas the DHOase is a Class 1B enzyme. CD spectroscopy indicated that association with ATCase does not involve a significant perturbation of the DHOase secondary structure, but the visible absorption spectrum of a Co2+-substituted DHOase is appreciably altered upon complex formation suggesting a change in the electronic environment of the active site. The association of DHOase with ATCase probably serves as a molecular switch that ensures that free, uncomplexed DHOase in the cell remains inactive. At pH 7.4, the equilibrium ratio of carbamoyl aspartate to dihydroorotate is 17 and complex formation may drive the reaction in the biosynthetic direction.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Evans, DR (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield St, Detroit, MI 48201 USA.	devans@cmb.biosci.wayne.edu		Purcarea, Cristina/0000-0001-5784-8545	NIGMS NIH HHS [GM/CA60371, GM/CA47399, R01 GM060371] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060371, R01GM047399] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahuja A, 2001, J BIOL CHEM, V276, P45694, DOI 10.1074/jbc.M106382200; BERGH ST, 1993, P NATL ACAD SCI USA, V90, P9818, DOI 10.1073/pnas.90.21.9818; CHRISTOPHERSON RI, 1979, J BIOL CHEM, V254, P2506; CHRISTOPHERSON RI, 1980, J BIOL CHEM, V255, P3358; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; Fields C., 1999, PATHS PYRIMIDINES, V7, P49; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Huang DTC, 1999, BIOCHEMISTRY-US, V38, P9964, DOI 10.1021/bi990859x; Hughes LE, 1999, CURR MICROBIOL, V39, P175, DOI 10.1007/s002849900441; Jones M E, 1980, Mol Biol Biochem Biophys, V32, P165; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; KELLY RE, 1986, J BIOL CHEM, V261, P6073; Kim GJ, 1998, BIOCHEM J, V330, P295, DOI 10.1042/bj3300295; Kim R, 1998, BIOTECHNOL LETT, V20, P207, DOI 10.1023/A:1005305330517; KRUNGKRAI J, 1990, BIOCHEMISTRY-US, V29, P6270, DOI 10.1021/bi00478a023; LIPSCOMB WN, 1994, ADV ENZYMOL RAMB, V68, P67; LOLLIER M, 1995, CURR GENET, V28, P138, DOI 10.1007/BF00315780; MALLY MI, 1980, J BIOL CHEM, V255, P1372; MUSMANNO LA, 1991, GENE, V99, P211, DOI 10.1016/0378-1119(91)90129-Y; OGAWA J, 1995, EUR J BIOCHEM, V229, P284, DOI 10.1111/j.1432-1033.1995.tb20467.x; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Purcarea C, 2003, J BIOL CHEM, V278, P52924, DOI 10.1074/jbc.M309383200; Purcarea C, 2002, ACTA CRYSTALLOGR D, V58, P154, DOI 10.1107/S0907444901017528; SANDER EG, 1965, J BIOL CHEM, V240, P3628; SCHURR MJ, 1995, J BACTERIOL, V177, P1751, DOI 10.1128/jb.177.7.1751-1759.1995; SHEPHERDSON M, 1993, FEMS MICROBIOL LETT, V114, P201, DOI 10.1111/j.1574-6968.1993.tb06574.x; SIMMER JP, 1990, P NATL ACAD SCI USA, V87, P174, DOI 10.1073/pnas.87.1.174; SOUCIET JL, 1989, GENE, V79, P59, DOI 10.1016/0378-1119(89)90092-9; TAYLOR WH, 1976, J BACTERIOL, V127, P863, DOI 10.1128/JB.127.2.863-873.1976; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vickrey JF, 2002, J BIOL CHEM, V277, P24490, DOI 10.1074/jbc.M200009200; WASHABAUGH MW, 1984, J BIOL CHEM, V259, P3293; WEBER K, 1969, J BIOL CHEM, V244, P4406; WILLIAMS NK, 1993, PROTEIN ENG, V6, P333, DOI 10.1093/protein/6.3.333; WILLIAMS NK, 1995, BIOCHEMISTRY-US, V34, P11344, DOI 10.1021/bi00036a007; ZIMMERMANN BH, 1993, BIOCHEMISTRY-US, V32, P1519, DOI 10.1021/bi00057a016; ZIMMERMANN BH, 1995, BIOCHEMISTRY-US, V34, P7038, DOI 10.1021/bi00021a015	39	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53136	53144		10.1074/jbc.M403009200	http://dx.doi.org/10.1074/jbc.M403009200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15381710	hybrid			2022-12-27	WOS:000225680600042
J	Yang, WR; Moore, IF; Koteva, KP; Bareich, DC; Hughes, DW; Wright, GD				Yang, WR; Moore, IF; Koteva, KP; Bareich, DC; Hughes, DW; Wright, GD			TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENES; DETERMINANTS; DEGRADATION	The tetracycline antibiotics block microbial translation and constitute an important group of antimicrobial agents that find broad clinical utility. Resistance to this class of antibiotics is primarily the result of active efflux or ribosomal protection; however, a novel mechanism of resistance has been reported to be oxygen-dependent destruction of the drugs catalyzed by the enzyme TetX. Paradoxically, the tetX genes have been identified on transposable elements found in anaerobic bacteria of the genus Bacteroides. Overexpression of recombinant TetX in Escherichia coli followed by protein purification revealed a stoichiometric complex with flavin adenine dinucleotide. Reconstitution of in vitro enzyme activity demonstrated a broad tetracycline antibiotic spectrum and a requirement for molecular oxygen and NADPH in antibiotic degradation. The tetracycline products of TetX activity were unstable at neutral pH, but mass spectral and NMR characterization under acidic conditions supported initial monohydroxylation at position 11a followed by intramolecular cyclization and non-enzymatic breakdown to other undefined products. TetX is therefore a FAD-dependent monooxygenase. The enzyme not only catalyzed efficient degradation of a broad range of tetracycline analogues but also conferred resistance to these antibiotics in vivo. This is the first molecular characterization of an antibiotic-inactivating monooxygenase, the origins of which may lie in environmental bacteria.	McMaster Univ, Antimicrobial Res Ctr, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Chem, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Wright, GD (corresponding author), McMaster Univ, Antimicrobial Res Ctr, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Koteva, Kalinka/0000-0002-6446-9567; Wright, Gerard/0000-0002-9129-7131				ASLESON GL, 1975, J AM CHEM SOC, V97, P6246, DOI 10.1021/ja00854a051; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; BLACKWOOD RK, 1963, J AM CHEM SOC, V85, P3943, DOI 10.1021/ja00907a010; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; GUINEY DG, 1984, PLASMID, V11, P248, DOI 10.1016/0147-619X(84)90031-3; LEATHERBARROW RJ, 2000, GRAFIT; Marshall CG, 1998, ANTIMICROB AGENTS CH, V42, P2215, DOI 10.1128/AAC.42.9.2215; McManus PS, 2002, ANNU REV PHYTOPATHOL, V40, P443, DOI 10.1146/annurev.phyto.40.120301.093927; McMurry LM, 2000, GRAM-POSITIVE PATHOGENS, P660; PARK BH, 1988, ANTIMICROB AGENTS CH, V32, P1797, DOI 10.1128/AAC.32.12.1797; Schmidt AS, 2001, APPL ENVIRON MICROB, V67, P5675, DOI 10.1128/AEM.67.12.5675-5682.2001; Schnappinger D, 1996, ARCH MICROBIOL, V165, P359, DOI 10.1007/s002030050339; Sengelov G, 2003, VET MICROBIOL, V95, P91, DOI 10.1016/S0378-1135(03)00123-8; SPEER BS, 1991, J BACTERIOL, V173, P176, DOI 10.1128/jb.173.1.176-183.1991; SPEER BS, 1988, J BACTERIOL, V170, P1423, DOI 10.1128/jb.170.4.1423-1429.1988; Sum PE, 1999, BIOORG MED CHEM LETT, V9, P1459, DOI 10.1016/S0960-894X(99)00216-4; Whittle G, 2001, APPL ENVIRON MICROB, V67, P3488, DOI 10.1128/AEM.67.8.3488-3495.2001	18	197	207	5	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52346	52352		10.1074/jbc.M409573200	http://dx.doi.org/10.1074/jbc.M409573200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452119	hybrid			2022-12-27	WOS:000225493400077
J	Chang, WY; Bryce, DM; D'Souza, SJA; Dagnino, L				Chang, WY; Bryce, DM; D'Souza, SJA; Dagnino, L			The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE MORPHOGENESIS; CELL-CYCLE PROGRESSION; DNA-REPLICATION; E2F FAMILY; TARGET GENES; IN-VIVO; S-PHASE; DEREGULATED EXPRESSION; DIFFERENTIATION; PROLIFERATION	The epidermis is a stratified epithelium constantly replenished through the ability of keratinocytes in its basal layer to proliferate and self-renew. The epidermis arises from a single-cell layer ectoderm during embryogenesis. Large proliferative capacity is central to ectodermal cell and basal keratinocyte function. DP-1, a heterodimeric partner of E2F transcription factors, is highly expressed in the ectoderm and all epidermal layers during embryogenesis. To investigate the role of DP-1 in epidermal morphogenesis, we inhibited DP-1 activity through exogenous expression of a dominant-negative mutant (dnDP-1). Expression of the dnDP-1 mutant interferes with binding of E2F/DP-1 heterodimers to DNA and inhibits DNA replication, as well as cyclin A mRNA and protein expression. Chromatin immunoprecipitation analysis demonstrated that the cyclin A promoter is predominantly bound in proliferating keratinocytes by complexes containing E2F-3 and E2F-4. Thus, the mechanisms of decreased expression of cyclin A in the presence of dnDP-1 seem to involve inactivation of DP-1 complexes containing E2F-3 and E2F-4. To assess the consequences on epidermal morphogenesis of inhibiting DP-1 activity, we expressed dnDP-1 in rat epithelial keratinocytes in organotypic culture and observed that DP-1 inhibition negatively affected stratification of these cells. Likewise, expression of dnDP-1 in embryonic ectoderm explants produced extensive disorganization of subsequently formed epidermal basal and suprabasal layers, interfering with normal epidermal formation. We conclude that DP-1 activity is required for normal epidermal morphogenesis and ectoderm-to-epidermis transition.	Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; Univ Western Ontario, Dept Pediat, London, ON N6A 5C1, Canada; Child Hlth Res Inst, London, ON N6A 5C1, Canada; Lawson Hlth Res Inst, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Dagnino, L (corresponding author), Univ Western Ontario, Dept Physiol, Med Sci Bldg, London, ON N6A 5C1, Canada.	ldagnino@uwo.ca		Bryce, Dawn/0000-0002-7403-2940; Dagnino, Lina/0000-0003-1483-5159				BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; BONEKO VM, 1988, ACTA ANAT, V133, P325; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Byrne C, 2003, J ANAT, V202, P113, DOI 10.1046/j.1469-7580.2003.00142.x; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Chuong CM, 2002, EXP DERMATOL, V11, P159; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; D'Souza SJA, 2001, J BIOL CHEM, V276, P23531, DOI 10.1074/jbc.M100780200; Dagnino L, 1997, MECH DEVELOP, V66, P13, DOI 10.1016/S0925-4773(97)00083-X; Dagnino L, 1997, CELL GROWTH DIFFER, V8, P553; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; de la Luna S, 1999, EMBO J, V18, P212, DOI 10.1093/emboj/18.1.212; Dicker AJ, 2000, ONCOGENE, V19, P2887, DOI 10.1038/sj.onc.1203610; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gopalkrishnan RV, 1996, ONCOGENE, V13, P2671; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HIRAI Y, 1989, DEVELOPMENT, V105, P271; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Humbert PO, 2000, GENE DEV, V14, P690; Humbert PO, 2000, MOL CELL, V6, P281, DOI 10.1016/S1097-2765(00)00029-0; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lania L, 1999, J CELL PHYSIOL, V179, P134, DOI 10.1002/(SICI)1097-4652(199905)179:2<134::AID-JCP3>3.0.CO;2-O; Lavia P, 1999, BIOESSAYS, V21, P221; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; MACCALLUM D K, 1990, Skin Pharmacology, V3, P86; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; Niemann C, 2002, TRENDS CELL BIOL, V12, P185, DOI 10.1016/S0962-8924(02)02263-8; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Paramio JM, 2000, J BIOL CHEM, V275, P41219, DOI 10.1074/jbc.M004973200; Paramio JM, 1998, ONCOGENE, V17, P949, DOI 10.1038/sj.onc.1202031; Pasonen-Seppanen S, 2001, HISTOCHEM CELL BIOL, V116, P287, DOI 10.1007/s004180100312; Pierce AM, 1998, P NATL ACAD SCI USA, V95, P8858, DOI 10.1073/pnas.95.15.8858; Rempel RE, 2000, MOL CELL, V6, P293, DOI 10.1016/S1097-2765(00)00030-7; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rodriguez-Puebla ML, 1998, ONCOGENE, V17, P2251, DOI 10.1038/sj.onc.1202131; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Vespa A, 2003, J BIOL CHEM, V278, P11528, DOI 10.1074/jbc.M208337200; Wang DW, 2000, MOL CELL BIOL, V20, P3417, DOI 10.1128/MCB.20.10.3417-3424.2000; Wang DW, 2001, MOL CARCINOGEN, V31, P90, DOI 10.1002/mc.1044; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Wu CL, 1996, MOL CELL BIOL, V16, P3698; WU CL, 1995, MOL CELL BIOL, V15, P2536; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yamada M, 2002, CYTOKINE, V17, P91, DOI 10.1006/cyto.2001.0992; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G	71	22	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51343	51353		10.1074/jbc.M408635200	http://dx.doi.org/10.1074/jbc.M408635200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448153	hybrid			2022-12-27	WOS:000225355800085
J	Davis, TH; Chen, CL; Isom, LL				Davis, TH; Chen, CL; Isom, LL			Sodium channel beta 1 subunits promote neurite outgrowth in cerebellar granule neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; CELL-ADHESION; FGF RECEPTOR; GENERALIZED EPILEPSY; EXTRACELLULAR DOMAIN; AUXILIARY SUBUNIT; FEBRILE SEIZURES; N-CADHERIN; TENASCIN-R; EXPRESSION	Many immunoglobulin superfamily members are integral in development through regulation of processes such as growth cone guidance, cell migration, and neurite outgrowth. We demonstrate that homophilic interactions between voltage-gated sodium channel beta1 subunits promote neurite extension in cerebellar granule neurons. Neurons isolated from wild-type or beta1(-/-) mice were plated on top of parental, mock-, or beta1-transfected fibroblasts. Wild-type neurons consistently showed increased neurite length when grown on beta1-transfected monolayers, whereas beta1(-/-) neurons showed no increase compared with control conditions. beta1-Mediated neurite extension was mimicked using a soluble beta1 extracellular domain and was blocked by antibodies directed against the beta1 extracellular domain. Immunohistochemical analysis suggests that the beta1 and beta4 subunits, but not beta2 and beta3, are expressed in cerebellar Bergmann glia as well as granule neurons. These results suggest a novel role for beta1 during neuronal development and are the first demonstration of a functional role for sodium channel beta subunit-mediated cell adhesive interactions.	Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Isom, LL (corresponding author), Univ Michigan, Dept Pharmacol, 1150 W Med Ctr Dr,1301 MSRB 3, Ann Arbor, MI 48109 USA.	lisom@umich.edu		Isom, Lori/0000-0002-9479-6729	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS043062] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07767] Funding Source: Medline; NIMH NIH HHS [R01MH59980] Funding Source: Medline; NINDS NIH HHS [F31NS43062] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altman J, 1997, DEV CEREBELLAR SYSTE; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; BIXBY JL, 1994, J CELL BIOL, V127, P1461, DOI 10.1083/jcb.127.5.1461; BOVOLENTA P, 1984, DEV BIOL, V102, P248, DOI 10.1016/0012-1606(84)90189-1; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Buttiglione M, 1996, MOL CELL NEUROSCI, V8, P53, DOI 10.1006/mcne.1996.0043; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kamiguchi H, 1998, MOL CELL NEUROSCI, V12, P48, DOI 10.1006/mcne.1998.0702; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Kolkova K, 2000, J NEUROSCI, V20, P2238; Levy-Mozziconacci A, 1998, EUR J NEUROSCI, V10, P2757, DOI 10.1046/j.1460-9568.1998.00283.x; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2004, J BIOL CHEM, V279, P40748, DOI 10.1074/jbc.M407243200; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; Meadows LS, 2002, J NEUROSCI, V22, P10699; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; Rolf B, 2002, J NEUROSCI, V22, P8357; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Schaller KL, 2003, CEREBELLUM, V2, P2, DOI 10.1080/14734220309424; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Skaper SD, 2001, PROG NEUROBIOL, V65, P593, DOI 10.1016/S0301-0082(01)00017-X; Soha JM, 1997, J COMP NEUROL, V389, P642, DOI 10.1002/(SICI)1096-9861(19971229)389:4<642::AID-CNE7>3.0.CO;2-0; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; TONG JF, 1993, BIOCHEM BIOPH RES CO, V195, P679, DOI 10.1006/bbrc.1993.2099; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Yu FH, 2003, J NEUROSCI, V23, P7577	42	79	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51424	51432		10.1074/jbc.M410830200	http://dx.doi.org/10.1074/jbc.M410830200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452131	hybrid			2022-12-27	WOS:000225355800094
J	Kapyla, J; Jaalinoja, J; Tulla, M; Ylostalo, J; Nissinen, L; Viitasalo, T; Vehvilainen, P; Marjomaki, V; Nykvist, P; Saamanen, AM; Farndale, RW; Birk, DE; Ala-Kokko, L; Heino, J				Kapyla, J; Jaalinoja, J; Tulla, M; Ylostalo, J; Nissinen, L; Viitasalo, T; Vehvilainen, P; Marjomaki, V; Nykvist, P; Saamanen, AM; Farndale, RW; Birk, DE; Ala-Kokko, L; Heino, J			The fibril-associated collagen IX provides a novel mechanism for cell adhesion to cartilaginous matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; INTEGRINS ALPHA(1)BETA(1); 3-DIMENSIONAL COLLAGEN; RECOGNITION SITE; GENE-EXPRESSION; V COLLAGEN; BINDING; DOMAIN; IDENTIFICATION; RECEPTOR	Collagen IX is the prototype fibril-associated collagen with interruptions in triple helix. In human cartilage it covers collagen fibrils, but its putative cellular receptors have been unknown. The reverse transcription-PCR analysis of human fetal tissues suggested that based on their distribution all four collagen receptor integrins, namely alpha(1)beta(1), alpha(2)beta(1), alpha(10)beta(1), and alpha(11)beta(1), are possible receptors for collagen IX. Furthermore primary chondrocytes and chondrosarcoma cells express the four integrins simultaneously. Chondrosarcoma cells, as well as Chinese hamster ovary cells transfected to express alpha(1)beta(1), alpha(2)beta(1), or alpha(10)beta(1) integrin as their only collagen receptor, showed fast attachment and spreading on human recombinant collagen IX indicating that it is an effective cell adhesion protein. To further study the recognition of collagen IX we produced recombinant alphaI domains in Escherichia coli. For each of the four alphaI domains, collagen IX was among the best collagenous ligands, making collagen IX exceptional compared with all other collagen subtypes tested so far. Rotary shadowing electron microscopy images of both alpha(1)I- and alpha(2)I-collagen IX complexes unveiled only one binding site located in the COL3 domain close to the kink between it and the COL2 domain. The recognition of collagen IX by alpha(2)I was considered to represent a novel mechanism for two reasons. First, collagen IX has no GFOGER motif, and the identified binding region lacks any similar sequences. Second, the alpha(2)I domain mutations D219R and H258V, which both decreased binding to collagen I and GFOGER, had very different effects on its binding to collagen IX. D219R had no effect, and H258V prevented type IX binding. Thus, our results indicate that collagen IX has unique cell adhesion properties when compared with other collagens, and it provides a novel mechanism for cell adhesion to cartilaginous matrix.	Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland; Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; Univ Oulu, Bioctr, Collagen Res Unit, FL-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem & Mol Biol, FL-90014 Oulu, Finland; Univ Turku, Dept Med Biochem, FI-20520 Turku, Finland; Univ Turku, Med Res Lab, FI-20520 Turku, Finland; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70112 USA; Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland	University of Turku; University of Jyvaskyla; University of Oulu; University of Oulu; University of Turku; University of Turku; University of Cambridge; Jefferson University; Tulane University; Tulane University; University of Turku	Heino, J (corresponding author), Univ Turku, Dept Biochem & Food Chem, Arcanum Vatselankatu2, FI-20014 Turku, Finland.	jyrki.heino@utu.fi	Birk, David/I-4072-2012; Ylostalo, Joni/AAH-9457-2019	Birk, David/0000-0002-4865-9088; Ylostalo, Joni/0000-0001-9746-1994; Marjomaki, Varpu/0000-0002-4592-5926; Kapyla, Jarmo/0000-0003-3036-713X; Nissinen, Liisa/0000-0002-6743-6736				BIRK DE, 1990, J CELL SCI, V95, P649; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIESEWITZ R, 1993, J BIOL CHEM, V268, P2989; BRUCKNER P, 1985, P NATL ACAD SCI USA, V82, P2608, DOI 10.1073/pnas.82.9.2608; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; Diab M, 1996, BIOCHEM J, V314, P327, DOI 10.1042/bj3140327; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Ekholm E, 2002, AM J PATHOL, V160, P1779, DOI 10.1016/S0002-9440(10)61124-8; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Gardner H, 1996, DEV BIOL, V175, P301, DOI 10.1006/dbio.1996.0116; Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575; HEINO J, 1989, J BIOL CHEM, V264, P380; Herouy Y, 1998, J INVEST DERMATOL, V111, P822, DOI 10.1046/j.1523-1747.1998.00369.x; Holden P, 1999, AM J HUM GENET, V65, P31, DOI 10.1086/302440; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; KERN A, 1994, J BIOL CHEM, V269, P22811; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Loeser RF, 2000, OSTEOARTHR CARTILAGE, V8, P96, DOI 10.1053/joca.1999.0277; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876; Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X; NORO A, 1983, J BIOL CHEM, V258, P9323; Nykvist P, 2000, J BIOL CHEM, V275, P8255, DOI 10.1074/jbc.275.11.8255; Nykvist P, 2001, J BIOL CHEM, V276, P38673, DOI 10.1074/jbc.M102589200; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; Sacca B, 2003, BIOCHEMISTRY-US, V42, P3429, DOI 10.1021/bi0206762; SANTALA P, 1994, J BIOL CHEM, V269, P1276; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Smith C, 2000, J BIOL CHEM, V275, P4205, DOI 10.1074/jbc.275.6.4205; Spayde EC, 2000, MATRIX BIOL, V19, P121, DOI 10.1016/S0945-053X(00)00055-X; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tuckwell DS, 1996, EUR J BIOCHEM, V241, P732, DOI 10.1111/j.1432-1033.1996.00732.x; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; VOIGT S, 1995, HISTOCHEM J, V27, P123; VUORIO E, 1984, FEBS LETT, V174, P238, DOI 10.1016/0014-5793(84)81165-5; WU JJ, 1992, J BIOL CHEM, V267, P23007; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zemmyo M, 2003, ARTHRITIS RHEUM-US, V48, P2873, DOI 10.1002/art.11246; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; ZUTTER MM, 1990, AM J PATHOL, V137, P113	67	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51677	51687		10.1074/jbc.M409412200	http://dx.doi.org/10.1074/jbc.M409412200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383545	hybrid			2022-12-27	WOS:000225355800124
J	Andraos, N; Tabor, S; Richardson, CC				Andraos, N; Tabor, S; Richardson, CC			The highly processive DNA polymerase of bacteriophage T5 - Role of the unique N and C termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEIC-ACID POLYMERASE; ESCHERICHIA-COLI; CONFERS PROCESSIVITY; STRAND DISPLACEMENT; PROTEIN; REPLICATION; BINDING; COMPLEX; MUTANT; DOMAIN	The DNA polymerase encoded by bacteriophage T5 has been reported previously to be processive and to catalyze extensive strand displacement synthesis. The enzyme, purified from phage-infected cells, did not require accessory proteins for these activities. Although T5 DNA polymerase shares extensive sequence homology with Escherichia coli DNA polymerase I and T7 DNA polymerase, it contains unique regions of 130 and 71 residues at its N and C termini, respectively. We cloned the gene encoding wild-type T5 DNA polymerase and characterized the overproduced protein. We also examined the effect of N- and C-terminal deletions on processivity and strand displacement synthesis. T5 DNA polymerase lacking its N- terminal 30 residues resembled the wild-type enzyme albeit with a 2-fold reduction in polymerase activity. Deletion of 24 residues at the C terminus resulted in a 30-fold reduction in polymerase activity on primed circular DNA, had dramatically reduced processivity, and was unable to carry out strand displacement synthesis. Deletion of 63 residues at the C terminus resulted in a 20,000-fold reduction in polymerase activity. The 3' to 5' double-stranded DNA exonuclease activity associated with T5 DNA polymerase was reduced by a factor of 5 in the polymerase truncated at the N terminus but was stimulated by a factor of 7 in the polymerase truncated at the C terminus. We propose a model in which the C terminus increases the affinity of the DNA for the polymerase active site, thus increasing processivity and decreasing the accessibility of the DNA to the exonuclease active site.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Paris 06, CNRS, UMR 7590, Lab Mineral Cristallog Paris, F-75252 Paris, France	Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	ccr@hms.harvard.edu			NIGMS NIH HHS [GM-54397] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; CHATTERJEE DK, 1991, GENE, V97, P13, DOI 10.1016/0378-1119(91)90004-U; DAS SK, 1976, J VIROL, V20, P70, DOI 10.1128/JVI.20.1.70-77.1976; DAS SK, 1980, J BIOL CHEM, V255, P7149; DAS SK, 1979, J BIOL CHEM, V254, P1227; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DEWAARD A, 1965, P NATL ACAD SCI USA, V54, P1241; DOPHEIDE TA, 1967, J BIOL CHEM, V242, P1833; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; ENGLER MJ, 1983, J BIOL CHEM, V258, P1165; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; FUJIMURA RK, 1976, J BIOL CHEM, V251, P2168; FUJIMURA RK, 1976, BIOCHEMISTRY-US, V15, P4403, DOI 10.1021/bi00665a009; He ZG, 2004, J BIOL CHEM, V279, P22190, DOI 10.1074/jbc.M401100200; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Kelman Z, 1998, STRUCTURE, V6, P121, DOI 10.1016/S0969-2126(98)00014-8; KORNBERG A, 1992, DNA REPLICATION, P494; Kumar JK, 2001, J BIOL CHEM, V276, P34905, DOI 10.1074/jbc.M104151200; LEAVITT MC, 1989, P NATL ACAD SCI USA, V86, P4465, DOI 10.1073/pnas.86.12.4465; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; MASAMUNE Y, 1971, J BIOL CHEM, V246, P2692; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; ORR CWM, 1965, J BIOL CHEM, V240, P4652; Rodriguez I, 2004, J MOL BIOL, V337, P829, DOI 10.1016/j.jmb.2004.02.018; Sambrook J., 2001, MOL CLONING LAB MANU; SCHILDKRAUT CL, 1964, J MOL BIOL, V9, P24, DOI 10.1016/S0022-2836(64)80089-9; STEUART CD, 1968, J BIOL CHEM, V243, P5308; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1989, J BIOL CHEM, V264, P6447; Truniger V, 2004, NUCLEIC ACIDS RES, V32, P361, DOI 10.1093/nar/gkh184; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118	37	19	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50609	50618		10.1074/jbc.M408428200	http://dx.doi.org/10.1074/jbc.M408428200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377656	hybrid			2022-12-27	WOS:000225229500125
J	Bai, M; Zhou, JM; Perrett, S				Bai, M; Zhou, JM; Perrett, S			The yeast prion protein Ure2 shows glutathione peroxidase activity in both native and fibrillar forms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; S-TRANSFERASE; HEAVY-METAL; CATALYTIC MECHANISM; AMYLOID FORMATION; CRYSTAL-STRUCTURE; IN-VITRO; DISEASE; DOMAIN; RESISTANCE	Ure2p is the precursor protein of the Saccharomyces cerevisiae prion [URE3]. Ure2p shows homology to glutathione transferases but lacks typical glutathione transferase activity. A recent study found that deletion of the Ure2 gene causes increased sensitivity to heavy metal ions and oxidants, whereas prion strains show normal sensitivity. To demonstrate that protection against oxidant toxicity is an inherent property of native and prion Ure2p requires biochemical characterization of the purified protein. Here we use steady-state kinetic methods to characterize the multisubstrate peroxidase activity of Ure2p using GSH with cumene hydroperoxide, hydrogen peroxide, or tert-butyl hydroperoxide as substrates. Glutathione-dependent peroxidase activity was proportional to the Ure2p concentration and showed optima at pH 8 and 40 degreesC. Michaelis-Menten behavior with convergent straight lines in double reciprocal plots was observed. This excludes a ping-pong mechanism and implies either a rapid-equilibrium random or a steady-state ordered sequential mechanism for Ure2p, consistent with its classification as a glutathione transferase. The mutant 90Ure2, which lacks the unstructured N-terminal prion domain, showed kinetic parameters identical to wild type. Fibrillar aggregates showed the same level of activity as native protein. Demonstration of peroxidase activity for Ure2 represents important progress in elucidation of its role in vivo. Further, establishment of an in vitro activity assay provides a valuable tool for the study of structure-function relationships of the Ure2 protein as both a prion and an enzyme.	Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhou, JM (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	zhoujm@sun5.ibp.ac.cn; sarah.perrett@iname.com	Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997				[Anonymous], 1973, CHEM KINETICS ENZYME; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Basu U, 2004, MOL GENET GENOMICS, V271, P627, DOI 10.1007/s00438-004-1015-7; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; Choi JH, 1998, J BIOL CHEM, V273, P29915, DOI 10.1074/jbc.273.45.29915; Collinson EJ, 2003, J BIOL CHEM, V278, P22492, DOI 10.1074/jbc.M301387200; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Fersht A., 1999, STRUCTURE MECH PROTE; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Galani D, 2002, J MOL BIOL, V315, P213, DOI 10.1006/jmbi.2001.5234; HOPE J, 1988, NATURE, V336, P390, DOI 10.1038/336390a0; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Labrou NE, 2001, BIOCHEM J, V358, P101, DOI 10.1042/0264-6021:3580101; Laidler K J, 1980, Methods Enzymol, V64, P227; Mannervik B, 1998, CHEM-BIOL INTERACT, V112, P15, DOI 10.1016/S0009-2797(97)00147-6; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Nay B, 1999, INSECT BIOCHEM MOLEC, V29, P71, DOI 10.1016/S0965-1748(98)00106-4; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rossjohn J, 1996, PROTEIN ENG, V9, P327, DOI 10.1093/protein/9.4.327; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; SEUBERT PA, 1985, ARCH BIOCHEM BIOPHYS, V240, P509, DOI 10.1016/0003-9861(85)90057-8; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Torrent J, 2003, BIOCHEMISTRY-US, V42, P1318, DOI 10.1021/bi0269916; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wu H, 2003, BIOCHEMISTRY-US, V42, P1129, DOI 10.1021/bi026857l; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhou JM, 2001, BIOCHEM BIOPH RES CO, V287, P147, DOI 10.1006/bbrc.2001.5556; Zhu L, 2003, BIOCHEM BIOPH RES CO, V311, P525, DOI 10.1016/j.bbrc.2003.10.027; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	52	91	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50025	50030		10.1074/jbc.M406612200	http://dx.doi.org/10.1074/jbc.M406612200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371425	hybrid			2022-12-27	WOS:000225229500060
J	Kumagai, A; Kim, SM; Dunphy, WG				Kumagai, A; Kim, SM; Dunphy, WG			Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; CHECKPOINT CONTROL; XENOPUS CHK1; BINDING; KINASE; DAMAGE; PHOSPHORYLATION; MRC1; PATHWAY	Claspin is necessary for the ATR-dependent activation of Chk1 in Xenopus egg extracts containing incompletely replicated DNA. ATR possesses a regulatory partner called ATRIP. We have studied the respective roles of ATR-ATRIP and Claspin in the activation of Chk1. ATR-ATRIP bound well to various DNA templates in Xenopus egg extracts. ATR-ATRIP bound to a single-stranded DNA template was weakly active. By contrast, the ATR-ATRIP complex on a DNA template containing both single- and double-stranded regions displayed a large increase in kinase activity. This observation suggests that ATR-ATRIP normally undergoes activation upon association with specific nucleic acid structures at DNA replication forks. Without Claspin, activated ATR-ATRIP phosphorylated Chk1 weakly in a cell-free reaction. The addition of Claspin to this reaction strongly stimulated the phosphorylation of Chk1 by ATR-ATRIP. Claspin also induced significant autophosphorylation of Chk1 in the absence of ATR-ATRIP. Taken together, these results indicate that the checkpoint-dependent phosphorylation of Chk1 is a multistep process involving activation of the ATR-ATRIP complex at replication forks and presentation of Chk1 to this complex by Claspin.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Dunphy, WG (corresponding author), CALTECH, Div Biol, 216-76,1200 E Calif Blvd, Pasadena, CA 91125 USA.	dunphy@cco.caltech.edu			NIGMS NIH HHS [GM043974, GM070891] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043974, R37GM043974, R01GM070891] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bomgarden RD, 2004, J BIOL CHEM, V279, P13346, DOI 10.1074/jbc.M311098200; Caldecott KW, 2003, SCIENCE, V302, P579, DOI 10.1126/science.1091463; Canman CE, 2003, CURR BIOL, V13, pR488, DOI 10.1016/S0960-9822(03)00410-X; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; De Souza CPC, 1999, MOL BIOL CELL, V10, P3661, DOI 10.1091/mbc.10.11.3661; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; KUMAGAI A, 1995, MOL BIOL CELL, V6, P199, DOI 10.1091/mbc.6.2.199; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Liu QH, 2000, GENE DEV, V14, P1448; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Oe T, 2001, DEV BIOL, V229, P250, DOI 10.1006/dbio.2000.9968; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Paciotti V, 2000, GENE DEV, V14, P2046; Rouse J, 2000, EMBO J, V19, P5801, DOI 10.1093/emboj/19.21.5801; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; Wakayama T, 2001, MOL CELL BIOL, V21, P755, DOI 10.1128/MCB.21.3.755-764.2001; Wang SX, 2000, FEBS LETT, V487, P277, DOI 10.1016/S0014-5793(00)02370-X; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wolkow TD, 2002, MOL BIOL CELL, V13, P480, DOI 10.1091/mbc.01-03-0104; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	48	112	115	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49599	49608		10.1074/jbc.M408353200	http://dx.doi.org/10.1074/jbc.M408353200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371427	Green Accepted, hybrid			2022-12-27	WOS:000225229500009
J	Kurata, S; Okuyama, T; Osada, M; Watanabe, T; Tomimori, Y; Sato, S; Iwai, A; Tsuji, T; Ikawa, Y; Katoh, I				Kurata, S; Okuyama, T; Osada, M; Watanabe, T; Tomimori, Y; Sato, S; Iwai, A; Tsuji, T; Ikawa, Y; Katoh, I			p51/p63 controls subunit alpha(3) of the major epidermis integrin anchoring the stem cells to the niche	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 HOMOLOG P63; SQUAMOUS-CELL; TERMINAL DIFFERENTIATION; TRANSCRIPTIONAL TARGET; EXPRESSION PATTERN; BASEMENT-MEMBRANE; GENE; ALPHA-3; GROWTH; MIGRATION	p51/p63, a member of the tumor suppressor p53 gene family, is crucial for skin development. We describe here identification of ITGA3 encoding integrin alpha(3) as a target of its trans-activating function, proposing that p51/p63 allows epidermal stem cells to express laminin receptor alpha(3)beta(1) for anchorage to the basement membrane. When activated by genotoxic stress or overexpressed ectopically in non-adherent cells, p51/p63 transduced a phenotype to attach to extracellular matrices, which was accompanied by expression of ITGA3. Motifs matching the p53-binding consensus sequence were located in a scattered form in intron 1 of human ITGA3, and served as p51/p63-responsive elements in reporter assays. In addition to the trans-activating ability of the TA isoform, we detected a positive effect of the DeltaN isoform on ITGA3. The high level alpha(3) production in human keratinocyte stem cells diminished upon elimination of p51/p63 by small interfering RNA or by Ca2+-induced differentiation. Furthermore, a chromatin immunoprecipitation experiment indicated a physical interaction of p51/p63 with intron 1 of ITGA3. This study provides a molecular basis for the standing hypothesis that p51/p63 is essential for epidermal-mesenchymal interactions.	Inst Phys & Chem Res, Ikawa Lab, Wako, Saitama 3510198, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Bunkyo Ku, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Grad Sch Allied Hlth Sci, Bunkyo Ku, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Dept Immune Regulat, Bunkyo Ku, Tokyo 1138510, Japan; Kyoritsu Coll Pharmaceut Sci, Dept Mol Physiol, Minato Ku, Tokyo 1058512, Japan; Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Tokyo 1428501, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Hoshi University	Katoh, I (corresponding author), Inst Phys & Chem Res, Ikawa Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	peace@postman.riken.jp						ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; Bakkers J, 2002, DEV CELL, V2, P617, DOI 10.1016/S1534-5807(02)00163-6; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; DiPersio CM, 2001, EXP CELL RES, V268, P45, DOI 10.1006/excr.2001.5273; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; DiRenzo J, 2002, CANCER RES, V62, P89; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Hagiwara K, 1999, CANCER RES, V59, P4165; Hashida H, 2002, INT J CANCER, V97, P518, DOI 10.1002/ijc.1625; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kappert K, 2000, HYPERTENSION, V35, P255, DOI 10.1161/01.HYP.35.1.255; Kato T, 2002, EUR J BIOCHEM, V269, P4524, DOI 10.1046/j.1432-1033.2002.03146.x; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Katoh I, 2004, J BIOL CHEM, V279, P15515, DOI 10.1074/jbc.M311819200; Koga F, 2003, BRIT J CANCER, V88, P740, DOI 10.1038/sj.bjc.6600764; Kojima T, 2001, BIOCHEM BIOPH RES CO, V281, P1170, DOI 10.1006/bbrc.2001.4486; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Lubman RL, 2000, AM J PHYSIOL-LUNG C, V279, pL183, DOI 10.1152/ajplung.2000.279.1.L183; Massion PP, 2003, CANCER RES, V63, P7113; McLure KG, 1999, EMBO J, V18, P763, DOI 10.1093/emboj/18.3.763; McLure KG, 1998, EMBO J, V17, P3342, DOI 10.1093/emboj/17.12.3342; MICHIELI P, 1994, CANCER RES, V54, P3391; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nagata M, 2003, INT J CANCER, V106, P683, DOI 10.1002/ijc.11283; NAKAMURA K, 1995, J CELL BIOL, V129, P1691, DOI 10.1083/jcb.129.6.1691; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; Nylander K, 2000, INT J CANCER, V87, P368, DOI 10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.3.CO;2-A; Okada Y, 2002, EXP CELL RES, V276, P194, DOI 10.1006/excr.2002.5535; Osada M, 2001, BIOCHEM BIOPH RES CO, V283, P1135, DOI 10.1006/bbrc.2001.4905; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586; Patriarca C, 1998, HUM PATHOL, V29, P1208, DOI 10.1016/S0046-8177(98)90247-7; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Quade BJ, 2001, GYNECOL ONCOL, V80, P24, DOI 10.1006/gyno.2000.5953; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Shimada A, 1999, CANCER RES, V59, P2781; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; STANLEY JR, 1983, J CELL BIOL, V96, P1809, DOI 10.1083/jcb.96.6.1809; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Tomimori Y, 2004, BIOCHEM BIOPH RES CO, V313, P230, DOI 10.1016/j.bbrc.2003.11.113; TSAO MC, 1982, J CELL PHYSIOL, V110, P219, DOI 10.1002/jcp.1041100217; Tsuji T, 2002, CLIN EXP METASTAS, V19, P127, DOI 10.1023/A:1014573204062; Tsuji T, 1999, J BIOCHEM, V125, P1183, DOI 10.1093/oxfordjournals.jbchem.a022402; Tysnes BB, 1996, INT J CANCER, V67, P777, DOI 10.1002/(SICI)1097-0215(19960917)67:6<777::AID-IJC5>3.0.CO;2-O; Wang ZM, 1999, J CELL SCI, V112, P2925; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wiebe JP, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-9; Yamaguchi K, 2000, INT J CANCER, V86, P684, DOI 10.1002/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	64	57	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50069	50077		10.1074/jbc.M406322200	http://dx.doi.org/10.1074/jbc.M406322200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15361520	hybrid			2022-12-27	WOS:000225229500065
J	Moise, AR; Kuksa, V; Imanishi, Y; Palczewski, K				Moise, AR; Kuksa, V; Imanishi, Y; Palczewski, K			Identification of all-trans-retinol: All-trans-13,14-dihydroretinol saturase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENT EPITHELIAL-CELLS; PHYTOENE DESATURASE; ESCHERICHIA-COLI; VITAMIN-A; CAROTENOID BIOSYNTHESIS; ALDEHYDE DEHYDROGENASE; SUBSTRATE-SPECIFICITY; HUMAN CYTOCHROME-P450; 9-CIS-RETINOIC ACID; VERTEBRATE RETINA	Retinoids carry out essential functions in vertebrate development and vision. Many of the retinoid processing enzymes remain to be identified at the molecular level. To expand the knowledge of retinoid biochemistry in vertebrates, we studied the enzymes involved in plant metabolism of carotenoids, a related group of compounds. We identified a family of vertebrate enzymes that share significant similarity and a putative phytoene desaturase domain with a recently described plant carotenoid isomerase (CRTISO), which isomerizes prolycopene to all-trans-lycopene. Comparison of heterologously expressed mouse and plant enzymes indicates that unlike plant CRTISO, the CRTISO-related mouse enzyme is inactive toward prolycopene. Instead, the CRTISO-related mouse enzyme is a retinol saturase carrying out the saturation of the 13-14 double bond of all-trans-retinol to produce all-trans-13,14-dihydroretinol. The product of mouse retinol saturase (RetSat) has a shifted UV absorbance maximum, lambda(max)=290 nm, compared with the parent compound, all-trans-retinol (lambda(max)=325 nm), and its MS analysis (m/z=288) indicates saturation of a double bond. The product was further identified as all-trans-13,14-dihydroretinol, since its characteristics were identical to those of a synthetic standard. Mouse RetSat is membrane-associated and expressed in many tissues, with the highest levels in liver, kidney, and intestine. All-trans-13,14-dihydroretinol was also detected in several tissues of animals maintained on a normal diet. Thus, saturation of all-transretinol to all-trans-13,14-dihydroretinol by RetSat produces a new metabolite of yet unknown biological function.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Moise, AR (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.	moise@u.washington.edu; palczews@u.washington.edu	AR, Moise/P-2474-2019; Imanishi, Yoshikazu/E-8178-2010; Moise, Alexander R/C-9498-2009; Moise, Alexander/A-7186-2008	AR, Moise/0000-0003-2307-6035; Imanishi, Yoshikazu/0000-0003-4696-4836; Moise, Alexander R/0000-0003-2307-6035; 	NATIONAL EYE INSTITUTE [R03EY015399] Funding Source: NIH RePORTER; NEI NIH HHS [R03 EY015399-03, R03 EY015399, R03 EY015399-04, R03 EY015399-01, R03 EY015399-02] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMUS G, 1989, IN VITRO CELL DEV B, V25, P1141; AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Bhat PV, 1995, GENE, V166, P303, DOI 10.1016/0378-1119(96)81752-5; Blobel G, 1979, Symp Soc Exp Biol, V33, P9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitenbach J, 2001, Z NATURFORSCH C, V56, P915; BUCK J, 1991, SCIENCE, V254, P1654, DOI 10.1126/science.1749937; BUCK J, 1993, J EXP MED, V178, P675, DOI 10.1084/jem.178.2.675; BUEHNER M, 1974, J MOL BIOL, V82, P563, DOI 10.1016/0022-2836(74)90249-6; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chou CF, 2002, J BIOL CHEM, V277, P25209, DOI 10.1074/jbc.M201947200; Cunningham FX, 1998, ANNU REV PLANT PHYS, V49, P557, DOI 10.1146/annurev.arplant.49.1.557; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DERGUINI F, 1995, J BIOL CHEM, V270, P18875, DOI 10.1074/jbc.270.32.18875; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Fujiwara S, 2003, ZOOL SCI, V20, P809, DOI 10.2108/zsj.20.809; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Giuliano G, 2003, TRENDS PLANT SCI, V8, P145, DOI 10.1016/S1360-1385(03)00053-0; Giuliano G, 2002, TRENDS PLANT SCI, V7, P427, DOI 10.1016/S1360-1385(02)02329-4; GIULIANO G, 1986, J BIOL CHEM, V261, P2925; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; HENGARTNER U, 1992, HELV CHIM ACTA, V75, P1848, DOI 10.1002/hlca.19920750611; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kuksa V, 2003, VISION RES, V43, P2959, DOI 10.1016/S0042-6989(03)00482-6; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; LAW WC, 1988, J AM CHEM SOC, V110, P5915, DOI 10.1021/ja00225a062; Lin M, 2003, J BIOL CHEM, V278, P9856, DOI 10.1074/jbc.M211417200; Masamoto K, 2001, PLANT CELL PHYSIOL, V42, P1398, DOI 10.1093/pcp/pce167; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mic FA, 2000, MECH DEVELOP, V97, P227, DOI 10.1016/S0925-4773(00)00434-2; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Penzes P, 1997, GENE, V191, P167, DOI 10.1016/S0378-1119(97)00054-1; Raisig A, 1996, J BIOCHEM-TOKYO, V119, P559; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandmann G, 2002, PHYSIOL PLANTARUM, V116, P431, DOI 10.1034/j.1399-3054.2002.1160401.x; Schmidt CK, 2002, BBA-MOL CELL BIOL L, V1583, P237, DOI 10.1016/S1388-1981(02)00212-3; Schneider C, 1997, PROTEIN EXPRES PURIF, V10, P175, DOI 10.1006/prep.1997.0730; Shirley MA, 1996, DRUG METAB DISPOS, V24, P293; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Wang Y, 2001, ONCOGENE, V20, P7710, DOI 10.1038/sj.onc.1204941; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; YAN B, 1995, J BIOL CHEM, V270, P29668; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476; Zechmeister L, 1941, P NATL ACAD SCI USA, V27, P468, DOI 10.1073/pnas.27.10.468; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	65	79	84	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50230	50242		10.1074/jbc.M409130200	http://dx.doi.org/10.1074/jbc.M409130200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15358783	Green Accepted, hybrid			2022-12-27	WOS:000225229500084
J	Yu, S; Michie, SA; Lowe, AW				Yu, S; Michie, SA; Lowe, AW			Absence of the major zymogen granule membrane protein, GP2, does not affect pancreatic morphology or secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAMM-HORSFALL PROTEIN; RAT PANCREAS; ACINAR-CELLS; EXOCRINE PANCREAS; ESCHERICHIA-COLI; GP-2; GLYCOPROTEIN; MICE; UROMODULIN; IDENTIFICATION	The majority of digestive enzymes in humans are produced in the pancreas where they are stored in zymogen granules before secretion into the intestine. GP2 is the major membrane protein present in zymogen granules of the exocrine pancreas. Numerous studies have shown that GP2 binds digestive enzymes such as amylase, thereby supporting a role in protein sorting to the zymogen granule. Other studies have suggested that GP2 is important in the formation of zymogen granules. A knock-out mouse was generated for GP2 to study the impact of the protein on pancreatic function. GP2-deficient mice displayed no gross signs of nutrient malabsorption such as weight loss, growth retardation, or diarrhea. Zymogen granules in the GP2 knock-out mice appeared normal on electron microscopy and contained the normal complement of proteins excluding GP2. Primary cultures of pancreatic acini appropriately responded to secretagogue stimulation with the secretion of digestive enzymes. The course of experimentally induced pancreatitis was also examined in the knock-out mice because proteins known to associate with GP2 have been found to possess a protective role. When GP2 knock-out mice were subjected to two different models of pancreatitis, no major differences were detected. In conclusion, GP2 is not essential for pancreatic exocrine secretion or zymogen granule formation. It is unlikely that GP2 serves a major intracellular role within the pancreatic acinar cell and may be functionally active after it is secreted from the pancreas.	Stanford Univ, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Ctr Digest Dis, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Lowe, AW (corresponding author), Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu			NIDDK NIH HHS [DK43294] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043294, R01DK043294] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087; Antonin W, 2002, MOL CELL BIOL, V22, P1545, DOI 10.1128/MCB.22.5.1545-1554.2002; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; BRAUN JEA, 1994, J BIOL CHEM, V269, P5328; COLOMER V, 1994, EMBO J, V13, P3711, DOI 10.1002/j.1460-2075.1994.tb06680.x; Dartsch H, 1998, EUR J CELL BIOL, V75, P211, DOI 10.1016/S0171-9335(98)80115-5; Demols A, 2000, PANCREAS, V20, P161, DOI 10.1097/00006676-200003000-00009; DITTIE A, 1992, EUR J CELL BIOL, V58, P243; FREEDMAN SD, 1993, BIOCHEM BIOPH RES CO, V197, P992, DOI 10.1006/bbrc.1993.2577; Fritz B.A., 1996, AM J PHYSIOL, V270, P176; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; Hao Y, 2004, ARCH PATHOL LAB MED, V128, P668; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; Imamura T, 2002, J BIOL CHEM, V277, P50725, DOI 10.1074/jbc.M204159200; JACOB M, 1992, BIOCHEM CELL BIOL, V70, P1105, DOI 10.1139/o92-156; Kalus I, 2002, BIOCHEM J, V362, P433, DOI 10.1042/0264-6021:3620433; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; LEBLOND FA, 1993, BIOCHEM J, V291, P289, DOI 10.1042/bj2910289; LOMBARDI B, 1975, AM J PATHOL, V81, P87; LOMBARDI B, 1975, AM J PATHOL, V79, P465; LOWE AW, 1994, GASTROENTEROLOGY, V107, P1819, DOI 10.1016/0016-5085(94)90826-5; MACDONAL.RJ, 1972, BIOCHEM BIOPH RES CO, V49, P377, DOI 10.1016/0006-291X(72)90421-4; MENOZZI D, 1990, METHOD ENZYMOL, V192, P271; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; RONZIO RA, 1978, BIOCHIM BIOPHYS ACTA, V508, P65, DOI 10.1016/0005-2736(78)90189-X; SCHEELE GA, 1994, PANCREAS, V9, P139, DOI 10.1097/00006676-199403000-00001; Schmidt K, 2001, J BIOL CHEM, V276, P14315, DOI 10.1074/jbc.M006221200; Schmidt K, 2000, J CELL SCI, V113, P2233; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yu S, 2004, BIOCHEM BIOPH RES CO, V322, P320, DOI 10.1016/j.bbrc.2004.07.120	36	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50274	50279		10.1074/jbc.M410599200	http://dx.doi.org/10.1074/jbc.M410599200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385539	hybrid			2022-12-27	WOS:000225229500089
J	Kunzelmann, K; Konig, J; Sun, J; Markovich, D; King, NJ; Karupiah, G; Young, JA; Cook, DI				Kunzelmann, K; Konig, J; Sun, J; Markovich, D; King, NJ; Karupiah, G; Young, JA; Cook, DI			Acute effects of parainfluenza virus on epithelial electrolyte transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE NA+ ABSORPTION; EXTRACELLULAR NUCLEOTIDES; PSEUDOMONAS-AERUGINOSA; MIDDLE-EAR; CLEARANCE; INFECTION; INHIBITION; ATP; HOSPITALIZATIONS; PATHOGENESIS	Parainfluenza viruses are important causes of respiratory disease in both children and adults. In particular, they are the major cause of the serious childhood illness croup (laryngotracheobronchitis). The infections produced by parainfluenza viruses are associated with the accumulation of ions and fluid in the respiratory tract. It is not known, however, whether this accumulation is because of a direct effect of the viruses on ion and fluid transport by the respiratory epithelium. Here we show that a model parainfluenza virus (the Sendai virus), in concentrations observed during respiratory infections, activates Cl- secretion and inhibits Na+ absorption across the tracheal epithelium. It does so by binding to a neuraminidase-insensitive glycolipid, possibly asialo-GM1, triggering the release of ATP, which then acts in an autocrine fashion on apical P2Y receptors to produce the observed changes in ion transport. These findings indicate that fluid accumulation in the respiratory tract associated with parainfluenza virus infection is attributable, at least in part, to direct effects of the virus on ion transport by the respiratory epithelium.	Univ Sydney, Sch Med Sci, Dept Physiol, Sydney, NSW 2006, Australia; Univ Queensland, Dept Physiol & Pharmacol, St Lucia, Qld 4072, Australia; Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia; Australian Natl Univ, John Curtin Sch Med Res, Woden, ACT 2606, Australia	University of Sydney; University of Queensland; University of Sydney; Australian National University; John Curtin School of Medical Research	Cook, DI (corresponding author), Univ Sydney, Sch Med Sci, Dept Physiol, Anderson Stuart Bldg F13, Sydney, NSW 2006, Australia.		Karupiah, Gunasegaran/J-4707-2013; Markovich, Daniel/F-7884-2012	Kunzelmann, Karl/0000-0002-4583-7037; Karupiah, Gunasegaran/0000-0001-6306-4405; King, Nicholas Jonathan Cole/0000-0002-3877-9772				Azzam ZS, 2001, J APPL PHYSIOL, V90, P1088, DOI 10.1152/jappl.2001.90.3.1088; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; BARBOUR S, 1992, J CELL PHYSIOL, V150, P610, DOI 10.1002/jcp.1041500322; Barker PM, 1997, J PEDIATR-US, V130, P373, DOI 10.1016/S0022-3476(97)70198-7; BOUCHER RC, 1982, J APPL PHYSIOL, V52, P893, DOI 10.1152/jappl.1982.52.4.893; CHANOCK RM, 2001, FIELDS VIROLOGY, V1, P1341; Cook DI, 2002, PFLUG ARCH EUR J PHY, V443, P339, DOI 10.1007/s00424-001-0729-1; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; Cuffe JE, 2000, J PHYSIOL-LONDON, V524, P77, DOI 10.1111/j.1469-7793.2000.00077.x; Davis IC, 2004, AM J PHYSIOL-LUNG C, V286, pL112, DOI 10.1152/ajplung.00218.2003; DESTGROTH SF, 1966, J EXP MED, V124, P347, DOI 10.1084/jem.124.3.347; Evans DJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1284, DOI 10.1152/ajpcell.1998.275.5.C1284; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; GRAHAM A, 1993, EXP LUNG RES, V19, P77, DOI 10.3109/01902149309071082; Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402; HENRICKSON KJ, 1994, CLIN INFECT DIS, V18, P770, DOI 10.1093/clinids/18.5.770; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; HOTEZ PJ, 1990, PEDIATR INFECT DIS J, V9, P751, DOI 10.1097/00006454-199010000-00017; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; JORIS L, 1991, AM J PHYSIOL, V260, pL510, DOI 10.1152/ajplung.1991.260.6.L510; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kunzelmann K, 2002, PFLUG ARCH EUR J PHY, V444, P220, DOI 10.1007/s00424-002-0796-y; LETZ B, 1995, J MEMBRANE BIOL, V148, P127; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 2000, AM J RESP CELL MOL, V23, P755, DOI 10.1165/ajrcmb.23.6.4207; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Marx A, 1997, J INFECT DIS, V176, P1423, DOI 10.1086/514137; Marx A, 1999, CLIN INFECT DIS, V29, P134, DOI 10.1086/520142; McNamara N, 2001, P NATL ACAD SCI USA, V98, P9086, DOI 10.1073/pnas.161290898; Morris AP, 2001, AM J PHYSIOL-GASTR L, V281, pG303, DOI 10.1152/ajpgi.2001.281.2.G303; OGASAWARA T, 1994, J VIROL, V68, P4022, DOI 10.1128/JVI.68.6.4022-4027.1994; PENACRUZ V, 1992, J INFECT DIS, V165, P846, DOI 10.1093/infdis/165.5.846; Portier F, 1999, AM J PHYSIOL-CELL PH, V276, pC312, DOI 10.1152/ajpcell.1999.276.2.C312; Prince GA, 2001, J VIROL, V75, P12446, DOI 10.1128/JVI.75.24.12446-12451.2001; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; ROBINSON TW, 1968, J MED MICROBIOL, V1, P89, DOI 10.1099/00222615-1-1-89; Scherrer U, 1999, ADV EXP MED BIOL, V474, P93; STUTTS MJ, 1986, AM REV RESPIR DIS, V134, P17; Suzuki T, 2001, J VIROL, V75, P4604, DOI 10.1128/JVI.75.10.4604-4613.2001; TAMAOKI J, 1991, INFECT IMMUN, V59, P716, DOI 10.1128/IAI.59.2.716-717.1991; Tarran R, 2001, MOL CELL, V8, P149, DOI 10.1016/S1097-2765(01)00286-6; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200	44	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48760	48766		10.1074/jbc.M409747200	http://dx.doi.org/10.1074/jbc.M409747200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364905	hybrid			2022-12-27	WOS:000225098100034
J	Lee, PHA; Trowbridge, JM; Taylor, KR; Morhenn, VB; Gallo, RL				Lee, PHA; Trowbridge, JM; Taylor, KR; Morhenn, VB; Gallo, RL			Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-COFACTOR-II; CELL-SURFACE PROTEOGLYCAN; GROWTH-FACTOR; CHONDROITIN SULFATE; EXPRESSION; SYNDECANS; DECORIN; BINDING; FAMILY; INHIBITION	Composition and architecture of the extracellular matrix dictate cell behavior. Proteoglycans bind multiple components of the extracellular matrix by serving as important regulators of cell behavior. Given the influence of culture architecture on cell function, we investigated whether switching NIH3T3 fibroblasts from growth on type 1 collagen in monolayer to a collagen gel might influence dermatan sulfate expression. Immunofluorescent staining, immunoblot, and Western blot demonstrated an induction in decorin expression in cells switched to collagen gels. This induction was associated with a 40-fold increase in decorin transcript expression determined by quantitative real time PCR. Disaccharide analysis of extracted glycosaminoglycans from collagen gels showed an increase in total glycosaminoglycan and in the ratio of chondroitin sulfate to heparan sulfate compared with monolayer culture. The ratio of chondroitin sulfate to heparan sulfate likewise increased on syndecan-1 from gel culture. Digestion with chondroitinase B showed that this induced chondroitin sulfate was dermatan sulfate. Syndecan-1 extracted from wounded mouse skin also displayed an increase in dermatan sulfate synthesis compared with unwounded skin. Furthermore, glycosaminoglycans from collagen gel culture activated keratinocyte growth factor, whereas glycosaminoglycans from monolayer culture lacked this ability. These findings suggest that regulation of dermatan sulfate and dermatan sulfate proteoglycan is dependent on extracellular matrix architecture. The ability of collagen gel culture to mimic better the in vivo dermal environment may be due in part to this influence on dermatan sulfate and dermatan sulfate proteoglycan synthesis.	Univ Calif San Diego, Div Dermatol, San Diego, CA 92161 USA; Vet Affairs San Diego Healthcare Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Gallo, RL (corresponding author), Mail Code 9111B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	rgallo@vapop.ucsd.edu	Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861	NATIONAL CANCER INSTITUTE [T32CA081211] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045676] Funding Source: NIH RePORTER; NCI NIH HHS [1T32 CA81211] Funding Source: Medline; NHLBI NIH HHS [HL-57345, HL7261] Funding Source: Medline; NIAID NIH HHS [AI-52453] Funding Source: Medline; NIAMS NIH HHS [AR-45676] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berman B, 1999, J BIOL CHEM, V274, P36132, DOI 10.1074/jbc.274.51.36132; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; CHOI HU, 1989, J BIOL CHEM, V264, P2876; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Demoor-Fossard M, 1998, BBA-GENE STRUCT EXPR, V1398, P179, DOI 10.1016/S0167-4781(98)00044-X; Di Carlo V, 1999, THROMB HAEMOSTASIS, V82, P30, DOI 10.1055/s-0037-1614625; ELENIUS K, 1994, J CELL SCI, V107, P2975; ELENIUS K, 1992, J BIOL CHEM, V267, P6435; ELENIUS K, 1991, J CELL BIOL, V114, P585, DOI 10.1083/jcb.114.3.585; Fernandez JA, 1999, THROMB HAEMOSTASIS, V82, P1462; Gallo R, 1996, J INVEST DERMATOL, V107, P676, DOI 10.1111/1523-1747.ep12365571; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Kuwaba K, 2002, J DERMATOL SCI, V29, P185, DOI 10.1016/S0923-1811(02)00023-3; Liaw PCY, 2001, J BIOL CHEM, V276, P20959, DOI 10.1074/jbc.M010584200; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; MALI M, 1993, J BIOL CHEM, V268, P24215; MASCELLANI G, 1993, BIOCHEM J, V296, P639, DOI 10.1042/bj2960639; Masuda T, 2004, MOL CELL NEUROSCI, V25, P217, DOI 10.1016/j.mcn.2003.10.005; Moulin V, 1996, BURNS, V22, P359, DOI 10.1016/0305-4179(95)00167-0; Olsson U, 2001, DIABETES, V50, P2126, DOI 10.2337/diabetes.50.9.2126; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Penc SF, 1999, J CLIN INVEST, V103, P1329, DOI 10.1172/JCI4742; PIERCE GF, 1994, J EXP MED, V179, P831, DOI 10.1084/jem.179.3.831; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; ROMARIS M, 1995, BIOCHEM J, V310, P73, DOI 10.1042/bj3100073; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sakai S, 2002, ANAL BIOCHEM, V302, P169, DOI 10.1006/abio.2001.5545; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; Senoo H, 1996, CELL BIOL INT, V20, P501, DOI 10.1006/cbir.1996.0065; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; STAIANOCOICO L, 1993, J EXP MED, V178, P865, DOI 10.1084/jem.178.3.865; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Wong WR, 2001, J FORMOS MED ASSOC, V100, P377; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6	46	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48640	48646		10.1074/jbc.M407241200	http://dx.doi.org/10.1074/jbc.M407241200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347686	hybrid			2022-12-27	WOS:000225098100020
J	Shao, E; Forgac, M				Shao, E; Forgac, M			Involvement of the nonhomologous region of subunit A of the yeast V-ATPase in coupling and in vivo dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; 3-DIMENSIONAL STRUCTURE; LUMINAL ACIDIFICATION; CROSS-LINKING; MEMBRANES; GENE; TRIPHOSPHATASE; LOCALIZATION; PURIFICATION	The catalytic nucleotide binding subunit ( subunit A) of the vacuolar proton-translocating ATPase ( or V-ATPase) is homologous to the beta-subunit of the F-ATPase but contains a 90-amino acid insert not present in the beta-subunit, termed the nonhomologous region. We previously demonstrated that mutations in this region lead to changes in coupling of proton transport and ATPase activity and to inhibition of in vivo dissociation of the V-ATPase complex, an important regulatory mechanism ( Shao, E., Nishi T., Kawasaki- Nishi, S., and Forgac, M. (2003) J. Biol. Chem. 278, 12985 - 12991). Measurement of the ATP dependence of coupling for the wild type and mutant proteins demonstrates that the coupling differences are observed at ATP concentrations up to 1 mM. A decrease in coupling efficiency is observed at higher ATP concentrations for the wild type and mutant V-ATPases. Immunoprecipitation of an epitope-tagged nonhomologous region from cell lysates indicates that this region is able to bind to the integral V-0 domain in the absence of the remainder of the A subunit, an interaction confirmed by immunoprecipitation of V-0. Interaction between the nonhomologous region and V-0 is reduced upon incubation of cells in the absence of glucose, suggesting that the nonhomologous region may act as a trigger to activate in vivo dissociation. Immunoprecipitation suggests that the epitope tag on the nonhomologous region becomes less accessible upon glucose withdrawal, possibly due to binding to another cellular target. In vivo dissociation of the V-ATPase in response to glucose removal is also blocked by chloroquine, a weak base that neutralizes the acidic pH of the vacuole. The results suggest that the dependence of in vivo dissociation of the V-ATPase on catalytic activity may be due to neutralization of the yeast vacuole, which in turn blocks glucose-dependent dissociation.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34928] Funding Source: Medline; NIGMS NIH HHS [GM34478, R37 GM034478, R01 GM034478] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BOWMAN BJ, 1988, J BIOL CHEM, V263, P14002; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; Bowman EJ, 2000, J EXP BIOL, V203, P97; Brown D, 2000, J EXP BIOL, V203, P137; Canonaco F, 2002, J BIOL CHEM, V277, P31303, DOI 10.1074/jbc.M204052200; Capaldi RA, 2000, J EXP BIOL, V203, P29; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; Emerson LR, 2002, ANTIMICROB AGENTS CH, V46, P787, DOI 10.1128/AAC.46.3.787-796.2002; FENG Y, 1992, J BIOL CHEM, V267, P5817; Fillingame RH, 2000, J EXP BIOL, V203, P9; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Futai M, 2000, J EXP BIOL, V203, P107; Futai M, 2000, BBA-BIOENERGETICS, V1458, P276, DOI 10.1016/S0005-2728(00)00080-3; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Graham LA, 2000, J EXP BIOL, V203, P61; HIRATA R, 1990, J BIOL CHEM, V265, P6726; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; MacLeod KJ, 1999, J BIOL CHEM, V274, P32869, DOI 10.1074/jbc.274.46.32869; Merzendorfer H, 1999, J BIOL CHEM, V274, P17372, DOI 10.1074/jbc.274.24.17372; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; NELSON N, 1992, J BIOENERG BIOMEMBR, V24, P407, DOI 10.1007/BF00762533; Nelson N, 2000, J EXP BIOL, V203, P89; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PUOPOLO K, 1991, J BIOL CHEM, V266, P24564; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Sambade M, 2004, J BIOL CHEM, V279, P17361, DOI 10.1074/jbc.M314104200; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; Tomashek JJ, 1997, J BIOL CHEM, V272, P16618, DOI 10.1074/jbc.272.26.16618; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Vasilyeva E, 1998, J BIOL CHEM, V273, P23823, DOI 10.1074/jbc.273.37.23823; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; Wieczorek H, 2000, J EXP BIOL, V203, P127; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	60	70	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48663	48670		10.1074/jbc.M408278200	http://dx.doi.org/10.1074/jbc.M408278200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355963	hybrid			2022-12-27	WOS:000225098100023
J	Bi, XN; Baudry, M; Liu, JH; Yao, YQ; Fu, L; Brucher, F; Lynch, G				Bi, XN; Baudry, M; Liu, JH; Yao, YQ; Fu, L; Brucher, F; Lynch, G			Inhibition of geranylgeranylation mediates the effects of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors on microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; LENS EPITHELIAL-CELLS; ALZHEIMERS-DISEASE; NITRIC-OXIDE; RHO-GTPASE; CYTOSKELETAL REORGANIZATION; KINASE PATHWAYS; STATIN THERAPY; IN-VITRO; CHOLESTEROL	Inflammatory responses involving microglia, the resident macrophages of the brain, are thought to contribute importantly to the progression of Alzheimer's disease ( AD) and possibly other neurodegenerative disorders. The present study tested whether the mevalonate-isoprenoid biosynthesis pathway, which affects inflammation in many types of tissues, tonically regulates microglial activation. This question takes on added significance given the potential use of statins, drugs that block the rate-limiting step (3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase)) in mevalonate and cholesterol synthesis, in AD treatment. Both mevastatin and simvastatin caused a concentration- and time-dependent activation of microglia in cultured rat hippocampal slices. This response consisted of a transformation of the cells from a typical resting configuration to an amoeboid, macrophage-like morphology, increased expression of a macrophage antigen, and up-regulation of the cytokine tumor necrosis factor-alpha. Evidence for proliferation was also obtained. Statin-induced microglial changes were blocked by mevalonate but not by cholesterol, indicating that they were probably due to suppression of isoprenoid synthesis. In accord with this, the statin effects were absent in slices co-incubated with geranylgeranyl pyrophosphate, a mevalonate product that provides for the prenylation of Rho GTPases. Finally, PD98089, a compound that blocks activation of extracellularly regulated kinases1/2, suppressed statin-induced up-regulation of tumor necrosis factor-alpha but had little effect on microglial transformation. These results suggest that 1) the mevalonate-isoprenoid pathway is involved in regulating microglial morphology and in controlling expression of certain cytokines and 2) statins have the potential for enhancing a component of AD with uncertain relationships to other features of the disease.	Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92617 USA; Univ So Calif, Neurobiol Program, Los Angeles, CA 90089 USA	University of California System; University of California Irvine; University of Southern California	Bi, XN (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, 101 Theory Dr,250, Irvine, CA 92617 USA.	xbi@uci.edu			NIA NIH HHS [AG-00538] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG000538] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Bednarski E, 1997, J NEUROSCI, V17, P4006; Begum N, 2002, DIABETES, V51, P2256, DOI 10.2337/diabetes.51.7.2256; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; BI X, 2001, SOC NEUR ABSTR, V27; Bi XN, 2001, P NATL ACAD SCI USA, V98, P8832, DOI 10.1073/pnas.151253098; Bi XN, 2000, METH MOL B, V144, P203; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Bollen ELEM, 2001, ARCH NEUROL-CHICAGO, V58, P1023, DOI 10.1001/archneur.58.6.1023; Brazil MI, 2000, J BIOL CHEM, V275, P16941, DOI 10.1074/jbc.M000937200; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Crisby M, 2002, ALZ DIS ASSOC DIS, V16, P131, DOI 10.1097/00002093-200207000-00001; Eberlein M, 2001, BRIT J PHARMACOL, V133, P1172, DOI 10.1038/sj.bjp.0704173; Finch Caleb E., 2002, P275; GALL C, 1979, J COMP NEUROL, V183, P539, DOI 10.1002/cne.901830306; Hoozemans JJM, 2003, CURR DRUG TARGETS, V4, P461, DOI 10.2174/1389450033490902; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; Huang KC, 2003, J BIOMED SCI, V10, P396, DOI 10.1159/000071159; Huh Y, 2003, NEUROSCI LETT, V349, P63, DOI 10.1016/S0304-3940(03)00743-2; Ikeda U, 2001, J CARDIOVASC PHARM, V38, P69, DOI 10.1097/00005344-200107000-00008; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KATO H, 1995, BRAIN RES, V694, P85, DOI 10.1016/0006-8993(95)00769-M; Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1; Kusama T, 2003, INT J ONCOL, V23, P1173; Lebowitz PF, 1997, J BIOL CHEM, V272, P16093, DOI 10.1074/jbc.272.26.16093; Lin YK, 1996, PLANT CELL, V8, P293, DOI 10.1105/tpc.8.2.293; Maddala R, 2003, MOL VIS, V9, P329; Maddala RL, 2001, INVEST OPHTH VIS SCI, V42, P2610; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x; Mizuno T, 1999, J BIOL CHEM, V274, P15110, DOI 10.1074/jbc.274.21.15110; Monick MM, 2003, J IMMUNOL, V171, P2625, DOI 10.4049/jimmunol.171.5.2625; Morgan Dave, 2003, Expert Rev Vaccines, V2, P53, DOI 10.1586/14760584.2.1.53; Nakano K, 2003, GENES CELLS, V8, P357, DOI 10.1046/j.1365-2443.2003.00639.x; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Pasinetti GM, 2002, J ALZHEIMERS DIS, V4, P435, DOI 10.3233/JAD-2002-4510; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; PRINCE M, 1994, NEUROLOGY, V44, P97; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Rul W, 2002, ANN NY ACAD SCI, V973, P145, DOI 10.1111/j.1749-6632.2002.tb04624.x; Schenk DB, 2002, NEUROBIOL AGING, V23, P677, DOI 10.1016/S0197-4580(02)00034-9; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SPARKS DL, 1990, NEUROBIOL AGING, V11, P601, DOI 10.1016/0197-4580(90)90024-T; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stuve O, 2003, CURR OPIN NEUROL, V16, P393, DOI 10.1097/01.wco.0000073942.19076.d1; Tafazoli F, 2003, INFECT IMMUN, V71, P872, DOI 10.1128/IAI.71.2.872-881.2003; Thorpe JL, 2004, DEV CELL, V6, P295, DOI 10.1016/S1534-5807(04)00032-2; Urmoneit B, 1998, PROSTAG OTH LIPID M, V55, P331, DOI 10.1016/S0090-6980(98)00032-X; van de Donk NWCJ, 2003, CLIN CANCER RES, V9, P5735; van de Donk NWCJ, 2003, BLOOD, V102, P3354, DOI 10.1182/blood-2003-03-0970; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Woods AG, 1999, NEUROSCIENCE, V91, P1277, DOI 10.1016/S0306-4522(98)00685-X; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zeng PY, 2003, ONCOGENE, V22, P1124, DOI 10.1038/sj.onc.1206181	66	55	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48238	48245		10.1074/jbc.M405442200	http://dx.doi.org/10.1074/jbc.M405442200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364922	hybrid			2022-12-27	WOS:000224957000099
J	Naoe, M; Ohwa, Y; Ishikawa, D; Ohshima, C; Nishikawa, S; Yamamoto, H; Endo, T				Naoe, M; Ohwa, Y; Ishikawa, D; Ohshima, C; Nishikawa, S; Yamamoto, H; Endo, T			Identification of Tim40 that mediates protein sorting to the mitochondrial intermembrane space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; OUTER-MEMBRANE; CYTOCHROME-C; IMPORT; TRANSLOCATION; SUBUNIT; STRAINS; COMPLEX	Most mitochondrial proteins are synthesized in the cytosol, imported into mitochondria, and sorted to one of the four mitochondrial subcompartments. Here we identified a new inner membrane protein, Tim40, that mediates sorting of small Tim proteins to the intermembrane space. Tim40 is essential for yeast cell growth, and its function in vivo requires six conserved Cys residues but not anchoring of the protein to the inner membrane by its N-terminal hydrophobic segment. Depletion of Tim40 impairs the import of small Tim proteins into mitochondria both in vivo and in vitro. In wild-type mitochondria, Tim40 forms a translocation intermediate with small Tim proteins prior to their assembly in the intermembrane space in vitro. These results suggest the essential role of Tim40 in sorting/assembly of small Tim proteins.	Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp						Adam A, 1999, EMBO J, V18, P313, DOI 10.1093/emboj/18.2.313; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Esaki M, 1999, P NATL ACAD SCI USA, V96, P11770, DOI 10.1073/pnas.96.21.11770; Esaki M, 2003, NAT STRUCT BIOL, V10, P988, DOI 10.1038/nsb1008; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; NARGANG FE, 1988, J BIOL CHEM, V263, P9388; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Rose M. D., 1990, METHODS YEAST GENOMI; SIKORSKI RS, 1989, GENETICS, V122, P19; Stuart RA, 1996, TRENDS BIOCHEM SCI, V21, P261, DOI 10.1016/S0968-0004(96)10035-9; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	23	173	179	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47815	47821		10.1074/jbc.M410272200	http://dx.doi.org/10.1074/jbc.M410272200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364952	hybrid			2022-12-27	WOS:000224957000050
J	Lovmar, M; Tenson, T; Ehrenberg, M				Lovmar, M; Tenson, T; Ehrenberg, M			Kinetics of macrolide action - The josamycin and erythromycin cases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE-BOND FORMATION; CELL-FREE SYSTEMS; RIBOSOMAL COMPLEX; TRANSFER-RNA; STRUCTURAL BASIS; POLYPEPTIDE-SYNTHESIS; BACTERIAL-RIBOSOMES; PROTEIN-SYNTHESIS; VIRGINIAMYCIN-S; ANTIBIOTICS	Members of the macrolide class of antibiotics inhibit peptide elongation on the ribosome by binding close to the peptidyltransferase center and blocking the peptide exit tunnel in the large ribosomal subunit. We have studied the modes of action of the macrolides josamycin, with a 16-membered lactone ring, and erythromycin, with a 14-membered lactone ring, in a cell-free mRNA translation system with pure components from Escherichia coli. We have found that the average lifetime on the ribosome is 3 h for josamycin and less than 2 min for erythromycin and that the dissociation constants for josamycin and erythromycin binding to the ribosome are 5.5 and 11 nM, respectively. Josamycin slows down formation of the first peptide bond of a nascent peptide in an amino acid-dependent way and completely inhibits formation of the second or third peptide bond, depending on peptide sequence. Erythromycin allows formation of longer peptide chains before the onset of inhibition. Both drugs stimulate the rate constants for drop-off of peptidyl-tRNA from the ribosome. In the josamycin case, drop-off is much faster than drug dissociation, whereas these rate constants are comparable in the erythromycin case. Therefore, at a saturating drug concentration, synthesis of full-length proteins is completely shut down by josamycin but not by erythromycin. It is likely that the bacteriotoxic effects of the drugs are caused by a combination of inhibition of protein elongation, on the one hand, and depletion of the intracellular pools of aminoacyl-tRNAs available for protein synthesis by drop-off and incomplete peptidyl-tRNA hydrolase activity, on the other hand.	Uppsala Univ, BMC, Program Mol Biol, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Univ Tartu, Inst Technol, EE-51010 Tartu, Estonia	Uppsala University; University of Tartu	Ehrenberg, M (corresponding author), Uppsala Univ, BMC, Program Mol Biol, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	ehrenberg@xray.bmc.uu.se	Tenson, Tanel/I-6431-2015	Tenson, Tanel/0000-0002-0260-3601				ANDERSSON S, 1987, BIOCHIMIE, V69, P901, DOI 10.1016/0300-9084(87)90218-5; ANTOUN A, 2004, BIOL PROCED ONLINE; Berisio R, 2003, J BACTERIOL, V185, P4276, DOI 10.1128/JB.185.14.4276-4279.2003; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; BRENNAN RJ, 1994, J CHEM SOC CHEM COMM, P1615, DOI 10.1039/c39940001615; CHINALI G, 1988, BIOCHIM BIOPHYS ACTA, V951, P42, DOI 10.1016/0167-4781(88)90023-1; CHINALI G, 1988, BIOCHIM BIOPHYS ACTA, V949, P71, DOI 10.1016/0167-4781(88)90056-5; DIGIAMBATTISTA M, 1987, J BIOL CHEM, V262, P8591; DINOS G, 1993, BIOCHEMISTRY-US, V32, P10638, DOI 10.1021/bi00091a014; Dinos GP, 2000, BIOCHEMISTRY-US, V39, P11621, DOI 10.1021/bi000811f; Dinos GP, 2003, MOL PHARMACOL, V63, P617, DOI 10.1124/mol.63.3.617; Dinos GP, 2001, MOL PHARMACOL, V59, P1441, DOI 10.1124/mol.59.6.1441; Ehrenberg M, 1990, RIBOSOMES PROTEIN SY, P101; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Heurgue-Hamard V, 2000, EMBO J, V19, P2701, DOI 10.1093/emboj/19.11.2701; HeurgueHamard V, 1996, EMBO J, V15, P2826, DOI 10.1002/j.1460-2075.1996.tb00643.x; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; MAO JCH, 1968, J BACTERIOL, V95, P1111, DOI 10.1128/JB.95.3.1111-1117.1968; MAO JCH, 1971, BIOCHEMISTRY-US, V10, P2054, DOI 10.1021/bi00787a014; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P441; MENNINGER JR, 1982, ANTIMICROB AGENTS CH, V21, P811, DOI 10.1128/AAC.21.5.811; Moore PB, 2002, NATURE, V418, P229, DOI 10.1038/418229a; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; OTAKA T, 1975, P NATL ACAD SCI USA, V72, P2649, DOI 10.1073/pnas.72.7.2649; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; Petropoulos AD, 2004, J BIOL CHEM, V279, P26518, DOI 10.1074/jbc.M313634200; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Schlunzen F, 2003, STRUCTURE, V11, P329, DOI 10.1016/S0969-2126(03)00022-4; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; Tenson T, 1999, J BACTERIOL, V181, P1617, DOI 10.1128/JB.181.5.1617-1622.1999; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; VAZQUEZ D, 1979, MOL BIOL BIOCH BIOPH, V30, P169; VESTER B, 1987, BIOCHIMIE, V69, P891, DOI 10.1016/0300-9084(87)90217-3; WALSH C, 2003, ANTIBIOTICS ACTIONS, P57; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797	42	56	69	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53506	53515		10.1074/jbc.M401625200	http://dx.doi.org/10.1074/jbc.M401625200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385552	hybrid			2022-12-27	WOS:000225680600086
J	Geiszt, M; Leto, TL				Geiszt, M; Leto, TL			The Nox family of NAD(P)H oxidases: Host defense and beyond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COLON EPITHELIAL-CELLS; SUPEROXIDE-GENERATING OXIDASE; RESPIRATORY BURST OXIDASE; SMOOTH-MUSCLE CELLS; NADPH-OXIDASE; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; SIGNAL-TRANSDUCTION; KINASE ACTIVATION; EXPRESSION		NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Semmelweis Univ, Fac Med, Dept Physiol, H-1444 Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Semmelweis University	Leto, TL (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	tleto@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, Z01AI000614] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Baker MA, 2004, MOL CELL ENDOCRINOL, V216, P47, DOI 10.1016/j.mce.2003.10.068; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; De Deken X, 2002, EXP CELL RES, V273, P187, DOI 10.1006/excr.2001.5444; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; DUPUY C, 1988, FEBS LETT, V233, P74, DOI 10.1016/0014-5793(88)81358-9; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; ELBERT BL, 1999, BLOOD, V94, P1864; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Katsuyama M, 2002, J BIOL CHEM, V277, P13438, DOI 10.1074/jbc.M111634200; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Kikuchi H, 2000, GENE, V254, P237, DOI 10.1016/S0378-1119(00)00258-4; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lee JR, 1998, EUR J IMMUNOL, V28, P4188, DOI 10.1002/(SICI)1521-4141(199812)28:12<4188::AID-IMMU4188>3.0.CO;2-B; Leto TL., 1999, INFLAMMATION BASIC P, P769; LOYA F, 1994, BLOOD, V84, P1831; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; REITER B, 1967, NATURE, V216, P328, DOI 10.1038/216328a0; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Suliman HB, 2004, BLOOD, V104, P43, DOI 10.1182/blood-2003-07-2240; SUMIMOTO H, 1989, BIOCHEM BIOPH RES CO, V165, P902, DOI 10.1016/S0006-291X(89)80051-8; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; VARMA SD, 1990, FREE RADICAL RES COM, V8, P73, DOI 10.3109/10715769009087976; Wang DS, 1996, P NATL ACAD SCI USA, V93, P13182, DOI 10.1073/pnas.93.23.13182; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200	61	365	381	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51715	51718		10.1074/jbc.R400024200	http://dx.doi.org/10.1074/jbc.R400024200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15364933	hybrid			2022-12-27	WOS:000225493400001
J	Rose, A; Froment, P; Perrot, V; Quon, MJ; LeRoith, D; Dupont, J				Rose, A; Froment, P; Perrot, V; Quon, MJ; LeRoith, D; Dupont, J			The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alpha T3 cells by protein kinase C alpha-mediated negative regulation of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PLECKSTRIN HOMOLOGY DOMAIN; GENE-EXPRESSION; IGF-I; PROSTATE-CANCER; MAP KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR-CLONING; COUPLED RECEPTORS; TRANSGENIC MICE	The luteinizing hormone-releasing hormone (LHRH) receptor is a G protein-coupled receptor involved in the synthesis and release of pituitary gonadotropins and in the proliferation and apoptosis of pituitary cells. Insulinlike growth factor-1 receptor (IGF-1R) is a tyrosine kinase receptor that has a mitogenic effect on pituitary cells. In this study, we used the alphaT3 gonadotrope cell line as a model to characterize the IGF-1R signaling pathways and to investigate whether this receptor interacts with the LHRH cascade. We found that IGF-1 activated the IGF-1R, insulin receptor substrate (IRS)-1, phosphatidylinositol 3-kinase, and Akt in a time-dependent manner in alphaT3 cells. The MAPK (ERK1/2, p38, and JNK) pathways were only weakly activated by IGF-1. In contrast, LHRH strongly stimulated the MAPK pathways but had no effect on Akt activation. Cotreatment with IGF-1 and LHRH had various effects on these signaling pathways. 1) It strongly increased IGF-1-induced tyrosine phosphorylation of IRS-1 and IRS-1-associated phosphatidylinositol 3-kinase through activation of the epidermal growth factor receptor. 2) It had an additive effect on ERK1/2 activation without modifying the phosphorylation of p38 and JNK1/2. 3) It strongly reduced IGF-1 activation of Akt. 3-(4,5-Dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide assays and cell cycle analysis revealed that, in addition to having an additive effect on ERK1/2 activation, cotreatment with IGF-1 and LHRH also had an additive effect on cell proliferation. The LHRH-induced inhibition of Akt stimulated by IGF-1 was completely blocked by Safingol, a protein kinase C (PKC) alpha-specific inhibitor, and by a dominant negative form of PKCalpha. Finally, we showed that the inhibitory effect of LHRH on IGF-1-induced PKCalpha-mediated Akt activation was associated with a marked reduction in Bad phosphorylation and a substantial decrease in the ability of IGF-1 to rescue alphaT3 cells from apoptosis induced by serum starvation. Our results demonstrate for the first time that several interactions take place between IGF-1 and LHRH receptors in gonadotrope cells.	NCCAM, Diabet Unit, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; INRA, Unite Physiol Reprod & Comportements, F-37380 Nouzilly, France; Univ Lyon 1, UMR INSERM U449 INRA 1235, RTH Laennec, Sch Med, F-69372 Lyon, France; NIDDK, Sect Mol & Cellular Physiol, Diabet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Franche-Comte; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dupont, J (corresponding author), INRA, Unite Physiol Reprod & Comportements, F-37380 Nouzilly, France.	jdupont@tours.inra.fr	Quon, Michael/B-1970-2008	QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z01AT000002, ZIAAT000002] Funding Source: NIH RePORTER	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Alarid ET, 1996, DEVELOPMENT, V122, P3319; ALBERTI VN, 1991, PATHOL RES PRACT, V187, P541, DOI 10.1016/S0344-0338(11)80138-X; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; BACH MA, 1992, ENDOCRINOLOGY, V131, P2588, DOI 10.1210/en.131.6.2588; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Baker DM, 2000, BIOL REPROD, V63, P865, DOI 10.1095/biolreprod63.3.865; Benard O, 2001, J BIOL CHEM, V276, P4554, DOI 10.1074/jbc.M006995200; BLAKESLEY VA, 1995, J BIOL CHEM, V270, P2764, DOI 10.1074/jbc.270.6.2764; BORGEAT P, 1972, P NATL ACAD SCI USA, V69, P2677, DOI 10.1073/pnas.69.9.2677; BOURNE GA, 1988, MOL CELL ENDOCRINOL, V58, P155, DOI 10.1016/0303-7207(88)90149-9; Cazzolli R, 2001, DIABETES, V50, P2210, DOI 10.2337/diabetes.50.10.2210; Childs GV, 2001, ENDOCRINOLOGY, V142, P847, DOI 10.1210/en.142.2.847; Conn P M, 1995, Vitam Horm, V50, P151, DOI 10.1016/S0083-6729(08)60656-1; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Daftary SS, 2003, ENDOCRINOLOGY, V144, P2034, DOI 10.1210/en.2002-221025; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Dondi D, 1998, BIOL SIGNAL RECEPT, V7, P55; Doornbos RP, 1999, J BIOL CHEM, V274, P8589, DOI 10.1074/jbc.274.13.8589; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; DUFOURNY B, 1995, J BIOL CHEM, V272, P23589; Dupont J, 2000, J BIOL CHEM, V275, P35893, DOI 10.1074/jbc.M006741200; Dupont J, 2003, RECENT PROG HORM RES, V58, P325, DOI 10.1210/rp.58.1.325; Emons G, 1998, J STEROID BIOCHEM, V65, P199, DOI 10.1016/S0960-0760(97)00189-1; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Grosse R, 2000, J BIOL CHEM, V275, P12251, DOI 10.1074/jbc.275.16.12251; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hashizume T, 2002, ANIM REPROD SCI, V70, P13, DOI 10.1016/S0378-4320(01)00190-7; HAWES BE, 1993, ENDOCRINOLOGY, V132, P2124, DOI 10.1210/en.132.5.2124; Hiney JK, 1996, ENDOCRINOLOGY, V137, P3717, DOI 10.1210/en.137.9.3717; Imai A, 2000, Vitam Horm, V59, P1, DOI 10.1016/S0083-6729(00)59002-5; Johnson CM, 1997, J NEUROSCI, V17, P6189; Jungwirth A, 1997, PROSTATE, V32, P164; KAKAR SS, 1994, MOL CELL ENDOCRINOL, V106, P145, DOI 10.1016/0303-7207(94)90196-1; KANEMATSU T, 1991, ACTA ENDOCRINOL-COP, V125, P227, DOI 10.1530/acta.0.1250227; Kang SK, 2000, MOL CELL ENDOCRINOL, V162, P157, DOI 10.1016/S0303-7207(00)00196-9; Kiley SC, 2003, KIDNEY INT, V63, P33, DOI 10.1046/j.1523-1755.2003.00706.x; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; KONISHI H, 1995, BIOCHEM BIOPH RES CO, V216, P526, DOI 10.1006/bbrc.1995.2654; Kratzmeier M, 1996, MOL CELL ENDOCRINOL, V118, P103, DOI 10.1016/0303-7207(96)03788-4; Krause D, 2001, J BIOL CHEM, V276, P19244, DOI 10.1074/jbc.M008186200; Kuemmerle JF, 1998, AM J PHYSIOL-GASTR L, V275, pG151, DOI 10.1152/ajpgi.1998.275.1.G151; Kuemmerle JF, 2003, AM J PHYSIOL-GASTR L, V284, pG411, DOI 10.1152/ajpgi.00310.2002; LeHoux JG, 2001, J BIOL CHEM, V276, P8021, DOI 10.1074/jbc.M009495200; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Levi NL, 1998, MOL ENDOCRINOL, V12, P815, DOI 10.1210/me.12.6.815; Lewy H, 2003, MOL CELL ENDOCRINOL, V203, P25, DOI 10.1016/S0303-7207(03)00119-9; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Liu FJ, 2002, J BIOL CHEM, V277, P32099, DOI 10.1074/jbc.M203639200; Longo KM, 1998, ENDOCRINOLOGY, V139, P1125, DOI 10.1210/en.139.3.1125; Marelli MM, 1999, ENDOCRINOLOGY, V140, P329; MITCHELL R, 1994, J ENDOCRINOL, V140, pR15, DOI 10.1677/joe.0.140R015; Moretti RM, 1996, J CLIN ENDOCR METAB, V81, P3930, DOI 10.1210/jc.81.11.3930; Motley ED, 2001, CELL MOL BIOL, V47, P1059; Mulvaney JM, 2000, J BIOL CHEM, V275, P14182, DOI 10.1074/jbc.275.19.14182; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Naor Z, 1998, FRONT NEUROENDOCRIN, V19, P1, DOI 10.1006/frne.1997.0162; Oomizu S, 1998, J ENDOCRINOL, V157, P53, DOI 10.1677/joe.0.1570053; Parrizas M, 1997, J BIOL CHEM, V272, P154; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PERRIN MH, 1993, BIOCHEM BIOPH RES CO, V191, P1139, DOI 10.1006/bbrc.1993.1335; REINHART J, 1992, J BIOL CHEM, V267, P21281; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; Roberson MS, 1999, ENDOCRINOLOGY, V140, P1310, DOI 10.1210/en.140.3.1310; ROBERSON MS, 1995, MOL CELL BIOL, V15, P3531; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; SHAH BH, 1994, MOL PHARMACOL, V46, P1; SIM PJ, 1995, MOL CELL ENDOCRINOL, V112, P257, DOI 10.1016/0303-7207(95)03616-F; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SOLDANI R, 1995, FERTIL STERIL, V64, P634, DOI 10.1016/S0015-0282(16)57804-2; SOLDANI R, 1994, EUR J ENDOCRINOL, V131, P641, DOI 10.1530/eje.0.1310641; Stanislaus D, 1997, MOL ENDOCRINOL, V11, P738, DOI 10.1210/me.11.6.738; Sundaresan S, 1996, ENDOCRINOLOGY, V137, P304, DOI 10.1210/en.137.1.304; Wang Y, 2002, EUR J ENDOCRINOL, V146, P447, DOI 10.1530/eje.0.1460447; Weil C, 1999, ENDOCRINOLOGY, V140, P2054, DOI 10.1210/en.140.5.2054; Wells A, 2002, CLIN CANCER RES, V8, P1251; Wen HC, 2003, CELL SIGNAL, V15, P37, DOI 10.1016/S0898-6568(02)00047-5; WHITLEY NC, 1995, BIOL REPROD, V53, P1359, DOI 10.1095/biolreprod53.6.1359; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Xia YX, 2001, EUR J ENDOCRINOL, V144, P73, DOI 10.1530/eje.0.1440073; Zhen SJ, 1997, MOL ENDOCRINOL, V11, P1145, DOI 10.1210/me.11.8.1145; Zheng WH, 2000, J BIOL CHEM, V275, P13377, DOI 10.1074/jbc.275.18.13377	86	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52500	52516		10.1074/jbc.M404571200	http://dx.doi.org/10.1074/jbc.M404571200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448167	hybrid			2022-12-27	WOS:000225493400096
J	Chang, TS; Jeong, W; Woo, HA; Lee, SM; Park, S; Rhee, SG				Chang, TS; Jeong, W; Woo, HA; Lee, SM; Park, S; Rhee, SG			Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOL-SPECIFIC ANTIOXIDANT; HYDROGEN-PEROXIDE; THIOREDOXIN; PROTEIN; FAMILY; IDENTIFICATION; OVEROXIDATION; LOCALIZATION; INACTIVATION; MECHANISM	Peroxiredoxins (Prxs) are a family of peroxidases that reduce hydroperoxides. The cysteine residue in the active site of certain eukaryotic Prx enzymes undergoes reversible oxidation to sulfinic acid (Cys-SO2H) during catalysis, and sulfiredoxin (Srx) has been identified as responsible for reversal of the resulting enzyme inactivation in yeast. We have now characterized mammalian orthologs of yeast Srx with an assay based on monitoring of the reduction of sulfinic Prx by immunoblot analysis with antibodies specific for the sulfinic state. Sulfinic reduction by mammalian Srx was found to be a slow process (k(cat) = 0.18/min) that requires ATP hydrolysis. ATP could be efficiently replaced by GTP, dATP, or dGTP but not by CTP, UTP, dCTP, or dTTP. Both glutathione and thioredoxin are potential physiological electron donors for the Srx reaction, given that their K-m values (1.8 mM and 1.2 muM, respectively) are in the range of their intracellular concentrations, and the V-max values obtained with the two reductants were similar. Although its pK(a) is relatively low ( similar to 7.3), the active site cysteine of Srx remained reduced even when the active site cysteine of most Prx molecules became oxidized. Finally, depletion of human Srx by RNA interference suggested that Srx is largely responsible for reduction of the Cys-SO2H of Prx in A549 human cells.	NHLBI, Lab Cell Signaling, NIH, Bethesda, MD 20892 USA; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ewha Womans University; Ewha Womans University	Rhee, SG (corresponding author), NIH, Bldg 50,Rm 3523,South Dr,MSC 8015, Bethesda, MD 20892 USA.	sgrhee@nih.gov	Woo, Hyun Ae/AAT-9586-2021					Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Georgiou G, 2003, SCIENCE, V300, P592, DOI 10.1126/science.1084976; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HALLIWELL B, 2000, FREE RADICAL BIO MED, P86; HOLMGREN A, 1978, BIOCHEMISTRY-US, V17, P4071, DOI 10.1021/bi00612a031; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; RHEE SG, 2000, SCI STKE, V53, P1; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; WOO JR, 2004, J BIOL CHEM; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	30	285	304	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50994	51001		10.1074/jbc.M409482200	http://dx.doi.org/10.1074/jbc.M409482200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448164	hybrid			2022-12-27	WOS:000225355800044
J	Sanders, T; Hawrot, E				Sanders, T; Hawrot, E			A novel pharmatope tag inserted into the beta 4 subunit confers allosteric modulation to neuronal nicotinic receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; ALPHA-BUNGAROTOXIN; STRUCTURAL-ANALYSIS; BINDING; COMPLEX; SENSITIVITY; DIVERSITY; MECHANISM; REVEALS; PROTEIN	alpha-Bungarotoxin, the classic nicotinic antagonist, has high specificity for muscle type alpha1 subunits in nicotinic acetylcholine receptors. In this study, we show that an 11-amino-acid pharmatope sequence, containing residues important for alpha-bungarotoxin binding to alpha1, confers functional alpha-bungarotoxin sensitivity when strategically placed into a neuronal non-alpha subunit, normally insensitive to this toxin. Remarkably, the mechanism of toxin inhibition is allosteric, not competitive as with neuromuscular nicotinic receptors. Our findings argue that alpha-bungarotoxin binding to the pharmatope, inserted at a subunit-subunit interface diametrically distinct from the agonist binding site, interferes with subunit interface movements critical for receptor activation. Our results, taken together with the structural similarities between nicotinic and GABA(A) receptors, suggest that this allosteric mechanism is conserved in the Cys-loop ion channel family. Furthermore, as a general strategy, the engineering of allosteric inhibitory sites through pharmatope tagging offers a powerful new tool for the study of membrane proteins.	Brown Med Sch, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Hawrot, E (corresponding author), Brown Med Sch, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	Edward_Hawrot@Brown.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034348, F32NS011027] Funding Source: NIH RePORTER; NCRR NIH HHS [RR15578] Funding Source: Medline; NIGMS NIH HHS [GM32629] Funding Source: Medline; NINDS NIH HHS [NS34348, NS11027] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; ANAND R, 1991, J BIOL CHEM, V266, P11192; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; Ernst M, 2003, NEUROSCIENCE, V119, P933, DOI 10.1016/S0306-4522(03)00288-4; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Groot-Kormelink PJ, 1998, J BIOL CHEM, V273, P15317, DOI 10.1074/jbc.273.25.15317; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Harel M, 2001, NEURON, V32, P265, DOI 10.1016/S0896-6273(01)00461-5; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Levandoski MM, 2003, EUR J PHARMACOL, V471, P9, DOI 10.1016/S0014-2999(03)01796-5; Levandoski MM, 1999, J BIOL CHEM, V274, P26113, DOI 10.1074/jbc.274.37.26113; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Moise L, 2002, J TOXICOL-TOXIN REV, V21, P293, DOI 10.1081/TXR-120014407; Moise L, 2002, J BIOL CHEM, V277, P12406, DOI 10.1074/jbc.M110320200; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Rosenthal JA, 1999, BIOCHEMISTRY-US, V38, P7847, DOI 10.1021/bi990045g; Samson AO, 2002, NEURON, V35, P319, DOI 10.1016/S0896-6273(02)00773-0; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; WEBER M, 1974, MOL PHARMACOL, V10, P15; Whiting PJ, 2003, CURR OPIN DRUG DISC, V6, P648; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Zeng HY, 2002, J BIOL CHEM, V277, P37439, DOI 10.1074/jbc.M205483200; Zeng HY, 2001, J BIOL CHEM, V276, P22930, DOI 10.1074/jbc.M102300200	35	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51460	51465		10.1074/jbc.M409533200	http://dx.doi.org/10.1074/jbc.M409533200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448163	hybrid			2022-12-27	WOS:000225355800098
J	Hanford, LE; Enghild, JJ; Valnickova, Z; Petersen, SV; Schaefer, LM; Schaefer, TM; Reinhart, TA; Oury, TD				Hanford, LE; Enghild, JJ; Valnickova, Z; Petersen, SV; Schaefer, LM; Schaefer, TM; Reinhart, TA; Oury, TD			Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE RECEPTOR; SIGNALING PATHWAYS; NEURITE OUTGROWTH; KAPPA-B; RAGE; EXPRESSION; PROTEIN; ACTIVATION; BLOCKADE; CLONING	The receptor for advanced glycation end products ( RAGE) is a member of the immunoglobulin superfamily of cell surface proteins that has been implicated as a progression factor in a number of pathologic conditions from chronic inflammation to cancer to Alzheimer's disease. In such conditions, RAGE acts to facilitate pathogenic processes. Its secreted isoform, soluble RAGE or sRAGE, has the ability to prevent RAGE signaling by acting as a decoy. sRAGE has been used successfully in animal models of a range of diseases to antagonize RAGE-mediated pathologic processes. In humans, sRAGE results from alternative splicing of RAGE mRNA. This study was aimed to determine whether the same holds true for mouse sRAGE and, in addition, to biochemically characterize mouse sRAGE. The biochemical characteristics examined include glycosylation and disulfide patterns. In addition, sRAGE was found to bind heparin, which may mediate its distribution in the extracellular matrix and cell surfaces of tissues. Finally, our data indicated that sRAGE in the mouse is likely produced by carboxyl-terminal truncation, in contrast to the alternative splicing mechanism reported in humans.	Univ Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA 15261 USA; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; Dartmouth Coll Sch Med, Dept Physiol, Lebanon, NH 03756 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aarhus University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College	Oury, TD (corresponding author), Univ Pittsburgh, Dept Pathol, Med Ctr, 3550 Terrace St,Scaife Hall S740, Pittsburgh, PA 15261 USA.	tdoury@pitt.edu		Vang Petersen, Steen/0000-0002-9338-911X; Enghild, Jan Johannes/0000-0001-9292-9172	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063700] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063700, R01-HL-063700] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Devaux Y, 2004, AM J RESP CRIT CARE, V169, pA456; Fattman CL, 2000, BIOCHEM BIOPH RES CO, V275, P542, DOI 10.1006/bbrc.2000.3327; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Hanford LE, 2003, AM J RESP CELL MOL, V29, pS77; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; JENDRISAK J, 1987, PROTEIN PURIFICATION, P75; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Renard C, 1997, MOL PHARMACOL, V52, P54, DOI 10.1124/mol.52.1.54; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SCHMIDT AM, 1994, J BIOL CHEM, V269, P9882; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Wear-Maggitti K, 2004, ANN PLAS SURG, V52, P519, DOI 10.1097/01.sap.0000122857.49274.8c; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371	28	182	194	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50019	50024		10.1074/jbc.M409782200	http://dx.doi.org/10.1074/jbc.M409782200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381690	Green Accepted, hybrid			2022-12-27	WOS:000225229500059
J	Leithe, E; Rivedal, E				Leithe, E; Rivedal, E			Ubiquitination and down-regulation of gap junction protein connexin-43 in response to 12-O-tetradecanoylphorbol 13-acetate treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER EPITHELIAL-CELLS; BREAST-TUMOR CELLS; INTERCELLULAR COMMUNICATION; PHORBOL-ESTER; PROTEASOME PATHWAY; INTRACELLULAR-TRANSPORT; LIFE-CYCLE; WILD-TYPE; KINASE-C; PHOSPHORYLATION	Gap junctions are specialized plasma membrane domains enriched in connexin proteins that form channels between adjacent cells. Gap junctions are highly dynamic, and modulation of the connexin turnover rate is considered to play an important role in the regulation of gap junctional intercellular communication. In the present study, we show that the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA) induces ubiquitination of connexin-43 (Cx43) in IAR20 rat liver epithelial cells. The accelerated ubiquitination of Cx43 in response to TPA occurred concomitantly with Cx43 hyperphosphorylation and inhibition of cell-cell communication via gap junctions. The TPA-induced ubiquitination of Cx43 was mediated via protein kinase C and partly involved the mitogen-activated protein kinase pathway. Following ubiquitination, Cx43 was internalized and degraded. The loss of Cx43 protein was counteracted by ammonium chloride, indicating that acidification of internalized Cx43 gap junctions is a prerequisite for its degradation. Furthermore, the Cx43 degradation was partly counteracted by leupeptin, an inhibitor of cathepsin B, H, and L. Cx43 internalization and subsequent degradation were blocked by inhibitors of the proteasome. Evidence is provided that Cx43 is modified by multiple monoubiquitins rather than a polyubiquitin chain in response to TPA. Moreover, the TPA-induced ubiquitination of Cx43 was blocked by proteasomal inhibitors. Taken together, the data indicate that Cx43 ubiquitination is a highly regulated process. Moreover, the results suggest that the proteasome might play an indirect role in Cx43 degradation by affecting the level of monoubiquitin conjugation and trafficking of Cx43 to endosomal compartments.	Norwegian Radium Hosp, Inst Canc Res, N-0310 Oslo, Norway	University of Oslo	Leithe, E (corresponding author), Norwegian Radium Hosp, Inst Canc Res, N-0310 Oslo, Norway.	eleithe@medisin.uio.no						Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ASAMOTO M, 1991, MOL CARCINOGEN, V4, P322, DOI 10.1002/mc.2940040411; BERTHOUD VM, 1992, EUR J CELL BIOL, V57, P40; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BRISSETTE JL, 1991, MOL CELL BIOL, V11, P5364, DOI 10.1128/MCB.11.10.5364; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Fujimuro M, 1997, EUR J BIOCHEM, V249, P427, DOI 10.1111/j.1432-1033.1997.00427.x; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Huang RP, 1998, CANCER RES, V58, P5089; Jordan K, 2001, J CELL SCI, V114, P763; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laird DW, 1996, J BIOENERG BIOMEMBR, V28, P311, DOI 10.1007/BF02110107; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; LARSEN WJ, 1978, TISSUE CELL, V10, P585, DOI 10.1016/S0040-8166(16)30351-2; LARSEN WJ, 1979, J CELL BIOL, V83, P576, DOI 10.1083/jcb.83.3.576; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2003, CARCINOGENESIS, V24, P1239, DOI 10.1093/carcin/bgg066; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; MONTESANO R, 1977, J NATL CANCER I, V59, P1651, DOI 10.1093/jnci/59.6.1651; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; NAUS CCG, 1993, EXP CELL RES, V206, P72, DOI 10.1006/excr.1993.1122; OH SY, 1991, BIOCHIM BIOPHYS ACTA, V1094, P243, DOI 10.1016/0167-4889(91)90016-Q; Omori Y, 1998, INT J CANCER, V78, P446, DOI 10.1002/(SICI)1097-0215(19981109)78:4<446::AID-IJC10>3.3.CO;2-4; Opsahl H, 2000, CELL ADHES COMMUN, V7, P367, DOI 10.3109/15419060009109019; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Rivedal E, 1996, CARCINOGENESIS, V17, P2321, DOI 10.1093/carcin/17.11.2321; RIVEDAL E, 1994, CARCINOGENESIS, V15, P689, DOI 10.1093/carcin/15.4.689; ROSE B, 1993, CARCINOGENESIS, V14, P1073, DOI 10.1093/carcin/14.5.1073; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; Strous GJ, 1999, J CELL SCI, V112, P1417; Thomas MA, 2003, J CELL SCI, V116, P2213, DOI 10.1242/jcs.00440; TRAUB O, 1989, J CELL BIOL, V108, P1039, DOI 10.1083/jcb.108.3.1039; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; YANCEY SB, 1982, EXP CELL RES, V139, P329, DOI 10.1016/0014-4827(82)90257-9	61	139	146	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50089	50096		10.1074/jbc.M402006200	http://dx.doi.org/10.1074/jbc.M402006200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371442	hybrid			2022-12-27	WOS:000225229500067
J	Park, SW; Moon, YA; Horton, JD				Park, SW; Moon, YA; Horton, JD			Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEINS; MODULAR ADAPTER PROTEIN; HAMSTER OVARY CELLS; LDL-RECEPTOR; SITE-1 PROTEASE; MEDIATED ENDOCYTOSIS; KNOCKOUT MICE; CHOLESTEROL; SREBP; HYPERCHOLESTEROLEMIA	Lipid homeostasis is transcriptionally regulated by three DNA-binding proteins, designated sterol regulatory element-binding protein (SREBP)-1a, - 1c, and -2. Oligonucleotide arrays hybridized with RNA made from livers of transgenic SREBP-1a, transgenic SREBP-2, and SREBP cleavage-activating protein knockout mice recently identified 33 genes regulated by SREBPs in liver, four of which had no known connection to lipid metabolism. One of the four genes was PCSK9, which encodes proprotein convertase subtilisin/kexin type 9a, a protein that belongs to the proteinase K subfamily of subtilases. Mutations in PCSK9 are associated with an autosomal dominant form of hypercholesterolemia. Here, we demonstrate that hepatic overexpression of either wild-type or mutant PCSK9 in mice results in hypercholesterolemia. The hypercholesterolemia is due to a post-transcriptional event causing a reduction in low density lipoprotein (LDL) receptor protein prior to the internalization and recycling of the receptor. Overexpression of PCSK9 in primary hepatocytes and in mice lacking the LDL receptor does not alter apolipoprotein B secretion. These data are consistent with PCSK9 affecting plasma LDL cholesterol levels by altering LDL receptor protein levels via a post-transcriptional mechanism.	Univ Texas, SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Horton, JD (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd,Rm L5-238, Dallas, TX 75390 USA.	jay.horton@utsouthwestern.edu		Park, Sahng Wook/0000-0002-9594-7074	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, R01HL038049] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-20948, HL-38049] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; *APPL BIOS, 2001, US B, V2; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1975, CELL, V6, P307, DOI 10.1016/0092-8674(75)90182-8; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Green M, 1979, Methods Enzymol, V58, P425; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; HERZ J, 1991, J BIOL CHEM, V266, P21232; Horton JD, 1999, J CLIN INVEST, V103, P1067, DOI 10.1172/JCI6246; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Michaely P, 2004, J BIOL CHEM, V279, P34023, DOI 10.1074/jbc.M405242200; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; Nyberg-Hoffman C, 1999, NAT MED, V5, P955, DOI 10.1038/11400; Ouguerram K, 2004, ARTERIOSCL THROM VAS, V24, P1448, DOI 10.1161/01.ATV.0000133684.77013.88; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Sambrook J., 2001, MOL CLONING LAB MANU; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	46	410	481	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50630	50638		10.1074/jbc.M410077200	http://dx.doi.org/10.1074/jbc.M410077200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385538	hybrid			2022-12-27	WOS:000225229500127
J	Thyagarajan, A; Szaro, BG				Thyagarajan, A; Szaro, BG			Phylogenetically conserved binding of specific K homology domain proteins to the 3 '-untranslated region of the vertebrate middle neurofilament mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; HNRNP-K; POSTTRANSCRIPTIONAL REGULATION; REGULATING NEUROFILAMENT; POLY(C)-BINDING PROTEINS; UNTRANSLATED REGION; NERVOUS-SYSTEM; RADIAL GROWTH; UP-REGULATION; OPTIC-NERVE	As axons mature, neurofilament-M (NF-M) expression rises, contributing to maturation of the axonal cytoskeleton and an expansion in axon caliber. This increase is partly due to a rise in NF-M mRNA stability. Such post-transcriptional regulation is often mediated through the binding of specific proteins to the 3'-untranslated region (3'-UTR) of mRNAs. Vertebrate NF-M 3'-UTRs are remarkably well conserved, prompting us to test whether similar proteins bind the 3'-UTRs of different vertebrate NF-Ms. Identification of such proteins could lead to insights into the regulation of NF-M expression during development and in response to trauma or disease. Ultraviolet cross-linking analysis of proteins isolated from adult frog (Xenopus laevis), mouse, and rat brains revealed three ribonucleoprotein complexes (97, 70, and 47 kDa) that were present in all species and bound specifically to NF-M 3'-UTRs. Affinity purification of NF-M 3'-UTR-binding proteins from rat brain followed by mass spectrometry and immunoprecipitation assays identified heterogeneous nuclear ribonucleoprotein (hnRNP) K and hnRNP E1 as the proteins forming the 70- and 47-kDa complexes, respectively. These RNA-binding proteins of the KH domain family recognize CU-rich motifs identical to ones present in NF-M 3'-UTRs. Ultraviolet cross-linking assays performed on Xenopus embryos at different stages of neural development demonstrated that whereas hnRNP K binding occurred at all stages, hnRNP E binding occurred only at the most mature stages of axon development. Since hnRNP E is known to stabilize mRNAs, these results raise the hypothesis that these proteins may contribute to the increases in cytoplasmic levels of NF-M mRNA that accompany axonal maturation.	SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; SUNY Albany, Neurosci Res Ctr, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Szaro, BG (corresponding author), SUNY Albany, Dept Biol Sci, 1400 Washington Ave, Albany, NY 12222 USA.	bgs86@cnsunix.albany.edu						Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Blaxall BC, 2000, J BIOL CHEM, V275, P4290, DOI 10.1074/jbc.275.6.4290; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Brody T, 2002, MECH DEVELOP, V113, P41, DOI 10.1016/S0925-4773(02)00010-2; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Canete-Soler R, 1998, J BIOL CHEM, V273, P12655, DOI 10.1074/jbc.273.20.12655; Canete-Soler R, 1998, J BIOL CHEM, V273, P12650, DOI 10.1074/jbc.273.20.12650; Canete-Soler R, 2001, J BIOL CHEM, V276, P32046, DOI 10.1074/jbc.M104104200; Canete-Soler R, 2000, BRAIN RES, V867, P265, DOI 10.1016/S0006-8993(00)02389-1; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; CzyzykKrzeska MF, 1996, J BIOL CHEM, V271, P3293, DOI 10.1074/jbc.271.6.3293; Davis LG, 1994, BASIC METHODS MOL BI; DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gamarnik AV, 1997, RNA, V3, P882; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; Ge WW, 2003, J BIOL CHEM, V278, P26558, DOI 10.1074/jbc.M302886200; Gervasi C, 2003, J COMP NEUROL, V461, P262, DOI 10.1002/cne.10695; Gervasi C, 1997, MOL BRAIN RES, V48, P229, DOI 10.1016/S0169-328X(97)00096-X; GOLDSTEIN ME, 1988, MOL BRAIN RES, V3, P287, DOI 10.1016/0169-328X(88)90051-4; Gravina P, 2002, GENE, V290, P193, DOI 10.1016/S0378-1119(02)00561-9; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hartley R, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-8; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Holcik M, 1997, P NATL ACAD SCI USA, V94, P2410, DOI 10.1073/pnas.94.6.2410; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Lee SK, 2003, J CELL SCI, V116, P4467, DOI 10.1242/jcs.00745; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; MOSKOWITZ PF, 1995, MOL BRAIN RES, V30, P211, DOI 10.1016/0169-328X(95)00006-E; MUMA NA, 1991, J NEUROCYTOL, V20, P844, DOI 10.1007/BF01191735; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; Nieuwkoop PD, 1956, NORMAL TABLE XENOPUS, P162; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Paulding WR, 2000, ADV EXP MED BIOL, V475, P111; Peng SSY, 1996, MOL CELL BIOL, V16, P1490; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Roosa JR, 2000, MOL BRAIN RES, V82, P35, DOI 10.1016/S0169-328X(00)00180-7; SAUVE DM, 1995, ANAL BIOCHEM, V226, P382, DOI 10.1006/abio.1995.1242; SCHLAEPFER WW, 1990, J NEUROSCI RES, V25, P39, DOI 10.1002/jnr.490250106; SCHWARTZ ML, 1990, J NEUROSCI RES, V27, P193, DOI 10.1002/jnr.490270209; SCHWARTZ ML, 1994, MOL BRAIN RES, V27, P215, DOI 10.1016/0169-328X(94)90003-5; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; SMITH C, 1998, RNA PROTEIN INTERACT, P109; Sotelo-Silveira JR, 2000, J NEUROSCI RES, V62, P65, DOI 10.1002/1097-4547(20001001)62:1<65::AID-JNR7>3.0.CO;2-Z; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; SZARO BG, 1989, DEV BRAIN RES, V48, P87, DOI 10.1016/0165-3806(89)90095-3; TESSER P, 1986, J NEUROCHEM, V47, P1235; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Walker KL, 2001, J NEUROSCI, V21, P9655, DOI 10.1523/JNEUROSCI.21-24-09655.2001; Wang XM, 1996, EMBO J, V15, P5040, DOI 10.1002/j.1460-2075.1996.tb00884.x; Weiner OD, 1996, NEUROSCI LETT, V213, P83, DOI 10.1016/0304-3940(96)12860-3; WEISS IM, 1994, MOL CELL BIOL, V14, P8123, DOI 10.1128/MCB.14.12.8123; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; WICKENS M, 1993, NATURE, V363, P305, DOI 10.1038/363305a0; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; WONG J, 1990, J NEUROSCI RES, V27, P332, DOI 10.1002/jnr.490270312; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; ZHAO YG, 1995, J NEUROSCI, V15, P4629; ZHAO YG, 1994, J COMP NEUROL, V343, P158, DOI 10.1002/cne.903430112; Zhu Y, 2002, NEUROSCIENCE, V110, P191, DOI 10.1016/S0306-4522(01)00522-X	73	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49680	49688		10.1074/jbc.M408915200	http://dx.doi.org/10.1074/jbc.M408915200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364910	hybrid			2022-12-27	WOS:000225229500018
J	Power, MR; Peng, YD; Maydanski, E; Marshall, JS; Lin, TJ				Power, MR; Peng, YD; Maydanski, E; Marshall, JS; Lin, TJ			The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MACROPHAGE-INFLAMMATORY PROTEIN-2; RESPIRATORY EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSES; CYSTIC-FIBROSIS; CUTTING EDGE; STAPHYLOCOCCUS-AUREUS; MYD88-DEFICIENT MICE; BACTERIAL-INFECTION; SIGNALING PATHWAYS	Toll-like receptors (TLR) induce distinct patterns of host responses through myeloid differentiation factor 88 (MyD88)-dependent and/or -independent pathways, depending on the nature of the pathogen. Pseudomonas aeruginosa is a cause of serious lung infection in immunocompromised individuals and cystic fibrosis patients. The role of the TLR-MyD88 pathway in P. aeruginosa-induced lung infection in vivo was examined in this study. MyD88(-/-) mice demonstrated an impaired clearance of P. aeruginosa from the lung. Little or no neutrophil recruitment was observed in the airways of MyD88(-/-) mice following P. aeruginosa lung infection. This observation was associated with a reduced production of inflammatory mediators that affect neutrophil recruitment, including macrophage-inflammatory protein-2, tumor necrosis factor, and interleukin-1beta in the airways of MyD88(-/-) mice. Similarly, MyD88(-/-) mice showed inhibited NF-kappaB activation in the lung following P. aeruginosa infection. Interestingly, P. aeruginosa infection induced a 7.5-fold increase of TLR2 mRNA expression in the lungs of MyD88(+/+) mice. Furthermore, host responses to P. aeruginosa lung infection in TLR2(-/-) and TLR4 mutant mice were partially inhibited compared with the responses of respective control mice. Taken together, our results indicate that the MyD88-dependent pathway is essential for the development of early host responses to P. aeruginosa infection, leading to the clearance of this bacterium, and that TLR2 and TLR4 are involved in this process.	Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3J 3G9, Canada; Dalhousie Univ, Dept Pathol, Halifax, NS B3J 3G9, Canada; Dalhousie Univ, Dept Pediat, Halifax, NS B3J 3G9, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Lin, TJ (corresponding author), Isaac Walton Killam Hlth Ctr, Dept Pediat, 5850 Univ Ave, Halifax, NS B3J 3G9, Canada.	tong-jun.lin@dal.ca		Coombs, Melanie/0000-0002-2036-8414; Marshall, Jean S./0000-0002-5642-1379				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Agramonte-Hevia J, 2002, FEMS IMMUNOL MED MIC, V34, P255, DOI 10.1016/S0928-8244(02)00408-X; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; CRIPPS AW, 1995, IMMUNOL CELL BIOL, V73, P418, DOI 10.1038/icb.1995.65; CROSS A, 1983, REV INFECT DIS, V5, pS837; CROUCH BS, 1996, CHEST, V109, P1019, DOI DOI 10.1378/CHEST.109.4.1019; DeBentzmann S, 1996, INFECT IMMUN, V64, P1582, DOI 10.1128/IAI.64.5.1582-1588.1996; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Faure K, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-1; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200; GEORGE SE, 1993, APPL ENVIRON MICROB, V59, P3585, DOI 10.1128/AEM.59.11.3585-3591.1993; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Greenberger PA, 1997, JAMA-J AM MED ASSOC, V278, P1924, DOI 10.1001/jama.278.22.1924; Hashimoto S, 1996, AM J PHYSIOL-LUNG C, V270, pL819, DOI 10.1152/ajplung.1996.270.5.L819; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kernacki KA, 1998, INFECT IMMUN, V66, P376, DOI 10.1128/IAI.66.1.376-379.1998; Kernacki KA, 2000, J IMMUNOL, V164, P1037, DOI 10.4049/jimmunol.164.2.1037; KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LIEBERMAN MM, 1983, J IMMUNOL, V131, P1; Lin TJ, 2002, J IMMUNOL, V169, P4522, DOI 10.4049/jimmunol.169.8.4522; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Moser C, 2002, CLIN EXP IMMUNOL, V127, P206, DOI 10.1046/j.1365-2249.2002.01731.x; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rudner XL, 2000, J IMMUNOL, V164, P6576, DOI 10.4049/jimmunol.164.12.6576; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Skerrett SJ, 2004, J IMMUNOL, V172, P3377, DOI 10.4049/jimmunol.172.6.3377; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Strieter RM, 2003, CURR OPIN INFECT DIS, V16, P193, DOI 10.1097/00001432-200306000-00002; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P841, DOI 10.1111/j.1348-0421.2003.tb03450.x; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Vogel Stefanie N, 2003, Mol Interv, V3, P466, DOI 10.1124/mi.3.8.466; Wagner JG, 2000, PHARMACOL REV, V52, P349; Weighardt H, 2002, J IMMUNOL, V169, P2823, DOI 10.4049/jimmunol.169.6.2823; WIDMER U, 1993, J IMMUNOL, V150, P4996; Yamaguchi T, 2000, J MED MICROBIOL, V49, P701, DOI 10.1099/0022-1317-49-8-701; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x	55	84	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49315	49322		10.1074/jbc.M402111200	http://dx.doi.org/10.1074/jbc.M402111200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15375173	hybrid			2022-12-27	WOS:000225098100100
J	Hardie, RC; Gu, YC; Martin, F; Sweeney, ST; Raghu, P				Hardie, RC; Gu, YC; Martin, F; Sweeney, ST; Raghu, P			In vivo light-induced and basal phospholipase C activity in Drosophila photoreceptors measured with genetically targeted phosphatidylinositol 4,5-bisphosphate-sensitive ion channels (Kir2.1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL KINASE MUTANT; RECTIFYING K+ CHANNELS; SENSITIVE CHANNELS; DIRECT ACTIVATION; TRPL CHANNELS; CA2+ CHANNEL; G-PROTEIN; MEMBRANE; CELLS; PIP2	The phosphatidylinositol 4,5-bisphosphate (PIP2)-sensitive inward rectifier channel Kir2.1 was expressed in Drosophila photoreceptors and used to monitor in vivo PIP2 levels. Since the wild-type (WT) Kir2.1 channel appeared to be saturated by the prevailing PIP2 concentration, we made a single amino acid substitution (R228Q), which reduced the effective affinity for PIP2 and yielded channels generating currents proportional to the PIP2 levels relevant for phototransduction. To isolate Kir2.1 currents, recordings were made from mutants lacking both classes of light-sensitive transient receptor potential channels (TRP and TRPL). Light resulted in the effective depletion of PIP2 by phospholipase C (PLC) in approximately three or four microvilli per absorbed photon at rates exceeding similar to150% of total microvillar phosphoinositides per second. PIP2 was resynthesized with a half-time of similar to50 s. When PIP2 resynthesis was prevented by depriving the cell of ATP, the Kir current spontaneously decayed at maximal rates representing a loss of similar to40% loss of total PIP2 per minute. This loss was attributed primarily to basal PLC activity, because it was greatly decreased in norpA mutants lacking PLC. We tried to confirm this by using the PLC inhibitor U73122; however, this was found to act as a novel inhibitor of the Kir2.1 channel. PIP2 levels were reduced similar to5-fold in the diacylglycerol kinase mutant (rdgA), but basal PLC activity was still pronounced, consistent with the suggestion that raised diacylglycerol levels are responsible for the constitutive TRP channel activity characteristic of this mutant.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of Cambridge; University of California System; University of California San Francisco	Hardie, RC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	rch14@hermes.cam.ac.uk	Padinjat, Raghu/Z-5578-2019; Martin, Fernando/AAZ-1300-2020	gu, yuchun/0000-0002-7558-0447; Sweeney, Sean/0000-0003-2673-9578; Martin, Fernando/0000-0003-4380-567X; Hardie, Roger/0000-0001-5531-3264				Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Agam K, 2004, CELL CALCIUM, V35, P87, DOI 10.1016/j.ceca.2003.08.001; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cho H, 2001, BRIT J PHARMACOL, V134, P1066, DOI 10.1038/sj.bjp.0704347; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; DEER JLR, 1995, J BIOL CHEM, V270, P12623, DOI 10.1074/jbc.270.21.12623; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; HARDIE RC, 1995, J COMP PHYSIOL A, V177, P707, DOI 10.1007/BF00187630; Hardie RC, 1997, CELL CALCIUM, V21, P431, DOI 10.1016/S0143-4160(97)90054-3; Hardie RC, 2003, J BIOL CHEM, V278, P18851, DOI 10.1074/jbc.M300310200; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P659, DOI 10.1113/jphysiol.1984.sp015089; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	42	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47773	47782		10.1074/jbc.M407525200	http://dx.doi.org/10.1074/jbc.M407525200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355960	hybrid			2022-12-27	WOS:000224957000045
J	Cheung, PY; Zhang, Y; Long, JF; Lin, SC; Zhang, MJ; Jiang, Y; Wu, ZG				Cheung, PY; Zhang, Y; Long, JF; Lin, SC; Zhang, MJ; Jiang, Y; Wu, ZG			p150(Glued), dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; LIVING CELLS; DYNACTIN; PROTEIN; PATHWAYS; EXPRESSION; TRANSPORT; SUBUNIT; COMPLEX	To look for regulators of the mitogen-activated protein kinase ( MAPK) kinase 6 (MKK6), a yeast two-hybrid screen was initiated using MKK6 as bait. p150(Glued) dynactin, a key component of the cytoplasmic dynein-dynactin motor complex, was found to specifically interact with MKK6 and its close homologue MKK3. Silencing of p150(Glued) expression by small interference RNA reduced the stimulus-induced phosphorylation of MKK3/6 and p38 MAPKs. The similar adverse effect was also seen when the cytoplasmic dynein motor was disrupted by other means. Like p150(Glued), MKK3/6 directly associate with microtubules. Disruption of microtubules prior to cell stimulation specifically inhibits the stimulus-induced phosphorylation of both MKK3/6 and p38 MAPKs. Our unexpected findings reveal a specific requirement for p150(Glued)/dynein/functional microtubules in activation of MKK3/6 and p38 MAPKs in vivo.	Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; First Mil Med Univ, Dept Pathophysiol, Guangzhou 510515, Peoples R China	Hong Kong University of Science & Technology; Yale University; Southern Medical University - China	Wu, ZG (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	bczgwu@ust.hk	Lin, SC/G-4666-2010; Long, Jiafu/B-7420-2012	Long, Jiafu/0000-0002-6625-0147; Zhang, Yi/0000-0003-2785-1780; Wu, Zhenguo/0000-0003-3049-8324; Zhang, Mingjie/0000-0001-9404-0190				Allan V, 2000, CURR BIOL, V10, pR432, DOI 10.1016/S0960-9822(00)00550-9; Allan V, 1996, CURR BIOL, V6, P630, DOI 10.1016/S0960-9822(09)00434-5; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Horenstein MG, 1997, BLOOD, V90, P1186, DOI 10.1182/blood.V90.3.1186; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PENNINGROTH SM, 1986, METHOD ENZYMOL, V134, P477; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016	21	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2004	279	44					45308	45311		10.1074/jbc.C400333200	http://dx.doi.org/10.1074/jbc.C400333200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	865IC	15375157	hybrid			2022-12-27	WOS:000224694900004
J	Nieman, KM; Rowling, MJ; Garrow, TA; Schalinske, KL				Nieman, KM; Rowling, MJ; Garrow, TA; Schalinske, KL			Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE N-METHYLTRANSFERASE; FOLATE-BINDING-PROTEIN; ONE-CARBON METABOLISM; PLASMA HOMOCYSTEINE; RAT-LIVER; DERIVATIVES; METHIONINE; ADENOSYLMETHIONINE; INHIBITION; SYNTHETASE	The hepatic enzyme glycine N-methyltransferase (GNMT) plays a major role in the control of methyl group and homocysteine metabolism. Because disruption of these vital pathways is associated with numerous pathologies, understanding GNMT control is important for evaluating methyl group regulation. Recently, gluconeogenic conditions have been shown to modulate homocysteine metabolism and treatment with glucocorticoids and/or all-trans-retinoic acid (RA)-induced active GNMT protein, thereby leading to methyl group loss. This study was conducted to determine the effect of diabetes, alone and in combination with RA, on GNMT regulation. Diabetes and RA increased GNMT activity 87 and 148%, respectively. Moreover, the induction of GNMT activity by diabetes and RA was reflected in its abundance. Cell culture studies demonstrated that pretreatment with insulin prevented GNMT induction by both RA and dexamethasone. There was a significant decline in homocysteine concentrations in diabetic rats, owing in part to a 38% increase in the abundance of the transsulfuration enzyme cystathionine beta-synthase; treatment of diabetic rats with RA prevented cystathionine beta-synthase induction. A diabetic state also increased the activity of the folate-independent homocysteine remethylation enzyme betaine-homocysteine S-methyltransferase, whereas the activity of the folate-dependent enzyme methionine synthase was diminished 52%. In contrast, RA treatment attenuated the streptozotocin-mediated increase in betaine-homocysteine S-methyltransferase, whereas methionine synthase activity remained diminished. These results indicate that both a diabetic condition and RA treatment have marked effects on the metabolism of methyl groups and homocysteine, a finding that may have significant implications for diabetics and their potential sensitivity to retinoids.	Iowa State Univ Sci & Technol, Dept Food Sci & Human Nutr, Ames, IA 50011 USA; Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA	Iowa State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Schalinske, KL (corresponding author), Iowa State Univ Sci & Technol, Dept Food Sci & Human Nutr, 220 MacKay Hall, Ames, IA 50011 USA.	kschalin@iastate.edu		Nieman, Kristin/0000-0001-7529-0872	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052501, R29DK052501] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52501] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALAGHI M, 1993, BIOCHEM J, V291, P145, DOI 10.1042/bj2910145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cantoni GL., 1980, NATURAL SULFUR COMPO, P67; COOK RJ, 1984, P NATL ACAD SCI-BIOL, V81, P3631, DOI 10.1073/pnas.81.12.3631; COOK RJ, 1989, J NUTR, V119, P612, DOI 10.1093/jn/119.4.612; FELL D, 1985, J CHROMATOGR, V345, P150, DOI 10.1016/0378-4347(85)80146-8; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gil B, 1997, ENDOCRINOLOGY, V138, P1251, DOI 10.1210/en.138.3.1251; Jacobs RL, 1998, DIABETES, V47, P1967, DOI 10.2337/diabetes.47.12.1967; Jacobs RL, 2001, J BIOL CHEM, V276, P43740, DOI 10.1074/jbc.M107553200; JENCKS DA, 1987, J BIOL CHEM, V262, P2485; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; KEATING JN, 1985, CLIN SCI, V69, P287, DOI 10.1042/cs0690287; KERR SJ, 1972, J BIOL CHEM, V247, P4248; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; Liu HH, 2003, J BIOMED SCI, V10, P87, DOI 10.1159/000068083; Loktionov A, 2003, J NUTR BIOCHEM, V14, P426, DOI 10.1016/S0955-2863(03)00032-9; McMullen MH, 2002, ARCH BIOCHEM BIOPHYS, V401, P73, DOI 10.1016/S0003-9861(02)00030-9; OGAWA H, 1998, EUR J BIOCHEM, V168, P141; Ozias MK, 2003, J NUTR, V133, P4090, DOI 10.1093/jn/133.12.4090; Ratnam S, 2002, J BIOL CHEM, V277, P42912, DOI 10.1074/jbc.M206588200; Ross SA, 2003, ANN NY ACAD SCI, V983, P197, DOI 10.1111/j.1749-6632.2003.tb05974.x; Rowling MJ, 2003, J NUTR, V133, P3392, DOI 10.1093/jn/133.11.3392; Rowling MJ, 2002, J NUTR, V132, P365, DOI 10.1093/jn/132.3.365; Rowling MJ, 2001, J NUTR, V131, P1914, DOI 10.1093/jn/131.7.1914; Schalinske KL, 1996, CARCINOGENESIS, V17, P1695, DOI 10.1093/carcin/17.8.1695; SCOTT JM, 1990, ANNU REV NUTR, V10, P277, DOI 10.1146/annurev.nu.10.070190.001425; SHANE B, 1985, ANNU REV NUTR, V5, P115, DOI 10.1146/annurev.nu.05.070185.000555; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; WAGNER C, 1989, J BIOL CHEM, V264, P9638; WAGNER C, 1985, BIOCHEM BIOPH RES CO, V127, P746, DOI 10.1016/S0006-291X(85)80006-1; Wagner C, 1995, FOLATE HLTH DIS, P23; Wijekoon EP, 2004, FASEB J, V18, pA546; Wysowski DK, 2002, J AM ACAD DERMATOL, V46, P505, DOI 10.1067/mjd.2002.120529; XUE GP, 1985, BIOCHEM INT, V10, P897; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210	37	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2004	279	44					45708	45712		10.1074/jbc.M408664200	http://dx.doi.org/10.1074/jbc.M408664200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	865IC	15347642	Green Published, hybrid			2022-12-27	WOS:000224694900052
J	Karmakar, S; Dhar, R; Das, C				Karmakar, S; Dhar, R; Das, C			Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; IV COLLAGENASE; HUMAN PLACENTA; E-CADHERIN; IN-VITRO; TRANSCRIPTIONAL SUPPRESSION; TROPHOBLAST INVASION; IMPLANTATION SITE	Trophoblast invasion, like tumor invasion, shares common biochemical mechanisms. However, in contrast to tumor invasion of a host tissue, trophoblastic invasion during implantation is strictly regulated, temporospatially. Factors responsible for these important regulatory processes are presently unknown; however, studies indicate that cytokines and growth factors present in the peri-implantation uterine milieu as the possible candidates. In this study we investigated the role of interleukin (IL) 12 in regulating trophoblast invasion and the expression of trophoblast proteases ( matrix metalloprotease (MMP)-2, MMP-9, and urokinase-type plasminogen activators) and their inhibitors ( tissue inhibitors of metalloprotease (TIMP) 1, TIMP-2, and plasminogen activator inhibitor (PAI)-1) using an in vitro tissue culture system of human choriocarcinoma cell line JEG-3. Our major findings show an anti-invasive role of IL-12, associated with an inhibitory effect on the proteases but with an opposite up-regulating influence on the protease inhibitor, TIMP-1, whereas TIMP-2 and plasminogen activator inhibitor 1 remained unaltered. Stimulation of JEG-3 cells with IL-12 also induced interferon (IFN)-gamma production, which when neutralized using a monoclonal anti-IFN-gamma antibody, F12, abrogates its ability to down-regulate the MMPs. IL-12 also mediates an IFN-gamma-dependent up-regulation of E-cadherin, thereby implying that alteration in cell-cell adhesion besides regulating the proteases and the inhibitors possibly contributes to the observed anti-invasive role of this cytokine. TIMP-1, although stimulated by IL-12, was found to be unaltered by antibody F12, thereby implying a possibility of an IL-12-dependent- IFN-gamma independent regulation. These findings thereby suggest an important role of IL-12 in modulation of trophoblast proteases and their inhibitors besides regulating cell-cell interactions and invasion during implantation, with far reaching possibilities for understanding the mechanism(s) and regulations of invasion and metastasis.	All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Karmakar, S (corresponding author), All India Inst Med Sci, Dept Biochem, Rm 3024, New Delhi 110029, India.	subhradipaiims@hotmail.com						Abraham M, 2002, INT IMMUNOL, V14, P1449, DOI 10.1093/intimm/dxf108; ALBINI A, 1987, CANCER RES, V47, P3239; Barber A, 2001, FASEB J, V15, P1158, DOI 10.1096/fj.00-0376com; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bischof P, 2002, J REPROD IMMUNOL, V55, P3, DOI 10.1016/S0165-0378(01)00142-5; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; CARMEN G, 1999, CLIN CANCER RES, V5, P3603; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Clark IM, 1997, BIOCHEM J, V324, P611, DOI 10.1042/bj3240611; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dias S, 1998, INT J CANCER, V75, P151, DOI 10.1002/(SICI)1097-0215(19980105)75:1<151::AID-IJC23>3.0.CO;2-I; Dias S, 1998, INT J CANCER, V78, P361, DOI 10.1002/(SICI)1097-0215(19981029)78:3<361::AID-IJC17>3.0.CO;2-9; Durand MK, 2004, THROMB HAEMOSTASIS, V91, P438, DOI 10.1160/TH03-12-0784; FEINBERG RF, 1989, LAB INVEST, V61, P20; FERNANDEZ PL, 1992, LAB INVEST, V66, P572; Franchimont D, 2000, J IMMUNOL, V164, P1768, DOI 10.4049/jimmunol.164.4.1768; FRISCH SM, 1990, MOL CELL BIOL, V10, P6524, DOI 10.1128/MCB.10.12.6524; Gao F, 2001, ENDOCRINE, V16, P47, DOI 10.1385/ENDO:16:1:47; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Goodman RH, 2000, GENE DEV, V14, P1553; GRAHAM CH, 1992, BIOCHEM CELL BIOL, V70, P867, DOI 10.1139/o92-135; Halin C, 2002, NAT BIOTECHNOL, V20, P264, DOI 10.1038/nbt0302-264; Han XY, 2003, J BIOL CHEM, V278, P47785, DOI 10.1074/jbc.M309482200; HARMAINEN A, 1992, LAB INVEST, V67, P191; Herrler Andreas, 2003, Reprod Biomed Online, V6, P244; Hiscox S, 1999, J CELL SCI, V112, P3081; HOFMANN GE, 1994, AM J OBSTET GYNECOL, V170, P671, DOI 10.1016/S0002-9378(94)70246-2; Hohn HP, 1998, EXP CELL RES, V244, P249, DOI 10.1006/excr.1998.4184; Isaka K, 2003, PLACENTA, V24, P53, DOI 10.1053/plac.2002.0867; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; KARMAKAR S, 2004, IN PRESS J REPROD IM; Kauma SW, 2000, J REPROD FERTIL, P31; KLIMAN HJ, 1990, P NATL ACAD SCI USA, V87, P3057, DOI 10.1073/pnas.87.8.3057; LAIHO M, 1987, J BIOL CHEM, V262, P17467; LALA PK, 1990, CANCER METAST REV, V9, P369, DOI 10.1007/BF00049525; Lala PK, 1996, PLACENTA, V17, P545, DOI 10.1016/S0143-4004(96)80071-3; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Lee SC, 2003, J BIOMED SCI, V10, P73, DOI 10.1159/000068082; LIBRACH CL, 1994, J BIOL CHEM, V269, P17125; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; LIOTTA LA, 1984, AM J PATHOL, V117, P339; Lucas ML, 2002, MOL THER, V5, P668, DOI 10.1006/mthe.2002.0601; Luo J, 1999, CANCER RES, V59, P3552; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; MARTIN O, 1982, AM J OBSTET GYNECOL, V142, P402, DOI 10.1016/S0002-9378(16)32380-8; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Nelissen I, 2002, J LEUKOCYTE BIOL, V71, P89; OKA H, 1993, CANCER RES, V53, P1696; Petraglia F, 1998, J REPROD IMMUNOL, V39, P221, DOI 10.1016/S0165-0378(98)00024-2; Pilka R, 2003, Ceska Gynekol, V68, P179; Polette M, 2004, CRIT REV ONCOL HEMAT, V49, P179, DOI 10.1016/j.critrevonc.2003.10.008; POLETTE M, 1994, LAB INVEST, V71, P838; Qin HW, 1998, J IMMUNOL, V161, P6664; Ruck P, 1996, PLACENTA, V17, P263, DOI 10.1016/S0143-4004(96)90047-8; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Shih IM, 2002, PLACENTA, V23, P706, DOI 10.1053/plac.2002.0864; SHIMONOVITZ S, 1994, AM J OBSTET GYNECOL, V171, P832, DOI 10.1016/0002-9378(94)90107-4; SOUNDARARAJAN R, 2004, REPROD BIOL ENDOCRIN, V2, P1; Tannenbaum CS, 1998, J IMMUNOL, V161, P927; Tannenbaum CS, 1996, J IMMUNOL, V156, P693; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; von Rango U, 2003, FERTIL STERIL, V79, P1176, DOI 10.1016/S0015-0282(02)04829-X; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2; YAGEL S, 1993, J CLIN ENDOCR METAB, V77, P1506, DOI 10.1210/jc.77.6.1506; Zourbas S, 2001, CLIN EXP IMMUNOL, V126, P519, DOI 10.1046/j.1365-2249.2001.01607.x; Zucker S, 2004, CANCER METAST REV, V23, P101, DOI 10.1023/A:1025867130437; Zygmunt M, 1998, AM J REPROD IMMUNOL, V40, P326; Zygmunt M, 1998, PLACENTA, V19, P587, DOI 10.1016/S0143-4004(98)90019-4	76	55	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2004	279	53					55297	55307		10.1074/jbc.M407013200	http://dx.doi.org/10.1074/jbc.M407013200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	882TI	15448160	hybrid			2022-12-27	WOS:000225960800041
J	Christensen, RA; Shtifman, A; Allen, PD; Lopez, JR; Querfurth, HW				Christensen, RA; Shtifman, A; Allen, PD; Lopez, JR; Querfurth, HW			Calcium dyshomeostasis in beta-amyloid and Tau-bearing skeletal myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOSITIS; NEURONAL CA2+ HOMEOSTASIS; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; SARCOPLASMIC-RETICULUM; MICROTUBULE-BINDING; PRECURSOR PROTEIN; MUSCLE FIBERS; IN-VIVO	The relative scarcity of inclusion-affected muscle cells or markers of cell death in inclusion body myositis (IBM) is in distinction to the specific and early intracellular deposition of several Alzheimer's Disease (AD)-related proteins. The current study examined the possible correlation between myotube beta-amyloid and/or Tau accumulations and a widespread mishandling of intracellular muscle calcium concentration that could potentially account for the unrelenting weakness in affected patients. Cultured myogenic cells (C2C12) expressed beta-amyloid-42 (Abeta(42)) and fetal Tau peptides, as human transgenes encoded by herpes simplex virus, either individually or concurrently. Co-expression of Abeta(42) in C2C12 myotubes resulted in hyperphosphorylation of Tau protein that was not observed when Tau was expressed alone. Resting calcium concentration and agonist-induced RyR-mediated Ca2+ release were examined using calcium-specific microelectrodes and Fluo-4 epifluorescence, respectively. Co-expression of Abeta(42) and Tau cooperatively elevated basal levels of myoplasmic- free calcium, an effect that was accompanied by depolarization of the plasma membrane. Sarcoplasmic reticulum (SR) calcium release, induced by KCl depolarization, was not affected by Abeta(42) or Tau. In contrast, expression of Abeta(42), Tau, or Abeta(42) together with Tau resulted in enhanced sensitivity of ryanodine receptors to activation by caffeine. Notably, expression of beta-amyloid, alone, was sufficient to result in an increased sensitivity to direct activation by caffeine. Current results indicate that amyloid proteins cooperate to raise resting calcium levels and that these effects are associated with a passive SR Ca2+ leak and Tau hyperphosphorylation in skeletal muscle.	Tufts Univ, Caritas St Elizabeths Med Ctr, Sch Med, Dept Neurol, Boston, MA 02135 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesia, Boston, MA 02115 USA	St. Elizabeth's Medical Center; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Querfurth, HW (corresponding author), Tufts Univ, Caritas St Elizabeths Med Ctr, Sch Med, Dept Neurol, 736 Cambridge St, Boston, MA 02135 USA.	henry.querfurth@tufts.edu			NIAMS NIH HHS [5R01AR046513, 1F32AR049160-1] Funding Source: Medline; NINDS NIH HHS [R01 NS041373] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR049160, R01AR046513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041373] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARISPE N, 1994, MOL CELL BIOCHEM, V140, P119, DOI 10.1007/BF00926750; Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; Askanas V, 1998, ARCH NEUROL-CHICAGO, V55, P915, DOI 10.1001/archneur.55.7.915; ASKANAS V, 1998, INCLUSION BODY MYOSI, P3; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; Goedert M., 1997, MOL GENETIC BASIS NE, P613; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gu YJ, 1996, J NEUROCHEM, V67, P1235; GUO G, 1997, J NEUROSCI, V17, P4212; HARTMANN H, 1993, BIOCHEM BIOPH RES CO, V194, P1216, DOI 10.1006/bbrc.1993.1952; Hartmann T, 1999, EUR ARCH PSY CLIN N, V249, P291, DOI 10.1007/s004060050102; HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; Hopf FW, 1996, J BIOL CHEM, V271, P22358, DOI 10.1074/jbc.271.37.22358; IANNACCONE ST, 1987, J CELL PHYSIOL, V133, P409, DOI 10.1002/jcp.1041330230; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; JAIMOVICH E, 1994, CELL CALCIUM, V15, P356, DOI 10.1016/0143-4160(94)90011-6; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; KANEMARU K, 1992, J NEUROCHEM, V58, P1667, DOI 10.1111/j.1471-4159.1992.tb10039.x; Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Le WD, 1997, J NEUROCHEM, V69, P978; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; LOPEZ JR, 1983, BIOPHYS J, V43, P1, DOI 10.1016/S0006-3495(83)84316-1; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; MARK RJ, 1995, J NEUROSCI, V15, P6239; MATTSON MP, 1993, TRENDS NEUROSCI, V16, P409, DOI 10.1016/0166-2236(93)90009-B; MATTSON MP, 1991, MOL CHEM NEUROPATHOL, V15, P117, DOI 10.1007/BF03159951; Mattson MP, 2000, J NEUROSCI, V20, P1358; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murakami N, 1998, J NEUROPATH EXP NEUR, V57, P664, DOI 10.1097/00005072-199807000-00003; Nagao SI, 1999, MUSCLE NERVE, V22, P61, DOI 10.1002/(SICI)1097-4598(199901)22:1<61::AID-MUS10>3.0.CO;2-Y; NEVE RL, 1999, CURRENT PROTOCOLS NE; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Querfurth HW, 2001, MOL CELL NEUROSCI, V17, P793, DOI 10.1006/mcne.2001.0972; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4450; Rizzuto R, 2003, NAT GENET, V34, P135, DOI 10.1038/ng0603-135; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Saiki Y, 1999, BIOCHEMISTRY-US, V38, P3112, DOI 10.1021/bi982250m; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shea TB, 1997, J NEUROSCI RES, V49, P759, DOI 10.1002/(SICI)1097-4547(19970915)49:6<759::AID-JNR10>3.0.CO;2-N; Shtifman A, 2004, AM J PHYSIOL-CELL PH, V286, pC73, DOI 10.1152/ajpcell.00194.2003; Shtifman A, 2002, J GEN PHYSIOL, V119, P15, DOI 10.1085/jgp.119.1.15; Suhara T, 2003, NEUROBIOL AGING, V24, P437, DOI 10.1016/S0197-4580(02)00135-5; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Tawil R, 2002, CURR OPIN RHEUMATOL, V14, P653, DOI 10.1097/00002281-200211000-00004; Town T, 2002, J NEUROSCI RES, V69, P362, DOI 10.1002/jnr.10299; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; WATANABE A, 1993, J BIOL CHEM, V268, P25712; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; YANO M, 1995, J BIOL CHEM, V270, P19936, DOI 10.1074/jbc.270.34.19936; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x; Zucchi R, 1997, PHARMACOL REV, V49, P1	78	24	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53524	53532		10.1074/jbc.M408473200	http://dx.doi.org/10.1074/jbc.M408473200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385569	hybrid			2022-12-27	WOS:000225680600088
J	De Sanctis, G; Ciaccio, C; Fasciglione, GF; Fiorucci, L; Gioia, M; Sinibaldi, F; Marini, S; Santucci, R; Coletta, M				De Sanctis, G; Ciaccio, C; Fasciglione, GF; Fiorucci, L; Gioia, M; Sinibaldi, F; Marini, S; Santucci, R; Coletta, M			Effect of axial coordination on the kinetics of assembly and folding of the two halves of horse heart cytochrome c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-EXCHANGE; HEME; ISOMERIZATION; MECHANISMS	The kinetics of the assembly of two complementary fragments of oxidized horse heart cytochrome c (cyt c), namely the heme-containing fragment-(1-56) and the fragment-(57-104), have been characterized at different pH values. At neutral pH the fragment-(1-56) is hexacoordinated and has two histidines axially ligated to the heme-Fe(III) (Santucci, R., Fiorucci, L., Sinibaldi, F., Polizio, F., Desideri, A., and Ascoli, F. (2000) Arch. Biochem. Biophys. 379, 331-336), thus mimicking what occurs in the folding intermediate of cyt c. The kinetics of the formation of the complex between the two fragments are characterized at pH 7.0 by a slow rate constant that is independent of the concentration of the reactants; conversely, at a low pH the kinetics are much faster and depend on the concentration of the fragments. This behavior suggests that the rate-limiting step observed in the recombination process of the fragments at neutral pH (that leads to the final coordination of Met-80) has to be ascribed to the detachment of the "misligated" histidine. Thus, the faster recombination rate at a low pH can be related to the fact that histidine is protonated and not able to coordinate to the metal. Furthermore, the independence of the rate constant on the concentration of the reactants observed at pH 7.0 can be accounted for by the occurrence of a conformational transition, which takes place immediately after the two fragments collapse together, likely simulating what induces the detachment of the misligated histidine during cytochrome folding.	Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; Univ Camerino, Dept Mol Cellular & Anim Biol, I-62032 Camerino, Italy	University of Rome Tor Vergata; University of Camerino	Coletta, M (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Via Montpellier 1, I-00133 Rome, Italy.	coletta@seneca.uniroma2.it	Coletta, Massimo/N-9049-2015; Coletta, Massimiliano/GSN-5927-2022; Marini, Stefano/B-1161-2012; Fasciglione, Giovanni Francesco/ABF-7738-2020; Gioia, Magda/ABF-8909-2020; Fiorucci, Laura/I-4555-2017	Marini, Stefano/0000-0003-1299-6696; Gioia, Magda/0000-0003-0352-3547; COLETTA, Massimiliano/0000-0002-5489-9467				Akiyama S, 2000, NAT STRUCT BIOL, V7, P514; Bai YW, 1999, P NATL ACAD SCI USA, V96, P477, DOI 10.1073/pnas.96.2.477; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Colon W, 1997, BIOCHEMISTRY-US, V36, P12535, DOI 10.1021/bi971697c; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Eaton WA, 2000, ANNU REV BIOPH BIOM, V29, P327, DOI 10.1146/annurev.biophys.29.1.327; ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023; FONTANA A, 1995, FEBS LETT, V362, P266, DOI 10.1016/0014-5793(95)00237-4; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; JONES CM, 1993, P NATL ACAD SCI USA, V90, P11860, DOI 10.1073/pnas.90.24.11860; MOORE GR, 1990, CYTOCHROMES EVOLUTIO; Myers JK, 2002, ANNU REV BIOCHEM, V71, P783, DOI 10.1146/annurev.biochem.71.110601.135346; PIELAK GJ, 1986, J AM CHEM SOC, V108, P2724, DOI 10.1021/ja00270a035; Pierce MM, 2000, J MOL BIOL, V298, P955, DOI 10.1006/jmbi.2000.3700; Pierce MM, 1997, PROTEIN SCI, V6, P618; Santucci R, 2000, ARCH BIOCHEM BIOPHYS, V379, P331, DOI 10.1006/abbi.2000.1885; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; Sinibaldi F, 2001, EUR J BIOCHEM, V268, P4537, DOI 10.1046/j.1432-1327.2001.02373.x; SOSNICK TR, 1994, NAT STRUCT BIOL, V1, P149, DOI 10.1038/nsb0394-149; STELLWAGEN E, 1974, BIOCHEM BIOPH RES CO, V60, P371, DOI 10.1016/0006-291X(74)90214-9; Yeh SR, 1997, NAT STRUCT BIOL, V4, P51, DOI 10.1038/nsb0197-51; Yeh SR, 1999, J BIOL CHEM, V274, P17853, DOI 10.1074/jbc.274.25.17853; Yeh SR, 1998, NAT STRUCT BIOL, V5, P222, DOI 10.1038/nsb0398-222	23	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					52860	52868		10.1074/jbc.M403127200	http://dx.doi.org/10.1074/jbc.M403127200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385558	hybrid			2022-12-27	WOS:000225680600010
J	Ilegems, E; Pick, HM; Deluz, C; Kellenberger, S; Vogel, H				Ilegems, E; Pick, HM; Deluz, C; Kellenberger, S; Vogel, H			Noninvasive imaging of 5-HT3 receptor trafficking in live cells - From biosynthesis to endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION CHANNELS; LIVING CELLS; PLASMA-MEMBRANE; LIGAND-BINDING; FUNCTIONAL EXPRESSION; SURFACE EXPRESSION; MAMMALIAN-CELLS; GENE-EXPRESSION	Sequential stages in the life cycle of the ionotropic 5-HT3 receptor (5-HT3R) were resolved temporally and spatially in live cells by multicolor fluorescence confocal microscopy. The insertion of the enhanced cyan fluorescent protein into the large intracellular loop delivered a fluorescent 5-HT3R fully functional in terms of ligand binding specificity and channel activity, which allowed for the first time a complete real- time visualization and documentation of intracellular biogenesis, membrane targeting, and ligand-mediated internalization of a receptor belonging to the ligand-gated ion channel superfamily. Fluorescence signals of newly expressed receptors were detectable in the endoplasmic reticulum about 3 h after transfection onset. At this stage receptor subunits assembled to form active ligand binding sites as demonstrated in situ by binding of a fluorescent 5-HT3R-specific antagonist. After novel protein synthesis was chemically blocked, the 5-HT3R populations in the endoplasmic reticulum and Golgi cisternae moved virtually quantitatively to the cell surface, indicating efficient receptor folding and assembly. Intracellular 5-HT3 receptors were trafficking in vesicle-like structures along microtubules to the cell surface at a velocity generally below 1 mum/s and were inserted into the plasma membrane in a characteristic cluster distribution overlapping with actin-rich domains. Internalization of cell surface 5-HT3 receptors was observed within minutes after exposure to an extracellular agonist. Our orchestrated use of spectrally distinguishable fluorescent labels for the receptor, its cognate ligand, and specific organelle markers can be regarded as a general approach allowing subcellular insights into dynamic processes of membrane receptor trafficking.	Swiss Fed Inst Technol, EPFL, LCPPM, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne; University of Lausanne	Vogel, H (corresponding author), Swiss Fed Inst Technol, EPFL, LCPPM, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.	horst.vogel@epfl.ch	Vogel, Horst/AAJ-5490-2021; Ilegems, Erwin/F-3493-2010	Ilegems, Erwin/0000-0002-5873-1186; Kellenberger, Stephan/0000-0003-1755-6198				BARNARD EA, 1992, TRENDS BIOCHEM SCI, V17, P368, DOI 10.1016/0968-0004(92)90002-Q; Barnes EM, 2000, LIFE SCI, V66, P1063, DOI 10.1016/S0024-3205(99)00469-5; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; BOESS FG, 1995, J NEUROCHEM, V64, P1401; Boyd GW, 2003, J BIOL CHEM, V278, P27681, DOI 10.1074/jbc.M304938200; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHAVEZ RA, 1992, J BIOL CHEM, V267, P23028; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dutton JL, 2000, NEUROPHARMACOLOGY, V39, P2054, DOI 10.1016/S0028-3908(00)00058-7; Emerit MB, 2002, MOL CELL NEUROSCI, V20, P110, DOI 10.1006/mcne.2002.1133; GREEN T, 1995, J BIOL CHEM, V270, P6056, DOI 10.1074/jbc.270.11.6056; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; Hall Z W, 1992, Trends Cell Biol, V2, P66, DOI 10.1016/0962-8924(92)90058-U; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hovius R, 1998, J NEUROCHEM, V70, P824; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; John PAS, 2001, J NEUROBIOL, V49, P212, DOI 10.1002/neu.1076; KAIN SR, 1995, BIOTECHNIQUES, V19, P650; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lippincott-Schwartz J, 2001, HISTOCHEM CELL BIOL, V116, P97; Maksay G, 2003, J RECEPT SIG TRANSD, V23, P255, DOI 10.1081/RRS-120025568; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Mitra M, 2001, J NEUROSCI, V21, P3000, DOI 10.1523/JNEUROSCI.21-09-03000.2001; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NarayFejesToth A, 1996, J BIOL CHEM, V271, P15436, DOI 10.1074/jbc.271.26.15436; Nashmi R, 2003, J NEUROSCI, V23, P11554; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Pick H, 2003, BIOCHEMISTRY-US, V42, P877, DOI 10.1021/bi026576d; Reeves DC, 2003, BIOPHYS J, V84, P2338, DOI 10.1016/S0006-3495(03)75039-5; SACKETT DL, 1993, BIOCHEMISTRY-US, V32, P13560, DOI 10.1021/bi00212a023; Schreiter C, 2003, J BIOL CHEM, V278, P22709, DOI 10.1074/jbc.M301801200; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SHERLINE P, 1975, J BIOL CHEM, V250, P5481; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Tairi AP, 1998, BIOCHEMISTRY-US, V37, P15850, DOI 10.1021/bi981812z; Toomre D, 1999, J CELL SCI, V112, P21; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; WERNER P, 1994, MOL BRAIN RES, V26, P233, DOI 10.1016/0169-328X(94)90095-7; WETTSTEIN FO, 1964, BIOCHIM BIOPHYS ACTA, V87, P525, DOI 10.1016/0926-6550(64)90131-8; Wohland T, 1999, BIOCHEMISTRY-US, V38, P8671, DOI 10.1021/bi990366s	45	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53346	53352		10.1074/jbc.M407467200	http://dx.doi.org/10.1074/jbc.M407467200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15452106	hybrid			2022-12-27	WOS:000225680600067
J	Sarkar, S; Chawla-Sarkar, M; Young, D; Nishiyama, K; Rayborn, ME; Hollyfield, JG; Sen, S				Sarkar, S; Chawla-Sarkar, M; Young, D; Nishiyama, K; Rayborn, ME; Hollyfield, JG; Sen, S			Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure (Publication with Expression of Concern. See vol. 295, pg. 3386, 2020) (Withdrawn Publication. See vol. 295, pg. 15425, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							INCREASED CARDIOMYOCYTE APOPTOSIS; MYOTROPHIN; MYOCYTES; BCL-2; TRANSITION; BAX	Cardiac hypertrophy and ensuing heart failure are among the most common causes of mortality worldwide, yet the triggering mechanisms for progression of hypertrophy to failure are not fully understood. Tissue homeostasis depends on proper relationships between cell proliferation, differentiation, and death and any imbalance between them results in compromised cardiac function. Recently, we developed a transgenic (Tg) mouse model that overexpress myotrophin (a 12-kDa protein that stimulates myocyte growth) in heart resulting in hypertrophy that progresses to heart failure. This provided us an appropriate model to study the disease process at any point from initiation of hypertrophy end-stage heart failure. We studied detailed apoptotic signaling and regenerative pathways and found that the Tg mouse heart undergoes myocyte loss and regeneration, but only at a late stage ( during transition to heart failure). Several apoptotic genes were up-regulated in 9-month-old Tg hearts compared with age-matched wild type or 4-week-old Tg hearts. Cardiac cell death during heart failure involved activation of Fas, tumor necrosis factor-alpha, and caspases 9, 8, and 3 and poly(ADP-ribose) polymerase cleavage. Tg mice with hypertrophy associated with compromised functionshowedsignificantup-regulationofcyclins, cyclin-dependent kinases (Cdks), and cell regeneration markers in myocytes. Furthermore, in human failing and nonfailing hearts, similar observations were documented including induction of active caspase 3 and Ki-67 proteins in dilated cardiomyopathic myocytes. Taken together, our data suggest that the stress of extensive myocardial damage from longstanding hypertrophy may cause myocytes to reenter the cell cycle. We demonstrate, for the first time in an animal model, that cell death and regeneration occur simultaneously in myocytes during end-stage heart failure, a phenomenon not observed at the onset of the disease process.	Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Taussig Canc Ctr, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sen, S (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol ND50, 9500 Euclid Ave, Cleveland, OH 44195 USA.	sens@ccf.org			NHLBI NIH HHS [HL27833, HL47794] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Black SC, 1998, J MOL CELL CARDIOL, V30, P733, DOI 10.1006/jmcc.1998.0660; Brady HJM, 1996, EMBO J, V15, P6991, DOI 10.1002/j.1460-2075.1996.tb01091.x; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; EDWARDS DR, 1994, TRENDS PHARMACOL SCI, V15, P239, DOI 10.1016/0165-6147(94)90318-2; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Ikeda S, 1999, CLIN SCI, V97, P239, DOI 10.1042/CS19980374; Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215; Kajstura J, 1996, LAB INVEST, V74, P86; Li ZH, 1997, AM J PHYSIOL-HEART C, V272, pH2313, DOI 10.1152/ajpheart.1997.272.5.H2313; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205; Mitra S, 2001, CYTOGENET CELL GENET, V93, P151, DOI 10.1159/000056974; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Reiss K, 1996, EXP CELL RES, V225, P44, DOI 10.1006/excr.1996.0155; Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200; Scarabelli TM, 2002, CIRC RES, V90, P745, DOI 10.1161/01.RES.0000015224.07870.9A; SEN S, 1990, J BIOL CHEM, V265, P16635; Sil P, 1998, CIRC RES, V82, P1173, DOI 10.1161/01.RES.82.11.1173; *US NIH, 1996, NIH PUBL, V8523; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; Zorc M, 2003, CARDIOVASC PATHOL, V12, P36, DOI 10.1016/S1054-8807(02)00134-5	29	34	36	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52630	52642		10.1074/jbc.M402037200	http://dx.doi.org/10.1074/jbc.M402037200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15385543	hybrid			2022-12-27	WOS:000225493400110
J	Horke, S; Reumann, K; Schulze, C; Grosse, F; Heise, T				Horke, S; Reumann, K; Schulze, C; Grosse, F; Heise, T			The La motif and the RNA recognition motifs of human la autoantigen contribute individually to RNA recognition and subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTS; SITE-MEDIATED TRANSLATION; SURFACE-PLASMON RESONANCE; PROTEIN MESSENGER-RNA; SS-B AUTOANTIGEN; IN-VITRO; NASCENT RNA; NUCLEOLAR LOCALIZATION; SMALL NUCLEAR; VIRUS-RNA	The human La autoantigen (hLa) protein is a predominantly nuclear phosphoprotein that contains three potential RNA binding domains referred to as the La motif and the (R) under bar NA (r) under bar ecognition (m) under bar otifs RRMs 1 and 2. With this report, we differentiated the contribution of its three RNA binding domains to RNA binding by combining in vitro and in vivo assays. Also, surface plasmon resonance technology was used to generate a model for the sequential contribution of the RNA binding domains to RNA binding. The results indicated that the La motif may contribute to specificity rather than affinity, whereas RRM1 is indispensable for association with pre-tRNA and hY1 RNA. Furthermore, RRM2 was not crucial for the interaction with various RNAs in vivo, although needed for full-affinity binding in vitro. Moreover, earlier studies suggest that RNA binding by hLa may direct its subcellular localization. As shown previously for RRM1, deletion of RNP2 sequence in RRM1 alters nucleolar distribution of hLa, not observed after deletion of the La motif. Here we discuss a model for precursor RNA binding based on a sequential association process mediated by RRM1 and the La motif.	Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Univ Hamburg Hosp, Ctr Mol Neurobiol, D-20251 Hamburg, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany	Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heise, T (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Postfach 201652,Martinistr 52, D-20251 Hamburg, Germany.	heise@hpi.uni-hamburg.de	Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Horke, Sven/0000-0003-1309-3923; Schulze, Christian/0000-0002-1442-1987				ALFANO C, 2004, NAT STRUCT MOL BIOL, V7, P1; Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; ALSPAUGH MA, 1976, ARTHRITIS RHEUM-US, V19, P216, DOI 10.1002/art.1780190214; Ayukawa K, 2000, J BIOL CHEM, V275, P34465, DOI 10.1074/jbc.M003673200; BABOONIAN C, 1989, CLIN EXP IMMUNOL, V78, P454; BACHMANN M, 1989, J GEN VIROL, V70, P881, DOI 10.1099/0022-1317-70-4-881; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Broekhuis CHD, 2000, BIOCHEMISTRY-US, V39, P3023, DOI 10.1021/bi992308c; Chakshusmathi G, 2003, EMBO J, V22, P6562, DOI 10.1093/emboj/cdg625; CHANG YN, 1994, J VIROL, V68, P7008, DOI 10.1128/JVI.68.11.7008-7020.1994; CHANG YN, 1995, J VIROL, V69, P618, DOI 10.1128/JVI.69.1.618-619.1995; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Dong G, 2004, EMBO J, V23, P1000, DOI 10.1038/sj.emboj.7600115; Ford LP, 2001, RNA, V7, P1068, DOI 10.1017/S1355838201010159; Goodier JL, 1997, MOL CELL BIOL, V17, P5823, DOI 10.1128/MCB.17.10.5823; Heise T, 1999, J VIROL, V73, P5767, DOI 10.1128/JVI.73.7.5767-5776.1999; Horke S, 2004, J BIOL CHEM, V279, P26563, DOI 10.1074/jbc.M401017200; Horke S, 2002, J BIOL CHEM, V277, P34949, DOI 10.1074/jbc.M201911200; Intine RV, 2003, MOL CELL, V12, P1301, DOI 10.1016/S1097-2765(03)00429-5; Jacks A, 2003, STRUCTURE, V11, P833, DOI 10.1016/S0969-2126(03)00121-7; Jacobson MR, 1997, J CELL SCI, V110, P829; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; Long KS, 2001, RNA, V7, P1589; MADORE SJ, 1984, J BIOL CHEM, V259, P1929; Maraia RJ, 2002, GENE EXPRESSION, V10, P41; Maraia RJ, 2001, MOL CELL BIOL, V21, P367, DOI 10.1128/MCB.21.2.367-379.2001; Maraia RJ, 2001, J CELL BIOL, V153, pF13, DOI 10.1083/jcb.153.4.F13; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; McLaren RS, 1997, MOL CELL BIOL, V17, P3028, DOI 10.1128/MCB.17.6.3028; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Nashimoto M, 2001, J MOL BIOL, V312, P975, DOI 10.1006/jmbi.2001.5026; Ohndorf UM, 2001, J BIOL CHEM, V276, P27188, DOI 10.1074/jbc.M102891200; Pellizzoni L, 1996, J MOL BIOL, V259, P904, DOI 10.1006/jmbi.1996.0368; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Pudi R, 2003, J BIOL CHEM, V278, P12231, DOI 10.1074/jbc.M210287200; Raats JMH, 2003, EUR J CELL BIOL, V82, P131, DOI 10.1078/0171-9335-00304; RINKE J, 1982, CELL, V29, P149, DOI 10.1016/0092-8674(82)90099-X; Rutjes SA, 1999, CELL DEATH DIFFER, V6, P976, DOI 10.1038/sj.cdd.4400571; Shiroki K, 1999, J VIROL, V73, P2193, DOI 10.1128/JVI.73.3.2193-2200.1999; Spangberg K, 2001, J GEN VIROL, V82, P113, DOI 10.1099/0022-1317-82-1-113; STEFANO JE, 1984, CELL, V36, P145, DOI 10.1016/0092-8674(84)90083-7; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Wolin SL, 1999, GENE DEV, V13, P1, DOI 10.1101/gad.13.1.1; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2	51	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50302	50309		10.1074/jbc.M407504200	http://dx.doi.org/10.1074/jbc.M407504200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371415	hybrid			2022-12-27	WOS:000225229500093
J	Munoz-Espin, D; Mateu, MG; Villar, L; Marina, A; Salas, M; Meijer, WJJ				Munoz-Espin, D; Mateu, MG; Villar, L; Marina, A; Salas, M; Meijer, WJJ			Phage sigma 29 DNA replication organizer membrane protein p16.7 contains a coiled coil and a dimeric, homeodomain-related, functional domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; TERMINAL PROTEIN; CELL-MEMBRANE; SWISS-MODEL; DIMERIZATION; SPECIFICITY; STABILITY; COMPLEX; GENES; HELIX	The Bacillus subtilis phage phi29-encoded membrane protein p16.7 is one of the few proteins known to be involved in prokaryotic membrane-associated DNA replication. Protein p16.7 contains an N-terminal transmembrane domain responsible for membrane localization. A soluble variant lacking the N-terminal membrane anchor, p16.7A, forms dimers in solution, binds to DNA, and has affinity for the phi29 terminal protein. Here we show that the soluble N-terminal half of p16.7A can form a dimeric coiled coil. However, a second domain, located in the C-terminal half of the protein, has been characterized as being the main domain responsible for p16.7 dimerization. This 70-residue C-terminal domain, named p16.7C, also constitutes the functional part of the protein as it binds to DNA and terminal protein. Sequence alignments, secondary structure predictions, and spectroscopic analyses suggest that p16.7C is evolutionarily related to DNA binding homeodomains, present in many eukaryotic transcriptional regulator proteins. Based on the results, a structural model of p16.7 is presented.	Univ Autonoma Madrid, Inst Biol Mol Eladio Vinuela, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, Inst Biol Mol Eladio Vinuela, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	msalas@cbm.uam.es	Salas, Margarita/J-9873-2014; Mateu, Mauricio/ABF-2146-2021; Ramírez, Anabel Marina/ABG-7125-2021	Salas, Margarita/0000-0001-5939-3441; Mateu, Mauricio/0000-0002-2915-1529; Ramírez, Anabel Marina/0000-0003-2927-6396; Meijer, Wilfried/0000-0003-1842-0049	NIGMS NIH HHS [2R01 GM27242-24] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAVO A, 1994, GENE, V148, P107, DOI 10.1016/0378-1119(94)90242-9; Burglin Thomas R., 1994, P25; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Darling PJ, 2000, BIOCHEMISTRY-US, V39, P11500, DOI 10.1021/bi000935s; de Jong RN, 1999, GENE, V236, P1, DOI 10.1016/S0378-1119(99)00249-8; de Jong RN, 2002, EMBO J, V21, P725, DOI 10.1093/emboj/21.4.725; ENGEL M, 1991, BIOCHEMISTRY-US, V30, P3161, DOI 10.1021/bi00227a002; FIRSHEIN W, 1989, ANNU REV MICROBIOL, V43, P89, DOI 10.1146/annurev.micro.43.1.89; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; IVARIE RD, 1973, VIROLOGY, V52, P351, DOI 10.1016/0042-6822(73)90330-9; Kaufman T C, 1990, Adv Genet, V27, P309; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Mateu MG, 2002, J MOL BIOL, V318, P519, DOI 10.1016/S0022-2836(02)00091-8; Meijer WJJ, 2001, MOL MICROBIOL, V39, P731, DOI 10.1046/j.1365-2958.2001.02260.x; Meijer WJJ, 2001, MICROBIOL MOL BIOL R, V65, P261, DOI 10.1128/MMBR.65.2.261-287.2001; MORENO F, 1974, VIROLOGY, V62, P1, DOI 10.1016/0042-6822(74)90298-0; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SALAS M, 1996, DNA REPLICATION EUKA, P131; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Serna-Rico A, 2002, J BIOL CHEM, V277, P6733, DOI 10.1074/jbc.M109312200; Serna-Rico A, 2003, EMBO J, V22, P2297, DOI 10.1093/emboj/cdg221; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sueoka N, 1998, PROG NUCLEIC ACID RE, V59, P35; Valdes R Jr, 1979, Methods Enzymol, V61, P125; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZABALLOS A, 1989, GENE, V83, P187, DOI 10.1016/0378-1119(89)90104-2	37	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50437	50445		10.1074/jbc.M403297200	http://dx.doi.org/10.1074/jbc.M403297200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371435	hybrid			2022-12-27	WOS:000225229500109
J	Xu, ZB; Chaudhary, D; Olland, S; Wolfrom, S; Czerwinski, R; Malakian, K; Lin, L; Stahl, ML; McCarthy, DJ; Benander, C; Fitz, L; Greco, R; Somers, WS; Mosyak, L				Xu, ZB; Chaudhary, D; Olland, S; Wolfrom, S; Czerwinski, R; Malakian, K; Lin, L; Stahl, ML; McCarthy, DJ; Benander, C; Fitz, L; Greco, R; Somers, WS; Mosyak, L			Catalytic domain crystal structure of protein kinase C-theta (PKC theta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT; PHOSPHORYLATION; ACTIVATION; DYNAMICS; COMPLEX; MOTIF; INHIBITORS; PDK1	A member of the novel protein kinase C (PKC) subfamily, PKCtheta, is an essential component of the T cell synapse and is required for optimal T cell activation and interleukin-2 production. Selective involvement of PKCtheta in TCR signaling makes this enzyme an attractive therapeutic target in T cell-mediated disease processes. In this report we describe the crystal structure of the catalytic domain of PKCtheta at 2.0-resolution. Human recombinant PKCtheta kinase domain was expressed in bacteria as catalytically active phosphorylated enzyme and co-crystallized with its subnanomolar, ATP site inhibitor staurosporine. The structure follows the classic bilobal kinase fold and shows the enzyme in its active conformation and phosphorylated state. Inhibitory interactions between conserved features of staurosporine and the ATP-binding cleft are accompanied by closing of the glycine-rich loop, which also maintains an inhibitory arrangement by blocking the phosphate recognition sub-site. The two major phosphorylation sites, Thr-538 in the activation loop and Ser-695 in the hydrophobic motif, are both occupied in the structure, playing key roles in stabilizing active conformation of the enzyme and indicative of PKCtheta autocatalytic phosphorylation and activation during bacterial expression. The PKCtheta-staurosporine complex represents the first kinase domain crystal structure of any PKC isotypes to be determined and as such should provide valuable insight into PKC specificity and into rational drug design strategies for PKCtheta selective leads.	Wyeth Ayerst Res, Dept Chem & Screening Sci, Cambridge, MA 02140 USA; Wyeth Ayerst Res, Inflammat Dept, Cambridge, MA 02140 USA	Pfizer; Pfizer	Somers, WS (corresponding author), Wyeth Ayerst Res, Dept Chem & Screening Sci, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	wsomers@wyeth.com; lmosyak@wyeth.com						Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Arendt CW, 2002, CURR OPIN IMMUNOL, V14, P323, DOI 10.1016/S0952-7915(02)00346-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Bauer B, 2001, J BIOL CHEM, V276, P31627, DOI 10.1074/jbc.M103098200; Bauer B, 2000, EUR J IMMUNOL, V30, P3645, DOI 10.1002/1521-4141(200012)30:12<3645::AID-IMMU3645>3.0.CO;2-#; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Breitenlechner C, 2003, STRUCTURE, V11, P1595, DOI 10.1016/j.str.2003.11.002; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; DELANO WL, 2002, PYMOL MOL GRPAHCIS S; Diaz-Flores E, 2003, J BIOL CHEM, V278, P29208, DOI 10.1074/jbc.M303165200; Gassel M, 2003, J MOL BIOL, V329, P1021, DOI 10.1016/S0022-2836(03)00518-7; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KARLSSON R, 1993, ACTA CRYSTALLOGR D, V49, P381, DOI 10.1107/S0907444993002306; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Prade L, 1997, STRUCTURE, V5, P1627, DOI 10.1016/S0969-2126(97)00310-9; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Tronrud DE, 1997, METHOD ENZYMOL, V277, P306, DOI 10.1016/S0076-6879(97)77017-4; Villalba M, 2002, CURR CANCER DRUG TAR, V2, P125, DOI 10.2174/1568009023333908; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yonemoto W, 1997, PROTEIN ENG, V10, P915, DOI 10.1093/protein/10.8.915; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	41	122	129	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50401	50409		10.1074/jbc.M409216200	http://dx.doi.org/10.1074/jbc.M409216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364937	hybrid			2022-12-27	WOS:000225229500105
J	Bhosale, P; Larson, AJ; Frederick, JM; Southwick, K; Thulin, CD; Bernstein, PS				Bhosale, P; Larson, AJ; Frederick, JM; Southwick, K; Thulin, CD; Bernstein, PS			Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN RETINA; CYTOPLASMIC MEMBRANE; IN-VITRO; CAROTENOIDS; ISOMERIZATION; DEGENERATION; XANTHOPHYLLS; PIGMENT; LUTEIN; LIVER	Uptake, metabolism, and stabilization of xanthophyll carotenoids in the retina are thought to be mediated by specific xanthophyll-binding proteins (XBPs). A membrane-associated XBP was purified from human macula using ion-exchange chromatography followed by gel-exclusion chromatography. Two-dimensional gel electrophoresis showed a prominent spot of 23 kDa and an isoelectric point of 5.7. Using mass spectral sequencing methods and the public NCBI database, it was identified as a Pi isoform of human glutathione S-transferase (GSTP1). Dietary (3R,3'R)-zeaxanthin displayed the highest affinity with an apparent K-d of 0.33 muM, followed by (3R,3'S-meso)-zeaxanthin with an apparent K-d of 0.52 muM. (3R,3'R,6'R)-Lutein did not display any high-affinity binding to GSTP1. Other human recombinant glutathione S-transferase (GST) proteins, GSTA1 and GSTM1, exhibited only low affinity binding of xanthophylls. (3R,3'S-meso)-Zeaxanthin, an optically inactive non-dietary xanthophyll carotenoid present in the human macula, exhibited a strong induced CD spectrum in association with human macular XBP that was nearly identical to the CD spectrum induced by GSTP1. Likewise, dietary (3R,3'R)-zeaxanthin displayed alterations in its CD spectrum in association with GSTP1 and XBP. Other mammalian xanthophyll carrier proteins such as tubulin, high-density lipoprotein, low-density lipoprotein, albumin, and beta-lactoglobulin did not bind zeaxanthins with high affinity, and they failed to induce or alter xanthophyll CD spectra to any significant extent. Immunocytochemistry with an antibody to GSTP1 on human macula sections showed highest labeling in the outer and inner plexiform layers. These results indicate that GSTP1 is a specific XBP in human macula that interacts with (3R,3'S-meso)-zeaxanthin and dietary (3R,3'R)-zeaxanthin in contrast to apparently weaker interactions with (3R,3'R,6'R)-lutein.	Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Utah System of Higher Education; University of Utah; Brigham Young University	Bernstein, PS (corresponding author), Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, 50 N Med Dr, Salt Lake City, UT 84132 USA.	paul.bernstein@hsc.utah.edu			NATIONAL EYE INSTITUTE [R01EY008123, R01EY011600, R29EY011600] Funding Source: NIH RePORTER; NEI NIH HHS [EY-08123, EY-11600] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adler A J, 1973, Methods Enzymol, V27, P675; AliOsman F, 1997, J BIOL CHEM, V272, P10004; Bernstein PS, 1997, INVEST OPHTH VIS SCI, V38, P167; Bernstein PS, 2002, OPHTHALMOLOGY, V109, P1780, DOI 10.1016/S0161-6420(02)01173-9; Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954; Billsten HH, 2003, PHOTOCHEM PHOTOBIOL, V78, P138, DOI 10.1562/0031-8655(2003)078<0138:PPOXIC>2.0.CO;2; BONE RA, 1993, INVEST OPHTH VIS SCI, V34, P2033; BUCHECKER R, 1995, CAROTENOIDS, P63; BULLERJAHN GS, 1986, J BACTERIOL, V167, P396, DOI 10.1128/jb.167.1.396-399.1986; Chen H, 1997, BIOCHEM J, V327, P721, DOI 10.1042/bj3270721; CLEVIDENCE BA, 1993, METHOD ENZYMOL, V214, P33; Crabtree DV, 2001, BIOORGAN MED CHEM, V9, P1967, DOI 10.1016/S0968-0896(01)00103-1; HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879; HJELMELAND LM, 1984, METHOD ENZYMOL, V104, P305; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; Juronen E, 2000, INVEST OPHTH VIS SCI, V41, P2262; Khachik F, 2002, INVEST OPHTH VIS SCI, V43, P3383; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; KROPF A, 1982, VISION RES, V22, P495, DOI 10.1016/0042-6989(82)90199-7; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Lederer B, 2003, BBA-GEN SUBJECTS, V1621, P226, DOI 10.1016/S0304-4165(03)00073-4; Lo HW, 1997, J BIOL CHEM, V272, P32743, DOI 10.1074/jbc.272.52.32743; Lutnaes BF, 2001, CHIRALITY, V13, P224, DOI 10.1002/chir.1023; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Moeller SM, 2000, J AM COLL NUTR, V19, p522S, DOI 10.1080/07315724.2000.10718975; Pettersson PL, 2001, J BIOL CHEM, V276, P11698, DOI 10.1074/jbc.M009146200; PFANDER H, 1992, METHOD ENZYMOL, V213, P3; Rao MN, 1997, J BIOL CHEM, V272, P24455, DOI 10.1074/jbc.272.39.24455; Rapp LM, 2000, INVEST OPHTH VIS SCI, V41, P1200; REDDY KJ, 1989, J BACTERIOL, V171, P3486, DOI 10.1128/jb.171.6.3486-3493.1989; Ruban AV, 1996, BIOCHEMISTRY-US, V35, P674, DOI 10.1021/bi9524878; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simonyi M, 2003, CHIRALITY, V15, P680, DOI 10.1002/chir.10282; SNODDERLY DM, 1991, INVEST OPHTH VIS SCI, V32, P268; SNODDERLY DM, 1984, INVEST OPHTH VIS SCI, V25, P674; Sommerburg O, 1999, CURR EYE RES, V19, P491, DOI 10.1076/ceyr.19.6.491.5276; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; van den Berg H, 1999, NUTR REV, V57, P1, DOI 10.1111/j.1753-4887.1999.tb01769.x; Yemelyanov AY, 2001, EXP EYE RES, V72, P381, DOI 10.1006/exer.2000.0965; ZAGALSKY PF, 1995, ADV SPACE RES, V16, P91, DOI 10.1016/0273-1177(95)00276-K; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072; Zsila F, 2002, BIOCHEM PHARMACOL, V64, P1651, DOI 10.1016/S0006-2952(02)01350-3; Zsila F, 2001, CHIRALITY, V13, P446, DOI 10.1002/chir.1060	45	203	213	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49447	49454		10.1074/jbc.M405334200	http://dx.doi.org/10.1074/jbc.M405334200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355982	hybrid			2022-12-27	WOS:000225098100114
J	Chamberlain, MD; Berry, TR; Pastor, MC; Anderson, DH				Chamberlain, MD; Berry, TR; Pastor, MC; Anderson, DH			The p85 alpha subunit of phosphatidylinositol 3 '-kinase binds to and stimulates the GTPase activity of rab proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; NUCLEOTIDE EXCHANGE; 3-KINASE ACTIVITY; AUTOANTIGEN EEA1; P85 SUBUNIT; RECEPTOR; ACTIVATION; DOMAIN; INTERNALIZATION	Rab5 and Rab4 are small monomeric GTPases localized on early endosomes and function in vesicle fusion events. These Rab proteins regulate the endocytosis and recycling or degradation of activated receptor tyrosine kinases such as the platelet-derived growth factor receptor (PDGFR). The p85alpha subunit of phosphatidylinositol 3'-kinase contains a BH domain with sequence homology to GTPase activating proteins (GAPs), but has not previously been shown to possess GAP activity. In this report, we demonstrate that p85alpha has GAP activity toward Rab5, Rab4, Cdc42, Rac1 and to a lesser extent Rab6, with little GAP activity toward Rab11. Purified recombinant Rab5 and p85alpha can bind directly to each other and not surprisingly, the p85alpha-encoded GAP activity is present in the BH domain. Because p85alpha stays bound to the PDGFR during receptor endocytosis, p85alpha will also be localized to the same early endosomal compartment as Rab5 and Rab4. Taken together, the physical co-localization and the ability of p85alpha to preferentially stimulate the down-regulation of Rab5 and Rab4 GTPases suggests that p85alpha regulates how long Rab5 and Rab4 remain in their GTP-bound active state. Cells expressing BH domain mutants of p85 show a reduced rate of PDGFR degradation as compared with wild type p85 expressing cells. These cells also show sustained activation of the mitogen-activated protein kinase and Akt pathways. Thus, the p85alpha protein may play a role in the down-regulation of activated receptors through its temporal control of the GTPase cycles of Rab5 and Rab4.	Saskatchewan Canc Agcy, Hlth Res Div, Canc Res Unit, Saskatoon, SK S7N 4H4, Canada; Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; Univ Saskatchewan, Dept Oncol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Anderson, DH (corresponding author), Saskatchewan Canc Agcy, Hlth Res Div, Canc Res Unit, 20 Campus Dr, Saskatoon, SK S7N 4H4, Canada.	danderson@scf.sk.ca	Chamberlain, Michael/A-9107-2016; Chamberlain, Michael Dean/AAX-1670-2021	Chamberlain, Michael/0000-0003-1813-8545; Chamberlain, Michael Dean/0000-0003-1813-8545				Anderson DH, 1998, ONCOGENE, V16, P2321, DOI 10.1038/sj.onc.1201780; Armstrong J, 2000, INT J BIOCHEM CELL B, V32, P303, DOI 10.1016/S1357-2725(99)00112-0; Barbieri MA, 1996, BIOCELL, V20, P331; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Chiarugi P, 2002, J CELL SCI, V115, P2219; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Fang Y, 2002, BIOCHEM BIOPH RES CO, V290, P1267, DOI 10.1006/bbrc.2002.6347; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; HART MJ, 1994, J BIOL CHEM, V269, P62; JOLY M, 1995, J BIOL CHEM, V270, P13225, DOI 10.1074/jbc.270.22.13225; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; KAPELLER R, 1993, MOL CELL BIOL, V13, P6052, DOI 10.1128/MCB.13.10.6052; King TR, 2000, J BIOL CHEM, V275, P36450, DOI 10.1074/jbc.M004720200; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Li GP, 1996, BIOCELL, V20, P325; Liu K, 1998, J BIOL CHEM, V273, P10087, DOI 10.1074/jbc.273.17.10087; Low BC, 1999, J BIOL CHEM, V274, P33123, DOI 10.1074/jbc.274.46.33123; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; NILSSON J, 1983, P NATL ACAD SCI-BIOL, V80, P5592, DOI 10.1073/pnas.80.18.5592; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; ROSENFELD ME, 1984, J CELL PHYSIOL, V121, P263, DOI 10.1002/jcp.1041210202; Rubino M, 2000, J BIOL CHEM, V275, P3745, DOI 10.1074/jbc.275.6.3745; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stenmark H, 2001, GENOME BIOL, V2; SUNG CK, 1994, J BIOL CHEM, V269, P12503; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	45	85	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48607	48614		10.1074/jbc.M409769200	http://dx.doi.org/10.1074/jbc.M409769200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15377662	hybrid			2022-12-27	WOS:000225098100016
J	Choi, J; Park, SY; Costantini, F; Jho, EH; Joo, CK				Choi, J; Park, SY; Costantini, F; Jho, EH; Joo, CK			Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by axin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APC TUMOR-SUPPRESSOR; WNT SIGNALING PATHWAY; BETA-CATENIN; NEGATIVE REGULATOR; HEPATOCELLULAR CARCINOMAS; SUBCELLULAR-LOCALIZATION; COLORECTAL-CANCER; NUCLEAR EXPORT; CANONICAL WNT; PROTEIN	Adenomatous polyposis coli (APC) protein and Axin form a complex that mediates the down-regulation of beta-catenin, a key effector of Wnt signaling. Truncation mutations in APC are responsible for familial and sporadic colorectal tumors due to failure in the down-regulation of beta-catenin. While the regulation of beta-catenin by APC has been extensively studied, the regulation of APC itself has received little attention. Here we show that the level of APC is down-regulated by the ubiquitin-proteasome pathway and that Wnt signaling inhibits the process. The domain responsible for the down-regulation and direct ubiquitination was identified. We also show an unexpected role for Axin in facilitating the ubiquitination-proteasome-mediated down-regulation of APC through the oligomerization of Axin. Our results suggest a new mechanism for the regulation of APC by Axin and Wnt signaling.	Univ Seoul, Dept Life Sci, Seoul 130743, South Korea; Catholic Univ Korea, Lab Ophthalmol & Visual Sci, Seoul 137701, South Korea; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	University of Seoul; Catholic University of Korea; Columbia University	Jho, EH (corresponding author), Univ Seoul, Dept Life Sci, 90 Cheonnong Dong, Seoul 130743, South Korea.	ej70@uos.ac.kr; ckjoo@catholic.ac.kr		Jho, Eek-hoon/0000-0003-2414-6234	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044265] Funding Source: NIH RePORTER; NICHD NIH HHS [HD44265] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Baeza N, 2003, ONCOGENE, V22, P632, DOI 10.1038/sj.onc.1206156; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fagman H, 2003, ONCOGENE, V22, P6013, DOI 10.1038/sj.onc.1206731; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; JOSLYN G, 1993, P NATL ACAD SCI USA, V90, P11109, DOI 10.1073/pnas.90.23.11109; Kikuchi A, 2003, CANCER SCI, V94, P225, DOI 10.1111/j.1349-7006.2003.tb01424.x; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Melman L, 2002, MOL BIOL CELL, V13, P3325, DOI 10.1091/mbc.E02-03-0152; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Sakanaka C, 1999, J BIOL CHEM, V274, P14090, DOI 10.1074/jbc.274.20.14090; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1993, CANCER RES, V53, P2728; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang F, 2001, MOL CELL BIOL, V21, P8143, DOI 10.1128/MCB.21.23.8143-8156.2001	59	34	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49188	49198		10.1074/jbc.M404655200	http://dx.doi.org/10.1074/jbc.M404655200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355978	hybrid			2022-12-27	WOS:000225098100084
J	Sauna, ZE; Nandigama, K; Ambudkar, SV				Sauna, ZE; Nandigama, K; Ambudkar, SV			Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis - Effect of transport substrates and characterization of the post-hydrolysis transition state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; NUCLEOTIDE-BINDING DOMAINS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MYOSIN MOTOR DOMAIN; CATALYTIC CYCLE; ABC TRANSPORTER; PROSTAGLANDIN E-2; CRYSTAL-STRUCTURE; 2ND DOMAIN; CELLS	Multidrug resistance protein 4 (MRP4/ABCC4), transports cyclic nucleoside monophosphates, nucleoside analog drugs, chemotherapeutic agents, and prostaglandins. In this study we characterize ATP hydrolysis by human MRP4 expressed in insect cells. MRP4 hydrolyzes ATP (K-m, 0.62 mM), which is inhibited by orthovanadate and beryllium fluoride. However, unlike ATPase activity of P-glycoprotein, which is equally sensitive to both inhibitors, MRP4-ATPase is more sensitive to beryllium fluoride than to orthovanadate. 8-Azido[alpha-P-32] ATP binds to MRP4 (concentration for half-maximal binding similar to3 muM) and is displaced by ATP or by its nonhydrolyzable analog AMPPNP (concentrations for half-maximal inhibition of 13.3 and 308 muM). MRP4 substrates, the prostaglandins E1 and E2, stimulate ATP hydrolysis 2- to 3-fold but do not affect the K-m for ATP. Several other substrates, azidothymidine, 9-(2-phosphonylmethoxyethyl) adenine, and methotrexate do not stimulate ATP hydrolysis but inhibit prostaglandin E2-stimulated ATP hydrolysis. Although both post-hydrolysis transition states MRP4.8-azido[alpha-P-32] ADP.Vi and MRP4.8-azido[alpha-P-32] ADP.beryllium fluoride can be generated, nucleotide trapping is similar to4-fold higher with beryllium fluoride. The divalent cations Mg2+ and Mn2+ support comparable levels of nucleotide binding, hydrolysis, and trapping. However, Co2+ increases 8-azido[alpha-P-32] ATP binding and beryllium fluoride-induced 8-azido[alpha-P-32] ADP trapping but does not support steady-state ATP hydrolysis. ADP inhibits basal and prostaglandin E2-stimulated ATP hydrolysis (concentrations for half-maximal inhibition 0.19 and 0.25 mM, respectively) and beryllium fluoride-induced 8-azido[alpha-P-32] ADP trapping, whereas P-i has no effect up to 20 mM. In aggregate, our results demonstrate that MRP4 exhibits substrate-stimulated ATP hydrolysis, and we propose a kinetic scheme suggesting that ADP release from the post-hydrolysis transition state may be the rate-limiting step during the catalytic cycle.	NCI, Cell Biol Lab, Ctr Canc Res, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ambudkar, SV (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH,Dept Hlth & Human Serv, Bldg 37, Bethesda, MD 20892 USA.	ambudkar@helix.nih.gov	Ambudkar, Suresh V/B-5964-2008; Ambudkar, Suresh V/L-1317-2016; Sauna, Zuben E./AAA-7149-2019		NATIONAL CANCER INSTITUTE [ZIABC010030, Z01BC010030] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi M, 2002, ADV DRUG DELIVER REV, V54, P1333, DOI 10.1016/S0169-409X(02)00166-7; Adam L, 2001, CANCER RES, V61, P81; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19633; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Bakos E, 2000, MOL PHARMACOL, V57, P760, DOI 10.1124/mol.57.4.760; Bera TK, 2002, P NATL ACAD SCI USA, V99, P6997, DOI 10.1073/pnas.102187299; BISHOP JE, 1988, J BIOL CHEM, V263, P1886; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Chick J, 1999, DRUG SAFETY, V20, P427, DOI 10.2165/00002018-199920050-00003; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Hooijberg JH, 2000, FEBS LETT, V469, P47, DOI 10.1016/S0014-5793(00)01238-2; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hou YX, 2003, J BIOL CHEM, V278, P3599, DOI 10.1074/jbc.M210480200; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Kerr ID, 2002, BBA-BIOMEMBRANES, V1561, P47, DOI 10.1016/S0304-4157(01)00008-9; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Kool M, 1997, CANCER RES, V57, P3537; Kruh GD, 2001, J BIOENERG BIOMEMBR, V33, P493, DOI 10.1023/A:1012827221844; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Lee K, 2000, JNCI-J NATL CANCER I, V92, P1934, DOI 10.1093/jnci/92.23.1934; Lee K, 1998, CANCER RES, V58, P2741; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; Loo TW, 2000, JNCI-J NATL CANCER I, V92, P898, DOI 10.1093/jnci/92.11.898; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2004, MOL PHARMACOL, V65, P675, DOI 10.1124/mol.65.3.675; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2001, J BIOENERG BIOMEMBR, V33, P481, DOI 10.1023/A:1012875105006; Sauna ZE, 2001, J BIOL CHEM, V276, P21199, DOI 10.1074/jbc.M100886200; Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, ACTA PHYSIOL SCAND, V163, P213; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vane JR, 1998, INFLAMM RES, V47, pS78; Warner TD, 2003, P NATL ACAD SCI USA, V100, P9108, DOI 10.1073/pnas.1733826100; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Yang RY, 2003, J BIOL CHEM, V278, P30764, DOI 10.1074/jbc.M304118200	68	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48855	48864		10.1074/jbc.M408849200	http://dx.doi.org/10.1074/jbc.M408849200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364914	hybrid			2022-12-27	WOS:000225098100047
J	Jayasinghe, SA; Langen, R				Jayasinghe, SA; Langen, R			Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; PARALLEL BETA-SHEET; DIABETES-MELLITUS; FULL-LENGTH; MODEL; ANTIPARALLEL; PEPTIDE; IDENTIFICATION; ORGANIZATION; RESIDUES	Pancreatic amyloid deposits, composed primarily of the 37-residue islet amyloid polypeptide (IAPP), are a characteristic feature found in more than 90% of patients with type II diabetes. Although IAPP amyloid deposits are associated with areas of pancreatic islet beta-cell dysfunction and depletion and are thought to play a role in disease, their structure is unknown. We used electron paramagnetic resonance spectroscopy to analyze eight spin-labeled derivatives of IAPP in an effort to determine structural features of the peptide. In solution, all eight derivatives gave rise to electron paramagnetic resonance spectra with sharp lines indicative of rapid motion on the sub-nanosecond time scale. These spectra are consistent with a rapidly tumbling and highly dynamic peptide. In contrast, spectra for the fibrillar form exhibit reduced mobility and the presence of strong intermolecular spin-spin interactions. The latter implies that the peptide subunits are ordered and that the same residues from neighboring peptides are in close proximity to one another. Our data are consistent with a parallel arrangement of IAPP peptides within the amyloid fibril. Analysis of spin label mobility indicates a high degree of order throughout the peptide, although the N-terminal region is slightly less ordered. Possible similarities with respect to the domain organization and parallelism of Alzheimer's amyloid beta peptide fibrils are discussed.	Univ So Calif, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	University of Southern California	Langen, R (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.	langen@usc.edu						Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; ASHBURN TT, 1992, J AM CHEM SOC, V114, P790, DOI 10.1021/ja00028a073; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; Balbach JJ, 2002, BIOPHYS J, V83, P1205, DOI 10.1016/S0006-3495(02)75244-2; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Cornish J, 1998, AM J PHYSIOL-ENDOC M, V274, pE827, DOI 10.1152/ajpendo.1998.274.5.E827; DEKONING EJP, 1993, DIABETOLOGIA, V36, P378, DOI 10.1007/BF00402271; DEKONING EJP, 1994, P NATL ACAD SCI USA, V91, P8467, DOI 10.1073/pnas.91.18.8467; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858; Gordon DJ, 2004, BIOPHYS J, V86, P428, DOI 10.1016/S0006-3495(04)74119-3; GRIFFITHS JM, 1995, J AM CHEM SOC, V117, P3539, DOI 10.1021/ja00117a023; Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kudva YC, 1998, BIOCHEM J, V331, P809, DOI 10.1042/bj3310809; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; MacArthur DLA, 1999, DIABETOLOGIA, V42, P1219, DOI 10.1007/s001250051295; Makin OS, 2004, J MOL BIOL, V335, P1279, DOI 10.1016/j.jmb.2003.11.048; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; OBRIEN T, 1995, AM J PATHOL, V147, P609; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Padrick SB, 2001, J MOL BIOL, V308, P783, DOI 10.1006/jmbi.2001.4608; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Serag AA, 2001, BIOCHEMISTRY-US, V40, P9089, DOI 10.1021/bi010655s; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2000, CURR OPIN CHEM BIOL, V4, P500, DOI 10.1016/S1367-5931(00)00123-X; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; WESTERMARK P, 1987, AM J PATHOL, V127, P414; Westermark P, 1996, FEBS LETT, V379, P203, DOI 10.1016/0014-5793(95)01512-4; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008	48	131	131	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48420	48425		10.1074/jbc.M406853200	http://dx.doi.org/10.1074/jbc.M406853200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15358791	hybrid			2022-12-27	WOS:000224957000118
J	Mi, ZY; Guo, HT; Wai, PY; Gao, CJ; Wei, JP; Kuo, PC				Mi, ZY; Guo, HT; Wai, PY; Gao, CJ; Wei, JP; Kuo, PC			Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; NEOPLASTIC TRANSFORMATION; BONE SIALOPROTEIN; GROWTH-FACTOR; PTEN GENE; PROMOTER; PROTEIN; INFLAMMATION; KINASE; OVEREXPRESSION	Cancer progression depends on an accumulation of metastasis-supporting cell signaling molecules, which target signal transduction pathways and, ultimately, gene expression. One such molecule, osteopontin (OPN), represents a key molecular signaling event in tumor progression and metastasis. However, the transcriptional regulatory mechanisms that underlie OPN expression in the setting of breast cancer have not been well studied. In this regard, we have examined the differential transcriptional regulation of OPN in the murine mammary epithelial tumor cell lines, 4T1 and 4T07, which are sublines derived from the parental population of 410.4 cells from Balb/cfC3H mice. These lines are phenotypically heterogeneous in their metastatic behavior. 4T1 hematogenously metastasizes to the lung, liver, bone, and brain, whereas 4T07 is highly tumorigenic but fails to metastasize. The tumor growth and metastatic spread of 4T1 cells closely mimics stage IV breast cancer. We demonstrate that a Ras-independent, phosphoinositide-3 kinase-dependent, c-Jun N-terminal kinase-dependent phosphorylation of c-Jun results in binding of an AP-1 c-Jun homodimer to the OPN promoter in 4T1 cells. This differential up-regulation of OPN gene transcription and protein expression in 4T1 cells conveys in vitro correlates of a metastatic phenotype. These results provide new insight into the transcriptional regulation of OPN as a key mediator of metastatic behavior in malignancy.	Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University	Kuo, PC (corresponding author), 110 Bell Bldg,DUMC Box 3522, Durham, NC 27710 USA.	kuo00004@mc.duke.edu		Gao, Chengjiang/0000-0002-9365-4497	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI044629, R01AI044629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM065113, R01GM065113, T32GM069331] Funding Source: NIH RePORTER; NIAID NIH HHS [AI44629] Funding Source: Medline; NIGMS NIH HHS [GM069331, GM65113] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal D, 2002, J NATL CANCER I, V94, P513; Attur MG, 2001, ARTHRITIS RHEUM-US, V44, P578, DOI 10.1002/1529-0131(200103)44:3<578::AID-ANR106>3.3.CO;2-Z; BAUTISTA DS, 1994, J BIOL CHEM, V269, P23280; BROWN LF, 1994, AM J PATHOL, V145, P610; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; Chung MJ, 2004, PATHOL INT, V54, P10, DOI 10.1111/j.1440-1827.2004.01576.x; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; CRAIG AM, 1991, GENE, V100, P163, DOI 10.1016/0378-1119(91)90362-F; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DENHARDT DT, 1995, ANN NY ACAD SCI, V760, P127, DOI 10.1111/j.1749-6632.1995.tb44625.x; Denhardt DT, 2003, CLIN EXP METASTAS, V20, P77, DOI 10.1023/A:1022550721404; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; DENHARDT DT, 1994, J CELL BIOCHEM, V56, P48, DOI 10.1002/jcb.240560109; El-Tanani M, 2001, CANCER RES, V61, P5619; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; Grano M, 2002, J BIOL REG HOMEOS AG, V16, P190; Heppner GH, 2000, BREAST CANCER RES, V2, P331; HIJIYA N, 1994, BIOCHEM J, V303, P255, DOI 10.1042/bj3030255; Korkola JE, 2003, CANCER RES, V63, P7167; Liu YN, 2004, ONCOGENE, V23, P278, DOI 10.1038/sj.onc.1207022; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; SENGER DR, 1983, NATURE, V302, P714, DOI 10.1038/302714a0; SENGER DR, 1988, CANCER RES, V48, P5770; Tan M, 1999, CANCER RES, V59, P1620; van Golen KL, 2002, CLIN EXP METASTAS, V19, P301, DOI 10.1023/A:1015518114931; Verbeek BS, 1998, FEBS LETT, V425, P145, DOI 10.1016/S0014-5793(98)00224-5; Weber GF, 1997, P ASSOC AM PHYSICIAN, V109, P1; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Wu Y, 2000, BRIT J CANCER, V83, P156; Zhang GX, 2003, MOL CELL BIOL, V23, P6507, DOI 10.1128/MCB.23.18.6507-6519.2003; Zhang GX, 2004, WORLD J GASTROENTERO, V10, P205	37	42	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46659	46667		10.1074/jbc.M407952200	http://dx.doi.org/10.1074/jbc.M407952200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347645	hybrid			2022-12-27	WOS:000224832400041
J	Yoo, HY; Shevchenko, A; Shevchenko, A; Dunphy, WG				Yoo, HY; Shevchenko, A; Shevchenko, A; Dunphy, WG			Mcm2 is a direct substrate of ATM and ATR during DNA damage and DNA replication checkpoint responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; CELL-FREE-EXTRACTS; EARLY EMBRYONIC LETHALITY; S-PHASE; ATAXIA-TELANGIECTASIA; DEPENDENT CHECKPOINT; PROTEINS; KINASE; CHK1; ACTIVATION	In vertebrates, ATM and ATR are critical regulators of checkpoint responses to damaged and incompletely replicated DNA. These checkpoint responses involve the activation of signaling pathways that inhibit the replication of chromosomes with DNA lesions. In this study, we describe the isolation of a cDNA encoding a full-length version of Xenopus ATM. Using antibodies against the regulatory domain of ATM, we have identified the essential replication protein Mcm2 as an ATM-binding protein in Xenopus egg extracts. Xenopus Mcm2 underwent phosphorylation at Ser(92) in response to the presence of double-stranded DNA breaks or DNA replication blocks in egg extracts. This phosphorylation involved both ATM and ATR, but the relative contribution of each kinase depended upon the checkpoint-inducing DNA signal. Furthermore, both ATM and ATR phosphorylated Mcm2 directly at Ser(92) in cell-free kinase assays. Immunodepletion of both ATM and ATR abrogated the checkpoint response that blocks chromosomal DNA replication in egg extracts containing double-stranded DNA breaks. These experiments indicate that ATM and ATR phosphorylate the functionally critical replication protein Mcm2 during both DNA damage and replication checkpoint responses in Xenopus egg extracts.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	California Institute of Technology; Max Planck Society	Dunphy, WG (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dunphy@cco.caltech.edu			NIGMS NIH HHS [GM43974] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043974, R01GM043974] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bailis JM, 2004, CURR OPIN GENET DEV, V14, P17, DOI 10.1016/j.gde.2003.11.002; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Brown EJ, 2000, GENE DEV, V14, P397; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; de Klein A, 2000, CURR BIOL, V10, P479, DOI 10.1016/S0960-9822(00)00447-4; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Guo ZJ, 2000, MOL BIOL CELL, V11, P1535, DOI 10.1091/mbc.11.5.1535; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Jeggo PA, 1998, TRENDS GENET, V14, P312, DOI 10.1016/S0168-9525(98)01511-X; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kobayashi T, 2002, J CELL SCI, V115, P3159; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Liang DT, 1999, J CELL SCI, V112, P559; Liu QH, 2000, GENE DEV, V14, P1448; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; MILLS AD, 1989, J CELL SCI, V94, P471; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Prokhorova TA, 2000, J BIOL CHEM, V275, P2491, DOI 10.1074/jbc.275.4.2491; Robertson K, 1999, ONCOGENE, V18, P7070, DOI 10.1038/sj.onc.1203194; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Thomas H, 2004, RAPID COMMUN MASS SP, V18, P923, DOI 10.1002/rcm.1427; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; YAN H, 1995, J CELL BIOL, V129, P1, DOI 10.1083/jcb.129.1.1; Yanow SK, 2003, J BIOL CHEM, V278, P41083, DOI 10.1074/jbc.M307144200; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	50	105	107	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53353	53364		10.1074/jbc.M408026200	http://dx.doi.org/10.1074/jbc.M408026200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15448142	hybrid, Green Accepted			2022-12-27	WOS:000225680600068
J	Fujita, M; Yoko-o, T; Okamoto, M; Jigami, Y				Fujita, M; Yoko-o, T; Okamoto, M; Jigami, Y			GPI7 involved in glycosylphosphatidylinositol biosynthesis is essential for yeast cell separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CANDIDA-ALBICANS; PROTEIN-KINASE; ANCHOR SYNTHESIS; PLASMA-MEMBRANE; BUDDING YEAST; WALL PROTEINS; GENE; PATHWAY	GPI7 is involved in adding ethanolaminephosphate to the second mannose in the biosynthesis of glycosylphosphatidylinositol (GPI) in Saccharomyces cerevisiae. We isolated gpi7 mutants, which have defects in cell separation and a daughter cell-specific growth defect at the non-permissive temperature. WSC1, RHO2, ROM2, GFA1, and CDC5 genes were isolated as multicopy suppressors of gpi7-2 mutant. Multicopy suppressors could suppress the growth defect of gpi7 mutants but not the cell separation defect. Loss of function mutations of genes involved in the Cbk1p-Ace2p pathway, which activates the expression of daughter-specific genes for cell separation after cytokinesis, bypassed the temperature-sensitive growth defect of gpi7 mutants. Furthermore, deletion of EGT2, one of the genes controlled by Ace2p and encoding a GPI-anchored protein required for cell separation, ameliorated the temperature sensitivity of the gpi7 mutant. In this mutant, Egt2p was displaced from the septal region to the cell cortex, indicating that GPI7 plays an important role in cell separation via the GPI-based modification of daughter-specific proteins in S. cerevisiae.	Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Jigami, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan.	jigami.yoshi@aist.go.jp	Fujita, Morihisa/AAM-4142-2020; Yoko-o, Takehiko/L-7093-2018	Yoko-o, Takehiko/0000-0003-0291-8299; Okamoto, michiyo/0000-0003-4280-6048				Abe H, 2003, GLYCOBIOLOGY, V13, P87, DOI 10.1093/glycob/cwg014; Bagnat M, 2002, P NATL ACAD SCI USA, V99, P14183, DOI 10.1073/pnas.172517799; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Baladron V, 2002, EUKARYOT CELL, V1, P774, DOI 10.1128/EC.1.5.774-786.2002; Benachour A, 1999, J BIOL CHEM, V274, P15251, DOI 10.1074/jbc.274.21.15251; BENGHEZAL M, 1995, J CELL BIOL, V130, P1333, DOI 10.1083/jcb.130.6.1333; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Cid VJ, 2002, MICROBIOL-SGM, V148, P2647, DOI 10.1099/00221287-148-9-2647; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Gaynor EC, 1999, MOL BIOL CELL, V10, P627, DOI 10.1091/mbc.10.3.627; Hamada K, 1998, MOL GEN GENET, V258, P53, DOI 10.1007/s004380050706; HAMBURGER D, 1995, J CELL BIOL, V129, P629, DOI 10.1083/jcb.129.3.629; Hardy CFJ, 1996, MOL CELL BIOL, V16, P6775; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; Horecka J, 2000, YEAST, V16, P967, DOI 10.1002/1097-0061(200007)16:10<967::AID-YEA597>3.0.CO;2-G; Imhof I, 2004, J BIOL CHEM, V279, P19614, DOI 10.1074/jbc.M401873200; Jacoby JJ, 1998, MOL GEN GENET, V258, P148, DOI 10.1007/s004380050717; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagorce A, 2002, EUR J BIOCHEM, V269, P1697, DOI 10.1046/j.1432-1327.2002.02814.x; Leidich SD, 1996, J BIOL CHEM, V271, P27829, DOI 10.1074/jbc.271.44.27829; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Morsomme P, 2003, J CELL BIOL, V162, P403, DOI 10.1083/jcb.200212101; MRSA V, 1993, J BACTERIOL, V175, P2102, DOI 10.1128/JB.175.7.2102-2106.1993; Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Richard M, 2002, MICROBIOL-SGM, V148, P2125, DOI 10.1099/00221287-148-7-2125; Richard M, 2002, MOL MICROBIOL, V44, P841, DOI 10.1046/j.1365-2958.2002.02926.x; Richard M, 2001, J BACTERIOL, V183, P3098, DOI 10.1128/JB.183.10.3098-3107.2001; Ross-Macdonald P, 1999, METHOD ENZYMOL, V303, P512; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schmidt M, 2002, J CELL SCI, V115, P293; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIPOS G, 1994, EMBO J, V13, P2789, DOI 10.1002/j.1460-2075.1994.tb06572.x; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133; TAKITA Y, 1995, MOL GEN GENET, V246, P269, DOI 10.1007/BF00288599; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Taron CH, 2000, MOL BIOL CELL, V11, P1611, DOI 10.1091/mbc.11.5.1611; Toh-e A, 1998, GENES GENET SYST, V73, P365, DOI 10.1266/ggs.73.365; Toh-e A, 1999, GENES GENET SYST, V74, P241, DOI 10.1266/ggs.74.241; Toh-e A, 2002, GENES GENET SYST, V77, P309, DOI 10.1266/ggs.77.309; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Umemura M, 2003, J BIOL CHEM, V278, P23639, DOI 10.1074/jbc.M301044200; WATZELE G, 1989, J BIOL CHEM, V264, P8753; Weiss EL, 2002, J CELL BIOL, V158, P885, DOI 10.1083/jcb.200203094	64	34	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51869	51879		10.1074/jbc.M405232200	http://dx.doi.org/10.1074/jbc.M405232200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452134	hybrid			2022-12-27	WOS:000225493400020
J	Kimber, MS; Martin, F; Lu, YJ; Houston, S; Vedadi, M; Dharamsi, A; Fiebig, KM; Schmid, M; Rock, CO				Kimber, MS; Martin, F; Lu, YJ; Houston, S; Vedadi, M; Dharamsi, A; Fiebig, KM; Schmid, M; Rock, CO			The structure of (3R)-hydroxyacyl-acyl carrier protein dehydratase (FabZ) from Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; HYDROXYDECANOYL THIOESTER DEHYDRASE; SYNTHASE III FABH; X-RAY-STRUCTURE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; PLASMODIUM-FALCIPARUM; THERMAL REGULATION; ACTIVE-SITE	Type II fatty acid biosynthesis systems are essential for membrane formation in bacteria, making the constituent proteins of this pathway attractive targets for antibacterial drug discovery. The third step in the elongation cycle of the type II fatty acid biosynthesis is catalyzed by beta-hydroxyacyl-(acyl carrier protein) (ACP) dehydratase. There are two isoforms. FabZ, which catalyzes the dehydration of (3R)-hydroxyacyl-ACP to trans-2-acyl-ACP, is a universally expressed component of the bacterial type II system. FabA, the second isoform, as has more limited distribution in nature and, in addition to dehydration, also carries out the isomerization of trans-2- to cis-3-decenoyl-ACP as an essential step in unsaturated fatty acid biosynthesis. We report the structure of FabZ from the important human pathogen Pseudomonas aeruginosa at 2.5 Angstrom of resolution. PaFabZ is a hexamer ( trimer of dimers) with the His/Glu catalytic dyad located within a deep, narrow tunnel formed at the dimer interface. Site-directed mutagenesis experiments showed that the obvious differences in the active site residues that distinguish the FabA and FabZ subfamilies of dehydratases do not account for the unique ability of FabA to catalyze isomerization. Because the catalytic machinery of the two enzymes is practically indistinguishable, the structural differences observed in the shape of the substrate binding channels of FabA and FabZ lead us to hypothesize that the different shapes of the tunnels control the conformation and positioning of the bound substrate, allowing FabA, but not FabZ, to catalyze the isomerization reaction.	St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.rock@stjude.org	Kimber, Matthew/Q-8144-2019	Houston, Simon/0000-0001-5961-5227; Fiebig, Klaus/0000-0002-9553-2645; Kimber, Matthew/0000-0001-9454-5586	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NIGMS NIH HHS [GM 34496] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ANNAND RR, 1993, J AM CHEM SOC, V115, P1088, DOI 10.1021/ja00056a038; Baldock C, 1998, J MOL BIOL, V284, P1529, DOI 10.1006/jmbi.1998.2271; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; BIRGE CH, 1967, BIOCHEM BIOPH RES CO, V26, P808; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Case D. A., 2002, AMBER 7; Choi KH, 2000, J BIOL CHEM, V275, P28201; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; CORNELL WD, 1995, J AM CHEM SOC, V117, P5197; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P612; DEMENDOZA D, 1983, TRENDS BIOCHEM SCI, V8, P49, DOI 10.1016/0968-0004(83)90388-2; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; GARWIN JL, 1980, J BIOL CHEM, V255, P1949; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Hoang TT, 1997, J BACTERIOL, V179, P5326, DOI 10.1128/jb.179.17.5326-5332.1997; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; KASS LR, 1967, J BIOL CHEM, V242, P4418; KASS LR, 1967, P NATL ACAD SCI USA, V58, P1168, DOI 10.1073/pnas.58.3.1168; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Levitt DG, 2001, ACTA CRYSTALLOGR D, V57, P1013, DOI 10.1107/S0907444901006394; Li J, 2000, NAT STRUCT BIOL, V7, P555; Marrakchi H, 2002, J BIOL CHEM, V277, P44809, DOI 10.1074/jbc.M208920200; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Price AC, 2003, J BACTERIOL, V185, P4136, DOI 10.1128/JB.185.14.4136-4143.2003; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; ROSENFELD IS, 1973, J BIOL CHEM, V248, P2452; Schujman GE, 2001, J BACTERIOL, V183, P3032, DOI 10.1128/JB.183.10.3032-3040.2001; Sharma SK, 2003, J BIOL CHEM, V278, P45661, DOI 10.1074/jbc.M304283200; SILBERT DF, 1967, P NATL ACAD SCI USA, V58, P1579, DOI 10.1073/pnas.58.4.1579; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; SWARNA MPL, 2004, ACTA CRYSTALLOGR D, V60, P120; Waller RF, 2003, ANTIMICROB AGENTS CH, V47, P297, DOI 10.1128/AAC.47.1.297-301.2003; Wang HH, 2004, J BIOL CHEM, V279, P34489, DOI 10.1074/jbc.M403874200; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; [No title captured]	51	107	112	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52593	52602		10.1074/jbc.M408105200	http://dx.doi.org/10.1074/jbc.M408105200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15371447	hybrid			2022-12-27	WOS:000225493400106
J	Seufferheld, M; Lea, CR; Vieira, M; Oldfield, E; Docampo, R				Seufferheld, M; Lea, CR; Vieira, M; Oldfield, E; Docampo, R			The H+-pyrophosphatase of Rhodospirillum rubrum is predominantly located in polyphosphate-rich acidocalcisomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-PUMPING PYROPHOSPHATASE; TRYPANOSOMA-CRUZI; INORGANIC PYROPHOSPHATE; PLASMA-MEMBRANE; TRANSLOCATING PYROPHOSPHATASE; CHLAMYDOMONAS-REINHARDTII; ESCHERICHIA-COLI; PLANT; IDENTIFICATION; LOCALIZATION	Acidocalcisomes are acidic, calcium storage compartments with a H+ pump located in their membrane that have been described in several unicellular eukaryotes, including trypanosomatid and apicomplexan parasites, algae, and slime molds, and have also been found in the bacterium Agrobacterium tumefaciens. In this work, we report that the H+-pyrophosphatase (H+-PPase) of Rhodospirillum rubrum, the first enzyme of this type that was identified and thought to be localized only to chromatophore membranes, is predominantly located in acidocalcisomes. The identification of the acidocalcisomes of R. rubrum was carried out by using transmission electron microscopy, x-ray microanalysis, and immunofluorescence microscopy. Purification of acidocalcisomes using iodixanol gradients indicated co-localization of the H+-PPase with pyrophosphate (PPi) and short and long chain polyphosphates (polyPs) but a lack of markers of the plasma membrane. polyP was also localized to the acidocalcisomes by using 4', 6'-diamino-2- phenylindole staining and identified by using P-31 NMR and biochemical methods. Calcium in the acidocalcisomes increased when the bacteria were incubated at high extracellular calcium concentrations. The number of acidocalcisomes and chromatophore membranes as well as the amounts of PPi and polyP increased when bacteria were grown in the light. Taken together, these results suggest that the H+-PPase of R. rubrum has two distinct roles depending on its location acting as an intracellular proton pump in acidocalcisomes but in PPi synthesis in the chromatophore membranes.	Univ Illinois, Dept Pathobiol, Mol Parasitol Lab, Urbana, IL 61802 USA; Univ Illinois, Ctr Zoonoses Res, Urbana, IL 61802 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Docampo, R (corresponding author), Univ Illinois, Dept Pathobiol, Mol Parasitol Lab, 2001 S Lincoln Ave, Urbana, IL 61802 USA.	rodoc@uiuc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI023259, R01AI023259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050694] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23259] Funding Source: Medline; NIGMS NIH HHS [GM50694] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Belogurov GA, 2002, J BIOL CHEM, V277, P22209, DOI 10.1074/jbc.M202951200; COHENBAZIRE G, 1963, BACTERIAL PHOTOSYNTH, P89; CROOK SM, 1986, J BACTERIOL, V167, P89, DOI 10.1128/jb.167.1.89-95.1986; DASILVA LP, 1993, ARCH BIOCHEM BIOPHYS, V30, P310; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Drebin R. A., 1988, P 15 ANN C COMP GRAP, P65, DOI DOI 10.1145/54852.378484; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Lin HJ, 2001, ANAL BIOCHEM, V294, P118, DOI 10.1006/abio.2001.5155; LONG AR, 1995, J PLANT PHYSIOL, V146, P629, DOI 10.1016/S0176-1617(11)81925-5; Lopez-Marques RL, 2004, J BACTERIOL, V186, P5418, DOI 10.1128/JB.186.16.5418-5426.2004; LUNDIN M, 1992, BIOCHIM BIOPHYS ACTA, V1098, P217, DOI 10.1016/S0005-2728(05)80339-1; Luo SH, 2001, EMBO J, V20, P55, DOI 10.1093/emboj/20.1.55; Maeshima M, 1999, PLANT CELL PHYSIOL, V40, P439, DOI 10.1093/oxfordjournals.pcp.a029560; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; Martinez R, 2002, MOL BIOCHEM PARASIT, V120, P205, DOI 10.1016/S0166-6851(01)00456-X; MEISSNER M, 2000, P 2000 IEEE S VOL VI, P81; Meyer A., 1904, BOT Z, V62, P113; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; MOYLE J, 1972, FEBS LETT, V23, P233, DOI 10.1016/0014-5793(72)80349-1; OELZE J, 1972, BIOCHIM BIOPHYS ACTA, V265, P209, DOI 10.1016/0304-4157(72)90003-2; PawleyJB, 1994, 3 DIMENSIONAL CONFOC, P47; Perez-Castineira JR, 2002, BIOCHEM BIOPH RES CO, V294, P567, DOI 10.1016/S0006-291X(02)00517-X; Perez-Castineira JR, 2001, FEBS LETT, V496, P6, DOI 10.1016/S0014-5793(01)02390-0; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; Robinson DG, 1996, PLANTA, V198, P95, DOI 10.1007/BF00197591; Robinson DG, 1998, BOT ACTA, V111, P108, DOI 10.1111/j.1438-8677.1998.tb00685.x; Romero I, 2003, ARCH MICROBIOL, V179, P377, DOI 10.1007/s00203-003-0537-4; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; RUSS JC, 1995, IMAGE PROCESSING HDB, P151; RUSS JC, 1995, IMAGE PROCESSING HDB, P1; SALIH GF, 1990, CURR RES PHOTOSYNTH, V3, P209; Schultz A, 2003, BBA-BIOENERGETICS, V1607, P141, DOI 10.1016/j.bbabio.2003.09.003; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Seufferheld M, 2003, J BIOL CHEM, V278, P29971, DOI 10.1074/jbc.M304548200; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; Slater, 1970, ELECTRON TRANSPORT E, P221; Van Wazer J. R., 1987, PHOSPHORUS NMR BIOL, P1; VANKEMPEN GMP, 1997, 3 D MICROSCOPY IMAGE, V4, P114; Vianello A, 1997, PLANT CELL PHYSIOL, V38, P87, DOI 10.1093/oxfordjournals.pcp.a029090; VONSTEDINGK LV, 1966, ARCH BIOCHEM BIOPHYS, V40, P400; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340; Zhen RG, 1997, ADV BOT RES, V25, P297, DOI 10.1016/S0065-2296(08)60156-1	52	64	68	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51193	51202		10.1074/jbc.M406099200	http://dx.doi.org/10.1074/jbc.M406099200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371423	hybrid			2022-12-27	WOS:000225355800066
J	Somerville, RPT; Jungers, KA; Apte, SS				Somerville, RPT; Jungers, KA; Apte, SS			Discovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; THROMBOSPONDIN MOTIFS; CHONDROITIN SULFATE; FAMILY; CLONING; AGGRECANASE-1; DISINTEGRIN; CLEAVAGE; PROTEIN; MEMBER	We describe the discovery and characterization of ADAMTS10, a novel metalloprotease encoded by a locus on human chromosome 19 and mouse chromosome 17. ADAMTS10 has the typical modular organization of the ADAMTS family, with five thrombospondin type 1 repeats and a cysteine-rich PLAC ( protease and lacunin) domain at the carboxyl terminus. Its domain organization and primary structure is similar to a novel long form of ADAMTS6. In contrast to many ADAMTS proteases, ADAMTS10 is widely expressed in adult tissues and throughout mouse embryo development. In situ hybridization analysis showed widespread expression of Adamts10 in the mouse embryo until 12.5 days of gestation, after which it is then expressed in a more restricted fashion, with especially strong expression in developing lung, bone, and craniofacial region. Mesenchymal, not epithelial, expression in the developing lung, kidney, gonad, salivary gland, and gastrointestinal tract is a consistent feature of Adamts10 regulation. N-terminal sequencing and treatment with decanoyl-Arg-Val-Lys- Arg-chloromethylketone indicate that the ADAMTS10 zymogen is processed by a subtilisin-like proprotein convertase at two sites (Arg(64)down arrowGly and Arg(233)down arrowSer). The widespread expression of ADAMTS10 suggests that furin, a ubiquitously expressed proprotein convertase, is the likely processing enzyme. ADAMTS10 expressed in HEK293F and COS-1 cells is N-glycosylated and is secreted into the medium, as well as sequestered at the cell surface and extracellular matrix, as demonstrated by cell surface biotinylation and immunolocalization in nonpermeabilized cells. ADAMTS10 is a functional metalloprotease as demonstrated by cleavage of alpha(2)-macroglobulin, although physiological substrates are presently unknown.	Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Orthopaed Res Ctr, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Apte, SS (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	aptes@ccf.org		Apte, Suneel/0000-0001-8441-1226	NIAMS NIH HHS [AR 49930] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049930, R56AR049930] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; Brinkmann T, 1997, J BIOL CHEM, V272, P11171; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Colige A, 1997, P NATL ACAD SCI USA, V94, P2374, DOI 10.1073/pnas.94.6.2374; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Colige A, 2002, J BIOL CHEM, V277, P5756, DOI 10.1074/jbc.M105601200; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Georgiadis KE, 1999, GENOMICS, V62, P312, DOI 10.1006/geno.1999.6014; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Iruela-Arispe ML, 2003, ANN NY ACAD SCI, V995, P183, DOI 10.1111/j.1749-6632.2003.tb03221.x; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nardi JB, 1999, INSECT BIOCHEM MOLEC, V29, P883, DOI 10.1016/S0965-1748(99)00064-8; Rao C, 2003, DEVELOPMENT, V130, P4665, DOI 10.1242/dev.00668; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Rodriguez-Manzaneque JC, 2002, BIOCHEM BIOPH RES CO, V293, P501; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Somerville RPT, 2003, J BIOL CHEM, V278, P9503, DOI 10.1074/jbc.M211009200; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tortorella MD, 2000, J BIOL CHEM, V275, P18566, DOI 10.1074/jbc.M909383199; Tortorella MD, 2004, J BIOL CHEM, V279, P17554, DOI 10.1074/jbc.M313041200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	40	66	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51208	51217		10.1074/jbc.M409036200	http://dx.doi.org/10.1074/jbc.M409036200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15355968	hybrid			2022-12-27	WOS:000225355800068
J	Tomaska, L; Willcox, S; Slezakova, J; Nosek, J; Griffith, JD				Tomaska, L; Willcox, S; Slezakova, J; Nosek, J; Griffith, JD			Taz1 binding to a fission yeast model telomere - Formation of telomeric loops and higher order structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; IN-VITRO; T-LOOPS; DNA-SEQUENCES; PROTEIN; TRF2; LENGTH; CHROMOSOMES; POLYMERASE; CHROMATIN	Similar to its human homologues TRF1 and TRF2, fission yeast Taz1 protein is a component of telomeric chromatin regulating proper telomere maintenance. As mammalian TRF1 and TRF2 proteins have been shown to directly bind telomeric DNA to form protein arrays and looped structures, termed t-loops, the ability of Taz1p to act on fission yeast telomeric DNA in similar ways was examined using purified protein and model DNA templates. When incubated with Taz1p, model telomeres containing 3' single-stranded telomeric overhangs formed t-loops at a frequency approaching 13%. Termini with blunt ends and non-telomeric overhangs were deficient in t-loop formation. In addition, we observed arrays of multiple Taz1p molecules bound to the telomeric regions, resembling the pattern of TRF1 binding. The presence of t-loops larger than the telomeric tract, a high frequency of end-bound DNAs and a donut shape of the Taz1p complex suggest that Taz1p binds the 3' overhang then extrudes a loop that grows in size as the donut slides along the duplex DNA. Based on these in vitro results we discuss possible general implications for fission yeast telomere dynamics.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava 84215, Slovakia; Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Comenius University Bratislava; Comenius University Bratislava; University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Mason Farm Rd CB7095, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; Tomaska, Lubomir/I-3071-2014; Nosek, Jozef/A-7581-2008	Tomaska, Lubomir/0000-0003-4886-1910; Nosek, Jozef/0000-0002-1020-5451	FIC NIH HHS [TW05654-01] Funding Source: Medline; NCI NIH HHS [CA19014] Funding Source: Medline; NIGMS NIH HHS [GM31819] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW005654] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Borchers C, 2000, ANAL CHEM, V72, P1163, DOI 10.1021/ac990937m; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Fotiadou P, 2004, CANCER RES, V64, P3830, DOI 10.1158/0008-5472.CAN-04-0136; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; McEachern MJ, 2000, P NATL ACAD SCI USA, V97, P11409, DOI 10.1073/pnas.210388397; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Park MJ, 2002, MOL CELLS, V13, P327; Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538; Rhodes D, 2002, EMBO REP, V3, P1139, DOI 10.1093/embo-reports/kvf246; Sadaie M, 2003, GENE DEV, V17, P2271, DOI 10.1101/gad.1112103; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stansel RM, 2002, J BIOL CHEM, V277, P11625, DOI 10.1074/jbc.C100764200; Stansel RM, 2001, EMBO J, V20, P5532; Tomaska L, 2002, MITOCHONDRION, V1, P455, DOI 10.1016/S1567-7249(02)00009-0; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; WANG SS, 1990, MOL CELL BIOL, V10, P4415, DOI 10.1128/MCB.10.8.4415; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	51	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50764	50772		10.1074/jbc.M409790200	http://dx.doi.org/10.1074/jbc.M409790200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383525	hybrid			2022-12-27	WOS:000225355800018
J	Williams, TM; Medina, F; Badano, I; Hazan, RB; Hutchinson, J; Muller, WJ; Chopra, NG; Scherer, PE; Pestell, RG; Lisanti, MP				Williams, TM; Medina, F; Badano, I; Hazan, RB; Hutchinson, J; Muller, WJ; Chopra, NG; Scherer, PE; Pestell, RG; Lisanti, MP			Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo - Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; NITRIC-OXIDE SYNTHASE; CYCLIN D1 OVEREXPRESSION; ROUS-SARCOMA VIRUS; MAP KINASE CASCADE; MEMBRANE DOMAINS; PROSTATE-CANCER; MICE SHOW; NULL MICE; RETINOBLASTOMA PROTEIN	Caveolin-1 (Cav-1) is the principal structural component of caveolae membrane domains in non-muscle cells, including mammary epithelia. There is now clear evidence that caveolin-1 influences the development of human cancers. For example, a dominant-negative mutation (P132L) in the Cav-1 gene has been detected in up to 16% of human breast cancer samples. However, the exact functional role of caveolin-1 remains controversial. Mechanistically, in cultured cell models, Cav-1 is known to function as a negative regulator of the Rasp-42/ 44 MAP kinase cascade and as a transcriptional repressor of cyclin D1 gene expression, possibly explaining its in vitro transformation suppressor activity. Genetic validation of this hypothesis at the in vivo and whole organismal level has been prevented by the lack of a Cav-1 (-/-)-null mouse model. Here, we examined the role of caveolin-1 in mammary tumorigenesis and lung metastasis using a molecular genetic approach. We interbred a well characterized transgenic mouse model of breast cancer, MMTV-PyMT ( mouse mammary tumor virus-polyoma middle T antigen), with Cav-1(-/-)-null mice. Then, we followed the onset and progression of mammary tumors and lung metastases in female mice over a 14-week period. Interestingly, PyMT/Cav-1 (-/-) mice showed an accelerated onset of mammary tumors, with increased multiplicity and tumor burden ( similar to 2-fold). No significant differences were detected between PyMT/ Cav-1 (-/-) and PyMT/ Cav-1 (+/-) mice, indicating that complete loss of caveolin-1 is required to accelerate both tumorigenesis and metastasis. Molecularly, mammary tumor samples derived from PyMT/Cav-1 (-/-) mice showed ERK-1/2 hyperactivation, cyclin D1 up-regulation, and Rb hyperphosphorylation, consistent with dysregulated cell proliferation. PyMT/Cav-1 (-/-) mice also developed markedly advanced metastatic lung disease. Conversely, recombinant expression of Cav-1 in a highly metastatic PyMT mammary carcinoma-derived cell line, namely Met-1 cells, suppressed lung metastasis by similar to4.5-fold. In vitro, these Cav-1-expressing Met-1 cells (Met-1/ Cav-1) demonstrated a similar to 4.8-fold reduction in invasion through Matrigel-coated membranes. Interestingly, delivery of a cell permeable peptide encoding the caveolin-1 scaffolding domain ( residues 82 - 101) into Met-1 cells was sufficient to inhibit invasion. Coincident with this decreased invasive index, Met-1/ Cav-1 cells exhibited marked reductions in MMP-9 and MMP-2 secretion and associated gelatinolytic activity, as well as diminished ERK-1/2 signaling in response to growth factor stimulation. These results demonstrate, for the first time, that caveolin-1 is a potent suppressor of mammary tumor growth and metastasis using novel in vivo animal model approaches.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol & Med, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol & Med, Bronx, NY 10461 USA; Albert Einstein Canc Ctr, Bronx, NY 10461 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; McGill Univ, Dept Med & Biochem, Montreal, PQ H3G 1Y6, Canada; Jacboi Med Ctr, Dept Pathol, Bronx, NY 10461 USA; Georgetown Univ, Dept Oncol, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Massachusetts Institute of Technology (MIT); Whitehead Institute; McGill University; Georgetown University	Lisanti, MP (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol & Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lisanti@aecom.yu.edu	Williams, Terence M/I-9614-2014; Scherer, Philipp E/K-7819-2012; Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013	Scherer, Philipp E/0000-0003-0680-3392; Lisanti, Michael/0000-0003-2034-1382; Badano, Ines/0000-0003-3033-3802	NCI NIH HHS [P30 CA51008-13, R01CA86072, R01CA75503, R01CA70896] Funding Source: Medline; NIDDK NIH HHS [R01-DK55758, T32-DK07513] Funding Source: Medline; NIGMS NIH HHS [T32-GM07288] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070896, R01CA075503, P30CA051008, R01CA086072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007513, R01DK055758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ALBINI A, 1987, CANCER RES, V47, P3239; Annabi B, 2001, BIOCHEM J, V353, P547, DOI 10.1042/0264-6021:3530547; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; COFFER P, 1994, ONCOGENE, V9, P911; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Coussens LM, 1996, CHEM BIOL, V3, P895, DOI 10.1016/S1074-5521(96)90178-7; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; DICKSON C, 1995, CANCER LETT, V90, P43, DOI 10.1016/0304-3835(94)03676-A; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Engelman JA, 1998, J BIOL CHEM, V273, P20448, DOI 10.1074/jbc.273.32.20448; FILMUS J, 1994, ONCOGENE, V9, P3627; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; GALARDY RE, 1994, CANCER RES, V54, P4715; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Geng Y, 2001, P NATL ACAD SCI USA, V98, P194, DOI 10.1073/pnas.011522998; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Han SE, 2004, INT J ONCOL, V24, P435; Hayashi K, 2001, CANCER RES, V61, P2361; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Hulit J, 2000, J BIOL CHEM, V275, P21203, DOI 10.1074/jbc.M000321200; Ichaso N, 2001, ONCOGENE, V20, P7908, DOI 10.1038/sj.onc.1204859; Itoh T, 1999, CLIN EXP METASTAS, V17, P177, DOI 10.1023/A:1006603723759; Itoh T, 1998, CANCER RES, V58, P1048; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; Kruger JS, 2003, MOL CANCER RES, V1, P801; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lapidus RG, 1998, J MAMMARY GLAND BIOL, V3, P85, DOI 10.1023/A:1018778403001; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li LK, 2001, CANCER RES, V61, P4386; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu J, 2002, J BIOL CHEM, V277, P10661, DOI 10.1074/jbc.M110354200; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; LIU JJ, 1995, MOL CELL BIOL, V15, P3654; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Maglione JE, 2001, CANCER RES, V61, P8298; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MCINTOSH GG, 1995, ONCOGENE, V11, P885; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Park DS, 2002, MOL BIOL CELL, V13, P3416, DOI 10.1091/mbc.02-05-0071; Puyraimond A, 2001, EXP CELL RES, V262, P28, DOI 10.1006/excr.2000.5069; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, BIOCHEM SOC T, V29, P494, DOI 10.1042/BST0290494; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SLOAN EK, 2004, ONCOGENE        0830; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Tahir SA, 2001, CANCER RES, V61, P3882; Tamura Y, 1998, J MED CHEM, V41, P640, DOI 10.1021/jm9707582; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Woodman SE, 2003, AM J PATHOL, V162, P2059, DOI 10.1016/S0002-9440(10)64337-4; Yang G, 1999, CANCER RES, V59, P5719; Yang G, 1998, CLIN CANCER RES, V4, P1873; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199	85	253	262	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51630	51646		10.1074/jbc.M409214200	http://dx.doi.org/10.1074/jbc.M409214200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15355971	hybrid			2022-12-27	WOS:000225355800119
J	Burri, L; Vascotto, K; Fredersdorf, S; Tiedt, R; Hall, MN; Lithgow, T				Burri, L; Vascotto, K; Fredersdorf, S; Tiedt, R; Hall, MN; Lithgow, T			Zim17, a novel zinc finger protein essential for protein import into mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; INTERMEMBRANE SPACE; YEAST MITOCHONDRIA; INNER MEMBRANE; DOMAIN; HSP70; DNAJ; TRANSLOCATION; FAMILY; HOMOLOG	Translocation of precursor proteins across the mitochondrial membranes requires the coordinated action of multisubunit translocases in the outer and inner membrane, and the driving force for translocation across the inner membrane is provided by the matrix-located heat shock protein 70 (mtHsp70). The central components of the protein import machinery are essential. Here we describe Zim17, an essential protein with a (ZI) under bar nc finger (M) under bar otif involved in protein import into mitochondria. Comparative genomics suggested a correction to the open reading frame of YNL310c, the gene encoding Zim17 in Saccharomyces cerevisiae. The revised open reading frame codes for a classic mitochondrial targeting signal, which is processed from Zim17 in the mitochondrial matrix. Loss of Zim17 selectively diminishes import of proteins into the matrix of mitochondria, but this loss of Zim17 is partially suppressed by overexpression of the J-protein Pam18/Tim14. We propose that Zim17 functions as an example of a "fractured" J-protein, where a protein like Zim17 contributes a zinc finger domain to Type III J-proteins, in toto providing for substrate loading onto Hsp70.	Univ Melbourne, Russell Grimwade Sch Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ Basel, Bioctr, CH-4056 Basel, Switzerland	University of Melbourne; University of Basel	Lithgow, T (corresponding author), Univ Melbourne, Russell Grimwade Sch Biochem & Mol Biol, Parkville, Vic 3010, Australia.	t.lithgow@unimelb.edu.au	Lithgow, Trevor J/H-5925-2017	Lithgow, Trevor J/0000-0002-0102-7884; Hall, Michael N/0000-0002-2998-0757				BAKER KP, 1990, NATURE, V348, P605, DOI 10.1038/348605a0; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; Becker S, 2001, GENE, V262, P15, DOI 10.1016/S0378-1119(00)00548-5; Beilharz T, 1998, J BIOL CHEM, V273, P35268, DOI 10.1074/jbc.273.52.35268; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; BRUNELLI JP, 1993, YEAST, V9, P1299, DOI 10.1002/yea.320091203; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; DAUM G, 1982, J BIOL CHEM, V257, P3075; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Gething MJ, 1996, CURR BIOL, V6, P1573, DOI 10.1016/S0960-9822(02)70775-6; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Jensen RE, 1999, CURR BIOL, V9, pR779, DOI 10.1016/S0960-9822(00)80012-3; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koehler CM, 2000, FEBS LETT, V476, P27, DOI 10.1016/S0014-5793(00)01664-1; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; KUBRICH M, 1995, CURR GENET, V27, P393, DOI 10.1007/BF00311207; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lucattini R, 2004, MOL BIOL EVOL, V21, P652, DOI 10.1093/molbev/msh058; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Martinez-Yamout M, 2000, J MOL BIOL, V300, P805, DOI 10.1006/jmbi.2000.3923; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Merlin A, 1999, J CELL BIOL, V145, P961, DOI 10.1083/jcb.145.5.961; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Rospert S, 1996, EMBO J, V15, P764, DOI 10.1002/j.1460-2075.1996.tb00412.x; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Sambrook J., 2001, MOL CLONING LAB MANU; SCHERER PE, 1990, EMBO J, V9, P4315, DOI 10.1002/j.1460-2075.1990.tb07880.x; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Voos W, 2003, MOL CELL, V11, P1, DOI 10.1016/S1097-2765(03)00002-9; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; WESTERMANN B, 1995, EMBO J, V14, P3452, DOI 10.1002/j.1460-2075.1995.tb07351.x; Westermann B, 1997, J MOL BIOL, V272, P477, DOI 10.1006/jmbi.1997.1267; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	59	43	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50243	50249		10.1074/jbc.M409194200	http://dx.doi.org/10.1074/jbc.M409194200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383543	hybrid, Green Accepted			2022-12-27	WOS:000225229500085
J	Koziczak, M; Hynes, NE				Koziczak, M; Hynes, NE			Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; ACTIVATED PROTEIN-KINASE; MAMMALIAN TARGET; MESSENGER-RNA; SIGNALING PATHWAYS; GENE-EXPRESSION; RAPAMYCIN; PHOSPHORYLATION; PROLIFERATION; INHIBITORS	Alterations in ErbB2 or fibroblast growth factor receptor-4 (FGFR-4) expression and activity occur in a significant fraction of breast cancers. Because signaling molecules and pathways cooperate to drive cancer progression, simultaneous targeting of multiple pathways is an appealing therapeutic strategy. With this in mind, we examined breast tumor cells for their sensitivity to the ErbB2 and FGFR inhibitors, PKI166 and PD173074, respectively. Simultaneous blocking of ErbB2 and FGFR-4 in MDA-MB-453 tumor cells had a stronger antiproliferative effect than treatment with individual inhibitors. Examination of cell cycle regulators revealed a novel translation-mediated mechanism whereby ErbB2 and FGFR-4 cooperate to regulate cyclin D1 levels. Our results showed that FGFR-4 and ErbB2 via the MAPK and the phosphatidylinositol 3-kinase/protein kinase B pathways, respectively, both contribute to the maintenance of constitutive activity of the mammalian target of rapamycin translational pathway. Dual inhibition of these receptors strongly blocked S6 kinase 1 (S6K1) activity and cyclin D1 translation, as attested by a decrease in cyclin D1 mRNA association with polysomes. Ectopic expression of active protein kinase B or active S6K1 abrogated the dual inhibitor-mediated down-regulation of cyclin D1 expression, demonstrating the importance of these FGFR-4/ErbB2 signaling targets in regulating cyclin D1 translation. S6K1 has the central role in this process, since small interfering RNA-targeted S6K1 depletion led to a decrease in cellular S6K1 activity and, as a consequence, repression of cyclin D1 expression. Thus, we propose a novel mechanism for controlling cyclin D1 expression downstream of combined activity of ErbB2 and FGFR-4 that involves S6K1-mediated translation.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Hynes, NE (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	nancy.hynes@fmi.ch						Adams J, 2002, CURR OPIN CHEM BIOL, V6, P486, DOI 10.1016/S1367-5931(02)00357-5; Bange J, 2002, CANCER RES, V62, P840; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; BERGER U, 1989, CANCER RES, V49, P5176; Contessa JN, 2002, ONCOGENE, V21, P4032, DOI 10.1038/sj.onc.1205500; Couch FJ, 1999, CANCER RES, V59, P1408; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Fadden P, 1997, J BIOL CHEM, V272, P10240; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gingras AC, 2001, GENE DEV, V15, P2852; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; HERBER B, 1994, ONCOGENE, V9, P1295; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; JEFFERIES HBJ, 1994, J BIOL CHEM, V269, P4367; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; Kawamata S, 1998, BLOOD, V91, P561, DOI 10.1182/blood.V91.2.561.561_561_569; KLINT P, 1999, FRONT BIOSCI, V4, P165; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Koziczak M, 2000, MOL CELL BIOL, V20, P2014, DOI 10.1128/MCB.20.6.2014-2022.2000; KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lenormand P, 1996, J BIOL CHEM, V271, P15762, DOI 10.1074/jbc.271.26.15762; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Munster PN, 2002, CANCER RES, V62, P3132; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Neve RM, 2000, ONCOGENE, V19, P1647, DOI 10.1038/sj.onc.1203470; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; Ross, 1998, Oncologist, V3, P237; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Yakes FM, 2002, CANCER RES, V62, P4132; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang YG, 2001, J BIOL CHEM, V276, P20913, DOI 10.1074/jbc.M009047200; Zubilewicz A, 2001, ONCOGENE, V20, P1403, DOI 10.1038/sj.onc.1204231	53	57	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50004	50011		10.1074/jbc.M404252200	http://dx.doi.org/10.1074/jbc.M404252200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377668	hybrid			2022-12-27	WOS:000225229500057
J	Hung, GC; Brown, CR; Wolfe, AB; Liu, JJ; Chiang, HL				Hung, GC; Brown, CR; Wolfe, AB; Liu, JJ; Chiang, HL			Degradation of the gluconeogenic enzymes fructose-1,6-bisphosphatase and malate dehydrogenase is mediated by distinct proteolytic pathways and signaling events	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; GLUCOSE-INDUCED DEGRADATION; PROTEIN COUPLED RECEPTOR; CATABOLITE INACTIVATION; MDH2 ISOZYME; CYCLIC-AMP; IN-VITRO; VACUOLE; PHOSPHORYLATION; REPRESSOR	The key gluconeogenic enzyme fructose-1,6-bisphosphatase (FBPase) is subjected to catabolite inactivation and degradation when glucose-starved cells are replenished with fresh glucose. In various studies, the proteasome and the vacuole have each been reported to be the major site of FBPase degradation. Because different growth conditions were used in these studies, we examined whether variations in growth conditions could alter the site of FBPase degradation. Here, we demonstrated that FBPase was degraded outside the vacuole ( most likely in the proteasome), when glucose was added to cells that were grown in low glucose media for a short period of time. By contrast, cells that were grown in the same low glucose media for longer periods of time degraded FBPase in the vacuole in response to glucose. Another gluconeogenic enzyme malate dehydrogenase (MDH2) showed the same degradation characteristics as FBPase in that the short term starvation of cells led to a non-vacuolar degradation, whereas long term starvation resulted in the vacuolar degradation of this protein. The N-terminal proline is required for the degradation of FBPase and MDH2 for both the vacuolar and nonvacuolar proteolytic pathways. The cAMP signaling pathway and the phosphorylation of glucose were needed for the vacuolar-dependent degradation of FBPase and MDH2. By contrast, the cAMP-dependent signaling pathway was not involved in the non-vacuolar degradation of these proteins, although the phosphorylation of glucose was required.	Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Brown, CR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	crb13@psu.edu			NIGMS NIH HHS [R01GM59480] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059480] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Brown CR, 2001, J BIOL CHEM, V276, P48017, DOI 10.1074/jbc.M109222200; Brown CR, 2003, J BIOL CHEM, V278, P25688, DOI 10.1074/jbc.M210549200; Brown CR, 2002, J CELL SCI, V115, P655; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CHIANG HL, 1991, NATURE, V350, P313, DOI 10.1038/350313a0; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Chiang MC, 1998, J CELL BIOL, V140, P1347, DOI 10.1083/jcb.140.6.1347; CLIFTON D, 1993, J BACTERIOL, V175, P3289, DOI 10.1128/jb.175.11.3289-3294.1993; Cui DY, 2004, J BIOL CHEM, V279, P9713, DOI 10.1074/jbc.M310793200; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; FOY JJ, 1978, J BACTERIOL, V136, P647, DOI 10.1128/JB.136.2.647-656.1978; GAMO FJ, 1994, EUR J BIOCHEM, V222, P879, DOI 10.1111/j.1432-1033.1994.tb18935.x; GANCEDO C, 1971, J BACTERIOL, V107, P401, DOI 10.1128/JB.107.2.401-405.1971; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gibson N, 2003, J BIOL CHEM, V278, P25628, DOI 10.1074/jbc.M213231200; Hammerle M, 1998, J BIOL CHEM, V273, P25000, DOI 10.1074/jbc.273.39.25000; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoffman M, 1996, GENETICS, V143, P1555; HOLZER H, 1989, RBC-CELL BIOL REV, V21, P305; HOLZER H, 1986, BIOMED BIOCHIM ACTA, V45, P1657; Horak J, 2002, J BIOL CHEM, V277, P8248, DOI 10.1074/jbc.M107255200; Huang PH, 1997, J CELL BIOL, V136, P803, DOI 10.1083/jcb.136.4.803; Jiang Y, 1998, EMBO J, V17, P6942, DOI 10.1093/emboj/17.23.6942; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; JONES EW, 1991, J BIOL CHEM, V266, P7963; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; MAZON MJ, 1982, J BIOL CHEM, V257, P1128; MINARD KI, 1994, ARCH BIOCHEM BIOPHYS, V315, P302, DOI 10.1006/abbi.1994.1504; MINARD KI, 1992, J BIOL CHEM, V267, P17458; MINARD KI, 1991, MOL CELL BIOL, V11, P370, DOI 10.1128/MCB.11.1.370; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; RITTENHOUSE J, 1987, J BIOL CHEM, V262, P10114; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rolland F, 2001, FEMS YEAST RES, V1, P33, DOI 10.1111/j.1567-1364.2001.tb00011.x; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; SCHORK SM, 1995, J BIOL CHEM, V270, P26446, DOI 10.1074/jbc.270.44.26446; SCHORK SM, 1994, FEBS LETT, V349, P270, DOI 10.1016/0014-5793(94)00668-7; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shieh HL, 1998, J BIOL CHEM, V273, P3381, DOI 10.1074/jbc.273.6.3381; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Smith FC, 1999, FEBS LETT, V453, P219, DOI 10.1016/S0014-5793(99)00725-5; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; WALSH RB, 1991, GENETICS, V128, P521; Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Zaragoza O, 1999, J BACTERIOL, V181, P2640, DOI 10.1128/JB.181.8.2640-2642.1999; Zaragoza O, 2001, FEBS LETT, V506, P262, DOI 10.1016/S0014-5793(01)02922-2	66	85	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49138	49150		10.1074/jbc.M404544200	http://dx.doi.org/10.1074/jbc.M404544200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358789	hybrid			2022-12-27	WOS:000225098100079
J	Orr, AW; Pallero, MA; Xiong, WC; Murphy-Ullrich, JE				Orr, AW; Pallero, MA; Xiong, WC; Murphy-Ullrich, JE			Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; PAXILLIN TYROSINE PHOSPHORYLATION; ENDOTHELIAL GROWTH-FACTOR; RECEPTOR-RELATED PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TERMINAL DOMAIN; CELL-MIGRATION; EPITHELIAL-CELLS; SWISS 3T3-CELLS; CROSS-TALK	Cells utilize dynamic interactions with the extracellular matrix to adapt to changing environmental conditions. Thrombospondin 1 (TSP1) induces focal adhesion disassembly and cell migration through a sequence (hep I) in its heparin-binding domain signaling through the calreticulin-low density lipoprotein receptor-related protein receptor complex. This involves the Galpha(i)-dependent activation of ERK and phosphoinositide ( PI) 3-kinase, both of which are required for focal adhesion disassembly. Focal adhesion kinase (FAK) regulates adhesion dynamics, acting in part by modulating RhoA activity, and FAK is implicated in ERK and PI 3-kinase activation. In this work, we sought to determine the role of FAK in TSP1-induced focal adhesion disassembly. TSP1/hep I does not stimulate focal adhesion disassembly in FAK knockout fibroblasts, whereas re-expressing FAK rescues responsiveness. Inhibiting FAK signaling through FRNK or FAK Y397F expression in endothelial cells also abrogates this response. TSP1/hep I stimulates a transient increase in FAK phosphorylation that requires calreticulin and Galpha(i), but not ERK or PI 3-kinase. Hep I does not activate ERK or PI 3-kinase in FAK knockout fibroblasts, suggesting activation occurs downstream of FAK. TSP1/hep I stimulates RhoA inactivation with kinetics corresponding to focal adhesion disassembly in a FAK, ERK, and PI 3-kinase-dependent manner. Furthermore, hep I does not stimulate focal adhesion disassembly in cells expressing constitutively active RhoA, suggesting that RhoA inactivation is required for this response. This is the first work to illustrate a connection between FAK phosphorylation in response to a soluble factor and RhoA inactivation, as well as the first report of PI 3-kinase and ERK in FAK regulation of RhoA activity.	Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Cell Adhes & Matrix Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Murphy-Ullrich, JE (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, VH 668,1530 3rd Ave S, Birmingham, AL 35294 USA.	murphy@path.uab.edu	Orr, Anthony/P-8927-2015	Orr, Anthony/0000-0002-2377-213X	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044575, T32HL007918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063861] Funding Source: NIH RePORTER; NCRR NIH HHS [C06RR15490] Funding Source: Medline; NHLBI NIH HHS [T32 HL07918, HL44575] Funding Source: Medline; NIGMS NIH HHS [GM63861] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEDI H, 1995, J BIOL CHEM, V270, P11367, DOI 10.1074/jbc.270.19.11367; Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Allen WE, 1997, J CELL SCI, V110, P707; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Baron V, 1998, J BIOL CHEM, V273, P7162, DOI 10.1074/jbc.273.12.7162; Brunton VG, 2001, NEOPLASIA, V3, P215, DOI 10.1038/sj.neo.7900149; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; DwyerNield LD, 1996, AM J PHYSIOL-LUNG C, V270, pL526, DOI 10.1152/ajplung.1996.270.4.L526; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; FINCHAM VJ, 1995, ONCOGENE, V10, P2247; Gahtan V, 1999, J VASC SURG, V29, P1031, DOI 10.1016/S0741-5214(99)70244-2; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Greenwood JA, 1998, J BIOL CHEM, V273, P1755, DOI 10.1074/jbc.273.3.1755; Greenwood JA, 1998, MICROSC RES TECHNIQ, V43, P420, DOI 10.1002/(SICI)1097-0029(19981201)43:5<420::AID-JEMT8>3.0.CO;2-B; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hauck CR, 2000, J BIOL CHEM, V275, P41092, DOI 10.1074/jbc.M005450200; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; ILIC D, 1995, BIOCHEM BIOPH RES CO, V209, P300, DOI 10.1006/bbrc.1995.1503; ILLC D, 1995, NATURE, V377, P539; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Lymn JS, 1999, ARTERIOSCL THROM VAS, V19, P2133, DOI 10.1161/01.ATV.19.9.2133; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; MURPHYULLRICH JE, 1993, J BIOL CHEM, V268, P26784; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Orr AW, 2004, FRONT BIOSCI-LANDMRK, V9, P1254, DOI 10.2741/1239; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Orr AW, 2002, J BIOL CHEM, V277, P20453, DOI 10.1074/jbc.M112091200; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pawlak G, 2002, J BIOL CHEM, V277, P26927, DOI 10.1074/jbc.M202261200; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; RANKIN S, 1994, J BIOL CHEM, V269, P704; Rankin S, 1996, J BIOL CHEM, V271, P7829, DOI 10.1074/jbc.271.13.7829; Ren XD, 2000, J CELL SCI, V113, P3673; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rodriguez-Fernandez JL, 1999, BIOESSAYS, V21, P1069, DOI 10.1002/(SICI)1521-1878(199912)22:1<1069::AID-BIES13>3.0.CO;2-C; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Taylor JM, 1999, J CELL SCI, V112, P231; TRANQUI L, 1995, EXP CELL RES, V217, P149, DOI 10.1006/excr.1995.1074; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; ZACHARY I, 1992, J BIOL CHEM, V267, P19031; Zamir E, 2001, J CELL SCI, V114, P3583	73	56	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48983	48992		10.1074/jbc.M404881200	http://dx.doi.org/10.1074/jbc.M404881200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371459	hybrid			2022-12-27	WOS:000225098100061
J	Sanjay, KS; Singh, SK; Gurha, P; Tran, EJ; Maxwell, ES; Gupta, R				Sanjay, KS; Singh, SK; Gurha, P; Tran, EJ; Maxwell, ES; Gupta, R			Sequential 2 '-O-methylation of archaeal pre-tRNA(Trp) nucleotides is guided by the intron-encoded but trans-acting box c/D ribonucleoprotein of pre-tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNAS; HALOBACTERIUM-VOLCANII; RIBOSE METHYLATION; SNORNP; PROTEIN; IDENTIFICATION; TRANSCRIPTION; PRECURSOR; HOMOLOGS	Haloferax volcanii pre-tRNA(Trp) processing requires box C/D ribonucleoprotein (RNP)-guided 2'-O-methylation of nucleotides C34 and U39 followed by intron excision. Positioning of the box C/D guide RNA within the intron of this pre-tRNA led to the assumption that nucleotide methylation is guided by the cis-positioned box C/D RNPs. We have now investigated the mechanism of 2'-O-methylation for the H. volcanii pre-tRNA(Trp) in vitro by assembling methylation-competent box C/D RNPs on both the pre-tRNA and the excised intron ( both linear and circular forms) using Methanocaldococcus jannaschii box C/D RNP core proteins. With both kinetic studies and single nucleotide substitutions of target and guide nucleotides, we now demonstrate that pre-tRNA methylation is guided in trans by the intron-encoded box C/D RNPs positioned in either another pre-tRNA(Trp) or in the excised intron. Methylation by in vitro assembled RNPs prefers but does not absolutely require Watson-Crick pairing between the guide and target nucleotides. We also demonstrate for the first time that methylation of two nucleotides guided by a single box C/D RNA is sequential, that is, box C'/D' RNP-guided U39 methylation first requires box C/D RNP-guided methylation of C34. Methylation of the two nucleotides of exogenous pre-tRNA(Trp) added to an H. volcanii cell extract also occurs sequentially and is also accomplished in trans using RNPs that pre-exist in the extract. Thus, this trans mechanism is analogous to eukaryal pre-rRNA 2'-O-methylation guided by intron-encoded but trans-acting box C/D small nucleolar RNPs. This trans mechanism could explain the observed accumulation of the excised H. volcanii pre-tRNA(Trp) intron in vivo. A trans mechanism would also eliminate the obligatory refolding of the pre-tRNA that would be required to carry out two cis-methylation reactions before pre-tRNA splicing.	So Illinois Univ, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA; N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	Southern Illinois University System; Southern Illinois University; University of North Carolina; North Carolina State University	Gupta, R (corresponding author), So Illinois Univ, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	rgupta@siumed.edu	Tran, Elizabeth/G-7818-2018	Tran, Elizabeth/0000-0002-9541-004X; Gurha, Priyatansh/0000-0003-4867-7785	NIGMS NIH HHS [GM55945] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Bortolin ML, 2003, NUCLEIC ACIDS RES, V31, P6524, DOI 10.1093/nar/gkg860; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576; d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518; DANIELS CJ, 1985, J BIOL CHEM, V260, P3132; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Dennis PP, 2001, MOL MICROBIOL, V40, P509, DOI 10.1046/j.1365-2958.2001.02381.x; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; GUPTA R, 1984, J BIOL CHEM, V259, P9461; King TH, 2001, MOL CELL BIOL, V21, P7731, DOI 10.1128/MCB.21.22.7731-7746.2001; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Maden BEH, 2001, METHODS, V25, P374, DOI 10.1006/meth.2001.1250; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Omer AD, 2003, MOL MICROBIOL, V48, P617, DOI 10.1046/j.1365-2958.2003.03483.x; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Salgia SR, 2003, RNA, V9, P319, DOI 10.1261/rna.2118203; Szewczak LBW, 2002, CHEM BIOL, V9, P1095, DOI 10.1016/S1074-5521(02)00239-9; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Terns MP, 2002, GENE EXPRESSION, V10, P17; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	28	51	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47661	47671		10.1074/jbc.M408868200	http://dx.doi.org/10.1074/jbc.M408868200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347671	hybrid			2022-12-27	WOS:000224957000031
J	Saoncella, S; Calautti, E; Neveu, W; Goetinck, PF				Saoncella, S; Calautti, E; Neveu, W; Goetinck, PF			Syndecan-4 regulates ATF-2 transcriptional activity in a Rac1-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASES; GENE-EXPRESSION; RHO-GTPASES; RAC; TRANSDUCTION; INTEGRINS; BINDING; JUN; PATHWAYS	Syndecan-4 is a transmembrane heparan sulfate proteoglycan that co-operates with integrins during cell-matrix interactions for the assembly of focal adhesions and actin stress fibers and in the phosphorylation of focal adhesion kinase (FAK) on Tyr(397). These cellular events are regulated by the small GTPase Rho, and in the absence of syndecan-4 ligation, cellular levels of GTP-bound Rho are decreased implicating syndecan-4 in the regulation of the small GTPases. In the present study we report that, compared with wild type cells, fibronectin-adherent syndecan-4-null fibroblasts showed enhanced lamellipodia and increased Rac1 activity that could be down-regulated by re-expression of syndecan-4 in the mutant cells. Consistent with the role for Rac1 in activating p38 and JNK signaling, syndecan-4-null cells display higher levels of active p38 MAPK and JNK that were abolished by the expression of a dominant-negative RacN17 mutant. Since p38 and JNK regulate gene expression by phosphorylating and activating transcription factors, we compared both the phosphorylation state and the transcriptional activity of the ATF-2 transcription factor, as a direct p38 and JNK target in syndecan-4-null and wild type cells. In the absence of syndecan-4, both ATF-2 phosphorylation and transcriptional activity were significantly more elevated compared with wild type cells, and both activities were decreased either by the re-expression of syndecan-4 or by the expression of RacN17. Our results reveal a novel function for syndecan-4 in modulating nuclear transcriptional activity and indicate an underlying mechanism that acts at the level of Rac1-p38/JNK signaling.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Goetinck, PF (corresponding author), MGH E, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	paul.goetinck@cbrc2.mgh.harvard.edu	Calautti, Enzo/M-8283-2018	Calautti, Enzo/0000-0002-4439-9709	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037490] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-37490] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Igishi T, 1999, J BIOL CHEM, V274, P30738, DOI 10.1074/jbc.274.43.30738; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; Ishiguro K, 2001, LAB INVEST, V81, P509, DOI 10.1038/labinvest.3780259; Kim J, 2001, BIOCHEM J, V360, P239, DOI 10.1042/0264-6021:3600239; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Li L, 2002, ARTERIOSCL THROM VAS, V22, P61, DOI 10.1161/hq0102.100314; LI L, 2002, J VASC SURG, V36, P1; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwartz MA, 2001, J CELL SCI, V114, P2553; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Wilcox-Adelman SA, 2002, GLYCOCONJUGATE J, V19, P305, DOI 10.1023/A:1025304602057; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Zhang YF, 1999, J BIOL CHEM, V274, P14786, DOI 10.1074/jbc.274.21.14786	36	29	29	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					47172	47176		10.1074/jbc.C400299200	http://dx.doi.org/10.1074/jbc.C400299200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15371457	hybrid			2022-12-27	WOS:000224832400104
J	Andrews, SR; Taylor, EJ; Pell, G; Vincent, F; Ducros, VMA; Davies, GJ; Lakey, JH; Gilbert, HJ				Andrews, SR; Taylor, EJ; Pell, G; Vincent, F; Ducros, VMA; Davies, GJ; Lakey, JH; Gilbert, HJ			The use of forced protein evolution to investigate and improve stability of family 10 xylanases - The production of Ca2+-independent stable xylanases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-FLUORESCENS; ALPHA-AMYLASE; THERMOSTABILITY; CALCIUM; BINDING; IDENTIFICATION; DELETION; DOMAINS; ENZYMES	Metal ions such as calcium often play a key role in protein thermostability. The inclusion of metal ions in industrial processes is, however, problematic. Thus, the evolution of enzymes that display enhanced stability, which is not reliant on divalent metals, is an important biotechnological goal. Here we have used forced protein evolution to interrogate whether the stabilizing effect of calcium in an industrially relevant enzyme can be replaced with amino acid substitutions. Our study has focused on the GH10 xylanase CjXyn10A from Cellvibrio japonicus, which contains an extended calcium binding loop that confers proteinase resistance and thermostability. Three rounds of error-prone PCR and selection identified a treble mutant, D262N/A80T/R347C, which in the absence of calcium is more thermostable than wild type CjXyn10A bound to the divalent metal. D262N influences the properties of the calcium binding site, A80T fills a cavity in the enzyme, increasing the number of hydrogen bonds and van der Waals interactions, and the R347C mutation introduces a disulfide bond that decreases the free energy of the unfolded enzyme. A derivative of CjXyn10A (CfCjXyn10A) in which the calcium binding loop has been replaced with a much shorter loop from Cellulomonas fimi CfXyn10A was also subjected to forced protein evolution to select for thermostablizing mutations. Two amino acid substitutions within the introduced loop and the A80T mutation increased the thermostability of the enzyme. This study demonstrates how forced protein evolution can be used to introduce enhanced stability into industrially relevant enzymes while removing calcium as a major stability determinant.	Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of York - UK; Newcastle University - UK	Gilbert, HJ (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	h.j.gilbert@ncl.ac.uk	Davies, Gideon J/A-9042-2011; Vincent, Florence/F-7137-2016	Davies, Gideon J/0000-0002-7343-776X; Taylor, Edward/0000-0003-4024-0976; vincent, Florence/0000-0002-8564-4184				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Declerck N, 2000, J MOL BIOL, V301, P1041, DOI 10.1006/jmbi.2000.4025; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emami K, 2002, J BACTERIOL, V184, P4124, DOI 10.1128/JB.184.15.4124-4133.2002; FERREIRA LMA, 1990, BIOCHEM J, V269, P261, DOI 10.1042/bj2690261; FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151; FONTES CMGA, 1995, APPL MICROBIOL BIOT, V43, P52, DOI 10.1007/BF00170622; Fontes CMGA, 2000, MICROBIOL-SGM, V146, P1959, DOI 10.1099/00221287-146-8-1959; Fuxreiter M, 1997, PROTEINS, V28, P183, DOI 10.1002/(SICI)1097-0134(199706)28:2<183::AID-PROT7>3.0.CO;2-G; Georis J, 2000, PROTEIN SCI, V9, P466; GREPINET O, 1988, J BACTERIOL, V170, P4582, DOI 10.1128/jb.170.10.4582-4588.1988; GREPINET O, 1988, J BACTERIOL, V170, P4576, DOI 10.1128/jb.170.10.4576-4581.1988; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; HALL J, 1993, BIO-TECHNOL, V11, P376, DOI 10.1038/nbt0393-376; HARRIS GW, 1994, STRUCTURE, V2, P1107, DOI 10.1016/S0969-2126(94)00112-X; Igarashi K, 1998, BIOCHEM BIOPH RES CO, V248, P372, DOI 10.1006/bbrc.1998.8970; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemeth A, 2002, BIOPHYS CHEM, V96, P229, DOI 10.1016/S0301-4622(02)00027-3; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1988, J BIOL CHEM, V263, P11820; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; PICKERSGILL RW, 1993, J MOL BIOL, V229, P246, DOI 10.1006/jmbi.1993.1023; Savchenko A, 2002, BIOCHEMISTRY-US, V41, P6193, DOI 10.1021/bi012106s; Silversides FG, 1999, POULTRY SCI, V78, P1184, DOI 10.1093/ps/78.8.1184; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Spurway TD, 1997, J BIOL CHEM, V272, P17523, DOI 10.1074/jbc.272.28.17523; Ueda KI, 1952, J AGR CHEM SOC JAPAN, V26, P35, DOI DOI 10.1271/NOGEIKAGAKU1924.26.35; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	33	41	42	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2004	279	52					54369	54379		10.1074/jbc.M409044200	http://dx.doi.org/10.1074/jbc.M409044200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	880MJ	15452124	hybrid			2022-12-27	WOS:000225793600059
J	Tardy, C; Autefage, H; Garcia, V; Levade, T; Andrieu-Abadie, N				Tardy, C; Autefage, H; Garcia, V; Levade, T; Andrieu-Abadie, N			Mannose 6-phosphorylated proteins are required for tumor necrosis factor-induced apoptosis - Defective response in I-cell disease fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL STORAGE DISEASES; NEURONAL CEROID-LIPOFUSCINOSIS; MEDIATED HEPATOCYTE APOPTOSIS; TRIPEPTIDYL PEPTIDASE-II; CYTOCHROME-C RELEASE; CATHEPSIN-D; 6-PHOSPHATE RECEPTORS; MICE DEFICIENT; TNF-ALPHA; ACID SPHINGOMYELINASE	Whereas caspases are essential components in apoptosis, other proteases seem to be involved in programmed cell death. This study investigated the role of lysosomal mannose 6-phosphorylated proteins in tumor necrosis factor (TNF)-induced apoptosis. We report that fibroblasts isolated from patients affected with inclusion-cell disease (ICD), having a deficient activity of almost all lysosomal hydrolases, are resistant to the toxic effect of TNF. These mutant cells exhibited a defect in TNF-induced caspase activation, Bid cleavage, and release of cytochrome c. In contrast, TNF-induced p42/p44 MAPK activation and CD54 expression remained unaltered. Human ICD lymphoblasts and fibroblasts derived from mice nullizygous for Igf2 and the two mannose 6-phosphate (M6P) receptors, Mpr300 and Mpr46, which develop an ICD-like phenotype, were also resistant to CD95 ligand and TNF, respectively. Moreover, correction of the lysosomal enzyme defect of ICD fibroblasts, using a medium enriched in M6P-containing proteins, enabled restoration of sensitivity to TNF. This effect was blocked by exogenous M6P but not by cathepsin B or L inhibitors. Altogether, these findings suggest that some M6P-bearing glycoproteins modulate the susceptibility to TNF-induced apoptosis. As a matter of fact, exogenous tripeptidyl peptidase 1, a lysosomal carboxypeptidase, could sensitize ICD fibroblasts to TNF. These observations highlight the hitherto unrecognized role of some mannose 6-phosphorylated proteins such as tripeptidyl peptidase 1 in the apoptotic cascade triggered by TNF.	Ctr Hosp Univ Rangueil, INSERM, U466, F-31059 Toulouse 9, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Andrieu-Abadie, N (corresponding author), Ctr Hosp Univ Rangueil, INSERM, U466, 1 Ave Jean Poulhes,TSA 50032, F-31059 Toulouse 9, France.	nandrieu@toulouse.inserm.fr	Levade, Thierry/O-8948-2014; Andrieu-Abadie, Nathalie/N-6793-2013; Tardy, Claudine/G-2737-2017; GARCIA, Virginie/W-8313-2019; Tardy, Claudine/AAE-5026-2019	Andrieu-Abadie, Nathalie/0000-0003-2698-1970; GARCIA, Virginie/0000-0002-9761-7036; Tardy, Claudine/0000-0002-5292-0672				Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Beyaert R, 2002, INT REV CYTOL, V214, P225; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Bosshard NU, 1996, VET PATHOL, V33, P1, DOI 10.1177/030098589603300101; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Chatelut M, 1997, CLIN CHIM ACTA, V262, P61, DOI 10.1016/S0009-8981(97)06527-3; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cho SG, 2000, J NEUROCHEM, V74, P1478, DOI 10.1046/j.1471-4159.2000.0741478.x; Cho SG, 2000, J NEUROSCI RES, V62, P234, DOI 10.1002/1097-4547(20001015)62:2<234::AID-JNR8>3.0.CO;2-8; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Czaja MJ, 2001, HEPATOLOGY, V34, P844, DOI 10.1053/jhep.2001.0340844; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Dempsey PW, 2003, CYTOKINE GROWTH F R, V14, P193, DOI 10.1016/S1359-6101(03)00021-2; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Dittmer F, 1998, TRANSGENIC RES, V7, P473, DOI 10.1023/A:1008823315416; Dittmer F, 1999, J CELL SCI, V112, P1591; Dressel R, 2004, J BIOL CHEM, V279, P20200, DOI 10.1074/jbc.M313108200; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Golabek AA, 2003, J BIOL CHEM, V278, P7135, DOI 10.1074/jbc.M211872200; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guicciardi ME, 2001, AM J PATHOL, V159, P2045, DOI 10.1016/S0002-9440(10)63056-8; HASILIK A, 1981, BIOCHEM BIOPH RES CO, V98, P761, DOI 10.1016/0006-291X(81)91177-3; Heinrich M, 1999, EMBO J, V18, P5252, DOI 10.1093/emboj/18.19.5252; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hilbi H, 2000, INFECT IMMUN, V68, P5502, DOI 10.1128/IAI.68.10.5502-5508.2000; Hishita T, 2001, CANCER RES, V61, P2878; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Johnson DE, 2000, LEUKEMIA, V14, P1695, DOI 10.1038/sj.leu.2401879; Jones B, 1998, AM J PHYSIOL-GASTR L, V275, pG723, DOI 10.1152/ajpgi.1998.275.4.G723; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; KAPLAN A, 1977, J CLIN INVEST, V60, P1088, DOI 10.1172/JCI108860; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Lane SC, 1996, J NEUROCHEM, V67, P677; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Lin L, 2001, J BIOL CHEM, V276, P2249, DOI 10.1074/jbc.M008562200; Lin L, 2001, BIOCHEM J, V357, P49, DOI 10.1042/0264-6021:3570049; LITTLE L, 1987, BIOCHEM J, V248, P151, DOI 10.1042/bj2480151; MA ZM, 1991, J BIOL CHEM, V266, P10589; MALAGARIECAZENA.S, 2002, EXPERT REV MOL MED, P1; Michallet MC, 2004, J IMMUNOL, V172, P5405, DOI 10.4049/jimmunol.172.9.5405; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nakanishi H, 2001, J NEUROSCI, V21, P7526, DOI 10.1523/JNEUROSCI.21-19-07526.2001; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Neuzil J, 2002, BIOCHEM J, V362, P709, DOI 10.1042/0264-6021:3620709; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; Roberg K, 1999, FREE RADICAL BIO MED, V27, P1228, DOI 10.1016/S0891-5849(99)00146-X; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Salvesen GS, 2001, J CLIN INVEST, V107, P21, DOI 10.1172/JCI11829; Segui B, 2001, J CLIN INVEST, V108, P143, DOI 10.1172/JCI200111498; Shimizu M, 1999, J IMMUNOL, V162, P7350; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Stefanis DD, 2002, BIOL CHEM, V383, P989, DOI 10.1515/BC.2002.106; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Tardy C, 2003, CELL DEATH DIFFER, V10, P1090, DOI 10.1038/sj.cdd.4401272; Tardy C, 2004, NEUROCHEM RES, V29, P871, DOI 10.1023/B:NERE.0000021232.05175.38; TOMKINSON B, 1987, P NATL ACAD SCI USA, V84, P7508, DOI 10.1073/pnas.84.21.7508; Tyynela J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786; Vancompernolle K, 1998, FEBS LETT, V438, P150, DOI 10.1016/S0014-5793(98)01275-7; Vigneswaran N, 2003, ORAL ONCOL, V39, P559, DOI 10.1016/S1368-8375(03)00038-1; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Vines DJ, 1999, FEBS LETT, V443, P131, DOI 10.1016/S0014-5793(98)01683-4; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; WIESMANN U, 1971, NEW ENGL J MED, V285, P1090; Winchester B, 2000, BIOCHEM SOC T, V28, P150, DOI 10.1042/bst0280150; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Yuan XM, 2002, P NATL ACAD SCI USA, V99, P6286, DOI 10.1073/pnas.092135599; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x	80	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					52914	52923		10.1074/jbc.M408261200	http://dx.doi.org/10.1074/jbc.M408261200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15452110	hybrid			2022-12-27	WOS:000225680600015
J	Morgan, HD; Dean, W; Coker, HA; Reik, W; Petersen-Mahrt, SK				Morgan, HD; Dean, W; Coker, HA; Reik, W; Petersen-Mahrt, SK			Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues - Implications for epigenetic reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; PRIMORDIAL GERM-CELLS; RNA EDITING ENZYME; SOMATIC HYPERMUTATION; MAMMALIAN DEVELOPMENT; ANTIBODY DIVERSIFICATION; GLYCOSYLASE ACTIVITY; PATERNAL GENOME; GENE-EXPRESSION	DNA deaminases of the Aid/Apobec family convert cytosine into uracil and play key roles in acquired and innate immunity. The epigenetic modification by methylation of cytosine in CpG dinucleotides is also mutagenic, but this is thought to occur by spontaneous deamination. Here we show that Aid and Apobec1 are 5-methylcytosine deaminases resulting in a thymine base opposite a guanine. Their action can thus lead to C --> T transition mutations in methylated DNA, or in conjunction with repair of the T:G mismatch, to demethylation. The Aid and Apobec1 genes are located in a cluster of pluripotency genes including Nanog and Stella and are co-expressed with these genes in oocytes, embryonic germ cells, and embryonic stem cells. These results suggest that Aid and perhaps some of its family members may have roles in epigenetic reprogramming and cell plasticity. Transition in CpG dinucleotides is the most frequent mutation in human genetic diseases, and sequence context analysis of CpG transitions in the APC tumor suppressor gene suggests that DNA deaminases may play a significant role in tumor etiology.	Babraham Inst, Lab Dev Genet & Imprinting, Dev Genet Programme, Cambridge CB2 4AT, England; Imperial Canc Res Fund, Clare Hall Labs, DNA Editing Lab, S Mimms EN6 3LD, Herts, England; MRC, Mol Biol Lab, Prot & Nucl Acid Chem Div, Cambridge CB2 2QH, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC Laboratory Molecular Biology	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Dev Genet Programme, Cambridge CB2 4AT, England.	wolf.reik@bbsrc.ac.uk	Reik, Wolf/I-6794-2012	Dean, Wendy/0000-0001-9441-5044; Reik, Wolf/0000-0003-0216-9881; Coker, Heather/0000-0001-9570-944X				Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Cedar H, 1999, NATURE, V397, P568, DOI 10.1038/17492; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; COHEN SS, 1957, J BIOL CHEM, V226, P631; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hardeland U, 2003, NUCLEIC ACIDS RES, V31, P2261, DOI 10.1093/nar/gkg344; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee J, 2002, DEVELOPMENT, V129, P1807; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; LINDAHL T, 1976, NATURE, V259, P64, DOI 10.1038/259064a0; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petersen-Mahrt SK, 2003, J BIOL CHEM, V278, P19583, DOI 10.1074/jbc.C300114200; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yu KF, 2004, J BIOL CHEM, V279, P6496, DOI 10.1074/jbc.M311616200; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	55	397	440	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52353	52360		10.1074/jbc.M407695200	http://dx.doi.org/10.1074/jbc.M407695200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448152	hybrid			2022-12-27	WOS:000225493400078
J	Stewart, AK; Kerr, N; Chernova, MN; Alper, SL; Vaughan-Jones, RD				Stewart, AK; Kerr, N; Chernova, MN; Alper, SL; Vaughan-Jones, RD			Acute pH-dependent regulation of AE2-mediated anion exchange involves discrete local surfaces of the NH2-terminal cytoplasmic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE-MEMBRANE BAND-3; CARBONIC-ANHYDRASE-II; INTRACELLULAR PH; HISTIDINE-RESIDUES; EXTRACELLULAR PH; GENE FAMILY; CELL-LINE; AE2; TRANSPORT; CHLORIDE	We have previously defined in the NH2-terminal cytoplasmic domain of the mouse AE2/SLC4A2 anion exchanger a critical role for the highly conserved amino acids (aa) 336-347 in determining wild-type pH sensitivity of anion transport. We have now engineered hexa-Ala ((A)(6)) and individual amino acid substitutions to investigate the importance to pH-dependent regulation of AE2 activity of the larger surrounding region of aa 312-578. 4,4'-Diisothiocyanostilbene-2,2'-disulfonic acid (DIDS)-sensitive Cl-36(-) efflux from AE2-expressing Xenopus oocytes was monitored during changes in pH(i) or pH(o) in HEPES-buffered and in 5% CO2/HCO3--buffered conditions. Wild-type AE2-mediated Cl-36(-) efflux was profoundly inhibited at low pH(o), with a pH(o(50)) value = 6.75 +/- 0.05 and was stimulated up to 10-fold by intracellular alkalinization. Individual mutation of several amino acid residues at non-contiguous sites preceding or following the conserved sequence aa 336-347 attenuated pHi and/or pHo sensitivity of Cl-36(-) efflux. The largest attenuation of pH sensitivity occurred with the AE2 mutant (A)(6)357-362. This effect was phenocopied by AE2 H360E, suggesting a crucial role for His(360). Homology modeling of the three-dimensional structure of the AE2 NH2-terminal cytoplasmic domain (based on the structure of the corresponding region of human AE1) predicts that those residues shown by mutagenesis to be functionally important define at least one localized surface region necessary for regulation of AE2 activity by pH.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Mol & Vasc Med Unit, Boston, MA 02215 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Renal Unit, Boston, MA 02215 USA; Univ Oxford, Physiol Lab, Burdon Sanderson Cardiac Sci Ctr, Oxford OX1 3PT, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Oxford	Alper, SL (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Mol & Vasc Med Unit, RW763 E Campus,330 Brookline Ave, Boston, MA 02215 USA.	salper@caregroup.harvard.edu			PHS HHS [34854, 43495] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alper SL, 2002, J NEPHROL, V15, pS41; ALPER SL, 1994, CELL PHYSIOL BIOCHEM, V4, P265, DOI 10.1159/000154730; Bevensee M. O., 2000, KIDNEY PHYSL PATHOPH, P391; Ch'en FFT, 2003, J PHYSIOL-LONDON, V552, P715, DOI 10.1113/jphysiol.2003.051888; Cha B, 2003, J MEMBRANE BIOL, V191, P49, DOI 10.1007/s00232-002-1044-2; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Chernova MN, 1997, BBA-BIOMEMBRANES, V1329, P111, DOI 10.1016/S0005-2736(97)00090-4; Chernova MN, 2003, AM J PHYSIOL-CELL PH, V284, pC1235, DOI 10.1152/ajpcell.00522.2002; Chow CW, 1999, J BIOL CHEM, V274, P10481, DOI 10.1074/jbc.274.15.10481; Flagg TP, 2002, J PHYSIOL-LONDON, V544, P351, DOI 10.1113/jphysiol.2002.027581; FUNDER J, 1976, J PHYSIOL-LONDON, V262, P679, DOI 10.1113/jphysiol.1976.sp011615; Gowen JA, 2002, BIOPHYS J, V83, P880, DOI 10.1016/S0006-3495(02)75215-6; GRINSTEIN S, 1978, BIOCHIM BIOPHYS ACTA, V507, P294, DOI 10.1016/0005-2736(78)90424-8; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; Jennings ML, 1992, KIDNEY PHYSL PATHOPH, P113; JIANG LW, 1994, AM J PHYSIOL, V267, pC845, DOI 10.1152/ajpcell.1994.267.3.C845; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; LEE BS, 1991, J BIOL CHEM, V266, P11448; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Morton MJ, 2003, PFLUG ARCH EUR J PHY, V445, P577, DOI 10.1007/s00424-002-0901-2; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; REINERTSEN KV, 1988, J BIOL CHEM, V263, P11117; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 2003, J AM SOC NEPHROL, V14, p304A; Stewart AK, 2002, J GEN PHYSIOL, V120, P707, DOI 10.1085/jgp.20028641; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; VAUGHANJONES RD, 1979, J PHYSIOL-LONDON, V295, P111, DOI 10.1113/jphysiol.1979.sp012957; VAUGHANJONES RD, 1986, J PHYSIOL-LONDON, V379, P377, DOI 10.1113/jphysiol.1986.sp016259; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Weeks DL, 2004, J BIOL CHEM, V279, P9944, DOI 10.1074/jbc.M312680200; Zhang DC, 2000, BLOOD, V96, P2925; Zhang Y, 1996, J BIOL CHEM, V271, P5741, DOI 10.1074/jbc.271.10.5741	37	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52664	52676		10.1074/jbc.M408108200	http://dx.doi.org/10.1074/jbc.M408108200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452108	hybrid			2022-12-27	WOS:000225493400113
J	Kao, WC; Chen, YR; Yi, EC; Lee, H; Tian, Q; Wu, KM; Tsai, SF; Yu, SSF; Chen, YJ; Aebersold, R; Chan, SI				Kao, WC; Chen, YR; Yi, EC; Lee, H; Tian, Q; Wu, KM; Tsai, SF; Yu, SSF; Chen, YJ; Aebersold, R; Chan, SI			Quantitative proteomic analysis of metabolic regulation by copper ions in Methylococcus capsulatus (Bath)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICULATE METHANE MONOOXYGENASE; METHYLOBACTERIUM-EXTORQUENS AM1; TANDEM MASS-SPECTROMETRY; METHANOTROPHIC BACTERIA; NUCLEOTIDE-SEQUENCE; STATISTICAL-MODEL; PROTEIN DATABASE; GENERATION; CLONING; SEARCH	Copper ions switch the oxidation of methane by soluble methane monooxygenase to particulate methane monooxygenase in Methylococcus capsulatus ( Bath). Toward understanding the change in cellular metabolism related to this transcriptional and metabolic switch, we have undertaken genomic sequencing and quantitative comparative analysis of the proteome in M. capsulatus ( Bath) grown under different copper-to-biomass ratios by cleavable isotope-coded affinity tag technology. Of the 682 proteins identified, the expressions of 60 proteins were stimulated by at least 2-fold by copper ions; 68 proteins were down-regulated by 2-fold or more. The 60 proteins overexpressed included the methane and carbohydrate metabolic enzymes, while the 68 proteins suppressed were mainly responsible for cellular signaling processes, indicating a role of copper ions in the expression of the genes associated with the metabolism of the organism downstream of methane oxidation. The study has also provided a complete	Acad Sinica, Inst Chem, Taipei 115, Taiwan; Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan; Inst Syst Biol, Seattle, WA 98103 USA; Natl Yang Ming Univ, Inst Genet & Genome Res Ctr, Taipei 112, Taiwan; Natl Hlth Res Inst, Div Mol & Genom Med, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Institute for Systems Biology (ISB); National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Chan, SI (corresponding author), Acad Sinica, Inst Chem, 128 Academia Rd,Sect 2, Taipei 115, Taiwan.	chans@chem.sinica.edu.tw	Chen, Yu-Ju/E-9481-2015; Tsai, Shih-Feng/E-3997-2010; Chan, Sunney I/F-2017-2015; Yu, Steve Sheng-Fa/E-4866-2015; Kao, Wei-Chun/AAJ-4068-2020	Chen, Yu-Ju/0000-0002-3178-6697; Yu, Steve Sheng-Fa/0000-0002-3462-065X; Kao, Wei-Chun/0000-0001-8687-6334; Lee, Hookeun/0000-0002-0696-8421				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON DJ, 1990, GENE, V90, P173, DOI 10.1016/0378-1119(90)90457-3; ANTHONY C, 1982, BIOCH METHYLOTROPHS, P296; Baxter NJ, 2002, ARCH MICROBIOL, V177, P279, DOI 10.1007/s00203-001-0387-x; Chan SI, 2004, BIOCHEMISTRY-US, V43, P4421, DOI 10.1021/bi0497603; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Cooper G, 2001, NATURE, V414, P879, DOI 10.1038/414879a; Csaki R, 2003, MICROBIOL-SGM, V149, P1785, DOI 10.1099/mic.0.26061-0; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kerr RA, 2004, SCIENCE, V303, P1953, DOI 10.1126/science.303.5666.1953; Li JX, 2003, MOL CELL PROTEOMICS, V2, P1198, DOI 10.1074/mcp.M300070-MCP200; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; MARK AS, 2001, NATURE, V414, P857; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Pomper BK, 2002, FEBS LETT, V523, P133, DOI 10.1016/S0014-5793(02)02962-9; QUAYLE JR, 1978, MICROBIOL REV, V42, P251, DOI 10.1128/MMBR.42.2.251-273.1978; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Stolyar S, 1999, MICROBIOL-UK, V145, P1235, DOI 10.1099/13500872-145-5-1235; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; TAKAGI M, 1990, J BACTERIOL, V172, P411, DOI 10.1128/JB.172.1.411-418.1990; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TROTSENKO YA, 2001, MIKROBIOLOGIYA, V70, P725; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Whittington DA, 2001, J AM CHEM SOC, V123, P827, DOI 10.1021/ja003240n; Xiong JJ, 2000, BIOCHEMISTRY-US, V39, P5117, DOI 10.1021/bi992796o; YI EC, 2004, CURRENT PROTOCOL PRO; Yu SSF, 2003, J BACTERIOL, V185, P5915, DOI 10.1128/JB.185.20.5915-5924.2003	36	70	79	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51554	51560		10.1074/jbc.M408013200	http://dx.doi.org/10.1074/jbc.M408013200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385566	hybrid, Green Published			2022-12-27	WOS:000225355800110
J	Sundberg, C; Thodeti, CK; Kveiborg, M; Larsson, C; Parker, P; Albrechtsen, R; Wewer, UM				Sundberg, C; Thodeti, CK; Kveiborg, M; Larsson, C; Parker, P; Albrechtsen, R; Wewer, UM			Regulation of ADAM12 cell-surface expression by protein kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; METALLOPROTEASE DISINTEGRIN ADAM12; AMYLOID PRECURSOR PROTEIN; CYSTEINE-RICH DOMAIN; MELTRIN-ALPHA; PKC-EPSILON; CONVERTING-ENZYME; GROWTH-FACTOR; SECRETASE CLEAVAGE; MYOBLAST FUSION	The ADAM ( a disintegrin and metalloprotease) family consists of multidomain cell-surface proteins that have a major impact on cell behavior. These transmembrane-anchored proteins are synthesized as proforms that have ( from the N terminus): a prodomain; a metalloprotease, disintegrin-like-, cysteine-rich, epidermal growth factor-like, and transmembrane domain; and a cytoplasmic tail. The 90-kDa mature form of human ADAM12 is generated in the trans-Golgi through cleavage of the prodomain by a furin-peptidase and is stored intracellularly until translocation to the cell surface as a constitutively active protein. However, little is known about the regulation of ADAM12 cell-surface translocation. Here, we used human RD rhabdomyosarcoma cells, which express ADAM12 at the cell surface, in a temporal pattern. We report that protein kinase C ( PKC) epsilon induces ADAM12 translocation to the cell surface and that catalytic activity of PKCepsilon is required for this translocation. The following results support this conclusion: 1) treatment of cells with 0.1 muM phorbol 12-myristate 13-acetate (PMA) enhanced ADAM12 cell-surface immunostaining, 2) ADAM12 and PKCepsilon could be co-immunoprecipitated from membrane-enriched fractions of PMA-treated cells, 3) RD cells transfected with EGFP-tagged, myristoylated PKCepsilon expressed more ADAM12 at the cell surface than did non-transfected cells, and 4) RD cells transfected with a kinase-inactive PKCepsilon mutant did not exhibit ADAM12 cell-surface translocation upon PMA treatment. Finally, we demonstrate that the C1 and C2 domains of PKCepsilon both contain a binding site for ADAM12. These studies show that PKCepsilon plays a critical role in the regulation of ADAM12 cell-surface expression.	Univ Copenhagen, Inst Mol Pathol, DK-2100 Copenhagen, Denmark; Lund Univ, Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden; Canc Res UK London Res Inst, London WC2A 3PX, England	University of Copenhagen; Lund University; Skane University Hospital; Cancer Research UK	Wewer, UM (corresponding author), Univ Copenhagen, Inst Mol Pathol, Frederik Vs Vej 11, DK-2100 Copenhagen, Denmark.	ullaw@pai.ku.dk	Parker, Peter j/D-5192-2013; Kveiborg, Marie/AAM-3019-2020	Kveiborg, Marie/0000-0002-1293-1019; parker, peter/0000-0002-6218-2933; Albrechtsen, Reidar/0000-0003-4180-1827				Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Astolfi A, 2001, GENE, V274, P139, DOI 10.1016/S0378-1119(01)00619-9; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; Blobel CP, 2002, INFLAMM RES, V51, P83, DOI 10.1007/BF02684007; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cao Y, 2003, MOL CELL BIOL, V23, P6725, DOI 10.1128/MCB.23.19.6725-6738.2003; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Cao Y, 2001, BIOCHEM J, V357, P353, DOI 10.1042/0264-6021:3570353; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Ivaska J, 2003, BIOCHEM SOC T, V31, P90, DOI 10.1042/bst0310090; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kawaguchi N, 2002, AM J PATHOL, V160, P1895, DOI 10.1016/S0002-9440(10)61136-4; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Kronqvist P, 2002, AM J PATHOL, V161, P1535, DOI 10.1016/S0002-9440(10)64431-8; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; Laigaard J, 2003, PRENATAL DIAG, V23, P1086, DOI 10.1002/pd.762; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Ling M, 2004, EXP CELL RES, V292, P135, DOI 10.1016/j.yexcr.2003.08.013; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Moghadaszadeh B, 2003, HUM MOL GENET, V12, P2467, DOI 10.1093/hmg/ddg264; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Shimizu E, 2003, BIOCHEM BIOPH RES CO, V309, P779, DOI 10.1016/j.bbrc.2003.08.070; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Troller U, 2004, CELL SIGNAL, V16, P245, DOI 10.1016/S0898-6568(03)00135-9; Van Eerdewegh P, 2001, GENET EPIDEMIOL, V21, pS67; Weskamp G, 2002, MOL CELL BIOL, V22, P1537, DOI 10.1128/MCB.22.5.1537-1544.2002; WOLFSBERG TG, 1995, J CELL BIOL, V131, P275, DOI 10.1083/jcb.131.2.275; Wolfsberg TG, 1996, DEV BIOL, V180, P389, DOI 10.1006/dbio.1996.0313; Wu DQ, 2002, CANCER RES, V62, P2423; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713; Zeidman R, 2002, MOL BIOL CELL, V13, P12, DOI 10.1091/mbc.01-04-0210	56	54	56	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51601	51611		10.1074/jbc.M403753200	http://dx.doi.org/10.1074/jbc.M403753200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15364951	hybrid			2022-12-27	WOS:000225355800116
J	Yoshida, M; Aizawa, T; Nakamura, T; Shitara, K; Hayakawa, Y; Matsubara, K; Miura, K; Kouno, T; Clark, KD; Strand, MR; Mizuguchi, M; Demura, M; Nitta, K; Kawano, K				Yoshida, M; Aizawa, T; Nakamura, T; Shitara, K; Hayakawa, Y; Matsubara, K; Miura, K; Kouno, T; Clark, KD; Strand, MR; Mizuguchi, M; Demura, M; Nitta, K; Kawano, K			The Gly-Gly linker region of the insect cytokine growth-blocking peptide is essential for activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; NUCLEAR-MAGNETIC-RESONANCE; MODEL-FREE APPROACH; BIOLOGICAL-ACTIVITY; PARALYTIC PEPTIDES; HEMOLYMPH; RELAXATION; RESIDUES; NMR; MACROMOLECULES	Growth-blocking peptide (GBP) is a 25-amino acid cytokine isolated from the lepidopteran insect Pseudaletia separata. GBP exhibits various biological activities such as regulation of larval growth of insects, proliferation of a few kinds of cultured cells, and stimulation of a class of insect immune cells called plasmatocytes. The tertiary structure of GBP consists of a well structured core domain and disordered N and C termini. Our previous studies revealed that, in addition to the structured core, specific residues in the unstructured N-terminal region (Glu1 and Phe(3)) are also essential for the plasmatocyte-stimulating activity. In this study, a number of deletion, insertion, and site-directed mutants targeting the unstructured N-terminal residues of GBP were constructed to gain more detailed insight into the mode of interaction between the N-terminal region and GBP receptor. Alteration of the backbone length of the linker region between the core structure and N-terminal domain reduced plasmatocyte-stimulating activity. The substitutions of Gly(5) or Gly(6) in this linker region with more bulky residues, such as Phe and Pro, also remarkably reduced this activity. We conclude that the interaction of GBP with its receptor depends on the relative position of the N-terminal domain to the core structure, and therefore the backbone flexibility of Gly residues in the linker region is necessary for adoption of a proper conformation suited to receptor binding. Additionally, antagonistic experiments using deletion mutants confirmed that not only the core domain but also the N-terminal region of GBP are required for "receptor-binding," and furthermore Phe(3) is a binding determinant of the N-terminal domain.	Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Saga Univ, Dept Agr, Saga 8408502, Japan; Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University of Toyama; Hokkaido University; Saga University; University System of Georgia; University of Georgia	Kawano, K (corresponding author), Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan.	kawano@sci.hokudai.ac.jp	Kawano, Keiichi/F-5265-2011; Demura, Makoto/F-5272-2011; Clark, Kevin/GQA-9811-2022; Aizawa, Tomoyasu/F-5278-2011	Demura, Makoto/0000-0003-0912-9284; Aizawa, Tomoyasu/0000-0001-9134-7576				Aizawa T, 2001, J BIOL CHEM, V276, P31813, DOI 10.1074/jbc.M105251200; Aizawa T, 1999, J BIOL CHEM, V274, P1887, DOI 10.1074/jbc.274.4.1887; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 2001, J BIOL CHEM, V276, P37431, DOI 10.1074/jbc.M105235200; Clark KD, 2001, J BIOL CHEM, V276, P18491, DOI 10.1074/jbc.M100579200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Furuya K, 1999, PEPTIDES, V20, P53, DOI 10.1016/S0196-9781(98)00148-X; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Ha SD, 1999, PEPTIDES, V20, P561, DOI 10.1016/S0196-9781(99)00008-X; Hayakawa Y, 1998, BIOCHEM BIOPH RES CO, V250, P194, DOI 10.1006/bbrc.1998.8959; HAYAKAWA Y, 1995, J INSECT PHYSIOL, V41, P1, DOI 10.1016/0022-1910(94)00077-T; HAYAKAWA Y, 1990, J BIOL CHEM, V265, P10813; HAYAKAWA Y, 1991, J BIOL CHEM, V266, P7982; HAYAKAWA Y, 1994, J BIOCHEM-TOKYO, V115, P15, DOI 10.1093/oxfordjournals.jbchem.a124291; HAYAKAWA Y, 1993, INSECT BIOCHEM MOLEC, V23, P225, DOI 10.1016/0965-1748(93)90003-B; KAY LE, 1989, J MAGN RESON, V84, P72, DOI 10.1016/0022-2364(89)90006-1; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mine S, 1999, J MOL BIOL, V286, P1547, DOI 10.1006/jmbi.1999.2572; Ohnishi A, 2001, J BIOL CHEM, V276, P37974; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PARMER AG, 1991, J AM CHEM SOC, V133, P4371; PIATTO M, 1992, J BIOMOL NMR, V2, P661; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Seino Atsushi, 1998, Journal of Sericultural Science of Japan, V67, P473; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; SKINNER WS, 1993, COMP BIOCHEM PHYS C, V104, P133, DOI 10.1016/0742-8413(93)90124-4; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Tada M, 2003, J BIOL CHEM, V278, P10778, DOI 10.1074/jbc.M211251200	30	6	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51331	51337		10.1074/jbc.M409382200	http://dx.doi.org/10.1074/jbc.M409382200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385535	hybrid			2022-12-27	WOS:000225355800083
J	Zhu, CL; Saberwal, G; Lu, YF; Platanias, LC; Eklund, EA				Zhu, CL; Saberwal, G; Lu, YF; Platanias, LC; Eklund, EA			The interferon consensus sequence-binding protein activates transcription of the gene encoding Neurofibromin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GP91(PHOX) EXPRESSION; HEMATOPOIETIC-CELLS; REGULATORY FACTOR-1; MYELOID CELLS; NF1 GENE; MACROPHAGES; ICSBP; PU.1; GROWTH; DIFFERENTIATION	Deficiency of the interferon consensus sequence-binding protein (ICSBP) is associated with increased myeloid cell proliferation in response to hematopoietic cytokines. However, previously identified ICSBP target genes do not indicate a mechanism for this "cytokine hypersensitivity." In these studies, we identify the gene encoding neurofibromin 1 (Nf1) as an ICSBP target gene, by chromatin immunoprecipitation. Additionally, we find decreased Nf1 expression in bone marrow-derived myeloid cells from ICSBP-/- mice. Since Nf1 deficiency is also associated with cytokine hypersensitivity, our results suggested that NF1 is a functionally significant ICSBP target gene. Consistent with this, we find that the hypersensitivity of ICSBP -/- myeloid cells to granulocyte monocyte colony-stimulating factor (GM-CSF) is reversed by expression of the Nf1 GAP-related domain. We also find that treatment of ICSBP-deficient myeloid cells with monocyte colony-stimulating factor (M-CSF) results in sustained Ras activation, ERK phosphorylation, and proliferation associated with impaired Nf1 expression. These M-CSF effects are reversed by ICSBP expression in ICSBP -/- cells. Consistent with this, we find that ICSBP activates the NF1 promoter in myeloid cell line transfectants and identify an ICSBP-binding NF1 cis element. Therefore, the absence of ICSBP leads to Nf1 deficiency, impairing down-regulation of Ras activation by GM-CSF or M-CSF. These results suggest that one mechanism of increased myeloid proliferation, in ICSBP-deficient cells, is decreased NF1 gene transcription. This novel ICSBP function provides insight into regulation of myelopoiesis under normal conditions and in myeloproliferative disorders.	Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Chicago Lakeside Vet Affairs Hosp, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 710 N Fairbanks Court,Olson Pavil,Rm 8524, Chicago, IL 60611 USA.	e-eklund@northwestern.edu			NATIONAL CANCER INSTITUTE [R01CA095266] Funding Source: NIH RePORTER; NCI NIH HHS [CA095266, CA95266] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; BOGUSKI M, 1990, NATURE, V366, P643; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Chatterjee D, 1997, CELL GROWTH DIFFER, V8, P1083; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Donovan S, 2002, CANCER CELL, V2, P507, DOI 10.1016/S1535-6108(02)00214-3; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Fehr T, 1997, J EXP MED, V185, P921, DOI 10.1084/jem.185.5.921; GABBIANELLI M, 1995, BLOOD, V86, P1661, DOI 10.1182/blood.V86.5.1661.bloodjournal8651661; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; GROOT RP, 1998, CELL SIGNAL, V10, P619; HAJRA A, 1994, GENOMICS, V21, P649, DOI 10.1006/geno.1994.1328; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Ingram DA, 2003, BLOOD, V101, P1984, DOI 10.1182/blood-2002-08-2635; Kallies A, 2002, BLOOD, V99, P3213, DOI 10.1182/blood.V99.9.3213; Kantakamalakul W, 1999, J IMMUNOL, V162, P7417; Kautz B, 2001, J BIOL CHEM, V276, P37868; KERST JM, 1992, EXP HEMATOL, V20, P1188; LARRICK JW, 1980, J IMMUNOL, V125, P6; Osborn M, 2000, CLIN GENET, V57, P221, DOI 10.1034/j.1399-0004.2000.570308.x; POLITIS AD, 1994, J IMMUNOL, V152, P2270; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; SCHWARTZ RM, 1991, BLOOD, V78, P3155; Sharf R, 1997, J BIOL CHEM, V272, P9785; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Zhang YY, 1998, J EXP MED, V187, P1893, DOI 10.1084/jem.187.11.1893	36	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50874	50885		10.1074/jbc.M405736200	http://dx.doi.org/10.1074/jbc.M405736200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371411	hybrid			2022-12-27	WOS:000225355800030
J	Atkins, AR; Gallin, WJ; Owens, GC; Edelman, GM; Cunningham, BA				Atkins, AR; Gallin, WJ; Owens, GC; Edelman, GM; Cunningham, BA			Neural cell adhesion molecule (N-CAM) homophilic binding mediated by the two N-terminal Ig domains is influenced by intramolecular domain-domain interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; STRUCTURAL BASIS; INTEGRIN RECOGNITION; EXTRACELLULAR DOMAIN; POLYSIALIC ACID; NCAM; MECHANISM; SURFACE; SUPERFAMILY; RECEPTOR	The mechanism by which the neural cell adhesion molecule, N-CAM, mediates homophilic interactions between cells has been variously attributed to an isologous interaction of the third immunoglobulin (Ig) domain, to reciprocal binding of the two N-terminal Ig domains, or to reciprocal interactions of all five Ig domains. Here, we have used a panel of recombinant proteins in a bead binding assay, as well as transfected and primary cells, to clarify the molecular mechanism of N-CAM homophilic binding. The entire extracellular region of N-CAM mediated bead aggregation in a concentration- and temperature-dependent manner. Interactions of the N-terminal Ig domains, Ig1 and Ig2, were essential for bead binding, based on deletion and mutation experiments and on antibody inhibition studies. These findings were largely in accord with aggregation experiments using transfected L cells or primary chick brain cells. Additionally, maximal binding was dependent on the integrity of the intramolecular domain-domain interactions throughout the extracellular region. We propose that these interactions maintain the relative orientation of each domain in an optimal configuration for binding. Our results suggest that the role of Ig3 in homophilic binding is largely structural. Several Ig3-specific reagents failed to affect N-CAM binding on beads or on cells, while an inhibitory effect of an Ig3-specific monoclonal antibody is probably due to perturbations at the Ig2-Ig3 boundary. Thus, it appears that reciprocal interactions between Ig1 and Ig2 are necessary and sufficient for N-CAM homophilic binding, but that maximal binding requires the quaternary structure of the extracellular region defined by intramolecular domain-domain interactions.	Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Inst Neurosci, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; University of Alberta	Cunningham, BA (corresponding author), Scripps Res Inst, Dept Neurobiol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bcunning@scripps.edu		Atkins, Annette/0000-0003-2558-7058	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016550, R37HD009635, R01HD009635] Funding Source: NIH RePORTER; NICHD NIH HHS [HD16550, HD09635] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Atkins AR, 1999, FEBS LETT, V451, P162, DOI 10.1016/S0014-5793(99)00554-2; Atkins AR, 2001, J MOL BIOL, V311, P161, DOI 10.1006/jmbi.2001.4861; Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; BERTOLOTTI R, 1980, P NATL ACAD SCI-BIOL, V77, P4831, DOI 10.1073/pnas.77.8.4831; BRACKENBURY R, 1981, P NATL ACAD SCI-BIOL, V78, P387, DOI 10.1073/pnas.78.1.387; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Casasnovas JM, 1997, NATURE, V387, P312, DOI 10.1038/387312a0; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen YT, 1996, ANAL BIOCHEM, V242, P276, DOI 10.1006/abio.1996.0466; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; CUNNINGHAM BA, 1983, P NATL ACAD SCI-BIOL, V80, P3116, DOI 10.1073/pnas.80.10.3116; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DICKSON G, 1987, CELL, V50, P1119, DOI 10.1016/0092-8674(87)90178-4; EDELMAN GM, 1991, ANNU REV BIOCHEM, V60, P155, DOI 10.1146/annurev.bi.60.070191.001103; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; GERARDYSCHAHN R, 1994, INT J CANCER, P38; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kasper C, 2000, NAT STRUCT BIOL, V7, P389; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; LECKBAND DE, 1992, SCIENCE, V255, P1419, DOI 10.1126/science.1542789; MAURO VP, 1992, J CELL BIOL, V119, P191, DOI 10.1083/jcb.119.1.191; Owens GC, 1998, CANCER RES, V58, P2020; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Pierres A, 1998, CELL ADHES COMMUN, V5, P375, DOI 10.3109/15419069809010783; Pierres A, 1997, FEBS LETT, V403, P239, DOI 10.1016/S0014-5793(97)00060-4; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Ranheim TS, 1996, P NATL ACAD SCI USA, V93, P4071, DOI 10.1073/pnas.93.9.4071; RAO Y, 1993, J BIOL CHEM, V268, P20630; RAO Y, 1992, J CELL BIOL, V118, P937, DOI 10.1083/jcb.118.4.937; RAO Y, 1994, J BIOL CHEM, V269, P27540; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Suzuki M, 2003, J BIOL CHEM, V278, P49459, DOI 10.1074/jbc.M308316200; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	41	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49633	49643		10.1074/jbc.M409159200	http://dx.doi.org/10.1074/jbc.M409159200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381695	hybrid			2022-12-27	WOS:000225229500013
J	Morishima, N; Nakanishi, K; Tsuchiya, K; Shibata, T; Seiwa, E				Morishima, N; Nakanishi, K; Tsuchiya, K; Shibata, T; Seiwa, E			Translocation of bim to the endoplasmic reticulum (ER) mediates ER stress signaling for activation of caspase-12 during ER stress-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY-MEMBERS; CELL-DEATH; BH3-ONLY PROTEINS; MITOCHONDRIAL DYSFUNCTION; BAX; MECHANISMS; RECEPTORS; BCL-X(L); PATHWAYS	Endoplasmic reticulum (ER) stress activates caspase-12 in murine cells, triggering the ER stress-specific cascade for implementation of apoptosis. In C2C12 murine myoblast cells, activation of the cascade occurs without release of cytochrome c from mitochondria, suggesting that the cascade is independent of mitochondrial damage. Stable overexpression of Bcl-xL in C2C12 cells suppressed activation of caspase-12 and apoptosis. In ER-stressed cells, but not in normal cells, Bcl-xL was co-immunoprecipitated with Bim, a pro-apoptotic member of the Bcl-2 family, suggesting that Bcl-xL sequesters Bim, thereby inhibiting the apoptotic signaling. Fractionation of C2C12 cells revealed that ER stress led to translocation of Bim from a dynein-rich compartment to the ER, while stable overexpression of Bcl-xL suppressed accumulation of Bim on the ER. Although the toxic effect of Bim had been previously observed only at the mitochondrial outer membrane, overexpression of a Bim derivative, Bim(ER), targeted at the surface of the ER led to apoptosis. A C2C12 transfectant overexpressing the caspase-12 suppressor protein was resistant to Bim(ER), suggesting that the toxic effect of Bim on the ER is dependent on activation of caspase-12. Knockdown of Bim by RNA interference provided cells resistant to ER stress. These results suggest that translocation of Bim to the ER in response to ER stress is an important step toward activation of caspase-12 and initiation of the ER stress-specific caspase cascade.	RIKEN, Inst Phys & Chem Res, Bioarchitect Res Grp, Wako, Saitama 3510198, Japan; RIKEN, Inst Phys & Chem Res, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; Saitama Univ, Dept Mol Biol, Fac Sci & Engn, Saitama 3388570, Japan	RIKEN; RIKEN; Saitama University	Morishima, N (corresponding author), RIKEN, Inst Phys & Chem Res, Bioarchitect Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	morishim@postman.riken.jp	Morishima, Nobuhiro/D-3946-2017; Nakanishi, Keiko/B-9963-2013					Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Ito Y, 2001, MOL CELL BIOL, V21, P6233, DOI 10.1128/MCB.21.18.6233-6242.2001; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kumar S, 2002, SCIENCE, V297, P1290, DOI 10.1126/science.1076118; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mattson MP, 2000, TRENDS NEUROSCI, V23, P222, DOI 10.1016/S0166-2236(00)01548-4; Mehmet H, 2000, NATURE, V403, P29, DOI 10.1038/47377; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rao RV, 2002, J BIOL CHEM, V277, P21836, DOI 10.1074/jbc.M202726200; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; Rudner J, 2001, J CELL SCI, V114, P4161; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	42	152	164	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50375	50381		10.1074/jbc.M408493200	http://dx.doi.org/10.1074/jbc.M408493200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15452118	hybrid			2022-12-27	WOS:000225229500102
J	Necula, M; Kuret, J				Necula, M; Kuret, J			Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-LIKE FILAMENTS; LASER-LIGHT SCATTERING; MICROTUBULE-BINDING; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; ACTIN POLYMERIZATION; DISEASE PATHOLOGY; BETA-STRUCTURE; END-PRODUCTS	Alzheimer's disease is defined in part by the intraneuronal aggregation of tau protein into filamentous lesions. The pathway is accompanied by posttranslational modifications including phosphorylation and glycation, each of which has been shown to promote tau fibrillization in vitro when present at high stoichiometry. To clarify the site-specific impact of posttranslational modification on tau fibrillization, the ability of recombinant full-length four repeat tau protein (htau40) and 11 pseudophosphorylation mutants to fibrillize in the presence of anionic inducer was assayed in vitro using transmission electron microscopy and laser light scattering assays. Tau glycated with D-glucose was examined as well. Both glycated tau and pseudophosphorylation mutants S199E, T212E, S214E, double mutant T212E/S214E, and triple mutant S199E/S202E/T205E yielded increased filament mass at equilibrium relative to wild-type tau. Increases in filament mass correlated strongly with decreases in critical concentration, indicating that both pseudophosphorylation and glycation promoted fibrillization by shifting equilibrium toward the fibrillized state. Analysis of reaction time courses further revealed that increases in filament mass were not associated with reduced lag times, indicating that these posttranslational modifications did not promote filament nucleation. The results suggest that site-specific posttranslational modifications can stabilize filaments once they nucleate, and thereby support their accumulation at low intracellular tau concentrations.	Ohio State Univ, Coll Med & Publ Hlth, Biophys Program, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kuret, J (corresponding author), Ohio State Univ, Ctr Biotechnol, 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu			NIA NIH HHS [AG14452] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abraha A, 2000, J CELL SCI, V113, P3737; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BRANDT R, 1993, J BIOL CHEM, V268, P3414; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; CROWTHER RA, 1994, FEBS LETT, V337, P135, DOI 10.1016/0014-5793(94)80260-2; Edelstein-Keshet L, 1998, B MATH BIOL, V60, P449, DOI 10.1006/bulm.1997.0011; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fath T, 2002, J NEUROSCI, V22, P9733; FESCE R, 1992, J BIOL CHEM, V267, P11289; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Garcia-Sierra F, 2003, J ALZHEIMERS DIS, V5, P65, DOI 10.3233/JAD-2003-5201; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Goedert M, 1996, ANN NY ACAD SCI, V777, P121, DOI 10.1111/j.1749-6632.1996.tb34410.x; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Kashchiev D., 2000, NUCL BASIC THEORY AP; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Ko LW, 2002, J MOL NEUROSCI, V19, P311; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; Ledesma MD, 1996, MOL CHEM NEUROPATHOL, V27, P249, DOI 10.1007/BF02815107; LEDESMA MD, 1994, J BIOL CHEM, V269, P21614; LEDESMA MD, 1995, J NEUROCHEM, V65, P1658; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Mena R, 1996, ACTA NEUROPATHOL, V91, P633, DOI 10.1007/s004010050477; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Nacharaju P, 1997, J NEUROCHEM, V69, P1709; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Necula M, 2004, ANAL BIOCHEM, V333, P205, DOI 10.1016/j.ab.2004.05.044; Necula M, 2004, ANAL BIOCHEM, V329, P238, DOI 10.1016/j.ab.2004.02.023; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Perez M, 1996, J NEUROCHEM, V67, P1183; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shahani N, 2002, CELL MOL LIFE SCI, V59, P1668, DOI 10.1007/PL00012495; Smith MA, 1996, NEUROSCI LETT, V217, P210, DOI 10.1016/S0304-3940(96)13100-1; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Timasheff S. N., 1981, PROTEIN PROTEIN INTE, P315; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Watanabe A, 1999, J BIOL CHEM, V274, P7368, DOI 10.1074/jbc.274.11.7368; WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306; Wilson DM, 1997, AM J PATHOL, V150, P2181; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; YAN SD, 1994, P NATL ACAD SCI USA, V91, P7787, DOI 10.1073/pnas.91.16.7787	76	112	115	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49694	49703		10.1074/jbc.M405527200	http://dx.doi.org/10.1074/jbc.M405527200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364924	hybrid			2022-12-27	WOS:000225229500020
J	Baglia, FA; Shrimpton, CN; Emsley, J; Kitagawa, K; Ruggeri, ZM; Lopez, JA; Walsh, PN				Baglia, FA; Shrimpton, CN; Emsley, J; Kitagawa, K; Ruggeri, ZM; Lopez, JA; Walsh, PN			Factor XI interacts with the leucine-rich repeats of glycoprotein Ib alpha on the activated platelet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; IX-V COMPLEX; COAGULATION-FACTOR-XI; FACTOR A1 DOMAIN; CRYSTAL-STRUCTURE; VONWILLEBRAND-FACTOR; BINDING-SITE; THROMBIN BINDING; IDENTIFICATION; AGGREGATION	Factor XI (FXI) binds specifically and reversibly to high affinity sites on the surface of stimulated platelets (K-d app of similar to10 nM; B-max of similar to1,500 sites/platelet) utilizing residues exposed on the Apple 3 domain in the presence of high molecular weight kininogen and Zn2+ or prothrombin and Ca2+. Because the FXI receptor in the platelet membrane is contained within the glycoprotein Ibalpha subunit of the glycoprotein Ib-IX-V complex (Baglia, F. A., Badellino, K. O., Li, C. Q., Lopez, J. A., and Walsh, P.N. (2002) J. Biol. Chem. 277, 1662-1668), we utilized mocarhagin, a cobra venom metalloproteinase, to generate a fragment (His(1)-Glu(282)) of glycoprotein Ibalpha that contains the leucine-rich repeats of the NH2-terminal globular domain and excludes the macroglycopeptide portion of glycocalicin, the soluble extracytoplasmic portion of glycoprotein Ibalpha. This fragment was able to compete with FXI for binding to activated platelets (K-i of 3.125+/-0.25 nM) with a potency similar to that of intact glycocalicin (K-i of 3.72+/-0.30 nM). However, a synthetic glycoprotein Ibalpha peptide, Asp(269)-Asp(287), containing a thrombin binding site had no effect on the binding of FXI to activated platelets. Moreover, the binding of I-125-labeled thrombin to glycocalicin was unaffected by the presence of FXI at concentrations up to 10(-5) M. The von Willebrand factor A1 domain, which binds the leucine-rich repeats, inhibited the binding of FXI to activated platelets. Thus, we examined the effect of synthetic peptides of each of the seven leucine-rich repeats on the binding of I-125-FXI to activated platelets. All leucine-rich repeat (LRR) peptides derived from glycoprotein Ibalpha were able to inhibit FXI binding to activated platelets in the following order of decreasing potency: LRR7, LRR1, LRR4, LRR5, LRR6, LRR3, and LRR2. However, the leucine-rich repeat synthetic peptides derived from glycoprotein Ibbeta and Toll protein had no effect. We conclude that FXI binds to glycoprotein Ibalpha at sites comprising the leucine-rich repeat sequences within the NH2-terminal globular domain that are separate and distinct from the thrombin-binding site.	Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; Vet Affairs Med Ctr, Houston, TX 77030 USA; Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England; Niigata Univ Pharm & Appl Life Sci, Niigata 9502081, Japan; Scripps Res Inst, Dept Mol & Expt Med, Div Expt Hemostasis & Thrombosis, Roon Res Ctr Arteriosclerosis & Thrombosis, La Jolla, CA 92037 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Nottingham; Niigata University; Scripps Research Institute	Walsh, PN (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, 3400 N Broad St, Philadelphia, PA 19140 USA.	pnw@temple.edu	emsley, jonas/A-8509-2016	emsley, jonas/0000-0002-8949-8030	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070683, P01HL064943, R01HL046213, P01HL048728, P01HL074124] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL46213, HL70683, HL74124, HL48728, HL64943] Funding Source: Medline; PHS HHS [P5065967] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baglia FA, 2000, J BIOL CHEM, V275, P20514, DOI 10.1074/jbc.M000464200; Baglia FA, 2000, J BIOL CHEM, V275, P31954, DOI 10.1074/jbc.M005465200; Baglia FA, 2003, J BIOL CHEM, V278, P21744, DOI 10.1074/jbc.M212991200; Baglia FA, 2002, J BIOL CHEM, V277, P1662, DOI 10.1074/jbc.M108319200; BAGLIA FA, 1995, J BIOL CHEM, V270, P6734, DOI 10.1074/jbc.270.12.6734; Baglia FA, 1998, BIOCHEMISTRY-US, V37, P2271, DOI 10.1021/bi972113+; BAGLIA FA, 2003, J THROMB HAEMOST S1, V1, pP1097; BINDER B, 1975, THROMB DIATH HAEMOST, V34, P354; BRUNNEE T, 1993, BLOOD, V81, P580; Cauwenberghs N, 2001, BLOOD, V98, P652, DOI 10.1182/blood.V98.3.652; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; De Cristofaro R, 2001, BIOCHEMISTRY-US, V40, P13268, DOI 10.1021/bi010491f; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; Dong JF, 2001, J BIOL CHEM, V276, P16690, DOI 10.1074/jbc.M101035200; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; GAILANI D, 1993, SEMIN THROMB HEMOST, V19, P396, DOI 10.1055/s-2007-993291; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; GRALNICK HR, 1994, P NATL ACAD SCI USA, V91, P6334, DOI 10.1073/pnas.91.14.6334; GREENGARD JS, 1986, BIOCHEMISTRY-US, V25, P3884, DOI 10.1021/bi00361a022; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HESS D, 1991, EUR J BIOCHEM, V199, P389, DOI 10.1111/j.1432-1033.1991.tb16135.x; Ho DH, 2000, BIOCHEMISTRY-US, V39, P316, DOI 10.1021/bi991851q; HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Kaplan A P, 1981, Ann N Y Acad Sci, V370, P253, DOI 10.1111/j.1749-6632.1981.tb29738.x; Kitagawa K, 2001, J ORG CHEM, V66, P1, DOI 10.1021/jo000895y; LI CY, 1995, BLOOD, V86, P3805, DOI 10.1182/blood.V86.10.3805.bloodjournal86103805; LOPEZ JA, 1988, P NATL ACAD SCI USA, V85, P2135, DOI 10.1073/pnas.85.7.2135; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P97; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Miyata S, 1996, J BIOL CHEM, V271, P9046, DOI 10.1074/jbc.271.15.9046; MOHRI H, 1989, J BIOL CHEM, V264, P17361; PETERSON DM, 1987, BLOOD, V69, P625; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; SCOTT JP, 1991, J BIOL CHEM, V266, P8149; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; THOMPSON RE, 1979, P NATL ACAD SCI USA, V76, P4862, DOI 10.1073/pnas.76.10.4862; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; Yun TH, 2003, J BIOL CHEM, V278, P48112, DOI 10.1074/jbc.M306925200	45	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49323	49329		10.1074/jbc.M407889200	http://dx.doi.org/10.1074/jbc.M407889200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15375170	hybrid			2022-12-27	WOS:000225098100101
J	Diks, SH; Kok, K; O'Toole, T; Hommes, DW; van Dijken, P; Joore, J; Peppelenbosch, MP				Diks, SH; Kok, K; O'Toole, T; Hommes, DW; van Dijken, P; Joore, J; Peppelenbosch, MP			Kinome profiling for studying lipopolysaccharide signal transduction in human peripheral blood mononuclear cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PHOSPHORYLATION SITES; HUMAN NEUTROPHILS; GENE-EXPRESSION; MICROARRAYS; PEPTIDE; ARRAYS; PHOSPHOBASE; DATABASE; COMPLEX	The DNA array technique allows comprehensive analysis of the genome and transcriptome, but the high throughput array-based assessment of intracellular signal transduction remains troublesome. The goal of this study was to test a new peptide array technology for studying the activity of all kinases of whole cell lysates, the kinome. Cell lysates from human peripheral blood mononuclear cells before and after stimulation with lipopolysaccharide were used for in vitro phosphorylation with [gamma-P-33] ATP arrays consisting of 192 peptides ( substrates for kinases) spotted on glass. The usefulness of peptide arrays for studying signal transduction was demonstrated by the generation of the first comprehensive description of the temporal kinetics of phosphorylation events induced by lipopolysaccharide stimulation. Furthermore analysis of the signals obtained suggested activation of p21Ras by lipopolysaccharide, and this was confirmed by direct measurement of p21Ras GTP levels in lipopolysaccharide-stimulated human peripheral blood mononuclear cells, which represents the first direct demonstration of p21Ras activation by stimulation of a Toll receptor family member. Further confidence in the usefulness of peptide array technology for studying signal transduction came from Western blot analysis of lipopolysaccharide-stimulated cells, which corroborated the signals obtained using peptide arrays as well as from the demonstration that kinase inhibitors effected peptide array phosphorylation patterns consistent with the expected action of these inhibitors. We conclude that this first metabolic array is a useful method to determine the enzymatic activities of a large group of kinases, offering high throughput analysis of cellular metabolism and signal transduction.	Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands; Univ Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; Pepscan Syst, NL-8219 PH Lelystad, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Kok, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, Meibergdreef 9,G2-132, NL-1105 AZ Amsterdam, Netherlands.	k.kok@amc.uva.nl		Joore, Jos/0000-0002-2744-4862; Peppelenbosch, Maikel/0000-0001-9112-6028				Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; Blom N, 1998, NUCLEIC ACIDS RES, V26, P382, DOI 10.1093/nar/26.1.382; Conway T, 2003, MOL MICROBIOL, V47, P879, DOI 10.1046/j.1365-2958.2003.03338.x; Coxon PY, 2003, CELL SIGNAL, V15, P993, DOI 10.1016/S0898-6568(03)00074-3; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; Diks SH, 2004, CURR TOP MED CHEM, V4, P1115, DOI 10.2174/1568026043388141; Diks SH, 2001, J ENDOTOXIN RES, V7, P335, DOI 10.1177/09680519010070050101; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q; Gilmore WJ, 2003, TOXICOLOGY, V184, P211, DOI 10.1016/S0300-483X(02)00581-4; Head MW, 1996, J CELL SCI, V109, P1029; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Houseman BT, 2002, TRENDS BIOTECHNOL, V20, P279, DOI 10.1016/S0167-7799(02)01984-4; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kreegipuu A, 1999, NUCLEIC ACIDS RES, V27, P237, DOI 10.1093/nar/27.1.237; Kristof AS, 2003, J BIOL CHEM, V278, P33637, DOI 10.1074/jbc.M301053200; Lee PS, 2000, CURR OPIN BIOTECH, V11, P171, DOI 10.1016/S0958-1669(00)00077-X; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; MacBeath G, 2000, SCIENCE, V289, P1760; Morrison D C, 1979, Adv Immunol, V28, P293; Palsson EM, 2000, J BIOL CHEM, V275, P7818, DOI 10.1074/jbc.275.11.7818; Peppelenbosch MP, 1999, BLOOD, V93, P4011, DOI 10.1182/blood.V93.11.4011.411a29_4011_4018; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Wurmbach E, 2002, NEUROCHEM RES, V27, P1027, DOI 10.1023/A:1020900720328; Zhou HP, 2003, AM J PHYSIOL-GASTR L, V284, pG472, DOI 10.1152/ajpgi.00345.2002; Zhu H, 2001, CURR OPIN CHEM BIOL, V5, P40, DOI 10.1016/S1367-5931(00)00170-8	33	111	114	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49206	49213		10.1074/jbc.M405028200	http://dx.doi.org/10.1074/jbc.M405028200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355981	hybrid			2022-12-27	WOS:000225098100086
J	Stein, S; Thomas, EK; Herzog, B; Westfall, MD; Rocheleau, JV; Jackson, RS; Wang, M; Liang, P				Stein, S; Thomas, EK; Herzog, B; Westfall, MD; Rocheleau, JV; Jackson, RS; Wang, M; Liang, P			NDRG1 is necessary for p53-dependent apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL DISPLAY ANALYSIS; TUMOR-SUPPRESSOR PROTEIN; N-MYC; GENE-EXPRESSION; CANCER-CELLS; DNA-DAMAGE; CAP43 GENE; PROSTATE-CANCER; COLON-CANCER; P53 PROTEIN	Although a number of target genes for the tumor suppressor p53 have been described, the mechanism of p53-dependent apoptosis is incompletely understood. Thus, it is essential to identify and characterize additional target genes that could mediate apoptosis. In the study reported here, we isolated a p53-regulated gene named NDRG1 (N-Myc down-regulated gene 1). Its expression is induced by DNA damage in a p53-dependent fashion. The promoter region of the NDRG1 gene contains a p53 binding site that confers p53-dependent transcriptional activation via a heterologous reporter. RNA interference and inducible gene expression approaches suggest that NDRG1 is necessary but not sufficient for p53-mediated caspase activation and apoptosis. This report further supports the notion that p53 controls a network of genes that are required for its apoptotic function.	Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Liang, P (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA.	S.Stein@med.uni-frankfurt.de; peng.liang@vanderbilt.edu		Rocheleau, Jonathan/0000-0002-1760-2564	NATIONAL CANCER INSTITUTE [R01CA076960, R01CA105024] Funding Source: NIH RePORTER; NCI NIH HHS [CA76960, CA105024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwala KL, 2000, BIOCHEM BIOPH RES CO, V272, P641, DOI 10.1006/bbrc.2000.2833; Arizti P, 2000, MOL CELL BIOL, V20, P7450, DOI 10.1128/MCB.20.20.7450-7459.2000; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cangul H, 2002, CELL BIOL TOXICOL, V18, P87, DOI 10.1023/A:1015376032736; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Cho Y, 2001, BIOTECHNIQUES, V30, P562, DOI 10.2144/01303rr01; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Guang RJ, 2000, CANCER RES, V60, P749; Herzog B, 2004, MOL ENDOCRINOL, V18, P807, DOI 10.1210/mg.2003-0384; Hohenstein P, 2003, TRENDS GENET, V19, P489, DOI 10.1016/S0168-9525(03)00193-8; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hunter M, 2003, HUM MUTAT, V22, P129, DOI 10.1002/humu.10240; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kurdistani SK, 1998, CANCER RES, V58, P4439; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Li J, 2003, MOL CELL BIOCHEM, V250, P91, DOI 10.1023/A:1024918328162; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; Liang P, 2002, BIOTECHNIQUES, V33, P338, DOI 10.2144/02332rv01; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Mackay A, 2003, ONCOGENE, V22, P2680, DOI 10.1038/sj.onc.1206349; MacLachlan TK, 2000, J BIOL CHEM, V275, P31869, DOI 10.1074/jbc.M003338200; Malette B, 2003, MOL HUM REPROD, V9, P671, DOI 10.1093/molehr/gag084; Masuda K, 2003, INT J CANCER, V105, P803, DOI 10.1002/ijc.11152; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Motwani M, 2002, CANCER RES, V62, P3950; Nimmrich I, 2000, CANCER LETT, V160, P37, DOI 10.1016/S0304-3835(00)00553-X; Nishie A, 2001, CLIN CANCER RES, V7, P2145; Okuda T, 2004, MOL CELL BIOL, V24, P3949, DOI 10.1128/MCB.24.9.3949-3956.2004; Park H, 2000, BIOCHEM BIOPH RES CO, V276, P321, DOI 10.1006/bbrc.2000.3475; Piquemal D, 1999, BBA-MOL CELL RES, V1450, P364, DOI 10.1016/S0167-4889(99)00056-7; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Salnikow K, 1999, TOXICOL APPL PHARM, V160, P127, DOI 10.1006/taap.1999.8759; Salnikow K, 2000, CANCER RES, V60, P38; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; Stein S, 2002, CELL MOL LIFE SCI, V59, P1274, DOI 10.1007/s00018-002-8506-7; Stein Susanne, 2003, Methods Mol Biol, V234, P51; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Taketomi Y, 2003, BIOCHEM BIOPH RES CO, V306, P339, DOI 10.1016/S0006-291X(03)00942-2; Ulrix W, 1999, FEBS LETT, V455, P23, DOI 10.1016/S0014-5793(99)00845-5; vanBelzen N, 1997, LAB INVEST, V77, P85; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Xu B, 1999, BIOL REPROD, V61, P681, DOI 10.1095/biolreprod61.3.681; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhou DJ, 1998, CANCER RES, V58, P2182; Zoroddu MA, 2001, J INORG BIOCHEM, V84, P47, DOI 10.1016/S0162-0134(00)00204-X	57	166	182	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48930	48940		10.1074/jbc.M400386200	http://dx.doi.org/10.1074/jbc.M400386200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15377670	hybrid			2022-12-27	WOS:000225098100055
J	Coyne, CB; Voelker, T; Pichla, SL; Bergelson, JM				Coyne, CB; Voelker, T; Pichla, SL; Bergelson, JM			The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP-1) within the tight junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; BLADDER-CANCER; LNX; CAR; IDENTIFICATION; PURIFICATION; EXPRESSION; MECHANISM; VIRUSES; LIGAND	The coxsackievirus and adenovirus receptor ( CAR) is a component of the epithelial cell tight junction. In a yeast two-hybrid screen we identified the multi-PDZ domain protein MUPP1 as an interaction partner for the CAR cytoplasmic domain. CAR and MUPP1 were found to colocalize at the tight junction, to coprecipitate from epithelial cells, and to interact in vitro. The interaction was found to specifically involve the PDZ-binding motif within the CAR C terminus and MUPP1 PDZ domain 13. In transfected cells, CAR recruited MUPP1 to cell-cell contacts. The inhibition of CAR expression with small interfering RNA inhibited MUPP1 localization to the tight junction. The results indicated that CAR interacts with MUPP1 and is involved in MUPP1 recruitment to the tight junction.	Childrens Hosp Philadelphia, Div Infect Dis, Abramson Res Ctr 1202, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bergelson, JM (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Abramson Res Ctr 1202, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	bergelson@email.chop.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007324] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL54734] Funding Source: Medline; NIAID NIH HHS [R01AI5228-1, T32AI07324] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Becamel C, 2001, J BIOL CHEM, V276, P12974, DOI 10.1074/jbc.M008089200; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Carson SD, 1997, BIOCHEM BIOPH RES CO, V233, P325, DOI 10.1006/bbrc.1997.6449; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Fuxe J, 2003, INT J CANCER, V103, P723, DOI 10.1002/ijc.10891; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Mancini A, 2000, FEBS LETT, V482, P54, DOI 10.1016/S0014-5793(00)02036-6; MAPOLES JE, 1985, J VIROL, V55, P560, DOI 10.1128/JVI.55.3.560-566.1985; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Okegawa T, 2001, CANCER RES, V61, P6592; Parker LL, 2003, J BIOL CHEM, V278, P21576, DOI 10.1074/jbc.M210973200; Sachs MD, 2002, UROLOGY, V60, P531, DOI 10.1016/S0090-4295(02)01748-X; Shieh JTC, 2002, J VIROL, V76, P9474, DOI 10.1128/JVI.76.18.9474-9480.2002; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Xie Y, 2001, BIOCHEM GENET, V39, P117, DOI 10.1023/A:1010269908398	27	102	106	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48079	48084		10.1074/jbc.M409061200	http://dx.doi.org/10.1074/jbc.M409061200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364909	hybrid			2022-12-27	WOS:000224957000080
J	Serres, S; Bezancon, E; Franconi, JM; Merle, M				Serres, S; Bezancon, E; Franconi, JM; Merle, M			Ex vivo analysis of lactate and glucose metabolism in the rat brain under different states of depressed activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; ADULT-MOUSE BRAIN; MONOCARBOXYLATE TRANSPORTER; NEURONAL-ACTIVITY; PYRUVATE-CARBOXYLASE; CEREBRAL METABOLISM; IN-VIVO; ASTROCYTES; GLUTAMATE; MCT2	Brain metabolism of glucose and lactate was analyzed by ex vivo NMR spectroscopy in rats presenting different cerebral activities induced after the administration of pentobarbital, alpha-chloralose, or morphine. The animals were infused with a solution of either [1-C-13] glucose plus lactate or glucose plus [3-C-13] lactate for 20 min. Brain metabolite contents and enrichments were determined from analyses of brain tissue perchloric acid extracts according to their post-mortem evolution kinetics. When amino acid enrichments were compared, both the brain metabolic activity and the contribution of blood glucose relative to that of blood lactate to brain metabolism were linked with cerebral activity. The data also indicated the production in the brain of lactate from glycolysis in a compartment other than the neurons, presumably the astrocytes, and its subsequent oxidative metabolism in neurons. Therefore, a brain electrical activity-dependent increase in the relative contribution of blood glucose to brain metabolism occurred via the increase in the metabolism of lactate generated from brain glycolysis at the expense of that of blood lactate. This result strengthens the hypothesis that brain lactate is involved in the coupling between neuronal activation and metabolism.	Univ Victor Segalen, CNRS, Unite Mixte Rech 5536, Unite Resonance Magnet Syst Biol, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Merle, M (corresponding author), Univ Victor Segalen, CNRS, Unite Mixte Rech 5536, Unite Resonance Magnet Syst Biol, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	merle@rmsb.u-bordeaux2.fr		serres, sebastien/0000-0002-1573-1581				BENYOSEPH O, 1993, BIOCHEM J, V291, P915, DOI 10.1042/bj2910915; Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; Broer S, 1997, J BIOL CHEM, V272, P30096, DOI 10.1074/jbc.272.48.30096; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Chih CP, 2001, TRENDS NEUROSCI, V24, P573, DOI 10.1016/S0166-2236(00)01920-2; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Cholet N, 2002, CEREB CORTEX, V12, P515, DOI 10.1093/cercor/12.5.515; Cruz F, 2001, J NEUROSCI RES, V66, P771, DOI 10.1002/jnr.10048; Demestre M, 1997, J PHYSIOL-LONDON, V499, P825, DOI 10.1113/jphysiol.1997.sp021971; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; GJEDDE A, 1980, J NEUROCHEM, V35, P1382, DOI 10.1111/j.1471-4159.1980.tb09013.x; Gruetter R, 1998, J NEUROCHEM, V70, P397; Haspel HC, 1999, J MEMBRANE BIOL, V169, P45, DOI 10.1007/PL00005900; Hassel B, 2000, J CEREBR BLOOD F MET, V20, P327, DOI 10.1097/00004647-200002000-00014; Hu YB, 1997, J NEUROCHEM, V69, P1484; Jones P, 1999, NEUROCHEM RES, V24, P1327, DOI 10.1023/A:1022516219647; LAMANNA JC, 1993, BRAIN RES, V614, P164, DOI 10.1016/0006-8993(93)91030-V; Lowry JP, 1997, J PHYSIOL-LONDON, V498, P497, DOI 10.1113/jphysiol.1997.sp021875; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merle M, 2002, J NEUROCHEM, V82, P47, DOI 10.1046/j.1471-4159.2002.00924.x; NORBERG K, 1975, BRAIN RES, V86, P31, DOI 10.1016/0006-8993(75)90635-6; OTSUKA T, 1991, AM J PHYSIOL, V261, pR265, DOI 10.1152/ajpregu.1991.261.2.R265; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2000, NEUROSCIENCE, V100, P617, DOI 10.1016/S0306-4522(00)00294-3; Pierre K, 2002, J CEREBR BLOOD F MET, V22, P586, DOI 10.1097/00004647-200205000-00010; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Qu H, 2000, DEV NEUROSCI-BASEL, V22, P429, DOI 10.1159/000017472; Schurr A, 2001, BRAIN RES, V895, P268, DOI 10.1016/S0006-8993(01)02082-0; Serres S, 2003, NMR BIOMED, V16, P430, DOI 10.1002/nbm.838; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; VEECH RL, 1973, RES METHODS NEUROCHE, V2, P171; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4; Waagepetersen HS, 2000, J NEUROCHEM, V75, P471, DOI 10.1046/j.1471-4159.2000.0750471.x; Zwingmann C, 2000, GLIA, V32, P286, DOI 10.1002/1098-1136(200012)32:3<286::AID-GLIA80>3.0.CO;2-P	36	42	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47881	47889		10.1074/jbc.M409429200	http://dx.doi.org/10.1074/jbc.M409429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15361523	hybrid			2022-12-27	WOS:000224957000058
J	Sorensen, TLM; Clausen, JD; Jensen, AML; Vilsen, B; Moller, JV; Andersen, JP; Nissen, P				Sorensen, TLM; Clausen, JD; Jensen, AML; Vilsen, B; Moller, JV; Andersen, JP; Nissen, P			Localization of a K+-binding site involved in dephosphorylation of the sarcoplasmic reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; INTRAMOLECULAR COMMUNICATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; A-DOMAIN; TRANSPORT; CA2+; DISSOCIATION; ACTIVATION; MECHANISM	K+ plays an important role for the function of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), but its binding site within the molecule has remained unidentified. We have located the binding site for a K+ ion in the P-domain by means of x-ray crystallography using crystals prepared in the presence of the K+ congener Rb+. Backbone carbonyls from the loop containing residues 711-715 together with the side chain of Glu(732) define the K+/Rb+ site in the Ca2+-ATPase conformation with bound Ca2+, ADP, and AlF4-. Functional analysis of Ca2+-ATPase mutants with alterations to Glu(732) shows that this site is indeed important for the stimulatory effect of K+ on the dephosphorylation rate. Comparison with the Ca2+-ATPase in a dephosphorylated E2 conformation suggests that the K+ site is involved in the correct movement and positioning of the A-domain during translocation and dephosphorylation.	Univ Aarhus, Dept Biophys, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark; Univ Aarhus, Ctr Struct Biol, Dept Mol Biol, DK-8000 Aarhus C, Denmark; Univ Aarhus, Dept Physiol, Inst Physiol & Biophys, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Moller, JV (corresponding author), Univ Aarhus, Dept Biophys, Inst Physiol & Biophys, Ole Worms Alle 158, DK-8000 Aarhus C, Denmark.	jvm@biophys.au.dk; jpa@fi.au.dk; nissen@bioxray.dk	Nissen, Poul/D-5774-2014; Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Vilsen, Bente/0000-0002-4727-9382; Lund Winther, Anne-Marie/0000-0002-5776-0989; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499; Nissen, Poul/0000-0003-0948-6628; Andersen, Jens Peter/0000-0003-0654-4300				ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buoninsegni FT, 2004, BIOPHYS J, V86, P3671, DOI 10.1529/biophysj.103.036608; Champeil P, 1997, BIOCHEMISTRY-US, V36, P12383, DOI 10.1021/bi9709699; CHAMPEIL P, 1986, J BIOL CHEM, V261, P6372; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2003, BIOCHEMISTRY-US, V42, P2585, DOI 10.1021/bi0271897; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; LEE AG, 1995, BIOCHEM J, V305, P225, DOI 10.1042/bj3050225; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; MEIS LD, 1971, J BIOL CHEM, V246, P4759; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER M, 1986, ADV PINEAL RES, V1, P51; Montigny C, 2004, J BIOL CHEM, V279, P43971, DOI 10.1074/jbc.M407142200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; SHIGEKAWA M, 1985, J BIOL CHEM, V260, P1679; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2000, J BIOL CHEM, V275, P28954, DOI 10.1074/jbc.M004072200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VARA F, 1982, J BIOL CHEM, V257, P2826; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330	27	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46355	46358		10.1074/jbc.C400414200	http://dx.doi.org/10.1074/jbc.C400414200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15383548	hybrid			2022-12-27	WOS:000224832400002
J	Kirilovsky, D; Roncel, M; Boussac, A; Wilson, A; Zurita, JL; Ducruet, JM; Bottin, H; Sugiura, M; Ortega, JM; Rutherford, AW				Kirilovsky, D; Roncel, M; Boussac, A; Wilson, A; Zurita, JL; Ducruet, JM; Bottin, H; Sugiura, M; Ortega, JM; Rutherford, AW			Cytochrome c(550) in the cyanobacterium Thermosynechococcus elongatus - Study of redox mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; EVOLVING PHOTOSYSTEM-II; PHOTOSYNTHETIC OXYGEN EVOLUTION; SP. PCC 6803; SYNECHOCOCCUS-ELONGATUS; THERMOLUMINESCENCE BANDS; PHOTOCHEMICAL ACTIVITY; ISOLATED CHLOROPLASTS; DELETION MUTAGENESIS; ANGSTROM RESOLUTION	Cytochrome c(550) is one of the extrinsic Photosystem II subunits in cyanobacteria and red algae. To study the possible role of the heme of the cytochrome c(550) we constructed two mutants of Thermosynechococcus elongatus in which the residue His-92, the sixth ligand of the heme, was replaced by a Met or a Cys in order to modify the redox properties of the heme. The H92M and H92C mutations changed the midpoint redox potential of the heme in the isolated cytochrome by +125 mV and -30 mV, respectively, compared with the wild type. The binding-induced increase of the redox potential observed in the wild type and the H92C mutant was absent in the H92M mutant. Both modified cytochromes were more easily detachable from the Photosystem II compared with the wild type. The Photosystem II activity in cells was not modified by the mutations suggesting that the redox potential of the cytochrome c(550) is not important for Photosystem II activity under normal growth conditions. A mutant lacking the cytochrome c(550) was also constructed. It showed a lowered affinity for Cl- and Ca2+ as reported earlier for the cytochrome c(550)-less Synechocystis 6803 mutant, but it showed a shorter lived S(2)Q(B)(-) state, rather than a stabilized S-2 state and rapid deactivation of the enzyme in the dark, which were characteristic of the Synechocystis mutant. It is suggested that the latter effects may be caused by loss ( or weaker binding) of the other extrinsic proteins rather than a direct effect of the absence of the cytochrome c(550).	CEA Saclay, URA Consejo Super Invest Cient 2096, Dept Biol Joliot Curie, Serv Bioenerget, F-91191 Gif Sur Yvette, France; Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; CSIC, Seville 41092, Spain	CEA; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC)	Kirilovsky, D (corresponding author), CEA Saclay, URA Consejo Super Invest Cient 2096, Dept Biol Joliot Curie, Serv Bioenerget, F-91191 Gif Sur Yvette, France.	diana.kirilovsky@cea.fr	Rutherford, Alfred W/A-7831-2019; RONCEL, MERCEDES/G-3035-2015; Ortega, José María/O-7697-2014; Kirilovsky, Diana/I-2359-2014	Rutherford, Alfred W/0000-0002-3124-154X; RONCEL, MERCEDES/0000-0001-8749-7432; Ortega, José María/0000-0002-7841-3687; Wilson, Adjele Flore/0000-0003-2622-3600; Kirilovsky, Diana/0000-0003-2146-3103				BERTHOMIEU C, 1992, BIOCHEMISTRY-US, V31, P11460, DOI 10.1021/bi00161a026; Blumberg WE, 1971, PROBES STRUCTURE FUN, V2, P215; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BURNAP RL, 1992, BIOCHEMISTRY-US, V31, P7404, DOI 10.1021/bi00147a027; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; Ducruet JM, 2003, J EXP BOT, V54, P2419, DOI 10.1093/jxb/erg268; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GOLDEN JW, 1988, SCIENCE, V242, P1421, DOI 10.1126/science.3144039; HOGANSON CW, 1990, BIOCHIM BIOPHYS ACTA, V1016, P203, DOI 10.1016/0005-2728(90)90059-D; HOLTON RW, 1963, SCIENCE, V142, P234, DOI 10.1126/science.142.3589.234; JOHNSON GN, 1995, BBA-BIOENERGETICS, V1229, P202, DOI 10.1016/0005-2728(95)00003-2; JOHNSON GN, 1994, BBA-BIOENERGETICS, V1184, P85, DOI 10.1016/0005-2728(94)90157-0; JOLIOT P, 1969, PHOTOCHEM PHOTOBIOL, V10, P309, DOI 10.1111/j.1751-1097.1969.tb05696.x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P599, DOI 10.1093/pcp/pce074; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kerfeld CA, 2003, PLANT CELL PHYSIOL, V44, P697, DOI 10.1093/pcp/pcg084; Kimura A, 2002, PLANT CELL PHYSIOL, V43, P932, DOI 10.1093/pcp/pcf110; KIRILOVSKY D, 1991, BIOCHIM BIOPHYS ACTA, V1060, P37, DOI 10.1016/S0005-2728(05)80116-1; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; KRIEGER A, 1993, BIOCHIM BIOPHYS ACTA, V1144, P411, DOI 10.1016/0005-2728(93)90128-3; LUMRY R, 1959, PLANT PHYSIOL, V34, P301, DOI 10.1104/pp.34.3.301; MIRANDA T, 1995, PHOTOSYNTH RES, V43, P251, DOI 10.1007/BF00029938; MIYAO M, 1987, BIOCHIM BIOPHYS ACTA, V890, P151, DOI 10.1016/0005-2728(87)90016-8; MOHANTY P, 1993, BIOCHIM BIOPHYS ACTA, V1144, P92, DOI 10.1016/0005-2728(93)90035-E; Muhlenhoff U, 1996, MOL GEN GENET, V252, P93, DOI 10.1007/s004389670011; NAVARRO JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P46, DOI 10.1006/abbi.1995.1202; NISHIYAMA Y, 1994, PLANT PHYSIOL, V105, P1313, DOI 10.1104/pp.105.4.1313; PAPAGEORGIOU GC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P361, DOI 10.1016/S0005-2728(05)80148-3; RIESKE JS, 1959, PLANT PHYSIOL, V34, P293, DOI 10.1104/pp.34.3.293; Roncel M, 2003, J BIOL INORG CHEM, V8, P206, DOI 10.1007/s00775-002-0406-7; RUTHERFORD AW, 1984, BIOCHIM BIOPHYS ACTA, V767, P548, DOI 10.1016/0005-2728(84)90054-9; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; SATOH K, 1972, PLANT CELL PHYSIOL, V13, P885, DOI 10.1093/oxfordjournals.pcp.a074800; Shen JR, 1997, J BIOL CHEM, V272, P17821, DOI 10.1074/jbc.272.28.17821; SHEN JR, 1995, BIOCHEMISTRY-US, V34, P12661, DOI 10.1021/bi00039a023; SHEN JR, 1995, J BIOL CHEM, V270, P6901, DOI 10.1074/jbc.270.12.6901; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; SHEN JR, 1992, FEBS LETT, V301, P145, DOI 10.1016/0014-5793(92)81235-E; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; VASS I, 1987, FEBS LETT, V211, P215, DOI 10.1016/0014-5793(87)81439-4; Vass I., 1992, TOPICS PHOTOSYNTHESI, P259; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	46	31	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					52869	52880		10.1074/jbc.M408206200	http://dx.doi.org/10.1074/jbc.M408206200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385568	Green Published, hybrid			2022-12-27	WOS:000225680600011
J	Azmi, S; Ozog, A; Taneja, R				Azmi, S; Ozog, A; Taneja, R			Sharp-1/DEC2 inhibits skeletal muscle differentiation through repression of myogenic transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; CELL-CYCLE; NEGATIVE REGULATOR; STRA13 EXPRESSION; GENE-EXPRESSION; MEF2 PROTEINS; DNA-BINDING; P19 CELLS; MYOD; ENHANCER	Skeletal muscle differentiation is regulated by the basic-helix-loop-helix (bHLH) family of transcription factors. The myogenic bHLH factors form heterodimers with the ubiquitously expressed bHLH E-proteins and bind E-box (CANNTG) sites present in the promoters of several muscle-specific genes. Our previous studies have shown that the bHLH factor Sharp-1 is expressed in skeletal muscle and interacts with MyoD and E-proteins. However, its role in regulation of myogenic differentiation remains unknown. We report here that endogenous Sharp-1 is expressed in proliferating C2C12 myoblasts and is down-regulated during myogenic differentiation. Constitutive expression of Sharp-1 in C2C12 myoblasts promotes cell cycle exit causing a decrease in cyclin D1 expression but blocks terminal differentiation. Although MyoD expression is not inhibited, the induction of differentiation-specific genes such as myogenin, MEF2C, and myosin heavy chain is impaired by Sharp-1 overexpression. We demonstrate that the interaction of Sharp-1 with MyoD and E-proteins results in reduced DNA binding and transactivation from MyoD-dependent E-box sites. Re-expression of MyoDsimilar toE47 rescues the differentiation defect imposed by Sharp-1, suggesting that myogenic bHLH factors function downstream of Sharp-1. Our data suggest that protein-protein interactions between Sharp-1, MyoD, and E47 resulting in interference with MyoD function underlies Sharp-1-mediated repression of myogenic differentiation.	Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Taneja, R (corresponding author), Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA.	reshma.taneja@mssm.edu	Taneja, Reshma/F-9658-2014	Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177				Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Azmi S, 2002, MECH DEVELOP, V114, P181, DOI 10.1016/S0925-4773(02)00049-7; Beadling C, 2001, ONCOGENE, V20, P1771, DOI 10.1038/sj.onc.1204212; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Cossins J, 2002, DEVELOPMENT, V129, P2195; CSERJESI P, 1991, MOL CELL BIOL, V11, P4854, DOI 10.1128/MCB.11.10.4854; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; FILVAROFF EH, 1994, DEVELOPMENT, V120, P1085; FRENCH BA, 1991, MOL CELL BIOL, V11, P2439, DOI 10.1128/MCB.11.5.2439; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Heller H, 2001, J BIOL CHEM, V276, P37307, DOI 10.1074/jbc.M103195200; Hughes M, 2004, DEV BIOL, V271, P26, DOI 10.1016/j.ydbio.2004.03.029; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LEDENT V, 2002, GENOME BIOL; Lemercier C, 1998, EMBO J, V17, P1412, DOI 10.1093/emboj/17.5.1412; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Olson E N, 1992, Semin Cell Biol, V3, P127; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Otten AD, 1997, CELL GROWTH DIFFER, V8, P1151; Porcher C, 1999, DEVELOPMENT, V126, P4603; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Rossner MJ, 1997, MOL CELL NEUROSCI, V9, P460, DOI 10.1006/mcne.1997.0640; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Seimiya M, 2002, BIOCHEM BIOPH RES CO, V292, P121, DOI 10.1006/bbrc.2002.6605; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Wang DZ, 2001, DEVELOPMENT, V128, P4623; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	61	64	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52643	52652		10.1074/jbc.M409188200	http://dx.doi.org/10.1074/jbc.M409188200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448136	hybrid			2022-12-27	WOS:000225493400111
J	Fernandez-Monreal, M; Lopez-Atalaya, JP; Benchenane, K; Cacquevel, M; Dulin, F; Le Caer, JP; Rossier, J; Jarrige, AC; MacKenzie, ET; Colloc'h, N; Ali, C; Vivien, D				Fernandez-Monreal, M; Lopez-Atalaya, JP; Benchenane, K; Cacquevel, M; Dulin, F; Le Caer, JP; Rossier, J; Jarrige, AC; MacKenzie, ET; Colloc'h, N; Ali, C; Vivien, D			Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR; NEURONAL DEGENERATION; PROTEASE INHIBITOR; MOUSE HIPPOCAMPUS; SERINE PROTEASES; SPLICE VARIANTS; LATE-PHASE; POTENTIATION; SEIZURE; MICE	Tissue-type plasminogen activator (tPA) has been involved in both physiological and pathological glutamatergic-dependent processes, such as synaptic plasticity, seizure, trauma, and stroke. In a previous study, we have shown that the proteolytic activity of tPA enhances the N-methyl-D-aspartate ( NMDA) receptor-mediated signaling in neurons (Nicole, O., Docagne, F., Ali, C., Margaill, I., Carmeliet, P., MacKenzie, E. T., Vivien, D., and Buisson, A. ( 2001) Nat. Med. 7, 59 - 64). Here, we show that tPA forms a direct complex with the amino-terminal domain (ATD) of the NR1 subunit of the NMDA receptor and cleaves this subunit at the arginine 260. Furthermore, point mutation analyses show that arginine 260 is necessary for both tPA-induced cleavage of the ATD of NR1 and tPA-induced potentiation of NMDA receptor signaling. Thus, tPA is the first binding protein described so far to interact with the ATD of NR1 and to modulate the NMDA receptor function.	Univ Caen, CNRS, UMR 6185, Ctr Cyceron, F-14074 Caen, France; Ecole Polytech, CNRS, UMR 7651, F-91128 Palaiseau, France; Ecole Super Phys & Chim Ind Ville Paris, CNRS, UMR 7637, F-75231 Paris 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Vivien, D (corresponding author), Univ Caen, CNRS, UMR 6185, Ctr Cyceron, Bd Henri Becquerel,BP 5229, F-14074 Caen, France.	d.vivien@neuro.unicaen.fr	Mackenzie, Eric Thomson/L-1938-2015; Lopez-Atalaya, Jose P/E-3983-2014; benchenane, karim/D-8023-2015; Colloc'h, Nathalie/L-1570-2015; Lopez-Atalaya, Jose P/M-3595-2018; Monreal, Monica Fernandez/P-6685-2019; LOPEZ-ATALAYA, JOSE P./ABC-6022-2020; Fernandez-Monreal, Mónica/I-7954-2012	benchenane, karim/0000-0001-7118-0748; Monreal, Monica Fernandez/0000-0001-7278-448X; Fernandez-Monreal, Mónica/0000-0001-7278-448X; MacKenzie, Eric T/0000-0003-1057-7033; LOPEZ-ATALAYA, JOSE P./0000-0001-6064-7584; Ali, Carine/0000-0001-8007-7910; VIVIEN, DENIS/0000-0002-7636-2185				Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Basham ME, 2001, J NEUROCHEM, V77, P318, DOI 10.1046/j.1471-4159.2001.t01-1-00239.x; Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011; Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; CARROLL PM, 1994, DEVELOPMENT, V120, P3173; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Davies BJ, 1998, J BIOL CHEM, V273, P23004, DOI 10.1074/jbc.273.36.23004; Douguet D, 2001, BIOINFORMATICS, V17, P752, DOI 10.1093/bioinformatics/17.8.752; DURAND GM, 1993, P NATL ACAD SCI USA, V90, P6731, DOI 10.1073/pnas.90.14.6731; Fernandez-Monreal M, 2004, MOL CELL NEUROSCI, V25, P594, DOI 10.1016/j.mcn.2003.11.002; Frey U, 1996, J NEUROSCI, V16, P2057; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gualandris A, 1996, J NEUROSCI, V16, P2220; Gveric D, 2001, BRAIN, V124, P1978, DOI 10.1093/brain/124.10.1978; Hoffman KB, 1998, BRAIN RES, V811, P29, DOI 10.1016/S0006-8993(98)00906-8; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liberatore GT, 2003, STROKE, V34, P537, DOI 10.1161/01.STR.0000049764.49162.76; Lu WQ, 2002, J NEUROSCI, V22, P10781; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Matys T, 2003, NAT MED, V9, P371, DOI 10.1038/nm0403-371; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Muller CM, 1998, NAT NEUROSCI, V1, P47, DOI 10.1038/248; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Petersen LC, 1996, BIOCHEMISTRY-US, V35, P266, DOI 10.1021/bi951501d; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; SEEDS NW, 1995, SCIENCE, V270, P1992, DOI 10.1126/science.270.5244.1992; SEEDS NW, 1992, ANN NY ACAD SCI, V667, P32; Seeds NW, 2003, J NEUROSCI, V23, P7368; Sharon R, 2002, MOL BRAIN RES, V104, P170, DOI 10.1016/S0169-328X(02)00354-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SUGIHARA H, 1992, BIOCHEM BIOPH RES CO, V185, P826, DOI 10.1016/0006-291X(92)91701-Q; SUMI Y, 1992, DEVELOPMENT, V116, P625; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Traynelis SF, 2001, NAT MED, V7, P17, DOI 10.1038/83289; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1997, J NEUROSCI, V17, P543; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	57	101	112	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50850	50856		10.1074/jbc.M407069200	http://dx.doi.org/10.1074/jbc.M407069200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448144	hybrid			2022-12-27	WOS:000225355800027
J	Griffith, CL; Klutts, JS; Zhang, LJ; Levery, SB; Doering, TL				Griffith, CL; Klutts, JS; Zhang, LJ; Levery, SB; Doering, TL			UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URIDINE DIPHOSPHOGLUCOSE DEHYDROGENASE; GLUCURONIC ACID DECARBOXYLASE; CELL-WALL POLYSACCHARIDES; MYOINOSITOL OXYGENASE; LIQUID-CHROMATOGRAPHY; FUNCTIONAL CLONING; SUBUNIT STRUCTURE; ESCHERICHIA-COLI; MUTANT STRAINS; O-ACETYLATION	Cryptococcus neoformans is a pathogenic fungus surrounded by an elaborate polysaccharide capsule that is strictly required for its virulence in humans and other mammals. Nearly half of the sugar residues in the capsule are derived from UDP-glucuronic acid or its metabolites. To examine the role of these nucleotide sugars in C. neoformans, the gene encoding UDP-glucose dehydrogenase was disrupted. Mass spectrometry analysis of nucleotide sugar pools showed that the resulting mutant lacked both UDP-glucuronic acid and its downstream product, UDP-xylose, thus confirming the effect of the knockout and indicating that an alternate pathway for UDP-glucuronic acid production was not used. The mutant was dramatically affected by the lack of specific sugar donors, demonstrating altered cell integrity, temperature sensitivity, lack of growth in an animal model of cryptococcosis, and morphological defects. Additionally, the polysaccharide capsule could not be detected on the mutant cells, although the possibility remains that abbreviated forms of capsule components are made, possibly without proper surface display. The capsule defect is largely independent of the other observed changes, as cells that are acapsular because of mutations in other genes show lack of virulence but do not exhibit alterations in cell integrity, temperature sensitivity, or cellular morphology. All of the observed alterations were reversed by correction of the gene disruption.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Univ New Hampshire, Dept Chem, Durham, NH 03824 USA	Washington University (WUSTL); Washington University (WUSTL); University System Of New Hampshire; University of New Hampshire	Doering, TL (corresponding author), Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	doering@wustl.edu		Klutts, James/0000-0003-3788-1940	NCRR NIH HHS [P20 RR16459] Funding Source: Medline; NIGMS NIH HHS [GM R01 069968, R01 GM066303, GM R01 066303, GM F32 072341] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM072341, R01GM066303, R01GM069968] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; AUSUBEL FM, 2004, CURRENT PROTOCOLS MO, V1; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; Belay T, 1997, INFECT IMMUN, V65, P718, DOI 10.1128/IAI.65.2.718-728.1997; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P7012, DOI 10.1021/bi000181h; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; CHERNIAK R, 1991, INFECT IMMUN, V59, P59, DOI 10.1128/IAI.59.1.59-64.1991; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; Cox GM, 1996, J MED VET MYCOL, V34, P385; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; FRANZEN JS, 1983, BIOCHIM BIOPHYS ACTA, V746, P146, DOI 10.1016/0167-4838(83)90068-7; FRANZEN JS, 1980, BIOCHIM BIOPHYS ACTA, V614, P242, DOI 10.1016/0005-2744(80)90214-4; GAINEY PA, 1972, BIOCHEM J, V129, P821, DOI 10.1042/bj1290821; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; JAENICKE R, 1986, BIOCHEMISTRY-US, V25, P7283, DOI 10.1021/bi00371a006; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Kanter U, 2003, YEAST, V20, P1317, DOI 10.1002/yea.1050; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; LOEWUS FA, 1962, P NATL ACAD SCI USA, V48, P421, DOI 10.1073/pnas.48.3.421; Maor BP, 2004, BIOCHEM J, V381, P131, DOI 10.1042/BJ20031075; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; NUMMILA K, 1995, MOL MICROBIOL, V16, P271, DOI 10.1111/j.1365-2958.1995.tb02299.x; Pierini LM, 2001, MOL MICROBIOL, V41, P105, DOI 10.1046/j.1365-2958.2001.02504.x; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; REDDY CC, 1981, J BIOL CHEM, V256, P8519; REDDY CC, 1981, J BIOL CHEM, V256, P8510; SASAKI K, 1984, PLANT CELL PHYSIOL, V25, P989; SCHILLER JG, 1976, BIOCHIM BIOPHYS ACTA, V453, P418, DOI 10.1016/0005-2795(76)90137-9; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Seitz B, 2000, PLANT J, V21, P537, DOI 10.1046/j.1365-313x.2000.00696.x; Sommer U, 2003, J BIOL CHEM, V278, P47724, DOI 10.1074/jbc.M307223200; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200	39	64	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51669	51676		10.1074/jbc.M408889200	http://dx.doi.org/10.1074/jbc.M408889200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383535	hybrid			2022-12-27	WOS:000225355800123
J	Inouye, M; Ke, HP; Yashio, A; Yamanaka, K; Nariya, H; Shimamoto, T; Inouye, S				Inouye, M; Ke, HP; Yashio, A; Yamanaka, K; Nariya, H; Shimamoto, T; Inouye, S			Complex formation between a putative 66-residue thumb domain of bacterial reverse transcriptase RT-Ec86 and the primer recognition RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; CDNA PRIMING REACTION; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; BIOSYNTHESIS; SEQUENCE; MSDNA	Reverse transcriptases (RT) are found in a minor population of Escherichia coli and are responsible for the synthesis of multicopy single-stranded DNA. These RTs specifically recognize RNA structures in their individual primer-template RNAs to initiate cDNA synthesis from the 2'-OH group of a specific internal G residue ( branching G residue). Here, we purified the 66-residue, C-terminal fragment of RT-Ec86, RT from E. coli, which is responsible for the synthesis of multicopy single-stranded DNA-Ec86. This fragment, RT-Ec86-( 255 - 320), was found to consist mainly of alpha-helical structures on the basis of its CD spectrum, which is consistent with the prediction of this region as the thumb domain from the structural alignment of RT-Ec86 with human immunodeficiency virus-1 RT. RT-Ec86-( 255 - 320) was able to bind to a 28-base synthetic RNA consisting of the 5'-end single-stranded RNA containing the branching G residue and the recognition stem-loop structure in the RT-Ec86 primer-template RNA with a K-d value of 5 x 10(-8) M. By stepwise shortening of the 5'-end single-stranded region of the RNA, RT-Ec86-( 255 - 320) was found still to be able to form a stable complex with only the stem-loop structure consisting of an 8-bp stem and a 3-base loop. In this stem-loop structure, the UUU loop was essential for the complex formation. RT-Ec73-(251 - 316) from another E. coli RT could not bind to the 28-base RNA for RT-Ec86 but could bind to its own stem-loop structure having a 3-base AGU loop. These results support the notion that the highly diverse C-terminal regions of bacterial RTs play an important role in recognizing their own specific primer-template RNA structure for the cDNA priming reaction.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; Kumamoto Univ, Inst Mol Embryol & Genet, Div Mol Cell Biol, Kumamoto 8620976, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Hiroshima University; Kumamoto University	Inouye, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 675 Hoes Lane, Piscataway, NJ 08854 USA.	inouye@umdnj.edu	Inouye, Sharon/R-7216-2019; Shimamoto, Tadashi/A-7109-2018	Shimamoto, Tadashi/0000-0002-5538-0595	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063853] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 R01 GM63853] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		HERZER PJ, 1992, MOL MICROBIOL, V6, P345, DOI 10.1111/j.1365-2958.1992.tb01477.x; HSU MY, 1989, J BIOL CHEM, V264, P6214; Inouye S, 1999, J BIOL CHEM, V274, P31236, DOI 10.1074/jbc.274.44.31236; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KAJITA Y, 1995, J BIOL CHEM, V270, P22167, DOI 10.1074/jbc.270.38.22167; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LAMPSON BC, 1989, SCIENCE, V243, P1033, DOI 10.1126/science.2466332; LIM D, 1989, CELL, V56, P891, DOI 10.1016/0092-8674(89)90693-4; LIM DB, 1992, MOL MICROBIOL, V6, P3531, DOI 10.1111/j.1365-2958.1992.tb01788.x; Lima TMO, 1997, PLASMID, V38, P25, DOI 10.1006/plas.1997.1298; Mao JR, 1997, J BACTERIOL, V179, P7865, DOI 10.1128/jb.179.24.7865-7868.1997; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; SHIMAMOTO T, 1995, J BIOL CHEM, V270, P581, DOI 10.1074/jbc.270.2.581; SHIMAMOTO T, 1993, J BIOL CHEM, V268, P2684; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; SUN J, 1991, J BACTERIOL, V173, P4171, DOI 10.1128/jb.173.13.4171-4181.1991; Yamanaka K, 2002, MOBILE DNA, VII, P784	17	3	3	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50735	50742		10.1074/jbc.M408462200	http://dx.doi.org/10.1074/jbc.M408462200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371452	hybrid			2022-12-27	WOS:000225355800015
J	Ahmed, R; Duncan, RF				Ahmed, R; Duncan, RF			Translational regulation of Hsp90 mRNA - AUG-proximal 5 '-untranslated region elements essential for preferential heat shock translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE-CHAIN INITIATION; GEL-ELECTROPHORESIS; SEQUENCE; CELLS; INACTIVATION; DEGRADATION; INHIBITION; 4E-BP	Heat shock in Drosophila results in repression of most normal (non-heat shock) mRNA translation and the preferential translation of the heat shock mRNAs. The sequence elements that confer preferential translation have been localized to the 5'-untranslated region (5'-UTR) for Hsp22 and Hsp70 mRNAs (in Drosophila). Hsp90 mRNA is unique among the heat shock mRNAs in having extensive secondary structure in its 5'-UTR and being abundantly represented in the non-heat shocked cell. In this study, we show that Hsp90 mRNA translation is inefficient at normal growth temperature, and substantially activated by heat shock. Its preferential translation is not based on an IRES-mediated translation pathway, because overexpression of eIF4E-BP inhibits its translation (and the translation of Hsp70 mRNA). The ability of Hsp90 mRNA to be preferentially translated is conferred by its 5'-UTR, but, in contrast to Hsp22 and -70, is primarily influenced by nucleotides close to the AUG initiation codon. We present a model to account for Hsp90 mRNA translation, incorporating results indicating that heat shock inhibits eIF4F activity, and that Hsp90 mRNA translation is sensitive to eIF4F inactivation.	Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Duncan, RF (corresponding author), Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA.	rduncan@usc.edu						BONNER JJ, 1984, CELL, V37, P979; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DUNCAN R, 1984, ANAL BIOCHEM, V138, P144, DOI 10.1016/0003-2697(84)90783-8; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; Duncan RF, 1999, EUR J BIOCHEM, V265, P728, DOI 10.1046/j.1432-1327.1999.00776.x; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; GARBE JC, 1989, GENETICS, V122, P403; Hess MA, 1996, NUCLEIC ACIDS RES, V24, P2441, DOI 10.1093/nar/24.12.2441; HOLMGREN R, 1981, P NATL ACAD SCI-BIOL, V78, P3775, DOI 10.1073/pnas.78.6.3775; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LINDQUIST S, 1990, ENZYME, V44, P147, DOI 10.1159/000468754; LINDQUIST S, 1980, J MOL BIOL, V137, P151, DOI 10.1016/0022-2836(80)90322-8; LINDQUIST S, 1987, TRANSLATIONAL REGULA, P187; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PANNIERS R, 1985, J BIOL CHEM, V260, P9648; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Scheper GC, 1997, J BIOL CHEM, V272, P26850, DOI 10.1074/jbc.272.43.26850; YOST HJ, 1990, TRENDS GENET, V6, P223, DOI 10.1016/0168-9525(90)90183-7; Yueh A, 2000, GENE DEV, V14, P414; YURA T, 1993, ANNU REV MICROBIOL, V47, P321, DOI 10.1146/annurev.mi.47.100193.001541; ZAPATA JM, 1991, J BIOL CHEM, V266, P16007; ZAPATA JM, 1994, J BIOL CHEM, V269, P18047; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49919	49930		10.1074/jbc.M404681200	http://dx.doi.org/10.1074/jbc.M404681200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15347681	hybrid			2022-12-27	WOS:000225229500047
J	Gutierrez-Juarez, R; Obici, S; Rossetti, L				Gutierrez-Juarez, R; Obici, S; Rossetti, L			Melanocortin-independent effects of leptin on hepatic glucose fluxes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSES INSULIN-RESISTANCE; CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; BODY-WEIGHT; VISCERAL ADIPOSITY; INDUCED ANOREXIA; ARCUATE NUCLEUS; SKELETAL-MUSCLE; GENE-EXPRESSION; CONSCIOUS RATS	Leptin and insulin share some hypothalamic signaling molecules, but their central administration induces different effects on hepatic glucose fluxes. Acute insulin infusion in the third cerebral ventricle inhibits endogenous glucose production (GP), whereas acute leptin infusion stimulates gluconeogenesis but does not alter GP because of a compensatory decrease in glycogenolysis. Because melanocortin agonists also stimulate hepatic gluconeogenesis, here we examined whether central melanocortin blockade modifies the acute effects of leptin on GP, on gluconeogenesis, on glycogenolysis, and/or on the hepatic expression of the gluconeogenic enzymes glucose-6-phosphatase (Glc-6-Pase) and phosphoenolpyruvate carboxykinase (PEPCK). Systemic or central administration of leptin alone did not alter GP, despite increasing both the rate of gluconeogenesis and the expression of Glc-6-Pase and PEPCK. When activation of the central melanocortin pathway was prevented, the effects of leptin on gluconeogenesis, Glc-6-Pase, and PEPCK were abolished, and a marked suppression of glycogenolysis resulted in decreased GP. We conclude that leptin regulates hepatic glucose fluxes through a melanocortin-dependent pathway leading to stimulation of gluconeogenesis and a melanocortin-independent pathway causing inhibition of GP and glycogenolysis.	Albert Einstein Coll Med, Ctr Diabet Res & Training, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Ctr Diabet Res & Training, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rossetti, L (corresponding author), Albert Einstein Coll Med, Ctr Diabet Res & Training, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048321, R01DK048321, R29DK045024, R01DK045024] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 45024, DK 48321] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Air EL, 2002, ENDOCRINOLOGY, V143, P2449, DOI 10.1210/en.143.6.2449; Bai YL, 1996, J BIOL CHEM, V271, P13939, DOI 10.1074/jbc.271.24.13939; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bluher S, 2004, DIABETES, V53, P82, DOI 10.2337/diabetes.53.1.82; Chinookoswong N, 1999, DIABETES, V48, P1487, DOI 10.2337/diabetes.48.7.1487; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; da Silva AA, 2004, HYPERTENSION, V43, P1312, DOI 10.1161/01.HYP.0000128421.23499.b9; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GIACCARI A, 1989, J CHROMATOGR-BIOMED, V497, P69, DOI 10.1016/0378-4347(89)80006-4; GIACCARI A, 1992, J CLIN INVEST, V89, P36, DOI 10.1172/JCI115583; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Hidaka S, 2002, FASEB J, V16, P509, DOI 10.1096/fj.01-0164com; HUANG W, 1994, J BIOL CHEM, V279, P21695; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kim YB, 2000, ENDOCRINOLOGY, V141, P2328, DOI 10.1210/en.141.7.2328; Lam NT, 2004, MOL ENDOCRINOL, V18, P1333, DOI 10.1210/me.2002-0193; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Muoio DM, 1999, AM J PHYSIOL-ENDOC M, V276, pE913, DOI 10.1152/ajpendo.1999.276.5.E913; Muzumdar R, 2003, FASEB J, V17, P1130, DOI 10.1096/fj.02-0991fje; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Pierroz DD, 2002, DIABETES, V51, P1337, DOI 10.2337/diabetes.51.5.1337; Rahmouni K, 2003, J NEUROSCI, V23, P5998, DOI 10.1523/JNEUROSCI.23-14-05998.2003; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; Rossetti L, 1997, J BIOL CHEM, V272, P27758, DOI 10.1074/jbc.272.44.27758; Rossetti L, 1996, J BIOL CHEM, V271, P203, DOI 10.1074/jbc.271.1.203; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shi ZQ, 1998, METABOLISM, V47, P1274, DOI 10.1016/S0026-0495(98)90336-5; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Yaspelkis BB, 2001, AM J PHYSIOL-ENDOC M, V280, pE130, DOI 10.1152/ajpendo.2001.280.1.E130; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	48	84	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49704	49715		10.1074/jbc.M408665200	http://dx.doi.org/10.1074/jbc.M408665200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364916	hybrid			2022-12-27	WOS:000225229500021
J	Kang, RJ; Swayze, R; Lise, MF; Gerrow, K; Mullard, A; Honer, WG; El-Husseini, A				Kang, RJ; Swayze, R; Lise, MF; Gerrow, K; Mullard, A; Honer, WG; El-Husseini, A			Presynaptic trafficking of synaptotagmin I is regulated by protein palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; FATTY ACYLATION; CALCIUM SENSOR; PC12 CELLS; T-SNARE; SNAP-25; BINDING; EXOCYTOSIS; DOMAINS	Protein palmitoylation plays a critical role in sorting and targeting of several proteins to pre- and postsynaptic sites. In this study, we have analyzed the role of palmitoylation in trafficking of synaptotagmin I and its modulation by synaptic activity. We found that palmitoylation of N-terminal cysteines contributed to sorting of synaptotagmin I to an intracellular vesicular compartment at the presynaptic terminal. Presynaptic targeting is a unique feature of N-terminal sequences of synaptotagmin I because the palmitoylated N terminus of synaptotagmin VII failed to localize to presynaptic sites. We also found that palmitate was stably associated with both synaptotagmin I and SNAP-25 and that rapid neuronal depolarization did not affect palmitate turnover on these proteins. However, long-term treatment with drugs that either block synaptic activity or disrupt SNARE complex assembly modulated palmitoylation and accumulation of synaptotagmin I at presynaptic sites. We conclude that palmitoylation is involved in trafficking of specific elements involved in transmitter release and that distinct mechanisms regulate addition and removal of palmitate on select neuronal proteins.	Univ British Columbia, Dept Psychiat, Ctr Complex Disorders, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	El-Husseini, A (corresponding author), Univ British Columbia, Dept Psychiat, Ctr Complex Disorders, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	alaa@interchange.ubc.ca		Swayze, Richard/0000-0003-0692-5648				Bradke F, 1998, BBA-MOL CELL RES, V1404, P245, DOI 10.1016/S0167-4889(98)00060-3; Calakos N, 1996, PHYSIOL REV, V76, P1; Chapman ER, 1996, BIOCHEM BIOPH RES CO, V225, P326, DOI 10.1006/bbrc.1996.1174; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Damer CK, 1996, J NEUROCHEM, V67, P1661; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; Fukuda M, 2000, J BIOL CHEM, V275, P28180; Fukuda M, 2001, J BIOL CHEM, V276, P27670, DOI 10.1074/jbc.M100851200; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Heindel U, 2003, FEBS LETT, V544, P57, DOI 10.1016/S0014-5793(03)00449-6; HESS DT, 1992, J NEUROSCI, V12, P4634; Honer WG, 1997, NEUROSCIENCE, V78, P99, DOI 10.1016/S0306-4522(96)00489-7; Kammer B, 2003, MOL CELL NEUROSCI, V23, P333, DOI 10.1016/S1044-7431(03)00064-2; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Krasnov PA, 2000, J CELL SCI, V113, P1389; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Patterson SI, 2002, BIOL RES, V35, P139, DOI 10.4067/S0716-97602002000200005; PERIN MS, 1991, J BIOL CHEM, V266, P623; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Veit M, 2000, BIOCHEM J, V345, P145, DOI 10.1042/0264-6021:3450145; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; ZUBER MX, 1989, NATURE, V341, P345, DOI 10.1038/341345a0	43	59	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50524	50536		10.1074/jbc.M404981200	http://dx.doi.org/10.1074/jbc.M404981200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355980	hybrid			2022-12-27	WOS:000225229500118
J	Xiao, RY; Wilkinson, B; Solovyov, A; Winther, JR; Holmgren, A; Lundstrom-Ljung, J; Gilbert, HF				Xiao, RY; Wilkinson, B; Solovyov, A; Winther, JR; Holmgren, A; Lundstrom-Ljung, J; Gilbert, HF			The contributions of protein disulfide isomerase and its homologues to oxidative protein folding in the yeast endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BOND FORMATION; ESCHERICHIA-COLI; RIBONUCLEASE-A; IN-VIVO; GENE; CATALYSIS; PATHWAY; THIOREDOXIN; SUPPRESSES	In vitro, protein disulfide isomerase (Pdi1p) introduces disulfides into proteins (oxidase activity) and provides quality control by catalyzing the rearrangement of incorrect disulfides (isomerase activity). Protein disulfide isomerase (PDI) is an essential protein in Saccharomyces cerevisiae, but the contributions of the catalytic activities of PDI to oxidative protein folding in the endoplasmic reticulum (ER) are unclear. Using variants of Pdi1p with impaired oxidase or isomerase activity, we show that isomerase-deficient mutants of PDI support wild-type growth even in a strain in which all of the PDI homologues of the yeast ER have been deleted. Although the oxidase activity of PDI is sufficient for wild-type growth, pulse-chase experiments monitoring the maturation of carboxypeptidase Y reveal that oxidative folding is greatly compromised in mutants that are defective in isomerase activity. Pdi1p and one or more of its ER homologues (Mpd1p, Mpd2p, Eug1p, Eps1p) are required for efficient carboxypeptidase Y maturation. Consistent with its function as a disulfide isomerase in vivo, the active sites of Pdi1p are partially reduced (32+/-8%) in vivo. These results suggest that PDI and its ER homologues contribute both oxidase and isomerase activities to the yeast ER. The isomerase activity of PDI can be compromised without affecting growth and viability, implying that yeast proteins that are essential under laboratory conditions may not require efficient disulfide isomerization.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; Carlsberg Lab, DK-2500 Copenhagen, Denmark; Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden	Baylor College of Medicine; Karolinska Institutet	Gilbert, HF (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, 1 Baylor Plaza, Houston, TX 77030 USA.	hgilbert@bcm.tmc.edu	Winther, Jakob R./K-4451-2014	Winther, Jakob R./0000-0001-6995-9154	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040379] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-40379] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Norgaard P, 2003, YEAST, V20, P645, DOI 10.1002/yea.978; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; SIKORSKI RS, 1989, GENETICS, V122, P19; Solovyov A, 2004, J BIOL CHEM, V279, P34095, DOI 10.1074/jbc.M405640200; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; TACHIBANA C, 1992, MOL CELL BIOL, V12, P4601, DOI 10.1128/MCB.12.10.4601; Tachikawa H, 1997, BIOCHEM BIOPH RES CO, V239, P710, DOI 10.1006/bbrc.1997.7426; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Walker KW, 1997, J BIOL CHEM, V272, P8845; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; Westphal V, 1999, J MOL BIOL, V286, P1229, DOI 10.1006/jmbi.1999.2560; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Xiao R, 2001, J BIOL CHEM, V276, P27975, DOI 10.1074/jbc.M104203200; Zhan XM, 1999, BIOTECHNOL PROGR, V15, P1033, DOI 10.1021/bp990083r	37	49	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49780	49786		10.1074/jbc.M409210200	http://dx.doi.org/10.1074/jbc.M409210200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377672	hybrid			2022-12-27	WOS:000225229500030
J	Zhao, LY; Liu, JL; Sidhu, GS; Niu, YX; Liu, Y; Wang, RP; Liao, DQ				Zhao, LY; Liu, JL; Sidhu, GS; Niu, YX; Liu, Y; Wang, RP; Liao, DQ			Negative regulation of p53 functions by Daxx and the involvement of MDM2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E1B 55-KILODALTON ONCOPROTEIN; EMBRYONIC LETHALITY; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; MDM2-DEFICIENT MICE; INDUCED APOPTOSIS; SYNDROME PROTEIN; TERMINAL DOMAIN; IN-VITRO; ACETYLATION	In normal cells p53 activity is tightly controlled and MDM2 is a known negative regulator. Here we show that via its acidic domain, Daxx binds to the COOH-terminal domain of p53, whose positive charges are critical for this interaction, as Lys to Arg mutations preserved, but Lys to Ala or Ser to Glu mutations abolished Daxx-p53 interaction. These results thus implicate acetylation and phosphorylation of p53 in regulating its binding to Daxx. Interestingly, whereas Daxx did not bind to p53 in cells as assessed by immunoprecipitation, MDM2 expression restored p53-Daxx interaction, and this correlated with deacetylation of p53. In p53/MDM2-null mouse embryonic fibroblasts (DKO MEF), Daxx repressed p53 target promoters whose p53-binding elements were required for the repression. Coexpression of Daxx and MDM2 led to further repression. p53 expression in DKO MEF induced apoptosis and Daxx expression relieved this effect. Similarly, in HCT116 cells, Daxx conferred striking resistance to 5-fluorouracil-induced apoptosis. As p53 is required for 5-fluorouracil-induced cell death, our data show that Daxx can suppress cell death induced by p53 overexpression and p53-dependent stress response. Collectively, our data reveal Daxx as a novel negative regulator of p53. Importantly, posttranslational modifications of p53 inhibit Daxx-p53 interaction, thereby relieving negative regulation of p53 by Daxx.	Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Sherbrooke, Fac Med, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1H 5N4, Canada	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Sherbrooke	Liao, DQ (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	dliao@ufl.edu			NATIONAL CANCER INSTITUTE [R01CA092236] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA92236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn J, 2001, NAT STRUCT BIOL, V8, P730, DOI 10.1038/nsb0901-730; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dornan D, 2003, J BIOL CHEM, V278, P13431, DOI 10.1074/jbc.M211460200; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Gongora R, 2001, IMMUNITY, V14, P727, DOI 10.1016/S1074-7613(01)00152-2; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hollenbach AD, 2002, J CELL SCI, V115, P3319; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jiang C, 1999, GENOMICS, V62, P508, DOI 10.1006/geno.1999.6052; JIN Y, 2002, J BIOL CHEM; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu Y, 2000, MOL CELL BIOL, V20, P5540, DOI 10.1128/MCB.20.15.5540-5553.2000; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohiro Y, 2003, MOL CELL BIOL, V23, P322, DOI 10.1128/MCB.23.1.322-334.2003; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Prives C, 1999, J PATHOL, V187, P112; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wiederschain D, 2001, J BIOL CHEM, V276, P27999, DOI 10.1074/jbc.M102400200; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhao LY, 2003, J VIROL, V77, P13171, DOI 10.1128/JVI.77.24.13171-13181.2003; Zhao LY, 2003, ONCOGENE, V22, P8316, DOI 10.1038/sj.onc.1206916; Zhao LY, 2003, J VIROL, V77, P11809, DOI 10.1128/JVI.77.21.11809-11821.2003; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	51	51	59	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50566	50579		10.1074/jbc.M406743200	http://dx.doi.org/10.1074/jbc.M406743200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364927	hybrid			2022-12-27	WOS:000225229500121
J	Lungu, AO; Jin, ZG; Yamawaki, H; Tanimoto, T; Wong, C; Berk, BC				Lungu, AO; Jin, ZG; Yamawaki, H; Tanimoto, T; Wong, C; Berk, BC			Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FLUID SHEAR-STRESS; INDUCED HYPERTENSION; STIMULATES PHOSPHORYLATION; IN-SITU; DYSFUNCTION; MECHANISMS; CALCIUM; CELLS; AKT	Fluid shear stress generated by blood flowing over the endothelium is a major determinant of arterial tone, vascular remodeling, and atherogenesis. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) plays an essential role in regulation of vascular function and structure by blood flow. Although cyclosporin A (CsA), an inhibitory ligand of cyclophilin A, is a widely used immunosuppressive drug, it causes arterial hypertension in part by impairing eNOS-dependent vasodilation. Here we show that CsA inhibits fluid shear stress-mediated eNOS activation in endothelial cells via decreasing cholesterol content in caveolae. Exposure of cultured bovine aortic endothelial cells to 1 muM CsA for 1 h significantly inhibited NO production and eNOS phosphorylation at Ser-1179 induced by flow (shear stress=12 dynes/cm(2)). The effect of CsA was not related to inhibition of two known eNOS kinases, protein kinase B (Akt) and protein kinase A, because CsA did not affect Akt or protein kinase A activation. In rabbit aorta perfused ex vivo, CsA also significantly inhibited flow-induced eNOS phosphorylation at Ser-1179 but had no effect on Akt measured by phosphorylation at Ser-473. However, CsA treatment decreased cholesterol content in caveolae and displaced eNOS from caveolae, which may be caused by CsA disrupting the association of caveolin-1 and cyclophilin A. The magnitude of the cholesterol depleting effect was similar to that of beta-cyclodextrin, a cholesterol-binding molecule, and beta-cyclodextrin had a similar inhibitory effect on flow-mediated eNOS activation. Treating bovine aortic endothelial cells for 24 h with 30 mug/ml cholesterol blocked the CsA effect and restored eNOS phosphorylation in response to flow. These data suggest that decreasing cholesterol content in caveolae by CsA is a potentially important pathogenic mechanism for CsA-induced endothelial dysfunction and hypertension.	Univ Rochester, Sch Med & Dent, Aab Inst Biomed Sci, Cardiovasc Res Ctr, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Aab Inst Biomed Sci, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Jin, ZG (corresponding author), Univ Rochester, Sch Med & Dent, Aab Inst Biomed Sci, Cardiovasc Res Ctr, 601 Elmwood Ave,Box 679, Rochester, NY 14642 USA.	zheng-gen_jin@urmc.rochester.edu		Berk, Bradford/0000-0002-2767-4115	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611, R01HL064839] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080611, HL-64839] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aizawa T, 2003, CIRC RES, V93, P406, DOI 10.1161/01.RES.0000091074.33584.F0; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Blair A, 1999, J BIOL CHEM, V274, P32512, DOI 10.1074/jbc.274.45.32512; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; Curtis JJ, 2002, CURR HYPERTENS REP, V4, P377, DOI 10.1007/s11906-002-0067-5; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DEHOFF JL, 1978, CLIN CHEM, V24, P433; DIEDERICH D, 1994, HYPERTENSION, V23, P957, DOI 10.1161/01.HYP.23.6.957; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; Gargalovic P, 2003, J LIPID RES, V44, P11, DOI 10.1194/jlr.R200005-JLR200; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Gonzalez E, 2002, J BIOL CHEM, V277, P39554, DOI 10.1074/jbc.M207299200; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; HIRATA K, 1995, HYPERTENSION, V25, P180, DOI 10.1161/01.HYP.25.2.180; Ito J, 2002, J BIOL CHEM, V277, P7929, DOI 10.1074/jbc.M103878200; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; KUCHAN MJ, 1994, AM J PHYSIOL, V266, pC628, DOI 10.1152/ajpcell.1994.266.3.C628; MALEK AM, 1993, P NATL ACAD SCI USA, V90, P5999, DOI 10.1073/pnas.90.13.5999; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Nichelle L, 2002, TRANSPLANT P, V34, P2824, DOI 10.1016/S0041-1345(02)03530-3; Oriji GK, 1999, AM J HYPERTENS, V12, P1091, DOI 10.1016/S0895-7061(99)00089-8; Oriji GK, 2001, PROSTAG LEUKOTR ESS, V65, P259, DOI 10.1054/plef.2001.0323; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; Peterson TE, 1999, CIRC RES, V85, P29; Razani B, 2001, J BIOL CHEM, V276, P38121; Rizzo V, 1998, J BIOL CHEM, V273, P26323, DOI 10.1074/jbc.273.41.26323; Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724; ROULLET JB, 1994, J CLIN INVEST, V93, P2244, DOI 10.1172/JCI117222; RUBANYI GM, 1986, AM J PHYSIOL, V250, P1145, DOI 10.1152/ajpheart.1986.250.6.H1145; Schwenger V, 2001, Curr Hypertens Rep, V3, P434, DOI 10.1007/s11906-001-0063-1; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SWANSON SKH, 1992, P NATL ACAD SCI USA, V89, P3741, DOI 10.1073/pnas.89.9.3741; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Yamawaki H, 2003, CIRCULATION, V108, P1619, DOI 10.1161/01.CIR.0000089373.49941.C4; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	51	66	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48794	48800		10.1074/jbc.M313897200	http://dx.doi.org/10.1074/jbc.M313897200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15383526	hybrid			2022-12-27	WOS:000225098100039
J	Silhan, J; Obsilova, V; Vecer, J; Herman, P; Sulc, M; Teisinger, J; Obsil, T				Silhan, J; Obsilova, V; Vecer, J; Herman, P; Sulc, M; Teisinger, J; Obsil, T			14-3-3 protein C-terminal stretch occupies ligand binding groove and is displaced by phosphopeptide binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; 14-3-3 PROTEINS; DNA-BINDING; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; ASSOCIATION; ACTIVATION; DOMAINS; SITE	14-3-3 proteins are important regulators of numerous cellular signaling circuits. They bind to phosphorylated protein ligands and regulate their functions by a number of different mechanisms. The C-terminal part of the 14-3-3 protein is known to be involved in the regulation of 14-3-3 binding properties. The structure of this region is unknown; however, a possible location of the C-terminal stretch within the ligand binding groove of the 14-3-3 protein has been suggested. To fully understand the role of the C-terminal stretch in the regulation of the 14-3-3 protein binding properties, we investigated the physical location of the C-terminal stretch and its changes upon the ligand binding. For this purpose, we have used Forster resonance energy transfer ( FRET) measurements and molecular dynamics simulation. FRET measurements between Trp(242) located at the end of the C-terminal stretch and a dansyl group attached at two different cysteine residues (Cys(25) or Cys(189)) indicated that in the absence of the ligand, the C-terminal stretch occupies the ligand binding groove of 14-3-3 protein. Our data also showed that phosphopeptide binding displaces the C-terminal stretch from the ligand binding groove. Intramolecular distances calculated from FRET measurements fit well with distances obtained from molecular dynamics simulation of full-length 14-3-3 zeta protein.	Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic; Charles Univ Prague, Fac Math & Phys, Inst Phys, CR-12116 Prague, Czech Republic; Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic; Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic.	obsil@natur.cuni.cz	Obsilova, Veronika/B-7116-2012; Sulc, Miroslav/K-1029-2014; Herman, Petr/A-2626-2008; Obsil, Tomas/B-7142-2012; Teisinger, Jan/B-7122-2012	Obsilova, Veronika/0000-0003-4887-0323; Sulc, Miroslav/0000-0002-2659-0489; Herman, Petr/0000-0001-6918-2576; Obsil, Tomas/0000-0003-4602-1272; 				BAUDETNESSLER S, 1993, BIOCHEMISTRY-US, V32, P8457, DOI 10.1021/bi00084a010; Bridges D, 2004, SCI STKE, V2004, pre10; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; BROCHON JC, 1999, FLUORESCENCE ANISOTR, P33; BRYAN RK, 1990, EUR BIOPHYS J, V18, P165, DOI 10.1007/BF02427376; CHEN R F, 1967, Analytical Letters, V1, P35; Dubois T, 1997, J BIOL CHEM, V272, P28882, DOI 10.1074/jbc.272.46.28882; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Hansson T, 1997, J MOL BIOL, V265, P118, DOI 10.1006/jmbi.1996.0716; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; ICHIMURA T, 1995, J BIOL CHEM, V270, P28515, DOI 10.1074/jbc.270.48.28515; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Polit A, 2003, EUR J BIOCHEM, V270, P1413, DOI 10.1046/j.1432-1033.2003.03497.x; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rommel C, 1996, ONCOGENE, V12, P609; Shen W, 2003, PLANT J, V34, P473, DOI 10.1046/j.1365-313X.2003.01739.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200	32	43	43	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49113	49119		10.1074/jbc.M408671200	http://dx.doi.org/10.1074/jbc.M408671200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347690	hybrid			2022-12-27	WOS:000225098100076
J	Yang, F; Peng, Y; Schoenberg, DR				Yang, F; Peng, Y; Schoenberg, DR			Endonuclease-mediated mRNA decay requires tyrosine phosphorylation of polysomal ribonuclease 1 (PMR1) for the targeting and degradation of polyribosome-bound substrate mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID-CELLS; XENOPUS-LAEVIS; CLEAVAGE; DESTABILIZATION; PROTEINS; KINASE; TURNOVER; PATHWAY; DOMAINS; REGION	PMR1 is an endonuclease that is activated by estrogen to degrade Xenopus albumin mRNA. A previous report showed that the functional unit of endonuclease-mediated mRNA decay is a similar to680-kDa polysome-bound complex that contains both PMR1 and substrate mRNA. PMR1 contains two domains involved in endonuclease targeting to polysomes, an N-terminal domain that lies between residues 200 and 250, and a C-terminal domain that lies within the last 100 residues. Loss of either domain inactivated PMR1 targeting to polysomes and stabilized albumin mRNA. The current study identified a phosphorylated tyrosine residue within the C-terminal polysome-targeting domain and showed that this modification is required for PMR1-mediated mRNA decay. Changing this tyrosine to phenylalanine inactivated the targeting of PMR1 to polysomes, blocked binding of PMR1 to the functional complex containing its substrate mRNA, prevented the targeting of a green fluorescent protein fusion protein to this complex, and stabilized albumin mRNA to degradation by PMR1 in vivo. A general tyrosine kinase inhibitor inhibited the phosphorylation of PMR1, which in turn inhibited PMR1-catalyzed degradation of albumin mRNA. These results indicate that one or more tyrosine kinases functions as a regulator of endonuclease-mediated mRNA decay.	Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Schoenberg, DR (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, 333 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	schoenberg.3@osu.edu	Schoenberg, Daniel/J-3423-2019	Schoenberg, Daniel/0000-0003-4570-1946	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038277] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, P30 CA16058] Funding Source: Medline; NIGMS NIH HHS [R01 GM038277, GM38277] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BINDER R, 1989, J BIOL CHEM, V264, P16910; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bremer KA, 2003, RNA, V9, P1157, DOI 10.1261/rna.5720303; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chernokalskaya E, 1998, RNA, V4, P1537, DOI 10.1017/S1355838298980451; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; Cunningham KS, 2001, NUCLEIC ACIDS RES, V29, P1156, DOI 10.1093/nar/29.5.1156; DAS GJ, 1998, RNA, V4, P766; DOMPENCIEL RE, 1995, J BIOL CHEM, V270, P6108, DOI 10.1074/jbc.270.11.6108; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Ming XF, 1998, EMBO J, V17, P6039, DOI 10.1093/emboj/17.20.6039; PASTORI RL, 1991, BIOCHEMISTRY-US, V30, P10490, DOI 10.1021/bi00107a018; PASTORI RL, 1991, MOL ENDOCRINOL, V5, P461, DOI 10.1210/mend-5-4-461; Schoenberg DR, 1999, METHODS, V17, P60, DOI 10.1006/meth.1998.0708; SCHOENBERG DR, 1989, MOL ENDOCRINOL, V3, P805, DOI 10.1210/mend-3-5-805; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; van Dijk EL, 2000, J MOL BIOL, V300, P449, DOI 10.1006/jmbi.2000.3856; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Yang F, 2004, MOL CELL, V14, P435, DOI 10.1016/j.molcel.2004.05.001	25	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48993	49002		10.1074/jbc.M409776200	http://dx.doi.org/10.1074/jbc.M409776200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15375158	Green Accepted, hybrid			2022-12-27	WOS:000225098100062
J	Deng, WL; Poppleton, H; Yasuda, S; Makarova, N; Shinozuka, Y; Wang, DA; Johnson, LR; Patel, TB; Tigyi, G				Deng, WL; Poppleton, H; Yasuda, S; Makarova, N; Shinozuka, Y; Wang, DA; Johnson, LR; Patel, TB; Tigyi, G			Optimal lysophosphatidic acid-induced DNA synthesis and cell migration but not survival require intact autophosphorylation sites of the epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; RAS-GRF/CDC25(MM) EXCHANGE FACTOR; INTESTINAL EPITHELIAL-CELLS; BETA-GAMMA-SUBUNITS; COUPLED RECEPTOR; EGF-RECEPTOR; TYROSINE KINASE; JUXTAMEMBRANE REGION; MITOGENIC ACTIVITY; RAS ACTIVATION	Lysophosphatidic acid (LPA)-elicited transphosphorylation of receptor tyrosine kinases has been implicated in mediating extracellular signal-regulated kinase (ERK)1/2 activation, which is necessary for LPA-induced cell proliferation, migration, and survival. B82L cells lack epidermal growth factor receptor ( EGFR) but express LPA(1-3), platelet-derived growth factor ( PDGF), ErbB2, and insulin-like growth factor receptor transcripts, yet LPA caused no detectable transphosphorylation of these receptor tyrosine kinases. LPA equally protected B82L cells, or transfectants expressing EGFR, the kinase dead EGFR(K721A), EGFR(Y5F) receptor mutant, which lacks five autophosphorylation sites, or EGFR(Y845F), which lacks the Src phosphorylation site from tumor necrosis factor-alpha-induced apoptosis. In contrast, LPA-elicited DNA synthesis and migration were augmented in cells expressing EGFR, EGFR(K721A), or EGFR(Y845F), but not EGFR(Y5F), although the PDGF responses were indistinguishable. LPA-induced transphosphorylation of the EGFR, ErbB2, or PDGF receptor was not required for its antiapoptotic effect. EGFR with or without intrinsic kinase activity or without the Src-phosphorylation site augmented, but was not required for, LPA-elicited cell proliferation or migration. In B82L cells, augmentation of these two LPA responses required intact autophosphorylation sites because among the four EGFR mutants, only cells expressing the EGFR(Y5F) mutant showed no enhancement. In EGFR(Y5F)-expressing cells, LPA failed to elicit tyrosine phosphorylation of Src homologous and collagen protein (SHC) and caused only a modest increase in ERK1/2 phosphorylation similar to that in wild-type B82L cells. The present data pinpoint the lack of importance of the intrinsic kinase activity in contrast to the importance of autophosphorylation sites of the EGFR for SHC phosphorylation in the enhancement of select ERK1/2-dependent LPA responses.	Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Ochanomizu Univ, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Ochanomizu University	Tigyi, G (corresponding author), 894 Union Ave, Memphis, TN 38163 USA.	gtigyi@physio1.utmem.edu		YASUDA, Satoshi/0000-0002-1011-0815	NCI NIH HHS [CA92160] Funding Source: Medline; NHLBI NIH HHS [HL59679, HL61469, HL48308] Funding Source: Medline; NIDDK NIH HHS [DK16505] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061469, R01HL059679, R01HL048308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK016505, R01DK016505] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Barbier AJ, 1999, J BIOL CHEM, V274, P14067, DOI 10.1074/jbc.274.20.14067; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Cunnick JM, 1998, J BIOL CHEM, V273, P14468, DOI 10.1074/jbc.273.23.14468; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DAUB H, 1996, NATURE, V379, P560; DECKER SJ, 1993, J BIOL CHEM, V268, P9176; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; Deng WL, 2003, AM J PHYSIOL-GASTR L, V284, pG821, DOI 10.1152/ajpgi.00406.2002; Deng WL, 2002, GASTROENTEROLOGY, V123, P206, DOI 10.1053/gast.2002.34209; Downward Julian, 2003, Biochem J, V376, pe9, DOI 10.1042/BJ20031745; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Goppelt-Struebe M, 2000, BIOCHEM J, V345, P217, DOI 10.1042/0264-6021:3450217; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Herrlich A, 1998, P NATL ACAD SCI USA, V95, P8985, DOI 10.1073/pnas.95.15.8985; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; Li J, 1999, J BIOL CHEM, V274, P11209, DOI 10.1074/jbc.274.16.11209; LI NX, 1994, ONCOGENE, V9, P3457; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Mattingly RR, 1999, CELL SIGNAL, V11, P603, DOI 10.1016/S0898-6568(99)00034-0; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; Poppleton H, 1996, J BIOL CHEM, V271, P6947, DOI 10.1074/jbc.271.12.6947; Poppleton HM, 1999, ARCH BIOCHEM BIOPHYS, V363, P227, DOI 10.1006/abbi.1998.1095; Poppleton HM, 2000, ARCH BIOCHEM BIOPHYS, V383, P309, DOI 10.1006/abbi.2000.2095; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ray RM, 2002, GASTROENTEROLOGY, V123, P196, DOI 10.1053/gast.2002.34216; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Rubio I, 2003, BIOCHEM J, V376, P571, DOI 10.1042/BJ20031410; Sakai T, 1999, J BIOL CHEM, V274, P15480, DOI 10.1074/jbc.274.22.15480; Sautin YY, 2001, AM J PHYSIOL-CELL PH, V281, pC2010, DOI 10.1152/ajpcell.00077.2001; SPIVAKKROIZMAN T, 1992, J BIOL CHEM, V267, P8056; Sun H, 1997, J BIOL CHEM, V272, P5413, DOI 10.1074/jbc.272.9.5413; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Wang DA, 2002, AM J PHYSIOL-CELL PH, V283, pC1646, DOI 10.1152/ajpcell.00323.2002; Wang LX, 2003, J BIOL CHEM, V278, P39931, DOI 10.1074/jbc.M302896200; WRIGHT JD, 1995, J BIOL CHEM, V270, P12085, DOI 10.1074/jbc.270.20.12085; Wright JD, 1996, BBA-MOL CELL RES, V1312, P85, DOI 10.1016/0167-4889(96)00027-4; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	52	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47871	47880		10.1074/jbc.M405443200	http://dx.doi.org/10.1074/jbc.M405443200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364923	hybrid			2022-12-27	WOS:000224957000057
J	Tanida, I; Ueno, T; Kominami, E				Tanida, I; Ueno, T; Kominami, E			Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met(121) to expose Gly(120) for lipidation and targeting to autophagosomal membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-ACTIVATING ENZYME; HOMOLOG; APG12P; MAP-LC3; GATE-16; GABARAP; CONJUGATION; APG7P/CVT2P; CYTOPLASM; APG8P	Human light chain 3/MAP1LC3B, an autophagosomal ortholog of yeast Atg8, is conjugated to phospholipid (PL) via ubiquitylation-like reactions mediated by human Atg7 and Atg3. Since human Atg4B was found to cleave the carboxyl terminus of MAP1LC3B in vitro, we hypothesized that this exposes its carboxyl-terminal Gly(120). It was recently reported, however, that when Myc-MAP1LC3B-His is expressed in HEK293 cells, its carboxyl terminus is not cleaved. (Tanida, I., Sou, Y.-s., Ezaki, J., Minematsu-Ikeguchi, N., Ueno, T., and Kominami, E. (2004) J. Biol. Chem. 279, 36268-36276). To clarify this contradiction, we sought to determine whether the carboxyl terminus of MAP1LC3B is cleaved to expose Gly(120) for further ubiquitylation-like reactions. When MAP1LC3B-3xFLAG and Myc-MAP1LC3B-His were expressed in HEK293 cells, their carboxyl termini were cleaved, whereas there was little cleavage of mutant proteins MAP1LC3B(G120A)-3xFLAG and Myc-MAP1LC3B(G120A)-His, containing Ala in place of Gly(120). An in vitro assay showed that Gly(120) is essential for carboxyl-terminal cleavage by human Atg4B as well as for formation of the intermediates Atg7-MAP1LC3B (ubiquitin-activating enzyme-substrate) and Atg3-MAP1LC3B (ubiquitin carrier protein-substrate). Recombinant MAP1LC3B-PL was fractionated into the 100,000 x g pellet in a manner similar to that shown for endogenous MAP1LC3B-PL. RNA interference of MAP1LC3B mRNA resulted in a decrease in both endogenous MAP1LC3B-PL and MAP1LC3B. These results indicate that the carboxyl terminus of MAP1LC3B is cleaved to expose Gly(120) for further ubiquitylation-like reactions.	Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan	Juntendo University	Kominami, E (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	kominami@med.juntendo.ac.jp	Kominami, Eiki/D-3802-2009; Tanida, Isei/C-8277-2009	Tanida, Isei/0000-0001-8999-3990				Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2004, AUTOPHAGY; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2002, BIOCHEM BIOPH RES CO, V292, P256, DOI 10.1006/bbrc.2002.6645; Tanida I, 2002, BIOCHEM BIOPH RES CO, V296, P1164, DOI 10.1016/S0006-291X(02)02057-0; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Yuan WP, 1999, MOL BIOL CELL, V10, P1353, DOI 10.1091/mbc.10.5.1353	18	206	216	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47704	47710		10.1074/jbc.M407016200	http://dx.doi.org/10.1074/jbc.M407016200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355958	hybrid			2022-12-27	WOS:000224957000036
J	Lytle, BL; Peterson, FC; Qiu, SH; Luo, M; Zhao, Q; Markley, JL; Volkman, BF				Lytle, BL; Peterson, FC; Qiu, SH; Luo, M; Zhao, Q; Markley, JL; Volkman, BF			Solution structure of a ubiquitin-like domain from tubulin-binding cofactor B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-TUBULIN; PROTEIN STRUCTURES; PB1 DOMAIN; FOLDING COFACTORS; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; FISSION YEAST; PC MOTIF; NMR; CHAPERONIN	Proper folding and assembly of tubulin alphabeta-heterodimers involves a stepwise progression mediated by a group of protein cofactors A through E. Upon release of the tubulin monomers from the chaperonin CCT, they are acted upon by each cofactor in the folding pathway through a unique combination of protein interaction domains. Three-dimensional structures have previously been reported for cofactor A and the C-terminal CAP-Gly domain of cofactor B (CoB). Here we report the NMR structure of the N-terminal domain of Caenorhabditis elegans CoB and show that it closely resembles ubiquitin as was recently postulated on the basis of bioinformatic analysis (Grynberg, M., Jaroszewski, L., and Godzik, A. (2003) BMC Bioinformatics 4, 46). CoB binds partially folded alpha-tubulin monomers, and a putative tubulin-binding motif within the N-terminal domain is identified from sequence and structure comparisons. Based on modeling of the homologous cofactor E ubiquitin-like domain, we hypothesize that cofactors B and E may associate via their beta-grasp domains in a manner analogous to the PB1 and caspase-activated deoxyribonuclease superfamily of protein interaction domains.	Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Univ Alabama, Ctr Biophys Sci & Engn, SE Collaboratory Struct Genom, Birmingham, AL 35294 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Volkman, BF (corresponding author), Ctr Eukaryot Struct Genom, Madison, WI 53706 USA.	bvolkman@mcw.edu	Volkman, Brian F./ABE-7312-2020; Volkman, Brian F./ABE-7306-2020	Volkman, Brian F./0000-0002-6681-5179; Volkman, Brian F./0000-0002-6681-5179	NIGMS NIH HHS [1 P50 GM64598] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064598] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Bartels C, 1996, J BIOMOL NMR, V7, P207, DOI 10.1007/BF00202037; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Billeter M, 1995, J BIOMOL NMR, V5, P1; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FONTALBA A, 1993, J CELL SCI, V106, P627; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Guasch A, 2002, J MOL BIOL, V318, P1139, DOI 10.1016/S0022-2836(02)00185-7; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MELKI R, 1993, J CELL BIOL, V122, P1301, DOI 10.1083/jcb.122.6.1301; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Otomo T, 2000, NAT STRUCT BIOL, V7, P658, DOI 10.1038/77957; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Ponting CP, 2002, TRENDS BIOCHEM SCI, V27, P10, DOI 10.1016/S0968-0004(01)02006-0; Radcliffe PA, 2000, MOL GEN GENET, V263, P752, DOI 10.1007/s004380000252; Radcliffe PA, 1999, MOL BIOL CELL, V10, P2987, DOI 10.1091/mbc.10.9.2987; Rickard JE, 1996, TRENDS CELL BIOL, V6, P178, DOI 10.1016/0962-8924(96)10017-9; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Steinbacher S, 1999, NAT STRUCT BIOL, V6, P1029, DOI 10.1038/14912; Terasawa H, 2001, EMBO J, V20, P3947, DOI 10.1093/emboj/20.15.3947; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yoshinaga S, 2003, EMBO J, V22, P4888, DOI 10.1093/emboj/cdg475	47	27	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46787	46793		10.1074/jbc.M409422200	http://dx.doi.org/10.1074/jbc.M409422200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15364906	hybrid			2022-12-27	WOS:000224832400058
J	Blatner, NR; Stahelin, RV; Diraviyam, K; Hawkins, PT; Hong, WJ; Murray, D; Cho, WH				Blatner, NR; Stahelin, RV; Diraviyam, K; Hawkins, PT; Hong, WJ; Murray, D; Cho, WH			The molecular basis of the differential subcellular localization of FYVE domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; SURFACE-PLASMON RESONANCE; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; PROTEIN INTERACTIONS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; EARLY ENDOSOMES; C2 DOMAINS; MEMBRANE; BINDING	This study systematically analyzed the structural and mechanistic basis of the regulation of subcellular membrane targeting using FYVE domains as a model. FYVE domains, which mediate the recruitment of signaling and membrane-trafficking proteins to phosphatidylinositol 3-phosphate-containing endosomes, exhibit distinct subcellular localization despite minor structural variations within the family. Biophysical measurements, cellular imaging, and computational analysis of various FYVE domains showed that the introduction of a single cationic residue and a hydrophobic loop into the membrane binding region of the FYVE domains dramatically enhanced their membrane interactions. The results indicated that there is a threshold affinity for endosomal localization and that endosomal targeting of FYVE domains is sensitive to small changes in membrane affinity about this threshold. Collectively these studies provide new insight into how subcellular localization of FYVE domains and other membrane targeting domains can be regulated by minimal structural and environmental changes.	Univ Illinois, Dept Chem, Chicago, IL 60607 USA; Cornell Univ, Weill Med Coll, Dept Immunol & Microbiol, New York, NY 10021 USA; Babraham Inst, Inositide Lab, Cambridge CB2 4AT, England; Inst Mol & Cell Biol, Membrane Biol Lab, Singapore 117609, Singapore	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cornell University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Cho, WH (corresponding author), Univ Illinois, Dept Chem, MC 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu	Stahelin, Robert/L-3567-2019; HONG, Wanjin/E-9927-2010	Stahelin, Robert/0000-0001-5443-7863; Hawkins, Phillip/0000-0002-6979-0464	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052598, R01GM053987, R01GM068849] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53987, GM68849, GM52598] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldi P, 1999, BIOINFORMATICS, V15, P937, DOI 10.1093/bioinformatics/15.11.937; Bates PA, 1999, PROTEINS, P47; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V558, P13, DOI 10.1016/0005-2736(79)90311-0; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BRUZIK KS, 1995, TETRAHEDRON LETT, V36, P2415, DOI 10.1016/0040-4039(95)00317-6; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Diraviyam K, 2003, J MOL BIOL, V328, P721, DOI 10.1016/S0022-2836(03)00325-5; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FERGUSON KM, 1995, NAT STRUCT BIOL, V2, P715, DOI 10.1038/nsb0995-715; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Ridley SH, 2001, J CELL SCI, V114, P3991; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VERGER R, 1982, CHEM PHYS LIPIDS, V30, P189, DOI 10.1016/0009-3084(82)90052-4; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xu Y, 2001, BIOCHEM J, V360, P513, DOI 10.1042/0264-6021:3600513; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	55	51	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53818	53827		10.1074/jbc.M408408200	http://dx.doi.org/10.1074/jbc.M408408200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15452113	hybrid			2022-12-27	WOS:000225680600120
J	Granier, S; Terrillon, S; Pascal, R; Demene, H; Bouvier, M; Guillon, G; Mendre, C				Granier, S; Terrillon, S; Pascal, R; Demene, H; Bouvier, M; Guillon, G; Mendre, C			A cyclic peptide mimicking the third intracellular loop of the V-2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; COUPLED RECEPTOR; SYNTHETIC PEPTIDES; PSEUDO-PROLINES; HIGH-AFFINITY; ACTIVATION; DIMERIZATION; BINDING; OLIGOMERIZATION; MEMBRANES	In this study, we investigated the mechanism by which a peptide mimicking the third cytoplasmic loop of the vasopressin V2 receptor inhibits signaling. This loop was synthesized as a cyclic peptide (i3 cyc) that adopted defined secondary structure in solution. We found that i3 cyc inhibited the adenylyl cyclase activity induced by vasopressin or a nonhydrolyzable analog of GTP, guanosine 5'-O-(3-thio) triphosphate. This peptide also affected the specific binding of [H-3] AVP by converting vasopressin binding sites from a high to a low affinity state without any effect on the global maximal binding capacity. The inhibitory actions of i3 cyc could also be observed in the presence of maximally uncoupling concentration of guanosine 5'-O-(3-thio) triphosphate, indicating a direct effect on the receptor itself and not exclusively on the interaction between the Gs protein and the V-2 receptor (V-2-R). Bioluminescence resonance energy-transfer experiments confirmed this assumption, because i3 cyc induced a significant inhibition of the bioluminescence resonance energy-transfer signal between the Renilla reniformis luciferase and the enhanced yellow fluorescent protein fused V-2-R. This suggests that the proper arrangement of the dimer could be an important prerequisite for triggering Gs protein activation. In addition to its effect on the receptor itself, the peptide exerted some of its actions at the G protein level, because it could also inhibit guanosine 5'-O-(3-thio) triphosphate-stimulated AC activity. Taken together, the data demonstrate that a peptide mimicking V-2-R third intracellular loop affects both the dimeric structural organization of the receptor and has direct inhibitory action on Gs.	CCIPE, INSERM, U469, F-34094 Montpellier, France; Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Univ Montpellier 2, UMR 5073, F-34095 Montpellier, France; Ctr Biochim Struct, CNRS, UMR 5048, INSERM,UMR 554,UM1, F-34060 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montreal; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Mendre, C (corresponding author), CCIPE, INSERM, U469, 141 Rue Cardonille, F-34094 Montpellier, France.	christiane.mendre@ccipe.cnrs.fr	Pascal, Robert/O-1559-2013; Bouvier, Michel/H-2758-2014; Granier, Sebastien/J-1089-2016; Déméné, Hélène/AAZ-1691-2021	Pascal, Robert/0000-0001-9579-2503; Bouvier, Michel/0000-0003-1128-0100; Déméné, Hélène/0000-0002-7531-4309				Andres M, 2002, BRIT J PHARMACOL, V135, P1828, DOI 10.1038/sj.bjp.0704634; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; BUTLEN D, 1978, MOL PHARMACOL, V14, P1006; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Demene H, 2003, BIOCHEMISTRY-US, V42, P8204, DOI 10.1021/bi027358n; Erlenbach I, 1998, J BIOL CHEM, V273, P26549, DOI 10.1074/jbc.273.41.26549; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FROESTL W, 1995, J MED CHEM, V38, P3313, DOI 10.1021/jm00017a016; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; GUILLON G, 1984, MOL PHARMACOL, V26, P241; Hayashida W, 1996, J BIOL CHEM, V271, P21985, DOI 10.1074/jbc.271.36.21985; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Kniazeff J, 2004, J NEUROSCI, V24, P370, DOI 10.1523/JNEUROSCI.3141-03.2004; KONIG B, 1994, BBA-MOL CELL RES, V1223, P261, DOI 10.1016/0167-4889(94)90235-6; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Liu J, 1996, J BIOL CHEM, V271, P8772, DOI 10.1074/jbc.271.15.8772; LUTTRELL LM, 1993, SCIENCE, V259, P1453, DOI 10.1126/science.8383880; Maggio R, 1996, J BIOL CHEM, V271, P31055, DOI 10.1074/jbc.271.49.31055; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mukhopadhyay S, 2001, EUR J BIOCHEM, V268, P499, DOI 10.1046/j.1432-1327.2001.01810.x; MUTTER M, 1995, PEPTIDE RES, V8, P145; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; ORLOFF J, 1962, J CLIN INVEST, V41, P702, DOI 10.1172/JCI104528; RANSNAS LA, 1988, J BIOL CHEM, V263, P17239; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; VARRAULT A, 1994, J BIOL CHEM, V269, P16720; Wohr T, 1996, J AM CHEM SOC, V118, P9218, DOI 10.1021/ja961509q; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	39	22	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50904	50914		10.1074/jbc.M405089200	http://dx.doi.org/10.1074/jbc.M405089200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452133	hybrid			2022-12-27	WOS:000225355800033
J	Maas, R				Maas, R			Prereplicative purine methylation and postreplicative demethylation in each DNA duplication of the Escherichia coli replication cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMID REPLICATION; REPA1 PROTEIN; METHYLTRANSFERASE; 7-METHYLGUANINE; GENE; 5-METHYLCYTOSINE; SENSITIVITY; MUTATIONS; REPLICON; INCREASE	Escherichia coli plasmid DNA activated for initiation of duplication is in a stable low linking number supercoiled conformation. Low linking number DNA is methylated at the internal purines of a frequent 5'-Pyr-Pyr-Pur- Pur tetramer with a 5'-Pyr-Pur-3' axis of symmetry and is cut at the axis of symmetry by pneumococcal restriction enzyme DpnI when methylated in both strands. Purine methylation is of adenine in one strand and guanine in the other. Methylation of one of the two purines is removed during the cell cycle, presumably before the reverse shift to the B-supercoiled conformation. The topological transition was reconstituted in vitro only with DNA unmethylated at purines. Methylation-restriction analyses coupled with the chemical properties of low-linking number DNA and B-DNA respectively, suggest that removal of guanine methylation is essential for the low-linking number to B-DNA transition and hence for the deactivation of replication. Demethylation of methylguanine could explain the presence in E. coli of the two-member inducible operon known as ada. Characteristics of ada suggest a cascade of chemical DNA modifications that reverse prereplicative guanine methylation. Guanine demethylation could provide a model for the pivotal role played by de novo methylation in replication and for the essential role of "repair" enzyme ExoIII in demethylation leading to the reversal of replicative DNA activation and other processes that affect DNA function.	NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Maas, R (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	maasr01@endeavor.med.nyu.edu						Bandaru B, 1996, J BIOL CHEM, V271, P7851, DOI 10.1074/jbc.271.13.7851; BOYE E, 1990, CELL, V62, P981, DOI 10.1016/0092-8674(90)90272-G; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; DEMPLE B, 1986, NUCLEIC ACIDS RES, V14, P5575, DOI 10.1093/nar/14.14.5575; DEMPLE B, 1982, J BIOL CHEM, V257, P13776; Gonzalgo ML, 1997, MUTAT RES-REV MUTAT, V386, P107, DOI 10.1016/S1383-5742(96)00047-6; GRIGG G, 1994, BIOESSAYS, V16, P431, DOI 10.1002/bies.950160612; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; JOHNSTON BH, 1985, CELL, V42, P713, DOI 10.1016/0092-8674(85)90268-5; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; KATAOKA H, 1985, MOL GEN GENET, V198, P263, DOI 10.1007/BF00383004; Kornberg A., 1992, DNA REPLICATION; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LITTLE JW, 1967, J BIOL CHEM, V242, P679; Maas R, 1997, J BACTERIOL, V179, P3823, DOI 10.1128/jb.179.12.3823-3827.1997; Maas R, 2001, CELL, V105, P945, DOI 10.1016/S0092-8674(01)00402-0; Maas R, 1997, J BACTERIOL, V179, P2163, DOI 10.1128/jb.179.7.2163-2168.1997; MACKAY WJ, 1994, J BACTERIOL, V176, P3224, DOI 10.1128/jb.176.11.3224-3230.1994; Maxam A M, 1980, Methods Enzymol, V65, P499; MESELSON M, 1958, P NATL ACAD SCI USA, V44, P671, DOI 10.1073/pnas.44.7.671; MOLLER A, 1981, P NATL ACAD SCI-BIOL, V78, P4777, DOI 10.1073/pnas.78.8.4777; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PAEK KH, 1986, J BACTERIOL, V165, P763, DOI 10.1128/jb.165.3.763-770.1986; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467; RIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P110; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; SAADI S, 1987, J BACTERIOL, V169, P1836, DOI 10.1128/jb.169.5.1836-1846.1987; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SASSANFAR M, 1991, J BIOL CHEM, V266, P2767; SASSEDWIGHT S, 1991, METHOD ENZYMOL, V208, P146; SCHENDEL PF, 1978, J BACTERIOL, V135, P466, DOI 10.1128/JB.135.2.466-475.1978; Sharath AN, 2000, BIOCHEMISTRY-US, V39, P14611, DOI 10.1021/bi001610e; TAN BH, 1990, MUTAT RES, V237, P229, DOI 10.1016/0921-8734(90)90004-B; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; YEBRA MJ, 1995, BIOCHEMISTRY-US, V34, P14752, DOI 10.1021/bi00045a016	36	1	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51568	51573		10.1074/jbc.M407394200	http://dx.doi.org/10.1074/jbc.M407394200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448156	hybrid			2022-12-27	WOS:000225355800112
J	Armstrong, JS; Yang, HY; Duan, W; Whiteman, M				Armstrong, JS; Yang, HY; Duan, W; Whiteman, M			Cytochrome bc(1) regulates the mitochondrial permeability transition by two distinct pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; IRON-SULFUR PROTEIN; RESPIRATORY-CHAIN; CELL-DEATH; CYCLOPHILIN-D; ELECTRON-TRANSFER; COMPLEX-III; SUPEROXIDE-PRODUCTION; HYDROGEN-PEROXIDE; BC1 COMPLEX	The mitochondrial permeability transition (MPT) pore is a calcium-sensitive channel in the mitochondrial inner membrane that plays a crucial role in cell death. Here we show that cytochrome bc(1) regulates the MPT in isolated rat liver mitochondria and in CEM and HL60 cells by two independent pathways. Glutathione depletion activated the MPT via increased production of reactive oxygen species (ROS) generated by cytochrome bc1. The ROS producing mechanism in cytochrome bc1 involves movement of the "Rieske" iron-sulfur protein subunit of the enzyme complex, because inhibition of cytochrome bc1 by pharmacologically blocking iron-sulfur protein movement completely abolished ROS production, MPT activation, and cell death. The classical inhibitor of the MPT, cyclosporine A, had no protective effect against MPT activation. In contrast, the calcium-activated, cyclosporine A-regulated MPT in rat liver mitochondria was also blocked with inhibitors of cytochrome bc1. These results indicate that electron flux through cytochrome bc1 regulates two distinct pathways to the MPT, one unregulated and involving mitochondrial ROS and the other regulated and activated by calcium.	Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore	National University of Singapore	Armstrong, JS (corresponding author), Natl Univ Singapore, Dept Biochem, Kent Rd, Singapore 117597, Singapore.	bchjsa@nus.edu.sg	Yang, Hongyuan/AAR-1326-2020; Whiteman, Matthew/C-6079-2009; Duan, Wei/A-5181-2015	Yang, Hongyuan/0000-0002-8482-6031; Whiteman, Matthew/0000-0002-6583-6779; Duan, Wei/0000-0001-5782-9184				Armstrong JS, 2003, J BIOL CHEM, V278, P49079, DOI 10.1074/jbc.M307841200; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; ARMSTRONG JS, 2004, IN PRESS IOVS; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; BASS DA, 1983, J IMMUNOL, V130, P1910; Bianchi C, 2003, BIOFACTORS, V18, P3, DOI 10.1002/biof.5520180202; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Boveris A, 2000, IUBMB LIFE, V50, P245, DOI 10.1080/15216540051080912; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Crompton M, 2000, J PHYSIOL-LONDON, V529, P11, DOI 10.1111/j.1469-7793.2000.00011.x; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; FAGIAN MM, 1990, J BIOL CHEM, V265, P19955; FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; He LH, 2003, J BIOL CHEM, V278, P16755, DOI 10.1074/jbc.M300153200; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lemasters JJ, 1999, BIOCHEM SOC SYMP, V66, P205, DOI 10.1042/bss0660205; Lemasters JJ, 1999, AM J PHYSIOL-GASTR L, V276, pG1, DOI 10.1152/ajpgi.1999.276.1.G1; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Moghaddas S, 2003, ARCH BIOCHEM BIOPHYS, V414, P59, DOI 10.1016/S0003-9861(03)00166-8; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; RAMSAY RR, 1981, P NATL ACAD SCI-BIOL, V78, P825, DOI 10.1073/pnas.78.2.825; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Sultan A, 2001, ARCH BIOCHEM BIOPHYS, V386, P37, DOI 10.1006/abbi.2000.2194; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Tsujimoto Y, 2002, BIOSCIENCE REP, V22, P47, DOI 10.1023/A:1016061006256; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Yang JH, 2001, J CELL SCI, V114, P1655; Yu CA, 1998, BBA-BIOENERGETICS, V1365, P151, DOI 10.1016/S0005-2728(98)00055-3; Zhang L, 2000, J BIOL CHEM, V275, P7656, DOI 10.1074/jbc.275.11.7656; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	55	45	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50420	50428		10.1074/jbc.M408882200	http://dx.doi.org/10.1074/jbc.M408882200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364912	Green Submitted, hybrid			2022-12-27	WOS:000225229500107
J	Copeland, JW; Copeland, SJ; Treisman, R				Copeland, JW; Copeland, SJ; Treisman, R			Homo-oligomerization is essential for F-actin assembly by the formin family FH2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; SMALL G-PROTEIN; DIAPHANOUS-RELATED FORMINS; CANINE KIDNEY-CELLS; SRF ACTIVITY; CYTOSKELETON; NUCLEATION; PROFILIN; DYNAMICS; MDIA1	Formin proteins regulate the actin and microtubule cytoskeletons and also control the activity of the SRF transcription factor through depletion of the G-actin pool. Although the conserved formin homology 2 (FH2) domains of the mDia1 and Bni1 formins can nucleate actin polymerization in vitro, the activity of other FH2 domains and the relationship between actin polymerization and microtubule reorganization have been controversial. We show that, similar to the mDia1 FH2 domain, the FH2 domains of mDia2 and ld are sufficient for SRF activation in vivo. We demonstrate that an mDia1 mutant defective for microtubule rearrangement in vivo is also defective in SRF activation in vivo as well as actin polymerization in vitro and that the mDia2 FH2 domain promotes actin polymerization in vitro. Using co-immunoprecipitation, we show that mDia1 is oligomeric in its inactive autoinhibited state in vivo, that the active mDia1 and mDia2 FH2 domains form homo- but not hetero-oligomers in vivo, and that oligomerization is abolished by inactivating FH2 deletion and point mutations. Nevertheless, inactive mDia1 FH2 domain mutants retain the ability to interfere with cellular mDia activity. Our results show that self-oligomerization is essential for SRF activation in vivo and F-actin assembly in vitro and provide strong support for recent structural models of the FH2 domain.	London Res Inst, Canc Res UK, Lincolns Inn Fields Labs, Transcript Lab, London C2A 3PX, England; London Res Inst, Canc Res UK, Lincolns Inn Fields Labs, Prot Isolat Lab, London C2A 3PX, England	Cancer Research UK; Cancer Research UK	Copeland, JW (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON K1H 8M5, Canada.	jcopelan@uottawa.ca		Treisman, Richard/0000-0002-9658-0067				Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Chan DC, 1996, J BIOL CHEM, V271, P23472, DOI 10.1074/jbc.271.38.23472; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Takaishi K, 2000, GENES CELLS, V5, P929, DOI 10.1046/j.1365-2443.2000.00377.x; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	27	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50250	50256		10.1074/jbc.M404429200	http://dx.doi.org/10.1074/jbc.M404429200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371418	hybrid			2022-12-27	WOS:000225229500086
J	Gan, XQ; Ma, ZH; Deng, N; Wang, JY; Ding, JP; Li, L				Gan, XQ; Ma, ZH; Deng, N; Wang, JY; Ding, JP; Li, L			Involvement of the C-terminal proline-rich motif of G protein-coupled receptor kinases in recognition of activated rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 GRK2; PHOSPHORYLATES TUBULIN; ESCHERICHIA-COLI; BETA-GAMMA; BINDING; DOMAIN; MECHANISM; SUBUNITS; MEMBRANE	G protein-coupled receptor kinases (GRKs) are a family of serine/threonine kinases that phosphorylate many activated G protein-coupled receptors (GPCRs) and play an important role in GPCR desensitization. Our previous work has demonstrated that the C-terminal conserved region (CC) of GRK-2 participates in interaction with rhodopsin and that this interaction is necessary for GRK-2-mediated receptor phosphorylation (Gan, X. Q., Wang, J. Y., Yang, Q. H., Li, Z., Liu, F., Pei, G., and Li, L. (2000) J. Biol. Chem. 275, 8469-8474). In this report, we further investigated whether the CC of other GRKs had the same functions and defined the specific sequences in CC that are required for the functions. The CC regions of GRK-1, GRK-2, and GRK-5, representatives of the three subfamilies of GRKs, could bind rhodopsin in vitro and inhibit GRK-2-mediated phosphorylation of rhodopsin, but not a peptide GRK substrate. Through a series of mutagenesis analyses, a proline-rich motif in the CC was identified as the key element involved in the interaction between the CC region and rhodopsin. Point mutations of this motif not only disrupted the interaction of GRK-2 with rhodopsin but also abolished the ability of GRK-2 to phosphorylate rhodopsin. The findings that the CC region of GRKs interact only with the light-activated but not the non-activated rhodopsin and that the N-terminal domain of GRK-2 interacts with rhodopsin in a light-independent manner suggest that the CC region is responsible for the recognition of activated GPCRs in the canonical model.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Proteom, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn	Ma, Zhihai/E-7130-2015; Deng, Ning/H-6561-2014	ding, jian ping/0000-0001-7029-7346; DENG, NING/0000-0002-1321-5508				Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Carman CV, 1998, J BIOL CHEM, V273, P20308, DOI 10.1074/jbc.273.32.20308; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; CHEN CY, 1993, J BIOL CHEM, V268, P7825; CHUANG TT, 1995, J BIOL CHEM, V270, P18660, DOI 10.1074/jbc.270.31.18660; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Day PW, 2003, BIOCHEMISTRY-US, V42, P9176, DOI 10.1021/bi034442+; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Freeman JLR, 1998, J BIOL CHEM, V273, P20653, DOI 10.1074/jbc.273.32.20653; Freeman JLR, 2002, BIOCHEMISTRY-US, V41, P12850, DOI 10.1021/bi020145d; Gan XQ, 1999, ACTA BIOCH BIOPH SIN, V31, P648; Gan XQ, 2000, J BIOL CHEM, V275, P8469, DOI 10.1074/jbc.275.12.8469; Haga K, 1998, EUR J BIOCHEM, V255, P363, DOI 10.1046/j.1432-1327.1998.2550363.x; INGLESE J, 1993, J BIOL CHEM, V268, P23735; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Oneyama C, 2003, CHEM BIOL, V10, P443, DOI 10.1016/S1074-5521(03)00101-7; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad SVN, 2001, J BIOL CHEM, V276, P18953, DOI 10.1074/jbc.M102376200; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Ruiz-Gomez A, 2000, J BIOL CHEM, V275, P29724, DOI 10.1074/jbc.M001864200; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; SHI W, 1995, J BIOL CHEM, V270, P2112, DOI 10.1074/jbc.270.5.2112; Shiina T, 2001, J BIOL CHEM, V276, P33019, DOI 10.1074/jbc.M100140200; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Yang QH, 1997, PROTEIN EXPRES PURIF, V10, P320, DOI 10.1006/prep.1997.0749	37	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49741	49746		10.1074/jbc.M407570200	http://dx.doi.org/10.1074/jbc.M407570200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375171	hybrid			2022-12-27	WOS:000225229500025
J	Garside, H; Stevens, A; Farrow, S; Normand, C; Houle, B; Berry, A; Maschera, B; Ray, D				Garside, H; Stevens, A; Farrow, S; Normand, C; Houle, B; Berry, A; Maschera, B; Ray, D			Glucocorticoid ligands specify different interactions with NF-kappa B by allosteric effects on the glucocorticoid receptor DNA binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; LIVING CELLS; CROSS-TALK; REPRESSION; ANTAGONISM; PROTEIN; COACTIVATOR-1; RECRUITMENT; INHIBITION	Glucocorticoids inhibit inflammation by acting through the glucocorticoid receptor (GR) and powerfully repressing NF-kappaB function. Ligand binding to the C-terminal of GR promotes the nuclear translocation of the receptor and binding to NF-kappaB through the GR DNA binding domain. We sought how ligand recognition influences the interaction between NF-kappaB and GR. Both dexamethasone ( agonist) and RU486 ( antagonist) promote efficient nuclear translocation, and we show occupancy of the same intranuclear compartment as NF-kappaB with both ligands. However, unlike dexamethasone, RU486 had negligible activity to inhibit NF-kappaB transactivation. This failure may stem from altered co-factor recruitment or altered interaction with NF-kappaB. Using both glutathione S-transferase pull-down and bioluminescence resonance energy transfer approaches, we identified a major glucocorticoid ligand effect on interaction between the GR and the p65 component of NF-kappaB, with RU486 inhibiting recruitment compared with dexamethasone. Using the bioluminescence resonance energy transfer assay, we found that RU486 efficiently recruited NCoR to the GR, unlike dexamethasone, which recruited SRC1. Therefore, RU486 promotes differential protein recruitment to both the C-terminal and DNA binding domain of the receptor. Importantly, using chromatin immunoprecipitation, we show that impaired interaction between GR and p65 with RU486 leads to reduced recruitment of the GR to the NF-kappaB-responsive region of the interleukin-8 promoter, again in contrast to dexamethasone that significantly increased GR binding. We demonstrate that ligand-induced conformation of the GR C-terminal has profound effects on the functional surface generated by the DNA binding domain of the GR. This has implications for understanding ligand-dependent interdomain communication.	Univ Manchester, Fac Med, Ctr Mol Med, Manchester M13 9PT, Lancs, England; Univ Manchester, Fac Med, Endocrine Sci Res Grp, Manchester M13 9PT, Lancs, England; GlaxoSmithKline, Dept Asthma Biol, Stevenage SG1 2NY, Herts, England; PerkinElmer Biosignal Inc, PerkinElmer Life & Analyt Sci, Montreal, PQ H3J 1R4, Canada; Montreal Proteom Network, Montreal, PQ, Canada	University of Manchester; University of Manchester; GlaxoSmithKline	Ray, D (corresponding author), Univ Manchester, Fac Med, Ctr Mol Med, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.w.ray@man.ac.uk	Stevens, Adam/D-6476-2012; Stevens, Adam/AAB-6301-2020	Stevens, Adam/0000-0002-1950-7325; Stevens, Adam/0000-0002-1950-7325; Ray, David/0000-0002-4739-6773				AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BECK CA, 1993, ENDOCRINOLOGY, V133, P728, DOI 10.1210/en.133.2.728; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Doucas V, 2000, P NATL ACAD SCI USA, V97, P11893, DOI 10.1073/pnas.220413297; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Nelson G, 2002, J CELL SCI, V115, P1137; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Pandit S, 2002, J BIOL CHEM, V277, P1538, DOI 10.1074/jbc.M105438200; QI M, 1990, MOL ENDOCRINOL, V4, P455, DOI 10.1210/mend-4-3-455; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHMIDT TJ, 1986, J STEROID BIOCHEM, V24, P853, DOI 10.1016/0022-4731(86)90446-2; Schulz M, 2002, J BIOL CHEM, V277, P26238, DOI 10.1074/jbc.M203268200; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Stevens A, 2003, MOL ENDOCRINOL, V17, P845, DOI 10.1210/me.2002-0320; Widen C, 2003, BIOCHEM J, V373, P211, DOI 10.1042/BJ20030175	30	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50050	50059		10.1074/jbc.M407309200	http://dx.doi.org/10.1074/jbc.M407309200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15355994	hybrid			2022-12-27	WOS:000225229500063
J	Kim, SJ; Kim, JH; Kim, YG; Lim, HS; Oh, JW				Kim, SJ; Kim, JH; Kim, YG; Lim, HS; Oh, JW			Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; POTENTIAL EFFECTOR; CATALYTIC DOMAIN; PHAGE DISPLAY; CDNA-CLONE; INITIATION; NS5B; REPLICATION; EXPRESSION	The hepatitis C virus (HCV) NS5B protein is the viral RNA-dependent RNA polymerase required for replication of the HCV RNA genome. We have identified a peptide that most closely resembles a short region of the protein kinase C-related kinase 2 (PRK2) by screening of a random 12-mer peptide library displayed on the surface of the M13 bacteriophage with NS5B proteins immobilized on microwell plates. Competitive phage enzyme-linked immunosorbent assay with a synthetic peptide showed that the phage clone displaying this peptide could bind HCV RNA polymerase with a high affinity. Coimmunoprecipitation and colocalization studies demonstrated in vivo interaction of NS5B with PRK2. In vitro kinase assays demonstrated that PRK2 specifically phosphorylates NS5B by interaction with the N-terminal finger domain of NS5B ( amino acids 1 - 187). Consistent with the in vitro NS5B-phosphorylating activity of PRK2, we detected the phosphorylated form of NS5B by metabolic cell labeling. Furthermore, HCV NS5B immunoprecipitated from HCV subgenomic replicon cells was specifically recognized by an antiphosphoserine antibody. Knock-down of the endogenous PRK2 expression using a PRK2-specific small interfering RNA inhibited HCV RNA replication. In contrast, PRK2 overexpression, which was accompanied by an increase of in the level of its active form, dramatically enhanced HCV RNA replication. Altogether, our results indicate that HCV RNA replication is regulated by NS5B phosphorylation by PRK2.	Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea	Yonsei University	Oh, JW (corresponding author), Yonsei Univ, Dept Biotechnol, 134 Sinchon Dong, Seoul 120749, South Korea.	jwoh@yonsei.ac.kr						Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Amin A, 2003, VIROLOGY, V313, P158, DOI 10.1016/S0042-6822(03)00313-1; Bahr C, 2000, J BIOL CHEM, V275, P36350, DOI 10.1074/jbc.M004771200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cortese R, 1996, CURR OPIN BIOTECH, V7, P616, DOI 10.1016/S0958-1669(96)80072-3; Cryns VL, 1997, J BIOL CHEM, V272, P29449, DOI 10.1074/jbc.272.47.29449; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Di Bisceglie Adrian M., 1998, Hepatology, V28, P1161, DOI 10.1002/hep.510280436; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hericourt F, 2000, BIOCHEM J, V349, P417, DOI 10.1042/0264-6021:3490417; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Hwang SB, 1997, VIROLOGY, V227, P439, DOI 10.1006/viro.1996.8357; Ishida R, 2001, CELL STRUCT FUNCT, V26, P215, DOI 10.1247/csf.26.215; Ishido S, 1998, BIOCHEM BIOPH RES CO, V244, P35, DOI 10.1006/bbrc.1998.8202; Ivashkina N, 2002, J VIROL, V76, P13088, DOI 10.1128/JVI.76.24.13088-13093.2002; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; KAVANAUGH WM, 1994, BIOCHEMISTRY-US, V33, P11046, DOI 10.1021/bi00202a026; Kay BK, 2001, METHODS, V24, P240, DOI 10.1006/meth.2001.1185; Kim SH, 2002, EMBO J, V21, P2292, DOI 10.1093/emboj/21.9.2292; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; KITAGAWA M, 1995, BIOCHEM J, V310, P657, DOI 10.1042/bj3100657; Koh H, 2000, J BIOL CHEM, V275, P34451, DOI 10.1074/jbc.M001753200; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee KJ, 2004, J VIROL, V78, P3797, DOI 10.1128/JVI.78.7.3797-3802.2004; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1996, J HEPATOL, V24, P11; LOHR HF, 1994, LIVER, V14, P161; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Mottola G, 2002, VIROLOGY, V293, P31, DOI 10.1006/viro.2001.1229; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; Neddermann P, 1999, J VIROL, V73, P9984, DOI 10.1128/JVI.73.12.9984-9991.1999; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Oh JW, 2000, J BIOL CHEM, V275, P17710, DOI 10.1074/jbc.M908781199; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Quilliam LA, 1996, J BIOL CHEM, V271, P28772, DOI 10.1074/jbc.271.46.28772; Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Schub O, 2001, J BIOL CHEM, V276, P38076; Sun WY, 2000, J BIOL CHEM, V275, P24421, DOI 10.1074/jbc.M003148200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Uchida M, 2002, HEPATOL RES, V22, P297, DOI 10.1016/S1386-6346(02)00005-0; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Wang MT, 2003, J BIOL CHEM, V278, P9489, DOI 10.1074/jbc.M209397200; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Yamamoto S, 2001, MOL CELL BIOL, V21, P1, DOI 10.1128/MCB.21.1.1-15.2001; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yu WP, 1997, J BIOL CHEM, V272, P10030; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	74	58	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50031	50041		10.1074/jbc.M408617200	http://dx.doi.org/10.1074/jbc.M408617200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364941	hybrid			2022-12-27	WOS:000225229500061
J	Mesmin, B; Robbe, K; Geny, B; Luton, F; Brandolin, G; Popoff, MR; Antonny, B				Mesmin, B; Robbe, K; Geny, B; Luton, F; Brandolin, G; Popoff, MR; Antonny, B			A phosphatidylserine-binding site in the cytosolic fragment of Clostridium sordellii lethal toxin facilitates glucosylation of membrane-bound Rac and is required for cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-PROTEINS; HA-RAS; COMPLEX; DOMAIN; MONOGLUCOSYLATION; TRANSLOCATION; CONSEQUENCES; LOCALIZATION; PURIFICATION; REGION	Large clostridial toxins glucosylate some small G proteins on a threonine residue, thereby preventing their interactions with effector molecules and regulators. We show that the glucosyltransferase domain of lethal toxin from Clostridium sordellii (LTcyt; amino acids 1-546), which is released into the cytosol during cell infection, binds preferentially to liposomes containing phosphatidylserine as compared with other anionic lipids. The binding of LTcyt to phosphatidylserine increases by two orders of magnitude the rate of glucosylation of liposome-bound geranyl-geranylated Rac-GDP. Limited proteolysis and deletion studies show that the binding site for phosphatidylserine lies within the first 18 N-terminal residues of LTcyt. Deletion of these residues abolishes the effect of phosphatidylserine on the activity of LTcyt on liposome-bound geranyl-geranylated Rac-GDP and prevents the morphological effects induced by LTcyt microinjection into various cells, but it does not affect the intrinsic activity of LTcyt on non-geranyl-geranylated Rac-GDP in solution. We conclude that the avidity of LTcyt for phosphatidylserine facilitates its targeting to the cytosolic leaflet of cell membranes and, notably, the plasma membrane, where this anionic lipid is abundant and where several targets of lethal toxin reside.	Inst Pasteur, Unite Bacteries Anaerobies & Toxines, F-75724 Paris 15, France; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Grenoble 1, CNRS, CEA, UMR 5092,Lab Biochim & Biophys Syst Integres, F-38054 Grenoble 9, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Popoff, MR (corresponding author), Inst Pasteur, Unite Bacteries Anaerobies & Toxines, 28 Rue Dr Roux, F-75724 Paris 15, France.	mpopoff@pasteur.fr; antonny@ipmc.cnrs.fr	Antonny, Bruno/ABH-7434-2020; Mesmin, Bruno/N-9246-2017; Luton, Frederic/N-7673-2017; Robbe-Sermesant, Karine/Q-2253-2016	Antonny, Bruno/0000-0002-9166-8668; Robbe-Sermesant, Karine/0000-0003-0580-3817; Mesmin, Bruno/0000-0002-5437-3246				Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Bhatnagar RS, 1997, TRENDS CELL BIOL, V7, P14, DOI 10.1016/S0962-8924(97)10044-7; Busch C, 1998, J BIOL CHEM, V273, P19566, DOI 10.1074/jbc.273.31.19566; Busch C, 2000, CURR OPIN STRUC BIOL, V10, P528, DOI 10.1016/S0959-440X(00)00126-3; Caccin P, 2003, FEBS LETT, V542, P132, DOI 10.1016/S0014-5793(03)00365-X; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Genth H, 1999, J BIOL CHEM, V274, P29050, DOI 10.1074/jbc.274.41.29050; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Herrmann C, 1998, J BIOL CHEM, V273, P16134, DOI 10.1074/jbc.273.26.16134; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hofmann F, 1998, INFECT IMMUN, V66, P1076, DOI 10.1128/IAI.66.3.1076-1081.1998; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Just I, 2000, HANDB EXP PHARM, V145, P307; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Murray D, 2002, CURR TOP MEMBR, V52, P277; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; POPOFF MR, 1987, INFECT IMMUN, V55, P35, DOI 10.1128/IAI.55.1.35-43.1987; Popoff MR, 1996, J BIOL CHEM, V271, P10217, DOI 10.1074/jbc.271.17.10217; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qa'Dan M, 2001, INFECT IMMUN, V69, P5487, DOI 10.1128/IAI.69.9.5487-5493.2001; Read PW, 2000, METHOD ENZYMOL, V325, P15; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Sehr P, 1998, BIOCHEMISTRY-US, V37, P5296, DOI 10.1021/bi972592c; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Vetter IR, 2000, J MOL BIOL, V301, P1091, DOI 10.1006/jmbi.2000.4045	33	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49876	49882		10.1074/jbc.M406903200	http://dx.doi.org/10.1074/jbc.M406903200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383551	hybrid			2022-12-27	WOS:000225229500041
J	Rossi, F; Han, Q; Li, JS; Li, JY; Rizzi, M				Rossi, F; Han, Q; Li, JS; Li, JY; Rizzi, M			Crystal structure of human kynurenine aminotransferase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-PHENYLPYRUVATE AMINOTRANSFERASE; THERMUS-THERMOPHILUS HB8; ASPARTATE-AMINOTRANSFERASE; BLOOD-PRESSURE; RAT-BRAIN; ACID; BIOACTIVATION; TRANSAMINASE; EXPRESSION; RECEPTOR	The kynurenine pathway has long been regarded as a valuable target for the treatment of several neurological disorders accompanied by unbalanced levels of metabolites along the catabolic cascade, kynurenic acid among them. The irreversible transamination of kynurenine is the sole source of kynurenic acid, and it is catalyzed by different isoforms of the 5'-pyridoxal phosphate-dependent kynurenine aminotransferase (KAT). The KAT-I isozyme has also been reported to possess beta-lyase activity toward several sulfur- and selenium-conjugated molecules, leading to the proposal of a role of the enzyme in carcinogenesis associated with environmental pollutants. We solved the structure of human KAT-I in its 5'-pyridoxal phosphate and pyridoxamine phosphate forms and in complex with the competing substrate L-Phe. The enzyme active site revealed a striking crown of aromatic residues decorating the ligand binding pocket, which we propose as a major molecular determinant for substrate recognition. Ligand-induced conformational changes affecting Tyr(101) and the Trp(18)-bearing alpha-helix H1 appear to play a central role in catalysis. Our data reveal a key structural role of Glu(27), providing a molecular basis for the reported loss of enzymatic activity displayed by the equivalent Glu-->Gly mutation in KAT-I of spontaneously hypertensive rats.	Univ Piemonte Orientale Amedeo Avogadro, DiSCAFF, Ist Nazl Fis Mat, I-28100 Novara, Italy; Univ Illinois, Dept Pathobiol, Urbana, IL 61802 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Eastern Piedmont Amedeo Avogadro; University of Illinois System; University of Illinois Urbana-Champaign	Rizzi, M (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, DiSCAFF, Ist Nazl Fis Mat, Via Bovio 6, I-28100 Novara, Italy.	rizzi@ipvgen.unipv.it	Han, Qian/AAS-2134-2020; Han, Qian/J-8696-2014	Han, Qian/0000-0001-6245-5252	NIAID NIH HHS [AI 44399] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044399] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERATIGIANI D, 1995, J NEUROCHEM, V64, P1448; Alkondon M, 2004, J NEUROSCI, V24, P4635, DOI 10.1523/JNEUROSCI.5631-03.2004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baran H, 1996, LIFE SCI, V58, P1891, DOI 10.1016/0024-3205(96)00173-7; BARAN H, 1994, J NEUROCHEM, V62, P730; Baran H, 1999, J NEURAL TRANSM, V106, P165, DOI 10.1007/s007020050149; BIRCH PJ, 1988, EUR J PHARMACOL, V154, P85, DOI 10.1016/0014-2999(88)90367-6; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BUCHLI R, 1995, J BIOL CHEM, V270, P29330, DOI 10.1074/jbc.270.49.29330; Colombari E, 2001, HYPERTENSION, V38, P549, DOI 10.1161/01.HYP.38.3.549; Commandeur JNM, 2000, J PHARMACOL EXP THER, V294, P753; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; COOPER AJL, 1974, J BIOL CHEM, V249, P2554; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; EASTMAN CL, 1989, BRAIN RES, V495, P225, DOI 10.1016/0006-8993(89)90216-3; Erhardt S, 2003, ADV EXP MED BIOL, V527, P155; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FUKUMOTO Y, 1991, J BIOL CHEM, V266, P4187; Goto M, 2004, J BIOL CHEM, V279, P16518, DOI 10.1074/jbc.M311575200; GRAMSBERGEN JBP, 1992, BRAIN RES, V588, P1, DOI 10.1016/0006-8993(92)91337-E; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Hosono A, 2003, J BIOCHEM, V134, P843, DOI 10.1093/jb/mvg210; Ito S, 2000, HYPERTENSION, V35, P413, DOI 10.1161/01.HYP.35.1.413; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAPOOR V, 1994, CLIN EXP PHARMACOL P, V21, P891, DOI 10.1111/j.1440-1681.1994.tb02460.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kwok JBJ, 2002, J BIOL CHEM, V277, P35779, DOI 10.1074/jbc.C200303200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; OKUNO E, 1991, BRAIN RES, V542, P307, DOI 10.1016/0006-8993(91)91583-M; OKUNO E, 1990, BRAIN RES, V534, P37, DOI 10.1016/0006-8993(90)90109-O; PELLICCIARI R, 1994, J MED CHEM, V37, P647, DOI 10.1021/jm00031a015; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; PERRY S, 1995, FEBS LETT, V360, P277, DOI 10.1016/0014-5793(95)00123-Q; Rooseboom M, 2002, CHEM RES TOXICOL, V15, P1610, DOI 10.1021/tx020034f; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Stone TW, 2001, PROG NEUROBIOL, V64, P185, DOI 10.1016/S0301-0082(00)00032-0; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Stone TW, 2000, TRENDS PHARMACOL SCI, V21, P149, DOI 10.1016/S0165-6147(00)01451-6; Ura H, 2001, J BIOCHEM, V130, P89, DOI 10.1093/oxfordjournals.jbchem.a002966; YAMAMOTO H, 1994, PEDIATR NEUROL, V10, P9, DOI 10.1016/0887-8994(94)90060-4	51	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50214	50220		10.1074/jbc.M409291200	http://dx.doi.org/10.1074/jbc.M409291200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364907	hybrid			2022-12-27	WOS:000225229500082
J	Burgess, SC; Hausler, N; Merritt, M; Jeffrey, FMH; Storey, C; Milde, A; Koshy, S; Lindner, J; Magnuson, MA; Malloy, CR; Sherry, AD				Burgess, SC; Hausler, N; Merritt, M; Jeffrey, FMH; Storey, C; Milde, A; Koshy, S; Lindner, J; Magnuson, MA; Malloy, CR; Sherry, AD			Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED-RAT-LIVER; NUCLEAR-MAGNETIC-RESONANCE; GLUCOSE-PRODUCTION; ENERGY-METABOLISM; C-13 NMR; INSULIN SENSITIVITY; OXYGEN-CONSUMPTION; DIABETES-MELLITUS; TRANSGENIC MICE; BETA-OXIDATION	Liver-specific phosphoenolpyruvate carboxykinase ( PEPCK) null mice, when fasted, maintain normal whole body glucose kinetics but develop dramatic hepatic steatosis. To identify the abnormalities of hepatic energy generation that lead to steatosis during fasting, we studied metabolic fluxes in livers lacking hepatic cytosolic PEPCK by NMR using H-2 and C-13 tracers. After a 4-h fast, glucose production from glycogenolysis and conversion of glycerol to glucose remains normal, whereas gluconeogenesis from tricarboxylic acid (TCA) cycle intermediates was nearly absent. Upon an extended 24-h fast, livers that lack PEPCK exhibit both 2-fold lower glucose production and oxygen consumption, compared with the controls, with all glucose production being derived only from glycerol. The mitochondrial reduction-oxidation (red-ox) state, as indicated by the NADH/ NAD(+) ratio, is 5-fold higher, and hepatic TCA cycle intermediate concentrations are dramatically increased in the PEPCK null livers. Consistent with this, flux through the TCA cycle and pyruvate cycling pathways is 10- and 40-fold lower, respectively. Disruption of hepatic cataplerosis due to loss of PEPCK leads to the accumulation of TCA cycle intermediates and a nearly complete blockage of gluconeogenesis from amino acids and lactate ( an energy demanding process) but intact gluconeogenesis from glycerol ( which contributes to net NADH production). Inhibition of the TCA cycle and fatty acid oxidation due to increased TCA cycle intermediate concentrations and reduced mitochondrial red-ox state lead to the development of steatosis.	Univ Texas, SW Med Ctr, Mary Nell & Ralph B Rogers Magnet Resonance Ctr, Dept Radiol, Dallas, TX 75235 USA; Univ Texas, Dept Chem, Richardson, TX 75083 USA; Vanderbilt Univ, Sch Med, Dept Mol Physiol, Nashville, TN 37232 USA; Univ Texas, SW Med Ctr, Vet Affairs N Texas Hlth Care Syst, Dept Internal Med, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; Vanderbilt University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Burgess, SC (corresponding author), Univ Texas, SW Med Ctr, Mary Nell & Ralph B Rogers Magnet Resonance Ctr, Dept Radiol, 5801 Forest Pk Rd, Dallas, TX 75235 USA.	shawn.burgess@utsouthwestern.edu	Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009; Lindner, Jill/K-5511-2012; Sherry, Dean/P-2348-2018	Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499; Lindner, Jill/0000-0002-8897-7494; Sherry, Dean/0000-0001-7150-8301; Merritt, Matthew/0000-0003-4617-9651; Malloy, Craig/0000-0001-5077-0642	NCRR NIH HHS [RR02584] Funding Source: Medline; NHLBI NIH HHS [HL-34557] Funding Source: Medline; NIDDK NIH HHS [U24-DK59632] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557, R01HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059632] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beale EG, 2004, TRENDS ENDOCRIN MET, V15, P129, DOI 10.1016/j.tem.2004.02.006; Beale EG, 2002, FASEB J, V16, P1695, DOI 10.1096/fj.02-0407rev; Beauvieux MC, 2001, J NUTR, V131, P1986, DOI 10.1093/jn/131.7.1986; BREMER J, 1972, BIOCHIM BIOPHYS ACTA, V280, P515, DOI 10.1016/0005-2760(72)90131-2; Burgess SC, 2003, ANAL BIOCHEM, V318, P321, DOI 10.1016/S0003-2697(03)00158-1; Burgess SC, 2003, ANAL BIOCHEM, V312, P228, DOI 10.1016/S0003-2697(02)00465-7; CHUNG YG, 1992, BIOCHEMISTRY-US, V31, P11159, DOI 10.1021/bi00160a029; COLET JM, 1994, MAGN RESON MATER PHY, V2, P303, DOI 10.1007/BF01705258; COOPER AJL, 1988, J BIOL CHEM, V263, P12268; DITULLIO NW, 1974, BIOCHEM J, V138, P387, DOI 10.1042/bj1380387; Dufour S., 1996, MAGN RESON MATER PHY, V4, P329; Eaton S, 1997, EUR J CLIN INVEST, V27, P719, DOI 10.1046/j.1365-2362.1997.1780727.x; FELLENIU.E, 1973, ACTA CHEM SCAND, V27, P2893, DOI 10.3891/acta.chem.scand.27-2893; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; GENEVE J, 1987, J PHARMACOL EXP THER, V242, P1133; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HILTUNEN JK, 1977, INT J BIOCHEM, V8, P505, DOI 10.1016/0020-711X(77)90112-4; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jones JG, 2001, AM J PHYSIOL-ENDOC M, V281, pE848, DOI 10.1152/ajpendo.2001.281.4.E848; Jones JG, 1997, FEBS LETT, V412, P131, DOI 10.1016/S0014-5793(97)00764-3; Kalhan SC, 2001, J BIOL CHEM, V276, P12928, DOI 10.1074/jbc.M006186200; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; KUWAJIMA M, 1986, J BIOL CHEM, V261, P2632; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; LANDAU BR, 1995, J CLIN INVEST, V95, P172, DOI 10.1172/JCI117635; LEHNINGER A, 2000, PRINCIPLES BIOCH, P586; Magnuson MA, 2003, J BIOL CHEM, V278, P32485, DOI 10.1074/jbc.R300020200; NEELY JR, 1967, AM J PHYSIOL, V212, P804; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; PERONI O, 1995, AM J PHYSIOL-ENDOC M, V269, pE516, DOI 10.1152/ajpendo.1995.269.3.E516; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; SCHOLZ R, 1984, EUR J BIOCHEM, V141, P223, DOI 10.1111/j.1432-1033.1984.tb08179.x; Schumann WC, 2001, ANAL BIOCHEM, V297, P195, DOI 10.1006/abio.2001.5326; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SHERRY AD, 1994, BIOCHEMISTRY-US, V33, P6268, DOI 10.1021/bi00186a029; Sherry AD, 1998, AM J PHYSIOL-HEART C, V274, pH591, DOI 10.1152/ajpheart.1998.274.2.H591; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Sunehag AL, 2001, PEDIATR RES, V50, P115, DOI 10.1203/00006450-200107000-00021; Sunehag AL, 1999, DIABETES, V48, P791, DOI 10.2337/diabetes.48.4.791; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; VENKATESAN S, 1988, BIOCHIM BIOPHYS ACTA, V960, P61, DOI 10.1016/0005-2760(88)90009-4; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Weis BC, 2004, MAGN RESON MED, V51, P649, DOI 10.1002/mrm.20057; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; YOUNES M, 1988, PHARMACOL TOXICOL, V63, P382, DOI 10.1111/j.1600-0773.1988.tb00972.x	47	124	127	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48941	48949		10.1074/jbc.M407120200	http://dx.doi.org/10.1074/jbc.M407120200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347677	hybrid			2022-12-27	WOS:000225098100056
J	Cherepanov, P; Devroe, E; Silver, PA; Engelman, A				Cherepanov, P; Devroe, E; Silver, PA; Engelman, A			Identification of an evolutionarily conserved domain in human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) that binds HIV-1 integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NUCLEAR-LOCALIZATION; HUMAN-CELLS; PREINTEGRATION COMPLEXES; LTR-RETROTRANSPOSONS; HUMAN GENOME; GENE FAMILY; PWWP DOMAIN; PROTEIN; DNA	Human lens epithelium-derived growth factor/transcriptional co-activator p75 (LEDGF/p75) protein was recently identified as a binding partner for HIV-1 integrase (IN) in human cells. In this work, we used biochemical and bioinformatic approaches to define the domain organization of LEDGF/p75. Using limited proteolysis and deletion mutagenesis we show that the protein contains a pair of evolutionarily conserved domains, assuming about 35% of its sequence. Whereas the N-terminal PWWP domain had been recognized previously, the second domain is novel. It is comprised of similar to80 amino acid residues and is both necessary and sufficient for binding to HIV-1 IN. Strikingly, the integrase binding domain (IBD) is not unique to LEDGF/p75, as a second human protein, hepatoma-derived growth factor-related protein 2 (HRP2), contains a homologous sequence. LEDGF/p75 and HRP2 IBDs avidly bound HIV-1 IN in an in vitro GST pull-down assay and each full-length protein potently stimulated HIV-1 IN activity in vitro. LEDGF/p75 and HRP2 are predicted to share a similar domain organization and have an evident evolutionary and likely functional relationship.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Engelman, A (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	alan_engelman@dfci.harvard.edu	Cherepanov, Peter P/F-6859-2010	Cherepanov, Peter P/0000-0002-0634-538X	NIAID NIH HHS [AI39394] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039394, R37AI039394] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; Brown P. O., 1997, P161; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Cherepanov P, 1997, MOL PHARMACOL, V52, P771, DOI 10.1124/mol.52.5.771; Cherepanov P, 1999, NUCLEIC ACIDS RES, V27, P2202, DOI 10.1093/nar/27.10.2202; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; COWAN R, 1990, Peptide Research, V3, P75; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Dietz F, 2002, BIOCHEM J, V366, P491, DOI 10.1042/BJ20011811; Engelman A, 1999, ADV VIRUS RES, V52, P411, DOI 10.1016/S0065-3527(08)60309-7; Engelman A, 2003, CURR TOP MICROBIOL, V281, P209; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Ikegame K, 1999, BIOCHEM BIOPH RES CO, V266, P81, DOI 10.1006/bbrc.1999.1733; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kishima Y, 2002, J BIOL CHEM, V277, P10315, DOI 10.1074/jbc.M111122200; LAFEMINA RL, 1992, J VIROL, V66, P7414, DOI 10.1128/JVI.66.12.7414-7419.1992; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Limon A, 2002, J VIROL, V76, P10598, DOI 10.1128/JVI.76.21.10598-10607.2002; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Maertens G, 2004, J BIOL CHEM, V279, P33421, DOI 10.1074/jbc.M404700200; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Mulder LCF, 2002, J BIOL CHEM, V277, P27489, DOI 10.1074/jbc.M203061200; Nakajima N, 2001, J VIROL, V75, P7944, DOI 10.1128/JVI.75.17.7944-7955.2001; Nishizawa Y, 2001, CELL TISSUE RES, V305, P107, DOI 10.1007/s004410100398; Parissi V, 2001, J VIROL, V75, P11344, DOI 10.1128/JVI.75.23.11344-11353.2001; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Slater LM, 2003, J MOL BIOL, V330, P571, DOI 10.1016/S0022-2836(03)00470-4; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; Willetts KE, 1999, J VIROL, V73, P1682, DOI 10.1128/JVI.73.2.1682-1688.1999; Wu X, 2002, CELL DEATH DIFFER, V9, P915, DOI 10.1038/sj.cdd.4401063; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Xie WW, 2001, MOL CELL BIOL, V21, P6606, DOI 10.1128/MCB.21.19.6606-6614.2001; Yieh L, 2002, J BIOL CHEM, V277, P25920, DOI 10.1074/jbc.M202729200; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100	59	225	234	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48883	48892		10.1074/jbc.M406307200	http://dx.doi.org/10.1074/jbc.M406307200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371438	hybrid, Green Published			2022-12-27	WOS:000225098100050
J	Giron-Monzon, L; Manelyte, L; Ahrends, R; Kirsch, D; Spengler, B; Friedhoff, P				Giron-Monzon, L; Manelyte, L; Ahrends, R; Kirsch, D; Spengler, B; Friedhoff, P			Mapping protein-protein interactions between MutL and MutH by cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; HOT-SPOTS; IN-VIVO; BINDING; SUBSTRATE	Strand discrimination in Escherichia coli DNA mismatch repair requires the activation of the endonuclease MutH by MutL. There is evidence that MutH binds to the N-terminal domain of MutL in an ATP-dependent manner; however, the interaction sites and the molecular mechanism of MutH activation have not yet been determined. We used a combination of site-directed mutagenesis and site-specific cross-linking to identify protein interaction sites between the proteins MutH and MutL. Unique cysteine residues were introduced in cysteine-free variants of MutH and MutL. The introduced cysteines were modified with the cross-linking reagent 4-maleimidobenzophenone. Photoactivation resulted in cross-links verified by mass spectrometry of some of the single cysteine variants to their respective Cys-free partner proteins. Moreover, we mapped the site of interaction by cross-linking different combinations of single cysteine MutH and MutL variants with thiol-specific homobifunctional cross-linkers of varying length. These results were used to model the MutH.MutL complex and to explain the ATP dependence of this interaction.	Univ Giessen, Inst Biochem FB 08, D-35392 Giessen, Germany; Univ Giessen, Inst Anorgan & Analyt Chem FB 08, D-35392 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Friedhoff, P (corresponding author), Univ Giessen, Inst Biochem FB 08, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	friedhoff@chemie.bio.uni-giessen.de	Spengler, Bernhard/A-9497-2012; Friedhoff, Peter/G-7905-2012	Ahrends, Robert/0000-0003-0232-3375; Spengler, Bernhard/0000-0003-0179-5653; Friedhoff, Peter/0000-0003-1946-1117				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Ban C, 1998, EMBO J, V17, P1526, DOI 10.1093/emboj/17.5.1526; Bjornson KP, 2003, J BIOL CHEM, V278, P18557, DOI 10.1074/jbc.M301101200; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; CREIGHTON TE, 1993, PROTEINS, P333; CUPPLES CG, 1989, P NATL ACAD SCI USA, V86, P5345, DOI 10.1073/pnas.86.14.5345; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Evans SJ, 2000, NUCLEIC ACIDS RES, V28, P1059, DOI 10.1093/nar/28.5.1059; FENG G, 1995, BIOTECHNIQUES, V19, P956; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Friedhoff P, 2003, J MOL BIOL, V325, P285, DOI 10.1016/S0022-2836(02)01224-X; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hsieh P, 2001, MUTAT RES-DNA REPAIR, V486, P71, DOI 10.1016/S0921-8777(01)00088-X; Junop MS, 2003, DNA REPAIR, V2, P387, DOI 10.1016/S1568-7864(02)00245-8; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Loh T, 2001, J BIOL CHEM, V276, P12113, DOI 10.1074/jbc.M007935200; Martik D, 2004, J BIOL CHEM, V279, P28402, DOI 10.1074/jbc.M312108200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Thomas E, 2002, BIOL CHEM, V383, P1459, DOI 10.1515/BC.2002.166; Toedt GH, 2003, NUCLEIC ACIDS RES, V31, P819, DOI 10.1093/nar/gkg191; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097	36	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49338	49345		10.1074/jbc.M409307200	http://dx.doi.org/10.1074/jbc.M409307200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371440	hybrid			2022-12-27	WOS:000225098100103
J	Muller, L; Schaupp, A; Walerych, D; Wegele, H; Buchner, J				Muller, L; Schaupp, A; Walerych, D; Wegele, H; Buchner, J			Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; DNA-BINDING ACTIVITY; N-TERMINAL DOMAIN; MUTANT P53; MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; IN-VITRO; SEQUENCE; CONTAINS	The activity and structural integrity of the tumor suppressor protein p53 is of crucial importance for the prevention of cancer. p53 is a conformational flexible and labile protein, in which structured and unstructured regions function in a synergistic manner. The molecular chaperone Hsp90 is known to bind to mutant and wild type p53 in vivo. Using highly purified proteins we analyzed the interaction and the binding sites between both proteins in detail. Our results demonstrate that Hsp90 binds to a folded, native-like conformation of p53 in vitro with micromolar affinity. Specifically, the DNA-binding domain of p53 and the middle and carboxyterminal domains of Hsp90 are responsible for this interaction, which is essential to stabilize p53 at physiological temperatures and to prevent it from irreversible thermal inactivation. Our results are in agreement with a model in which Hsp90 is required to maintain the folded, active state of p53 by a reversible interaction, thus introducing an additional level of regulation.	Tech Univ Munich, Dept Chem, D-85747 Garching, Germany; Int Inst Mol & Cell Biol Warsaw, Dept Mol Biol, PL-02109 Warsaw, Poland	Technical University of Munich; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Buchner, J (corresponding author), Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.	johannes.buchner@ch.tum.de	Walerych, Dawid/I-2517-2016; Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737; Walerych, Dawid/0000-0002-8440-1375				Ahn J, 2001, NAT STRUCT BIOL, V8, P730, DOI 10.1038/nsb0901-730; BALL RK, 1984, EMBO J, V3, P1485, DOI 10.1002/j.1460-2075.1984.tb02000.x; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; Buchner J, 1998, METHOD ENZYMOL, V290, P409, DOI 10.1016/S0076-6879(98)90034-9; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLORE GM, 1995, NAT STRUCT BIOL, V2, P321, DOI 10.1038/nsb0495-321; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Hansen S, 1996, J BIOL CHEM, V271, P3917; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Johnson BD, 2000, J BIOL CHEM, V275, P32499, DOI 10.1074/jbc.M005195200; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Klein C, 2001, J BIOL CHEM, V276, P49020, DOI 10.1074/jbc.M107516200; Knarr G, 2002, J MOL BIOL, V318, P611, DOI 10.1016/S0022-2836(02)00166-3; LAI BT, 1984, MOL CELL BIOL, V4, P2802, DOI 10.1128/MCB.4.12.2802; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; Maki CG, 1996, CANCER RES, V56, P2649; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Minami M, 2001, EUR J BIOCHEM, V268, P2520, DOI 10.1046/j.1432-1327.2001.02145.x; Nagata Y, 1999, ONCOGENE, V18, P6037, DOI 10.1038/sj.onc.1202978; Nakamura Y, 2004, CANCER SCI, V95, P7, DOI 10.1111/j.1349-7006.2004.tb03163.x; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REBBE NF, 1987, GENE, V53, P235, DOI 10.1016/0378-1119(87)90012-6; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; Sepehrnia B, 1996, J BIOL CHEM, V271, P15084, DOI 10.1074/jbc.271.25.15084; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; SOUSSI T, 1994, INT J CANCER, V57, P1, DOI 10.1002/ijc.2910570102; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; STURZBECHER HW, 1992, ONCOGENE, V7, P1513; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Yakovleva T, 2001, J BIOL CHEM, V276, P15650, DOI 10.1074/jbc.M100482200; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	68	111	112	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48846	48854		10.1074/jbc.M407687200	http://dx.doi.org/10.1074/jbc.M407687200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358771	hybrid			2022-12-27	WOS:000225098100046
J	Tian, R; Li, SJ; Wang, DL; Zhao, Z; Liu, Y; He, RQ				Tian, R; Li, SJ; Wang, DL; Zhao, Z; Liu, Y; He, RQ			The acidic C-terminal domain stabilizes the chaperone function of protein disulfide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTATE-DEHYDROGENASE; LACTIC-DEHYDROGENASE; RIBONUCLEASE-A; REACTIVATION; DENATURATION; THIOREDOXIN; DEPENDENCE; SUBUNIT; ENZYME	Protein disulfide isomerase (PDI, EC 5.3.4.1) is a chaperone and catalyzes the formation and rearrangement of disulfide bonds in proteins. Domain c-(463-491), containing 18 acidic residues, is an interesting and important C-terminal extension of PDI. In this study, the PDI mutant abb'a', in which domain c is truncated, was used to investigate the relationship between the C-terminal structure and chaperone function. Reactivation and light-scattering experiments show that both wild-type PDI and abb'a' interact with lactate dehydrogenase (LDH, EC 1.1.1.27), which tends to self-aggregate during reactivation. The interaction enhances reactivation of LDH and reduces aggregation. According to these results, it seems as if domain c might be dispensable to the chaperone function of PDI. However, abb'a' is prone to self-aggregation and causes increased aggregation of LDH during thermal denaturation. In contrast, wildtype PDI remains active as a chaperone under these conditions and prevents self-aggregation of LDH. Furthermore, measurements of intrinsic fluorescence and difference absorbance during denaturation show that abb'a' is much more labile to heat or guanidine hydrochloride denaturation than wild-type PDI. This suggests that domain c is required for the stabilization and maintenance of the chaperone function of PDI under extreme conditions.	Chinese Acad Sci, Inst Biophys, Lab Visual Informat Proc, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, RQ (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Visual Informat Proc, 15 Da Tun Rd, Beijing 100101, Peoples R China.	herq@sun5.ibp.ac.cn	Liu, Ying/D-8933-2013; li, shengjian/B-4866-2013	Liu, Ying/0000-0003-0802-3832; 				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAI H, 1994, J BIOL CHEM, V269, P24550; Chen YH, 2000, BIOCHEM J, V351, P233, DOI 10.1042/0264-6021:3510233; Churchich JE, 1999, BIOCHEM BIOPH RES CO, V261, P41, DOI 10.1006/bbrc.1999.0908; Dai Y, 1997, J BIOL CHEM, V272, P27572, DOI 10.1074/jbc.272.44.27572; Dams T, 1996, EUR J BIOCHEM, V240, P274, DOI 10.1111/j.1432-1033.1996.0274h.x; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; FREEDMAN RB, 1989, BIOCHEM SOC SYMP, V55, P167; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; HANA TB, 1976, BIOCHIM BIOPHYS ACTA, V445, P261; Hayano T, 1995, FEBS LETT, V377, P505, DOI 10.1016/0014-5793(95)01410-1; JAENICKE R, 1971, EUR J BIOCHEM, V23, P150, DOI 10.1111/j.1432-1033.1971.tb01602.x; JAENICKE R, 1990, PROTEIN STRUCTURE PR, P191; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MA YZ, 1991, BIOCHEM J, V277, P207, DOI 10.1042/bj2770207; NOIVA R, 1997, PROLYL 4 HYDROXYLASE, P369; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; PUIG A, 1994, J BIOL CHEM, V269, P7764; RUDOLPH R, 1979, BIOCHEMISTRY-US, V18, P5572, DOI 10.1021/bi00592a008; Ruoppolo M, 2003, PROTEIN SCI, V12, P939, DOI 10.1110/ps.0242803; Song JL, 1997, BIOCHEM J, V328, P841, DOI 10.1042/bj3280841; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; TSOU CL, 1965, ACTA BIOCH BIOPH SIN, V5, P398; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651; YU XC, 1994, BBA-PROTEIN STRUCT M, V1207, P109, DOI 10.1016/0167-4838(94)90058-2	29	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48830	48835		10.1074/jbc.M407076200	http://dx.doi.org/10.1074/jbc.M407076200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358778	hybrid			2022-12-27	WOS:000225098100044
J	Zhao, Q; Chang, XB				Zhao, Q; Chang, XB			Mutation of the aromatic amino acid interacting with adenine moiety of ATP to a polar residue alters the properties of multidrug resistance protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CYSTIC-FIBROSIS MUTATIONS; TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN P-GLYCOPROTEIN; BREAST-CANCER CELLS; ABC TRANSPORTER; LEUKOTRIENE C-4; GENE; SITES; OVEREXPRESSION	Structural analyses of several bacterial ATP-binding cassette (ABC) transporters indicate that an aromatic amino acid residue in a nucleotide-binding domain (NBD) interacts with the adenine ring of the bound ATP and contributes to the ATP binding. Substitution of this aromatic residue with a polar serine residue in bacterial histidine transporter completely abolished both ATP binding and ATP-dependent histidine transport. However, substitution of the aromatic amino acid residue in the human cystic fibrosis transmembrane conductance regulator with a polar cysteine residue did not have any effect on the ATP-dependent chloride channel function of the protein. To determine whether the other eucaryotic ABC transporters use the strategy analogous to that in some bacterial ABC transporters, the aromatic Trp(653) residue in NBD1 and the Tyr(1302) residue in NBD2 of human multidrug resistance-associated protein 1 (MRP1) was mutated to either a different aromatic residue or a polar cysteine residue. Substitution of the aromatic residue with a different aromatic amino acid, such as W653Y or Y1302W, did not affect ATP-dependent leukotriene C4 (LTC4) transport. In contrast, substitution of the aromatic residue with a polar cysteine residue, such as W653C or Y1302C, decreased the affinity for ATP, resulting in greatly increased K-d values for ATP binding or K-m values for ATP in ATP-dependent LTC4 transport. Interestingly, although substitution of the aromatic Trp(653) in NBD1 of MRP1 with a polar cysteine residue greatly decreases the affinity for ATP, the ATP-dependent LTC4 transport activities are much higher than that of wild-type MRP1, supporting our hypothesis that the increased release rate of the bound ATP from the mutated NBD1 facilitates the protein to start a new cycle of ATP-dependent solute transport.	Mayo Clin, Coll Med, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic Phoenix; SC Johnson & Son	Chang, XB (corresponding author), Mayo Clin, Coll Med, SC Johnson Med Res Ctr, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	xbchang@mayo.edu			NCI NIH HHS [CA89078] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089078] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allikmets R, 1998, CANCER RES, V58, P5337; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Berger AL, 2000, J BIOL CHEM, V275, P29407, DOI 10.1074/jbc.M004790200; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; CHEN YN, 1990, J BIOL CHEM, V265, P10073; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Coutelle Charles, 1992, Human Mutation, V1, P109, DOI 10.1002/humu.1380010205; Cui LY, 2001, ARCH BIOCHEM BIOPHYS, V392, P153, DOI 10.1006/abbi.2001.2441; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Gao M, 1996, J BIOL CHEM, V271, P27782, DOI 10.1074/jbc.271.44.27782; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Hrycyna CA, 1999, BIOCHEMISTRY-US, V38, P13887, DOI 10.1021/bi991115m; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; LEIER I, 1994, EUR J BIOCHEM, V220, P599, DOI 10.1111/j.1432-1033.1994.tb18661.x; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; MIRSKI SEL, 1987, CANCER RES, V47, P2594; Ramaen O, 2003, BIOCHEM J, V376, P749, DOI 10.1042/BJ20030998; REISS J, 1991, HUM GENET, V87, P457; Ren XQ, 2004, MOL PHARMACOL, V65, P1536, DOI 10.1124/mol.65.6.1536; RONINSON IB, 1992, BIOCHEM PHARMACOL, V43, P95, DOI 10.1016/0006-2952(92)90666-7; SHRIMPTON AE, 1991, J MED GENET, V28, P317, DOI 10.1136/jmg.28.5.317; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilkinson DJ, 1996, J GEN PHYSIOL, V107, P103, DOI 10.1085/jgp.107.1.103; Yang RY, 2003, J BIOL CHEM, V278, P30764, DOI 10.1074/jbc.M304118200; Zhu QC, 1997, ONCOL RES, V9, P229	34	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48505	48512		10.1074/jbc.M408343200	http://dx.doi.org/10.1074/jbc.M408343200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355964	hybrid			2022-12-27	WOS:000225098100005
J	Mille, C; Janbon, G; Delplace, F; Ibata-Ombetta, S; Gaillardin, C; Strecker, G; Jouault, T; Trinel, PA; Poulain, D				Mille, C; Janbon, G; Delplace, F; Ibata-Ombetta, S; Gaillardin, C; Strecker, G; Jouault, T; Trinel, PA; Poulain, D			Inactivation of CaMIT1 inhibits Candida albicans phospholipomannan beta-mannosylation, reduces virulence, and alters cell wall protein beta-mannosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,2-LINKED OLIGOMANNOSIDIC EPITOPES; SABOURAUD LIQUID-MEDIUM; NECROSIS-FACTOR-ALPHA; SACCHAROMYCES-CEREVISIAE; SEROTYPE-A; MONOCLONAL-ANTIBODIES; YEAST EXTRACT; IN-VITRO; MACROPHAGE; MANNANS	Studies on Candida albicans phospholipomannan have suggested a novel biosynthetic pathway for yeast glycosphingolipids. This pathway is thought to diverge from the usual pathway at the mannose-inositol-phosphoceramide (MIPC) step. To confirm this hypothesis, a C. albicans gene homologue for the Saccharomyces cerevisiae SUR1 gene was identified and named MIT1 as it coded for GDP-mannose: inositol-phospho-ceramide mannose transferase. Two copies of this gene were disrupted. Western blots of cell extracts revealed that strain mit1Delta contained no PLM. Thin layer chromatography and mass spectrometry confirmed that mit1Delta did not synthesize MIPC, demonstrating a role of MIT1 in the mannosylation of C. albicans IPCs. As MIT1 disruption prevented downstream beta-1,2 mannosylation, mit1Delta represents a new C. albicans mutant affected in the expression of these specific virulence attributes, which act as adhesins/immunomodulators. mit1Delta was less virulent during both the acute and chronic phases of systemic infection in mice (75 and 50% reduction in mortality, respectively). In vitro, mit1Delta was not able to escape macrophage lysis through down-regulation of the ERK1/2 phosphorylation pathway previously shown to be triggered by PLM. Phenotypic analysis also revealed pleiotropic effects of MIT1 disruption. The most striking observation was a reduced beta-mannosylation of phosphopeptidomannan. Increased beta-mannosylation of mannoproteins was observed under growth conditions that prevented the association of beta-oligomannosides with phosphopeptidomannan, but not with PLM. This suggests that C. albicans has strong regulatory mechanisms associating beta-oligomannoses with different cell wall carrier molecules. These mechanisms and the impact of the different presentations of beta-oligomannoses on the host response need to be defined.	Fac Med Lille, Lab Mycol Fondamentale & Appl, Equipe INSERM, E0360, F-59045 Lille, France; Inst Pasteur, Unite Mycol Mol, F-75015 Paris, France; Univ Sci & Technol Lille, CNRS, Unite Mixte Rech 8576, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; Inst Natl Agron Paris Grignon, Lab Genet Mol & Cellulaire, F-78850 Thiverval Grignon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; AgroParisTech	Poulain, D (corresponding author), Fac Med Lille, Lab Mycol Fondamentale & Appl, Equipe INSERM, E0360, Pole Rech,Pl Verdun, F-59045 Lille, France.	dpoulain@univ-lille2.fr	Jouault, Thierry/J-7437-2012; Jouault, Thierry/I-1071-2018; Janbon, Guilhem/AAL-6607-2021; Janbon, Guilhem/AAW-7398-2021; Poulain, Daniel/I-6095-2018	Jouault, Thierry/0000-0003-1988-8647; Janbon, Guilhem/0000-0002-4788-1154; Poulain, Daniel/0000-0002-0729-5468				Beeler TJ, 1997, MOL GEN GENET, V255, P570, DOI 10.1007/s004380050530; CANNON RD, 1992, MOL GEN GENET, V235, P453, DOI 10.1007/BF00279393; CANTELLI C, 1995, MICROBIOL-SGM, V141, P2693, DOI 10.1099/13500872-141-10-2693; Choi W, 2003, YEAST, V20, P1053, DOI 10.1002/yea.1022; Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; FAILLE C, 1991, BIOCHEM BIOPH RES CO, V181, P1251, DOI 10.1016/0006-291X(91)92073-S; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Fradin C, 1996, J LEUKOCYTE BIOL, V60, P81, DOI 10.1002/jlb.60.1.81; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; HANSON BA, 1980, J LIPID RES, V21, P309; Ibata-Ombetta S, 2003, J BIOL CHEM, V278, P13086, DOI 10.1074/jbc.M210680200; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Jouault T, 1998, J INFECT DIS, V178, P792, DOI 10.1086/515361; JOUAULT T, 1994, IMMUNOLOGY, V83, P268; JOUAULT T, 1995, INFECT IMMUN, V63, P2378, DOI 10.1128/IAI.63.6.2378-2381.1995; Jouault T, 2000, INFECT IMMUN, V68, P965, DOI 10.1128/IAI.68.2.965-968.2000; Kang CD, 2000, LEUKEMIA RES, V24, P527, DOI 10.1016/S0145-2126(00)00010-2; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; KOBAYASHI H, 1994, INFECT IMMUN, V62, P968, DOI 10.1128/IAI.62.3.968-973.1994; KOBAYASHI H, 1992, INFECT IMMUN, V60, P2106, DOI 10.1128/IAI.60.5.2106-2109.1992; KOBAYASHI H, 1991, BIOCHEM BIOPH RES CO, V175, P1003, DOI 10.1016/0006-291X(91)91664-X; KOCOUREK J, 1969, J BACTERIOL, V100, P1175, DOI 10.1128/JB.100.3.1175-1181.1969; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lunghi P, 2003, LEUKEMIA, V17, P1783, DOI 10.1038/sj.leu.2403032; Nitz M, 2002, J BIOL CHEM, V277, P3440, DOI 10.1074/jbc.M109274200; Park MT, 2003, J BIOL CHEM, V278, P50624, DOI 10.1074/jbc.M309011200; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Poulain D, 2002, INFECT IMMUN, V70, P4323, DOI 10.1128/IAI.70.8.4323-4328.2002; RUSTCHENKO EP, 1994, J BACTERIOL, V176, P3231, DOI 10.1128/jb.176.11.3231-3241.1994; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Sendid B, 2004, J CLIN MICROBIOL, V42, P164, DOI 10.1128/JCM.42.1.164-171.2004; SUZUKI A, 1995, FEBS LETT, V373, P275, DOI 10.1016/0014-5793(95)01061-I; Trinel PA, 1997, HOST-FUNGUS INTERPLAY, P37; TRINEL PA, 1992, INFECT IMMUN, V60, P3845, DOI 10.1128/IAI.60.9.3845-3851.1992; Trinel PA, 2002, J BIOL CHEM, V277, P37260, DOI 10.1074/jbc.M202295200; TRINEL PA, 1993, INFECT IMMUN, V61, P4398, DOI 10.1128/IAI.61.10.4398-4405.1993; Trinel PA, 1996, MICROBIOL-UK, V142, P2263, DOI 10.1099/13500872-142-8-2263; Trinel PA, 2002, INFECT IMMUN, V70, P5274, DOI 10.1128/IAI.70.9.5274-5278.2002; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Zhong B, 2003, BLOOD, V101, P3240, DOI 10.1182/blood-2001-12-0180	49	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47952	47960		10.1074/jbc.M405534200	http://dx.doi.org/10.1074/jbc.M405534200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347680	hybrid, Green Published			2022-12-27	WOS:000224957000065
J	Qu, QH; Lee, SJ; Boos, W				Qu, QH; Lee, SJ; Boos, W			TreT, a novel trehalose glycosyltransferring synthase of the hyperthermophilic Archaeon Thermococcus litoralis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; ESCHERICHIA-COLI; BIOCHEMICAL-ANALYSIS; CRYSTAL-STRUCTURE; SUCROSE SYNTHASE; BINDING PROTEIN; GENE; METABOLISM; CLONING; SYSTEM	The gene cluster in Thermococcus litoralis encoding a multicomponent and binding protein-dependent ABC transporter for trehalose and maltose contains an open reading frame of unknown function. We cloned this gene (now called treT), expressed it in Escherichia coli, purified the encoded protein, and identified it as an enzyme forming trehalose and ADP from ADP-glucose and glucose. The enzyme can also use UDP- and GDP-glucose but with less efficiency. The reaction is reversible, and ADP-glucose plus glucose can also be formed from trehalose and ADP. The rate of reaction and the equilibrium favor the formation of trehalose. At 90degreesC, the optimal temperature for the enzymatic reaction, the half-maximal concentration of ADP-glucose at saturating glucose concentrations is 1.14 mM and the V-max is 160 units/mg protein. In the reverse reaction, the half-maximal concentration of trehalose at saturating ADP concentrations is 11.5 mM and the V-max was estimated to be 17 units/mg protein. Under non-denaturating in vitro conditions the enzyme behaves as a dimer of identical subunits of 48 kDa. As the transporter encoded in the same gene cluster, TreT is induced by trehalose and maltose in the growth medium.	Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Boos, W (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	winfried.boos@uni-konstanz.de	Lee, Sungjae/AAI-8586-2020	Lee, Sungjae/0000-0002-3997-9020				BOOS W, 1987, J BIOL CHEM, V262, P13212; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; DiRuggiero J, 2000, MOL MICROBIOL, V38, P684, DOI 10.1046/j.1365-2958.2000.02161.x; Eis C, 2001, BIOCHEM J, V356, P757, DOI 10.1042/0264-6021:3560757; Eis C, 1999, BIOCHEM J, V341, P385, DOI 10.1042/0264-6021:3410385; Greller G, 1999, J BIOL CHEM, V274, P20259, DOI 10.1074/jbc.274.29.20259; Greller G, 2001, EUR J BIOCHEM, V268, P4011, DOI 10.1046/j.1432-1327.2001.02313.x; Higashiyama T, 2002, PURE APPL CHEM, V74, P1263, DOI 10.1351/pac200274071263; HIRIMBUREGAMA K, 1992, J GEN MICROBIOL, V138, P2035, DOI 10.1099/00221287-138-10-2035; Horlacher R, 1996, J BACTERIOL, V178, P6250, DOI 10.1128/jb.178.21.6250-6257.1996; Horlacher R, 1998, J BACTERIOL, V180, P680, DOI 10.1128/JB.180.3.680-689.1998; KLEIN W, 1995, J BACTERIOL, V177, P4043, DOI 10.1128/jb.177.14.4043-4052.1995; Lamosa P, 1998, APPL ENVIRON MICROB, V64, P3591; Lee SJ, 2003, J BIOL CHEM, V278, P983, DOI 10.1074/jbc.M210236200; Maruta K, 1996, BBA-GEN SUBJECTS, V1291, P177, DOI 10.1016/S0304-4165(96)00082-7; Porchia AC, 1999, PLANTA, V210, P34, DOI 10.1007/s004250050651; Qu QH, 2004, EXTREMOPHILES, V8, P301, DOI 10.1007/s00792-004-0392-5; RIMMELE M, 1994, J BACTERIOL, V176, P5654, DOI 10.1128/JB.176.18.5654-5664.1994; SEBKOVA V, 1995, PLANT PHYSIOL, V108, P75, DOI 10.1104/pp.108.1.75; Selig M, 1997, ARCH MICROBIOL, V167, P217, DOI 10.1007/BF03356097; Shockley KR, 2003, APPL ENVIRON MICROB, V69, P2365, DOI 10.1128/AEM.69.4.2365-2371.2003; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Tsusaki K, 1997, BBA-GEN SUBJECTS, V1334, P28, DOI 10.1016/S0304-4165(96)00103-1; Xavier KB, 1999, J BACTERIOL, V181, P3358, DOI 10.1128/JB.181.11.3358-3367.1999; Xavier KB, 1996, J BACTERIOL, V178, P4773, DOI 10.1128/jb.178.16.4773-4777.1996	26	80	85	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47890	47897		10.1074/jbc.M404955200	http://dx.doi.org/10.1074/jbc.M404955200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364950	hybrid			2022-12-27	WOS:000224957000059
J	Canovas, D; Vooijs, R; Schat, H; de Lorenzo, V				Canovas, D; Vooijs, R; Schat, H; de Lorenzo, V			The role of thiol species in the hypertolerance of Aspergillus sp P37 to arsenic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-METAL DETOXIFICATION; PHYTOCHELATIN SYNTHASE; SACCHAROMYCES-CEREVISIAE; IN-VITRO; TOLERANCE; GLUTATHIONE; GENE; NIDULANS; PLANTS; TRANSFERASE	Aspergillus sp. P37 is an arsenate-hypertolerant fungus isolated from a river in Spain with a long history of contamination with metals. This strain is able to grow in the presence of 0.2 M arsenate, i.e. 20-fold higher than the reference strain, Aspergillus nidulans TS1. Although Aspergillus sp. P37 reduces As( V) to As(III), which is slowly pumped out of the cell, the measured efflux of oxyanions is insufficient to explain the high tolerance levels of this strain. To gain an insight into this paradox, the accumulation of acid-soluble thiol species in Aspergillus sp. P37 when exposed to arsenic was compared with that of the arsenic-sensitive A. nidulans TS1 strain. Increasing levels of arsenic in the medium did not diminish the intracellular pool of reduced glutathione in Aspergillus sp. P37, in sharp contrast with the decline of glutathione in A. nidulans under the same conditions. Furthermore, concentrations of arsenic that were inhibitory for the sensitive A. nidulans strain ( e. g. 50 mM and above) provoked a massive formation of vacuoles filled with thiol species. Because the major fraction of the cellular arsenic was present as the glutathione conjugate As(GS)(3), it is plausible that the arsenic-hypertolerant phenotype of Aspergillus sp. P37 is in part due to an enhanced capacity to maintain a large intracellular glutathione pool under conditions of arsenic exposure and to sequester As( GS) 3 in vacuoles. High pressure liquid chromatography analysis of cell extracts revealed that the contact of Aspergillus sp. P37 ( but not A. nidulans) with high arsenic concentrations (greater than or equal to 150 mM) induced the production of small quantities of a distinct thiol species indistinguishable from plant phytochelatin-2. Yet, we argue that phytochelatins do not explain arsenic resistance in Aspergillus, and we advocate the role of As( GS) 3 complexes in arsenic detoxification.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Ecol & Physiol Plants, NL-1081 HV Amsterdam, Netherlands; CSIC, Ctr Astrobiol, Inst Nacl Tecn Aerospacial, Madrid 28850, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Vrije Universiteit Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	de Lorenzo, V (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Camous Cantablanco, E-28049 Madrid, Spain.	vdlorenzo@cnb.uam.es	Schat, Henk/AAB-8723-2019; Cánovas, David/L-7628-2014	Cánovas, David/0000-0002-7293-7332; de Lorenzo, Victor/0000-0002-6041-2731				Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; Bleeker PM, 2003, NEW PHYTOL, V157, P33, DOI 10.1046/j.1469-8137.2003.00542.x; Canovas D, 2003, ENVIRON MICROBIOL, V5, P1242, DOI 10.1046/j.1462-2920.2003.00463.x; Canovas D, 2003, ENVIRON MICROBIOL, V5, P133, DOI 10.1046/j.1462-2920.2003.00386.x; Canovas D, 2003, ENVIRON MICROBIOL, V5, P1087, DOI 10.1046/j.1462-2920.2003.00508.x; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; CLUTTERBUCK AJ, 1993, GENETIC MAPS LOCUS M; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; COLE SPC, 1994, CANCER RES, V54, P5902; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; de Souza CC, 1998, CURR GENET, V33, P60, DOI 10.1007/s002940050309; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; Fraser JA, 2002, APPL ENVIRON MICROB, V68, P2802, DOI 10.1128/AEM.68.6.2802-2808.2002; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hartley-Whitaker J, 2001, PLANT PHYSIOL, V126, P299, DOI 10.1104/pp.126.1.299; Kaiser C., 1994, METHODS YEAST GENETI; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; LO JF, 1992, BIOCHEM J, V288, P977, DOI 10.1042/bj2880977; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; MEHRA RK, 1988, P NATL ACAD SCI USA, V85, P8815, DOI 10.1073/pnas.85.23.8815; Miersch J, 2001, MYCOL RES, V105, P883, DOI 10.1017/S095375620100404X; Mingot JM, 1999, J BIOL CHEM, V274, P14545, DOI 10.1074/jbc.274.21.14545; Pickering IJ, 2000, PLANT PHYSIOL, V122, P1171, DOI 10.1104/pp.122.4.1171; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Schat H, 2002, J EXP BOT, V53, P2381, DOI 10.1093/jxb/erf107; Shimizu M, 1998, TOXICOL SCI, V45, P204, DOI 10.1093/toxsci/45.2.204; Sneller FEC, 2000, J AGR FOOD CHEM, V48, P4014, DOI 10.1021/jf9903105; TAMAKI S, 1992, REV ENVIRON CONTAM T, V124, P79; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110	35	65	68	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51234	51240		10.1074/jbc.M408622200	http://dx.doi.org/10.1074/jbc.M408622200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15364940	hybrid, Green Published			2022-12-27	WOS:000225355800071
J	Felczak, MM; Kaguni, JM				Felczak, MM; Kaguni, JM			The Box VII motif of Escherichia coli DnaA protein is required for DnaA oligomerization at the E-coli replication origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL ORIGIN; GEL-ELECTROPHORESIS; BINDING DOMAIN; ATP BINDING; INITIATION; COMPLEX; HELICASE; GENE; SITES; RECOGNITION	Escherichia coli DnaA protein initiates DNA replication from the chromosomal origin, oriC, and regulates the frequency of this process. Structure-function studies indicate that the replication initiator comprises four domains. Based on the structural similarity of Aquifex aeolicus DnaA to other AAA(+) proteins that are oligomeric, it was proposed that Domain III functions in oligomerization at oriC (Erzberger, J. P., Pirruccello, M. M., and Berger, J. M. ( 2002) EMBO J. 21, 4763 - 4773). Because the Box VII motif within Domain III is conserved among DnaA homologues and may function in oligomerization, we substituted conserved Box VII amino acids of E. coli DnaA with alanine by site-directed mutagenesis to examine the role of this motif. All mutant proteins are inactive in initiation from oriC in vivo and in vitro, but they support RK2 plasmid DNA replication in vivo. Thus, RK2 requires only a subset of DnaA functions for plasmid DNA replication. Biochemical studies on a mutant DnaA carrying an alanine substitution at arginine 281 (R281A) in Box VII show that it is inactive in in vitro replication of an oriC plasmid, but this defect is not from the failure to bind to ATP, DnaB in the DnaB-DnaC complex, or oriC. Because the mutant DnaA is also active in the strand opening of oriC, whereas DnaB fails to bind to this unwound region, the open structure is insufficient by itself to load DnaB helicase. Our results show that the mutant fails to form a stable oligomeric DnaA-oriC complex, which is required for the loading of DnaB.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Kaguni, JM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	kaguni@msu.edu		Kaguni, Jon/0000-0002-3096-4447	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033992] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM033992, GM33992] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; BAKER TA, 1987, J BIOL CHEM, V262, P6877; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Blaesing F, 2000, MOL MICROBIOL, V36, P557, DOI 10.1046/j.1365-2958.2000.01881.x; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; Carr KM, 1996, MOL MICROBIOL, V20, P1307, DOI 10.1111/j.1365-2958.1996.tb02649.x; Carr KM, 2002, J BIOL CHEM, V277, P39815, DOI 10.1074/jbc.M205031200; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; Clover BP, 2001, CELL, V105, P925, DOI 10.1016/S0092-8674(01)00400-7; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; Doran KS, 1999, J BIOL CHEM, V274, P17918, DOI 10.1074/jbc.274.25.17918; DURLAND RH, 1990, J BACTERIOL, V172, P3859, DOI 10.1128/jb.172.7.3859-3867.1990; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; FRIED MG, 1994, NUCLEIC ACIDS RES, V22, P5054, DOI 10.1093/nar/22.23.5054; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FULLER RS, 1981, P NATL ACAD SCI-BIOL, V78, P7370, DOI 10.1073/pnas.78.12.7370; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Garner J, 1996, EMBO J, V15, P3477, DOI 10.1002/j.1460-2075.1996.tb00714.x; HWANG DS, 1988, J BIOL CHEM, V263, P10633; Jakimowicz D, 1998, MICROBIOL-SGM, V144, P1281, DOI 10.1099/00221287-144-5-1281; Kaguni JM, 1997, MOL CELLS, V7, P145; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Kornberg A., 1992, DNA REPLICATION; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Margulies C, 1996, J BIOL CHEM, V271, P17035, DOI 10.1074/jbc.271.29.17035; MARGULIES CA, 1997, INFLUENCE IHF FIS OR; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MASAI H, 1990, J BIOL CHEM, V265, P15134; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Neuwald AF, 1999, GENOME RES, V9, P27; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Simmons LA, 2003, MOL MICROBIOL, V49, P849, DOI 10.1046/j.1365-2958.2003.03603.x; Simmons LA, 2003, MOL MICROBIOL, V47, P755, DOI 10.1046/j.1365-2958.2003.03333.x; Sutton MD, 1997, J MOL BIOL, V271, P693, DOI 10.1006/jmbi.1997.1209; Sutton MD, 1997, J MOL BIOL, V274, P546, DOI 10.1006/jmbi.1997.1425; Sutton MD, 1997, J BIOL CHEM, V272, P23017, DOI 10.1074/jbc.272.37.23017; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Vossen KM, 1997, ANAL BIOCHEM, V245, P85, DOI 10.1006/abio.1996.9944; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; WOELKER B, 1993, NUCLEIC ACIDS RES, V21, P5025, DOI 10.1093/nar/21.22.5025	50	57	57	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51156	51162		10.1074/jbc.M409695200	http://dx.doi.org/10.1074/jbc.M409695200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371441	hybrid			2022-12-27	WOS:000225355800062
J	Roy, R; Wewer, UM; Zurakowski, D; Pories, SE; Moses, MA				Roy, R; Wewer, UM; Zurakowski, D; Pories, SE; Moses, MA			ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							12 MELTRIN ALPHA; CYSTEINE-RICH DOMAIN; CONVERTING-ENZYME; URINARY PROTEINS; CELL-MIGRATION; IN-VITRO; METALLOPROTEASE; ADAM12; TIMP-3; INHIBITORS	ADAM 12 is a member of a family of disintegrin-containing metalloproteases that have been implicated in a variety of diseases including Alzheimer's disease, arthritis, and cancer. We purified ADAM 12 from the urine of breast cancer patients via Q-Sepharose anion exchange and gelatin-Sepharose affinity chromatography followed by protein identification by matrix-assisted laser desorption/ ionization-time of flight mass spectrometry. Four peptides were identified that spanned the amino acid sequence of ADAM 12. Immunoblot analysis using ADAM 12-specific antibodies detected an similar to 68-kDa band identified as the mature form of ADAM 12. To characterize catalytic properties of ADAM 12, full-length ADAM 12-S was expressed in COS-7 cells and purified. Substrate specificity studies demonstrated that ADAM 12-S degrades gelatin, type IV collagen, and fibronectin but not type I collagen or casein. Gelatinase activity of ADAM 12 was completely abrogated by zinc chelators 1,10-phenanthroline and EDTA and was partially inhibited by the hydroxamate inhibitor Marimastat. Endogenous matrix metalloprotease inhibitor TIMP-3 inhibited activity. To validate our initial identification of this enzyme in human urine, 117 urine samples from breast cancer patients and controls were analyzed by immunoblot. The majority of samples from cancer patients were positive for ADAM 12 ( 67 of 71, sensitivity 0.94) compared with urine from controls in which ADAM 12 was detected with significantly lower frequency. Densitometric analyses of immunoblots demonstrated that ADAM 12 protein levels were higher in urine from breast cancer patients than in control urine. In addition, median levels of ADAM 12 in urine significantly increased with disease progression. These data demonstrate for the first time that ADAM 12 is a gelatinase, that it can be detected in breast cancer patient urine, and that increased urinary levels of this protein correlate with breast cancer progression. They further support the possibility that detection of urinary ADAM 12 may prove useful in the development of noninvasive diagnostic and prognostic tests for breast and perhaps other cancers.	Harvard Univ, Childrens Hosp, Program Vasc Biol, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Childrens Hosp, Dept Orthoped Surg & Biostat, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Cambridge, MA 02138 USA; Mt Auburn Hosp, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Copenhagen, Inst Mol Pathol, Copenhagen, Denmark	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Mount Auburn Hospital; Harvard University; Harvard Medical School; University of Copenhagen	Moses, MA (corresponding author), Harvard Univ, Childrens Hosp, Program Vasc Biol, Karp Family Res Bldg,Floor 12,300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu	Pories, Susan/AAB-1757-2019	Pories, Susan/0000-0001-7315-9993				Alfandari D, 2001, CURR BIOL, V11, P918, DOI 10.1016/S0960-9822(01)00263-9; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; BEREK JS, 1995, CANCER-AM CANCER SOC, V76, P2092, DOI 10.1002/1097-0142(19951115)76:10+<2092::AID-CNCR2820761331>3.0.CO;2-T; Breslow N.E., 1980, STAT METHODS CANC RE, P192; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; Chubinskaya S, 2001, J HISTOCHEM CYTOCHEM, V49, P1165, DOI 10.1177/002215540104900910; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Lochter A, 1998, ANN NY ACAD SCI, V857, P180, DOI 10.1111/j.1749-6632.1998.tb10116.x; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Martin J, 2002, J BIOL CHEM, V277, P33683, DOI 10.1074/jbc.M200988200; Millichip MI, 1998, BIOCHEM BIOPH RES CO, V245, P594, DOI 10.1006/bbrc.1998.8485; MOERTEL CG, 1993, JAMA-J AM MED ASSOC, V270, P943, DOI 10.1001/jama.270.8.943; Moses MA, 1998, CANCER RES, V58, P1395; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; Pieper R, 2004, PROTEOMICS, V4, P1159, DOI 10.1002/pmic.200300661; Prestigiacomo AP, 1996, J UROLOGY, V156, P350, DOI 10.1016/S0022-5347(01)65847-6; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; SHANNON JD, 1989, J BIOL CHEM, V264, P11575; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Thongboonkerd V, 2002, KIDNEY INT, V62, P1461, DOI 10.1046/j.1523-1755.2002.00565.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zou J, 2004, J BIOL CHEM, V279, P9818, DOI 10.1074/jbc.M309696200	32	189	203	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51323	51330		10.1074/jbc.M409565200	http://dx.doi.org/10.1074/jbc.M409565200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15381692	hybrid			2022-12-27	WOS:000225355800082
J	Sankaranarayanan, K; Jaiswal, AK				Sankaranarayanan, K; Jaiswal, AK			Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H : quinone oxidoreductase1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; FUNCTIONAL-CHARACTERIZATION; ACTIVATION; CARCINOGENESIS; SUSCEPTIBILITY; TRANSFERASES; DISRUPTION; DEFICIENCY; COMPLEXITY; RADICALS	Antioxidant-response element (ARE) and nuclear factor Nrf2-mediated expression and coordinated induction of genes encoding chemopreventive proteins, including NQO1, are critical mechanisms in chemoprotection. Recently, Nrf3, a new member of the Nrf family with substantial homology to Nrf2, was identified and cloned. In this report, we have investigated the role of Nrf3 in ARE-mediated gene expression and induction of NQO1 in response to antioxidants. Overexpression of Nrf3 in Hep-G2 cells led to a concentration-dependent decrease in transfected and endogenous NQO1 gene expression and induction in response to antioxidant tert-butylhydroquinone (t-BHQ). Deletion mutation analysis revealed that Nrf3 repression of NQO1 gene expression required heterodimerization and DNA binding domains but not transcriptional activation domain of Nrf3. Bandshift and supershift assays with in vitro transcribed and translated proteins and nuclear extracts from Hep-G2 cells treated with Me2SO and t-BHQ and immunoprecipitation assays demonstrated that Nrf3 associates with small Maf proteins to bind to the ARE. RNA interference specific to Nrf3 reduced intracellular Nrf3 leading to increased expression and induction of transfected and endogenous NQO1 gene expression in response to t-BHQ. These results combined suggest that Nrf3 is a negative regulator of ARE-mediated gene expression.	Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine	Jaiswal, AK (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.	AJAISWAL@BCM.TMC.EDU			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047466, R29GM047466] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47466] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; BREIMER LH, 1990, MOL CARCINOGEN, V3, P188, DOI 10.1002/mc.2940030405; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Derjuga A, 2004, MOL CELL BIOL, V24, P3286, DOI 10.1128/MCB.24.8.3286-3294.2004; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jaiswal AK, 2004, METHOD ENZYMOL, V378, P221; JOSEPH P, 1994, P NATL ACAD SCI USA, V91, P8413, DOI 10.1073/pnas.91.18.8413; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; LAST JA, 1994, ENVIRON HEALTH PERSP, V102, P179, DOI 10.2307/3432236; Long DJ, 2000, CANCER RES, V60, P5913; Long DJ, 2002, CANCER RES, V62, P3030; Long DJ, 2001, JNCI-J NATL CANCER I, V93, P1166, DOI 10.1093/jnci/93.15.1166; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627	32	83	91	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50810	50817		10.1074/jbc.M404984200	http://dx.doi.org/10.1074/jbc.M404984200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385560	hybrid			2022-12-27	WOS:000225355800023
J	Suk, JY; Jensen, S; McGettrick, A; Willis, AC; Whiteman, P; Redfield, C; Handford, PA				Suk, JY; Jensen, S; McGettrick, A; Willis, AC; Whiteman, P; Redfield, C; Handford, PA			Structural consequences of cysteine substitutions C1977Y and C1977R in calcium-binding epidermal growth factor-like domain 30 of human fibrillin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-S; EGF-LIKE DOMAINS; HUMAN FACTOR-IX; MARFAN-SYNDROME; MOLECULAR-GENETICS; FBN1 MUTATIONS; FACTOR MODULES; IN-VITRO; PAIR; AFFINITY	The largest group of disease-causing mutations affecting calcium-binding epidermal growth factor-like (cbEGF) domain function in a wide variety of extracellular and transmembrane proteins is that which results in cysteine substitutions. Although known to introduce proteolytic susceptibility, the detailed structural consequences of cysteine substitutions in cbEGF domains are unknown. Here, we studied pathogenic mutations C1977Y and C1977R, which affect cbEGF30 of human fibrillin-1, in a recombinant three cbEGF domain fragment (cbEGF29- 31). Limited proteolysis, H-1 NMR, and calcium chelation studies have been used to probe the effect of each substitution on cbEGF30 and its flanking domains. Analysis of the wild-type fragment identified two high affinity and one low affinity calcium-binding sites. Each substitution caused the loss of high affinity calcium binding to cbEGF30, consistent with intradomain misfolding, but the calcium binding properties of cbEGF29 and cbEGF31 were surprisingly unaffected. Further analysis of mutant fragments showed that domain packing of cbEGF29 - 30, but not cbEGF30 - 31, was disrupted. These data demonstrate that C1977Y and C1977R have localized structural effects, confined to the N-terminal end of the mutant domain, which disrupt domain packing. Cysteine substitutions affecting other cbEGF disulfide bonds are likely to have different effects. This proposed structural heterogeneity may underlie the observed differences in stability and cellular trafficking of proteins containing such changes.	Univ Oxford, Dept Biochem, Div Mol & Cellular Biochem, Oxford OX1 3QU, England; Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; Univ Oxford, Dept Biochem, Oxford OX1 3TA, England; Univ Oxford, Oxford Ctr Mol Sci, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Handford, PA (corresponding author), Univ Oxford, Dept Biochem, Div Mol & Cellular Biochem, Oxford OX1 3QU, England.	penny@bioch.ox.ac.uk	Jensen, Sacha A./AAB-4034-2019	Jensen, Sacha A./0000-0002-0560-9531; Redfield, Christina/0000-0001-7297-7708				AOYAMA T, 1995, AM J MED GENET, V58, P169, DOI 10.1002/ajmg.1320580216; AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Booms P, 2000, HUM GENET, V107, P216, DOI 10.1007/s004390000368; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; FENG YQ, 1991, BIOPHYS J, V59, P323, DOI 10.1016/S0006-3495(91)82226-3; Giannelli F, 1997, NUCLEIC ACIDS RES, V25, P133, DOI 10.1093/nar/25.1.133; Halliday D, 1999, HUM GENET, V105, P587, DOI 10.1007/s004390051150; Halliday DJ, 2002, J MED GENET, V39, P589, DOI 10.1136/jmg.39.8.589; HANDFORD P, 1995, J BIOL CHEM, V270, P6751, DOI 10.1074/jbc.270.12.6751; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kettle S, 1999, J MOL BIOL, V285, P1277, DOI 10.1006/jmbi.1998.2368; Knott V, 1996, J MOL BIOL, V255, P22, DOI 10.1006/jmbi.1996.0003; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LINSE S, 1987, BIOCHEMISTRY-US, V26, P6723, DOI 10.1021/bi00395a023; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; MAYHEW M, 1992, PROTEIN ENG, V5, P489, DOI 10.1093/protein/5.6.489; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Rand MD, 1997, PROTEIN SCI, V6, P2059; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Robinson PN, 2000, J MED GENET, V37, P9, DOI 10.1136/jmg.37.1.9; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Smallridge RS, 1999, J MOL BIOL, V286, P661, DOI 10.1006/jmbi.1998.2536; Stenberg Y, 1999, J MOL BIOL, V293, P653, DOI 10.1006/jmbi.1999.3139; Stenberg Y, 1997, EUR J BIOCHEM, V248, P163, DOI 10.1111/j.1432-1033.1997.t01-1-00163.x; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Whiteman P, 1998, PROTEIN ENG, V11, P957, DOI 10.1093/protein/11.11.957; Whiteman P, 2001, J BIOL CHEM, V276, P17156, DOI 10.1074/jbc.M006547200; Whiteman P, 1998, J BIOL CHEM, V273, P7807, DOI 10.1074/jbc.273.14.7807	39	33	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51258	51265		10.1074/jbc.M408156200	http://dx.doi.org/10.1074/jbc.M408156200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371449	hybrid			2022-12-27	WOS:000225355800074
J	Hong, Y; Sundaram, S; Shin, DJ; Stanley, P				Hong, Y; Sundaram, S; Shin, DJ; Stanley, P			The Lec23 Chinese hamster ovary mutant is a sensitive host for detecting mutations in alpha-glucosidase I that give rise to congenital disorder of glycosylation IIb (CDG IIb)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; SIALIC ACID TRANSPORTER; MAMMARY-GLAND; MASS-SPECTROMETRY; D-MANNOSIDASE; CHO CELLS; GLYCOPROTEINS; CALNEXIN; BIOSYNTHESIS; DEFICIENT	Lec23 Chinese hamster ovary cells are defective in alpha-glucosidase I activity, which removes the distal alpha(1,2)-linked glucose residue from Glc(3)Man(9)GlcNAc(2) moieties attached to glycoproteins in the endoplasmic reticulum. Mutations in the human GCS1 gene give rise to the congenital disorder of glycosylation termed CDG IIb. Lec23 mutant cells have been shown to alter lectin binding and to synthesize predominantly oligomannosyl N-glycans on endogenous glycoproteins. A single point mutation (TCC to TTC; Ser to Phe) was identified in Lec23 Gcs1 cDNA and genomic DNA. Serine at the analogous position is highly conserved in all GCS1 gene homologues. A human GCS1 cDNA reverted the Lec23 phenotype, whereas GCS1 cDNA carrying the lec23 mutation (S440F in human) did not. By contrast, GCS1 cDNA with an R486T or F652L CDG IIb mutation gave substantial rescue of the Lec23 phenotype. Nevertheless, in vitro assays of each enzyme gave no detectable alpha-glucosidase I activity. Clearly the R486T and F652L GCS1 mutations are only mildly debilitating in an intact cell, whereas the S440F mutation largely inactivates alpha-glucosidase I both in vitro and in vivo. However, the S440F alpha-glucosidase I may have a small amount of alpha-glucosidase I activity in vivo based on the low levels of complex N-glycans in Lec23. A sensitive test for complex N-glycans showed the presence of polysialic acid on the neural cell adhesion molecule. The Lec23 Chinese hamster ovary mutant represents a sensitive host for detecting a wide range of mutations in human GCS1 that give rise to CDG IIb.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Chonnam Natl Univ, Sch Med, Gen Res Ctr Enter Bacteria, Kwangju 501746, South Korea; Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju 501746, South Korea	Yeshiva University; Albert Einstein College of Medicine; Chonnam National University; Chonnam National University	Stanley, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stanley@aecom.yu.edu		Stanley, Pamela/0000-0001-5704-3747	NCI NIH HHS [P01 CA13330, R01 CA34634] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boedeker JC, 1999, J LIPID RES, V40, P1627; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Chen P, 1997, ANAL BIOCHEM, V244, P144, DOI 10.1006/abio.1996.9874; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1235; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 1996, P NATL ACAD SCI USA, V93, P7572, DOI 10.1073/pnas.93.15.7572; Endo T, 2003, BIOL PHARM BULL, V26, P1641, DOI 10.1248/bpb.26.1641; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fenouillet E, 1996, VIROLOGY, V218, P224, DOI 10.1006/viro.1996.0182; Fenouillet E, 1997, VIROLOGY, V231, P89, DOI 10.1006/viro.1997.8505; Freeze HH, 2002, BBA-GEN SUBJECTS, V1573, P388, DOI 10.1016/S0304-4165(02)00408-7; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HIRAIZUMI S, 1993, J BIOL CHEM, V268, P9927; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Hong YJ, 2003, J BIOL CHEM, V278, P53045, DOI 10.1074/jbc.M309967200; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; Jaeken J, 2004, J Inherit Metab Dis, V27, P423, DOI 10.1023/B:BOLI.0000031221.44647.9e; Kojima N, 1998, J BIOCHEM-TOKYO, V124, P726, DOI 10.1093/oxfordjournals.jbchem.a022173; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; Martin PT, 2003, GLYCOBIOLOGY, V13, p67R, DOI 10.1093/glycob/cwg077; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; Powell AK, 1996, RAPID COMMUN MASS SP, V10, P1027; PUKAZHENTHI BS, 1993, J BIOL CHEM, V268, P6445; RAY MK, 1991, J BIOL CHEM, V266, P22818; Romaniouk A, 1997, GLYCOBIOLOGY, V7, P399, DOI 10.1093/glycob/7.3.399; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; SHAILUBHAI K, 1990, J BIOL CHEM, V265, P9701; SHAILUBHAI K, 1991, J BIOL CHEM, V266, P16587; SHAILUBHAI K, 1987, BIOCHEM J, V247, P555, DOI 10.1042/bj2470555; Spiro MJ, 2000, GLYCOBIOLOGY, V10, P521, DOI 10.1093/glycob/10.5.521; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; STANLEY P, 1984, ARCH BIOCHEM BIOPHYS, V230, P363, DOI 10.1016/0003-9861(84)90119-X; STANLEY P, 1990, SOMAT CELL MOLEC GEN, V16, P211, DOI 10.1007/BF01233357; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Volker C, 2002, GLYCOBIOLOGY, V12, P473, DOI 10.1093/glycob/cwf050; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47	47	18	18	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49894	49901		10.1074/jbc.M410121200	http://dx.doi.org/10.1074/jbc.M410121200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383536	hybrid			2022-12-27	WOS:000225229500044
J	Mukai, T; Kawai, S; Mori, S; Mikami, B; Murata, K				Mukai, T; Kawai, S; Mori, S; Mikami, B; Murata, K			Crystal structure of bacterial inorganic polyphosphate/ATP-glucomannokinase - Insights into kinase evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRAIN HEXOKINASE; ADP-DEPENDENT GLUCOKINASE; SP STRAIN KM; YEAST HEXOKINASE; CONFORMATIONAL-CHANGE; ALLOSTERIC REGULATION; MEMBRANE ASSOCIATION; PROTEIN STRUCTURES; DIFFRACTION DATA; SUGAR KINASES	Inorganic polyphosphate ( poly( P)) is a biological high energy compound presumed to be an ancient energy carrier preceding ATP. Several poly(P)-dependent kinases that use poly( P) as a phosphoryl donor are known to function in bacteria, but crystal structures of these kinases have not been solved. Here we present the crystal structure of bacterial poly( P)/ATP-glucomannokinase, belonging to Gram-positive bacterial glucokinase, complexed with 1 glucose molecule and 2 phosphate molecules at 1.8 Angstrom resolution, being the first among poly(P)-dependent kinases and bacterial glucokinases. The poly( P)/ATP-glucomannokinase structure enabled us to understand the structural relationship of bacterial glucokinase to eucaryotic hexokinase and ADP-glucokinase, which has remained a matter of debate. These comparisons also enabled us to propose putative binding sites for phosphoryl groups for ATP and especially for poly( P) and to obtain insights into the evolution of kinase, particularly from primordial poly(P)-specific to ubiquitous ATP-specific proteins.	Kyoto Univ, Grad Sch Agr, Dept Basic & Appl Mol Biotechnol, Div Food & Biol Sci, Kyoto 6110011, Japan; Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Lab Food Qual Design & Dev, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Dept Basic & Appl Mol Biotechnol, Div Food & Biol Sci, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp						Aleshin AE, 1998, FEBS LETT, V434, P42, DOI 10.1016/S0014-5793(98)00952-1; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; ANDERSON CM, 1979, SCIENCE, V204, P375, DOI 10.1126/science.220706; ANDERSON CM, 1978, J MOL BIOL, V123, P15, DOI 10.1016/0022-2836(78)90374-1; ARORA KK, 1991, J BIOL CHEM, V266, P5359; BENNETT WS, 1980, J MOL BIOL, V140, P183, DOI 10.1016/0022-2836(80)90102-3; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BORK P, 1993, PROTEIN SCI, V2, P31; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1996, XPLOR VERSION 3 851; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Cesar MD, 1998, ARCH BIOCHEM BIOPHYS, V350, P109; Cheek S, 2002, J MOL BIOL, V320, P855, DOI 10.1016/S0022-2836(02)00538-7; Fang TY, 1998, J BIOL CHEM, V273, P19548, DOI 10.1074/jbc.273.31.19548; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kawai S, 2000, BIOCHEM BIOPH RES CO, V276, P57, DOI 10.1006/bbrc.2000.3433; Kornberg A, 1999, Prog Mol Subcell Biol, V23, P1; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mukai T, 2003, ACTA CRYSTALLOGR D, V59, P1662, DOI 10.1107/S0907444903015464; Mukai T, 2003, APPL ENVIRON MICROB, V69, P3849, DOI 10.1128/AEM.69.7.3849-3857.2003; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips N F, 1999, Prog Mol Subcell Biol, V23, P101; POLAKIS PG, 1985, ARCH BIOCHEM BIOPHYS, V236, P328, DOI 10.1016/0003-9861(85)90633-2; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rosano C, 1999, STRUCT FOLD DES, V7, P1427, DOI 10.1016/S0969-2126(00)80032-5; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STEITZ TA, 1976, J MOL BIOL, V104, P197, DOI 10.1016/0022-2836(76)90009-7; Tanaka S, 2003, J BACTERIOL, V185, P5654, DOI 10.1128/JB.185.18.5654-5656.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wu G, 2001, GENE, V264, P265, DOI 10.1016/S0378-1119(01)00329-8; Zeng CB, 1998, J BIOL CHEM, V273, P700, DOI 10.1074/jbc.273.2.700	46	36	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50591	50600		10.1074/jbc.M408126200	http://dx.doi.org/10.1074/jbc.M408126200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377666	hybrid			2022-12-27	WOS:000225229500123
J	Purvis, AR; Sadler, JE				Purvis, AR; Sadler, JE			A covalent oxidoreductase intermediate in propeptide-dependent von Willebrand factor multimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL CELLS; VONWILLEBRAND-FACTOR VWF; ENDOPLASMIC-RETICULUM; POLYPEPTIDE-CHAIN; PROTEIN; PROPOLYPEPTIDE; IDENTIFICATION; LOCALIZATION; DIMERIZATION; REQUIREMENTS	The assembly of von Willebrand factor multimers in the Golgi apparatus requires D1D2 domains of the von Willebrand factor propeptide, which may act as an oxidoreductase to promote disulfide bond formation or rearrangement between two D3 domains in the mature subunit. This mechanism predicts that the propeptide should form a transient intrachain disulfide bond with the D3 domain before multimerization. Such an intermediate was detected using truncated subunits that simplify the analysis of the multimerization process. When only the D1D2D'D3 region of von Willebrand factor was expressed in baby hamster kidney cells, the propeptide and D'D3 formed an intrachain disulfide-linked species in the endoplasmic reticulum that could be identified by two-dimensional gel electrophoresis after cleavage with thrombin or furin. This intermediate rearranged in the Golgi to form free propeptide and D'D3 dimers that were secreted. A similar intracellular disulfide-linked species was identified in cells expressing the propeptide and D'D3 as separate proteins and in cells expressing full-length von Willebrand factor. These results support a model in which the propeptide acts as an oxidoreductase to promote von Willebrand factor multimerization in the Golgi apparatus.	Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sadler, JE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, 660 S Euclid Ave,Box 8022, St Louis, MO 63110 USA.	esadler@im.wustl.edu	Sadler, Evan/D-8556-2011	Sadler, J. Evan/0000-0001-5705-469X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072917] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL72917] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bodo I, 2001, BLOOD, V98, P2973, DOI 10.1182/blood.V98.10.2973; FAY PJ, 1982, P NATL ACAD SCI-BIOL, V79, P7200, DOI 10.1073/pnas.79.23.7200; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Gitler C, 1997, ANAL BIOCHEM, V252, P48, DOI 10.1006/abio.1997.2294; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Katsumi A, 2000, J BIOL CHEM, V275, P25585, DOI 10.1074/jbc.M002654200; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MAYADAS TN, 1992, P NATL ACAD SCI USA, V89, P3531, DOI 10.1073/pnas.89.8.3531; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; NACHMAN R, 1977, J CLIN INVEST, V60, P914, DOI 10.1172/JCI108846; REHEMTULLA A, 1992, BLOOD, V79, P2349; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; VISCHER UM, 1994, BLOOD, V83, P3536; VOORBERG J, 1990, EMBO J, V9, P797, DOI 10.1002/j.1460-2075.1990.tb08176.x; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WAGNER DD, 1987, P NATL ACAD SCI USA, V84, P1955, DOI 10.1073/pnas.84.7.1955; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WAGNER DD, 1985, J CELL BIOL, V101, P112, DOI 10.1083/jcb.101.1.112; WAGNER DD, 1984, J CELL BIOL, V99, P2123, DOI 10.1083/jcb.99.6.2123; WAGNER DD, 1983, J BIOL CHEM, V258, P2065; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9	25	40	41	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49982	49988		10.1074/jbc.M408727200	http://dx.doi.org/10.1074/jbc.M408727200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385532	hybrid			2022-12-27	WOS:000225229500054
J	Solanas, G; Miravet, S; Casagolda, D; Castano, J; Raurell, I; Corrionero, A; de Herreros, AG; Dunach, M				Solanas, G; Miravet, S; Casagolda, D; Castano, J; Raurell, I; Corrionero, A; de Herreros, AG; Dunach, M			beta-catenin and plakoglobin N- and C-tails determine ligand specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; BINDING; CADHERIN; PROTEINS; ASSOCIATION; DESMOSOMES; INTERACTS; PYGOPUS; REGION	beta-Catenin and plakoglobin are related proteins involved in the regulation of adherens junctions and desmosomes. Moreover, by binding to Tcf-4, they can act as transcriptional modulators of genes involved in embryonic development and tumorigenesis. However, they associate to distinct Tcf-4 subdomains causing opposing effects on Tcf-4 binding to DNA: whereas beta-catenin does not affect this binding, plakoglobin prevents it. Both proteins are composed by two N- and C-tails and a central armadillo repeat domain. Interaction of Tcf-4, as well as other desmosomal or adherens junction components, with beta-catenin or plakoglobin takes place through the central armadillo domain. Here we show that, as reported for beta-catenin, plakoglobin terminal tails also interact with the central domain and regulate the ability of this region to bind to different cofactors. Moreover the specificity of the interaction of beta-catenin and plakoglobin with different subdomains in Tcf-4 or with other junctional components resides within the terminal tails and not in the armadillo domain. For instance, a chimeric protein in which the central domain of beta-catenin was replaced by that of plakoglobin presented the same specificity as wild-type beta-catenin. Therefore, the terminal tails of these proteins are responsible for discerning among binding of factors to the armadillo domain. These results contribute to the understanding of the molecular basis of the interactions established by these key regulators of epithelial tumorigenesis.	Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Spain; Univ Pompeu Fabra, Inst Municipal Invest Med, Unitat Biol Cellular & Mol, E-08003 Barcelona, Spain	Autonomous University of Barcelona; University of Barcelona; Pompeu Fabra University	de Herreros, AG (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Unitat Biofis, E-08193 Barcelona, Spain.	agarcia@imim.es; mireia.dunach@uab.es	de Herreros, A Garcia/H-3104-2014; Dunach, Mireia/E-3604-2015	de Herreros, A Garcia/0000-0001-5270-0808; Dunach, Mireia/0000-0001-9844-5603; Solanas, Guiomar/0000-0001-8388-8647; Castano Cardoso, Julio/0000-0002-0712-5856				Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Feng Y, 2003, CANCER RES, V63, P8726; Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hu PQ, 2001, J INVEST DERMATOL, V117, P1059, DOI 10.1046/j.0022-202x.2001.01523.x; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kolligs FT, 2000, GENE DEV, V14, P1319; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Miravet S, 2002, J BIOL CHEM, V277, P1884, DOI 10.1074/jbc.M110248200; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Polakis P, 2000, GENE DEV, V14, P1837; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Williams BO, 2000, ONCOGENE, V19, P5720, DOI 10.1038/sj.onc.1203921; Zhurinsky J, 2000, J CELL SCI, V113, P3127; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	35	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49849	49856		10.1074/jbc.M408685200	http://dx.doi.org/10.1074/jbc.M408685200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381698	hybrid			2022-12-27	WOS:000225229500038
J	Gee, GV; Tsomaia, N; Mierke, DF; Atwood, WJ				Gee, GV; Tsomaia, N; Mierke, DF; Atwood, WJ			Modeling a sialic acid binding pocket in the external loops of JC virus VP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALYLOLIGOSACCHARIDE RECEPTORS; SWISS-MODEL; GLIAL-CELLS; POLYOMAVIRUS; INFECTION	JC virus (JCV) is a common human polyomavirus that infects over 70% of the population worldwide. JCV has a restricted cell tropism that is caused partly by the initial interaction between the virus and sialic acid-containing host cell receptors. To identify the molecular interactions between the virus and its cellular receptor, we used a combined approach of site-directed mutagenesis and homology-based molecular modeling. A model of the major viral capsid protein VP1 based on sequence alignment with other closely related polyomaviruses allowed us to target specific amino acids in the extracellular loops of VP1 for mutagenesis. An analysis of the growth rates of 17 point mutants led to the identification of VP1 amino acids that are critical in virus-host cell receptor interactions. Molecular dynamics simulations were then used to build and confirm a model of the interaction between VP1 and the sialic acid component of the JCV receptor.	Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; Brown Univ, Grad Program Mol & Cell Biol & Biochem, Providence, RI 02912 USA; Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Atwood, WJ (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, Box G-B616,171 Meeting St, Providence, RI 02912 USA.	Walter_Atwood@Brown.edu		Gee, Gretchen/0000-0003-0403-3240	NCI NIH HHS [R01 CA71878] Funding Source: Medline; NINDS NIH HHS [R01 NS43097] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043097] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATWOOD WJ, 1989, J VIROL, V63, P4474, DOI 10.1128/JVI.63.10.4474-4477.1989; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; CAHAN LD, 1983, VIROLOGY, V130, P281, DOI 10.1016/0042-6822(83)90083-1; FREUND R, 1991, J VIROL, V65, P350, DOI 10.1128/JVI.65.1.350-355.1991; FRIED H, 1981, VIROLOGY, V109, P188, DOI 10.1016/0042-6822(81)90485-2; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hou J, 2000, J NEUROVIROL, V6, pS98; Komagome R, 2002, J VIROL, V76, P12992, DOI 10.1128/JVI.76.24.12992-13000.2002; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Liu CK, 1998, J VIROL, V72, P4643, DOI 10.1128/JVI.72.6.4643-4649.1998; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Monaco MCG, 1996, J VIROL, V70, P7004, DOI 10.1128/JVI.70.10.7004-7012.1996; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; VACANTE DA, 1989, VIROLOGY, V170, P353, DOI 10.1016/0042-6822(89)90425-X	17	36	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49172	49176		10.1074/jbc.M409326200	http://dx.doi.org/10.1074/jbc.M409326200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347668	hybrid			2022-12-27	WOS:000225098100082
J	Potthast, R; Abbey-Hosch, SE; Antos, LK; Marchant, JS; Kuhn, M; Potter, LR				Potthast, R; Abbey-Hosch, SE; Antos, LK; Marchant, JS; Kuhn, M; Potter, LR			Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CGMP ACCUMULATION; DESENSITIZATION; ACTIVATION; MECHANISM; CELLS; PATHWAY; FAMILY	C-type natriuretic peptide binding to natriuretic peptide receptor-B (NPR-B) stimulates cGMP synthesis, which regulates vasorelaxation, cell proliferation, and bone growth. Here, we investigated the mechanistic basis for hyperosmotic and lysophosphatidic acid-dependent inhibition of NPR-B. Whole cell cGMP measurements and guanylyl cyclase assays indicated that acute hyperosmolarity decreased NPR-B activity in a reversible, concentration- and time-dependent manner, whereas chronic exposure had no effect. Acute hyperosmolarity elevated intracellular calcium in a concentration-dependent fashion that paralleled NPR-B desensitization. A calcium chelator, but not a protein kinase C inhibitor, blocked both calcium elevations and desensitization. Hyperosmotic medium stimulated NPR-B dephosphorylation, and the receptor was rapidly rephosphorylated and resensitized when the hypertonic media was removed. Lysophosphatidic acid also inhibited NPR-B in a calcium- and phosphorylation-dependent process, consistent with calcium being a universal regulator of NPR-B. The absolute requirement of dephosphorylation in this process was demonstrated by showing that a receptor with glutamates substituted at all known NPR-B phosphorylation sites is unresponsive to hyperosmotic stimuli. This is the first study to measure the phosphorylation state of an endogenous guanylyl cyclase and to link intracellular calcium elevations with its dephosphorylation.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Univ Klinikum Munster, Inst Pharmacol & Toxicol, D-48149 Munster, Germany	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Munster	Potter, LR (corresponding author), 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	potter@umn.edu	MARCHANT, Jonathan/B-8051-2009; Marchant, Jonathan/Q-5484-2019	MARCHANT, Jonathan/0000-0001-6592-0877; Marchant, Jonathan/0000-0001-6592-0877	NHLBI NIH HHS [R01 HL066397, R01HL66397] Funding Source: Medline; NIAMS NIH HHS [AR07612] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbey SE, 2003, ENDOCRINOLOGY, V144, P240, DOI 10.1210/en.2002-220702; Abbey SE, 2002, J BIOL CHEM, V277, P42423, DOI 10.1074/jbc.M206686200; Abbey-Hosch SE, 2004, HYPERTENSION, V43, P1103, DOI 10.1161/01.HYP.0000124668.80811.d3; Chrisman TD, 1999, J BIOL CHEM, V274, P4293, DOI 10.1074/jbc.274.7.4293; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; CLAVELL AL, 1993, AM J PHYSIOL, V264, P290; FURUYA M, 1991, BIOCHEM BIOPH RES CO, V177, P927, DOI 10.1016/0006-291X(91)90627-J; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; HANEDA M, 1991, KIDNEY INT, V40, P188, DOI 10.1038/ki.1991.199; IIMURA O, 1995, PFLUG ARCH EUR J PHY, V430, P81, DOI 10.1007/BF00373842; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; KATAFUCHI T, 1992, J BIOL CHEM, V267, P7624; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; Levin ER, 1998, NEW ENGL J MED, V339, P321; NAMBI P, 1986, P NATL ACAD SCI USA, V83, P8492, DOI 10.1073/pnas.83.22.8492; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Schulz S, 1999, VITAM HORM, V57, P123; SECHI LA, 1995, J CLIN INVEST, V95, P2451, DOI 10.1172/JCI117945; SMITS P, 1993, DIABETES, V42, P1454, DOI 10.2337/diabetes.42.10.1454; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUGA S, 1992, J CLIN INVEST, V90, P1145, DOI 10.1172/JCI115933; TSUTAMOTO T, 1993, CIRCULATION, V87, P70, DOI 10.1161/01.CIR.87.1.70; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695	27	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48513	48519		10.1074/jbc.M408247200	http://dx.doi.org/10.1074/jbc.M408247200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371450	hybrid			2022-12-27	WOS:000225098100006
J	Lu, HL; Macosko, J; Habel-Rodriguez, D; Keller, RW; Brozik, JA; Keller, DJ				Lu, HL; Macosko, J; Habel-Rodriguez, D; Keller, RW; Brozik, JA; Keller, DJ			Closing of the fingers domain generates motor forces in the HIV reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; DNA-POLYMERASES; COMPLEX; INHIBITION; FIDELITY; REPLICATION; RESISTANCE; MECHANISM; KINETICS	Using the force sensor of an atomic force microscope, motor forces of the human immunodeficiency virus-1 reverse transcriptase were measured during active replication of a short DNA transcript. At low load forces the polymerase is mechanically slowed, whereas at high force (similar to15 piconewton) it stalls. From recordings of estimated polymerase turnover velocity versus load force, an approximate force-velocity curve has been constructed. The shape of the curve suggests that load force strongly inhibits the rate-limiting step of the polymerase turnover cycle and that the combined effect of load on all steps involves an effective motion of about 1.6 nm. Earlier results from pre-steady-state kinetics experiments have identified the rate-limiting step as the closing of the fingers domain to form a tight catalytic complex. Together these findings indicate that the closing of the fingers domain is a major force-generating step for human immunodeficiency virus reverse transcriptase and, by extension, for all DNA polymerase machines.	Univ New Mexico, Dept Chem, Albuquerque, NM 87106 USA	University of New Mexico	Keller, DJ (corresponding author), Univ New Mexico, Dept Chem, Albuquerque, NM 87106 USA.	dkeller@unm.edu	lu, hailong/C-7754-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063808] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63808] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Furman PA, 2000, CURR PHARM DESIGN, V6, P547, DOI 10.2174/1381612003400777; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; KATI WM, 1992, J BIOL CHEM, V267, P25988; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Krebs R, 1997, BIOCHEMISTRY-US, V36, P10292, DOI 10.1021/bi970512z; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; Pop MP, 1996, BIOCHEMISTRY-US, V35, P5054, DOI 10.1021/bi9530292; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614	19	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2004	279	52					54529	54532		10.1074/jbc.M407193200	http://dx.doi.org/10.1074/jbc.M407193200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	880MJ	15385563	hybrid			2022-12-27	WOS:000225793600077
J	Zhang, YL; Joiner, WJ; Bhattacharjee, A; Rassendren, F; Magoski, NS; Kaczmarek, LK				Zhang, YL; Joiner, WJ; Bhattacharjee, A; Rassendren, F; Magoski, NS; Kaczmarek, LK			The appearance of a protein kinase A-regulated splice isoform of slo is associated with the maturation of neurons that control reproductive behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; BAG CELL NEURONS; CA2+-ACTIVATED K+ CHANNEL; RAT CORTICAL-NEURONS; LARGE-CONDUCTANCE; CA CHANNELS; PEPTIDERGIC NEURONS; CATION CHANNEL; BK CHANNEL; CALCIUM	In response to brief synaptic stimulation that activates protein kinase A (PKA), the bag cell neurons of Aplysia trigger the onset of reproductive behaviors by generating a prolonged afterdischarge. In juvenile animals, such afterdischarges are inhibited by a high density of Ca2+-activated K+ (BK) channels, encoded by the slo gene. An increase in this current also follows an afterdischarge in mature animals, contributing to a subsequent refractory state that limits reproductive behaviors. Using a bag cell cDNA library, we have isolated two alternative transcripts of the slo gene, differing in the presence (slo-a) or absence (slo-b) of a consensus phosphorylation site for PKA. Expression of either isoform in Chinese hamster ovary cells produced Ca2+- and voltage-dependent channels with macroscopic and unitary properties matching those in bag cell neurons. The isoforms differed, however, in their response to application of the catalytic subunit of PKA, which reduced the open probability of Slo-a, an effect that was reversed by a PKA inhibitor. In contrast, PKA had no effect on Slo-b. By immunocytochemistry, we determined that the PKA-regulated Slo-a subunit is present in adult, but not juvenile, bag cell neurons. Patch clamp recordings from adult and juvenile bag cell neurons confirmed that PKA decreases BK channel activity only in adults. Our findings suggest that a change in the identity of Slo isoforms expressed during development allows mature neurons to generate afterdischarges that are required for reproduction.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Univ Penn, Dept Neurosci, Philadelphia, PA USA; CNRS, UPR 1142, Inst Genet Humaine, F-34396 Montpellier 5, France; Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Yale University; University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Queens University - Canada	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	leonard.kaczmarek@yale.edu	Rassendren, Francois/AAA-6190-2021	Rassendren, Francois/0000-0003-3320-2461				AZHDERIAN EM, 1994, NEURON, V12, P1223, DOI 10.1016/0896-6273(94)90439-1; BIELEFELDT K, 1994, J PHYSIOL-LONDON, V475, P241, DOI 10.1113/jphysiol.1994.sp020065; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; Brenner R, 1996, J NEUROSCI, V16, P1827; Brenner R, 1996, DEV BIOL, V177, P536, DOI 10.1006/dbio.1996.0183; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; CONN PJ, 1989, MOL NEUROBIOL, V3, P237, DOI 10.1007/BF02740607; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; GHO M, 1992, J EXP BIOL, V170, P93; GLASS DB, 1989, J BIOL CHEM, V264, P14579; Hall SK, 2000, J BIOL CHEM, V275, P3749, DOI 10.1074/jbc.275.6.3749; JENNINGS KR, 1982, J NEUROSCI, V2, P158; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; KACZMAREK LK, 1978, P NATL ACAD SCI USA, V75, P5200, DOI 10.1073/pnas.75.10.5200; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; KACZMAREK LK, 1984, J NEUROPHYSIOL, V52, P340, DOI 10.1152/jn.1984.52.2.340; KACZMAREK LK, 1982, BRAIN RES, V238, P105, DOI 10.1016/0006-8993(82)90774-0; Kandel E. R., 1979, BEHAV BIOL APLYSIA C; KUPFERMANN I, 1970, J NEUROPHYSIOL, V33, P865, DOI 10.1152/jn.1970.33.6.865; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LEE K, 1995, J PHYSIOL-LONDON, V488, P319, DOI 10.1113/jphysiol.1995.sp020969; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; LOECHNER KJ, 1990, BRAIN RES, V532, P1, DOI 10.1016/0006-8993(90)91733-W; Magoski NS, 2000, J PHYSIOL-LONDON, V522, P271, DOI 10.1111/j.1469-7793.2000.t01-2-00271.x; Nara M, 2000, AM J PHYSIOL-CELL PH, V279, pC1938, DOI 10.1152/ajpcell.2000.279.6.C1938; Nick TA, 1996, J NEUROSCI, V16, P7583; Nick TA, 1996, J NEUROPHYSIOL, V76, P3351, DOI 10.1152/jn.1996.76.5.3351; PEREZ G, 1994, AM J PHYSIOL, V266, pC1459, DOI 10.1152/ajpcell.1994.266.5.C1459; Piskorowski R, 2002, NATURE, V420, P499, DOI 10.1038/nature01199; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; REINHART PH, 1991, J NEUROSCI, V11, P1627; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Shipston MJ, 1996, J PHYSIOL-LONDON, V493, P665, DOI 10.1113/jphysiol.1996.sp021413; Shipston MJ, 1996, J BIOL CHEM, V271, P9197, DOI 10.1074/jbc.271.16.9197; Smith MA, 2000, NEUROSCIENCE, V95, P33; Tian LJ, 1998, J BIOL CHEM, V273, P13531, DOI 10.1074/jbc.273.22.13531; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallen K., 2002, HORMONES BRAIN BEHAV, P385, DOI DOI 10.1016/B978-012532104-4/50071-8; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WILSON GF, 1993, NATURE, V366, P433, DOI 10.1038/366433a0; Xia XM, 1998, J NEUROSCI, V18, P2360; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Xia XM, 2000, J NEUROSCI, V20, P4890; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhang YL, 2002, J NEUROSCI, V22, P10134; Zhou XB, 2000, J PHYSIOL-LONDON, V524, P339, DOI 10.1111/j.1469-7793.2000.t01-1-00339.x; Zhou Y, 2003, NEUROPHARMACOLOGY, V45, P714, DOI 10.1016/S0028-3908(03)00285-5	55	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52324	52330		10.1074/jbc.M408543200	http://dx.doi.org/10.1074/jbc.M408543200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15375169	hybrid			2022-12-27	WOS:000225493400074
J	Chang, MC; Wu, HL; Lee, JJ; Lee, PH; Chang, HH; Hahn, LJ; Lin, BR; Chen, YJ; Jeng, JH				Chang, MC; Wu, HL; Lee, JJ; Lee, PH; Chang, HH; Hahn, LJ; Lin, BR; Chen, YJ; Jeng, JH			The induction of prostaglandin E-2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETEL QUID; RISK-FACTORS; CYCLOOXYGENASE-2 EXPRESSION; HEPATOCELLULAR-CARCINOMA; EPITHELIAL-CELLS; C-FOS; INFLAMMATION; ARECOLINE; PATHWAY; KINASE	There are about 200 - 600 million betel quid (BQ) chewers in the world. BQ chewing is one of the major risk factor of hepatocarcinoma, oropharyngeal, and esophagus cancers in Taiwan, India, and Southeast Asian countries. Thus, the precise molecular mechanisms deserve investigation. We used cultured primary keratinocytes and KB cells, RT-PCR, flow cytometry, Western blotting, and ELISA to evaluate whether alterations in early gene expression is crucial in the carcinogenic processes of BQ. We observed the induction of c-Fos mRNA expression in human gingival keratinocyte (GK) and KB carcinoma cells by areca nut ( AN) extract and arecoline. A maximal increment in c-fos gene expression was shown at about 30 min after challenge. AN extract ( 100 - 800 mug/ml) and arecoline (0.1 - 0.8 mM) also stimulated ERK1/ ERK2 phosphorylation with a maximal stimulation at 5 - 10 min of exposure. Pretreatment by U0126 ( 30 muM), a MEK inhibitor, markedly inhibited the c-Fos, cyclooxygenase-2 (COX-2), and IL-6 mRNA expression of the KB epithelial cells. In addition, U0126 and PD98059 ( 50 muM) also decreased AN extract- and arecoline-associated PGE(2) and IL-6 production in GK and KB cells. However, U0126 by itself arrested the cells in G(0)/G(1) phase, but was not able to prevent AN- and arecoline-induced cell death or apoptosis. In contrast, U0126 enhanced the AN- induced apoptosis of KB cells. AN ingredients thus play a significant role in the pathogenesis of oropharyngeal cancer by activation of MEK1/ERK/c-Fos pathway, which promotes keratinocyte inflammation, cell survival, and affects cell cycle progression.	Natl Taiwan Univ Hosp, Coll Med, Sch Dent,Dept Dent, Lab Dent Pharmacol & Toxicol, Taipei, Taiwan; Chang Gung Inst Technol, Team Biomed Sci, Taoyuan, Taiwan; Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; Natl Taiwan Univ Hosp, Dept Diagnotherapeut, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Jeng, JH (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Sch Dent,Dept Dent, Lab Dent Pharmacol & Toxicol, 1 Chang Te St, Taipei, Taiwan.	huei@ha.mc.ntu.edu.tw	Lee, Po-Hsuen/I-7061-2018	Jeng, Jiiang-Huei/0000-0002-2068-5380; CHEN, YI-JANE/0000-0002-9178-8379; LEE, JANG-JAER/0000-0003-0964-0840; LIN, BOR-RU/0000-0001-9545-7393				Brognard J, 2002, CELL DEATH DIFFER, V9, P893, DOI 10.1038/sj.cdd.4401054; Caraglia M, 2003, CELL DEATH DIFFER, V10, P218, DOI 10.1038/sj.cdd.4401131; Dannenberg AJ, 2001, ANN NY ACAD SCI, V952, P109, DOI 10.1111/j.1749-6632.2001.tb02731.x; Dooley S, 1996, ANN RHEUM DIS, V55, P298, DOI 10.1136/ard.55.5.298; FISHER C, 1991, DEVELOPMENT, V111, P253; Formanek M, 1998, J ORAL PATHOL MED, V27, P202; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Glinghammar B, 2001, GASTROENTEROLOGY, V120, P401, DOI 10.1053/gast.2001.21188; Guo YS, 2002, J BIOL CHEM, V277, P48755, DOI 10.1074/jbc.M209016200; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Ho PS, 2002, J ORAL PATHOL MED, V31, P213, DOI 10.1034/j.1600-0714.2002.310404.x; HONN KV, 1981, PROSTAG OTH LIPID M, V21, P833, DOI 10.1016/0090-6980(81)90240-9; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang X, 2003, TOXICOL APPL PHARM, V191, P40, DOI 10.1016/S0041-008X(03)00194-7; IARC, 1985, IARC MON EV CARC RIS, V37; Jeng JH, 1999, J ORAL PATHOL MED, V28, P64; Jeng JH, 2000, CARCINOGENESIS, V21, P1365, DOI 10.1093/carcin/21.7.1365; JENG JH, 1994, J DENT RES, V73, P1043, DOI 10.1177/00220345940730050501; Jeng JH, 2003, CARCINOGENESIS, V24, P1301, DOI 10.1093/carcin/bgg083; Jeng JH, 2004, CELL MOL LIFE SCI, V61, P83, DOI 10.1007/s00018-003-3272-8; Jeng JH, 2002, FREE RADICAL BIO MED, V32, P860, DOI 10.1016/S0891-5849(02)00749-9; Jeng JH, 2001, ORAL ONCOL, V37, P477, DOI 10.1016/S1368-8375(01)00003-3; Kaina B, 1997, CANCER RES, V57, P2721; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; Leu CM, 2003, ONCOGENE, V22, P7809, DOI 10.1038/sj.onc.1207084; Lin JK, 2002, ARCH PHARM RES, V25, P561, DOI 10.1007/BF02976924; Mishima K, 2002, ORAL ONCOL, V38, P468, DOI 10.1016/S1368-8375(01)00104-X; Misra SP, 1998, POSTGRAD MED J, V74, P733, DOI 10.1136/pgmj.74.878.733; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Orlando Roy C, 2002, Rev Gastroenterol Disord, V2 Suppl 2, pS2; Oyama N, 1999, J INVEST DERMATOL, V113, P600, DOI 10.1046/j.1523-1747.1999.00734.x; PANIGRAHI GB, 1982, MUTAT RES, V103, P197, DOI 10.1016/0165-7992(82)90029-X; PARKIN DM, 1991, INT J CANCER, V48, P323, DOI 10.1002/ijc.2910480302; Peng JP, 2002, HUM PATHOL, V33, P100, DOI 10.1053/hupa.2002.30187; Phukan RK, 2001, BRIT J CANCER, V85, P661, DOI 10.1054/bjoc.2001.1920; Roberts RA, 1999, CARCINOGENESIS, V20, P1397, DOI 10.1093/carcin/20.8.1397; SANKARANARAYANAN R, 1991, INT J CANCER, V49, P485, DOI 10.1002/ijc.2910490402; SHIN H, 1995, CLIN IMMUNOL IMMUNOP, V76, P225, DOI 10.1006/clin.1995.1120; SHIRNAME LP, 1984, CARCINOGENESIS, V5, P501, DOI 10.1093/carcin/5.4.501; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; SPITZ MR, 1994, SEMIN ONCOL, V21, P281; STICH HF, 1981, MUTAT RES, V90, P355, DOI 10.1016/0165-1218(81)90058-6; Sun CA, 2003, AM J EPIDEMIOL, V157, P674, DOI 10.1093/aje/kwg041; SUNDQVIST K, 1992, INT J CANCER, V52, P305, DOI 10.1002/ijc.2910520225; SUNDQVIST K, 1989, CANCER RES, V49, P5294; Tominaga S, 1999, CANCER LETT, V143, pS19, DOI 10.1016/S0304-3835(99)90005-8; Tsai JF, 2003, MEDICINE, V82, P365, DOI 10.1097/01.md.0000090401.56130.59; Tsuji S, 2003, ALIMENT PHARM THER, V18, P82, DOI 10.1046/j.1365-2036.18.s1.22.x; Wang LS, 1999, BRIT J CANCER, V80, P1617, DOI 10.1038/sj.bjc.6690571; Wang LY, 2003, CANCER CAUSE CONTROL, V14, P241, DOI 10.1023/A:1023636619477; Wu MT, 2003, BRIT J CANCER, V89, P1202, DOI 10.1038/sj.bjc.6601251; YAAR M, 1993, CLIN RES, V41, pA486, DOI 10.1006/excr.1993.1143; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6; Zimmermann KC, 1999, CANCER RES, V59, P198	54	112	114	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50676	50683		10.1074/jbc.M404465200	http://dx.doi.org/10.1074/jbc.M404465200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15375172	hybrid, Green Published			2022-12-27	WOS:000225355800008
J	Diamond, TL; Roshal, M; Jamburuthugoda, VK; Reynolds, HM; Merriam, AR; Lee, KY; Balakrishnan, M; Bambara, RA; Planelles, V; Dewhurst, S; Kim, B				Diamond, TL; Roshal, M; Jamburuthugoda, VK; Reynolds, HM; Merriam, AR; Lee, KY; Balakrishnan, M; Bambara, RA; Planelles, V; Dewhurst, S; Kim, B			Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERFORMANCE LIQUID-CHROMATOGRAPHY; RIBONUCLEOTIDE REDUCTASE; DNA-SYNTHESIS; DEOXYRIBONUCLEOSIDE TRIPHOSPHATES; FIDELITY; CELLS; REPLICATION; PYRIMIDINE; DAMAGE	Retroviruses utilize cellular dNTPs to perform proviral DNA synthesis in infected host cells. Unlike oncoretroviruses, which replicate in dividing cells, lentiviruses, such as human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus, are capable of efficiently replicating in non-dividing cells ( terminally differentiated macrophages) as well as dividing cells (i.e. activated CD4+ T cells). In general, non-dividing cells are likely to have low cellular dNTP content compared with dividing cells. Here, by employing a novel assay for cellular dNTP content, we determined the dNTP concentrations in two HIV-1 target cells, macrophages and activated CD4+ T cells. We found that human macrophages contained 130 250- fold lower dNTP concentrations than activated human CD4+ T cells. Biochemical analysis revealed that, unlike oncoretroviral reverse transcriptases (RTs), lentiviral RTs efficiently synthesize DNA even in the presence of the low dNTP concentrations equivalent to those found in macrophages. In keeping with this observation, HIV-1 vectors containing mutant HIV-1 RTs, which kinetically mimic oncoretroviral RTs, failed to transduce human macrophages despite retaining normal infectivity for activated CD4+ T cells and other dividing cells. These results suggest that the ability of HIV-1 to infect macrophages, which is essential to establishing the early pathogenesis of HIV-1 infection, depends, at least in part, on enzymatic adaptation of HIV-1 RT to efficiently catalyze DNA synthesis in limited cellular dNTP substrate environments.	Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	University of Rochester; University of Rochester; University of Rochester; Utah System of Higher Education; University of Utah	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Dewhurst, Stephen/0000-0001-7729-7920	NIAID NIH HHS [R56 AI049057, R01 AI087508, AI49057, R01 AI049781, T32 AI049815, AI49781, R01 AI049057, R56 AI049781, T32 AI49815] Funding Source: Medline; NIGMS NIH HHS [GM49573, R01 GM049573] Funding Source: Medline; NIMH NIH HHS [P01 MH64570, P01 MH064570] Funding Source: Medline; NINDS NIH HHS [S11 NS43499, S11 NS043499] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R01AI049057, R56AI049057, R01AI087508, T32AI049815, R56AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [S11NS043499] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Angus SP, 2002, J BIOL CHEM, V277, P44376, DOI 10.1074/jbc.M205911200; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Decosterd LA, 1999, ANAL BIOCHEM, V270, P59, DOI 10.1006/abio.1999.4066; DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107; Diamond TL, 2003, J BIOL CHEM, V278, P29913, DOI 10.1074/jbc.M211754200; Diamond TL, 2001, J BIOL CHEM, V276, P23624, DOI 10.1074/jbc.M102496200; DIPIERRO D, 1995, ANAL BIOCHEM, V231, P407, DOI 10.1006/abio.1995.0071; DURBAN EM, 1981, P NATL ACAD SCI-BIOL, V78, P3600, DOI 10.1073/pnas.78.6.3600; DURBAN EM, 1981, J VIROL, V37, P488, DOI 10.1128/JVI.37.1.488-492.1981; FULLER SA, 1982, BIOCHEM J, V206, P131, DOI 10.1042/bj2060131; Gutierrez-Rivas M, 1999, J MOL BIOL, V290, P615, DOI 10.1006/jmbi.1999.2880; Hauschka P V, 1973, Methods Cell Biol, V7, P361; Huang D, 2003, J CHROMATOGR B, V784, P101, DOI 10.1016/S1570-0232(02)00780-8; JACKSON RC, 1980, CANCER RES, V40, P1286; Kaushik N, 2000, BIOCHEMISTRY-US, V39, P2912, DOI 10.1021/bi991376w; Kim B, 1997, METHODS, V12, P318, DOI 10.1006/meth.1997.0485; Kinter A, 2000, IMMUNOL REV, V177, P88, DOI 10.1034/j.1600-065X.2000.17708.x; Klimatcheva E, 2001, MOL THER, V3, P928, DOI 10.1006/mthe.2001.0344; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Malboeuf CM, 2001, BIOTECHNIQUES, V30, P1074, DOI 10.2144/01305rr06; MAYBAUM J, 1980, J CHROMATOGR, V188, P149, DOI 10.1016/S0021-9673(00)88425-3; Menendez-Arias L, 1998, BIOCHEMISTRY-US, V37, P16636, DOI 10.1021/bi981830g; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; MUNCHPETERSEN B, 1973, EXP CELL RES, V79, P249, DOI 10.1016/0014-4827(73)90442-4; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; Roy B, 1999, ANAL BIOCHEM, V269, P403, DOI 10.1006/abio.1999.4051; SKOOG L, 1974, J BIOL CHEM, V249, P6434; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	40	218	221	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51545	51553		10.1074/jbc.M408573200	http://dx.doi.org/10.1074/jbc.M408573200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452123	Green Accepted, hybrid			2022-12-27	WOS:000225355800109
J	Epand, RM; Epand, RF; Sayer, BG; Datta, G; Chaddha, M; Anantharamaiah, GM				Epand, RM; Epand, RF; Sayer, BG; Datta, G; Chaddha, M; Anantharamaiah, GM			Two homologous apolipoprotein AI mimetic peptides - Relationship between membrane interactions and biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-RICH DOMAINS; MICE; ATHEROSCLEROSIS; PROTEINS; MODEL	Two related 18-amino acid, class A, amphipathic helical peptides termed 3F-2 and 3F(14) were chosen for this study. Although they have identical amino acid compositions and many similar biophysical properties, 3F-2 is more potent than 3F(14) as an apolipoprotein AI mimetic peptide. The two peptides exhibit similar gross conformational properties, forming structures of high helical content on a membrane surface. However, the thermal denaturation transition of 3F-2 is more cooperative, suggesting a higher degree of oligomerization on the membrane. Both 3F-2 and 3F(14) promote the segregation of cholesterol in membranes containing phosphatidylcholine and cholesterol, but 3F-2 exhibits a greater selectivity for partitioning into cholesterol-depleted regions of the membrane. Magic angle spinning/NMR studies indicate that the aromatic residues of 3F-2 are stacked in the presence of lipid. The aromatic side chains of this peptide also penetrate more deeply into membranes of phosphatidylcholine with cholesterol compared with 3F(14). Using the fluorescent probe, 1,3-dipyrenylpropane, we monitored the properties of the lipid hydrocarbon environment. 3F-2 had a greater effect in altering the properties of the hydrocarbon region of the membrane. The results are consistent with our proposed model of the effect of peptide shape on the nature of the difference in peptide insertion into the bilayer.	McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Chem, Hamilton, ON L8N 3Z5, Canada; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA	McMaster University; McMaster University; McMaster University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Epand, RM (corresponding author), McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada.	epand@mcmaster.ca	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	NHLBI NIH HHS [HL 34343, R01 HL 65663] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343, R01HL065663] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; ANANTHARAMAIAH GM, 1993, AMPHIPATHIC HELIX, P109; Arnold MR, 2002, BIOPHYS CHEM, V96, P129, DOI 10.1016/S0301-4622(02)00018-2; Datta G, 2004, J BIOL CHEM, V279, P26509, DOI 10.1074/jbc.M314276200; Datta G, 2001, J LIPID RES, V42, P1096; Epand RM, 2004, BBA-BIOMEMBRANES, V1666, P227, DOI 10.1016/j.bbamem.2004.07.004; Epand RM, 2004, BIOCHEMISTRY-US, V43, P5073, DOI 10.1021/bi049786u; Epand RM, 2003, BIOCHEMISTRY-US, V42, P14677, DOI 10.1021/bi035587j; FORBES J, 1988, J CHEM SOC FARAD T 1, V84, P3821, DOI 10.1039/f19888403821; Garber DW, 2001, J LIPID RES, V42, P545; Guo W, 1996, BIOPHYS J, V71, P2857, DOI 10.1016/S0006-3495(96)79482-1; Hartel S, 1998, ANAL BIOCHEM, V258, P277, DOI 10.1006/abio.1998.2594; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MELNICK RL, 1981, BIOPHYS J, V34, P499, DOI 10.1016/S0006-3495(81)84864-3; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab Mohamad, 2003, Curr Opin Investig Drugs, V4, P1100; Ou ZJ, 2003, CIRCULATION, V107, P1520, DOI 10.1161/01.CIR.0000061949.17174.B6; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; ZLATKIS A, 1953, J LAB CLIN MED, V41, P486	20	20	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51404	51414		10.1074/jbc.M408581200	http://dx.doi.org/10.1074/jbc.M408581200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15358763				2022-12-27	WOS:000225355800092
J	Kisselev, OG; Downs, MA; McDowell, JH; Hargrave, PA				Kisselev, OG; Downs, MA; McDowell, JH; Hargrave, PA			Conformational changes in the phosphorylated C-terminal domain of rhodopsin during rhodopsin arrestin interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR DARK-ADAPTATION; PROTEIN-COUPLED RECEPTOR; POTASSIUM CHANNELS; IN-VIVO; SYNTHETIC PHOSPHOPEPTIDE; MULTIPLE PHOSPHORYLATION; LIGHT ACTIVATION; BOVINE RHODOPSIN; BETA-ARRESTINS; NMR STRUCTURE	Phosphorylation of activated G-protein-coupled receptors and the subsequent binding of arrestin mark major molecular events of homologous desensitization. In the visual system, interactions between arrestin and the phosphorylated rhodopsin are pivotal for proper termination of visual signals. By using high resolution proton nuclear magnetic resonance spectroscopy of the phosphorylated C terminus of rhodopsin, represented by a synthetic 7-phosphopolypeptide, we show that the arrestin-bound conformation is a well ordered helix-loop structure connected to rhodopsin via a flexible linker. In a model of the rhodopsin-arrestin complex, the phosphates point in the direction of arrestin and form a continuous negatively charged surface, which is stabilized by a number of positively charged lysine and arginine residues of arrestin. Opposite to the mostly extended structure of the unphosphorylated C-terminal domain of rhodopsin, the arrestin-bound C-terminal helix is a compact domain that occupies a central position between the cytoplasmic loops and occludes the key binding sites of transducin. In conjunction with other binding sites, the helix-loop structure provides a mechanism of shielding phosphates in the center of the rhodopsin-arrestin complex and appears critical in guiding arrestin for high affinity binding with rhodopsin.	St Louis Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63104 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	Saint Louis University; Saint Louis University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kisselev, OG (corresponding author), St Louis Univ, Sch Med, Dept Ophthalmol, 1755 S Grand Blvd, St Louis, MO 63104 USA.	kisselev@slu.edu			NEI NIH HHS [EY06225] Funding Source: Medline; NIGMS NIH HHS [GM63203] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM063203, R01GM063203] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antz C, 1999, NAT STRUCT BIOL, V6, P146; Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Arendt A, 1996, PROTEIN PEPTIDE LETT, V3, P361; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; Bentrop D, 2001, J BIOL CHEM, V276, P42116, DOI 10.1074/jbc.M107118200; Brannock MT, 1999, BIOCHEMISTRY-US, V38, P3770, DOI 10.1021/bi982419w; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Dorey M, 1999, BBA-BIOMEMBRANES, V1416, P217, DOI 10.1016/S0005-2736(98)00224-7; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Getmanova E, 2004, BIOCHEMISTRY-US, V43, P1126, DOI 10.1021/bi030120u; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hodsdon ME, 1996, J MOL BIOL, V264, P585, DOI 10.1006/jmbi.1996.0663; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Kisselev OG, 2004, FEBS LETT, V564, P307, DOI 10.1016/S0014-5793(04)00226-1; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Luttrell LM, 2002, J CELL SCI, V115, P455; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; MCDOWELL JH, 1993, BIOCHEMISTRY-US, V32, P4968, DOI 10.1021/bi00069a036; McDowell JH, 1999, BIOCHEMISTRY-US, V38, P6119, DOI 10.1021/bi990175p; McDowell JH, 2001, INVEST OPHTH VIS SCI, V42, P1439; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PFISTER C, 1985, SCIENCE, V228, P891, DOI 10.1126/science.2988124; PUIG J, 1995, FEBS LETT, V362, P185, DOI 10.1016/0014-5793(95)00225-X; Raman D, 2003, J NEUROCHEM, V84, P1040, DOI 10.1046/j.1471-4159.2003.01598.x; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Smith WC, 1999, BIOCHEMISTRY-US, V38, P2752, DOI 10.1021/bi982643l; SOLARO CR, 1992, SCIENCE, V257, P1694, DOI 10.1126/science.1529355; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	41	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51203	51207		10.1074/jbc.M407341200	http://dx.doi.org/10.1074/jbc.M407341200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15351781	hybrid			2022-12-27	WOS:000225355800067
J	Vooijs, M; Schroeter, EH; Pan, YH; Blandford, M; Kopan, R				Vooijs, M; Schroeter, EH; Pan, YH; Blandford, M; Kopan, R			Ectodomain shedding and intramembrane cleavage of mammalian notch proteins is not regulated through oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE CLEAVAGE; SIGNAL PEPTIDE PEPTIDASE; DISEASE GAMMA-SECRETASE; OF-FUNCTION MUTATIONS; TRANSMEMBRANE DOMAIN; ALZHEIMERS-DISEASE; DISINTEGRIN-METALLOPROTEASE; CAENORHABDITIS-ELEGANS; INTRACELLULAR DOMAIN	Intramembrane cleaving proteases such as site 2 protease, gamma-secretase, and signal peptide peptidase hydrolyze peptide bonds within the transmembrane domain (TMD) of signaling molecules such as SREBP, Notch, and HLA-E, respectively. All three enzymes require a prior cleavage at the juxtamembrane region by another protease. It has been proposed that removing the extracellular domain allows dissociation of substrate TMD, held together by the extracellular domain or loop. Using gamma-secretase as a model intramembrane cleaving protease and Notch as a model substrate, we investigated whether activating and inactivating mutations in Notch modulate gamma-secretase cleavage through changes in oligomerization. We find that although the Notch epidermal growth factor repeats can promote dimer formation, most surface Notch molecules in mammalian cells are monomeric as are constitutively active or inactive Notch1 proteins. Using a bacterial assay for TM dimerization, we find that the isolated TMD of Notch and amyloid precursor protein self-associate and that mutations affecting Notch cleavage by gamma-secretase cleavage do not alter TMD dimerization. Our results indicate that ligand-induced reversal of controlled TMD dimerization by the Notch extracellular domain is unlikely to underlie the regulatory mechanism of intramembranous cleavage.	Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Kopan, R (corresponding author), Washington Univ, Sch Med, Dept Med, Div Dermatol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	kopan@wustl.edu	Kopan, Raphael/AAF-1357-2022; Vooijs, Marc/K-3522-2019; Kopan, Raphael/AFG-3275-2022	Kopan, Raphael/0000-0002-0350-2730	NIGMS NIH HHS [GM55479] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Aster JC, 1999, BIOCHEMISTRY-US, V38, P4736, DOI 10.1021/bi982713o; ASUNDI VK, 1995, J BIOL CHEM, V270, P26404, DOI 10.1074/jbc.270.44.26404; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; Berry LW, 1997, DEVELOPMENT, V124, P925; Blat Y, 2002, BIOCHEM BIOPH RES CO, V299, P569, DOI 10.1016/S0006-291X(02)02705-5; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; DECELIS JF, 1994, GENETICS, V136, P183; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; GOLDE TE, 2003, SCI STKE, pRE4; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; GREENWALD I, 1994, CURR OPIN GENET DEV, V4, P556, DOI 10.1016/0959-437X(94)90072-B; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huber O, 1999, J CELL SCI, V112, P4415; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; Kopan R, 1996, CURR OPIN NEUROBIOL, V6, P594, DOI 10.1016/S0959-4388(96)80090-0; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Borgne R, 2003, CURR BIOL, V13, pR273, DOI 10.1016/S0960-9822(03)00199-4; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Li YH, 2002, BIOCHEMISTRY-US, V41, P4921, DOI 10.1021/bi011894i; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; MUMM JS, 2000, THESIS WASHINGTON U; Nakajima M, 2000, J NEUROSCI RES, V62, P311, DOI 10.1002/1097-4547(20001015)62:2<311::AID-JNR16>3.0.CO;2-G; Parks AL, 2000, DEVELOPMENT, V127, P1373; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rand MD, 1997, PROTEIN SCI, V6, P2059; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Raya A, 2004, NATURE, V427, P121, DOI 10.1038/nature02190; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sakamoto K, 2002, DEV BIOL, V241, P313, DOI 10.1006/dbio.2001.0517; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Vardar D, 2003, BIOCHEMISTRY-US, V42, P7061, DOI 10.1021/bi034156y; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	72	59	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50864	50873		10.1074/jbc.M409430200	http://dx.doi.org/10.1074/jbc.M409430200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448134	hybrid			2022-12-27	WOS:000225355800029
J	Yahiro, K; Wada, A; Yamasaki, E; Nakayama, M; Nishi, Y; Hisatsune, J; Morinaga, N; Sap, J; Noda, M; Moss, J; Hirayama, T				Yahiro, K; Wada, A; Yamasaki, E; Nakayama, M; Nishi, Y; Hisatsune, J; Morinaga, N; Sap, J; Noda, M; Moss, J; Hirayama, T			Essential domain of receptor tyrosine phosphatase beta (RPTP beta) for interaction with Helicobacter pylori vacuolating cytotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACA TOXIN; NERVOUS-SYSTEM; ZETA/RPTP-BETA; MICE DEFICIENT; PTP-ALPHA; PROTEIN; BINDING; INDUCTION; PHOSPHORYLATION; IDENTIFICATION	Helicobacter pylori produces a potent exotoxin, VacA, which causes progressive vacuolation as well as gastric injury. Although VacA was able to interact with two receptor-like protein tyrosine phosphatases, RPTPbeta and RPTPalpha, RPTPbeta was found to be responsible for gastric damage caused by VacA. To define the region of RPTPbeta involved in VacA binding, we made mutants of human cDNA RPTPbeta-B, a short receptor form of RPTPbeta. Immunoprecipitation experiments to assess VacA binding to RPTPbeta-B mutants indicated that five residues (QTTQP) at positions 747 - 751 of the extracellular domain of RPTPbeta-B ( which is commonly retained in RPTPbeta-A, a long form of RPTPbeta) play a crucial role in its interaction with VacA, resulting in vacuolation as well as Git-1 phosphorylation. Transfected cells expressing deletion mutant Delta752, which lacks QTTQP, or the double point mutant Delta747 (T748A, T749A) had diminished vacuolation in response to VacA. Treatment of RPTPbeta-B and Delta747 ( which have QTTQP at 747 - 751) with neuraminidase and O-glycosidase diminished their VacA binding, whereas chondroitinase ABC did not have an effect. No inhibitory effect of pleiotrophin, a natural RPTPbeta ligand, on VacA binding to RPTPbeta-B or Delta747 was observed, supporting the conclusion that the extracellular region of RPTPbeta-B responsible for VacA binding is different from that involved in binding pleiotrophin. These data define the region in the RPTPbeta extracellular domain critical for VacA binding, in particular the sequence QTTQP at positions 747 - 751 with crucial threonines at positions 748 and 749 and are consistent with a role for terminal sialic acids possibly because of threonine glycosylation.	Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan; Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chiba 2608670, Japan; Japan Sci & Technol Corp, PRESTO, Saitama 3320012, Japan; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Nagasaki University; Chiba University; Japan Science & Technology Agency (JST); New York University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hirayama, T (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Bacteriol, Nagasaki 8528523, Japan.	hirayama@net.nagasaki-u.ac.jp		Yahiro, Kinnosuke/0000-0002-9813-0780	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659, Z01HL000659] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Cover TL, 2003, CANCER RES, V63, P951; COVER TL, 1992, HUM PATHOL, V23, P1004, DOI 10.1016/0046-8177(92)90261-Z; de Bernard M, 2000, EMBO J, V19, P48, DOI 10.1093/emboj/19.1.48; de Bernard M, 1998, INFECT IMMUN, V66, P6014, DOI 10.1128/IAI.66.12.6014-6016.1998; Del Giudice G, 2001, ANNU REV IMMUNOL, V19, P523, DOI 10.1146/annurev.immunol.19.1.523; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Galmiche A, 2000, EMBO J, V19, P6361, DOI 10.1093/emboj/19.23.6361; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Garwood J, 2001, RESTOR NEUROL NEUROS, V19, P51; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Haunso A, 1999, BRAIN RES, V834, P219, DOI 10.1016/S0006-8993(99)01596-6; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kimura M, 1999, MICROB PATHOGENESIS, V26, P45, DOI 10.1006/mpat.1998.0241; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; Kuck D, 2001, INFECT IMMUN, V69, P5080, DOI 10.1128/IAI.69.8.5080-5087.2001; LEUNK RD, 1988, J MED MICROBIOL, V26, P93, DOI 10.1099/00222615-26-2-93; LEVY JB, 1993, J BIOL CHEM, V268, P10573; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; MANETTI R, 1995, INFECT IMMUN, V63, P4476, DOI 10.1128/IAI.63.11.4476-4480.1995; Massari P, 1998, INFECT IMMUN, V66, P3981, DOI 10.1128/IAI.66.8.3981-3984.1998; Mcclain MS, 2003, J BIOL CHEM, V278, P12101, DOI 10.1074/jbc.M212595200; McGee DJ, 1999, CURR TOP MICROBIOL, V241, P155; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; MeyerPuttlitz B, 1996, J COMP NEUROL, V366, P44, DOI 10.1002/(SICI)1096-9861(19960226)366:1<44::AID-CNE4>3.0.CO;2-K; MORINALI M, 1998, J EXP MED, V187, P135; Murai KK, 2002, CURR BIOL, V12, P181, DOI 10.1016/S0960-9822(02)00680-2; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Nakayama M, 2004, J BIOL CHEM, V279, P7024, DOI 10.1074/jbc.M308898200; Padilla PI, 2000, J BIOL CHEM, V275, P15200, DOI 10.1074/jbc.275.20.15200; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Papini E, 2001, TOXICON, V39, P1757, DOI 10.1016/S0041-0101(01)00162-3; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Peek RM, 2003, NAT GENET, V33, P328, DOI 10.1038/ng0303-328; Prinz C, 2003, TRENDS MICROBIOL, V11, P134, DOI 10.1016/S0966-842X(03)00024-6; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; SAP J, 1990, P NATL ACAD SCI USA, V87, P6112, DOI 10.1073/pnas.87.16.6112; SU J, 1994, J BIOL CHEM, V269, P18731; Sundrud MS, 2004, P NATL ACAD SCI USA, V101, P7727, DOI 10.1073/pnas.0401528101; Supajatura V, 2002, J IMMUNOL, V168, P2603, DOI 10.4049/jimmunol.168.6.2603; Suzuki J, 2001, J CLIN INVEST, V107, P363, DOI 10.1172/JCI10254; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; Yahiro K, 1997, BIOCHEM BIOPH RES CO, V238, P629, DOI 10.1006/bbrc.1997.7345; Yahiro K, 1999, J BIOL CHEM, V274, P36693, DOI 10.1074/jbc.274.51.36693; Yahiro K, 2003, J BIOL CHEM, V278, P19183, DOI 10.1074/jbc.M300117200; Ye D, 1999, J BIOL CHEM, V274, P9277, DOI 10.1074/jbc.274.14.9277	51	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51013	51021		10.1074/jbc.M406473200	http://dx.doi.org/10.1074/jbc.M406473200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383529	hybrid			2022-12-27	WOS:000225355800046
J	Kurosaki, M; Terao, M; Barzago, MM; Bastone, A; Bernardinello, D; Salmona, M; Garattini, E				Kurosaki, M; Terao, M; Barzago, MM; Bastone, A; Bernardinello, D; Salmona, M; Garattini, E			The aldehyde oxidase gene cluster in mice and rats - Aldehyde oxidase homologue 3, a novel member of the molybdo-flavoenzyme family with selective expression in the olfactory mucosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER XANTHINE DEHYDROGENASE; MOLECULAR-CLONING; CDNA CLONING; COMAMONAS-ACIDOVORANS; FUNCTIONAL EXPRESSION; OXIDOREDUCTASE GENE; TISSUE DISTRIBUTION; RETINAL OXIDASE; MOUSE; PURIFICATION	Mammalian molybdo-flavoenzymes are oxidases requiring FAD and molybdopterin ( molybdenum cofactor) for their catalytic activity. This family of proteins was thought to consist of four members, xanthine oxidoreductase, aldehyde oxidase 1 (AOX1), and the aldehyde oxidase homologues 1 and 2 (AOH1 and AOH2, respectively). Whereas the first two enzymes are present in humans and various other mammalian species, the last two proteins have been described only in mice. Here, we report on the identification, in both mice and rats, of a novel molybdo-flavoenzyme, AOH3. In addition, we have cloned the cDNAs coding for rat AOH1 and AOH2, demonstrating that this animal species has the same complement of molybdo-flavoproteins as the mouse. The AOH3 cDNA is characterized by remarkable similarity to AOX1, AOH1, AOH2, and xanthine oxidoreductase cDNAs. Mouse AOH3 is selectively expressed in Bowman's glands of the olfactory mucosa, although small amounts of the corresponding mRNA are present also in the skin. In the former location, two alternatively spliced forms of the AOH3 transcript with different 3'-untranslated regions were identified. The general properties of AOH3 were determined by purification of mouse AOH3 from the olfactory mucosa. The enzyme possesses aldehyde oxidase activity and oxidizes, albeit with low efficiency, exogenous substrates that are recognized by AOH1 and AOX1. The Aoh3 gene maps to mouse chromosome 1 band c1 and rat chromosome 7 in close proximity to the Aox1, Aoh1, and Aoh2 loci and has an exon/intron structure almost identical to that of the other molybdo-flavoenzyme genes in the two species.	Mario Negri Inst Pharmacol Res, Ctr Catullo & Daniela Borgomainerio, Mol Biol Lab, I-20157 Milan, Italy; Mario Negri Inst Pharmacol Res, Dept Mol Pharmacol & Biochem, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, E (corresponding author), Mario Negri Inst Pharmacol Res, Ctr Catullo & Daniela Borgomainerio, Mol Biol Lab, Via Eritrea 62, I-20157 Milan, Italy.	egarattini@marionegri.it	Terao, Mineko/AAA-6415-2020; terao, mineko/AAU-8089-2020; Barzago, Maria Monica/AAA-6402-2020; salmona, mario/AAA-7116-2020; salmona, mario/ABI-4066-2020; KUROSAKI, Mami/ABG-2224-2020; Garattini, Enrico/AAI-1998-2019	Terao, Mineko/0000-0002-9976-9869; Barzago, Maria Monica/0000-0002-6952-0069; salmona, mario/0000-0002-9098-9873; KUROSAKI, Mami/0000-0001-8231-713X; Garattini, Enrico/0000-0001-8983-886X				AMAYA Y, 1990, J BIOL CHEM, V265, P14170; Ambroziak W, 1999, J BIOL CHEM, V274, P33366, DOI 10.1074/jbc.274.47.33366; BEEDHAM C, 1995, ARCH BIOCHEM BIOPHYS, V319, P481, DOI 10.1006/abbi.1995.1320; BERGER R, 1995, SOMAT CELL MOLEC GEN, V21, P121, DOI 10.1007/BF02255787; Berglund L, 1996, J DAIRY SCI, V79, P198, DOI 10.3168/jds.S0022-0302(96)76351-8; Calzi ML, 1995, J BIOL CHEM, V270, P31037, DOI 10.1074/jbc.270.52.31037; CAZZANIGA G, 1994, GENOMICS, V23, P390, DOI 10.1006/geno.1994.1515; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Demontis S, 1999, BBA-GENE STRUCT EXPR, V1489, P207, DOI 10.1016/S0167-4781(99)00174-8; EDMONDSON DE, 1989, BIOCHEMISTRY-US, V28, P5924, DOI 10.1021/bi00440a032; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Godber Ben, 1997, Biochemical Society Transactions, V25, p519S; Gonzalez FJ, 2003, ARCH BIOCHEM BIOPHYS, V409, P153, DOI 10.1016/S0003-9861(02)00364-8; Harrison R, 2004, DRUG METAB REV, V36, P363, DOI 10.1081/DMR-120037569; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hatt H, 1999, CELL MOL BIOL, V45, P285; Hoff T, 1998, BBA-GENE STRUCT EXPR, V1398, P397, DOI 10.1016/S0167-4781(98)00085-2; HOLMES RS, 1979, BIOCHEM GENET, V17, P517, DOI 10.1007/BF00498887; Huang DY, 1999, ARCH BIOCHEM BIOPHYS, V364, P264, DOI 10.1006/abbi.1999.1129; Huard JMT, 1998, J COMP NEUROL, V400, P469; ICHIDA K, 1993, GENE, V133, P279; Ivanov NV, 2003, EUR J BIOCHEM, V270, P4744, DOI 10.1046/j.1432-1033.2003.03875.x; Kappl R, 2002, MET IONS BIOL SYST, V39, P481; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kurosaki M, 1999, BIOCHEM J, V341, P71, DOI 10.1042/0264-6021:3410071; Lake BG, 2002, XENOBIOTICA, V32, P835, DOI 10.1080/00498250210158915; Linder N, 1999, LAB INVEST, V79, P967; Mendel RR, 2002, MET IONS BIOL SYST, V39, P317; Mendel RR, 2002, J EXP BOT, V53, P1689, DOI 10.1093/jxb/erf038; Nishino T, 1997, J BIOL CHEM, V272, P29859, DOI 10.1074/jbc.272.47.29859; NISHINO T, 1989, J BIOL CHEM, V264, P5468; Piras E, 2003, J HISTOCHEM CYTOCHEM, V51, P1545, DOI 10.1177/002215540305101114; Rooseboom M, 2004, PHARMACOL REV, V56, P53, DOI 10.1124/pr.56.1.3; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; RYTKONEN EMK, 1995, CYTOGENET CELL GENET, V68, P61, DOI 10.1159/000133890; Saksela M, 1996, BIOCHEM J, V315, P235, DOI 10.1042/bj3150235; SATO A, 1995, J BIOL CHEM, V270, P2818, DOI 10.1074/jbc.270.6.2818; Schindelin H, 2001, ADV PROTEIN CHEM, V58, P47; Seo M, 2000, P NATL ACAD SCI USA, V97, P12908, DOI 10.1073/pnas.220426197; SHAW S, 1990, BIOCHEM J, V268, P579, DOI 10.1042/bj2680579; TATSUMI K, 1986, CANCER RES, V46, P1089; Terao M, 1997, BIOCHEM SOC T, V25, P791, DOI 10.1042/bst0250791; Terao M, 2000, J BIOL CHEM, V275, P30690, DOI 10.1074/jbc.M005355200; Terao M, 1998, BIOCHEM J, V332, P383, DOI 10.1042/bj3320383; TERAO M, 1992, BIOCHEM J, V283, P863, DOI 10.1042/bj2830863; Terao M, 2001, J BIOL CHEM, V276, P46347, DOI 10.1074/jbc.M105744200; TOMITA S, 1993, FEBS LETT, V336, P272, DOI 10.1016/0014-5793(93)80818-F; Tsuchida S, 2001, J VET MED SCI, V63, P353, DOI 10.1292/jvms.63.353; VENTURA SM, 1981, HORM RES, V14, P250, DOI 10.1159/000179395; Vila R, 2004, J BIOL CHEM, V279, P8668, DOI 10.1074/jbc.M308137200; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; Wittle AE, 1999, MOL GEN GENET, V261, P672, DOI 10.1007/s004380050010; Wright RM, 1999, J BIOL CHEM, V274, P3878, DOI 10.1074/jbc.274.6.3878; WRIGHT RM, 1993, P NATL ACAD SCI USA, V90, P10690, DOI 10.1073/pnas.90.22.10690; Xiang Q, 1996, BIOCHEMISTRY-US, V35, P5441, DOI 10.1021/bi952880d; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P13734; XU P, 1994, BIOCHEM BIOPH RES CO, V199, P998, DOI 10.1006/bbrc.1994.1328; Yoshihara S, 1997, ARCH BIOCHEM BIOPHYS, V338, P29, DOI 10.1006/abbi.1996.9774	60	51	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50482	50498		10.1074/jbc.M408734200	http://dx.doi.org/10.1074/jbc.M408734200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383531	hybrid			2022-12-27	WOS:000225229500114
J	Qanungo, S; Wang, M; Nieminen, AL				Qanungo, S; Wang, M; Nieminen, AL			N-acetyl-L-cysteine enhances apoptosis through inhibition of nuclear factor-kappa B in hypoxic murine embryonic fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; NECROTIC CELL-DEATH; CANCER CELLS; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; REDOX REGULATION; SOLID TUMORS; OXYGEN; ACETYLCYSTEINE; GLUTATHIONE	In this study, we investigated the role of reduced glutathione (GSH) and nuclear factor-kappaB (NFkappaB) in hypoxia-induced apoptosis. Hypoxia caused p53-dependent apoptosis in murine embryonic fibroblasts transfected with Ras and E1A. N-Acetyl-L- cysteine (NAC) but not other antioxidants, such as the vitamin E analog trolox and epigallocatechin-3-gallate, enhanced hypoxia-induced caspase-3 activation and apoptosis. NAC also enhanced hypoxia-induced apoptosis in two human cancer cell lines, MIA PaCa-2 pancreatic cancer cells and A549 lung carcinoma cells. In murine embryonic fibroblasts, all three antioxidants blocked hypoxia-induced reactive oxygen species formation. NAC did not enhance hypoxia-induced cytochrome c release but did enhance poly( ADP ribose) polymerase cleavage, indicating that NAC acted at a post-mitochondrial level. NAC-mediated enhancement of apoptosis was mimicked by incubating cells with GSH monoester, which increased intracellular GSH similarly to NAC. Hypoxia promoted degradation of an inhibitor of kappaB (IkappaBalpha), NFkappaB-p65 translocation into the nucleus, NFkappaB binding to DNA, and subsequent transactivation of NFkappaB, which increased X chromosome-linked inhibitor of apoptosis protein levels. NAC failed to block degradation by IkappaBalpha and sequestration of the p65 subunit of NFkappaB to the nucleus. However, NAC did abrogate hypoxia-induced NFkappaB binding to DNA, NFkappaB-dependent gene expression, and induction of X chromosome-linked inhibitor of apoptosis protein. In conclusion, NAC enhanced hypoxic apoptosis by a mechanism apparently involving GSH-dependent suppression of NFkappaB transactivation.	Case Western Reserve Univ, Case Comprehens Canc Ctr Labs, Sch Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Nieminen, AL (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr Labs, Sch Med, 3-134 Wolstein Res Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	axn25@case.edu			NCI NIH HHS [P30 CA43703] Funding Source: Medline; NINDS NIH HHS [R01 NS39469] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039469] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bogatcheva NV, 2003, J INVEST MED, V51, P341, DOI 10.1136/jim-51-06-30; Bose S, 2003, P NATL ACAD SCI USA, V100, P10890, DOI 10.1073/pnas.1832775100; Brar SS, 2001, AM J PHYSIOL-CELL PH, V280, pC659, DOI 10.1152/ajpcell.2001.280.3.C659; Brunelle JK, 2004, J BIOL CHEM, V279, P4305, DOI 10.1074/jbc.M312241200; Cazals V, 1999, BBA-MOL CELL RES, V1448, P349, DOI 10.1016/S0167-4889(98)00095-0; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; DAWSON TL, 1993, AM J PHYSIOL, V264, P961; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Jiang BB, 2000, HYPERTENSION, V35, P914, DOI 10.1161/01.HYP.35.4.914; JONES DP, 1995, IMMUNOL LETT, V45, P205, DOI 10.1016/0165-2478(95)00004-O; Kabore AF, 2001, J CELL SCI, V114, P293; Kamata H, 2002, ANN NY ACAD SCI, V973, P419, DOI 10.1111/j.1749-6632.2002.tb04675.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Mansfield KD, 2004, J APPL PHYSIOL, V97, P1358, DOI 10.1152/japplphysiol.00449.2004; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Michiels C, 2002, FREE RADICAL BIO MED, V33, P1231, DOI 10.1016/S0891-5849(02)01045-6; Montiel-Duarte C, 2004, BIOCHEM PHARMACOL, V67, P1025, DOI 10.1016/j.bcp.2003.10.020; NIEMINEN AL, 1988, CELL CALCIUM, V9, P237, DOI 10.1016/0143-4160(88)90004-8; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; Nulton-Persson AC, 2003, BIOCHEMISTRY-US, V42, P4235, DOI 10.1021/bi027370f; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Park SA, 2000, J NEUROCHEM, V75, P946, DOI 10.1046/j.1471-4159.2000.0750946.x; Porwol T, 1998, EUR J BIOCHEM, V256, P16, DOI 10.1046/j.1432-1327.1998.2560016.x; Qanungo S, 2003, NEOPLASIA, V5, P367, DOI 10.1016/S1476-5586(03)80030-1; Qanungo S, 2002, ONCOGENE, V21, P4149, DOI 10.1038/sj.onc.1205508; Renard P, 1997, BIOCHEM PHARMACOL, V53, P149, DOI 10.1016/S0006-2952(96)00645-4; Rieber M, 2003, BIOCHEM PHARMACOL, V65, P1593, DOI 10.1016/S0006-2952(03)00147-3; Rothwarf D.M., 1999, SCI STKE, V1999, pRE1; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845, DOI 10.1128/MCB.18.5.2845; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Seres T, 1996, J IMMUNOL, V156, P1973; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; VANZANDWIJK N, 1995, CHEST, V107, P1437, DOI 10.1378/chest.107.5.1437; Wang CY, 1999, MOL CELL BIOL, V19, P5923; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	52	85	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50455	50464		10.1074/jbc.M406749200	http://dx.doi.org/10.1074/jbc.M406749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375156	hybrid			2022-12-27	WOS:000225229500111
J	Sordet, O; Khan, QA; Plo, I; Pourquier, P; Urasaki, Y; Yoshido, A; Antony, S; Kohlhagen, G; Solary, E; Saparbaev, M; Laval, J; Pommier, Y				Sordet, O; Khan, QA; Plo, I; Pourquier, P; Urasaki, Y; Yoshido, A; Antony, S; Kohlhagen, G; Solary, E; Saparbaev, M; Laval, J; Pommier, Y			Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MAMMALIAN-CELLS; FILTER ELUTION; HL-60 CELLS; INDUCTION; DAMAGE; CLEAVAGE; FRAGMENTATION; INHIBITORS; MECHANISM	Topoisomerase I (Top1), an abundant nuclear enzyme expressed throughout the cell cycle, relaxes DNA supercoiling by forming transient covalent DNA cleavage complexes. We show here that staurosporine, a ubiquitous inducer of apoptosis in mammalian cells, stabilizes cellular Top1 cleavage complexes. These complexes are formed indirectly as staurosporine cannot induce Top1 cleavage complexes in normal DNA with recombinant Top1 or nuclear extract from normal cells. In treated cells, staurosporine produces oxidative DNA lesions and generates reactive oxygen species (ROS). Quenching of these ROS by the antioxidant N-acetyl-L-cysteine or inhibition of the mitochondrial dependent production of ROS by the caspase inhibitor benzyloxycarbonyl-VAD prevents staurosporine-induced Top1 cleavage complexes. Down-regulation of Top1 by small interfering RNA decreases staurosporine-induced apoptotic DNA fragmentation. We propose that Top1 cleavage complexes resulting from oxidative DNA lesions generated by ROS in staurosporine-treated cells contribute to the full apoptotic response.	NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; CEA, Lab Recombinat Mech, F-92265 Fontenay Aux Roses, France; Inst Bergonie, INSERM, E347, Mol Pharmacol Grp, F-33076 Bordeaux, France; Fac Med, INSERM, U517, F-21033 Dijon, France; Inst Gustave Roussy, F-94805 Villejuif, France; Fukui Med Univ, Dept Med 1, Fukui, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Gustave Roussy; University of Fukui	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bldg 37,Rm 5068, Bethesda, MD 20892 USA.	pommier@nih.gov	Plo, Isabelle/AAT-6742-2021; Sordet, Olivier/M-3271-2014; Pourquier, Philippe/O-8030-2018; Plo, Isabelle/C-9056-2017; Saparbaev, Murat K/N-3225-2015; Saparbaev, Murat/AAC-5478-2020	Sordet, Olivier/0000-0001-6027-4925; Pourquier, Philippe/0000-0001-5326-3005; Plo, Isabelle/0000-0002-5915-6910; Saparbaev, Murat K/0000-0002-4630-1074; Saparbaev, Murat/0000-0002-4630-1074; Solary, Eric/0000-0002-8629-1341	NATIONAL CANCER INSTITUTE [ZIABC006150, Z01BC006150] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; BERTRAND R, 1995, DRUG DEVELOP RES, V34, P138, DOI 10.1002/ddr.430340206; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; BONVEN BJ, 1985, CELL, V41, P541, DOI 10.1016/S0092-8674(85)80027-1; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Daroui P, 2004, J BIOL CHEM, V279, P14587, DOI 10.1074/jbc.M311370200; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Kessel M, 2002, MOL CELL BIOCHEM, V234, P301, DOI 10.1023/A:1015927406142; Kohn KW, 1996, BIOESSAYS, V18, P505, DOI 10.1002/bies.950180613; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; MATTERN MR, 1993, ONCOL RES, V5, P467; Meng LH, 2003, CURR TOP MED CHEM, V3, P305; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Pourquier P, 2000, P NATL ACAD SCI USA, V97, P1885, DOI 10.1073/pnas.97.4.1885; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Pourquier Philippe, 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P303; Reinhold WC, 2003, CANCER RES, V63, P1000; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Soe K, 2004, DNA REPAIR, V3, P387, DOI 10.1016/j.dnarep.2003.12.003; SOLARY E, 1993, BLOOD, V81, P1359; Sordet O, 2004, CELL CYCLE, V3, P1095; Sordet O, 2004, J BIOL CHEM, V279, P33968, DOI 10.1074/jbc.M404620200; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; SUBRAMANIAN D, 1995, CANCER RES, V55, P2097; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Tafani M, 2001, CANCER RES, V61, P2459; Tainton KM, 2000, BIOCHEM BIOPH RES CO, V276, P231, DOI 10.1006/bbrc.2000.3459; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yoshida A, 1998, CANCER RES, V58, P2576; Yoshida A, 2003, J BIOL CHEM, V278, P37768, DOI 10.1074/jbc.M304914200	40	56	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50499	50504		10.1074/jbc.M410277200	http://dx.doi.org/10.1074/jbc.M410277200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448130	hybrid			2022-12-27	WOS:000225229500115
J	Herrmann, F; Bossert, M; Schwander, A; Akgun, E; Fackelmayer, FO				Herrmann, F; Bossert, M; Schwander, A; Akgun, E; Fackelmayer, FO			Arginine methylation of scaffold attachment factor A by heterogeneous nuclear ribonucleoprotein particle-associated PRMT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; HNRNP-U/SAF-A; IN-VIVO; N-METHYLTRANSFERASE; SAF-A; SUBSTRATE-SPECIFICITY; SUBCELLULAR-LOCALIZATION; MATRIX PROTEIN; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR	Components of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex and other nucleic acid-binding proteins are subject to methylation on specific arginine residues by the catalytic activity of arginine methyltransferases. The methylation has been implicated in transcriptional regulation and RNA and protein trafficking and signal transduction, but the mechanism by which these functions are achieved has remained undetermined. We show here that the predominant arginine methyltransferase in human cells, protein arginine methyltransferase 1 (PRMT1), is associated with hnRNP complexes, dependent on the methylation status of the cell, and that it methylates its preferred substrates in situ. Binding of PRMT1 occurs through physical interaction with scaffold attachment factor A (SAF-A), also known as hnRNP-U, which is quantitatively methylated by PRMT1 in all investigated cell lines as determined by a novel, highly specific, methylation-sensitive antibody.	Heinrich Pette Inst, Dept Mol Cell Biol, D-20251 Hamburg, Germany	Heinrich Pette Institute	Fackelmayer, FO (corresponding author), Heinrich Pette Inst, Dept Mol Cell Biol, Martinistr 52, D-20251 Hamburg, Germany.	frank@Fackelmayer.de						Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Altschuler L, 1999, J INTERF CYTOK RES, V19, P189, DOI 10.1089/107999099314333; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; CHRISTENSEN ME, 1988, BIOCHEM BIOPH RES CO, V155, P1278, DOI 10.1016/S0006-291X(88)81279-8; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Eggert H, 2001, J STEROID BIOCHEM, V78, P59, DOI 10.1016/S0960-0760(01)00074-7; Eggert M, 1997, J BIOL CHEM, V272, P28471, DOI 10.1074/jbc.272.45.28471; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Gohring F, 1997, BIOCHEMISTRY-US, V36, P8276, DOI 10.1021/bi970480f; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Helbig R, 2003, CHROMOSOMA, V112, P173, DOI 10.1007/s00412-003-0258-0; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Jenke BHC, 2002, EMBO REP, V3, P349, DOI 10.1093/embo-reports/kvf070; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LISCHWE MA, 1985, J BIOL CHEM, V260, P14304; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pawlak MR, 2002, J CELL BIOCHEM, V87, P394, DOI 10.1002/jcb.10307; RAWAL N, 1994, BIOCHEM J, V300, P483, DOI 10.1042/bj3000483; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tang YT, 1998, MOL ENDOCRINOL, V12, P1420, DOI 10.1210/me.12.9.1420; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	44	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48774	48779		10.1074/jbc.M407332200	http://dx.doi.org/10.1074/jbc.M407332200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364944	hybrid			2022-12-27	WOS:000225098100036
J	Vazquez-Ibar, JL; Guan, L; Weinglass, AB; Verner, G; Gordillo, R; Kaback, HR				Vazquez-Ibar, JL; Guan, L; Weinglass, AB; Verner, G; Gordillo, R; Kaback, HR			Sugar recognition by the lactose permease of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TRANSPORT PROTEIN; SUBSTRATE-BINDING SITE; HELIX-VIII; TRYPTOPHAN FLUORESCENCE; SCANNING MUTAGENESIS; MASS-SPECTROMETRY; LAC PERMEASE; RESIDUES; MECHANISM; GLU126	Biochemical, luminescence and mass spectroscopy approaches indicate that Trp- 151 (helix V) plays an important role in hydrophobic stacking with the galactopyranosyl ring of substrate and that Glu-269 (helix VIII) is essential for substrate affinity and specificity. The x-ray structure of the lactose permease (LacY) with bound substrate is consistent with these conclusions and suggests that a possible H-bond between Glu-269 and Trp-151 may play a critical role in the architecture of the binding site. We have now probed this relationship by exploiting the intrinsic luminescence of a single Trp- 151 LacY with various replacements for Glu-269. Mutations at position 269 dramatically alter the environment of Trp- 151 in a manner that correlates with binding affinity of LacY substrates. Furthermore, chemical modification of Trp- 151 with N-bromosuccinimide indicates that Glu-269 forms an H-bond with the indole N. It is concluded that 1) an H-bond between the indole N and Glu-269 optimizes the formation of the substrate binding site in the inward facing conformation of LacY, and 2) the disposition of the residues implicated in sugar binding in different conformers suggests that sugar binding by LacY involves induced fit.	Univ Calif Los Angeles, Howard Hughes Med Inst, Inst Mol Biol, Dept Physiol,MacDonald Res Labs 5 748, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Inst Mol Biol, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gordillo, R (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Inst Mol Biol, Dept Physiol,MacDonald Res Labs 5 748, Box 951662, Los Angeles, CA 90095 USA.	RonaldK@HHMI.UCLA.edu	Guan, Lan/B-5288-2010; Vazquez-Ibar, Jose-Luis/AAD-8827-2021	Vazquez-Ibar, Jose-Luis/0000-0002-8314-3378; Gordillo, Ruth/0000-0001-6533-2493	NIDDK NIH HHS [DK51131:09] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051131] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; COSTELLO MJ, 1987, J BIOL CHEM, V262, P17072; COUTINHO A, 1993, J CHEM EDUC, V70, P425, DOI 10.1021/ed070p425; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; FOSTER DL, 1983, J BIOL CHEM, V258, P31; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Frillingos S, 1997, PROTEIN SCI, V6, P431; Frillingos S, 1997, PROTEIN SCI, V6, P438; Frillingos S, 1997, BIOCHEMISTRY-US, V36, P14284, DOI 10.1021/bi972314d; Guan L, 2003, BIOCHEMISTRY-US, V42, P1377, DOI 10.1021/bi027152m; He MM, 1997, BIOCHEMISTRY-US, V36, P13688, DOI 10.1021/bi9715324; Hirai T, 2003, J BACTERIOL, V185, P1712, DOI 10.1128/JB.185.5.1712-1718.2003; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kaback H R, 1974, Methods Enzymol, V31, P698; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaback HR, 1997, Q REV BIOPHYS, V30, P333, DOI 10.1017/S0033583597003387; KONINGS WN, 1996, HDB BIOL PHYS TRANSP; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lundblad RL, 1995, TECHNIQUES PROTEIN M, V1, P187; Maki AH, 2001, BIOCHEMISTRY-US, V40, P1403, DOI 10.1021/bi002010i; Misra A, 2000, BIOCHEMISTRY-US, V39, P13772, DOI 10.1021/bi0015663; OLSEN SG, 1989, J BIOL CHEM, V264, P15982; PHILLIPS RS, 1986, J AM CHEM SOC, V108, P2023, DOI 10.1021/ja00268a049; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; Sahin-Toth M, 2002, BIOCHEMISTRY-US, V41, P13039, DOI 10.1021/bi0203076; Sahin-Toth M, 2000, BIOCHEMISTRY-US, V39, P5097, DOI 10.1021/bi0000263; Sahin-Toth M, 2001, BIOCHEMISTRY-US, V40, P13015, DOI 10.1021/bi011233l; Sahin-Toth M, 1999, BIOCHEMISTRY-US, V38, P813, DOI 10.1021/bi982200h; SAHINTOTH M, 1994, P NATL ACAD SCI USA, V91, P5421, DOI 10.1073/pnas.91.12.5421; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; SANDERMANN H, 1977, EUR J BIOCHEM, V80, P507, DOI 10.1111/j.1432-1033.1977.tb11906.x; Smirnova IN, 2003, BIOCHEMISTRY-US, V42, P3025, DOI 10.1021/bi027329c; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; UJWAL ML, 1994, MOL MEMBR BIOL, V11, P9, DOI 10.3109/09687689409161024; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Venkatesan P, 1998, P NATL ACAD SCI USA, V95, P9802, DOI 10.1073/pnas.95.17.9802; Weinglass A, 2004, J BIOL CHEM, V279, P41858, DOI 10.1074/jbc.M407555200; Weinglass AB, 2003, EMBO J, V22, P1467, DOI 10.1093/emboj/cdg145; Weinglass AB, 2002, J MOL BIOL, V315, P561, DOI 10.1006/jmbi.2001.5289; Wolin CD, 2000, BIOCHEMISTRY-US, V39, P6130, DOI 10.1021/bi0001269; WU JH, 1994, BIOCHEMISTRY-US, V33, P12166, DOI 10.1021/bi00206a020; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	48	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49214	49221		10.1074/jbc.M407408200	http://dx.doi.org/10.1074/jbc.M407408200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364943	hybrid			2022-12-27	WOS:000225098100087
J	Fitzgerald, ML; Okuhira, K; Short, GF; Manning, JJ; Bell, SA; Freeman, MW				Fitzgerald, ML; Okuhira, K; Short, GF; Manning, JJ; Bell, SA; Freeman, MW			ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; TANGIER-DISEASE; ABCA1 TRANSPORTER; GUANYLATE KINASES; PDZ DOMAINS; PROTEIN; MECHANISM; MUTATIONS; COMPLEX; EVOLUTION	The stimulation of cellular cholesterol and phospholipid efflux by apolipoprotein A-I is mediated by the activity of the ATP-binding cassette transporter A1 (ABCA1). Individuals with Tangier disease harbor loss-of-function mutations in this transporter that have proven useful in illuminating its activity. Here, we analyze a mutation that deletes the last 46 residues of the 2261 amino acid transporter (Delta46) and eliminates its lipid efflux. As the final four amino acids of the C terminus represent a putative PDZ-binding motif, we initially characterized deletion mutants lacking only these residues. Although a moderate decline in lipid efflux was detected, this decline was not as profound as that seen in the Delta46 mutant. Subsequent systematic analysis of the ABCA1 C terminus revealed a novel, highly conserved motif (VFVNFA) that was required for lipid efflux. Alteration of this motif, which is present in some but not all members of the ABCA family, did not prevent trafficking of the transporter to the plasma membrane but did eliminate its binding of apoA-I. Chimeric transporters, generated by substituting the C termini of either ABCA4 or ABCA7 for the endogenous terminus, demonstrated that ABCA1 could stimulate cholesterol efflux without its PDZ-binding motif but not without the VFVNFA motif. When a peptide containing the VFVNFA sequence was introduced into ABCA1-expressing cells, ABCA1-mediated lipid efflux was also markedly inhibited. These results indicate that the C-terminal VFVNFA motif of ABCA1 is essential for its lipid efflux activity. The data also suggest that this motif participates in novel protein-protein interactions that may be shared among members of the ABCA family.	Massachusetts Gen Hosp, Lipid Metab Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Fitzgerald, ML (corresponding author), Massachusetts Gen Hosp, Lipid Metab Unit, Boston, MA 02114 USA.	mfitzger@molbio.mgh.harvard.edu; freeman@molbio.mg.harvard.edu			NHLBI NIH HHS [HL68988, HL72358, HL45098] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072358, R01HL068988, R01HL045098, K08HL145098] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brousseau ME, 2000, J LIPID RES, V41, P433; Buechler C, 2002, J BIOL CHEM, V277, P41307, DOI 10.1074/jbc.C200436200; Buechler C, 2002, BIOCHEM BIOPH RES CO, V293, P759, DOI 10.1016/S0006-291X(02)00303-0; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Clee SM, 2001, CIRCULATION, V103, P1198; Davidson B, 2003, P NATL ACAD SCI USA, V100, P11469, DOI 10.1073/pnas.1634991100; Dean M, 2001, J LIPID RES, V42, P1007; Denis M, 2004, J BIOL CHEM, V279, P7384, DOI 10.1074/jbc.M306963200; Fielding PE, 2000, BIOCHEMISTRY-US, V39, P14113, DOI 10.1021/bi0004192; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Fitzgerald ML, 1999, BIOCHEM J, V342, P353, DOI 10.1042/0264-6021:3420353; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Joly N, 2004, J BIOL CHEM, V279, P33123, DOI 10.1074/jbc.M403615200; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Neufeld EB, 2004, J BIOL CHEM, V279, P15571, DOI 10.1074/jbc.M314160200; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9	42	60	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48477	48485		10.1074/jbc.M409848200	http://dx.doi.org/10.1074/jbc.M409848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347662	hybrid			2022-12-27	WOS:000224957000125
J	Rezaie, AR; Kittur, FS				Rezaie, AR; Kittur, FS			The critical role of the 185-189-loop in the factor Xa interaction with Na plus and factor Va in the prothrombinase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TICK ANTICOAGULANT PEPTIDE; BLOOD-COAGULATION FACTOR; SODIUM-BINDING-SITE; BOVINE FACTOR XA; CATALYTIC-ACTIVITY; BASIC RESIDUES; PROTEIN-C; FACTOR-IX; S1 SITE; INHIBITION	The S1 site (Asp(189)) of factor Xa (fXa) is located on a loop (residues 185-189) that contains three solvent-exposed charged residues (Asp(185), Lys(186), and Glu(188)) below the active-site pocket of the protease. To investigate the role of these residues in the catalytic function of fXa, we expressed three mutants of the protease in which the charges of these residues were neutralized by their substitutions with Ala (D185A, K186A, and E188A). Kinetic studies revealed that E188A has a normal catalytic activity toward small synthetic and natural substrates and inhibitors of fXa; however, the same activities were slightly (similar to2-fold) and dramatically (similar to20-50-fold) impaired for the D185A and K186A mutants, respectively. Further studies revealed that the affinity of D185A and K186A for interaction with Na+ has also been altered, with a modest impairment (similar to2-fold) for the former and a dramatic impairment for the latter mutant. Both prothrombinase and direct binding studies indicated that K186A also has an similar to6-fold impaired affinity for factor Va. Interestingly, a saturating concentration of factor Va restored the catalytic defect of K186A in reactions with prothrombin and the recombinant tick anticoagulant peptide that is known to interact with the Na+ loop of fXa, but not with other substrates. These results suggest that factor Va interacts with 185-189-loop for fXa, which is energetically linked to the Na+-binding site of the protease.	St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu	Kittur, Farooqahmed S/G-3832-2012	Kittur, Farooqahmed/0000-0002-2272-3387	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062565, R01HL068571] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 62565, HL 68571] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; Beck DO, 2004, J BIOL CHEM, V279, P3084, DOI 10.1074/jbc.M306850200; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Chen L, 2004, PROTEIN SCI, V13, P431, DOI 10.1110/ps.03406904; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; KRISHNASWAMY S, 1994, BIOCHEMISTRY-US, V33, P7897, DOI 10.1021/bi00191a017; LEYTUS SP, 1986, BIOCHEMISTRY-US, V25, P5098, DOI 10.1021/bi00366a018; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; NESHEIM ME, 1981, J BIOL CHEM, V256, P6537; OLSON ST, 1991, ARCH BIOCHEM BIOPHYS, V286, P533, DOI 10.1016/0003-9861(91)90076-U; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Rezaie AR, 2000, J BIOL CHEM, V275, P3320, DOI 10.1074/jbc.275.5.3320; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P1817, DOI 10.1021/bi992006a; Rezaie AR, 2004, BIOCHEMISTRY-US, V43, P3368, DOI 10.1021/bi036177y; Rezaie AR, 2004, BIOCHEMISTRY-US, V43, P2898, DOI 10.1021/bi036145a; Rezaie AR, 2003, THROMB HAEMOSTASIS, V89, P112; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; ROSING J, 1980, J BIOL CHEM, V255, P274; Rudolph AE, 2001, J BIOL CHEM, V276, P5123, DOI 10.1074/jbc.M006961200; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; VLASUK GP, 1993, THROMB HAEMOSTASIS, V70, P212; Wei AZ, 1998, J MOL BIOL, V283, P147, DOI 10.1006/jmbi.1998.2069; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	34	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48262	48269		10.1074/jbc.M409964200	http://dx.doi.org/10.1074/jbc.M409964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347660	hybrid			2022-12-27	WOS:000224957000102
J	Siletsky, SA; Pawate, AS; Weiss, K; Gennis, RB; Konstantinov, AA				Siletsky, SA; Pawate, AS; Weiss, K; Gennis, RB; Konstantinov, AA			Transmembrane charge separation during the ferryl-oxo -> oxidized transition in a nonpumping mutant of cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-ELECTRON REDUCTION; PROTON-PUMPING MECHANISM; RHODOBACTER-SPHAEROIDES; PARACOCCUS-DENITRIFICANS; CATALYTIC CYCLE; ENERGY TRANSDUCTION; HISTIDINE CYCLE; TRANSLOCATION; MODEL; RESOLUTION	The N139D mutant of cytochrome c oxidase from Rhodobacter sphaeroides retains full steady state oxidase activity but completely lacks proton translocation coupled to turnover in reconstituted liposomes ( Pawate, A. S., Morgan, J., Namslauer, A., Mills, D., Brzezinski, P., Ferguson-Miller, S., and Gennis, R. B. ( 2002) Biochemistry 41, 13417 - 13423). Here, time-resolved electron transfer and vectorial charge translocation in the ferryl-oxo --> oxidized transition ( transfer of the 4th electron in the catalytic cycle) have been studied with the N139D mutant using ruthenium(II)-tris-bipyridyl complex as a photoactive single-electron donor. With the wild type oxidase, the flash-induced generation of Deltaphi in the ferryl-oxo 3 oxidized transition begins with rapid vectorial electron transfer from Cu-A to heme a (tau similar to 15 mus), followed by two protonic phases, referred to as the intermediate (0.4 ms) and slow electrogenic phases (1.5 ms). In the N139D mutant, only a single protonic phase (tau similar to 0.6 ms) is observed, which was associated with electron transfer from heme a to the heme a(3)/Cu-B site and decelerates similar to 4-fold in D2O. With the wild type oxidase, such a high H2O/D2O solvent isotope effect is characteristic of only the slow (1.5 ms) phase. Presumably, the 0.6-ms electrogenic phase in the N139D mutant reports proton transfer from the inner aqueous phase to Glu-286, replacing the "chemical" proton transferred from Glu-286 to the heme a(3)/Cu-B site. The transfer occurs through the D-channel, because it is observed also in the N139D/K362M double mutant in which the K-channel is blocked. It is concluded that the intermediate electrogenic phase observed in the wild type enzyme is missing in the N139D mutant and is because of translocation of the "pumped" proton from Glu-286 to the D-ring propionate of heme a(3) or to release of this proton to the outer aqueous phase. Significantly, with the wild type oxidase, the protonic electrogenic phase associated with proton pumping ( similar to 0.4 ms) precedes the electrogenic phase associated with the oxygen chemistry ( similar to 1.5 ms).	Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia; Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Lomonosov Moscow State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Konstantinov, AA (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Khokhlova 4, Moscow 119992, Russia.	konst@genebee.msu.su	Pawate, Ashtamurthy S/B-6843-2008; Siletsky, Sergey A./D-8076-2012	Pawate, Ashtamurthy S/0000-0002-0700-9871; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016101, R01HL016101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026916] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16101] Funding Source: Medline; NIGMS NIH HHS [R01 GM026916] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARTZATBANOV VY, 1978, FEBS LETT, V87, P180, DOI 10.1016/0014-5793(78)80327-5; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Brzezinski P, 2004, TRENDS BIOCHEM SCI, V29, P380, DOI 10.1016/j.tibs.2004.05.008; Fabian M, 2001, BIOCHEMISTRY-US, V40, P1867, DOI 10.1021/bi002373i; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Hinkle P C, 1979, Methods Enzymol, V55, P748; HOSLER JP, 1992, J BIOL CHEM, V267, P24264; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwaki M, 2002, BBA-BIOENERGETICS, V1555, P116, DOI 10.1016/S0005-2728(02)00265-7; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Junemann S, 1997, BIOCHEMISTRY-US, V36, P14456, DOI 10.1021/bi971458p; Konstantinov AA, 1998, J BIOENERG BIOMEMBR, V30, P121, DOI 10.1023/A:1020571930850; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; KONSTANTINOV AA, 1977, DOKL AKAD NAUK SSSR+, V237, P713; Liao GL, 1996, BBA-BIOENERGETICS, V1274, P109, DOI 10.1016/0005-2728(96)00014-X; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; MITCHELL DM, 1995, FEBS LETT, V368, P148, DOI 10.1016/0014-5793(95)00626-K; MITCHELL P, 1988, ANN NY ACAD SCI, V550, P185, DOI 10.1111/j.1749-6632.1988.tb35335.x; MITCHELL P, 1968, CHEMIOSMOTIC COUPLIN, P1; MORGAN JE, 1994, J BIOENERG BIOMEMBR, V26, P599, DOI 10.1007/BF00831534; Namslauer A, 2003, P NATL ACAD SCI USA, V100, P15543, DOI 10.1073/pnas.2432106100; NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497; Pawate AS, 2002, BIOCHEMISTRY-US, V41, P13417, DOI 10.1021/bi026582+; Pfitzner U, 2000, BIOCHEMISTRY-US, V39, P6756, DOI 10.1021/bi992235x; Popovic DM, 2004, FEBS LETT, V566, P126, DOI 10.1016/j.febslet.2004.04.016; Popovic DM, 2004, J AM CHEM SOC, V126, P1858, DOI 10.1021/ja038267w; PROVENCHER SW, 1976, BIOPHYS J, V16, P27, DOI 10.1016/S0006-3495(76)85660-3; Puustinen A, 1999, P NATL ACAD SCI USA, V96, P35, DOI 10.1073/pnas.96.1.35; RICH P, 1997, BIOENERGETICS, V4, P419; RICH PR, 1995, AUST J PLANT PHYSIOL, V22, P479, DOI 10.1071/PP9950479; Ruitenberg M, 2000, P NATL ACAD SCI USA, V97, P4632, DOI 10.1073/pnas.080079097; Ruitenberg M, 2002, NATURE, V417, P99, DOI 10.1038/417099a; Siegbahn PEM, 2004, BBA-BIOENERGETICS, V1655, P45, DOI 10.1016/j.bbabio.2003.07.003; Siletsky S, 1999, BIOCHEMISTRY-US, V38, P4853, DOI 10.1021/bi982614a; SILETSKY SA, 1998, THESIS MOSCOW STATE; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; VANNESTE WH, 1966, BIOCHEMISTRY-US, V5, P838, DOI 10.1021/bi00867a005; Wikstrom M, 2000, BBA-BIOENERGETICS, V1458, P188, DOI 10.1016/S0005-2728(00)00068-2; WIKSTROM M, 1992, J BIOL CHEM, V267, P10266; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; Xavier AV, 2004, BBA-BIOENERGETICS, V1658, P23, DOI 10.1016/j.bbabio.2004.03.017; Xavier AV, 2002, FEBS LETT, V532, P261, DOI 10.1016/S0014-5793(02)03692-X; ZASLAVSKY D, 1993, FEBS LETT, V336, P389, DOI 10.1016/0014-5793(93)80843-J; Zaslavsky D, 1998, BIOCHEMISTRY-US, V37, P14910, DOI 10.1021/bi981490z; Zheng XH, 2003, BBA-BIOENERGETICS, V1557, P99, DOI 10.1016/S0005-2728(03)00002-1	50	69	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52558	52565		10.1074/jbc.M407549200	http://dx.doi.org/10.1074/jbc.M407549200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15385565	hybrid			2022-12-27	WOS:000225493400102
J	Hu, HT; Sheehan, JH; Chazin, WJ				Hu, HT; Sheehan, JH; Chazin, WJ			The mode of action of centrin - Binding of Ca2+ and a peptide fragment of Kar1p to the C-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; CALCIUM-FREE CALMODULIN; EF-HAND PROTEIN; CONFORMATIONAL-CHANGE; YEAST CALMODULIN; APO-CALMODULIN; TROPONIN-C; DUPLICATION; CALTRACTIN; SITES	Centrin is an EF-hand calcium-binding protein closely related to the prototypical calcium sensor protein calmodulin. It is found in microtubule-organizing centers of organisms ranging from algae and yeast to man. In vitro, the C-terminal domain of centrin binds to the yeast centrosomal protein Kar1p in a calcium-dependent manner, whereas the N-terminal domain does not show any appreciable affinity for Kar1p. To obtain deeper insights into the structural basis for centrin's function, we have characterized the affinities of the C-terminal domain of Chlamydomonas reinhardtii centrin for calcium and for a peptide fragment of Kar1p using CD, fluorescence, and NMR spectroscopy. Calcium binding site IV in C. reinhardtii centrin was found to bind Ca2+ similar to 100-fold more strongly than site III. In the absence of Ca2+, the protein occupies a mixture of closed conformations. Binding of a single ion in site IV is sufficient to radically alter the conformational equilibrium, promoting occupancy of an open conformation. However, an exchange between closed and open conformations remains even at saturating levels of Ca2+. The population of the open conformation is substantially stabilized by the presence of the target peptide Kar1p-(239 - 257) to a point where a single ion bound in site IV is sufficient to completely shift the conformational equilibrium to the open conformation. This is reflected in the enhancement of the Ca2+ affinity in this site by more than an order of magnitude. These data confirm the direct coupling of the Ca2+ binding-induced shift in the equilibrium between the closed and open conformations to the binding of the peptide. Combined with the common localization of the two proteins in the microtubule organizing center, our results suggest that centrin is constitutively bound to Kar1p through its C-terminal domain and that centrin's calcium sensor activities are mediated by the N-terminal domain.	Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Phys, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biol Struct, 5142 BIOSCI MRBIII, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu		Hu, Haitao/0000-0002-0312-1954; Sheehan, Jonathan/0000-0002-9641-7577	NCI NIH HHS [P30 CA68485] Funding Source: Medline; NIEHS NIH HHS [P50 ES00267] Funding Source: Medline; NIGMS NIH HHS [T32 GM-08240, R01 GM-40120] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040120] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ababou A, 2001, BIOCHEMISTRY-US, V40, P12719, DOI 10.1021/bi010405b; Akyol Z, 2004, J BIOL CHEM, V279, P2166, DOI 10.1074/jbc.M302542200; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BAYLEY P, 1984, BIOCHEM BIOPH RES CO, V120, P185, DOI 10.1016/0006-291X(84)91431-1; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; BIGGINS S, 1994, J CELL BIOL, V125, P843, DOI 10.1083/jcb.125.4.843; CARLSTROM G, 1993, J MOL BIOL, V231, P415, DOI 10.1006/jmbi.1993.1291; Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; FARAH CS, 1994, J BIOL CHEM, V269, P5230; Geier BM, 1996, J BIOL CHEM, V271, P28366, DOI 10.1074/jbc.271.45.28366; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hu HT, 2003, J MOL BIOL, V330, P473, DOI 10.1016/S0022-2836(03)00619-3; Ivanovska I, 2001, GENETICS, V157, P503; KELLER CH, 1982, BIOCHEMISTRY-US, V21, P156, DOI 10.1021/bi00530a027; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LINSE S, 1995, PROTEIN SCI, V4, P1038, DOI 10.1002/pro.5560040602; LINSE S, 1991, J BIOL CHEM, V266, P8050; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; Martin SR, 1999, PROTEIN SCI, V8, P2444; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; OHYA Y, 1994, GENETICS, V138, P1041; OLWIN BB, 1984, J BIOL CHEM, V259, P949; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; SCHIEBEL E, 1995, TRENDS CELL BIOL, V5, P197, DOI 10.1016/S0962-8924(00)88999-0; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; She MD, 1998, J MOL BIOL, V281, P445, DOI 10.1006/jmbi.1998.1933; SPANG A, 1995, J CELL BIOL, V128, P863, DOI 10.1083/jcb.128.5.863; STEINER RF, 1984, BIOPOLYMERS, V23, P1121, DOI 10.1002/bip.360230612; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Szczesna D, 1996, J BIOL CHEM, V271, P8381, DOI 10.1074/jbc.271.14.8381; TAILLON BE, 1992, J CELL BIOL, V119, P1613, DOI 10.1083/jcb.119.6.1613; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Veeraraghavan S, 2002, J BIOL CHEM, V277, P28564, DOI 10.1074/jbc.M112232200; WEBER C, 1994, J BIOL CHEM, V269, P15795; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; YAZAWA M, 1992, BIOCHEMISTRY-US, V31, P3171, DOI 10.1021/bi00127a018; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	42	52	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50895	50903		10.1074/jbc.M404233200	http://dx.doi.org/10.1074/jbc.M404233200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452116	hybrid			2022-12-27	WOS:000225355800032
J	Joseph, JW; Koshkin, V; Saleh, MC; Sivitz, WI; Zhang, CY; Lowell, BB; Chan, CB; Wheeler, MB				Joseph, JW; Koshkin, V; Saleh, MC; Sivitz, WI; Zhang, CY; Lowell, BB; Chan, CB; Wheeler, MB			Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-ISLET CELLS; INSULIN-SECRETION; COMMON POLYMORPHISM; ENERGY-METABOLISM; GENE-EXPRESSION; OBESITY; APOPTOSIS; PROMOTER; MICE; UCP2	Chronic exposure to elevated free fatty acids (lipotoxicity) induces uncoupling protein (UCP2) in the pancreatic beta-cell, and therefore a causal link between UCP2 and beta-cell defects associated with obesity may exist. Recently, we showed that lipid treatment in vivo and in vitro in UCP2(-/-) mice/islets does not result in any loss in beta-cell glucose sensitivity. We have now assessed the mechanism of maintained beta-cell function in UCP2(-/-) mice by exposing islets to 0.4 mM palmitate for 48 h. Palmitate treatment increased triglyceride concentrations in wild type (WT) but not UCP2(-/-) islets because of higher palmitate oxidation rates in the UCP2(-/-) islets. Dispersed beta-cells from the palmitate-exposed WT islets had reduced glucose-stimulated hyperpolarization of the mitochondrial membrane potential compared with both control WT and palmitate-exposed UCP2(-/-) beta-cells. The glucose-stimulated increases in the ATP/ADP ratio and cytosolic Ca2+ are attenuated in palmitate-treated WT but not UCP2(-/-) beta-cells. Exposure to palmitate reduced glucose-stimulated insulin secretion (GSIS) in WT islets, whereas UCP2(-/-) islets had enhanced GSIS. Overexpression of recombinant UCP2 but not enhanced green fluorescent protein in beta-cells resulted in a loss of glucose-stimulated hyperpolarization of the mitochondrial membrane potential and GSIS similar to that seen in WT islets exposed to palmitate. Reactive oxygen species (ROS) are known to increase the activity of UCP2. We showed that ROS levels were elevated in control UCP2(-/-) islets as compared with WT and UCP2(-/-) islets overexpressing UCP2 and that palmitate increased ROS in WT and UCP2(-/-) islets overexpressing UCP2 but not in UCP2(-/-) islets. Thus, UCP2(-/-) islets resisted the toxic effects of palmitate by maintaining glucose-dependent metabolism-secretion coupling. We propose that higher free fatty acid oxidation rates prevent accumulation of triglyceride in UCP2(-/-) islets, such accumulation being a phenomenon associated with lipotoxicity.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Iowa, Dept Internal Med, Div Endocrinol, Iowa City, IA 52246 USA; Univ Iowa, Dept Internal Med, Div Metab, Iowa City, IA 52246 USA; Univ Prince Edward Isl, Atlantic Vet Coll, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada; Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	University of Toronto; University of Toronto; University of Iowa; University of Iowa; University of Prince Edward Island; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle,Rm 3352, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Sivitz, William/0000-0002-7829-0189; Wheeler, Michael B./0000-0002-7480-7267				Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Barbu A, 2002, MOL CELL ENDOCRINOL, V190, P75, DOI 10.1016/S0303-7207(02)00009-6; BERTS A, 1995, BIOCHEM BIOPH RES CO, V208, P644, DOI 10.1006/bbrc.1995.1387; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; BRUBAKER PL, 1989, ENDOCRINOLOGY, V124, P3003, DOI 10.1210/endo-124-6-3003; BRUBAKER PL, 1992, J BIOL CHEM, V267, P20728; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; Chandra J, 2001, DIABETES, V50, pS44, DOI 10.2337/diabetes.50.2007.S44; CHEN SY, 1994, DIABETES, V43, P878, DOI 10.2337/diabetes.43.7.878; Dhamrait SS, 2004, EUR HEART J, V25, P468, DOI 10.1016/j.ehj.2004.01.007; DRUCKER DJ, 1991, ENDOCRINOLOGY, V128, P394, DOI 10.1210/endo-128-1-394; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; ERECINSKA M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P273, DOI 10.1016/0167-4838(92)90555-R; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Sasahara M, 2004, DIABETES, V53, P482, DOI 10.2337/diabetes.53.2.482; SCHULTZ V, 1993, ANAL BIOCHEM, V215, P302, DOI 10.1006/abio.1993.1591; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	36	154	163	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51049	51056		10.1074/jbc.M409189200	http://dx.doi.org/10.1074/jbc.M409189200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448158	hybrid			2022-12-27	WOS:000225355800050
J	Kao, HI; Campbell, JL; Bambara, RA				Kao, HI; Campbell, JL; Bambara, RA			Dna2p helicase/nuclease is a tracking protein, like FEN1, for flap cleavage during Okazaki fragment maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; REPLICATION-PROTEIN; HELICASE ACTIVITY; CRYSTAL-STRUCTURE; POLYMERASE-DELTA; IN-VIVO; YEAST; ENDONUCLEASE-1	During cellular DNA replication the lagging strand is generated as discontinuous segments called Okazaki fragments. Each contains an initiator RNA primer that is removed prior to joining of the strands. Primer removal in eukaryotes requires displacement of the primer into a flap that is cleaved off by flap endonuclease 1 (FEN1). FEN1 employs a unique tracking mechanism that requires the recognition of the free 5' terminus and then movement to the base of the flap for cleavage. Abnormally long flaps are coated by replication protein A (RPA), inhibiting FEN1 cleavage. A second nuclease, Dna2p, is needed to cleave an RPA-coated flap producing a short RPA-free flap, favored by FEN1. Here we show that Dna2p is also a tracking protein. Annealed primers or conjugated biotin-streptavidin complex block Dna2p entry and movement. Single-stranded binding protein-coated flaps inhibit Dna2p cleavage. Like FEN1, Dna2p can track over substrates with a non-Watson Crick base, such as a biotin, or a missing base within a chain. Unlike FEN1, Dna2p shows evidence of a "threading-like" mechanism that does not support tracking over a branched substrate. We propose that the two nucleases both track, Dna2p first and then FEN1, to remove initiator RNA via long flap intermediates.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1979, J BIOL CHEM, V254, P1495; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Driscoll HC, 2003, J BIOL CHEM, V278, P41126, DOI 10.1074/jbc.M304798200; Formosa T, 1999, GENETICS, V151, P1459; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Kang HY, 2000, GENETICS, V155, P1055; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KORNBERG A, 1992, DNA REPLICATION, P140; Kunkel TA, 1997, CELL, V88, P155, DOI 10.1016/S0092-8674(00)81832-2; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; NETHANEL T, 1992, J VIROL, V66, P6634, DOI 10.1128/JVI.66.11.6634-6640.1992; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Weitao T, 2003, MUTAT RES-FUND MOL M, V532, P157, DOI 10.1016/j.mrfmmm.2003.08.015; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Yong YQ, 1996, CHEM RES TOXICOL, V9, P179, DOI 10.1021/tx950112h; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	47	65	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50840	50849		10.1074/jbc.M409231200	http://dx.doi.org/10.1074/jbc.M409231200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448135	Green Accepted, hybrid			2022-12-27	WOS:000225355800026
J	Garrigue-Antar, L; Francois, V; Kadler, KE				Garrigue-Antar, L; Francois, V; Kadler, KE			Deletion of epidermal growth factor-like domains converts mammalian tolloid into a chordinase and effective procollagen C-proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-1; DORSAL-VENTRAL PATTERN; X-RAY-STRUCTURE; DROSOPHILA EMBRYO; ACTIVITY GRADIENT; CRYSTAL-STRUCTURE; ASTACIN FAMILY; BINDING; MEMBER; METALLOPROTEINASES	Bone morphogenetic protein (BMP)-1 and mammalian tolloid (mTld) are Ca2+-dependent metalloproteinases that result from alternative splicing of the bmp1 gene. They have different proteinase activities, e.g. BMP-1 effectively cleaves procollagen (an extracellular matrix protein) and chordin (a BMP antagonist), whereas mTld is a poor procollagen proteinase and will not cleave chordin in the absence of twisted gastrulation. This is perplexing because mTld (being the longer variant) might be expected to cleave all substrates cleaved by BMP-1. Studies have shown that the minimal structure for procollagen proteinase activity is proteinase-CUB1-CUB2 (BMP-1DeltaEC3) and therefore lacking the epidermal growth factor (EGF)-like domain thought to account for the Ca2+ dependence of BMP-1. In this study we generated three deletion mutants of mTld that lacked either one or both EGF-like domains (referred to as "mTld-DeltaEGF"). The mutated proteins were poorly but sufficiently secreted from 293-EBNA cells for in vitro assays of procollagen and chordin cleavage. Most surprisingly, the mTld-DeltaEGF mutants required Ca2+ for proteolytic activity, thereby showing that the EGF-like domains do not account for the Ca2+ dependence of BMP-1/mTld. Moreover, the mTld-DeltaEGFs are effective procollagen proteinases and cleave chordin. Furthermore, BMP-1DeltaEC3 cleaves chordin and requires Ca2+ for activity. Studies using nondenaturing gels showed that mTld molecules lacking EGF-like domains have a loose conformation such that in the presence of Ca2+ binding sites for chordin and procollagen on the "BMP-1-part" of the molecule are exposed. We propose that the EGF-like domains could hold CUB4/5 domains in locations that exclude substrates cleavable by BMP-1.	Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; CNRS, UPR 1142, Inst Genet Humaine, F-34396 Montpellier 5, France	University of Manchester; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Kadler, KE (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	karl.kadler@man.ac.uk	KADLER, KARL/ABI-2403-2020	KADLER, KARL/0000-0003-4977-4683; Garrigue-Antar, Laure/0000-0001-6331-8882				Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; DALE L, 1992, DEVELOPMENT, V115, P573; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; FRANCOIS V, 1995, CELL, V80, P19, DOI 10.1016/0092-8674(95)90446-8; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Gagne SM, 1998, J MOL BIOL, V278, P667, DOI 10.1006/jmbi.1998.1723; Garrigue-Antar L, 2001, J BIOL CHEM, V276, P26237, DOI 10.1074/jbc.M010814200; GOMISRUTH FX, 1994, J BIOL CHEM, V269, P17111; Gregory LA, 2004, J BIOL CHEM, V279, P29391, DOI 10.1074/jbc.M402687200; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Jones CM, 1996, DEVELOPMENT, V122, P1545; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Larrain J, 2000, DEVELOPMENT, V127, P821; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Lhomond G, 1996, EUR J BIOCHEM, V238, P744, DOI 10.1111/j.1432-1033.1996.0744w.x; Li SW, 1996, P NATL ACAD SCI USA, V93, P5127, DOI 10.1073/pnas.93.10.5127; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Millet C, 2001, MECH DEVELOP, V106, P85, DOI 10.1016/S0925-4773(01)00423-3; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Scott IC, 2001, NATURE, V410, P475, DOI 10.1038/35068572; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Sunnerhagen M, 1996, BIOCHEMISTRY-US, V35, P11547, DOI 10.1021/bi960633j; Suzuki N, 1996, DEVELOPMENT, V122, P3587; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Varela PF, 1997, J MOL BIOL, V274, P635, DOI 10.1006/jmbi.1997.1424; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	52	26	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49835	49841		10.1074/jbc.M408134200	http://dx.doi.org/10.1074/jbc.M408134200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381708	Green Published, hybrid			2022-12-27	WOS:000225229500036
J	He, JQ; Bellini, M; Xu, JG; Castleberry, AM; Hall, RA				He, JQ; Bellini, M; Xu, JG; Castleberry, AM; Hall, RA			Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta 1-adrenergic receptor surface expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTORS; D-ASPARTATE RECEPTORS; BETA(1)-ADRENERGIC RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; FREQUENCY STIMULATION; SYNAPTIC PLASTICITY; GOLGI PROTEIN; HEART-FAILURE; PDZ PROTEINS; MODULATION	G protein-coupled receptors such as the beta1-adrenergic receptor (beta1AR) must be trafficked to the plasma membrane in order to bind with their extracellular ligands and regulate cellular physiology. By using glutathione S-transferase pull-down techniques, we found that the beta1AR carboxyl terminus directly interacts with the cystic fibrosis transmembrane conductance regulator-associated ligand (CAL; also known as PIST, GOPC, and FIG), a protein known to be primarily localized to the Golgi apparatus. CAL contains two predicted coiled-coil domains and one PSD-95/Discs-large/ZO-1 homology (PDZ) domain. The beta1AR carboxyl terminus (CT) binds to the PDZ domain of CAL, with the last few amino acids (ESKV) of the beta1AR-CT being the key determinants for the interaction. Mutation of the terminal valine residue resulted in markedly reduced association of the beta1AR-CT with CAL. Numerous other mutations to the ESKV motif also impaired the beta1AR-CT/CAL interaction, suggesting that this motif is close to optimal for association with the CAL PDZ domain. In cells, full-length beta1AR robustly associates with CAL, and this interaction is abolished by mutation of the terminal valine to alanine of the receptor (V477A), as determined by co-immunoprecipitation experiments and immunofluorescence co-localization studies. Consistent with observations that CAL is a Golgi-associated protein, overexpression of CAL reduces surface expression of beta1AR. Interaction with CAL promotes retention of beta1AR within the cell, whereas PSD-95, another beta1AR-associated PDZ domain-containing protein, competitively blocks beta1AR association with CAL and promotes receptor trafficking to the cell surface. These data reveal that CAL, a novel beta1AR-binding partner, modulates beta1AR intracellular trafficking, thereby revealing a new mechanism of regulation for beta1AR anterograde trafficking through the endoplasmic reticulum-Golgi complex to the plasma membrane.	Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr, Atlanta, GA 30322 USA; Capital Univ Med Sci, Dept Biochem, Beijing 100054, Peoples R China; Peking Univ, Basic Med Coll, Inst Vasc Med, Stem Cell Ctr, Beijing 100083, Peoples R China	Emory University; Capital Medical University; Peking University	He, JQ (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Rollins Res Ctr 5113, 1510 Clifton Rd, Atlanta, GA 30322 USA.	jqhe53@hotmail.com; rhall@pharm.emory.edu		Hall, Randy/0000-0002-8318-8728	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060982] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM60982] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Charest A, 2001, J BIOL CHEM, V276, P29456, DOI 10.1074/jbc.M104137200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Dorn GW, 2004, CIRCULATION, V109, P150, DOI 10.1161/01.CIR.0000111581.15521.F5; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; He JQ, 2003, ONCOGENE, V22, P4524, DOI 10.1038/sj.onc.1206767; He JQ, 2002, BIOCHEM BIOPH RES CO, V297, P565, DOI 10.1016/S0006-291X(02)02259-3; He JQ, 2001, J BIOL CHEM, V276, P41559, DOI 10.1074/jbc.M106859200; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; Huet G, 2003, BIOCHIMIE, V85, P323, DOI 10.1016/S0300-9084(03)00056-7; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Hunt CA, 1996, J NEUROSCI, V16, P1380; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lowe JB, 2002, IMMUNOL REV, V186, P19, DOI 10.1034/j.1600-065X.2002.18603.x; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Pak Y, 2002, MOL CELL BIOL, V22, P7942, DOI 10.1128/MCB.22.22.7942-7952.2002; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Wang SJ, 1999, J NEUROSCI, V19, P570; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Watanabe Y, 1996, NEUROSCIENCE, V71, P1031, DOI 10.1016/0306-4522(95)00498-X; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu JG, 2003, J BIOL CHEM, V278, P10770, DOI 10.1074/jbc.M207968200; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Yao RJ, 2001, BIOCHEM BIOPH RES CO, V286, P771, DOI 10.1006/bbrc.2001.5430; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9	42	48	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50190	50196		10.1074/jbc.M404876200	http://dx.doi.org/10.1074/jbc.M404876200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15358775	hybrid			2022-12-27	WOS:000225229500079
J	Hemmi, H; Shibuya, K; Takahashi, Y; Nakayama, T; Nishino, T				Hemmi, H; Shibuya, K; Takahashi, Y; Nakayama, T; Nishino, T			(S)-2,3-Di-O-geranylgeranylglyceryl phosphate synthase from the thermoacidophilic Archaeon Sulfolobus solfataricus - Molecular cloning and characterization of a membrane-intrinsic prenyltransferase involved in the biosynthesis of archaeal ether-linked membrane lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENANTIOMERIC GLYCEROPHOSPHATE BACKBONE; FARNESYLGERANYL DIPHOSPHATE SYNTHASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; SN-GLYCEROL-1-PHOSPHATE DEHYDROGENASE; THERMOPLASMA-ACIDOPHILUM; METHANOGENIC ARCHAEA; ESCHERICHIA-COLI; PURIFICATION; ENZYME; GENE	The core structure of membrane lipids of archaea have some unique properties that permit archaea to be distinguished from the others, i.e. bacteria and eukaryotes. (S)-2,3-Di-O-geranylgeranylglyceryl phosphate synthase, which catalyzes the transfer of a geranylgeranyl group from geranylgeranyl diphosphate to (S)-3-O-geranylgeranylglyceryl phosphate, is involved in the biosynthesis of archaeal membrane lipids. Enzymes of the UbiA prenyltransferase family are known to catalyze the transfer of a prenyl group to various acceptors with hydrophobic ring structures in the biosynthesis of respiratory quinones, hemes, chlorophylls, vitamin E, and shikonin. The thermoacidophilic archaeon Sulfolobus solfataricus was found to encode three homologues of UbiA prenyltransferase in its genome. One of the homologues encoded by SSO0583 was expressed in Escherichia coli, purified, and characterized. Radio-assay and mass spectrometry analysis data indicated that the enzyme specifically catalyzes the biosynthesis of ( S)-2,3-di-O- geranylgeranylglyceryl phosphate. The fact that the orthologues of the enzyme are encoded in almost all archaeal genomes clearly indicates the importance of their functions. A phylogenetic tree constructed using the amino acid sequences of some typical members of the UbiA prenyltransferase family and their homologues from S. solfataricus suggests that the two other S. solfataricus homologues, excluding the ( S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase, are involved in the production of respiratory quinone and heme, respectively. We propose here that archaeal prenyltransferases involved in membrane lipid biosynthesis might be prototypes of the protein family and that archaea might have played an important role in the molecular evolution of prenyltransferases.	Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	Tohoku University	Hemmi, H (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Yama 07, Sendai, Miyagi 9808579, Japan.	hhemmi@seika.che.tohoku.ac.jp	Hemmi, Hisashi/I-6868-2014	Hemmi, Hisashi/0000-0002-9538-809X				Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; Beifuss U, 2000, ANGEW CHEM INT EDIT, V39, P2470, DOI 10.1002/1521-3773(20000717)39:14<2470::AID-ANIE2470>3.0.CO;2-R; CHEN AJ, 1993, J BIOL CHEM, V268, P21701; CHEN AJ, 1994, ARCH BIOCHEM BIOPHYS, V314, P399, DOI 10.1006/abbi.1994.1459; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; DEROSA M, 1977, J CHEM SOC PERK T 1, P653, DOI 10.1039/p19770000653; Eguchi T, 2003, TETRAHEDRON LETT, V44, P3275, DOI 10.1016/S0040-4039(03)00627-0; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; GAMBACORTA A, 1994, SYST APPL MICROBIOL, V16, P518; Kon T, 2002, J BACTERIOL, V184, P1395, DOI 10.1128/JB.184.5.1395-1401.2002; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Morii H, 2000, J BIOL CHEM, V275, P36568, DOI 10.1074/jbc.M005925200; Morii H, 2003, J BACTERIOL, V185, P1181, DOI 10.1128/JB.185.4.1181-1189.2003; Muhlenweg A, 1998, PLANTA, V205, P407, DOI 10.1007/s004250050337; Nemoto N, 2003, J BIOCHEM, V133, P651, DOI 10.1093/jb/mvg083; NISHIHARA M, 1995, J BIOCHEM-TOKYO, V117, P933, DOI 10.1093/oxfordjournals.jbchem.a124822; Nishihara M, 1997, J BIOCHEM-TOKYO, V122, P572; OHNUMA S, 1994, J BIOL CHEM, V269, P14792; Soderberg T, 2001, BIOCHEMISTRY-US, V40, P14847, DOI 10.1021/bi0111799; TACHIBANA A, 1994, FEBS LETT, V341, P291, DOI 10.1016/0014-5793(94)80475-3; Tachibana A, 2000, EUR J BIOCHEM, V267, P321, DOI 10.1046/j.1432-1327.2000.00967.x; Wang CW, 1999, BIOTECHNOL BIOENG, V62, P235, DOI 10.1002/(SICI)1097-0290(19990120)62:2<235::AID-BIT14>3.0.CO;2-U; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; ZHANG DL, 1990, J AM CHEM SOC, V112, P1264, DOI 10.1021/ja00159a067; ZHANG DL, 1993, J ORG CHEM, V58, P3919, DOI 10.1021/jo00067a025; ZHANG DL, 1993, J AM CHEM SOC, V115, P1270, DOI 10.1021/ja00057a008; ZHANG DL, 1993, ANAL BIOCHEM, V213, P356, DOI 10.1006/abio.1993.1432	28	50	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50197	50203		10.1074/jbc.M409207200	http://dx.doi.org/10.1074/jbc.M409207200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15356000	hybrid			2022-12-27	WOS:000225229500080
J	Nakatsukasa, K; Okada, S; Umebayashi, K; Fukuda, R; Nishikawa, S; Endo, T				Nakatsukasa, K; Okada, S; Umebayashi, K; Fukuda, R; Nishikawa, S; Endo, T			Roles of O-mannosylation of aberrant proteins in reduction of the load for endoplasmic reticulum chaperones in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSIDASE-LIKE PROTEIN; MISFOLDED SECRETORY PROTEIN; NIVEUS ASPARTIC PROTEINASE; ALPHA-FACTOR PRECURSOR; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; RETRO-TRANSLOCATION; MOLECULAR CHAPERONES; DEGRADATION; ER	The protein quality control system in the endoplasmic reticulum (ER) ensures that only properly folded proteins are deployed throughout the cells. When nonnative proteins accumulate in the ER, the unfolded protein response is triggered to limit further accumulation of nonnative proteins and the ER is cleared of accumulated nonnative proteins by the ER-associated degradation (ERAD). In the yeast ER, aberrant nonnative proteins are mainly directed for the ERAD, but a distinct fraction of them instead receive O-mannosylation. In order to test whether O-mannosylation might also be a mechanism to process aberrant proteins in the ER, here we analyzed the effect of O-mannosylation on two kinds of model aberrant proteins, a series of N-glycosylation site mutants of prepro-alpha-factor and a pro-region-deleted derivative of Rhizopus niveus aspartic proteinase-I (Deltapro) both in vitro and in vivo. O-Mannosylation increases solubilities of the aberrant proteins and renders them less dependent on the ER chaperone, BiP, for being soluble. The release from ER chaperones allows the aberrant proteins to exit out of the ER for the normal secretory pathway transport. When the gene for Pmt2p, responsible for the O-mannosylation of these aberrant proteins, and that for the ERAD were simultaneously deleted, the cell exhibited enhanced unfolded protein response. O-Mannosylation may therefore function as a fail-safe mechanism for the ERAD by solubilizing the aberrant proteins that overflowed from the ERAD pathway and reducing the load for ER chaperones.	Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Natl Inst Genet, Dept Cell Genet, Shizuoka 4118540, Japan; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Nagoya Univ, Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Japan Science & Technology Agency (JST); Nagoya University; Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp						Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brachmann CB, 1998, YEAST, V14, P115; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fukuda R, 1996, J BIOL CHEM, V271, P14252, DOI 10.1074/jbc.271.24.14252; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HORIUCHI H, 1990, AGR BIOL CHEM TOKYO, V54, P1771, DOI 10.1080/00021369.1990.10870223; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Ioannou YA, 1998, BIOCHEM J, V332, P789, DOI 10.1042/bj3320789; Jakob CA, 2001, EMBO REP, V2, P423; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Kaiser C., 1994, METHODS YEAST GENETI; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; KURJAN J, 1982, CELL, V30, P933, DOI 10.1016/0092-8674(82)90298-7; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; NISHIKAWA S, 1994, MOL BIOL CELL, V5, P1129, DOI 10.1091/mbc.5.10.1129; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; NISHIKAWA S, 1991, BIOCHIM BIOPHYS ACTA, V1093, P135, DOI 10.1016/0167-4889(91)90114-D; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Proszynski TJ, 2004, MOL BIOL CELL, V15, P1533, DOI 10.1091/mbc.E03-07-0511; Ritter C, 2000, NAT STRUCT BIOL, V7, P278; Sanders SL, 1999, J CELL BIOL, V145, P1177, DOI 10.1083/jcb.145.6.1177; SCHULKE N, 1988, J BIOL CHEM, V263, P8832; SIKORSKI RS, 1989, GENETICS, V122, P19; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Umebayashi K, 2001, J BIOL CHEM, V276, P41444, DOI 10.1074/jbc.M105829200; Umebayashi K, 1997, YEAST, V13, P1009; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Wojczyk BS, 1998, GLYCOBIOLOGY, V8, P121, DOI 10.1093/glycob/8.2.121; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	57	60	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49762	49772		10.1074/jbc.M403234200	http://dx.doi.org/10.1074/jbc.M403234200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377669	hybrid			2022-12-27	WOS:000225229500028
J	Singh, CR; Yamamoto, Y; Asano, K				Singh, CR; Yamamoto, Y; Asano, K			Physical association of eukaryotic initiation factor (eIF) 5 carboxyl-terminal domain with the lysine-rich eIF2 beta segment strongly enhances its binding to eIF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION INITIATION; MULTIFACTOR COMPLEX; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; BETA-SUBUNIT; YEAST; GCN4; EVOLUTION; SELECTION; CAP	The carboxyl-terminal domain (CTD) of eukaryotic initiation factor (eIF) 5 interacts with eIF1, eIF2beta, and eIF3c, thereby mediating formation of the multifactor complex (MFC), an important intermediate for the 43 S preinitiation complex assembly. Here we demonstrate in vitro formation of a nearly stoichiometric quaternary complex containing eIF1 and the minimal segments of eIF2beta, eIF3c, and eIF5. In vivo, overexpression of eIF2 and tRNA(i)(Met) suppresses the temperature-sensitive phenotype of tif5-7A altering eIF5-CTD by increasing interaction of the mutant eIF5 with eIF2 by mass action and restoring its defective interaction with eIF3. By contrast, overexpression of eIF1 exacerbated the tif5-7A phenotype because eIF1 forms unusual inhibitory complexes with a hyperstoichiometric amount of eIF1. Formation of such complexes leads to increased GCN4 translation, independent of eIF2 phosphorylation (general control derepressed or Gcd(-) phenotype). We also provide biochemical evidence indicating that the association of eIF5-CTD with eIF2beta strongly enhances its binding to eIF3c. Our results suggest strongly that MFC formation is an ordered event involving specific enhancement of eIF5-CTD binding to eIF3 on its binding to eIF2beta. We propose that the primary function of eIF5-CTD is to serve as an assembly guide by rapidly promoting stoichiometric MFC assembly with the aid of eIF2 while excluding formation of nonfunctional complexes.	Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA	Kansas State University	Asano, K (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Ackert Hall, Manhattan, KS 66506 USA.	kasano@ksu.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064781] Funding Source: NIH RePORTER; NCRR NIH HHS [1P20 RR15563] Funding Source: Medline; NIGMS NIH HHS [R01 GM64781] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boesen T, 2004, J BIOL CHEM, V279, P10584, DOI 10.1074/jbc.M311055200; CIGAN AM, 1991, MOL CELL BIOL, V11, P3217, DOI 10.1128/MCB.11.6.3217; Das S, 2000, MOL CELL BIOL, V20, P3942, DOI 10.1128/MCB.20.11.3942-3950.2000; Das S, 1997, J BIOL CHEM, V272, P31712, DOI 10.1074/jbc.272.50.31712; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; Donahue TF, 2000, COLD SPRING HARBOR M, V39, P487; Endy D, 2003, NATURE, V426, P614, DOI 10.1038/426614a; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; HANNIG EM, 1993, MOL CELL BIOL, V13, P506, DOI 10.1128/MCB.13.1.506; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; KOONIN EV, 1995, PROTEIN SCI, V4, P1608, DOI 10.1002/pro.5560040819; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Nielsen KH, 2004, EMBO J, V23, P1166, DOI 10.1038/sj.emboj.7600116; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Paulin FEM, 2001, CURR BIOL, V11, P55, DOI 10.1016/S0960-9822(00)00025-7; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Valasek L, 1998, J BIOL CHEM, V273, P21253, DOI 10.1074/jbc.273.33.21253; Valasek L, 2003, GENE DEV, V17, P786, DOI 10.1101/gad.1065403; Valasek L, 2002, EMBO J, V21, P5886, DOI 10.1093/emboj/cdf563; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178; Zhou P, 2001, P NATL ACAD SCI USA, V98, P6051, DOI 10.1073/pnas.111145098	34	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49644	49655		10.1074/jbc.M409609200	http://dx.doi.org/10.1074/jbc.M409609200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377664	hybrid			2022-12-27	WOS:000225229500014
J	Tang, HL; Yeh, LS; Chen, NK; Ripmaster, T; Schimmel, P; Wang, CC				Tang, HL; Yeh, LS; Chen, NK; Ripmaster, T; Schimmel, P; Wang, CC			Translation of a yeast mitochondrial tRNA synthetase initiated at redundant non-AUG codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE ENCODES; MESSENGER-RNAS; PROTEIN; SELECTION; REGION; AMINOACYLATION; RECOGNITION; FEATURES; THALIANA	Although initiation of translation at non-AUG codons occurs occasionally in prokaryotes and higher eukaryotes, it has not been reported in yeast until very recently. Evidence presented here shows that redundant ACG codons are recognized as alternative translation start sites for ALA1, the only gene in Saccharomyces cerevisiae coding for alanyl-tRNA synthetase. ALA1 is shown to be a bifunctional gene that provides both cytoplasmic and mitochondrial activities. Unlike most bifunctional genes that contain alternative in-frame AUG initiators, there is only one AUG codon, designated AUG(1), close to the 5'-end of the ALA1 open reading frame. Transcriptional mapping identified three overlapping transcripts, with 5'-ends at positions 54, 105, and 117 nucleotides upstream of AUG(1), respectively. Site-specific mutagenesis demonstrated that the cytoplasmic and mitochondrial functions of ALA1 are provided by two protein isoforms with distinct amino termini; that is, a short cytoplasmic form initiated at AUG(1) and a longer mitochondrial isoform initiated at two upstream in-frame ACG codons, i.e. ACG(-25) and ACG(-24). These two ACG codons function redundantly in initiation of translation. Either codon can function in the absence of the other. The short transcript appears to serve as the template for the cytoplasmic form, whereas the longer transcripts are likely to code for both isoforms via alternative initiation. Because yeast ribosomes in general cannot efficiently recognize a non-AUG initiator, this unique feature of redundancy of non-AUG initiators in a single mRNA may in itself represent a novel paradigm for translation initiation from poor initiators.	Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Natl Cent Univ, Dept Life Sci, Chungli 32054, Taiwan; Tzu Chi Univ, Dept Life Sci, Hualien 97041, Taiwan; MIT, Dept Biol, Cambridge, MA 02139 USA	Scripps Research Institute; National Central University; Tzu Chi University; Massachusetts Institute of Technology (MIT)	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd,BCC-379, La Jolla, CA 92037 USA.	schimmel@scripps.edu; dukewang@cc.ncu.edu.tw			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23562] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramczyk D, 2003, YEAST, V20, P1045, DOI 10.1002/yea.1020; ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; DONAHUE TF, 1988, MOL CELL BIOL, V8, P2955, DOI 10.1128/MCB.8.7.2955; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; MARECHALDROUARD L, 1993, ANN REV CELL BIOL, V8, P115; Martinis SA, 1999, BIOCHIMIE, V81, P683, DOI 10.1016/S0300-9084(99)80126-6; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; Mireau H, 1996, PLANT CELL, V8, P1027, DOI 10.1105/tpc.8.6.1027; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; RIPMASTER TL, 1995, P NATL ACAD SCI USA, V92, P4932, DOI 10.1073/pnas.92.11.4932; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Sadler R, 1999, J VIROL, V73, P5722, DOI 10.1128/JVI.73.7.5722-5730.1999; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Schimmel P, 1999, TRENDS BIOCHEM SCI, V24, P127, DOI 10.1016/S0968-0004(99)01369-9; SHERMAN F, 1980, CELL, V20, P215, DOI 10.1016/0092-8674(80)90249-4; SIKORSKI RS, 1989, GENETICS, V122, P19; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Turner RJ, 2000, J BIOL CHEM, V275, P27681; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x	40	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49656	49663		10.1074/jbc.M408081200	http://dx.doi.org/10.1074/jbc.M408081200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15358761	hybrid			2022-12-27	WOS:000225229500015
J	Viney, TJ; Schmidt, TW; Gierasch, W; Sattar, AW; Yaggie, RE; Kuburas, A; Quinn, JP; Coulson, JM; Russo, AF				Viney, TJ; Schmidt, TW; Gierasch, W; Sattar, AW; Yaggie, RE; Kuburas, A; Quinn, JP; Coulson, JM; Russo, AF			Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UPSTREAM STIMULATORY FACTOR; HELIX-LOOP-HELIX; TRIGEMINAL GANGLIA NEURONS; ACID DECARBOXYLASE GENE; HUMAN CALCITONIN GENE; NUCLEAR FACTOR 3-BETA; TRANSCRIPTION FACTORS; DNA-BINDING; E-BOX; WINGED-HELIX	An 18-bp enhancer controls cell-specific expression of the calcitonin/calcitonin gene-related peptide gene. The enhancer is bound by a heterodimer of the bHLH-Zip protein USF-1 and -2 and a cell-specific factor from thyroid C cell lines. In this report we have identified the cell-specific factor as the forkhead protein Foxa2 (previously HNF-3beta). Binding of Foxa2 to the 18-bp enhancer was demonstrated using electrophoretic mobility shift assays. The cell-specific DNA-protein complex was selectively competed by a series of Foxa2 DNA binding sites, and the addition of Foxa2 antiserum supershifted the complex. Likewise, a complex similar to that seen with extracts from thyroid C cell lines was generated using an extract from heterologous cells expressing recombinant Foxa2. Interestingly, overexpression of Foxa2 activated the 18-bp enhancer in heterologous cells but only in the presence of the adjacent helix-loop-helix motif. Likewise, coexpression of USF proteins with Foxa2 yielded greater activation than by Foxa2 alone. Unexpectedly, Foxa2 overexpression repressed activity in the CA77 thyroid C cell line, suggesting that Foxa2 may interact with additional cofactors. The stimulatory role of Foxa2 at the calcitonin/calcitonin gene-related peptide gene enhancer was confirmed by short interfering RNA-mediated knockdown of Foxa2. As seen with Foxa2 overexpression, the effect of Foxa2 knockdown also required the adjacent helix-loop-helix motif. These results provide the first evidence for combinatorial control of gene expression by bHLH-Zip and forkhead proteins.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Liverpool, Dept Human Anat & Cell Biol, Liverpool L69 3GE, Merseyside, England	University of Iowa; University of Liverpool	Russo, AF (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	andrew-russo@uiowa.edu	; Quinn, John/A-2972-2010	Viney, Tim/0000-0001-6444-1188; Coulson, Judy/0000-0003-2191-2001; Russo, Andrew/0000-0002-8156-5649; Quinn, John/0000-0003-3551-7803	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025969] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 25969] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AGUANNO A, 1995, J NEUROCHEM, V65, P1944; Allander SV, 1997, ENDOCRINOLOGY, V138, P4291, DOI 10.1210/en.138.10.4291; BALL DW, 1992, NUCLEIC ACIDS RES, V20, P117, DOI 10.1093/nar/20.1.117; BRACQ S, 1993, FEBS LETT, V331, P15, DOI 10.1016/0014-5793(93)80288-6; BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0; Chen WG, 2003, J NEUROSCI, V23, P2572; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; COPP DH, 1992, ENDOCRINOLOGY, V131, P1007, DOI 10.1210/en.131.3.1007; COSTA RH, 1991, NUCLEIC ACIDS RES, V19, P4139, DOI 10.1093/nar/19.15.4139; Coulson JM, 2003, BIOCHEM J, V369, P549, DOI 10.1042/BJ20021176; Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Durham PL, 2000, MOL ENDOCRINOL, V14, P1570, DOI 10.1210/me.14.10.1570; Durham PL, 2004, BRAIN RES, V997, P103, DOI 10.1016/j.brainres.2003.11.005; Durham PL, 2003, J NEUROSCI, V23, P807; Durham PL, 1998, MOL ENDOCRINOL, V12, P1002, DOI 10.1210/me.12.7.1002; Edvinsson L, 2003, EXPERT OPIN THER TAR, V7, P377, DOI 10.1517/eott.7.3.377.22440; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FISHER RJ, 1992, J BIOL CHEM, V267, P17957; Foucher I, 2003, DEVELOPMENT, V130, P1867, DOI 10.1242/dev.00414; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Heckert LL, 2001, MOL ENDOCRINOL, V15, P704, DOI 10.1210/me.15.5.704; Hoff AO, 2002, J CLIN INVEST, V110, P1849, DOI 10.1172/JCI200214218; Ismail PM, 1999, ONCOGENE, V18, P5582, DOI 10.1038/sj.onc.1202932; Jacob A, 1997, EXP CELL RES, V234, P277, DOI 10.1006/excr.1997.3622; Kaestner KH, 2000, GENE DEV, V14, P142; Labosky PA, 1998, MECH DEVELOP, V76, P185, DOI 10.1016/S0925-4773(98)00105-1; Lanigan TM, 1997, J BIOL CHEM, V272, P18316, DOI 10.1074/jbc.272.29.18316; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; LILLYCROP KA, 1993, VIROLOGY, V196, P888, DOI 10.1006/viro.1993.1552; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; Martin CC, 2003, BIOCHEM J, V371, P675, DOI 10.1042/BJ20021585; MCCULLOCH J, 1986, P NATL ACAD SCI USA, V83, P5731, DOI 10.1073/pnas.83.15.5731; MCMAHON AP, 1994, CURR BIOL, V4, P903, DOI 10.1016/S0960-9822(00)00200-1; METZ R, 1991, ONCOGENE, V6, P2165; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; PELEG S, 1990, MOL ENDOCRINOL, V4, P1750, DOI 10.1210/mend-4-11-1750; PHILIPPE J, 1995, MOL ENDOCRINOL, V9, P368, DOI 10.1210/me.9.3.368; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; PREIBISZ JJ, 1993, AM J HYPERTENS, V6, P434, DOI 10.1093/ajh/6.5.434; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; Raynal JF, 1998, MOL BRAIN RES, V56, P227, DOI 10.1016/S0169-328X(98)00048-5; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; STOLARSKYFREDMAN L, 1990, MOL ENDOCRINOL, V4, P497, DOI 10.1210/mend-4-3-497; Tsay W, 1997, DNA CELL BIOL, V16, P569, DOI 10.1089/dna.1997.16.569; TVERBERG LA, 1993, J BIOL CHEM, V268, P15965; VanRossum D, 1997, NEUROSCI BIOBEHAV R, V21, P649, DOI 10.1016/S0149-7634(96)00023-1; Waeber C, 2003, NEUROLOGY, V61, pS9, DOI 10.1212/WNL.61.8_suppl_4.S9; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Zaidi M, 2002, J CLIN INVEST, V110, P1769, DOI 10.1172/JCI200217425	57	16	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49948	49955		10.1074/jbc.M406659200	http://dx.doi.org/10.1074/jbc.M406659200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385550	hybrid			2022-12-27	WOS:000225229500050
J	Yamaguchi, K; Lee, SH; Eling, TE; Baek, SJ				Yamaguchi, K; Lee, SH; Eling, TE; Baek, SJ			Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; BETA SUPERFAMILY MEMBER; COLON-CANCER CELLS; GROWTH-FACTOR-BETA; 3-KINASE INHIBITOR; MOLECULAR-CLONING; SIGNALING PATHWAY; CARCINOMA CELLS; KINASE 3-BETA; TUMOR-CELLS	The signaling pathway of phosphatidylinositol 3-kinase (PI3K)/AKT, which is involved in cell survival, proliferation, and growth, has become a major focus in targeting cancer therapeutics. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) was previously identified as a gene induced by several anti-tumorigenic compounds including nonsteroidal anti-inflammatory drugs, peroxisome proliferator-activated receptor gamma ligands, and dietary compounds. NAG-1 has been shown to exhibit anti-tumorigenic and/or pro-apoptotic activities in vivo and in vitro. In this report, we showed a PI3K/AKT/glycogen synthase kinase-3beta (GSK-3beta) pathway regulates NAG-1 expression in human colorectal cancer cells as assessed by the inhibition of PI3K, AKT, and GSK-3beta. PI3K inhibition by LY294002 showed an increase in NAG-1 protein and mRNA expression, and 1L-6-hydroxymethyl-chiroinositol 2(R)-2-O-methyl-3-O-octadecylcarbonate (AKT inhibitor) also induced NAG-1 expression. LY294002 caused increased apoptosis, cell cycle, and cell growth arrest in HCT-116 cells. Inhibition of GSK-3beta, which is negatively regulated by AKT, using AR-A014418 and lithium chloride completely abolished LY294002-induced NAG-1 expression as well as the NAG-1 promoter activity. Furthermore, the down-regulation of GSK-3 gene using small interference RNA resulted in a decline of the NAG-1 expression in the presence of LY294002. These data suggest that expression of NAG-1 is regulated by PI3K/AKT/GSK-3beta pathway in HCT-116 cells and may provide a further understanding of the important role of PI3K/AKT/GSK-3beta pathway in tumorigenesis.	Univ Tennessee, Coll Vet Med, Dept Pathobiol, Lab Environm Carcinogensis, Knoxville, TN 37996 USA; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Baek, SJ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Pathobiol, Lab Environm Carcinogensis, 2407 River Dr, Knoxville, TN 37996 USA.	sbaek2@utk.edu		Baek, Seung/0000-0001-7866-7778	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011657] Funding Source: NIH RePORTER; NIEHS NIH HHS [K22ES011657] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Baek SJ, 2004, J BIOL CHEM, V279, P6883, DOI 10.1074/jbc.M305295200; Baek SJ, 2002, J PHARMACOL EXP THER, V301, P1126, DOI 10.1124/jpet.301.3.1126; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baek SJ, 2001, J BIOL CHEM, V276, P33384, DOI 10.1074/jbc.M101814200; Baek SJ, 2001, MOL PHARMACOL, V59, P901, DOI 10.1124/mol.59.4.901; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bottone FG, 2002, J NUTR, V132, P773, DOI 10.1093/jn/132.4.773; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Casagrande F, 1998, FEBS LETT, V422, P385, DOI 10.1016/S0014-5793(98)00043-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Izuishi K, 2000, CANCER RES, V60, P6201; Khaleghpour K, 2004, CARCINOGENESIS, V25, P241, DOI 10.1093/carcin/bgg195; Kim KS, 2002, GASTROENTEROLOGY, V122, P1388, DOI 10.1053/gast.2002.32972; Krystal GW, 2002, MOL CANCER THER, V1, P913; Kulik G, 2001, CANCER RES, V61, P2713; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Li PX, 2000, J BIOL CHEM, V275, P20127, DOI 10.1074/jbc.M909580199; Liu T, 2003, CANCER RES, V63, P5034; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Monks A, 2003, MOL PHARMACOL, V63, P766, DOI 10.1124/mol.63.3.766; Newman D, 2003, MOL PHARMACOL, V63, P557, DOI 10.1124/mol.63.3.557; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Semba S, 2002, CLIN CANCER RES, V8, P1957; Sheng HM, 2001, J BIOL CHEM, V276, P18075, DOI 10.1074/jbc.M009689200; Shingu T, 2003, CANCER RES, V63, P4044; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200; Wilson LC, 2003, INT J CANCER, V105, P747, DOI 10.1002/ijc.11173; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	42	89	97	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49617	49623		10.1074/jbc.M408796200	http://dx.doi.org/10.1074/jbc.M408796200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377673	hybrid			2022-12-27	WOS:000225229500011
J	Antoniacci, LM; Kenna, MA; Uetz, P; Fields, S; Skibbens, RV				Antoniacci, LM; Kenna, MA; Uetz, P; Fields, S; Skibbens, RV			The spindle pole body assembly component Mps3p/Nep98p functions in sister chromatid cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR DIVISION; DNA-REPLICATION; YEAST; PROTEIN; CHROMOSOME; COMPLEX; GENOME; IDENTIFICATION; ESTABLISHMENT	For successful chromosome segregation during mitosis, several processes must occur early in the cell cycle, including spindle pole duplication, DNA replication, and the establishment of cohesion between nascent sister chromatids. Spindle pole body duplication begins in G(1) and continues during early S-phase as spindle pole bodies mature and start to separate. Key steps in spindle pole body duplication are the sequential recruitment of Cdc31p and Spc42p by the nuclear envelope transmembrane protein Msp3p/Nep98p (herein termed Mps3p). Concurrent with DNA replication, Ctf7p/Eco1p (herein termed Ctf7p) ensures that nascent sister chromatids are paired together, identifying the products of replication as sister chromatids. Here, we provide the first evidence that the nuclear envelope spindle pole body assembly component Mps3p performs a function critical to sister chromatid cohesion. Mps3p was identified as interacting with Ctf7p from a genome-wide two-hybrid screen, and the physical interaction was confirmed by both in vivo (co-immunoprecipitation) and in vitro (GST pull-down) assays. An in vivo cohesion assay on new mps3/nep98 alleles revealed that loss of Mps3p results in precocious sister chromatid separation and that Mps3p functions after G(1), coincident with Ctf7p. Mps3p is not required for cohesion during mitosis, revealing that Mps3p functions in cohesion establishment and not maintenance. Mutated Mps3p that results in cohesion defects no longer binds to Ctf7p in vitro, demonstrating that the interaction between Mps3p and Ctf7p is physiologically relevant. In support of this model, mps3 ctf7 double mutant cells exhibit conditional synthetic lethality. These findings document a new role for Mps3p in sister chromatid cohesion and provide novel insights into the mechanism by which a spindle pole body component, when mutated, contributes to aneuploidy.	Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genet, Seattle, WA 98195 USA	Lehigh University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@Lehigh.edu	Uetz, Peter/A-7119-2012	Uetz, Peter/0000-0001-6194-4927	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adams IR, 2000, TRENDS CELL BIOL, V10, P329, DOI 10.1016/S0962-8924(00)01798-0; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brosh RM, 2002, EXP GERONTOL, V37, P491, DOI 10.1016/S0531-5565(01)00227-3; Cassimeris Lynne, 2003, Current Issues in Molecular Biology, V5, P99; Castillo AR, 2002, J CELL BIOL, V156, P453, DOI 10.1083/jcb.200111025; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cohen-Fix O, 2001, CELL, V106, P137, DOI 10.1016/S0092-8674(01)00439-1; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Francis SE, 2000, CURR TOP DEV BIOL, V49, P105; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; James P, 1996, GENETICS, V144, P1425; Jasperson SL, 2002, J CELL BIOL, V159, P945, DOI 10.1083/jcb.200208169; KASSENBROCK CK, 1993, EMBO J, V12, P3023, DOI 10.1002/j.1460-2075.1993.tb05971.x; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Krause SA, 2001, MOL CELL BIOL, V21, P5156, DOI 10.1128/MCB.21.15.5156-5168.2001; KURLANDZKA A, 1995, YEAST, V11, P885, DOI 10.1002/yea.320110910; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nishikawa S, 2003, J BIOL CHEM, V278, P9938, DOI 10.1074/jbc.M210934200; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Skibbens RV, 2000, GENOME RES, V10, P1664, DOI 10.1101/gr.153600; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Teixeira MT, 2002, J MOL BIOL, V321, P551, DOI 10.1016/S0022-2836(02)00652-6; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99	51	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49542	49550		10.1074/jbc.M404324200	http://dx.doi.org/10.1074/jbc.M404324200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355977	hybrid			2022-12-27	WOS:000225098100125
J	Lee, M; Kim, JY; Anderson, WB				Lee, M; Kim, JY; Anderson, WB			Src tyrosine kinase inhibitor PP2 markedly enhances Ras-independent activation of Raf-1 protein kinase by phorbol myristate acetate and H2O2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; HYDROGEN-PEROXIDE; PHOSPHORYLATION SITES; C-EPSILON; B-RAF; TRANSDUCTION; SERINE; REQUIREMENT; MEMBRANE; RECEPTOR	Recently we reported that simultaneous treatment of NIH 3T3 cells with the combination of phorbol myristate acetate (PMA) and hydrogen peroxide (H2O2) resulted in synergistic activation of Raf-1 kinase ( Lee, M., Petrovics, G., and Anderson, W. B. ( 2003) Biochem. Biophys. Res. Commun. 311, 1026 - 1033). In this study we have demonstrated that PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d] pyrimidine), a potent and selective inhibitor of the Src-family tyrosine kinase, greatly potentiated the ability of PMA and/or H2O2 to activate Raf-1 kinase, whereas it blocked the tyrosine phosphorylation of Raf-1. Unlike PMA/H2O2 treatment, which showed transient activation, PP2-mediated Raf-1 activation was sustained and continued to increase through 4 h of treatment. Transient transfection studies with a dominant-negative mutant of Ras (N19Ras) indicated that this PP2-induced activation of Raf-1 was Ras-independent. Moreover, PP2 showed no effect on platelet-derived growth factor-induced Raf-1 activation. Interestingly, mutation of the reported Raf-1 Src family tyrosine kinase phosphorylation site by conversion of tyrosines 340 and 341 to phenylalanine (YY340/341FF Raf) had limited effect on the ability of PP2 to induce significant stimulation of Raf-1 kinase activity. Taken together, our results suggest that a tyrosine phosphorylation event is involved in the negative feedback regulation of Raf-1. Inhibition of a Src family tyrosine kinase by PP2 appears to alleviate this tyrosine kinase-mediated inhibition of Raf-1 and allow activating modification( s) of Raf-1 to proceed. This PP2 effect resulted in significant and sustained Ras-independent activation of Raf-1 by PMA and H2O2.	Korea Res Inst Chem Technol, Korea Inst Toxicol, Lab Genet Toxicol, Taejon 305600, South Korea; NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA	Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Anderson, WB (corresponding author), Korea Res Inst Chem Technol, Korea Inst Toxicol, Lab Genet Toxicol, POB 123, Taejon 305600, South Korea.	mikelee@kitox.re.kr						Abe MK, 1998, AM J RESP CELL MOL, V18, P562, DOI 10.1165/ajrcmb.18.4.2958; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; ANDERSON WB, 1995, ADV CYCLIC NUCLEOTID, V19, P287; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Bjorkoy G, 1997, J BIOL CHEM, V272, P11557; Cacace AM, 1996, ONCOGENE, V13, P2517; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Ferrier AF, 1997, J BIOL CHEM, V272, P2136; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; GERHARD C, 2003, NAT CELL BIOL, V5, P377; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hindley A, 2002, J CELL SCI, V115, P1575; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jelinek T, 1996, MOL CELL BIOL, V16, P1027; Kasid U, 1996, NATURE, V382, P813, DOI 10.1038/382813a0; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; Laird AD, 1999, J BIOL CHEM, V274, P4430, DOI 10.1074/jbc.274.7.4430; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee M, 2003, BIOCHEM BIOPH RES CO, V311, P1026, DOI 10.1016/j.bbrc.2003.10.107; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL M, 1995, MOL REPROD DEV, V42, P493, DOI 10.1002/mrd.1080420418; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; MORRISON DK, 1995, MOL REPROD DEV, V42, P507, DOI 10.1002/mrd.1080420420; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Morrison DK, 2001, J CELL SCI, V114, P1609; Morrison P, 1996, J BIOL CHEM, V271, P12891, DOI 10.1074/jbc.271.22.12891; MURAKAMI MS, 2001, SCI STKE; Natarajan V, 1998, ENVIRON HEALTH PERSP, V106, P1205, DOI 10.2307/3433987; OLAH Z, 1995, BIOCHEM BIOPH RES CO, V214, P340, DOI 10.1006/bbrc.1995.2293; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; PREISS J, 1986, J BIOL CHEM, V261, P8597; Raabe T, 2003, CURR BIOL, V13, pR635, DOI 10.1016/S0960-9822(03)00568-2; Rao GN, 1996, ONCOGENE, V13, P713; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schwartzberg PL, 1998, ONCOGENE, V17, P1463, DOI 10.1038/sj.onc.1202176; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Ueffing M, 1997, ONCOGENE, V15, P2921, DOI 10.1038/sj.onc.1201477; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zimmermann S, 1997, ONCOGENE, V15, P1503, DOI 10.1038/sj.onc.1201322; Ziogas A, 1998, J BIOL CHEM, V273, P24108, DOI 10.1074/jbc.273.37.24108; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	76	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48692	48701		10.1074/jbc.M403132200	http://dx.doi.org/10.1074/jbc.M403132200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15356004	hybrid			2022-12-27	WOS:000225098100026
J	Macauley, MS; Errington, WJ; Okon, M; Scharpf, M; Mackereth, CD; Schulman, BA; McIntosh, LP				Macauley, MS; Errington, WJ; Okon, M; Scharpf, M; Mackereth, CD; Schulman, BA; McIntosh, LP			Structural and dynamic independence of isopeptide-linked RanGAP1 and SUMO-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; MOLYBDOPTERIN SYNTHASE; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; UBIQUITIN; BINDING; UBC9; NMR; IDENTIFICATION; COMPLEX	Although sumoylation regulates a diverse and growing number of recognized biological processes, the molecular mechanisms by which the covalent attachment of the ubiquitin-like protein SUMO can alter the properties of a target protein remain to be established. To address this question, we have used NMR spectroscopy to characterize the complex of mature SUMO-1 with the C-terminal domain of human RanGAP1. Based on amide chemical shift and N-15 relaxation measurements, we show that the C terminus of SUMO-1 and the loop containing the consensus sumoylation site in RanGAP1 are both conformationally flexible. Furthermore, the overall structure and backbone dynamics of each protein remain unchanged upon the covalent linkage of Lys(524) in RanGAP1 to the C-terminal Gly(97) of SUMO-1. Therefore, SUMO-1 and RanGAP1 behave as "beads-on-a-string," connected by a flexible isopeptide tether. Accordingly, the sumoylation-dependent interaction of RanGAP1 with the nucleoporin RanBP2 may arise through the bipartite recognition of both RanGAP1 and SUMO-1 rather than through a new binding surface induced in either individual protein upon their covalent linkage. We hypothesize that this conformational flexibility may be a general feature contributing to the recognition of ubiquitin-like modified proteins by their downstream effector machineries.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada; St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA	University of British Columbia; University of British Columbia; University of British Columbia; St Jude Children's Research Hospital; St Jude Children's Research Hospital	McIntosh, LP (corresponding author), Univ British Columbia, Dept Biochem, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintosh@otter.biochem.ubc.ca	Mackereth, Cameron D./F-7946-2013	Mackereth, Cameron D./0000-0002-0776-7947; Macauley, Matthew/0000-0003-4579-1048	NIGMS NIH HHS [R01GM69530] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; COOK WJ, 1992, J BIOL CHEM, V267, P16467; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fuchs Serge Y, 2002, Cell, V110, P531, DOI 10.1016/S0092-8674(02)00902-9; Goddard T. D., 1999, SPARKY; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Jin CW, 2001, INT J BIOL MACROMOL, V28, P227, DOI 10.1016/S0141-8130(00)00169-0; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; MCINTOSH LP, 1990, Q REV BIOPHYS, V23, P1, DOI 10.1017/S0033583500005400; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rudolph MJ, 2003, J BIOL CHEM, V278, P14514, DOI 10.1074/jbc.M300449200; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wagner G, 1997, NAT STRUCT BIOL, V4, P841; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	46	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49131	49137		10.1074/jbc.M408705200	http://dx.doi.org/10.1074/jbc.M408705200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355965	hybrid			2022-12-27	WOS:000225098100078
J	Okamoto, H; Watanabe, K; Ikeuchi, Y; Suzuki, T; Endo, Y; Hori, H				Okamoto, H; Watanabe, K; Ikeuchi, Y; Suzuki, T; Endo, Y; Hori, H			Substrate tRNA recognition mechanism of tRNA (m(7)G46) methyltransferase from Aquifex aeolicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TRANSFER-RNA; ANTICODON WOBBLE POSITION; ESCHERICHIA-COLI; PSEUDOURIDINE-SYNTHASE; GUANINE TRANSGLYCOSYLASE; SACCHAROMYCES-CEREVISIAE; GM18 METHYLTRANSFERASE; MODIFICATION DATABASE; NUCLEOTIDE-SEQUENCE; MODIFICATION ENZYME	Transfer RNA (m(7)G46) methyltransferase catalyzes the methyl transfer from S-adenosylmethionine to N-7 atom of the guanine 46 residue in tRNA. Analysis of the Aquifex aeolicus genome revealed one candidate open reading frame, aq065, encoding this gene. The aq065 protein was expressed in Escherichia coli and purified to homogeneity on 15% SDS-polyacrylamide gel electrophoresis. Although the overall amino acid sequence of the aq065 protein differs considerably from that of E. coli YggH, the purified aq065 protein possessed a tRNA (m(7)G46) methyltransferase activity. The modified nucleoside and its location were determined by liquid chromatography-mass spectroscopy. To clarify the RNA recognition mechanism of the enzyme, we investigated the methyl transfer activity to 28 variants of yeast tRNA(Phe) and E. coli tRNA(Thr). It was confirmed that 5'-leader and 3'-trailer RNAs of tRNA precursor are not required for the methyl transfer. We found that the enzyme specificity was critically dependent on the size of the variable loop. Experiments using truncated variants showed that the variable loop sequence inserted between two stems is recognized as a substrate, and the most important recognition site is contained within the T stem. These results indicate that the L-shaped tRNA structure is not required for methyl acceptance activity. It was also found that nucleotide substitutions around G46 in three-dimensional core decrease the activity.	Ehime Univ, Fac Engn, Dept Appl Chem, Matsuyama, Ehime 7908577, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Kashiwa, Chiba 2778562, Japan; Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan	Ehime University; University of Tokyo; Ehime University; Ehime University	Hori, H (corresponding author), Ehime Univ, Fac Engn, Dept Appl Chem, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Suzuki, Tsutomu/J-1776-2015; ikeuchi, yoshiho/C-1713-2014; Ikeuchi, Yoshiho/N-1057-2019; Hori, Hiroyuki/AAB-3911-2021	Suzuki, Tsutomu/0000-0002-9731-1731; ikeuchi, yoshiho/0000-0002-2829-3840; 				Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019; Ansmant I, 2001, J BIOL CHEM, V276, P34934, DOI 10.1074/jbc.M103131200; ASCHHOFF HJ, 1976, NUCLEIC ACIDS RES, V3, P3109, DOI 10.1093/nar/3.11.3109; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; Benne R., 1998, MODIFICATION EDITING, P543; Bjork Glenn R., 1995, P165; Bjork GR, 1992, TRANSFER RNA PROTEIN, P23; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P353; CARBON P, 1983, EMBO J, V2, P1093, DOI 10.1002/j.1460-2075.1983.tb01551.x; CHANG S, 1975, J BIOL CHEM, V250, P5542; CIMINO F, 1981, MOL CELL BIOCHEM, V36, P95, DOI 10.1007/BF02354908; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; De Bie LGS, 2003, J BACTERIOL, V185, P3238, DOI 10.1128/JB.185.10.3238-3243.2003; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DRABKIN HJ, 1985, J BIOL CHEM, V260, P5580; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; DROOGMANS L, 1986, EMBO J, V5, P1105, DOI 10.1002/j.1460-2075.1986.tb04329.x; EDQVIST J, 1993, NUCLEIC ACIDS RES, V21, P413, DOI 10.1093/nar/21.3.413; EDQVIST J, 1992, NUCLEIC ACIDS RES, V20, P6575, DOI 10.1093/nar/20.24.6575; GARCIA GR, 1998, MODIFICATION EDITING, P555; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; GU XG, 1994, BIOCHEMISTRY-US, V33, P2255, DOI 10.1021/bi00174a036; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; Hori H, 1998, J BIOL CHEM, V273, P25721, DOI 10.1074/jbc.273.40.25721; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; HURWITZ J, 1964, J BIOL CHEM, V239, P3474; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; JAKAB G, 1990, NUCLEIC ACIDS RES, V18, P7444, DOI 10.1093/nar/18.24.7444; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KOSKI RA, 1982, J BIOL CHEM, V257, P4514; Kung FL, 2000, RNA, V6, P233, DOI 10.1017/S135583820099191X; Lecointe F, 1998, J BIOL CHEM, V273, P1316, DOI 10.1074/jbc.273.3.1316; Li JN, 1999, RNA, V5, P395, DOI 10.1017/S1355838299980834; Matsuyama S, 1998, J BIOL CHEM, V273, P3363, DOI 10.1074/jbc.273.6.3363; McCloskey JA, 1998, NUCLEIC ACIDS RES, V26, P196, DOI 10.1093/nar/26.1.196; MELTON DA, 1980, NATURE, V284, P143, DOI 10.1038/284143a0; MOROZOV IA, 1982, EUR J BIOCHEM, V129, P429, DOI 10.1111/j.1432-1033.1982.tb07068.x; Motorin Y, 1998, RNA, V4, P856, DOI 10.1017/S1355838298980396; Motorin Y, 1999, RNA, V5, P1105, DOI 10.1017/S1355838299982201; NAKANISHI S, 1994, J BIOL CHEM, V269, P32221; Ohtsuki T, 1998, J BIOCHEM-TOKYO, V124, P28, DOI 10.1093/oxfordjournals.jbchem.a022092; Pan H, 2003, P NATL ACAD SCI USA, V100, P12648, DOI 10.1073/pnas.2135585100; Phannachet K, 2004, NUCLEIC ACIDS RES, V32, P1422, DOI 10.1093/nar/gkh287; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; Redlak M, 1997, BIOCHEMISTRY-US, V36, P8699, DOI 10.1021/bi9701538; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Roovers M, 2004, NUCLEIC ACIDS RES, V32, P465, DOI 10.1093/nar/gkh191; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Soderberg T, 2000, BIOCHEMISTRY-US, V39, P6546, DOI 10.1021/bi992775u; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; STANGE N, 1987, EMBO J, V6, P2811, DOI 10.1002/j.1460-2075.1987.tb02577.x; Tomita K, 1998, BBA-GENE STRUCT EXPR, V1399, P78, DOI 10.1016/S0167-4781(98)00099-2; Watanabe M, 2001, J BIOL CHEM, V276, P2387, DOI 10.1074/jbc.M005043200; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; Xie W, 2003, NAT STRUCT BIOL, V10, P781, DOI 10.1038/nsb976	59	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49151	49159		10.1074/jbc.M408209200	http://dx.doi.org/10.1074/jbc.M408209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358762	hybrid			2022-12-27	WOS:000225098100080
J	Seaver, LC; Imlay, JA				Seaver, LC; Imlay, JA			Are respiratory enzymes the primary sources of intracellular hydrogen peroxide?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; ESCHERICHIA-COLI K-12; MANGANESE-SUPEROXIDE-DISMUTASE; CATALYZED CHAIN OXIDATION; FUMARATE REDUCTASE; POSITIVE REGULATOR; REDUCED FLAVINS; DNA-DAMAGE; OXYGEN; RADICALS	Endogenous H2O2 is believed to be a source of chronic damage in aerobic organisms. To quantify H2O2 formation, we have generated strains of Escherichia coli that lack intracellular scavenging enzymes. The H2O2 that is formed within these mutants diffuses out into the medium, where it can be measured. We sought to test the prevailing hypothesis that this H2O2 is primarily generated by the autoxidation of redox enzymes within the respiratory chain. The rate of H2O2 production increased when oxygen levels were raised, confirming that H2O2 is formed by an adventitious chemical process. However, mutants that lacked NADH dehydrogenase II and fumarate reductase, the most oxidizable components of the respiratory chain in vitro, continued to form H2O2 at normal rates. NADH dehydrogenase II did generate substantial H2O2 when it was overproduced or when quinones were absent, forcing electrons to accumulate on the enzyme. Mutants that lacked both NADH dehydrogenases respired very slowly, as expected; however, these mutants showed no diminution of H2O2 excretion, suggesting that H2O2 is primarily formed by a source outside the respiratory chain. That source has not yet been identified. In respiring cells the rate of H2O2 production was similar to0.5% the rate of total oxygen consumption, with only modest changes when cells used different carbon sources.	Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	jimlay@uiuc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049640, R01GM049640] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49640, GM07283] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; BIELSKI BHJ, 1976, J BIOL CHEM, V251, P3841; BLAUT M, 1989, J BIOL CHEM, V264, P13599; BOLING M, 1984, J BACTERIOL, V160, P706, DOI 10.1128/JB.160.2.706-710.1984; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1982, SUPEROXIDE DISMUTASE, V2, P15; CALHOUN MW, 1993, J BACTERIOL, V175, P3013, DOI 10.1128/JB.175.10.3013-3019.1993; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CHAN PC, 1980, J BIOL CHEM, V255, P874; CHAN PC, 1974, J BIOL CHEM, V249, P1317; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHANG EC, 1991, J BIOL CHEM, V266, P4417; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Fridovich I, 2004, AGING CELL, V3, P13, DOI 10.1046/j.1474-9728.2003.00075.x; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P92; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; GARDNER PR, 1991, J BIOL CHEM, V266, P1478; GAUDU P, 1994, J BIOL CHEM, V269, P8182; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; KUO CF, 1987, J BIOL CHEM, V262, P4724; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LIOCHEV SI, 1992, P NATL ACAD SCI USA, V89, P5892, DOI 10.1073/pnas.89.13.5892; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Messner KR, 1999, J BIOL CHEM, V274, P10119, DOI 10.1074/jbc.274.15.10119; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Miller JH, 1972, EXPT MOL GENETICS, P201; MORIMYO M, 1982, J BACTERIOL, V152, P208; NAQUI A, 1986, ANNU REV BIOCHEM, V55, P137, DOI 10.1146/annurev.biochem.55.1.137; SAKAMOTO H, 1984, J BACTERIOL, V159, P418, DOI 10.1128/JB.159.1.418-420.1984; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Staniek K, 1999, BBA-BIOENERGETICS, V1413, P70, DOI 10.1016/S0005-2728(99)00083-3; Staniek K, 2000, BBA-BIOENERGETICS, V1460, P268, DOI 10.1016/S0005-2728(00)00152-3; THORNALLEY P, 1984, BIOCHIM BIOPHYS ACTA, V797, P276, DOI 10.1016/0304-4165(84)90131-4; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P75, DOI 10.1016/0005-2728(77)90070-6; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; WANNER BL, 1986, J MOL BIOL, V191, P39, DOI 10.1016/0022-2836(86)90421-3; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Yamashita M, 1996, J BACTERIOL, V178, P2941, DOI 10.1128/jb.178.10.2941-2947.1996	56	157	165	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48742	48750		10.1074/jbc.M408754200	http://dx.doi.org/10.1074/jbc.M408754200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15361522	hybrid			2022-12-27	WOS:000225098100032
J	De Genst, E; Handelberg, F; Van Meirhaeghe, A; Vynck, S; Loris, R; Wyns, L; Muyldermans, S				De Genst, E; Handelberg, F; Van Meirhaeghe, A; Vynck, S; Loris, R; Wyns, L; Muyldermans, S			Chemical basis for the affinity maturation of a camel single domain antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ANTIBODIES; PROTEIN-PROTEIN INTERACTIONS; SOMATIC HYPERMUTATION; EXPERIMENTAL-DESIGN; COMBINING SITE; FREE-ENERGY; ANTIGEN; BINDING; CRYSTALLOGRAPHY; RECOGNITION	Affinity maturation of classic antibodies supposedly proceeds through the pre-organization of the reactive germ line conformational isomer. It is less evident to foresee how this can be accomplished by camelid heavy-chain antibodies lacking light chains. Although these antibodies are subjected to somatic hypermutation, their antigen-binding fragment consists of a single domain with restricted flexibility in favor of binding energy. An antigen-binding domain derived from a dromedary heavy-chain antibody, cAb-Lys3, accumulated five amino acid substitutions in CDR1 and CDR2 upon maturation against lysozyme. Three of these residues have hydrophobic side chains, replacing serines, and participate in the hydrophobic core of the CDR1 in the mature antibody, suggesting that conformational rearrangements might occur in this loop during maturation. However, transition state analysis of the binding kinetics of mature cAb-Lys3 and germ line variants show that the maturation of this antibody relies on events late in the reaction pathway. This is reflected by a limited perturbation of k(a) and a significantly decreased k(d) upon maturation. In addition, binding reactions and the maturation event are predominantly enthalpically driven. Therefore, maturation proceeds through the increase of favorable binding interactions, or by the reduction of the enthalpic penalty for desolvation, as opposed to large entropic penalties associated with conformational changes and structural plasticity. Furthermore, the crystal structure of the mutant with a restored germ line CDR2 sequence illustrates that the matured hydrophobic core of CDR1 in cAb-Lys3 might be compensated in the germ line precursor by burying solvent molecules engaged in a stable hydrogen-bonding network with CDR1 and CDR2.	Free Univ Brussels VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	De Genst, E (corresponding author), Free Univ Brussels VIB, Dept Mol & Cellular Interact, Pleinlaan 2, B-1050 Brussels, Belgium.	edegenst@vub.ac.be	Muyldermans, Serge V/C-6418-2016; Loris, Remy/GPG-0894-2022; Muyldermans, Serge/AAC-7374-2019	Muyldermans, Serge V/0000-0002-3678-3575; Muyldermans, Serge/0000-0002-3678-3575; Loris, Remy/0000-0002-8862-3338				Bond CJ, 2003, J MOL BIOL, V332, P643, DOI 10.1016/S0022-2836(03)00967-7; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cauerhff A, 2004, P NATL ACAD SCI USA, V101, P3539, DOI 10.1073/pnas.0400060101; Chong LT, 1999, P NATL ACAD SCI USA, V96, P14330, DOI 10.1073/pnas.96.25.14330; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; De Genst E, 2002, J BIOL CHEM, V277, P29897, DOI 10.1074/jbc.M202359200; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Decanniere K, 2000, J MOL BIOL, V300, P83, DOI 10.1006/jmbi.2000.3839; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; ITO W, 1995, J MOL BIOL, V248, P729, DOI 10.1006/jmbi.1995.0255; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kabat EA, 1991, SEQUENCES PROTEINS I; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Milstein C, 1996, ADV PROTEIN CHEM, V49, P451, DOI 10.1016/S0065-3233(08)60494-5; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Weill JC, 1996, IMMUNOL TODAY, V17, P92, DOI 10.1016/0167-5699(96)80586-X; Yang PL, 1999, J MOL BIOL, V294, P1191, DOI 10.1006/jmbi.1999.3197	33	56	64	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53593	53601		10.1074/jbc.M407843200	http://dx.doi.org/10.1074/jbc.M407843200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15383540	hybrid			2022-12-27	WOS:000225680600095
J	Holst, B; Holliday, ND; Bach, A; Elling, CE; Cox, HM; Schwartz, TW				Holst, B; Holliday, ND; Bach, A; Elling, CE; Cox, HM; Schwartz, TW			Common structural basis for constitutive activity of the ghrelin receptor family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GROWTH-HORMONE SECRETAGOGUE; DEPENDENT GENE-EXPRESSION; CANNABINOID CB1 RECEPTORS; SERUM RESPONSE FACTOR; LIGAND-BINDING SITES; NEURITE RETRACTION; SIGNALING PATHWAYS; INVERSE AGONISM; ENDOCYTOSIS	Three members of the ghrelin receptor family were characterized in parallel: the ghrelin receptor, the neurotensin receptor 2 and the orphan receptor GPR39. In transiently transfected COS-7 and human embryonic kidney 293 cells, all three receptors displayed a high degree of ligand-independent signaling activity. The structurally homologous motilin receptor served as a constitutively silent control; upon agonist stimulation, however, it signaled with a similar efficacy to the three related receptors. The constitutive activity of the ghrelin receptor and of neurotensin receptor 2 through the G(q), phospholipase C pathway was similar to50% of their maximal capacity as determined through inositol phosphate accumulation. These two receptors also showed very high constitutive activity in activation of cAMP response element-driven transcription. GPR39 displayed a clear but lower degree of constitutive activity through the inositol phosphate and cAMP response element pathways. In contrast, GPR39 signaled with the highest constitutive activity in respect of activation of serum response element-dependent transcription, in part, possibly, through G(12/13) and Rho kinase. Antibody feeding experiments demonstrated that the epitope-tagged ghrelin receptor was constitutively internalized but could be trapped at the cell surface by an inverse agonist, whereas GPR39 remained at the cell surface. Mutational analysis showed that the constitutive activity of both the ghrelin receptor and GPR39 could systematically be tuned up and down depending on the size and hydrophobicity of the side chain in position VI: 16 in the context of an aromatic residue at VII:09 and a large hydrophobic residue at VII:06. It is concluded that the three ghrelin-like receptors display an unusually high degree of constitutive activity, the structural basis for which is determined by an aromatic cluster on the inner face of the extracellular ends of TMs VI and VII.	Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, DK-2200 Copenhagen, Denmark; Kings Coll London, Ctr Res Neurosci, London SE1 1UL, England; 7TM Pharma AS, DK-2970 Horsholm, Denmark	University of Copenhagen; University of London; King's College London	Holst, B (corresponding author), Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	b.holst@molpharm.dk	Cox, Helen M/F-2783-2015; Holliday, Nicholas/A-3607-2009	Holst, Birgitte/0000-0001-7432-097X; Cox, Helen/0000-0001-9024-1497; Schwartz, Thue W./0000-0002-0261-6904; Bach, Anders/0000-0003-4305-9910; Holliday, Nicholas/0000-0002-2900-828X				Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; Choi KC, 2003, ENDOCRINOLOGY, V144, P754, DOI 10.1210/en.2002-220783; Dobner PR, 2003, LIFE SCI, V73, P801, DOI 10.1016/S0024-3205(03)00411-9; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; FARRENS DL, 1996, SCIENCE, V274, P468; Filipek S, 2003, ANNU REV BIOPH BIOM, V32, P375, DOI 10.1146/annurev.biophys.32.110601.142520; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gruijthuijsen YK, 2002, J VIROL, V76, P1328, DOI 10.1128/JVI.76.3.1328-1338.2002; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Holst B, 2003, ANN NY ACAD SCI, V994, P1, DOI 10.1111/j.1749-6632.2003.tb03156.x; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Katoh H, 1998, J BIOL CHEM, V273, P28700, DOI 10.1074/jbc.273.44.28700; Kim MS, 2003, NEUROREPORT, V14, P1317, DOI [10.1097/01.wnr.0000078703.79393.d2, 10.1097/00001756-200307180-00006]; Kim MS, 2004, MOL ENDOCRINOL, V18, P2291, DOI 10.1210/me.2003-0459; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; McKee KK, 1997, GENOMICS, V46, P426, DOI 10.1006/geno.1997.5069; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Miserey-Lenkei S, 2002, J BIOL CHEM, V277, P5891, DOI 10.1074/jbc.M108398200; Nagle DL, 1999, NATURE, V398, P148, DOI 10.1038/18210; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Ponimaskin EG, 2002, J BIOL CHEM, V277, P20812, DOI 10.1074/jbc.M112216200; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Richard F, 2001, MOL PHARMACOL, V60, P1392, DOI 10.1124/mol.60.6.1392; Rosenkilde MM, 2000, J BIOL CHEM, V275, P26309, DOI 10.1074/jbc.M003800200; ROSENKILDE MM, 2004, HDB CELL SIGNALING; Savinainen JR, 2003, BRIT J PHARMACOL, V140, P1451, DOI 10.1038/sj.bjp.0705577; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 2002, NATURE, V418, P595, DOI 10.1038/418595a; Schwartz T.W., 2002, TXB RECEPTOR PHARM, P81; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Singh LP, 2001, DIABETES, V50, P2355, DOI 10.2337/diabetes.50.10.2355; Smit MJ, 2002, J VIROL, V76, P1744, DOI 10.1128/JVI.76.4.1744-1752.2002; Smith RG, 2001, ENDOCRINE, V14, P9, DOI 10.1385/ENDO:14:1:009; Sodhi A, 2000, CANCER RES, V60, P4873; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Waldhoer M, 2003, J BIOL CHEM, V278, P19473, DOI 10.1074/jbc.M213179200; Whistler JL, 2002, TRAFFIC, V3, P866, DOI 10.1034/j.1600-0854.2002.31203.x; Wilbanks AM, 2002, BIOCHEMISTRY-US, V41, P11981, DOI 10.1021/bi020275m	61	271	280	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53806	53817		10.1074/jbc.M407676200	http://dx.doi.org/10.1074/jbc.M407676200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15383539	hybrid			2022-12-27	WOS:000225680600119
J	Cassera, MB; Gozzo, FC; D'Alexandri, FL; Merino, EF; del Portillo, HA; Peres, VJ; Almeida, IC; Eberlin, MN; Wunderlich, G; Wiesner, J; Jomaa, H; Kimura, EA; Katzin, AM				Cassera, MB; Gozzo, FC; D'Alexandri, FL; Merino, EF; del Portillo, HA; Peres, VJ; Almeida, IC; Eberlin, MN; Wunderlich, G; Wiesner, J; Jomaa, H; Kimura, EA; Katzin, AM			The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; MEVALONATE-INDEPENDENT PATHWAY; ISOPRENOID BIOSYNTHESIS; ESCHERICHIA-COLI; NONMEVALONATE PATHWAY; HETEROLOGOUS EXPRESSION; ISOPENTENYL DIPHOSPHATE; EARLY STEPS; COENZYME-Q	Two genes encoding the enzymes 1-deoxy-D-xylulose-5-phosphate synthase and 1-deoxy-D-xylulose-5-phosphate reductoisomerase have been recently identified, suggesting that isoprenoid biosynthesis in Plasmodium falciparum depends on the methylerythritol phosphate ( MEP) pathway, and that fosmidomycin could inhibit the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. The metabolite 1-deoxy-D-xylulose-5-phosphate is not only an intermediate of the MEP pathway for the biosynthesis of isopentenyl diphosphate but is also involved in the biosynthesis of thiamin (vitamin B-1) and pyridoxal (vitamin B-6) in plants and many microorganisms. Herein we report the first isolation and characterization of most downstream intermediates of the MEP pathway in the three intraerythrocytic stages of P. falciparum. These include, 1-deoxy-D-xylulose-5-phosphate, 2-C-methyl-D-erythritol-4-phosphate, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol, 4-(cytidine-5-diphospho)-2-C-methyl-D-erythritol-2-phosphate, and 2-C-methyl-D-erythritol-2,4-cyclodiphosphate. These intermediates were purified by HPLC and structurally characterized via biochemical and electrospray mass spectrometric analyses. We have also investigated the effect of fosmidomycin on the biosynthesis of each intermediate of this pathway and isoprenoid biosynthesis (dolichols and ubiquinones). For the first time, therefore, it is demonstrated that the MEP pathway is functionally active in all intraerythrocytic forms of P. falciparum, and de novo biosynthesis of pyridoxal in a protozoan is reported. Its absence in the human host makes both pathways very attractive as potential new targets for antimalarial drug development.	Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; Univ Giessen, Inst Biochem, D-35392 Giessen, Germany; Univ Estadual Campinas, Inst Chem, Thomson Mass Spectrometry Lab, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Justus Liebig University Giessen; Universidade Estadual de Campinas	Katzin, AM (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Av Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.	amkatzin@icb.usp.br	Cassera, Maria/L-1572-2013; Almeida, Igor C./AAF-9409-2019; Gozzo, Fabio/F-8123-2010; Katzin, Alejandro/E-9862-2013; del Portillo, Hernando A/L-2131-2014; Eberlin, Marcos N/B-8106-2012; Wunderlich, Gerhard/G-8245-2012	Almeida, Igor C./0000-0002-2443-8213; Katzin, Alejandro/0000-0002-4782-2162; del Portillo, Hernando A/0000-0002-5278-3452; Wunderlich, Gerhard/0000-0003-1724-0337				Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; Aubouy A, 2003, ANTIMICROB AGENTS CH, V47, P231, DOI 10.1128/AAC.47.1.231-237.2003; Barkovich R, 2001, METAB ENG, V3, P27, DOI 10.1006/mben.2000.0168; Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; Bouvier F, 1998, PLANT PHYSIOL, V117, P1423, DOI 10.1104/pp.117.4.1423; BRAUNBRETON C, 1986, MOL BIOCHEM PARASIT, V20, P33, DOI 10.1016/0166-6851(86)90140-4; Cane DE, 1999, J AM CHEM SOC, V121, P7722, DOI 10.1021/ja9914947; Cane DE, 2000, J AM CHEM SOC, V122, P4213, DOI 10.1021/ja000224h; Couto AS, 1999, BIOCHEM J, V341, P629, DOI 10.1042/0264-6021:3410629; CRANMER SL, 1995, J BIOL CHEM, V270, P15045, DOI 10.1074/jbc.270.25.15045; de Macedo CS, 2002, FEMS MICROBIOL LETT, V207, P13, DOI 10.1111/j.1574-6968.2002.tb11021.x; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Ehrenshaft M, 2001, J BACTERIOL, V183, P3383, DOI 10.1128/JB.183.11.3383-3390.2001; Eisenreich W, 2001, TRENDS PLANT SCI, V6, P78, DOI 10.1016/S1360-1385(00)01812-4; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; Elliott JL, 2001, BIOCHEM J, V355, P733, DOI 10.1042/bj3550733; Ershov YV, 2002, J BACTERIOL, V184, P5045, DOI 10.1128/JB.184.18.5045-5051.2002; Fellermeier M, 2003, PHYTOCHEMISTRY, V64, P199, DOI 10.1016/S0031-9422(03)00197-3; Fellermeier MA, 1998, FEBS LETT, V437, P278, DOI 10.1016/S0014-5793(98)01250-2; Fevre EM, 1999, ANN TROP MED PARASIT, V93, P549, DOI 10.1080/00034989958050; FLESCH G, 1988, EUR J BIOCHEM, V175, P405, DOI 10.1111/j.1432-1033.1988.tb14210.x; Galperin MY, 1997, MOL MICROBIOL, V24, P443, DOI 10.1046/j.1365-2958.1997.3671706.x; Giner JL, 1998, CHEM COMMUN, P1857, DOI 10.1039/a804461i; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hecht S, 2001, P NATL ACAD SCI USA, V98, P14837, DOI 10.1073/pnas.201399298; Herz S, 2000, P NATL ACAD SCI USA, V97, P2486, DOI 10.1073/pnas.040554697; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kimura EA, 1996, J BIOL CHEM, V271, P14452, DOI 10.1074/jbc.271.24.14452; KIRCHMEIER RL, 1978, J PHARM SCI, V67, P1444, DOI 10.1002/jps.2600671032; Kitajima J, 2003, PHYTOCHEMISTRY, V62, P115, DOI 10.1016/S0031-9422(02)00438-7; Kuzuyama T, 2000, J BACTERIOL, V182, P891, DOI 10.1128/JB.182.4.891-897.2000; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P4509, DOI 10.1016/S0040-4039(98)00802-8; LAM HM, 1990, J BACTERIOL, V172, P6518, DOI 10.1128/jb.172.11.6518-6528.1990; LAM HM, 1992, J BACTERIOL, V174, P6033, DOI 10.1128/JB.174.19.6033-6045.1992; LAM HM, 1992, J BACTERIOL, V174, P1554, DOI 10.1128/jb.174.5.1554-1567.1992; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lange BM, 1999, ARCH BIOCHEM BIOPHYS, V365, P170, DOI 10.1006/abbi.1999.1168; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Lell B, 2003, ANTIMICROB AGENTS CH, V47, P735, DOI 10.1128/AAC.47.2.735-738.2003; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Monkkonen H, 2000, J CHROMATOGR B, V738, P395, DOI 10.1016/S0378-4347(99)00559-9; Moore SA, 2002, LANCET INFECT DIS, V2, P737, DOI 10.1016/S1473-3099(02)00451-6; OKAMOTO T, 1985, J CHROMATOGR, V342, P35, DOI 10.1016/S0378-4347(00)84487-4; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Poliquin K, 2004, J BACTERIOL, V186, P4685, DOI 10.1128/JB.186.14.4685-4693.2004; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; ROA BB, 1989, J BACTERIOL, V171, P4767, DOI 10.1128/jb.171.9.4767-4777.1989; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Rohdich F, 2001, EUR J BIOCHEM, V268, P3190, DOI 10.1046/j.1432-1327.2001.02204.x; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Sabino AA, 2004, ANGEW CHEM INT EDIT, V43, P2514, DOI 10.1002/anie.200353076; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schwender J, 1999, FEBS LETT, V455, P140, DOI 10.1016/S0014-5793(99)00849-2; Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Takahashi S, 1998, P NATL ACAD SCI USA, V95, P9879, DOI 10.1073/pnas.95.17.9879; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wetzel DK, 2004, FEBS LETT, V564, P143, DOI 10.1016/S0014-5793(04)00329-1; WHITE RH, 1978, BIOCHEMISTRY-US, V17, P3833, DOI 10.1021/bi00611a024; Wiesner J, 2002, ANTIMICROB AGENTS CH, V46, P2889, DOI 10.1128/AAC.46.9.2889-2894.2002; Wolff M, 2002, TETRAHEDRON LETT, V43, P2555, DOI 10.1016/S0040-4039(02)00293-9	73	98	99	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51749	51759		10.1074/jbc.M408360200	http://dx.doi.org/10.1074/jbc.M408360200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452112	hybrid			2022-12-27	WOS:000225493400007
J	Engel, K; Zhou, MY; Wang, J				Engel, K; Zhou, MY; Wang, J			Identification and characterization of a novel monoamine transporter in the human brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE TRANSPORTER; NUCLEUS-ACCUMBENS; SEROTONIN; DOPAMINE; CLONING; EXPRESSION; PLASTICITY; COCAINE; KIDNEY; OCT3	Precise control of monoamine neurotransmitter levels in the extracellular fluids of the brain is critical in maintaining efficient and robust neurotransmission. High affinity transporters in the solute carrier SLC6A family function in removing monoamines from the neurosynaptic cleft. Emerging evidence suggests that these transporters are only one part of a system of transporters that work in concert to maintain brain homeostasis of monoamines. Here we report the cloning and characterization of a new human plasma membrane monoamine transporter, PMAT. The PMAT cDNA encodes a protein of 530 amino acid residues with 10 - 12 transmembrane segments. PMAT is not homologous to known neurotransmitter transporters but exhibits low homology to members of the equilibrative nucleoside transporter family. When expressed in Madin-Darby canine kidney cells and Xenopus laevis oocytes, PMAT efficiently transports serotonin (K-m = 114 muM), dopamine (K-m = 329 muM), and the neurotoxin 1-methyl-4-phenylpyridinium (K-m = 33 muM). In contrast, there is no significant interaction of PMAT with nucleosides or nucleobases. PMAT-mediated monoamine transport does not require Na+ or Cl- but appears to be sensitive to changes in membrane potential. Northern blot analysis showed that PMAT is predominantly expressed in the human brain and widely distributed in the central nervous system. These studies demonstrate that PMAT may be a novel low affinity transporter for biogenic amines, which, under certain conditions, might supplement the role of the high affinity transporters in the brain.	Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wang, J (corresponding author), Univ Washington, Dept Pharmaceut, H272J,Hlth Sci Bldg, Seattle, WA 98195 USA.	jowang@u.washington.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066233] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066233, GM66233] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acimovic Y, 2002, MOL BIOL EVOL, V19, P2199, DOI 10.1093/oxfordjournals.molbev.a004044; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BLAKELY RD, 1994, J EXP BIOL, V196, P263; Brown P, 2000, J NEUROSCI, V20, P1952; Bunin MA, 1998, J NEUROSCI, V18, P4854; CARLSSON A, 1987, ANNU REV NEUROSCI, V10, P19; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Grundemann D, 1998, NAT NEUROSCI, V1, P349, DOI 10.1038/1557; GU H, 1994, J BIOL CHEM, V269, P7124; Inazu M, 1999, LIFE SCI, V64, P2239, DOI 10.1016/S0024-3205(99)00175-7; IZENWASSER S, 1990, BRAIN RES, V520, P303, DOI 10.1016/0006-8993(90)91719-W; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; MIREYLEES SE, 1986, BIOCHEM PHARMACOL, V35, P4065, DOI 10.1016/0006-2952(86)90029-8; Pan YJ, 2001, DEV BRAIN RES, V126, P125, DOI 10.1016/S0165-3806(00)00145-0; PAULMICHL M, 1985, PFLUG ARCH EUR J PHY, V405, P102, DOI 10.1007/BF00584529; Ravary A, 2001, EUR J NEUROSCI, V13, P1349, DOI 10.1046/j.0953-816x.2001.1511.x; Reyes-Haro D, 2003, J NEUROSCI RES, V74, P97, DOI 10.1002/jnr.10724; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Wang J, 1999, J BIOL CHEM, V274, P2298, DOI 10.1074/jbc.274.4.2298; Wang J, 1997, AM J PHYSIOL-RENAL, V273, pF1058, DOI 10.1152/ajprenal.1997.273.6.F1058; Wayment HK, 2001, J NEUROSCI, V21, P35, DOI 10.1523/JNEUROSCI.21-01-00035.2001; Wu X, 1998, J BIOL CHEM, V273, P32776, DOI 10.1074/jbc.273.49.32776; Wu XA, 2000, AM J PHYSIOL-RENAL, V279, pF449, DOI 10.1152/ajprenal.2000.279.3.F449; Wu XH, 1999, GENE, V233, P163, DOI 10.1016/S0378-1119(99)00143-2	31	206	213	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50042	50049		10.1074/jbc.M407913200	http://dx.doi.org/10.1074/jbc.M407913200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448143	hybrid			2022-12-27	WOS:000225229500062
J	Liao, P; Yu, DJ; Lu, SQ; Tang, ZZ; Liang, MC; Zeng, SH; Lin, WM; Soong, TW				Liao, P; Yu, DJ; Lu, SQ; Tang, ZZ; Liang, MC; Zeng, SH; Lin, WM; Soong, TW			Smooth muscle-selective alternatively spliced exon generates functional variation in Ca(v)1.2 calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CA2+ CHANNELS; ALPHA(1C) SUBUNIT; ALPHA-1 SUBUNIT; CURRENT-DENSITY; N-TERMINUS; INACTIVATION; MODULATION; EXPRESSION; LOCALIZATION	Voltage-gated calcium channels play a major role in many important processes including muscle contraction, neurotransmission, excitation-transcription coupling, and hormone secretion. To date, 10 calcium channel alpha(1)-subunits have been reported, of which four code for L-type calcium channels. In our previous work, we uncovered by transcript-scanning the presence of 19 alternatively spliced exons in the L-type Ca(v)1.2 alpha(1)-subunit. Here, we report the smooth muscle-selective expression of alternatively spliced exon 9* in Ca(v)1.2 channels found on arterial smooth muscle. Specific polyclonal antibody against exon 9* localized the intense expression of 9*-containing Ca(v)1.2 channels on the smooth muscle wall of arteries, but the expression on cardiac muscle was low. Whole-cell patch clamp recordings of the 9*-containing Ca(v)1.2 channels in HEK293 cells demonstrated -9 and -11-mV hyperpolarized shift in voltage-dependent activation and current-voltage relationships, respectively. The steady-state inactivation property and sensitivity to blockade by nifedipine of the +/-exon 9* splice variants were, however, not significantly different. Such cell-selective expression of an alternatively spliced exon strongly indicates the customization and fine tuning of calcium channel functions through alternative splicing of the pore-forming alpha(1)-subunit. The generation of proteomic variations by alternative splicing of the calcium channel Ca(v)1.2 alpha(1)-subunit can potentially provide a flexible mechanism for muscle or neuronal cells to respond to various physiological signals or to diseases.	Natl Univ Singapore, Dept Physiol, Fac Med, Singapore 117597, Singapore; Natl Inst Neurosci, Singapore 308433, Singapore; Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Ngee Ann Polytech, Singapore 599489, Singapore	National University of Singapore; National Neuroscience Institute (NNI); Johns Hopkins University	Soong, TW (corresponding author), Natl Univ Singapore, Dept Physiol, Fac Med, Blk MD9,2 Med Dr, Singapore 117597, Singapore.	phsstw@nus.edu.sg		Soong, Tuck Wah/0000-0002-0876-0325; Liang, Mui Cheng/0000-0003-1208-0733				Abernethy DR, 2002, J PHARMACOL EXP THER, V300, P724, DOI 10.1124/jpet.300.3.724; Bell TJ, 2004, NEURON, V41, P127, DOI 10.1016/S0896-6273(03)00801-8; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Bielefeldt K, 1999, J LAB CLIN MED, V133, P469, DOI 10.1016/S0022-2143(99)90024-0; Bourinet E, 1999, NAT NEUROSCI, V2, P407, DOI 10.1038/8070; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; HADLEY RW, 1991, J GEN PHYSIOL, V98, P265, DOI 10.1085/jgp.98.2.265; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Keef KD, 2001, AM J PHYSIOL-CELL PH, V281, pC1743; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14889, DOI 10.1073/pnas.94.26.14889; Ludwig A, 1997, J NEUROSCI, V17, P1339; MA WJ, 1992, J BIOL CHEM, V267, P22728; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Mittman S, 1999, NEUROSCI LETT, V269, P121, DOI 10.1016/S0304-3940(99)00319-5; Mittman S, 1999, NEUROSCI LETT, V274, P143, DOI 10.1016/S0304-3940(99)00716-8; NELSON MT, 1988, NATURE, V336, P382, DOI 10.1038/336382a0; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Shistik E, 1999, J BIOL CHEM, V274, P31145, DOI 10.1074/jbc.274.44.31145; Shistik E, 1998, J BIOL CHEM, V273, P17901, DOI 10.1074/jbc.273.28.17901; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Soong TW, 2002, J NEUROSCI, V22, P10142; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; TANAKA O, 1995, MOL BRAIN RES, V30, P1, DOI 10.1016/0169-328X(94)00265-G; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Welling A, 1997, CIRC RES, V81, P526, DOI 10.1161/01.RES.81.4.526; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yang YB, 2000, J MOL CELL CARDIOL, V32, P973, DOI 10.1006/jmcc.2000.1138; Zamponi GW, 1997, NATURE, V385, P442, DOI 10.1038/385442a0; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	44	69	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50329	50335		10.1074/jbc.M409436200	http://dx.doi.org/10.1074/jbc.M409436200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381693	hybrid			2022-12-27	WOS:000225229500096
J	O'Keeffe, D; Olson, ST; Gasiunas, N; Gallagher, J; Baglin, TP; Huntington, JA				O'Keeffe, D; Olson, ST; Gasiunas, N; Gallagher, J; Baglin, TP; Huntington, JA			The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMATAN SULFATE; HIGH-AFFINITY; CONFORMATIONAL-CHANGE; PROTEINASE REACTIONS; THROMBIN INHIBITION; ANTICOAGULANT; ACCELERATION; INACTIVATION; CHAIN; SITE	The serpin heparin cofactor II (HCII) is a glycosaminoglycan-activated inhibitor of thrombin that circulates at a high concentration in the blood. The antithrombotic effect of heparin, however, is due primarily to the specific interaction of a fraction of heparin chains with the related serpin antithrombin (AT). What currently prevents selective therapeutic activation of HCII is the lack of knowledge of the determinants of glycosaminoglycan binding specificity. In this report we investigate the heparin binding properties of HCII and conclude that binding is nonspecific with a minimal heparin length of 13 monosaccharide units required and affinity critically dependent on ionic strength. Rapid kinetics of heparin binding indicate an induced fit mechanism that involves a conformational change in HCII. Thus, HCII binds to heparin in a manner analogous to the interaction of AT with low affinity heparin. A fully allosteric 2000-fold heparin activation of thrombin inhibition by HCII is demonstrated for heparin chains up to 26 monosaccharide units in length. We conclude that the heparin-binding mechanism of HCII is closely analogous to that of AT and that the induced fit mechanism suggests the potential design or discovery of specific HCII agonists.	Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Div Struct Med,Thrombosis Res Unit, Cambridge CB2 2XY, England; Univ Manchester, Dept Med Oncol, Manchester M20 4BX, Lancs, England; Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Cambridge; University of Manchester; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Huntington, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Div Struct Med,Thrombosis Res Unit, Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.	jah52@cam.ac.uk			MRC [G117/444] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068629, R29HL039888, P01HL064013, R37HL039888, R01HL039888] Funding Source: NIH RePORTER; Medical Research Council [G117/444] Funding Source: Medline; NHLBI NIH HHS [HL39888, HL68629, HL64013] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aihara K, 2004, CIRCULATION, V109, P2761, DOI 10.1161/01.CIR.0000129968.46095.F3; Atchley WR, 2001, MOL BIOL EVOL, V18, P1502, DOI 10.1093/oxfordjournals.molbev.a003936; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Belzar KJ, 2000, J BIOL CHEM, V275, P8733, DOI 10.1074/jbc.275.12.8733; BRAY B, 1989, BIOCHEM J, V262, P225, DOI 10.1042/bj2620225; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Gandossi E, 1998, THROMB HAEMOSTASIS, V80, P840; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; He L, 2002, J CLIN INVEST, V109, P213, DOI 10.1172/JCI200213432; Huntington JA, 2003, TRENDS PHARMACOL SCI, V24, P589, DOI 10.1016/j.tips.2003.09.002; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Liaw PCY, 1999, J BIOL CHEM, V274, P27597, DOI 10.1074/jbc.274.39.27597; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; Mascellani G, 1996, THROMB RES, V84, P21, DOI 10.1016/0049-3848(96)00158-2; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OSCARSSON LG, 1989, J BIOL CHEM, V264, P296; PETITOU M, 1988, J BIOL CHEM, V263, P8685; Ragg H, 2001, MOL BIOL EVOL, V18, P577, DOI 10.1093/oxfordjournals.molbev.a003838; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SCULLY MF, 1987, THROMB RES, V46, P491, DOI 10.1016/0049-3848(87)90136-8; SHEEHAN JP, 1994, J BIOL CHEM, V269, P32747; SIE P, 1986, BRIT J HAEMATOL, V64, P707, DOI 10.1111/j.1365-2141.1986.tb02232.x; SIE P, 1993, BLOOD, V81, P1771; SIE P, 1988, BIOCHIM BIOPHYS ACTA, V966, P188, DOI 10.1016/0304-4165(88)90111-0; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Takamori N, 2004, CIRCULATION, V109, P481, DOI 10.1161/01.CIR.0000109695.39671.37; Tollefsen DM, 2002, ARCH PATHOL LAB MED, V126, P1394; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; Verhamme IM, 2004, J BIOL CHEM, V279, P9785, DOI 10.1074/jbc.M313962200; Weitz JI, 1999, CIRCULATION, V99, P682, DOI 10.1161/01.CIR.99.5.682; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723	38	45	45	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50267	50273		10.1074/jbc.M408774200	http://dx.doi.org/10.1074/jbc.M408774200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371417	hybrid			2022-12-27	WOS:000225229500088
J	Ujvari, A; Luse, DS				Ujvari, A; Luse, DS			Newly initiated RNA encounters a factor involved in splicing immediately upon emerging from within RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; NASCENT RNA; TRANSCRIPTION ELONGATION; MESSENGER-RNA; COMPLEX; U2AF; RESOLUTION; SUBUNITS; SITE; DNA	We employed RNA-protein cross-linking to map the path of the nascent RNA as it emerges from within RNA polymerase II. A UV-cross-linkable uridine analog was incorporated at two positions within the first five nucleotides of the transcript. Only the two largest subunits of RNA polymerase II cross-linked to the transcript in complexes containing 17-24-nucleotide (nt) RNAs. Extension of the RNA to 26 or 28 nt revealed an additional strong cross-link to the splicing factor U2AF65. In U17 complexes, in which the RNA is still contained within the polymerase, U2AF65 is tightly bound. In contrast, U2AF65 is more loosely bound in C28 transcription complexes, in which about 10 nt of transcript have emerged from the RNA polymerase. Cross-linking of U2AF65 to RNA in a C28 complex was eliminated by the addition of an excess of an RNA oligonucleotide containing the consensus U2AF65 binding site, but U2AF65 was not displaced by a nonconsensus RNA. These findings indicate that U2AF65 shifts from protein-protein to protein-RNA interactions as the RNA emerges from the polymerase. During transcription of one particular template at low UTP concentration, RNA polymerase II pauses just after synthesizing a transcript segment that is a U2AF65 binding site. Dwell time of the polymerase at this pause site was significantly and specifically reduced by the addition of recombinant U2AF65 to the transcription reaction. Therefore, the association of U2AF65 with RNA polymerase II may function not only to deliver U2AF65 to the nascent transcript but also to modulate efficient transcript elongation.	Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin Fdn, Dept Mol Biol, Lerner Res Inst, NC20,9500 Euclid Ave, Cleveland, OH 44195 USA.	lused@ccf.org			NIGMS NIH HHS [GM 29487] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029487] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; BARTHOLOMEW B, 1986, J BIOL CHEM, V261, P14226; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Blanchette M, 2004, MOL CELL, V14, P775, DOI 10.1016/j.molcel.2004.06.012; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Gu HD, 2003, NUCLEIC ACIDS RES, V31, P6264, DOI 10.1093/nar/gkg823; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; HANNA MM, 1983, P NATL ACAD SCI-BIOL, V80, P4238, DOI 10.1073/pnas.80.14.4238; Hartzog GA, 2003, CURR OPIN GENET DEV, V13, P119, DOI 10.1016/S0959-437X(03)00024-8; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kent OA, 2003, J BIOL CHEM, V278, P50572, DOI 10.1074/jbc.M307976200; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Manley JL, 2002, NAT STRUCT BIOL, V9, P790, DOI 10.1038/nsb1102-790; MCKUNE K, 1995, MOL CELL BIOL, V15, P6895; Meisenheimer KM, 2000, METHOD ENZYMOL, V318, P88; Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; RICE GA, 1991, P NATL ACAD SCI USA, V88, P4245, DOI 10.1073/pnas.88.10.4245; Robert F, 2002, J BIOL CHEM, V277, P9302, DOI 10.1074/jbc.M110516200; Samkurashvili I, 1998, MOL CELL BIOL, V18, P5343, DOI 10.1128/MCB.18.9.5343; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shilatifard A, 2004, BBA-GENE STRUCT EXPR, V1677, P79, DOI 10.1016/j.bbaexp.2003.11.013; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Ujvari A, 2002, J BIOL CHEM, V277, P32527, DOI 10.1074/jbc.M201145200; VALCARCEL J, 1997, MRNA FORMATION FUNCT, P31; Washington K, 2002, J BIOL CHEM, V277, P40442, DOI 10.1074/jbc.M205687200; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200; Zolotukhin AS, 2002, J BIOL CHEM, V277, P3935, DOI 10.1074/jbc.M107598200; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	48	39	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49773	49779		10.1074/jbc.M409087200	http://dx.doi.org/10.1074/jbc.M409087200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377657	hybrid			2022-12-27	WOS:000225229500029
J	Gloster, TM; Macdonald, JM; Tarling, CA; Stick, RV; Withers, SG; Davies, GJ				Gloster, TM; Macdonald, JM; Tarling, CA; Stick, RV; Withers, SG; Davies, GJ			Structural, thermodynamic, and kinetic analyses of tetrahydrooxazine-derived inhibitors bound to beta-glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-RESOLUTION ANALYSES; REACTION COORDINATE; GLYCOSIDASE; ISOFAGOMINE; ENZYMES; BINDING; ENDOGLUCANASE; REFINEMENT; MOLSCRIPT; POTENT	The understanding of transition state mimicry in glycoside hydrolysis is increasingly important both in the quest for novel specific therapeutic agents and for the deduction of enzyme function and mechanism. To aid comprehension, inhibitors can be characterized through kinetic, thermodynamic, and structural dissection to build an "inhibition profile." Here we dissect the binding of a tetrahydrooxazine inhibitor and its derivatives, which display K-i values around 500 nM. X-ray structures with both a beta-glucosidase, at 2 Angstrom resolution, and an endoglucanase at atomic (similar to1Angstrom) resolution reveal similar interactions between the tetrahydrooxazine inhibitor and both enzymes. Kinetic analyses reveal the pH dependence of k(cat)/K-m and 1/K-i with both enzyme systems, and isothermal titration calorimetry unveils the enthalpic and entropic contributions to beta-glucosidase inhibition. The pH dependence of enzyme activity mirrored that of 1/K-i in both enzymes, unlike the cases of isofagomine and 1-deoxynojirimycin that have been characterized previously. Calorimetric dissection reveals a large favorable enthalpy that is partially offset by an unfavorable entropy upon binding. In terms of the similar profile for the pH dependence of 1/K-i and the pH dependence of k(cat)/K-m, the significant enthalpy of binding when compared with other glycosidase inhibitors, and the tight binding at the optimal pH of the enzymes tested, tetrahydrooxazine and its derivatives are a significantly better class of glycosidase inhibitor than previously assumed.	Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England; Univ Western Australia, Sch Biomed & Chem Sci M313, Crawley, WA 6009, Australia; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	University of York - UK; University of Western Australia; University of British Columbia	Davies, GJ (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	davies@ysbl.york.ac.uk	Davies, Gideon J/A-9042-2011; Macdonald, James M/H-4209-2013	Davies, Gideon J/0000-0002-7343-776X; 				Bach P, 1999, TETRAHEDRON LETT, V40, P3461, DOI 10.1016/S0040-4039(99)00423-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Best WM, 2002, CAN J CHEM, V80, P857, DOI 10.1139/V02-060; Bulow A, 2000, J AM CHEM SOC, V122, P8567, DOI 10.1021/ja001762x; Coutinho PM, 1999, ROY SOC CH, P3; DAVIES G, 1997, COMPREHENSIVE BIOL C, V1, P119; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P1926, DOI 10.1021/bi972162m; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Ganem B, 1996, ACCOUNTS CHEM RES, V29, P340, DOI 10.1021/ar9502184; Gloster TM, 2004, CHEM COMMUN, P1794, DOI 10.1039/b405152a; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Ichikawa Y, 1998, J AM CHEM SOC, V120, P3007, DOI 10.1021/ja973443k; JESPERSEN TM, 1994, ANGEW CHEM INT EDIT, V33, P1778, DOI 10.1002/anie.199417781; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R.J., 2001, GRAFIT VERSION 5; Macdonald JM, 2002, AUST J CHEM, V55, P747, DOI 10.1071/CH02165; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; McIntosh LP, 1996, BIOCHEMISTRY-US, V35, P9958, DOI 10.1021/bi9613234; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; Snider MJ, 2001, BIOCHEMISTRY-US, V40, P11364, DOI 10.1021/bi011189+; Varrot A, 2003, J AM CHEM SOC, V125, P7496, DOI 10.1021/ja034917k; Varrot A, 2003, ACTA CRYSTALLOGR D, V59, P447, DOI 10.1107/S0907444902023405; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Withers S. G., 1999, IMINOSUGARS GLYCOSID, P188; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Wolfenden R, 1998, J AM CHEM SOC, V120, P6814, DOI 10.1021/ja9813055; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	33	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49236	49242		10.1074/jbc.M407195200	http://dx.doi.org/10.1074/jbc.M407195200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15356002	hybrid			2022-12-27	WOS:000225098100090
J	Komenda, J; Reisinger, V; Muller, BC; Dobakova, M; Granvogl, B; Eichacker, LA				Komenda, J; Reisinger, V; Muller, BC; Dobakova, M; Granvogl, B; Eichacker, LA			Accumulation of the D2 protein is a key regulatory step for assembly of the photosystem II reaction center complex in Synechocystis PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; ENCODED D1 PROTEIN; MEMBRANE-PROTEIN; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; DIRECTED MUTAGENESIS; DELETION MUTAGENESIS; THYLAKOID MEMBRANES; ELECTRON-TRANSPORT; GENE-PRODUCT	Accumulation of monomer and dimer photosystem (PS) II reaction center core complexes has been analyzed by two-dimensional Blue-native/ SDS-PAGE in Synechocystis PCC 6803 wild type and in mutant strains lacking genes psbA, psbB, psbC, psbDIC/DII, or the psbEFLJ operon. In vivo pulse-chase radiolabeling experiments revealed that mutant cells assembled PSII precomplexes only. In DeltapsbC and DeltapsbB, assembly of reaction center cores lacking CP43 and reaction center complexes was detected, respectively. In DeltapsbA, protein subunits CP43, CP47, D2, and cytochrome b(559) were synthesized, but proteins did not assemble. Similarly, in DeltapsbD/C lacking D2, and CP43, the de novo synthesized proteins D1, CP47, and cytochrome b559 did not form any mutual complexes, indicating that assembly of the reaction center complex is a prerequisite for assembly with core subunits CP47 and CP43. Finally, although CP43 and CP47 accumulated in DeltapsbEFLJ, D2 was neither expressed nor accumulated. We, furthermore, show that the amount of D2 is high in the strain lacking D1, whereas the amount of D1 is low in the strain lacking D2. We conclude that expression of the psbEFLJ operon is a prerequisite for D2 accumulation that is the key regulatory step for D1 accumulation and consecutive assembly of the PSII reaction center complex.	Univ Munich, Inst Bot, D-80368 Munich, Germany; Opatovicky Mlyn, Inst Microbiol, Trebon 37981, Czech Republic; Univ S Bohemia, Inst Phys Biol, Nove Hrady 37005, Czech Republic; Hoffmann La Roche AG, RCMG, CH-4070 Basel, Switzerland	University of Munich; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Roche Holding	Eichacker, LA (corresponding author), Univ Munich, Inst Bot, Menzinger Str 67, D-80368 Munich, Germany.	eichacker@lmu.de	Komenda, Josef/H-4083-2014	Komenda, Josef/0000-0003-4588-0382				ANBUDURAI PR, 1993, Z NATURFORSCH C, V48, P267; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Barber J, 2002, CURR OPIN STRUC BIOL, V12, P523, DOI 10.1016/S0959-440X(02)00357-3; Barber J, 2003, Q REV BIOPHYS, V36, P71, DOI 10.1017/S0033583502003839; Bergantino E, 2003, J BIOL CHEM, V278, P41820, DOI 10.1074/jbc.M303096200; Choquet Y, 2001, BIOCHEM SOC T, V29, P421, DOI 10.1042/BST0290421; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; EGGERS B, 1993, BIOCHEMISTRY-US, V32, P11419, DOI 10.1021/bi00093a020; EICHACKER LA, 2001, Patent No. 101195974; ErmakovaGerdes S, 1996, PLANT MOL BIOL, V30, P243, DOI 10.1007/BF00020111; HAAG E, 1993, BIOCHEMISTRY-US, V32, P4444, DOI 10.1021/bi00067a037; Hager M, 2002, J BIOL CHEM, V277, P14031, DOI 10.1074/jbc.M112053200; IKEUCHI M, 1991, J BIOL CHEM, V266, P11111; Ikeuchi M, 1995, MOL GEN GENET, V249, P622, DOI 10.1007/BF00418031; Inagaki N, 2001, FEBS LETT, V509, P197, DOI 10.1016/S0014-5793(01)03180-5; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; KOMENDA J, 1995, EUR J BIOCHEM, V233, P677, DOI 10.1111/j.1432-1033.1995.677_2.x; Komenda J, 2002, EUR J BIOCHEM, V269, P610, DOI 10.1046/j.0014-2956.2001.02693.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIND LK, 1993, J BIOL CHEM, V268, P1575; MAYES SR, 1993, BIOCHEMISTRY-US, V32, P1454, DOI 10.1021/bi00057a008; Morais F, 1998, J BIOL CHEM, V273, P29315, DOI 10.1074/jbc.273.45.29315; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; NILSSON FJ, 1992, PLANT MOL BIOL, V14, P1051; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; OHAD I, 1984, J CELL BIOL, V99, P481, DOI 10.1083/jcb.99.2.481; Ohnishi N, 2001, J BIOL CHEM, V276, P33798, DOI 10.1074/jbc.M104454200; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; Ozawa S, 1997, PLANT MOL BIOL, V34, P151, DOI 10.1023/A:1005800909495; PAKRASI HB, 1988, EMBO J, V7, P325, DOI 10.1002/j.1460-2075.1988.tb02816.x; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; PAKRASI HB, 1990, Z NATURFORSCH C, V45, P423; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PRASIL O, 1992, TOPICS PHOTOSYNTHESI, V11, P295; Regel RE, 2001, J BIOL CHEM, V276, P41473, DOI 10.1074/jbc.M102007200; ROGNER M, 1991, BIOCHEMISTRY-US, V30, P5387; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shi LX, 2000, J BIOL CHEM, V275, P37945, DOI 10.1074/jbc.M006300200; SHUKLA VK, 1992, MOL MICROBIOL, V6, P947, DOI 10.1111/j.1365-2958.1992.tb01544.x; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Sugimoto I, 2003, J BIOL CHEM, V278, P45004, DOI 10.1074/jbc.M307537200; Swiatek M, 2003, MOL GENET GENOMICS, V268, P699, DOI 10.1007/s00438-002-0791-1; Swiatek M, 2001, PLANT CELL, V13, P1347, DOI 10.1105/tpc.13.6.1347; Szabo I, 2001, EUR J BIOCHEM, V268, P5129, DOI 10.1046/j.0014-2956.2001.02441.x; TAKAHASHI Y, 1994, PLANT MOL BIOL, V24, P779, DOI 10.1007/BF00029859; Thidholm E, 2002, FEBS LETT, V513, P217, DOI 10.1016/S0014-5793(02)02314-1; Tichy M, 2003, BBA-BIOENERGETICS, V1605, P55, DOI 10.1016/S0005-2728(03)00064-1; vanWijk KJ, 1996, J BIOL CHEM, V271, P9627, DOI 10.1074/jbc.271.16.9627; vanWijk KJ, 1997, BIOCHEMISTRY-US, V36, P6178, DOI 10.1021/bi962921l; VERMAAS WFJ, 1988, PHOTOSYNTH RES, V17, P97, DOI 10.1007/BF00047683; WELLBURN AR, 1984, ADV PHOTOSYNTHESIS R, V2, P10; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; YU JJ, 1990, PLANT CELL, V2, P315; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4; Zhang LX, 2001, J BIOL CHEM, V276, P37809; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	60	132	139	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48620	48629		10.1074/jbc.M405725200	http://dx.doi.org/10.1074/jbc.M405725200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347679	hybrid			2022-12-27	WOS:000225098100018
J	Rotem, D; Schuldiner, S				Rotem, D; Schuldiner, S			EmrE, a multidrug transporter from Escherichia coli, transports monovalent and divalent substrates with the same stoichiometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON BINDING-SITE; NA+/H+ ANTIPORTER; ACTIVE-TRANSPORT; EFFLUX; MEMBRANE; PH; PROTEIN; MODEL; GENES; MDFA	Multidrug transporters recognize and transport substrates with apparently little common structural features. At times these substrates are neutral, negatively, or positively charged, and only limited information is available as to how these proteins deal with the energetic consequences of transport of substrates with different charges. Multidrug transporters and drug-specific efflux systems are responsible for clinically significant resistance to chemotherapeutic agents in pathogenic bacteria, fungi, parasites, and human cancer cells. Understanding how these efflux systems handle different substrates may also have practical implications in the development of strategies to overcome the resistance mechanisms mediated by these proteins. Here, we compare transport of monovalent and divalent substrates by EmrE, a multidrug transporter from Escherichia coli, in intact cells and in proteoliposomes reconstituted with the purified protein. The results demonstrated that whereas the transport of monovalent substrates involves charge movement (i.e. electrogenic), the transport of divalent substrate does not (i.e. electroneutral). Together with previous results, these findings suggest that an EmrE dimer exchanges two protons per substrate molecule during each transport cycle. In intact cells, under conditions where the only driving force is the electrical potential, EmrE confers resistance to monovalent substrates but not to divalent ones. In the presence of proton gradients, resistance to both types of substrates is detected. The finding that under some conditions EmrE does not remove certain types of drugs points out the importance of an in-depth understanding of mechanisms of action of multidrug transporters to devise strategies for coping with the problem of multidrug resistance.	Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012; Rotem, Dvir/G-1396-2013	Schuldiner, Shimon/0000-0002-4874-6237; Rotem, Dvir/0000-0002-1840-6530	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16708] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bibi E, 2001, J MOL MICROB BIOTECH, V3, P171; Brown MH, 2001, J MOL MICROB BIOTECH, V3, P163; Chung Y J, 2001, Curr Opin Drug Discov Devel, V4, P237; EISENBERG ES, 1984, J BACTERIOL, V157, P863, DOI 10.1128/JB.157.3.863-867.1984; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; MINAKAMI H, 1990, J BACTERIOL, V172, P691, DOI 10.1128/jb.172.2.691-695.1990; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; PADAN E, 1987, J MEMBRANE BIOL, V95, P189, DOI 10.1007/BF01869481; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; Schuldiner S, 2001, J MOL MICROB BIOTECH, V3, P155; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; SCHULDINER S, 1975, BIOCHEMISTRY-US, V14, P5451, DOI 10.1021/bi00696a011; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Ueda K, 1997, SEMIN CANCER BIOL, V8, P151, DOI 10.1006/scbi.1997.0066; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yerushalmi H, 2000, FEBS LETT, V476, P93, DOI 10.1016/S0014-5793(00)01677-X; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; ZILBERSTEIN D, 1979, BIOCHEMISTRY-US, V18, P669, DOI 10.1021/bi00571a018	39	63	65	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48787	48793		10.1074/jbc.M408187200	http://dx.doi.org/10.1074/jbc.M408187200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371426	hybrid			2022-12-27	WOS:000225098100038
J	Lamkanfi, M; Denecker, G; Kalai, M; D'hondt, K; Meeus, A; Declercq, W; Saelens, X; Vandenabeele, P				Lamkanfi, M; Denecker, G; Kalai, M; D'hondt, K; Meeus, A; Declercq, W; Saelens, X; Vandenabeele, P			INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1 beta generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-GAMMA; GENE-EXPRESSION; MICE DEFICIENT; INFLAMMATORY CASPASES; CONVERTING-ENZYME; STRUCTURAL BASIS; SEPTIC SHOCK; ACTIVATION; APOPTOSIS; IL-1-BETA	Using in silico methods for screening the human genome for new caspase recruitment domain (CARD) proteins, we have identified INCA ( Inhibitory CARD) as a protein that shares 81% identity with the prodomain of caspase-1. The INCA gene is located on chromosome 11q22 between the genes of COP/Pseudo-ICE and ICEBERG, two other CARD proteins that arose from caspase-1 gene duplications. We show that INCA mRNA is expressed in many tissues. INCA is specifically upregulated by interferon-gamma in the monocytic cell lines THP-1 and U937. INCA physically interacts with procaspase-1 and blocks the release of mature IL-1beta from LPS-stimulated macrophages. Unlike COP/Pseudo-ICE and procaspase-1, INCA does not interact with RIP2 and does not induce NF-kappaB activation. Our data show that INCA is a novel intracellular regulator of procaspase-1 activation, involved in the regulation of pro-IL-1beta processing and its release during inflammation.	State Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signalling & Cell Death, B-9052 Zwijnaarde, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), State Univ Ghent VIB, Dept Mol Biomed Res, Unit Mol Signalling & Cell Death, Technol Pk 927, B-9052 Zwijnaarde, Belgium.	Peter.Vandenabeele@dmbr.UGent.be	Denecker, Geertrui/E-8134-2010; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009; Saelens, Xavier/N-5728-2015	Vandenabeele, Peter/0000-0002-6669-8822; Denecker, Geertrui/0000-0002-2515-2911; , Xavier/0000-0002-3861-6965				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Freeman BD, 2000, EXPERT OPIN INV DRUG, V9, P1651, DOI 10.1517/13543784.9.7.1651; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; HOPKINS SJ, 1989, J IMMUNOL METHODS, V120, P271, DOI 10.1016/0022-1759(89)90252-4; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Kalai M, 2003, J CELL BIOL, V162, P457, DOI 10.1083/jcb.200303157; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2004, J BIOL CHEM, V279, P24785, DOI 10.1074/jbc.M400985200; Lamkanfi M, 2004, CELL DEATH DIFFER, V11, P365, DOI 10.1038/sj.cdd.4401364; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; LAMKANFI M, 2003, CASPASES THEIR ROLE, P1; Lee SH, 2001, J BIOL CHEM, V276, P34495, DOI 10.1074/jbc.M101415200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; NATANSON C, 1994, ANN INTERN MED, V120, P771, DOI 10.7326/0003-4819-120-9-199405010-00009; Netea MG, 2000, J IMMUNOL, V164, P2644, DOI 10.4049/jimmunol.164.5.2644; O'Reilly M, 1999, SHOCK, V12, P411, DOI 10.1097/00024382-199912000-00001; OMAHONEY JV, 1994, DNA CELL BIOL, V13, P1227, DOI 10.1089/dna.1994.13.1227; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Sakao Y, 1999, INT IMMUNOL, V11, P471, DOI 10.1093/intimm/11.3.471; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; Stehlik C, 2003, J BIOL CHEM, V278, P31941, DOI 10.1074/jbc.M300009200; Tamura T, 1996, BIOCHEM BIOPH RES CO, V229, P21, DOI 10.1006/bbrc.1996.1752; VanCriekinge W, 1996, J BIOL CHEM, V271, P27245, DOI 10.1074/jbc.271.44.27245; VANDENABEELE P, 1990, LYMPHOKINE RES, V9, P381; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	42	80	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51729	51738		10.1074/jbc.M407891200	http://dx.doi.org/10.1074/jbc.M407891200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15383541	hybrid			2022-12-27	WOS:000225493400004
J	Mahapatra, NR; Mahata, M; Hazra, PP; McDonough, PM; O'Connor, DT; Mahata, SK				Mahapatra, NR; Mahata, M; Hazra, PP; McDonough, PM; O'Connor, DT; Mahata, SK			A dynamic pool of calcium in catecholamine storage vesicles - Exploration in living cells by a novel vesicle-targeted chromogranin A-aequorin chimeric photoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; ENDOPLASMIC-RETICULUM; RECOMBINANT AEQUORIN; CA2+ CONCENTRATION; RECEPTOR/CA2+ CHANNEL; SECRETORY VESICLES; REGULATED PATHWAY; GENE-EXPRESSION; PROTEIN; GRANULES	Chromaffin vesicles contain very high concentration of Ca2+ ( similar to 20 - 40 mM total), compared with similar to 100 nM in the cytosol. Aequorin, a jellyfish photoprotein with Ca2+-dependent luminescence, measures [Ca2+] in specific subcellular compartments wherein proteins with organelle-specific trafficking domains are fused in-frame to aequorin. Because of the presence of vesicular trafficking domain within CgA we engineered sorting of an expressed human CgA-Aequorin fusion protein (hCgA-Aeq) into the vesicle compartment as confirmed by sucrose density gradients and confocal immunofluorescent co-localization studies. hCgA-Aeq and cytoplasmic aequorin (Cyto-Aeq) luminescence displayed linear functions of [Ca2+] in vitro, over > 5 log(10) orders of magnitude ( r > 0.99), and down to at least 10(-7) M sensitivity. Calibrating the pH dependence of hCgA-Aeq luminescence allowed estimation of [Ca2+](ves) at granule interior pH ( similar to 5.5). In the cytoplasm, Cyto-Aeq accurately determined [Ca2+](cyto) under both basal ([Ca2+](cyto) = 130 +/- 35 nM) and exocytosis-stimulated conditions, confirmed by an independent reference technique (Indo-1 fluorescence). The hCgA-Aeq chimera determined vesicular free [Ca2+](ves) = 1.4 +/- 0.3 muM under basal conditions indicating that > 99% of granule total Ca2+ is in a "bound" state. The basal free [Ca2+](ves)/[Ca2+](cyto) ratio was thus similar to 10.8-fold, indicating active, dynamic Ca2+ uptake from cytosol into the granules. Stimulation of exocytotic secretion revealed prompt, dynamic increases in both [Ca2+](ves) and [Ca2+](cyto), and an exponential relation between the two ( y = 0.99 x e((1.53x)), r = 0.99), reflecting a persistent [Ca2+](ves)/[Ca2+](cyto) gradient, even during sharp increments of both values. Studies with inhibitors of Ca2+ translocation (Ca2+-ATPase), Na+/ Ca+-exchange, Na+/ H+-exchange, and vesicle acidification ( H+-translocating ATPase), documented a role for these four ion transporter classes in accumulation of Ca2+ inside the vesicles.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	O'Connor, DT (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	doconnor@ucsd.edu; smahata@ucsd.edu	Mahapatra, Nitish R/D-4123-2014; Mahata, Sushil/AAF-8781-2021	Mahapatra, Nitish R/0000-0002-0695-3510; 				ABERER W, 1979, J NEUROCHEM, V33, P797, DOI 10.1111/j.1471-4159.1979.tb05227.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; CASEY RP, 1977, BIOCHEMISTRY-US, V16, P972, DOI 10.1021/bi00624a025; Chiesa A, 2001, BIOCHEM J, V355, P1, DOI 10.1042/0264-6021:3550001; DAWSON RMC, 1986, DATA BIOCH RES, P6; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; DOUGLAS WW, 1968, BRIT J PHARMACOL, V34, P453, DOI DOI 10.1111/J.1476-5381.1968.TB08474.X; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAIGH JR, 1993, NEUROREPORT, V4, P571, DOI 10.1097/00001756-199305000-00028; HAIGH JR, 1989, BIOCHEM J, V259, P485, DOI 10.1042/bj2590485; HELMAN LJ, 1988, J BIOL CHEM, V263, P11559; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hilfiker S, 2003, BIOCHEM SOC T, V31, P828, DOI 10.1042/BST0310828; JAN CR, 1992, J BIOL CHEM, V267, P9695; JOHNSON RG, 1976, J BIOL CHEM, V251, P2189; KAGAYA Y, 1995, J CLIN INVEST, V95, P2766, DOI 10.1172/JCI117980; LATTANZIO FA, 1990, BIOCHEM BIOPH RES CO, V171, P102, DOI 10.1016/0006-291X(90)91362-V; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Machado JD, 2000, J BIOL CHEM, V275, P20274, DOI 10.1074/jbc.M000930200; Machado JD, 2002, CIRC RES, V91, P830, DOI 10.1161/01.RES.0000039530.30495.6F; Mahapatra NR, 2000, ENDOCRINOLOGY, V141, P3668, DOI 10.1210/en.141.10.3668; Mahata SK, 1999, NEUROSCIENCE, V88, P405, DOI 10.1016/S0306-4522(98)00225-5; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Pan CY, 1998, BIOCHEM J, V336, P305, DOI 10.1042/bj3360305; Park YB, 1996, J PHYSIOL-LONDON, V492, P329, DOI 10.1113/jphysiol.1996.sp021312; PARMER RJ, 1993, J CLIN INVEST, V92, P1042, DOI 10.1172/JCI116609; PHILLIPS JH, 1981, BIOCHEM J, V200, P99, DOI 10.1042/bj2000099; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Rigual R, 2002, EUR J NEUROSCI, V16, P1690, DOI 10.1046/j.1460-9568.11-2.02244.x; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robert V, 2000, METHOD ENZYMOL, V327, P440, DOI 10.1016/S0076-6879(00)27295-9; RUTTER GA, 1993, J BIOL CHEM, V268, P22385; Schneider AS, 2002, ANN NY ACAD SCI, V971, P142, DOI 10.1111/j.1749-6632.2002.tb04449.x; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Tang KC, 1997, J CLIN INVEST, V100, P1180, DOI 10.1172/JCI119630; Tang YM, 2000, J NEUROCHEM, V74, P702, DOI 10.1046/j.1471-4159.2000.740702.x; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; VIDEEN JS, 1992, J BIOL CHEM, V267, P3066; Villalobos C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0630com; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; Yoo SH, 2002, ANN NY ACAD SCI, V971, P300, DOI 10.1111/j.1749-6632.2002.tb04484.x; Yoo SH, 2000, TRENDS NEUROSCI, V23, P424, DOI 10.1016/S0166-2236(00)01621-0	55	44	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51107	51121		10.1074/jbc.M408742200	http://dx.doi.org/10.1074/jbc.M408742200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15358782	hybrid			2022-12-27	WOS:000225355800057
J	Hii, CS; Anson, DS; Costabile, M; Mukaro, V; Dunning, K; Ferrante, A				Hii, CS; Anson, DS; Costabile, M; Mukaro, V; Dunning, K; Ferrante, A			Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; ARACHIDONIC-ACID; POLYMORPHONUCLEAR LEUKOCYTES; POTENTIAL ROLE; NADPH-OXIDASE; GROWTH-FACTOR; TNF-ALPHA; ERK5; RECEPTOR	The role of the extracellular signal-regulated kinase (ERK) 1 and ERK2 in the neutrophil chemotactic response remains to be identified since a previously used specific inhibitor of MEK1 and MEK2, PD98059, that was used to provide evidence for a role of ERK1 and ERK2 in regulating chemotaxis, has recently been reported to also inhibit MEK5. This issue is made more critical by our present finding that human neutrophils express mitogen-activated protein (MAP) kinase/ERK kinase (MEK) 5 and ERK5 (Big MAP kinase), and that their activities were stimulated by the bacterial tripeptide, formyl methionyl-leucyl-phenylalanine (fMLP). Dose response studies demonstrated a bell-shaped profile of fMLP-stimulated MEK5 and ERK5 activation, but this was left-shifted when compared with the profile of fMLP-stimulated chemotaxis. Kinetics studies demonstrated increases in kinase activity within 2 min, peaking at 3-5 min, and MEK5 activation was more persistent than that of ERK5. There were some similarities as well as differences in the pattern of activation between fMLP-stimulated ERK1 and ERK2, and MEK5-ERK5 activation. The up-regulation of MEK5-ERK5 activities was dependent on phosphatidylinositol 3-kinase. Studies with the recently described specific MEK inhibitor, PD184352, at concentrations that inhibited ERK1 and ERK2 but not ERK5 activity demonstrate that the ERK1 and ERK2 modules were involved in regulating fMLP-stimulated chemotaxis and chemokinesis. Our data suggest that the MEK5-ERK5 module is likely to regulate neutrophil responses at very low chemoattractant concentrations whereas at higher concentrations, a shift to the ERK1/ERK2 and p38 modules is apparent.	Womens & Childrens Hosp, Dept Immunopathol, Adelaide, SA 5006, Australia; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia; Univ Adelaide, Dept Pediat, Adelaide, SA 5000, Australia	Womens & Childrens Hospital Australia; Womens & Childrens Hospital Australia; University of South Australia; University of Adelaide	Hii, CS (corresponding author), Womens & Childrens Hosp, Dept Immunopathol, 72 King William Rd, Adelaide, SA 5006, Australia.	charles.hii@adelaide.edu.au	costabile, maurizio/AEN-4356-2022; Dunning, Kylie/GLU-0471-2022	costabile, maurizio/0000-0002-2162-6497; Dunning, Kylie/0000-0002-0462-6479; Mukaro, Violet/0000-0002-3968-6551				Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Avdi NJ, 1996, J BIOL CHEM, V271, P33598, DOI 10.1074/jbc.271.52.33598; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Doring G, 2000, Paediatr Respir Rev, V1, P101, DOI 10.1053/prrv.2000.0030; Drost EM, 2002, EUR J IMMUNOL, V32, P393, DOI 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5; Dwivedi PP, 2002, J BIOL CHEM, V277, P29643, DOI 10.1074/jbc.M204561200; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; FERRANTE A, 1982, J IMMUNOL METHODS, V48, P81, DOI 10.1016/0022-1759(82)90212-5; Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heuertz RM, 1999, J BIOL CHEM, V274, P17968, DOI 10.1074/jbc.274.25.17968; Hii CST, 1999, INFECT IMMUN, V67, P1297, DOI 10.1128/IAI.67.3.1297-1302.1999; HII CST, 1995, J BIOL CHEM, V270, P4201, DOI 10.1074/jbc.270.9.4201; Hii CST, 1998, J BIOL CHEM, V273, P19277, DOI 10.1074/jbc.273.30.19277; Hii CST, 2001, J BIOL CHEM, V276, P27246, DOI 10.1074/jbc.M103250200; Huang ZH, 1997, BIOCHEM J, V325, P553, DOI 10.1042/bj3250553; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lehman JA, 2001, AM J PHYSIOL-CELL PH, V280, pC183, DOI 10.1152/ajpcell.2001.280.1.C183; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Mody N, 2003, BIOCHEM J, V372, P567, DOI 10.1042/BJ20030193; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Naccache PH, 2000, J BIOL CHEM, V275, P23636, DOI 10.1074/jbc.M001780200; Nagata T, 2001, BRIT J ANAESTH, V86, P853, DOI 10.1093/bja/86.6.853; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; NELSON RD, 1975, J IMMUNOL, V115, P1650; Nicol RL, 2001, EMBO J, V20, P2757, DOI 10.1093/emboj/20.11.2757; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Pearson GW, 2002, J BIOL CHEM, V277, P48094, DOI 10.1074/jbc.M208535200; PILLINGER MH, 1995, RHEUM DIS CLIN N AM, V21, P691; POWIS G, 1994, CANCER RES, V54, P2419; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Takami M, 2002, J IMMUNOL, V168, P4559, DOI 10.4049/jimmunol.168.9.4559; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WORTHEN GS, 1994, J CLIN INVEST, V94, P815, DOI 10.1172/JCI117401; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xythalis D, 2002, INFLAMMATION, V26, P83, DOI 10.1023/A:1014836211643; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zu YL, 1998, J IMMUNOL, V160, P1982	51	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49825	49834		10.1074/jbc.M406892200	http://dx.doi.org/10.1074/jbc.M406892200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381709	Green Published, hybrid			2022-12-27	WOS:000225229500035
J	Ghersi, E; Noviello, C; D'Adamio, L				Ghersi, E; Noviello, C; D'Adamio, L			Amyloid-beta protein precursor (A beta PP) intracellular domain-associated protein-1 proteins bind to A beta PP and modulate its processing in an isoform-specific manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; RECEPTOR-RELATED PROTEIN; GAMMA-SECRETASE; SIGNAL-TRANSDUCTION; CYTOPLASMIC DOMAIN; MISSENSE MUTATIONS; PRESENILIN; CLEAVAGE; GENE; FE65	The amyloid-beta protein precursor (AbetaPP) is a type I transmembrane molecule that undergoes several finely regulated cleavage events. The physiopathological relevance of AbetaPP derives from the fact that its aberrant processing strongly correlates with the onset of Alzheimer's disease (AD). AD is a neurodegenerative disorder characterized by neuronal cell death, loss of synapses, and deposition of misfolded protein plaques in the brain; the main constituent of these plaques is the amyloid-beta peptide, a 40 - 42 amino-acid-long protein fragment derived by AbetaPP upon two sequential processing events. Mutations in the genes encoding for AbetaPP and some of the enzymes responsible for its processing are strongly associated with familial forms of early onset AD. Therefore, the elucidation of the mechanisms underlying AbetaPP metabolism appears crucial to understanding the basis for the onset of AD. Apart from Abeta, upon processing of AbetaPP other fragments are generated. The long extracellular domain is released in the extracellular space, whereas the short cytoplasmic tail, named AbetaPP intracellular domain (AID) is released intracellularly. AID appears be involved in several cellular processes, apoptosis, calcium homeostasis, and transcriptional regulation. We have recently reported the cloning and characterization of different isoforms of AID associated protein-1 (AIDA-1), a novel AID-binding protein. Here we further analyzed the interaction between several AIDA-1 isoforms and the cytoplasmic tail of AbetaPP. Our data demonstrated that the interaction between the two molecules is regulated by alternative splicing of the AIDA-1 proteins. Furthermore, we provide data supporting a possible function for AIDA-1a as a modulator of AbetaPP processing.	Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	D'Adamio, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ldadamio@aecom.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	NATIONAL INSTITUTE ON AGING [R01AG022024, R01AG021588] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG22024, R01 AG21588] Funding Source: Medline; Telethon [GFP02006] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Telethon(Fondazione Telethon)		Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Ghersi E, 2004, J ALZHEIMERS DIS, V6, P67; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Matsuda S, 2001, J NEUROSCI, V21, P6597; McLoughlin DM, 1996, FEBS LETT, V397, P197; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Noviello C, 2003, J BIOL CHEM, V278, P31843, DOI 10.1074/jbc.M304133200; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Siegel R. M., 2000, SCI STKE, V2000, ppl1; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	55	38	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49105	49112		10.1074/jbc.M405329200	http://dx.doi.org/10.1074/jbc.M405329200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347684	hybrid			2022-12-27	WOS:000225098100075
J	Squires, EJ; Sueyoshi, T; Negishi, M				Squires, EJ; Sueyoshi, T; Negishi, M			Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; ENHANCER MODULE; CYP2B GENE; CAR; PROTEIN; TRANSCRIPTION; IDENTIFICATION	The pregnane X receptor (PXR) plays an important role in the response to xenobiotics and endogenous toxins. We have used a specific anti-PXR antibody in the Western blotting of mouse liver nuclear extracts to show that PXR is accumulated in the nucleus after treatment with 5-pregnen-3beta-ol-20-one-16alpha-carbonitrile (PCN), followed by an increase in Cyp3a11 mRNA. Expression of wild type PXR and various mutants as green fluorescent fusion proteins in mouse livers showed that PXR was retained in the cytoplasm from where PCN treatment translocated PXR into the nucleus. Furthermore, the xenochemical response signal, the nuclear translocation signal, and the activation function 2 domain were all required for the nuclear translocation to occur. Immunoprecipitation experiments using the hsp90 antibody demonstrated the presence of PXR in a complex with the endogenous cytoplasmic constitutive active/androstane receptor retention protein (CCRP) in HepG2 cells. Fluorescence resonance energy transfer analysis of mouse liver sections after co-expression of cyan fluorescent protein-CCRP and yellow fluorescent protein-PXR also indicated that CCRP and PXR were closely associated in vivo. Overexpression of exogenous CCRP increased the cytoplasmic level of the PXR.CCRP.hsp90 complex, whereas a decrease in endogenous CCRP by treatment with small interfering RNA for CCRP repressed the PXR-mediated reporter activity in HepG2 cells. We conclude that the CCRP mediates the retention of PXR in the cytosol and modulates the activation of PXR in response to PCN treatment.	NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Pharmacogenet Sect, Reprod & Dev Toxicol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080040, ZIAES080040] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berg P, 2001, J BIOL CHEM, V276, P43231, DOI 10.1074/jbc.M105261200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HARPUR AG, 2001, MOL CLONING LAB MANU; Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hood JK, 1999, CURR OPIN CELL BIOL, V11, P241, DOI 10.1016/S0955-0674(99)80032-5; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kawana K, 2003, MOL PHARMACOL, V63, P524, DOI 10.1124/mol.63.3.524; KOBAYASHI K, 2003, MOL PHARMACOL, V64, P1; Murthy AE, 1996, DNA CELL BIOL, V15, P727, DOI 10.1089/dna.1996.15.727; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Racz A, 1999, J BIOL CHEM, V274, P19352, DOI 10.1074/jbc.274.27.19352; Sonoda J, 2003, CURR DRUG METAB, V4, P59, DOI 10.2174/1389200033336739; Sueyoshi T, 2002, METHOD ENZYMOL, V357, P205; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; SUEYOSHI T, 1995, MOL CELL BIOL, V15, P4158; Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	27	144	154	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49307	49314		10.1074/jbc.M407281200	http://dx.doi.org/10.1074/jbc.M407281200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347657	hybrid			2022-12-27	WOS:000225098100099
J	Razidlo, GL; Kortum, RL; Haferbier, JL; Lewis, RE				Razidlo, GL; Kortum, RL; Haferbier, JL; Lewis, RE			Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN MAP KINASE; SIGNAL-TRANSDUCTION; SCAFFOLD PROTEINS; 14-3-3 BINDING; RAS EFFECTORS; GENE ENCODES; C-ELEGANS; SUPPRESSOR; MEK	Kinase suppressor of Ras (KSR) is a molecular scaffold that interacts with the components of the Raf/MEK/ERK kinase cascade and positively regulates ERK signaling. Phosphorylation of KSR1, particularly at Ser(392), is a critical regulator of KSR1 subcellular localization and ERK activation. We examined the role of phosphorylation of both Ser(392) and Thr(274) in regulating ERK activation and cell proliferation. We hypothesized that KSR1 phosphorylation is involved in generating signaling specificity through the Raf/MEK/ERK kinase cascade in response to stimulation by different growth factors. In fibroblasts, platelet-derived growth factor stimulation induces sustained ERK activation and promotes S-phase entry. Treatment with epidermal growth factor induces transient ERK activation but fails to drive cells into S phase. Mutation of Ser(392) and Thr(274) ( KSR1.TVSA) promotes sustained ERK activation and cell cycle progression with either platelet-derived growth factor or epidermal growth factor treatment. KSR1(-/-) mouse embryo fibroblasts expressing KSR1. TVSA proliferate two times faster and grow to a higher density than cells expressing the same level of wild-type KSR1. In addition, KSR1. TVSA is more stable than wild-type KSR1. These data demonstrate that phosphorylation and stability of the molecular scaffold KSR1 are critical regulators of growth factor-specific responses that promote cell proliferation.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Lewis, RE (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	rlewis@unmc.edu	Lewis, Robert E./H-3404-2019	Razidlo, Gina/0000-0002-9042-2738	NATIONAL CANCER INSTITUTE [R01CA090400, P30CA036727] Funding Source: NIH RePORTER; NCI NIH HHS [CA90400, CA36727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; Bar-Sagi D, 2001, MOL CELL BIOL, V21, P1441, DOI 10.1128/MCB.21.5.1441-1443.2001; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Brennan JA, 2002, J BIOL CHEM, V277, P5369, DOI 10.1074/jbc.M109875200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Elion EA, 1998, SCIENCE, V281, P1625, DOI 10.1126/science.281.5383.1625; FERRELL JE, 2000, SCI STKE; Giblett SM, 2002, CELL GROWTH DIFFER, V13, P307; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Kortum RL, 2004, MOL CELL BIOL, V24, P4407, DOI 10.1128/MCB.24.10.4407-4416.2004; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lozano J, 2003, CANCER RES, V63, P4232; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schillace RV, 1999, J CLIN INVEST, V103, P761, DOI 10.1172/JCI6491; SCHLESSINGER J, 1994, COLD SPRING HARB SYM, V59, P173, DOI 10.1101/SQB.1994.059.01.021; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Stewart S, 1999, MOL CELL BIOL, V19, P5523; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Volle DJ, 1999, BIOCHEMISTRY-US, V38, P5130, DOI 10.1021/bi983050d; Wang XN, 2004, J CELL PHYSIOL, V198, P333, DOI 10.1002/jcp.10443; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xing HR, 2000, J BIOL CHEM, V275, P17276, DOI 10.1074/jbc.C900989199; Xing HR, 2004, J BIOL CHEM, V279, P26210, DOI 10.1074/jbc.M401323200; Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	48	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47808	47814		10.1074/jbc.M406395200	http://dx.doi.org/10.1074/jbc.M406395200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15371409	hybrid			2022-12-27	WOS:000224957000049
J	He, LS; Grammer, AC; Wu, XL; Lipsky, PE				He, LS; Grammer, AC; Wu, XL; Lipsky, PE			TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; RESONANCE ENERGY-TRANSFER; LYMPHOTOXIN-BETA-RECEPTOR; TERMINAL KINASE; C-JUN; SUBCELLULAR-LOCALIZATION; FLUORESCENT PROTEIN; SPLICE-VARIANT; SINGLE-LASER; RING FINGER	FRET experiments utilizing confocal microscopy or flow cytometry assessed homo- and heterotrimeric association of human tumor necrosis factor receptor-associated factors (TRAF) in living cells. Following transfection of HeLa cells with plasmids expressing CFP- or YFP-TRAF fusion proteins, constitutive homotypic association of TRAF2, -3, and -5 was observed, as well as heterotypic association of TRAF1-TRAF2 and TRAF3-TRAF5. A novel heterotypic association between TRAF2 and -3 was detected and confirmed by immunoprecipitation in Ramos B cells that constitutively express both TRAF2 and -3. Experiments employing deletion mutants of TRAF2 and TRAF3 revealed that this heterotypic interaction minimally involved the TRAF-C domain of TRAF3 as well as the TRAF-N domain and zinc fingers 4 and 5 of TRAF2. A novel flow cytometric FRET analysis utilizing a two-step approach to achieve linked FRET from CFP to YFP to HcRed established that TRAF2 and -3 constitutively form homo- and heterotrimers. The functional importance of TRAF2-TRAF3 heterotrimerization was demonstrated by the finding that TRAF3 inhibited spontaneous NF-kappaB, but not AP-1, activation induced by TRAF2. Ligation of CD40 on Ramos B cells by recombinant CD154 caused TRAF2 and TRAF3 to dissociate, whereas overexpression of TRAF3 in Ramos B cells inhibited CD154-induced TRAF2-mediated activation of NF-kappaB. Together, these results reveal a novel association between TRAF2 and TRAF3 that is mediated by unique portions of each protein and that specifically regulates activation of NF-kappaB, but not AP-1.	NIAMS, NIH, US Dept HHS, Bethesda, MD 20892 USA; NIH, Glow Cytometry Sect, Off Sci & Technol, US Dept HHS, Bethesda, MD 20892 USA; NIH, Cell Biol Grp B, Autoimmun Branch, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA	Lipsky, PE (corresponding author), NIAMS, NIH, US Dept HHS, 9000 Rockville Pike,Bldg 10,Rm 9N228, Bethesda, MD 20892 USA.	lipskyp@mail.nih.gov		Grammer, Amrie/0000-0001-7142-2284	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041140, Z01AR041128] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Annunziata CM, 2000, BLOOD, V96, P2841; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Arron JR, 2002, J EXP MED, V196, P923, DOI 10.1084/jem.20020774; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brink R, 1998, J BIOL CHEM, V273, P4129, DOI 10.1074/jbc.273.7.4129; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Cannons JL, 2002, J IMMUNOL, V169, P2828, DOI 10.4049/jimmunol.169.6.2828; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Dadgostar H, 1998, J BIOL CHEM, V273, P24775, DOI 10.1074/jbc.273.38.24775; Dadgostar H, 2003, FEBS LETT, V553, P403, DOI 10.1016/S0014-5793(03)01072-X; Dadgostar H, 2000, J BIOL CHEM, V275, P2539, DOI 10.1074/jbc.275.4.2539; Ely KR, 2002, J MOL RECOGNIT, V15, P286, DOI 10.1002/jmr.589; Force WR, 2000, J BIOL CHEM, V275, P11121, DOI 10.1074/jbc.275.15.11121; Frew IJ, 2003, MOL CELL BIOL, V23, P9150, DOI 10.1128/MCB.23.24.9150-9161.2003; Gamper C, 2001, HUM IMMUNOL, V62, P1167, DOI 10.1016/S0198-8859(01)00284-1; Grammer A C, 2000, Adv Immunol, V76, P61; Grammer AC, 1998, J IMMUNOL, V161, P1183; Ha H, 2003, EXP MOL MED, V35, P279, DOI 10.1038/emm.2003.38; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; He LS, 2003, CYTOM PART A, V53A, P39, DOI 10.1002/cyto.a.10037; Hong JW, 2003, P NATL ACAD SCI USA, V100, P12301, DOI 10.1073/pnas.2133048100; Hong X, 2001, FEBS LETT, V499, P133, DOI 10.1016/S0014-5793(01)02535-2; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lee ZH, 2001, J LEUKOCYTE BIOL, V69, P490; Leo E, 1999, J BIOL CHEM, V274, P22414, DOI 10.1074/jbc.274.32.22414; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; Ni CZ, 2002, ACTA CRYSTALLOGR D, V58, P1340, DOI 10.1107/S0907444902008958; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Oukka M, 2004, J EXP MED, V199, P15, DOI 10.1084/jem.20030421; Prell RA, 2003, J IMMUNOL, V171, P5997, DOI 10.4049/jimmunol.171.11.5997; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sharma N, 2001, AM J PATHOL, V159, P339, DOI 10.1016/S0002-9440(10)61700-2; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Sinha SK, 2002, J BIOL CHEM, V277, P44953, DOI 10.1074/jbc.M207923200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaori-Kondo A, 2000, BIOCHEM BIOPH RES CO, V272, P856, DOI 10.1006/bbrc.2000.2860; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsao DHH, 2000, MOL CELL, V5, P1051, DOI 10.1016/S1097-2765(00)80270-1; van Eyndhoven WG, 1999, MOL IMMUNOL, V36, P647, DOI 10.1016/S0161-5890(99)00079-6; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	56	69	76	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2004	279	53					55855	55865		10.1074/jbc.M407284200	http://dx.doi.org/10.1074/jbc.M407284200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	882TI	15383523	hybrid			2022-12-27	WOS:000225960800109
J	Barth, A; Bezlyepkina, N				Barth, A; Bezlyepkina, N			P-O bond destabilization accelerates phosphoenzyme hydrolysis of sarcoplasmic reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED DIFFERENCE SPECTROSCOPY; TIME-RESOLVED FTIR; MOLECULAR INTERPRETATION; CONFORMATIONAL-CHANGES; PROTEIN-STRUCTURE; ACETYL PHOSPHATE; CATALYTIC CYCLE; ATP; PHOSPHORYLATION; ENZYME	The phosphate group of the ADP-insensitive phosphoenzyme (E2-P) of sarcoplasmic reticulum Ca2+-ATPase (SERCA1a) was studied with infrared spectroscopy to understand the high hydrolysis rate of E2-P. By monitoring an autocatalyzed isotope exchange reaction, three stretching vibrations of the transiently bound phosphate group were selectively observed against a background of 50,000 protein vibrations. They were found at 1194, 1137, and 1115 cm(-1). This information was evaluated using the bond valence model and empirical correlations. Compared with the model compound acetyl phosphate, structure and charge distribution of the E2-P aspartyl phosphate resemble somewhat the transition state in a dissociative phosphate transfer reaction; the aspartyl phosphate of E2-P has 0.02 Angstrom shorter terminal P-O bonds and a 0.09 Angstrom longer bridging P-O bond that is similar to20% weaker, the angle between the terminal P-O bonds is wider, and -0.2 formal charges are shifted from the phosphate group to the aspartyl moiety. The weaker bridging P-O bond of E2-P accounts for a 10(11)-10(15)-fold hydrolysis rate enhancement, implying that P-O bond destabilization facilitates phosphoenzyme hydrolysis. P-O bond destabilization is caused by a shift of noncovalent interactions from the phosphate oxygens to the aspartyl oxygens. We suggest that the relative positioning of Mg2+ and Lys(684) between phosphate and aspartyl oxygens controls the hydrolysis rate of the ATPase phosphoenzymes and related phosphoproteins.	Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; Goethe Univ Frankfurt, Inst Biophys, D-60590 Frankfurt, Germany	Stockholm University; Goethe University Frankfurt	Bezlyepkina, N (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	Andreas.Barth@dbb.su.se	Barth, Andreas/N-8872-2013	Barth, Andreas/0000-0001-5784-7673				ALBEN JO, 1968, BIOCHEMISTRY-US, V7, P175, DOI 10.1021/bi00841a022; ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Barth A, 1999, J BIOL CHEM, V274, P22170, DOI 10.1074/jbc.274.32.22170; BARTH A, 1994, BBA-BIOMEMBRANES, V1194, P75, DOI 10.1016/0005-2736(94)90205-4; Barth A, 1998, BIOPHYS J, V75, P538, DOI 10.1016/S0006-3495(98)77543-5; Barth A, 1996, J BIOL CHEM, V271, P30637, DOI 10.1074/jbc.271.48.30637; BARTH A, 1991, BIOCHIM BIOPHYS ACTA, V1057, P115, DOI 10.1016/S0005-2728(05)80091-X; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2002, BIOPOLYMERS, V67, P237, DOI 10.1002/bip.10085; BARTH A, 1990, FEBS LETT, V277, P147, DOI 10.1016/0014-5793(90)80830-C; Barth A, 2000, FEBS LETT, V477, P151, DOI 10.1016/S0014-5793(00)01782-8; BELASCO JG, 1980, BIOCHEMISTRY-US, V19, P472, DOI 10.1021/bi00544a012; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; Brown I.D., 2002, CHEM BOND INORGANIC; BROWN ID, 1992, ACTA CRYSTALLOGR B, V48, P553, DOI 10.1107/S0108768192002453; BROWN ID, 1976, ACTA CRYSTALLOGR B, V32, P1957, DOI 10.1107/S0567740876006869; BYSTROM A, 1951, ACTA CHEM SCAND, V5, P1003, DOI 10.3891/acta.chem.scand.05-1003; Cepus V, 1998, BIOCHEMISTRY-US, V37, P10263, DOI 10.1021/bi973183j; CHALOUB RM, 1979, J BIOL CHEM, V254, P9464; Cheng H, 2001, BIOCHEMISTRY-US, V40, P4035, DOI 10.1021/bi0021131; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2; DEMEIS L, 1988, FEBS LETT, V232, P73, DOI 10.1016/0014-5793(88)80389-2; Deng H, 2001, PRACT SPECTROSC SERI, V24, P477; Deng H, 1998, J PHYS CHEM B, V102, P3617, DOI 10.1021/jp973314q; DISABATO G, 1961, J AM CHEM SOC, V83, P4400, DOI 10.1021/ja01482a025; Du XL, 2000, J BIOL CHEM, V275, P8492, DOI 10.1074/jbc.275.12.8492; DUPONT Y, 1983, FEBS LETT, V156, P93, DOI 10.1016/0014-5793(83)80255-5; Fershts A, 1999, STRUCTURE MECH PROTE, P330; GANS P, 1971, VIBRATING MOL; Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HASSELBACH W, 1981, MEMBRANE TRANSPORT, P183; HERSCHBACH D, 1961, J CHEM PHYS, V35, P458, DOI 10.1063/1.1731952; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P5172, DOI 10.1021/bi00473a025; HERZBERG G, 1950, MOL SPECTRA MOL STRU, V1, P100; HORVATH G, 1987, ACTA CHIM HUNG, V124, P819; INESI G, 1985, ENZYMES BIOL MEMBR, V3, P157; JENCKS WP, 1989, METHOD ENZYMOL, V171, P145; JOHNSTON HS, 1964, J AM CHEM SOC, V86, P1643, DOI 10.1021/ja01062a044; Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C; KANAZAWA T, 1973, J BIOL CHEM, V248, P3163; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; LAYTON EM, 1956, J CHEM PHYS, V25, P135, DOI 10.1063/1.1742805; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; LEHNINGER AL, 1993, PRINCIPLES BIOCH, P66; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; MANTELE W, 1993, TRENDS BIOCHEM SCI, V18, P197, DOI 10.1016/0968-0004(93)90186-Q; Martonosi A, 1985, Soc Gen Physiol Ser, V39, P57; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; Mintz E, 1997, BBA-BIOENERGETICS, V1318, P52, DOI 10.1016/S0005-2728(96)00132-6; MURRAYRUST P, 1975, J AM CHEM SOC, V97, P921, DOI 10.1021/ja00837a055; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Pauling L, 1929, J AM CHEM SOC, V51, P1010, DOI 10.1021/ja01379a006; POHLE W, 1991, J MOL STRUCT, V242, P333, DOI 10.1016/0022-2860(91)87145-8; RAUCH B, 1977, Z NATURFORSCH C, V32, P828; Schulz G.E., 1979, PRINCIPLES PROTEIN S, P28; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P4157; SIEBERT F, 1995, METHOD ENZYMOL, V246, P501; Sigel H, 1999, J AM CHEM SOC, V121, P6248, DOI 10.1021/ja9904181; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; VIEYRA A, 1979, BIOCHIM BIOPHYS ACTA, V568, P437, DOI 10.1016/0005-2744(79)90312-7; VILSEN B, 1991, J BIOL CHEM, V266, P16157; Wharton CW, 2000, NAT PROD REP, V17, P447, DOI 10.1039/b002066o; ZIOLKOWSKI J, 1985, J SOLID STATE CHEM, V57, P269, DOI 10.1016/0022-4596(85)90152-5; ZIOLKOWSKI J, 1985, J SOLID STATE CHEM, V57, P291, DOI 10.1016/0022-4596(85)90153-7; ZIOLKOWSKI J, 1983, J CATAL, V84, P317; Zscherp C, 2001, BIOCHEMISTRY-US, V40, P1875, DOI 10.1021/bi002567y	74	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51888	51896		10.1074/jbc.M410867200	http://dx.doi.org/10.1074/jbc.M410867200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452115	hybrid			2022-12-27	WOS:000225493400022
J	Mullner, C; Broos, LAM; van den Maagdenberg, AMJM; Striessnig, J				Mullner, C; Broos, LAM; van den Maagdenberg, AMJM; Striessnig, J			Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Ca(v)2.1 Ca2+ channel gating - Evidence for beta-subunit isoform-specific effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM-CHANNEL; EPISODIC ATAXIA TYPE-2; FUNCTIONAL CONSEQUENCES; SYNAPTIC-TRANSMISSION; PROGRESSIVE ATAXIA; EXPRESSION; BRAIN; IDENTIFICATION; HETEROGENEITY; HIPPOCAMPUS	Mutations in the Ca(v)2.1 alpha1-subunit of P/Q-type Ca2+ channels cause human diseases, including familial hemiplegic migraine type-1 (FHM1). FHM1 mutations alter channel gating and enhanced channel activity at negative potentials appears to be a common pathogenetic mechanism. Different beta-subunit isoforms (primarily beta(4) and beta(3)) participate in the formation of Ca(v)2.1 channel complexes in mammalian brain. Here we investigated not only whether FHM1 mutations K1336E (KE), W1684R (WR), and V1696I (VI) can affect Ca(v)2.1 channel function but focused on the important question whether mutation-induced changes on channel gating depend on the beta-subunit isoform. Mutants were co-expressed in Xenopus oocytes together with beta(1), beta(3), or beta(4) and alpha(2)delta(1) subunits, and channel function was analyzed using the two-electrode voltage-clamp technique. WR shifted the voltage dependence for steady-state inactivation of Ba2+ inward currents (I-Ba) to more negative voltages with all beta-subunits tested. In contrast, a similar shift was observed for KE only when expressed with beta(3). All mutations promoted IBa decay during pulse trains only when expressed with beta(1) or beta(3) but not with beta(4). Enhanced decay could be explained by delayed recovery from inactivation. KE accelerated I-Ba inactivation only when co-expressed with beta(3), and VI slowed inactivation only with beta(1) or beta(3). KE and WR shifted channel activation of I-Ba to more negative voltages. As the beta-subunit composition of Ca(v)2.1 channels varies in different brain regions, our data predict that the functional FHM1 phenotype also varies between different neuronal compartments.	Univ Innsbruck, Inst Pharm, Abt Pharmakol & Toxikol, A-6020 Innsbruck, Austria; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 Leiden, Netherlands	University of Innsbruck; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Striessnig, J (corresponding author), Univ Innsbruck, Inst Pharm, Abt Pharmakol & Toxikol, Peter Mayrstr 1-I, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Striessnig, Joerg/S-9334-2017; van den Maagdenberg, Arn M.J.M./AAE-9052-2019	Striessnig, Joerg/0000-0002-9406-7120; 	Austrian Science Fund FWF [P 17109] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Bayliss DA, 1997, J NEUROPHYSIOL, V77, P1362, DOI 10.1152/jn.1997.77.3.1362; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Day NC, 1998, MOL BRAIN RES, V60, P259, DOI 10.1016/S0169-328X(98)00186-7; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Grabner M, 1996, NEURON, V16, P207, DOI 10.1016/S0896-6273(00)80037-9; Guida S, 2001, AM J HUM GENET, V68, P759, DOI 10.1086/318804; Hans M, 1999, J NEUROSCI, V19, P1610; Jen J, 1999, NEUROLOGY, V53, P34, DOI 10.1212/WNL.53.1.34; Jen J, 2001, NEUROLOGY, V57, P1843, DOI 10.1212/WNL.57.10.1843; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kors EE, 2003, ARCH NEUROL-CHICAGO, V60, P684, DOI 10.1001/archneur.60.5.684; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Kraus RL, 2000, J BIOL CHEM, V275, P9239, DOI 10.1074/jbc.275.13.9239; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Lie AA, 1999, NEUROSCIENCE, V93, P449, DOI 10.1016/S0306-4522(99)00162-1; Liu HY, 1996, J BIOL CHEM, V271, P13804, DOI 10.1074/jbc.271.23.13804; Ludwig A, 1997, J NEUROSCI, V17, P1339; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2819, DOI 10.1073/pnas.262787699; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Pietrobon D, 2002, MOL NEUROBIOL, V25, P31, DOI 10.1385/MN:25:1:031; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Tottene A, 2002, P NATL ACAD SCI USA, V99, P13284, DOI 10.1073/pnas.192242399; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; Wappl E, 2002, J BIOL CHEM, V277, P6960, DOI 10.1074/jbc.M110948200; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403	31	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51844	51850		10.1074/jbc.M408756200	http://dx.doi.org/10.1074/jbc.M408756200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448138	hybrid			2022-12-27	WOS:000225493400017
J	de Fourmestraux, V; Neubauer, H; Poussin, C; Farmer, P; Falquet, L; Burcelin, R; Delorenzi, M; Thorens, B				de Fourmestraux, V; Neubauer, H; Poussin, C; Farmer, P; Falquet, L; Burcelin, R; Delorenzi, M; Thorens, B			Transcript profiling suggests that differential metabolic adaptation of mice to a high fat diet is associated with changes in liver to muscle lipid fluxes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; NITRIC-OXIDE SYNTHASE; INDUCED INSULIN-RESISTANCE; GENE-EXPRESSION; CANCER EPIGENETICS; DNA METHYLATION; ACID OXIDATION; OBESITY; LEPTIN; OVEREXPRESSION	Genetically homogenous C57Bl/6 mice display differential metabolic adaptation when fed a high fat diet for 9 months. Most become obese and diabetic, but a significant fraction remains lean and diabetic or lean and non-diabetic. Here, we performed microarray analysis of "metabolic" transcripts expressed in liver and hindlimb muscles to evaluate: (i) whether expressed transcript patterns could indicate changes in metabolic pathways associated with the different phenotypes, (ii) how these changes differed from the early metabolic adaptation to short term high fat feeding, and (iii) whether gene classifiers could be established that were characteristic of each metabolic phenotype. Our data indicate that obesity/diabetes was associated with preserved hepatic lipogenic gene expression and increased plasma levels of very low density lipoprotein and, in muscle, with an increase in lipoprotein lipase gene expression. This suggests increased muscle fatty acid uptake, which may favor insulin resistance. In contrast, the lean mice showed a strong reduction in the expression of hepatic lipogenic genes, in particular of Scd-1, a gene linked to sensitivity to diet-induced obesity; the lean and non-diabetic mice presented an additional increased expression of eNos in liver. After 1 week of high fat feeding the liver gene expression pattern was distinct from that seen at 9 months in any of the three mouse groups, thus indicating progressive establishment of the different phenotypes. Strikingly, development of the obese phenotype involved re-expression of Scd-1 and other lipogenic genes. Finally, gene classifiers could be established that were characteristic of each metabolic phenotype. Together, these data suggest that epigenetic mechanisms influence gene expression patterns and metabolic fates.	Univ Lausanne, Inst Physiol, CH-1005 Lausanne, Switzerland; Inst Suisse Rech Expt Canc, Natl Ctr Competence Res Mol Oncol, CH-1066 Epalinges, Switzerland; Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland; Univ Toulouse 3, CHU Rangueil, CNRS, UMR 5018,IFR31, F-31403 Toulouse, France	University of Lausanne; Swiss Institute of Bioinformatics; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Thorens, B (corresponding author), Univ Lausanne, Inst Physiol, CH-1005 Lausanne, Switzerland.	Bernard.Thorens@iphysiol.unil.ch	burcelin, remy/M-6013-2014; Neubauer, Hans/C-4467-2016; Falquet, Laurent/C-2541-2013	Neubauer, Hans/0000-0002-3467-4105; 				Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; BUCHANAN TA, 1992, AM J PHYSIOL, V263, pR785, DOI 10.1152/ajpregu.1992.263.4.R785; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Butler A A, 2001, Trends Genet, V17, pS50, DOI 10.1016/S0168-9525(01)02481-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Maier S, 2002, J NUTR, V132, p2440S, DOI 10.1093/jn/132.8.2440S; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Nagase H, 1996, AM J PHYSIOL-REG I, V270, pR489, DOI 10.1152/ajpregu.1996.270.3.R489; Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/00041433-200306000-00005; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Yoshimura A, 1998, CYTOKINE GROWTH F R, V9, P197, DOI 10.1016/S1359-6101(98)00019-7; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P6386, DOI 10.1073/pnas.94.12.6386; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	39	69	76	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50743	50753		10.1074/jbc.M408014200	http://dx.doi.org/10.1074/jbc.M408014200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15377667	hybrid			2022-12-27	WOS:000225355800016
J	Garbarino-Pico, E; Carpentieri, AR; Contin, MA; Sarmiento, MI; Brocco, MA; Panzetta, P; Rosenstein, RE; Caputto, BL; Guido, ME				Garbarino-Pico, E; Carpentieri, AR; Contin, MA; Sarmiento, MI; Brocco, MA; Panzetta, P; Rosenstein, RE; Caputto, BL; Guido, ME			Retinal ganglion cells are autonomous circadian oscillators synthesizing N-acetylserotonin during the day	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLDEN-HAMSTER RETINA; EARLY GENE-EXPRESSION; CHICKEN PINEAL-GLAND; ACETYLTRANSFERASE ACTIVITY; SUPRACHIASMATIC NUCLEUS; MELATONIN SYNTHESIS; MESSENGER-RNA; CYCLIC-AMP; PHOTIC REGULATION; MAMMALIAN RETINA	Retinal ganglion cells send visual and circadian information to the brain regarding the environmental light-dark cycles. We investigated the capability of retinal ganglion cells of synthesizing melatonin, a highly reliable circadian marker that regulates retinal physiology, as well as the capacity of these cells to function as autonomous circadian oscillators. Chick retinal ganglion cells presented higher levels of melatonin assessed by radioimmunoassay during both the subjective day in constant darkness and the light phase of a light-dark cycle. Similar changes were observed in mRNA levels and activity of arylalkylamine N-acetyltransferase, a key enzyme in melatonin biosynthesis, with the highest levels of both parameters during the subjective day. These daily variations were preceded by the elevation of cyclic-AMP content, the second messenger involved in the regulation of melatonin biosynthesis. Moreover, cultures of immunopurified retinal ganglion cells at embryonic day 8 synchronized by medium exchange synthesized a [H-3] melatonin-like indole from [H-3] tryptophan. This [H-3] indole was rapidly released to the culture medium and exhibited a daily variation, with levels peaking 8 h after synchronization, which declined a few hours later. Cultures of embryonic retinal ganglion cells also showed self-sustained daily rhythms in arylalkylamine N-acetyltransferase mRNA expression during at least three cycles with a period near 24 h. These rhythms were also observed after the application of glutamate. The results demonstrate that chick retinal ganglion cells may function as autonomous circadian oscillators synthesizing a melatonin-like indole during the day.	Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina; Univ Buenos Aires, Fac Med, Dept Bioquim Humana, RA-1121 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of Buenos Aires	Guido, ME (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina.	mguido@dqb.fcq.unc.edu.ar	Agata, Carpentieri/AAE-4504-2022	Carpentieri, Agata/0000-0002-6426-0501; Garbarino Pico, Eduardo/0000-0002-2931-2038				ALONSOGOMEZ AL, 1995, J NEUROCHEM, V46, P33; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; AVENDANO G, 1990, NEUROCHEM INT, V17, P117, DOI 10.1016/0197-0186(90)90075-5; AXELROD J, 1961, J BIOL CHEM, V236, P211; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Bayarri MJ, 2003, BRAIN RES, V969, P175, DOI 10.1016/S0006-8993(03)02297-2; Benyassi A, 2000, NEUROREPORT, V11, P255, DOI 10.1097/00001756-200002070-00006; Bernard M, 1997, J NEUROCHEM, V68, P213; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; BESHARSE JC, 1983, SCIENCE, V219, P1341, DOI 10.1126/science.6828862; BINKLEY S, 1979, NATURE, V281, P479, DOI 10.1038/281479a0; BINKLEY S, 1980, J COMP PHYSIOL, V139, P103, DOI 10.1007/BF00691023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandstatter R, 2000, P NATL ACAD SCI USA, V97, P12324, DOI 10.1073/pnas.200354997; Brocco MA, 2002, NEUROSCI LETT, V328, P221, DOI 10.1016/S0304-3940(02)00516-5; Brocco MA, 1999, DEV BRAIN RES, V118, P23, DOI 10.1016/S0165-3806(99)00120-0; Butowt R, 2000, J NEUROSCI METH, V95, P29, DOI 10.1016/S0165-0270(99)00149-1; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; *CAN WHOL DRUG ASS, 1999, GUID GOV REL PROGR, P1; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; CASSONE VM, 1990, J COMP PHYSIOL A, V167, P187; CHAMPNEY TH, 1984, J NEUROSCI RES, V11, P59, DOI 10.1002/jnr.490110107; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chong NW, 1998, MOL BRAIN RES, V61, P243, DOI 10.1016/S0169-328X(98)00219-8; Coon SL, 1999, J BIOL CHEM, V274, P9076, DOI 10.1074/jbc.274.13.9076; David-Gray ZK, 1998, NAT NEUROSCI, V1, P655, DOI 10.1038/3656; DOWSING BJ, 1992, MOL BRAIN RES, V14, P250, DOI 10.1016/0169-328X(92)90180-J; DUBOCOVICH ML, 1983, NATURE, V306, P782, DOI 10.1038/306782a0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; FAILLACE MP, 1995, NEUROREPORT, V6, P2093, DOI 10.1097/00001756-199510010-00033; Faillace MP, 1996, J NEUROCHEM, V67, P623; FAILLACE MP, 1994, J NEUROCHEM, V62, P1995; Falcon J, 2003, J NEUROENDOCRINOL, V15, P378, DOI 10.1046/j.1365-2826.2003.00993.x; FALCON J, 1991, CELL TISSUE RES, V265, P601, DOI 10.1007/BF00340884; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; FRENCH PW, 1986, J NEUROSCI RES, V16, P479, DOI 10.1002/jnr.490160304; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Green CB, 1998, TRENDS CELL BIOL, V8, P224, DOI 10.1016/S0962-8924(98)01269-0; GREENBERGER LM, 1985, J COMP NEUROL, V239, P361, DOI 10.1002/cne.902390402; Guido ME, 1999, NEUROSCIENCE, V90, P555, DOI 10.1016/S0306-4522(98)00467-9; Guido ME, 2002, NEUROCHEM RES, V27, P1473, DOI 10.1023/A:1021696321391; Guido ME, 1999, MOL BRAIN RES, V67, P247, DOI 10.1016/S0169-328X(99)00074-1; Guido ME, 1999, BRAIN RES PROTOC, V4, P147, DOI 10.1016/S1385-299X(99)00013-6; Guido ME, 2001, J NEUROCHEM, V76, P835, DOI 10.1046/j.1471-4159.2001.00081.x; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; HAMM HE, 1983, BRAIN RES, V266, P287, DOI 10.1016/0006-8993(83)90660-1; HAMM HE, 1980, P NATL ACAD SCI-BIOL, V77, P4998, DOI 10.1073/pnas.77.8.4998; Haque R, 2002, NEUROREPORT, V13, P2247, DOI 10.1097/00001756-200212030-00016; Hastings J.W., 1991, NEURAL INTEGRATIVE A, P435; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Higgs MH, 1999, J NEUROSCI, V19, P3691; Iigo M, 1997, NEUROREPORT, V8, P1631; IUVONE PM, 1991, J NEUROCHEM, V57, P615, DOI 10.1111/j.1471-4159.1991.tb03792.x; IUVONE PM, 1990, J NEUROCHEM, V55, P673, DOI 10.1111/j.1471-4159.1990.tb04186.x; Iuvone PM, 2002, INVEST OPHTH VIS SCI, V43, P564; IUVONE PM, 1990, J NEUROCHEM, V54, P1562, DOI 10.1111/j.1471-4159.1990.tb01205.x; IUVONE PM, 2000, MELATONIN 4 DECADES, P31; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; KLEIN DC, 1969, ANAL BIOCHEM, V31, P480, DOI 10.1016/0003-2697(69)90290-5; Larkin P, 1999, MOL BRAIN RES, V70, P253, DOI 10.1016/S0169-328X(99)00154-0; Liu CM, 2004, CELL TISSUE RES, V315, P197, DOI 10.1007/s00441-003-0822-1; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Matsui K, 1998, J NEUROSCI, V18, P4500; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MORIN LP, 1994, BRAIN RES REV, V19, P102, DOI 10.1016/0165-0173(94)90005-1; Natesan AK, 2002, VISUAL NEUROSCI, V19, P265, DOI 10.1017/S0952523802192042; Niki T, 1998, BIOCHEM BIOPH RES CO, V248, P115, DOI 10.1006/bbrc.1998.8916; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; REPPERT SM, 1995, NEURON, V15, P1003, DOI 10.1016/0896-6273(95)90090-X; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 1997, J BIOL RHYTHM, V12, P528, DOI 10.1177/074873049701200606; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; RUSAK B, 1990, ANNU REV NEUROSCI, V13, P387, DOI 10.1146/annurev.ne.13.030190.002131; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; TAKAHASHI JS, 1979, FED PROC, V38, P2583; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; TESSIERLAVIGNE M, 1991, PRINCIPLES NEURAL SC, P400; THOMAS KB, 1993, BRAIN RES, V601, P303; Tosini G, 2000, CHRONOBIOL INT, V17, P599, DOI 10.1081/CBI-100101067; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; UNDERWOOD H, 1990, J BIOL RHYTHM, V5, P257, DOI 10.1177/074873049000500307; VALENZUELA P, 1981, NATURE, V289, P650, DOI 10.1038/289650a0; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T; Yoshimura T, 2001, AM J PHYSIOL-REG I, V280, pR1185, DOI 10.1152/ajpregu.2001.280.4.R1185; ZACHMANN A, 1992, CAN J ZOOL, V70, P25, DOI 10.1139/z92-004; ZAWILSKA JB, 1992, NEUROSCI LETT, V135, P71, DOI 10.1016/0304-3940(92)90138-W	100	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51172	51181		10.1074/jbc.M309248200	http://dx.doi.org/10.1074/jbc.M309248200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448149	hybrid			2022-12-27	WOS:000225355800064
J	Park, SJ; Wu, CH; Gordon, JD; Zhong, XL; Emami, A; Safa, AR				Park, SJ; Wu, CH; Gordon, JD; Zhong, XL; Emami, A; Safa, AR			Taxol induces caspase-10-dependent apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PACLITAXEL-INDUCED APOPTOSIS; LEUKEMIA-CELL LINE; HUMAN NEUROBLASTOMA-CELLS; BREAST-CARCINOMA CELLS; DRUG-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; CHEMOTHERAPEUTIC DRUGS; CASPASE ACTIVATION; OCCURS DOWNSTREAM; ANTICANCER DRUGS	Taxol ( paclitaxel) is known to inhibit cell growth and trigger significant apoptosis in various cancer cells. Although taxol induces apoptosis of cancer cells, its exact mechanism of action is not yet known. In this study we investigated death receptors, FAS-associated death domain protein (FADD), the activation of caspases-10 and - 8 as well as the downstream caspases, and reactive oxygen species (ROS) in taxol-induced apoptosis in the CCRF-HSB-2 human lymphoblastic leukemia cell line. Pretreating the cells with neutralizing antibodies to Fas, tumor necrosis factor (TNF)-alpha receptor 1, or TNF-related apoptosis-inducing ligand receptors (DR4 and DR5) did not affect taxol-induced apoptosis, but transfection of the cells with a dominant negative FADD plasmid resulted in inhibition of taxol-induced apoptosis, revealing that taxol induces apoptosis independently of these death receptors but dependently on FADD. Furthermore, the drug induced activation of caspases-10, - 8, - 6, and - 3, cleaved Bcl-2, Bid, poly(ADP-ribose) polymerase, and lamin B, and down-regulated cellular levels of FLICE-like inhibitory protein ( FLIP) and X-chromosome-linked inhibitor of apoptosis protein ( XIAP). However, despite the release of cytochrome c from the mitochondria in taxol-treated cells, caspase-9 was not activated. Inhibitors of caspases-8, - 6, or - 3 partially inhibited taxol-induced apoptosis, whereas the caspase-10 inhibitor totally abrogated this process. Taxol-induced apoptosis was also associated with decreased mitochondrial membrane potential (DeltaPsim) and a significant increase in ROS generation. However, increased ROS production was not directly involved in taxol-triggered apoptosis. Therefore, these results demonstrate for the first time that taxol induces FADD-dependent apoptosis primarily through activation of caspase-10 but independently of death receptors.	Indiana Univ, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; Indiana Univ, Ctr Canc, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Safa, AR (corresponding author), Indiana Univ, Dept Pharmacol & Toxicol, 1044 W Walnut R4-119, Indianapolis, IN 46202 USA.	asafa@iupui.edu		Zhong, Xiaoling/0000-0002-9458-5382; Gordon, John/0000-0002-9781-9842	NATIONAL CANCER INSTITUTE [R01CA090878, R01CA080734, R01CA101743] Funding Source: NIH RePORTER; NCI NIH HHS [CA 90878, CA 080734, CA 101743] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amos LA, 1999, CHEM BIOL, V6, pR65, DOI 10.1016/S1074-5521(99)89002-4; Andre N, 2000, CANCER RES, V60, P5349; Andre N, 2002, FEBS LETT, V532, P256, DOI 10.1016/S0014-5793(02)03691-8; Aronis A, 2003, CELL DEATH DIFFER, V10, P335, DOI 10.1038/sj.cdd.4401150; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Boudny V, 2002, BRIT J CANCER, V86, P463, DOI 10.1038/sj.bjc.6600080; Cai JY, 1999, J BIOENERG BIOMEMBR, V31, P327, DOI 10.1023/A:1005423818280; Chang DW, 2003, J BIOL CHEM, V278, P16466, DOI 10.1074/jbc.C300089200; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dewson G, 2003, ONCOGENE, V22, P2643, DOI 10.1038/sj.onc.1206326; DING AH, 1990, SCIENCE, V248, P370, DOI 10.1126/science.1970196; Do Yoo Y, 1998, CLIN CANCER RES, V4, P3063; Fan WM, 1999, BIOCHEM PHARMACOL, V57, P1215; Ferreira CG, 2000, CANCER RES, V60, P7133; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; Gordon J, 2003, INT J CANCER, V103, P316, DOI 10.1002/ijc.10828; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Huang Y, 1999, ONCOGENE, V18, P3431, DOI 10.1038/sj.onc.1202685; Huisman C, 2002, CLIN CANCER RES, V8, P596; Hussein MR, 2003, J PATHOL, V199, P275, DOI 10.1002/path.1300; Ibrado AM, 1997, CANCER RES, V57, P1109; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kidd JF, 2002, J BIOL CHEM, V277, P6504, DOI 10.1074/jbc.M106802200; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kitamura K, 2000, LEUKEMIA, V14, P1743, DOI 10.1038/sj.leu.2401900; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin HL, 2000, CANCER-AM CANCER SOC, V89, P983, DOI 10.1002/1097-0142(20000901)89:5<983::AID-CNCR7>3.3.CO;2-7; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; McGinnis KM, 2003, NEUROCHEM INT, V42, P517, DOI 10.1016/S0197-0186(02)00078-5; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Mullan PB, 2001, ONCOGENE, V20, P6123, DOI 10.1038/sj.onc.1204712; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Newton K, 2000, J EXP MED, V191, P195, DOI 10.1084/jem.191.1.195; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Nimmanapalli R, 2001, CANCER RES, V61, P759; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Okano J, 2001, J BIOL CHEM, V276, P19555, DOI 10.1074/jbc.M011164200; Perkins C, 2000, BLOOD, V95, P1014, DOI 10.1182/blood.V95.3.1014.003k04_1014_1022; Salah-Eldin AE, 2003, INT J CANCER, V103, P53, DOI 10.1002/ijc.10782; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Stadheim TA, 2001, CANCER RES, V61, P1533; Stone AA, 2000, EXP CELL RES, V254, P110, DOI 10.1006/excr.1999.4731; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Tudor G, 2000, CELL DEATH DIFFER, V7, P574, DOI 10.1038/sj.cdd.4400688; Varbiro G, 2001, FREE RADICAL BIO MED, V31, P548, DOI 10.1016/S0891-5849(01)00616-5; Vikhanskaya F, 1998, EXP CELL RES, V241, P96, DOI 10.1006/excr.1998.4018; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wajant H, 1998, CURR BIOL, V8, P113, DOI 10.1016/S0960-9822(98)70042-9; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Werner AB, 2002, J BIOL CHEM, V277, P40760, DOI 10.1074/jbc.M204351200; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Wolfson M, 1997, INT J CANCER, V70, P248, DOI 10.1002/(SICI)1097-0215(19970117)70:2<248::AID-IJC17>3.0.CO;2-E; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Wu CH, 2002, ONCOGENE, V21, P5160, DOI 10.1038/sj.onc.1205639; Wu CH, 2001, ONCOGENE, V20, P7006, DOI 10.1038/sj.onc.1204893; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Yeung TK, 1999, BIOCHEM BIOPH RES CO, V263, P398, DOI 10.1006/bbrc.1999.1375; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	74	179	183	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51057	51067		10.1074/jbc.M406543200	http://dx.doi.org/10.1074/jbc.M406543200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452117	hybrid			2022-12-27	WOS:000225355800051
J	Rothblum, K; Stahl, RC; Carey, DJ				Rothblum, K; Stahl, RC; Carey, DJ			Constitutive release of alpha 4 type V collagen N-terminal domain by Schwann cells and binding to cell surface and extracellular matrix heparan sulfate proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION; IDENTIFICATION; SYNDECAN-3; RECEPTORS; CHAIN	During peripheral nerve development, Schwann cells synthesize collagen type V molecules that contain alpha4(V) chains. This collagen subunit possesses an N-terminal domain (NTD) that contains a unique high affinity heparin binding site. The alpha4(V)-NTD is adhesive for Schwann cells and sensory neurons and is an excellent substrate for Schwann cell and axonal migration. Here we show that the alpha4(V)-NTD is released constitutively by Schwann cells both in culture and in vivo. In cultures of neonatal rat Schwann cells, alpha4(V)-NTD release is increased significantly by ascorbate treatment, which facilitates collagen post-translational modification and collagen trimer assembly. In peripheral nerve tissue, the alpha4(V)-NTD is localized to the region of the outer Schwann cell membrane and associated extracellular matrix. The released alpha4(V)-NTD binds to the cell surface and extracellular matrix heparan sulfate proteoglycans of Schwann cells. Pull-down assays and immunofluorescent staining showed that the major alpha4(V)-NTD-binding proteins are glypican-1 and perlecan. alpha4(V)-NTD binding occurs via a mechanism that requires the high affinity heparin binding site and that is blocked by soluble heparin, demonstrating that binding to proteoglycans is mediated by their heparan sulfate chains.	Geisinger Med Clin, Weis Ctr Res, Danville, PA 17822 USA	Geisinger Medical Center	Carey, DJ (corresponding author), Geisinger Med Clin, Weis Ctr Res, 100 N Acad Ave, Danville, PA 17822 USA.	djcarey@geisinger.edu			NINDS NIH HHS [NS21925] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021925] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANTON ES, 1994, DEV BIOL, V164, P133, DOI 10.1006/dbio.1994.1186; Asundi VK, 2003, J NEUROSCI RES, V73, P593, DOI 10.1002/jnr.10699; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; CAREY DJ, 1993, EXP CELL RES, V208, P10, DOI 10.1006/excr.1993.1217; CAREY DJ, 1990, J CELL BIOL, V111, P2053, DOI 10.1083/jcb.111.5.2053; Carey DJ, 1997, BIOCHEM J, V327, P1; CAREY DJ, 1986, J CELL BIOL, V102, P2224; Chernousov MA, 2000, J BIOL CHEM, V275, P28208; Chernousov MA, 1999, J NEUROSCI RES, V56, P284, DOI 10.1002/(SICI)1097-4547(19990501)56:3<284::AID-JNR8>3.3.CO;2-H; Chernousov MA, 1996, J BIOL CHEM, V271, P13844, DOI 10.1074/jbc.271.23.13844; Chernousov MA, 1998, J CELL SCI, V111, P2763; Chernousov MA, 2001, J NEUROSCI, V21, P6125, DOI 10.1523/JNEUROSCI.21-16-06125.2001; Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593; ECCLESTON PA, 1992, EXP CELL RES, V199, P1, DOI 10.1016/0014-4827(92)90455-H; Erdman R, 2002, J BIOL CHEM, V277, P7619, DOI 10.1074/jbc.M111311200; Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547; Rousseau JC, 1996, J BIOL CHEM, V271, P23743, DOI 10.1074/jbc.271.39.23743; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200	19	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51282	51288		10.1074/jbc.M408837200	http://dx.doi.org/10.1074/jbc.M408837200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15383532	hybrid			2022-12-27	WOS:000225355800077
J	Jacobs, CM; Boldingh, KA; Slagsvold, HH; Thoresen, GH; Paulsen, RE				Jacobs, CM; Boldingh, KA; Slagsvold, HH; Thoresen, GH; Paulsen, RE			ERK2 prohibits apoptosis-induced subcellular translocation of orphan nuclear receptor NGFI-B/TR3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; CEREBELLAR GRANULE NEURONS; NGFI-B; MEMBRANE DEPOLARIZATION; GLUTAMATE NEUROTOXICITY; INDUCIBLE MEMBER; CELL-DEATH; PC12 CELLS; GENE	Transcription factor NGFI-B ( neuronal growth factor-induced clone B), also called Nur77 or TR3, is an immediate early gene and an orphan member of the nuclear receptor family. The NGFI-B protein also has a function distinct from that of a transcription factor; it translocates to mitochondria to initiate apoptosis. Recently, it was demonstrated that NGFI-B interacts with Bcl-2 by inducing a conformational change in Bcl-2, converting it from protector to a killer (Lin, B., Kolluri, S. K., Lin, F., Liu, W., Han, Y. H., Cao, X., Dawson, M. I., Reed, J. C., and Zhang, X. K. ( 2004) Cell 116, 527 - 540). After exposing rat cerebellar granule neurons to glutamate ( 100 muM, 15 min), NGFI-B translocated to the mitochondria. Growth factors such as the epidermal growth factor activate the MAP kinase ERK, the activity of which may determine whether a cell survives or undergoes apoptosis. In the present study we found that the epidermal growth factor activated ERK2 in cerebellar granule neurons and that this activation prohibited glutamate-induced subcellular translocation of NGFI-B. Likewise, overexpressed active ERK2 resulted in a predominant nuclear localization of green fluorescent protein-tagged NGFI-B. Thus, activation of ERK2 may overcome apoptosis-induced subcellular translocation of NGFI-B. This finding represents a novel and rapid growth factor survival pathway that is independent of gene regulation.	Univ Oslo, Inst Pharm, N-0316 Oslo, Norway	University of Oslo	Paulsen, RE (corresponding author), Univ Oslo, Inst Pharm, POB 1068 Blindern, N-0316 Oslo, Norway.	r.e.paulsen@farmasi.uio.no		Paulsen, Ragnhild Elisabeth/0000-0003-0154-8775				ABE K, 1992, NEUROSCI RES, V14, P117, DOI 10.1016/0168-0102(92)90087-S; ANDERSON NG, 1991, J BIOL CHEM, V266, P10131; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BOONSTRA J, 1983, J CELL BIOL, V97, P92, DOI 10.1083/jcb.97.1.92; CASPER D, 1995, J NEUROCHEM, V65, P1016; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Ciani E, 1995, J MOL NEUROSCI, V6, P131, DOI 10.1007/BF02736772; Ciani E, 1996, BRAIN RES, V728, P1; DAVIS IJ, 1993, MOL ENDOCRINOL, V7, P953, DOI 10.1210/me.7.8.953; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAHRNER TJ, 1990, MOL CELL BIOL, V10, P6454, DOI 10.1128/MCB.10.12.6454; GALLO V, 1987, J NEUROSCI, V7, P2203; Gunn-Moore FJ, 1998, NEUROSCI LETT, V250, P53, DOI 10.1016/S0304-3940(98)00438-8; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HAZEL TG, 1991, MOL CELL BIOL, V11, P3239, DOI 10.1128/MCB.11.6.3239; Katagiri Y, 1997, J BIOL CHEM, V272, P31278, DOI 10.1074/jbc.272.50.31278; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MAIESE K, 1993, J NEUROSCI, V13, P3034; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Olney J W, 1986, Adv Exp Med Biol, V203, P631; Slagsvold HH, 2002, BIOCHEM BIOPH RES CO, V291, P1146, DOI 10.1006/bbrc.2002.6579; Slagsvold HH, 2003, BRAIN RES, V984, P111, DOI 10.1016/S0006-8993(03)03119-6; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Thoresen GH, 1998, J CELL PHYSIOL, V175, P10, DOI 10.1002/(SICI)1097-4652(199804)175:1<10::AID-JCP2>3.3.CO;2-6; WATSON MA, 1989, MOL CELL BIOL, V9, P4213, DOI 10.1128/MCB.9.10.4213; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	35	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50097	50101		10.1074/jbc.M409145200	http://dx.doi.org/10.1074/jbc.M409145200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448159	hybrid			2022-12-27	WOS:000225229500068
J	Paschinger, K; Rendic, D; Lochnit, GN; Jantsch, V; Wilson, IBH				Paschinger, K; Rendic, D; Lochnit, GN; Jantsch, V; Wilson, IBH			Molecular basis of anti-horseradish peroxidase staining in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; FUCOSYL-TRANSFERASE; DROSOPHILA-MELANOGASTER; INSECT GLYCOPROTEIN; MASS-SPECTROMETRY; IMPORTANT EPITOPE; CDNA CLONING; LEWIS-X; GLYCANS; EXPRESSION	Cross-reactivity with anti-horseradish peroxidase antiserum is a feature of many glycoproteins from plants and invertebrates; indeed staining with this reagent has been used to track neurons in Drosophila melanogaster and Caenorhabditis elegans. Although in insects the evidence indicates that the cross-reaction results from the presence of core alpha1,3-fucosylated N-glycans, the molecular basis for anti-horseradish peroxidase staining in nematodes has been unresolved to date. By using Western blots of wild-type and mutant C. elegans extracts in conjunction with specific inhibitors, we show that the cross-reaction is due to core alpha1,3-fucosylation. Of the various mutants examined, one with a deletion of the fut-1 (K08F8.3) gene showed no reaction to anti-horseradish peroxidase; the molecular phenotype was rescued by injection of either the K08F8 cosmid or the fut-1 open reading frame under control of the let-858 promoter. Furthermore, expression of fut-1 cDNA in Pichia and insect cells in conjunction with antibody staining, high pressure liquid chromatography, and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analyses showed that FUT-1 is a core alpha1,3-fucosyltransferase with an unusual substrate specificity. It is the only core fucosyltransferase in plants and animals described to date that does not require the prior action of N-acetylglucosaminyltransferase I.	Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria; Univ Giessen, Inst Biochem, D-35292 Giessen, Germany; Univ Vienna, Inst Bot, A-1030 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Justus Liebig University Giessen; University of Vienna	Wilson, IBH (corresponding author), Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria.	iwilson@edv2.boku.ac.at	Jantsch, Verena/A-3910-2017; Rendic, Dubravko/A-9368-2010; Wilson, Iain/B-3326-2009	Jantsch, Verena/0000-0002-1978-682X; Wilson, Iain/0000-0001-8996-1518; Paschinger, Katharina/0000-0002-3594-7136				ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; Bencurova M, 2004, GLYCOBIOLOGY, V14, P457, DOI 10.1093/glycob/cwh058; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; Cipollo JF, 2002, J BIOL CHEM, V277, P49143, DOI 10.1074/jbc.M208020200; CUMMINGS RD, 2000, Patent No. 0014199; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; DeBose-Boyd RA, 1998, GLYCOCONJUGATE J, V15, P789, DOI 10.1023/A:1006912032273; Dell A, 1999, BBA-MOL BASIS DIS, V1455, P353, DOI 10.1016/S0925-4439(99)00064-2; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; Friedl CH, 2003, BIOCHEM J, V369, P89, DOI 10.1042/BJ20021074; Gerdt S, 1999, EUR J BIOCHEM, V266, P952, DOI 10.1046/j.1432-1327.1999.00937.x; GEYER R, 1994, METHOD ENZYMOL, V230, P86; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Haase A, 2001, DEV GENES EVOL, V211, P428, DOI 10.1007/s004270100173; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Hanneman A, 2003, GLYCOBIOLOGY, V13, P899; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; Haslam SM, 2003, BIOCHIMIE, V85, P25, DOI 10.1016/S0300-9084(03)00041-5; Haslam SM, 2002, BIOCHEM SOC SYMP, V69, P117; Haslam SM, 1998, MOL BIOCHEM PARASIT, V93, P143, DOI 10.1016/S0166-6851(98)00020-6; Hirabayashi J, 2002, J BIOCHEM, V132, P103, DOI 10.1093/oxfordjournals.jbchem.a003186; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; JASMER DP, 1993, J IMMUNOL, V151, P5450; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Khoo KH, 2001, GLYCOBIOLOGY, V11, P149, DOI 10.1093/glycob/11.2.149; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; Leiter H, 1999, J BIOL CHEM, V274, P21830, DOI 10.1074/jbc.274.31.21830; MCMANUS MT, 1988, PLANTA, V175, P506, DOI 10.1007/BF00393072; Mello C, 1995, METHOD CELL BIOL, V48, P451; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Mucha J, 2004, BIOCHEM J, V382, P67, DOI 10.1042/BJ20040535; Natsuka S, 2002, J BIOCHEM, V131, P807, DOI 10.1093/oxfordjournals.jbchem.a003169; Nguyen K, 2001, GLYCOBIOLOGY, V11, P885; Nyame AK, 1998, GLYCOBIOLOGY, V8, P615, DOI 10.1093/glycob/8.6.615; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; PAZPARENTE J, 1985, CARBOHYD RES, V141, P41; PRENNER C, 1992, BIOCHEM J, V284, P377, DOI 10.1042/bj2840377; Roitinger A, 1998, GLYCOCONJUGATE J, V15, P89, DOI 10.1023/A:1006951802623; Schachter H, 2002, BIOCHEM SOC SYMP, V69, P1; SIDDIQUI SS, 1991, J NEUROGENET, V7, P193, DOI 10.3109/01677069109167433; STAUDACHER E, 1992, EUR J BIOCHEM, V207, P987, DOI 10.1111/j.1432-1033.1992.tb17134.x; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Tawill S, 2004, INFECT IMMUN, V72, P398, DOI 10.1128/IAI.72.1.398-407.2004; TRETTER V, 1993, INT ARCH ALLERGY IMM, V102, P259, DOI 10.1159/000236534; van Die I, 1999, FEBS LETT, V463, P189, DOI 10.1016/S0014-5793(99)01508-2; Vervelde L, 2003, GLYCOBIOLOGY, V13, P795, DOI 10.1093/glycob/cwg107; Warren CE, 2002, GLYCOBIOLOGY, V12, p8G; Warren CE, 2002, J BIOL CHEM, V277, P22829, DOI 10.1074/jbc.M201390200; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Wilson IBH, 2001, GLYCOCONJUGATE J, V18, P439, DOI 10.1023/A:1016030000527; Wilson IBH, 2001, BBA-GEN SUBJECTS, V1527, P88, DOI 10.1016/S0304-4165(01)00151-9; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931; Zheng QL, 2002, J BIOL CHEM, V277, P39823, DOI 10.1074/jbc.M207487200; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	60	63	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49588	49598		10.1074/jbc.M408978200	http://dx.doi.org/10.1074/jbc.M408978200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364955	hybrid			2022-12-27	WOS:000225229500008
J	Westergaard, UB; Sorensen, ES; Hermey, G; Nielsen, MS; Nykjaer, A; Kirkegaard, K; Jacobsen, C; Gliemann, J; Madsen, P; Petersen, CM				Westergaard, UB; Sorensen, ES; Hermey, G; Nielsen, MS; Nykjaer, A; Kirkegaard, K; Jacobsen, C; Gliemann, J; Madsen, P; Petersen, CM			Functional organization of the sortilin Vps10p domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; MOSAIC RECEPTOR; FAMILY-MEMBER; SORTILIN/NEUROTENSIN RECEPTOR-3; IN-VITRO; BINDS; IDENTIFICATION; CHAPERONE; INTERNALIZATION; TRAFFICKING	A Vps10p domain makes up the entire luminal part of Sortilin, and this type of domain is the hallmark of a new family of neuronal receptors that target a variety of ligands, including neurotrophins and neuropeptides. We have shown that two structural features of the Vps10p domain, the N-terminal propeptide and the C-terminal segment of ten conserved cysteines (10CC), are key elements in the function of Sortilin. The propeptide has two functions. (i) It binds the mature part of Sortilin and prevents ligands in the biosynthetic pathway from binding to the uncleaved proreceptor, and (ii) it facilitates receptor transport in early Golgi compartments by a mechanism that does not depend on its ability to prevent ligand binding. In contrast, other Vps10p domain receptors, such as SorLA and SorCS3, do not need their propeptide for normal and swift processing. The 10CC segment constitutes an exchangeable module containing five conserved disulfide bridges, and using module-shuffling and truncations, we have shown that the 10CC segment is a major ligand-binding region in Sortilin.	Aarhus Univ, Inst Med Biochem, DK-8000 Aarhus C, Denmark; Aarhus Univ, Dept Mol Biol, Prot Chem Lab, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Petersen, CM (corresponding author), Aarhus Univ, Inst Med Biochem, Ole Worms Alle,Bldg 170, DK-8000 Aarhus C, Denmark.	cmp@biokemi.au.dk	Nielsen, Morten Schallburg/G-9498-2016; Hermey, Guido/AAC-5565-2020; Matrone, Carmela/AAR-5405-2020	Nielsen, Morten Schallburg/0000-0001-9863-9694; Hermey, Guido/0000-0003-4762-5262; Sorensen, Esben Skipper/0000-0002-7050-3354; Kirkegaard, Kirstine/0000-0001-8267-9042; Madsen, Peder Sondergaard/0000-0002-8845-4802; Nykjaer, Anders/0000-0001-6422-6736				Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; Conticello SG, 2003, J BIOL CHEM, V278, P26311, DOI 10.1074/jbc.C300141200; Ellgaard L, 1997, EUR J BIOCHEM, V244, P544, DOI 10.1111/j.1432-1033.1997.00544.x; Gliemann J, 2004, BIOCHEM J, V381, P203, DOI 10.1042/BJ20040149; Hermans-Borgmeyer I, 1998, MECH DEVELOP, V70, P65, DOI 10.1016/S0925-4773(97)00177-9; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Hermey G, 1999, BIOCHEM BIOPH RES CO, V266, P347, DOI 10.1006/bbrc.1999.1822; Hermey G, 2003, J BIOL CHEM, V278, P7390, DOI 10.1074/jbc.M210851200; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Lefrancois S, 2003, EMBO J, V22, P6430, DOI 10.1093/emboj/cdg629; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Navarro V, 2001, FEBS LETT, V495, P100, DOI 10.1016/S0014-5793(01)02367-5; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; SCHERZER CR, 2004, ARCH NEUROL-CHICAGO, V61, P1178; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Willnow TE, 1998, BIOL CHEM, V379, P1025; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Zhu YJ, 2004, CIRC RES, V94, P752, DOI 10.1161/01.RES.0000120862.79154.0F; Zhu YJ, 2002, CIRCULATION, V105, P1830, DOI 10.1161/01.CIR.0000014413.91312.EF	31	68	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50221	50229		10.1074/jbc.M408873200	http://dx.doi.org/10.1074/jbc.M408873200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364913	hybrid			2022-12-27	WOS:000225229500083
J	Blanchette, JM; Abazeed, ME; Fuller, RS				Blanchette, JM; Abazeed, ME; Fuller, RS			Cell-free reconstitution of transport from the trans-Golgi network to the late endosome/prevacuolar compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN RETENTION; CLATHRIN-COATED VESICLES; SACCHAROMYCES-CEREVISIAE; KEX2 PROTEASE; PREVACUOLAR COMPARTMENT; LOCALIZATION SIGNAL; ENDOSOME TRANSPORT; SORTING RECEPTOR; CYTOSOLIC TAIL; YEAST	Vesicle-mediated transport between the trans-Golgi network (TGN) and the late endosome/prevacuolar compartment (PVC) is an essential step in lysosomal/vacuolar biogenesis. In addition, localization of integral membrane proteins to the TGN requires continual cycles of vesicular transport between the TGN and endosomal compartments. Genetic and biochemical analyses in yeast have identified a variety of proteins required for TGN-to-PVC transport. However, the precise mechanisms of vesicle formation, transport, and fusion have not been fully elucidated. To study the steps of TGN-to-PVC transport in mechanistic detail, we have developed a cell-free assay to monitor delivery of the processing protease Kex2p from the TGN to PVC compartments containing a Kex2p substrate. Transport is time-, temperature, and ATP-dependent and requires the t-SNARE Pep12p. Moreover, cell-free delivery of Kex2p to the PVC results in the co-integration of Kex2p into PVC membranes containing the Kex2p substrate as determined by co-immunoisolation of Kex2p and the substrate using antibody against the Kex2p cytosolic tail. This work represents the first cell-free reconstitution and biochemical analysis of the essential vacuolar/lysosomal sorting step TGN to late endosome transport.	Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fuller, RS (corresponding author), Univ Michigan, Dept Biol Chem, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.	bfuller@umich.edu	Abazeed, Mohamed/AAN-2376-2020	Abazeed, Mohamed/0000-0002-6614-4440	NCI NIH HHS [P30 CA46592] Funding Source: Medline; NIGMS NIH HHS [GM50915, GM39697, GM07544, R01 GM050915, T32 GM007544] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050915, T32GM007544, R55GM039697, R01GM039697] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER D, 1989, METHOD CELL BIOL, V31, P127; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; Balch W E, 1988, Prog Clin Biol Res, V270, P333; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1989, J BIOL CHEM, V264, P16965; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Brickner JH, 2001, J CELL BIOL, V155, P969, DOI 10.1083/jcb.200104093; Bryant NJ, 1997, J CELL BIOL, V136, P287, DOI 10.1083/jcb.136.2.287; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; CEREGHINO JL, 1995, MOL BIOL CELL, V6, P1089, DOI 10.1091/mbc.6.9.1089; Cooper AA, 1996, J CELL BIOL, V133, P529, DOI 10.1083/jcb.133.3.529; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Deloche O, 2001, MOL BIOL CELL, V12, P475, DOI 10.1091/mbc.12.2.475; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; GODA Y, 1992, METHOD ENZYMOL, V219, P153; GODA Y, 1988, CELL, V55, P309, DOI 10.1016/0092-8674(88)90054-2; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602; Ha SA, 2003, MOL BIOL CELL, V14, P1319, DOI 10.1091/mbc.E02-10-0686; Harlow E., 1988, ANTIBODIES LABORATOR, P628; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; PAYNE GS, 1989, SCIENCE, V245, P1358, DOI 10.1126/science.2675311; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Redding K, 1996, MOL BIOL CELL, V7, P1667, DOI 10.1091/mbc.7.11.1667; REDDING K, 1991, J CELL BIOL, V113, P527, DOI 10.1083/jcb.113.3.527; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; ROTHMAN JE, 1986, CELL, V46, P5, DOI 10.1016/0092-8674(86)90852-4; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531; Sipos G, 2004, MOL BIOL CELL, V15, P3196, DOI 10.1091/mbc.E03-10-0755; Sipos G, 2002, METHOD ENZYMOL, V351, P351; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Vida T, 1999, J CELL BIOL, V146, P85; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WILCOX CA, 1992, MOL BIOL CELL, V3, P1353, DOI 10.1091/mbc.3.12.1353	45	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48767	48773		10.1074/jbc.M406368200	http://dx.doi.org/10.1074/jbc.M406368200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364946	hybrid			2022-12-27	WOS:000225098100035
J	Furumoto, Y; Nunomura, S; Terada, T; Rivera, J; Ra, C				Furumoto, Y; Nunomura, S; Terada, T; Rivera, J; Ra, C			The Fc epsilon RI beta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and I kappa B kinase phosphorylation and mast cell cytokine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; IMMUNOGLOBULIN-E RECEPTOR; LYN KINASE; INOSITOL 5'-PHOSPHATASE; NEGATIVE REGULATION; ALLERGIC RESPONSE; SUBUNIT; DOMAIN; SHIP; DEGRANULATION	The high affinity IgE Fc receptor (FcepsilonRI) beta chain functions as a signal amplifier and has been linked to atopy, asthma, and allergy. Herein, we report on a previously unrecognized negative regulatory role for the nonconventional beta chain immunoreceptor tyrosine-based activation motif that contains three tyrosine residues (YX5YX3Y). Degranulation and leukotriene production was found to be impaired in cells expressing the mutated FcepsilonRIbeta immunoreceptor tyrosine-based activation motifs FYY, YYF, FYF, and FFF. In contrast, cytokine synthesis and secretion were enhanced in the YFY and FFF mutants. FcepsilonRI phosphorylation and Lyn kinase co-immunoprecipitation was intact in the YFY mutant but was lost in the FYF and FFF mutants. The phosphorylation of Syk, LAT, phospholipase gamma1/2, and Src-homology 2 domain-containing protein phosphatase 2 was intact, whereas the phosphorylation of SHIP-1 was significantly reduced in the YFY mutant cells. The FYF and FFF mutants were defective in phosphorylating all of these molecules. In contrast, the phosphorylation of ERK, p38 MAPK, IkappaB kinase beta(IKKbeta), and nuclear NFkappaB activity was enhanced in the YFY and FFF mutants. These findings show that the FcepsilonRIbeta functions to both selectively amplify (degranulation and leukotriene secretion) and dampen (lymphokine) mast cell effector responses.	NIAMSD, Mol Inflammat Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; Nihon Univ, Grad Sch Med Sci, Adv Med Res Ctr, Div Mol Cell Immunobiol & Allergol,Itabashi Ku, Tokyo 1378610, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Nihon University	Rivera, J (corresponding author), NIAMS, NIH, Bldg 10,Rm 9N228, Bethesda, MD 20892 USA.	juan_rivera@nih.gov	Nunomura, Satoshi/Q-4249-2017	Nunomura, Satoshi/0000-0002-9315-4185	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041101, ZIAAR041101] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baran CP, 2003, J BIOL CHEM, V278, P38628, DOI 10.1074/jbc.M305021200; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Donnadieu E, 2000, J IMMUNOL, V165, P3917, DOI 10.4049/jimmunol.165.7.3917; Donnadieu E, 2000, IMMUNITY, V12, P515, DOI 10.1016/S1074-7613(00)80203-4; EISEMAN E, 1992, NATURE, V355, P78; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Furumoto Y, 2000, BIOCHEM BIOPH RES CO, V273, P765, DOI 10.1006/bbrc.2000.2989; GORDON JR, 1997, IGE RECEPTOR FCERI F, P209; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gupta N, 1999, J BIOL CHEM, V274, P7489, DOI 10.1074/jbc.274.11.7489; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; Hill MR, 1996, HUM MOL GENET, V5, P959, DOI 10.1093/hmg/5.7.959; Hiraoka S, 1999, INT IMMUNOL, V11, P199, DOI 10.1093/intimm/11.2.199; Huber M, 1999, CURR TOP MICROBIOL, V244, P29; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kim YK, 2002, CLIN EXP ALLERGY, V32, P751, DOI 10.1046/j.1365-2222.2002.01295.x; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Li XX, 2002, EXP HEMATOL, V30, P285, DOI 10.1016/S0301-472X(02)00777-4; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; LIU FT, 1980, J IMMUNOL, V124, P2728; Lu-Kuo JM, 1999, J BIOL CHEM, V274, P5791, DOI 10.1074/jbc.274.9.5791; Malbec O, 1998, J IMMUNOL, V160, P1647; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Nadler M J, 2000, Adv Immunol, V76, P325; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; PAOLINI R, 1992, P NATL ACAD SCI USA, V89, P10733, DOI 10.1073/pnas.89.22.10733; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Pelletier C, 1998, J IMMUNOL, V161, P4768; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Saitoh S, 2003, J EXP MED, V198, P831, DOI 10.1084/jem.20030574; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; SWIETER M, 1995, J IMMUNOL, V155, P5330; VARINBLANK N, 1990, J BIOL CHEM, V265, P15685; Vonakis BM, 1997, J BIOL CHEM, V272, P24072, DOI 10.1074/jbc.272.38.24072; Vonakis BM, 2001, J BIOL CHEM, V276, P1041, DOI 10.1074/jbc.M003397200; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Wilson BS, 2001, J CELL BIOL, V154, P645, DOI 10.1083/jcb.200104049; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251	52	91	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49177	49187		10.1074/jbc.M404730200	http://dx.doi.org/10.1074/jbc.M404730200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355979	hybrid			2022-12-27	WOS:000225098100083
J	Murata, Y; Hamada, S; Morishita, H; Mutoh, T; Yagi, T				Murata, Y; Hamada, S; Morishita, H; Mutoh, T; Yagi, T			Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC ORGANIZATION; ADHESION RECEPTOR; LARGE FAMILY; N-CADHERIN; SPECIFICITY; MOLECULES; TRANSPORT; SYNAPSES; PROMOTER; SURVIVAL	The protocadherin-alpha (CNR/Pcdhalpha) and protocadherin-gamma (Pcdhgamma) proteins, members of the cadherin superfamily, are putative cell recognition/adhesion molecules in the brain. Overexpressed cadherins are generally expressed on the cell surface and elicit cell adhesion activity in several cell lines, although hardly any overexpressed CNR/Pcdhalpha proteins are expressed on the cell surface, except on HEK293T cells, which show low expression. We analyzed the expression of CNR/Pcdhalpha and Pcdhgamma in HEK293T cells and found that they formed a protein complex and that Pcdhgamma enhanced the surface expression of CNR/Pcdhalpha. This enhanced surface expression was confirmed by flow cytometry analysis and by marking cell surface proteins with biotin. The enhancement was observed using different combinations of CNR/Pcdhalpha and Pcdhgamma proteins. The surface expression activity was enhanced by the extracellular domains of the proteins, which could bind each other. Their cytoplasmic domains also had binding activity and influenced their localization. Their protein-protein interaction was also detected in extracts of mouse brain and two neuroblastoma cell lines. Thus, interactions between CNR/Pcdhalpha and Pcdhgamma regulate their surface expression and contribute to the combinatorial diversity of cell recognition proteins in the brain.	Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Yagi, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Morishita, Hirofumi/J-9619-2015	Morishita, Hirofumi/0000-0002-1045-1337; Murata, Yoji/0000-0002-9576-7030				Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mutoh T, 2004, EXP CELL RES, V294, P494, DOI 10.1016/j.yexcr.2003.11.019; OBATA S, 1995, J CELL SCI, V108, P3765; Obata S, 1998, CELL ADHES COMMUN, V6, P323, DOI 10.3109/15419069809010791; Phillips GR, 2003, J NEUROSCI, V23, P5096; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; Takei Y, 2001, GENOMICS, V72, P321, DOI 10.1006/geno.2000.6468; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; UEDA T, 1979, J CELL BIOL, V83, P308, DOI 10.1083/jcb.83.2.308; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169	27	77	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49508	49516		10.1074/jbc.M408771200	http://dx.doi.org/10.1074/jbc.M408771200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347688	hybrid			2022-12-27	WOS:000225098100121
J	Tsuneshige, A; Kanaori, K; Samuni, U; Danstker, D; Friedman, JM; Neya, S; Giangiacomo, L; Yonetani, T				Tsuneshige, A; Kanaori, K; Samuni, U; Danstker, D; Friedman, JM; Neya, S; Giangiacomo, L; Yonetani, T			Semihemoglobins, high oxygen affinity dimeric forms of human hemoglobin respond efficiently to allosteric effectors without forming tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; FUNCTIONAL PROPERTIES; HYBRID HEMOGLOBIN; CRYSTAL-STRUCTURE; ADULT HEMOGLOBIN; R-STATE; T-STATE; BINDING; ALPHA; BETA	Significant reduction in oxygen affinity resulting from interactions between heterotropic allosteric effectors and hemoglobin in not only the unligated derivative but also the fully ligated form has been reported (Tsuneshige, A., Park, S. I., and Yonetani, T. ( 2002) Biophys. Chem. 98, 49 - 63; Yonetani, T., Park, S. I., Tsuneshige, A., Imai, K., and Kanaori, K. ( 2002) J. Biol. Chem. 277, 34508 - 34520). To further investigate this effect in more detail, alpha- and beta-semihemoglobins, namely, alpha(heme)beta(apo) and alpha(apo) beta(heme), respectively, were prepared and characterized with respect to the impact of allosteric effectors on both conformation and ligand binding properties. Semihemoglobins are dimers characterized by a high affinity for oxygen and lack of cooperativity. We found that, compared with stripped conditions, semihemoglobins responded to effectors ( inositol hexaphosphate and L35) by decreasing the affinity for oxygen by 60- and 130-fold for alpha- and beta-semihemoglobins, respectively. H-1 NMR and sedimentation velocity experiments carried out with their ligated and unligated forms in the absence and presence of effectors revealed that semihemoglobins always remain as single-heme-carrying dimers. Recombination kinetics of their photolyzed CO derivatives showed that effectors did indeed interact with their ligated forms. Measurements of the Fe-His stretching mode show that the semihemoglobins undergo a large ligand binding-induced conformational shift and that both ligand-free and ligand derivatives respond to the presence of effectors. Contradictions to the Monod-Wyman-Changeaux/Perutz allosteric model arise since 1) the modulation of ligand affinity is not achieved in semihemoglobins by the formation of a low affinity T conformation ( quaternary effect) but by direct interaction with effectors, 2) effectors do interact significantly with ligated forms of high affinity semihemoglobins, and 3) modulation of the ligand affinity and the cooperativity are not necessarily linked but instead can be separated into two distinct phenomena that can be isolated.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Johnson Res Fdn, Philadelphia, PA 19104 USA; Kyoto Inst Technol, Dept Appl Biol, Kyoto 6068585, Japan; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2638522, Japan; Univ Roma La Sapienza, Dept Biomed Sci, Inst Mol Biol & Pathol, CNR, I-00185 Rome, Italy	University of Pennsylvania; Kyoto Institute of Technology; Yeshiva University; Albert Einstein College of Medicine; Chiba University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Tsuneshige, A (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	ants@mail.med.upenn.edu			NHLBI NIH HHS [HL-14508] Funding Source: Medline; NIGMS NIH HHS [P01-GM58890] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL014508, R37HL014508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058890] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackers GK, 2000, PROTEINS, P23; Ackers GK, 2002, P NATL ACAD SCI USA, V99, P9777, DOI 10.1073/pnas.152225999; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BARNEJEE R, 1967, BIOCHIM BIOPHYS ACTA, V133, P545; BENESCH RE, 1986, J MOL BIOL, V190, P481, DOI 10.1016/0022-2836(86)90016-1; BUCCI E, 1965, J BIOL CHEM, V240, pP551; Cassoly R, 1981, Methods Enzymol, V76, P121; CASSOLY R, 1967, BIOCHIM BIOPHYS ACTA, V133, P557, DOI 10.1016/0005-2795(67)90560-0; CASSOLY R, 1971, EUR J BIOCHEM, V19, P514, DOI 10.1111/j.1432-1033.1971.tb01343.x; CHIANCONE E, 1972, J MOL BIOL, V70, P675, DOI 10.1016/0022-2836(72)90566-9; DALVIT C, 1985, BIOCHEMISTRY-US, V24, P3398, DOI 10.1021/bi00335a003; Dantsker D, 2002, J MOL BIOL, V315, P239, DOI 10.1006/jmbi.2001.5218; DAUGHERTY MA, 1991, P NATL ACAD SCI USA, V88, P1110, DOI 10.1073/pnas.88.4.1110; Fronticelli C, 2002, BIOPHYS CHEM, V98, P115, DOI 10.1016/S0301-4622(02)00089-3; FUNG LWM, 1975, BIOCHEMISTRY-US, V14, P2526, DOI 10.1021/bi00682a036; IMAI K, 1970, Biochimica et Biophysica Acta, V200, P189, DOI 10.1016/0005-2795(70)90163-7; Imai K, 1981, Methods Enzymol, V76, P438; KAWAMURAKONISHI Y, 1988, BIOCHEM BIOPH RES CO, V156, P348, DOI 10.1016/S0006-291X(88)80847-7; KAWAMURAKONISHI Y, 1992, EUR BIOPHYS J BIOPHY, V21, P85; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Kidd RD, 2001, BIOCHEMISTRY-US, V40, P15669, DOI 10.1021/bi011329f; KISTER J, 1987, BIOPHYS J, V52, P527, DOI 10.1016/S0006-3495(87)83242-3; LALEZARI I, 1988, P NATL ACAD SCI USA, V85, P6117, DOI 10.1073/pnas.85.16.6117; LALEZARI I, 1990, P NATL ACAD SCI USA, V85, P1515; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOULTON DP, 1994, BIOCHEM BIOPH RES CO, V199, P1278, DOI 10.1006/bbrc.1994.1369; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1986, J AM CHEM SOC, V108, P1064, DOI 10.1021/ja00265a036; PERUTZ MF, 1968, NATURE, V256, P759; Peterson ES, 2004, BIOCHEMISTRY-US, V43, P4832, DOI 10.1021/bi035481o; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P4346, DOI 10.1021/bi9708693; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Ramadas N, 1999, BIOPHYS J, V76, P1796, DOI 10.1016/S0006-3495(99)77340-6; ROSSIFANELLI A, 1961, J BIOL CHEM, V236, P397; ROSSIFANELLI A, 1958, ARCH BIOCHEM BIOPHYS, V77, P478, DOI 10.1016/0003-9861(58)90094-8; ROSSIFANELLI A, 1961, J BIOL CHEM, V236, P391; Rujan IN, 2002, PROTEINS, V49, P413, DOI 10.1002/prot.10240; RUSSU IM, 1987, BIOCHIM BIOPHYS ACTA, V914, P40, DOI 10.1016/0167-4838(87)90159-2; Safo MK, 2001, PROTEIN SCI, V10, P951, DOI 10.1110/ps.50601; Samuni U, 2003, BIOCHEMISTRY-US, V42, P8272, DOI 10.1021/bi020648j; Samuni U, 2002, J BIOL CHEM, V277, P25783, DOI 10.1074/jbc.M200301200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shibayama N, 1998, BIOCHEMISTRY-US, V37, P6221, DOI 10.1021/bi980134d; Shibayama N, 2002, J BIOL CHEM, V277, P38791, DOI 10.1074/jbc.M205461200; Tsai CH, 2002, BIOPHYS CHEM, V98, P15, DOI 10.1016/S0301-4622(02)00081-9; TSUNESHIGE A, 1993, J BIOL CHEM, V268, P23031; Tsuneshige A, 2002, BIOPHYS CHEM, V98, P49, DOI 10.1016/S0301-4622(02)00084-4; WATERMAN MR, 1971, ARCH BIOCHEM BIOPHYS, V145, P448, DOI 10.1016/S0003-9861(71)80004-8; WINTERHALTER KH, 1968, BIOCHEMISTRY-US, V7, P2228, DOI 10.1021/bi00846a027; Yasuda JP, 2002, EUR J BIOCHEM, V269, P202, DOI 10.1046/j.0014-2956.2002.02635.x; Yonetani T, 2003, CR BIOL, V326, P523, DOI 10.1016/S1631-0691(03)00150-1; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200	52	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48959	48967		10.1074/jbc.M405909200	http://dx.doi.org/10.1074/jbc.M405909200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15361521	hybrid			2022-12-27	WOS:000225098100058
J	Strack, S; Cribbs, JT; Gomez, L				Strack, S; Cribbs, JT; Gomez, L			Critical role for protein phosphatase 2A heterotrimers in mammalian cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; REGULATORY B-SUBUNITS; A-SUBUNIT; CATALYTIC SUBUNIT; DNA-REPLICATION; ALPHA-SUBUNIT; OKADAIC ACID; CORE ENZYME; BETA; BINDING	The predominant forms of protein phosphatase 2A (PP2A), one of the major Ser/Thr phosphatases, are dimers of catalytic (C) and scaffolding (A) subunits and trimers with an additional variable regulatory subunit. In mammals, catalytic and scaffolding subunits are encoded by two genes each (alpha/beta), whereas three gene families (B, B', and B") with a total of 12 genes contribute PP2A regulatory subunits. We generated stable PC12 cell lines in which the major scaffolding Aalpha subunit can be knocked down by inducible RNA interference (RNAi) to study its role in cell viability. Aalpha RNAi decreased total PP2A activity as well as protein levels of C, B, and B' but not B" subunits. Inhibitor experiments indicate that monomeric C and B subunits are degraded by the proteosome. Knock-down of Aalpha triggered cell death by redundant apoptotic and non-apoptotic mechanisms because the inhibition of RNAi-associated caspase activation failed to stall cell death. PP2A holoenzymes positively regulate survival kinase signaling, because RNAi reduced basal and epidermal growth factor-stimulated Akt phosphorylation. RNAi-resistant Aalpha cDNAs rescued RNAi-induced loss of the C subunit, and Aalpha point mutants prevented regulatory subunit degradation as predicted from each mutant's binding specificity. In transient, stable, and stable-inducible rescue experiments, both wild-type Abeta and Aalpha mutants capable of binding to at least one family of regulatory subunits were able to delay Aalpha RNAi-induced death of PC12 cells. However, only the expression of wild-type Aalpha restored viability completely. Thus, heterotrimeric PP2A holoenzymes containing the Aalpha subunit and members of all three regulatory subunit families are necessary for mammalian cell viability.	Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Strack, S (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu		Strack, Stefan/0000-0002-6175-7280; Lavadie-Gomez, Eleanor/0000-0002-0602-5618	NINDS NIH HHS [NS43254] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043254] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Barbier AJ, 1999, J BIOL CHEM, V274, P14067, DOI 10.1074/jbc.274.20.14067; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CAYLA X, 1990, BIOCHEMISTRY-US, V29, P658, DOI 10.1021/bi00455a010; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chou DM, 2002, J BIOL CHEM, V277, P40520, DOI 10.1074/jbc.M207226200; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; Gehringer MM, 2004, FEBS LETT, V557, P1, DOI 10.1016/S0014-5793(03)01447-9; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Gual P, 2001, ONCOGENE, V20, P156, DOI 10.1038/sj.onc.1204047; Hannon Gregory J, 2004, Methods Mol Biol, V257, P255, DOI 10.1385/1-59259-750-5:255; Ivins KJ, 1999, J BIOL CHEM, V274, P2107, DOI 10.1074/jbc.274.4.2107; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KHEWGOODALL Y, 1988, FEBS LETT, V238, P265, DOI 10.1016/0014-5793(88)80493-9; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; NESTEROV A, 1994, ARCH BIOCHEM BIOPHYS, V313, P351, DOI 10.1006/abbi.1994.1398; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 1999, J VIROL, V73, P839, DOI 10.1128/JVI.73.1.839-842.1999; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Strack S, 2002, J BIOL CHEM, V277, P41525, DOI 10.1074/jbc.M203767200; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Voorhoeve PM, 1999, ONCOGENE, V18, P515, DOI 10.1038/sj.onc.1202316; WATERS SB, 1995, J BIOL CHEM, V270, P20883, DOI 10.1074/jbc.270.36.20883; Yan Z, 2000, MOL CELL BIOL, V20, P1021, DOI 10.1128/MCB.20.3.1021-1029.2000; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	56	111	114	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47732	47739		10.1074/jbc.M408015200	http://dx.doi.org/10.1074/jbc.M408015200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364932	hybrid			2022-12-27	WOS:000224957000040
J	van der Spuy, J; Cheetham, ME				van der Spuy, J; Cheetham, ME			The Leber congenital amaurosis protein AIPL1 modulates the nuclear translocation of NUB1 and suppresses inclusion formation by NUB1 fragments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; X-ASSOCIATED PROTEIN-2; AH RECEPTOR; SUBCELLULAR-LOCALIZATION; DIOXIN RECEPTOR; CORE COMPLEX; NEDD8; UBIQUITINATION; XAP2; INTERACTS	Mutations in the aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) cause the blinding disease Leber congenital amaurosis (LCA). The similarity of AIPL1 to AIP has led to suggestions that AIPL1 could function in a similar manner to AIP in facilitating protein translocation and as a component of chaperone complexes. AIPL1 interacts with the cell cycle regulator NEDD8 ultimate buster protein 1 (NUB1). As AIPL1 is predominantly cytoplasmic and NUB1 is predominantly nuclear, we tested the hypothesis that AIPL1 could modulate the nuclear translocation of NUB1. Co-transfection of AIPL1 with GFP-NUB1 resulted in a shift of GFP-NUB1 subcellular distribution toward the cytoplasm. Interestingly, AIPL1 was able to act in a chaperone-like fashion to efficiently suppress inclusion formation by NUB1 fragments. Co-transfection of AIPL1 with GFP-NUB1-N and GFP-NUB1-C resulted in an AIPL1-dependent suppression of GFP-NUB1-N perinuclear inclusions and GFP-NUB1-C intranuclear inclusions leading to the redistribution of these fragments in the cytoplasm. This chaperone-like function of AIPL1 was specific for NUB1, since AIPL1 was unable to suppress the inclusion formation by unrelated aggregation-prone proteins and AIP had no effect on NUB1 localization or inclusion formation. We examined the effect of a range of pathogenic and engineered mutations on the ability of AIPL1 to modulate NUB1 localization or inclusion formation. With the exception of W278X, which formed non-functional SDS-insoluble inclusions, all of the pathogenic mutations studied were soluble and could modulate NUB1 with varying efficiency compared with the wildtype protein. The effect of AIPL1 on NUB1 required the C-terminal region of AIPL1, as engineered C-terminal truncation mutations had no effect on NUB1. These data show that AIPL1 can modulate protein translocation and act in a chaperone-like manner and suggest that AIPL1 is an important modulator of NUB1 cellular function.	UCL, Inst Ophthalmol, Div Pathol, London EC1V 9EL, England	University of London; University College London	Cheetham, ME (corresponding author), UCL, Inst Ophthalmol, Div Pathol, London EC1V 9EL, England.	michael.cheetham@ucl.ac.uk	Cheetham, Michael/B-4672-2011	van der Spuy, Jacqueline/0000-0001-5906-2116; Cheetham, Michael/0000-0001-6429-654X				Akey DT, 2002, HUM MOL GENET, V11, P2723, DOI 10.1093/hmg/11.22.2723; Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; Berg P, 2002, J BIOL CHEM, V277, P32310, DOI 10.1074/jbc.M203351200; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chapple JP, 2002, INVEST OPHTH VIS SCI, V43, P2015; Chapple JP, 2001, TRENDS MOL MED, V7, P414, DOI 10.1016/S1471-4914(01)02103-7; Cheung-Flynn J, 2003, J BIOL CHEM, V278, P17388, DOI 10.1074/jbc.M300955200; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kanaya K, 2004, BIOCHEM BIOPH RES CO, V317, P768, DOI 10.1016/j.bbrc.2004.03.108; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kito K, 2001, J BIOL CHEM, V276, P20603, DOI 10.1074/jbc.M100920200; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Lees MJ, 2003, J BIOL CHEM, V278, P35878, DOI 10.1074/jbc.M302430200; Ma Q, 1997, J BIOL CHEM, V272, P8878; Meyer BK, 2000, CELL STRESS CHAPERON, V5, P243, DOI 10.1379/1466-1268(2000)005<0243:AHARLA>2.0.CO;2; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Ramamurthy V, 2003, P NATL ACAD SCI USA, V100, P12630, DOI 10.1073/pnas.2134194100; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Saliba RS, 2002, J CELL SCI, V115, P2907; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Tanaka T, 2004, EUR J BIOCHEM, V271, P972, DOI 10.1111/j.1432-1033.2004.03999.x; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; van der Spuy J, 2003, INVEST OPHTH VIS SCI, V44, P5396, DOI 10.1167/iovs.03-0686; van der Spuy J, 2002, HUM MOL GENET, V11, P823, DOI 10.1093/hmg/11.7.823; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	40	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48038	48047		10.1074/jbc.M407871200	http://dx.doi.org/10.1074/jbc.M407871200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347646	hybrid			2022-12-27	WOS:000224957000075
J	Okahara, F; Ikawa, H; Kanaho, Y; Maehama, T				Okahara, F; Ikawa, H; Kanaho, Y; Maehama, T			Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE PHOSPHATASES; PDZ DOMAIN; BINDING; MYOTUBULARIN; PTEN/MMAC1; KINASE; MAGI-2; REGION; SITES; CELLS	The tumor suppressor PTEN plays an essential role in regulating signaling pathways involved in cell growth and apoptosis and is inactivated in a wide variety of tumors. In this study, we have identified a protein, referred to as PICT-1 ( protein interacting with carboxyl terminus 1), that binds to the C terminus of PTEN and regulates its phosphorylation and turnover. Down-regulation of PICT-1 in MCF7 cells by RNA interference enhances the degradation of PTEN with a concomitant decrease in its phosphorylation. PTEN C-terminal tumor-associated mutants, which are highly susceptible to protein degradation, have lost the ability to bind to PICT-1 along with their reduced phosphorylation, suggesting that their rapid turnover results from impaired binding to PICT-1. Our results identify PICT-1 as a PTEN-interacting protein that promotes the phosphorylation and stability of PTEN. These findings suggest a novel molecular mechanism underlying the turnover of PTEN, which also provides an explanation for the loss of PTEN function due to C-terminal mutations.	Tokyo Metropolitan Inst Med Sci, Dept Pharmacol, Bunkyo Ku, Tokyo 1138613, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University	Maehama, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Pharmacol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	tmaehama@rinshoken.or.jp	Maehama, Tomohiko/AAX-8926-2020; Maehama, Tomohiko/HGB-4896-2022	Maehama, Tomohiko/0000-0002-9685-2317				Adey NB, 2000, CANCER RES, V60, P35; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Birle D, 2002, J IMMUNOL, V169, P286, DOI 10.4049/jimmunol.169.1.286; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Smith JS, 2000, GENOMICS, V64, P44, DOI 10.1006/geno.1999.6101; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Tolkacheva T, 2001, CANCER RES, V61, P4985; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	24	108	113	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2004	279	44					45300	45303		10.1074/jbc.C400377200	http://dx.doi.org/10.1074/jbc.C400377200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	865IC	15355975	hybrid			2022-12-27	WOS:000224694900002
J	Hilgarth, RS; Murphy, LA; Skaggs, HS; Wilkerson, DC; Xing, HY; Sarge, KD				Hilgarth, RS; Murphy, LA; Skaggs, HS; Wilkerson, DC; Xing, HY; Sarge, KD			Regulation and function of SUMO modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEAR-PORE COMPLEX; SHOCK TRANSCRIPTION FACTOR-1; PAPILLOMAVIRUS E1 PROTEIN; GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; HUMAN CYTOMEGALOVIRUS; COVALENT MODIFICATION; TOPOISOMERASE-I; SUBCELLULAR-LOCALIZATION; SUBSTRATE PROTEINS		Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Sarge, KD (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 800 Rose St, Lexington, KY 40536 USA.	kdsarge@uky.edu						Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Biggins S, 2001, GENETICS, V159, P453; Bohren KM, 2004, J BIOL CHEM, V279, P27233, DOI 10.1074/jbc.M402273200; Castillo AG, 2004, J VIROL, V78, P2758, DOI 10.1128/JVI.78.6.2758-2769.2004; Chakrabarti SR, 2000, P NATL ACAD SCI USA, V97, P13281, DOI 10.1073/pnas.240315897; Colombo R, 2002, EMBO REP, V3, P1062, DOI 10.1093/embo-reports/kvf213; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Fukagawa T, 2001, NUCLEIC ACIDS RES, V29, P3796, DOI 10.1093/nar/29.18.3796; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Gravel A, 2004, J GEN VIROL, V85, P1319, DOI 10.1099/vir.0.19610-0; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hateboer G, 1996, J BIOL CHEM, V271, P25906, DOI 10.1074/jbc.271.42.25906; Hay RT, 1999, PHILOS T R SOC B, V354, P1601, DOI 10.1098/rstb.1999.0504; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hilgarth RS, 2003, BIOCHEM BIOPH RES CO, V303, P196, DOI 10.1016/S0006-291X(03)00312-7; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lee HR, 2004, J VIROL, V78, P6527, DOI 10.1128/JVI.78.12.6527-6542.2004; Lee JM, 2003, FEBS LETT, V555, P322, DOI 10.1016/S0014-5793(03)01268-7; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Ling Y, 2004, NUCLEIC ACIDS RES, V32, P598, DOI 10.1093/nar/gkh195; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mo YY, 2002, J BIOL CHEM, V277, P2958, DOI 10.1074/jbc.M108263200; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Ohshima T, 2004, J BIOL CHEM, V279, P29551, DOI 10.1074/jbc.M403866200; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rangasamy D, 2000, J BIOL CHEM, V275, P37999, DOI 10.1074/jbc.M007777200; Rangasamy D, 2000, J BIOL CHEM, V275, P30487, DOI 10.1074/jbc.M003898200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Seeler JS, 2001, ONCOGENE, V20, P7243, DOI 10.1038/sj.onc.1204758; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vassileva MT, 2004, MOL CELL BIOL, V24, P3623, DOI 10.1128/MCB.24.9.3623-3632.2004; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Weger S, 2003, EXP CELL RES, V290, P13, DOI 10.1016/S0014-4827(03)00292-1; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Xu YX, 2001, J VIROL, V75, P10683, DOI 10.1128/JVI.75.22.10683-10695.2001; Yamamoto H, 2003, EMBO J, V22, P2047, DOI 10.1093/emboj/cdg204; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhao YM, 2004, J BIOL CHEM, V279, P20999, DOI 10.1074/jbc.M401541200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	81	96	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2004	279	52					53899	53902		10.1074/jbc.R400021200	http://dx.doi.org/10.1074/jbc.R400021200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	880MJ	15448161	hybrid			2022-12-27	WOS:000225793600001
J	Jadlowiec, J; Koch, H; Zhang, XY; Campbell, PG; Seyedain, M; Sfeir, C				Jadlowiec, J; Koch, H; Zhang, XY; Campbell, PG; Seyedain, M; Sfeir, C			Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENTIN MATRIX PROTEIN-1; EXTRACELLULAR-MATRIX; OSTEOBLASTIC DIFFERENTIATION; HYDROXYAPATITE FORMATION; TRANSCRIPTION FACTOR; OSTEOGENIC DIFFERENTIATION; BONE-FORMATION; I COLLAGEN; PHOSPHOPROTEIN; INDUCTION	Extracellular matrix proteins (ECMs) serve as both a structural support for cells and a dynamic biochemical network that directs cellular activities. ECM proteins such as those of the SIBLING family ( small integrin-binding ligand glycoprotein) could possess inherent growth factor activity. In this study, we demonstrate that exon 5 of dentin matrix protein 3 ( phosphophoryn ( PP)), a non-collagenous dentin ECM protein and SIBLING protein family member, up-regulates osteoblast marker genes in primary human adult mesenchymal stem cells (hMSCs), a mouse osteoblastic cell line (MC3T3-E1), and a mouse fibroblastic cell line (NIH3T3). Quantitative real-time PCR technology was used to quantify gene expression levels of bone markers such as Runx2, Osx (Osterix), bone/liver/kidney Alp ( alkaline phosphatase), Ocn ( osteocalcin), and Bsp ( bone sialoprotein) in response to recombinant PP and stably transfected PP. PP up-regulated Runx2, Osx, and Ocn gene expression. PP increased OCN protein production in hMSCs and MC3T3-E1. ALP activity and calcium deposition was increased by PP in hMSC. Furthermore, an alpha(v)beta(3) integrin-blocking antibody significantly inhibited recombinant PP-induced expression of Runx2 in hMSCs, suggesting that signaling by PP is mediated through the integrin pathway. PP was also shown to activate p38, ERK1/2, and JNK, three components of the MAPK pathway. These data demonstrate a novel signaling function for PP in cell differentiation beyond the hypothesized role of PP in biomineralization.	Univ Pittsburgh, Dept Oral Med & Pathol, Sch Dent Med, Pittsburgh, PA 15261 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Bone Tissue Engn Ctr, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Inst Complex Engineered Syst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Sfeir, C (corresponding author), Univ Pittsburgh, Dept Oral Med & Pathol, Sch Dent Med, 693A Salk Hall, Pittsburgh, PA 15261 USA.	csfeir@pitt.edu						ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Applied Biosystems, 2001, APPL BIOS US B; BISSELL MJ, 1987, J CELL SCI, P327; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931; Chaplet M, 2003, J BONE MINER RES, V18, P1506, DOI 10.1359/jbmr.2003.18.8.1506; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; DEVRIES IG, 1989, HISTOCHEMISTRY, V91, P69, DOI 10.1007/BF00501914; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hayashibara T, 2004, J BONE MINER RES, V19, P455, DOI 10.1359/JBMR.0301263; He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; KUBOKI Y, 1979, J DENT RES, V58, P1926, DOI 10.1177/00220345790580092001; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026; Liapis H, 1996, DIAGN MOL PATHOL, V5, P127, DOI 10.1097/00019606-199606000-00008; LINDE A, 1980, J BIOL CHEM, V255, P5931; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MACDOUGALL M, 1985, BIOCHEM J, V232, P493, DOI 10.1042/bj2320493; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; RICHARDSON WS, 1978, J BIOL CHEM, V253, P8042; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Sastry SK, 1996, DEV BIOL, V180, P455, DOI 10.1006/dbio.1996.0319; Sfeir C, 1996, CONNECT TISSUE RES, V35, P215, DOI 10.3109/03008209609029194; SFEIR C, 1995, J BONE MINER RES, V10, P607; Sfeir C., 2000, CHEM BIOL MINERALIZE, P181; Shi ST, 1996, J BONE MINER RES, V11, P1139, DOI 10.1002/jbmr.5650110813; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Veis A, 2002, MICROSC RES TECHNIQ, V59, P342, DOI 10.1002/jemt.10216; Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; VEIS A, 1993, J BONE MINER RES, V8, pS493; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WEINSTOCK M, 1973, J CELL BIOL, V56, P838, DOI 10.1083/jcb.56.3.838; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x	60	127	139	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53323	53330		10.1074/jbc.M404934200	http://dx.doi.org/10.1074/jbc.M404934200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15371433	hybrid			2022-12-27	WOS:000225680600064
J	Chiocco, MJ; Kulnane, LS; Younkin, L; Younkin, S; Evin, G; Lamb, BT				Chiocco, MJ; Kulnane, LS; Younkin, L; Younkin, S; Evin, G; Lamb, BT			Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE PATIENTS; PRECURSOR-PROTEIN; ARTIFICIAL CHROMOSOME; MOUSE MODEL; HUMAN BRAIN; EXPRESSION; BACE1; APP; DEFICITS; IDENTIFICATION	Amyloid-beta (Abeta) the primary component of the senile plaques found in Alzheimer's disease ( AD) is generated by the rate-limiting cleavage of amyloid precursor protein (APP) by beta-secretase followed by gamma-secretase cleavage. Identification of the primary beta-secretase gene, BACE1, provides a unique opportunity to examine the role this unique aspartyl protease plays in altering Abeta metabolism and deposition that occurs in AD. The current experiments seek to examine how modulating beta-secretase expression and activity alters APP processing and Abeta metabolism in vivo. Genomic-based BACE1 transgenic mice were generated that overexpress human BACE1 mRNA and protein. The highest expressing BACE1 transgenic line was mated to transgenic mice containing human APP transgenes. Our biochemical and histochemical studies demonstrate that mice overexpressing both BACE1 and APP show specific alterations in APP processing and age-dependent Abeta deposition. We observed elevated levels of Abeta isoforms as well as significant increases of Abeta deposits in these double transgenic animals. In particular, the double transgenics exhibited a unique cortical deposition profile, which is consistent with a significant increase of BACE1 expression in the cortex relative to other brain regions. Elevated BACE1 expression coupled with increased deposition provides functional evidence for beta-secretase as a primary effector in regional amyloid deposition in the AD brain. Our studies demonstrate, for the first time, that modulation of BACE1 activity may play a significant role in AD pathogenesis in vivo.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	Case Western Reserve University; University Hospitals of Cleveland; Mayo Clinic; University of Melbourne	Lamb, BT (corresponding author), Case Western Reserve Univ, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.	btl@po.cwru.edu	Evin, Genevieve M/E-5891-2013		NCI NIH HHS [CA43703, P30 CA043703] Funding Source: Medline; NIA NIH HHS [P50 AG008012, AG08012, AG14451, R01 AG023012, R01 AG023012-01A1] Funding Source: Medline; NIGMS NIH HHS [GM08056-21] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008012, R29AG014451, R01AG023012, R01AG014451] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Clarimon J, 2003, J NEUROL, V250, P956, DOI 10.1007/s00415-003-1127-8; Delatour B, 2004, NEUROBIOL DIS, V16, P41, DOI 10.1016/j.nbd.2004.01.008; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gold G, 2003, AM J MED GENET B, V119B, P44, DOI 10.1002/ajmg.b.10010; HOGAN B, 1994, MANIPULATING MOUSE E, P217; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Irizarry MC, 2001, AM J PATHOL, V158, P173, DOI 10.1016/S0002-9440(10)63955-7; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P625; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Kovacs T, 2001, NEUROREPORT, V12, P285, DOI 10.1097/00001756-200102120-00021; Kulnane LS, 2001, NEUROBIOL DIS, V8, P982, DOI 10.1006/nbdi.2001.0446; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Lehman EJH, 2003, NEUROBIOL AGING, V24, P645, DOI 10.1016/S0197-4580(02)00153-7; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Liu HC, 2003, BRAIN RES, V961, P88, DOI 10.1016/S0006-8993(02)03849-0; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohajeri MH, 2004, J NEURAL TRANSM, V111, P413, DOI 10.1007/s00702-003-0057-z; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Nicolaou M, 2001, NEUROGENETICS, V3, P203; Nowotny P, 2001, NEUROREPORT, V12, P1799, DOI 10.1097/00001756-200107030-00008; PAXINOS GF, 2001, MOUSE BRAIN STEREOTA, P108; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; SAMBROOK J, 2001, MOL CLONING LAB MANU, V1, P23; Saunders A.J, 1999, SCIENCE, V286, P1255, DOI DOI 10.1126/SCIENCE.286.5443.1255A; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Serby M, 1996, BIOL PSYCHIAT, V39, P375, DOI 10.1016/0006-3223(95)00472-6; SERBY M, 1991, AM J PSYCHIAT, V148, P357; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sun AY, 2002, EXP NEUROL, V175, P10, DOI 10.1006/exnr.2002.7875; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zohar O, 2003, MOL BRAIN RES, V115, P63, DOI 10.1016/S0169-328X(03)00182-7	55	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52535	52542		10.1074/jbc.M409680200	http://dx.doi.org/10.1074/jbc.M409680200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452128	hybrid, Green Accepted			2022-12-27	WOS:000225493400099
J	Sen, N; Das, BB; Ganguly, A; Mukherjee, T; Bandyopadhyay, S; Majumder, HK				Sen, N; Das, BB; Ganguly, A; Mukherjee, T; Bandyopadhyay, S; Majumder, HK			Camptothecin-induced imbalance in intracellular cation homeostasis regulates programmed cell death in unicellular hemoflagellate Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED THYMOCYTE APOPTOSIS; PLASMA-MEMBRANE; CYTOCHROME-C; DNA TOPOISOMERASES; EARLY EVENTS; ACTIVATION; PROMASTIGOTES; CLEAVAGE; CA2+; DEPOLARIZATION	Leishmania, a unicellular trypanosomatid protozoan parasite, causes a wide range of human diseases ranging from the localized self-healing cutaneous lesions to fatal visceral leishmaniasis. However, it undergoes a process of programmed cell death during treatment with the topoisomerase I poison camptothecin (CPT). The present study shows that CPT-induced formation of reactive oxygen species increases the level of cytosolic calcium through the release of calcium ions from intracellular stores as well as by influx of extracellular calcium. Elevation of cytosolic calcium is responsible for depolarization of mitochondrial membrane potential (DeltaPsi(m)), which is followed by a significant decrease in intracellular pH levels. CPT-induced oxidative stress also causes impairment of the Na+-K+-ATPase pump and subsequently decreases the intracellular K+ level in leishmanial cells. A decrease in both intracellular pH and K+ levels propagates the apoptotic process through activation of caspase 3-like proteases by rapid formation of cytochrome c-mediated apoptotic complex. In addition to caspase-like protease activation, a lower level of intracellular K+ also enhances the activation of apoptotic nucleases at the late stage of apoptosis. This suggests that the physiological level of pH and K+ are inhibitory for apoptotic DNA fragmentation and caspase-like protease activation in leishmanial cells. Moreover, unlike mammalian cells, the intracellular ATP level gradually decreases with an increase in the number of apoptotic cells after the loss of DeltaPsi(m). Taken together, the elucidation of biochemical events, which tightly regulate the process of growth arrest and death of Leishmania donovani promastigotes, allows us to define a more comprehensive view of cell death during treatment with CPT.	Indian Inst Chem Biol, Div Mol Parasitol, Kolkata 700032, W Bengal, India; Indian Inst Chem Biol, Div Infect Dis, Kolkata 700032, W Bengal, India; Indian Inst Chem Biol, Div Immunol, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Majumder, HK (corresponding author), Indian Inst Chem Biol, Div Mol Parasitol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	hkmajumder@iicb.res.in	DAS, BENU BRATA BRATA/AAX-4347-2021; Sen, Nilkantha/AAW-9788-2020; Das, Benu Brata/AAC-3452-2022	DAS, BENU BRATA BRATA/0000-0003-2519-7105; 				Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; CHAKRABORTY AK, 1993, INDIAN J BIOCHEM BIO, V30, P257; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cunningham D, 1999, SEMIN ONCOL, V26, P6; Das M, 2001, J CELL SCI, V114, P2461; Facompre M, 2001, BIOCHEM PHARMACOL, V61, P299, DOI 10.1016/S0006-2952(00)00553-0; Felibertt P, 1995, MOL BIOCHEM PARASIT, V74, P179, DOI 10.1016/0166-6851(95)02497-2; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P217, DOI 10.1113/jphysiol.1967.sp008297; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hughes FM, 1998, CELL DEATH DIFFER, V5, P1017; JEZEK P, 1990, J BIOL CHEM, V265, P10522; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kayalar C, 1996, P NATL ACAD SCI USA, V93, P2234, DOI 10.1073/pnas.93.5.2234; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; KRICKA LJ, 1988, ANAL BIOCHEM, V175, P14, DOI 10.1016/0003-2697(88)90354-5; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; LANCASTER JR, 1989, FEBS LETT, V248, P169, DOI 10.1016/0014-5793(89)80454-5; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mandal D, 1997, BIOCHEM J, V322, P251, DOI 10.1042/bj3220251; Mann CL, 2001, ENDOCRINOLOGY, V142, P5059, DOI 10.1210/en.142.12.5059; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Mukherjee T, 2001, J BIOL CHEM, V276, P5563, DOI 10.1074/jbc.M008469200; NOSSERI C, 1994, EXP CELL RES, V212, P367, DOI 10.1006/excr.1994.1156; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; SARKAR D, 1995, FEBS LETT, V375, P83, DOI 10.1016/0014-5793(95)01161-7; SCHWARTZMAN RA, 1991, ENDOCRINOLOGY, V128, P1190, DOI 10.1210/endo-128-2-1190; SCHWARTZMAN RA, 1993, ENDOCRINOLOGY, V133, P91; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sledge GW, 1999, SEMIN ONCOL, V26, P1; Stefanelli C, 1997, BIOCHEM J, V322, P909, DOI 10.1042/bj3220909; SUTCLIFFE JA, 1989, ANTIMICROB AGENTS CH, V33, P2027, DOI 10.1128/AAC.33.12.2027; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; TSAO YP, 1993, CANCER RES, V53, P5908; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; WANG JC, 1991, J BIOL CHEM, V266, P6659; WYLLIE AH, 1995, CURR OPIN GENET DEV, V5, P97, DOI 10.1016/S0959-437X(95)90060-8; Yasuhara N, 1997, GENES CELLS, V2, P55, DOI 10.1046/j.1365-2443.1997.1010302.x; Yu A, 2000, BBA-MOL CELL BIOL L, V1487, P296, DOI 10.1016/S1388-1981(00)00100-1; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	45	106	111	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52366	52375		10.1074/jbc.M406705200	http://dx.doi.org/10.1074/jbc.M406705200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15355995	hybrid			2022-12-27	WOS:000225493400080
J	Solis-Garrido, LM; Pintado, AJ; Andres-Mateos, E; Figueroa, MA; Matute, C; Montiel, C				Solis-Garrido, LM; Pintado, AJ; Andres-Mateos, E; Figueroa, MA; Matute, C; Montiel, C			Cross-talk between native plasmalemmal Na+/Ca2+ exchanger and inositol 1,4,5-trisphosphate-sensitive Ca2+ internal store in Xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; INTRACELLULAR CALCIUM; LYSOPHOSPHATIDIC ACID; NA+-CA2+ EXCHANGER; MOLECULAR-CLONING; FERTILIZATION; RELEASE; RECEPTORS; EGGS; TRISPHOSPHATE	Because the presence of a native plasmalemmal Na+/ Ca2+ exchange (NCX) activity in Xenopus laevis oocytes remains controversial, its possible functional role in these cells is poorly understood. Here, in experiments on control oocytes and oocytes overexpressing a cloned NCX1 cardiac protein, confocal microscopy combined with electrophysiological techniques reveal that these cells express an endogenous NCX protein forming a functional microdomain with inositol 1,4,5-trisphosphate receptors (InsP(3)R) that controls intracellular Ca2+ in a restricted subplasmalemmal space. The following data obtained in control denuded oocytes are consistent with this view: (i) reverse transcription-PCR revealed that the oocyte expresses two transcripts for the NCX1 and NCX3 isoforms; (ii) immunofluorescence experiments showed that native NCX1 and InsP(3)Rs are largely codistributed in discrete areas of the plasma membrane in close apposition to the cortical endoplasmic reticulum shell; (iii) when stimulated by rabbit serum, which elevates intracellular Ca2+ mediated by InsP(3), voltage-clamped oocytes display a large and transient inward Ca2+-activated chloride current, I-Cl(Ca), as a result of the Ca2+ rise at the inner surface membrane; (iv) this current is significantly enhanced by KB-R7943 and by an extracellular sodium-depleted medium, two maneuvers that prevent "Ca2+ extrusion" via NCX; and ( v) blocking NCX enhanced the ICl(Ca) elicited by InsP(3) but not by Ca2+ photolysis in oocytes injected with the respective caged compounds. Moreover, overexpression of cardiac NCX1, confirmed by confocal microscopy, has functional consequences for the "Ca2+ influx" but not for the serum-elicited "Ca2+ efflux" mode of basal exchange activity and does not alter the number of endogenous NCX/InsP(3)Rs colocalization sites. Our results suggest that native NCX, because of its strategic position, may regulate InsP(3)-mediated Ca2+ signaling during the early phases of oocyte maturation and/or fertilization, and furthermore foreign cardiac protein is excluded from the Ca2+ microdomains surrounding the native NCX/InsP(3)Rs complex in the oocyte.	Univ Autonoma Madrid, Dept Farmacol, Fac Med, Madrid 28029, Spain; Univ Basque Country, Fac Med, Dept Neurociencias, Leioa 48940, Spain	Autonomous University of Madrid; University of Basque Country	Montiel, C (corresponding author), Univ Autonoma Madrid, Dept Farmacol, Fac Med, C Arzobispo Morcillo 4, Madrid 28029, Spain.	carmen.montiel@uam.es	Montiel, Carmen/L-1407-2017; Matute, Carlos/N-5559-2014; Andres-Mateos, Eva/B-4691-2008	Montiel, Carmen/0000-0003-4845-0484; Matute, Carlos/0000-0001-8672-711X; 				Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BUSA WB, 1985, J CELL BIOL, V100, P1325, DOI 10.1083/jcb.100.4.1325; BUSA WB, 1985, J CELL BIOL, V101, P677, DOI 10.1083/jcb.101.2.677; Callamaras N, 1998, J PHYSIOL-LONDON, V511, P395, DOI 10.1111/j.1469-7793.1998.395bh.x; Callamaras N, 1999, J GEN PHYSIOL, V113, P199, DOI 10.1085/jgp.113.2.199; Demandolx D, 1997, J MICROSC-OXFORD, V185, P21, DOI 10.1046/j.1365-2818.1997.1470704.x; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FRANK JS, 1992, J CELL BIOL, V117, P337, DOI 10.1083/jcb.117.2.337; GOLDMAN WF, 1994, J NEUROSCI, V14, P5834; Golovina VA, 1996, GLIA, V16, P296; Guo Z, 1996, P NATL ACAD SCI USA, V93, P14367, DOI 10.1073/pnas.93.25.14367; HAN JK, 1990, J CELL BIOL, V110, P1103, DOI 10.1083/jcb.110.4.1103; He CL, 1997, BIOL REPROD, V57, P1245, DOI 10.1095/biolreprod57.5.1245; He CL, 1999, BIOL REPROD, V61, P935, DOI 10.1095/biolreprod61.4.935; Herrero CJ, 1999, BRIT J PHARMACOL, V127, P1375, DOI 10.1038/sj.bjp.0702692; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; HILGEMANN DW, 1989, PFLUG ARCH EUR J PHY, V415, P247, DOI 10.1007/BF00370601; IGUSA Y, 1983, J PHYSIOL-LONDON, V340, P611, DOI 10.1113/jphysiol.1983.sp014783; Iwamoto T, 1998, AM J PHYSIOL-CELL PH, V275, pC423, DOI 10.1152/ajpcell.1998.275.2.C423; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; IWATA T, 1996, ANN NY ACAD SCI, V15, P37; JUHASZOVA M, 1994, AM J PHYSIOL, V266, pC234, DOI 10.1152/ajpcell.1994.266.1.C234; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kimura Y, 2001, J BIOL CHEM, V276, P15208, DOI 10.1074/jbc.M011588200; Kraev A, 1996, GENOMICS, V37, P105, DOI 10.1006/geno.1996.0526; KUME S, 1993, CELL, V73, P555, DOI 10.1016/0092-8674(93)90142-D; LI ZP, 1994, J BIOL CHEM, V269, P17434; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; LONGONI S, 1988, AM J PHYSIOL, V255, pC870, DOI 10.1152/ajpcell.1988.255.6.C870; Machaty Z, 2002, BIOL REPROD, V67, P1133, DOI 10.1095/biolreprod67.4.1133; Marchant JS, 2002, AM J PHYSIOL-CELL PH, V282, pC1374, DOI 10.1152/ajpcell.00446.2001; Marchant JS, 2001, BRIT J PHARMACOL, V132, P1396, DOI 10.1038/sj.bjp.0703922; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; MILEDI R, 1989, J PHYSIOL-LONDON, V416, P601, DOI 10.1113/jphysiol.1989.sp017780; MILEDI R, 1982, EMBO J, V1, P1307, DOI 10.1002/j.1460-2075.1982.tb01315.x; MIYAZAKI S, 1993, DEV BIOL, V158, P62, DOI 10.1006/dbio.1993.1168; Montiel C, 1997, EUR J PHARMACOL, V332, P183, DOI 10.1016/S0014-2999(97)01073-X; MOORE EDW, 1993, NATURE, V365, P657, DOI 10.1038/365657a0; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; Nicoll DA, 1996, J BIOL CHEM, V271, P24914, DOI 10.1074/jbc.271.40.24914; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; NUCCITELLI R, 1993, DEV BIOL, V158, P200, DOI 10.1006/dbio.1993.1179; Ottolia M, 2001, J BIOL CHEM, V276, P19603, DOI 10.1074/jbc.M101489200; PARKER I, 1987, PROC R SOC SER B-BIO, V232, P59, DOI 10.1098/rspb.1987.0061; PARKER I, 1991, J PHYSIOL-LONDON, V433, P229, DOI 10.1113/jphysiol.1991.sp018423; PARYS JB, 1992, J BIOL CHEM, V267, P18776; Pepperell JR, 1999, BIOL REPROD, V60, P1137, DOI 10.1095/biolreprod60.5.1137; Pintado AJ, 2000, BRIT J PHARMACOL, V130, P1893, DOI 10.1038/sj.bjp.0703519; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; SCHLIEF T, 1995, J PHYSIOL-LONDON, V486, P123, DOI 10.1113/jphysiol.1995.sp020796; Snow P, 1996, DEV BIOL, V180, P108, DOI 10.1006/dbio.1996.0288; Sobolevsky AI, 1999, NEUROPHARMACOLOGY, V38, P1235, DOI 10.1016/S0028-3908(99)00040-4; STITH BJ, 1993, MOL BIOL CELL, V4, P435, DOI 10.1091/mbc.4.4.435; SUPPLISSON S, 1991, DEV BIOL, V145, P231, DOI 10.1016/0012-1606(91)90122-J; SWANN K, 1994, CELL CALCIUM, V15, P331, DOI 10.1016/0143-4160(94)90072-8; TIGYI G, 1990, P NATL ACAD SCI USA, V87, P1521, DOI 10.1073/pnas.87.4.1521; Watano T, 1996, BRIT J PHARMACOL, V119, P555, DOI 10.1111/j.1476-5381.1996.tb15708.x; ZERNICKAGOETZ M, 1995, J CELL SCI, V108, P469	59	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52414	52424		10.1074/jbc.M408872200	http://dx.doi.org/10.1074/jbc.M408872200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15375168	hybrid			2022-12-27	WOS:000225493400086
J	Friedmann, E; Lemberg, MK; Weihofen, A; Dev, KK; Dengler, U; Rovelli, G; Martoglio, B				Friedmann, E; Lemberg, MK; Weihofen, A; Dev, KK; Dengler, U; Rovelli, G; Martoglio, B			Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN BIOSYNTHESIS; GAMMA-SECRETASE; INTRAMEMBRANE PROTEOLYSIS; ALZHEIMERS-DISEASE; ACTIVE-SITE; IDENTIFICATION; RECONSTITUTION; GLYCOSYLATION; PREDICTIONS; CLEAVAGE	The human genome encodes seven intramembrane-cleaving GXGD aspartic proteases. These are the two presenilins that activate signaling molecules and are implicated in Alzheimer's disease, signal peptide peptidase (SPP), required for immune surveillance, and fourSPP-like candidate proteases (SPPLs), of unknown function. Here we describe a comparative analysis of the topologies of SPP and its human homologues, SPPL2a, - 2b, - 2c, and - 3. We demonstrate that their N-terminal extensions are located in the extracellular space and, except for SPPL3, are modified with N-glycans. Whereas SPPL2a, - 2b, and - 2c contain a signal sequence, SPP and SPPL3 contain a type I signal anchor sequence for initiation of protein translocation and membrane insertion. The hydrophilic loops joining the transmembrane regions, which contain the catalytic residues, are facing the exoplasm. The C termini of all these proteins are exposed toward the cytosol. Taken together, our study demonstrates that SPP and its homologues are all of the same principal structure with a catalytic domain embedded in the membrane in opposite orientation to that of presenilins. Other than presenilins, SPPL2a, - 2b, - 2c, and - 3 are therefore predicted to cleave type II-oriented substrate peptides like the prototypic protease SPP.	ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; Novartis Pharma AG, Nervous Syst Res, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Novartis Pharma AG, Funct Gen, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Novartis; Novartis	Martoglio, B (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland.	bruno.martoglio@bc.biol.ethz.ch	Weihofen, Andreas/A-1566-2011; Lemberg, Marius K/B-8881-2016	Lemberg, Marius K/0000-0002-0996-1268; Dev, Kumlesh/0000-0003-4274-9119; Weihofen, Andreas/0000-0001-6265-9087				An FY, 1999, J BACTERIOL, V181, P5915, DOI 10.1128/JB.181.19.5915-5921.1999; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Green DH, 2000, J BACTERIOL, V182, P278, DOI 10.1128/JB.182.2.278-285.2000; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; High S, 1999, BIOCHEM SOC T, V27, P883, DOI 10.1042/bst0270883; Kall L, 2002, FEBS LETT, V532, P415, DOI 10.1016/S0014-5793(02)03730-4; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; LAU JTY, 1983, J BIOL CHEM, V258, P5255; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Lemberg MK, 2003, ANAL BIOCHEM, V319, P327, DOI 10.1016/S0003-2697(03)00298-7; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li XJ, 1996, NEURON, V17, P1015, DOI 10.1016/S0896-6273(00)80231-7; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Martoglio B, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P265; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakai T, 1999, J BIOL CHEM, V274, P23647, DOI 10.1074/jbc.274.33.23647; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nilsson J, 2000, FEBS LETT, V486, P267, DOI 10.1016/S0014-5793(00)02321-8; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Ott CM, 2002, J CELL SCI, V115, P2003; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; TOWNSLEY FM, 1994, EUR J CELL BIOL, V64, P211; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WADA I, 1991, J BIOL CHEM, V266, P19599; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	46	81	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50790	50798		10.1074/jbc.M407898200	http://dx.doi.org/10.1074/jbc.M407898200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385547	Green Published, hybrid			2022-12-27	WOS:000225355800021
J	Olson, GE; Winfrey, VP; NagDas, SK; Melner, MH				Olson, GE; Winfrey, VP; NagDas, SK; Melner, MH			Region-specific expression and secretion of the fibrinogen-related protein, fgl2, by epithelial cells of the hamster epididymis and its role in disposal of defective spermatozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM QUALITY-CONTROL; PROTHROMBINASE ACTIVITY; SPONTANEOUS-ABORTION; VIRAL-HEPATITIS; GENE-EXPRESSION; O-GLYCOSYLATION; T-LYMPHOCYTES; IFN-GAMMA; UBIQUITIN; IDENTIFICATION	The cauda epididymidis functions in the storage and protection of mature, fertile spermatozoa. We previously identified a region-specific secretory glycoprotein ( termed HEP64) of the hamster proximal cauda epididymidis that specifically bound and coated the nonviable, but not the viable, spermatozoa within the epididymal lumen. In this study we employed expression screening of a hamster epididymal cDNA library to obtain the full-length sequence of HEP64 and to identify it as the fibrinogen-like protein fgl2. Northern blot analysis demonstrated that fgl2 mRNA is highly expressed by the proximal cauda epididymidis in comparison to other hamster tissues examined, and, in situ hybridization analysis of the epididymis revealed that fgl2 mRNA exhibited a region- and principal cell-specific expression pattern. Immunohistochemistry confirmed the association of fgl2 with abnormal spermatozoa in the cauda epididymidis and revealed smaller fgl2-containing particles. Immunoelectron microscopy revealed that fgl2 was distributed throughout an amorphous, "death cocoon," complex assembled onto abnormal spermatozoa and that the smaller fgl2 aggregates consisted of the amorphous material with embedded sperm fragments, organelles, and membrane vesicles. A protocol was developed to isolate an enriched death cocoon fraction. SDS-PAGE and microsequence analyses revealed that the M-r 64,000 fgl2 monomer was assembled into two disulfide-linked oligomers of M-r 260,000 and 280,000. These data demonstrate that the epididymis possesses a specific mechanism to identify and envelop defective spermatozoa with a protein complex containing the fibrinogen-like protein fgl2. We propose that this represents an important protective mechanism not only to shield the viable sperm population from potentially deleterious enzymes released by dying spermatozoa but also to prevent the release of sperm proteins that could initiate an immune response if they escaped the epididymal environment.	Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Obstet & Gynecol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Olson, GE (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	gary.olson@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020419] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20419] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Bailey R, 1999, MOL CELL ENDOCRINOL, V151, P17, DOI 10.1016/S0303-7207(99)00016-7; Barroso G, 2000, HUM REPROD, V15, P1338, DOI 10.1093/humrep/15.6.1338; BEDFORD JM, 1975, HDB PHYSL, P303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chan CWY, 2002, J IMMUNOL, V168, P5170, DOI 10.4049/jimmunol.168.10.5170; Clark DA, 2001, MOL HUM REPROD, V7, P185, DOI 10.1093/molehr/7.2.185; Clark DA, 1999, AM J REPROD IMMUNOL, V42, P37; COOPER TG, 1977, AM J ANAT, V149, P93, DOI 10.1002/aja.1001490107; Cooper TG, 2002, J CELL SCI, V115, P5; CORNWALL GA, 1992, MOL ENDOCRINOL, V6, P1653, DOI 10.1210/me.6.10.1653; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Ding JW, 1997, J VIROL, V71, P9223, DOI 10.1128/JVI.71.12.9223-9230.1997; DOOLITTLE RF, 1992, PROTEIN SCI, V1, P1563, DOI 10.1002/pro.5560011204; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; GLOVER TD, 1961, NATURE, V190, P185, DOI 10.1038/190185b0; Hancock WW, 2004, P NATL ACAD SCI USA, V101, P3005, DOI 10.1073/pnas.0308369101; Hansen JE, 1997, NUCLEIC ACIDS RES, V25, P278, DOI 10.1093/nar/25.1.278; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; HANSEN JE, 1995, BIOCHEM J, V308, P801, DOI 10.1042/bj3080801; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Hinton BT, 1996, CURR TOP DEV BIOL, V33, P61, DOI 10.1016/S0070-2153(08)60337-3; HINTON BT, 1995, MICROSC RES TECHNIQ, V30, P67, DOI 10.1002/jemt.1070300106; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Jervis KM, 2001, BIOL REPROD, V65, P696, DOI 10.1095/biolreprod65.3.696; Jones R, 1998, J REPROD FERTIL, P73; Jones RC, 1999, INT J ANDROL, V22, P57; Kirchhoff C, 1998, ANDROLOGIA, V30, P225; Kirchhoff C, 1999, INT REV CYTOL, V188, P133; Knackstedt M, 2001, AM J REPROD IMMUNOL, V46, P196, DOI 10.1034/j.1600-0897.2001.d01-3.x; KOYAMA T, 1987, P NATL ACAD SCI USA, V84, P1609, DOI 10.1073/pnas.84.6.1609; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFUSE WP, 1995, CELL IMMUNOL, V163, P187, DOI 10.1006/cimm.1995.1115; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Levy GA, 2000, AM J PATHOL, V156, P1217, DOI 10.1016/S0002-9440(10)64992-9; Marazzi S, 1998, J IMMUNOL, V161, P138; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Martan J., 1969, Biology of Reproduction Suppl, VNo. 1, P134, DOI 10.1095/biolreprod1.Supplement_1.134; NagDas SK, 2000, BIOL REPROD, V63, P1428, DOI 10.1095/biolreprod63.5.1428; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OLSON GE, 1988, BIOL REPROD, V39, P1145, DOI 10.1095/biolreprod39.5.1145; Olson GE, 1998, CELL TISSUE RES, V293, P489, DOI 10.1007/s004410051141; Olson GE, 2003, MICROSC RES TECHNIQ, V61, P46, DOI 10.1002/jemt.10316; ORGEBINCRIST MC, 1975, HDB PHYSL 7, P319; PANOSKALTSISMORTARI A, 1995, BIOTECHNIQUES, V18, P300; PARR RL, 1995, J VIROL, V69, P5033, DOI 10.1128/JVI.69.8.5033-5038.1995; RUEGG C, 1995, GENE, V160, P257, DOI 10.1016/0378-1119(95)00240-7; Rychlik DF, 2003, J SOC GYNECOL INVEST, V10, P67, DOI 10.1016/S1071-5576(02)00252-6; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Simeone FA, 1931, J EXP BIOL, V8, P163; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Sutovsky P, 2001, J CELL SCI, V114, P1665; Sutovsky P, 2002, MOL REPROD DEV, V61, P406, DOI 10.1002/mrd.10101; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEISSENBERG R, 1994, INT J ANDROL, V17, P256, DOI 10.1111/j.1365-2605.1994.tb01251.x; Yuwaraj S, 2001, GENOMICS, V71, P330, DOI 10.1006/geno.2000.6444	61	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51266	51274		10.1074/jbc.M410485200	http://dx.doi.org/10.1074/jbc.M410485200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15377663	hybrid			2022-12-27	WOS:000225355800075
J	Walker, KA; Mallik, P; Pratt, TS; Osuna, R				Walker, KA; Mallik, P; Pratt, TS; Osuna, R			The Escherichia coli fis promoter is regulated by changes in the levels of its transcription initiation nucleotide CTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA TRANSCRIPTION; DEPENDENT REITERATIVE TRANSCRIPTION; SALMONELLA-TYPHIMURIUM-PYRC; THIN-LAYER-CHROMATOGRAPHY; GROWTH-RATE REGULATION; SENSITIVE SELECTION; STRINGENT CONTROL; START SITES; OPERON EXPRESSION; NUCLEOSIDE TRIPHOSPHATE	Expression of the Escherichia coli nucleoid-associated protein Fis ( factor for inversion stimulation) is controlled at the transcriptional level in accordance with the nutritional availability. It is highly expressed during early logarithmic growth phase in cells growing in rich medium but poorly expressed in late logarithmic and stationary phase. However, fis mRNA expression is prolonged at high levels throughout the logarithmic and early stationary phase when the preferred transcription initiation site (+1C) is replaced with A or G, indicating that initiation with CTP is a required component of the regulation pattern. We show that RNA polymerase-fis promoter complexes are short lived and that transcription is stimulated over 20-fold from linear or supercoiled DNA if CTP is present during formation of initiation complexes, which serves to stabilize these complexes. Use of fis promoter fusions to lacZ indicated that fis promoter transcription is sensitive to the intracellular pool of the predominant initiating NTP. Growth conditions resulting in increases in CTP pools also result in corresponding increases in fis mRNA levels. Measurements of NTP pools performed throughout the growth of the bacterial culture in rich medium revealed a dramatic increase in all four NTP levels during the transition from stationary to logarithmic growth phase, followed by reproducible oscillations in their levels during logarithmic growth, which later decrease during the transition from logarithmic to stationary phase. In particular, CTP pools fluctuate in a manner consistent with a role in regulating fis expression. These observations support a model whereby fis expression is subject to regulation by the availability of its initiating NTP.	SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Washington University (WUSTL)	Osuna, R (corresponding author), SUNY Albany, Dept Biol Sci, 1400 Washington Ave, Albany, NY 12222 USA.	osuna@albany.edu		Walker, Kimberly A/0000-0002-6360-2792	NIGMS NIH HHS [GM52051] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052051, R29GM052051] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER MD, 1978, J BACTERIOL, V133, P149, DOI 10.1128/JB.133.1.149-157.1978; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; Beach MB, 1998, J BACTERIOL, V180, P5932, DOI 10.1128/JB.180.22.5932-5946.1998; BECK C, 1973, J MOL BIOL, V78, P117, DOI 10.1016/0022-2836(73)90431-2; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Cabrera JE, 2001, J BACTERIOL, V183, P6126, DOI 10.1128/JB.183.20.6126-6134.2001; Caramel A, 2000, MOL MICROBIOL, V36, P85, DOI 10.1046/j.1365-2958.2000.01827.x; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CASE CC, 1988, GENE, V72, P219, DOI 10.1016/0378-1119(88)90147-3; Claret L, 1996, J MOL BIOL, V263, P126, DOI 10.1006/jmbi.1996.0564; DICKSON RR, 1989, J BACTERIOL, V171, P4862, DOI 10.1128/jb.171.9.4862-4870.1989; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Goldberg MD, 2001, MOL MICROBIOL, V41, P549, DOI 10.1046/j.1365-2958.2001.02526.x; GonzalezGil G, 1996, MOL MICROBIOL, V22, P21, DOI 10.1111/j.1365-2958.1996.tb02652.x; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Green J, 1996, MOL MICROBIOL, V20, P1043, DOI 10.1111/j.1365-2958.1996.tb02545.x; Han XS, 1998, J BACTERIOL, V180, P705, DOI 10.1128/JB.180.3.705-713.1998; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Hershberg R, 2001, NUCLEIC ACIDS RES, V29, P277, DOI 10.1093/nar/29.1.277; IRR J, 1969, J BIOL CHEM, V244, P2233; Jacobson BA, 1998, MOL MICROBIOL, V28, P1315, DOI 10.1046/j.1365-2958.1998.00897.x; JENSEN KF, 1979, J BACTERIOL, V138, P731, DOI 10.1128/JB.138.3.731-738.1979; JENSEN KF, 1979, ANAL BIOCHEM, V98, P254, DOI 10.1016/0003-2697(79)90138-6; JENSEN KF, 1989, J GEN MICROBIOL, V135, P805; JUSTESEN J, 1975, J BACTERIOL, V123, P851, DOI 10.1128/JB.123.3.851-854.1975; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; LIU CG, 1994, GENE DEV, V8, P2904, DOI 10.1101/gad.8.23.2904; LIU J, 1994, J BACTERIOL, V176, P2938, DOI 10.1128/JB.176.10.2938-2945.1994; Mallik P, 2004, J BACTERIOL, V186, P122, DOI 10.1128/JB.186.1.122-135.2004; Martin RG, 1997, J BACTERIOL, V179, P7410, DOI 10.1128/jb.179.23.7410-7419.1997; Miller J. H, 1972, EXPT MOL GENETICS; Murray HD, 2004, MOL MICROBIOL, V52, P1375, DOI 10.1111/j.1365-2958.2004.04060.x; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; NEUHARD J, 1986, EUR J BIOCHEM, V157, P335, DOI 10.1111/j.1432-1033.1986.tb09673.x; NEUHARD J, 1987, ESCHERICHIA COLI SAL, V1, P445; NILSSON L, 1994, J BIOL CHEM, V269, P9460; NILSSON L, 1992, J BACTERIOL, V174, P921, DOI 10.1128/jb.174.3.921-929.1992; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; POULSEN P, 1987, MOL GEN GENET, V208, P152, DOI 10.1007/BF00330436; Pratt TS, 1997, J BACTERIOL, V179, P6367, DOI 10.1128/jb.179.20.6367-6377.1997; QI FX, 1995, J MOL BIOL, V254, P552, DOI 10.1006/jmbi.1995.0638; RANDERATH E, 1964, J CHROMATOGR, V16, P126, DOI 10.1016/S0021-9673(01)82446-8; ROLAND KL, 1985, J BACTERIOL, V163, P991, DOI 10.1128/JB.163.3.991-999.1985; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Schneider DA, 2003, J BACTERIOL, V185, P6185, DOI 10.1128/JB.185.20.6185-6191.2003; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; Schneider R, 2000, MOL MICROBIOL, V38, P167, DOI 10.1046/j.1365-2958.2000.02129.x; Sheikh J, 2001, MOL MICROBIOL, V41, P983, DOI 10.1046/j.1365-2958.2001.02512.x; Shin D, 2003, J BIOL CHEM, V278, P14776, DOI 10.1074/jbc.M213248200; SILVER S, 1996, TRANSPORT INORGANIC, P1091; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SORENSEN KI, 1993, J BACTERIOL, V175, P4137; SORENSEN KI, 1991, MOL GEN GENET, V225, P249, DOI 10.1007/BF00269856; Tu AHT, 1997, J BACTERIOL, V179, P6665, DOI 10.1128/jb.179.21.6665-6673.1997; VOGEL U, 1991, J BACTERIOL, V173, P1168, DOI 10.1128/jb.173.3.1168-1174.1991; Walker KA, 2002, J BACTERIOL, V184, P4783, DOI 10.1128/JB.184.17.4783-4791.2002; Walker KA, 1999, J BACTERIOL, V181, P1269, DOI 10.1128/JB.181.4.1269-1280.1999; Weinstein-Fischer D, 2000, MOL MICROBIOL, V35, P1413, DOI 10.1046/j.1365-2958.2000.01805.x; WILSON HR, 1992, J BACTERIOL, V174, P514, DOI 10.1128/jb.174.2.514-524.1992; WU CW, 1969, BIOCHEMISTRY-US, V8, P4458, DOI 10.1021/bi00839a035; Wu HC, 1998, MOL MICROBIOL, V27, P493, DOI 10.1046/j.1365-2958.1998.00699.x; XU JM, 1995, J BACTERIOL, V177, P938, DOI 10.1128/jb.177.4.938-947.1995	70	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50818	50828		10.1074/jbc.M406285200	http://dx.doi.org/10.1074/jbc.M406285200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385561	hybrid			2022-12-27	WOS:000225355800024
J	Auty, R; Steen, H; Myers, LC; Persinger, J; Bartholomew, B; Gygi, SP; Buratowski, S				Auty, R; Steen, H; Myers, LC; Persinger, J; Bartholomew, B; Gygi, SP; Buratowski, S			Purification of active TFIID from Saccharomyces cerevisiae - Extensive promoter contacts and co-activator function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; RSP5 UBIQUITIN LIGASE; TRANSCRIPTION FACTOR; BINDING PROTEIN; AFFINITY PURIFICATION; CRYSTAL-STRUCTURE; GENE-EXPRESSION; TATA; COMPLEXES	The basal transcription factor TFIID is composed of the TATA-binding protein (TBP) and 14 TBP-associated factors (TAFs). Although TBP alone binds to the TATA box of DNA and supports basal transcription, the TAFs have essential functions that remain poorly defined. In order to study its properties, TFIID was purified from Saccharomyces cerevisiae using a newly developed affinity tag. Analysis of the final elution by mass spectrometry confirms the presence of all the known TAFs and TBP, as well as Rsp5, Bul1, Ubp3, Bre5, Cka1, and Cka2. Both Taf1 and Taf5 are ubiquitinated, and the ubiquitination pattern of TFIID changes when BUL1 or BRE5 is deleted. Purified TFIID binds specifically to promoter DNA in a manner stabilized by TFIIA, and these complexes can be analyzed by native gel electrophoresis. Phenanthroline-copper footprinting and photoaffinity cross-linking indicate that TFIID makes extensive contacts upstream and downstream of the TATA box. TFIID supports basal transcription and activated transcription, both of which are enhanced by TFIIA.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA; So Illinois Univ, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Dartmouth College; Southern Illinois University System; Southern Illinois University	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	steveb@hms.harvard.edu		Steen, Hanno/0000-0003-0179-6648	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R29GM046498, R01GM062483] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46498, GM62483] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; BARTHOLOMEW B, 1991, MOL CELL BIOL, V11, P5181, DOI 10.1128/MCB.11.10.5181; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; BURATOWSKI S, 1988, NATURE, V334, P37, DOI 10.1038/334037a0; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200; Chapman RD, 2004, NUCLEIC ACIDS RES, V32, P35, DOI 10.1093/nar/gkh172; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; DAHMUS ME, 1981, J BIOL CHEM, V256, P3332; Emami KH, 1997, GENE DEV, V11, P3007, DOI 10.1101/gad.11.22.3007; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hannan RD, 1998, J BIOL CHEM, V273, P1257, DOI 10.1074/jbc.273.2.1257; HENRY NL, 1992, J BIOL CHEM, V267, P23388; Honey S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e24; HORIKOSHI M, 1988, CELL, V54, P665, DOI 10.1016/S0092-8674(88)80011-4; Hu P, 2003, MOL CELL, V12, P699, DOI 10.1016/j.molcel.2003.08.011; Johnston IM, 2002, MOL CELL BIOL, V22, P3757, DOI 10.1128/MCB.22.11.3757-3768.2002; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Komarnitsky PB, 1998, MOL CELL BIOL, V18, P5861, DOI 10.1128/MCB.18.10.5861; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; KUWABARA M, 1986, BIOCHEMISTRY-US, V25, P7401, DOI 10.1021/bi00371a023; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; Matangkasombut O, 2000, GENE DEV, V14, P951; Moazed D, 1996, CELL, V86, P667, DOI 10.1016/S0092-8674(00)80139-7; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Palancade B, 2002, J BIOL CHEM, V277, P36061, DOI 10.1074/jbc.M205192200; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saez-Vasquez J, 2001, PLANT MOL BIOL, V47, P449, DOI 10.1023/A:1011619413393; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Sawa C, 2004, MOL CELL BIOL, V24, P4734, DOI 10.1128/MCB.24.11.4734-4742.2004; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Sengupta SM, 1999, METHODS, V19, P434, DOI 10.1006/meth.1999.0880; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Wu XY, 2001, CURR GENET, V40, P234, DOI 10.1007/s00294-001-0257-8; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255	56	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49973	49981		10.1074/jbc.M409849200	http://dx.doi.org/10.1074/jbc.M409849200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15448131	hybrid			2022-12-27	WOS:000225229500053
J	Inoue, D; Kido, S; Matsumoto, T				Inoue, D; Kido, S; Matsumoto, T			Transcriptional induction of FosB/Delta FosB gene by mechanical stress in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; ELEMENT-BINDING PROTEIN; DELTA-FOSB; BONE-FORMATION; C-FOS; TRANSGENIC MICE; SHEAR-STRESS; SPACE-FLIGHT; EXPRESSION; CELLS	Mechanical stress to bone plays a critical role in maintaining bone mass and strength. However, the molecular mechanism of mechanical stress-induced bone formation is not fully understood. In the present study, we demonstrate that FosB and its spliced variant DeltaFosB, which is known to increase bone mass by stimulating bone formation in vivo, is rapidly induced by mechanical loading in mouse hind limb bone in vivo and by fluid shear stress (FSS) in mouse calvarial osteoblasts in vitro both at the mRNA and protein levels. FSS induction of FosB/DeltaFosB gene expression was dependent on gadlinium-sensitive Ca2+ influx and subsequent activation of ERK1/2. Analysis of the mouse FosB/DeltaFosB gene upstream regulatory region with luciferase reporter gene assays revealed that the FosB/DeltaFosB induction by FSS occurred at the transcriptional level and was conferred by a short fragment from -603 to -327. DNA precipitation assays and DNA decoy experiments indicated that ERK-dependent activation of CREB binding to a CRE/AP-1 like element (designated "CRE2") at the position of -413 largely contributed to the transcriptional effects of FSS. These results suggest that DeltaFosB participates in mechanical stress-induced intracellular signaling cascades that activate the osteogenic program in osteoblasts.	Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, Tokushima 7708503, Japan	Tokushima University	Inoue, D (corresponding author), Univ Tokushima, Grad Sch Med, Dept Med & Bioregulatory Sci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	inoued@clin.med.tokushima-u.ac.jp						Ahn JD, 2003, BIOCHEM BIOPH RES CO, V310, P1048, DOI 10.1016/j.bbrc.2003.09.124; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Inoue D, 1998, J BIOL CHEM, V273, P4180, DOI 10.1074/jbc.273.7.4180; Inoue D, 1997, J BIOL CHEM, V272, P25386, DOI 10.1074/jbc.272.40.25386; Inoue M, 2000, BONE, V26, P281, DOI 10.1016/S8756-3282(99)00282-3; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kveiborg M, 2002, ENDOCRINOLOGY, V143, P4304, DOI 10.1210/en.2002-220420; LAZO PS, 1992, NUCLEIC ACIDS RES, V20, P343, DOI 10.1093/nar/20.2.343; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Lee IK, 2003, CURR DRUG TARGETS, V4, P619, DOI 10.2174/1389450033490821; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Matsumoto T, 1998, BONE, V22, p89S, DOI 10.1016/S8756-3282(98)00018-0; Matsushita M, 1997, INFLAMM RES, V46, P461, DOI 10.1007/s000110050225; Mikuni-Takagaki Y, 1999, J BONE MINER METAB, V17, P57, DOI 10.1007/s007740050065; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; MUMBERG D, 1991, GENE DEV, V5, P1212, DOI 10.1101/gad.5.7.1212; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nashat AH, 2003, MOL CELL BIOL, V23, P4788, DOI 10.1128/MCB.23.14.4788-4795.2003; Nestler EJ, 1999, BRAIN RES, V835, P10, DOI 10.1016/S0006-8993(98)01191-3; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Ohkubo N, 2001, J BIOL CHEM, V276, P3046, DOI 10.1074/jbc.M005070200; Ono K, 2002, J BONE MINER RES, V17, P774, DOI 10.1359/jbmr.2002.17.5.774; Peake MA, 2003, FEBS LETT, V537, P117, DOI 10.1016/S0014-5793(03)00108-X; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; SADOSHIMA J, 1993, CIRC RES, V73, P424, DOI 10.1161/01.RES.73.3.424; Sakai K, 1999, J BONE MINER RES, V14, P2089, DOI 10.1359/jbmr.1999.14.12.2089; Sakata T, 1999, J BONE MINER RES, V14, P1596, DOI 10.1359/jbmr.1999.14.9.1596; Schneider V, 1995, ACTA ASTRONAUT, V36, P463, DOI 10.1016/0094-5765(95)00131-X; Sims NA, 2002, BONE, V30, P32, DOI 10.1016/S8756-3282(01)00622-6; Song KS, 2003, J BIOL CHEM, V278, P34890, DOI 10.1074/jbc.M303911200; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Weinreb M, 1997, BONE, V20, P347, DOI 10.1016/S8756-3282(97)00011-2; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; YEN J, 1991, P NATL ACAD SCI USA, V88, P5077, DOI 10.1073/pnas.88.12.5077; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200	44	77	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49795	49803		10.1074/jbc.M404096200	http://dx.doi.org/10.1074/jbc.M404096200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383527	hybrid			2022-12-27	WOS:000225229500032
J	Keil, U; Bonert, A; Marques, CA; Scherping, I; Weyermann, JR; Strosznajder, JB; Muller-Spahn, F; Haass, C; Czech, C; Pradier, L; Muller, WE; Eckert, A				Keil, U; Bonert, A; Marques, CA; Scherping, I; Weyermann, JR; Strosznajder, JB; Muller-Spahn, F; Haass, C; Czech, C; Pradier, L; Muller, WE; Eckert, A			Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; GAMMA-SECRETASE INHIBITOR; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; OXIDATIVE STRESS; A-BETA; PLAQUE-FORMATION; CELL-DEATH; IN-VITRO; PEPTIDE	Increasing evidence suggests an important role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease. Thus, we investigated the effects of acute and chronic exposure to increasing concentrations of amyloid beta(Abeta) on mitochondrial function and nitric oxide (NO) production in vitro and in vivo. Our data demonstrate that PC12 cells and human embryonic kidney cells bearing the Swedish double mutation in the amyloid precursor protein gene (APPsw), exhibiting substantial Abeta levels, have increased NO levels and reduced ATP levels. The inhibition of intracellular Abeta production by a functional gamma-secretase inhibitor normalizes NO and ATP levels, indicating a direct involvement of Abeta in these processes. Extracellular treatment of PC12 cells with comparable Abeta concentrations only leads to weak changes, demonstrating the important role of intracellular Abeta. In 3-month-old APP transgenic (tg) mice, which exhibit no plaques but already detectable Abeta levels in the brain, reduced ATP levels can also be observed showing the in vivo relevance of our findings. Moreover, we could demonstrate that APP is present in the mitochondria of APPsw PC12 cells. This presence might be directly involved in the impairment of cytochrome c oxidase activity and depletion of ATP levels in APPsw PC12 cells. In addition, APPsw human embryonic kidney cells, which produce 20-fold increased Abeta levels compared with APPsw PC12 cells, and APP tg mice already show a significantly decreased mitochondrial membrane potential under basal conditions. We suggest a hypothetical sequence of pathogenic steps linking mutant APP expression and amyloid production with enhanced NO production and mitochondrial dysfunction finally leading to cell death.	Goethe Univ Frankfurt, Bioctr, Dept Pharmacol, D-60439 Frankfurt, Germany; Goethe Univ Frankfurt, Bioctr, Dept Pharmaceut Technol, D-60439 Frankfurt, Germany; Polish Acad Sci, Med Res Ctr, Dept Cellular Signaling, PL-02106 Warsaw, Poland; Psychiatr Univ Clin, Neurobiol Res Lab, CH-4025 Basel, Switzerland; Adolf Butenandt Inst, Dept Biochem, D-80336 Munich, Germany; Aventis Pharma Res & Dev, F-94403 Vitry Sur Seine, France	Goethe University Frankfurt; Goethe University Frankfurt; Polish Academy of Sciences; University of Munich; Sanofi-Aventis; Sanofi France	Eckert, A (corresponding author), Goethe Univ Frankfurt, Bioctr, Dept Pharmacol, Bldg N260,Marie Curie Str 9, D-60439 Frankfurt, Germany.	A.Eckert@em.uni-frankfurt.de		Strosznajder, Joanna/0000-0002-6213-1212; Eckert, Anne/0000-0002-9341-3669; Marques, Celio/0000-0002-8438-2354; Muller, Werner E.G./0000-0002-8223-3689; Czech, Christian/0000-0001-7746-0134				Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Babu BR, 1998, J BIOL CHEM, V273, P8882, DOI 10.1074/jbc.273.15.8882; Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5; Bayer TA, 2001, BRAIN PATHOL, V11, P1; Beal MF, 1996, CURR OPIN NEUROBIOL, V6, P661, DOI 10.1016/S0959-4388(96)80100-0; Behl C, 2000, J NEURAL TRANSM, V107, P1325, DOI 10.1007/s007020070021; Blanchard V, 2003, EXP NEUROL, V184, P247, DOI 10.1016/S0014-4886(03)00252-8; Blass JP, 2002, J ALZHEIMERS DIS, V4, P225, DOI 10.3233/JAD-2002-4312; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Canevari L, 1999, FEBS LETT, V457, P131, DOI 10.1016/S0014-5793(99)01028-5; Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2; Casley CS, 2002, NEUROBIOL DIS, V10, P258, DOI 10.1006/nbdi.2002.0516; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Christen Y, 2000, AM J CLIN NUTR, V71, p621S, DOI 10.1093/ajcn/71.2.621s; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; de la Monte SM, 2003, LAB INVEST, V83, P287, DOI 10.1097/01.LAB.0000056995.07053.C0; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckert A, 2001, J NEUROSCI RES, V64, P183, DOI 10.1002/jnr.1064; Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartmann T, 1999, EUR ARCH PSY CLIN N, V249, P291, DOI 10.1007/s004060050102; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Jang JH, 2003, FREE RADICAL BIO MED, V34, P1100, DOI 10.1016/S0891-5849(03)00062-5; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Kojima H, 2001, J NEUROCHEM, V76, P1404, DOI 10.1046/j.1471-4159.2001.00161.x; Krohn AJ, 1999, J NEUROSCI, V19, P7394, DOI 10.1523/JNEUROSCI.19-17-07394.1999; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Law A, 2001, BRAIN RES REV, V35, P73, DOI 10.1016/S0165-0173(00)00051-5; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marques CA, 2003, J BIOL CHEM, V278, P28294, DOI 10.1074/jbc.M212265200; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; PARKER WD, 1994, NEUROLOGY, V44, P1086, DOI 10.1212/WNL.44.6.1086; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; Pereira C, 1998, NEUROREPORT, V9, P1749, DOI 10.1097/00001756-199806010-00015; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Rasmussen UF, 2000, MOL CELL BIOCHEM, V208, P37, DOI 10.1023/A:1007046028132; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Sarti Paolo, 2003, Ital J Biochem, V52, P37; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Smith MA, 1997, J NEUROSCI, V17, P2653; STOLL L, 1992, NEUROBIOL AGING, V13, P39, DOI 10.1016/0197-4580(92)90006-J; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; van Gurp M, 2003, BIOCHEM BIOPH RES CO, V304, P487, DOI 10.1016/S0006-291X(03)00621-1; Vandermeeren M, 2001, NEUROSCI LETT, V315, P145, DOI 10.1016/S0304-3940(01)02369-2; Vieira HLA, 2001, ONCOGENE, V20, P4305, DOI 10.1038/sj.onc.1204575; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	78	247	260	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50310	50320		10.1074/jbc.M405600200	http://dx.doi.org/10.1074/jbc.M405600200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371443	hybrid			2022-12-27	WOS:000225229500094
J	Benjannet, S; Rhainds, D; Essalmani, R; Mayne, J; Wickham, L; Jin, WJ; Asselin, MC; Hamelin, J; Varret, M; Allard, D; Trillard, M; Abifadel, M; Tebon, A; Attie, AD; Rader, DJ; Boileau, C; Brissette, L; Chretien, M; Prat, A; Seidah, NG				Benjannet, S; Rhainds, D; Essalmani, R; Mayne, J; Wickham, L; Jin, WJ; Asselin, MC; Hamelin, J; Varret, M; Allard, D; Trillard, M; Abifadel, M; Tebon, A; Attie, AD; Rader, DJ; Boileau, C; Brissette, L; Chretien, M; Prat, A; Seidah, NG			NARC-1/PCSK9 and its natural mutants - Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PROPROTEIN CONVERTASE; FAMILIAL HYPERCHOLESTEROLEMIA; MEDIATED ENDOCYTOSIS; PROHORMONE CONVERTASES; PROTEIN; PCSK9; MUTATIONS; BINDING; MICE	The discovery of autosomal dominant hypercholesterolemic patients with mutations in the PCSK9 gene, encoding the proprotein convertase NARC-1, resulting in the missense mutations suggested a role in low density lipoprotein (LDL) metabolism. We show that the endoplasmic reticulum-localized proNARC-1 to NARC-1 zymogen conversion is Ca2+-independent and that within the zymogen autocatalytic processing site SS (V) under bar FA (Q) under bar down arrowSI (P) under bar Val at P4 and Pro at P3' are critical. The S127R and D374Y mutations result in similar to50-60% and greater than or equal to98% decrease in zymogen processing, respectively. In contrast, the double [D374Y+N157K], F216L, and R218S natural mutants resulted in normal zymogen processing. The cell surface LDL receptor (LDLR) levels are reduced by 35% in lymphoblasts of S127R patients. The LDLR levels are also reduced in stable HepG2 cells overexpressing NARC-1 or its natural mutant S127R, and this reduction is abrogated in the presence of 5 mM ammonium chloride, suggesting that overexpression of NARC-1 increases the turnover rate of the LDLR. Adenoviral expression of wild type human NARC-1 in mice resulted in a maximal similar to9-fold increase in circulating LDL cholesterol, while in LDLR(-/-) mice a delayed similar to2-fold increase in LDL cholesterol was observed. In conclusion, NARC-1 seems to affect both the level of LDLR and that of circulating apoB-containing lipoproteins in an LDLR-dependent and -independent fashion.	Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; Ottawa Hlth Res Inst, Dis Ageing Unit, Reg Prot Chem Ctr, Ottawa, ON K1Y 4E9, Canada; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Paris 05, APHP, Hop Necker Enfants Malad, INSERM,U383, F-75743 Paris 15, France; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute; University of Pennsylvania; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Wisconsin System; University of Wisconsin Madison; University of Quebec; University of Quebec Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013; Abifadel, Marianne/ABH-5370-2020; boileau, catherine/M-4482-2017; Prat, Annik/S-6757-2018; VARRET, Mathilde/C-2279-2016	Seidah, Nabil/0000-0001-6503-9342; boileau, catherine/0000-0002-0371-7539; Prat, Annik/0000-0002-8007-5277; VARRET, Mathilde/0000-0001-9261-1551; ABIFADEL, Marianne/0000-0001-7645-8323; ALLARD, Delphine/0000-0001-7534-8982; CHRETIEN, Michel/0000-0002-8588-4460	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056593] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56593] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; BRAYDEN DJ, 1989, BRIT J PHARMACOL, V98, P809, DOI 10.1111/j.1476-5381.1989.tb14609.x; Brissette L, 1996, BIOCHEM J, V318, P841, DOI 10.1042/bj3180841; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Conesa M, 2003, BIOCHEM J, V370, P703, DOI 10.1042/BJ20021301; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; GEKLE M, 1995, AM J PHYSIOL-RENAL, V268, pF899, DOI 10.1152/ajprenal.1995.268.5.F899; GLUSCHANKOF P, 1994, EMBO J, V13, P2280, DOI 10.1002/j.1460-2075.1994.tb06510.x; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gregersen N, 2001, J INHERIT METAB DIS, V24, P189, DOI 10.1023/A:1010319001722; Hatch F T, 1968, Adv Lipid Res, V6, P1; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HORTIN G, 1986, BIOCHEM BIOPH RES CO, V141, P326, DOI 10.1016/S0006-291X(86)80372-2; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; KINGUNDERWOOD L, 1991, CLIN GENET, V40, P17; KOPFLER WP, 1994, CIRCULATION, V90, P1319, DOI 10.1161/01.CIR.90.3.1319; KRIEGER M, 1983, CELL, V33, P413, DOI 10.1016/0092-8674(83)90423-3; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; LANGER T, 1972, J CLIN INVEST, V51, P1528, DOI 10.1172/JCI106949; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; LOUIE LG, 1991, AM J HUM GENET, V48, P637; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Michaely P, 2004, J BIOL CHEM, V279, P34023, DOI 10.1074/jbc.M405242200; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ouguerram K, 2004, ARTERIOSCL THROM VAS, V24, P1448, DOI 10.1161/01.ATV.0000133684.77013.88; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; REED PW, 1972, J BIOL CHEM, V247, P6970; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; SEIDAH NG, 2001, ENZYMES CO POSTTRANS, P237; SELDAH NG, 2003, P NATL ACAD SCI USA, V100, P928; Shioji K, 2004, J HUM GENET, V49, P109, DOI 10.1007/s10038-003-0114-3; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SOUTAR AK, 1992, J INTERN MED, V231, P633, DOI 10.1111/j.1365-2796.1992.tb01252.x; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; THYBERG J, 1985, EXP CELL RES, V159, P1, DOI 10.1016/S0014-4827(85)80032-X; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Tremblay AJ, 2004, J LIPID RES, V45, P866, DOI 10.1194/jlr.M300448-JLR200; Twisk J, 2000, J CLIN INVEST, V105, P521, DOI 10.1172/JCI8623; Varret M, 1999, AM J HUM GENET, V64, P1378, DOI 10.1086/302370; Wang L, 1997, J BIOL CHEM, V272, P27644, DOI 10.1074/jbc.272.44.27644; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; YOSHIMURA A, 1987, J BIOL CHEM, V262, P13299; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107	62	488	546	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48865	48875		10.1074/jbc.M409699200	http://dx.doi.org/10.1074/jbc.M409699200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358785	hybrid			2022-12-27	WOS:000225098100048
J	Korencic, D; Polycarpo, C; Weygand-Durasevic, I; Soll, D				Korencic, D; Polycarpo, C; Weygand-Durasevic, I; Soll, D			Differential modes of transfer RNA(Ser) recognition in Methanosarcina barkeri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; SACCHAROMYCES-CEREVISIAE TRNA(LEU); ACCEPTOR IN-VITRO; ESCHERICHIA-COLI; IDENTITY DETERMINANTS; TRANSFER RNA(TYR); CRYSTAL-STRUCTURE; HUMAN TRNA(SER); ELEMENTS; NUCLEOTIDES	Two dissimilar seryl-transfer RNA (tRNA) synthetases (SerRSs) exist in Methanosarcina barkeri, one of bacterial type and the other resembling SerRSs present only in some methanogenic archaea. To investigate the requirements of these enzymes for tRNA(Ser) recognition, serylation of variant transcripts of M. barkeri tRNA(Ser) was kinetically analyzed in vitro with pure enzyme preparations. Characteristically for the serine system, the length of the variable arm was shown to be crucial for both enzymes, as was the identity of the discriminator base (G73). Moreover, a novel determinant for the specific tRNA(Ser) recognition was identified as the anticodon stem base pair G30:C40; its contribution to the efficiency of serylation was remarkable for both SerRSs. However, despite these similarities, the two SerRSs do not possess a uniform mode of tRNA(Ser) recognition, and additional determinants are necessary for serylation specificity by the methanogenic enzyme. In particular, the methanogenic SerRS relies on G1:C72 identity and on the number of unpaired nucleotides at the base of the variable stem for tRNA(Ser) recognition, unlike its bacterial type counterpart. We propose that such a distinction between the two enzymes in tRNA(Ser) identity determinants reflects their evolutionary pathways, hence attesting to their diversity.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Univ Zagreb, Fac Sci, Dept Chem, Zagreb 10000, Croatia; Rudjer Boskovic Inst, Zagreb 10000, Croatia	Yale University; Yale University; University of Zagreb; Rudjer Boskovic Institute	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208114,266 Whitney Ave, New Haven, CT 06520 USA.	soll@trna.chem.yale.edu	Polycarpo, Carla R/G-2832-2011	Polycarpo, Carla/0000-0001-9663-3563				ACHSEL T, 1993, EMBO J, V12, P3333, DOI 10.1002/j.1460-2075.1993.tb06003.x; Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; ASAHARA H, 1993, J MOL BIOL, V231, P219, DOI 10.1006/jmbi.1993.1277; ASAHARA H, 1994, J MOL BIOL, V236, P738, DOI 10.1006/jmbi.1994.1186; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; BOCK A, 2004, AMINOACYL TRNA SYNTH, P320; BREITSCHOPF K, 1995, NUCLEIC ACIDS RES, V23, P3633, DOI 10.1093/nar/23.18.3633; Breitschopf K, 1996, NUCLEIC ACIDS RES, V24, P405, DOI 10.1093/nar/24.3.405; BREITSCHOPF K, 1994, EMBO J, V13, P3166, DOI 10.1002/j.1460-2075.1994.tb06615.x; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; DOCKBREGEON AC, 1990, EUR J BIOCHEM, V188, P283, DOI 10.1111/j.1432-1033.1990.tb15401.x; Fechter P, 2001, EUR J BIOCHEM, V268, P761, DOI 10.1046/j.1432-1327.2001.01931.x; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HIMENO H, 1990, NUCLEIC ACIDS RES, V18, P6815, DOI 10.1093/nar/18.23.6815; HIMENO H, 1991, NUCLEIC ACIDS RES, V19, P6379, DOI 10.1093/nar/19.23.6379; Himeno H, 1997, J MOL BIOL, V268, P704, DOI 10.1006/jmbi.1997.0991; Kim HS, 1998, J BACTERIOL, V180, P6446, DOI 10.1128/JB.180.24.6446-6449.1998; Korencic D, 2002, FOOD TECHNOL BIOTECH, V40, P255; Lenhard B, 1999, NUCLEIC ACIDS RES, V27, P721, DOI 10.1093/nar/27.3.721; MCCLAIN WH, 1993, FASEB J, V7, P72, DOI 10.1096/fasebj.7.1.8422977; MCCLAIN WH, 1988, SCIENCE, V241, P1804, DOI 10.1126/science.2459773; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; NAZARENKO IA, 1992, NUCLEIC ACIDS RES, V20, P475, DOI 10.1093/nar/20.3.475; NORMANLY J, 1986, NATURE, V321, P213, DOI 10.1038/321213a0; NORMANLY J, 1992, P NATL ACAD SCI USA, V89, P5680, DOI 10.1073/pnas.89.12.5680; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; Pallanck Leo, 1995, P371; PRICE S, 1993, FEBS LETT, V324, P167, DOI 10.1016/0014-5793(93)81386-E; Ruan BF, 2004, J BACTERIOL, V186, P8, DOI 10.1128/JB.186.1.8-14.2004; Saks ME, 1996, EMBO J, V15, P2843, DOI 10.1002/j.1460-2075.1996.tb00645.x; SAKS ME, 1994, SCIENCE, V263, P191, DOI 10.1126/science.7506844; Salazar JC, 2001, FEBS LETT, V491, P257, DOI 10.1016/S0014-5793(01)02214-1; SAMPSON JR, 1993, NUCLEIC ACIDS RES, V21, P4467, DOI 10.1093/nar/21.19.4467; SCHATZ D, 1991, P NATL ACAD SCI USA, V88, P6132, DOI 10.1073/pnas.88.14.6132; Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200; Soma A, 1996, J MOL BIOL, V263, P707, DOI 10.1006/jmbi.1996.0610; Soma A, 1999, J MOL BIOL, V293, P1029, DOI 10.1006/jmbi.1999.3219; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Takeuchi N, 2001, J BIOL CHEM, V276, P20064, DOI 10.1074/jbc.M101007200; UEDA T, 1992, NUCLEIC ACIDS RES, V20, P2217, DOI 10.1093/nar/20.9.2217; WEYGANDDURASEVIC I, 1994, J BACTERIOL, V176, P232; WEYGANDDURASEVIC I, 1993, EUR J BIOCHEM, V214, P869, DOI 10.1111/j.1432-1033.1993.tb17990.x; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; WU XQ, 1993, NUCLEIC ACIDS RES, V21, P5589, DOI 10.1093/nar/21.24.5589; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373; YOKOGAWA T, 1991, NUCLEIC ACIDS RES, V19, P6101, DOI 10.1093/nar/19.22.6101; Yokogawa T, 2000, J BIOL CHEM, V275, P19913, DOI 10.1074/jbc.M908473199	47	35	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48780	48786		10.1074/jbc.M408753200	http://dx.doi.org/10.1074/jbc.M408753200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364939	hybrid			2022-12-27	WOS:000225098100037
J	Ost, TWB; Clark, JP; Anderson, JLR; Yellowlees, LJ; Daff, S; Chapman, SK				Ost, TWB; Clark, JP; Anderson, JLR; Yellowlees, LJ; Daff, S; Chapman, SK			4-Cyanopyridine, a versatile spectroscopic probe for cytochrome P450BM3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; FLAVOCYTOCHROME P-450 BM3; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; LIVER MICROSOMES; HEME; SPIN; BINDING; SUBSTRATE; COMPLEXES	The nitrogenous pi-acceptor ligand 4-cyanopyridine (4CNPy) exhibits reversible ligation to ferrous heme in the flavocytochrome P450 BM3 (K-d=1.8 muM for wild type P450 BM3) via its pyridine ring nitrogen. The reduced P450-4CNPy adduct displays unusual spectral properties that provide a useful spectroscopic handle to probe particular aspects of this P450. 4CNPy is competitively displaced upon substrate binding, allowing a convenient route to the determination of substrate dissociation constants for ferrous P450 highlighting an increase in P450 substrate affinity on heme reduction. For wild type P450 BM3, K-d(red)(laurate)=82.4 muM (cf. K-d(ox)=364 muM). In addition, an unusual spectral feature in the red region of the absorption spectrum of the reduced P450-4CNPy adduct is observed that can be assigned as a metal-to-ligand charge transfer (MLCT). It was discovered that the energy of this MLCT varies linearly with respect to the P450 heme reduction potential. By studying the energy of this MLCT for a series of BM3 active site mutants with differing reduction potential (E-m), the relationship E-MLCT=(3.53 x E-m)+17,005 cm(-1) was derived. The use of this ligand thus provides a quick and accurate method for predicting the heme reduction potentials of a series of P450 BM3 mutations using visible spectroscopy, without the requirement for redox potentiometry.	Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Edinburgh	Chapman, SK (corresponding author), Univ Edinburgh, Dept Chem, W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	s.k.chapman@ed.ac.uk		Anderson, Ross/0000-0002-6796-0482				CHAMPION PM, 1975, BIOCHEMISTRY-US, V14, P4151, DOI 10.1021/bi00690a001; Cowart LA, 2001, ARCH BIOCHEM BIOPHYS, V387, P117, DOI 10.1006/abbi.2000.2246; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; DEMONTELLANO PRO, 1995, CYTOCHROME P450 STRU, P473; DODSWORTH ES, 1986, CHEM PHYS LETT, V124, P152, DOI 10.1016/0009-2614(86)85135-1; FORD P, 1968, J AM CHEM SOC, V90, P1187, DOI 10.1021/ja01007a015; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; LEVER ABP, 1990, INORG CHEM, V29, P1271, DOI 10.1021/ic00331a030; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; LOIDA PJ, 1993, BIOCHEMISTRY-US, V32, P11530, DOI 10.1021/bi00094a009; Miles CS, 2000, BBA-PROTEIN STRUCT M, V1543, P383, DOI 10.1016/S0167-4838(00)00236-3; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Munro AW, 1999, BIOCHEM SOC T, V27, P190, DOI 10.1042/bst0270190; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1962, J BIOL CHEM, V237, P1375; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Presta A, 1998, J AM CHEM SOC, V120, P9460, DOI 10.1021/ja9740374; SAFO MK, 1992, J AM CHEM SOC, V114, P7066, DOI 10.1021/ja00044a017; SAFO MK, 1994, J AM CHEM SOC, V116, P7760, DOI 10.1021/ja00096a037; SHARROCK M, 1976, BIOCHIM BIOPHYS ACTA, V420, P8, DOI 10.1016/0005-2795(76)90340-8; SLIGAR SG, 1979, BIOCHEM BIOPH RES CO, V90, P925, DOI 10.1016/0006-291X(79)91916-8; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; SONO M, 1982, J BIOL CHEM, V257, P8308; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Tosha T, 2003, J BIOL CHEM, V278, P39809, DOI 10.1074/jbc.M304265200; TSAI R, 1970, P NATL ACAD SCI USA, V66, P1157, DOI 10.1073/pnas.66.4.1157	30	14	14	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48876	48882		10.1074/jbc.M408601200	http://dx.doi.org/10.1074/jbc.M408601200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364917	hybrid			2022-12-27	WOS:000225098100049
J	Pedley, KF; Martin, GB				Pedley, KF; Martin, GB			Identification of MAPKs and their possible MAPK kinase activators involved in the Pto-mediated defense response of tomato	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-DISEASE RESISTANCE; INDUCED PROTEIN-KINASE; BACTERIAL SPECK DISEASE; SALICYLIC-ACID; CELL-DEATH; PATHOGEN INTERACTIONS; TRANSCRIPTION FACTORS; TRANSGENIC PLANTS; MOLECULAR-BASIS; TOBACCO	The Pto kinase mediates resistance to bacterial speck disease in tomato by activating host defenses upon recognition of Pseudomonas syringae pv. tomato strains expressing the AvrPto or AvrPtoB proteins. Previous gene-silencing experiments have indicated that mitogen activated protein kinase (MAPK) cascades play a key role downstream of the Pto kinase to activate host defense responses. Here we use biochemical methods to demonstrate that two tomato MAPKs, LeMPK2 and LeMPK3, are activated in leaves in a Pto-specific manner upon expression of AvrPto and AvrPtoB. We show that these same MAPKs are activated upon overexpression of LeMAPKKKalpha, a protein previously demonstrated to be involved in Pto-mediated immunity. We identified two phylogenetically unrelated MAPK kinases (LeMKK2 and LeMKK4) that when overexpressed in leaves elicit cell death and activate LeMPK2 and LeMPK3. In vitro analysis demonstrated that LeMKK2 and LeMKK4 each phosphorylate the same subset of three MAPKs. Together these data provide biochemical evidence for the involvement of MAPK cascades in Pto-mediated resistance.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Martin, GB (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	gbm7@cornell.edu	Martin, Gregory B/F-6262-2011	Martin, Gregory B/0000-0003-0044-6830				Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Chang JH, 2000, MOL PLANT MICROBE IN, V13, P568, DOI 10.1094/MPMI.2000.13.5.568; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Grant M, 1999, CURR OPIN PLANT BIOL, V2, P312, DOI 10.1016/S1369-5266(99)80055-7; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Gu YQ, 2000, PLANT CELL, V12, P771, DOI 10.1105/tpc.12.5.771; He XH, 2004, PLANT J, V38, P563, DOI 10.1111/j.1365-313X.2004.02073.x; Holley SR, 2003, PLANT PHYSIOL, V132, P1728, DOI 10.1104/pp.103.024414; Hoyos ME, 2000, PLANT PHYSIOL, V122, P1355, DOI 10.1104/pp.122.4.1355; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Kim CY, 2004, PLANT J, V38, P142, DOI 10.1111/j.1365-313X.2004.02033.x; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Liu YD, 2003, PLANT J, V34, P149, DOI 10.1046/j.1365-313X.2003.01709.x; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mayrose M, 2004, J BIOL CHEM, V279, P14819, DOI 10.1074/jbc.M313388200; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voronin V, 2004, FEBS LETT, V560, P86, DOI 10.1016/S0014-5793(04)00076-6; Voronin V, 2001, PLANT MOL BIOL, V45, P679, DOI 10.1023/A:1010645431133; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7225, DOI 10.1073/pnas.95.12.7225; Zhang SQ, 2001, PLANT CELL, V13, P1877, DOI 10.1105/tpc.13.8.1877; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809; Zhang SQ, 2000, PLANT J, V23, P339, DOI 10.1046/j.1365-313x.2000.00780.x; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	42	97	104	5	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49229	49235		10.1074/jbc.M410323200	http://dx.doi.org/10.1074/jbc.M410323200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371431	hybrid			2022-12-27	WOS:000225098100089
J	Zeng, LF; Liao, HL; Liu, Y; Lee, TS; Zhu, MJ; Wang, X; Stemerman, MB; Zhu, Y; Shyy, JYJ				Zeng, LF; Liao, HL; Liu, Y; Lee, TS; Zhu, MJ; Wang, X; Stemerman, MB; Zhu, Y; Shyy, JYJ			Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells - A novel role of SREBP in regulating cholesterol metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN DEFICIENCY; SHEAR-STRESS ACTIVATION; TANGIER-DISEASE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; UP-REGULATION; ABCA1 GENE; PROMOTER; EFFLUX; LIVER	ATP-binding cassette transporter A1 (ABCA1) is a pivotal regulator of cholesterol efflux from cells to apolipoproteins, whereas sterol-responsive element-binding protein 2 (SREBP2) is the key protein regulating cholesterol synthesis and uptake. We investigated the regulation of ABCA1 by SREBP2 in vascular endothelial cells (ECs). Our results showed that sterol depletion activated SREBP2 and increased its target, low density lipoprotein receptor mRNA, with a concurrent decrease in the ABCA1 mRNA. Transient transfection analysis revealed that sterol depletion decreased the ABCA1 promoter activity by 50%, but low density lipoprotein receptor promoter- and the sterol-responsive element-driven luciferase activities were increased. Overexpression of the N terminus of SREBP2 (SREBP2(N)), an active form of SREBP2, also inhibited the ABCA1 promoter activity. Functionally adenovirus-mediated SREBP2(N) expression increased cholesterol accumulation and decreased apoA-I-mediated cholesterol efflux. The conserved E-box motif was responsible for the SREBP2(N)-mediated inhibition since mutation of the E-box increased the basal activity of the ABCA1 promoter and abolished the inhibitory effect of SREBP2(N). Furthermore sterol depletion and SREBP2(N) overexpression induced the binding of SREBP2(N) to both consensus and ABCA1-specific E-box. Chromatin immunoprecipitation assay demonstrated that serum starvation enhanced the association of SREBP2 and the ABCA1 promoter in ECs. To correlate this mechanism pathophysiologically, we found that oscillatory flow caused the activation of SREBP2 and therefore attenuated ABCA1 promoter activity in ECs. Thus, this SREBP-regulated mechanism may control the efflux of cholesterol, which is a newly defined function of SREBP2 in ECs in addition to its role in cholesterol uptake and biosynthesis.	Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; Peking Univ, Ctr Hlth Sci, Key Lab Mol Cardiovasc Sci Educ Minist, Dept Physiol, Beijing 100083, Peoples R China	University of California System; University of California Riverside; Peking University	Zhu, Y (corresponding author), Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA.	yi.zhu@ucr.edu	Lee, Tzong-Shyuan/AAE-5803-2020	Lee, Tzong-Shyuan/0000-0002-9593-4062	NHLBI NIH HHS [HL33742, HL77448, HL56707] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077448, R29HL056707, R01HL056707, R01HL033742] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; Costet P, 2000, J BIOL CHEM, V275, P28240; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Fielding CJ, 1997, J LIPID RES, V38, P1503; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Langmann T, 2002, J BIOL CHEM, V277, P14443, DOI 10.1074/jbc.M110270200; Liao HL, 2002, ARTERIOSCL THROM VAS, V22, P127, DOI 10.1161/hq1201.101772; Lin T, 2003, CIRC RES, V92, P1296, DOI 10.1161/01.RES.0000078780.65824.8B; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200; Porsch-Ozcurumez M, 2001, J BIOL CHEM, V276, P12427, DOI 10.1074/jbc.M100218200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rodriguez C, 2003, CARDIOVASC RES, V58, P178, DOI 10.1016/S0008-6363(02)00856-8; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Tall AR, 2000, J CLIN INVEST, V106, P1205, DOI 10.1172/JCI11538; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; Yang XP, 2002, J LIPID RES, V43, P297; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zhu Y, 2000, ARTERIOSCL THROM VAS, V20, P2465, DOI 10.1161/01.ATV.20.11.2465; Zhu Y, 1998, ARTERIOSCL THROM VAS, V18, P473, DOI 10.1161/01.ATV.18.3.473	36	86	94	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48801	48807		10.1074/jbc.M407817200	http://dx.doi.org/10.1074/jbc.M407817200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358760	hybrid			2022-12-27	WOS:000225098100040
J	Kumagai, T; Matsukawa, N; Kaneko, Y; Kusumi, Y; Mitsumata, M; Uchida, K				Kumagai, T; Matsukawa, N; Kaneko, Y; Kusumi, Y; Mitsumata, M; Uchida, K			A lipid peroxidation-derived inflammatory mediator - Identification of 4-hydroxy-2-nonenal as a potential inducer of cyclooxygenase-2 in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; LOW-DENSITY-LIPOPROTEIN; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; VASCULAR ENDOTHELIAL-CELLS; MESSENGER-RNA STABILITY; GROWTH-FACTOR-RECEPTOR; SMOOTH-MUSCLE CELLS; TRANSCRIPTIONAL REGULATION; NUCLEAR-FACTOR	Cyclooxygenases (COXs) catalyze the conversion of arachidonic acid to eicosanoids, which mediate a variety of biological actions involved in vascular pathophysiology. In the present study, we investigated the role of lipid peroxidation products in the up-regulation of COX-2, an inducible isoform responsible for high levels of prostaglandin production during inflammation and immune responses. COX-2 was found to colocalize with 4-hydroxy-2-nonenal (HNE), a major lipid peroxidation-derived aldehyde, in foamy macrophages within human atheromatous lesions, suggesting that COX-2 expression may be associated with the accumulation of lipid peroxidation products within macrophages. To test the hypothesis that lipid peroxidation products might be involved in the regulation of prostanoid biosynthesis, we conducted a screen of oxidized fatty acid metabolites and found that, among the compounds tested, only HNE showed inducibility of the COX-2 protein in RAW264.7 macrophages. In addition, intraperitoneal administration of HNE resulted in an increase in cell numbers in the peritoneal cavity that was associated with significant increases in the peritoneal and tissue levels of COX-2 in mice. To understand the possible signaling mechanism underlying the inducing effect of HNE on COX-2 up-regulation, we examined the phosphorylation events that may lead to COX-2 induction and found that HNE did not stimulate the induction of nitric oxide synthase and activation of NF-kappaB but significantly activated p38 mitogen-activated protein kinase and its upstream kinase in RAW264.7 macrophages. Tyrosine kinases, such as the epidermal growth factor-like and Src family tyrosine kinases, appeared to mediate the stabilization of COX-2 mRNA via the p38 mitogen-activated protein kinase pathway. These findings suggest that HNE accumulated in macrophages/foam cells may represent an inflammatory mediator that plays a role in stimulation of the inflammatory response and contributes to the progression of atherogenesis.	Nagoya Univ, Lab Food & Biodynam, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; Nihon Univ, Sch Med, Dept Pathol, Tokyo 1738610, Japan	Nagoya University; Nagoya University; Nihon University	Uchida, K (corresponding author), Nagoya Univ, Lab Food & Biodynam, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp		Uchida, Koji/0000-0003-3894-5299				Baughman RP, 1999, SARCOIDOSIS VASC DIF, V16, P57; CATHCART MK, 1985, J LEUKOCYTE BIOL, V38, P341, DOI 10.1002/jlb.38.2.341; Chung FL, 2000, CANCER RES, V60, P1507; DAVIDGE ST, 1995, CIRC RES, V77, P274, DOI 10.1161/01.RES.77.2.274; De Montarby L., 1988, TETRAHEDRON LETT, V29, P3895; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Dianzani Mario Umberto, 2003, Molecular Aspects of Medicine, V24, P263; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Escargueil-Blanc I, 2001, CIRCULATION, V104, P1814, DOI 10.1161/hc4001.097179; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; ESTERBAUER H, 1990, CHEM RES TOXICOL, V3, P77, DOI 10.1021/tx00014a001; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; FitzGerald GA, 2000, ANN MED, V32, P21; FRANCHI AM, 1994, P NATL ACAD SCI USA, V91, P539, DOI 10.1073/pnas.91.2.539; Gallois C, 1998, J BIOL CHEM, V273, P23183, DOI 10.1074/jbc.273.36.23183; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; HEINECKE JW, 1986, J CLIN INVEST, V77, P757, DOI 10.1172/JCI112371; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; HENRIKSEN T, 1981, P NATL ACAD SCI-BIOL, V78, P6499, DOI 10.1073/pnas.78.10.6499; Hwang D, 1997, BIOCHEM PHARMACOL, V54, P87, DOI 10.1016/S0006-2952(97)00154-8; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Kumagai T, 2002, ARCH BIOCHEM BIOPHYS, V397, P240, DOI 10.1006/abbi.2001.2601; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Liu W, 1999, J CELL SCI, V112, P2409; Mark RJ, 1997, J NEUROCHEM, V68, P255; MILANO S, 1995, PROSTAG OTH LIPID M, V49, P105, DOI 10.1016/0090-6980(94)00004-G; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; MOREL DW, 1984, ARTERIOSCLEROSIS, V4, P357, DOI 10.1161/01.ATV.4.4.357; MORI M, 1994, AM J PATHOL, V144, P200; Oe T, 2003, J BIOL CHEM, V278, P42098, DOI 10.1074/jbc.M308167200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P336, DOI 10.1161/01.ATV.10.3.336; SALVEMINI D, 1994, J CLIN INVEST, V93, P1940, DOI 10.1172/JCI117185; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Schonbeck U, 1999, AM J PATHOL, V155, P1281, DOI 10.1016/S0002-9440(10)65230-3; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; STEINBERG D, 1995, ADV EXP MED BIOL, V369, P39; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; Suc I, 1998, FASEB J, V12, P665, DOI 10.1096/fasebj.12.9.665; TETSUKA T, 1994, P NATL ACAD SCI USA, V91, P12168, DOI 10.1073/pnas.91.25.12168; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wacker M, 2001, CHEM-BIOL INTERACT, V137, P269, DOI 10.1016/S0009-2797(01)00259-9; Yadav PN, 2003, J PHARMACOL EXP THER, V305, P925, DOI 10.1124/jpet.103.049171; YAMADA T, 1992, RES COMMUN CHEM PATH, V77, P121	57	121	127	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48389	48396		10.1074/jbc.M409935200	http://dx.doi.org/10.1074/jbc.M409935200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355999	hybrid			2022-12-27	WOS:000224957000114
J	Lima, LMTR; Silva, JL				Lima, LMTR; Silva, JL			Positive contribution of hydration on DNA binding by E2c protein from papillomavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREFERENTIAL HYDRATION; OSMOTIC-STRESS; CRYSTAL-STRUCTURE; WATER RELEASE; MACROMOLECULAR HYDRATION; FLUORESCENCE ANISOTROPY; BOVINE PAPILLOMAVIRUS; ALLOSTERIC REGULATION; LINKED FUNCTIONS; RECEPTOR-ALPHA	Protein-nucleic acid interactions are responsible for the regulation of key biological events such as genomic transcription and recombination and viral replication. However, the recognition mechanisms involved in these processes are not completely understood. Here, we investigate the dominant forces involved in protein-protein and protein-DNA interactions for the 80-amino-acid C-terminal domain of the E2 protein (E2c) from human papillomavirus (HPV-16). The E2c protein is a homodimer that specifically binds to double-stranded DNA containing the consensus sequence ACCG-N4-CGGT, where N is any nucleotide. DNA binding affinity is reduced by lowering water chemical potential, accompanied by an increase in cooperativity. Wyman linkage relations between affinity and water chemical potential indicate that 11 additional water molecules are bound in the formation of the complex between E2c and DNA. Salt dissociation isotherms showed that 10 counterions are released upon association, even at low water activity, indicating that this latter variable does not change the electrostatic component of the interaction. Further analysis demonstrates a strong dependence of cooperativity of binding on the protein concentration. Altogether, these results reveal a novel binding pathway in which the consolidated complex may achieve its final form via a monomer-DNA intermediate, which favors the binding of a second monomer. This molecular mechanism reveals the contributions of multiple conformers in a tight virus genome modulation that seems to be important in the cell infection scenario.	Univ Fed Rio de Janeiro, CCS, Fac Farm, BR-21941 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Nacl Ressonancia Magnet Nucl Macromol, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lima, LMTR (corresponding author), Univ Fed Rio de Janeiro, CCS, Fac Farm, Bss34,Ilha Fundao, BR-21941 Rio De Janeiro, Brazil.	mauricio@pharma.ufrj.br; Jerson@bioqmed.ufrj.br	SILVA, JERSON Lima/GRF-1442-2022; Lima, Luis Mauricio/AAL-2098-2021; Silva, Jerson/J-8984-2014	SILVA, JERSON Lima/0000-0001-9523-9441; Silva, Jerson/0000-0001-9523-9441; TR Lima, Luis Mauricio/0000-0001-6020-0504				ACKERS GK, 1983, J MOL BIOL, V170, P223, DOI 10.1016/S0022-2836(83)80234-4; Alexander KA, 1996, BIOCHEMISTRY-US, V35, P9864, DOI 10.1021/bi960447d; ANDROPHY EJ, 1987, NATURE, V325, P70, DOI 10.1038/325070a0; Antson AA, 2000, NATURE, V403, P805, DOI 10.1038/35001638; BERRY RS, 2000, PHYS CHEM, P694; Boyer M, 2000, NUCLEIC ACIDS RES, V28, P2494, DOI 10.1093/nar/28.13.2494; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P863; COLOMBO MF, 1992, SCIENCE, V256, P655, DOI 10.1126/science.1585178; Colombo MF, 1999, BIOCHEMISTRY-US, V38, P11741, DOI 10.1021/bi9905361; COLOMBO MF, 1994, P NATL ACAD SCI USA, V91, P10517, DOI 10.1073/pnas.91.22.10517; Darling PJ, 2000, J MOL BIOL, V302, P625, DOI 10.1006/jmbi.2000.4050; Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827; Dell G, 2003, J MOL BIOL, V334, P979, DOI 10.1016/j.jmb.2003.10.009; Di Pietro SM, 2003, BIOCHEMISTRY-US, V42, P6218, DOI 10.1021/bi026866u; DUPONT Y, 1983, FEBS LETT, V156, P93, DOI 10.1016/0014-5793(83)80255-5; Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r; Foguel D, 1998, J BIOL CHEM, V273, P9050, DOI 10.1074/jbc.273.15.9050; Foguel D, 1996, P NATL ACAD SCI USA, V93, P10642, DOI 10.1073/pnas.93.20.10642; GARNER MM, 1995, EMBO J, V14, P1257, DOI 10.1002/j.1460-2075.1995.tb07109.x; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4677, DOI 10.1021/bi00519a024; Harris SF, 1999, SCIENCE, V284, P1673, DOI 10.1126/science.284.5420.1673; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; Hines CS, 1998, J MOL BIOL, V276, P809, DOI 10.1006/jmbi.1997.1578; JELESAROV I, 1994, BIOCHEMISTRY-US, V33, P13321, DOI 10.1021/bi00249a019; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; KORNBLATT MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P495, DOI 10.1006/abbi.1993.1542; Lewis H, 1999, J MOL BIOL, V294, P885, DOI 10.1006/jmbi.1999.3314; Liang H, 1996, BIOCHEMISTRY-US, V35, P2095, DOI 10.1021/bi951932w; Lima LMTR, 2000, P NATL ACAD SCI USA, V97, P14289, DOI 10.1073/pnas.250352197; Lynch TW, 2000, J BIOL CHEM, V275, P30561, DOI 10.1074/jbc.M000266200; MCBRIDE AA, 1988, EMBO J, V7, P533, DOI 10.1002/j.1460-2075.1988.tb02842.x; MILLS FC, 1976, BIOCHEMISTRY-US, V15, P5350, DOI 10.1021/bi00669a023; Mok YK, 2000, PROTEIN SCI, V9, P799; Mok YK, 1996, NAT STRUCT BIOL, V3, P711, DOI 10.1038/nsb0896-711; Mok YK, 1996, PROTEIN SCI, V5, P310; MONINI P, 1991, J VIROL, V65, P2124, DOI 10.1128/JVI.65.4.2124-2130.1991; OLIVEIRA AC, 1994, J MOL BIOL, V240, P184, DOI 10.1006/jmbi.1994.1433; Parsegian VA, 2000, P NATL ACAD SCI USA, V97, P3987, DOI 10.1073/pnas.97.8.3987; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; ROBINSON CR, 1994, BIOCHEMISTRY-US, V33, P3787, DOI 10.1021/bi00179a001; Robinson CR, 1996, PROTEIN SCI, V5, P2119, DOI 10.1002/pro.5560051019; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P2186, DOI 10.1073/pnas.95.5.2186; Ruggiero Neto Joao, 2001, Cellular and Molecular Biology (Noisy-Le-Grand), V47, P801; Salvay AG, 2003, BIOPHYS J, V84, P564, DOI 10.1016/S0006-3495(03)74876-0; SANDERS CM, 1994, NUCLEIC ACIDS RES, V22, P4890, DOI 10.1093/nar/22.23.4890; Senear DF, 1998, METHODS, V16, P3, DOI 10.1006/meth.1998.0641; Shimizu S, 2004, P NATL ACAD SCI USA, V101, P1195, DOI 10.1073/pnas.0305836101; SHORE JD, 1976, BIOCHEMISTRY-US, V15, P875, DOI 10.1021/bi00649a023; Sidorova NY, 1996, P NATL ACAD SCI USA, V93, P12272, DOI 10.1073/pnas.93.22.12272; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; SILVA JL, 1993, PROTEIN SCI, V2, P945, DOI 10.1002/pro.5560020608; Suarez MC, 2003, BIOCHEMISTRY-US, V42, P5522, DOI 10.1021/bi027102h; Swaminathan CP, 1999, J BIOL CHEM, V274, P31272, DOI 10.1074/jbc.274.44.31272; TANFORD C, 1969, J MOL BIOL, V39, P539, DOI 10.1016/0022-2836(69)90143-0; Thain A, 1997, J BIOL CHEM, V272, P8236, DOI 10.1074/jbc.272.13.8236; Timasheff SN, 1998, P NATL ACAD SCI USA, V95, P7363, DOI 10.1073/pnas.95.13.7363; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e; Vossen KM, 1997, BIOCHEMISTRY-US, V36, P11640, DOI 10.1021/bi971193e; Weber G., 1992, PROTEIN INTERACTIONS; WOLF AV, 1986, CRC HDB CHEM PHYSICS, pD266; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Wyman J, 1990, BINDING LINKAGE FUNC	68	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47968	47974		10.1074/jbc.M407696200	http://dx.doi.org/10.1074/jbc.M407696200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15361525	hybrid			2022-12-27	WOS:000224957000067
J	Wenstrup, RJ; Florer, JB; Brunskill, EW; Bell, SM; Chervoneva, I; Birk, DE				Wenstrup, RJ; Florer, JB; Brunskill, EW; Bell, SM; Chervoneva, I; Birk, DE			Type V collagen controls the initiation of collagen fibril assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; FIBRILLOGENESIS IN-SITU; LETHAL MUTATION; ORGANIZATION; COL5A1; MICE; EXPRESSION; SEGMENTS; MECHANISM; EVOLUTION	Vertebrate collagen fibrils are heterotypically composed of a quantitatively major and minor fibril collagen. In non-cartilaginous tissues, type I collagen accounts for the majority of the collagen mass, and collagen type V, the functions of which are poorly understood, is a minor component. Type V collagen has been implicated in the regulation of fibril diameter, and we reported recently preliminary evidence that type V collagen is required for collagen fibril nucleation (Wenstrup, R. J., Florer, J. B., Cole, W. G., Willing, M. C., and Birk, D. E. ( 2004) J. Cell. Biochem. 92, 113 - 124). The purpose of this study was to define the roles of type V collagen in the regulation of collagen fibrillogenesis and matrix assembly. Mouse embryos completely deficient in pro-alpha1(V) chains were created by homologous recombination. The col5a1-/- animals die in early embryogenesis, at approximately embryonic day 10. The type V collagen-deficient mice demonstrate a virtual lack of collagen fibril formation. In contrast, the col5a1+/- animals are viable. The reduced type V collagen content is associated with a 50% reduction in fibril number and dermal collagen content. In addition, relatively normal, cylindrical fibrils are assembled with a second population of large, structurally abnormal collagen fibrils. The structural properties of the abnormal matrix are decreased relative to the wild type control animals. These data indicate a central role for the evolutionary, ancient type V collagen in the regulation of fibrillogenesis. The complete dependence of fibril formation on type V collagen is indicative of the critical role of the latter in early fibril initiation. In addition, this fibril collagen is important in the determination of fibril structure and matrix organization.	Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45229 USA; Univ Cincinnati, Dept Internal Med, Cincinnati, OH 45267 USA; Thomas Jefferson Univ, Dept Anat & Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Anat & Cell Biol, Philadelphia, PA 19107 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Jefferson University; Jefferson University	Wenstrup, RJ (corresponding author), Childrens Hosp Res Fdn, Div Human Genet, 3333 Burnet Ave,ML 4006, Cincinnati, OH 45229 USA.	richard.wenstrup@cchmc.org	Birk, David/I-4072-2012	Birk, David/0000-0002-4865-9088; Bell, Sheila/0000-0002-1946-0969	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047054] Funding Source: NIH RePORTER; NEI NIH HHS [EY05129] Funding Source: Medline; NIAMS NIH HHS [AR47054] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADACHI E, 1986, CONNECT TISSUE RES, V14, P257, DOI 10.3109/03008208609017469; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bell SM, 1998, MECH DEVELOP, V74, P41, DOI 10.1016/S0925-4773(98)00065-3; BERG RA, 1982, METHOD ENZYMOL, V82, P372; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; Birk DE, 1997, DEV DYNAM, V208, P291; Birk DE, 1996, MATRIX BIOL, V15, P111, DOI 10.1016/S0945-053X(96)90152-3; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; BIRK DE, 1990, J CELL SCI, V95, P649; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Exposito JY, 2000, MATRIX BIOL, V19, P275, DOI 10.1016/S0945-053X(00)00067-6; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; FITCH JM, 1984, P NATL ACAD SCI-BIOL, V81, P2791, DOI 10.1073/pnas.81.9.2791; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; JAENISCH R, 1983, CELL, V32, P209, DOI 10.1016/0092-8674(83)90511-1; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kadler KE, 1996, BIOCHEM J, V316, P1; Kadler KE, 2000, MATRIX BIOL, V19, P359, DOI 10.1016/S0945-053X(00)00082-2; KRATOCHWIL K, 1989, CELL, V57, P807, DOI 10.1016/0092-8674(89)90795-2; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; Nagy A., 2003, MANIPULATING MOUSE E; NIYIBIZI C, 1993, BIOCHIM BIOPHYS ACTA, V1203, P304, DOI 10.1016/0167-4838(93)90099-D; NIYIBIZI C, 1994, EUR J BIOCHEM, V224, P943, DOI 10.1111/j.1432-1033.1994.00943.x; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; Tillet E, 1996, COMP BIOCHEM PHYS B, V113, P239, DOI 10.1016/0305-0491(95)02014-4; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; Wenstrup RJ, 1996, J BIOL CHEM, V271, P10271, DOI 10.1074/jbc.271.17.10271; Wenstrup RJ, 2004, J CELL BIOCHEM, V92, P113, DOI 10.1002/jcb.20024; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930	42	335	352	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53331	53337		10.1074/jbc.M409622200	http://dx.doi.org/10.1074/jbc.M409622200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15383546	hybrid			2022-12-27	WOS:000225680600065
J	Muslimov, IA; Nimmrich, V; Hernandez, AI; Tcherepanov, A; Sacktor, TC; Tiedge, H				Muslimov, IA; Nimmrich, V; Hernandez, AI; Tcherepanov, A; Sacktor, TC; Tiedge, H			Dendritic transport and localization of protein kinase M zeta mRNA - Implications for molecular memory consolidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; BC1 RNA; SUBCELLULAR-LOCALIZATION; TARGETING ELEMENT; TRANSLATION; NEUROSCIENCE; TRAFFICKING; MAINTENANCE; MECHANISM	Protein kinase Mzeta (PKMzeta) is an atypical protein kinase C isoform that has been implicated in the protein synthesis-dependent maintenance of long term potentiation and memory storage in the brain. Synapse-associated kinases are uniquely positioned to promote enduring consolidation of structural and functional modifications at the synapse, provided that kinase mRNA is available on site for local input-specific translation. We now report that the mRNA encoding PKMzeta is rapidly transported and specifically localized to synaptodendritic neuronal domains. Transport of PKMzeta mRNA is specified by two cis-acting dendritic targeting elements (Mzeta DTEs). Mzeta DTE1, located at the interface of the 5'-untranslated region and the open reading frame, directs somato-dendritic export of the mRNA. Mzeta DTE2, in contrast, is located in the 3'-untranslated region and is required for delivery of the mRNA to distal dendritic segments. Colocalization with translational repressor BC1 RNA in hippocampal dendrites suggests that PKMzeta mRNA may be subject to translational control in local domains. Dendritic localization of PKMzeta mRNA provides a molecular basis for the functional integration of synaptic signal transduction and translational control pathways.	SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Tiedge, H (corresponding author), SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	htiedge@downstate.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057068, R37MH057068, R29MH053576, R01MH053576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034158, R01NS046769] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH057068, MH53576, R01 MH057068, R01 MH053576, R29 MH053576, MH57068] Funding Source: Medline; NINDS NIH HHS [NS46769, NS34158, R01 NS046769] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; Blichenberg A, 2001, EUR J NEUROSCI, V13, P1881, DOI 10.1046/j.0953-816x.2001.01565.x; Brosius J, 2001, Results Probl Cell Differ, V34, P129; BRUCKENSTEIN DA, 1990, NEURON, V5, P809, DOI 10.1016/0896-6273(90)90340-L; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; FORSSPETTER S, 1986, J NEUROSCI RES, V16, P141, DOI 10.1002/jnr.490160114; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Goslin K., 1998, CULTURING NERVE CELL, P339; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Higgins D., 1991, CULTURING NERVE CELL, P177; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Jain C, 1996, CELL, V87, P115, DOI 10.1016/S0092-8674(00)81328-8; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Kakegawa W, 2004, EUR J NEUROSCI, V20, P101, DOI 10.1111/j.1460-9568.2004.03461.x; KELLY PT, 1982, BRAIN RES, V233, P265, DOI 10.1016/0006-8993(82)91202-1; Kindler S, 1997, MOL CELL ENDOCRINOL, V128, P7, DOI 10.1016/S0303-7207(97)04015-X; KLEIMAN R, 1990, NEURON, V5, P821, DOI 10.1016/0896-6273(90)90341-C; LANDRY CF, 1994, MOL BRAIN RES, V27, P1, DOI 10.1016/0169-328X(94)90178-3; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marshall BS, 2000, DNA CELL BIOL, V19, P707, DOI 10.1089/104454900750058071; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; MONAGHAN DT, 1983, NATURE, V306, P176, DOI 10.1038/306176a0; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Muslimov IA, 1998, J CELL BIOL, V141, P1601, DOI 10.1083/jcb.141.7.1601; Muslimov IA, 1997, J NEUROSCI, V17, P4722; Muslimov IA, 2002, J NEUROSCI, V22, P4293, DOI 10.1523/JNEUROSCI.22-11-04293.2002; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Osten P, 1996, J NEUROSCI, V16, P2444; Paulsen O, 2002, NAT NEUROSCI, V5, P289, DOI 10.1038/nn0402-289; POWELL CM, 1994, J BIOL CHEM, V269, P27958; Prakash N, 1997, EUR J NEUROSCI, V9, P523, DOI 10.1111/j.1460-9568.1997.tb01629.x; RICHTER D, 2001, CELL POLARITY SUBCEL; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; SCHWARTZ JH, 1993, P NATL ACAD SCI USA, V90, P8310, DOI 10.1073/pnas.90.18.8310; Shan JG, 2003, J NEUROSCI, V23, P8859; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Thio GL, 2000, DEV BIOL, V221, P435, DOI 10.1006/dbio.2000.9690; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; Tiedge H, 1999, SCIENCE, V283, P186, DOI 10.1126/science.283.5399.186; TIEDGE H, 1991, DNA CELL BIOL, V10, P143, DOI 10.1089/dna.1991.10.143; Tiedge H, 1996, J NEUROSCI, V16, P7171; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; Wang HD, 2002, J NEUROSCI, V22, P10232; Wells DG, 2000, CURR OPIN NEUROBIOL, V10, P132, DOI 10.1016/S0959-4388(99)00050-1; Wells DG, 2000, NAT NEUROSCI, V3, P1062, DOI 10.1038/80560; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11; Zuker M, 2000, CURR OPIN STRUC BIOL, V10, P303, DOI 10.1016/S0959-440X(00)00088-9	51	86	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52613	52622		10.1074/jbc.M409240200	http://dx.doi.org/10.1074/jbc.M409240200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15371429	Green Accepted, hybrid			2022-12-27	WOS:000225493400108
J	Chen, H; Pan, YX; Dudenhausen, EE; Kilberg, MS				Chen, H; Pan, YX; Dudenhausen, EE; Kilberg, MS			Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region/leucine zipper transcription factors as well as localized histone acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; STRESS-RESPONSE; KINASE; ACTIVATION; ATF4; RNA; BETA; PHOSPHORYLATION; PROLIFERATION; TRANSLATION	Expression of human asparagine synthetase (ASNS), which catalyzes asparagine and glutamate biosynthesis, is transcriptionally induced following amino acid deprivation. Previous overexpression and electrophoresis mobility shift analysis showed the involvement of the transcription factors ATF4, C/EBPbeta, and ATF3-FL through the nutrient-sensing response element-1 (NSRE-1) within the ASNS promoter. Amino acid deprivation caused an elevated mRNA level for ATF4, C/EBPbeta, and ATF3-FL, and the present study established that the nuclear protein content for ATF4 and ATF3-FL were increased during amino acid limitation, whereas C/EBPbeta-LIP declined slightly. The total amount of C/EBPbeta-LAP protein was unchanged, but changes in the distribution among multiple C/EBPbeta-LAP forms were observed. Overexpression studies established that ATF4, ATF3-FL, and C/EBPbeta-LAP could coordinately modulate the transcription from the human ASNS promoter. Chromatin immunoprecipitation demonstrated that amino acid deprivation increased ATF3-FL, ATF4, and C/EBPbeta binding to the ASNS promoter and enhanced promoter association of RNA polymerase II, TATA-binding protein, and TFIIB of the general transcription machinery. A time course revealed a markedly different temporal order of interaction between these transcription factors and the ASNS promoter. During the initial 2 h, there was a 20-fold increase in ATF4 binding and a rapid increase in histone H3 and H4 acetylation, which closely paralleled the increased transcription rate of the ASNS gene, whereas the increase in ATF3-FL and C/EBPbeta binding was considerably slower and more closely correlated with the decline in transcription rate between 2 and 6 h. The data suggest that ATF3-FL and C/EBPbeta act as transcriptional suppressors for the ASNS gene to counterbalance the transcription rate activated by ATF4 following amino acid deprivation.	Univ Florida, Coll Med, Dept Biochem & Mol Biol, JHMHC,Genet Inst, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, JHMHC,Genet Inst, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu	Pan, Yuan-Xiang/C-6576-2019	Pan, Yuan-Xiang/0000-0003-3219-4367	NIDDK NIH HHS [DK-52064] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052064] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Buck M, 2003, HEPATOLOGY, V37, P731, DOI 10.1053/jhep.2003.50155; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; GONG SS, 1991, MOL CELL BIOL, V11, P6059, DOI 10.1128/MCB.11.12.6059; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kilberg M, 2002, J NUTR, V132, P1801, DOI 10.1093/jn/132.7.1801; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Leung-Pineda V, 2002, J BIOL CHEM, V277, P16585, DOI 10.1074/jbc.M110972200; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Marten NW, 1996, BIOCHEM J, V317, P361, DOI 10.1042/bj3170361; MARTEN NW, 1994, FASEB J, V8, P538, DOI 10.1096/fasebj.8.8.8181673; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; SEARS RC, 1994, MOL CELL BIOL, V14, P4855, DOI 10.1128/MCB.14.7.4855; Siu F, 2001, J BIOL CHEM, V276, P48100, DOI 10.1074/jbc.M109533200; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang J, 2003, J BIOL CHEM, V278, P32899, DOI 10.1074/jbc.M305456200; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	38	157	160	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50829	50839		10.1074/jbc.M409173200	http://dx.doi.org/10.1074/jbc.M409173200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385533	hybrid			2022-12-27	WOS:000225355800025
J	Khurts, S; Masutomi, K; Delgermaa, L; Arai, K; Oishi, N; Mizuno, H; Hayashi, N; Hahn, WC; Murakami, S				Khurts, S; Masutomi, K; Delgermaa, L; Arai, K; Oishi, N; Mizuno, H; Hayashi, N; Hahn, WC; Murakami, S			Nucleolin interacts with telomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C VIRUS NS5B; CATALYTIC SUBUNIT; RNA COMPONENT; HUMAN-CELLS; IN-VITRO; REVERSE-TRANSCRIPTASE; ENZYME-ACTIVITY; PROTEIN; LOCALIZATION; DOMAIN	Telomerase is a specialized reverse transcriptase composed of core RNA and protein subunits which plays essential roles in maintaining telomeres in actively dividing cells. Recent work indicates that telomerase shuttles between subcellular compartments during assembly and in response to specific stimuli. In particular, telomerase colocalizes with nucleoli in normal human fibroblasts. Here, we show that nucleolin, a major nucleolar phosphoprotein, interacts with telomerase and alters its subcellular localization. Nucleolin binds the human telomerase reverse transcriptase subunit ( hTERT) through interactions with its RNA binding domain 4 and carboxyl-terminal RGG domain, and this binding also involves the telomerase RNA subunit hTERC. The protein-protein interaction between nucleolin and hTERT is critical for the nucleolar localization of hTERT. These findings indicate that interaction of hTERT and nucleolin participates in the dynamic intracellular localization of telomerase complex.	Kanazawa Univ, Canc Res Inst, Dept Mol Biol, Kanazawa, Ishikawa 9200934, Japan; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Kanazawa University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Murakami, S (corresponding author), Kanazawa Univ, Canc Res Inst, Dept Mol Biol, Takara Machi 13-1, Kanazawa, Ishikawa 9200934, Japan.	semuraka@kenroku.kanazawa-u.ac.jp	Mizuno, Hideki/E-9133-2011	Hayashi, Naoyuki/0000-0001-9626-3689	NATIONAL CANCER INSTITUTE [K01CA094223] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA94223] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Beattie TL, 1998, CURR BIOL, V8, P177, DOI 10.1016/S0960-9822(98)70067-3; Bryan TM, 1997, HUM MOL GENET, V6, P921, DOI 10.1093/hmg/6.6.921; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Ginisty H, 1999, J CELL SCI, V112, P761; Guiducci C, 2001, ONCOGENE, V20, P714, DOI 10.1038/sj.onc.1204145; Hirano M, 2003, J BIOL CHEM, V278, P5109, DOI 10.1074/jbc.M207629200; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Lukowiak AA, 2001, RNA, V7, P1833; Masutomi K, 2000, J BIOL CHEM, V275, P22568, DOI 10.1074/jbc.M000622200; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; MURAKAMI S, 1994, J BIOL CHEM, V269, P15118; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Narayanan A, 1999, EMBO J, V18, P5120, DOI 10.1093/emboj/18.18.5120; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Yang YH, 2002, EXP CELL RES, V277, P201, DOI 10.1006/excr.2002.5541; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525	33	95	105	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51508	51515		10.1074/jbc.M407643200	http://dx.doi.org/10.1074/jbc.M407643200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371412	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000225355800104
J	Lee, KS; You, KH; Choo, JK; Han, YM; Yu, K				Lee, KS; You, KH; Choo, JK; Han, YM; Yu, K			Drosophila short neuropeptide F regulates food intake and body size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEEDING-BEHAVIOR; GENE-EXPRESSION; MUSHROOM BODIES; NERVOUS-SYSTEM; MELANOGASTER; PEPTIDES; RECEPTOR; PEPTIDOMICS; INTEGRATION; MUTANTS	Neuropeptides regulate a wide range of animal behavior including food consumption, circadian rhythms, and anxiety. Recently, Drosophila neuropeptide F, which is the homolog of the vertebrate neuropeptide Y, was cloned, and the function of Drosophila neuropeptide F in feeding behaviors was well characterized. However, the function of the structurally related short neuropeptide F (sNPF) was unknown. Here, we report the cloning, RNA, and peptide localizations, and functional characterizations of the Drosophila sNPF gene. The sNPF gene encodes the preprotein containing putative RLRF amide peptides and was expressed in the nervous system of late stage embryos and larvae. The embryonic and larval localization of the sNPF peptide in the nervous systems revealed the larval central nervous system neural circuit from the neurons in the brain to thoracic axons and to connective axons in the ventral ganglion. In the adult brain, the sNPF peptide was localized in the medulla and the mushroom body. However, the sNPF peptide was not detected in the gut. The sNPF mRNA and the peptide were expressed during all developmental stages from embryo to adult. From the feeding assay, the gain-of-function sNPF mutants expressed in nervous systems promoted food intake, whereas the loss-of-function mutants suppressed food intake. Also, sNPF overexpression in nervous systems produced bigger and heavier flies. These findings indicate that the sNPF is expressed in the nervous systems to control food intake and regulate body size in Drosophila melanogaster.	Korea Res Inst Biosci & Biotechnol, Lab Dev & Differentiat, Taejon 395333, South Korea; Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; Chungnam Natl Univ, Sch Biol Sci, Taejon 305764, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chung Ang University; Chungnam National University	Yu, K (corresponding author), Korea Res Inst Biosci & Biotechnol, Lab Dev & Differentiat, 52 Eoun Dong, Taejon 395333, South Korea.	kweonyu@kribb.re.kr	Han, Yong-Mahn/C-1652-2011	Yu, Kweon/0000-0002-4942-2576				Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; ASHBURNER M, 1989, DROSOPHILA LAB HDB, P140; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; CARLSON J, 1991, TRENDS NEUROSCI, V14, P520, DOI 10.1016/0166-2236(91)90004-E; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Heisenberg M., 1989, Progress in Zoology, V37, P3; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Huang YQ, 1998, INSECT BIOCHEM MOLEC, V28, P345, DOI 10.1016/S0965-1748(98)00007-1; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Lange AB, 1998, PEPTIDES, V19, P459, DOI 10.1016/S0196-9781(97)00465-8; MAULE AG, 1995, HYDROBIOLOGIA, V305, P297, DOI 10.1007/BF00036410; Meinertzhagen Ian A., 1993, P1363; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Predel R, 2004, J COMP NEUROL, V474, P379, DOI 10.1002/cne.20145; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; SHON B, 2001, BIOCHEM J, V360, P31; Spittaels K, 1996, INSECT BIOCHEM MOLEC, V26, P375, DOI 10.1016/0965-1748(95)00104-2; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STRAUSFELD NJ, 1976, ATLAS INSECT BRAIN, P5; WAHLESTEDT C, 1993, ANNU REV PHARMACOL, V33, P309, DOI 10.1146/annurev.pa.33.040193.001521; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Yu K, 2000, DEVELOPMENT, V127, P2143; Yu K, 1996, DEVELOPMENT, V122, P4033; Zimanyi IA, 1998, CURR PHARM DESIGN, V4, P349; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	39	243	249	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50781	50789		10.1074/jbc.M407842200	http://dx.doi.org/10.1074/jbc.M407842200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15385546	hybrid			2022-12-27	WOS:000225355800020
J	Coombes, BK; Brown, NF; Valdez, Y; Brumell, JH; Finlay, BB				Coombes, BK; Brown, NF; Valdez, Y; Brumell, JH; Finlay, BB			Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; HOST-CELLS; ACTIN CYTOSKELETON; MURINE MACROPHAGES; SSRA-SSRB; SYSTEM; IDENTIFICATION; EFFECTORS; PROTEINS	Salmonella pathogenicity island (SPI)-2 is pivotal to the intracellular survival of Salmonella and for virulence in mammals. SPI-2 encodes virulence factors (called effectors) that are translocated into the host cell, a type III secretion apparatus and a two-component regulatory system that regulates intracellular expression of SPI-2. Salmonella SPI-2 secretion activity appears to be induced in response to acidification of the vacuole in which it replicates. Here we show that the expression of the SPI-2 proteins, SseB and SseD (filament and pore forming components of the secretion apparatus, respectively) in response to acidification requires an intact secretion system and SsaL, a Salmonella homologue of SepL, a regulator required for type III-dependent secretion of translocators but not effectors in attaching and effacing gastrointestinal pathogens. We show that the expression of SPI-2-encoded effectors is acid-regulated but can be uncoupled from the expression of filament and translocon components, thus showing a differential requirement of SsaL for expression. The secretion and translocation of SPI-2-encoded effectors requires SsaL, but SsaL is dispensable for the secretion of SPI-2 effectors encoded in other pathogenicity loci, suggesting a secretion regulation function for SsaL. Further, we demonstrate that the differential expression of adjacent genes within the sseA operon (sseD and sseE) occurs at the transcriptional level. These data indicate that a Salmonella SPI-2 activation state is achieved by an acid-regulated response that requires SsaL. These data also suggest the existence of a previously unrecognized regulatory element within SPI-2 for the "effector operon" region downstream of sseD that might demarcate the expression of translocators and effectors.	Univ British Columbia, Biotechnol Lab, Michael Smith Labs, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Microbiol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Biotechnol Lab, Michael Smith Labs, 237-6174 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.	bfinlay@interchange.ubc.ca	Coombes, Brian K/A-1727-2009; Brown, Nat/HHN-8551-2022	Coombes, Brian/0000-0001-9883-1010				AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Beuzon CR, 1999, MOL MICROBIOL, V33, P806, DOI 10.1046/j.1365-2958.1999.01527.x; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Brumell JH, 2002, TRAFFIC, V3, P407, DOI 10.1034/j.1600-0854.2002.30604.x; Brumell JH, 2001, CELL MICROBIOL, V3, P75, DOI 10.1046/j.1462-5822.2001.00087.x; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coombes BK, 2003, MICROBES INFECT, V5, P561, DOI 10.1016/S1286-4579(03)00094-7; Day JB, 2003, INFECT IMMUN, V71, P6680, DOI 10.1128/IAI.71.11.6680-6685.2003; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; Gavigan SA, 1999, J BIOL CHEM, V274, P16010, DOI 10.1074/jbc.274.23.16010; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Ho TD, 2002, J BACTERIOL, V184, P5234, DOI 10.1128/JB.184.19.5234-5239.2002; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; JENNINGS MP, 1993, MOL MICROBIOL, V9, P155, DOI 10.1111/j.1365-2958.1993.tb01677.x; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Kresse AU, 2000, J BACTERIOL, V182, P6490, DOI 10.1128/JB.182.22.6490-6498.2000; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Meresse S, 2001, CELL MICROBIOL, V3, P567, DOI 10.1046/j.1462-5822.2001.00141.x; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; Miao EA, 2002, J BACTERIOL, V184, P1493, DOI 10.1128/JB.184.5.1493-1497.2002; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Ruiz-Albert J, 2003, MICROBIOL-SGM, V149, P1103, DOI 10.1099/mic.0.26190-0; Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517; Senear DF, 1998, METHOD ENZYMOL, V295, P403; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Zurawski DV, 2003, MOL MICROBIOL, V47, P1341, DOI 10.1046/j.1365-2958.2003.03373.x	48	128	133	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49804	49815		10.1074/jbc.M404299200	http://dx.doi.org/10.1074/jbc.M404299200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383528	hybrid			2022-12-27	WOS:000225229500033
J	Lausen, J; Cho, SG; Liu, SH; Werner, MH				Lausen, J; Cho, SG; Liu, SH; Werner, MH			The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE ACETYLATION; FUSION PROTEIN; TRANSCRIPTIONAL REPRESSION; T(8-21); GENE; COREPRESSOR; COMPLEX; T(8/21); OLIGOMERIZATION	The acute human leukemias are associated with the presence of chimeric gene products that arise from spontaneous chromosomal translocations. The t(8;21) translocation gene product led to the discovery of the (E) under bar ight (T) under bar wenty-(O) under bar ne (ETO) gene. When fused to RUNX1, ETO is thought to mediate the formation of a repressive complex at RUNX1-dependent genes. ETO has also been found to act as a co-repressor of the promyelocytic zinc finger and Bcl-6 oncoproteins, suggesting that it may play a common role as a transcriptional co-repressor leading to human disease. An analysis of ETO-mediated repression revealed that one of the key binding partners of ETO is the nuclear receptor co-repressor (N-CoR). It is shown that two highly conserved domains of ETO interact with repression domains I and III of N-CoR. One of the ETO domains displays significant homology to Drosophila TAF(II)110, whereas the other is a predicted zinc binding motif that engages a conserved PPLXP motif in repression domain III of N-CoR. Together, these domains of ETO cooperate in repression with N-CoR and the binding sites in N-CoR overlap with those for other repressive factors. Thus, ETO has the potential to participate in a number of repressive complexes, which can be distinguished by their binding partners and target genes.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA	Rockefeller University	Werner, MH (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave,Box 42, New York, NY 10021 USA.	mwerner@portugal.rockefeller.edu						Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bailey P, 1999, MOL ENDOCRINOL, V13, P1155, DOI 10.1210/me.13.7.1155; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Calabi F, 2001, MOL CELL BIOL, V21, P5658, DOI 10.1128/MCB.21.16.5658-5666.2001; Cao Y, 2002, MECH DEVELOP, V119, P35, DOI 10.1016/S0925-4773(02)00285-X; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chevallier N, 2004, BLOOD, V103, P1454, DOI 10.1182/blood-2003-06-2081; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Coustry F, 1998, BIOCHEM J, V331, P291, DOI 10.1042/bj3310291; ERICKSON P, 1992, BLOOD, V80, P1825; ERICKSON PF, 1994, CANCER RES, V54, P1782; Felinski EA, 1999, J BIOL CHEM, V274, P11672, DOI 10.1074/jbc.274.17.11672; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fukuyama T, 2001, ONCOGENE, V20, P6225, DOI 10.1038/sj.onc.1204794; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hildebrand D, 2001, J BIOL CHEM, V276, P9889, DOI 10.1074/jbc.M010582200; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Jepsen K, 2002, J CELL SCI, V115, P689; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846, DOI 10.1128/MCB.18.2.846; Licht JD, 2001, ONCOGENE, V20, P5660, DOI 10.1038/sj.onc.1204593; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; McGhee L, 2003, J CELL BIOCHEM, V89, P1005, DOI 10.1002/jcb.10548; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wolford JK, 1998, GENE, V212, P103, DOI 10.1016/S0378-1119(98)00141-3; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang JS, 2001, MOL CELL BIOL, V21, P156, DOI 10.1128/MCB.21.1.156-163.2001	50	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49281	49288		10.1074/jbc.M407239200	http://dx.doi.org/10.1074/jbc.M407239200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15377655	hybrid			2022-12-27	WOS:000225098100096
J	Senin II; Hoppner-Heitmann, D; Polkovnikova, OO; Churumova, VA; Tikhomirova, NK; Philippov, PP; Koch, KW				Senin, II; Hoppner-Heitmann, D; Polkovnikova, OO; Churumova, VA; Tikhomirova, NK; Philippov, PP; Koch, KW			Recoverin and rhodopsin kinase activity in detergent-resistant membrane rafts from rod outer segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ACTIVATING PROTEIN; PHOTORECEPTOR GUANYLYL CYCLASE; LIGHT-DRIVEN TRANSLOCATION; DISK MEMBRANES; CA2+-MYRISTOYL SWITCH; CELLS; TRANSDUCIN; VERTEBRATE; PHOTOTRANSDUCTION; PHOSPHORYLATION	Cholesterol-rich membranes or detergent-resistant membranes (DRMs) have recently been isolated from bovine rod outer segments and were shown to contain several signaling proteins such as, for example, transducin and its effector, cGMP-phosphodiesterase PDE6. Here we report the presence of rhodopsin kinase and recoverin in DRMs that were isolated in either light or dark conditions at high and low Ca(2+) concentrations. Inhibition of rhodopsin kinase activity by recoverin was more effective in DRMs than in the initial rod outer segment membranes. Furthermore, the Ca(2+) sensitivity of rhodopsin kinase inhibition in DRMs was shifted to lower free Ca(2+) concentration in comparison with the initial rod outer segment membranes (IC(50) = 0.76 muM in DRMs and 1.91 muM in rod outer segments). We relate this effect to the high cholesterol content of DRMs because manipulating the cholesterol content of rod outer segment membranes by methyl-beta-cyclodextrin yielded a similar shift of the Ca(2+)-dependent dose-response curve of rhodopsin kinase inhibition. Furthermore, a high cholesterol content in the membranes also increased the ratio of the membrane-bound form of recoverin to its cytoplasmic free form. These data suggest that the Ca(2+)-dependent feedback loop that involves recoverin is spatially heterogeneous in the rod cell.	Forschungszentrum Julich, Inst Biol Informat Verarbeitung 1, D-52425 Julich, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia	Helmholtz Association; Research Center Julich; Lomonosov Moscow State University	Koch, KW (corresponding author), Forschungszentrum Julich, Inst Biol Informat Verarbeitung 1, Postbox 1913, D-52425 Julich, Germany.	k.w.koch@fz-juelich.de	Philippov, Pavel P/A-8939-2012; Koch, Karl-Wilhelm/C-9551-2015; Senin, Ivan I/D-9163-2012	Koch, Karl-Wilhelm/0000-0003-1501-0044; 				Boesze-Battaglia K, 2002, J BIOL CHEM, V277, P41843, DOI 10.1074/jbc.M207111200; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P18867; Brouwers JFHM, 1998, J LIPID RES, V39, P344; Brown BM, 2002, BIOCHEMISTRY-US, V41, P13526, DOI 10.1021/bi0204490; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Elliott MH, 2003, BIOCHEMISTRY-US, V42, P7892, DOI 10.1021/bi027162n; Erickson MA, 1998, P NATL ACAD SCI USA, V95, P6474, DOI 10.1073/pnas.95.11.6474; Fischer T, 2002, SPECTROSC-INT J, V16, P271, DOI 10.1155/2002/630549; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORODOVIKOVA EN, 1994, FEBS LETT, V349, P187, DOI 10.1016/0014-5793(94)00661-X; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; HURST WJ, 1984, J AM OIL CHEM SOC, V61, P1462, DOI 10.1007/BF02636365; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; KOCH KW, 1994, EMBO J, V13, P3312, DOI 10.1002/j.1460-2075.1994.tb06633.x; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; LAMBRECHT HG, 1992, BIOCHIM BIOPHYS ACTA, V1160, P63, DOI 10.1016/0167-4838(92)90038-F; LETTER WS, 1992, J LIQ CHROMATOGR, V15, P253, DOI 10.1080/10826079208017168; Liu H, 2003, BIOCHEM BIOPH RES CO, V303, P19, DOI 10.1016/S0006-291X(03)00284-5; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; Otto-Bruce AE, 1998, P NATL ACAD SCI USA, V95, P15014, DOI 10.1073/pnas.95.25.15014; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; SCHNAPF JL, 1983, J PHYSIOL-LONDON, V343, P147, DOI 10.1113/jphysiol.1983.sp014886; Senin II, 2003, J MOL BIOL, V330, P409, DOI 10.1016/S0022-2836(03)00581-3; Senin II, 2002, ADV EXP MED BIOL, V514, P69; Senin II, 2002, J BIOL CHEM, V277, P50365, DOI 10.1074/jbc.M204338200; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; WUTHIER RE, 1996, J LIPID RES, V7, P558; Zhang HB, 2003, MOL VIS, V9, P231; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	46	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48647	48653		10.1074/jbc.M402516200	http://dx.doi.org/10.1074/jbc.M402516200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355976	Green Published, hybrid			2022-12-27	WOS:000225098100021
J	Zhang, J; Huang, WD; Qatanani, M; Evans, RM; Moore, DD				Zhang, J; Huang, WD; Qatanani, M; Evans, RM; Moore, DD			The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; XENOBIOTIC RESPONSE; LITHOCHOLIC ACID; ACTIVATED RECEPTOR; CAR; INDUCTION; METABOLISM; PXR; SULFOTRANSFERASE; IDENTIFICATION	A double null mouse line (2XENKO) lacking the xenobiotic receptors CAR (constitutive androstane receptor) (NR1I3) and PXR (pregnane X receptor) (NR1I2) was generated to study their functions in response to potentially toxic xenobiotic and endobiotic stimuli. Like the single knockouts, the 2XENKO mice are viable and fertile and show no overt phenotypes under normal conditions. As expected, they are completely insensitive to broad range xenobiotic inducers able to activate both receptors, such as clotrimazole and dieldrin. Comparisons of the single and double knockouts reveal specific roles for the two receptors. Thus, PXR does not contribute to the process of acetaminophen hepatotoxicity mediated by CAR, but both receptors contribute to the protective response to the hydrophobic bile acid lithocholic acid (LCA). As previously observed with PXR (Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., and Evans, R. M. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 3375-3380), pharmacologic activation of CAR induces multiple LCA detoxifying enzymes and provides strong protection against LCA toxicity. Comparison of their responses to LCA treatment demonstrates that CAR predominantly mediates induction of the cytochrome p450 CYP3A11 and the multidrug resistance-associated protein 3 transporter, whereas PXR is the major regulator of the Na+-dependent organic anion transporter 2. These differential responses may account for the significant sensitivity of the CAR knockouts, but not the PXR knockouts, to an acute LCA dose. Because this sensitivity is not further increased in the 2XENKO mice, CAR may play a primary role in acute responses to this toxic endobiotic. These results define a central role for CAR in LCA detoxification and show that CAR and PXR function coordinately to regulate both xenobiotic and bile acid metabolism.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Salk Institute	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	moore@bcm.tmc.edu	Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965	NIDDK NIH HHS [F32 DK63780, U19 DK062434, R01 DK46546] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046546, U19DK062434, F32DK063780] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1; CHEN LJ, 1985, ARCH BIOCHEM BIOPHYS, V241, P371, DOI 10.1016/0003-9861(85)90559-4; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; CHIANG JYL, 1998, FRONT BIOSCI, V3, P176; del Castillo-Olivares A, 2001, NUCLEIC ACIDS RES, V29, P4035, DOI 10.1093/nar/29.19.4035; Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200; Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200; HOFMANN AF, 1990, HEPATOLOGY, V12, P17; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224; Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100; Jenkins JK, 2002, ANN PHARMACOTHER, V36, P1462; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kitada H, 2003, J BIOL CHEM, V278, P17838, DOI 10.1074/jbc.M210634200; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; RADOMINSKA A, 1993, SEMIN LIVER DIS, V13, P219, DOI 10.1055/s-2007-1007351; Saini SPS, 2004, MOL PHARMACOL, V65, P292, DOI 10.1124/mol.65.2.292; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sonoda J, 2003, CURR DRUG METAB, V4, P59, DOI 10.2174/1389200033336739; Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Xiong H, 2002, DRUG METAB DISPOS, V30, P918, DOI 10.1124/dmd.30.8.918; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502	42	184	187	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49517	49522		10.1074/jbc.M409041200	http://dx.doi.org/10.1074/jbc.M409041200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358766	hybrid			2022-12-27	WOS:000225098100122
J	Zhou, GS; Boomer, JS; Tan, TH				Zhou, GS; Boomer, JS; Tan, TH			Protein phosphatase 4 is a positive regulator of hematopoietic progenitor kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; CASPASE-MEDIATED CLEAVAGE; BETA SIGNAL-TRANSDUCTION; GERMINAL CENTER KINASE; ADAPTER PROTEINS; KAPPA-B; HEMATOPOIETIC-PROGENITOR-KINASE-1 HPK1; P21-ACTIVATED KINASE; PROTEASOME PATHWAY; TYROSINE KINASE	Hematopoietic progenitor kinase 1 (HPK1) is a hematopoietic specific mammalian Ste20-like protein kinase and has been implicated in many cellular signaling pathways including T cell receptor (TCR) signaling. However, little is known about the in vivo regulation of HPK1. We present evidence that HPK1 is positively regulated by protein phosphatase 4 (PP4; also called PPX and PPP4), a serine/threonine phosphatase. We found that PP4 interacted with HPK1 and that the proline-rich region of HPK1 was necessary and sufficient for this interaction. We also found that PP4 had phosphatase activity toward HPK1 in vivo and that co-transfection of PP4 with HPK1 resulted in specific kinase activation of HPK1. Moreover, we found that the PP4-induced HPK1 kinase activation was accompanied by an increase in protein expression of HPK1. Pulse-chase analysis showed that PP4 increased the half-life of HPK1. Further studies showed that HPK1 was subject to regulation by ubiquitination and ubiquitin-targeted degradation and that PP4 inhibited HPK1 ubiquitination. In addition, we found that TCR stimulation enhanced the PP4-HPK1 interaction and that wild-type PP4 enhanced, whereas a phosphatase-dead PP4 mutant inhibited, TCR-induced activation of HPK1 in Jurkat T cells. Combined with the observation that PP4 enhanced HPK1-induced JNK activation, our studies identify PP4 as a positive regulator for HPK1 and the HPK1-JNK signaling pathway.	Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	Baylor College of Medicine	Tan, TH (corresponding author), Baylor Coll Med, Dept Immunol, 1 Baylor Plaza,M929, Houston, TX 77030 USA.	ttan@bcm.tmc.edu	Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170	NATIONAL CANCER INSTITUTE [R01CA087076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042532] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA87076] Funding Source: Medline; NIAID NIH HHS [R01-AI42532] Funding Source: Medline; PHS HHS [5-T32-A107495] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anafi M, 1997, J BIOL CHEM, V272, P27804, DOI 10.1074/jbc.272.44.27804; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; BREWIS ND, 1992, BIOCHIM BIOPHYS ACTA, V1171, P231, DOI 10.1016/0167-4781(92)90129-N; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Chen YR, 2000, INT J ONCOL, V16, P651; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Dounay AB, 2002, CURR MED CHEM, V9, P1939, DOI 10.2174/0929867023368791; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Ensenat D, 1999, J BIOL CHEM, V274, P33945, DOI 10.1074/jbc.274.48.33945; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Geisberger Roland, 2002, Dev Immunol, V9, P127, DOI 10.1080/1044667031000137584; Han J, 2003, J BIOL CHEM, V278, P52195, DOI 10.1074/jbc.M305026200; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Hastie CJ, 2000, BIOCHEM J, V347, P845, DOI 10.1042/0264-6021:3470845; Helps NR, 1998, J CELL SCI, V111, P1331; Hu MCT, 1999, ONCOGENE, V18, P5514, DOI 10.1038/sj.onc.1202740; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Hu MCT, 2001, GENE, V278, P89, DOI 10.1016/S0378-1119(01)00734-X; Hu MCT, 1998, J BIOL CHEM, V273, P33561, DOI 10.1074/jbc.273.50.33561; Ito Y, 2001, J BIOL CHEM, V276, P18130, DOI 10.1074/jbc.M007294200; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; JaramilloBabb VL, 1996, J BIOL CHEM, V271, P5988, DOI 10.1074/jbc.271.11.5988; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Koh CG, 2002, CURR BIOL, V12, P317, DOI 10.1016/S0960-9822(02)00652-8; Le Bras S, 2004, J BIOL CHEM, V279, P15550, DOI 10.1074/jbc.M312659200; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Ling P, 1999, MOL CELL BIOL, V19, P1359; Ling P, 2001, J BIOL CHEM, V276, P18908, DOI 10.1074/jbc.M101485200; LING P, 2002, RECENT RES DEV MOL C, V3, P297; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu SK, 2000, J IMMUNOL, V165, P1417, DOI 10.4049/jimmunol.165.3.1417; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Mihindukulasuriya KA, 2004, J BIOL CHEM, V279, P46588, DOI 10.1074/jbc.M408067200; MORI S, 1992, J BIOL CHEM, V267, P6429; Mourtada-Maarabouni M, 2003, CELL DEATH DIFFER, V10, P1016, DOI 10.1038/sj.cdd.4401274; Nagata Y, 1999, BLOOD, V93, P3347, DOI 10.1182/blood.V93.10.3347.410k06_3347_3354; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Pillet NA, 2003, J BIOL CHEM, V278, P48720, DOI 10.1074/jbc.M306745200; Roig J, 2000, P NATL ACAD SCI USA, V97, P14346, DOI 10.1073/pnas.97.26.14346; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sauer K, 2001, J BIOL CHEM, V276, P45207, DOI 10.1074/jbc.M106811200; Sawasdikosol S, 2003, BLOOD, V101, P3687, DOI 10.1182/blood-2002-07-2316; Schulze-Luehrmann J, 2002, BLOOD, V100, P954, DOI 10.1182/blood-2002-01-0089; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; Theodosiou AM, 1996, HUM MOL GENET, V5, P675, DOI 10.1093/hmg/5.5.675; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Tu H, 1999, MOL CELL BIOL, V19, P602; Wada T, 2001, J AM SOC NEPHROL, V12, P2601, DOI 10.1681/ASN.V12122601; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2002, J BIOL CHEM, V277, P15766, DOI 10.1074/jbc.M111733200; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yeh PY, 2004, J BIOL CHEM, V279, P26143, DOI 10.1074/jbc.M402362200; Yu J, 2001, MOL CELL BIOL, V21, P6102, DOI 10.1128/MCB.21.18.6102-6112.2001; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200; Zhou GS, 1999, J BIOL CHEM, V274, P13133, DOI 10.1074/jbc.274.19.13133	80	31	38	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49551	49561		10.1074/jbc.M410317200	http://dx.doi.org/10.1074/jbc.M410317200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364934	hybrid			2022-12-27	WOS:000225098100126
J	Lee, CG; Reichman, TW; Baik, T; Mathews, MB				Lee, CG; Reichman, TW; Baik, T; Mathews, MB			MLE functions as a transcriptional regulator of the roX2 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOSAGE COMPENSATION COMPLEX; X-CHROMOSOME INACTIVATION; MSL COMPLEX; DROSOPHILA-MELANOGASTER; ACETYL TRANSFERASE; SEX DETERMINATION; MALELESS PROTEIN; RNA HELICASE; XIST GENE; CHROMATIN	Dosage compensation is a process that equalizes transcription activity between the sexes. In Drosophila, two non-coding RNA, roX1 and roX2, and at least six protein regulators, MSL-1, MSL-2, MSL-3, MLE, MOF, and JIL-1, have been identified as essential for dosage compensation. Although there is accumulating evidence of the intricate functional and physical interactions between protein and RNA regulators, little is known about how roX RNA expression and function are modulated in coordination with protein regulators. In this report, we have found that a relatively short (about 350 bp) upstream genomic region of the roX2 gene, Prox2, harbors an activity that drives transcription of the downstream gene. Our study has shown that MLE can stimulate the transcription activity of Prox2 and that MLE associates with Prox2 through direct interaction with a newly identified 54-bp repeat, Prox. Our observations suggest a novel mechanism by which roX2 RNA is regulated at the transcriptional level.	Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, CG (corresponding author), Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.	leecg@umdnj.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34552] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Brockdorff N, 2002, TRENDS GENET, V18, P352, DOI 10.1016/S0168-9525(02)02717-8; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chang KA, 1998, GENETICS, V150, P699; Chiang PW, 2003, GENETICS, V165, P1167; Cohen DE, 2002, CURR OPIN GENET DEV, V12, P219, DOI 10.1016/S0959-437X(02)00289-7; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Franke A, 1999, MOL CELL, V4, P117, DOI 10.1016/S1097-2765(00)80193-8; GORMAN M, 1995, DEVELOPMENT, V121, P463; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; HODGKIN J, 1990, NATURE, V344, P721, DOI 10.1038/344721a0; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; Lee CG, 1997, EMBO J, V16, P2671, DOI 10.1093/emboj/16.10.2671; Meller VH, 2003, MECH DEVELOP, V120, P759, DOI 10.1016/S0925-4773(03)00157-6; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; MUKHERJEE AS, 1965, NATURE, V207, P785, DOI 10.1038/207785a0; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; PALMER MJ, 1993, GENETICS, V134, P545; Pannuti A, 2000, CURR OPIN GENET DEV, V10, P644, DOI 10.1016/S0959-437X(00)00136-2; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; Park Y, 2001, SCIENCE, V293, P1083, DOI 10.1126/science.1063073; PARKHURST SM, 1994, SCIENCE, V264, P924, DOI 10.1126/science.8178152; Richter L, 1996, GENES CELLS, V1, P325, DOI 10.1046/j.1365-2443.1996.26027.x; Scott MJ, 2000, EMBO J, V19, P144, DOI 10.1093/emboj/19.1.144; Zhou K, 2003, NUCLEIC ACIDS RES, V31, P2253, DOI 10.1093/nar/gkg328	37	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47740	47745		10.1074/jbc.M408207200	http://dx.doi.org/10.1074/jbc.M408207200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15358781	hybrid			2022-12-27	WOS:000224957000041
J	Lemaire, C; Guibet-Grandmougin, F; Angles, D; Dujardin, G; Bonnefoy, N				Lemaire, C; Guibet-Grandmougin, F; Angles, D; Dujardin, G; Bonnefoy, N			A yeast mitochondrial membrane methyltransferase-like protein can compensate for oxa1 mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI YIDC; CYTOCHROME-C-OXIDASE; COX2 MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; INNER-MEMBRANE; ATP SYNTHASE; NUCLEAR GENE; FUNCTIONAL COMPLEMENTATION; NEUROSPORA-CRASSA; EXPORT MACHINERY	Members of the Oxa1p/Alb3/YidC family mediate the insertion of various organelle or bacterial hydrophobic proteins into membranes. They present at least five transmembrane segments (TM) linked by hydrophilic domains located on both sides of the membrane. To examine how Oxa1p structure relates to its function, we have introduced point mutations and large deletions into various domains of the yeast mitochondrial protein. These mutants allowed us to show the importance of the first TM domain as well as a synergistic interaction between the first loop and the C-terminal tail, which both protrude into the matrix. These mutants also led to the isolation of a high copy suppressor, OMS1, which encodes a member of the methyltransferase family. Overexpression of OMS1 seems to increase the steady-state level of both the mutant and wild-type Oxa1p. We show that Oms1p is a mitochondrial inner membrane protein inserted independently of Oxa1p. Oms1p presents one TM and a N-in C-out topology with the C-terminal domain carrying the methyltransferase-like domain. A conserved motif within this domain is essential for the suppression of oxa1 mutations. We discuss the possible role of Oms1p on Oxa1p intermembrane space domain.	CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bonnefoy, N (corresponding author), CNRS, Ctr Genet Mol, UPR 2167, Ave Terrasse, F-91198 Gif Sur Yvette, France.	bonnefoy@cgm.cnrs-gif.fr	Bonnefoy, Nathalie/GYD-2949-2022	Bonnefoy, Nathalie/0000-0002-5068-8849				Altamura N, 1996, FEBS LETT, V382, P111, DOI 10.1016/0014-5793(96)00165-2; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; BONNEFOY N, 1994, P NATL ACAD SCI USA, V91, P11978, DOI 10.1073/pnas.91.25.11978; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; Bonnefoy N, 2001, MOL CELL BIOL, V21, P2359, DOI 10.1128/MCB.21.7.2359-2372.2001; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; BRASSEUR G, 1995, J BIOL CHEM, V270, P29356, DOI 10.1074/jbc.270.49.29356; Funes S, 2004, MOL BIOL CELL, V15, P1853, DOI 10.1091/mbc.e03-11-0789; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; GROUDINSKY O, 1993, MOL GEN GENET, V240, P419, DOI 10.1007/BF00280396; Hamel P, 1998, GENETICS, V150, P601; Hamel P, 1997, PLANT J, V12, P1319, DOI 10.1046/j.1365-313x.1997.12061319.x; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Kermorgant M, 1997, CURR GENET, V31, P302, DOI 10.1007/s002940050209; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; Lemaire C, 2000, J BIOL CHEM, V275, P23471, DOI 10.1074/jbc.M002045200; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; MULERO JJ, 1994, MOL GEN GENET, V242, P383, DOI 10.1007/BF00281787; Nargang FE, 2002, J BIOL CHEM, V277, P12846, DOI 10.1074/jbc.M112099200; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Ossenbuhl F, 2004, PLANT CELL, V16, P1790, DOI 10.1105/tpc.023226; PAJOT P, 1976, EUR J BIOCHEM, V63, P263, DOI 10.1111/j.1432-1033.1976.tb10228.x; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Rep M, 1996, CURR GENET, V30, P206, DOI 10.1007/s002940050122; Saint-Georges Y, 2001, P NATL ACAD SCI USA, V98, P13814, DOI 10.1073/pnas.251503098; Sanchirico ME, 1998, EMBO J, V17, P5796, DOI 10.1093/emboj/17.19.5796; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; SIKORSKI RS, 1989, GENETICS, V122, P19; Spannagel C, 1998, BIOCHEMISTRY-US, V37, P615, DOI 10.1021/bi9714971; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; TAKATA Y, 1994, J BIOL CHEM, V269, P5537; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Yen MR, 2001, FEMS MICROBIOL LETT, V204, P223, DOI 10.1111/j.1574-6968.2001.tb10889.x; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h	52	32	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47464	47472		10.1074/jbc.M404861200	http://dx.doi.org/10.1074/jbc.M404861200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355998	Green Published, hybrid			2022-12-27	WOS:000224957000008
J	Tourbez, M; Firanescu, C; Yang, A; Unipan, L; Duchambon, P; Blouquit, Y; Craescu, CT				Tourbez, M; Firanescu, C; Yang, A; Unipan, L; Duchambon, P; Blouquit, Y; Craescu, CT			Calcium-dependent self-assembly of human centrin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN; BINDING; TEMPERATURE; CELLS; YEAST; POLYMERIZATION; CALMODULIN	Human centrin 2 (HsCen2) is a member of the EF-hand superfamily of calcium-binding proteins, often associated with the centrosomes and basal bodies. These organelles exhibit different morphological aspects, including a variety of centrin-containing fibers that connect the two centrioles or other structural elements of the pericentriolar space. The molecular basis of the Ca2+-sensitive fibers and their precise role in centrosome duplication are not known. To explore the possible structural role of HsCen2, we initiated a physicochemical study of the self-assembly properties of the purified protein in vitro. Using light scattering experiments, we investigated the temporal evolution of the assembly process and characterized the dependence on various chemical and physical factors, including temperature, di-cation concentration, ionic strength, protein concentration, and pH. The reversible self-assembly revealed many features of a large-size protein polymerization, with nucleation and elongation steps. Kinetic and equilibrium experiments show that a hydrophobic fluorescent probe (ANS) inhibits the polymerization by interfering with the nucleation step, probably through interactions with the apolar exposed sites on the protein surface. A truncated form of HsCen2, lacking the first 25 residues (Delta25HsCen2), shows no detectable self-assembly, pointing to the critical role played by the N-terminal fragment in the supermolecular organization of HsCen2. As revealed by isothermal titration experiments, the isolated N-terminal domains bind with a significant affinity (2 x 10(5) M-1) to preformed oligomers of Delta25HsCen2 through an entropy-driven mechanism.	Ctr Univ Paris Sud, INSERM, F-91405 Orsay, France; Ctr Univ Paris Sud, Inst Curie Rech, F-91405 Orsay, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Craescu, CT (corresponding author), Ctr Univ Paris Sud, INSERM, Batiment 112, F-91405 Orsay, France.	Gil.Craescu@curie.u-psud.fr	Chilom, Claudia Gabriela/S-2425-2018	Chilom, Claudia Gabriela/0000-0003-3662-9268				BARON AT, 1994, J CELL SCI, V107, P2993; Beisson J, 2001, PROTIST, V152, P339, DOI 10.1078/1434-4610-00072; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Campbell I.D, 1984, BIOL SPECTROSCOPY; CARLIER MF, 1978, BIOCHEMISTRY-US, V17, P1908, DOI 10.1021/bi00603a017; CARLIER MF, 1991, J BIOL CHEM, V266, P1; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Durussel I, 2000, FEBS LETT, V472, P208, DOI 10.1016/S0014-5793(00)01452-6; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gavet O, 2003, MOL BIOL CELL, V14, P1818, DOI 10.1091/mbc.E02-11-0709; Greer SC, 2002, ANNU REV PHYS CHEM, V53, P173, DOI 10.1146/annurev.physchem.53.082301.111949; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laoukili J, 2000, J CELL SCI, V113, P1355; Liliom K, 1999, BIOCHEM BIOPH RES CO, V264, P605, DOI 10.1006/bbrc.1999.1547; LINSE S, 1991, J BIOL CHEM, V266, P8050; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Matei E, 2003, BIOCHEMISTRY-US, V42, P1439, DOI 10.1021/bi0269714; MCFADDEN GI, 1987, J CELL BIOL, V105, P903, DOI 10.1083/jcb.105.2.903; McPhail D, 1997, J CHEM SOC FARADAY T, V93, P2283, DOI 10.1039/a701327b; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Mispelter J, 2000, J MAGN RESON, V143, P229, DOI 10.1006/jmre.1999.2006; NA GC, 1982, METHOD ENZYMOL, V85, P393; Paoletti A, 1996, J CELL SCI, V109, P3089; Popescu A, 2003, J BIOL CHEM, V278, P40252, DOI 10.1074/jbc.M302546200; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SALISBURY JL, 1995, CURR OPIN CELL BIOL, V7, P39; SALISBURY JL, 1978, SCIENCE, V202, P975, DOI 10.1126/science.202.4371.975; Salisbury JL, 1998, J EUKARYOT MICROBIOL, V45, P28, DOI 10.1111/j.1550-7408.1998.tb05064.x; SCHIEBEL E, 1995, TRENDS CELL BIOL, V5, P197, DOI 10.1016/S0962-8924(00)88999-0; Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559; Tang DX, 1998, EXP EYE RES, V67, P113, DOI 10.1006/exer.1998.0497; Wiech H, 1996, J BIOL CHEM, V271, P22453, DOI 10.1074/jbc.271.37.22453; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Wolfrum U, 2002, ADV EXP MED BIOL, V514, P155	42	62	65	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47672	47680		10.1074/jbc.M404996200	http://dx.doi.org/10.1074/jbc.M404996200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15356003	hybrid			2022-12-27	WOS:000224957000032
J	Hanafy, KA; Martin, E; Murad, F				Hanafy, KA; Martin, E; Murad, F			CCT eta, a novel soluble guanylyl cyclase-interacting protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MOLECULAR CHAPERONES; CYCLIC-GMP; EXPRESSION; TCP-1; CELLS	Nitric oxide (NO) transduces most of its biological effects through activation of the heterodimeric enzyme, soluble guanylyl cyclase (sGC). Activation of sGC results in the production of cGMP from GTP. In this paper, we demonstrate a novel protein interaction between CCT ( chaperonin containing t-complex polypeptide) subunit eta and the alpha(1)beta(1) isoform of sGC. CCTeta was found to interact with the beta(1) subunit of sGC via a yeast-two-hybrid screen. This interaction was then confirmed in vitro with a co-immunoprecipitation from mouse brain. The interaction between these two proteins was further supported by a co-localization of the proteins within rat brain. Using the yeast two-hybrid system, CCTeta was found to bind to the N-terminal portion of sGC. In vitro assays with purified CCTeta and Sf9 lysate expressing sGC resulted in a 30-50% inhibition of diethylamine diazeniumdiolate-NO-stimulated sGC activity. The same assays were then performed using BAY41-2272, an NO-independent allosteric sGC activator, and CCTeta had no effect on this activity. Furthermore, CCTeta had no effect on basal or sodium nitroprusside-stimulated alphabeta(Cys-105) sGC, a constitutively active mutant that only lacks the heme group. The N-terminal 94 amino acids of CCTeta seem to be critical for the mediation of this inhibition. Lastly, a 45% inhibition of sGC activity by CCTeta was seen in vivo in BE2 cells stably transfected with CCTeta and treated with sodium nitroprusside. These data suggest that CCTeta binds to sGC and, in cooperation with some other factor, inhibits its activity by modifying the binding of NO to the heme group or the subsequent conformational changes.	Univ Texas, Houston Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; Univ Texas, Houston Sch Med, Inst Mol Med, Houston, TX 77030 USA	University of Texas System; University of Texas System	Murad, F (corresponding author), Univ Texas, Houston Sch Med, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA.	ferid.murad@uth.tmc.edu		Martin, Emil/0000-0002-9094-4165	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061731] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL64221] Funding Source: Medline; NIGMS NIH HHS [GM61731] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellamy TC, 2002, BRIT J PHARMACOL, V136, P95, DOI 10.1038/sj.bjp.0704687; BRANDWEIN H, 1981, P NATL ACAD SCI-BIOL, V78, P4241, DOI 10.1073/pnas.78.7.4241; Brown CR, 1996, J BIOL CHEM, V271, P833, DOI 10.1074/jbc.271.2.833; Casalou C, 2001, BBA-GENE STRUCT EXPR, V1522, P9, DOI 10.1016/S0167-4781(01)00294-9; Dunn AY, 2001, J STRUCT BIOL, V135, P176, DOI 10.1006/jsbi.2001.4380; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HYNES G, 1995, FEBS LETT, V358, P129, DOI 10.1016/0014-5793(94)01408-S; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Lucas KA, 2000, PHARMACOL REV, V52, P375; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; MURAD F, 1993, ADV SEC MESS PHOSPH, V28, P101; Murad F, 1994, Adv Pharmacol, V26, P19, DOI 10.1016/S1054-3589(08)60049-6; Rademacher F, 1998, MICROBIOL-SGM, V144, P2951, DOI 10.1099/00221287-144-11-2951; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; Zabel U, 2002, NAT CELL BIOL, V4, P307, DOI 10.1038/ncb775	18	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46946	46953		10.1074/jbc.M404134200	http://dx.doi.org/10.1074/jbc.M404134200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347653	hybrid			2022-12-27	WOS:000224832400078
J	Sugimoto, I; Murakami, H; Tonami, Y; Moriyama, A; Nakanishi, M				Sugimoto, I; Murakami, H; Tonami, Y; Moriyama, A; Nakanishi, M			DNA replication checkpoint control mediated by the spindle checkpoint protein Mad2p in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SCHIZOSACCHAROMYCES-POMBE; DAMAGE CHECKPOINTS; S-PHASE; SACCHAROMYCES-CEREVISIAE; GENETICALLY INTERACTS; KINETOCHORES; MITOSIS; HOMOLOG; CDS1	The relationship between the DNA replication and spindle checkpoints of the cell cycle is unclear, given that in most eukaryotes, spindle formation occurs only after DNA replication is complete. Fission yeast rad3 mutant cells, which are deficient in DNA replication checkpoint function, enter, progress through, and exit mitosis even when DNA replication is blocked. In contrast, the entry of cds1 mutant cells into mitosis is delayed by several hours when DNA replication is inhibited. We show here that this delay in mitotic entry in cds1 cells is due in part to activation of the spindle checkpoint protein Mad2p. In the presence of the DNA replication inhibitor hydroxyurea (HU), cds1 mad2 cells entered and progressed through mitosis earlier than did cds1 cells. Overexpression of Mad2p or inactivation of Slp1p, a regulator of the anaphase-promoting complex, also rescued the checkpoint defect of HU-treated rad3 cells. Rad3p was shown to be involved in the physical interaction between Mad2p and Slp1p in the presence of HU. These results suggested that Mad2p and Slp1p act downstream of Rad3p in the DNA replication checkpoint and that Mad2p is required for the DNA replication checkpoint when Cds1p is compromised.	Nagoya City Univ, Grad Sch Med, Dept Biochem & Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Grad Sch Nat Sci, Div Biomol Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; London Res Inst, Lincolns Inn Fields Labs, Canc Res UK, Cell Cycle Lab, London WC2A 3PX, England	Nagoya City University; Nagoya City University; Cancer Research UK	Murakami, H (corresponding author), Nagoya City Univ, Grad Sch Med, Dept Biochem & Cell Biol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	hmura@med.nagoya-cu.ac.jp		Murakami-Tonami, Yuko/0000-0002-6347-1630				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Garber PM, 2002, GENETICS, V161, P521; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Hagan IM, 1998, J CELL SCI, V111, P1603; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ikui AE, 2002, J CELL SCI, V115, P1603; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Matsumoto T, 1997, MOL CELL BIOL, V17, P742, DOI 10.1128/MCB.17.2.742; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Murakami H, 2000, BIOCHEM J, V349, P1, DOI 10.1042/0264-6021:3490001; Murakami H, 2002, NAT CELL BIOL, V4, P384, DOI 10.1038/ncb789; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rhind N, 1998, MOL CELL BIOL, V18, P3782, DOI 10.1128/MCB.18.7.3782; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Yamano H, 1996, EMBO J, V15, P5268, DOI 10.1002/j.1460-2075.1996.tb00912.x; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	34	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					47372	47378		10.1074/jbc.M403231200	http://dx.doi.org/10.1074/jbc.M403231200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15347659	hybrid			2022-12-27	WOS:000224832400126
J	Aller, SG; Eng, ET; De Feo, CJ; Unger, VM				Aller, SG; Eng, ET; De Feo, CJ; Unger, VM			Eukaryotic CTR copper uptake transporters require two faces of the third transmembrane domain for helix packing, oligomerization, and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; GXXXG MOTIF; PROTEIN-DEGRADATION; CRYSTAL-STRUCTURE; YEAST; AFFINITY; GENE; ASSOCIATION; SEQUENCE	Members of the copper uptake transporter (CTR) family from yeast, plants, and mammals including human are required for cellular uptake of the essential metal copper. Based on biochemical data, CTRs have three transmembrane domains and have been shown to oligomerize in the membrane. Among individual members of the family, there is little amino acid sequence identity, raising questions as to how these proteins adopt a common fold, oligomerize, and participate in copper transport. Using site-directed mutagenesis, tryptophan scanning, genetic complementation, subcellular localization, chemical cross-linking, and the yeast unfolded protein response, we demonstrated that at least half of the third transmembrane domain (TM3) plays a vital role in CTR structure and function. The results of our analysis showed that TM3 contains two functionally distinct faces. One face bears a highly conserved Gly-X-X-X-Gly (GG4) motif, which we showed to be essential for CTR oligomerization. Moreover, we showed that steric constraints reach past the GG4-motif itself including amino acid residues that are not conserved throughout the CTR family. A second face of TM3 contains three amino acid positions that, when mutated to tryptophan, cause predominantly abnormal localization but are still partially functional in growth complementation experiments. These mutations cluster on the face opposite to the GG4-bearing face of TM3 where they may mediate interactions with the remaining two transmembrane domains. Taken together, our data support TM3 as being buried within trimeric CTR where it plays an essential role in CTR assembly.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Unger, VM (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.	vinzenz.unger@yale.edu		Eng, Edward/0000-0002-8014-7269; Aller, Stephen/0000-0003-0379-5534	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, R01GM066145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS045550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA017088] Funding Source: NIH RePORTER; NIDA NIH HHS [DA017088, R21 DA017088] Funding Source: Medline; NIGMS NIH HHS [R01 GM066145, T32 GM07223, GM66145] Funding Source: Medline; NINDS NIH HHS [F31 NS045550, F32 NS455550] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1994, J BIOL CHEM, V269, P25660; DiDonato M, 1997, BBA-MOL BASIS DIS, V1360, P3, DOI 10.1016/S0925-4439(96)00064-6; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; KAMPFENKEL K, 1995, J BIOL CHEM, V270, P28479, DOI 10.1074/jbc.270.47.28479; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Lin XJ, 2002, MOL PHARMACOL, V62, P1154, DOI 10.1124/mol.62.5.1154; Linder M, 1991, BIOCH COPPER; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marvin ME, 2003, MICROBIOL-SGM, V149, P1461, DOI 10.1099/mic.0.26172-0; Melnyk RA, 2004, J BIOL CHEM, V279, P16591, DOI 10.1074/jbc.M313936200; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200; Pena MMO, 2000, J BIOL CHEM, V275, P33244, DOI 10.1074/jbc.M005392200; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Riggio M, 2002, BBA-GENE STRUCT EXPR, V1576, P127, DOI 10.1016/S0167-4781(02)00337-8; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG311, DOI 10.1152/ajpgi.1999.276.2.G311; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Strausak D, 2001, BRAIN RES BULL, V55, P175, DOI 10.1016/S0361-9230(01)00454-3; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Zanusso G, 2001, J BIOL CHEM, V276, P40377, DOI 10.1074/jbc.C100458200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	45	83	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2004	279	51					53435	53441		10.1074/jbc.M409421200	http://dx.doi.org/10.1074/jbc.M409421200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	878XL	15385536	Green Accepted, hybrid			2022-12-27	WOS:000225680600077
J	Dgany, O; Gonzalez, A; Sofer, O; Wang, WX; Zolotnitsky, G; Wolf, A; Shoham, Y; Altman, A; Wolf, SG; Shoseyov, O; Almog, O				Dgany, O; Gonzalez, A; Sofer, O; Wang, WX; Zolotnitsky, G; Wolf, A; Shoham, Y; Altman, A; Wolf, SG; Shoseyov, O; Almog, O			The structural basis of the thermostability of SP1, a novel plant (Populus tremula) boiling stable protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIFFERENTIAL ACCUMULATION; SUCROSE SYNTHASE; STRESS; REFINEMENT; TOLERANCE; LESSONS; ENZYMES; GENES	We previously reported on a new boiling stable protein isolated from aspen plants ( Populus tremula), which we named SP1. SP1 is a stress-related protein with no significant sequence homology to other stress-related proteins. It is a 108-amino-acid hydrophilic polypeptide with a molecular mass of 12.4 kDa (Wang, W. X., Pelah, D., Alergand, T., Shoseyov, O., and Altman, A. ( 2002) Plant Physiol. 130, 865 - 875) and is found in an oligomeric form. Preliminary electron microscopy studies and matrix-assisted laser desorption ionization time-of-flight mass spectrometry experiments showed that SP1 is a dodecamer composed of two stacking hexamers. We performed a SDS-PAGE analysis, a differential scanning calorimetric study, and crystal structure determination to further characterize SP1. SDS-PAGE indicated a spontaneous assembly of SP1 to one stable oligomeric form, a dodecamer. Differential scanning calorimetric showed that SP1 has high thermostability i.e. T-m of 107 degreesC (at pH 7.8). The crystal structure of SP1 was initially determined to 2.4 Angstrom resolution by multi-wavelength anomalous dispersion method from a crystal belonging to the space group I422. The phases were extended to 1.8 Angstrom resolution using data from a different crystal form (P21). The final refined molecule includes 106 of the 108 residues and 132 water molecules ( on average for each chain). The R-free is 20.1%. The crystal structure indicated that the SP1 molecule has a ferredoxin-like fold. Strong interactions between each two molecules create a stable dimer. Six dimers associate to form a ring-like-shaped dodecamer strongly resembling the particle visualized in the electron microscopy studies. No structural similarity was found between the crystal structure of SP1 and the crystal structure of other stress-related proteins such as small heat shock proteins, whose structure has been already determined. This structural study further supports our previous report that SP1 may represent a new family of stress-related proteins with high thermostability and oligomerization.	Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA; Technion Israel Inst Technol, Dept Food Engn & Biotechnol, Inst Catalysis Sci & Technol, IL-32000 Haifa, Israel; Fulcrum SP Ltd, IL-46104 Herzliyya, Israel; Weizmann Inst Sci, Elect Microscopy Unit, IL-76100 Rehovot, Israel	Ben Gurion University; Hebrew University of Jerusalem; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Technion Israel Institute of Technology; Weizmann Institute of Science	Almog, O (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, IL-84105 Beer Sheva, Israel.	almogo@bgu.ac.il	Shoham, Yuval/M-4409-2013; WOLF, SHARON G/K-1768-2012; Li, Laigeng/AAA-2067-2020	WOLF, SHARON G/0000-0002-5337-5063; Li, Laigeng/0000-0001-6924-4431; Wang, Wang-Xia/0000-0002-8104-3779				Almog O, 2003, J MOL BIOL, V332, P1071, DOI 10.1016/j.jmb.2003.07.011; Almog O, 2002, J BIOL CHEM, V277, P27553, DOI 10.1074/jbc.M111777200; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHEN Q, 1994, J BIOL CHEM, V269, P13216; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Evans PR, 1999, ACTA CRYSTALLOGR D, V55, P1771, DOI 10.1107/S0907444999011117; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; LUZZATI V, 1953, ACTA CRYSTALLOGR, V6, P142, DOI 10.1107/S0365110X53000508; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PELAH D, 1995, TREE PHYSIOL, V15, P673, DOI 10.1093/treephys/15.10.673; Pelah D, 1997, PHYSIOL PLANTARUM, V99, P153, DOI 10.1034/j.1399-3054.1997.990121.x; Pelah D, 1997, J PLANT PHYSIOL, V151, P96, DOI 10.1016/S0176-1617(97)80043-0; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang WX, 2003, ACTA CRYSTALLOGR D, V59, P512, DOI 10.1107/S0907444902022618; Wang WX, 2002, PLANT PHYSIOL, V130, P865, DOI 10.1104/pp.002436; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wintrode PL, 2001, ADV PROTEIN CHEM, V55, P161, DOI 10.1016/S0065-3233(01)55004-4	33	70	78	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51516	51523		10.1074/jbc.M409952200	http://dx.doi.org/10.1074/jbc.M409952200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371455	hybrid			2022-12-27	WOS:000225355800105
J	Ding, WG; Toyoda, F; Matsuura, H				Ding, WG; Toyoda, F; Matsuura, H			Regulation of cardiac I-Ks potassium current by membrane phosphatidylinositol 4,5-bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CURRENT; INWARD RECTIFIER; PHOSPHOLIPASE-C; 2 COMPONENTS; G-PROTEINS; CHANNELS; ACTIVATION; MODULATION; INHIBITION; RECEPTOR	Regulation of the slowly activating component of delayed rectifier K+ current (I-Ks) by membrane phospholipid phosphatidylinositol 4,5-bisphosphate ( PtdIns( 4,5) P-2) was examined in guinea pig atrial myocytes using the whole-cell patch clamp method. I-Ks was elicited by depolarizing voltage steps given from a holding potential of - 50 mV, and the effect of various test reagents on IKs was assessed by measuring the amplitude of tail current elicited upon return to the holding potential following a 2-s depolarization to + 30 mV. Intracellular application of 50 muM wortmannin through a recording pipette evoked a progressive increase in I-Ks over a 10-15- min period to 208.5 +/- 14.6% (n = 9) of initial magnitude obtained shortly after rupture of the patch membrane. Intracellular application of anti-PtdIns(4,5) P-2 monoclonal antibody also increased the amplitude of IKs to 198.4 +/- 19.9% (n = 5). In contrast, intracellular loading with exogenous PtdIns(4,5) P-2 at 10 and 100 muM produced a marked decrease in the amplitude of I-Ks to 54.3 +/- 3.8% ( n = 5) and 44.8 +/- 8.2% ( n = 5), respectively. Intracellular application of neomycin ( 50 muM) or aluminum ( 50 muM) evoked an increase in the amplitude of I-Ks to 161.0 +/- 13.5% ( n = 4) and 150.0 +/- 8.2% ( n = 4), respectively. These results strongly suggest that I-Ks channel is inhibited by endogenous membrane PtdIns( 4,5) P-2 through the electrostatic interaction with the negatively charged head group on PtdIns(4,5) P-2. Potentiation of I-Ks by P2Y receptor stimulation with 50 muM ATP was almost totally abolished when PtdIns( 4,5) P-2 was included in the pipette solution, suggesting that depletion of membrane PtdIns(4,5) P-2 is involved in the potentiation of I-Ks by P2Y receptor stimulation. Thus, membrane PtdIns( 4,5) P-2 may act as an important physiological regulator of I-Ks in guinea pig atrial myocytes.	Shiga Univ Med Sci, Dept Physiol, Shiga 5202192, Japan	Shiga University of Medical Science	Ding, WG (corresponding author), Shiga Univ Med Sci, Dept Physiol, Shiga 5202192, Japan.	ding@belle.shiga-med.ac.jp						Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Bosch RF, 1998, CARDIOVASC RES, V38, P441, DOI 10.1016/S0008-6363(98)00021-2; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Busch AE, 1996, PFLUG ARCH EUR J PHY, V432, P1094, DOI 10.1007/s004240050240; Cho H, 2002, J BIOL CHEM, V277, P27742, DOI 10.1074/jbc.M203660200; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Ford CP, 2003, J NEUROSCI, V23, P4931, DOI 10.1523/jneurosci.23-12-04931.2003; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; HABUCHI Y, 1992, AM J PHYSIOL, V262, pH345, DOI 10.1152/ajpheart.1992.262.2.H345; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hara Y, 1997, EUR J PHARMACOL, V324, P295, DOI 10.1016/S0014-2999(97)00088-5; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; Loussouarn G, 2003, EMBO J, V22, P5412, DOI 10.1093/emboj/cdg526; Matsuura H, 1996, J PHYSIOL-LONDON, V490, P647, DOI 10.1113/jphysiol.1996.sp021174; Matsuura H, 1996, J PHYSIOL-LONDON, V490, P659, DOI 10.1113/jphysiol.1996.sp021175; Matsuura H, 1997, J PHYSIOL-LONDON, V503, P45, DOI 10.1111/j.1469-7793.1997.045bi.x; Matsuura H, 1996, J PHYSIOL-LONDON, V497, P379, DOI 10.1113/jphysiol.1996.sp021775; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; Meyers R, 1997, J BIOL CHEM, V272, P4384, DOI 10.1074/jbc.272.7.4384; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Oketani N, 2002, AM J PHYSIOL-HEART C, V282, pH757, DOI 10.1152/ajpheart.00246.2001; POWELL T, 1980, J PHYSIOL-LONDON, V302, P131; RAGAZZI E, 1991, CIRC RES, V68, P1035, DOI 10.1161/01.RES.68.4.1035; Ralevic V, 1998, PHARMACOL REV, V50, P413; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TOHSE N, 1987, AM J PHYSIOL, V253, pH1321, DOI 10.1152/ajpheart.1987.253.5.H1321; TOHSE N, 1992, CIRC RES, V71, P1441, DOI 10.1161/01.RES.71.6.1441; TOHSE N, 1200, AM J PHYSL, V258; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TSIEN RY, 1980, BIOCHIM BIOPHYS ACTA, V599, P623, DOI 10.1016/0005-2736(80)90205-9; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Wu L, 2002, NATURE, V419, P947, DOI 10.1038/nature01118; Xie LH, 1999, J PHYSIOL-LONDON, V514, P655, DOI 10.1111/j.1469-7793.1999.655ad.x; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	51	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50726	50734		10.1074/jbc.M409374200	http://dx.doi.org/10.1074/jbc.M409374200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15364935	hybrid			2022-12-27	WOS:000225355800014
J	Steel, R; Doherty, JP; Buzzard, K; Clemons, N; Hawkins, CJ; Anderson, RL				Steel, R; Doherty, JP; Buzzard, K; Clemons, N; Hawkins, CJ; Anderson, RL			Hsp72 inhibits apoptosis upstream of the mitochondria and not through interactions with Apaf-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; STRESS-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; N-TERMINAL KINASE; DEPENDENT FORMATION; ENERGY DEPRIVATION; CELL-DEATH; ACTIVATION; HEAT-SHOCK-PROTEIN-70; CASPASE-2	Hsp72 protects cells against apoptosis in response to various stresses. By simultaneously measuring cytochrome c localization and nuclear morphology in mouse embryo fibroblasts, we have shown that Hsp72 blocks cytochrome c release from mitochondria in response to cytotoxic stress and that permeabilization of the outer mitochondrial membrane is the critical point in deciding the fate of the cell. Hsp72 did not inhibit apoptosis in mouse embryo fibroblasts once cytochrome c had been released from the mitochondria. Recent reports have claimed that Hsp72 can prevent caspase activation by inhibiting the oligomerization of Apaf-1 in the presence of cytochrome c and dATP. We now show that this apparent function of recombinant Hsp72 is due to the presence of salt in the Hsp72 preparation and that the same response can be achieved by the addition of heat-denatured Hsp72 in the same high salt buffer or by the high salt buffer alone. Hsp72 expressed in a range of different cell lines had no inhibitory effect on cytochrome c-stimulated caspase activity of cytosolic extracts. We conclude that the protective effect of Hsp72 occurs upstream of the mitochondria and not through the inhibition of the apoptosome.	Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia; Murdock Childrens Res Inst, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Murdoch Children's Research Institute	Anderson, RL (corresponding author), Peter MacCallum Canc Ctr, ABeckett St,Locked Bag 1, Melbourne, Vic 8006, Australia.	robin.anderson@petermac.org	Anderson, Robin/I-2306-2013; Anderson, Robin/K-6966-2019; Clemons, Nicholas/AAN-6516-2020; Hawkins, Christine/B-8769-2011; Anderson, Robin/S-1005-2017	Clemons, Nicholas/0000-0001-9283-9978; Hawkins, Christine/0000-0001-8120-1071; /0000-0002-0423-6120; Anderson, Robin/0000-0002-6841-7422	NATIONAL CANCER INSTITUTE [R01CA081421] Funding Source: NIH RePORTER; NCI NIH HHS [CA81421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Creagh EM, 2000, EXP CELL RES, V257, P58, DOI 10.1006/excr.2000.4856; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Gabai VL, 2002, MOL CELL BIOL, V22, P3415, DOI 10.1128/MCB.22.10.3415-3424.2002; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; GABAI VL, 1993, FEBS LETT, V327, P247, DOI 10.1016/0014-5793(93)80997-9; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; HARTL FU, 1995, CURR OPIN STRUC BIOL, V5, P92; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Janicke RU, 2001, ONCOGENE, V20, P5043, DOI 10.1038/sj.onc.1204659; KABAKOV AE, 1995, EXP CELL RES, V217, P15, DOI 10.1006/excr.1995.1058; KIM DH, 1995, P NATL ACAD SCI USA, V92, P2126, DOI 10.1073/pnas.92.6.2126; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329; Lemaire C, 1998, FEBS LETT, V425, P266, DOI 10.1016/S0014-5793(98)00252-X; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; LI LG, 1995, EXP CELL RES, V217, P460, DOI 10.1006/excr.1995.1110; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; Marsden VS, 2004, J CELL BIOL, V165, P775, DOI 10.1083/jcb.200312030; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; NEVINS JR, 1982, CELL, V29, P913, DOI 10.1016/0092-8674(82)90453-6; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samali A, 2001, CELL STRESS CHAPERON, V6, P49, DOI 10.1379/1466-1268(2001)006<0049:HPMOTC>2.0.CO;2; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Segal MS, 2001, AM J PHYSIOL-CELL PH, V281, pC1196, DOI 10.1152/ajpcell.2001.281.4.C1196; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Tsuchiya D, 2003, J CEREBR BLOOD F MET, V23, P718, DOI 10.1097/01.WCB.0000054756.97390.F7; Volbracht C, 2001, MOL MED, V7, P36, DOI 10.1007/BF03401837; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; WU BJ, 1986, MOL CELL BIOL, V6, P2994, DOI 10.1128/MCB.6.8.2994; Yaglom JA, 2003, J BIOL CHEM, V278, P50483, DOI 10.1074/jbc.M306903200; Zhuang JG, 1998, TOXICOL LETT, V103, P121, DOI 10.1016/S0378-4274(98)00296-3; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	54	107	114	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51490	51499		10.1074/jbc.M401314200	http://dx.doi.org/10.1074/jbc.M401314200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371421	hybrid			2022-12-27	WOS:000225355800102
J	Wang, P; Nie, J; Pei, DQ				Wang, P; Nie, J; Pei, DQ			The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE INHIBITOR; CATALYTIC-DOMAIN; GELATINASE-A; PROGELATINASE; PROTEOLYSIS; BINDING; OLIGOMERIZATION; (TIMP)-2; RECEPTOR; CLEAVAGE	Membrane-type matrix metalloproteinase-1 (MT1-MMP) plays a key role in tumor invasion and metastasis by degrading the extracellular matrix and activating proMMP2. Here we show that the conserved hemopexin domain is required for MT1-MMP-mediated invasion and growth in three-dimensional type I collagen matrix but not proMMP2 activation. Deletion of the hemopexin domains in MT1-, MT2-, MT3-, MT5-, and MT6-MMP does not impair their abilities to activate proMMP2. In fact, hemopexin-less MT5- and MT6-MMP activate proMMP2 better than their wild type counterparts. On the other hand, hemopexin-less MT1-MMP fails to promote cell invasion into type I collagen but retains the capacity to enhance the growth of Madin-Darby canine kidney cells as cysts in three-dimensional collagen matrix. Moreover, the hemopexin domain is also required for MT1-MMP-mediated invasion/scattering of MCF-7 cells in three-dimensional collagen matrix. Because growth and invasion in a three-dimensional model may correlate with tumor invasiveness in vivo, our data suggest that the hemopexin domains of MT-MMPs should be targeted for the development of anti-cancer therapies by employing screening assays developed for three-dimensional models rather than their enzymatic activity toward proMMP2.	Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Pei, DQ (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	peixx003@umn.edu			NCI NIH HHS [CA76308] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA076308, R01CA076308] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Butler GS, 1997, EUR J BIOCHEM, V244, P653, DOI 10.1111/j.1432-1033.1997.t01-1-00653.x; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Deryugina EI, 2002, CANCER RES, V62, P580; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jiang AX, 2003, J BIOL CHEM, V278, P38765, DOI 10.1074/jbc.M306618200; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kang TB, 2000, FASEB J, V14, P2559, DOI 10.1096/fj.00-0269com; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nie J, 2003, CANCER RES, V63, P6758; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Toth M, 2000, J BIOL CHEM, V275, P41415, DOI 10.1074/jbc.M006871200; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Wang X, 1999, FEBS LETT, V462, P261, DOI 10.1016/S0014-5793(99)01534-3; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	45	38	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51148	51155		10.1074/jbc.M409074200	http://dx.doi.org/10.1074/jbc.M409074200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15381707	hybrid			2022-12-27	WOS:000225355800061
J	Al-Rasheed, NM; Chana, RS; Baines, RJ; Willars, GB; Brunskill, NJ				Al-Rasheed, NM; Chana, RS; Baines, RJ; Willars, GB; Brunskill, NJ			Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells - Dependent on phosphatidylinositol 3-kinase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; GENE-EXPRESSION; SIGNALING PATHWAYS; GLUCOSE-TOLERANCE; RESISTANCE; BINDING; CD36; PHOSPHORYLATION; TRANSPORT; PREVENTS	Peroxisome proliferator-activated receptor gamma (PPARgamma) has key roles in the regulation of adipogenesis, inflammation, and lipid and glucose metabolism. C-peptide is believed to be inert and without appreciable biological functions. Recent studies suggest that C-peptide possesses multiple functions. The present study investigated the effects of insulin and C-peptide on PPARgamma transcriptional activity in opossum kidney proximal tubular cells. Both insulin and C-peptide induced a concentration-dependent stimulation of PPARgamma transcriptional activity. Both agents substantially augmented thiazolidinedione-stimulated PPARgamma transcriptional activity. Neither insulin nor C-peptide had any effect on the expression levels of PPARgamma. GW9662, a PPARgamma antagonist, blocked PPARgamma activation by thiazolidinediones but had no effect on either insulin- or C-peptide-stimulated PPARgamma transcriptional activity. Co-transfection of opossum kidney cells with dominant negative mitogen-activated protein kinase kinase significantly depressed basal PPARgamma transcriptional activity but had no effect on that induced by either insulin or C-peptide. Both insulin- and C-peptide-stimulated PPARgamma transcriptional activity were attenuated by wortmannin and by expression of a dominant negative phosphatidylinositol (PI) 3-kinase p85 regulatory subunit. In addition PI 3-kinase-dependent phosphorylation of PPARgamma was observed after stimulation by C-peptide or insulin. C-peptide effects but not insulin on PPARgamma transcriptional activity were abolished by pertussis toxin pretreatment. Finally both C-peptide and insulin positively control the expression of the PPARgamma-regulated CD36 scavenger receptor in human THP-1 monocytes. We concluded that insulin and C-peptide can stimulate PPARgamma activity in a ligand-independent fashion and that this effect is mediated by PI 3-kinase. These results support a new and potentially important physiological role for C-peptide in regulation of PPARgamma-related cell functions.	Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; King Saud Univ, Dept Pharmacol, Riyadh, Saudi Arabia	University of Leicester; University of Leicester; King Saud University	Brunskill, NJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.	njb18@le.ac.uk		Nigel, Brunskill/0000-0002-7109-7108				Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Al-Rasheed NM, 2004, DIABETOLOGIA, V47, P987, DOI 10.1007/s00125-004-1404-9; Arici M, 2003, J AM SOC NEPHROL, V14, P17, DOI 10.1097/01.ASN.0000042167.66685.EA; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; Brunskill NJ, 1998, J CLIN INVEST, V101, P2140, DOI 10.1172/JCI1923; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chana RS, 2004, KIDNEY INT, V65, P2081, DOI 10.1111/j.1523-1755.2004.00624.x; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448; Grunberger G, 2001, DIABETOLOGIA, V44, P1247, DOI 10.1007/s001250100632; Hevener AL, 2001, DIABETES, V50, P2316, DOI 10.2337/diabetes.50.10.2316; Huh HY, 1996, BLOOD, V87, P2020; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Johansson J, 2002, BIOCHEM BIOPH RES CO, V295, P1035, DOI 10.1016/S0006-291X(02)00721-0; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kitamura T, 2003, DIABETOLOGIA, V46, P1698, DOI 10.1007/s00125-003-1232-3; Kitamura T, 2002, BIOCHEM J, V366, P737, DOI 10.1042/BJ20020344; Kliewer SA, 1998, CURR OPIN GENET DEV, V8, P576, DOI 10.1016/S0959-437X(98)80014-2; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; MAX N, 2004, ARTERIOSCLER THROMB, V24, P540; Nicholson AC, 2004, TRENDS CARDIOVAS MED, V14, P8, DOI 10.1016/j.tcm.2003.09.004; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Qi NN, 2002, J BIOL CHEM, V277, P48501, DOI 10.1074/jbc.M206655200; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Rigler R, 1999, P NATL ACAD SCI USA, V96, P13318, DOI 10.1073/pnas.96.23.13318; Seda O, 2003, PHYSIOL GENOMICS, V12, P73, DOI 10.1152/physiolgenomics.00113.2002; Sima AAF, 2001, DIABETOLOGIA, V44, P889, DOI 10.1007/s001250100570; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wahren J, 2004, CLIN PHYSIOL FUNCT I, V24, P180, DOI 10.1111/j.1475-097X.2004.00558.x; Wahren J, 2000, AM J PHYSIOL-ENDOC M, V278, pE759, DOI 10.1152/ajpendo.2000.278.5.E759; Walcher D, 2004, DIABETES, V53, P1664, DOI 10.2337/diabetes.53.7.1664; Werman A, 1997, J BIOL CHEM, V272, P20230, DOI 10.1074/jbc.272.32.20230; Wu W, 1996, ACTA PHYSIOL SCAND, V157, P253, DOI 10.1046/j.1365-201X.1996.489236000.x; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF966, DOI 10.1152/ajprenal.1999.277.6.F966; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771; ZIERATH JR, 1991, DIABETOLOGIA, V34, P899, DOI 10.1007/BF00400197; Zierath JR, 1996, DIABETOLOGIA, V39, P306	43	58	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49747	49754		10.1074/jbc.M408268200	http://dx.doi.org/10.1074/jbc.M408268200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375153	hybrid			2022-12-27	WOS:000225229500026
J	Benzaghou, I; Bougie, I; Bisaillon, M				Benzaghou, I; Bougie, I; Bisaillon, M			Effect of metal ion binding on the structural stability of the hepatitis C virus RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL PROTEIN 5B; DE-NOVO INITIATION; 3'-5' EXONUCLEASE ACTIVITY; VIRAL REPLICATION; CRYSTAL-STRUCTURE; NS5B PROTEIN; MECHANISM; IDENTIFICATION; SITE; REQUIREMENTS	The RNA polymerase activity of the hepatitis C virus, a major human pathogen, has previously been shown to be supported by metal ions. In the present study, we report a systematic analysis of the effect of metal ion binding on the structural stability of the hepatitis C virus RNA polymerase. Chemical and thermal denaturation assays revealed that the stability of the protein is increased significantly in the presence of metal ions. Structural analyses clearly established that metal ion binding increases hydrophobic exposure on the RNA polymerase surface. Furthermore, our denaturation studies, coupled with polymerization assays, demonstrate that the active site region of the polymerase is more sensitive to chemical denaturant than other structural scaffolds. We also report the first detailed study of the thermodynamic parameters involved in the interaction between the hepatitis C virus RNA polymerase and metal ions. Finally, a mutational analysis was also performed to investigate the importance of Asp(220), Asp(318), and Asp(319) for metal ion binding. This mutational study underscores a strict requirement for each of the residues for metal binding, indicating that the active center of the HCV RNA polymerase is intolerant to virtually any perturbations of the metal coordination sphere, thereby highlighting the critical role of the enzyme-bound metal ions. Overall, our results indicate that metal ions play a dual modulatory role in the RNA polymerase reaction by promoting both a favorable geometry of the active site for catalysis and by increasing the structural stability of the enzyme.	Univ Sherbrooke, Fac Med, Dept Biochim, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Bisaillon, M (corresponding author), Univ Sherbrooke, Fac Med, Dept Biochim, 3001 12E Ave, Sherbrooke, PQ J1H 5N4, Canada.	Martin.Bisaillon@USherbrooke.ca						Al RH, 1998, VIRUS RES, V53, P141, DOI 10.1016/S0168-1702(97)00147-0; ALTER HJ, 1995, BLOOD, V85, P1681, DOI 10.1182/blood.V85.7.1681.bloodjournal8571681; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Bougie I, 2003, J BIOL CHEM, V278, P3868, DOI 10.1074/jbc.M209785200; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; CALHOUN DB, 1983, BIOCHEMISTRY-US, V22, P1533, DOI 10.1021/bi00276a003; Carroll SS, 2000, BIOCHEMISTRY-US, V39, P8243, DOI 10.1021/bi991992s; Cheney IW, 2002, VIROLOGY, V297, P298, DOI 10.1006/viro.2002.1461; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DeFrancesco R, 1996, METHOD ENZYMOL, V275, P58; Dimitrova M, 2003, J VIROL, V77, P5401, DOI 10.1128/JVI.77.9.5401-5414.2003; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; HOUGHTON M, 1996, VIROLOGY, P1035; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Hung HC, 2001, PROTEIN SCI, V10, P34, DOI 10.1110/ps.35201; JANEWAY CML, 1993, BIOCHEMISTRY-US, V32, P1601, DOI 10.1021/bi00057a026; Johnson RB, 2000, ARCH BIOCHEM BIOPHYS, V377, P129, DOI 10.1006/abbi.2000.1749; Kao CC, 2000, J VIROL, V74, P11121, DOI 10.1128/JVI.74.23.11121-11128.2000; LABOWICZ JR, 1999, PRINCIPLES FLUORESCE, P237; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lohmann V, 2000, J VIRAL HEPATITIS, V7, P167; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; Oh JW, 2000, J BIOL CHEM, V275, P17710, DOI 10.1074/jbc.M908781199; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sarbah SA, 2000, J CLIN GASTROENTEROL, V30, P125, DOI 10.1097/00004836-200003000-00005; Scolnick LR, 1997, BIOCHEMISTRY-US, V36, P10558, DOI 10.1021/bi970800v; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Sun XL, 2000, BIOCHEM BIOPH RES CO, V268, P798, DOI 10.1006/bbrc.2000.2120; Tomei L, 2000, J GEN VIROL, V81, P759, DOI 10.1099/0022-1317-81-3-759; Uchiyama Y, 2002, HEPATOL RES, V23, P90, DOI 10.1016/S1386-6346(01)00167-X; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yuan ZH, 1997, BIOCHEM BIOPH RES CO, V232, P231, DOI 10.1006/bbrc.1997.6249; Zhong WD, 2000, J VIROL, V74, P2017, DOI 10.1128/JVI.74.4.2017-2022.2000; Zhong WD, 2000, J VIROL, V74, P9134, DOI 10.1128/JVI.74.19.9134-9143.2000	49	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49755	49761		10.1074/jbc.M409657200	http://dx.doi.org/10.1074/jbc.M409657200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375162	hybrid			2022-12-27	WOS:000225229500027
J	Lookene, A; Zhang, LY; Hultin, M; Olivecrona, G				Lookene, A; Zhang, LY; Hultin, M; Olivecrona, G			Rapid subunit exchange in dimeric lipoprotein lipase and properties of the inactive monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; MISSENSE MUTATIONS; MOLECULAR-WEIGHT; HEPARIN-BINDING; GENE; IDENTIFICATION; CONSEQUENCES; METABOLISM; PARAMETERS; PROTEINS	Lipoprotein lipase (LPL), a key enzyme in the metabolism of triglyceride-rich plasma lipoproteins, is a homodimer. Dissociation to monomers leads to loss of activity. Evidence that LPL dimers rapidly exchange subunits was demonstrated by fluorescence resonance energy transfer between lipase subunits labeled with Oregon Green and tetrametylrhodamine, respectively, and also by formation of heterodimers composed of radiolabeled and biotinylated lipase subunits captured on streptavidine-agarose. Compartmental modeling of the inactivation kinetics confirmed that rapid subunit exchange must occur. Studies of activity loss indicated the existence of a monomer that can form catalytically active dimers, but this intermediate state has not been possible to isolate and remains hypothetical. Differences in solution properties and conformation between the stable but catalytically inactive monomeric form of LPL and the active dimers were studied by static light scattering, intrinsic fluorescence, and probing with 4,4'-dianilino- 1,1'-binaphtyl-5,5'-disulfonic acid and acrylamide. The catalytically inactive monomer appeared to have a more flexible and exposed structure than the dimers and to be more prone to aggregation. By limited proteolysis the conformational changes accompanying dissociation of the dimers to inactive monomers were localized mainly to the central part of the subunit, probably corresponding to the region for subunit interaction.	Umea Univ, Dept Med Biosci Physiol Chem, SE-90187 Umea, Sweden; Tallinn Univ Technol, Dept Gen Technol, EE-12618 Tallinn, Estonia; Umea Univ, Dept Surg & Perioperat Sci, SE-90185 Umea, Sweden	Umea University; Tallinn University of Technology; Umea University	Olivecrona, G (corresponding author), Umea Univ, Dept Med Biosci Physiol Chem, Bldg 6M,3rd Fl, SE-90187 Umea, Sweden.	Gunilla.Olivecrona@medbio.umu.se	Hultin, Magnus/A-1321-2010	Hultin, Magnus/0000-0003-2935-7161				BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; BENGTSSONOLIVECRONA G, 1986, EUR J BIOCHEM, V161, P281, DOI 10.1111/j.1432-1033.1986.tb10444.x; Bergo M, 2002, J BIOL CHEM, V277, P11927, DOI 10.1074/jbc.M200325200; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; EGELRUD T, 1972, J BIOL CHEM, V247, P6212; Hanyu O, 2004, ATHEROSCLEROSIS, V174, P385, DOI 10.1016/j.atherosclerosis.2004.01.034; HATA A, 1992, J BIOL CHEM, V267, P20132; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; IVERIUS PH, 1976, J BIOL CHEM, V251, P7791; Keiper T, 2001, J LIPID RES, V42, P1180; KRAPP A, 1995, J LIPID RES, V36, P2362; LOOKENE A, 1993, EUR J BIOCHEM, V213, P185, DOI 10.1111/j.1432-1033.1993.tb17747.x; Lookene A, 2003, J BIOL CHEM, V278, P37183, DOI 10.1074/jbc.M303894200; Lookene A, 1997, BIOCHEMISTRY-US, V36, P5267, DOI 10.1021/bi962699k; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; Lutz EP, 2004, J BIOL CHEM, V279, P238, DOI 10.1074/jbc.M310559200; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; NYKJAER A, 1993, J BIOL CHEM, V268, P15048; Olivecrona G, 1997, METHOD ENZYMOL, V286, P102; OLIVECRONA G, 1995, ATHEROSCLEROSIS, V10, P250; OLIVECRONA T, 1982, EUR J BIOCHEM, V124, P629, DOI 10.1111/j.1432-1033.1982.tb06640.x; Olivecrona T., 1984, P205; OSBORNE JC, 1985, BIOCHEMISTRY-US, V24, P5606, DOI 10.1021/bi00341a048; Pentikainen MO, 2000, J BIOL CHEM, V275, P5694, DOI 10.1074/jbc.275.8.5694; Peterson J, 2002, J LIPID RES, V43, P398; PETERSON J, 1992, J LIPID RES, V33, P1165; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Santamarina-Fojo Silvia, 1994, Current Opinion in Lipidology, V5, P117; Stein Y, 2003, ATHEROSCLEROSIS, V170, P1, DOI 10.1016/S0021-9150(03)00014-5; TORNVALL P, 1995, ARTERIOSCL THROM VAS, V15, P1086, DOI 10.1161/01.ATV.15.8.1086; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; VILELLA E, 1993, J LIPID RES, V34, P1555; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Wu GS, 2003, J BIOL CHEM, V278, P11925, DOI 10.1074/jbc.M212736200; Zhang LY, 2003, J BIOL CHEM, V278, P29344, DOI 10.1074/jbc.M300455200; [No title captured]	39	47	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49964	49972		10.1074/jbc.M407419200	http://dx.doi.org/10.1074/jbc.M407419200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15385564	hybrid			2022-12-27	WOS:000225229500052
J	Chou, CL; Christensen, BM; Frische, S; Vorum, H; Desai, RA; Hoffert, JD; de Lanerolle, P; Nielsen, S; Knepper, MA				Chou, CL; Christensen, BM; Frische, S; Vorum, H; Desai, RA; Hoffert, JD; de Lanerolle, P; Nielsen, S; Knepper, MA			Non-muscle myosin II and myosin light chain kinase are downstream targets for vasopressin signaling in the renal collecting duct	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-DERIVED VESICLES; BLADDER GRANULAR-CELL; TOAD URINARY-BLADDER; RAT-KIDNEY; F-ACTIN; WATER PERMEABILITY; EPITHELIAL-CELLS; AQUAPORIN-2 TRAFFICKING; ORGANELLE TRANSPORT; INTRACELLULAR CA2+	We have previously demonstrated that vasopressin increases the water permeability of the inner medullary collecting duct (IMCD) by inducing trafficking of aquaporin-2 to the apical plasma membrane and that this response is dependent on intracellular calcium mobilization and calmodulin activation. Here, we address the hypothesis that this water permeability response is mediated in part through activation of the calcium/calmodulin-dependent myosin light chain kinase (MLCK) and regulation of non-muscle myosin II. Immunoblotting and immunocytochemistry demonstrated the presence of MLCK, the myosin regulatory light chain (MLC), and the IIA and IIB isoforms of the non-muscle myosin heavy chain in rat IMCD cells. Two-dimensional electrophoresis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry identified two isoforms of MLC, both of which also exist in phosphorylated and non-phosphorylated forms. P-32 incubation of the inner medulla followed by autoradiography of two-dimensional gels demonstrated increased P-32 labeling of both isoforms in response to the V-2 receptor agonist [deamino-Cys(1), D-Arg(8)] vasopressin (DDAVP). Time course studies of MLC phosphorylation in IMCD suspensions ( using immunoblotting with anti-phospho-MLC antibodies) showed that the increase in phosphorylation could be detected as early as 30 s after exposure to vasopressin. The MLCK inhibitor ML-7 blocked the DDAVP-induced MLC phosphorylation and substantially reduced [Arg(8)] vasopressin (AVP)stimulated water permeability. AVP-induced MLC phosphorylation was associated with a rearrangement of actin filaments ( Alexa Fluor 568-phalloidin) in primary cultures of IMCD cells. These results demonstrate that MLC phosphorylation by MLCK represents a downstream effect of AVP-activated calcium/calmodulin signaling in IMCD cells and point to a role for non-muscle myosin II in regulation of water permeability by vasopressin.	NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bethesda, MD 20892 USA; Univ Aarhus, Inst Anat, Water & Salt Res Ctr, DK-8000 Aarhus, Denmark; Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Aarhus University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Knepper, MA (corresponding author), NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bldg 10,Rm 6N260,10 Ctr Dr,MSC-1603, Bethesda, MD 20892 USA.	knep@helix.nih.gov	Frische, Sebastian/B-2332-2009; Knepper, Mark/AAF-8412-2020	Frische, Sebastian/0000-0002-0270-3602; Christensen, Birgitte Monster/0000-0002-6140-4629; Desai, Ravi/0000-0002-4217-3351	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001285] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HL999999, Z01 HL001285-21] Funding Source: Medline; NHLBI NIH HHS [Z01-HL-02182-KE] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALZAHID G, 1977, J MEMBRANE BIOL, V31, P103, DOI 10.1007/BF01869401; Ashby MC, 2002, PHYSIOL REV, V82, P701, DOI 10.1152/physrev.00006.2002; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BURG M, 1966, AM J PHYSIOL, V210, P1293, DOI 10.1152/ajplegacy.1966.210.6.1293; Cai S, 1998, AM J PHYSIOL-CELL PH, V275, pC1349, DOI 10.1152/ajpcell.1998.275.5.C1349; Chabardes D, 1996, J BIOL CHEM, V271, P19264, DOI 10.1074/jbc.271.32.19264; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Chen Y, 2003, J BIOL CHEM, V278, P46094, DOI 10.1074/jbc.M305311200; Chou CL, 1998, AM J PHYSIOL-RENAL, V274, pF564, DOI 10.1152/ajprenal.1998.274.3.F564; Chou CL, 2000, J BIOL CHEM, V275, P36839, DOI 10.1074/jbc.M005552200; Christensen BM, 2003, AM J PHYSIOL-RENAL, V284, pF701, DOI 10.1152/ajprenal.00234.2002; DELANEROLLE P, 1981, P NATL ACAD SCI-BIOL, V78, P4738; DePina AS, 1999, MICROSC RES TECHNIQ, V47, P93, DOI 10.1002/(SICI)1097-0029(19991015)47:2<93::AID-JEMT2>3.0.CO;2-P; DING G, 1991, AM J PHYSIOL, V260, pC9, DOI 10.1152/ajpcell.1991.260.1.C9; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V270, pF623, DOI 10.1152/ajprenal.1996.270.4.F623; FATH KR, 1993, J CELL BIOL, V120, P117, DOI 10.1083/jcb.120.1.117; FRANKI N, 1992, AM J PHYSIOL, V263, pC995, DOI 10.1152/ajpcell.1992.263.5.C995; GANOTE CE, 1968, J CELL BIOL, V36, P355, DOI 10.1083/jcb.36.2.355; GAO Y, 1992, AM J PHYSIOL, V263, pC908, DOI 10.1152/ajpcell.1992.263.4.C908; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; GRANTHAM JJ, 1969, J CELL BIOL, V41, P562, DOI 10.1083/jcb.41.2.562; Gustafson CE, 2000, AM J PHYSIOL-RENAL, V278, pF317, DOI 10.1152/ajprenal.2000.278.2.F317; Hecht G, 1996, AM J PHYSIOL-CELL PH, V271, pC1678, DOI 10.1152/ajpcell.1996.271.5.C1678; HOLMGREN K, 1992, AM J PHYSIOL, V262, pC672, DOI 10.1152/ajpcell.1992.262.3.C672; Ikonen E, 1997, J CELL SCI, V110, P2155; Jeon US, 2003, NEPHRON EXP NEPHROL, V93, pE36, DOI 10.1159/000066651; KACHADORIAN WA, 1979, AM J PHYSIOL, V236, pF14, DOI 10.1152/ajprenal.1979.236.1.F14; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; LEVINE SD, 1981, J CLIN INVEST, V67, P662, DOI 10.1172/JCI110081; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Lueck A, 1998, J CELL SCI, V111, P3633; MAEDA Y, 1993, AM J PHYSIOL, V265, pF15, DOI 10.1152/ajprenal.1993.265.1.F15; Marples D, 1998, AM J PHYSIOL-RENAL, V274, pF384, DOI 10.1152/ajprenal.1998.274.2.F384; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Martin K, 2003, PROTEOMICS, V3, P1244, DOI 10.1002/pmic.200300445; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; MILLERHANCE WC, 1988, J BIOL CHEM, V263, P13979; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Musch A, 1997, J CELL BIOL, V138, P291, DOI 10.1083/jcb.138.2.291; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Nelson WJ, 2001, TRENDS CELL BIOL, V11, P483, DOI 10.1016/S0962-8924(01)02145-6; NIELSEN S, 1993, AM J PHYSIOL, V265, pF225, DOI 10.1152/ajprenal.1993.265.2.F225; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rogers SL, 1998, CURR BIOL, V8, P161, DOI 10.1016/S0960-9822(98)70063-6; SABOLIC I, 1995, J MEMBRANE BIOL, V143, P165, DOI 10.1007/BF00233445; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SIMON H, 1993, AM J PHYSIOL, V265, pC757, DOI 10.1152/ajpcell.1993.265.3.C757; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; STAR RA, 1988, J CLIN INVEST, V81, P1879, DOI 10.1172/JCI113534; Tamma G, 2003, J CELL SCI, V116, P1519, DOI 10.1242/jcs.00355; Tamma G, 2001, AM J PHYSIOL-RENAL, V281, pF1092, DOI 10.1152/ajprenal.0091.2001; TAYLOR A, 1973, SCIENCE, V181, P347, DOI 10.1126/science.181.4097.347; WADE JB, 1988, AM J PHYSIOL, V255, pC526, DOI 10.1152/ajpcell.1988.255.4.C526; WALL SM, 1992, AM J PHYSIOL, V262, pF989, DOI 10.1152/ajprenal.1992.262.6.F989; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606	65	86	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49026	49035		10.1074/jbc.M408565200	http://dx.doi.org/10.1074/jbc.M408565200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347643	hybrid			2022-12-27	WOS:000225098100066
J	Gambarotta, G; Garzotto, D; Destro, E; Mautino, B; Giampietro, C; Cutrupi, S; Dati, C; Cattaneo, E; Fasolo, A; Perroteau, I				Gambarotta, G; Garzotto, D; Destro, E; Mautino, B; Giampietro, C; Cutrupi, S; Dati, C; Cattaneo, E; Fasolo, A; Perroteau, I			ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1 beta 1-induced migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; NEUREGULIN RECEPTOR ERBB4; ACTIVATED PROTEIN-KINASE; MOUSE OLFACTORY-BULB; RAT PC12 CELLS; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; ADULT-RAT; TYROSINE KINASE; GAMMA-SECRETASE	Activation of the receptor tyrosine kinase ErbB4 leads to various cellular responses such as proliferation, survival, differentiation, and chemotaxis. Two pairs of naturally occurring ErbB4 isoforms differing in their juxtamembrane (JMa/JMb) and C termini (cyt1/cyt2) have been described. To examine the role of ErbB4 in neuron migration, we cloned and stably transfected each of the four ErbB4 isoforms in ST14A cells (a neural progenitor cell line derived from the striatum of embryonic day 14 rats) endogenously expressing the other members of the ErbB family: ErbB1, ErbB2, and ErbB3. Using immunoprecipitation assays, we showed that the neuregulin-1beta1 (NRG1beta1) stimulus induced ErbB4 tyrosine phosphorylation and phosphatidylinositol 3-kinase (PI3K) recruitment and activation (as demonstrated by Akt phosphorylation) either directly (ErbB4 cyt1 isoform) or indirectly (ErbB4 cyt2 isoform). We examined the ability of the four ErbB4 isoforms to induce chemotaxis and cell proliferation in response to NRG1beta1 stimulation. Using migration assays, we observed that only ErbB4-expressing cells stimulated with NRG1beta1 showed a significant increase in migration, whereas the growth rate remained unchanged. Additional assays showed that inhibition of PI3K (but not of phospholipase Cgamma) dramatically reduced migratory activity. Our data show that ErbB4 signaling via PI3K activation plays a fundamental role in controlling NRG1beta1-induced migration.	Univ Turin, Dept Human & Anim Biol, I-10123 Turin, Italy; Univ Piemonto Orientale, Dept Med Sci, I-28100 Novara, Italy; Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy	University of Turin; University of Eastern Piedmont Amedeo Avogadro; University of Milan	Gambarotta, G (corresponding author), Univ Turin, Dept Human & Anim Biol, Via Accademia Albertina 13, I-10123 Turin, Italy.	giovanna.gambarotta@unito.it	Gambarotta, Giovanna/I-8473-2012; cutrupi, santina/AAC-4479-2022; Giampietro, Costanza/D-4643-2016	Gambarotta, Giovanna/0000-0002-8380-5925; Giampietro, Costanza/0000-0001-5229-3835; Perroteau, Isabelle/0000-0001-9797-2276; CATTANEO, ELENA/0000-0002-0755-4917; CUTRUPI, SANTINA/0000-0002-2358-5852				Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; Bonfanti L, 1997, NEUROSCIENCE, V81, P489, DOI 10.1016/S0306-4522(97)00090-0; Carpenter CL, 1997, ADV ENZYME REGUL, V37, P377, DOI 10.1016/S0065-2571(96)00005-2; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chausovsky A, 1998, MOL BIOL CELL, V9, P3195, DOI 10.1091/mbc.9.11.3195; Chausovsky A, 2000, ONCOGENE, V19, P878, DOI 10.1038/sj.onc.1203410; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; Cohen BM, 1996, J BIOL CHEM, V271, P4813; Coskun V, 2002, J NEUROSCI RES, V69, P795, DOI 10.1002/jnr.10336; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fasolo A, 2002, CHEM SENSES, V27, P581, DOI 10.1093/chemse/27.6.581; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; HELLYER NJ, 1995, GENE, V165, P279, DOI 10.1016/0378-1119(95)00436-A; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Juang SH, 1996, ONCOGENE, V12, P1033; Junttila TT, 2000, TRENDS CARDIOVAS MED, V10, P304, DOI 10.1016/S1050-1738(01)00065-2; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; KAPELLER R, 1995, J BIOL CHEM, V270, P25985, DOI 10.1074/jbc.270.43.25985; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KIM HH, 1994, J BIOL CHEM, V269, P24747; Kita Y, 1998, J CELL SCI, V111, P907; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lai C, 2004, BIOCHEM BIOPH RES CO, V319, P603, DOI 10.1016/j.bbrc.2004.05.027; Lai C, 2004, BIOCHEM BIOPH RES CO, V314, P535, DOI 10.1016/j.bbrc.2003.12.131; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lindholm T, 2002, EXP BRAIN RES, V142, P81, DOI 10.1007/s0021-001-0922-7; Lundberg C, 1997, EXP NEUROL, V145, P342, DOI 10.1006/exnr.1997.6503; Mautino B, 2004, PROTEIN EXPRES PURIF, V35, P25, DOI 10.1016/j.pep.2003.12.012; Meyer D, 1997, DEVELOPMENT, V124, P3575; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Oberto M, 2001, EUR J NEUROSCI, V14, P513, DOI 10.1046/j.0953-816x.2001.01667.x; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Omerovic J, 2004, EXP CELL RES, V294, P469, DOI 10.1016/j.yexcr.2003.12.002; Perroteau I, 1998, ANN NY ACAD SCI, V855, P255, DOI 10.1111/j.1749-6632.1998.tb10578.x; Perroteau I, 1999, CELL MOL BIOL, V45, P293; PINKASKRAMARSKI R, 1994, P NATL ACAD SCI USA, V91, P9387, DOI 10.1073/pnas.91.20.9387; PinkasKramarski R, 1997, ONCOGENE, V15, P2803, DOI 10.1038/sj.onc.1201466; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Pollock GS, 1999, EUR J NEUROSCI, V11, P769, DOI 10.1046/j.1460-9568.1999.00484.x; Raabe TD, 1997, J NEUROCHEM, V69, P1859; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Vecchi M, 1996, J BIOL CHEM, V271, P18989, DOI 10.1074/jbc.271.31.18989; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Vijapurkar U, 2003, EXP CELL RES, V284, P291, DOI 10.1016/S0014-4827(02)00040-X; WAINWRIGHT MS, 1995, J NEUROSCI, V15, P676; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	77	59	61	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48808	48816		10.1074/jbc.M408374200	http://dx.doi.org/10.1074/jbc.M408374200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355992	Green Published, hybrid			2022-12-27	WOS:000225098100041
J	Smyth, LM; Bobalova, J; Mendoza, MG; Lew, C; Mutafova-Yambolieva, VN				Smyth, LM; Bobalova, J; Mendoza, MG; Lew, C; Mutafova-Yambolieva, VN			Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; CANINE MESENTERIC-ARTERY; PIG VAS-DEFERENS; PRESYNAPTIC RECEPTORS; FLUORESCENT ANALOG; SYMPATHETIC-NERVES; ADENOSINE; NORADRENALINE; COTRANSMISSION; NAADP	Chemical signaling in autonomic neuromuscular transmission involves agents that function as neurotransmitters and/or neuromodulators. Using high performance liquid chromatography techniques with fluorescence and electrochemical detection we observed that, in addition to ATP and norepinephrine (NE), electrical field stimulation (EFS, 4-16 Hz, 0.1-0.3 ms, 15 V, 60-120 s) of isolated vascular and non-vascular preparations co-releases a previously unidentified compound with apparent nucleotide or nucleoside structure. Extensive screening of more than 25 nucleotides and nucleosides followed by detailed peak identification revealed that beta-nicotinamide adenine dinucleotide (beta-NAD) is released in tissue superfusates upon EFS of canine mesenteric artery (CMA), canine urinary bladder, and murine urinary bladder in the amounts of 7.1+/-0.7, 26.5+/-4.5, and 15.1+/-3.2 fmol/mg of tissue, respectively. Smaller amounts of the beta-NAD metabolites cyclic adenosine 5'-diphosphoribose (cADPR) and ADPR were also present in the superfusates collected during EFS of CMA (2.5+/-0.9 and 5.8+/-0.8 fmol/mg of tissue, respectively), canine urinary bladder (1.8+/-0.5 and 9.0+/-6.0 fmol/mg of tissue, respectively), and murine urinary bladder (1.4+/-0.1 and 6.2+/-2.4 fmol/mg of tissue, respectively). The three nucleotides were also detected in the samples collected before EFS (0.2-1.6 fmol/mg of tissue). Exogenous beta-NAD, cADPR, and ADPR (all 100 nM) reduced the release of NE in CMA at 16 Hz from 27.8+/-6.0 fmol/mg of tissue to 15.5+/-5.0, 12+/-3.0, and 10.0+/-4.0 fmol/mg of tissue, respectively. In conclusion, we detected constitutive and nerve-evoked overflow of beta-NAD, cADPR, and ADPR in vascular and non-vascular smooth muscles, beta-NAD being the prevailing compound. These substances modulate the release of NE, implicating novel nucleotide mechanisms of autonomic nervous system control of smooth muscle.	Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Mutafova-Yambolieva, VN (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Anderson Me Bldg,MS 352, Reno, NV 89557 USA.	vnm@med.unr.edu	Bobalova, Janette/H-6244-2014	Bobalova, Janette/0000-0003-2395-0845	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060031] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL060031, HL-60031] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		APRIGLIANO O, 1976, J PHARMACOL EXP THER, V198, P568; BARRIO JR, 1972, P NATL ACAD SCI USA, V69, P2039, DOI 10.1073/pnas.69.8.2039; Bobalova J, 2003, CLIN EXP PHARMACOL P, V30, P194, DOI 10.1046/j.1440-1681.2003.03808.x; Bobalova J, 2002, ANAL BIOCHEM, V305, P269, DOI 10.1006/abio.2002.5667; Bobalova J, 2001, J AUTON PHARMACOL, V21, P47, DOI 10.1046/j.1365-2680.2001.00207.x; Bobalova J, 2001, CLIN EXP PHARMACOL P, V28, P397; Boehm S, 2002, PHARMACOL REV, V54, P43, DOI 10.1124/pr.54.1.43; Burnstock G, 1999, BRAIN RES BULL, V50, P355, DOI 10.1016/S0361-9230(99)00103-3; BURNSTOCK G, 1990, ARCH INT PHARMACOD T, V304, P7; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; da Silva CP, 1998, J CHROMATOGR B, V707, P43, DOI 10.1016/S0378-4347(97)00622-1; Duarte-Araujo M, 2004, BRIT J PHARMACOL, V141, P925, DOI 10.1038/sj.bjp.0705697; Ernsberger U, 2001, AUTON NEUROSCI-BASIC, V94, P1, DOI 10.1016/S1566-0702(01)00336-8; FURNESS JB, 1989, ANNU REV PHARMACOL, V29, P289, DOI 10.1146/annurev.pa.29.040189.001445; GORDON EL, 1986, J BIOL CHEM, V261, P5496; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; Leckie C, 2003, J BIOL CHEM, V278, P12247, DOI 10.1074/jbc.M210770200; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEVITT B, 1984, ANAL BIOCHEM, V137, P93, DOI 10.1016/0003-2697(84)90352-X; Lundberg JM, 1996, PHARMACOL REV, V48, P113; Mutafova-Yambolieva VN, 2000, GEN PHARMACOL-VASC S, V34, P127, DOI 10.1016/S0306-3623(00)00054-9; Mutafova-Yambolieva VN, 2003, CARDIOVASC RES, V57, P217, DOI 10.1016/S0008-6363(02)00648-X; Mutafova-Yambolieva VN, 1998, BRIT J PHARMACOL, V123, P136, DOI 10.1038/sj.bjp.0701579; PLESNER L, 1995, INT REV CYTOL, V158, P141; Queiroz G, 2003, J NEUROCHEM, V85, P740, DOI 10.1046/j.1471-4159.2003.01715.x; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; Sher E, 1998, J BIOENERG BIOMEMBR, V30, P399, DOI 10.1023/A:1021945907635; STJARNE L, 1994, ADV SEC MESS PHOSPH, V29, P461; TAKAHASHI K, 1995, FEBS LETT, V371, P204, DOI 10.1016/0014-5793(95)00914-U; Todorov LD, 1996, J PHYSIOL-LONDON, V496, P731, DOI 10.1113/jphysiol.1996.sp021723; Todorov LD, 1997, NATURE, V387, P76, DOI 10.1038/387076a0; WESTFALL DP, 1990, ANN NY ACAD SCI, V603, P300; Zhang FJ, 1999, BIOORGAN MED CHEM, V7, P653, DOI 10.1016/S0968-0896(98)00256-9; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3	37	65	68	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48893	48903		10.1074/jbc.M407266200	http://dx.doi.org/10.1074/jbc.M407266200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364945	hybrid			2022-12-27	WOS:000225098100051
J	Kawakami, Y; Nishimoto, H; Kitaura, J; Maeda-Yamamoto, M; Kato, RM; Littman, DR; Rawlings, DJ; Kawakami, T				Kawakami, Y; Nishimoto, H; Kitaura, J; Maeda-Yamamoto, M; Kato, RM; Littman, DR; Rawlings, DJ; Kawakami, T			Protein kinase C beta II regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INTEGRIN-LINKED KINASE; SER473 KINASE; PDK2 ACTIVITY; MAST-CELLS; ACTIVATION; INSULIN; MICE; INHIBITION; DEFICIENT	Akt (= protein kinase B), a subfamily of the AGC serine/threonine kinases, plays critical roles in survival, proliferation, glucose metabolism, and other cellular functions. Akt activation requires the recruitment of the enzyme to the plasma membrane by interacting with membrane-bound lipid products of phosphatidylinositol 3-kinase. Membrane-bound Akt is then phosphorylated at two sites for its full activation; Thr-308 in the activation loop of the kinase domain is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1) and Ser-473 in the C-terminal hydrophobic motif by a putative kinase PDK2. The identity of PDK2 has been elusive. Here we present evidence that conventional isoforms of protein kinase C (PKC), particularly PKCbetaII, can regulate Akt activity by directly phosphorylating Ser-473 in vitro and in IgE/antigen-stimulated mast cells. By contrast, PKCbeta is not required for Ser-473 phosphorylation in mast cells stimulated with stem cell factor or interleukin-3, in serum-stimulated fibroblasts, or in antigen receptor-stimulated T or B lymphocytes. Therefore, PKCbetaII appears to work as a cell type- and stimulus-specific PDK2.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; NARO, Natl Inst Vegetables & Tea Sci, Shizuoka 4288501, Japan; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; NYU, Sch Med, Howard Hughes Med Inst, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, Dept Microbiol, New York, NY 10016 USA	La Jolla Institute for Immunology; National Agriculture & Food Research Organization - Japan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; New York University; Howard Hughes Medical Institute; New York University	Kawakami, T (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	toshi@liai.org	Kawakami, Toshiaki/O-1616-2015	Maeda-Yamamoto, Mari/0000-0002-4494-7509	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033617, R01AI038348] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38348, AI33617] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1999, MOL CELL BIOL, V19, P5061; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; CHAN TO, 2001, SCI STKE; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Hill MM, 2002, CURR BIOL, V12, P1251, DOI 10.1016/S0960-9822(02)00973-9; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Hodgkinson CP, 2002, BIOCHEMISTRY-US, V41, P10351, DOI 10.1021/bi026065r; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Kawakami Y, 2000, P NATL ACAD SCI USA, V97, P7423, DOI 10.1073/pnas.120175097; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; ONO Y, 1987, SCIENCE, V236, P1116, DOI 10.1126/science.3576226; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3	34	148	154	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47720	47725		10.1074/jbc.M408797200	http://dx.doi.org/10.1074/jbc.M408797200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15364915	hybrid			2022-12-27	WOS:000224957000038
J	Scott, C; Higgins, ME; Davies, JP; Ioannou, YA				Scott, C; Higgins, ME; Davies, JP; Ioannou, YA			Targeting of NPC1 to late endosomes involves multiple signals, including one residing within the putative sterol-sensing domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK C1; MANNOSE 6-PHOSPHATE RECEPTOR; TRANS-GOLGI NETWORK; CYTOPLASMIC TAIL; MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; SORTING MOTIF; STRUCTURAL REQUIREMENTS; TRANSMEMBRANE DOMAINS; RETRIEVAL RECEPTOR	The NPC1 protein is a multipass transmembrane protein whose deficiency causes the autosomal recessive lipid storage disorder Niemann-Pick type C1. NPC1 localizes predominantly to late endosomes and has a dileucine motif located within a small cytoplasmic tail thought to target the protein to this location. Our data have suggested previously that the protein can reach its correct location in the absence of its cytoplasmic tail, suggesting that other signals contribute to NPC1 targeting. By using various FLAG-tagged and CD32-NPC1 chimeric fusion constructs, we show that multiple signals are responsible for the trafficking of NPC1 to the endosomal compartment, including the dileucine motif and a previously unidentified signal residing within the putative sterol-sensing domain transmembrane domain 3. Neither region alone was capable of directing heterologous CD32 fusions to late endosomes exclusively via the trans-Golgi network to the late endosome route taken by wild-type NPC1; transmembrane domain 3 was unable to maintain CD32 in late endosomes, indicating that two or more signals work in concert to target and retain NPC1 in this compartment. In addition we confirm that the tail dileucine motif is not essential for NPC1 targeting to late endosomes, and we discuss the implications of this finding along with the previously unappreciated role for transmembrane domain 3 in NPC1 localization and function.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ioannou, YA (corresponding author), Mt Sinai Sch Med, Dept Human Genet, Box 1498,5th Ave & 100th St, New York, NY 10029 USA.	yiannis.ioannou@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054736] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK54736, R01 DK065792] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P2729, DOI 10.1074/jbc.273.5.2729; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BREMNES B, 1994, J CELL SCI, V107, P2021; BROOKS DG, 1989, J EXP MED, V170, P1369, DOI 10.1084/jem.170.4.1369; Cherqui S, 2001, J BIOL CHEM, V276, P13314, DOI 10.1074/jbc.M010562200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Denzer K, 1997, BIOCHEM J, V326, P497, DOI 10.1042/bj3260497; Dietrich J, 1996, J BIOL CHEM, V271, P11441, DOI 10.1074/jbc.271.19.11441; Epping EA, 2002, J BIOL CHEM, V277, P34860, DOI 10.1074/jbc.M202987200; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; HARTER C, 1992, J CELL BIOL, V117, P311, DOI 10.1083/jcb.117.2.311; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Higgins ME, 2001, J LIPID RES, V42, P1939; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; John BJ, 2003, J IMMUNOL, V170, P3534, DOI 10.4049/jimmunol.170.7.3534; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; Kang S, 1998, J BIOL CHEM, V273, P20644, DOI 10.1074/jbc.273.32.20644; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Obermuller S, 2002, J CELL SCI, V115, P185; OGATA S, 1994, J BIOL CHEM, V269, P5210; PENTCHEV PG, 1994, BBA-MOL BASIS DIS, V1225, P235, DOI 10.1016/0925-4439(94)90001-9; Potter PK, 1999, EUR J IMMUNOL, V29, P3936, DOI 10.1002/(SICI)1521-4141(199912)29:12<3936::AID-IMMU3936>3.3.CO;2-B; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schweizer A, 1996, J CELL BIOL, V132, P577, DOI 10.1083/jcb.132.4.577; Setaluri V, 2000, PIGM CELL RES, V13, P128, DOI 10.1034/j.1600-0749.2000.130302.x; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Stephens DJ, 1998, BIOCHEM J, V335, P567, DOI 10.1042/bj3350567; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Teuchert M, 1999, J BIOL CHEM, V274, P36781, DOI 10.1074/jbc.274.51.36781; Tikkanen R, 2000, TRAFFIC, V1, P631, DOI 10.1034/j.1600-0854.2000.010807.x; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Watari H, 1999, P NATL ACAD SCI USA, V96, P805, DOI 10.1073/pnas.96.3.805; White S, 1998, J BIOL CHEM, V273, P14355, DOI 10.1074/jbc.273.23.14355; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	55	29	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					48214	48223		10.1074/jbc.M406090200	http://dx.doi.org/10.1074/jbc.M406090200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15347664	hybrid			2022-12-27	WOS:000224957000096
J	Li, Y; Soos, TJ; Li, XH; Wu, J; DeGennaro, M; Sun, XJ; Littman, DR; Birnbaum, MJ; Polakiewicz, RD				Li, Y; Soos, TJ; Li, XH; Wu, J; DeGennaro, M; Sun, XJ; Littman, DR; Birnbaum, MJ; Polakiewicz, RD			Protein kinase C theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; SUBSTRATE-1 TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; SKELETAL-MUSCLE; PKC-THETA; T-LYMPHOCYTES; FATTY-ACIDS; RESISTANCE; ACTIVATION; OBESITY	Obesity and stress inhibit insulin action by activating protein kinases that enhance serine phosphorylation of IRS1 and have been thus associated to insulin resistance and the development of type II diabetes. The protein kinase C theta(PKCtheta) is activated by free-fatty acids, and its activity is higher in muscle from obese diabetic patients. However, a molecular link between PKCtheta and insulin resistance has not been defined yet. Here we show that PKCtheta phosphorylates IRS1 at serine 1101 blocking IRS1 tyrosine phosphorylation and downstream activation of the Akt pathway. Mutation of Ser(1101) to alanine makes IRS1 insensitive to the effect of PKCtheta and restores insulin signaling in culture cells. These results provide a novel mechanism linking the activation of PKCtheta to the inhibition of insulin signaling.	Cell Signaling Technol Inc, Beverly, MA 01915 USA; NYU, Sch Med, Howard Hughes Med Inst, Skirball Inst Biomol Med,Mol Pathogenesis Program, New York, NY 10016 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Chicago, Endocrinol Sect, Chicago, IL 60637 USA	Howard Hughes Medical Institute; New York University; Howard Hughes Medical Institute; University of Pennsylvania; University of Chicago	Polakiewicz, RD (corresponding author), Cell Signaling Technol Inc, 166B Cummings Ctr, Beverly, MA 01915 USA.	rpolakiewicz@cellsignal.com	; DeGennaro, Matthew/H-4975-2015	Birnbaum, Morris/0000-0001-9972-8680; DeGennaro, Matthew/0000-0003-3837-4430				Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; BAIER G, 1994, EUR J BIOCHEM, V225, P195, DOI 10.1111/j.1432-1033.1994.00195.x; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Boden G, 2002, AM J PHYSIOL-ENDOC M, V283, pE12, DOI 10.1152/ajpendo.00429.2001; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Giraud J, 2004, J BIOL CHEM, V279, P3447, DOI 10.1074/jbc.M308631200; Greene MW, 2004, BIOCHEM J, V378, P105, DOI 10.1042/BJ20031493; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Itani SI, 2001, METABOLISM, V50, P553, DOI 10.1053/meta.2001.22512; Itani SI, 2000, DIABETES, V49, P1353, DOI 10.2337/diabetes.49.8.1353; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li Y, 2003, MOL CELL BIOL, V23, P6255, DOI 10.1128/MCB.23.17.6255-6266.2003; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Polakiewicz RD, 1998, J BIOL CHEM, V273, P23534, DOI 10.1074/jbc.273.36.23534; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Serra C, 2003, J CELL PHYSIOL, V196, P89, DOI 10.1002/jcp.10278; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8	36	242	255	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2004	279	44					45304	45307		10.1074/jbc.C400186200	http://dx.doi.org/10.1074/jbc.C400186200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	865IC	15364919	hybrid			2022-12-27	WOS:000224694900003
J	Taguchi, H; Tsukuda, K; Motojima, F; Koike-Takeshita, A; Yoshida, M				Taguchi, H; Tsukuda, K; Motojima, F; Koike-Takeshita, A; Yoshida, M			BeFx stops the chaperonin cycle of GroEL-GroES and generates a complex with double folding chambers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA-LACTALBUMIN; CENTRAL CAVITY; PROTEIN; BINDING; ATP; POLYPEPTIDE; SUBSTRATE; 2.8-ANGSTROM; MECHANISM	Coupling with ATP hydrolysis and cooperating with GroES, the double ring chaperonin GroEL assists the folding of other proteins. Here we report novel GroEL-GroES complexes formed in fluoroberyllate (BeFx) that can mimic the phosphate part of the enzyme-bound nucleotides. In ATP, BeFx stops the functional turnover of GroEL by preventing GroES release and produces a symmetric 1: 2 GroEL-GroES complex in which both GroEL rings contain ADP.BeFx and an encapsulated substrate protein. In ADP, the substrate protein-loaded GroEL cannot bind GroES. In ADP plus BeFx, however, it can bind GroES to form a stable 1: 1 GroEL-GroES complex in which one of GroEL rings contains ADP.BeFx and an encapsulated substrate protein. This 1: 1 GroEL-GroES complex is converted into the symmetric 1: 2 GroEL-GroES complex when GroES is supplied in ATP plus BeFx. Thus, BeFx stabilizes two GroEL-GroES complexes; one with a single folding chamber and the other with double folding chambers. These results shed light on the intermediate ADP.P-i nucleotide states in the functional cycle of GroEL.	Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Yoshida, M (corresponding author), Tokyo Inst Technol, Chem Resources Lab, R1-7,4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	myoshida@res.titech.ac.jp	Motojima, Fumihiro/J-2389-2014; taguchi, hideki/AAM-2663-2021; Taguchi, Hideki/B-6946-2009	Motojima, Fumihiro/0000-0003-4461-8673; taguchi, hideki/0000-0002-6612-9339; Taguchi, Hideki/0000-0002-6612-9339				Aoki K, 1997, J BIOL CHEM, V272, P32158, DOI 10.1074/jbc.272.51.32158; Aoki K, 2000, J BIOL CHEM, V275, P13755, DOI 10.1074/jbc.275.18.13755; AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HISABORI T, 1992, J BIOL CHEM, V267, P4551; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; Inobe T, 2003, J MOL BIOL, V329, P121, DOI 10.1016/S0022-2836(03)00409-1; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MELKI R, 1994, MOL CELL BIOL, V14, P2895, DOI 10.1128/MCB.14.5.2895; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; OKAZAKI A, 1994, NAT STRUCT BIOL, V1, P439, DOI 10.1038/nsb0794-439; PERALTA D, 1994, FEBS LETT, V339, P45, DOI 10.1016/0014-5793(94)80381-1; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; TAGUCHI H, 1995, FEBS LETT, V359, P195, DOI 10.1016/0014-5793(95)00041-7; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	38	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2004	279	44					45737	45743		10.1074/jbc.M406795200	http://dx.doi.org/10.1074/jbc.M406795200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	865IC	15347650	hybrid			2022-12-27	WOS:000224694900056
J	Liu, MF; Garges, S; Adhya, S				Liu, MF; Garges, S; Adhya, S			LacP1 promoter with an extended-10 motif - Pleiotropic effects of cyclic AMP protein at different steps of transcription initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RECEPTOR PROTEIN; OPEN COMPLEX-FORMATION; COLI RNA-POLYMERASE; PHAGE-PHI-29 REGULATORY PROTEIN-P4; ESCHERICHIA-COLI; ACTIVATOR PROTEIN; ALPHA-SUBUNIT; GALACTOSE OPERON; 434 REPRESSOR; IN-VIVO	The cyclic AMP receptor protein (CRP), which activates transcription from the wild-type lacP1 promoter and most of its mutants, represses productive RNA synthesis from a lacP1 promoter variant that contains an extended -10 element, although CRP enhances RNA polymerase binding as well as open complex formation in both promoters. Moreover, abortive RNA synthesis, which is already higher in the extended -10 variant compared with the parent promoter, was further enhanced by CRP. These results, together with the observed decrease in productive RNA synthesis, indicate that CRP, while facilitating the earlier steps of initiation, inhibits transcription from the extended -10 lacP1 by hindering promoter clearance. We propose that CRP decreases energetic barriers to RNA polymerase binding, isomerization, and abortive RNA synthesis but stabilizes the abortive RNA initiating complex, which results in increasing the activation energy of the transition state before the elongation complex. The results demonstrate for the first time that a DNA-binding regulatory protein acts as an activator or a repressor in different steps of the transcription initiation pathway because of the energetic differences of the intermediate complex in the same promoter.	NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Adhya, S (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Rm 5138, Bethesda, MD 20892 USA.	sadhya@helix.nih.gov		liu, mo fang/0000-0003-1800-466X	NATIONAL CANCER INSTITUTE [ZIABC008751, Z01BC008751] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AIBA H, 1985, J BIOL CHEM, V260, P3063; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Burns HD, 1999, NUCLEIC ACIDS RES, V27, P2051, DOI 10.1093/nar/27.9.2051; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CHOY HE, 1992, P NATL ACAD SCI USA, V89, P11264, DOI 10.1073/pnas.89.23.11264; CHOY HE, 1993, P NATL ACAD SCI USA, V90, P472, DOI 10.1073/pnas.90.2.472; CHOY HE, 1995, EMBO J, V14, P4523, DOI 10.1002/j.1460-2075.1995.tb00131.x; DEUSCHLE U, 1986, EMBO J, V5, P2987, DOI 10.1002/j.1460-2075.1986.tb04596.x; Eichenberger P, 1996, BIOCHEMISTRY-US, V35, P15302, DOI 10.1021/bi961377d; Eichenberger P, 1997, P NATL ACAD SCI USA, V94, P9022, DOI 10.1073/pnas.94.17.9022; ELLINGER T, 1994, J MOL BIOL, V239, P455, DOI 10.1006/jmbi.1994.1388; ESCHENLAUER AC, 1991, J BACTERIOL, V173, P5024, DOI 10.1128/jb.173.16.5024-5029.1991; HERBERT M, 1986, P NATL ACAD SCI USA, V83, P2807, DOI 10.1073/pnas.83.9.2807; KAMMERER W, 1986, EMBO J, V5, P2995, DOI 10.1002/j.1460-2075.1986.tb04597.x; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; LAVIGNE M, 1992, J MOL BIOL, V224, P293, DOI 10.1016/0022-2836(92)90995-V; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; Liu MF, 2003, J BIOL CHEM, V278, P39755, DOI 10.1074/jbc.M305995200; LOWE PA, 1979, BIOCHEMISTRY-US, V18, P1344, DOI 10.1021/bi00574a034; Monsalve M, 1996, EMBO J, V15, P383, DOI 10.1002/j.1460-2075.1996.tb00368.x; Monsalve M, 1997, MOL CELL, V1, P99, DOI 10.1016/S1097-2765(00)80011-8; Monsalve M, 1996, P NATL ACAD SCI USA, V93, P8913, DOI 10.1073/pnas.93.17.8913; MORI K, 1985, J BIOL CHEM, V260, P4838; Muller-Hill B, 1998, CURR OPIN MICROBIOL, V1, P145, DOI 10.1016/S1369-5274(98)80004-0; MUSSO RE, 1977, CELL, V12, P847, DOI 10.1016/0092-8674(77)90283-5; NUEZ B, 1992, P NATL ACAD SCI USA, V89, P11401, DOI 10.1073/pnas.89.23.11401; PTASHNE M, 1980, CELL, V19, P1, DOI 10.1016/0092-8674(80)90383-9; Rawlinson ELA, 2002, BIOCHIMIE, V84, P559, DOI 10.1016/S0300-9084(02)01420-7; REZNIKOFF WS, 1978, OPERON, P221; ROJO F, 1991, EMBO J, V10, P3429, DOI 10.1002/j.1460-2075.1991.tb04907.x; Roy S, 1998, J BIOL CHEM, V273, P14059, DOI 10.1074/jbc.273.23.14059; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; Ryu S, 1998, GENE, V223, P235, DOI 10.1016/S0378-1119(98)00237-6; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; STRANEY DC, 1989, J MOL BIOL, V206, P41, DOI 10.1016/0022-2836(89)90522-6; Sukhodolets MV, 1998, J BIOL CHEM, V273, P7018, DOI 10.1074/jbc.273.12.7018; Sullivan JJ, 1997, BIOCHEMISTRY-US, V36, P8005, DOI 10.1021/bi970363k; TAGAMI H, 1995, NUCLEIC ACIDS RES, V23, P599, DOI 10.1093/nar/23.4.599; Tagami H, 1998, EMBO J, V17, P1759, DOI 10.1093/emboj/17.6.1759; ValentinHansen P, 1996, MOL MICROBIOL, V20, P461, DOI 10.1046/j.1365-2958.1996.5341056.x; XIONG XF, 1991, J BACTERIOL, V173, P4570, DOI 10.1128/jb.173.15.4570-4577.1991; Xu J, 2000, DNA CELL BIOL, V19, P621, DOI 10.1089/104454900750019380; Xu J, 2001, J MOL BIOL, V309, P573, DOI 10.1006/jmbi.2001.4702	44	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2004	279	52					54552	54557		10.1074/jbc.M408609200	http://dx.doi.org/10.1074/jbc.M408609200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	880MJ	15385551	hybrid			2022-12-27	WOS:000225793600080
J	Chien, CH; Huang, LH; Chou, CY; Chen, YS; Han, YS; Chang, GG; Liang, PH; Chen, X				Chien, CH; Huang, LH; Chou, CY; Chen, YS; Han, YS; Chang, GG; Liang, PH; Chen, X			One site mutation disrupts dimer formation in human DPP-IV proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-IV; HUMAN CYTOMEGALOVIRUS PROTEASE; IMPROVED GLUCOSE-TOLERANCE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; INSULIN-SECRETION; DIMERIZATION; PURIFICATION; INHIBITION; STABILITY	DPP-IV is a prolyl dipeptidase, cleaving the peptide bond after the penultimate proline residue. It is an important drug target for the treatment of type II diabetes. DPP-IV is active as a dimer, and monomeric DPP-IV has been speculated to be inactive. In this study, we have identified the C-terminal loop of DPP-IV, highly conserved among prolyl dipeptidases, as essential for dimer formation and optimal catalysis. The conserved residue His(750) on the loop contributes significantly for dimer stability. We have determined the quaternary structures of the wild type, H750A, and H750E mutant enzymes by several independent methods including chemical cross-linking, gel electrophoresis, size exclusion chromatography, and analytical ultracentrifugation. Wild-type DPP-IV exists as dimers both in the intact cell and in vitro after purification from human semen or insect cells. The H750A mutation results in a mixture of DPP-IV dimer and monomer. H750A dimer has the same kinetic constants as those of the wild type, whereas the H750A monomer has a 60-fold decrease in k(cat). Replacement of His(750) with a negatively charged Glu (H750E) results in nearly exclusive monomers with a 300-fold decrease in catalytic activity. Interestingly, there is no dynamic equilibrium between the dimer and the monomer for all forms of DPP-IVs studied here. This is the first study of the function of the C-terminal loop as well as monomeric mutant DPP-IVs with respect to their enzymatic activities. The study has important implications for the discovery of drugs targeted to the dimer interface.	Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei 115, Taiwan; Natl Def Med Ctr, Grad Inst Life Sci, Taipei 115, Taiwan; Natl Yang Ming Univ, Fac Life Sci, Taipei 112, Taiwan; Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Chen, X (corresponding author), Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei 115, Taiwan.	xchen@nhri.org.tw	Chen, Xin/D-2073-2010; Liang, Po-Huang/H-6610-2015	Liang, Po-Huang/0000-0003-1207-5256; Chou, Chi-Yuan/0000-0002-3400-171X; HAN, YU-SAN/0000-0002-9236-9045				Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Ahren B, 2000, EUR J PHARMACOL, V404, P239, DOI 10.1016/S0014-2999(00)00600-2; Batra R, 2001, NAT STRUCT BIOL, V8, P810, DOI 10.1038/nsb0901-810; Boggetto N, 2002, BIOL CHEM, V383, P1321, DOI 10.1515/BC.2002.150; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Chang HC, 2003, J BIOL CHEM, V278, P23996, DOI 10.1074/jbc.M213242200; Chen YS, 2004, PROTEIN EXPRES PURIF, V35, P142, DOI 10.1016/j.pep.2003.12.019; Cole JL, 1996, BIOCHEMISTRY-US, V35, P15601, DOI 10.1021/bi961719f; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; DADDONA PE, 1978, J BIOL CHEM, V253, P4617; Darke PL, 1996, J BIOL CHEM, V271, P7445, DOI 10.1074/jbc.271.13.7445; DARKE PL, 1994, METHOD ENZYMOL, V241, P104; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; De Meester I, 2000, ADV EXP MED BIOL, V477, P67; Deacon CF, 2001, DIABETES, V50, P1588, DOI 10.2337/diabetes.50.7.1588; DeMeester I, 1996, J IMMUNOL METHODS, V189, P99, DOI 10.1016/0022-1759(95)00239-1; Drucker DJ, 2003, EXPERT OPIN INV DRUG, V12, P87, DOI 10.1517/13543784.12.1.87; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; KATO T, 1978, CLIN CHEM, V24, P1163; KENNY AJ, 1976, BIOCHEM J, V157, P169, DOI 10.1042/bj1570169; Khayat R, 2004, BIOCHEMISTRY-US, V43, P316, DOI 10.1021/bi035170d; KREIS TE, 1986, CELL, V46, P929, DOI 10.1016/0092-8674(86)90075-9; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lambeir AM, 1997, BBA-PROTEIN STRUCT M, V1340, P215, DOI 10.1016/S0167-4838(97)00045-9; Lee DF, 2000, J VIROL, V74, P11873, DOI 10.1128/JVI.74.24.11873-11880.2000; Liang PH, 1998, BIOCHEMISTRY-US, V37, P5923, DOI 10.1021/bi9726077; Margosiak SA, 1996, BIOCHEMISTRY-US, V35, P5300, DOI 10.1021/bi952842u; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Pauly RP, 1996, J BIOL CHEM, V271, P23222, DOI 10.1074/jbc.271.38.23222; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Pospisilik JA, 2002, DIABETES, V51, P2677, DOI 10.2337/diabetes.51.9.2677; PUSCHEL G, 1982, EUR J BIOCHEM, V126, P359, DOI 10.1111/j.1432-1033.1982.tb06788.x; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; RIEMANN D, 1995, CLIN EXP IMMUNOL, V100, P277; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; SAISON M, 1983, BIOCHEM J, V216, P177, DOI 10.1042/bj2160177; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt U, 1997, J BIOL CHEM, V272, P7732, DOI 10.1074/jbc.272.12.7732; Sudre B, 2002, DIABETES, V51, P1461, DOI 10.2337/diabetes.51.5.1461; Thoma R, 2003, STRUCTURE, V11, P947, DOI 10.1016/S0969-2126(03)00160-6; Villhauer EB, 2002, J MED CHEM, V45, P2362, DOI 10.1021/jm025522z; YAMANAKA G, 1995, J BIOL CHEM, V270, P30168; Zutshi R, 1998, CURR OPIN CHEM BIOL, V2, P62, DOI 10.1016/S1367-5931(98)80036-7	48	71	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52338	52345		10.1074/jbc.M406185200	http://dx.doi.org/10.1074/jbc.M406185200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15448155	hybrid			2022-12-27	WOS:000225493400076
J	Berwin, B; Delneste, Y; Lovingood, RV; Post, SR; Pizzo, SV				Berwin, B; Delneste, Y; Lovingood, RV; Post, SR; Pizzo, SV			SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; MURINE MACROPHAGES; DENDRITIC CELLS; CUTTING EDGE; CROSS-PRESENTATION; GRP94(GP96)-ASSOCIATED PEPTIDES; ENDOTOXIN CONTAMINATION; ANTIGEN PRESENTATION; SURFACE EXPRESSION	Calreticulin and gp96 (GRP94) traffic associated peptides into the major histocompatibility complex class-I cross-presentation pathway of antigen-presenting cells (APCs). Efficient accession of the cross-presentation pathway requires APC receptor-mediated endocytosis of the chaperone/peptide complexes. Previously, scavenger receptor class-A (SRA) was shown to play a substantial role in trafficking gp96 and calreticulin into macrophages, accounting for half of total receptor-mediated uptake. However, the scavenger receptor ligand fucoidin competed the chaperone uptake beyond that accounted for by SRA, indicating that another scavenger receptor(s) may also contribute. Consistent with this hypothesis, we showed that the residual calreticulin uptake into SRA -/- macrophages is competed by the scavenger receptor ligand acetylated-low density lipoprotein (LDL). We now report that an additional scavenger receptor, SREC-I ( scavenger receptor expressed by endothelial cell-I), mediates the endocytosis of calreticulin and gp96. Ectopic expression of SREC-I in Chinese hamster ovary cells yielded chaperone recognition and uptake, and these processes were competed by the inhibitory ligands fucoidin and acetylated (Ac) LDL. Although AcLDL competes for the chaperone interactions with SRA and SREC, we showed that not all of the scavenger receptors, which bind AcLDL, bind calreticulin or gp96. The overexpression of SREC-I in macrophages increased chaperone endocytosis, indicating that SREC-I functions in APCs and that the cytosolic components necessary for the endocytosis of SREC-I and its cargo are present and not limiting in APCs. These data identify a novel class of ligands for SREC-I and provide insight into the mechanisms by which APCs and potentially endothelial cells traffic chaperone/antigen complexes.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Univ Hosp, INSERM, U564, F-49933 Angers, France; Univ Kentucky, Lexington, KY 40536 USA	Duke University; Duke University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; University of Kentucky	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	pizzo001@mc.duke.edu	Delneste, Yves/O-3956-2016; DELNESTE, Yves/K-7367-2015	DELNESTE, Yves/0000-0002-2142-596X; Post, Steven/0000-0002-4711-1723; Berwin, Brent/0000-0001-9196-3256	NCI NIH HHS [1F32CA9016901] Funding Source: Medline; NHLBI NIH HHS [HL-24066, HL-68072] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA090169] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068072, R37HL024066, R01HL024066] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAM R, 1995, J IMMUNOL, V154, P1; Adachi H, 2002, J BIOL CHEM, V277, P24014, DOI 10.1074/jbc.M201854200; Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Baker-LePain JC, 2004, J IMMUNOL, V172, P4195, DOI 10.4049/jimmunol.172.7.4195; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Bansal P, 1999, J IMMUNOL, V162, P4430; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Basu S, 1999, J EXP MED, V189, P797, DOI 10.1084/jem.189.5.797; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Berwin B, 2002, TRAFFIC, V3, P358, DOI 10.1034/j.1600-0854.2002.30505.x; Berwin B, 2002, J IMMUNOL, V168, P4282, DOI 10.4049/jimmunol.168.9.4282; Berwin B, 2001, J BIOL CHEM, V276, P21083, DOI 10.1074/jbc.M101836200; Binder RJ, 2000, J IMMUNOL, V165, P6029, DOI 10.4049/jimmunol.165.11.6029; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Blachere NE, 1997, J EXP MED, V186, P1315, DOI 10.1084/jem.186.8.1315; Brinker KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1453, DOI 10.1152/ajplung.2001.281.6.L1453; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Eggleton P, 1999, SCAND J IMMUNOL, V49, P466; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; Manjili MH, 2003, J IMMUNOL, V171, P4054, DOI 10.4049/jimmunol.171.8.4054; Manjili MH, 2002, CANCER RES, V62, P1737; Martin CA, 2003, J IMMUNOL, V171, P5736, DOI 10.4049/jimmunol.171.11.5736; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Millar DG, 2003, NAT MED, V9, P1469, DOI 10.1038/nm962; Nair S, 1999, J IMMUNOL, V162, P6426; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Peiser L, 2001, MICROBES INFECT, V3, P149, DOI 10.1016/S1286-4579(00)01362-9; Pike SE, 1999, BLOOD, V94, P2461, DOI 10.1182/blood.V94.7.2461.419a26_2461_2468; Pike SE, 1998, J EXP MED, V188, P2349, DOI 10.1084/jem.188.12.2349; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Post SR, 2002, J LIPID RES, V43, P1829, DOI 10.1194/jlr.M200231-JLR200; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Reed RC, 2003, J BIOL CHEM, V278, P31853, DOI 10.1074/jbc.M305480200; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Singh-Jasuja H, 2000, J EXP MED, V191, P1965, DOI 10.1084/jem.191.11.1965; Singh-Jasuja H, 2000, CELL STRESS CHAPERON, V5, P462, DOI 10.1379/1466-1268(2000)005<0462:THSPGA>2.0.CO;2; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1994, CURR OPIN IMMUNOL, V6, P728, DOI 10.1016/0952-7915(94)90076-0; Strbo N, 2003, IMMUNITY, V18, P381, DOI 10.1016/S1074-7613(03)00056-6; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; Todryk S, 1999, J IMMUNOL, V163, P1398; Todryk SM, 2000, IMMUNOLOGY, V99, P334, DOI 10.1046/j.1365-2567.2000.00002.x; UDONO H, 1994, P NATL ACAD SCI USA, V91, P3077, DOI 10.1073/pnas.91.8.3077; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; VABULAS RM, 2002, J BIOL CHEM, V23, P23; Wassenberg JJ, 1999, J CELL SCI, V112, P2167; Wearsch PA, 1996, PROTEIN EXPRES PURIF, V7, P114, DOI 10.1006/prep.1996.0015; Whitman SC, 2000, J LIPID RES, V41, P807; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50; Yamazaki K, 1999, J IMMUNOL, V163, P5178; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	74	97	104	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51250	51257		10.1074/jbc.M406202200	http://dx.doi.org/10.1074/jbc.M406202200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15371419	hybrid			2022-12-27	WOS:000225355800073
J	Geiszt, M; Lekstrom, K; Leto, TL				Geiszt, M; Lekstrom, K; Leto, TL			Analysis of mRNA transcripts from the NAD(P)H oxidase 1 (Nox1) gene - Evidence against production of the NADPH oxidase homolog-1 short (NOH-1S) transcript variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON EPITHELIAL-CELLS; H+ CHANNEL; SUPEROXIDE; CLONING; PROTON; CONDUCTANCE; GP91-PHOX; COMPONENT; CYTOCHROME-B558; FLAVOPROTEIN	Recent reports indicate that NAD(P) H oxidase 1 (Nox1) mRNA undergoes alternative splicing, producing a short transcript (NOH-1S) encoding a novel H+ channel. Although the H+ transport properties of NOH-1S-transfected cells resemble those of many cells, the production of a NOH-1S protein was never documented. We characterized Nox1 transcripts in colon-derived cells and present evidence that mRNA splicing does not produce NOH-1S; rather, NOH-1S appears to be an artifact of template switching during cDNA synthesis. The NOH-1S transcript was not observed by Northern blotting, despite claims of its abundance based on RNase protection assays. The shortened cDNA was generated by avian myeloblastosis virus reverse transcriptase, but not by thermally stable reverse transcriptase under conditions that produce full-length Nox1. Analysis of shortened cDNAs detected NOH-1S sequence and other variants that differ at the alleged splice junction site. Although no appropriate RNA splicing sites were found within Nox1 to account for NOH-1S formation, we found repetitive sequence elements bordering the deleted region, which could promote intramolecular template switching during cDNA synthesis. Template switching was confirmed in vitro, where the deleted cDNA was generated by avian myeloblastosis virus reverse transcriptase from a synthetic, full-length Nox1 RNA template. A survey of the expressed sequence tags database suggests that similar switching phenomena occur between repetitive elements in other Nox family transcripts, indicating such cloning artifacts are common. In contrast, genuine RNA splicing does account for another Nox1 transcript lacking the entire exon 11, which is abundant in colon cells but encodes a protein incapable of supporting superoxide production.	NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Semmelweis University	Leto, TL (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike,Bldg 10,Rm 11N106, Bethesda, MD 20892 USA.	tleto@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000614, ZIAAI000614] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; CHANG MS, 1995, J BIOL CHEM, V270, P511, DOI 10.1074/jbc.270.2.511; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; DeCoursey TE, 2002, J GEN PHYSIOL, V120, P773, DOI 10.1085/jgp.20028704; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Henderson LM, 1999, J GEN PHYSIOL, V114, P771, DOI 10.1085/jgp.114.6.771; Henderson LM, 2002, J GEN PHYSIOL, V120, P759, DOI 10.1085/jgp.20028708; HENDERSON LM, 1995, J BIOL CHEM, V270, P5909, DOI 10.1074/jbc.270.11.5909; Henderson LM, 1997, BIOCHEM J, V325, P701, DOI 10.1042/bj3250701; KAPLUS PA, 1991, SCIENCE, V251, P60; Leto TL., 1999, INFLAMMATION BASIC P, P769; LEWIN B, 1997, GENES, V6, P885; LUKACS GL, 1993, AM J PHYSIOL, V265, pC3, DOI 10.1152/ajpcell.1993.265.1.C3; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Maturana A, 2002, J GEN PHYSIOL, V120, P781, DOI 10.1085/jgp.20028713; Morgan D, 2002, J GEN PHYSIOL, V119, P571, DOI 10.1085/jgp.20018544; NANDA A, 1994, J BIOL CHEM, V269, P27280; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; Touret N, 2002, J GEN PHYSIOL, V120, P767, DOI 10.1085/jgp.20028706; VIBEPEDERSEN K, 1986, FEBS LETT, V207, P287, DOI 10.1016/0014-5793(86)81506-X	36	36	37	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51661	51668		10.1074/jbc.M409325200	http://dx.doi.org/10.1074/jbc.M409325200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15375166	hybrid			2022-12-27	WOS:000225355800122
J	Maita, N; Hatakeyama, K; Okada, K; Hakoshima, T				Maita, N; Hatakeyama, K; Okada, K; Hakoshima, T			Structural basis of biopterin-induced inhibition of GTP cyclohydrolase I by GFRP, its feedback regulatory protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPA-RESPONSIVE DYSTONIA; CRYSTAL-STRUCTURE; TETRAHYDROBIOPTERIN; PURIFICATION; MUTATION; RAT; PHENYLALANINE; COMPLEXES; BINDING; CLONING	GTP cyclohydrolase I (GTPCHI) is the rate-limiting enzyme involved in the biosynthesis of tetrahydrobiopterin, a key cofactor necessary for nitric oxide synthase and for the hydroxylases that are involved in the production of catecholamines and serotonin. In animals, the GTPCHI feedback regulatory protein ( GFRP) binds GTPCHI to mediate feed-forward activation of GTPCHI activity in the presence of phenylalanine, whereas it induces feedback inhibition of enzyme activity in the presence of biopterin. Here, we have reported the crystal structure of the biopterin-induced inhibitory complex of GTPCHI and GFRP and compared it with the previously reported phenylalanine-induced stimulatory complex. The structure reveals five biopterin molecules located at each interface between GTPCHI and GFRP. Induced fitting structural changes by the biopterin binding expand large conformational changes in GTPCHI peptide segments forming the active site, resulting in inhibition of the activity. By locating 3,4-dihydroxyphenylalanine-responsive dystonia mutations in the complex structure, we found mutations that may possibly disturb the GFRP-mediated regulation of GTPCHI.	Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; Jap Sci & Technol Agcy, CREST, Nara 6300192, Japan; Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Japan Science & Technology Agency (JST); Nara Institute of Science & Technology	Hakoshima, T (corresponding author), Univ Pittsburgh, Dept Surg, 497 Scaife Hall, Pittsburgh, PA 15213 USA.	hakosima@bs.naist.jp	Maita, Nobuo/J-1443-2012	Maita, Nobuo/0000-0003-2260-5783	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051257] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK51257] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; Bader G, 2001, J MOL BIOL, V312, P1051, DOI 10.1006/jmbi.2001.5011; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brique S, 1999, NEUROREPORT, V10, P487, DOI 10.1097/00001756-199902250-00008; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cosentino F, 1998, J CLIN INVEST, V101, P1530, DOI 10.1172/JCI650; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HATAKEYAMA K, 1989, J BIOL CHEM, V264, P21660; ICHINOSE H, 1995, J BIOL CHEM, V270, P10062, DOI 10.1074/jbc.270.17.10062; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Maita N, 2002, P NATL ACAD SCI USA, V99, P1212, DOI 10.1073/pnas.022646999; Maita N, 2001, ACTA CRYSTALLOGR D, V57, P1153, DOI 10.1107/S0907444901005558; Meininger CJ, 2000, BIOCHEM J, V349, P353, DOI 10.1042/0264-6021:3490353; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; Nar H, 1995, P NATL ACAD SCI USA, V92, P12120, DOI 10.1073/pnas.92.26.12120; NAR H, 1995, STRUCTURE, V3, P459, DOI 10.1016/S0969-2126(01)00179-4; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762; NYGAARD TG, 1995, CURR OPIN NEUROL, V8, P310, DOI 10.1097/00019052-199508000-00011; Pieper GM, 1997, J CARDIOVASC PHARM, V29, P8, DOI 10.1097/00005344-199701000-00002; Skrygan M, 2001, J INHERIT METAB DIS, V24, P345, DOI 10.1023/A:1010544316387; Steinberger D, 2000, NEUROLOGY, V55, P1735, DOI 10.1212/WNL.55.11.1735; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tassin J, 2000, BRAIN, V123, P1112, DOI 10.1093/brain/123.6.1112; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Yoneyama T, 1997, J BIOL CHEM, V272, P9690; Yoneyama T, 2001, PROTEIN SCI, V10, P871, DOI 10.1110/ps.38501; Yoneyama T, 2001, ARCH BIOCHEM BIOPHYS, V388, P67, DOI 10.1006/abbi.2001.2288; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102	36	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51534	51540		10.1074/jbc.M409440200	http://dx.doi.org/10.1074/jbc.M409440200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448133	hybrid			2022-12-27	WOS:000225355800107
J	Wang, W; Ungermannova, D; Chen, L; Liu, XD				Wang, W; Ungermannova, D; Chen, L; Liu, XD			Molecular and biochemical characterization of the Skp2-Cks1 binding interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR P27; BOX PROTEIN SKP2; CELL-CYCLE; DEPENDENT DEGRADATION; UBIQUITIN LIGASE; PHOSPHORYLATION; CANCER; CKS1; EXPRESSION; REGULATORS	SCFSkp2 is a multisubunit E3 ubiquitin ligase responsible for ubiquitination of cell cycle inhibitor p27. Ubiquitination of p27 requires an adapter protein, Cks1, to be in direct association with Skp2. The exact interface between Skp2 and Cks1 has not been elucidated. Here we have reported the definition of the critical functional interface between Skp2 and Cks1. We have identified eight amino acid residues in two discrete regions of Skp2 that are engaged in Cks1 binding. Mutation of any of these eight residues alone or in combination results in the loss of Cks1 association and negates Skp2-dependent p27 ubiquitination. These eight amino acid residues map on the same side of the Skp2 structure and likely constitute a functional binding surface for Cks1. Four of the eight amino acid residues are located in the largely unstructured carboxyl-terminal tail region of Skp2. These results uncovered the specificity of the Skp2-Cks1 interaction and reveal a critical function for the structurally flexible carboxyl-terminal tail region of Skp2 in Cks1 recognition and substrate ubiquitination.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	Xuedong.Liu@Colorado.edu		LIU, XUEDONG/0000-0001-7209-4964	NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER; NCI NIH HHS [CA107098-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Ganiatsas S, 2001, ONCOGENE, V20, P3641, DOI 10.1038/sj.onc.1204501; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Harper JW, 2001, CURR BIOL, V11, pR431, DOI 10.1016/S0960-9822(01)00253-6; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; SIMON KE, 1995, CELL GROWTH DIFFER, V6, P1261; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang W, 2003, J BIOL CHEM, V278, P32390, DOI 10.1074/jbc.M305241200; Wang W, 2004, ONCOGENE, V23, P1064, DOI 10.1038/sj.onc.1207204; Xu K, 2003, BIOCHEM J, V371, P957, DOI 10.1042/BJ20021722; Yang G, 2002, CLIN CANCER RES, V8, P3419	29	13	14	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51362	51369		10.1074/jbc.M405944200	http://dx.doi.org/10.1074/jbc.M405944200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15452136	hybrid			2022-12-27	WOS:000225355800087
J	Wilkinson, SP; Grove, A				Wilkinson, SP; Grove, A			HucR, a novel uric acid-responsive member of the MarR family of transcriptional regulators from Deinococcus radiodurans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; PROTEIN SECONDARY STRUCTURE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CIRCULAR-DICHROISM SPECTRA; MULTIDRUG EFFLUX OPERON; MEXA-MEXB-OPRM; ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; DNA-BINDING	The MarR family of transcriptional regulators comprises a subset of winged helix DNA-binding proteins and includes numerous members that function in environmental surveillance of aromatic compounds. We describe the characterization of HucR, a novel MarR homolog from Deinococcus radiodurans that demonstrates phenolic sensing capabilities. HucR binds as a homodimer to a single site within its promoter/operator region with K-d = 0.29 +/- 0.02 nM. The HucR binding site contains a pseudopalindromic sequence, composed of 8-bp half-sites separated by 2 bp. The location of the HucR binding site in the intergenic region between hucR and a putative uricase suggests a mechanism of simultaneous co-repression of these two genes. The substrate of uricase, uric acid, is an efficient antagonist of DNA binding, reducing HucR-DNA complex formation to 50% at 0.26 mM ligand, compared with 5.2 and 46 mM for the aromatic compounds salicylate and acetylsalicylate, respectively. Enhanced levels in vivo of hucR and uricase transcript and increased uricase activity under conditions of excess uric acid further indicate a novel regulatory mechanism of aromatic catabolism in D. radiodurans. Since uric acid is a scavenger of reactive oxygen species, we hypothesize that HucR is a participant in the intrinsic resistance of D. radiodurans to high levels of oxidative stress.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Wilkinson, SP (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	swilki2@lsu.edu; agrove@lsu.edu	Grove, Anne/O-5998-2015	Grove, Anne/0000-0002-4390-0354; Wilkinson, Steven/0000-0002-8075-4448				Alekshun MN, 1997, ANTIMICROB AGENTS CH, V41, P2067, DOI 10.1128/AAC.41.10.2067; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; ARIZA RR, 1994, J BACTERIOL, V176, P143, DOI 10.1128/JB.176.1.143-148.1994; Ausubel F. M., 1998, CURRENT PROTOCOLS MO, V1; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; BONGAERTS GPA, 1976, J BACTERIOL, V125, P689, DOI 10.1128/JB.125.2.689-697.1976; Brooun A, 1999, J BACTERIOL, V181, P5131, DOI 10.1128/JB.181.16.5131-5133.1999; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; CARBONNEAU MA, 1989, ARCH BIOCHEM BIOPHYS, V275, P244, DOI 10.1016/0003-9861(89)90370-6; Carra JH, 1997, BIOCHEMISTRY-US, V36, P526, DOI 10.1021/bi962206b; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Dalrymple BP, 1997, MICROBIOL-SGM, V143, P1203, DOI 10.1099/00221287-143-4-1203; Diaz E, 2000, CURR OPIN BIOTECH, V11, P467, DOI 10.1016/S0958-1669(00)00126-9; Earl AM, 2002, J BACTERIOL, V184, P1003, DOI 10.1128/jb.184.4.1003-1009.2002; Egland PG, 1999, J BACTERIOL, V181, P2102, DOI 10.1128/JB.181.7.2102-2109.1999; Evans K, 2001, J BACTERIOL, V183, P807, DOI 10.1128/JB.183.3.807-812.2001; Felitsky DJ, 2003, BIOCHEMISTRY-US, V42, P2202, DOI 10.1021/bi0270992; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Galan B, 2003, NUCLEIC ACIDS RES, V31, P6598, DOI 10.1093/nar/gkg851; HACHLER H, 1991, J BACTERIOL, V173, P5532; Hink HU, 2002, ARTERIOSCL THROM VAS, V22, P1402, DOI 10.1161/01.ATV.0000027524.86752.02; Imhoff RD, 2003, BIOCHEMISTRY-US, V42, P4094, DOI 10.1021/bi027377x; Kean RB, 2000, J IMMUNOL, V165, P6511, DOI 10.4049/jimmunol.165.11.6511; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Lobley A, 2001, BIOPHYS J, V80, p373A; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Machin M, 2004, COMP BIOCHEM PHYS B, V137, P383, DOI 10.1016/j.cbpc.2004.01.002; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; MARTIN RG, 1995, P NATL ACAD SCI USA, V92, P5456, DOI 10.1073/pnas.92.12.5456; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; MISRA HP, 1976, ARCH BIOCHEM BIOPHYS, V176, P577, DOI 10.1016/0003-9861(76)90201-0; Moken MC, 1997, ANTIMICROB AGENTS CH, V41, P2770, DOI 10.1128/AAC.41.12.2770; Narumi I, 2001, J BACTERIOL, V183, P6951, DOI 10.1128/JB.183.23.6951-6956.2001; Oscarsson J, 1996, MOL MICROBIOL, V20, P191, DOI 10.1111/j.1365-2958.1996.tb02500.x; Ouhammouch M, 2001, EMBO J, V20, P146, DOI 10.1093/emboj/20.1.146; Poole K, 1996, ANTIMICROB AGENTS CH, V40, P2021, DOI 10.1128/AAC.40.9.2021; Providenti MA, 2001, APPL ENVIRON MICROB, V67, P3530, DOI 10.1128/AEM.67.8.3530-3541.2001; Rainey FA, 1997, INT J SYST BACTERIOL, V47, P510, DOI 10.1099/00207713-47-2-510; RAMSAY GD, 1994, METHOD ENZYMOL, V240, P615; Reverchon S, 2002, J BACTERIOL, V184, P654, DOI 10.1128/JB.184.3.654-665.2002; ROPER DI, 1993, MOL GEN GENET, V237, P241, DOI 10.1007/BF00282806; Rouanet C, 1999, J BACTERIOL, V181, P5948, DOI 10.1128/JB.181.19.5948-5957.1999; Sambrook J., 2001, MOL CLONING LAB MANU; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Scott GS, 2002, P NATL ACAD SCI USA, V99, P16303, DOI 10.1073/pnas.212645999; SEOANE AS, 1995, J BACTERIOL, V177, P3414, DOI 10.1128/jb.177.12.3414-3419.1995; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; SULAVIK MC, 1995, MOL MED, V1, P436, DOI 10.1007/BF03401581; SWEET DM, 1976, MUTAT RES, V34, P175, DOI 10.1016/0027-5107(76)90122-6; WANG P, 1995, CAN J MICROBIOL, V41, P170, DOI 10.1139/m95-023; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Xiong A, 2000, ANTIMICROB AGENTS CH, V44, P2905, DOI 10.1128/AAC.44.10.2905-2907.2000	59	92	99	7	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51442	51450		10.1074/jbc.M405586200	http://dx.doi.org/10.1074/jbc.M405586200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15448166	Green Published, hybrid			2022-12-27	WOS:000225355800096
J	Truscott, M; Raynal, L; Wang, YF; Berube, G; Leduy, L; Nepveu, A				Truscott, M; Raynal, L; Wang, YF; Berube, G; Leduy, L; Nepveu, A			The N-terminal region of the CCAAT displacement protein (CDP)/Cux transcription factor functions as an autoinhibitory domain that modulates DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CUT HOMEODOMAIN PROTEIN; CELL TYPE SPECIFICATION; DROSOPHILA WING MARGIN; SENSORY ORGAN IDENTITY; GAMMA-GLOBIN GENE; FACTOR HINF-D; S-PHASE; REGULATORY ELEMENT; TUMOR SUPPRESSORS; AUTO-INHIBITION	The CCAAT displacement protein/Cut homeobox (CDP/Cux) transcription factor is expressed as multiple isoforms that may contain up to four DNA-binding domains: Cut repeats 1, 2, and 3 (CR1, CR2, CR3) and the Cut homeodomain (HD). The full-length protein, which contains all four DNA-binding domains, is surprisingly less efficient than the shorter isoforms in DNA binding. Using a panel of recombinant proteins expressed in mammalian or bacterial cells, we have identified a domain at the extreme N terminus of the protein that can inhibit DNA binding. This domain was able to inhibit the activity of full-length CDP/Cux and of proteins containing various combinations of DNA-binding domains: CR1CR2, CR3HD, or CR2CR3HD. Since inhibition of DNA binding was also observed with purified proteins obtained from bacteria, we conclude that autoinhibition does not require post-translational modification or interaction with an interacting protein but instead functions through an intramolecular mechanism. Antibodies directed against the N-terminal region were able to partially relieve inhibition. In vivo, the transition between the inactive and active states for DNA binding is likely to be governed by posttranslational modifications and/or interaction with one or more protein partners. In addition, we show that the relief of autoinhibition can be accomplished via the proteolytic processing of CDP/Cux. Altogether, these results reveal a novel mode of regulation that serves to modulate the DNA binding activity of CDP/Cux.	McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Oncol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University; McGill University	Nepveu, A (corresponding author), 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020	Truscott, Mary/0000-0002-2324-6383				ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Banan M, 1997, J BIOL CHEM, V272, P18440, DOI 10.1074/jbc.272.29.18440; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BLANC R, 1942, U CALIF PUBL ZOOL, V49; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Catt D, 1999, CELL MOL BIOL, V45, P1149; Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Cowley DO, 2000, GENE DEV, V14, P366; ELHODIRI HM, 1995, MOL CELL BIOL, V15, P3587; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2002, CANCER RES, V62, P6625; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Gupta S, 2003, J CELL PHYSIOL, V196, P541, DOI 10.1002/jcp.10335; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; HARADA R, 1994, J BIOL CHEM, V269, P2062; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hertweck H, 1931, Z WISS ZOOL ABT A, V139, P559; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Howcroft TK, 1997, ANAL BIOCHEM, V244, P22, DOI 10.1006/abio.1996.9868; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JACK J, 1992, GENETICS, V131, P353; JACK J, 1991, DEVELOPMENT, V113, P735; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Ledford AW, 2002, DEV BIOL, V245, P157, DOI 10.1006/dbio.2002.0636; Lemay S, 2000, MOL CELL BIOL, V20, P2743, DOI 10.1128/MCB.20.8.2743-2754.2000; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Li SD, 2000, P NATL ACAD SCI USA, V97, P7166, DOI 10.1073/pnas.130028697; LIEVENS PMJ, 1995, J BIOL CHEM, V270, P12745, DOI 10.1074/jbc.270.21.12745; Liu JQ, 1999, MOL CELL BIOL, V19, P4918; LIU S, 1992, DEV BIOL, V150, P133, DOI 10.1016/0012-1606(92)90013-7; LIU S, 1991, GENETICS, V127, P151; Luo W, 1996, J BIOL CHEM, V271, P18203, DOI 10.1074/jbc.271.30.18203; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Mailly F, 1996, MOL CELL BIOL, V16, P5346; Martin-Soudant N, 2000, LEUKEMIA, V14, P863, DOI 10.1038/sj.leu.2401764; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; O'Connor MJ, 2000, J VIROL, V74, P401, DOI 10.1128/JVI.74.1.401-410.2000; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pattison S, 1997, J VIROL, V71, P2013, DOI 10.1128/JVI.71.3.2013-2022.1997; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Santaguida M, 2001, J BIOL CHEM, V276, P45780, DOI 10.1074/jbc.M107978200; SCOTT MP, 1992, CELL, V71, P551, DOI 10.1016/0092-8674(92)90588-4; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Skalicky JJ, 1996, PROTEIN SCI, V5, P296; Skalnik DG, 2002, GENE, V284, P1, DOI 10.1016/S0378-1119(02)00387-6; SKALNIK DG, 1991, J BIOL CHEM, V266, P16736; Stunkel W, 2000, J VIROL, V74, P2489, DOI 10.1128/JVI.74.6.2489-2501.2000; SUPERTIFURGA G, 1989, BIOCHIM BIOPHYS ACTA, V1007, P237, DOI 10.1016/0167-4781(89)90046-8; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; Tian G, 1999, MOL CELL BIOL, V19, P2946; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Tufarelli C, 1998, DEV BIOL, V200, P69, DOI 10.1006/dbio.1998.8950; VALARCHE I, 1993, DEVELOPMENT, V119, P881; van Gurp MF, 1999, CANCER RES, V59, P5980; VandenHeuvel GB, 1996, BIOL REPROD, V55, P731, DOI 10.1095/biolreprod55.4.731; VANWIJNEN AJ, 1989, J BIOL CHEM, V264, P15034; vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516; vanWijnen AJ, 1997, J CELL BIOCHEM, V66, P512, DOI 10.1002/(SICI)1097-4644(19970915)66:4<512::AID-JCB10>3.0.CO;2-D; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	87	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49787	49794		10.1074/jbc.M409484200	http://dx.doi.org/10.1074/jbc.M409484200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15377665	hybrid			2022-12-27	WOS:000225229500031
J	Yoon-Robarts, M; Blouin, AG; Bleker, S; Kleinschmidt, JA; Aggarawal, AK; Escalante, CR; Linden, RM				Yoon-Robarts, M; Blouin, AG; Bleker, S; Kleinschmidt, JA; Aggarawal, AK; Escalante, CR; Linden, RM			Residues within the B ' motif are critical for DNA binding by the superfamily 3 helicase Rep40 of adeno-associated virus type 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IN-VITRO; REPLICATIVE HELICASE; MUTATIONAL ANALYSIS; BIOCHEMICAL-CHARACTERIZATION; NUCLEASE DOMAIN; PROTEIN; REP68; SITE; AAV	We have recently published the crystal structure of the adeno-associated virus type 2 superfamily 3 (SF3) helicase Rep40. Although based on its biochemical properties it is unlikely that Rep40 plays a central role as a replicative helicase the involvement of this motor protein in DNA packaging has recently been demonstrated. Here we focused our attention on residues that fall within and adjacent to the B' motif of SF3 helicases that directly interact with single-stranded DNA during translocation of the motor protein. In vitro, alanine substitution at positions Lys-404 or Lys-406 abrogated the ability of the protein to interact with single-stranded DNA as demonstrated by electrophoretic mobility shift assay and fluorescence anisotropy, and accordingly these mutants could not unwind a partially duplex DNA substrate. Despite this loss of helicase activity, basal ATPase activity in these mutants remained intact. However, unlike the wild-type protein, K404A and K406A ATPase activity was not stimulated by DNA. As predicted, disruption of motor activity through interference with DNA binding resulted in an inability of Rep40 to package adeno-associated virus DNA in a tissue culture-based assay. Taken together, we characterized, for the first time in an SF3 helicase family member, residues that are directly involved in single-stranded DNA binding and that are critical for the Rep motor activity. Based on our findings we propose B' as the signature motif of SF3 helicases that is responsible for the complex interactions required for the coupling of DNA binding and ATP hydrolysis.	Mt Sinai Sch Med, Struct Biol Ctr, Dept Physiol & Biophys, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; Deutsch Krebsforschungszentrum, Appl Tumor Virol Program, D-69120 Heidelberg, Germany	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Helmholtz Association; German Cancer Research Center (DKFZ)	Escalante, CR (corresponding author), Mt Sinai Sch Med, Struct Biol Ctr, Dept Physiol & Biophys, New York, NY 10029 USA.	escalant@inka.mssm.edu; Michael.Linden@mssm.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062234] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI41706] Funding Source: Medline; NIGMS NIH HHS [R01 GM/AI62234] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATCHISON RW, 1966, VIROLOGY, V29, P353, DOI 10.1016/0042-6822(66)90045-6; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; BOHENZKY RA, 1988, VIROLOGY, V166, P316, DOI 10.1016/0042-6822(88)90502-8; BULLER RML, 1981, J VIROL, V40, P241, DOI 10.1128/JVI.40.1.241-247.1981; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cathomen T, 2000, J VIROL, V74, P2372, DOI 10.1128/JVI.74.5.2372-2382.2000; Collaco RF, 2003, J BIOL CHEM, V278, P34011, DOI 10.1074/jbc.M301537200; Davis MD, 2000, J VIROL, V74, P2936, DOI 10.1128/JVI.74.6.2936-2942.2000; Davis MD, 1999, J VIROL, V73, P2084, DOI 10.1128/JVI.73.3.2084-2093.1999; Dubielzig R, 1999, J VIROL, V73, P8989, DOI 10.1128/JVI.73.11.8989-8998.1999; GORBALENYA AE, 1990, FEBS LETT, V262, P145, DOI 10.1016/0014-5793(90)80175-I; Grimm D, 1999, GENE THER, V6, P1322, DOI 10.1038/sj.gt.3300946; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; James JA, 2003, STRUCTURE, V11, P1025, DOI 10.1016/S0969-2126(03)00152-7; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; MCCARTY DM, 1992, J VIROL, V66, P4050, DOI 10.1128/JVI.66.7.4050-4057.1992; MENDELSON E, 1986, J VIROL, V60, P823, DOI 10.1128/JVI.60.3.823-832.1986; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith RH, 1998, J VIROL, V72, P4874, DOI 10.1128/JVI.72.6.4874-4881.1998; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Walker SL, 1997, J VIROL, V71, P6996, DOI 10.1128/JVI.71.9.6996-7004.1997; WARD P, 1995, VIROLOGY, V209, P692, DOI 10.1006/viro.1995.1306; WEINDLER FW, 1991, J VIROL, V65, P2476, DOI 10.1128/JVI.65.5.2476-2483.1991; WISTUBA A, 1995, J VIROL, V69, P5311, DOI 10.1128/JVI.69.9.5311-5319.1995; YANG QC, 1992, J VIROL, V66, P6058, DOI 10.1128/JVI.66.10.6058-6069.1992; Yoon M, 2001, J VIROL, V75, P3230, DOI 10.1128/JVI.75.7.3230-3239.2001; Yoon-Robarts M, 2003, J BIOL CHEM, V278, P4912, DOI 10.1074/jbc.M209750200; Zhou XH, 1999, J VIROL, V73, P1580, DOI 10.1128/JVI.73.2.1580-1590.1999	42	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50472	50481		10.1074/jbc.M403900200	http://dx.doi.org/10.1074/jbc.M403900200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371437	hybrid			2022-12-27	WOS:000225229500113
J	Ren, YG; Kirsebom, LA; Virtanen, A				Ren, YG; Kirsebom, LA; Virtanen, A			Coordination of divalent metal ions in the active site of poly(A)-specific ribonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; 3'-5' EXONUCLEASE ACTIVITY; MAMMALIAN MESSENGER-RNA; ESCHERICHIA-COLI; KLENOW FRAGMENT; DEADENYLATION; MECHANISM; STEREOCHEMISTRY; IDENTIFICATION; CATALYSIS	Poly(A)-specific ribonuclease (PARN) is a highly poly(A)-specific 3'-exoribonuclease that efficiently degrades mRNA poly( A) tails. PARN belongs to the DEDD family of nucleases, and four conserved residues are essential for PARN activity, i.e. Asp-28, Glu-30, Asp-292, and Asp-382. Here we have investigated how catalytically important divalent metal ions are coordinated in the active site of PARN. Each of the conserved amino acid residues was substituted with cysteines, and it was found that all four mutants were inactive in the presence of Mg2+. However, in the presence of Mn2+, Zn2+, Co2+, or Cd2+, PARN activity was rescued from the PARN(D28C), PARN(D292C), and PARN(D382C) variants, suggesting that these three amino acids interact with catalytically essential metal ions. It was found that the shortest sufficient substrate for PARN activity was adenosine trinucleotide (A(3)) in the presence of Mg2+ or Cd2+. Interestingly, adenosine dinucleotide (A(2)) was efficiently hydrolyzed in the presence of Mn2+, Zn2+, or Co2+, suggesting that the substrate length requirement for PARN can be modulated by the identity of the divalent metal ion. Finally, introduction of phosphorothioate modifications into the A(3) substrate demonstrated that the scissile bond non-bridging phosphate oxygen in the pro-R position plays an important role during cleavage, most likely by coordinating a catalytically important divalent metal ion. Based on our data we discuss binding and coordination of divalent metal ions in the active site of PARN.	Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Uppsala University	Virtanen, A (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.	anders.virtanen@icm.uu.se						ASTROM J, 1991, EMBO J, V10, P3067, DOI 10.1002/j.1460-2075.1991.tb07858.x; ASTROM J, 1992, J BIOL CHEM, V267, P18154; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brautigam CA, 1999, CHEM BIOL, V6, P901, DOI 10.1016/S1074-5521(00)80009-5; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Brautigam CA, 1999, BIOCHEMISTRY-US, V38, P696, DOI 10.1021/bi981537g; BURGERS PMJ, 1978, P NATL ACAD SCI USA, V75, P4798, DOI 10.1073/pnas.75.10.4798; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Derbyshire V, 1995, METHOD ENZYMOL, V262, P363; DERBYSHIRE V, 1991, EMBO J, V10, P17, DOI 10.1002/j.1460-2075.1991.tb07916.x; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; Gao M, 2000, MOL CELL, V5, P479, DOI 10.1016/S1097-2765(00)80442-6; JAFFE EK, 1978, J BIOL CHEM, V253, P4823; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; Shan S, 2001, BIOCHEMISTRY-US, V40, P5161, DOI 10.1021/bi002887h; SLIM G, 1991, NUCLEIC ACIDS RES, V19, P1183, DOI 10.1093/nar/19.6.1183; Sontheimer EJ, 1999, GENE DEV, V13, P1729, DOI 10.1101/gad.13.13.1729; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Verma S, 1998, ANNU REV BIOCHEM, V67, P99, DOI 10.1146/annurev.biochem.67.1.99; Vortler LCS, 2000, METHOD ENZYMOL, V317, P74; Warnecke JM, 1999, J MOL BIOL, V290, P433, DOI 10.1006/jmbi.1999.2890; Warnecke JM, 2000, NUCLEIC ACIDS RES, V28, P720, DOI 10.1093/nar/28.3.720; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	33	32	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48702	48706		10.1074/jbc.M403858200	http://dx.doi.org/10.1074/jbc.M403858200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358788	hybrid			2022-12-27	WOS:000225098100027
J	Viggiani, A; Siani, L; Notomista, E; Birolo, L; Pucci, P; Di Donato, A				Viggiani, A; Siani, L; Notomista, E; Birolo, L; Pucci, P; Di Donato, A			The role of the conserved residues His-246, His-199, and Tyr-255 in the catalysis of catechol 2,3-dioxygenase from Pseudomonas stutzeri OX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRADIOL CLEAVAGE MECHANISM; 2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE; MICROBIAL-DEGRADATION; SUBSTRATE-SPECIFICITY; OXIDATIVE CLEAVAGE; GLOBIFORMIS CM-2; ACTIVE-SITE; DIOXYGENASES; PUTIDA; ENZYMES	Catechol 2,3-dioxygenase (C2,3O) from Pseudomonas stutzeri OX1, which is able to grow on various aromatic substrates as the sole source of carbon and energy, has been expressed in Escherichia coli, purified, characterized, and found to be very similar to other dioxygenases from Pseudomonas species. Interestingly, the activity of the protein shows a rather unusual pH dependence when assayed on catechol. A model of the catalytic mechanism was developed that is able to reproduce the catalytic behavior of the protein as a function of the pH. The model includes multiple equilibria and four productive intermediates with different ionization states of the enzyme-substrate complex. The fitting of the theoretical curve to the experimental data suggests that a tyrosine and two histidine residues are involved in catalysis. Mutants (H246N)-, (H246A)-, (H199N)- and (Y255F)- C2,3O were produced to investigate the role of highly conserved His-199, His-246, and Tyr-255. The strongly reduced activity of the mutants suggests a primary catalytic role for each of these residues. Moreover, mutants at positions 199 and 246 display pH profiles different from that of the wild-type protein, thus indicating that residues His-246 and His-199 play a role in determining the unusual pH dependence of the enzyme. In addition, electron-withdrawing groups on catechol, which increase the acidity of the phenolic hydroxyl group, are able to counterbalance the effect of the mutation H246N in reducing catalytic activity but cause a further reduction of the activity of ( H199N)- C2,3O. This finding suggests that His-246 is involved in the initial catechol deprotonation, whereas His-199 promotes the reaction between oxygen and the aromatic ring.	Univ Naples Federico II, Dipartimento Chim Biol, I-80134 Naples, Italy; Univ Naples Federico II, Dipartimento Chim Organ & Biochim, I-80126 Naples, Italy	University of Naples Federico II; University of Naples Federico II	Di Donato, A (corresponding author), Univ Naples Federico II, Dipartimento Chim Biol, Via Mezzocannone 16, I-80134 Naples, Italy.	didonato@unina.it	Di Donato, Alberto/G-5494-2012	PUCCI, Pietro/0000-0002-5885-1495; DI DONATO, Alberto/0000-0001-9129-9850; NOTOMISTA, Eugenio/0000-0003-0097-6487; BIROLO, Leila/0000-0002-0915-7501				BOLDT YR, 1995, J BACTERIOL, V177, P1225, DOI 10.1128/jb.177.5.1225-1232.1995; Boldt YR, 1997, BIOCHEMISTRY-US, V36, P2147, DOI 10.1021/bi962362i; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugg TDH, 2001, CHEM COMMUN, P941, DOI 10.1039/b100484k; Bugg TDH, 1998, NAT PROD REP, V15, P513; CERDAN P, 1994, J BACTERIOL, V176, P6074, DOI 10.1128/jb.176.19.6074-6081.1994; CERDAN P, 1995, EUR J BIOCHEM, V229, P113, DOI 10.1111/j.1432-1033.1995.0113l.x; Deeth RJ, 2003, J BIOL INORG CHEM, V8, P409, DOI 10.1007/s00775-002-0430-7; Eltis LD, 1996, J BACTERIOL, V178, P5930, DOI 10.1128/jb.178.20.5930-5937.1996; Groce SL, 2003, J AM CHEM SOC, V125, P11780, DOI 10.1021/ja0368103; HARAYAMA S, 1993, MOL GEN GENET, V239, P81, DOI 10.1007/BF00281605; HARAYAMA S, 1989, J BIOL CHEM, V264, P15328; Holman CM, 1999, BIOCHEMISTRY-US, V38, P677, DOI 10.1021/bi9822170; Hugo N, 1998, J BIOL CHEM, V273, P9622, DOI 10.1074/jbc.273.16.9622; Hugo N, 2000, J BACTERIOL, V182, P5580, DOI 10.1128/JB.182.19.5580-5585.2000; Kang BS, 1998, BIOCHEM BIOPH RES CO, V245, P791, DOI 10.1006/bbrc.1998.8511; Kita A, 1999, STRUCTURE, V7, P25, DOI 10.1016/S0969-2126(99)80006-9; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin G, 2001, J AM CHEM SOC, V123, P5030, DOI 10.1021/ja004280u; Mars AE, 1997, J BACTERIOL, V179, P4530, DOI 10.1128/jb.179.14.4530-4537.1997; NEWMAN LM, 1995, BIOCHEMISTRY-US, V34, P14066, DOI 10.1021/bi00043a012; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; QUE L, 1983, ADV INORG BIOCHEM, V5, P167; REINEKE W, 1988, ANNU REV MICROBIOL, V42, P263, DOI 10.1146/annurev.mi.42.100188.001403; Reynolds MF, 2003, J BIOL INORG CHEM, V8, P263, DOI 10.1007/s00775-002-0411-x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Scognamiglio R, 2001, PROTEIN SCI, V10, P482, DOI 10.1110/ps.35701; SHU LJ, 1995, BIOCHEMISTRY-US, V34, P6649, DOI 10.1021/bi00020a010; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; Timmis KN, 1999, TRENDS BIOTECHNOL, V17, P201, DOI 10.1016/S0167-7799(98)01295-5; Vaillancourt FH, 2002, J BIOL CHEM, V277, P2019, DOI 10.1074/jbc.M106890200; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; VIGGIANI A, 2003, P 2 EUR BIOR C CHAN, P457; Whiting AK, 1996, BIOCHEMISTRY-US, V35, P160, DOI 10.1021/bi951979h; Winfield CJ, 2000, J CHEM SOC PERK T 1, P3277, DOI 10.1039/b004265j; Xia M, 1999, J BIOL CHEM, V274, P3323, DOI 10.1074/jbc.274.6.3323	39	45	45	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48630	48639		10.1074/jbc.M406243200	http://dx.doi.org/10.1074/jbc.M406243200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347689	hybrid			2022-12-27	WOS:000225098100019
J	Yang, XL; Wang, WG; Fan, JS; Lal, A; Yang, DM; Cheng, HP; Gorospe, M				Yang, XL; Wang, WG; Fan, JS; Lal, A; Yang, DM; Cheng, HP; Gorospe, M			Prostaglandin A(2)-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GENE-EXPRESSION; CYCLOPENTENONE PROSTAGLANDIN; NUCLEAR IMPORT; ELEMENT; GROWTH; DEGRADATION; INDUCTION; TURNOVER; INHIBITION	Treatment with the stress agent prostaglandin A(2) (PGA(2)) induces expression of the cyclin-dependent kinase inhibitor p21. Here, we present evidence that p21 expression increases through PGA(2)-triggered stabilization of the p21 mRNA and further show that these events require the mitogen-activated protein (MAP) kinase ERK. Binding experiments using either endogenous p21 mRNA or in vitro-labeled p21 transcripts revealed a specific PGA(2)-dependent association of the p21 mRNA with the RNA-binding protein HuR. Interestingly, although inhibition of the ERK pathway did not prevent the PGA(2)-triggered increase in cytoplasmic HuR, it did impair the formation of endogenous and in vitro [HuR-p21 mRNA] complexes and further prevented the PGA(2)-mediated stabilization of the p21 mRNA, suggesting that ERK-mediated events were required for binding HuR to the p21 mRNA and preventing its decay. RNA interference-based knockdown of HuR abundance further served to demonstrate the contribution of HuR-mediated p21 mRNA stabilization toward enhancing p21 expression after PGA(2) treatment. Collectively, our results indicate that PGA(2) stabilizes the p21 mRNA through an ERK-independent increase in cytoplasmic HuR levels and an ERK-dependent association of HuR with the p21 mRNA.	NIA, Cellular & Mol Biol Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Gorospe, M (corresponding author), NIA, Cellular & Mol Biol Lab, Intramural Res Program, NIH, Box 12,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	myriam-gorospe@nih.gov	Heping, Cheng/AAE-2680-2019	Heping, Cheng/0000-0002-9604-6702	NATIONAL INSTITUTE ON AGING [Z01AG000511, Z01AG000852, ZIAAG000511] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; AMICI C, 1993, EXP CELL RES, V207, P230, DOI 10.1006/excr.1993.1188; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; CAGEN LM, 1975, BIOCHIM BIOPHYS ACTA, V398, P205, DOI 10.1016/0005-2760(75)90184-8; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHOI AMK, 1994, FASEB J, V8, P1048, DOI 10.1096/fasebj.8.13.7926370; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FUKUSHIMA M, 1994, ANN NY ACAD SCI, V744, P161, DOI 10.1111/j.1749-6632.1994.tb52733.x; FUKUSHIMA M, 1992, PROSTAG LEUKOTR ESS, V47, P1, DOI 10.1016/0952-3278(92)90178-L; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Gorospe M, 1996, MOL CELL BIOL, V16, P762; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; Gorospe M, 1996, MOL CELL BIOL, V16, P6654; GOROSPE M, 1994, J BIOL CHEM, V269, P11845; GOROSPE M, 2003, HDB CELL SIGNALING, P283; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; HOLBROOK NJ, 1992, MOL CELL BIOL, V12, P1528, DOI 10.1128/MCB.12.4.1528; HUGHESFULFORD M, 1994, J CELL BIOCHEM, V54, P265, DOI 10.1002/jcb.240540302; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; Joseph B, 1998, J BIOL CHEM, V273, P20511, DOI 10.1074/jbc.273.32.20511; Joubert AM, 2003, CANCER LETT, V191, P203, DOI 10.1016/S0304-3835(02)00625-0; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KIKUCHI Y, 1992, J CANCER RES CLIN, V118, P453, DOI 10.1007/BF01629429; KIKUCHI Y, 1992, INT J IMMUNOPHARMACO, V14, P105; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; NEGISHI M, 1995, BBA-LIPID LIPID MET, V1259, P109, DOI 10.1016/0005-2760(95)00146-4; OHNO K, 1986, BIOCHEM BIOPH RES CO, V139, P808, DOI 10.1016/S0006-291X(86)80062-6; PARKER J, 1992, BIOCHEM PHARMACOL, V43, P1053, DOI 10.1016/0006-2952(92)90612-M; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SASAKI H, 1994, ANTI-CANCER DRUG, V5, P131, DOI 10.1097/00001813-199404000-00002; SASAKI H, 1991, GYNECOL ONCOL, V41, P36, DOI 10.1016/0090-8258(91)90251-Y; Satoh T, 2003, EUR J NEUROSCI, V17, P2249, DOI 10.1046/j.1460-9568.2003.02688.x; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Straus DS, 2001, MED RES REV, V21, P185, DOI 10.1002/med.1006; Takahashi S, 1998, BIOCHEM J, V335, P35, DOI 10.1042/bj3350035; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Tran H, 2003, MOL CELL BIOL, V23, P7177, DOI 10.1128/MCB.23.20.7177-7188.2003; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	68	63	65	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49298	49306		10.1074/jbc.M407535200	http://dx.doi.org/10.1074/jbc.M407535200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15371446	hybrid			2022-12-27	WOS:000225098100098
J	Chytil, A; Waltner-Law, M; West, R; Friedman, D; Aakre, M; Barker, D; Law, B				Chytil, A; Waltner-Law, M; West, R; Friedman, D; Aakre, M; Barker, D; Law, B			Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; INDUCED GROWTH ARREST; DEPENDENT KINASE; RETINOBLASTOMA PROTEIN; FARNESYLTRANSFERASE INHIBITOR; NUCLEAR ANTIGEN; DOWN-REGULATION; CDK INHIBITORS; BREAST-CANCER; DNA-SYNTHESIS	Cyclin D1 is frequently overexpressed in human breast cancers, and cyclin D1 overexpression correlates with poor prognosis. Cyclin D1-Cdk2 complexes were previously observed in human breast cancer cell lines, but their role in cell cycle regulation and transformation was not investigated. This report demonstrates that Cdk2 in cyclin D1-Cdk2 complexes from mammary epithelial cells is phosphorylated on the activating phosphorylation site, Thr(160). Furthermore, cyclin D1-Cdk2 complexes catalyze Rb phosphorylation on multiple sites in vitro. As a model to investigate the biological and biochemical functions of cyclin D1-Cdk2 complexes, and the mechanisms by which cyclin D1 activates Cdk2, a cyclin D1-Cdk2 fusion gene was constructed. The cyclin D1-Cdk2 fusion protein expressed in epithelial cells was phosphorylated on Thr160 and catalyzed the phosphorylation of Rb on multiple sites in vitro and in vivo. Kinase activity was not observed if either the cyclin D1 or Cdk2 domain was mutationally inactivated. Mutational inactivation of the cyclin D1 domain prevented activating phosphorylation of the Cdk2 domain on Thr160. These results indicate that the cyclin D1 domain of the fusion protein activated the Cdk2 domain through an intramolecular mechanism. Cells stably expressing the cyclin D1-Cdk2 fusion protein exhibited several hallmarks of transformation including hyperphosphorylation of Rb, resistance to TGFbeta-induced growth arrest, and anchorage-independent proliferation in soft agar. We propose that cyclin D1-Cdk2 complexes mediate some of the transforming effects of cyclin D1 and demonstrate that the cyclin D1-Cdk2 fusion protein is a useful model to investigate the biological functions of cyclin D1-Cdk2 complexes.	Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Mass Spectrometry Res Ctr, Vanderbilt Proteom Lab, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Law, B (corresponding author), Univ Florida, Shands Canc Ctr, Dept Pharmacol & Therapeut, Acad RSCH BLDG,Rm R5-126,1600 SW Archer Rd,POB 10, Gainesville, FL 32610 USA.	bklaw@pharmacology.ufl.edu	Barker, David JP/A-5671-2013		NATIONAL CANCER INSTITUTE [P30CA068485, R01CA093651] Funding Source: NIH RePORTER; NCI NIH HHS [CA68485, R01-CA93651] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afshari CA, 1996, CELL GROWTH DIFFER, V7, P979; Bandyopadhyay A, 1998, CARCINOGENESIS, V19, P1907, DOI 10.1093/carcin/19.11.1907; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brown KA, 2004, BREAST CANCER RES, V6, pR130, DOI 10.1186/bcr762; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Doebis C, 2002, TRANSPL IMMUNOL, V9, P323, DOI 10.1016/S0966-3274(02)00034-5; DOU QP, 1994, BIOCHEM BIOPH RES CO, V205, P1859, DOI 10.1006/bbrc.1994.2887; DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Higashi H, 1996, EUR J BIOCHEM, V237, P460, DOI 10.1111/j.1432-1033.1996.0460k.x; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; HORTON LE, 1995, CELL GROWTH DIFFER, V6, P395; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Law BK, 2000, J BIOL CHEM, V275, P38261, DOI 10.1074/jbc.M005545200; Law BK, 1999, J BIOL CHEM, V274, P4743, DOI 10.1074/jbc.274.8.4743; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; Law BK, 2002, MOL CELL BIOL, V22, P8184, DOI 10.1128/MCB.22.23.8184-8198.2002; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Muraoka RS, 2001, J CELL BIOL, V153, P917, DOI 10.1083/jcb.153.5.917; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060, DOI 10.1074/jbc.270.29.17060; Pan WJ, 2001, CANCER RES, V61, P2885; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; Rao RN, 1999, ONCOGENE, V18, P6343, DOI 10.1038/sj.onc.1203009; Resnitzky D, 1997, MOL CELL BIOL, V17, P5640, DOI 10.1128/MCB.17.9.5640; SALOMON DS, 1987, J CELL PHYSIOL, V130, P397, DOI 10.1002/jcp.1041300313; Sasano H, 1997, ANTICANCER RES, V17, P3685; Shiyanov P, 1996, MOL CELL BIOL, V16, P737; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sutherland RL, 2002, BREAST CANCER RES, V4, P14, DOI 10.1186/bcr411; Sweeney KJ, 1998, ONCOGENE, V16, P2865, DOI 10.1038/sj.onc.1201814; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; ZHU L, 1995, GENE DEV, V9, P1740, DOI 10.1101/gad.9.14.1740	45	40	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47688	47698		10.1074/jbc.M405938200	http://dx.doi.org/10.1074/jbc.M405938200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355984	hybrid			2022-12-27	WOS:000224957000034
J	Fukuchi, M; Tabuchi, A; Tsuda, M				Fukuchi, M; Tabuchi, A; Tsuda, M			Activity-dependent transcriptional activation and mRNA stabilization for cumulative expression of pituitary adenylate cyclase-activating polypeptide mRNA controlled by calcium and cAMP signals in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; GENE PROMOTER-I; PACAP GENE; MAP KINASE; MEMBRANE DEPOLARIZATION; SPLICE VARIANTS; C-FOS; CREB; RECEPTOR; BDNF	Although it has been established that an activity-dependent gene transcription is induced by the calcium (Ca2+) signals in neurons, it is unclear how the specific mRNA moieties are transiently accumulated in response to synaptic transmission which evokes multiple intracellular signals including Ca2+ and cAMP ones. The expression of pituitary adenylate cyclase activating polypeptide (PACAP), a neuropeptide, is controlled by Ca2+ signals evoked via membrane depolarization in neurons, and, in cultured rat cortical neuronal cells, we found that the Ca2+ signal-mediated activation of the PACAP gene promoter was critically controlled by a single cAMP-response element (CRE) located at around -200, to which the CRE-binding protein predominantly bound. The Ca2+ signal-induced expression of PACAP mRNA was enhanced by forskolin, which evokes cAMP signals. In support, the PACAP gene promoter was synergistically enhanced by Ca2+ and cAMP signals through the CRE, accompanying a prolonged activation of extracellular signal-related protein kinase 1/2 and CRE-binding protein. On the other hand, sole administration of forskolin markedly reduced the cellular content of PACAP mRNA, which was restored by the addition of Ca2+ signals. We found that the stability of PACAP mRNA was increased in response to Ca2+ signals but not that of activity-regulated cytoskeleton-associated protein (Arc) mRNA, indicating an activity-dependent stabilization of specific mRNA species in neurons, which can antagonize the regulation mediated by cAMP signals. Thus, the transcriptional activation and mRNA stabilization are coordinately regulated by Ca2+ and cAMP signals for the cumulative expression of PACAP mRNA in neurons.	Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Biol Chem, Toyama 9310194, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1500002, Japan	University of Toyama; Japan Science & Technology Agency (JST)	Tsuda, M (corresponding author), Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Biol Chem, Sugitani 2630, Toyama 9310194, Japan.	tsuda@ms.toyama-mpu.ac.jp		Fukuchi, Mamoru/0000-0002-6807-8707				Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Brandenburg CA, 1997, J NEUROSCI, V17, P4045; Chen WG, 2003, J NEUROSCI, V23, P2572; Cummings KJ, 2002, MOL CELL ENDOCRINOL, V192, P133, DOI 10.1016/S0303-7207(02)00028-X; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Hansen TVO, 2004, J NEUROCHEM, V89, P15, DOI 10.1046/j.1471-4159.2003.02252.x; Harakall SA, 1998, ANN NY ACAD SCI, V865, P367, DOI 10.1111/j.1749-6632.1998.tb11197.x; Hashimoto H, 2000, J NEUROCHEM, V74, P501, DOI 10.1046/j.1471-4159.2000.740501.x; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jean D, 1998, J BIOL CHEM, V273, P24884, DOI 10.1074/jbc.273.38.24884; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Li M, 1999, NEUROENDOCRINOLOGY, V69, P217, DOI 10.1159/000054422; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Otto C, 2001, J NEUROSCI, V21, P5520, DOI 10.1523/JNEUROSCI.21-15-05520.2001; Park JI, 2000, MOL HUM REPROD, V6, P238, DOI 10.1093/molehr/6.3.238; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Sasaki M, 2000, P NATL ACAD SCI USA, V97, P8617, DOI 10.1073/pnas.97.15.8617; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Tabuchi A, 2001, NEUROSCI RES, V39, P85, DOI 10.1016/S0168-0102(00)00200-5; Tabuchi A, 2001, NEUROREPORT, V12, P1181, DOI 10.1097/00001756-200105080-00026; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Tabuchi A, 1998, BIOCHEM BIOPH RES CO, V253, P818, DOI 10.1006/bbrc.1998.9854; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vaudry D, 2000, PHARMACOL REV, V52, P269; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; White SL, 2000, ANN NY ACAD SCI, V921, P370; Yamamoto K, 1998, GENE, V211, P63, DOI 10.1016/S0378-1119(98)00110-3	40	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2004	279	46					47856	47865		10.1074/jbc.M409090200	http://dx.doi.org/10.1074/jbc.M409090200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	869BJ	15355970	hybrid			2022-12-27	WOS:000224957000055
J	Sapra, AK; Arava, Y; Khandelia, P; Vijayraghavan, U				Sapra, AK; Arava, Y; Khandelia, P; Vijayraghavan, U			Genome-wide analysis of Pre-mRNA splicing - Intron features govern the requirement for the second-step factor, Prp17 in Saccharomyces cerevisiae and Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; SPLICEOSOME ACTIVATION; SYSTEMATIC ANALYSIS; DNA-REPLICATION; YEAST; EXPRESSION; COMPLEXES; MUTANTS; PROTEIN; SLU7	Removal of pre-mRNA introns is an essential step in eukaryotic genome interpretation. The spliceosome, a ribonucleoprotein performs this critical function; however, precise roles for many of its proteins remain unknown. Genome-wide consequences triggered by the loss of a specific factor can elucidate its function in splicing and its impact on other cellular processes. We have employed splicing-sensitive DNA microarrays, with yeast open reading frames and intron sequences, to detect changes in splicing efficiency and global expression. Comparison of expression profiles, for intron-containing transcripts, among mutants of two second-step factors, Prp17 and Prp22, reveals their unique and shared effects on global splicing. This analysis enabled the identification of substrates dependent on Prp17. We find a significant Prp17 role in splicing of introns which are longer than 200nts and note its dispensability when introns have a less than or equal to 13-nucleotide spacing between their branch point nucleotide and 3' splice site. In vitro splicing of substrates with varying branch nucleotide to 3' splice site distances supports the differential Prp17 dependencies inferred from the in vivo analysis. Furthermore, we tested the predicted dispensability of Prp17 for splicing short introns in the evolutionarily distant yeast, Schizosaccharomyces pombe, where the genome contains predominantly short introns. SpPrp17 was non-essential at all growth temperatures implying that functional evolution of splicing factors is integrated with genome evolution. Together our studies point to a role for budding yeast Prp17 in splicing of subsets of introns and have predictive value for deciphering the functions of splicing factors in gene expression and regulation in other eukaryotes.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Indian Institute of Science (IISC) - Bangalore; Stanford University	Vijayraghavan, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	uvr@mcbl.iisc.ernet.in						ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Ben-Yehuda S, 2000, GENETICS, V154, P61; BENYEHUDA S, 1998, RNA NY, V4, P1503; Biggins S, 2001, GENETICS, V159, P453; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Brys A, 1996, RNA, V2, P707; Chawla G, 2003, NUCLEIC ACIDS RES, V31, P2333, DOI 10.1093/nar/gkg333; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Dahan O, 2004, NUCLEIC ACIDS RES, V32, P2529, DOI 10.1093/nar/gkh574; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; JOHNSTON LH, 1982, MOL GEN GENET, V186, P439, DOI 10.1007/BF00729466; JONES MH, 1995, P NATL ACAD SCI USA, V92, P9687, DOI 10.1073/pnas.92.21.9687; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lindsey LA, 1998, J BIOL CHEM, V273, P32771, DOI 10.1074/jbc.273.49.32771; Lindsey-Boltz LA, 2000, RNA, V6, P1289, DOI 10.1017/S1355838200000327; McPheeters DS, 2003, MOL CELL BIOL, V23, P4174, DOI 10.1128/MCB.23.12.4174-4186.2003; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi R, 1998, MOL CELL BIOL, V18, P4097, DOI 10.1128/MCB.18.7.4097; Schwer B, 1998, EMBO J, V17, P2086, DOI 10.1093/emboj/17.7.2086; SHEA JE, 1994, NUCLEIC ACIDS RES, V22, P5555, DOI 10.1093/nar/22.25.5555; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; THOMPSONJAGER S, 1987, MOL CELL BIOL, V7, P4010, DOI 10.1128/MCB.7.11.4010; UMEN JG, 1995, RNA, V1, P584; Urushiyama S, 1996, MOL GEN GENET, V253, P118, DOI 10.1007/s004380050304; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; VIJAYRAGHAVAN U, 1986, EMBO J, V5, P1683, DOI 10.1002/j.1460-2075.1986.tb04412.x; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Zhang XP, 1997, NUCLEIC ACIDS RES, V25, P2146, DOI 10.1093/nar/25.11.2146; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792; Zhu WG, 2002, GENETICS, V160, P1319	43	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52437	52446		10.1074/jbc.M408815200	http://dx.doi.org/10.1074/jbc.M408815200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15452114	hybrid			2022-12-27	WOS:000225493400088
J	Tupling, AR; Gramolini, AO; Duhamel, TA; Kondo, H; Asahi, M; Tsuchiya, SC; Borrelli, MJ; Lepock, JR; Otsu, K; Hori, M; MacLennan, DH; Green, HJ				Tupling, AR; Gramolini, AO; Duhamel, TA; Kondo, H; Asahi, M; Tsuchiya, SC; Borrelli, MJ; Lepock, JR; Otsu, K; Hori, M; MacLennan, DH; Green, HJ			HSP70 binds to the fast-twitch skeletal muscle sarco(endo) plasmic reticulum Ca2+-ATPase (SERCA1a) and prevents thermal inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SARCOPLASMIC-RETICULUM; OXIDATIVE STRESS; RAT MUSCLE; TRANSGENIC MICE; SR CA2+-ATPASE; CA-ATPASE; PHOSPHOLAMBAN; CA-2+-ATPASE; DENATURATION	This study examined whether HSP70 could bind to and protect against thermal inactivation of SERCA1a, the SERCA isoform expressed in adult fast-twitch skeletal muscle. Sarcoplasmic reticulum vesicles prepared from rat gastrocnemius muscle were incubated with purified HSP70 at both 37 and 41 degreesC for either 30, 60, or 120 min. Maximal SERCA1a activity (mumol/g protein/min) in the absence of HSP70 was reduced progressively with time, with greater reductions occurring at 41 degreesC compared with 37 degreesC. HSP70 protected against thermal inactivation of SERCA1a activity at 37 degreesC but not at 41 degreesC and only at 30 and 60 min but not at 120 min. HSP70 also protected against reductions in binding capacity for fluorescein isothiocyanate, a fluorescent probe that binds to Lys515 in the nucleotide binding domain of SERCA, at 30 and 60 min but not at 120 min, an effect that was independent of temperature. HEK-293 cells were cotransfected with cDNAs encoding rabbit SERCA1a and human HSP-EYFP and subjected to 40 degreesC for 1 h. Immunohistochemistry revealed nearly complete co-localization of SERCA1a with HSP70 under these conditions. Co-immunoprecipitation showed physical interaction between HSP70 and SERCA1a under all thermal conditions both in vitro and in HEK-293 cells. Modeling showed that the fluorescein isothiocyanate-binding site of intact SERCA1a in the E2 form lies in its close proximity to a potential interaction site between SERCA1a and HSP70. These results indicate that HSP70 can bind to SERCA1a and, depending on the severity of heat stress, protect SERCA1a function by stabilizing the nucleotide binding domain.	Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L6, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Osaka Univ, Dept Internal Med & Therapeut, Grad Sch Med, Suita, Osaka 5650871, Japan; William Beaumont Hosp, Dept Radiat Oncol, Royal Oak, MI 48073 USA	University of Waterloo; University of Toronto; University of Toronto; Osaka University; Beaumont Health	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, 200 Univ Ave, Waterloo, ON N2L 3G1, Canada.	rtupling@uwaterloo.ca	Duhamel, Todd/ABA-9623-2020; Duhamel, Todd A/F-4433-2017	Duhamel, Todd/0000-0001-8467-4800; Duhamel, Todd A/0000-0001-8467-4800; Tupling, A. Russell/0000-0002-3895-6767				Arnaud C, 2002, BRIT J PHARMACOL, V135, P1776, DOI 10.1038/sj.bjp.0704619; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Bidmon B, 2000, KIDNEY INT, V58, P2400, DOI 10.1046/j.1523-1755.2000.00423.x; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Bruskov VI, 2002, NUCLEIC ACIDS RES, V30, P1354, DOI 10.1093/nar/30.6.1354; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Callahan MK, 2002, J BIOL CHEM, V277, P33604, DOI 10.1074/jbc.M202890200; Choudhary Gaurav, 2002, Congest Heart Fail, V8, P148, DOI 10.1111/j.1527-5299.2002.00716.x; CLARKE DM, 1990, J BIOL CHEM, V265, P17405; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Davidson GA, 1996, BBA-GEN SUBJECTS, V1289, P187, DOI 10.1016/0304-4165(95)00155-7; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Favero TG, 1998, J APPL PHYSIOL, V84, P425, DOI 10.1152/jappl.1998.84.2.425; HEADS RJ, 1995, J MOL CELL CARDIOL, V27, P1669, DOI 10.1016/S0022-2828(95)90722-X; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Javed MUH, 1999, BIOCHEM MOL BIOL INT, V47, P631; KAMPINGA HH, 1993, J CELL SCI, V104, P11; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Klebl BM, 1998, FEBS LETT, V422, P381, DOI 10.1016/S0014-5793(98)00053-2; KNOWLTON A, 1997, HEAT SHOCK PROTEINS, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBERER E, 1987, EUR J BIOCHEM, V162, P555, DOI 10.1111/j.1432-1033.1987.tb10675.x; LEPOCK JR, 1990, BIOCHEMISTRY-US, V29, P681, DOI 10.1021/bi00455a013; Lepore DA, 2000, MUSCLE NERVE, V23, P1847, DOI 10.1002/1097-4598(200012)23:12<1847::AID-MUS8>3.0.CO;2-U; LIU X, 2003, ANN REV PHARM TOXICO, V44, P349; LUCKIN KA, 1991, BIOCHEM MED METAB B, V46, P391, DOI 10.1016/0885-4505(91)90087-2; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Maglara AA, 2003, J PHYSIOL-LONDON, V548, P837, DOI 10.1113/jphysiol.2002.034520; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Matsunaga S, 2001, J MUSCLE RES CELL M, V22, P685, DOI 10.1023/A:1016310607568; MATSUSHITA S, 1992, BIOCHEM J, V285, P303, DOI 10.1042/bj2850303; MCINTOSH DB, 1978, J BIOL CHEM, V253, P5140; Morris TE, 1997, FREE RADICAL BIO MED, V22, P37, DOI 10.1016/S0891-5849(96)00238-9; OBrien PJ, 1997, MOL CELL BIOCHEM, V173, P135, DOI 10.1023/A:1006840013439; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PLUMIER JCL, 1995, J CLIN INVEST, V95, P1854, DOI 10.1172/JCI117865; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Reid MB, 2001, J APPL PHYSIOL, V90, P724, DOI 10.1152/jappl.2001.90.2.724; Rice WJ, 2001, BIOPHYS J, V80, P2187, DOI 10.1016/S0006-3495(01)76191-7; Rubin BB, 1996, J APPL PHYSIOL, V80, P369, DOI 10.1152/jappl.1996.80.2.369; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; Schertzer JD, 2002, AM J PHYSIOL-ENDOC M, V283, pE722, DOI 10.1152/ajpendo.00204.2002; Schertzer JD, 2003, AM J PHYSIOL-ENDOC M, V284, pE597, DOI 10.1152/ajpendo.00190.2002; Senisterra GA, 1997, BIOCHEMISTRY-US, V36, P11002, DOI 10.1021/bi9711590; Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier; Temsah RM, 1999, AM J PHYSIOL-HEART C, V277, pH584, DOI 10.1152/ajpheart.1999.277.2.H584; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tupling R, 2001, AM J PHYSIOL-ENDOC M, V281, pE224, DOI 10.1152/ajpendo.2001.281.2.E224; Tupling R, 2001, AM J PHYSIOL-REG I, V281, pR1681, DOI 10.1152/ajpregu.2001.281.5.R1681; Viner RI, 1997, BIOCHEMISTRY-US, V36, P7706, DOI 10.1021/bi970058z; Viner RI, 1999, BIOCHEMISTRY-US, V38, P12408, DOI 10.1021/bi9909445; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; WU KD, 1993, AM J PHYSIOL, V264, pC333, DOI 10.1152/ajpcell.1993.264.2.C333; Xu KY, 1997, CIRC RES, V80, P76, DOI 10.1161/01.RES.80.1.76; Zucchi R, 2001, PHARMACOL THERAPEUT, V89, P47, DOI 10.1016/S0163-7258(00)00103-0	61	64	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					52382	52389		10.1074/jbc.M409336200	http://dx.doi.org/10.1074/jbc.M409336200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15371420	hybrid			2022-12-27	WOS:000225493400082
J	Pierreux, CE; Vanhorenbeeck, V; Jacquemin, P; Lemaigre, FP; Rousseau, GG				Pierreux, CE; Vanhorenbeeck, V; Jacquemin, P; Lemaigre, FP; Rousseau, GG			The transcription factor hepatocyte nuclear factor-6/Onecut-1 controls the expression of its paralog Onecut-3 in developing mouse endoderm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN MEMBER; CELL LINES; LIVER; HOMEODOMAIN; GENE; DIFFERENTIATION; PANCREAS; HNF-6; ACTIVATOR; PROTEINS	During development, the endoderm gives rise to several organs, including the pancreas and liver. This differentiation process requires spatial and temporal regulation of gene expression in the endoderm by a network of tissue-specific transcription factors whose elucidation is far from complete. These factors include the Onecut protein hepatocyte nuclear factor-6 (HNF-6), which controls pancreas and liver development as shown in our previous work on Hnf6 knock-out embryos. In mammals, HNF-6 has two paralogs, Onecut-2 (OC-2) and OC-3, whose patterns of expression in the adult overlap with that of HNF-6. In the present work, we examine the expression profile of the three Onecut factors in the developing mouse endoderm. We show that HNF-6, OC-2, and OC-3 are expressed sequentially, which defines new steps in endoderm differentiation. By analyzing Hnf6 knock-out embryos we find that HNF-6 is required for expression of the Oc3 gene in the endoderm. We show that OC-3 colocalizes with HNF-6 in the endoderm and in embryonic pancreas and liver. Based on transfection, chromatin immunoprecipitation, and whole embryo electroporation experiments, we demonstrate that HNF-6 can bind to and stimulate the expression of the Oc3 gene. This study identifies a regulatory cascade between two paralogous transcription factors, sheds new light on the interpretation of the Hnf6 knock-out phenotype, and broadens the transcription factors network operating during development of the endoderm, liver, and pancreas.	Inst Cellular Pathol, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; Catholic Univ Louvain, B-1200 Brussels, Belgium	Universite Catholique Louvain	Rousseau, GG (corresponding author), ICP URL, HORM Unit, Box 7529,75 Ave Hippocrate, B-1200 Brussels, Belgium.	christophe.pierreux@horm.ucl.ac.be	Jacquemin, Patrick/ABA-7932-2021	Lemaigre, Frederic/0000-0002-3609-434X				Briancon N, 2004, J BIOL CHEM, V279, P33398, DOI 10.1074/jbc.M405312200; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; Clotman F, 2002, DEVELOPMENT, V129, P1819; Grapin-Botton A, 2000, TRENDS GENET, V16, P124, DOI 10.1016/S0168-9525(99)01957-5; Hong SK, 2002, MECH DEVELOP, V112, P199, DOI 10.1016/S0925-4773(01)00647-5; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, GENE EXPR PATTERNS, V3, P639, DOI 10.1016/S1567-133X(03)00110-8; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552; Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Nguyen DNT, 2000, MECH DEVELOP, V97, P57, DOI 10.1016/S0925-4773(00)00431-7; Nowling T, 2003, J BIOL CHEM, V278, P13696, DOI 10.1074/jbc.M207567200; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; PLUMBRUDEWIEZ N, 2004, IN PRESS HEPATOLOGY; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Streeper RS, 2001, J BIOL CHEM, V276, P19111, DOI 10.1074/jbc.M101442200; Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101; Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123; van Eyll JM, 2004, J CELL SCI, V117, P2077, DOI 10.1242/jcs.01067; Vanhorenbeeck V, 2002, BIOCHEM BIOPH RES CO, V292, P848, DOI 10.1006/bbrc.2002.6760; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393	27	30	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					51298	51304		10.1074/jbc.M409038200	http://dx.doi.org/10.1074/jbc.M409038200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15381696	hybrid			2022-12-27	WOS:000225355800079
J	Cilenti, L; Soundarapandian, MM; Kyriazis, GA; Stratico, V; Singh, S; Gupta, S; Bonventre, JV; Alnemri, ES; Zervos, AS				Cilenti, L; Soundarapandian, MM; Kyriazis, GA; Stratico, V; Singh, S; Gupta, S; Bonventre, JV; Alnemri, ES; Zervos, AS			Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; INHIBITOR; INTERACTS; HTRA; MITOCHONDRIA; CHAPERONE; ASSAY; XIAP; MND2	Omi/HtrA2 is a nuclear-encoded mitochondrial serine protease that has a pro-apoptotic function in mammalian cells. Upon induction of apoptosis, Omi translocates to the cytoplasm and participates in caspase-dependent apoptosis by binding and degrading inhibitor of apoptosis proteins. Omi can also initiate caspase-independent apoptosis in a process that relies entirely on its ability to function as an active protease. To investigate the mechanism of Omi-induced apoptosis, we set out to isolate novel substrates that are cleaved by this protease. We identified HS1-associated protein X-1 (HAX-1), a mitochondrial anti-apoptotic protein, as a specific Omi interactor that is cleaved by Omi both in vitro and in vivo. HAX-1 degradation follows Omi activation in cells treated with various apoptotic stimuli. Using a specific inhibitor of Omi, HAX-1 degradation is prevented and cell death is reduced. Cleavage of HAX-1 was not observed in a cell line derived from motor neuron degeneration 2 mice that carry a mutated form of Omi that affects its proteolytic activity. Degradation of HAX-1 is an early event in the apoptotic process and occurs while Omi is still confined in the mitochondria. Our results suggest that Omi has a unique pro-apoptotic function in mitochondria that involves removal of the HAX-1 antiapoptotic protein. This function is distinct from its ability to activate caspase-dependent apoptosis in the cytoplasm by degrading inhibitor of apoptosis proteins.	Univ Cent Florida, Biomol Sci Ctr, Burnett Coll Biomed Sci, Orlando, FL 32826 USA; Thomas Jefferson Univ, Ctr Apoptosis Res, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Inst, Philadelphia, PA 19107 USA; Harvard Univ, Sch Med, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA	State University System of Florida; University of Central Florida; Jefferson University; Jefferson University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zervos, AS (corresponding author), Univ Cent Florida, Biomol Sci Ctr, Burnett Coll Biomed Sci, 12722 Res Pkwy, Orlando, FL 32826 USA.	azervos@mail.ucf.edu	Alnemri, Emad S/B-4526-2010; Gupta, Sanjeev/AAG-9749-2020; gupta, sanjeev/B-2824-2008	Gupta, Sanjeev/0000-0002-4691-6853; gupta, sanjeev/0000-0002-4691-6853; Kyriazis, George/0000-0001-9514-3482	NIDDK NIH HHS [DK55734-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055734] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blink E, 2004, CELL DEATH DIFFER, V11, P937, DOI 10.1038/sj.cdd.4401409; Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Derby E, 2001, IMMUNOL LETT, V78, P35, DOI 10.1016/S0165-2478(01)00226-7; Dufva M, 2001, J GEN VIROL, V82, P1581, DOI 10.1099/0022-1317-82-7-1581; Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581; Fantin VR, 2004, CANCER RES, V64, P329, DOI 10.1158/0008-5472.CAN-03-0899; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; GATEAU O, 1978, EUR J BIOCHEM, V88, P613, DOI 10.1111/j.1432-1033.1978.tb12488.x; Gupta S, 2004, J BIOL CHEM, V279, P45844, DOI 10.1074/jbc.M404940200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Herault O, 1999, BRIT J HAEMATOL, V104, P530, DOI 10.1046/j.1365-2141.1999.01203.x; JONES JM, 1993, GENOMICS, V16, P669, DOI 10.1006/geno.1993.1246; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kim DY, 2002, ACTA CRYSTALLOGR D, V58, P170, DOI 10.1107/S0907444901018248; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Matsuda G, 2003, MICROBIOL IMMUNOL, V47, P91, DOI 10.1111/j.1348-0421.2003.tb02790.x; Mirmohammadsadegh A, 2003, J INVEST DERMATOL, V120, P1045, DOI 10.1046/j.1523-1747.2003.12247.x; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Trencia A, 2004, J BIOL CHEM, V279, P46566, DOI 10.1074/jbc.M406317200; Vaux DL, 2003, CELL, V115, P251, DOI 10.1016/S0092-8674(03)00851-1; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	32	150	156	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50295	50301		10.1074/jbc.M406006200	http://dx.doi.org/10.1074/jbc.M406006200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15371414	hybrid, Green Published			2022-12-27	WOS:000225229500092
J	Ralat, LA; Colman, RF				Ralat, LA; Colman, RF			Glutathione S-Transferase Pi has at least three distinguishable xenobiotic substrate sites close to its glutathione-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE RESIDUES; 3-DIMENSIONAL STRUCTURE; CHEMICAL-MODIFICATION; DIRECTED MUTAGENESIS; HUMAN PLACENTA; THIOL-GROUP; P1-1; A1-1; MONOBROMOBIMANE; ISOTHIOCYANATES	Benzyl isothiocyanate (BITC), present in cruciferous vegetables, is an efficient substrate of human glutathione S-transferase P1-1 (hGST P1-1). BITC also acts as an affinity label of hGST P1-1 in the absence of glutathione, yielding an enzyme inactive toward BITC as substrate. As monitored by using BITC as substrate, the dependence of k of inactivation (K-I) of hGST P1-1 on [ BITC] is hyperbolic, with K-I = 66 +/- 7 muM. The enzyme incorporates 2 mol of BITC/mol of enzyme subunit upon complete inactivation. S-Methylglutathione and 8-anilino-1-naphthalene sulfonate (ANS) each yield partial protection against inactivation and decrease reagent incorporation, whereas S-(N-benzylthiocarbamoyl) glutathione or S-methylglutathione + ANS protects completely. Mapping of proteolytic digests of modified enzyme by using mass spectrometry reveals that Tyr(103) and Cys(47) are modified equally. S- Methylglutathione reduces modification of Cys47, indicating this residue is at/near the glutathione binding region, whereas ANS decreases modification of Tyr(103), suggesting this residue is at/near the BITC substrate site, which is also near the binding site of ANS. The Y103F and Y103S mutant enzymes were generated, expressed, and purified. Both mutants handle substrate 1-chloro-2,4-dinitrobenzene normally; however, Y103S exhibits a 30-fold increase in Km for BITC and binds ANS poorly, whereas Y103F has a normal K-m for BITC and K-d for ANS. These results indicate that an aromatic residue at position 103 is essential for the binding of BITC and ANS. This study provides evidence for the existence of a novel xenobiotic substrate site in hGST P1-1, which can be occupied by benzyl isothiocyanate and is distinct from that of monobromobimane and 1-chloro-2,4 dinitrobenzene.	Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Colman, RF (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	rfcolman@chem.udel.edu			NATIONAL CANCER INSTITUTE [R01CA066561] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA66561] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACETO A, 1989, BIOCHEM PHARMACOL, V38, P3653, DOI 10.1016/0006-2952(89)90568-6; Ahn SY, 2003, B KOREAN CHEM SOC, V24, P1188; BICO P, 1994, BIOCHIM BIOPHYS ACTA, V1247, P225; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CACCURI AM, 1990, EUR J BIOCHEM, V189, P493, DOI 10.1111/j.1432-1033.1990.tb15514.x; CACCURI AM, 1992, ARCH BIOCHEM BIOPHYS, V297, P119, DOI 10.1016/0003-9861(92)90648-G; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; CHEN WL, 1992, BIOCHEM J, V286, P205, DOI 10.1042/bj2860205; COLMAN RF, 1997, PROTEIN FUNCTION, P155; DESIDERI A, 1991, J BIOL CHEM, V266, P2063; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HONG KH, 1993, PROTEIN ENG, V6, P93; HSIEH JC, 1991, BIOCHEM J, V278, P293, DOI 10.1042/bj2780293; HULBERT PB, 1983, J PHARM PHARMACOL, V35, P384, DOI 10.1111/j.2042-7158.1983.tb02962.x; JI XH, 1995, BIOCHEMISTRY-US, V34, P5317, DOI 10.1021/bi00016a003; JI XH, 1994, BIOCHEMISTRY-US, V33, P1043, DOI 10.1021/bi00171a002; Ji XH, 1997, BIOCHEMISTRY-US, V36, P9690, DOI 10.1021/bi970805s; Kase H, 1998, ACTA CYTOL, V42, P1397, DOI 10.1159/000332174; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Kolobe D, 2004, BIOCHEM J, V382, P703, DOI 10.1042/BJ20040056; KONG KH, 1992, BIOCHEM BIOPH RES CO, V184, P194, DOI 10.1016/0006-291X(92)91177-R; KONG KH, 1991, BIOCHEM BIOPH RES CO, V181, P748, DOI 10.1016/0006-291X(91)91254-A; KONG KH, 1992, BIOCHEM BIOPH RES CO, V182, P1122, DOI 10.1016/0006-291X(92)91848-K; LOBELLO M, 1990, FEBS LETT, V263, P389, DOI 10.1016/0014-5793(90)81421-J; Lyon RP, 2002, BIOCHEMISTRY-US, V41, P10920, DOI 10.1021/bi0262810; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; MANOHARAN TH, 1992, J BIOL CHEM, V267, P18940; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; MEYER DJ, 1995, BIOCHEM J, V306, P565, DOI 10.1042/bj3060565; Morrow CS, 1998, J BIOL CHEM, V273, P20114, DOI 10.1074/jbc.273.32.20114; Niitsu Y, 1998, CHEM-BIOL INTERACT, V112, P325; NISHIHIRA J, 1992, BIOCHEM BIOPH RES CO, V188, P424, DOI 10.1016/0006-291X(92)92402-J; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Oakley AJ, 1998, BIOCHEMISTRY-US, V37, P9912, DOI 10.1021/bi980323w; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Park HJ, 2001, B KOREAN CHEM SOC, V22, P77; Penefsky H S, 1979, Methods Enzymol, V56, P527; Ralat LA, 2004, FASEB J, V18, pC241; Ralat LA, 2003, PROTEIN SCI, V12, P2575, DOI 10.1110/ps.03249303; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; WILCE MCJ, 1995, EMBO J, V14, P2133, DOI 10.1002/j.1460-2075.1995.tb07207.x; ZHANG YS, 1995, BIOCHEM BIOPH RES CO, V206, P748, DOI 10.1006/bbrc.1995.1106	48	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50204	50213		10.1074/jbc.M407445200	http://dx.doi.org/10.1074/jbc.M407445200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15347687	hybrid			2022-12-27	WOS:000225229500081
J	Dufner-Beattie, J; Kuo, YM; Gitschier, J; Andrews, GK				Dufner-Beattie, J; Kuo, YM; Gitschier, J; Andrews, GK			The adaptive response to dietary zinc in mice involves the differential cellular localization and zinc regulation of the zinc transporters ZIP4 and ZIP5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE METALLOTHIONEIN-I; LETHAL MILK; STIMULATED ENDOCYTOSIS; ANTIGEN RETRIEVAL; MOLECULAR-BIOLOGY; LIV-1 SUBFAMILY; GENE; EXPRESSION; FAMILY; DEFICIENCY	The ZIP5 gene encodes a protein closely related to ZIP4, a zinc transporter mutated in the human genetic disorder acrodermatitis enteropathica. Herein, we demonstrate that mouse ZIP5 and ZIP4 genes are co-expressed in several tissues involved in zinc homeostasis ( intestine, pancreas, embryonic yolk sac). However, unlike expression of the ZIP4 gene, which is induced during periods of zinc deficiency, ZIP5 gene expression is unaltered by dietary zinc. Immunohistochemistry localizes ZIP5 to the basolateral surfaces of enterocytes, acinar cells, and visceral endoderm cells in mice fed a zinc-adequate diet. However, this protein is removed from these cell surfaces and internalized during dietary zinc deficiency. In contrast, ZIP4 is induced and recruited to the apical surface of enterocytes and endoderm cells during zinc deficiency. In the pancreas, ZIP4 is expressed in beta-cells, whereas ZIP5 is expressed in acinar cells. These results suggest that the function of ZIP5 is antagonistic to that of ZIP4 in the control of zinc homeostasis; rather than functioning in the acquisition of dietary zinc, as does ZIP4, ZIP5 may function in the removal of zinc from the body. Thus, during periods when dietary zinc is replete, ZIP5 may function to remove zinc from the blood via the pancreas and intestine, the major sites of zinc excretion in mammals, whereas the acquisition of dietary zinc by intestinal ZIP4 would be minimal. In contrast, during periods of dietary zinc deficiency when secretion of zinc by the pancreas and intestine is minimized, ZIP5 is removed from the cell surface, and the intestinal uptake of zinc is augmented by induction of ZIP4.	Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Andrews, GK (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Mail Stop 3030,39th & Rainbow Blvd, Kansas City, KS 66160 USA.	gandrews@kumc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063975, R01DK050181] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK50181, DK063975] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKLAND ML, 1992, J NUTR, V122, P1214, DOI 10.1093/jn/122.6.1214; Andrews GK, 2004, GENESIS, V40, P74, DOI 10.1002/gene.20067; Andrews GK, 1999, J NUTR, V129, P1643, DOI 10.1093/jn/129.9.1643; Andrews GK, 2001, EMBO J, V20, P1114, DOI 10.1093/emboj/20.5.1114; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Clifford KS, 2000, DIABETES RES CLIN PR, V49, P77, DOI 10.1016/S0168-8227(00)00141-8; Cragg RA, 2002, J BIOL CHEM, V277, P22789, DOI 10.1074/jbc.M200577200; Dalton T, 1996, J NUTR, V126, P825, DOI 10.1093/jn/126.4.825; DALTON T, 1994, NUCLEIC ACIDS RES, V22, P5016, DOI 10.1093/nar/22.23.5016; DANKS DM, 1985, CLIN ENDOCRINOL META, V14, P591, DOI 10.1016/S0300-595X(85)80008-6; DANKS DM, 1986, J MED GENET, V23, P99, DOI 10.1136/jmg.23.2.99; DeLisle RC, 1996, AM J PHYSIOL-CELL PH, V271, pC1103, DOI 10.1152/ajpcell.1996.271.4.C1103; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P50142, DOI 10.1074/jbc.M304163200; Eide D, 1997, CURR OPIN CELL BIOL, V9, P573, DOI 10.1016/S0955-0674(97)80036-1; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; FAIRWEATHERTAIT SJ, 1993, AM J CLIN NUTR, V57, P696, DOI 10.1093/ajcn/57.5.696a; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Gaither LA, 2000, J BIOL CHEM, V275, P5560, DOI 10.1074/jbc.275.8.5560; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Hambidge M, 2001, ANNU REV NUTR, V21, P429, DOI 10.1146/annurev.nutr.21.1.429; Harris ED, 2002, NUTR REV, V60, P121, DOI 10.1301/00296640260085877; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; HURLEY L, 1981, PHYSIOL REV, V61, P249, DOI 10.1152/physrev.1981.61.2.249; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kim BE, 2004, J BIOL CHEM, V279, P4523, DOI 10.1074/jbc.M310799200; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Krotova KY, 2003, AM J PHYSIOL-LUNG C, V284, pL1037, DOI 10.1152/ajplung.00308.2002; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Laftah AH, 2004, BLOOD, V103, P3940, DOI 10.1182/blood-2003-03-0953; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lee DK, 2003, J NUTR, V133, P45, DOI 10.1093/jn/133.1.45; MANNING DL, 1988, MOL CELL ENDOCRINOL, V59, P205, DOI 10.1016/0303-7207(88)90105-0; MCCLAIN CJ, 1990, J LAB CLIN MED, V116, P275; Miret S, 2003, ANNU REV NUTR, V23, P283, DOI 10.1146/annurev.nutr.23.011702.073139; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PILETZ JE, 1978, SCIENCE, V199, P181, DOI 10.1126/science.619449; RECORD IR, 1987, NEUROTOXICOLOGY, V8, P369; Rodriguez E, 2004, ENDOCRINOLOGY, V145, P679, DOI 10.1210/en.2003-0755; Sagawa N, 2003, BRIT J CANCER, V88, P606, DOI 10.1038/sj.bjc.6600739; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SHI SR, 1993, J HISTOCHEM CYTOCHEM, V41, P1599, DOI 10.1177/41.11.7691930; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Thomas LR, 2002, J BIOL CHEM, V277, P34343, DOI 10.1074/jbc.M204169200; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang FD, 2004, J BIOL CHEM, V279, P24631, DOI 10.1074/jbc.M400680200; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	56	163	168	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49082	49090		10.1074/jbc.M409962200	http://dx.doi.org/10.1074/jbc.M409962200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15358787	hybrid			2022-12-27	WOS:000225098100072
J	Grohmanova, K; Schlaepfer, D; Hess, D; Gutierrez, P; Beck, M; Kroschewski, R				Grohmanova, K; Schlaepfer, D; Hess, D; Gutierrez, P; Beck, M; Kroschewski, R			Phosphorylation of IQGAP1 modulates its binding to Cdc42, revealing a new type of Rho-GTPase regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE; E-CADHERIN; SEC7 DOMAIN; PROTEIN; RAC1; CALMODULIN; MEMBRANE; ORGANIZATION; GENTHREADER; ADHERENS	The Rho-GTPase Cdc42 is important for the establishment and maintenance of epithelial polarity. Signaling from Cdc42 is propagated via its effector molecules that specifically bind to Cdc42 in the GTP-bound form. The cell-cell contact regulator and actin-binding protein IQGAP1 is described as effector of Cdc42 and Rac. Unexpectedly, we show in this study that IQGAP1 bound also directly nucleotide-depleted Cdc42 (Cdc42-ND). This interaction was enhanced in the presence of phosphatase inhibitors and in epithelial cells without cell-cell contacts. Tandem mass spectrometry analysis and immunoprecipitation experiments revealed that IQGAP1 was Ser(1443)-phosphorylated in vivo, potentially by protein kinase Cepsilon and upon loss of cell-cell contacts. In addition, we identified two independent domains of the IQGAP1 C terminus that bound exclusively Cdc42-ND. These domains interacted with each other, favoring the binding to Cdc42-GTP. Moreover, phosphorylation on Ser(1443) strongly inhibited this intramolecular interaction. Thus, we unraveled a molecular mechanism that reveals a novel type of Rho-GTPase regulator. We propose that, depending on its phosphorylation state, IQGAP1 might serve as an effector or sequester nucleotide-free Cdc42 to prevent signaling.	ETH, Inst Biochem, CH-8093 Zurich, Switzerland; Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Miescher Institute for Biomedical Research	Kroschewski, R (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	kroschewski@bc.biol.ethz.ch		Kroschewski, Ruth/0000-0002-6032-2568				Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cohen D, 2001, TRAFFIC, V2, P556, DOI 10.1034/j.1600-0854.2001.20805.x; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Fukuhara A, 2003, J BIOL CHEM, V278, P51885, DOI 10.1074/jbc.M308015200; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hu PQ, 2001, J INVEST DERMATOL, V117, P1059, DOI 10.1046/j.0022-202x.2001.01523.x; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kato J, 2000, BIOCHEM BIOPH RES CO, V268, P141, DOI 10.1006/bbrc.2000.2106; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Krendel M, 1999, P NATL ACAD SCI USA, V96, P9666, DOI 10.1073/pnas.96.17.9666; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Nuoffer C, 1997, MOL BIOL CELL, V8, P1305, DOI 10.1091/mbc.8.7.1305; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Schlumberger MC, 2003, J BIOL CHEM, V278, P27149, DOI 10.1074/jbc.M302475200; Schrimpf SP, 2001, ELECTROPHORESIS, V22, P1224, DOI 10.1002/1522-2683()22:6&lt;1224::AID-ELPS1224&gt;3.0.CO;2-I; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	41	68	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48495	48504		10.1074/jbc.M408113200	http://dx.doi.org/10.1074/jbc.M408113200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15355962	hybrid			2022-12-27	WOS:000225098100004
J	Jenkins, CM; Mancuso, DJ; Yan, W; Sims, HF; Gibson, B; Gross, RW				Jenkins, CM; Mancuso, DJ; Yan, W; Sims, HF; Gibson, B; Gross, RW			Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A(2) family members possessing triacylglycerol lipase and acylglycerol transacylase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; MESSENGER-RNA EXPRESSION; LIPID ACYL HYDROLASE; FATTY-ACID RELEASE; ADIPOSE-TISSUE; SUICIDE INHIBITION; GENE-EXPRESSION; OBESITY; PROTEIN; ADIPONUTRIN	Genetic knockout of hormone-sensitive lipase in mice has implicated the presence of other intracellular triacylglycerol (TAG) lipases mediating TAG hydrolysis in adipocytes. Despite intense interest in these TAG lipases, their molecular identities thus far are largely unknown. Sequence data base searches for proteins containing calcium-independent phospholipase A(2) ( iPLA(2)) dual signature nucleotide ((G/A) XGXXG) and lipase (GXSXG) consensus sequence motifs identified a novel subfamily of three putative iPLA(2)/lipase family members designated iPLA(2)epsilon, iPLA(2)zeta, and iPLA(2)eta (previously named adiponutrin, TTS-2.2, and GS2, respectively) of previously unknown catalytic function. Herein we describe the cloning, heterologous expression, and affinity purification of the three human isoforms of this iPLA(2) subfamily in Sf9 cells, and we demonstrate that each possesses abundant TAG lipase activity. Moreover, iPLA(2)epsilon, iPLA(2)zeta, and iPLA(2)eta also possess acylglycerol transacylase activity utilizing mono-olein as an acyl donor which, in the presence of mono-olein or diolein acceptors, results in the synthesis of diolein and triolein, respectively. (E)-6-(Bromomethylene)-3-(1-naphthalenyl)-2H-tetrahydropyran-2- one, a mechanism-based suicide substrate inhibitor of all known iPLA(2)s, inhibits the triglyceride lipase activity of each of the three isoforms similarly (IC50 = 0.1 - 0.5 muM). Quantitative PCR revealed dramatically increased expression of iPLA(2)epsilon and iPLA(2)zeta transcripts during the hormone-induced differentiation of 3T3-L1 cells into adipocytes and identified the presence of all three iPLA(2) isoforms in human SW872 liposarcoma cells. Collectively, these results identify three novel TAG lipases/acylglycerol transacylases that likely participate in TAG hydrolysis and the acyl-CoA independent transacylation of acylglycerols, thereby facilitating energy mobilization and storage in adipocytes.	Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Chem, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.				NHLBI NIH HHS [5PO1HL57278-08, 5RO1HL41250-12] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041250, P01HL057278] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDREWS DL, 1988, BIOCHEM J, V252, P199, DOI 10.1042/bj2520199; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; ELIA M, 1987, METABOLISM, V36, P251, DOI 10.1016/0026-0495(87)90184-3; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Glorian M, 2001, BIOCHIMIE, V83, P933, DOI 10.1016/S0300-9084(01)01343-8; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; HULSMANN WC, 1980, BIOCHIM BIOPHYS ACTA, V618, P364, DOI 10.1016/0005-2760(80)90043-0; Izem L, 2001, J BIOL CHEM, V276, P26534, DOI 10.1074/jbc.M103624200; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Jensen MD, 2001, AM J PHYSIOL-ENDOC M, V281, pE789; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE WC, 1994, GENOMICS, V22, P372, DOI 10.1006/geno.1994.1397; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Pinsirodom P, 2000, J AGR FOOD CHEM, V48, P155, DOI 10.1021/jf990338g; Polson D, 2003, HORM METAB RES, V35, P508; Polson DA, 2004, J NUTR BIOCHEM, V15, P242, DOI 10.1016/j.nutbio.2003.11.009; Polson DA, 2003, BIOCHEM BIOPH RES CO, V301, P261, DOI 10.1016/S0006-291X(02)03027-9; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SHAPIRO LJ, 1989, P NATL ACAD SCI USA, V86, P8477, DOI 10.1073/pnas.86.21.8477; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Van Hermelen V, 1999, J BIOL CHEM, V274, P18243, DOI 10.1074/jbc.274.26.18243; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; WAITE M, 1973, J BIOL CHEM, V248, P7985; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; ZUPAN LA, 1993, J MED CHEM, V36, P95, DOI 10.1021/jm00053a012	57	658	712	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48968	48975		10.1074/jbc.M407841200	http://dx.doi.org/10.1074/jbc.M407841200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15364929	hybrid			2022-12-27	WOS:000225098100059
J	Saito-Nakano, Y; Yasuda, T; Nakada-Tsukui, K; Leippe, M; Nozaki, T				Saito-Nakano, Y; Yasuda, T; Nakada-Tsukui, K; Leippe, M; Nozaki, T			Rab5-associated Vacuoles play a unique role in phagocytosis of the enteric protozoan parasite Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; MYCOBACTERIAL PHAGOSOME MATURATION; RAB PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR CHARACTERIZATION; CYSTEINE PROTEINASES; ENDOCYTIC PATHWAY; MEMBRANE-FUSION; MACROPHAGES; YEAST	In mammals, Rab5 and Rab7 play a specific and coordinated role in a sequential process during phagosome maturation. Here, we report that Rab5 and Rab7 in the enteric protozoan parasite Entamoeba histolytica, EhRab5 and EhRab7A, are involved in steps that are distinct from those known for mammals. EhRab5 and EhRab7A were localized to independent small vesicular structures at steady state. Priming with red blood cells induced the formation of large vacuoles associated with both EhRab5 and EhRab7A ("prephagosomal vacuoles (PPV)") in the amoeba within an incubation period of 5-10 min. PPV emerged de novo physically and distinct from phagosomes. PPV were gradually acidified and matured by fusion with lysosomes containing a digestive hydrolase, cysteine proteinase, and a membrane-permeabilizing peptide amoebapore. After EhRab5 dissociated from PPV, 5-10 min later, the EhRab7A-PPV fused with phagosomes, and EhRab7A finally dissociated from the phagosomes. Immunoelectron and light micrographs showed that PPV contained small vesicle-like structures containing fluid-phase markers and amoebapores, which were not evenly distributed within PPV, suggesting that the mechanism was similar to multivesicular body formation in PPV generation. In contrast to Rab5 from other organisms, EhRab5 was involved exclusively in phagocytosis, but not in endocytosis. Overexpression of wild-type EhRab5 enhanced phagocytosis and the transport of amoebapore to phagosomes. Conversely, expression of an EhRab5Q67L GTP form mutant impaired the formation of PPV and phagocytosis. Altogether, we propose that the amoebic Rab5 plays an important role in the formation of unique vacuoles, which is essential for engulfment of erythrocytes and important for packaging of lysosomal hydrolases, prior to the targeting to phagosomes.	Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; Univ Kiel, Inst Zool, D-24118 Kiel, Germany; Japan Sci & Technol Agcy, Percursory Res Embryon Sci & Technol, Tokyo 1900012, Japan	National Institute of Infectious Diseases (NIID); University of Kiel; Japan Science & Technology Agency (JST)	Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	nozaki@nih.go.jp	Leippe, Matthias/AAP-1677-2020					Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; [Anonymous], 1997, Epidemiol Bull, V18, P13; BAILEY GB, 1990, INFECT IMMUN, V58, P43, DOI 10.1128/IAI.58.1.43-47.1990; Batista EDO, 2000, PARASITOL RES, V86, P881, DOI 10.1007/s004360000269; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Cheng XJ, 1998, PARASITOL RES, V84, P632, DOI 10.1007/s004360050462; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Damiani MT, 2003, EXP CELL RES, V289, P152, DOI 10.1016/S0014-4827(03)00253-2; DESJARDINS M, 1995, TRENDS CELL BIOL, V5, P183, DOI 10.1016/S0962-8924(00)88989-8; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DIAMOND LS, 1972, J VIROL, V9, P326, DOI 10.1128/JVI.9.2.326-341.1972; Duclos S, 2000, J CELL SCI, V113, P3531; Field H, 1998, J BIOL CHEM, V273, P32102, DOI 10.1074/jbc.273.48.32102; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Ghosh SK, 1997, INFECT IMMUN, V65, P4243, DOI 10.1128/IAI.65.10.4243-4249.1997; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Guillen N, 1998, J CELL SCI, V111, P1729; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Hamann L, 1997, MOL BIOCHEM PARASIT, V84, P83, DOI 10.1016/S0166-6851(96)02771-5; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hashim S, 2000, J BIOL CHEM, V275, P16281, DOI 10.1074/jbc.275.21.16281; Hellberg A, 2000, MOL BIOCHEM PARASIT, V105, P305, DOI 10.1016/S0166-6851(99)00194-2; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Jahraus A, 1998, J BIOL CHEM, V273, P30379, DOI 10.1074/jbc.273.46.30379; Jaunin F, 1998, EXP CELL RES, V243, P67, DOI 10.1006/excr.1998.4131; Jay DG, 1996, CELL, V86, P853, DOI 10.1016/S0092-8674(00)80160-9; Juarez P, 2001, MOL BIOCHEM PARASIT, V116, P223, DOI 10.1016/S0166-6851(01)00311-5; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Labruyere E, 2003, J CELL SCI, V116, P61, DOI 10.1242/jcs.00190; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; Leippe M, 1999, DEV COMP IMMUNOL, V23, P267, DOI 10.1016/S0145-305X(99)00010-5; Mazzuco A, 1997, MICRON, V28, P241, DOI 10.1016/S0968-4328(97)00024-3; Nickel R, 1998, FEBS LETT, V437, P153, DOI 10.1016/S0014-5793(98)01220-4; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NOVIKOFF AB, 1972, J HISTOCHEM CYTOCHEM, V20, P1006, DOI 10.1177/20.12.1006; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; Petri WA, 2002, CURR OPIN MICROBIOL, V5, P443, DOI 10.1016/S1369-5274(02)00335-1; POMMIER CG, 1983, J EXP MED, V157, P1844, DOI 10.1084/jem.157.6.1844; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Ramakrishnan G, 2001, PARASITOL INT, V50, P47, DOI 10.1016/S1383-5769(00)00067-2; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; Rodriguez MA, 2000, MOL BIOCHEM PARASIT, V108, P199, DOI 10.1016/S0166-6851(00)00216-4; Rupper A, 2001, J CELL SCI, V114, P2449; Saito-Nakano Y, 2001, MOL BIOCHEM PARASIT, V116, P219, DOI 10.1016/S0166-6851(01)00318-8; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Silver LL, 2003, CURR OPIN MICROBIOL, V6, P431, DOI 10.1016/j.mib.2003.08.004; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SINGERKRUGER B, 1995, J CELL SCI, V108, P3509; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2001, GENOME BIOL, V2; Tanaka T, 1997, BIOCHEM BIOPH RES CO, V236, P611, DOI 10.1006/bbrc.1997.7019; Temesvari LA, 1999, MOL BIOCHEM PARASIT, V103, P225, DOI 10.1016/S0166-6851(99)00133-4; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Ueda T, 2002, CURR OPIN PLANT BIOL, V5, P513, DOI 10.1016/S1369-5266(02)00299-6; Vargas-Villarreal J, 1998, PARASITOL RES, V84, P310, DOI 10.1007/s004360050401; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vines RR, 1998, MOL BIOL CELL, V9, P2069, DOI 10.1091/mbc.9.8.2069; Voigt H, 1999, J CELL SCI, V112, P1191; WICHMANN H, 1992, CELL, V71, P1131, DOI 10.1016/S0092-8674(05)80062-5	73	104	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					49497	49507		10.1074/jbc.M403987200	http://dx.doi.org/10.1074/jbc.M403987200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15347665	hybrid			2022-12-27	WOS:000225098100120
J	Banik, SSR; Counter, CM				Banik, SSR; Counter, CM			Characterization of interactions between PinX1 and human telomerase Subunits hTERT and hTR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; REVERSE-TRANSCRIPTASE; NUCLEOLAR LOCALIZATION; ENZYME-ACTIVITY; IN-VIVO; RNA; PROTEIN; DOMAIN; DNA; PROCESSIVITY	The addition of telomeric repeats to chromosome ends by the enzyme telomerase is a highly orchestrated process. Although much is known regarding telomerase catalytic activity in vitro, less is known about how this activity is regulated in vivo to ensure proper telomere elongation. One protein that appears to be involved in negatively regulating telomerase function in vivo is PinX1 because overexpression of PinX1 inhibits telomerase activity and causes telomere shortening. To understand the nature of this repression, we characterized the interactions among PinX1 and the core components of telomerase, the human telomerase reverse transcriptase ( hTERT) and associated human telomerase RNA (hTR). We now show that in vitro PinX1 binds directly to the hTERT protein subunit, primarily to the hTR-binding domain, as well as to the hTR subunit. However, in a cellular context, the association of PinX1 with hTR is dependent on the presence of hTERT. Taken together, we suggest that PinX1 represses telomerase activity in vivo by binding to the assembled hTERT.hTR complex.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NCI NIH HHS [CA082481] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P342, DOI 10.1016/S0968-0004(99)01437-1; Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; Armbruster BN, 2003, MOL CELL BIOL, V23, P3237, DOI 10.1128/MCB.23.9.3237-3246.2003; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Beattie TL, 2000, MOL BIOL CELL, V11, P3329, DOI 10.1091/mbc.11.10.3329; Cabuy E, 2001, VIRCHOWS ARCH, V439, P176, DOI 10.1007/s004280100466; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Huard S, 2003, NUCLEIC ACIDS RES, V31, P4059, DOI 10.1093/nar/gkg437; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Lustig AJ, 2001, NAT STRUCT BIOL, V8, P297, DOI 10.1038/86157; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Narayanan A, 1999, EMBO J, V18, P5120, DOI 10.1093/emboj/18.18.5120; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; Song H, 2004, BIOCHEM BIOPH RES CO, V316, P1116, DOI 10.1016/j.bbrc.2004.02.166; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Xia JQ, 2000, MOL CELL BIOL, V20, P5196, DOI 10.1128/MCB.20.14.5196-5207.2000; Yang YH, 2002, EXP CELL RES, V277, P201, DOI 10.1006/excr.2002.5541; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	30	66	73	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 10	2004	279	50					51745	51748		10.1074/jbc.M408131200	http://dx.doi.org/10.1074/jbc.M408131200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	876JT	15381700	hybrid			2022-12-27	WOS:000225493400006
J	Marin-Esteban, V; Falk, K; Rotzschke, O				Marin-Esteban, V; Falk, K; Rotzschke, O			"Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MHC; MYELIN BASIC-PROTEIN; BINDING; COMPLEXES; EXCHANGE; ANTIGEN; HLA-DR1; DISSOCIATION; ASSOCIATION; STABILITY	We had recently identified small molecular compounds that are able to accelerate the ligand exchange reactions of HLA-DR molecules. Here we show that this acceleration is due to the induction of a "peptide-receptive" state. Dissociation experiments of soluble HLA-DR2.CLIP ( class II-associated invariant chain peptide) complex and peptide-binding studies with "nonreceptive" empty HLA-DR1 and -DR2 molecules revealed that the presence of a small phenolic compound carrying an H-bond donor group ( -OH) results in the drastic increase of both off- and on-rates. The rate-limiting step for ligand exchange, the transition of the major histocompatibility complex molecule from a nonreceptive into the receptive state, is normally mediated by interaction with the chaperone HLA-DM. In this respect, the effect of small molecules resembles that of the natural catalyst, except that they are still active at neutral pH. These "chemical analogues" of HLA-DM can therefore modulate the response of CD4+ T cells by editing the antigen composition of surface-bound class II major histocompatibility complex on living antigen-presenting cells.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Falk, K (corresponding author), Max Delbruck Ctr Mol Med, Robert Rosslestr 10, D-13125 Berlin, Germany.	falk@mdc-berlin.de; roetzsch@mdc-berlin.de	Marin-Esteban, Viviana/A-8856-2014; Roetzschke, Olaf/GXH-0012-2022					BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Busch R, 1996, EMBO J, V15, P418, DOI 10.1002/j.1460-2075.1996.tb00372.x; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Falk K, 2000, J EXP MED, V191, P717, DOI 10.1084/jem.191.4.717; Falk K, 2002, J BIOL CHEM, V277, P2709, DOI 10.1074/jbc.M109098200; Gauthier L, 1998, P NATL ACAD SCI USA, V95, P11828, DOI 10.1073/pnas.95.20.11828; Joshi RV, 2000, BIOCHEMISTRY-US, V39, P3751, DOI 10.1021/bi9923656; KROPSHOFER H, 1995, P NATL ACAD SCI USA, V92, P8313, DOI 10.1073/pnas.92.18.8313; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Marin-Esteban V, 2003, J AUTOIMMUN, V20, P63, DOI 10.1016/S0896-8411(02)00107-5; McFarland BJ, 1999, J IMMUNOL, V163, P3567; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Rosloniec EF, 1998, J IMMUNOL, V160, P2573; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Stratikos E, 2002, J EXP MED, V196, P173, DOI 10.1084/jem.20020117; Vacchino JF, 2001, J IMMUNOL, V166, P6680, DOI 10.4049/jimmunol.166.11.6680; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; Zarutskie JA, 2001, P NATL ACAD SCI USA, V98, P12450, DOI 10.1073/pnas.211439398	31	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2004	279	49					50684	50690		10.1074/jbc.M407598200	http://dx.doi.org/10.1074/jbc.M407598200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	874MZ	15381703	hybrid			2022-12-27	WOS:000225355800009
J	Gratschev, D; Blom, T; Bjorklund, S; Tornquist, K				Gratschev, D; Blom, T; Bjorklund, S; Tornquist, K			Phosphatase inhibition reveals a calcium entry pathway dependent on protein kinase A in thyroid FRTL-5 cells - Comparison with store-operated calcium entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IODIDE EFFLUX; CA2+ CHANNELS; PHOSPHOLIPASE-C; MOLECULAR-BASIS; TRPC3 CHANNELS; ACTIVATION; RECEPTOR; CA-2; OSCILLATIONS; STIMULATION	Calcium entry through store-operated calcium channels is an important entry mechanism. In the present report we have described a novel calcium entry pathway that is independent of depletion of intracellular calcium stores. Treatment of the cells with the phosphatase inhibitor calyculin A (caly A), which blocked thapsigargin-evoked store-operated calcium entry (SOCE), induced a potent concentration-dependent calcium entry. In a calcium-free buffer, acute addition of caly A evoked a very modest increase in cytosolic free calcium ([Ca2+](i)). This increase was not from the agonist-mobilizable calcium stores, as the thapsigargin-evoked increase in [Ca2+](i) was unaltered in caly A-treated cells. The caly A-evoked calcium entry was not blocked by Gd3+ or 2-APB, whereas SOCE was. Caly A enhanced the entry of barium, indicating that the increase in intracellular calcium was not the result of a decreased extrusion of calcium from the cytosol. Jasplakinolide and cytochalasin D had only marginal effects on calcium entry. The protein kinase A (PKA) inhibitor H-89 and an inhibitory peptide for PKA abolished the caly A-evoked entry of both calcium and barium. The SOCE was, however, enhanced in cells treated with H-89. In cells grown in the absence of thyrotropin (TSH), the caly A-evoked entry of calcium was smaller compared with cells grown in TSH-containing buffer. Stimulation of cells grown without TSH with forskolin or TSH restored the calyculin A-evoked calcium entry to that seen in cells grown in TSH-containing buffer. SOCE was decreased in these cells. Our results thus suggest that TSH, through the production of cAMP and activation of PKA, regulates a calcium entry pathway in thyroid cells. The pathway is distinctly different from the SOCE. As TSH is the main regulator of thyroid cells, we suggest that the novel calcium entry pathway participates in the regulation of basal calcium levels in thyroid cells.	Abo Akad Univ, BioCity, Dept Biol, Turku 20520, Finland; Turku Grad Sch Biomed Sci, Turku 20520, Finland; Biomedicum Heslinki, Minerva Fdn, Inst Med Res, Helsinki 00250, Finland	Abo Akademi University; University of Turku; University of Helsinki	Tornquist, K (corresponding author), Abo Akad Univ, BioCity, Dept Biol, Artillerigatan 6, Turku 20520, Finland.	kid.tornqvist@abo.fi						Albert AP, 2002, J PHYSIOL-LONDON, V544, P113, DOI 10.1113/jphysiol.2002.022574; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; BERMAN MI, 1987, MOL CELL ENDOCRINOL, V54, P151, DOI 10.1016/0303-7207(87)90152-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CORDA D, 1985, J BIOL CHEM, V260, P9230; Ekokoski E, 2001, J CELL PHYSIOL, V187, P166, DOI 10.1002/jcp.1070; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Laglia G, 1996, ENDOCRINOLOGY, V137, P3170, DOI 10.1210/en.137.8.3170; Lalevee N, 2003, ENDOCRINOLOGY, V144, P4575, DOI 10.1210/en.2003-0268; Larsson O, 1997, SCIENCE, V278, P471, DOI 10.1126/science.278.5337.471; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma R, 2001, J BIOL CHEM, V276, P25759, DOI 10.1074/jbc.M011241200; Mignen O, 2003, J BIOL CHEM, V278, P40088, DOI 10.1074/jbc.M306365200; Mignen O, 2003, J BIOL CHEM, V278, P10174, DOI 10.1074/jbc.M212536200; MONTERO M, 1994, J BIOL CHEM, V269, P3963; NORSTEDT C, 1990, ANAL BIOCHEM, V189, P231; OKAJIMA F, 1988, ENDOCRINOLOGY, V123, P1035, DOI 10.1210/endo-123-2-1035; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Putney JW, 2001, J CELL SCI, V114, P2223; RANDRIAMAMPITA C, 1995, J BIOL CHEM, V270, P29, DOI 10.1074/jbc.270.1.29; Rosado JA, 2001, J BIOL CHEM, V276, P15666, DOI 10.1074/jbc.M009217200; ROSADO JA, 2000, J BIOL CHEM, V275; Schuhmann K, 1997, J GEN PHYSIOL, V110, P503, DOI 10.1085/jgp.110.5.503; Shuttleworth TJ, 1998, J BIOL CHEM, V273, P32636, DOI 10.1074/jbc.273.49.32636; Shuttleworth TJ, 2003, BIOCHEM SOC T, V31, P916; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; TORNQUIST K, 1993, BIOCHEM J, V290, P443; Tornquist K, 1996, J CELL PHYSIOL, V166, P241; TORNQUIST K, 1992, J CELL PHYSIOL, V150, P90, DOI 10.1002/jcp.1041500113; TORNQUIST K, 1994, CELL CALCIUM, V15, P153, DOI 10.1016/0143-4160(94)90054-X; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; WEISS SJ, 1984, ENDOCRINOLOGY, V114, P1108, DOI 10.1210/endo-114-4-1108	40	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49816	49824		10.1074/jbc.M406364200	http://dx.doi.org/10.1074/jbc.M406364200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381705	hybrid			2022-12-27	WOS:000225229500034
J	Kani, S; Oishi, I; Yamamoto, H; Yoda, A; Suzuki, H; Nomachi, A; Iozumi, K; Nishita, M; Kikuchi, A; Takumi, T; Minami, Y				Kani, S; Oishi, I; Yamamoto, H; Yoda, A; Suzuki, H; Nomachi, A; Iozumi, K; Nishita, M; Kikuchi, A; Takumi, T; Minami, Y			The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase I epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE ROBINOW-SYNDROME; GROWTH-FACTOR RECEPTOR; BRACHYDACTYLY TYPE-B; CATENIN DEGRADATION COMPLEX; WNT SIGNALING PATHWAY; PROTEIN-KINASE; BETA-CATENIN; MOUSE DEVELOPMENT; INSULIN-RECEPTOR; DEPENDENT DEGRADATION	Ror2, a member of the mammalian Ror family of receptor tyrosine kinases, plays important roles in developmental morphogenesis, although the mechanism underlying activation of Ror2 remains largely elusive. We show that when expressed in mammalian cells, Ror2 associates with casein kinase Iepsilon (CKIepsilon), a crucial regulator of Wnt signaling. This association occurs primarily via the cytoplasmic C-terminal proline-rich domain of Ror2. We also show that Ror2 is phosphorylated by CKIepsilon on serine/threonine residues, in its C-terminal serine/ threonine-rich 2 domain, resulting in autophosphorylation of Ror2 on tyrosine residues. Furthermore, it was found that association of Ror2 with CKIepsilon is required for its serine/ threonine phosphorylation by CKIepsilon. Site-directed mutagenesis of tyrosine residues in Ror2 reveals that the sites of phosphorylation are contained among the five tyrosine residues in the proline-rich domain but not among the four tyrosine residues in the tyrosine kinase domain. Moreover, we show that in mammalian cells, CKIepsilon-mediated phosphorylation of Ror2 on serine/ threonine and tyrosine residues is followed by the tyrosine phosphorylation of G protein-coupled receptor kinase 2, a kinase with a developmental expression pattern that is remarkably similar to that of Ror2. Intriguingly, a mutant of Ror2 lacking five tyrosine residues, including the autophosphorylation sites, fails to tyrosine phosphorylate G protein-coupled receptor kinase 2. This indicates that autophosphorylation of Ror2 is required for full activation of its tyrosine kinase activity. These findings demonstrate a novel role for CKIepsilon in the regulation of Ror2 tyrosine kinase.	Kobe Univ, Grad Sch Med, Fac Med Sci, Dept Genome Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Hiroshima 7348551, Japan; Osaka Biosci Inst, Osaka 5650874, Japan	Kobe University; Hiroshima University	Kani, S (corresponding author), Kobe Univ, Grad Sch Med, Fac Med Sci, Dept Genome Sci,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kani@med.kobe-u.ac.jp	Oishi, Isao/L-8639-2018	Oishi, Isao/0000-0003-3682-5349				Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Afzal AR, 2003, HUM MUTAT, V22, P1, DOI 10.1002/humu.10233; Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Barbier AJ, 1999, J BIOL CHEM, V274, P14067, DOI 10.1074/jbc.274.20.14067; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Ding YN, 2002, TRENDS BIOCHEM SCI, V27, P327, DOI 10.1016/S0968-0004(02)02137-0; Elorza A, 2003, J BIOL CHEM, V278, P29164, DOI 10.1074/jbc.M304314200; Fan GF, 2001, J BIOL CHEM, V276, P13240, DOI 10.1074/jbc.M011578200; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; GRANDE J, 1988, FEBS LETT, V232, P130, DOI 10.1016/0014-5793(88)80401-0; Hikasa H, 2002, DEVELOPMENT, V129, P5227; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Matsuda T, 2003, J BIOL CHEM, V278, P29057, DOI 10.1074/jbc.M302199200; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Patton MA, 2002, J MED GENET, V39, P305, DOI 10.1136/jmg.39.5.305; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; ROTH RA, 1987, DIABETES, V36, P123, DOI 10.2337/diabetes.36.1.123; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Schwabe GC, 2004, DEV DYNAM, V229, P400, DOI 10.1002/dvdy.10466; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; Sefton M, 2000, MECH DEVELOP, V98, P127, DOI 10.1016/S0925-4773(00)00441-X; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Yoda A, 2003, J RECEPT SIG TRANSD, V23, P1, DOI 10.1081/RRS-120018757	49	73	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					50102	50109		10.1074/jbc.M409039200	http://dx.doi.org/10.1074/jbc.M409039200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15375164	hybrid			2022-12-27	WOS:000225229500069
J	Kim, JH; Stallcup, MR				Kim, JH; Stallcup, MR			Role of the coiled-coil coactivator (CoCoA) in aryl hydrocarbon receptor-mediated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSLOCATOR PROTEIN; ESTROGEN-RECEPTOR; AH RECEPTOR; GENE-EXPRESSION; CYTOCHROME P4501A1; ACTIVATION DOMAIN; CORE COMPLEX; CROSS-TALK; CELL-CYCLE; IN-VIVO	The aryl hydrocarbon receptor (AHR) and AHR nuclear translocator (ARNT) are DNA binding transcription factors with basic helix-loop-helix/Per-Arnt-Sim (bHLH-PAS) domains. These two proteins form a heterodimer that mediates the toxic and biological effects of the environmental contaminant and AHR ligand 2,3,7,8-tetrachlorodibenzo-pdioxin. The coiled-coil protein coiled-coil coactivator (CoCoA) is a secondary coactivator for nuclear receptors and enhances nuclear receptor function by interacting with the bHLH-PAS domain of p160 coactivators. We report here that CoCoA also binds the bHLH-PAS domains of AHR and ARNT and functions as a potent primary coactivator for them; i.e. CoCoA does not require p160 coactivators for binding to and serving as a coactivator for AHR and ARNT. Endogenous CoCoA was recruited to a natural AHR target gene promoter in a 2,3,7,8- tetrachlorodibenzo-p-dioxin-dependent manner. Moreover, reduction of CoCoA mRNA levels by small interfering RNA inhibited the transcriptional activation by AHR and ARNT. Our data support a physiological role for CoCoA as a transcriptional coactivator in AHR/ARNT-mediated transcription.	Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Dept Pathol, HMR 301,2011 Zonal Ave, Los Angeles, CA 90089 USA.	stallcup@usc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK43093] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLBORG UG, 1995, CRIT REV TOXICOL, V25, P463, DOI 10.3109/10408449509017924; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Corton JC, 1996, TOXICOL APPL PHARM, V139, P272, DOI 10.1006/taap.1996.0166; Denison MS, 2002, CHEM-BIOL INTERACT, V141, P3, DOI 10.1016/S0009-2797(02)00063-7; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hoffer A, 1996, TOXICOL APPL PHARM, V141, P238; Huffman JL, 2001, J BIOL CHEM, V276, P40537, DOI 10.1074/jbc.M105675200; Jones LC, 2002, J BIOL CHEM, V277, P22515, DOI 10.1074/jbc.M200740200; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kharat I, 1996, J BIOL CHEM, V271, P10533, DOI 10.1074/jbc.271.18.10533; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Kobayashi A, 1997, J BIOCHEM, V122, P703; Kumar MB, 1999, GENE EXPRESSION, V8, P273; Kumar MB, 1999, J BIOL CHEM, V274, P22155, DOI 10.1074/jbc.274.32.22155; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Nguyen TA, 1999, ARCH BIOCHEM BIOPHYS, V367, P250, DOI 10.1006/abbi.1999.1282; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Porter W, 2001, J MOL ENDOCRINOL, V26, P31, DOI 10.1677/jme.0.0260031; PROBST MR, 1993, MOL PHARMACOL, V44, P511; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; Rowlands JC, 1996, MOL PHARMACOL, V50, P538; Safe S, 2003, CHEM RES TOXICOL, V16, P807, DOI 10.1021/tx034036r; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Wang S, 2004, J BIOL CHEM, V279, P13593, DOI 10.1074/jbc.M312274200; Wang S, 2002, J BIOL CHEM, V277, P11821, DOI 10.1074/jbc.M110122200; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116	36	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49842	49848		10.1074/jbc.M408535200	http://dx.doi.org/10.1074/jbc.M408535200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15383530	hybrid			2022-12-27	WOS:000225229500037
J	Mesnier, D; Baneres, JL				Mesnier, D; Baneres, JL			Cooperative conformational changes in a G-protein-coupled receptor dimer, the leukotriene B-4 receptor BLT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTROPIN-CHORIOGONADOTROPIN RECEPTOR; HORMONE RECEPTORS; SPLICE VARIANT; GPCR FUNCTION; CELL-SURFACE; GB2 SUBUNITS; OLIGOMERIZATION; AGONIST; ACTIVATION; HETERODIMERIZATION	We have used an isolated receptor, the leukotriene B-4 receptor BLT1, to analyze the mechanism of receptor activation in a G-protein-coupled receptor dimer. The isolated receptor is essentially a dimer whether the agonist is present or not, provided the detergent used stabilizes the inactive dimeric assembly. We have produced a receptor mutant where Cys(97) in the third transmembrane domain has been replaced by a serine. This mutation leads to an similar to100-fold decrease in the affinity for the agonist. 5-Hydroxytryptophan has then been introduced at position 234 in the C97A mutant sixth transmembrane domain. Agonist binding to the labeled receptor is associated with variations in the fluorescence properties of 5-hydroxytryptophan due to specific agonist-induced conformational changes. The C97A mutant labeled with 5-hydroxytryptophan has then been associated with a wild-type receptor in a dimeric complex that has been subsequently purified. The purified complex activates its G-protein partner in a similar manner as the wildtype homodimer. Due to the difference in the affinity for the agonist between the wild-type and mutant protomers in this dimer, we have been able to reach a state where one of the protomers, the mutant, is in its unliganded state, whereas the other, the wild type, is loaded with the agonist. We show that agonist binding to the wild-type receptor induces specific changes in the conformation of the unliganded protomer, as evidenced by the variations in the emission of the 5-hydroxytryptophan residue in the mutant receptor. These data provide a direct demonstration for agonist-induced cooperative conformational changes in a GPCR dimer.	Fac Pharm Montpellier, CNRS, UMR 5074, F-34093 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Baneres, JL (corresponding author), Fac Pharm Montpellier, CNRS, UMR 5074, 15 Av Ch Flahault,BP 14491, F-34093 Montpellier 5, France.	jean-louis.baneres@univ-montp1.fr		Baneres, jean-louis/0000-0001-7078-1285				Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Bockaert J, 2002, INT REV CYTOL, V212, P63; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913; Grosse R, 1997, MOL ENDOCRINOL, V11, P1305, DOI 10.1210/me.11.9.1305; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Karpa KD, 2000, MOL PHARMACOL, V58, P677, DOI 10.1124/mol.58.4.677; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kobilka BK, 2002, J PEPT RES, V60, P317, DOI 10.1034/j.1399-3011.2002.21062.x; Lee CW, 2002, J BIOL CHEM, V277, P15795, DOI 10.1074/jbc.M111818200; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Milligan G, 2001, J CELL SCI, V114, P1265; Parmentier ML, 2002, TRENDS PHARMACOL SCI, V23, P268, DOI 10.1016/S0165-6147(02)02016-3; Perron A, 2003, J BIOL CHEM, V278, P27956, DOI 10.1074/jbc.M212302200; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Poudrel JM, 1999, J MED CHEM, V42, P5289, DOI 10.1021/jm9910573; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Sillen A, 2001, SPR S FLUOR, V1, P413; Stanasila L, 2003, J BIOL CHEM, V278, P40239, DOI 10.1074/jbc.M306085200; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; XIE YB, 1990, J BIOL CHEM, V265, P21411	35	62	62	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49664	49670		10.1074/jbc.M404941200	http://dx.doi.org/10.1074/jbc.M404941200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15358776	hybrid			2022-12-27	WOS:000225229500016
J	Patnaik, SK; Potvin, B; Stanley, P				Patnaik, SK; Potvin, B; Stanley, P			LEC12 and LEC29 gain-of-function Chinese hamster ovary mutants reveal mechanisms for regulating VIM-2 antigen synthesis and E-selectin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWIS-X EXPRESSION; CHO-CELLS; ALPHA-1,3-FUCOSYL-TRANSFERASE-IX FUT9; CARBOHYDRATE LIGANDS; MOLECULAR-CLONING; GDP-FUCOSE; ADHESION; DISTINCT; GENES; TIX	LEC12 and LEC29 are two gain-of-function Chinese hamster ovary glycosylation mutants that express the Fut9 gene encoding alpha(1,3) fucosyltransferase IX (alpha(1,3) Fuc-TIX). Both mutants express the Lewis X (Le(X)) determinant Galbeta(1,4)[Fucalpha(1,3)] GlcNAc, and LEC12, but not LEC29 cells, also express the VIM-2 antigen SAalpha(2,3) Galbeta(1,4) GlcNAcbeta(1,3) Galbeta(1,4)[Fucalpha(1,3)] GlcNAc. Here we show that LEC29 cells transfected with a Fut9 cDNA express VIM-2, and thus LEC29 cells synthesize appropriate acceptors to generate the VIM-2 epitope. Semiquantitative reverse transcription-PCR showed that LEC12 has 10- to 20-fold less Fut9 gene transcripts than LEC29. However, Western analysis revealed that LEC12 has similar to20 times more Fut9 protein than LEC29. The latter finding was consistent with our previous observation that LEC12 has similar to40 times more in vitro alpha(1,3) Fuc-T activity than LEC29. The basis for the difference in Fut9 protein levels was found to lie in sequence differences in the 5'-untranslated regions (5'-UTR) of LEC12 and LEC29 Fut9 gene transcripts. Whereas reporter assays with the respective 5'-UTR regions linked to luciferase did not indicate a reduced translation efficiency caused by the LEC29 5'-UTR, transfected full-length LEC29 Fut9 cDNA or in vitro-synthesized full-length LEC29 Fut9 RNA gave less Fut9 protein than similar constructs with a LEC12 5'-UTR. This difference appears to be largely responsible for the reduced alpha(1,3) Fuc-TIX activity and lack of VIM-2 expression of LEC29 cells. This could be of physiological relevance, because LEC29 and parent Chinese hamster ovary cells transiently expressing a Fut9 cDNA were able to bind mouse E-selectin, although they did not express sialyl-LeX.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stanley@aecom.yu.edu		Stanley, Pamela/0000-0001-5704-3747	NCI NIH HHS [P01 CA13330, R01 CA30645] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA030645] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; CAMERON HS, 1995, J BIOL CHEM, V270, P20112, DOI 10.1074/jbc.270.34.20112; CAMPBELL C, 1983, CELL, V35, P303, DOI 10.1016/0092-8674(83)90233-7; CAMPBELL C, 1984, J BIOL CHEM, V259, P1208; DORNER AJ, 1991, J VIROL, V65, P4713, DOI 10.1128/JVI.65.9.4713-4719.1991; Favre D, 2001, J VIROL METHODS, V92, P177, DOI 10.1016/S0166-0934(00)00285-8; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; HAHNE M, 1993, J CELL BIOL, V121, P655, DOI 10.1083/jcb.121.3.655; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; Huang MC, 2002, J BIOL CHEM, V277, P47786, DOI 10.1074/jbc.M208283200; Kannagi R, 2002, CURR OPIN STRUC BIOL, V12, P599, DOI 10.1016/S0959-440X(02)00365-2; Kozak M, 2002, MAMM GENOME, V13, P401, DOI 10.1007/s00335-002-4002-5; Kudo T, 2004, MOL CELL BIOL, V24, P4221, DOI 10.1128/MCB.24.10.4221-4228.2004; Kudo T, 1998, J BIOL CHEM, V273, P26729, DOI 10.1074/jbc.273.41.26729; Kudo T, 1998, LAB INVEST, V78, P797; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; MACHER BA, 1988, J BIOL CHEM, V263, P10186; Mokdad-Gargouri R, 2001, NUCLEIC ACIDS RES, V29, P1222, DOI 10.1093/nar/29.5.1222; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; Oulmouden A, 1997, J BIOL CHEM, V272, P8764, DOI 10.1074/jbc.272.13.8764; Patnaik SK, 2000, ARCH BIOCHEM BIOPHYS, V375, P322, DOI 10.1006/abbi.1999.1693; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; POTVIN B, 1991, CELL REGUL, V2, P989, DOI 10.1091/mbc.2.12.989; POTVIN B, 1990, J BIOL CHEM, V265, P1615; Shimoda Y, 2002, J BIOL CHEM, V277, P2033, DOI 10.1074/jbc.M108495200; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stanley P, 1996, GLYCOBIOLOGY, V6, P695, DOI 10.1093/glycob/6.7.695; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1; Stroud MR, 1996, BIOCHEMISTRY-US, V35, P770, DOI 10.1021/bi952461g; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; Toivonen S, 2002, GLYCOBIOLOGY, V12, P361, DOI 10.1093/glycob/12.6.361; Zerfaoui M, 2000, EUR J BIOCHEM, V267, P53, DOI 10.1046/j.1432-1327.2000.00958.x; Zhang AM, 1999, J BIOL CHEM, V274, P10439, DOI 10.1074/jbc.274.15.10439; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49716	49726		10.1074/jbc.M408755200	http://dx.doi.org/10.1074/jbc.M408755200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15364956	hybrid			2022-12-27	WOS:000225229500022
J	Pop, SM; Kolarik, RJ; Ragsdale, SW				Pop, SM; Kolarik, RJ; Ragsdale, SW			Regulation of anaerobic dehalorespiration by the transcriptional activator CprK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE SULFINIC ACID; COLI FNR PROTEIN; DESULFITOBACTERIUM-DEHALOGENANS; ESCHERICHIA-COLI; REDUCTIVE DEHALOGENATION; REDOX REGULATION; MICROBIAL DEHALOGENATION; THIOREDOXIN REDUCTASE; TETRACHLOROETHENE; PEROXIREDOXINS	Desulfomonile, Desulfitobacterium, and Dehalobacter are anaerobic microbes that can derive energy from the reductive dehalogenation of chlorinated organic compounds, many of which are environmental pollutants. There is very little information about how anaerobic dehalorespiration is regulated. An open reading frame within the Desulfitobacterium dehalogenans chlorophenol reductase (cpr) gene cluster (cprK) was proposed to be a transcriptional regulatory protein (Smidt, H., van Leest, M., van der Oost, J., and deVos, W. M. (2000) J. Bacteriol. 182, 5683-5691). We have cloned, actively overexpressed in Escherichia coli, and purified to homogeneity the D. dehalogenans CprK. The results of electrophoretic mobility shift assays, DNA footprinting studies, and promoter-lac fusion experiments indicate that CprK is a transcriptional activator of the cpr gene cluster. CprK binds 3-chloro-4-hydroxyphenylacetate (CHPA) with high affinity (K-d=3.5 muM, determined by isothermal titration calorimetry), which promotes its specific interaction with a DNA sequence (TTAAT-N4-ACTAA) located upstream of the -35 and -10 promoter regions of several cpr genes and activates transcription of these genes. Binding to the upstream "box" sequence increases the affinity of CprK for CHPA by similar to10-fold (K-d=0.4 muM, determined by electrophoretic mobility shift assays). Chlorophenylacetate, which lacks the ortho-hydroxy group, and hydroxyphenylacetate, lacking the chlorine group, do not activate transcription or promote DNA binding, even at millimolar concentrations, at least 1000-fold higher than the K-d value for CHPA. Lacking metals, CprK is oxygen-sensitive. Oxidation by diamide, which converts thiols to the disulfide, inactivates CprK, and reduction of the oxidized protein by dithiothreitol fully restores DNA binding, indicating that CprK is redox-regulated and is active only when reduced. This is the first reported characterization of a transcriptional regulator of anaerobic dehalorespiration.	Univ Nebraska, Beadle Ctr, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Ragsdale, SW (corresponding author), Univ Nebraska, Beadle Ctr, Dept Biochem, Lincoln, NE 68588 USA.	sragsdale1@unl.edu			NCRR NIH HHS [1P20RR17675] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Copley SD, 1998, CURR OPIN CHEM BIOL, V2, P613, DOI 10.1016/S1367-5931(98)80092-6; Copley SD, 1997, CHEM BIOL, V4, P169, DOI 10.1016/S1074-5521(97)90285-4; El Fantroussi S, 1998, BIOTECHNOL PROGR, V14, P167, DOI 10.1021/bp980011k; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; Georgiou G, 2002, CELL, V111, P607, DOI 10.1016/S0092-8674(02)01165-0; GREEN J, 1993, MOL MICROBIOL, V8, P61, DOI 10.1111/j.1365-2958.1993.tb01203.x; Green J, 2001, ADV MICROB PHYSIOL, V44, P1, DOI 10.1016/S0065-2911(01)44010-0; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Holliger C, 1998, ARCH MICROBIOL, V169, P313, DOI 10.1007/s002030050577; Janssen DB, 2001, CURR OPIN BIOTECH, V12, P254, DOI 10.1016/S0958-1669(00)00208-1; JONES JB, 1977, COMMUN SOIL SCI PLAN, V8, P349, DOI 10.1080/00103627709366727; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Krasotkina J, 2001, J BIOL CHEM, V276, P40991, DOI 10.1074/jbc.M106217200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DJ, 2000, MOL MICROBIOL, V37, P1032, DOI 10.1046/j.1365-2958.2000.02086.x; Li B, 1998, NUCLEIC ACIDS RES, V26, P2075, DOI 10.1093/nar/26.9.2075; LI SF, 1988, J BIOL CHEM, V263, P13700; Lucana DOD, 2003, MOL GENET GENOMICS, V268, P618, DOI 10.1007/s00438-002-0776-0; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Miller J. H, 1972, EXPT MOL GENETICS; MOHN WW, 1992, MICROBIOL REV, V56, P482, DOI 10.1128/MMBR.56.3.482-507.1992; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Rabinowitz J, 1972, Methods Enzymol, V24, P431; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Smidt H, 2000, J BACTERIOL, V182, P5683, DOI 10.1128/JB.182.20.5683-5691.2000; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; UTKIN I, 1995, APPL ENVIRON MICROB, V61, P346, DOI 10.1128/AEM.61.1.346-351.1995; van de Pas BA, 2001, ARCH MICROBIOL, V176, P165, DOI 10.1007/s002030100316; van de Pas BA, 1999, J BIOL CHEM, V274, P20287, DOI 10.1074/jbc.274.29.20287; Villemur R, 2002, CAN J MICROBIOL, V48, P697, DOI 10.1139/w02-057; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; Wiegel J, 1999, APPL ENVIRON MICROB, V65, P2217; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; YE DY, 1992, APPL ENVIRON MICROB, V58, P1110, DOI 10.1128/AEM.58.4.1110-1114.1992; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	40	37	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2004	279	48					49910	49918		10.1074/jbc.M409435200	http://dx.doi.org/10.1074/jbc.M409435200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872SU	15381694	hybrid			2022-12-27	WOS:000225229500046
J	Morii, E; Oboki, K				Morii, E; Oboki, K			MITF is necessary for generation of prostaglandin D-2 in mouse mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; MUTANT MICE; EXPRESSION; GENE; MICROPHTHALMIA; SYNTHASE-2; ACTIVATION; PHENOTYPE; RASGRP4	Mast cells generate eicosanoids that are linked to asthma and other inflammatory diseases. A basic-helix-loop-helix leucine zipper transcription factor termed MITF is essential for the development of mast cells. Although other substances also linked to inflammatory reactions ( such as various proteases and serotonin) require MITF for their expression, the role of MITF in eicosanoid generation has not been studied. We examined eicosanoid generation in bone marrow-derived mast cells (BMMCs) of tg/tg mice that lack MITF. Most eicosanoids generated by BMMCs are either prostaglandin (PG) D-2 or leukotriene C-4. The former is synthesized via the cyclooxygenase pathway, whereas the latter is synthesized via the 5-lipoxygenase pathway. In response to stimulation with IgE and antigens, BMMCs of tg/tg mice synthesized leukotriene C-4 normally. However, neither immediate nor delayed PGD(2) production was detected in these BMMCs. This indicates that MITF is a transcription factor that specifically activates the cyclooxygenase pathway, but not the 5-lipoxygenase pathway. Significant decreases in expression of hematopoietic PGD(2) synthase (hPGDS, a terminal synthase for PGD(2)) were observed at both mRNA and protein levels in tg/tg BMMCs. MITF transactivated the hPGDS gene via a CACCTG motif located in the promoter region. MITF appeared to be essential for generation of PGD(2) by enhancing expression of the hPGDS gene in BMMCs.	Osaka Univ, Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan	Osaka University	Morii, E (corresponding author), Osaka Univ, Sch Med, Dept Pathol, Rm C2,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	morii@patho.med.osaka-u.ac.jp	Oboki, Keisuke/AAR-1813-2020					Diaz BL, 2002, J IMMUNOL, V168, P1397, DOI 10.4049/jimmunol.168.3.1397; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Inoue H, 2000, J BIOL CHEM, V275, P28028; Ito A, 1998, BLOOD, V91, P3210, DOI 10.1182/blood.V91.9.3210.3210_3210_3221; Jippo T, 1999, BLOOD, V93, P1942, DOI 10.1182/blood.V93.6.1942.406k08_1942_1950; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; KAWATA R, 1995, J IMMUNOL, V155, P818; Kitamura Y, 2002, MOL IMMUNOL, V38, P1173, DOI 10.1016/S0161-5890(02)00058-5; Kitamura Y, 2002, INT ARCH ALLERGY IMM, V127, P106, DOI 10.1159/000048178; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Morii E, 2004, BLOOD, V104, P1656, DOI 10.1182/blood-2004-01-0247; Morii E, 2001, BIOCHEM BIOPH RES CO, V289, P1243, DOI 10.1006/bbrc.2001.6077; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; Morii E, 1997, BLOOD, V90, P3057, DOI 10.1182/blood.V90.8.3057; Morii E, 2001, BLOOD, V97, P2038, DOI 10.1182/blood.V97.7.2038; MURAKAMI M, 1994, ANN NY ACAD SCI, V744, P84, DOI 10.1111/j.1749-6632.1994.tb52726.x; MURAKAMI M, 1995, J IMMUNOL, V155, P4445; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; OBOKI K, IN PRESS AM J PATHOL; Ogihara H, 2001, BLOOD, V97, P645, DOI 10.1182/blood.V97.3.645; RAZIN E, 1982, P NATL ACAD SCI-BIOL, V79, P4665, DOI 10.1073/pnas.79.15.4665; Reddy ST, 1997, J BIOL CHEM, V272, P3231, DOI 10.1074/jbc.272.6.3231; STEVENS RL, 1989, IMMUNOL TODAY, V10, P381, DOI 10.1016/0167-5699(89)90272-7; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200	29	27	27	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2004	279	47					48923	48929		10.1074/jbc.M407026200	http://dx.doi.org/10.1074/jbc.M407026200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	870ZP	15375155	hybrid			2022-12-27	WOS:000225098100054
J	Kayed, R; Sokolov, Y; Edmonds, B; McIntire, TM; Milton, SC; Hall, JE; Glabe, CG				Kayed, R; Sokolov, Y; Edmonds, B; McIntire, TM; Milton, SC; Hall, JE; Glabe, CG			Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; MEMBRANES; CHANNELS; AGGREGATION; MECHANISM; TOXICITY; PEPTIDE; IMPLIES	Amyloid fibrillization is multistep process involving soluble oligomeric intermediates, including spherical oligomers and protofibrils. Amyloid oligomers have a common, generic structure, and they are intrinsically toxic to cells, even when formed from non-disease related proteins, which implies they also share a common mechanism of pathogenesis and toxicity. Here we report that soluble oligomers from several types of amyloids specifically increase lipid bilayer conductance regardless of the sequence, while fibrils and soluble low molecular weight species have no effect. The increase in membrane conductance occurs without any evidence of discrete channel or pore formation or ion selectivity. The conductance is dependent on the concentration of oligomers and can be reversed by anti-oligomer antibody. These results indicate that soluble oligomers from many types of amyloidogenic proteins and peptides increase membrane conductance in a conformation-specific fashion and suggest that this may represent the common primary mechanism of pathogenesis in amyloid-related degenerative diseases.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Glabe, CG (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu	Hall, James E/K-6306-2012		NATIONAL INSTITUTE ON AGING [P50AG016573] Funding Source: NIH RePORTER; NIA NIH HHS [AG16573, AG00538] Funding Source: Medline; NINDS NIH HHS [NS31230] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; EHRING GR, 1992, J MEMBRANE BIOL, V126, P75; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hirakura Y, 1999, J NEUROSCI RES, V57, P458, DOI 10.1002/(SICI)1097-4547(19990815)57:4<458::AID-JNR5>3.0.CO;2-4; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; MATTSON MP, 1993, TRENDS NEUROSCI, V16, P409, DOI 10.1016/0166-2236(93)90009-B; Sokolov Y, 2000, J GEN PHYSIOL, V115, P571, DOI 10.1085/jgp.115.5.571	18	735	759	0	84	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2004	279	45					46363	46366		10.1074/jbc.C400260200	http://dx.doi.org/10.1074/jbc.C400260200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	867HE	15385542	hybrid			2022-12-27	WOS:000224832400004
